PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bolton, HM; Burgess, PW; Gilbert, SJ; Serpell, L				Bolton, Heather M.; Burgess, Paul W.; Gilbert, Sam J.; Serpell, Lucy			Increased Set Shifting Costs in Fasted Healthy Volunteers	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; RESTORED ANOREXIA-NERVOSA; CEREBRAL-BLOOD-FLOW; EATING-DISORDERS; BULIMIA-NERVOSA; EXECUTIVE FUNCTION; FUTURE-DIRECTIONS; CENTRAL COHERENCE; EDE-Q	We investigated the impact of temporary food restriction on a set shifting task requiring participants to judge clusters of pictures against a frequently changing rule. 60 healthy female participants underwent two testing sessions: once after fasting for 16 hours and once in a satiated state. Participants also completed a battery of questionnaires (Hospital Anxiety and Depression Scale [HADS]; Persistence, Perseveration and Perfectionism Questionnaire [PPPQ-22]; and Eating Disorders Examination Questionnaire [EDE-Q6]). Set shifting costs were significantly increased after fasting; this effect was independent of self-reported mood and perseveration. Furthermore, higher levels of weight concern predicted a general performance decrement under conditions of fasting. We conclude that relatively short periods of fasting can lead to set shifting impairments. This finding may have relevance to studies of development, individual differences, and the interpretation of psychometric tests. It also could have implications for understanding the etiology and maintenance of eating disorders, in which impaired set shifting has been implicated.	[Bolton, Heather M.; Burgess, Paul W.; Gilbert, Sam J.; Serpell, Lucy] UCL, Div Psychol & Language Sci, London, England; [Bolton, Heather M.] South London & Maudsley NHS Fdn Trust, Bethlem Royal Hosp, Beckenham, Kent, England; [Serpell, Lucy] North East London NHS Fdn Trust, Porters Ave Hlth Ctr, Dagenham, Essex, England	University of London; University College London	Bolton, HM (corresponding author), UCL, Div Psychol & Language Sci, London, England.	boltonheather@gmail.com	Gilbert, Sam J./C-1909-2008; Gilbert, Sam/V-2503-2019; Burgess, Paul W/A-1811-2010	Gilbert, Sam J./0000-0002-3839-7045; Gilbert, Sam/0000-0002-3839-7045; Serpell, Lucy/0000-0001-8543-8383	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	SJG is supported by a Royal Society University Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras WS, 2008, NORD J PSYCHIAT, V62, P19, DOI 10.1080/08039480802315632; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Benau EM, 2014, APPETITE, V77, P52, DOI 10.1016/j.appet.2014.02.014; Berkman ND, 2007, INT J EAT DISORDER, V40, P293, DOI 10.1002/eat.20369; Bissonette GB, 2013, BEHAV BRAIN RES, V250, P91, DOI 10.1016/j.bbr.2013.04.037; Brooks SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022259; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Danner UN, 2012, INT J EAT DISORDER, V45, P685, DOI 10.1002/eat.22007; Doniger GA, 2006, BEHAV NEUROSCI, V120, P804, DOI 10.1037/0735-7044.120.4.804; Duchesne Monica, 2004, Rev. Bras. Psiquiatr., V26, P107, DOI 10.1590/S1516-44462004000200008; Epling WF, 2006, INT J EAT DISORDER, V3, P27; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fairburn Christopher G., 1993, P317; Fassino S, 2002, INT J EAT DISORDER, V31, P274, DOI 10.1002/eat.10028; Giel KE, 2012, PSYCHIAT RES, V200, P538, DOI 10.1016/j.psychres.2012.06.004; Gillberg IC, 2010, J CLIN EXP NEUROPSYC, V32, P358, DOI 10.1080/13803390903066857; Gowers S, 2004, J CHILD PSYCHOL PSYC, V45, P63, DOI 10.1046/j.0021-9630.2003.00309.x; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; Ilonen T, 2000, NORD J PSYCHIAT, V54, P275, DOI 10.1080/080394800448156; Kanakam N, 2013, WORLD J BIOL PSYCHIA, V14, P464, DOI 10.3109/15622975.2012.665478; Keys A, 1950, BIOL HUMAN FASTING; Kingston K, 1996, PSYCHOL MED, V26, P15, DOI 10.1017/S0033291700033687; Kojima S, 2005, PSYCHIAT RES-NEUROIM, V140, P251, DOI 10.1016/j.pscychresns.2005.08.002; Lang K, 2014, INT J EAT DISORDER, V47, P394, DOI 10.1002/eat.22235; Lindner SE, 2014, EUR EAT DISORD REV, V22, P252, DOI 10.1002/erv.2293; Lopez C, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-40; Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;349::AID-EAT15&gt;3.0.CO;2-M; McCormick LM, 2008, INT J EAT DISORDER, V41, P602, DOI 10.1002/eat.20549; Merwin Rhonda M, 2011, Eat Disord, V19, P62, DOI 10.1080/10640266.2011.533606; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Muhlau M, 2007, AM J PSYCHIAT, V164, P1850, DOI 10.1176/appi.ajp.2007.06111861; Nikendei C, 2011, PSYCHOL MED, V41, P829, DOI 10.1017/S0033291710001121; Oberndorfer TA, 2011, INT J EAT DISORDER, V44, P1, DOI 10.1002/eat.20750; Owen L, 2013, BRIT J NUTR, V110, P1873, DOI 10.1017/S0007114513001141; Owen Lauren, 2012, Psychopharmacology (Berl), V220, P577, DOI 10.1007/s00213-011-2510-2; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Piech RM, 2009, COGNITION EMOTION, V23, P528, DOI 10.1080/02699930802012153; Pollice C, 1997, INT J EAT DISORDER, V21, P367, DOI 10.1002/(SICI)1098-108X(1997)21:4&lt;367::AID-EAT10&gt;3.0.CO;2-W; Rastam M, 2001, DEV MED CHILD NEUROL, V43, P239, DOI 10.1017/S0012162201000457; Reimers S, 2005, DEV PSYCHOL, V41, P661, DOI 10.1037/0012-1649.41.4.661; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Salbach-Andrae H, 2008, CHILD PSYCHIAT HUM D, V39, P261, DOI 10.1007/s10578-007-0086-1; SANDSON J, 1987, NEUROLOGY, V37, P1736, DOI 10.1212/WNL.37.11.1736; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; Serpell L, 2009, BEHAV THER, V40, P260, DOI 10.1016/j.beth.2008.07.001; Shott ME, 2012, EUR EAT DISORD REV, V20, P343, DOI 10.1002/erv.2172; Sidiropoulos Michael, 2007, Mcgill J Med, V10, P20; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Steinglass J, 2006, INT J EAT DISORDER, V39, P267, DOI 10.1002/eat.20244; Stewart SH, 1997, INT J EAT DISORDER, V21, P129, DOI 10.1002/(SICI)1098-108X(199703)21:2&lt;129::AID-EAT3&gt;3.0.CO;2-N; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Tchanturia K, 2002, Eat Weight Disord, V7, P312; Tchanturia K., 2010, COGNITIVE REMEDIATIO; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Tchanturia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020462; Tchanturia K, 2011, CURR TOP BEHAV NEURO, V6, P269, DOI 10.1007/7854_2010_90; Tenconi E, 2010, WORLD J BIOL PSYCHIA, V11, P813, DOI 10.3109/15622975.2010.483250; Treasure J, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-13; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Wagner A, 2006, BIOL PSYCHIAT, V59, P291, DOI 10.1016/j.biopsych.2005.06.014; Wilsdon A, 2006, J PSYCHIATR RES, V40, P746, DOI 10.1016/j.jpsychires.2005.10.006; Zakzanis KK, 2010, J NEUROPSYCHOL, V4, P89, DOI 10.1348/174866409X459674; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101946	10.1371/journal.pone.0101946	http://dx.doi.org/10.1371/journal.pone.0101946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025179	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400028
J	Marlin, D; Nicolson, SW; Yusuf, AA; Stevenson, PC; Heyman, HM; Kruger, K				Marlin, Danica; Nicolson, Susan W.; Yusuf, Abdullahi A.; Stevenson, Philip C.; Heyman, Heino M.; Krueger, Kerstin			The Only African Wild Tobacco, Nicotiana africana: Alkaloid Content and the Effect of Herbivory	PLOS ONE			English	Article							INDUCED RESPONSES; INDUCED DEFENSE; LEAF HERBIVORY; EVOLUTION; NECTAR; COSTS; RESISTANCE; TOLERANCE; PLANTS; DAMAGE	Herbivory in some Nicotiana species is known to induce alkaloid production. This study examined herbivore-induced defenses in the nornicotine-rich African tobacco N. africana, the only Nicotiana species indigenous to Africa. We tested the predictions that: 1) N. africana will have high constitutive levels of leaf, flower and nectar alkaloids; 2) leaf herbivory by the African bollworm Helicoverpa armigera will induce increased alkaloid levels in leaves, flowers and nectar; and 3) increased alkaloid concentrations in herbivore-damaged plants will negatively affect larval growth. We grew N. africana in large pots in a greenhouse and exposed flowering plants to densities of one, three and six fourth-instar larvae of H. armigera, for four days. Leaves, flowers and nectar were analyzed for nicotine, nornicotine and anabasine. The principal leaf alkaloid was nornicotine (mean: 28 mu g/g dry mass) followed by anabasine (4.9 mu g/g) and nicotine (0.6 mu g/g). Nornicotine was found in low quantities in the flowers, but no nicotine or anabasine were recorded. The nectar contained none of the alkaloids measured. Larval growth was reduced when leaves of flowering plants were exposed to six larvae. As predicted by the optimal defense theory, herbivory had a localized effect and caused an increase in nornicotine concentrations in both undamaged top leaves of herbivore damaged plants and herbivore damaged leaves exposed to one and three larvae. The nicotine concentration increased in damaged compared to undamaged middle leaves. The nornicotine concentration was lower in damaged leaves of plants exposed to six compared to three larvae, suggesting that N. africana rather invests in new growth as opposed to protecting older leaves under severe attack. The results indicate that the nornicotine-rich N. africana will be unattractive to herbivores and more so when damaged, but that potential pollinators will be unaffected because the nectar remains alkaloid-free even after herbivory.	[Marlin, Danica; Nicolson, Susan W.; Yusuf, Abdullahi A.; Krueger, Kerstin] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Stevenson, Philip C.] Royal Bot Gardens, Richmond, Surrey, England; [Stevenson, Philip C.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England; [Heyman, Heino M.; Krueger, Kerstin] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa	University of Pretoria; Royal Botanic Gardens, Kew; University of Greenwich; University of Pretoria	Kruger, K (corresponding author), Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	kkruger@zoology.up.ac.za	Krüger, Kerstin/A-6082-2011; Yusuf, Abdullahi Ahmed/E-4701-2011; Marlin, Danica/AAW-3988-2021; stevenson, philip c/E-8741-2013; Marlin, Danica/J-4218-2019; Heyman, Heino Martin/I-1670-2014; Stevenson, Philip C/E-8822-2013	Krüger, Kerstin/0000-0001-6357-1589; Yusuf, Abdullahi Ahmed/0000-0002-8625-6490; Marlin, Danica/0000-0003-3153-5246; stevenson, philip c/0000-0002-0736-3619; Heyman, Heino Martin/0000-0003-0941-2506; Stevenson, Philip C/0000-0002-0736-3619; Nicolson, Susan/0000-0001-6024-9383	National Research Foundation of South Africa [73671]; University of Pretoria; BBSRC [BB/I000445/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000445/1] Funding Source: researchfish	National Research Foundation of South Africa(National Research Foundation - South Africa); University of Pretoria; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the National Research Foundation of South Africa (73671) and the University of Pretoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Baldwin IT, 1999, J CHEM ECOL, V25, P3, DOI 10.1023/A:1020880931488; BALDWIN IT, 1988, J CHEM ECOL, V14, P1113, DOI 10.1007/BF01019339; BALDWIN IT, 1994, OECOLOGIA, V97, P424, DOI 10.1007/BF00317335; BALDWIN IT, 1993, J CHEM ECOL, V19, P1143, DOI 10.1007/BF00987376; BALDWIN IT, 1988, OECOLOGIA, V75, P367, DOI 10.1007/BF00376939; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Cherry Andy, 2003, P329, DOI 10.1079/9780851996394.0329; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; CORESTA, 2009, SCAL COD GROWTH STAG; Craven P, 2004, NICOTIANA AFRICANA; Dobson A.J., 2013, INTRO STAT MODELLING; Euler M, 1996, OECOLOGIA, V107, P102, DOI 10.1007/BF00582240; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Giess W, 1982, DINTERIA, V16, P11; Goodspeed TH, 1954, CHRONICA BOT; Halpern SL, 2010, OECOLOGIA, V163, P961, DOI 10.1007/s00442-010-1651-z; Heil M, 2001, EUR J PLANT PATHOL, V107, P137, DOI 10.1023/A:1008793009517; Heil M, 2010, EVOL ECOL, V24, P555, DOI 10.1007/s10682-009-9348-7; Hoft M, 1996, OECOLOGIA, V107, P160, DOI 10.1007/BF00327899; JEFFREY RN, 1964, PLANT PHYSIOL, V39, P480, DOI 10.1104/pp.39.3.480; Kaplan I, 2008, J CHEM ECOL, V34, P1349, DOI 10.1007/s10886-008-9541-0; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Ladiges PY, 2011, J BIOGEOGR, V38, P2066, DOI 10.1111/j.1365-2699.2011.02554.x; Leete, 1983, ALKALOIDS CHEM BIOL, V1, P85; Lerch-Henning S, 2013, J AVIAN BIOL, V44, P408, DOI 10.1111/j.1600-048X.2013.00079.x; Manson JS, 2013, J ECOL, V101, P1604, DOI 10.1111/1365-2745.12144; McCall AC, 2006, OECOLOGIA, V146, P566, DOI 10.1007/s00442-005-0284-0; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Meier U., 2018, GROWTH STAGES MONOAN, DOI [10.5073/20180906-074619, DOI 10.5073/20180906-074619]; NARAYAN RKJ, 1987, PLANT SYST EVOL, V157, P161, DOI 10.1007/BF00936195; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Ohnmeiss TE, 1997, NEW PHYTOL, V137, P441, DOI 10.1046/j.1469-8137.1997.00845.x; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Payne R., 2012, INTRO GENSTAT WINDOW; Preisser EL, 2007, ACTA OECOL, V31, P210, DOI 10.1016/j.actao.2006.09.004; Purrington CB, 2000, CURR OPIN PLANT BIOL, V3, P305, DOI 10.1016/S1369-5266(00)00085-6; Raguso RA, 2006, PHYTOCHEMISTRY, V67, P1931, DOI 10.1016/j.phytochem.2006.05.038; Richardson CH, 1936, J ECON ENTOMOL, V29, P850, DOI 10.1093/jee/29.5.850; SAITOH F, 1985, PHYTOCHEMISTRY, V24, P477, DOI 10.1016/S0031-9422(00)80751-7; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; SEVERSON RF, 1988, J CHEM ECOL, V14, P1485, DOI 10.1007/BF01012420; SISSON VA, 1990, BEITR TABAKFORSCH, V14, P327, DOI 10.2478/cttr-2013-0610; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Van Dam NM, 2001, ECOL ENTOMOL, V26, P578, DOI 10.1046/j.1365-2311.2001.00366.x; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; YANG RSH, 1969, ANN ENTOMOL SOC AM, V62, P141, DOI 10.1093/aesa/62.1.141; Zangerl A. R., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P363; Zangerl AR, 2003, BASIC APPL ECOL, V4, P91, DOI 10.1078/1439-1791-00135	56	11	12	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102661	10.1371/journal.pone.0102661	http://dx.doi.org/10.1371/journal.pone.0102661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025217	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000339992400099
J	Walter, S; Glymour, M; Avendano, M				Walter, Stefan; Glymour, Maria; Avendano, Mauricio			The Health Effects of US Unemployment Insurance Policy: Does Income from Unemployment Benefits Prevent Cardiovascular Disease?	PLOS ONE			English	Article							INVOLUNTARY JOB LOSS; CORONARY-HEART-DISEASE; RETIREMENT SURVEY; MYOCARDIAL-INFARCTION; OLDER WORKERS; DEPRESSIVE SYMPTOMS; FINNISH MEN; ILL HEALTH; STROKE; RISK	Objective: Previous studies suggest that unemployment predicts increased cardiovascular disease (CVD) risk, but whether unemployment insurance programs mitigate this risk has not been assessed. Exploiting US state variations in unemployment insurance benefit programs, we tested the hypothesis that more generous benefits reduce CVD risk. Methods: Cohort data came from 16,108 participants in the Health and Retirement Study (HRS) aged 50-65 at baseline interviewed from 1992 to 2010. Data on first and recurrent CVD diagnosis assessed through biennial interviews were linked to the generosity of unemployment benefit programmes in each state and year. Using state fixed-effect models, we assessed whether state changes in the generosity of unemployment benefits predicted CVD risk. Results: States with higher unemployment benefits had lower incidence of CVD, so that a 1% increase in benefits was associated with 18% lower odds of CVD (OR: 0.82, 95%-CI: 0.71-0.94). This association remained after introducing US census regional division fixed effects, but disappeared after introducing state fixed effects (OR: 1.02, 95%-CI: 0.79-1.31). This was consistent with the fact that unemployment was not associated with CVD risk in state-fixed effect models. Conclusion: Although states with more generous unemployment benefits had lower CVD incidence, this appeared to be due to confounding by state-level characteristics. Possible explanations are the lack of short-term effects of unemployment on CVD risk. Future studies should assess whether benefits at earlier stages of the life-course influence long-term risk of CVD.	[Walter, Stefan; Glymour, Maria; Avendano, Mauricio] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Walter, Stefan] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands; [Walter, Stefan] Erasmus Univ, Dept Epidemiol, Med Ctr, Rotterdam, Netherlands; [Glymour, Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Avendano, Mauricio] Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, London WC2A 2AE, England	Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; University of London; London School Economics & Political Science	Walter, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	swalter@hsph.harvard.edu	Avendano, Mauricio/C-9658-2018	Avendano, Mauricio/0000-0002-7295-2911; Glymour, M. Maria/0000-0001-9644-3081; Walter, Stefan/0000-0002-6010-7550	Robert Wood Johnsons Foundation	Robert Wood Johnsons Foundation	Stefan Walter and Mauricio Avedano were supported by a Robert Wood Johnsons Foundation seed grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano M, 2008, STROKE, V39, P1533, DOI 10.1161/STROKEAHA.107.490383; Bartley M, 2010, J EPIDEMIOL COMMUN H, V64, P5, DOI 10.1136/jech.2009.089797; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Chan S, 1999, AM ECON REV, V89, P211, DOI 10.1257/aer.89.2.211; Clemens Tom, 2009, Health Stat Q, P7; Deb P, 2011, J HEALTH ECON, V30, P317, DOI 10.1016/j.jhealeco.2010.12.009; Falba T, 2005, ADDICTION, V100, P1330, DOI 10.1111/j.1360-0443.2005.01150.x; Gallo WT, 2006, OCCUP ENVIRON MED, V63, P683, DOI 10.1136/oem.2006.026823; Gallo WT, 2006, INT ARCH OCC ENV HEA, V80, P109, DOI 10.1007/s00420-006-0108-5; Gallo WT, 2006, J GERONTOL B-PSYCHOL, V61, pS221, DOI 10.1093/geronb/61.4.S221; Gallo WT, 2009, RES AGING, V31, P345, DOI 10.1177/0164027508330722; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Gallo WT, 2001, J GERONTOL B-PSYCHOL, V56, pS3, DOI 10.1093/geronb/56.1.S3; Glymour MM, 2009, STROKE, V40, P873, DOI 10.1161/STROKEAHA.108.529479; Grimaud O, 2011, AGE AGEING, V40, P116, DOI 10.1093/ageing/afq142; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Herd P, 2008, MILBANK Q, V86, P5, DOI 10.1111/j.1468-0009.2007.00512.x; Hintikka J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-410; JACOBSON LS, 1993, AM ECON REV, V83, P685; Johnson Richard W., 2013, FINANCIAL CONSEQUENC; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; KAWACHI I, 1994, CIRCULATION, V89, P1992, DOI 10.1161/01.CIR.89.5.1992; KUBZANSKY LD, 2000, SOCIAL EPIDEMIOLOGY, P213; Lindahl M, 2005, J HUM RESOUR, V40, P144, DOI 10.3368/jhr.XL.1.144; Lundin A, 2010, J EPIDEMIOL COMMUN H, V64, P22, DOI 10.1136/jech.2008.079269; Mandal B, 2011, SOC SCI MED, V72, P576, DOI 10.1016/j.socscimed.2010.11.014; Martikainen P, 2007, AM J EPIDEMIOL, V165, P1070, DOI 10.1093/aje/kwm057; MARTIKAINEN PT, 1990, BMJ-BRIT MED J, V301, P407, DOI 10.1136/bmj.301.6749.407; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Sjolander P, 2008, SCAND J PUBLIC HEALT, V36, P84, DOI 10.1177/1403494807085305; Smith JP, 2007, J HUM RESOUR, V42, P739; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Toivanen S, 2011, SCAND J PUBLIC HEALT, V39, P797, DOI 10.1177/1403494811418280; Vroman, 2001, LOW BENEFIT RECIPIEN; Vroman W., 2009, MON LABOR REV; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101193	10.1371/journal.pone.0101193	http://dx.doi.org/10.1371/journal.pone.0101193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025281	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400010
J	Adham, M; Stoker, SD; Wildeman, MA; Rachmadi, L; Gondhowiardjo, S; Atmakusumah, D; Gatot, D; Fles, R; Greijer, AE; Hermani, B; Middeldorp, JM; Tan, IB				Adham, Marlinda; Stoker, Sharon D.; Wildeman, Maarten A.; Rachmadi, Lisnawati; Gondhowiardjo, Soehartati; Atmakusumah, Djumhana; Gatot, Djayadiman; Fles, Renske; Greijer, Astrid E.; Hermani, Bambang; Middeldorp, Jaap M.; Tan, I. Bing			Current Status of Cancer Care for Young Patients with Nasopharyngeal Carcinoma in Jakarta, Indonesia	PLOS ONE			English	Article							CHILDREN; RADIOTHERAPY; MANAGEMENT	Background: Nasopharyngeal carcinoma (NPC) is endemic in Indonesia and 20% of the patients are diagnosed before the age of 31. This study evaluates presentation and treatment outcome of young patients in Jakarta, in a tertiary referral centre. Methods: Forty-nine patients under the age of 31, diagnosed with NPC between July 2004 and January 2007, were evaluated. Baseline data included histological type, stage of disease and presenting symptoms. We intended to follow all patients after diagnosis to reveal treatment outcome and overall survival (OS). Results: All but two patients had advanced stage disease (94%), 7 (14%) had distant metastasis. The median interval between start of complaints and diagnosis was 9 months. Forty-two patients were planned for curative intent treatment. Eleven patients (26%) never started treatment, 2 patients did not complete treatment and 3 patients did not return after finishing treatment. Four patients died before radiation could start. Three patients died within 4 months after treatment. Nine patients (21%) had a complete response. Due to the high number of patients who were lost to follow-up (LFU), OS was analyzed as follows: a best-case (patients censored at last contact) and a worst-case scenario (assuming that patients who did not finish treatment or had disease at last contact would have died). The 2-year OS for patients without distant metastases was 39-71%. Conclusion: Treatment outcome for young patients with NPC in this institute was poor. Improvement can be achieved when NPC is diagnosed at an earlier stage and when there is better treatment compliance.	[Adham, Marlinda; Rachmadi, Lisnawati; Gondhowiardjo, Soehartati; Atmakusumah, Djumhana; Hermani, Bambang] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Gatot, Djayadiman] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Med Oncol Pediat Dept, Jakarta, Indonesia; [Stoker, Sharon D.; Wildeman, Maarten A.; Fles, Renske; Tan, I. Bing] Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Greijer, Astrid E.; Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Tan, I. Bing] Gadjah Mada Univ, Ear Nose & Throat Dept, Yogyakarta, Indonesia; [Wildeman, Maarten A.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands; [Tan, I. Bing] Univ Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, NL-1105 AZ Amsterdam, Netherlands	University of Indonesia; University of Indonesia; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Gadjah Mada University; University of Amsterdam; Academic Medical Center Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Tan, IB (corresponding author), Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands.	I.tan@nki.nl		Adham, Marlinda/0000-0003-2461-9628; Middeldorp, Jaap Michiel/0000-0002-0765-4125	Dutch Cancer Society [KWF-VUmc IN2006-21]	Dutch Cancer Society(KWF Kankerbestrijding)	This study was sponsored by a grant of the Dutch Cancer Society, project number KWF-VUmc IN2006-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Akimoto T, 1997, JPN J CLIN ONCOL, V27, P240, DOI 10.1093/jjco/27.4.240; Ayan I, 2003, LANCET ONCOL, V4, P13, DOI 10.1016/S1470-2045(03)00956-2; Ayan I, 1996, INT J RADIAT ONCOL, V35, P485, DOI 10.1016/0360-3016(96)00018-1; Buehrlen M, 2012, CANCER-AM CANCER SOC, V118, P4892, DOI 10.1002/cncr.27395; Cheuk DKL, 2011, CANCER-AM CANCER SOC, V117, P197, DOI 10.1002/cncr.25376; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; Downing NL, 2009, INT J RADIAT ONCOL, V75, P1064, DOI 10.1016/j.ijrobp.2008.12.030; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fles R, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-81; Gondhowiardjo Sa, 2008, Biomed Imaging Interv J, V4, pe42, DOI 10.2349/biij.4.3.e42; Ho KY, 2008, J OTOLARYNGOL-HEAD N, V37, P362, DOI 10.2310/7070.2008.0071; Hutajulu SH, 2012, THESIS; Ji Ming-fang, 2011, Chin J Cancer, V30, P120; Kimman M, 2012, ASIAN PAC J CANCER P, V13, P411, DOI 10.7314/APJCP.2012.13.2.411; Laskar S, 2004, INT J RADIAT ONCOL, V58, P189, DOI 10.1016/S0360-3016(03)00773-9; Lee A. W. M., 1997, Hong Kong Medical Journal, V3, P355; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Mertens R, 2005, CANCER-AM CANCER SOC, V104, P1083, DOI 10.1002/cncr.21258; Ozyar E, 2006, RADIOTHER ONCOL, V81, P39, DOI 10.1016/j.radonc.2006.08.019; Platek ME, 2012, HEAD NECK-J SCI SPEC, V35, P684; Satriana S, 2012, SOCIAL PROTECTION AS; Slotman BJ, 2005, RADIOTHER ONCOL, V75, P349, DOI 10.1016/j.radonc.2004.12.005; Stoker SD, 2014, PLOS ONE, V23; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Wildeman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032756; Wildeman MA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-190; Wolden SL, 2000, INT J RADIAT ONCOL, V46, P859, DOI 10.1016/S0360-3016(99)00493-9	31	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102353	10.1371/journal.pone.0102353	http://dx.doi.org/10.1371/journal.pone.0102353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019625	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600072
J	Huang, CM; Lin, M; Chen, QY; Lin, JX; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lu, J				Huang, Changming; Lin, Mi; Chen, Qiyue; Lin, Jianxian; Zheng, Chaohui; Li, Ping; Xie, Jianwei; Wang, Jiabin; Lu, Jun			A Modified Delta-Shaped Gastroduodenostomy in Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: A Safe and Feasible Technique	PLOS ONE			English	Article							BILLROTH-I GASTRECTOMY; EXTRACORPOREAL GASTRODUODENOSTOMY; ASSISTED GASTRECTOMY; TERM OUTCOMES; INTRACORPOREAL; ANASTOMOSIS; METAANALYSIS; MULTICENTER; EXPERIENCE; TRIAL	Background: The present study introduced a modified delta-shaped gastroduodenostomy (DSG) technique and assessed the safety, feasibility and clinical results of this procedure in patients undergoing totally laparoscopic distal gastrectomy (TLDG) for gastric cancer (GC). Materials and Methods: A total of 102 patients with distal GC undergoing TLDG with modified DSG between January 2013 and December 2013 were enrolled. A retrospective study was performed using a prospectively maintained comprehensive database to evaluate the results of the procedure. Univariate and multivariate analyses were performed to estimate the predictive factors for postoperative morbidity. Results: The mean operation time was 150.6 +/- 30.2 min, the mean anastomosis time was 12.2 +/- 4.2 min, the mean blood loss was 48.2 +/- 33.2 ml, and the mean times to first flatus, fluid diet, soft diet and postoperative hospital stay were 3.8 +/- 1.3 days, 5.0 +/- 1.0 days, 7.4 +/- 2.1 days and 12.0 +/- 6.5 days, respectively. Two patients with minor anastomotic leakage after surgery were managed conservatively; no patient experienced any complications around the anastomosis, such as anastomotic stricture or anastomotic hemorrhage. Univariate analysis showed that age, gastric cancer with hemorrhage and cardiovascular disease combined were significant factors that affected postoperative morbidity (P<0.05). Multivariate analysis found that gastric cancer with hemorrhage was the independent risk factor for the postoperative morbidity (P = 0.042). At a median follow-up of 7 months, no patients had died or experienced recurrent or metastatic disease. Conclusions: The modified DSG was technically safe and feasible, with acceptable surgical outcomes, in patients undergoing TLDG for GC, and this procedure may be promising in these patients.	[Huang, Changming; Lin, Mi; Chen, Qiyue; Lin, Jianxian; Zheng, Chaohui; Li, Ping; Xie, Jianwei; Wang, Jiabin; Lu, Jun] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China.	hcmlr2002@163.com	Zheng, Chao-hui/HGE-3348-2022; Li, Ping/GYV-4914-2022	Zheng, Chao-hui/0000-0001-8680-3127; 	National Key Clinical Specialty Discipline Construction program of China [[2012]649]	National Key Clinical Specialty Discipline Construction program of China	The authors were funded by the National Key Clinical Specialty Discipline Construction program of China (No. [2012]649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hamabe A, 2012, SURG ENDOSC, V26, P1702, DOI 10.1007/s00464-011-2096-0; Huang Chang-ming, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P121; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Ikeda O, 2009, SURG ENDOSC, V23, P2374, DOI 10.1007/s00464-009-0360-3; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kanaya S, 2002, J AM COLL SURGEONS, V195, P284, DOI 10.1016/S1072-7515(02)01239-5; Kanaya S, 2011, GASTRIC CANCER, V14, P365, DOI 10.1007/s10120-011-0054-0; Kim BS, 2011, J LAPAROENDOSC ADV S, V21, P387, DOI 10.1089/lap.2010.0515; Kim DG, 2013, SURG ENDOSC, V27, P3153, DOI 10.1007/s00464-013-2869-8; Kim JJ, 2008, SURG ENDOSC, V22, P436, DOI 10.1007/s00464-007-9446-y; Kim KH, 2012, DIGEST SURG, V29, P165, DOI 10.1159/000338088; Kim MG, 2011, WORLD J SURG, V35, P1327, DOI 10.1007/s00268-011-1034-6; Kim MG, 2011, SURG ENDOSC, V25, P1076, DOI 10.1007/s00464-010-1319-0; Kim YW, 2008, ANN SURG, V248, P721, DOI 10.1097/SLA.0b013e318185e62e; Kinoshita T, 2011, SURG ENDOSC, V25, P1395, DOI 10.1007/s00464-010-1402-6; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Lee SW, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-267; Noshiro H, 2011, GASTRIC CANCER, V14, P385, DOI 10.1007/s10120-011-0082-9; Okabe H, 2013, ANN SURG, P1; Park DJ, 2012, SURG ENDOSC, V26, P1548, DOI 10.1007/s00464-011-2065-7; Qiu JG, 2013, SURG LAPARO ENDO PER, V23, P1, DOI 10.1097/SLE.0b013e3182747af7; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z	23	17	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102736	10.1371/journal.pone.0102736	http://dx.doi.org/10.1371/journal.pone.0102736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019646	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600098
J	Kushnir, VA; Yu, Y; Barad, DH; Weghofer, A; Himaya, E; Lee, HJ; Wu, YG; Shohat-Tal, A; Lazzaroni-Tealdi, E; Gleicher, N				Kushnir, Vitaly A.; Yu, Yao; Barad, David H.; Weghofer, Andrea; Himaya, Eric; Lee, Ho-Joon; Wu, Yan-Guang; Shohat-Tal, Aya; Lazzaroni-Tealdi, Emanuela; Gleicher, Norbert			Utilizing FMR1 Gene Mutations as Predictors of Treatment Success in Human In Vitro Fertilization	PLOS ONE			English	Article							OVARIAN AGING PATTERNS; SIZED CGG REPEAT; INTERMEDIATE; RESERVE; DONORS	Context: Mutations of the fragile X mental retardation 1 (FMR1) gene are associated with distinct ovarian aging patterns. Objective: To confirm in human in vitro fertilization (IVF) that FMR1 affects outcomes, and to determine whether this reflects differences in ovarian aging between FMR1 mutations, egg/embryo quality or an effect on implantation. Design, Setting, Patients: IVF outcomes were investigated in a private infertility center in reference to patients' FMR1 mutations based on a normal range of CGG(n=26-34) and sub-genotypes high (CGG(n>34)) and low (CGG(<26)). The study included 3 distinct sections and study populations: (i) A generalized mixed-effects model of morphology (777 embryos, 168 IVF cycles, 125 infertile women at all ages) investigated whether embryo quality is associated with FMR1; (ii) 1041 embryos in 149 IVF cycles in presumed fertile women assessed whether the FMR1 gene is associated with aneuploidy; (iii) 352 infertile patients (< age 38; in 1st IVF cycles) and 179 donor-recipient cycles, assessed whether the FMR1 gene affects IVF pregnancy chances via oocyte/embryo quality or non-oocyte maternal factors. Interventions: Standardized IVF protocols. Main Outcome Measures: Morphologic embryo quality, ploidy and pregnancy rates. Results: (i) Embryo morphology was reduced in presence of a low FMR1 allele (P = 0.032). In absence of a low allele, the odds ratio (OR) of chance of good (vs. fair/poor) embryos was 1.637. (ii) FMR1 was not associated with aneuploidy, though aneuploidy increased with female age. (iii) Recipient pregnancy rates were neither associated with donor age or donor FMR1. In absence of a low FMR1 allele, OR of clinical pregnancy (vs. chemical or no pregnancy) was 2.244 in middle-aged infertility patients. Conclusions: A low FMR1 allele (CGG(<26)) is associated with significantly poorer morphologic embryo quality and pregnancy chance. As women age, low FMR1 alleles affect IVF pregnancy chances by reducing egg/embryo quality by mechanisms other than embryo aneuploidy.	[Kushnir, Vitaly A.; Yu, Yao; Barad, David H.; Weghofer, Andrea; Lee, Ho-Joon; Wu, Yan-Guang; Shohat-Tal, Aya; Lazzaroni-Tealdi, Emanuela; Gleicher, Norbert] Ctr Human Reprod, New York, NY 10021 USA; [Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY USA; [Weghofer, Andrea] Univ Vienna, Sch Med, Dept Obstet & Gynecol, Vienna, Austria; [Himaya, Eric] McGill Univ, Gatineau Hosp, Quebec City, PQ, Canada	University of Vienna; McGill University	Kushnir, VA (corresponding author), Ctr Human Reprod, New York, NY 10021 USA.	vkushnir@thechr.com	Barad, David/AAF-4332-2021; Yu, Yao/O-3224-2016		Foundation for Reproductive Medicine and Center for Human Reproduction	Foundation for Reproductive Medicine and Center for Human Reproduction	This work was supported by Foundation for Reproductive Medicine and Center for Human Reproduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Ferder I, 2013, REPRODUCTION, V145, P335, DOI 10.1530/REP-12-0305; Fragouli E, 2012, SEMIN REPROD MED, V30, P289, DOI 10.1055/s-0032-1313908; Gleicher N, 2012, HUM REPROD, V27, P2; Gleicher N, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-80; Gleicher N, 2013, HUM REPROD, V28, P1084, DOI 10.1093/humrep/det033; Gleicher N, 2012, J ASSIST REPROD GEN, V29, P1159, DOI 10.1007/s10815-012-9871-2; Gleicher N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-77; Gleicher N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033638; Gleicher N, 2012, J AUTOIMMUN, V38, pJ74, DOI 10.1016/j.jaut.2011.05.016; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Gleicher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-140; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Gleicher NN, 2012, HUM REPROD, V27, P2241, DOI 10.1093/humrep/des161; Goto S, 2011, FERTIL STERIL, V95, P948, DOI 10.1016/j.fertnstert.2010.06.067; Kushnir VA, 2013, FERTIL STERIL, V100, pS114, DOI 10.1016/j.fertnstert.2013.07.1656; Lledo B, 2012, HUM REPROD, V27, P609, DOI 10.1093/humrep/der415; Sen A, 2014, NAT REV ENDOCRINOL, V10, P37, DOI 10.1038/nrendo.2013.212; Setti AS, 2011, EUR J OBSTET GYN R B, V159, P364, DOI 10.1016/j.ejogrb.2011.07.031	23	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102274	10.1371/journal.pone.0102274	http://dx.doi.org/10.1371/journal.pone.0102274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019151	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600058
J	Marti, H; Koschwanez, M; Pesch, T; Blenn, C; Borel, N				Marti, Hanna; Koschwanez, Maria; Pesch, Theresa; Blenn, Christian; Borel, Nicole			Water-Filtered Infrared A Irradiation in Combination with Visible Light Inhibits Acute Chlamydial Infection	PLOS ONE			English	Article							ENDOCERVICAL EPITHELIAL-CELLS; TRACHOMATIS INFECTION; HELA-CELLS; HOST-CELLS; EXPRESSION; SECRETION; CYTOKINE; RESISTANCE; PERSISTENCE; ACTIVATION	New therapeutic strategies are needed to overcome drawbacks in treatment of infections with intracellular bacteria. Chlamydiaceae are Gram-negative bacteria implicated in acute and chronic diseases such as abortion in animals and trachoma in humans. Water-filtered infrared A (wIRA) is short wavelength infrared radiation with a spectrum ranging from 780 to 1400 nm. In clinical settings, wIRA alone and in combination with visible light (VIS) has proven its efficacy in acute and chronic wound healing processes. This is the first study to demonstrate that wIRA irradiation combined with VIS (wIRA/VIS) diminishes recovery of infectious elementary bodies (EBs) of both intra-and extracellular Chlamydia (C.) in two different cell lines (Vero, HeLa) regardless of the chlamydial strain (C. pecorum, C. trachomatis serovar E) as shown by indirect immunofluorescence and titration by subpassage. Moreover, a single exposure to wIRA/VIS at 40 hours post infection (hpi) led to a significant reduction of C. pecorum inclusion frequency in Vero cells and C. trachomatis in HeLa cells, respectively. A triple dose of irradiation (24, 36, 40 hpi) during the course of C. trachomatis infection further reduced chlamydial inclusion frequency in HeLa cells without inducing the chlamydial persistence/stress response, as ascertained by electron microscopy. Irradiation of host cells (HeLa, Vero) neither affected cell viability nor induced any molecular markers of cytotoxicity as investigated by Alamar blue assay and Western blot analysis. Chlamydial infection, irradiation, and the combination of both showed a similar release pattern of a subset of pro-inflammatory cytokines (MIF/GIF, Serpin E1, RANTES, IL-6, IL-8) and chemokines (IL-16, IP-10, ENA-78, MIG, MIP-1 alpha/beta) from host cells. Initial investigation into the mechanism indicated possible thermal effects on Chlamydia due to irradiation. In summary, we demonstrate a non-chemical reduction of chlamydial infection using the combination of water-filtered infrared A and visible light.	[Marti, Hanna; Koschwanez, Maria; Borel, Nicole] Univ Zurich Vetsuisse, Inst Vet Pathol, Zurich, Switzerland; [Pesch, Theresa; Blenn, Christian] Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Zurich; University of Zurich	Borel, N (corresponding author), Univ Zurich Vetsuisse, Inst Vet Pathol, Zurich, Switzerland.	n.borel@access.uzh.ch	Borel, Nicole/GPP-1073-2022; Marti, Hanna/AAA-3955-2021; Borel, Nicole/M-6204-2016	Borel, Nicole/0000-0002-1556-9262; Marti, Hanna/0000-0002-8398-4708; Borel, Nicole/0000-0002-1556-9262	Dr. Erwin Braun Foundation, Basel, Switzerland	Dr. Erwin Braun Foundation, Basel, Switzerland	This work was financially supported by the Dr. Erwin Braun Foundation, Basel, Switzerland, awarded to Christian Blenn and Nicole Borel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AA., 2010, PATHOGENESIS BACTERI, P575; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; Blenn C, 2011, CELL MOL LIFE SCI, V68, P1455, DOI 10.1007/s00018-010-0533-1; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Borel N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-201; Buckner LR, 2013, CYTOKINE, V63, P151, DOI 10.1016/j.cyto.2013.04.022; Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chancey ST, 2012, FUTURE MICROBIOL, V7, P959, DOI [10.2217/fmb.12.63, 10.2217/FMB.12.63]; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Cunha LD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00076; Dean D, 2013, EMERG INFECT DIS, V19, P1948, DOI 10.3201/eid1912.130656; Deka S, 2006, CELL MICROBIOL, V8, P149, DOI 10.1111/j.1462-5822.2005.00608.x; Dessus-Babus S, 2000, CELL MICROBIOL, V2, P317, DOI 10.1046/j.1462-5822.2000.00058.x; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Di Paolo NC, 2014, METHODS MOL BIOL, V1089, P133, DOI 10.1007/978-1-62703-679-5_10; Dreses-Werringloer U, 2003, ANTIMICROB AGENTS CH, V47, P2316, DOI 10.1128/AAC.47.7.2316-2318.2003; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Ermolaeva SA, 2012, J MED MICROBIOL, V61, P793, DOI 10.1099/jmm.0.038117-0; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; GALASSO GJ, 1961, J IMMUNOL, V86, P382; Gervassi A, 2004, INFECT IMMUN, V72, P7231, DOI 10.1128/IAI.72.12.7231-7239.2004; Guseva NV, 2007, INFECT IMMUN, V75, P553, DOI 10.1128/IAI.01517-06; Hammerschlag MR, 2012, EXPERT OPIN PHARMACO, V13, P545, DOI 10.1517/14656566.2012.658776; Hartel M, 2006, BRIT J SURG, V93, P952, DOI 10.1002/bjs.5429; Hoffmann G, 2007, GMS KRANKENHHYG INTE, V2, pDoc54; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Jung T, 2010, FREE RADICAL BIO MED, V48, P153, DOI 10.1016/j.freeradbiomed.2009.10.036; KAHANE S, 1992, FEMS MICROBIOL LETT, V97, P25; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kutlin A, 2005, ANTIMICROB AGENTS CH, V49, P903, DOI 10.1128/AAC.49.3.903-907.2005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maxion HK, 2002, INFECT IMMUN, V70, P1538, DOI 10.1128/IAI.70.3.1538-1546.2002; Mohamad KY, 2010, VET RES, V41, DOI 10.1051/vetres/2009075; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Rank RG, 2010, INFECT IMMUN, V78, P536, DOI 10.1128/IAI.00772-09; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; Schachter J., 1999, CHLAMYDIA, P156; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schieke SM, 2002, J INVEST DERMATOL, V119, P1323, DOI 10.1046/j.1523-1747.2002.19630.x; Schoborg RV, 2011, MICROBES INFECT, V13, P649, DOI 10.1016/j.micinf.2011.03.004; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Shah A, 2002, INT J HYPERTHER, V18, P534, DOI 10.1080/02656730210157843; Suchland RJ, 2005, ANTIMICROB AGENTS CH, V49, P1120, DOI 10.1128/AAC.49.3.1120-1126.2005; Tormakangas L, 2010, INFECT IMMUN, V78, P2714, DOI 10.1128/IAI.01456-09; Wasson CJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-176; Wright J, 2013, MED CLIN N AM, V97, P667, DOI 10.1016/j.mcna.2013.02.006; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102239	10.1371/journal.pone.0102239	http://dx.doi.org/10.1371/journal.pone.0102239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019934	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000339618600056
J	Shao, HW; Ou, YS; Wang, T; Shen, H; Wu, FL; Zhang, WF; Tao, CL; Yuan, Y; Bo, HB; Wang, H; Huang, SL				Shao, Hongwei; Ou, Yusheng; Wang, Teng; Shen, Han; Wu, Fenglin; Zhang, Wenfeng; Tao, Changli; Yuan, Yin; Bo, Huaben; Wang, Hui; Huang, Shulin			Differences in TCR-V beta Repertoire and Effector Phenotype between Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes Increase with Age	PLOS ONE			English	Article							T-CELL GENERATION; IMMUNE-SYSTEM; GENE USAGE; MELANOMA; CD8; CD4(+); CANCER; MICROENVIRONMENT; DIVERSITY; SEQUENCES	Tumor infiltrating lymphocytes (TIL) reflect the host's anti-tumor immune response, and can be a valuable predictor of prognosis. However, many properties of TIL are not fully understood. In the present study, TCR-V beta repertoires of cancer patients were primarily analyzed by flow cytometry. Abnormally expressed TCR-V beta subfamilies were generally found in both TIL and peripheral blood lymphocytes (PBL) of each patient. Of note, increased patient age was associated with increasingly biased TCR-V beta repertoire in TIL but not in PBL, and the dispersion degree of the differences of TCR-V beta subfamilies between TIL and PBL correlated positively with age (P = 0.007). Utilizing immunoscope analysis, we identified the age-related reduction in TCR-V beta diversity, but polyclonal pattern was predominant in significantly expanded TCR-V beta subfamilies. In addition, we found that older patients possessed a decreased ratio of CD8(+)CD62L(+) non-effector cells in TIL compared to PBL, implying age-related increase of CD8(+)CD62L(-) effector cells in TIL. The colocalization analysis of CD8 and CD3, however, suggested the suppressed activity of these effector cells in tumor microenvironment. These findings further elucidate the properties of TIL, showing an increasing difference between TIL and PBL with age, which may provide insight for the development of effective immunotherapies for cancer patients of different ages.	[Shao, Hongwei; Ou, Yusheng; Wang, Teng; Shen, Han; Wu, Fenglin; Zhang, Wenfeng; Tao, Changli; Yuan, Yin; Bo, Huaben; Wang, Hui; Huang, Shulin] Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou, Guangdong, Peoples R China; [Shao, Hongwei; Ou, Yusheng; Wang, Teng; Shen, Han; Wu, Fenglin; Zhang, Wenfeng; Tao, Changli; Yuan, Yin; Bo, Huaben; Wang, Hui; Huang, Shulin] Guangdong Pharmaceut Univ, Sch Biosci & Biopharmaceut, Guangzhou, Guangdong, Peoples R China; [Huang, Shulin] Southern Med Univ, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Southern Medical University - China	Huang, SL (corresponding author), Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou, Guangdong, Peoples R China.	shulhuang@sina.com	shao, hongwei/GWC-1808-2022; shen, han/AAQ-5341-2021	Shen, Han/0000-0003-0366-4403	National Natural Science Foundation of China [31100664, 31300737, 81303292]; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2009ZX09103-708]; Natural Science Foundation of Guangdong Province [10151022401000024]; Faculty Development and Research Funds of GDPU	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for "Significant New Drugs Development''; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Faculty Development and Research Funds of GDPU	This work was supported by the National Natural Science Foundation of China (No. 31100664, 31300737, 81303292), National Major Scientific and Technological Special Project for "Significant New Drugs Development'' (No. 2009ZX09103-708), Natural Science Foundation of Guangdong Province (No. 10151022401000024), and a grant from Faculty Development and Research Funds of GDPU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380; Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005; Blohm U, 2002, J IMMUNOL, V169, P5522, DOI 10.4049/jimmunol.169.10.5522; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; Demotte N, 2002, EUR J IMMUNOL, V32, P1688, DOI 10.1002/1521-4141(200206)32:6<1688::AID-IMMU1688>3.0.CO;2-9; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Dudley ME, 2013, J CLIN ONCOL, V31, P2152, DOI 10.1200/JCO.2012.46.6441; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Echchakir H, 1999, INT J CANCER, V81, P205, DOI 10.1002/(SICI)1097-0215(19990412)81:2<205::AID-IJC7>3.0.CO;2-M; FERRADINI L, 1992, CANCER RES, V52, P4649; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gebhard DH, 1999, J INFECT DIS, V180, P1503, DOI 10.1086/315089; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; HOLMES EC, 1985, ANN SURG, V202, P335, DOI 10.1097/00000658-198509000-00010; IOANNIDES CG, 1991, J IMMUNOL, V146, P1700; KUDOH S, 1995, CANCER IMMUNOL IMMUN, V41, P175, DOI 10.1007/s002620050216; Lyons GE, 2006, CANCER RES, V66, P11455, DOI 10.1158/0008-5472.CAN-06-2379; Nagorsen D, 2003, CLIN CANCER RES, V9, P4296; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Nishimura MI, 1998, J IMMUNOTHER, V21, P352, DOI 10.1097/00002371-199809000-00003; Rezvany MR, 2003, BLOOD, V101, P1063, DOI 10.1182/blood-2002-03-0746; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Rymkiewicz PD, 2012, IMMUNOL RES, V53, P235, DOI 10.1007/s12026-012-8289-3; Sainz-Perez A, 2012, CANCER RES, V72, P3557, DOI 10.1158/0008-5472.CAN-12-0277; SALVI S, 1995, CANCER RES, V55, P3374; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Selin LK, 2004, SEMIN IMMUNOL, V16, P335, DOI 10.1016/j.smim.2004.08.014; SENSI M, 1995, IMMUNOL TODAY, V16, P588, DOI 10.1016/0167-5699(95)80082-4; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Steinmann G G, 1986, Curr Top Pathol, V75, P43; Thor Straten Per, 2004, J Transl Med, V2, P11; Voss Stephan, 1993, P411; WEI S, 1994, IMMUNOGENETICS, V40, P27, DOI 10.1007/BF00163961; Wong JL, 2013, CANCER RES, V73, P4653, DOI 10.1158/0008-5472.CAN-12-4366; Wu FL, 2013, CANCER LETT, V339, P195, DOI 10.1016/j.canlet.2013.06.009; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yannelli JR, 1996, INT J CANCER, V65, P413, DOI 10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-#; Yu R, 2005, EUR J IMMUNOL, V35, P1754, DOI 10.1002/eji.200425866; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102327	10.1371/journal.pone.0102327	http://dx.doi.org/10.1371/journal.pone.0102327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019226	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600068
J	Wolfsgruber, S; Wagner, M; Schmidtke, K; Frolich, L; Kurz, A; Schulz, S; Hampel, H; Heuser, I; Peters, O; Reischies, FM; Jahn, H; Luckhaus, C; Hull, M; Gertz, HJ; Schroder, J; Pantel, J; Rienhoff, O; Ruther, E; Henn, F; Wiltfang, J; Maier, W; Kornhuber, J; Jessen, F				Wolfsgruber, Steffen; Wagner, Michael; Schmidtke, Klaus; Froelich, Lutz; Kurz, Alexander; Schulz, Stefanie; Hampel, Harald; Heuser, Isabella; Peters, Oliver; Reischies, Friedel M.; Jahn, Holger; Luckhaus, Christian; Huell, Michael; Gertz, Hermann-Josef; Schroeder, Johannes; Pantel, Johannes; Rienhoff, Otto; Ruether, Eckart; Henn, Fritz; Wiltfang, Jens; Maier, Wolfgang; Kornhuber, Johannes; Jessen, Frank			Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID BURDEN; COMPLAINTS; DIAGNOSIS; ASSOCIATION; MCI; ANOSOGNOSIA; DEPRESSION; PREDICTION; AWARENESS	Background: Concerns about worsening memory ("memory concerns"; MC) and impairment in memory performance are both predictors of Alzheimer's dementia (AD). The relationship of both in dementia prediction at the pre-dementia disease stage, however, is not well explored. Refined understanding of the contribution of both MC and memory performance in dementia prediction is crucial for defining at-risk populations. We examined the risk of incident AD by MC and memory performance in patients with mild cognitive impairment (MCI). Methods: We analyzed data of 417 MCI patients from a longitudinal multicenter observational study. Patients were classified based on presence (n = 305) vs. absence (n = 112) of MC. Risk of incident AD was estimated with Cox Proportional-Hazards regression models. Results: Risk of incident AD was increased by MC (HR = 2.55, 95% CI: 1.33-4.89), lower memory performance (HR = 0.63, 95% CI: 0.56-0.71) and ApoE4-genotype (HR = 1.89, 95% CI: 1.18-3.02). An interaction effect between MC and memory performance was observed. The predictive power of MC was greatest for patients with very mild memory impairment and decreased with increasing memory impairment. Conclusions: Our data suggest that the power of MC as a predictor of future dementia at the MCI stage varies with the patients' level of cognitive impairment. While MC are predictive at early stage MCI, their predictive value at more advanced stages of MCI is reduced. This suggests that loss of insight related to AD may occur at the late stage of MCI.	[Wolfsgruber, Steffen; Wagner, Michael; Maier, Wolfgang; Jessen, Frank] Univ Bonn, Dept Psychiat, Bonn, Germany; [Wolfsgruber, Steffen; Wagner, Michael; Maier, Wolfgang; Jessen, Frank] German Ctr Neurodegenerat Dis, Bonn, Germany; [Schmidtke, Klaus] Ortenau Klinikum, Ctr Geriatr Med, Offenburg Gengenbach, Germany; [Froelich, Lutz] Cent Inst Mental Hlth, Dept Gerontopsychiat, Mannheim, Germany; [Kurz, Alexander] Tech Univ Munich, Dept Psychiat, D-80290 Munich, Germany; [Schulz, Stefanie] Univ Aachen, Dept Neurol, Aachen, Germany; [Schulz, Stefanie; Ruether, Eckart] Univ Gottingen, Dept Psychiat, D-37073 Gottingen, Germany; [Hampel, Harald] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Heuser, Isabella; Peters, Oliver; Reischies, Friedel M.] Charite, Dept Psychiat, Berlin, Germany; [Jahn, Holger] Univ Hamburg, Dept Psychiat, Hamburg, Germany; [Luckhaus, Christian] Univ Dusseldorf, Fac Med, Dept Psychiat & Psychotherapy, Dusseldorf, Germany; [Huell, Michael] Univ Freiburg, Ctr Geriatr Med & Gerontol, D-79106 Freiburg, Germany; [Gertz, Hermann-Josef] Univ Leipzig, Dept Psychiat, D-04109 Leipzig, Germany; [Schroeder, Johannes] Heidelberg Univ, Dept Psychiat, Heidelberg, Germany; [Pantel, Johannes] Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany; [Rienhoff, Otto] Univ Gottingen, Dept Med Informat, D-37073 Gottingen, Germany; [Henn, Fritz] Brookhaven Natl Lab, Upton, NY 11973 USA; [Wiltfang, Jens] Univ Essen Gesamthsch, Dept Psychiat, Essen, Germany; [Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat, D-91054 Erlangen, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Central Institute of Mental Health; Technical University of Munich; University of Munich; RWTH Aachen University; University of Gottingen; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; Heinrich Heine University Dusseldorf; University of Freiburg; Leipzig University; Ruprecht Karls University Heidelberg; Goethe University Frankfurt; University of Gottingen; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Duisburg Essen; University of Erlangen Nuremberg	Wolfsgruber, S (corresponding author), Univ Bonn, Dept Psychiat, Bonn, Germany.	Steffen.Wolfsgruber@ukb.uni-bonn.de	Frölich, Lutz/AAA-6940-2019; Kornhuber, Johannes/B-9613-2014; Pantel, Johannes/ABC-6341-2020; , eruether@msn.com/K-2369-2019; Wagner, Michael/E-2325-2011; Jessen, Frank/AAK-6170-2020; Cruz e Silva, Odete/AAH-5595-2020; Jahn, Holger/A-9255-2008	Frölich, Lutz/0000-0003-1494-0813; Kornhuber, Johannes/0000-0002-8096-3987; Wagner, Michael/0000-0003-2589-6440; Jahn, Holger/0000-0003-3607-7651; Peters, Oliver/0000-0003-0568-2998; Wiltfang, Jens/0000-0003-1492-5330; Hampel, Harald/0000-0003-0894-8982	German Federal Ministry of Education and Research (BMBF): Kompetenznetz Demenzen [01GI0420]; Katharina-Hardt-Foundation, Bad Homburg, Germany	German Federal Ministry of Education and Research (BMBF): Kompetenznetz Demenzen(Federal Ministry of Education & Research (BMBF)); Katharina-Hardt-Foundation, Bad Homburg, Germany	This study has been supported by a grant from the German Federal Ministry of Education and Research (BMBF): Kompetenznetz Demenzen (01GI0420). Harald Hampel was supported by grants of the Katharina-Hardt-Foundation, Bad Homburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; Buckley R, 2013, INT PSYCHOGERIATR, V25, P1307, DOI 10.1017/S1041610213000665; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; Espinosa A, 2013, J ALZHEIMERS DIS, V34, P769, DOI 10.3233/JAD-122002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galeone F, 2011, INT J GERIATR PSYCH, V26, P695, DOI 10.1002/gps.2583; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Grambaite R, 2013, DEMENT GER COGN D EX, V3, P291, DOI 10.1159/000354188; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P76, DOI 10.1016/j.jalz.2012.09.017; Jessen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016852; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Kalbe E, 2005, DEMENT GERIATR COGN, V19, P349, DOI 10.1159/000084704; Kornhuber J, 2009, DEMENT GERIATR COGN, V27, P404, DOI 10.1159/000210388; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2012, NEUROLOGY, V79, P1570, DOI 10.1212/WNL.0b013e31826e2696; Mitchell AJ, 2008, INT J GERIATR PSYCH, V23, P1191, DOI 10.1002/gps.2053; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mosconi L, 2008, BIOL PSYCHIAT, V63, P609, DOI 10.1016/j.biopsych.2007.05.030; Muller-Thomsen T, 2005, ARCH CLIN NEUROPSYCH, V20, P271, DOI 10.1016/j.acn.2004.03.010; Nobili F, 2010, J ALZHEIMERS DIS, V22, P993, DOI 10.3233/JAD-2010-100423; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rabin LA, 2012, J AM GERIATR SOC, V60, P1128, DOI 10.1111/j.1532-5415.2012.03956.x; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Roberts JL, 2009, DEMENT GERIATR COGN, V28, P95, DOI 10.1159/000234911; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Scheef L, 2012, NEUROLOGY, V79, P1332, DOI 10.1212/WNL.0b013e31826c1a8d; Sotaniemi M, 2012, ACTA NEUROL SCAND, V125, P16, DOI 10.1111/j.1600-0404.2010.01459.x; Tierney MC, 1996, ARCH NEUROL-CHICAGO, V53, P423, DOI 10.1001/archneur.1996.00550050053023; van Oijen M, 2007, ALZHEIMERS DEMENT, V3, P92, DOI 10.1016/j.jalz.2007.01.011; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Vogel A, 2005, INT J GERIATR PSYCH, V20, P238, DOI 10.1002/gps.1272; Vogel A, 2004, DEMENT GERIATR COGN, V17, P181, DOI 10.1159/000076354; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wolfsgruber S, 2013, AM J GERIATR PSYCHIA; Xu WL, 2013, J ALZHEIMERS DIS, V33, P507, DOI 10.3233/JAD-2012-121369	41	31	32	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e100812	10.1371/journal.pone.0100812	http://dx.doi.org/10.1371/journal.pone.0100812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019225	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600007
J	Zhao, MH; Kwon, JW; Liang, S; Kim, SH; Li, YH; Oh, JS; Kim, NH; Cui, XS				Zhao, Ming-Hui; Kwon, Jung-Woo; Liang, Shuang; Kim, Seon-Hyang; Li, Ying-Hua; Oh, Jeong-Su; Kim, Nam-Hyung; Cui, Xiang-Shun			Zinc Regulates Meiotic Resumption in Porcine Oocytes via a Protein Kinase C-Related Pathway (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							MATURATION-PROMOTING FACTOR; PIG OOCYTES; CELL-CYCLE; GERMINAL VESICLE; MOUSE OOCYTES; CUMULUS CELLS; MEIOSIS-II; ACTIVATION; FERTILIZATION; GONADOTROPINS	Zinc is an extremely important trace element that plays important roles in several biological processes. However, the function of zinc in meiotic division of porcine oocytes is unknown. In this study, we investigated the role of zinc during meiotic resumption in in vitro matured porcine oocytes. During meiotic division, a massive release of zinc was observed. The level of free zinc in the cytoplasm significantly increased during maturation. Depletion of zinc using N, N, N', N'-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN), a Zn2+ chelator, blocked meiotic resumption in a dose dependent manner. The level of phosphorylated mitogen activated protein kinase (MAPK) and p34(cdc2) kinase activity were reduced when zinc was depleted. Moreover, zinc depletion reduced the levels of phosphorylated protein kinase C (PKC) substrates in a dose dependent manner. Real-time PCR analysis showed that expression of the MAPK-and maturation promoting factor related genes C-mos, CyclinB1, and Cdc2 was downregulated following zinc depletion. Treatment with the PKC agonist phorbol 12-myristate 13-acetate (PMA) increased phosphorylation of PKC substrates and MAPK and increased p34(cdc2) kinase activity. This rescued the meiotic arrest, even in the presence of TPEN. Activation of PKC by PMA increased the level of zinc in the cytoplasm. These data demonstrate that zinc is required for meiotic resumption in porcine oocytes, and this appears to be regulated via a PKC related pathway.	[Zhao, Ming-Hui; Kwon, Jung-Woo; Liang, Shuang; Kim, Seon-Hyang; Li, Ying-Hua; Kim, Nam-Hyung; Cui, Xiang-Shun] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Zhao, Ming-Hui; Kwon, Jung-Woo; Liang, Shuang; Kim, Seon-Hyang; Kim, Nam-Hyung; Cui, Xiang-Shun] Brain Korea 21 Ctr Bioresource Dev, Cheongju, South Korea; [Oh, Jeong-Su] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Genet Engn, Suwon, South Korea	Chungbuk National University; Sungkyunkwan University (SKKU)	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea.	nhkim@chungbuk.ac.kr; xscui@chungbuk.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00909801, PJ009594]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by grants from the Next-Generation BioGreen 21 Program (PJ00909801 and PJ009594), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avazeri N, 2004, J CELL SCI, V117, P4969, DOI 10.1242/jcs.01375; Bernhardt ML, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097253; Bernhardt ML, 2011, BIOL REPROD, V84, P526, DOI 10.1095/biolreprod.110.086488; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Chen WY, 2000, MOL REPROD DEV, V56, P74, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;74::AID-MRD9&gt;3.0.CO;2-6; COSKUN S, 1995, MOL REPROD DEV, V42, P311, DOI 10.1002/mrd.1080420308; Doree M, 2002, J CELL SCI, V115, P2461; Endo T, 2006, REPRODUCTION, V131, P439, DOI 10.1530/rep.1.00924; Fan HY, 2004, BIOL REPROD, V70, P1178, DOI 10.1095/biolreprod.103.024737; Fan HY, 2003, BIOL REPROD, V68, P968, DOI 10.1095/biolreprod.102.008839; Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; HEDBERG KK, 1994, J CELL PHYSIOL, V158, P337, DOI 10.1002/jcp.1041580216; HUNTER RHF, 1966, J REPROD FERTIL, V12, P525, DOI 10.1530/jrf.0.0120525; INOUE M, 1995, ZYGOTE, V3, P265, DOI 10.1017/S0967199400002665; Kim AM, 2011, ACS CHEM BIOL, V6, P716, DOI 10.1021/cb200084y; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kong BY, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099390; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LEFEVRE B, 1992, J EXP ZOOL, V264, P206, DOI 10.1002/jez.1402640213; Li YH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109850; Lisle RS, 2013, REPRODUCTION, V145, P381, DOI 10.1530/REP-12-0338; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Meinecke B, 2003, ZYGOTE, V11, P7, DOI 10.1017/S0967199403001023; MOTLIK J, 1976, J EXP ZOOL, V198, P155, DOI 10.1002/jez.1401980205; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PROCHAZKA R, 1989, CELL DIFFER DEV, V27, P175, DOI 10.1016/0922-3371(89)90698-9; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; SCHWABE JWR, 1991, TRENDS BIOCHEM SCI, V16, P291, DOI 10.1016/0968-0004(91)90121-B; Shoujo A, 2000, J MAMM OVA RES, V17, P35; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Sun QY, 1997, DEV GROWTH DIFFER, V39, P523, DOI 10.1046/j.1440-169X.1997.t01-2-00014.x; Tian X, 2012, ENDOCRINOLOGY, V153, P873, DOI 10.1210/en.2011-1599; Viveiros MM, 2001, DEV BIOL, V235, P330, DOI 10.1006/dbio.2001.0311; Yu BZ, 2004, CELL BIOCHEM FUNCT, V22, P291, DOI 10.1002/cbf.1103; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031	40	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102097	10.1371/journal.pone.0102097	http://dx.doi.org/10.1371/journal.pone.0102097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019390	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600045
J	Bladowska, J; Knysz, B; Zimny, A; Malyszczak, K; Koltowska, A; Szewczyk, P; Gasiorowski, J; Furdal, M; Sasiadek, MJ				Bladowska, Joanna; Knysz, Brygida; Zimny, Anna; Malyszczak, Krzysztof; Koltowska, Anna; Szewczyk, Pawel; Gasiorowski, Jacek; Furdal, Michal; Sasiadek, Marek J.			Value of Perfusion-Weighted MR Imaging in the Assessment of Early Cerebral Alterations in Neurologically Asymptomatic HIV-1-Positive and HCV-Positive Patients	PLOS ONE			English	Article							HEPATITIS-C; BLOOD-FLOW; EMISSION-TOMOGRAPHY; HIV; METABOLISM; INFECTION; THERAPY; RISK	Background and Purpose: Asymptomatic central nervous system (CNS) involvement occurs in the early stage of the human immunodeficiency virus (HIV) infection. It has been documented that the hepatitis C virus (HCV) can replicate in the CNS. The aim of the study was to evaluate early disturbances in cerebral microcirculation using magnetic resonance (MR) perfusion-weighted imaging (PWI) in asymptomatic HIV-1-positive and HCV-positive patients, as well as to assess the correlation between PWI measurements and the clinical data. Materials and Methods: Fifty-six patients: 17 HIV-1-positive non-treated, 18 HIV-1-positive treated with combination antiretroviral therapy (cART), 7 HIV-1/HCV-positive non-treated, 14 HCV-positive before antiviral therapy and 18 control subjects were enrolled in the study. PWI was performed with a 1.5T MR unit using dynamic susceptibility contrast (DSC) method. Cerebral blood volume (CBV) measurements relative to cerebellum (rCBV) were evaluated in the posterior cingulated region (PCG), basal ganglia (BG), temporoparietal (TPC) and frontal cortices (FC), as well as in white matter of frontoparietal areas. Correlations of rCBV values with immunologic data and liver histology activity index (HAI) were analyzed. Results: Significantly lower rCBV values were found in the right TPC and left FC as well as in PCG in HIV-1-positive naiive (p = 0.009; p = 0.020; p = 0.012), HIV-1 cART treated (p = 0.007; p = 0.009; p = 0.033), HIV-1/HCV-positive (p = 0.007; p = 0.027; p = 0.045) and HCV-positive patients (p = 0.010; p = 0.005; p = 0.045) compared to controls. HIV-1-positive cART treated and HIV-1/HCV-positive patients demonstrated lower rCBV values in the right FC (p = 0.009; p = 0.032, respectively) and the left TPC (p = 0.036; p = 0.005, respectively), while HCV-positive subjects revealed lower rCBV values in the left TPC region (p = 0.003). We found significantly elevated rCBV values in BG in HCV-positive patients (p = 0.0002; p, 0.0001) compared to controls as well as to all HIV-1-positive subjects. There were no significant correlations of rCBV values and CD4 T cell count or HAI score. Conclusions: PWI examination enables the assessment of HIV-related as well as HCV-related early cerebral dysfunction in asymptomatic subjects. HCV-infected patients seem to reveal the most pronounced perfusion changes.	[Bladowska, Joanna; Zimny, Anna; Koltowska, Anna; Szewczyk, Pawel; Sasiadek, Marek J.] Wroclaw Med Univ, Chair Radiol, Dept Gen Radiol Intervent Radiol & Neuroradiol, Wroclaw, Poland; [Knysz, Brygida; Gasiorowski, Jacek] Wroclaw Med Univ, Dept Infect Dis Liver Dis & Acquired Immune Defic, Wroclaw, Poland; [Malyszczak, Krzysztof] Wroclaw Med Univ, Dept Psychiat, Div Psychotherapy & Psychosomat Med, Wroclaw, Poland; [Furdal, Michal] Reg Specialist Hosp, Dept Cardiol, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University	Bladowska, J (corresponding author), Wroclaw Med Univ, Chair Radiol, Dept Gen Radiol Intervent Radiol & Neuroradiol, Wroclaw, Poland.	asia.bladowska@gmail.com	Małyszczak, Krzysztof/ABD-5670-2021	Małyszczak, Krzysztof/0000-0001-6295-2742; Koltowska, Anna/0000-0003-2508-9817; Knysz, Brygida/0000-0003-2605-1079; Sasiadek, Marek/0000-0003-3627-118X	Wroclaw Medical University [ST-146]	Wroclaw Medical University	Supported by Wroclaw Medical University Grant ST-146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; Bladowska J, 2013, J HEPATOL, V59, P651, DOI 10.1016/j.jhep.2013.05.008; Bladowska J, 2013, EUR J RADIOL, V82, P686, DOI 10.1016/j.ejrad.2012.11.029; Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; Byrnes V, 2012, J HEPATOL, V56, P549, DOI 10.1016/j.jhep.2011.09.015; Carvalho RJ, 2012, WORLD J GASTROENTERO, V18, P188, DOI 10.3748/wjg.v18.i2.188; CATAFAU AM, 1994, J NUCL MED, V35, P1041; Chang L, 2000, NEUROLOGY, V54, P389, DOI 10.1212/WNL.54.2.389; Clifford DB, 2005, J NEUROVIROL, V11, P67, DOI 10.1080/13550280500513762; Gruis KL, 2003, ARCH NEUROL-CHICAGO, V60, P877, DOI 10.1001/archneur.60.6.877; Gutierrez J, 2013, NEUROPATHOLOGY, V33, P256, DOI 10.1111/j.1440-1789.2012.01358.x; HARRIS GJ, 1994, AIDS, V8, P495, DOI 10.1097/00002030-199404000-00012; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Laskus T, 2005, AIDS, V19, pS140, DOI 10.1097/01.aids.0000192083.41561.00; Lee MH, 2010, STROKE, V41, P2894, DOI 10.1161/STROKEAHA.110.598136; Lentz MR, 2009, NEUROLOGY, V72, P1465, DOI 10.1212/WNL.0b013e3181a2e90a; Li CX, 2011, NEUROIMAGE, V58, P286, DOI 10.1016/j.neuroimage.2011.05.068; Liner Kevin J 2nd, 2010, Curr HIV/AIDS Rep, V7, P85, DOI 10.1007/s11904-010-0042-8; Monaco S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/236148; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Rottenberg DA, 1996, J NUCL MED, V37, P1133; Rumboldt Z, 2008, NEUROIMAG CLIN N AM, V18, P85, DOI 10.1016/j.nic.2007.12.006; TALBOT PR, 1994, EUR J NUCL MED, V21, P503; Tanaka M, 1995, Ann Nucl Med, V9, P43; Towgood KJ, 2013, HUM BRAIN MAPP, V34, P2484, DOI 10.1002/hbm.22078; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; Vivithanaporn P, 2012, J NEUROL SCI, V312, P45, DOI 10.1016/j.jns.2011.08.025; von Giesen HJ, 2000, ARCH NEUROL-CHICAGO, V57, P1601, DOI 10.1001/archneur.57.11.1601; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wenserski F, 2003, RADIOLOGY, V228, P185, DOI 10.1148/radiol.2281010683; Zimny A, 2010, MED SCI MONIT S1, V16, P5	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102214	10.1371/journal.pone.0102214	http://dx.doi.org/10.1371/journal.pone.0102214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013963	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400076
J	Heimiller, J; Sridharan, V; Huntley, J; Wesley, CS; Singh, R				Heimiller, Joseph; Sridharan, Vinod; Huntley, Jim; Wesley, Cedric S.; Singh, Ravinder			Drosophila Polypyrimidine Tract-Binding Protein (DmPTB) Regulates Dorso-Ventral Patterning Genes in Embryos	PLOS ONE			English	Article							ALTERNATIVE 3'-SPLICE-SITE SELECTION; IN-VIVO; CELL FATE; NOTCH; RNA; PTB; EXPRESSION; DIFFERENTIATION; COMPLEXES; MORPHOGEN	The Drosophila polypyrimidine tract-binding protein (dmPTB or hephaestus) plays an important role during embryogenesis. A loss of function mutation, heph(03429), results in varied defects in embryonic developmental processes, leading to embryonic lethality. However, the suite of molecular functions that are disrupted in the mutant remains unknown. We have used an unbiased high throughput sequencing approach to identify transcripts that are misregulated in this mutant. Misregulated transcripts show evidence of significantly altered patterns of splicing (exon skipping, 5' and 3' splice site switching), alternative 5' ends, and mRNA level changes (up and down regulation). These findings are independently supported by reverse-transcription-polymerase chain reaction (RT-PCR) analysis and in situ hybridization. We show that a group of genes, such as Zerknullt, z600 and screw are among the most upregulated in the mutant and have been functionally linked to dorso-ventral patterning and/or dorsal closure processes. Thus, loss of dmPTB function results in specific misregulated transcripts, including those that provide the missing link between the loss of dmPTB function and observed developmental defects in embryogenesis. This study provides the first comprehensive repertoire of genes affected in vivo in the heph mutant in Drosophila and offers insight into the role of dmPTB during embryonic development.	[Heimiller, Joseph; Sridharan, Vinod; Singh, Ravinder] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Huntley, Jim] Univ Colorado, BioFrontiers Next Gen Sequencing Facil, Boulder, CO 80309 USA; [Wesley, Cedric S.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Wesley, Cedric S.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Singh, R (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	rsingh@colorado.edu	Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020		University of Colorado Boulder; National Institutes of Health [HD062928]; Butcher Foundation award	University of Colorado Boulder; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Butcher Foundation award	The Butcher Foundation award, Departmental funds (R. S.), and National Institutes of Health - HD062928 (CSW). Article processing charge was funded by the University of Colorado Boulder Libraries Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashburner M, 1989, DROSOPHILA, p2v; Bejsovec A, 2013, MOL REPROD DEV, V80, P882, DOI 10.1002/mrd.22228; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Clerte C, 2006, RNA, V12, P457, DOI 10.1261/rna.2178406; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Dansereau DA, 2002, DEVELOPMENT, V129, P5553, DOI 10.1242/dev.00153; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Gonzalez-Reyes A, 1997, DEVELOPMENT, V124, P4927; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Kafasla P, 2012, BIOCHEM SOC T, V40, P815, DOI 10.1042/BST20120044; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LIN CH, 1995, RNA, V1, P234; McDermott SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069978; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Perez I, 1997, RNA, V3, P764; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robida M, 2010, P NATL ACAD SCI USA, V107, P12570, DOI 10.1073/pnas.1007935107; Robida MD, 2003, EMBO J, V22, P2924, DOI 10.1093/emboj/cdg301; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SCHULZ RA, 1989, DEV BIOL, V136, P211, DOI 10.1016/0012-1606(89)90143-7; Shepherd A, 2010, DEV DYNAM, V239, P1220, DOI 10.1002/dvdy.22262; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Stein D, 1998, DEVELOPMENT, V125, P2159; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Tremmel DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067789; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wesley CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021876; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e98585	10.1371/journal.pone.0098585	http://dx.doi.org/10.1371/journal.pone.0098585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014769	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400003
J	Mabuto, T; Latka, MH; Kuwane, B; Churchyard, GJ; Charalambous, S; Hoffmann, CJ				Mabuto, Tonderai; Latka, Mary H.; Kuwane, Bulelani; Churchyard, Gavin J.; Charalambous, Salome; Hoffmann, Christopher J.			Four Models of HIV Counseling and Testing: Utilization and Test Results in South Africa	PLOS ONE			English	Article							CLUSTER-RANDOMIZED-TRIAL; SERVICES; HOME; INTERVENTION; PREVENTION; MEN; KNOWLEDGE; PROGRAM; LINKAGE; UGANDA	Background: HIV Counseling and Testing (HCT) is the point-of-entry for pathways of HIV care and prevention. However, HCT is not reaching many who are HIV infected and this may be related to the HCT provision model. We describe HCT utilization and HIV diagnosis using four models of HCT delivery: clinic-based, urban mobile, rural mobile, and stand-alone. Methods: Using cross-sectional data from routine HCT provided in South Africa, we described client characteristics and HIV test results from information collected during service delivery between January 2009 and June 2012. Results: 118,358 clients received services at clinic-based units, 18,597; stand-alone, 28,937; urban mobile, 38,840; and rural mobile, 31,984. By unit, clients were similar in terms of median age (range 28-31), but differed in sex distribution, employment status, prior testing, and perceived HIV risk. Urban mobile units had the highest proportion of male clients (52%). Rural mobile units reached the highest proportion of clients with no prior HCT (61%) and reporting no perceived HIV risk (64%). Overall, 10,862 clients (9.3%) tested HIV-positive. Conclusions: Client characteristics varied by HCT model. Importantly, rural and urban mobile units reached more men, first-time testers, and clients who considered themselves to be at low risk for HIV.	[Mabuto, Tonderai; Latka, Mary H.; Kuwane, Bulelani; Churchyard, Gavin J.; Charalambous, Salome; Hoffmann, Christopher J.] Aurum Inst, Johannesburg, South Africa; [Latka, Mary H.; Churchyard, Gavin J.; Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin J.] London Sch Hyg & Trop Med, London WC1, England; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University	Hoffmann, CJ (corresponding author), Aurum Inst, Johannesburg, South Africa.	choffmann@jhmi.edu		Hoffmann, Christopher/0000-0002-9422-0519; Charalambous, Salome/0000-0001-7143-1009; Churchyard, Gavin/0000-0002-4269-3699	PEPFAR [U2GPS000811]; SATBAT [U2RTW007370/3]; National Institutes of Health [K23AI083099]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI083099] Funding Source: NIH RePORTER	PEPFAR; SATBAT; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The HIV counseling and testing described in this analysis was supported by a PEPFAR Cooperative Agreement number U2GPS000811. TM was partially supported by SATBAT U2RTW007370/3. CJH was partially supported by a National Institutes of Health grant award K23AI083099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Baral SD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18768; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Doherty T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3481; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Joint United Nations Programme on HIV/AIDS, 2013, GETT ZER HIV E SO AF; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Kranzer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025244; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marum E, 2012, JAIDS-J ACQ IMM DEF, V60, pS63, DOI 10.1097/QAI.0b013e31825f313b; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Maughan-Brown B, 2014, AIDS BEHAV, V18, P958, DOI 10.1007/s10461-013-0636-4; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Metro Trading Company, 2012, ANN REPORT; Mulogo EM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-54; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Shisana O, 2014, S AFRICAN NATL HIV P; South African National Department of Health, 2010, NAT HIV COUNS TEST P; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; Vu L, 2013, SEX TRANSM INFECT, V89, P659, DOI 10.1136/sextrans-2013-051065; World Health Organization, 2012, SERV DEL APPR HIV TE	33	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102267	10.1371/journal.pone.0102267	http://dx.doi.org/10.1371/journal.pone.0102267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013938	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400083
J	Singer, P; Helic, D; Taraghi, B; Strohmaier, M				Singer, Philipp; Helic, Denis; Taraghi, Behnam; Strohmaier, Markus			Detecting Memory and Structure in Human Navigation Patterns Using Markov Chain Models of Varying Order	PLOS ONE			English	Article							WEB; INFERENCE; USERS	One of the most frequently used models for understanding human navigation on the Web is the Markov chain model, where Web pages are represented as states and hyperlinks as probabilities of navigating from one page to another. Predominantly, human navigation on the Web has been thought to satisfy the memoryless Markov property stating that the next page a user visits only depends on her current page and not on previously visited ones. This idea has found its way in numerous applications such as Google's PageRank algorithm and others. Recently, new studies suggested that human navigation may better be modeled using higher order Markov chain models, i.e., the next page depends on a longer history of past clicks. Yet, this finding is preliminary and does not account for the higher complexity of higher order Markov chain models which is why the memoryless model is still widely used. In this work we thoroughly present a diverse array of advanced inference methods for determining the appropriate Markov chain order. We highlight strengths and weaknesses of each method and apply them for investigating memory and structure of human navigation on the Web. Our experiments reveal that the complexity of higher order models grows faster than their utility, and thus we confirm that the memoryless model represents a quite practical model for human navigation on a page level. However, when we expand our analysis to a topical level, where we abstract away from specific page transitions to transitions between topics, we find that the memoryless assumption is violated and specific regularities can be observed. We report results from experiments with two types of navigational datasets (goal-oriented vs. free form) and observe interesting structural differences that make a strong argument for more contextual studies of human navigation in future work.	[Singer, Philipp; Strohmaier, Markus] GESIS Leibniz Inst Social Sci, Cologne, Germany; [Helic, Denis] Graz Univ Technol, Knowledge Technol Inst, A-8010 Graz, Austria; [Taraghi, Behnam] Graz Univ Technol, Inst Informat Syst & Comp Media, A-8010 Graz, Austria; [Strohmaier, Markus] Univ Koblenz Landau, Inst Web Sci & Technol, Koblenz, Germany	Leibniz Institut fur Sozialwissenschaften (GESIS); Graz University of Technology; Graz University of Technology; University of Koblenz & Landau	Singer, P (corresponding author), GESIS Leibniz Inst Social Sci, Cologne, Germany.	philipp.singer@gesis.org		Helic, Denis/0000-0003-0725-7450	DFG [STR 1191/3-2]; FWF Austrian Science Fund [P24866]	DFG(German Research Foundation (DFG)); FWF Austrian Science Fund(Austrian Science Fund (FWF))	This research was in part funded by the DFG German Science Fund research project "Pragmatics and Semantics in Social Tagging Systems II" (STR 1191/3-2) as well as the FWF Austrian Science Fund research project "Navigability of Decentralized Information Networks" (P24866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson CR, 2001, P 17 INT JOINT C ART, P79; [Anonymous], ENCY COGNITIVE SCI; Baigorri A, 2009, ARXIV09100264; BARTLETT MS, 1951, P CAMB PHILOS SOC, V47, P86, DOI 10.1017/S0305004100026402; Bestavros A., 1995, Proceedings of the 1995 ACM CIKM International Conference on Information and Knowledge Management, P403, DOI 10.1145/221270.221653; Borges J, 2000, LECT NOTES COMPUT SC, V1836, P92; Borges J, 2007, IEEE T KNOWL DATA EN, V19, P441, DOI 10.1109/TKDE.2007.1012; Box George E.P., 2011, BAYESIAN INFERENCE S, V40; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cadez I, 2003, DATA MIN KNOWL DISC, V7, P399, DOI 10.1023/A:1024992613384; CATLEDGE LD, 1995, COMPUT NETWORKS ISDN, V27, P1065, DOI 10.1016/0169-7552(95)00043-7; Chierichetti F, 2012, P 21 INT C WORLD WID; Csiszar I, 2000, ANN STAT, V28, P1601; Deshpande M., 2004, ACM T INTERNET TECHN, V4, P163, DOI DOI 10.1145/990301.990304; Durbin R., 1998, BIOL SEQUENCE ANAL P; GATES P, 1976, J APPL METEOROL, V15, P1145, DOI 10.1175/1520-0450(1976)015<1145:OMCMTS>2.0.CO;2; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; Huberman BA, 1998, NOVELTY SOCIAL SEARC; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KATZ RW, 1981, TECHNOMETRICS, V23, P243, DOI 10.2307/1267787; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kumar Ravi, 2010, P 19 INT C WORLD WID, P561, DOI DOI 10.1145/1772690.1772748; Lempel R, 2000, COMPUT NETW, V33, P387, DOI 10.1016/S1389-1286(00)00034-7; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; MacKay D.J.C., 1992, THESIS CALTECH; MacKay D. J. C., 2003, INFORM THEORY INFERE; Morrison DE, 2006, SIGNIFICANCE TEST CO; Murray I, 2005, NOTE EVIDENCE BAYESI; Perkowitz M, 1997, INT JOINT CONF ARTIF, P16; Pirolli P. L. T., 1999, World Wide Web, V2, P29, DOI 10.1023/A:1019288403823; Pitkow J, 1999, P 2 C USENIX S INT T, V2; Rendle Steffen, 2010, P 19 INT C WORLD WID, P811, DOI DOI 10.1145/1772690.1772773; Rosvall M, 2013, ARXIV13054807; Royall R., 1997, STAT EVIDENCE LIKELI, V71; Sarukkai RR, 2000, COMPUT NETW, V33, P377, DOI 10.1016/S1389-1286(00)00044-X; Scaria AT, 2014, LAST CLICK WHY USERS; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sen R, 2003, J COMPUT GRAPH STAT, V12, P143, DOI 10.1198/1061860031275; Singer P, 2014, PATH TOOLS, DOI [10.5281/zenodo.10229, DOI 10.5281/ZENODO.10229]; Stigler S.M., 2002, STAT TABLE HIST STAT; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Strelioff CC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011106; TONG H, 1975, J APPL PROBAB, V12, P488, DOI 10.2307/3212863; Wang C, 2012, SCI REPORTS; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; West R., 2012, WWW, P619, DOI DOI 10.1145/2187836.2187920; West R, 2012, ICWSM; West R, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1598; Xing DS, 2004, INFORM SOFTWARE TECH, V46, P55, DOI 10.1016/S0950-5849(03)00109-5; Zukerman I, 1999, CISM COURSES LECT, P275	55	48	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102070	10.1371/journal.pone.0102070	http://dx.doi.org/10.1371/journal.pone.0102070			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013937	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400062
J	Ciurte, A; Bresson, X; Cuisenaire, O; Houhou, N; Nedevschi, S; Thiran, JP; Cuadra, MB				Ciurte, Anca; Bresson, Xavier; Cuisenaire, Olivier; Houhou, Nawal; Nedevschi, Sergiu; Thiran, Jean-Philippe; Cuadra, Meritxell Bach			Semi-Supervised Segmentation of Ultrasound Images Based on Patch Representation and Continuous Min Cut	PLOS ONE			English	Article							BOUNDARY DETECTION; LEFT-VENTRICLE; ALGORITHMS; TEXTURE; SPECKLE; MINIMIZATION; TRACKING; MODELS; TUMORS; SNAKE	Ultrasound segmentation is a challenging problem due to the inherent speckle and some artifacts like shadows, attenuation and signal dropout. Existing methods need to include strong priors like shape priors or analytical intensity models to succeed in the segmentation. However, such priors tend to limit these methods to a specific target or imaging settings, and they are not always applicable to pathological cases. This work introduces a semi-supervised segmentation framework for ultrasound imaging that alleviates the limitation of fully automatic segmentation, that is, it is applicable to any kind of target and imaging settings. Our methodology uses a graph of image patches to represent the ultrasound image and user-assisted initialization with labels, which acts as soft priors. The segmentation problem is formulated as a continuous minimum cut problem and solved with an efficient optimization algorithm. We validate our segmentation framework on clinical ultrasound imaging (prostate, fetus, and tumors of the liver and eye). We obtain high similarity agreement with the ground truth provided by medical expert delineations in all applications (94% DICE values in average) and the proposed algorithm performs favorably with the literature.	[Ciurte, Anca; Nedevschi, Sergiu] Tech Univ Cluj Napoca, Dept Comp Sci, Cluj Napoca, Romania; [Ciurte, Anca; Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland; [Bresson, Xavier; Cuisenaire, Olivier; Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Univ Hosp Ctr, Dept Radiol, Lausanne, Switzerland; [Bresson, Xavier; Cuisenaire, Olivier; Houhou, Nawal; Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Univ Lausanne, Lausanne, Switzerland; [Bresson, Xavier; Cuisenaire, Olivier; Cuadra, Meritxell Bach] Signal Proc Core, Ctr Biomed Imaging, Lausanne, Switzerland; [Houhou, Nawal] Univ Hosp Ctr, SIB, Lausanne, Switzerland	Technical University of Cluj Napoca; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Swiss Institute of Bioinformatics	Ciurte, A (corresponding author), Tech Univ Cluj Napoca, Dept Comp Sci, Cluj Napoca, Romania.	Anca.Ciurte@cs.utcluj.ro	Nedevschi, Sergiu S/G-5262-2016	Nedevschi, Sergiu S/0000-0003-2018-4647; Thiran, Jean-Philippe/0000-0003-2938-9657; Bach Cuadra, Meritxell/0000-0003-2730-4285; Cuisenaire, Olivier/0000-0002-9611-5026	PRODOC Project of Technical University of Cluj-Napoca; Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; Center for Biomedical Imaging (CIBM) of EPFL; foundation Leenaards; foundation Louis-Jeantet;  [FNS-205321-141283];  [CTI-13741.1]	PRODOC Project of Technical University of Cluj-Napoca; Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; Center for Biomedical Imaging (CIBM) of EPFL; foundation Leenaards; foundation Louis-Jeantet; ; 	This work is supported by PRODOC Project of Technical University of Cluj-Napoca and by the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities and EPFL, and the foundations Leenaards and Louis-Jeantet, and by the FNS-205321-141283 and CTI-13741.1 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Flores M, 2008, MATH INDUST-CHAM, V12, P858; Altman DG, 1997, ULTRASOUND OBST GYN, V10, P174, DOI 10.1046/j.1469-0705.1997.10030174.x; Anquez J, 2008, I S BIOMED IMAGING, P17, DOI 10.1109/ISBI.2008.4540921; Bae E, 2009, INT J COMPUT VISION, V92, P112; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Chang RF, 2003, ULTRASOUND MED BIOL, V29, P1571, DOI 10.1016/S0301-5629(03)00992-X; Chen DR, 2002, ULTRASOUND MED BIOL, V28, P1301, DOI 10.1016/S0301-5629(02)00620-8; Chen Y, 2007, INT J COMPUT VISION, V71, P259, DOI 10.1007/s11263-006-8524-2; Cheng JR, 2006, IEEE T INF TECHNOL B, V10, P414, DOI 10.1109/TITB.2005.859887; Chiang HH, 2010, I S BIOMED IMAGING, P177, DOI 10.1109/ISBI.2010.5490384; Ciurte A, 2011, I S BIOMED IMAGING, P969, DOI 10.1109/ISBI.2011.5872564; Corsi C, 2002, IEEE T MED IMAGING, V21, P1202, DOI 10.1109/TMI.2002.804418; Coupe P, 2009, IEEE T IMAGE PROCESS, V18, P2221, DOI 10.1109/TIP.2009.2024064; Cuadra MB, 2009, COMPUTATIONAL VISION, P53; Cvancarova M, 2005, INT CONGR SER, V1281, P218, DOI 10.1016/j.ics.2005.03.190; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Duval V., 2010, PARAMETER CHOICE NON; Efros A. A., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1033, DOI 10.1109/ICCV.1999.790383; Fenster A, 2001, PHYS MED BIOL, V46, pR67, DOI 10.1088/0031-9155/46/5/201; Fledelius HC, 1997, ULTRASOUND MED BIOL, V23, P365, DOI 10.1016/S0301-5629(96)00213-X; Flusser J, 2000, PATTERN RECOGN, V33, P1405, DOI 10.1016/S0031-3203(99)00127-2; Glowinski R, 1975, APPROXIAMTION ELEMEN; Glowinski R., 1989, AUGMENTED LAGRANGIAN; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Gong LX, 2004, IEEE T MED IMAGING, V23, P340, DOI 10.1109/TMI.2004.824237; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Houhou N, 2009, LECT NOTES COMPUT SC, V5567, P112, DOI 10.1007/978-3-642-02256-2_10; Huang XJ, 2012, LECT NOTES COMPUT SC, V7512, P58, DOI 10.1007/978-3-642-33454-2_8; Huang XJ, 2014, MED IMAGE ANAL, V18, P253, DOI 10.1016/j.media.2013.10.012; Ledesma-Carbayo MJ, 2005, IEEE T MED IMAGING, V24, P1113, DOI 10.1109/TMI.2005.852050; Lee AB, 2003, INT J COMPUT VISION, V54, P83, DOI 10.1023/A:1023705401078; Lee WL, 2005, INFORM SCIENCES, V175, P177, DOI 10.1016/j.ins.2005.01.007; Lellmann J, 2011, SIAM J IMAGING SCI, V4, P1049, DOI 10.1137/100805844; Li Y, 2004, ACM SIGGRAPH; LOUPAS T, 1989, IEEE T CIRCUITS SYST, V36, P129, DOI 10.1109/31.16577; Mignotte M, 2001, PATTERN ANAL APPL, V4, P256, DOI 10.1007/PL00010988; Nieuwenhuis C., 2013, INT J COMPUTER VISIO; Noble JA, 2006, IEEE T MED IMAGING, V25, P987, DOI 10.1109/TMI.2006.877092; OOSTERVELD BJ, 1985, ULTRASONIC IMAGING, V7, P142, DOI 10.1016/0161-7346(85)90073-2; Paragios N, 2005, LECT NOTES COMPUT SC, V3459, P131; Pock T, 2009, PROC CVPR IEEE, P810, DOI 10.1109/CVPRW.2009.5206604; Revell J, 2005, IEEE T MED IMAGING, V24, P755, DOI 10.1109/TMI.2005.848331; Rother Carsten, 2004, ACM SIGGRAPH; Rueda S, 2014, IEEE T MED IMAGING, V33, P797, DOI 10.1109/TMI.2013.2276943; Sarris I, 2012, ULTRASOUND OBST GYN, V39, P266, DOI 10.1002/uog.10082; Setzer S, 2011, INT J COMPUT VISION, V92, P265, DOI 10.1007/s11263-010-0357-3; Shao F, 2003, J ULTRAS MED, V22, P605, DOI 10.7863/jum.2003.22.6.605; Shen DG, 2003, IEEE T MED IMAGING, V22, P539, DOI 10.1109/TMI.2003.809057; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; STRANG G, 1983, MATH PROGRAM, V26, P123, DOI 10.1007/BF02592050; Tao Z, 2006, IEEE T MED IMAGING, V25, P1483, DOI 10.1109/TMI.2006.881376; Unal G, 2008, IEEE T INF TECHNOL B, V12, P335, DOI 10.1109/TITB.2008.920620; Unger M, 2008, BRITISH MACHINE VISI; Xiao GF, 2002, IEEE T MED IMAGING, V21, P48, DOI 10.1109/42.981233; Xie J, 2005, IEEE T MED IMAGING, V24, P45, DOI 10.1109/TMI.2004.837792; Yan PK, 2011, IEEE T BIO-MED ENG, V58, P633, DOI 10.1109/TBME.2010.2094195; Yuan J, 2010, 1061 UCLA CAM; Zouqi M, 2009, 2009 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE FOR IMAGE PROCESSING, P33, DOI 10.1109/CIIP.2009.4937877	65	24	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100972	10.1371/journal.pone.0100972	http://dx.doi.org/10.1371/journal.pone.0100972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010530	Green Published, gold			2022-12-27	WOS:000338763800009
J	Floderer, M; Prchal-Murphy, M; Vizzardelli, C				Floderer, Melanie; Prchal-Murphy, Michaela; Vizzardelli, Caterina			Dendritic Cell-Secreted Lipocalin2 Induces CD8(+) T-Cell Apoptosis, Contributes to T-Cell Priming and Leads to a T(H)1 Phenotype	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-PHASE PROTEIN; IMMUNE-RESPONSES; INDOLEAMINE 2,3-DIOXYGENASE; CANCER; ACTIVATION; IRON; IMMUNOTHERAPY; SUPPRESSION; EXPRESSION	Lipocalin 2 (LCN2), which is highly expressed by dendritic cells (DCs) when treated with dexamethasone (Dex) and lipopolysaccharide (LPS), plays a key role in the defence against bacteria and is also involved in the autocrine apoptosis of T-cells. However, the function of LCN2 when secreted by DCs is unknown: this is a critical gap in our understanding of the regulation of innate and adaptive immune systems. Tolerance, stimulation and suppression are functions of DCs that facilitate the fine-tuning of the immune responses and which are possibly influenced by LCN2 secretion. We therefore examined the role of LCN2 in DC/T-cell interaction. WT or Lcn2(-/-) bone marrow-derived DCs were stimulated with LPS or LPS+IFN-gamma with and without Dex and subsequently co-cultured with T-cells from ovalbumin-specific TCR transgenic (OT-I and OT-II) mice. We found that CD8(+) T-cell apoptosis was highly reduced when Lcn2(-/-) DCs were compared with WT. An in vivo CTL assay, using LPS-treated DCs, showed diminished killing ability in mice that had received Lcn2(-/-) DCs compared with WT DCs. As a consequence, we analysed T-cell proliferation and found that LCN2 participates in T-cell-priming in a dose-dependent manner and promotes a T(H)1 microenvironment. DC-secreted LCN2, whose function has previously been unknown, may in fact have an important role in regulating the balance between T(H)1 and T(H)2. Our results yield insights into DC-secreted LCN2 activity, which could play a pivotal role in cellular immune therapy and in regulating immune responses.	[Floderer, Melanie; Vizzardelli, Caterina] St Anna Childrens Canc Res Inst, Lab Tumour Immunol, Vienna, Austria; [Prchal-Murphy, Michaela] Univ Vet Med Vienna, Dept Biomed Sci, Inst Pharmacol & Toxicol, Vienna, Austria	Saint Anna Children's Hospital; University of Veterinary Medicine Vienna	Vizzardelli, C (corresponding author), St Anna Childrens Canc Res Inst, Lab Tumour Immunol, Vienna, Austria.	caterina.vizzardelli@ccri.at		Vizzardelli, Caterina/0000-0001-9262-6710	St. Anna Kinderkrebsforschung	St. Anna Kinderkrebsforschung	This work was supported by St. Anna Kinderkrebsforschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 2009, J LEUKOCYTE BIOL, V85, P243, DOI 10.1189/jlb.0608374; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer M, 1999, IMMUNOLOGY, V97, P699, DOI 10.1046/j.1365-2567.1999.00811.x; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Devireddy LR, CELL, V141, P1006; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Felzmann T, 2005, CANCER IMMUNOL IMMUN, V54, P769, DOI 10.1007/s00262-004-0637-2; Felzmann T, 2002, ONKOLOGIE, V25, P456, DOI 10.1159/000067441; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Granucci F, 2008, CELL MOL LIFE SCI, V65, P1683, DOI 10.1007/s00018-008-8009-2; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harden JL, 2012, IMMUNOL INVEST, V41, P738, DOI 10.3109/08820139.2012.676122; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Huttner KG, 2005, CANCER IMMUNOL IMMUN, V54, P67, DOI 10.1007/s00262-004-0571-3; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Luger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054879; Matyszak MK, 2000, EUR J IMMUNOL, V30, P1233, DOI 10.1002/(SICI)1521-4141(200004)30:4<1233::AID-IMMU1233>3.0.CO;2-F; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nava S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052301; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Reilly PT, 2013, ONCOGENE, V32, P1233, DOI 10.1038/onc.2012.159; Ryon J, 2002, BIOCHEM J, V367, P271, DOI 10.1042/BJ20020026; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Simma O, 2009, CANCER RES, V69, P203, DOI 10.1158/0008-5472.CAN-08-1705; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Volchenkov R, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4294; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Warszawska JM, 2013, J CLIN INVEST, V123, P3363, DOI 10.1172/JCI67911; Yacoub Mona-Rita, 2012, Inflammation & Allergy Drug Targets, V11, P285; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhou F, 2013, IMMUNOL RES; Zhou F, 2012, EUR J IMMUNOL, V42, P1449, DOI 10.1002/eji.201141733; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175	55	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101881	10.1371/journal.pone.0101881	http://dx.doi.org/10.1371/journal.pone.0101881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010215	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800049
J	Baron-Cohen, S; Cassidy, S; Auyeung, B; Allison, C; Achoukhi, M; Robertson, S; Pohl, A; Lai, MC				Baron-Cohen, Simon; Cassidy, Sarah; Auyeung, Bonnie; Allison, Carrie; Achoukhi, Maryam; Robertson, Sarah; Pohl, Alexa; Lai, Meng-Chuan			Attenuation of Typical Sex Differences in 800 Adults with Autism vs. 3,900 Controls	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SPECTRUM QUOTIENT AQ; SYSTEMATIZING QUOTIENT; ASPERGER-SYNDROME; CHILDHOOD AUTISM; EMPATHY QUOTIENT; DISORDERS; GENDER; FEMALES; BRAIN	Sex differences have been reported in autistic traits and systemizing (male advantage), and empathizing (female advantage) among typically developing individuals. In individuals with autism, these cognitive-behavioural profiles correspond to predictions from the "extreme male brain" (EMB) theory of autism (extreme scores on autistic traits and systemizing, below average on empathizing). Sex differences within autism, however, have been under-investigated. Here we show in 811 adults (454 females) with autism and 3,906 age-matched typical control adults (2,562 females) who completed the Empathy Quotient (EQ), the Systemizing Quotient-Revised (SQ-R), and the Autism Spectrum Quotient (AQ), that typical females on average scored higher on the EQ, typical males scored higher on the SQ-R and AQ, and both males and females with autism showed a shift toward the extreme of the "male profile" on these measures and in the distribution of "brain types" (the discrepancy between standardized EQ and SQ-R scores). Further, normative sex differences are attenuated but not abolished in adults with autism. The findings provide strong support for the EMB theory of autism, and highlight differences between males and females with autism.	[Baron-Cohen, Simon; Cassidy, Sarah; Auyeung, Bonnie; Allison, Carrie; Achoukhi, Maryam; Robertson, Sarah; Pohl, Alexa; Lai, Meng-Chuan] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Baron-Cohen, Simon; Lai, Meng-Chuan] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge Lifespan Asperger Syndrome Serv CLASS C, Cambridge, England; [Auyeung, Bonnie] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Lai, Meng-Chuan] Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan	University of Cambridge; University of Edinburgh; National Taiwan University; National Taiwan University Hospital	Baron-Cohen, S (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	sb205@cam.ac.uk; mcl45@cam.ac.uk	Lai, Meng-Chuan/K-7407-2016; Cassidy, Sarah/K-8147-2015	Lai, Meng-Chuan/0000-0002-9593-5508; Cassidy, Sarah/0000-0003-1982-3034; Baron-Cohen, Simon/0000-0001-9217-2544	UK Medical Research Council; Wellcome Trust; Autism Research Trust; William Binks Autism Neuroscience Fellowship; European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; Medical Research Council [G0600977] Funding Source: researchfish; MRC [G0600977] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Autism Research Trust; William Binks Autism Neuroscience Fellowship; European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study received funding from the UK Medical Research Council, the Wellcome Trust, and the Autism Research Trust. Meng-Chuan Lai was supported by the William Binks Autism Neuroscience Fellowship, the European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS), and Wolfson College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2008, J AUTISM DEV DISORD, V38, P1414, DOI 10.1007/s10803-007-0509-7; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Beacher FDCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038355; Begeer S, 2013, J AUTISM DEV DISORD, V43, P1151, DOI 10.1007/s10803-012-1656-z; Bejerot S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087961; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Bolte S, 2011, AUTISM, V15, P497, DOI 10.1177/1362361310391116; Carter AS, 2007, J AUTISM DEV DISORD, V37, P86, DOI 10.1007/s10803-006-0331-7; Constantino JN, 2012, J AM ACAD CHILD PSY, V51, P756, DOI 10.1016/j.jaac.2012.05.017; Daniels AM, 2011, J AUTISM DEV DISORD, V41, P110, DOI 10.1007/s10803-010-1031-x; Dworzynski K, 2012, J AM ACAD CHILD PSY, V51, P788, DOI 10.1016/j.jaac.2012.05.018; Field A., 2013, DISCOVERING STAT USI; Frazier TW, 2014, J AM ACAD CHILD PSY, V53, P329, DOI 10.1016/j.jaac.2013.12.004; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Gould J., 2011, GOOD AUTISM PRACTICE, V12, P34; Harris A., 2011, INT M AUT RES SAN DI; Hinkka-Yli-Salomaki S, 2014, NORD J PSYCHIAT, V68, P472, DOI 10.3109/08039488.2013.861017; Holtmann M, 2007, DEV MED CHILD NEUROL, V49, P361, DOI 10.1111/j.1469-8749.2007.00361.x; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Jensen CM, 2014, J AUTISM DEV DISORD, V44, P1808, DOI 10.1007/s10803-014-2053-6; Kirkovski M, 2013, J AUTISM DEV DISORD, V43, P2584, DOI 10.1007/s10803-013-1811-1; Knickmeyer RC, 2008, J AUTISM DEV DISORD, V38, P1028, DOI 10.1007/s10803-007-0475-0; Kreiser NL, 2014, CLIN CHILD FAM PSYCH, V17, P67, DOI 10.1007/s10567-013-0148-9; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lai MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047198; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lemler M, 2012, DISCUSSIONS, V8, P2; Lemon JM, 2011, J AUTISM DEV DISORD, V41, P352, DOI 10.1007/s10803-010-1039-2; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Mattila ML, 2011, J AM ACAD CHILD PSY, V50, P583, DOI 10.1016/j.jaac.2011.04.001; MCLENNAN JD, 1993, J AUTISM DEV DISORD, V23, P217, DOI 10.1007/BF01046216; Pilowsky T, 1998, J AUTISM DEV DISORD, V28, P143, DOI 10.1023/A:1026092632466; Pohl A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-27; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Saemundsen E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002748; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Schaafsma SM, 2014, FRONT NEUROENDOCRIN, V35, P255, DOI 10.1016/j.yfrne.2014.03.006; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Szatmari P, 2012, AM J MED GENET B, V159B, P5, DOI 10.1002/ajmg.b.31238; Van Wijngaarden-Cremers PJM, 2014, J AUTISM DEV DISORD, V44, P627, DOI 10.1007/s10803-013-1913-9; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; WING L, 1981, PSYCHIAT RES, V5, P129, DOI 10.1016/0165-1781(81)90043-3	58	99	106	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102251	10.1371/journal.pone.0102251	http://dx.doi.org/10.1371/journal.pone.0102251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029203	Green Published, gold			2022-12-27	WOS:000341306600051
J	Li, N; Yang, L; Ou, W; Zhang, L; Zhang, SL; Wang, SY				Li, Ning; Yang, Lu; Ou, Wei; Zhang, Liang; Zhang, Song-liang; Wang, Si-yu			Meta-Analysis of EGFR Tyrosine Kinase Inhibitors Compared with Chemotherapy as Second-Line Treatment in Pretreated Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PHASE-III TRIAL; PROGRESSION-FREE SURVIVAL; OPEN-LABEL; RANDOMIZED-TRIAL; SUPPORTIVE CARE; GEFITINIB; DOCETAXEL; ERLOTINIB; EFFICACY; MULTICENTER	Background: Since efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) versus chemotherapy in the treatment of patients with pretreated advanced non-small cell lung cancer (NSCLC) remain controversial, we performed a meta-analysis to compare them. Methods: An internet search of several databases was performed, including PubMed, Embase, and the Cochrane database. Randomized trials that compared an EGFR-TKI with chemotherapy in the second-line setting were included. The outcomes were progression-free survival (PFS), overall survival (OS), objective response rate (ORR), and grade 3-4 toxicities. The PFS, OS for the EGFR mutation-positive (EGFR M+) and EGFR mutation-negative (EGFR M-) subgroups were pooled. The pooled hazard ratios (HRs) and odds ratios (ORs) with their corresponding confidence intervals (CIs) were calculated on the STATA software. Results: Our meta-analysis combined 3,825 patients from 10 randomized trials. Overall, EGFR-TKIs and second-line chemotherapy have equivalent efficacy in terms of PFS (HR, 1.03; 95% CI, 0.87-1.21; P = 0.73; I-2 = 78.7%, P-heterogeneity<0.001), OS (HR, 1.00; 95% CI, 0.92-1.08; P = 0.90; I-2 = 0.0%, P-heterogeneity = 0.88), and ORR (OR, 1.34; 95% CI, 0.86-2.08; P = 0.20; I-2 = 73.1%, P-heterogeneity<0.001). However, subgroup analysis based on EGFR mutation status showed that second-line chemotherapy significantly improved PFS (HR, 1.35; 95% CI, 1.09-1.66; P = 0.01; I-2 = 55.7%, P-heterogeneity = 0.046) for EGFR M- patients, whereas OS was equal (HR, 0.96; 95% CI, 0.77-1.19; P = 0.69; I-2 = 0.0%, P-heterogeneity = 0.43); EGFR-TKIs significantly improved PFS (HR, 0.28; 95% CI, 0.15-0.53; P<0.001; I-2 = 4.1%, P-heterogeneity = 0.35) for EGFR M+ patients, whereas OS was equal (HR, 0.86; 95% CI, 0.44-1.68; P = 0.65; I-2 = 0.0%, P-heterogeneity = 0.77). Compared with chemotherapy, EGFR-TKIs led to more grade 3-4 rash, but less fatigue/asthenia disorder, leukopenia and thrombocytopenia. Conclusions: Our analysis suggests that chemotherapy in the second-line setting can prolong PFS in EGFR M- patients, whereas it has no impact on OS. EGFR-TKIs seem superior over chemotherapy as second-line therapy for EGFR M+ patients. Our findings support obtaining information on EGFR mutational status before initiation of second-line treatment.	[Li, Ning; Ou, Wei; Zhang, Song-liang; Wang, Si-yu] Sun Yat Sen Univ, Dept Thorac Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Lu] Sun Yat Sen Univ, Dept Breast Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Liang] Tianjin First Ctr Hosp, Dept Thorac Surg, Tianjin, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, SY (corresponding author), Sun Yat Sen Univ, Dept Thorac Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	wsysums@163.net		Wang, Si-Yu/0000-0002-7603-2012				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Cufer T, 2006, ANTI-CANCER DRUG, V17, P401, DOI 10.1097/01.cad.0000203381.99490.ab; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gao GH, 2013, J CLIN ONCOL, V31; Garassino MC, 2012, J CLIN ONCOL S, V30; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hotta K, 2013, LUNG CANCER, V79, P20, DOI 10.1016/j.lungcan.2012.10.007; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karampeazis A, 2013, CANCER-AM CANCER SOC, V119, P2754, DOI 10.1002/cncr.28132; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lee DH, 2010, CLIN CANCER RES, V16, P1307, DOI 10.1158/1078-0432.CCR-09-1903; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mok TSK, 2009, J CLIN ONCOL, V27, P5080, DOI 10.1200/JCO.2008.21.5541; Okano Y, 2013, J CLIN ONCOL, V31; Paz-Ares L, 2012, LANCET ONCOL, V13, P225, DOI 10.1016/S1470-2045(12)70001-3; Qi WX, 2012, ASIAN PAC J CANCER P, V13, P5177, DOI 10.7314/APJCP.2012.13.10.5177; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Soria JC, 2010, ANN ONCOL, V21, P2324, DOI 10.1093/annonc/mdq204; Sun JM, 2012, CANCER-AM CANCER SOC, V118, P6234, DOI 10.1002/cncr.27630; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang SY, 2013, J CLIN ONCOL S, V31, P2013; Yang JJ, 2013, J CLIN ONCOL, V31	34	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102777	10.1371/journal.pone.0102777	http://dx.doi.org/10.1371/journal.pone.0102777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029199	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600099
J	Love, DC; Fry, JP; Genello, L; Hill, ES; Frederick, JA; Li, XM; Semmens, K				Love, David C.; Fry, Jillian P.; Genello, Laura; Hill, Elizabeth S.; Frederick, J. Adam; Li, Ximin; Semmens, Ken			An International Survey of Aquaponics Practitioners	PLOS ONE			English	Article							FISH; AQUACULTURE; WATER; AQUAFEEDS	Aquaponics, a combination of fish farming and soilless plant farming, is growing in popularity and gaining attention as an important and potentially more sustainable method of food production. The aim of this study was to document and analyze the production methods, experiences, motivations, and demographics of aquaponics practitioners in the United States (US) and internationally. The survey was distributed online using a chain sampling method that relied on referrals from initial respondents, with 809 respondents meeting the inclusion criteria. The majority of respondents were from the US (80%), male (78%), and had at least a high school degree (91%). The mean age of respondents was 47613 years old. Most respondents (52%) had three years or less of aquaponics experience. Respondents typically raised tilapia or ornamental fish and a variety of leafy green vegetables, herbs, and fruiting crops. Respondents were most often motivated to become involved in aquaponics to grow their own food, for environmental sustainability reasons, and for personal health reasons. Many respondents employed more than one method to raise crops, and used alternative or environmentally sustainable sources of energy, water, and fish feed. In general, our findings suggest that aquaponics is a dynamic and rapidly growing field with participants who are actively experimenting with and adopting new technologies. Additional research and outreach is needed to evaluate and communicate best practices within the field. This survey is the first large-scale effort to track aquaponics in the US and provides information that can better inform policy, research, and education efforts regarding aquaponics as it matures and possibly evolves into a mainstream form of agriculture.	[Love, David C.; Fry, Jillian P.; Genello, Laura] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA; [Love, David C.; Fry, Jillian P.; Genello, Laura] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Hill, Elizabeth S.] Univ Maryland Extens, Baltimore, MD USA; [Frederick, J. Adam] Univ Maryland, Maryland Sea Grant Coll, College Pk, MD 20742 USA; [Li, Ximin] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Semmens, Ken] W Virginia Univ, Agr & Nat Resources Unit, Extens Serv, Morgantown, WV 26506 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; West Virginia University	Love, DC (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA.	dlove@jhsph.edu		Li, Ximin/0000-0002-0460-6515	Johns Hopkins Center for a Livable Future with a gift from the GRACE Communications Foundation	Johns Hopkins Center for a Livable Future with a gift from the GRACE Communications Foundation	The work was funded by the Johns Hopkins Center for a Livable Future with a gift from the GRACE Communications Foundation (www.gracelinks.org) who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blidariu F., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P1; BOHL M, 1977, AQUACULTURE, V11, P323, DOI 10.1016/0044-8486(77)90081-3; COLLINS MT, 1975, J FISH RES BOARD CAN, V32, P2025, DOI 10.1139/f75-238; Dalrymple D.G., 1973, CONTROLLED ENV AGR G; Falah M. A. F., 2013, International Journal of Agricultural Technology, V9, P769; Florida Fish and Wildlife Conservation Commission, 2014, AQ LIC PERM; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gericke WF, 1940, COMPLETE GUIDE SOILL; Goodman E. R, 2011, AQUAPONICS COMMUNITY; Hardy RW, 2002, RESPONSIBLE MARINE AQUACULTURE, P311, DOI 10.1079/9780851996042.0311; Lennard WA, 2006, AQUACULT INT, V14, P539, DOI 10.1007/s10499-006-9053-2; LEWIS WM, 1978, T AM FISH SOC, V107, P92, DOI 10.1577/1548-8659(1978)107<92:UOHTMQ>2.0.CO;2; Licamele J.D., 2009, BIOMASS PRODUCTION N; McMurtry M, 1992, THESIS N CAROLINA ST; MCMURTRY M R, 1990, Applied Agricultural Research, V5, P280; Metcalf SS, 2011, APPL GEOGR, V31, P1242, DOI 10.1016/j.apgeog.2011.01.008; Mollison B, 1981, PERMACULTURE ONE PER; NAEGEL LCA, 1977, AQUACULTURE, V10, P17, DOI 10.1016/0044-8486(77)90029-1; Naylor R, 2005, ANNU REV ENV RESOUR, V30, P185, DOI 10.1146/annurev.energy.30.081804.121034; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; New South Wales Department of Primary Industries, 2014, TIL; POPMA T. J., 1995, WORLDWIDE PROSPECTS; Rakocy J.E., 2012, AQUACULTURE PRODUCTI, P344, DOI [10.1002/9781118250105.CH14, DOI 10.1002/9781118250105.CH14, 10.1002/9781118250105.ch14]; Rakocy JE, 2006, SRAC PUBL, V454; Rakocy JE, 1984, RECIRCULATING SYSTEM, P103; Shultz RC, 2014, EVOLUTION AQUAPONICS; Smyth JoleneD., 2008, INTERNET MAIL MIXED; Sneed K., 1975, AQUACULTURE FISH FAR, V1, P18; SUTTON RJ, 1982, PROG FISH CULT, V44, P55, DOI 10.1577/1548-8659(1982)44[55:FOOAFP]2.0.CO;2; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Timmons MB., 2010, RECIRCULATING AQUACU; Todd J., 1980, J NEW ALCHEMISTS, V6, P108; Tortorello M, 2010, SPOTLESS GARDEN; US Department of Agriculture (USDA), 2007, CENS AGR FARM AG; *USDA, 2006, CENS AQ 2005, V3; Wardlow George W., 2002, Journal of Natural Resources and Life Sciences Education, V31, P55; Watson AM, 2013, LIPIDS, V48, P899, DOI 10.1007/s11745-013-3814-2; WATTEN BJ, 1984, AQUACULTURE, V41, P271, DOI 10.1016/0044-8486(84)90290-4; Zweig R.D., 1986, AQUAC MAG, V12, P34	39	99	107	6	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102662	10.1371/journal.pone.0102662	http://dx.doi.org/10.1371/journal.pone.0102662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029125	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600090
J	Till, B; Tran, US; Voracek, M; Sonneck, G; Niederkrotenthaler, T				Till, Benedikt; Tran, Ulrich S.; Voracek, Martin; Sonneck, Gernot; Niederkrotenthaler, Thomas			Associations between Film Preferences and Risk Factors for Suicide: An Online Survey	PLOS ONE			English	Article							ADOLESCENT SMOKING INITIATION; TELEVISION; IMPACT; SCALE; HOPELESSNESS; PORTRAYALS; RECEPTION; MOVIES	Several studies indicate that exposure to suicide in movies is linked to subsequent imitative suicidal behavior, so-called copycat suicides, but little is currently known about whether the link between exposure to suicidal movies and suicidality is reflected in individual film preferences. 943 individuals participated in an online survey. We assessed associations between preferred film genres as well as individual exposure to and rating of 50 pre-selected films (including 25 featuring a suicide) with suicidal ideation, hopelessness, depression, life satisfaction, and psychoticism. Multiple regression analyses showed that preferences for film noir movies and milieu dramas were associated with higher scores on suicidal ideation, depression and psychoticism, and low scores on life satisfaction. Furthermore, preferences for thrillers and horror movies as well as preferences for tragicomedies, tragedies and melodramas were associated with higher scores of some of the suicide risk factors. There was also a dose-response relationship between positive rating of suicide films and higher life satisfaction. Due to the cross-sectional design of the study causality cannot be assessed. Individual film genre preferences seem to reflect risk factors of suicide, with film genres focusing on sad contents being preferred by individuals with higher scores on suicide risk factors. However, suicide movies are more enjoyed by viewers with higher life satisfaction, which may reflect a better ability to cope with such content.	[Till, Benedikt; Niederkrotenthaler, Thomas] Med Univ Vienna, Ctr Publ Hlth, Inst Social Med, Suicide Res Unit, Vienna, Austria; [Tran, Ulrich S.; Voracek, Martin] Univ Vienna, Sch Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Voracek, Martin] Univ Gottingen, Georg Elias Muller Dept Psychol, D-37073 Gottingen, Germany; [Sonneck, Gernot] Crisis Intervent Ctr, Vienna, Austria; [Sonneck, Gernot] Ludwig Boltzmann Inst Social Psychiat, Vienna, Austria	Medical University of Vienna; University of Vienna; University of Gottingen; Ludwig Boltzmann Institute	Till, B (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Inst Social Med, Suicide Res Unit, Vienna, Austria.	benedikt.till@meduniwien.ac.at	Voracek, Martin/S-5865-2016	Voracek, Martin/0000-0001-6109-6155; Niederkrotenthaler, Thomas/0000-0001-9550-628X; Tran, Ulrich/0000-0002-6589-3167; Till, Benedikt/0000-0002-2099-5469	Medical University of Vienna; University of Vienna	Medical University of Vienna; University of Vienna	Benedikt Till's and Thomas Niederkrotenthaler's salary was funded by the Medical University of Vienna. Ulrich Tran's and Martin Voracek's salary was funded by the University of Vienna. This work was not funded by any grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1988, MANUAL BECK HOPELESS; BECK AT, 1990, AM J PSYCHIAT, V147, P190; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; de Wied M., 1994, POETICS, V23, P91, DOI 10.1016/0304-422X(94)00010-4; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dirks T, 2014, MELODRAMA FILMS; Etzersdorfer E, 1998, ARCH SUICIDE RES, V4, P67, DOI 10.1080/13811119808258290; Etzersdorfer E, 2008, SUIZIDALITAT MEDIEN, P33; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gehring W.D., 1988, HDB AM FILM GENRES; GERBNER G, 1980, J COMMUN, V30, P10, DOI 10.1111/j.1460-2466.1980.tb01987.x; Gerbner G., 1986, PERSPECTIVES MEDIA E, P17; Gill, 1988, SUICIDE PROBABILITY; GOULD MS, 1986, NEW ENGL J MED, V315, P690, DOI 10.1056/NEJM198609113151107; Hamiltion C, 2013, THEORY THEATRE OTHER; Holmes BM, 2009, SOCIAL PSYCHOLOGY: NEW RESEARCH, P117; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Krampen G., 1994, SKALEN ERFASSUNG HOF; LEHRL S, 1983, ERLANGER DEPRESSIONS; MARES ML, 1992, COMMUN RES, V19, P459, DOI 10.1177/009365092019004004; Martin G, 1998, ARCH SUICIDE RES, V4, P51, DOI 10.1023/A:1009635819191; Martin G, 1996, ARCH SUICIDE RES, V2, P103, DOI 10.1080/13811119608251960; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Nabi RL, 2006, J COMMUN, V56, P689, DOI 10.1111/j.1460-2466.2006.00315.x; Naremore J, 1995, FILM Q, V49, P12; OSTROFF RB, 1987, NEW ENGL J MED, V316, P876; Ringel E, 1997, SELBSTMORD ABSCHLUSS; Sargent JD, 2005, PEDIATRICS, V116, P1183, DOI 10.1542/peds.2005-0714; Sargent JD, 2004, PEDIATRICS, V114, P149, DOI 10.1542/peds.114.1.149; Sargent JD, 2001, BRIT MED J, V323, P1394, DOI 10.1136/bmj.323.7326.1394; SCHMIDTKE A, 1988, PSYCHOL MED, V18, P665, DOI 10.1017/S0033291700008345; STACK S, 2008, SUIZIDALITAT MEDIEN, P59; Stack S., 2014, SOCIOL FOCUS, V47, P61, DOI [DOI 10.1080/00380237.2014.856707, https://doi.org/10.1080/00380237.2014.856707]; Stack S, 2014, SUICIDE LIFE-THREAT, V44, P46, DOI 10.1111/sltb.12054; Stack Steven, 2012, SUICIDE MOVIES SOCIA; Statistik Austria, 2011, BILD BEV ALT 25 BIS; Till B, 2011, J MEDIA PSYCHOL-GER, V23, P149, DOI 10.1027/1864-1105/a000048; Till B, 2013, DEATH STUD, V37, P383, DOI 10.1080/07481187.2012.673531; Till B, 2010, SUICIDE LIFE-THREAT, V40, P319, DOI 10.1521/suli.2010.40.4.319; Zillmann D., 1988, COMMUNICATION SOCIAL, P157	43	10	10	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102293	10.1371/journal.pone.0102293	http://dx.doi.org/10.1371/journal.pone.0102293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25028966	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600057
J	DeFaveri, J; Shikano, T; Merila, J				DeFaveri, Jacquelin; Shikano, Takahito; Merila, Juha			Geographic Variation in Age Structure and Longevity in the Nine-Spined Stickleback (Pungitius pungitius)	PLOS ONE			English	Article							LIFE-HISTORY; NINESPINE STICKLEBACK; GROWTH; FISH; SIZE; POPULATIONS; EVOLUTION; GASTEROSTEUS; FORMALDEHYDE; PARAMETERS	Variation in age and size of mature nine-spined sticklebacks (Pungitius pungitius) within and among 16 Fennoscandian populations were assessed using skeletochronology. The average age of individuals in a given population varied from 1.7 to 4.7 years. Fish from pond populations were on average older than those from lake and marine populations, and females tended to be older than males. Reproduction in marine and lake populations commenced typically at an age of two years, whereas that in ponds at an age of three years. The maximum life span of the fish varied from 3 to 7 years. Mean body size within and among populations increased with increasing age, but the habitat and population differences in body size persisted even after accounting for variation in population age (and sex) structure. Hence, the population differences in mean body size are not explainable by age differences alone. As such, much of the pronounced intraspecific variation in population age structure can be attributed to delayed maturation and extended longevity of the pond fish. The results are contrasted and discussed in the context of similar data from the three-spined stickleback (Gasterosteus aculeatus) occupying the same geographic area.	[DeFaveri, Jacquelin; Shikano, Takahito; Merila, Juha] Univ Helsinki, Ecol Genet Res Unit, Dept Biosci, Helsinki, Finland	University of Helsinki	Merila, J (corresponding author), Univ Helsinki, Ecol Genet Res Unit, Dept Biosci, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008; Shikano, Takahito/D-7347-2015	Merila, Juha/0000-0001-9614-0072; 	Academy of Finland [265211]	Academy of Finland(Academy of Finland)	The authors' research was supported by Academy of Finland (grant # 265211 to JM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Ghani NI, 2012, BIOL J LINN SOC, V107, P521, DOI 10.1111/j.1095-8312.2012.01956.x; ALM GUNNAR, 1959, REPT INST FRESHWATER RES DROTTNINGHOLM, V40, P5; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Baker J, 1994, EVOLUTIONARY BIOL TH; Baker JA, 2008, BEHAVIOUR, V145, P579, DOI 10.1163/156853908792451539; BECK SD, 1971, ANN ENTOMOL SOC AM, V64, P946, DOI 10.1093/aesa/64.4.946; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BERVEN KA, 1983, AM ZOOL, V23, P85; Beverton R.J.H., 1959, CIBA FDN C AGEING, V5, P142, DOI DOI 10.1002/9780470715253.CH10; BEVERTON RJH, 1992, J FISH BIOL, V41, P137, DOI 10.1111/j.1095-8649.1992.tb03875.x; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; COAD BW, 1973, AM MIDL NAT, V90, P498, DOI 10.2307/2424479; DeFaveri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080866; DRYER WR, 1966, T AM FISH SOC, V95, P248, DOI 10.1577/1548-8659(1966)95[248:BDOFIT]2.0.CO;2; Fox CJ, 1996, J PLANKTON RES, V18, P483, DOI 10.1093/plankt/18.4.483; FOX MG, 1991, CAN J FISH AQUAT SCI, V48, P1792, DOI 10.1139/f91-211; Gallagher CP, 2011, ECOL FRESHW FISH, V20, P646, DOI 10.1111/j.1600-0633.2011.00516.x; Gambling SJ, 2012, CAN J ZOOL, V90, P284, DOI 10.1139/Z11-133; Ghani NIA, 2013, J EVOLUTION BIOL, V26, P775, DOI 10.1111/jeb.12085; GRISWOLD BL, 1973, FISH B-NOAA, V71, P1039; Heibo E, 2005, ECOLOGY, V86, P3377, DOI 10.1890/04-1620; Herczeg G, 2012, EVOL ECOL, V26, P109, DOI 10.1007/s10682-011-9491-9; Herczeg G, 2009, EVOLUTION, V63, P3190, DOI 10.1111/j.1558-5646.2009.00781.x; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; JONES JW, 1950, J ANIM ECOL, V19, P59, DOI 10.2307/1571; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; JORDE PE, 1995, GENETICS, V139, P1077; Kainulainen-Immonen T, 1980, THESIS U TURKU; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kristoffersen JB, 1998, SARSIA, V83, P95; Kuusela K, 2006, INT VER THEOR ANGEW, V29, P1409; LEINER M., 1934, ZEITSCH WISS BIOL ABT A ZEITSCH MORPH U OKOL TIERE, V28, P107, DOI 10.1007/BF00424080; Lucek K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049377; Mangel M, 2001, EXP GERONTOL, V36, P765, DOI 10.1016/S0531-5565(00)00240-0; Merila J, 2013, ANN NY ACAD SCI, V1289, P18, DOI 10.1111/nyas.12089; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Morita K, 2006, EVOLUTION, V60, P1516, DOI 10.1111/j.0014-3820.2006.tb01230.x; Moser D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050620; Neat FC, 2008, J FISH BIOL, V73, P2527, DOI 10.1111/j.1095-8649.2008.02107.x; Ostlund-Nilsson S., 2010, BIOL 3 SPINED STICKL; PENCZAK T, 1981, EKOL POL-POL J ECOL, V29, P233; POLICANSKY D, 1983, AM ZOOL, V23, P57; REIMCHEN TE, 1992, CAN FIELD NAT, V106, P122; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; ROFF DA, 1984, CAN J FISH AQUAT SCI, V41, P989, DOI 10.1139/f84-114; Roff Derek A., 1992; SCHRAMM HL, 1989, T AM FISH SOC, V118, P546, DOI 10.1577/1548-8659(1989)118<0546:FOAIOO>2.3.CO;2; Shikano T, 2013, G3-GENES GENOM GENET, V3, P1833, DOI 10.1534/g3.113.007237; Shikano Takahito, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-119; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Shimada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028859; SHIRVELL CS, 1981, J FISH BIOL, V18, P377, DOI 10.1111/j.1095-8649.1981.tb03779.x; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; Teacher AGF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019476; Waples RS, 2010, MOL ECOL RESOUR, V10, P785, DOI 10.1111/j.1755-0998.2010.02876.x; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	56	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102660	10.1371/journal.pone.0102660	http://dx.doi.org/10.1371/journal.pone.0102660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025183	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400098
J	Stein, P; Gogoll, K; Tenzer, S; Schild, H; Stevanovic, S; Langguth, P; Radsak, MP				Stein, Pamela; Gogoll, Karsten; Tenzer, Stefan; Schild, Hansjoerg; Stevanovic, Stefan; Langguth, Peter; Radsak, Markus P.			Efficacy of Imiquimod-Based Transcutaneous Immunization Using a Nano-Dispersed Emulsion Gel Formulation	PLOS ONE			English	Article							MELANOMA PATIENTS; DENDRITIC CELLS; IMMUNOTHERAPY; VACCINATION; DELIVERY; PEPTIDE; PROTEIN; PERSPECTIVE; ACTIVATION; LIGATION	Background: Transcutaneous immunization (TCI) approaches utilize skin associated lymphatic tissues to elicit specific immune responses. In this context, the imidazoquinoline derivative imiquimod formulated in Aldara applied onto intact skin together with a cytotoxic T lymphocyte (CTL) epitope induces potent CTL responses. However, the feasibility and efficacy of the commercial imiquimod formulation Aldara is limited by its physicochemical properties as well as its immunogenicity. Methodology/Principal Findings: To overcome these obstacles, we developed an imiquimod-containing emulsion gel (IMI-Gel) and characterized it in comparison to Aldara for rheological properties and in vitro mouse skin permeation in a Franz diffusion cell system. Imiquimod was readily released from Aldara, while IMI-Gel showed markedly decreased drug release. Nevertheless, comparing vaccination potency of Aldara or IMI-Gel-based TCI in C57BL/6 mice against the model cytotoxic T-lymphocyte epitope SIINFEKL, we found that IMI-Gel was equally effective in terms of the frequency of peptide-specific T-cells and in vivo cytolytic activity. Importantly, transcutaneous delivery of IMI-Gel for vaccination was clearly superior to the subcutaneous or oral route of administration. Finally, IMI-Gel based TCI was at least equally effective compared to Aldara-based TCI in rejection of established SIINFEKL-expressing E. G7 tumors in a therapeutic setup indicated by enhanced tumor rejection and survival. Conclusion/Significance: In summary, we developed a novel imiquimod formulation with feasible pharmaceutical properties and immunological efficacy that fosters the rational design of a next generation transcutaneous vaccination platform suitable for the treatment of cancer or persistent virus infections.	[Stein, Pamela; Tenzer, Stefan; Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Inst Immunol, Med Ctr, Mainz, Germany; [Gogoll, Karsten; Langguth, Peter] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany; [Stevanovic, Stefan] Univ Tubingen, Dept Immunol, Tubingen, Germany; [Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Dept Med 3, Med Ctr, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz	Radsak, MP (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med 3, Med Ctr, D-55122 Mainz, Germany.	radsak@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020; Radsak, Markus P/L-3651-2013	Tenzer, Stefan/0000-0003-3034-0017; Radsak, Markus P/0000-0002-3991-5721	Deutsche Forschungsgemeinschaft [KFO 183, Ra988/4-2]; CI3 Cluster [BMBF 131A035A, GRK 1043]; "Forschungszentrum Immunologie (FZI)'' of the University Medical Center Mainz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CI3 Cluster; "Forschungszentrum Immunologie (FZI)'' of the University Medical Center Mainz	This work was supported by grants from the Deutsche Forschungsgemeinschaft KFO 183 to M.P.R. and H.S. (Ra988/4-2), CI3 Cluster (BMBF 131A035A, the GRK 1043 International Graduate School of Immunotherapy (H.S.), "Forschungszentrum Immunologie (FZI)'' of the University Medical Center Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2008, J IMMUNOL, V181, P776, DOI 10.4049/jimmunol.181.1.776; Bal SM, 2010, J CONTROL RELEASE, V148, P266, DOI 10.1016/j.jconrel.2010.09.018; De Paula D, 2008, BIOMED CHROMATOGR, V22, P1416, DOI 10.1002/bmc.1075; Edwards L, 1998, ARCH DERMATOL, V134, P25, DOI 10.1001/archderm.134.1.25; Feyerabend S, 2009, PROSTATE, V69, P917, DOI 10.1002/pros.20941; Glenn GM, 1998, NATURE, V391, P851, DOI 10.1038/36014; Gogoll K, 2012, BIOPHARM DRUG DISPOS, V33, P218, DOI 10.1002/bdd.1787; Hilleman MR, 2000, VACCINE, V18, P1436, DOI 10.1016/S0264-410X(99)00434-X; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Knorr F, 2009, EUR J PHARM BIOPHARM, V71, P173, DOI 10.1016/j.ejpb.2008.11.001; Matsuo K, 2013, VACCINE, V31, P2403, DOI 10.1016/j.vaccine.2013.03.022; Matsuo K, 2011, BIOL PHARM BULL, V34, P586, DOI 10.1248/bpb.34.586; Mikszta JA, 2008, EXPERT REV VACCINES, V7, P1329, DOI 10.1586/14760584.7.9.1329; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Navi Daniel, 2004, Dermatol Online J, V10, P4; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Stein P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027911; Stein P, 2011, J INVEST DERMATOL, V131, P211, DOI 10.1038/jid.2010.254; Stoitzner P, 2008, J IMMUNOL, V180, P1991, DOI 10.4049/jimmunol.180.3.1991; van den Berg JH, 2010, J CONTROL RELEASE, V141, P234, DOI 10.1016/j.jconrel.2009.09.005; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Warger T, 2007, CLIN REV ALLERG IMMU, V32, P57, DOI 10.1007/s12016-007-0020-0; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015	28	30	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102664	10.1371/journal.pone.0102664	http://dx.doi.org/10.1371/journal.pone.0102664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025233	Green Submitted, gold, Green Published			2022-12-27	WOS:000339992400100
J	Navarro, A; Fos, S; Laguna, E; Duran, D; Rey, L; Rubio-Sanz, L; Imperial, J; Ruiz-Argueso, T				Navarro, Albert; Fos, Simon; Laguna, Emilio; Duran, David; Rey, Luis; Rubio-Sanz, Laura; Imperial, Juan; Ruiz-Argueeso, Tomas			Conservation of Endangered Lupinus mariae-josephae in Its Natural Habitat by Inoculation with Selected, Native Bradyrhizobium Strains	PLOS ONE			English	Article							GENETIC DIVERSITY; SOILS; REGION; DIVERSIFICATION; POPULATIONS; SERRADELLA; NODULATION; FABACEAE; ALBUS	Lupinus mariae-josephae is a recently discovered endemism that is only found in alkaline-limed soils, a unique habitat for lupines, from a small area in Valencia region (Spain). In these soils, L. mariae-josephae grows in just a few defined patches, and previous conservation efforts directed towards controlled plant reproduction have been unsuccessful. We have previously shown that L. mariae-josephae plants establish a specific root nodule symbiosis with bradyrhizobia present in those soils, and we reasoned that the paucity of these bacteria in soils might contribute to the lack of success in reproducing plants for conservation purposes. Greenhouse experiments using L. mariae-josephae trap-plants showed the absence or near absence of L. mariae-josephae-nodulating bacteria in "terra rossa'' soils of Valencia outside of L. mariae-josephae plant patches, and in other "terra rossa'' or alkaline red soils of the Iberian Peninsula and Balearic Islands outside of the Valencia L. mariae-josephae endemism region. Among the bradyrhizobia able to establish an efficient symbiosis with L. mariae-josephae plants, two strains, LmjC and LmjM3 were selected as inoculum for seed coating. Two planting experiments were carried out in consecutive years under natural conditions in areas with edapho-climatic characteristics identical to those sustaining natural L. mariae-josephae populations, and successful reproduction of the plant was achieved. Interestingly, the successful reproductive cycle was absolutely dependent on seedling inoculation with effective bradyrhizobia, and optimal performance was observed in plants inoculated with LmjC, a strain that had previously shown the most efficient behavior under controlled conditions. Our results define conditions for L. mariae-josephae conservation and for extension to alkaline-limed soil habitats, where no other known lupine can thrive.	[Navarro, Albert; Fos, Simon; Laguna, Emilio] Generalitat Valenciana, Conselleria Infraestruct Terr & Medio Ambiente, Serv Vida Silvestre, VAERSA,CIEF, Valencia, Spain; [Duran, David; Rey, Luis; Rubio-Sanz, Laura; Imperial, Juan; Ruiz-Argueeso, Tomas] Univ Politecn Madrid, CBGP, Pozuelo De Alarcon, Madrid, Spain; [Duran, David; Rey, Luis; Rubio-Sanz, Laura; Imperial, Juan; Ruiz-Argueeso, Tomas] Univ Politecn Madrid, Dept Biotecnol ETSI Agronomos, Pozuelo De Alarcon, Madrid, Spain; [Rubio-Sanz, Laura] Univ Politecn Madrid, Escuela Ingenieros Tecn Agr, Madrid, Spain; [Imperial, Juan] CSIC, Madrid, Spain	Center for Forestry Research & Experimentation (CIEF); Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Ruiz-Argueso, T (corresponding author), Univ Politecn Madrid, CBGP, Campus Montegancedo, Pozuelo De Alarcon, Madrid, Spain.	t.ruizargueso@upm.es	imperial, Juan/G-3925-2015; Rey, Luis/A-3389-2014; Ruiz-Argueso, TOMAS-ANDRES/I-1803-2015; Lumbreras, Emilio Laguna/H-9518-2015; Wendt, David Duran/A-2031-2019	imperial, Juan/0000-0002-5002-6458; Rey, Luis/0000-0003-3477-6942; Ruiz-Argueso, TOMAS-ANDRES/0000-0001-9118-3065; Lumbreras, Emilio Laguna/0000-0002-9674-2767; Wendt, David Duran/0000-0003-3940-3395; Fos Martin, Simon/0000-0003-0976-5459; Laura, Rubio-Sanz/0000-0003-4144-4428	FBBVA [BIOCON08-078]; Comunidad de Madrid [Microambiente S2009/AMB-1551]; MICINN (MICROGEN) [Consolider Ingenio 2010 CSD2009-00006, CGL2011-26932]	FBBVA(BBVA Foundation); Comunidad de Madrid(Comunidad de Madrid); MICINN (MICROGEN)	This research was supported by FBBVA (BIOCON08-078) and Comunidad de Madrid (Microambiente S2009/AMB-1551) to TRA and by MICINN (MICROGEN, Consolider Ingenio 2010 CSD2009-00006, and CGL2011-26932) to JI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilella A, 2010, COLECCION BIODIVERSI, V18; Ainouche A, 2004, PLANT SYST EVOL, V246, P211, DOI 10.1007/s00606-004-0149-8; Ainouche AK, 1999, AM J BOT, V86, P590, DOI 10.2307/2656820; Allison L.E., 1965, METHODS SOIL ANAL, P1379, DOI DOI 10.2134/AGRONMONOGR9.2.C40; AMARGER N, 1983, AGRONOMIE, V3, P995, DOI 10.1051/agro:19831008; Botha WJ, 2002, BIOL FERT SOILS, V36, P335, DOI 10.1007/s00374-002-0540-y; Duran D, 2013, SYST APPL MICROBIOL, V36, P128, DOI 10.1016/j.syapm.2012.10.008; Eastwood R. J., 2008, Lupins for health and wealth. Proceedings of the 12th International Lupin Conference, Fremantle, Western Australia, 14-18 September 2008, P346; Fos S., 2006, TOLL NEGRE, V8, P21; Gladstones J. S., 1998, P1; Ramirez-Bahena MH, 2012, SYST APPL MICROBIOL, V35, P334, DOI 10.1016/j.syapm.2012.05.003; Howieson John G., 1998, P149; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Jarabo-Lorenzo A, 2003, SYST APPL MICROBIOL, V26, P611, DOI 10.1078/072320203770865927; Kerley SJ, 2000, PLANT SOIL, V218, P197, DOI 10.1023/A:1014967720952; Laguna E, 2004, BIOL CONSERV, V119, P421, DOI 10.1016/j.biocon.2004.01.001; Mahe F, 2011, GENET RESOUR CROP EV, V58, P101, DOI 10.1007/s10722-010-9580-6; Merino E, 2008, J GEOL, V116, P62, DOI 10.1086/524675; Muhs DR, 2010, QUATERNARY SCI REV, V29, P2518, DOI 10.1016/j.quascirev.2010.04.013; Navarro Peris A.J., 2006, FLORA MONTIBERICA, P59; Pascual Higinio, 2004, Anales del Jardin Botanico de Madrid, V61, P69; RUIZARGUESO T, 1979, ANN INIA SERIE PRODU, V11, P127; Sanchez-Canizares C, 2011, SYST APPL MICROBIOL, V34, P207, DOI 10.1016/j.syapm.2010.11.020; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; Stepkowski T, 2005, APPL ENVIRON MICROB, V71, P7041, DOI 10.1128/AEM.71.11.7041-7052.2005; Stepkowski T, 2011, SYST APPL MICROBIOL, V34, P368, DOI 10.1016/j.syapm.2011.03.002; TANG C, 1995, AUST J EXP AGR, V35, P87, DOI 10.1071/EA9950087; TANG CX, 1993, PLANT SOIL, V152, P269, DOI 10.1007/BF00029097; TORRENT J, 1986, GEODERMA, V37, P57, DOI 10.1016/0016-7061(86)90043-1; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Yaalon DH, 1997, CATENA, V28, P157, DOI 10.1016/S0341-8162(96)00035-5	31	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102205	10.1371/journal.pone.0102205	http://dx.doi.org/10.1371/journal.pone.0102205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019379	Green Accepted, Green Published, gold			2022-12-27	WOS:000339618600053
J	Ray, JG; Redelmeier, DA; Urquia, ML; Guttmann, A; McDonald, SD; Vermeulen, MJ				Ray, Joel G.; Redelmeier, Donald A.; Urquia, Marcelo L.; Guttmann, Astrid; McDonald, Sarah D.; Vermeulen, Marian J.			Risk of Cerebral Palsy among the Offspring of Immigrants	PLOS ONE			English	Article							INTRAUTERINE GROWTH; GESTATIONAL-AGE; BIRTH; PREECLAMPSIA; PREVALENCE; CHILDREN; PLACENTA; FEATURES; INFANTS; LESIONS	Background: Cerebral palsy (CP) has a multifactorial etiology, and placental vascular disease may be one major risk factor. The risk of placental vascular disease may be lower among some immigrant groups. We studied the association between immigrant status and the risk of CP. Methods: We conducted a population-based retrospective cohort study of all singleton and twin livebirths in Ontario between 2002-2008, and who survived >= 28 days after birth. Each child was assessed for CP up to age 4 years, based on either a single inpatient or >= 2 outpatient pediatric diagnoses of CP. Relative to non-immigrants (n = 566,668), the risk of CP was assessed for all immigrants (n = 177,390), and further evaluated by World region of origin. Cox proportional hazard ratios (aHR) were adjusted for maternal age, income, diabetes mellitus, obesity, tobacco use, Caesarean delivery, year of delivery, physician visits, twin pregnancy, preterm delivery, as well as small-and large-for-gestational age birthweight. Results: There were 1346 cases of CP, with a lower rate among immigrants (1.45 per 1000) than non-immigrants (1.92 per 1000) (aHR 0.77, 95% confidence interval [CI] 0.67 to 0.88). Mothers from East Asia and the Pacific (aHR 0.54, 95% CI 0.39 to 0.77) and the Caribbean (aHR 0.58, 95% CI 0.37 to 0.93) were at a significantly lower risk of having a child with CP. Whether further adjusting for preeclampsia, gestational hypertension, placental abruption or placental infraction, or upon using a competing risk analysis that further accounted for stillbirth and neonatal death, these results did not change. Conclusions: Immigration and ethnicity appear to attenuate the risk of CP, and this effect is not fully explained by known risk factors.	[Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON, Canada; [Ray, Joel G.; Vermeulen, Marian J.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Inst Clin Evaluat Sci, Dept Med & Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Urquia, Marcelo L.] St Michaels Hosp, Inst Clin Evaluat Sci, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Inst Clin Evaluat Sci, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Inst Clin Evaluat Sci, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Diagnost Imaging, Div Maternal Fetal Med, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Div Maternal Fetal Med, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; McMaster University	Ray, JG (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.	rayj@smh.ca		Urquia, Marcelo/0000-0002-8289-8090	OFCP Research Fund, Ontario Federation for Cerebral Palsy	OFCP Research Fund, Ontario Federation for Cerebral Palsy	This work was funded by OFCP Research Fund, Ontario Federation for Cerebral Palsy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Becher JC, 2006, BJOG-INT J OBSTET GY, V113, P310, DOI 10.1111/j.1471-0528.2006.00852.x; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; Blair E, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.022; Bolen J C, 2000, MMWR CDC Surveill Summ, V49, P1; EVANS P, 1985, ARCH DIS CHILD, V60, P940, DOI 10.1136/adc.60.10.940; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gee EM, 2004, CAN J AGING, V23, pS61; Greenwood C, 2005, ARCH DIS CHILD-FETAL, V90, P141, DOI 10.1136/adc.2004.052860; Grobman WA, 2013, AM J OBSTET GYNECOL, V209; Hawkins F., 1972, CANADA IMMIGRATION P; Hecht JL, 2008, PATHOLOGY, V40, P372, DOI 10.1080/00313020802035865; Hemming K, 2008, ARCH DIS CHILD-FETAL, V93, pF121, DOI 10.1136/adc.2007.121129; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Janik MDC, 2013, J PEDIATR-US, V163, P1307, DOI 10.1016/j.jpeds.2013.06.062; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Kraus FT, 1999, HUM PATHOL, V30, P759, DOI 10.1016/S0046-8177(99)90136-3; Kumazaki K, 2002, PEDIATRICS, V109, P650, DOI 10.1542/peds.109.4.650; Kustec S, 2004, CITIZENSHIP IMMIGRAT; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Neff JM, 2002, AMBUL PEDIATR, V2, P71, DOI 10.1367/1539-4409(2002)002<0071:IACCWC>2.0.CO;2; Newstead J, 2007, Expert Rev Cardiovasc Ther, V5, P283, DOI 10.1586/14779072.5.2.283; Perlman JM, 1997, PEDIATRICS, V99, P851, DOI 10.1542/peds.99.6.851; Rasmussen S, 1999, PAEDIATR PERINAT EP, V13, P9; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Ray JG, 2007, CAN MED ASSOC J, V176, P1419, DOI 10.1503/cmaj.061680; Ray JG, 2005, J OBSTET GYNAECOL CA, V27, P1095, DOI 10.1016/S1701-2163(16)30391-7; Ray JG, 2012, J OBSTET GYNAECOL CA, V34, P159, DOI 10.1016/S1701-2163(16)35159-3; Redline RW, 2005, AM J OBSTET GYNECOL, V192, P452, DOI 10.1016/j.ajog.2004.07.030; Redline RW, 1998, ARCH PATHOL LAB MED, V122, P1091; Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236; Rouse DJ, 2008, NEW ENGL J MED, V359, P895, DOI 10.1056/NEJMoa0801187; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1097, DOI 10.1016/0002-9378(95)91333-5; SALAFIA CM, 1991, AM J OBSTET GYNECOL, V165, P934, DOI 10.1016/0002-9378(91)90443-U; Salihu HM, 2008, SEMIN PERINATOL, V32, P232, DOI 10.1053/j.semperi.2008.04.002; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Strand KM, 2013, BMJ-BRIT MED J, V347, pf4089, DOI DOI 10.1136/BMJ.F4089; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Urquia ML, 2010, BJOG-INT J OBSTET GY, V117, P591, DOI 10.1111/j.1471-0528.2010.02523.x; Urquia ML, 2012, J OBSTET GYNAECOL CA, V34, P348, DOI 10.1016/S1701-2163(16)35215-X; Wu YW, 2011, PEDIATRICS, V127, pE674, DOI 10.1542/peds.2010-1656	42	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102275	10.1371/journal.pone.0102275	http://dx.doi.org/10.1371/journal.pone.0102275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019202	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600059
J	Sinibaldi, E; Argiolas, A; Puleo, GL; Mazzolai, B				Sinibaldi, Edoardo; Argiolas, Alfredo; Puleo, Gian Luigi; Mazzolai, Barbara			Another Lesson from Plants: The Forward Osmosis-Based Actuator	PLOS ONE			English	Article							POLYMER; WATER; PRINCIPLES; SELECTION; SYSTEMS; PHYSICS; DESIGN; GROWTH; ROOTS; POWER	Osmotic actuation is a ubiquitous plant-inspired actuation strategy that has a very low power consumption but is capable of generating effective movements in a wide variety of environmental conditions. In light of these features, we aimed to develop a novel, low-power-consumption actuator that is capable of generating suitable forces during a characteristic actuation time on the order of a few minutes. Based on the analysis of plant movements and on osmotic actuation modeling, we designed and fabricated a forward osmosis-based actuator with a typical size of 10 mm and a characteristic time of 2-5 minutes. To the best of our knowledge, this is the fastest osmotic actuator developed so far. Moreover, the achieved timescale can be compared to that of a typical plant cell, thanks to the integrated strategy that we pursued by concurrently addressing and solving design and material issues, as paradigmatically explained by the bioinspired approach. Our osmotic actuator produces forces above 20 N, while containing the power consumption (on the order of 1 mW). Furthermore, based on the agreement between model predictions and experimental observations, we also discuss the actuator performance (including power consumption, maximum force, energy density and thermodynamic efficiency) in relation to existing actuation technologies. In light of the achievements of the present study, the proposed osmotic actuator holds potential for effective exploitation in bioinspired robotics systems.	[Sinibaldi, Edoardo; Argiolas, Alfredo; Puleo, Gian Luigi; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Pontedera, Italy; [Argiolas, Alfredo] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna	Sinibaldi, E (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Pontedera, Italy.	edoardo.sinibaldi@iit.it; barbara.mazzolai@iit.it	Mazzolai, Barbara/I-8876-2016; Sinibaldi, Edoardo/AAV-9599-2021	Mazzolai, Barbara/0000-0003-0722-8350; Sinibaldi, Edoardo/0000-0002-9755-3431	European Community [293431]	European Community(European Commission)	This work was supported by the European Community's 7th Framework Programme under the Grant Agreement No. 293431 of the PLANTOID project (www.plantoidproject.eu; http://cordis.europa.eu/fp7/ict/fet-open/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alici G, 2011, SENSOR ACTUAT B-CHEM, V157, P72, DOI 10.1016/j.snb.2011.03.028; Anjanappa M., 1994, Smart Materials and Structures, V3, P83, DOI 10.1088/0964-1726/3/2/001; [Anonymous], 2010, CELLULAR MAT NATURE; Atkins P., 2006, ATKINS PHYS CHEM; Bartlett PA, 2001, SENSOR ACTUAT A-PHYS, V91, P133, DOI 10.1016/S0924-4247(01)00475-7; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bell DJ, 2005, J MICROMECH MICROENG, V15, pS153, DOI 10.1088/0960-1317/15/7/022; Benard WL, 1998, J MICROELECTROMECH S, V7, P245, DOI 10.1109/84.679390; Bengough AG, 1997, PLANT SOIL, V189, P155, DOI 10.1023/A:1004240706284; Bigue JPL, 2013, IEEE-ASME T MECH, V18, P169, DOI 10.1109/TMECH.2011.2164930; Biso M, 2011, CARBON, V49, P2253, DOI 10.1016/j.carbon.2011.01.057; Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Chang T, 2001, IEEE T CONTR SYST T, V9, P69, DOI 10.1109/87.896747; Cheng ZY, 2001, SENSOR ACTUAT A-PHYS, V90, P138, DOI 10.1016/S0924-4247(01)00496-4; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; CHOU CP, 1994, IEEE INT CONF ROBOT, P281, DOI 10.1109/ROBOT.1994.350977; Cianchetti M, 2009, SENSOR ACTUAT B-CHEM, V142, P288, DOI 10.1016/j.snb.2009.08.039; Cinquin P, 2005, US patent, Patent No. [0158841 A1, 0158841]; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Darwin C., 1875, INSECTIVOROUS PLANTS; Darwin C. R, 1880, POWER MOVEMENTS PLAN; Dumais J, 2012, ANNU REV FLUID MECH, V44, P453, DOI 10.1146/annurev-fluid-120710-101200; FLEURATLESSARD P, 1988, BIOL REV, V63, P1, DOI 10.1111/j.1469-185X.1988.tb00467.x; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Forterre Y, 2013, J EXP BOT, V64, P4745, DOI 10.1093/jxb/ert230; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Fu YQ, 2004, SENSOR ACTUAT A-PHYS, V112, P395, DOI 10.1016/j.sna.2004.02.019; Gilroy S, 2008, PLANT TROPISMS, P1; Grunwald A, 2008, SENSOR ACTUAT A-PHYS, V144, P161, DOI 10.1016/j.sna.2007.12.034; Harrington MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1336; Herrlich S, 2012, ADV DRUG DELIVER REV, V64, P1617, DOI 10.1016/j.addr.2012.02.003; HILL BS, 1981, Q REV BIOPHYS, V14, P173, DOI 10.1017/S0033583500002249; Holmes DP, 2007, ADV MATER, V19, P3589, DOI 10.1002/adma.200700584; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Hunter I., 1992, ROBOT REV, P299, DOI [10.5555/146312, DOI 10.5555/146312]; Hunter I. W., 1992, Technical Digest. IEEE Solid-State Sensor and Actuator Workshop (Cat. No.92TH0403-X), P178, DOI 10.1109/SOLSEN.1992.228297; Jordan T, 2000, 209861 NASACR; Joyeux M, 2011, FRONT LIFE SCI, V5, P71, DOI 10.1080/21553769.2012.708907; Kaneto K, 2007, SMART MATER STRUCT, V16, pS250, DOI 10.1088/0964-1726/16/2/S08; Knipfer T, 2010, NEW PHYTOL, V187, P159, DOI 10.1111/j.1469-8137.2010.03240.x; Kornbluh R, 1998, IEEE INT CONF ROBOT, P2147, DOI 10.1109/ROBOT.1998.680638; Kusaka M, 2003, J COMPOS MATER, DOI [10.1177/0021998302040565, DOI 10.1177/0021998302040565]; Lee H, 2010, SOFT MATTER, V6, P4342, DOI 10.1039/c0sm00092b; Lenouvel F, 2009, US patent, Patent No. [0120082 A1, 0120082]; Li YH, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065013; Madden JD, 2003, IEEE J OCEANIC ENG, P706; Madden JD, 2007, SCIENCE, V318, P1094, DOI 10.1126/science.1146351; Maitland DJ, 2000, US patent, Patent No. [US006102917A, 006102917]; Malone E, 2006, RAPID PROTOTYPING J, V12, P244, DOI 10.1108/13552540610707004; Martone PT, 2010, INTEGR COMP BIOL, V50, P888, DOI 10.1093/icb/icq122; Mazzolai B, 2011, IEEE-ASME T MECH, V16, P201, DOI 10.1109/TMECH.2009.2038997; Najem J, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/9/094026; Nakamura Y, 1997, PROC IEEE MICR ELECT, P262, DOI 10.1109/MEMSYS.1997.581821; Paik IH, 2006, SMART MATER STRUCT, V15, P1476, DOI 10.1088/0964-1726/15/5/037; Pelrine R, 2000, MAT SCI ENG C-BIO S, V11, P89, DOI 10.1016/S0928-4931(00)00128-4; Piyasena ME, 2009, SENSOR ACTUAT B-CHEM, V141, P263, DOI 10.1016/j.snb.2009.05.014; Plante JS, 2007, SENSOR ACTUAT A-PHYS, V137, P96, DOI 10.1016/j.sna.2007.01.017; Poppinga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045735; Priya S, 2005, JPN J APPL PHYS 2, V44, pL104, DOI 10.1143/JJAP.44.L104; Shahinpoor M, 2001, SMART MATER STRUCT, V10, P819, DOI 10.1088/0964-1726/10/4/327; Shenoy DK, 2002, SENSOR ACTUAT A-PHYS, V96, P184, DOI 10.1016/S0924-4247(01)00793-2; Shimizu K, 2013, J BIOSCI BIOENG, V115, P115, DOI 10.1016/j.jbiosc.2012.08.024; Sinibaldi E, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/025002; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Spinks G, 2005, PROC SPIE, V5759, P314, DOI 10.1117/12.598407; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sundaresan VB, 2008, SENSOR ACTUAT B-CHEM, V131, P384, DOI 10.1016/j.snb.2007.11.057; Thrasher M. A., 1994, Smart Materials and Structures, V3, P226, DOI 10.1088/0964-1726/3/2/019; Timoshenko S., 1964, THEORY PLATES SHELLS, V2; ULANOWICZ RE, 1995, ECOL MODEL, V79, P49, DOI 10.1016/0304-3800(94)00032-D; Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292; Wang CM, 2012, LAB CHIP, V12, P1710, DOI 10.1039/c2lc40059f; Zupan M, 2002, ADV ENG MATER, V4, P933, DOI 10.1002/adem.200290009	76	31	31	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102461	10.1371/journal.pone.0102461	http://dx.doi.org/10.1371/journal.pone.0102461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020043	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600083
J	Boldrini, NT; Freitas, LB; Coutinho, AR; Loureiro, FZ; Spano, LC; Miranda, AE				Boldrini, Neide T.; Freitas, Luciana B.; Coutinho, Amanda R.; Loureiro, Flavia Z.; Spano, Liliana C.; Miranda, Angelica E.			High-Grade Cervical Lesions among Women Attending a Reference Clinic in Brazil: Associated Factors and Comparison among Screening Methods	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS HPV; INTRAEPITHELIAL LESIONS; EUROPEAN GUIDELINES; QUALITY-ASSURANCE; YOUNG-WOMEN; CANCER; RISK; NEOPLASIA; ACCURACY	Background: Although screening for cervical cancer is recommended for women in most countries, the incidence of cervical cancer is greater in developing countries. Our goal was to determine the prevalence and factors associated with high-grade lesions/cervical cancer among women attending a reference clinic in Brazil and evaluate the correlation of histology with cytology, colposcopy and the high-risk HPV (HR-HPV) tests. Methods: A cross-sectional study of women attending a colposcopy clinic was carried out. The patients were interviewed to collect demographic, epidemiological and clinical data. Specimens were collected for cervical cytology, Chlamydia trachomatis and HPV testing using the Hybrid Capture (HC) and PCR tests. Colposcopy was performed for all patients and biopsy for histology when cell abnormalities or cervical intraepithelial neoplasia (CIN) were present. Results: A total of 291 women participated in the study. The median age was 38 years (DIQ: 30-48 years). The prevalence of histologically confirmed high-grade lesions/cervical cancer was 18.2% (95%, CI: 13.8%-22.6%), with 48 (16.5%) cases of CIN-2/CIN-3 and 5 (1.7%) cases of invasive carcinoma. In the final logistic regression model, for ages between 30 and 49 years old [OR = 4.4 (95%: 1.01-19.04), history of smoking [OR = 2.4 (95%, CI: 1.14-5.18)], practice of anal intercourse [OR = 2.4 (95%, CI: 1.10-5.03)] and having positive HC test for HR-HPV [OR = 11.23 (95%, CI: 4 0.79-26, 36)] remained independently associated with high-grade lesions/cervical cancer. A total of 64.7% of the cases CIN-3\Ca in situ were related to HPV-16. Non-oncogenic HPV were only found in CIN-1 biopsy results. Compared to histology, the sensitivity of cytology was 31.8%, the specificity 95.5%; the sensitivity of colposcopy for high-grade lesions/cervical cancer was 51.0%, specificity was 91.4% and the concordance with HPV testing was high. Conclusions: The results confirm an association of HR-HPV with precursor lesions for cervical cancer. These data emphasize that cytological screening to detect precursor lesions is still important in some regions and that HR-HPV should be included for screening.	[Boldrini, Neide T.; Freitas, Luciana B.; Coutinho, Amanda R.; Loureiro, Flavia Z.; Spano, Liliana C.; Miranda, Angelica E.] Univ Fed Espirito Santo UFES, Fed Univ Espirito Santo, Postgrad Program Infect Dis, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo	Miranda, AE (corresponding author), Univ Fed Espirito Santo UFES, Fed Univ Espirito Santo, Postgrad Program Infect Dis, Vitoria, ES, Brazil.	espinosa@ndi.ufes.br	Miranda, Angelica/AAE-5571-2021	Miranda, Angelica/0000-0002-5556-8379	Research Foundation of Espirito Santo State - FAPES (PPSUS) [45501521/2009]	Research Foundation of Espirito Santo State - FAPES (PPSUS)	Research Foundation of Espirito Santo State - FAPES (PPSUS, Grant #45501521/2009) funded this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daraji WI, 2009, INT J CLIN EXP PATHO, V2, P48; Altekruse SF, 2003, AM J OBSTET GYNECOL, V188, P657, DOI 10.1067/mob.2003.132; Anderson JR, 2006, CLIN INFECT DIS, V42, P562, DOI 10.1086/499357; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P677, DOI 10.1158/1055-9965.EPI-04-0569; Burk RD, 2003, CANCER RES, V63, P7215; Carvalho M.O.O, 2005, Braz J Infect Dis, V9, P398, DOI 10.1590/S1413-86702005000500007; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Chang VTC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3495730; Cong XY, 2007, GYNECOL ONCOL, V107, pS133, DOI 10.1016/j.ygyno.2007.08.080; Correa FD, 2012, SAO PAULO MED J, V130, P44, DOI 10.1590/S1516-31802012000100008; Correnti M, 2011, GYNECOL ONCOL, V121, P527, DOI 10.1016/j.ygyno.2011.02.003; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Cytryn A, 2009, SAO PAULO MED J, V127, P283, DOI 10.1590/S1516-31802009000500007; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gunnell AS, 2007, CANCER EPIDEM BIOMAR, V16, P2641, DOI 10.1158/1055-9965.EPI-07-0278; INCA, 2011, COORD GER AC ESTR CO COORD GER AC ESTR CO; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Lizano M, 2009, ARCH MED RES, V40, P428, DOI 10.1016/j.arcmed.2009.06.001; Meijer CJ, 2006, GYNECOL ONCOL, V103, P12, DOI 10.1016/j.ygyno.2006.07.031; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Raposo LM, 2011, CAD SAUDE PUBLICA, V27, P1281, DOI 10.1590/S0102-311X2011000700004; Safaeian M, 2007, OBSTET GYN CLIN N AM, V34, P739, DOI 10.1016/j.ogc.2007.09.004; Oliveira LHS, 2010, REV SOC BRAS MED TRO, V43, P4, DOI 10.1590/S0037-86822010000100002; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; Vizcaino AP, 2000, INT J CANCER, V86, P429, DOI 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D; Wang Ying, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P27; Workowisky KA, 2010, MMWR RECOMM REP, V55, P74; World Health Organization (WHO). ICO Information Centre on Human Papilloma Virus (HPV) and Cervical Cancer, 2010, HUM PAP REL CANC BRA; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; zur Hausen H, 1996, BIOCHIM BIOPHYS ACTA, V1288, P55	36	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102169	10.1371/journal.pone.0102169	http://dx.doi.org/10.1371/journal.pone.0102169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25019210	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400074
J	Olah, K; Elekes, F; Brody, G; Kiraly, I				Olah, Katalin; Elekes, Fruzsina; Brody, Gabor; Kiraly, Ildiko			Social Category Formation Is Induced by Cues of Sharing Knowledge in Young Children	PLOS ONE			English	Article							NATIVE LANGUAGE; INFANTS; RACE; COGNITION; EVOLUTION; GENDER; FEMALE; FACES; PREFERENCES; SPEAKERS	Previous research has shown that human infants and young children are sensitive to the boundaries of certain social groups, which supports the idea that the capacity to represent social categories constitutes a fundamental characteristic of the human cognitive system. However, the function this capacity serves is still debated. We propose that during social categorization the human mind aims at mapping out social groups defined by a certain set of shared knowledge. An eye-tracking paradigm was designed to test whether two-year-old children differentially associate conventional versus non-conventional tool use with language-use, reflecting an organization of information that is induced by cues of shared knowledge. Children first watched videos depicting a male model perform goal-directed actions either in a conventional or in a non-conventional way. In the test phase children were presented with photographs taken of the model and of a similarly aged unfamiliar person while listening to a foreign (Experiment 1) or a native language (Experiment 2) text. Upon hearing the foreign utterance children looked at the model first if he had been seen to act in an unconventional way during familiarization. In contrast, children looked at the other person if the model had performed conventional tool use actions. No such differences were found in case of the native language. The results suggest that children take the conventionality of behavior into account in forming representations about a person, and they generalize to other qualities of the person based on this information.	[Olah, Katalin; Elekes, Fruzsina; Brody, Gabor; Kiraly, Ildiko] Eotvos Lorand Univ, Dept Cognit Psychol, Budapest, Hungary; [Olah, Katalin; Elekes, Fruzsina] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Olah, K (corresponding author), Eotvos Lorand Univ, Dept Cognit Psychol, Budapest, Hungary.	olah.katalin@ttk.mta.hu	Király, Ildikó/AGD-5122-2022; Elekes, Fruzsina/AAQ-6873-2020	Király, Ildikó/0000-0002-4857-1764; 	National Development Agency [KMOP-4.2.1/B-10-2011-0002];  [K-109352];  [K-100695]	National Development Agency; ; 	The project received financial funding from the National Development Agency (URL: www.nfu.hu/?lang=en, grant number: KMOP-4.2.1/B-10-2011-0002) and the number: K-109352 and K-100695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1961, INTERGROUP COOPERATI; Bahrick LE, 1998, CHILD DEV, V69, P1263, DOI 10.2307/1132264; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Boyd R, 2009, PHILOS T R SOC B, V364, P3281, DOI 10.1098/rstb.2009.0134; Buttelmann D, 2013, CHILD DEV, V84, P422, DOI 10.1111/j.1467-8624.2012.01860.x; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; Csibra G, 2006, ATTENTION PERFORM, P249; Dunham Y, 2008, TRENDS COGN SCI, V12, P248, DOI 10.1016/j.tics.2008.04.006; Fiske ST, 2000, EUR J SOC PSYCHOL, V30, P299, DOI 10.1002/(SICI)1099-0992(200005/06)30:3<299::AID-EJSP2>3.0.CO;2-F; Gergely G., 2006, ROOTS HUMAN SOCIALIT, P229; He Z, 2012, BCCCD12 BUD HUNG 12; HIRSCHFELD L, 1996, RACE MAKING; HIRSCHFELD LA, 1995, COGNITION, V54, P209, DOI 10.1016/0010-0277(95)91425-R; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kinzler KD, 2012, J COGN DEV, V13, P67, DOI 10.1080/15248372.2011.567200; Kinzler KD, 2011, COGNITION, V119, P1, DOI 10.1016/j.cognition.2010.10.019; Kinzler KD, 2011, DEVELOPMENTAL SCI, V14, P106, DOI 10.1111/j.1467-7687.2010.00965.x; Kinzler KD, 2009, SOC COGNITION, V27, P623, DOI 10.1521/soco.2009.27.4.623; LEINBACH MD, 1993, INFANT BEHAV DEV, V16, P317, DOI 10.1016/0163-6383(93)80038-A; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; MILLER CL, 1983, INFANT BEHAV DEV, V6, P313, DOI 10.1016/S0163-6383(83)80040-X; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; POULINDUBOIS D, 1994, DEV PSYCHOL, V30, P436, DOI 10.1037/0012-1649.30.3.436; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Rakoczy H, 2008, DEV PSYCHOL, V44, P875, DOI 10.1037/0012-1649.44.3.875; Sidanius J., 1993, PREJUDICE POLITICS A, P173; Sperber D, 2004, TRENDS COGN SCI, V8, P40, DOI 10.1016/j.tics.2003.11.002; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Turner J.C., 1987, REDISCOVERING SOCIAL; Uttley L, 2013, INT J BEHAV DEV, P1; WALKER-ANDREWS A S, 1991, Ecological Psychology, V3, P55, DOI 10.1207/s15326969eco0302_1	33	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101680	10.1371/journal.pone.0101680	http://dx.doi.org/10.1371/journal.pone.0101680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014363	Green Published, gold			2022-12-27	WOS:000339378400031
J	Romandini, M; Peresani, M; Laroulandie, V; Metz, L; Pastoors, A; Vaquero, M; Slimak, L				Romandini, Matteo; Peresani, Marco; Laroulandie, Veronique; Metz, Laure; Pastoors, Andreas; Vaquero, Manuel; Slimak, Ludovic			Convergent Evidence of Eagle Talons Used by Late Neanderthals in Europe: A Further Assessment on Symbolism	PLOS ONE			English	Article							HISTORICAL STRUCTURE; CULTURAL SHIFTS; MOULA-GUERCY; FUMANE CAVE; MIDDLE; DIVERSITY; ARDECHE; BP	To contribute to have a better understanding of the symbolic or not use of certain items by Neanderthals, this work presents new evidence of the deliberate removal of raptor claws occurred in Mediterranean Europe during the recent phases of the Mousterian. Rio Secco Cave in the north-east of Italy and Mandrin Cave in the Middle Rhone valley have recently produced two golden eagle pedal phalanges from contexts not younger than 49.1-48.0 ky cal BP at Rio Secco and dated around 50.0 ky cal BP at Mandrin. The bones show cut-marks located on the proximal end ascribable to the cutting of the tendons and the incision of the cortical organic tissues. Also supported by an experimental removal of large raptor claws, our reconstruction explains that the deliberate detachment occurred without damaging the claw, in a way comparable at a general level with other Mousterian contexts across Europe. After excluding that these specimens met the nutritional requirements for human subsistence, we discuss the possible implications these findings perform in our current knowledge of the European Middle Palaeolithic context.	[Romandini, Matteo; Peresani, Marco] Univ Ferrara, Dipartimento Studi Umanistici, Sez Sci Preistor & Antropol, I-44100 Ferrara, Italy; [Laroulandie, Veronique] Univ Bordeaux, CNRS, PACEA UMR5199, Talence, France; [Metz, Laure] Univ Aix Marseille, UMR LAMPEA 7269, Aix En Provence, France; [Pastoors, Andreas] Neanderthal Museum, Mettmann, Germany; [Vaquero, Manuel] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Slimak, Ludovic] Univ Toulouse 2, CNRS, UMR 5608, Toulouse, France	University of Ferrara; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Peresani, M (corresponding author), Univ Ferrara, Dipartimento Studi Umanistici, Sez Sci Preistor & Antropol, Corso Ercole Este 32, I-44100 Ferrara, Italy.	marco.peresani@unife.it; slimak@univ-tlse2.fr	Vaquero, Manuel/W-1405-2019; Peresani, Marco/X-1343-2019; Slimak, Ludovic/AAG-7890-2020; Laroulandie, Véronique/AAD-6860-2019	Vaquero, Manuel/0000-0001-6572-8543; Laroulandie, Véronique/0000-0002-9745-6578; Metz, Laure/0000-0003-0304-5645; Peresani, Marco/0000-0001-6562-6336	Administration of the Clauzetto Municipality; Friuli Venezia Giulia Region; Ecomuseo delle Dolomiti Friulane "Lis Aganis"; BIM Tagliamento Consortium; Pordenone Province; Fondazione CRUP; Buzzi Unicem Spa; Albino Armani winegrover; Fantinel winegrovers; French Rhone-Alpes Regional Archaeological Service (SRA-DRAC) from Lyon; Committee and Research Exploration of the National Geographic Society [9222-11]	Administration of the Clauzetto Municipality; Friuli Venezia Giulia Region(Regione Friuli Venezia Giulia); Ecomuseo delle Dolomiti Friulane "Lis Aganis"; BIM Tagliamento Consortium; Pordenone Province; Fondazione CRUP; Buzzi Unicem Spa; Albino Armani winegrover; Fantinel winegrovers; French Rhone-Alpes Regional Archaeological Service (SRA-DRAC) from Lyon(Region Auvergne-Rhone-Alpes); Committee and Research Exploration of the National Geographic Society(National Geographic Society)	Financial support to Rio Secco Research Project is provided by the Administration of the Clauzetto Municipality and the Friuli Venezia Giulia Region and a group of public institutions (Ecomuseo delle Dolomiti Friulane "Lis Aganis", BIM Tagliamento Consortium, Pordenone Province), Foundations (Fondazione CRUP) and private companies (Buzzi Unicem Spa, Albino Armani winegrover, Fantinel winegrovers). Grotte Mandrin researches were conducted with the full financial support of the French Rhone-Alpes Regional Archaeological Service (SRA-DRAC) from Lyon. The experimental butchering was supported by the Committee and Research Exploration of the National Geographic Society (Grant 9222-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; Blasco R, 2013, QUATERNARY SCI REV, V70, P124, DOI 10.1016/j.quascirev.2013.03.008; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2010, CR PALEVOL, V9, P171, DOI 10.1016/j.crpv.2010.05.004; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Defleur A, 1999, SCIENCE, V286, P128, DOI 10.1126/science.286.5437.128; Dibble Harold L., 2009, Paleoanthropology, V2009, P182; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; Fiore I, 2004, INT J OSTEOARCHAEOL, V14, P273, DOI 10.1002/oa.761; Gaudzinski-Windheuser S, 2009, VERTEBR PALEOBIOL PA, P99, DOI 10.1007/978-1-4020-9699-0_7; Gourichon L, 1994, THESIS U LUMIERE LYO; Granger JM, 1997, CR ACAD SCI II A, V325, P537, DOI 10.1016/S1251-8050(97)89874-6; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Kuhn SL, 2004, ISRAELI J PREHIST SO, V34, P5; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Laroulandie V., 2000, THESIS U BORDEAUX BO; Laroulandie V., 2010, GRONINGEN ARCHAEOLOG, V12, P219; Laroulandie V., 2004, APPROCHES FONCTIONNE, P387; Lenssen-Erz T, 2012, ROCK ART RES INST MO, P47; Mallye JB, 2013, PALEO, V24, P235; Maslow A. H., 1954, MOTIVATION PERSONALI; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Mourer-Chauvire C, 1975, ISSUES GEOLOGICAL LA, V64; Mourer-Chauvire C., 1989, BAUME GIGNY JURA 27, P121; Mussini C, 2012, TRANSITIONS RUPTURE, VI, P133; Peresani M, J FIELD ARC IN PRESS; Peresani M, 2014, J ANTHROPOL SCI, V92, P1; Peresani M, 2012, ANTIQUITY PROJECT GA, V86, P332; Peresani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068572; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Peresani M, 2012, QUATERN INT, V247, P125, DOI 10.1016/j.quaint.2011.02.006; Rendu W, 2013, P NATL ACAD SCI USA, V108, P3888; Romandini M., 2013, EUR ASS STUD HUM EV, P189; Simmons T, 1998, INT J OSTEOARCHAEOL, V8, P79, DOI 10.1002/(SICI)1099-1212(199803/04)8:2<79::AID-OA386>3.0.CO;2-I; Slimak L, GALLIA PREH IN PRESS; Slimak L., 2004, THESIS U PROVENCE; Slimak L, 2008, J ARCHAEOL SCI, V35, P2204, DOI 10.1016/j.jas.2008.02.005; Slimak L, 2007, CR PALEVOL, V6, P301, DOI 10.1016/j.crpv.2007.02.004; Slimak L, 2006, CR PALEVOL, V5, P909, DOI 10.1016/j.crpv.2006.05.002; Soressi M., 2008, SOCIETE PREHISTORIQU, P95; Soressi M, 2007, NEANDERTALIENS BIOL, P297; Street M, 2013, MONOGRAPHIEN ROMISCH, V104; Talamo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095376; Valensi P, 2012, QUATERN INT, V252, P48, DOI 10.1016/j.quaint.2011.07.028; White R, 2002, GALLIA PREHISTOIRE S, VXXXIV, P257; White T.D., 1992, PREHISTORIC CANNIBAL; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	49	88	89	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101278	10.1371/journal.pone.0101278	http://dx.doi.org/10.1371/journal.pone.0101278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK9RG	25010346	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800018
J	Wheelhouse, N; Coyle, C; Barlow, PG; Mitchell, S; Greub, G; Baszler, T; Rae, MT; Longbottom, D				Wheelhouse, Nick; Coyle, Christopher; Barlow, Peter G.; Mitchell, Stephen; Greub, Gilbert; Baszler, Tim; Rae, Mick T.; Longbottom, David			Waddlia chondrophila Infects and Multiplies in Ovine Trophoblast Cells Stimulating an Inflammatory Immune Response	PLOS ONE			English	Article							ABORTED BOVINE FETUS; REAL-TIME PCR; CHLAMYDIA-TRACHOMATIS; HUMAN MACROPHAGES; NEOSPORA-CANINUM; GENE; NOD1; INTERLEUKIN-8; RICKETTSIA; RECEPTOR	Background: Waddlia chondrophila (W. chondrophila) is an emerging abortifacient organism which has been identified in the placentae of humans and cattle. The organism is a member of the order Chlamydiales, and shares many similarities at the genome level and in growth studies with other well-characterised zoonotic chlamydial abortifacients, such as Chlamydia abortus (C. abortus). This study investigates the growth of the organism and its effects upon pro-inflammatory cytokine expression in a ruminant placental cell line which we have previously utilised in a model of C. abortus pathogenicity. Methodology/Principal Findings: Using qPCR, fluorescent immunocytochemistry and electron microscopy, we characterised the infection and growth of W. chondrophila within the ovine trophoblast AH-1 cell line. Inclusions were visible from 6 h post-infection (p.i.) and exponential growth of the organism could be observed over a 60 h time-course, with significant levels of host cell lysis being observed only after 36 h p.i. Expression of CXCL8, TNF-alpha, IL-1 alpha and IL-1 beta were determined 24 h p.i. A statistically significant response in the expression of CXCL8, TNF-alpha and IL-1 beta could be observed following active infection with W. chondrophila. However a significant increase in IL-1 beta expression was also observed following the exposure of cells to UV-killed organisms, indicating the stimulation of multiple innate recognition pathways. Conclusions/Significance: W. chondrophila infects and grows in the ruminant trophoblast AH-1 cell line exhibiting a complete chlamydial replicative cycle. Infection of the trophoblasts resulted in the expression of pro-inflammatory cytokines in a dose-dependent manner similar to that observed with C. abortus in previous studies, suggesting similarities in the pathogenesis of infection between the two organisms.	[Wheelhouse, Nick; Longbottom, David] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Coyle, Christopher; Barlow, Peter G.; Rae, Mick T.] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Mitchell, Stephen] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland; [Greub, Gilbert] Univ Lausanne, Lausanne, Switzerland; [Baszler, Tim] Washington State Univ, Coll Vet Med, Washington Anim Dis Diagnost Lab, Pullman, WA 99164 USA	Moredun Research Institute; Edinburgh Napier University; University of Edinburgh; University of Lausanne; Washington State University	Wheelhouse, N (corresponding author), Moredun Res Inst, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	nick.wheelhouse@moredun.ac.uk	Longbottom, David/GWZ-8448-2022; Greub, Gilbert GG/K-5804-2017; Barlow, Peter/O-4078-2019	Longbottom, David/0000-0003-0086-8443; Greub, Gilbert GG/0000-0001-9529-3317; Barlow, Peter/0000-0002-6516-9312; Wheelhouse, Nick/0000-0002-2803-0055; Molodiuc, Veaceslav/0000-0002-3014-4203	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Edinburgh Napier University Research Excellence Award; Biotechnology and Biological Sciences Research Council (BBSRC); Zoetis [BB/J015083/1]; Biotechnology and Biological Sciences Research Council [BB/J015083/1] Funding Source: researchfish; BBSRC [BB/J015083/1] Funding Source: UKRI	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Edinburgh Napier University Research Excellence Award; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, http://www.scotland.gov.uk/), an Edinburgh Napier University Research Excellence Award, and through the Industrial partnership award awarded by the Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk/) and Zoetis (grant no. BB/J015083/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkallah M, 2013, VET MICROBIOL, V164, P101, DOI 10.1016/j.vetmic.2013.01.036; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Baud D, 2014, EMERG INFECT DIS, V20, P460, DOI 10.3201/eid2003.131019; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; Crawford T. B., 1989, P 8 C VET HEM DIS ST, P121; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dilbeck-Robertson P, 2003, J VET DIAGN INVEST, V15, P568, DOI 10.1177/104063870301500609; Fach SJ, 2007, VIRAL IMMUNOL, V20, P119, DOI 10.1089/vim.2006.0056; Goy G, 2008, MICROBES INFECT, V10, P556, DOI 10.1016/j.micinf.2008.02.003; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Haldorson GJ, 2006, EXP PARASITOL, V112, P172, DOI 10.1016/j.exppara.2005.11.004; Henning K, 2002, VET MICROBIOL, V85, P285, DOI 10.1016/S0378-1135(01)00510-7; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kebbi-Beghdadi C, 2011, MICROBES INFECT, V13, P566, DOI 10.1016/j.micinf.2011.01.020; Kebbi-Beghdadi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028605; Kebbi-Beghdadi C, 2011, FEMS IMMUNOL MED MIC, V63, P339, DOI 10.1111/j.1574-695X.2011.00856.x; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Lienard J, 2011, J CLIN MICROBIOL, V49, P2637, DOI 10.1128/JCM.00114-11; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Rurangirwa FR, 1999, INT J SYST BACTERIOL, V49, P577, DOI 10.1099/00207713-49-2-577; Smeed Jennifer A, 2007, BMC Vet Res, V3, P18, DOI 10.1186/1746-6148-3-18; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wheelhouse N, 2009, J REPROD IMMUNOL, V80, P49, DOI 10.1016/j.jri.2008.12.003	28	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102386	10.1371/journal.pone.0102386	http://dx.doi.org/10.1371/journal.pone.0102386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010668	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800098
J	Lin, CW; Lo, S; Hsu, C; Hsieh, CH; Chang, YF; Hou, BS; Kao, YH; Lin, CC; Yu, ML; Yuan, SS; Hsieh, YC				Lin, Chih-Wen; Lo, Steven; Hsu, Chin; Hsieh, Chi-Hsun; Chang, Ya-Fang; Hou, Bao-Sheng; Kao, Ying-Hsien; Lin, Chih-Che; Yu, Ming-Lung; Yuan, Shyng-Shiou; Hsieh, Ya-Ching			T-Cell Autophagy Deficiency Increases Mortality and Suppresses Immune Responses after Sepsis	PLOS ONE			English	Article							PROTEIN-ACTIVATING ENZYME; MYCOBACTERIUM-TUBERCULOSIS; IMPROVES SURVIVAL; CECAL LIGATION; SEPTIC MICE; IFN-GAMMA; APOPTOSIS; CLEARANCE; INFECTION; INJURY	Background: Although the role of autophagy in sepsis has been characterized in several organs, its role in the adaptive immune system remains to be ascertained. This study aimed to investigate the role of autophagy in sepsis-induced T cell apoptosis and immunosuppression, using knockout mice with T cell specific deletion of autophagy essential gene Atg7. Methods and Results: Sepsis was induced in a cecal ligation and puncture (CLP) model, with T-cell-specific Atg7-knockout mice compared to control mice. Autophagic vacuoles examined by electron microscopy were decreased in the spleen after CLP. Autophagy proteins LC3-II and ATG7, and autophagosomes and autolysosomes stained by Cyto-ID Green and acridine orange were decreased in CD4(+) and CD8(+) splenocytes at 18 h and 24 h after CLP. This decrease in autophagy was associated with increased apoptosis of CD4(+) and CD8(+) after CLP. Moreover, mice lacking Atg7 in T lymphocytes showed an increase in sepsis-induced mortality, T cell apoptosis and loss of CD4(+) and CD8(+) T cells, in comparison to control mice. This was accompanied by suppressed cytokine production of Th1/Th2/Th17 by CD4(+) T cells, reduced phagocytosis in macrophages and decreased bacterial clearance in the spleen after sepsis. Conclusion: These results indicated that sepsis led to down-regulation of autophagy in T lymphocytes, which may result in enhanced apoptosis induction and decreased survival in sepsis. Autophagy may therefore play a protective role against sepsis-induced T lymphocyte apoptosis and immunosuppression.	[Lin, Chih-Wen; Hou, Bao-Sheng] I Shou Univ, E Da Hosp, Dept Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan; [Lo, Steven] I Shou Univ, E Da Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Chang, Ya-Fang; Hou, Bao-Sheng; Kao, Ying-Hsien; Yuan, Shyng-Shiou; Hsieh, Ya-Ching] I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Lin, Chih-Wen] I Shou Univ, E Da Hosp, Hlth Examinat Ctr, Kaohsiung, Taiwan; [Lo, Steven] Royal Infirm, Canniesburn Plast Surg Unit, Glasgow G31 2ER, Lanark, Scotland; [Lin, Chih-Wen; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Physiol, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung, Taiwan; [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Hsieh, Chi-Hsun] China Med Univ, China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Hsieh, Chi-Hsun] Benq Med Ctr Suzhou, Dept Surg, Suzhou, Peoples R China; [Lin, Chih-Che] Kaohsiung Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Kaohsiung, Taiwan; [Lin, Chih-Che] Chang Gung Univ, Coll Med, Gueishan, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Royal Infirmary of Edinburgh; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Yuan, SS (corresponding author), I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan.	yuanssf@ms33.hinet.net	Yu, Ming-Lung/AAZ-4306-2020; Kao, Ying-Hsien/H-4134-2019	Yu, Ming-Lung/0000-0001-8145-1900; Lin, Chih-Wen/0000-0003-2344-5056; Kao, Ying-Hsien/0000-0001-7803-9384; yuan, shyng-shiou/0000-0002-4753-788X	E-Da hospital [EDAHT101030, EDAHT101023, EDAHT100023, NSC 102-2320-B-037-022-]	E-Da hospital	This work was supported by E-Da hospital grants EDAHT101030, EDAHT101023, EDAHT100023 and NSC 102-2320-B-037-022-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala A, 1999, SHOCK, V11, P211, DOI 10.1097/00024382-199903000-00010; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; BAKER CC, 1983, SURGERY, V94, P331; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Chien WS, 2011, SHOCK, V35, P506, DOI 10.1097/SHK.0b013e31820b2f05; D'Elios MM, 2011, J INFECT DEV COUNTR, V5, P640, DOI 10.3855/jidc.2019; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Gao WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073229; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Holley MM, 2012, J IMMUNOL, V188, P1360, DOI 10.4049/jimmunol.1101660; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hsiao HW, 2012, SHOCK, V37, P289, DOI 10.1097/SHK.0b013e318240b52a; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Hsieh YC, 2009, TRENDS MOL MED, V15, P129, DOI 10.1016/j.molmed.2009.01.002; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee JS, 2012, METHODS, V56, P375, DOI 10.1016/j.ymeth.2011.11.006; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lin CW, 2014, SHOCK, V41, P241, DOI 10.1097/SHK.0000000000000111; Liu MS, 2012, CRIT CARE MED, V40, P2132, DOI 10.1097/CCM.0b013e31824e1e20; Lo S, 2012, ANN SURG; Lo S, 2013, ANN SURG, V257, P352, DOI 10.1097/SLA.0b013e318269d0e2; Ma N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069779; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Seto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086017; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Vogel TR, 2010, ANN SURG, V252, P1065, DOI 10.1097/SLA.0b013e3181dcf36e; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8; Weil BR, 2011, SHOCK, V36, P235, DOI 10.1097/SHK.0b013e318225f6ae; Zhang YB, 2013, J IMMUNOL, V190, P4725, DOI 10.4049/jimmunol.1203024	41	30	47	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102066	10.1371/journal.pone.0102066	http://dx.doi.org/10.1371/journal.pone.0102066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029098	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600034
J	Lippman, SA; Treves-Kagan, S; Gilvydis, JM; Naidoo, E; Khumalo-Sakutukwa, G; Darbes, L; Raphela, E; Ntswane, L; Barnhart, S				Lippman, Sheri A.; Treves-Kagan, Sarah; Gilvydis, Jennifer M.; Naidoo, Evasen; Khumalo-Sakutukwa, Gertrude; Darbes, Lynae; Raphela, Elsie; Ntswane, Lebogang; Barnhart, Scott			Informing Comprehensive HIV Prevention: A Situational Analysis of the HIV Prevention and Care Context, North West Province South Africa	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; CONDOM USE; TRANSACTIONAL SEX; PROJECT ACCEPT; YOUNG-PEOPLE; RISK-FACTORS; HPTN 043; HEALTH; STIGMA; INTERVENTIONS	Objective: Building a successful combination prevention program requires understanding the community's local epidemiological profile, the social community norms that shape vulnerability to HIV and access to care, and the available community resources. We carried out a situational analysis in order to shape a comprehensive HIV prevention program that address local barriers to care at multiple contextual levels in the North West Province of South Africa. Method: The situational analysis was conducted in two sub-districts in 2012 and guided by an adaptation of WHO's Strategic Approach, a predominantly qualitative method, including observation of service delivery points and in-depth interviews and focus groups with local leaders, providers, and community members, in order to recommend context-specific HIV prevention strategies. Analysis began during fieldwork with nightly discussions of findings and continued with coding original textual data from the fieldwork notebooks and a select number of recorded interviews. Results: We conducted over 200 individual and group interviews and gleaned four principal social barriers to HIV prevention and care, including: HIV fatalism, traditional gender norms, HIV-related stigma, and challenges with communication around HIV, all of which fuel the HIV epidemic. At the different levels of response needed to stem the epidemic, we found evidence of national policies and programs that are mitigating the social risk factors but little community-based responses that address social risk factors to HIV. Conclusions: Understanding social and structural barriers to care helped shape our comprehensive HIV prevention program, which address the four 'themes' identified into each component of the program. Activities are underway to engage communities, offer community-based testing in high transmission areas, community stigma reduction, and a positive health, dignity and prevention program for stigma reduction and improve communication skills. The situational analysis process successfully shaped key programmatic decisions and cultivated a deeper collaboration with local stakeholders to support program implementation.	[Lippman, Sheri A.; Treves-Kagan, Sarah; Khumalo-Sakutukwa, Gertrude; Darbes, Lynae] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Gilvydis, Jennifer M.; Naidoo, Evasen; Raphela, Elsie; Ntswane, Lebogang] Univ Washington, Int Training & Educ Ctr Hlth ITECH South Africa, Pretoria, South Africa; [Barnhart, Scott] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Lippman, SA (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	sheri.lippman@ucsf.edu		Lippman, Sheri/0000-0003-3152-9372; Darbes, Lynae/0000-0003-4738-6812	Centers for Disease Control and Prevention [5U2GGH000324-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by the Cooperative Agreement 5U2GGH000324-02 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the views of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, P11; Campbell C, 2005, AIDS CARE, V17, P471, DOI 10.1080/09540120412331319705; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Campbell C., 2003, LETTING DIE WHY HIV; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Darbes LA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-64; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; Dworkin SL, 2011, AM J PUBLIC HEALTH, V101, P995, DOI 10.2105/AJPH.2009.191106; Fitch, 2000, Int J Drug Policy, V11, P63, DOI 10.1016/S0955-3959(99)00056-0; Fredman S., 2012, COMP STUDY ANTIDISCR; Freire P., 2013, PEDAGOGY OPPRESSED T; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Jewkes R, 2008, BMJ, V337; Jewkes R, 2006, LANCET, V368, P430, DOI 10.1016/S0140-6736(06)69130-7; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson LF, 2012, ACCESS ANTIRETROVIRA; Kalichman SC, 2007, AIDS CARE, V19, P20, DOI 10.1080/09540120600984003; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2009, PREV SCI, V10, P260, DOI 10.1007/s11121-009-0129-x; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kaufman CE, 2004, CULT HEALTH SEX, V6, P377, DOI 10.1080/13691050410001680492; Kevany S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-459; Kinsler JJ, 2007, AIDS PATIENT CARE ST, V21, P584, DOI 10.1089/apc.2006.0202; Lambert H, 2005, CULT HEALTH SEX, V7, P527, DOI 10.1080/13691050500245818; Leclerc-Madlala S, 1997, Med Anthropol, V17, P363, DOI 10.1080/01459740.1997.9966146; Lippman SA, 2007, SOC SCI MED, V64, P2464, DOI 10.1016/j.socscimed.2007.02.048; Lippman SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078208; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; MANDERSON L, 1992, SOC SCI MED, V35, P839, DOI 10.1016/0277-9536(92)90098-B; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; Medley A, 2013, AIDS CARE, V25, P1569, DOI 10.1080/09540121.2013.793269; Merson M, 2008, LANCET, V372, P1805, DOI 10.1016/S0140-6736(08)61752-3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mosavel M, 2012, HEALTH PROMOT INT, V27, P323, DOI 10.1093/heapro/dar041; National Department of Health, 2012, NAT ANT SENT HIV SYP; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Peacock D, 2009, J ACQUIR IMMUNE DEFI, V1; Pettifor A, 2009, EFFECTS CASH TRANSFE; Pitpitan EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045631; President's Emergency Plan for AIDS Relief (PEPFAR), 2011, GUID PREV SEX TRANSM; Pulerwitz J., 2004, PROMOTING HLTH RELAT; Rodriguez-Garcia R, 2013, AIDS CARE, V25, pS7, DOI 10.1080/09540121.2013.764395; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Shisana RT, 2014, S AFRICAN NATL HIV P; SHOOP DM, 1994, J ADOLESCENCE, V17, P137, DOI 10.1006/jado.1994.1014; Skinner D, 2004, SAHARA J, V1, P157; South Africa, 1996, CONSTITUTION REPUBLI, DOI DOI 10.1017/S0021855300011499; South African National AIDS Council, 2010, NAT HIV COUNS TEST C; South African National Department of Health, 2012, CLIN GUID MAN HIV AI; Spicehandler J, 1994, EXPANDING FAMILY PLA; StatsSA, 2007, COMM SURV LAB FORC; StatsSA, 2011, COMM SURV; Stemple L, 2008, AIDS, P22; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Treves-Kagan S, RAPID ASSES IN PRESS; Trotter R.T., 2001, FIELD METHOD, V13, P137, DOI [10.1177/1525822X0101300202, DOI 10.1177/1525822X0101300202]; Ulin PR, 2005, QUALITATIVE METHODS; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2012, UNAIDS COUNTR PROF S; Underwood C, 2011, J COMMUN, V61, P197, DOI 10.1111/j.1460-2466.2011.01537.x; Vandenhoudt H, 2010, AIDS EDUC PREV, V22, P328, DOI 10.1521/aeap.2010.22.4.328; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; WHO, 2002, MAK DEC CONTR INTR G; World Health Organization, 2005, STRAT APPR IMPR QUAL; World Health Organization, 2013, GLOB TUB REP WHO; Zuch M, 2012, AIDS BEHAV, V16, P564, DOI 10.1007/s10461-011-0089-6	77	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102904	10.1371/journal.pone.0102904	http://dx.doi.org/10.1371/journal.pone.0102904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25028976	Green Published, gold			2022-12-27	WOS:000341306600105
J	Rizwani, W; Schaal, C; Kunigal, S; Coppola, D; Chellappan, S				Rizwani, Wasia; Schaal, Courtney; Kunigal, Sateesh; Coppola, Domenico; Chellappan, Srikumar			Mammalian Lysine Histone Demethylase KDM2A Regulates E2F1-Mediated Gene Transcription in Breast Cancer Cells	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; REPRESSES TRANSCRIPTION; MYOEPITHELIAL CELLS; GROWTH; RB; MECHANISM; E2F; PROLIFERATION; DEACETYLASE; TRANSITION	It is established that histone modifications like acetylation, methylation, phosphorylation and ubiquitination affect chromatin structure and modulate gene expression. Lysine methylation/demethylation on Histone H3 and H4 is known to affect transcription and is mediated by histone methyl transferases and histone demethylases. KDM2A/JHDM1A/FBXL11 is a JmjC-containing histone demethylase that targets mono-and dimethylated Lys36 residues of Histone H3; its function in breast cancer is not fully understood. Here we show that KDM2A is strongly expressed in myoepithelial cells (MEPC) in breast cancer tissues by immunohistochemistry. Ductal cells from ductal carcinoma in situ (DCIS) and infiltrating ductal carcinoma (IDC) show positive staining for KDM2A, the expression decreases with disease progression to metastasis. Since breast MEPCs have tumor-suppressive and anti-angiogenic properties, we hypothesized that KDM2A could be contributing to some of these functions. Silencing KDM2A with small interfering RNAs demonstrated increased invasion and migration of breast cancer cells by suppressing a subset of matrix metalloproteinases (MMP-2, -9, -14 and -15), as seen by real-time PCR. HUVEC cells showed increased angiogenic tubule formation ability in the absence of KDM2A, with a concomitant increase in the expression of VEGF receptors, FLT-1 and KDR. KDM2A physically bound to both Rb and E2F1 in a cell cycle dependent manner and repressed E2F1 transcriptional activity. Chromatin immunoprecipitation (ChIP) assays revealed that KDM2A associates with E2F1-regulated proliferative promoters CDC25A and TS in early G-phase and dissociates in S-phase. Further, KDM2A could also be detected on MMP9, 14 and 15 promoters, as well as promoters of FLT1 and KDR. KDM2A could suppress E2F1-mediated induction of these promoters in transient transfection experiments. These results suggest a regulatory role for KDM2A in breast cancer cell invasion and migration, through the regulation of E2F1 function.	[Rizwani, Wasia; Schaal, Courtney; Kunigal, Sateesh; Chellappan, Srikumar] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chellappan, S (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	Srikumar.Chellappan@moffitt.org			NIH [CA77301]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA077301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the grant CA77301 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Belotti D, 2003, CANCER RES, V63, P5224; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Chau CM, 2008, J VIROL, V82, P3428, DOI 10.1128/JVI.01412-07; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Kato H, 2001, J CLIN MICROBIOL, V39, P1391, DOI 10.1128/JCM.39.4.1391-1395.2001; Liu QY, 2012, INORG CHEM, V51, P2381, DOI 10.1021/ic2023727; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Nguyen M, 2000, ONCOGENE, V19, P3449, DOI 10.1038/sj.onc.1203677; Nijwening JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025235; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Pandey PR, FRONT BIOSCI, V15, P226; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Pillai S, 2011, MOL CELL BIOL, V31, P3052, DOI 10.1128/MCB.01311-10; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Rastogi S, 2012, CELL DEATH DIFFER, V19, P274, DOI 10.1038/cdd.2011.93; Reed SI, 1997, CANCER SURV, V29, P7; Rizwani W, 2009, CELL CYCLE, V8, P1621, DOI 10.4161/cc.8.10.8578; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; RUDLAND PS, 1987, CANCER METAST REV, V6, P55, DOI 10.1007/BF00047609; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Simpson PT, 2004, J PATHOL, V202, P274, DOI 10.1002/path.1530; Smith AE, 2009, GENOME RES, V19, P1325, DOI 10.1101/gr.085530.108; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Tavassoli F, 1999, NORMAL DEV ANOMALIES, P1; Tavassoli FA, 2001, VIRCHOWS ARCH, V438, P221; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Zhang RR, 2003, BREAST CANCER RES, V5, pR151, DOI 10.1186/bcr635; Zhou JC, 2012, MOL CELL BIOL, V32, P479, DOI 10.1128/MCB.06332-11	47	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100888	10.1371/journal.pone.0100888	http://dx.doi.org/10.1371/journal.pone.0100888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029110	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600010
J	Yang, CY; Wang, LL; Wang, JJ; Jiang, QF; Qiu, LM; Zhang, H; Song, LS				Yang, Chuanyan; Wang, Lingling; Wang, Jingjing; Jiang, Qiufen; Qiu, Limei; Zhang, Huan; Song, Linsheng			The Polymorphism in the Promoter of HSP70 Gene Is Associated with Heat Tolerance of Two Congener Endemic Bay Scallops (Argopecten irradians irradians and A. i. concentricus)	PLOS ONE			English	Article							SHOCK PROTEINS; INTERSPECIFIC VARIATION; CPG ODNS; EXPRESSION; THERMOTOLERANCE; STRESS; HEAT-SHOCK-PROTEIN-70; RESPONSES; EVOLUTIONARY; ARABIDOPSIS	Background: The heat shock protein 70 (HSP70) is one kind of molecular chaperones, which plays a key role in protein metabolism under normal and stress conditions. Methodology: In the present study, the mRNA expressions of HSP70 under normal physiological condition and after acute heat stress were investigated in gills of two bay scallop populations (Argopecten irradians irradians and A.i. concentricus). The heat resistant scallops A.i. concentricus showed significantly lower basal level and higher induction of HSP70 compared with that of the heat sensitive scallops A. i. irradians. The promoter sequence of HSP70 gene from bay scallop (AiHSP70) was cloned and the polymorphisms within this region were investigated to analyze their association with heat tolerance. Totally 11 single nucleotide polymorphisms (SNPs) were identified, and four of them (2967, 2480, 2408 and 283) were associated with heat tolerance after HWE analysis and association analysis. Based on the result of linkage disequilibrium analysis, the in vitro transcriptional activities of AiHSP70 promoters with different genotype were further determined, and the results showed that promoter from A. i. concentricus exhibited higher transcriptional activity than that from A. i. irradians (P < 0.05). Conclusions: The results provided insights into the molecular mechanisms underlying the thermal adaptation of different congener endemic bay scallops, which suggested that the increased heat tolerance of A. i. concentricus (compared with A. i. irradians) was associated with the higher expression of AiHSP70. Meanwhile, the 2967 GG, 2480 AA, 2408 TT and 283 AG genotypes could be potential markers for scallop selection breeding with higher heat tolerance.	[Yang, Chuanyan; Wang, Lingling; Wang, Jingjing; Jiang, Qiufen; Qiu, Limei; Zhang, Huan; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Jiang, Qiufen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Jingjing] Qingdao Agr Univ, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao Agricultural University	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn			National Basic Research Program of China (973 Program) from the Chinese Ministry of Science and Technology [2010CB126404]; National Science Foundation of China [JQ201110]; Shandong Provincial Natural Science Foundation	National Basic Research Program of China (973 Program) from the Chinese Ministry of Science and Technology(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126404) from the Chinese Ministry of Science and Technology, and grants (JQ201110) from National Science Foundation of China and Shandong Provincial Natural Science Foundation, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Basirico L, 2011, CELL STRESS CHAPERON, V16, P441, DOI 10.1007/s12192-011-0257-7; Bedulina DS, 2013, MOL ECOL, V22, P1416, DOI 10.1111/mec.12136; Cellura C, 2006, DEV COMP IMMUNOL, V30, P984, DOI 10.1016/j.dci.2005.12.009; Dahlgaard J, 1998, FUNCT ECOL, V12, P786, DOI 10.1046/j.1365-2435.1998.00246.x; De Maio A, 2014, CURR PROTEIN PEPT SC, V15, P225, DOI 10.2174/1389203715666140331113057; Deb R, 2013, GENE, V532, P230, DOI 10.1016/j.gene.2013.09.037; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Evgen'ev MB, 2007, J BIOSCIENCES, V32, P489, DOI 10.1007/s12038-007-0048-6; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Garbuz D, 2003, J EXP BIOL, V206, P2399, DOI 10.1242/jeb.00429; Garbuz DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-74; Hofmann GE, 1996, MAR BIOL, V126, P65, DOI 10.1007/BF00571378; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Lee JH, 1996, MOL GEN GENET, V252, P11, DOI 10.1007/BF02173200; Li L, 2009, FISH SHELLFISH IMMUN, V27, P136, DOI 10.1016/j.fsi.2008.12.005; Liu Xiao, 2006, Oceanologia et Limnologia Sinica, V37, P61; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Lu J, 2009, FASEB J, V23, P3459, DOI 10.1096/fj.09-136549; Mizrahi T, 2012, CELL STRESS CHAPERON, V17, P523, DOI 10.1007/s12192-012-0341-7; Oda S, 2010, ZOOL SCI, V27, P410, DOI 10.2108/zsj.27.410; Park H, 2007, CELL STRESS CHAPERON, V12, P275, DOI 10.1379/CSC-271.1; Qu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089040; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Schwerin M, 2001, BBA-GENE STRUCT EXPR, V1522, P108, DOI 10.1016/S0167-4781(01)00313-X; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh R, 2006, CELL STRESS CHAPERON, V11, P208, DOI 10.1379/CSC-184R.1; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Sun R, 2014, DEV COMP IMMUNOL, V43, P15, DOI 10.1016/j.dci.2013.10.005; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Taldone T, 2014, EXPERT OPIN THER PAT, V24, P501, DOI 10.1517/13543776.2014.887681; Tanguy A, 2001, GENE, V273, P123, DOI 10.1016/S0378-1119(01)00577-7; Tomanek L, 1999, J EXP BIOL, V202, P2925; Wang L, 2013, ISJ-INVERT SURVIV J, V10, P77; Xiong Q, 2013, CELL STRESS CHAPERON, V18, P711, DOI 10.1007/s12192-013-0421-3; Yang CY, 2013, GENE, V526, P429, DOI 10.1016/j.gene.2013.05.033; Yang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032012; Yang YN, 2013, CELL STRESS CHAPERON, V18, P475, DOI 10.1007/s12192-013-0402-6; Zatsepina OG, 2000, J EXP BIOL, V203, P1017; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang F., 1999, MAR SCI-CHINA, V1, P47; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2014, FISH PHYSIOL BIOCHEM, V40, P221, DOI 10.1007/s10695-013-9838-y; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P418, DOI 10.1016/j.dci.2009.11.012; Zhou YJ, 2014, CANCER IMMUNOL RES, V2, P217, DOI 10.1158/2326-6066.CIR-13-0132	46	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102332	10.1371/journal.pone.0102332	http://dx.doi.org/10.1371/journal.pone.0102332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028964	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600065
J	Fang, WF; Douglas, IS; Wang, CC; Kao, HC; Chang, YT; Tseng, CC; Huang, KT; Chang, HC; Lin, MC				Fang, Wen-Feng; Douglas, Ivor S.; Wang, Chin-Chou; Kao, Hsu-Ching; Chang, Ya-Ting; Tseng, Chia-Cheng; Huang, Kuo-Tung; Chang, Huang-Chih; Lin, Meng-Chih			5-Lipoxygenase Activating Protein (FLAP) Dependent Leukotriene Biosynthesis Inhibition (MK591) Attenuates Lipid A Endotoxin-Induced Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; SEPTIC SHOCK; SEPSIS; MICE; LIPOPOLYSACCHARIDE; MECHANISMS; RECEPTORS; PATHWAY; TLR4; GENE	The Lipid A moiety of endotoxin potently activates TLR-4 dependent host innate immune responses. We demonstrate that Lipid-A mediated leukotriene biosynthesis regulates pathogen-associated molecular patterns (PAMP)-dependent macrophage activation. Stimulation of murine macrophages (RAW264.7) with E. coli 0111:B4 endotoxin (LPS) or Kdo2-lipid A (Lipid A) induced inflammation and Lipid A was sufficient to induce TLR-4 mediated macrophage inflammation and rapid ERK activation. The contribution of leukotriene biosynthesis was evaluated with a 5-lipoxygenase activating protein (FLAP) inhibitor, MK591. MK591 pre-treatment not only enhanced but also sustained ERK activation for up to 4 hours after LPS and Lipid A stimulation while inhibiting cell proliferation and enhancing cellular apoptosis. Leukotriene biosynthesis inhibition attenuated inflammation induced by either whole LPS or the Lipid A fraction. These responses were regulated by inhibition of the key biosynthesis enzymes for the proinflammatory eicosanoids, 5-lipoxygenase (5-LO), and cyclooxygenase-2 (COX-2) quantified by immunoblotting. Inhibition of leukotriene biosynthesis differentially regulated TLR-2 and TLR-4 cell surface expression assessed by flow cytometry, suggesting a close mechanistic association between TLR expression and 5-LO associated eicosanoid activity in activated macrophages. Furthermore, MK591 pre-treatment enhanced ERK activation and inhibited cell proliferation after LPS or Lipid A stimulation. These effects were regulated in part by increased apoptosis and modulation of cell surface TLR expression. Together, these data clarify the mechanistic association between 5-lipoxygenase activating protein-mediated leukotriene biosynthesis and 5-LO dependent eicosanoid metabolites in mediating the TLR-dependent inflammatory response after endotoxin exposure typical of bacterial sepsis.	[Fang, Wen-Feng; Wang, Chin-Chou; Kao, Hsu-Ching; Chang, Ya-Ting; Tseng, Chia-Cheng; Huang, Kuo-Tung; Chang, Huang-Chih; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan; [Douglas, Ivor S.] Univ Colorado, Div Pulm Sci & Crit Care Med, Denver, CO 80202 USA; [Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; University of Colorado System; University of Colorado Denver; Denver Health Medical Center	Fang, WF (corresponding author), Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.	wenfengfang@yahoo.com.tw; idouglas@dhha.org; mengchih@adm.cgmh.org.tw	Douglas, Ivor S/AAC-6245-2021; Fang, Wen-Feng/AAT-6296-2021	Douglas, Ivor S/0000-0002-4541-1431; Fang, Wen-Feng/0000-0003-0350-9059	Taiwan National Science Council Grant [NSC 97-2314-B-182A-082-, NSC 101-2314-B-182A-094-]; MSD IISP (Investigator-Initiated Study Program) [37346]; Chang Gung Memorial Hospital Grant [CMRPG890661, CMRPG890662, CMRPG8C0551]	Taiwan National Science Council Grant; MSD IISP (Investigator-Initiated Study Program); Chang Gung Memorial Hospital Grant(Chang Gung Memorial Hospital)	The work was supported in part by Taiwan National Science Council Grant (NSC 97-2314-B-182A-082-, NSC 101-2314-B-182A-094-), MSD IISP (Investigator-Initiated Study Program #37346), and Chang Gung Memorial Hospital Grant (CMRPG890661, CMRPG890662, CMRPG8C0551) to Wen-Feng Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caironi P, 2005, AM J RESP CRIT CARE, V172, P334, DOI 10.1164/rccm.200501-034OC; David MD, 2005, J IMMUNOL, V175, P8236, DOI 10.4049/jimmunol.175.12.8236; Eun JC, 2011, SHOCK, V35, P240, DOI 10.1097/SHK.0b013e3181faceb3; Fang W, 2008, AM J RESP CRIT CARE, V177, pA282; Fang WF, 2007, AM J PHYSIOL-LUNG C, V293, pL336, DOI 10.1152/ajplung.00011.2007; Gao HM, 2008, SEMIN IMMUNOPATHOL, V30, P29, DOI 10.1007/s00281-007-0101-4; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Mendis C, 2008, FEBS J, V275, P3088, DOI 10.1111/j.1742-4658.2008.06462.x; Monteiro APT, 2014, AM J RESP CELL MOL, V50, P87, DOI 10.1165/rcmb.2012-0525OC; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Park MS, 2012, AM J RESP CRIT CARE, V186, P72, DOI 10.1164/rccm.201109-1593OC; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Petersen B, 2011, ANESTHESIOLOGY, V115, P804, DOI 10.1097/ALN.0b013e31822e94bd; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; RIETSCHEL ET, 1973, INFECT IMMUN, V8, P173, DOI 10.1128/IAI.8.2.173-177.1973; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Wu TT, 2009, TOXICOL LETT, V191, P195, DOI 10.1016/j.toxlet.2009.08.025; Zhang Wei, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P622	27	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102622	10.1371/journal.pone.0102622	http://dx.doi.org/10.1371/journal.pone.0102622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025775	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400095
J	Kamtchueng, C; Stebenne, ME; Delannoy, A; Wilhelm, E; Leger, H; Benecke, AG; Bell, B				Kamtchueng, Catherine; Stebenne, Marie-Eve; Delannoy, Aurelie; Wilhelm, Emmanuelle; Leger, Helene; Benecke, Arndt G.; Bell, Brendan			Alternative Splicing of TAF6: Downstream Transcriptome Impacts and Upstream RNA Splice Control Elements	PLOS ONE			English	Article							PRE-MESSENGER-RNA; GENE-EXPRESSION ANALYSIS; SECONDARY STRUCTURE; IN-VIVO; IDENTIFICATION; APOPTOSIS; COMPLEX; CANCER; PROGRESSION; PROTEINS	The TAF6 delta pathway of apoptosis can dictate life versus death decisions independently of the status of p53 tumor suppressor. TAF6 delta is an inducible pro-apoptotic subunit of the general RNA polymerase II (Pol II) transcription factor TFIID. Alternative splice site choice of TAF6 delta has been shown to be a pivotal event in triggering death via the TAF6 delta pathway, yet nothing is currently known about the mechanisms that promote TAF6 delta splicing. Furthermore the transcriptome impact of the gain of function of TAF6 delta versus the loss of function of the major TAF6 alpha splice form remains undefined. Here we employ comparative microarray analysis to show that TAF6 delta drives a transcriptome profile distinct from that resulting from depletion of TAF6 alpha. To define the cis-acting RNA elements responsible for TAF6 delta alternative splicing we performed a mutational analysis of a TAF6 minigene system. The data point to several new RNA elements that can modulate TAF6 delta and also reveal a role for RNA secondary structure in the selection of TAF6 delta.	[Kamtchueng, Catherine; Stebenne, Marie-Eve; Delannoy, Aurelie; Wilhelm, Emmanuelle; Bell, Brendan] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Kamtchueng, Catherine; Stebenne, Marie-Eve; Delannoy, Aurelie; Wilhelm, Emmanuelle; Bell, Brendan] CHUS, Ctr Rech, Sherbrooke, PQ, Canada; [Leger, Helene; Benecke, Arndt G.] CNRS, Inst Hautes Etud Sci, Bures Sur Yvette, France; [Benecke, Arndt G.] Univ Paris 06, CNRS, UMR8246, Paris, France	University of Sherbrooke; University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Bell, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA Grp, Pavillon Rech Appl Canc,3201 Rue Jean Migneault, Sherbrooke, PQ J1K 2R1, Canada.	Brendan.Bell@USherbrooke.ca	Léger, Hélène/AAX-5076-2020; Benecke, Arndt G./T-1079-2019	Leger, Helene/0000-0003-1116-8637	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the award of a NSERC Discover Grant to B. Bell. The funding agency website is http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Aoyagi N, 2001, MOL CELL BIOL, V21, P6808, DOI 10.1128/MCB.21.20.6808-6819.2001; Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bieniossek C., 2013, NATURE; Brysbaert Guillaume, 2010, Genomics Proteomics & Bioinformatics, V8, P57, DOI 10.1016/S1672-0229(10)60006-X; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Jin YF, 2011, RNA BIOL, V8, P450, DOI 10.4161/rna.8.3.15388; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Noth S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-307; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P90, DOI 10.1016/S1672-0229(06)60021-1; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P212, DOI 10.1016/S1672-0229(07)60002-3; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Rasmussen AL, 2012, HEPATOLOGY, V56, P17, DOI 10.1002/hep.25612; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Tchitchek Nicolas, 2012, Genomics Proteomics & Bioinformatics, V10, P127, DOI 10.1016/j.gpb.2012.06.002; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang W, 2004, MOL CANCER RES, V2, P442; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Wilhelm E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-10; Wilhelm Emmanuelle, 2008, BMC Res Notes, V1, P94, DOI 10.1186/1756-0500-1-94; Wilhelm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002721; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102399	10.1371/journal.pone.0102399	http://dx.doi.org/10.1371/journal.pone.0102399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025302	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400070
J	McClure, DL; Kieke, BA; Sundaram, ME; Simpson, MD; Meece, JK; Sifakis, F; Gasser, RA; Belongia, EA				McClure, David L.; Kieke, Burney A.; Sundaram, Maria E.; Simpson, Melissa D.; Meece, Jennifer K.; Sifakis, Frangiscos; Gasser, Robert A., Jr.; Belongia, Edward A.			Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection in a Community Cohort of Adults >= 50 Years Old	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; INFLUENZA VACCINES; RISK-FACTORS; OUTCOMES; ILLNESS	Background: Diagnostic testing for respiratory syncytial virus (RSV) is not routinely performed in adults. We estimated medically attended RSV seasonal incidence in a community cohort of adults >= 50 years old during four influenza seasons (2006-07 through 2009-10). Methods: Patients seeking care for acute respiratory illness (ARI) were prospectively enrolled and tested for RSV by multiplex RT-PCR. Results from enrolled patients were used to estimate projected cases among non-enrolled patients with ARI. The seasonal incidence of medically attended RSV was the sum of actual and projected cases divided by the community cohort denominator. Since each enrollment period did not include the entire RSV season, incidence estimates were adjusted to account for the statewide proportion of RSV occurring outside the study enrollment period. Results: There were 16,088 to 17,694 adults in the cohort each season and 164 RSV cases in all 4 seasons. The overall seasonal incidence of medically attended RSV was 154 episodes (95% CI, 132-180) per 10,000 persons; the incidence was highest in 2007-08 (179) and lowest in 2006-07 (110). Among persons 50-59, 60-69, and >= 70 years old, RSV incidence was 124 (95% CI, 99-156), 147 (95% CI, 110-196), and 199 (95% CI, 153-258), respectively. Conclusions: The incidence of medically attended RSV increased with age and was similar during four seasons.	[McClure, David L.; Kieke, Burney A.; Sundaram, Maria E.; Simpson, Melissa D.; Meece, Jennifer K.; Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Sifakis, Frangiscos; Gasser, Robert A., Jr.] MedImmune LLC, Gaithersburg, MD USA	AstraZeneca; Medimmune	McClure, DL (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI 54449 USA.	Mcclure.david@marshfieldclinic.org	Sundaram, Maria/W-2575-2019	Sundaram, Maria/0000-0001-8056-3302; Belongia, Edward/0000-0001-7478-0415	MedImmune LLC.	MedImmune LLC.(AstraZenecaMedimmune)	Funding for this research was provided by MedImmune LLC. The funders had no role in study design, data collection and analysis, or decision to publish. They had a coauthor role in preparation of the manuscript.	Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Duncan CB, 2009, J INFECT DIS, V200, P1242, DOI 10.1086/605948; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fleming DM, 2007, EPIDEMIOL INFECT, V135, P1099, DOI 10.1017/S0950268807007881; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Greenlee Robert T, 2003, Clin Med Res, V1, P273; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Pierce VM, 2012, J CLIN MICROBIOL, V50, P3458, DOI 10.1128/JCM.01384-12; Sirri L, 2013, PSYCHOTHER PSYCHOSOM, V82, P74, DOI 10.1159/000343508; Sundaram ME, 2014, CLIN INFECT DIS, V58, P342, DOI 10.1093/cid/cit767; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Walsh EE, 2013, J INFECT DIS, V207, P1424, DOI 10.1093/infdis/jit038; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	22	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102586	10.1371/journal.pone.0102586	http://dx.doi.org/10.1371/journal.pone.0102586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025344	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400092
J	Sato, D; Yamashiro, K; Onishi, H; Baba, Y; Nakazawa, S; Shimoyama, Y; Maruyama, A				Sato, Daisuke; Yamashiro, Koya; Onishi, Hideaki; Baba, Yasuhiro; Nakazawa, Sho; Shimoyama, Yoshimitsu; Maruyama, Atsuo			Whole-Body Water Flow Stimulation to the Lower Limbs Modulates Excitability of Primary Motor Cortical Regions Innervating the Hands: A Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							CORTEX EXCITABILITY; ELECTRICAL-STIMULATION; CORTICOCORTICAL INHIBITION; CUTANEOMOTOR INTEGRATION; INTRINSIC CONNECTIONS; SOMATOSENSORY INPUT; EVOKED POTENTIALS; HUMANS; PLASTICITY; FACILITATION	Whole-body water immersion (WI) has been reported to change sensorimotor integration. However, primary motor cortical excitability is not affected by low-intensity afferent input. Here we explored the effects of whole-body WI and water flow stimulation (WF) on corticospinal excitability and intracortical circuits. Eight healthy subjects participated in this study. We measured the amplitude of motor-evoked potentials (MEPs) produced by single transcranial magnetic stimulation (TMS) pulses and examined conditioned MEP amplitudes by paired-pulse TMS. We evaluated short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF) using the paired-TMS technique before and after 15-min intervention periods. Two interventions used were whole-body WI with water flow to the lower limbs (whole-body WF) and whole-body WI without water flow to the lower limbs (whole-body WI). The experimental sequence included a baseline TMS assessment (T0), intervention for 15 min, a second TMS assessment immediately after intervention (T1), a 10 min resting period, a third TMS assessment (T2), a 10 min resting period, a fourth TMS assessment (T3), a 10 min resting period, and the final TMS assessment (T4). SICI and ICF were evaluated using a conditioning stimulus of 90% active motor threshold and a test stimulus adjusted to produce MEPs of approximately 1-1.2 mV, and were tested at intrastimulus intervals of 3 and 10 ms, respectively. Whole-body WF significantly increased MEP amplitude by single-pulse TMS and led to a decrease in SICI in the contralateral motor cortex at T1, T2 and T3. Whole-body WF also induced increased corticospinal excitability and decreased SICI. In contrast, whole-body WI did not change corticospinal excitability or intracortical circuits.	[Sato, Daisuke; Yamashiro, Koya; Onishi, Hideaki; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Sato, Daisuke; Yamashiro, Koya; Baba, Yasuhiro; Nakazawa, Sho; Shimoyama, Yoshimitsu; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Onishi, Hideaki] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan	Niigata University; Niigata University; Niigata University	Sato, D (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	daisuke@nuhw.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Niigata University of Health and Welfare	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Niigata University of Health and Welfare	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. It was also supported by a Grant-in-Aid for Advanced Research from the Niigata University of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA H, 1973, EXP BRAIN RES, V16, P507, DOI 10.1007/BF00234477; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Bressel E, 2011, MED SCI SPORTS EXERC; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; Christova M, 2011, EUR J APPL PHYSIOL, V111, P3051, DOI 10.1007/s00421-011-1933-0; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; DENOORDHOUT AM, 1992, J PHYSIOL-LONDON, V447, P535, DOI 10.1113/jphysiol.1992.sp019016; DEUSCHL G, 1991, EXP BRAIN RES, V83, P403; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GATTER KC, 1978, BRAIN, V101, P513, DOI 10.1093/brain/101.3.513; Golaszewski SM, 2012, CLIN NEUROPHYSIOL, V123, P193, DOI 10.1016/j.clinph.2011.06.010; Golaszewski SM, 2010, CLIN NEUROPHYSIOL, V121, P248, DOI 10.1016/j.clinph.2009.09.024; Hallett M, 1999, EEG CL N SU, V50, P85; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Ilic TV, 2002, NEUROSCI LETT, V319, P116, DOI 10.1016/S0304-3940(01)02563-0; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; JONES EG, 1980, BRAIN RES REV, V2, P1, DOI 10.1016/0165-0173(80)90002-8; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; Koch G, 2009, J PHYSIOL-LONDON, V587, P4281, DOI 10.1113/jphysiol.2009.174086; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Man IOW, 2003, MED SCI SPORT EXER, V35, P630, DOI 10.1249/01.MSS.0000058432.29149.08; Mileva KN, 2009, EXP PHYSIOL, V94, P103, DOI 10.1113/expphysiol.2008.042689; Naito E, 2007, EUR J NEUROSCI, V25, P3476, DOI 10.1111/j.1460-9568.2007.05587.x; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Ridding MC, 2001, J PHYSIOL-LONDON, V537, P623, DOI 10.1111/j.1469-7793.2001.00623.x; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Rosenkranz K, 2003, J PHYSIOL-LONDON, V551, P649, DOI 10.1113/jphysiol.2003.043752; Rossini PM, 1996, MUSCLE NERVE, V19, P1302; Sato D, 2013, CLIN NEUROPHYSIOL; Sato D, 2012, BRAIN TOPOGR, V25, P220, DOI 10.1007/s10548-011-0204-z; Sato D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-13; Takahashi K, 2011, BRAIN STIMUL, V4, P90, DOI 10.1016/j.brs.2010.07.001; Tamburin S, 2001, EXP BRAIN RES, V141, P232, DOI 10.1007/s002210100859; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; White E.L., 1989, CORTICAL CIRCUITS SY; Wilcock IM, 2006, SPORTS MED, V36, P747, DOI 10.2165/00007256-200636090-00003; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 2002, CLIN NEUROPHYSIOL, V113, P1308, DOI 10.1016/S1388-2457(02)00171-2; Ziemann U, 1996, EXP BRAIN RES, V109, P127	46	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102472	10.1371/journal.pone.0102472	http://dx.doi.org/10.1371/journal.pone.0102472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025129	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400077
J	Testa, ML; Chojniak, R; Sene, LS; Damascena, AS; Guimaraes, MD; Szklaruk, J; Marchiori, E				Testa, Maria Luiza; Chojniak, Rubens; Sene, Leticia Silva; Damascena, Aline Santos; Guimaraes, Marcos Duarte; Szklaruk, Janio; Marchiori, Edson			Is DWI/ADC a Useful Tool in the Characterization of Focal Hepatic Lesions Suspected of Malignancy?	PLOS ONE			English	Article							LIVER-LESIONS; METASTASIS; DIAGNOSIS; MRI	Objective: Apparent diffusion coefficient (ADC) values calculated through magnetic resonance imaging have been proposed as a useful tool to distinguish benign from malignant liver lesions. Most studies however included simple cysts in their analysis. Liver cysts are easy to diagnose, have very high ADC values and their inclusion facilitates differentiation in the ADC values between benign and malignant liver lesions groups. We prospectively evaluated the ability of ADC values to differentiate metastatic liver lesions from all benign or only solid benign liver lesions. Material and Methods: Sixty-seven adult cancer patients with 188 liver lesions were evaluated. Lesions were categorized as metastatic or benign throughout imaging and clinical evaluation. One hundred and five (105) metastatic lesions and 83 benign lesions including hemangiomas (37), cysts (42), adenomas (2) and focal nodular hyperplasias (2) were evaluated. ADC values were calculated for each lesion utilizing two b values (0 and 600 sec/mm(2)). Results: The average ADC value for cysts was 2.4x10(-3) mm(2)/sec (CI: 2.1-2.6), for solid benign lesions was 1.4x10(-3) mm(2)/sec (CI: 1.1-1.7) and for metastases was 1.0x10(-3) mm(2)/sec (CI: 0.8-1.3). There was a difference between the ADC values of metastases and benign solid lesions (p<0.0001). With the ADC value of 1.5x10(-3) mm(2)/sec as a cut off it is possible to distinguish metastatic from benign liver lesions, including cysts, with an accuracy of 78%. But to distinguish metastatic from benign solid liver lesions the best ADC cut off value was 1.2x10(-3) mm(2)/sec and the accuracy drops to 71%. Conclusions: ADC values proved to be helpful in the distinction between metastasis and benign solid hepatic lesions. But the exclusion of cysts in the analysis point out to a lower cut off value and lower accuracy than previously reported.	[Testa, Maria Luiza; Chojniak, Rubens; Sene, Leticia Silva; Guimaraes, Marcos Duarte] AC Camargo Canc Ctr, Dept Diagnost Radiol, Sao Paulo, Brazil; [Damascena, Aline Santos] AC Camargo Canc Ctr, CIPE Int Ctr Res, Sao Paulo, Brazil; [Szklaruk, Janio] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Marchiori, Edson] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Universidade Federal do Rio de Janeiro	Chojniak, R (corresponding author), AC Camargo Canc Ctr, Dept Diagnost Radiol, Sao Paulo, Brazil.	chojniak@uol.com.br	Guimaraes, Marcos/N-8412-2013; Chojniak, Rubens/L-3770-2013; Marchiori, Edson/C-1205-2013	Guimaraes, Marcos/0000-0002-4662-5845; Chojniak, Rubens/0000-0002-8096-252X; Marchiori, Edson/0000-0001-8797-7380				Bruegel M, 2008, AM J ROENTGENOL, V191, P1421, DOI 10.2214/AJR.07.3279; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Coenegrachts K, 2007, BRIT J RADIOL, V80, P524, DOI 10.1259/bjr/33156643; Estorch Montserrat, 2013, Recent Results Cancer Res, V187, P403, DOI 10.1007/978-3-642-10853-2_14; Figueras J, 2009, CIR ESPAN, V85, P325, DOI 10.1016/j.ciresp.2008.09.014; Fowler KJ, 2011, HEPATOLOGY, V54, P2227, DOI 10.1002/hep.24679; Galea N, 2013, J MAGN RESON IMAGING, V37, P1260, DOI 10.1002/jmri.23947; Goel A K, 1994, Trop Gastroenterol, V15, P37; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Neter J, 2004, APPL LINEAR STAT MOD, P1030; Parikh T, 2008, RADIOLOGY, V246, P812, DOI 10.1148/radiol.2463070432; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P133, DOI DOI 10.1007/0-387-22747-4_4; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P57, DOI [DOI 10.1198/JASA.2001.S411, 10.1007/0- 387-22747-4]; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Xu JM, 2011, J CANCER RES CLIN, V137, P1379, DOI 10.1007/s00432-011-0999-8	19	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101944	10.1371/journal.pone.0101944	http://dx.doi.org/10.1371/journal.pone.0101944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025151	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400027
J	Vanderlinde, EM; Zhong, S; Li, G; Martynowski, D; Grochulski, P; Howard, SP				Vanderlinde, Elizabeth M.; Zhong, Su; Li, Gang; Martynowski, Dariusz; Grochulski, Pawel; Howard, S. Peter			Assembly of the Type Two Secretion System in Aeromonas hydrophila Involves Direct Interaction between the Periplasmic Domains of the Assembly Factor ExeB and the Secretin ExeD	PLOS ONE			English	Article							II SECRETION; PROTEIN SECRETION; COMPLEX-FORMATION; MEMBRANE-PROTEIN; OUTER-MEMBRANE; MACHINERY; PEPTIDOGLYCAN; MUTAGENESIS; TRANSPORT; INSIGHTS	The type two secretion system is a large, trans-envelope apparatus that secretes toxins across the outer membrane of many Gram-negative bacteria. In Aeromonas hydrophila, ExeA interacts with peptidoglycan and forms a heteromultimeric complex with ExeB that is required for assembly of the ExeD secretin of the secretion system in the outer membrane. While the peptidoglycan-ExeAB (PG-AB) complex is required for ExeD assembly, the assembly mechanism remains unresolved. We analyzed protein-protein interactions to address the hypothesis that ExeD assembly in the outer membrane requires direct interaction with the PG-AB complex. Yeast and bacterial two hybrid analyses demonstrated an interaction between the periplasmic domains of ExeB and ExeD. Two-codon insertion mutagenesis of exeD disrupted lipase secretion, and immunoblotting of whole cells demonstrated significantly reduced secretin in mutant cells. Mapping of the two-codon insertions and deletion analysis showed that the ExeB-ExeD interaction involves the N0 and N1 subdomains of ExeD. Rotational anisotropy using the purified periplasmic domains of ExeB and ExeD determined that the apparent dissociation constant of the interaction is 1.19+/-0.16 mu M. These results contribute important support for a putative mechanism by which the PG-AB complex facilitates assembly of ExeD through direct interaction between ExeB and ExeD. Furthermore, our results provide novel insight into the assembly function of ExeB that may contribute to elucidating the role of homologous proteins in secretion of toxins from other Gram negative pathogens.	[Vanderlinde, Elizabeth M.; Zhong, Su; Li, Gang; Martynowski, Dariusz; Howard, S. Peter] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Grochulski, Pawel] Canadian Light Source, Saskatoon, SK, Canada; [Grochulski, Pawel] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Howard, SP (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	peter.howard@usask.ca	Martynowski, Dariusz/AAU-6083-2020	Martynowski, Dariusz/0000-0001-7617-7716; Vanderlinde, Elizabeth/0000-0002-6002-1861	Natural Sciences and Engineering Research Council [203383]; Saskatchewan Health Research Foundation (SHRF) [2700]; SHRF Postdoctoral Fellowship Award [2720]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF); SHRF Postdoctoral Fellowship Award	This work was supported by Natural Sciences and Engineering Research Council Discovery Grant # 203383, and Saskatchewan Health Research Foundation (SHRF) grant # 2700. EMV was supported by SHRF Postdoctoral Fellowship Award #2720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ast VM, 2002, MOL MICROBIOL, V44, P217, DOI 10.1046/j.1365-2958.2002.02870.x; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Condemine G, 2000, MICROBIOL-UK, V146, P639, DOI 10.1099/00221287-146-3-639; Douet V, 2004, RES MICROBIOL, V155, P71, DOI 10.1016/j.resmic.2003.10.001; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Fu Y, 2003, DNA REPAIR, V2, P1435, DOI 10.1016/j.dnarep.2003.08.013; Howard SP, 2013, RES MICROBIOL, V164, P535, DOI 10.1016/j.resmic.2013.03.018; Howard SP, 2006, MOL MICROBIOL, V59, P1062, DOI 10.1111/j.1365-2958.2005.05003.x; Howard SP, 1996, MOL MICROBIOL, V22, P595, DOI 10.1046/j.1365-2958.1996.d01-1713.x; JAHAGIRDAR R, 1994, J BACTERIOL, V176, P6819, DOI 10.1128/JB.176.22.6819-6826.1994; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2013, J STRUCT BIOL, V183, P354, DOI 10.1016/j.jsb.2013.06.013; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Li G, 2011, J BACTERIOL, V193, P197, DOI 10.1128/JB.00882-10; Li G, 2010, MOL MICROBIOL, V76, P772, DOI 10.1111/j.1365-2958.2010.07138.x; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Martynowski D, 2013, ACTA CRYSTALLOGR D, V69, P142, DOI 10.1107/S0907444912042710; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Pastushok L, 2005, J BIOL CHEM, V280, P17891, DOI 10.1074/jbc.M410469200; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rondelet A, 2013, RES MICROBIOL, V164, P556, DOI 10.1016/j.resmic.2013.03.005; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Schoenhofen IC, 1998, MOL MICROBIOL, V29, P1237, DOI 10.1046/j.1365-2958.1998.01011.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SLAUCH JM, 1991, METHOD ENZYMOL, V204, P213; Strozen TG, 2011, J BACTERIOL, V193, P2322, DOI 10.1128/JB.01413-10; Van der Meeren R, 2013, J BIOL CHEM, V288, P1214, DOI 10.1074/jbc.M112.432096; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338	41	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102038	10.1371/journal.pone.0102038	http://dx.doi.org/10.1371/journal.pone.0102038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025769	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400036
J	Wang, Y; Xue, J; Zhou, XD; You, M; Du, Q; Yang, X; He, JZ; Zou, J; Cheng, L; Li, MY; Li, YQ; Zhu, YP; Li, JY; Shi, WY; Xu, X				Wang, Yan; Xue, Jing; Zhou, Xuedong; You, Meng; Du, Qin; Yang, Xue; He, Jingzhi; Zou, Jing; Cheng, Lei; Li, Mingyun; Li, Yuqing; Zhu, Yiping; Li, Jiyao; Shi, Wenyuan; Xu, Xin			Oral Microbiota Distinguishes Acute Lymphoblastic Leukemia Pediatric Hosts from Healthy Populations	PLOS ONE			English	Article							ABIOTROPHIA-DEFECTIVA; BLOOD-STREAM; CHILDREN; CHEMOTHERAPY; BACTERIA; SALIVA; FLORA; PERIODONTITIS; INFECTIONS; MICROFLORA	In leukemia, oral manifestations indicate aberrations in oral microbiota. Microbiota structure is determined by both host and environmental factors. In human hosts, how health status shapes the composition of oral microbiota is largely unknown. Taking advantage of advances in high-throughput sequencing, we compared the composition of supragingival plaque microbiota of acute lymphoblastic leukemia (ALL) pediatric patients with healthy controls. The oral microbiota of leukemia patients had lower richness and less diversity compared to healthy controls. Microbial samples clustered into two major groups, one of ALL patients and another of healthy children, with different structure and composition. Abundance changes of certain taxa including the Phylum Firmicutes, the Class Bacilli, the Order Lactobacillales, the Family Aerococcaceae and Carnobacteriaceae, as well as the Genus Abiotrophia and Granulicatella were associated with leukemia status. ALL patients demonstrated a structural imbalance of the oral microbiota, characterized by reduced diversity and abundance alterations, possibly involved in systemic infections, indicating the importance of immune status in shaping the structure of oral microbiota.	[Wang, Yan; Xue, Jing; Zhou, Xuedong; You, Meng; Du, Qin; He, Jingzhi; Cheng, Lei; Li, Mingyun; Li, Yuqing; Li, Jiyao; Xu, Xin] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Yang, Xue; Zhu, Yiping] Sichuan Univ, Dept Pediat Hematol & Oncol, West China Univ Hosp 2, Chengdu 610064, Peoples R China; [Zou, Jing] Sichuan Univ, Dept Pediat Dent, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	Sichuan University; Sichuan University; Sichuan University; University of California System; University of California Los Angeles	Xu, X (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.	nixux1982@hotmail.com	SHI, wen/GPW-9531-2022; ZHOU, XUE/F-6129-2013	Cheng, Lei/0000-0002-2762-4740; Zou, Jing/0000-0002-3618-9672; Zhou, Xuedong/0000-0002-9319-7302; Xu, Xin/0000-0003-4608-4556; You, Meng/0000-0001-6189-1845; Wang, Yan/0000-0002-7136-9353	International S&T Cooperation Program of China [2011DFA30940]; National Basic Research Program of China ("973 Pilot Research Program") [2011CB512108]; National Science & Technology Pillar Program [2012BAI07B03]; National Natural Science Foundation of China [81200782]; Doctoral Fund of Ministry of Education of China [20120181120002]	International S&T Cooperation Program of China; National Basic Research Program of China ("973 Pilot Research Program")(National Basic Research Program of China); National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by the International S&T Cooperation Program of China (grant number: 2011DFA30940), the National Basic Research Program of China ("973 Pilot Research Program," grant Number: 2011CB512108), the National Science & Technology Pillar Program during the 12th Five-year Plan Period (grant number: 2012BAI07B03), National Natural Science Foundation of China (grant number: 81200782) and Doctoral Fund of Ministry of Education of China (grant number: 20120181120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT AP, 1986, J PERIODONTOL, V57, P579, DOI 10.1902/jop.1986.57.9.579; Belstrom D, 2014, J CLIN PERIODONTOL, V41, P104, DOI 10.1111/jcpe.12190; Cargill JS, 2012, J MED MICROBIOL, V61, P755, DOI 10.1099/jmm.0.039693-0; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; GALILI D, 1992, ORAL SURG ORAL MED O, V74, P459, DOI 10.1016/0030-4220(92)90295-2; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; GREENBERG MS, 1982, ORAL SURG ORAL MED O, V53, P32, DOI 10.1016/0030-4220(82)90483-2; Hague Anne L, 2008, J Dent Hyg, V82, P22; Hegde AM, 2011, J CLIN PEDIATR DENT, V35, P319, DOI 10.17796/jcpd.35.3.u5kx28q33m760834; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hou G L, 1997, Oral Dis, V3, P31; Hu YJ, 2013, INT J ORAL SCI, V5, P21, DOI 10.1038/ijos.2013.15; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056343; Javed F, 2012, CRIT REV ONCOL HEMAT, V83, P303, DOI 10.1016/j.critrevonc.2011.11.003; Khan S A, 2001, J Natl Cancer Inst Monogr, P31, DOI 10.1093/oxfordjournals.jncimonographs.a003437; KITCHINGMAN GR, 1985, BLOOD, V65, P725; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Krych L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062578; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Liao CH, 2004, CLIN INFECT DIS, V38, P452, DOI 10.1086/381098; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lucas VS, 1997, J INFECTION, V35, P135, DOI 10.1016/S0163-4453(97)91545-0; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer U, 2000, J ORAL PATHOL MED, V29, P153, DOI 10.1034/j.1600-0714.2000.290402.x; OSULLIVAN EA, 1993, ORAL SURG ORAL MED O, V76, P161, DOI 10.1016/0030-4220(93)90198-D; Paunica SC, 2009, HEMATOLOGY, V14, P341, DOI 10.1179/102453309X12473408860505; Phulpin-Weibel A, 2013, J MED MICROBIOL, V62, P789, DOI 10.1099/jmm.0.047191-0; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Saber MH, 2012, J ENDODONT, V38, P1484, DOI 10.1016/j.joen.2012.06.037; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Senn L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-9; Sixou JL, 1998, ORAL ONCOL, V34, P476, DOI 10.1016/S1368-8375(98)00062-1; Tjwa E, 2008, NEW ENGL J MED, V359, pE21, DOI 10.1056/NEJMicm064633; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; van Vliet MJ, 2009, CLIN INFECT DIS, V49, P262, DOI 10.1086/599346; von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33; WAHLIN YB, 1991, ORAL SURG ORAL MED O, V72, P300, DOI 10.1016/0030-4220(91)90219-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang XL, 2000, CANCER IMMUNOL IMMUN, V49, P165, DOI 10.1007/s002620050616	49	34	35	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102116	10.1371/journal.pone.0102116	http://dx.doi.org/10.1371/journal.pone.0102116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025462	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400043
J	Zhang, WW; Shen, L; Deng, ZT; Ding, YB; Mo, XM; Xu, ZF; Gao, Q; Yi, L				Zhang, Wenwen; Shen, Li; Deng, Zhantao; Ding, Yibing; Mo, Xuming; Xu, Zhengfeng; Gao, Qian; Yi, Long			Novel Missense Variants of ZFPM2/FOG2 Identified in Conotruncal Heart Defect Patients Do Not Impair Interaction with GATA4	PLOS ONE			English	Article							TETRALOGY; GENE; MUTATIONS; FALLOT; FOG-2; MORPHOGENESIS; ANOMALIES	Conotruncal heart defect (CTD) is a complex form of congenital heart disease and usually has a poor prognosis. ZFPM2/FOG2 encodes a transcription cofactor that interacts with GATA4 to regulate cardiac development. This regulation has been established in knockout mouse models that display a range of heart malformations, especially CTD. Although previous studies have identified several missense variants in ZFPM2/FOG2 that may cause CTD, it remains unclear whether they are involved in CTD pathogenesis because the study populations were limited and the functional status was unknown. In this report, we screened a larger CTD population, which comprised 145 tetralogy of Fallot (TOF), 37 double-outlet ventricle outflow (DORV), and 18 transposition of the great artery (TGA), to investigate exon mutations as well as copy number variations in ZFPM2/FOG2. Four variants (p.V339I in one DORV, p.A426T in one DORV, p.M703L in three TOF, p.T843M in one TOF) were found in six patients, of which two are reported here for the first time. No copy number variations of the gene were detected. GST pull-down assays demonstrated that all potentially deleterious variants, including those previously reported, did not impair the interaction with GATA4, except for variant p.M544I and p.K737E, which subtly impaired the binding. Thus, these missense variants may be involved in other mechanisms underlying CTD or may be unrelated to CTD occurrence.	[Zhang, Wenwen; Deng, Zhantao; Ding, Yibing; Gao, Qian; Yi, Long] Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Wenwen; Deng, Zhantao; Ding, Yibing; Gao, Qian; Yi, Long] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Shen, Li] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Cardiothorac Surg, Shanghai 200030, Peoples R China; [Mo, Xuming] Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Xu, Zhengfeng] Nanjing Matern & Child Hlth Hosp, Ctr Prenatal Diag, Nanjing Med Sch, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Shanghai Jiao Tong University	Gao, Q (corresponding author), Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China.	qian_gao@nju.edu.cn; yilong@nju.edu.cn			National Natural Science Foundation of China [81170002, 81030013, 81371449]; Jiangsu Province Health Department of Medicine leading talent and innovation team project [LJ201109]; Nanjing University Undergraduate Innovation Program [G1210284109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Health Department of Medicine leading talent and innovation team project; Nanjing University Undergraduate Innovation Program	The National Natural Science Foundation of China (81170002,81030013,81371449). Jiangsu Province Health Department of Medicine leading talent and innovation team project (LJ201109). Nanjing University Undergraduate Innovation Program (G1210284109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; Bashamboo A, 2014, HUM MOL GENET, V23, P3657, DOI 10.1093/hmg/ddu074; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; De Luca A, 2011, CLIN GENET, V80, P184, DOI 10.1111/j.1399-0004.2010.01523.x; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Finelli P, 2007, CLIN GENET, V71, P195, DOI 10.1111/j.1399-0004.2007.00752.x; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Huang XM, 2014, MOL BIOL REP, V41, P2671, DOI 10.1007/s11033-014-3126-5; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Nemer Georges, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9410; OMalley CD, 1996, TERATOLOGY, V53, P374; Pizzuti A, 2003, HUM MUTAT, V22, P372, DOI 10.1002/humu.10261; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Stern RF, 2004, BIOTECHNIQUES, V37, P399, DOI 10.2144/04373ST04; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tan ZP, 2012, CLIN GENET, V82, P466, DOI 10.1111/j.1399-0004.2011.01787.x; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Yang C, 2009, ELECTROPHORESIS, V30, P465, DOI 10.1002/elps.200800321	25	16	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102379	10.1371/journal.pone.0102379	http://dx.doi.org/10.1371/journal.pone.0102379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025186	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400068
J	Hart, BL; Hart, LA; Thigpen, AP; Willits, NH				Hart, Benjamin L.; Hart, Lynette A.; Thigpen, Abigail P.; Willits, Neil H.			Long-Term Health Effects of Neutering Dogs: Comparison of Labrador Retrievers with Golden Retrievers	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; RISK-FACTORS; GONADECTOMY; CANCER; TUMORS; BREED; CATS; AGE; ASSOCIATIONS; ANIMALS	Our recent study on the effects of neutering (including spaying) in Golden Retrievers in markedly increasing the incidence of two joint disorders and three cancers prompted this study and a comparison of Golden and Labrador Retrievers. Veterinary hospital records were examined over a 13-year period for the effects of neutering during specified age ranges: before 6 mo., and during 6-11 mo., year 1 or years 2 through 8. The joint disorders examined were hip dysplasia, cranial cruciate ligament tear and elbow dysplasia. The cancers examined were lymphosarcoma, hemangiosarcoma, mast cell tumor, and mammary cancer. The results for the Golden Retriever were similar to the previous study, but there were notable differences between breeds. In Labrador Retrievers, where about 5 percent of gonadally intact males and females had one or more joint disorders, neutering at <6 mo. doubled the incidence of one or more joint disorders in both sexes. In male and female Golden Retrievers, with the same 5 percent rate of joint disorders in intact dogs, neutering at <6 mo. increased the incidence of a joint disorder to 4-5 times that of intact dogs. The incidence of one or more cancers in female Labrador Retrievers increased slightly above the 3 percent level of intact females with neutering. In contrast, in female Golden Retrievers, with the same 3 percent rate of one or more cancers in intact females, neutering at all periods through 8 years of age increased the rate of at least one of the cancers by 3-4 times. In male Golden and Labrador Retrievers neutering had relatively minor effects in increasing the occurrence of cancers. Comparisons of cancers in the two breeds suggest that the occurrence of cancers in female Golden Retrievers is a reflection of particular vulnerability to gonadal hormone removal.	[Hart, Benjamin L.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Hart, Lynette A.; Thigpen, Abigail P.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Willits, Neil H.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hart, BL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	blhart@ucdavis.edu	Fiumefreddo, Andrea/T-2977-2019; Hart, Lynette/L-4833-2019	Hart, Lynette/0000-0002-7133-6535; hart, benjamin/0000-0003-2342-6058	Canine Health Foundation [01488-A]; Center for Companion Animal Health University of California, Davis [2009-54-F/M]	Canine Health Foundation; Center for Companion Animal Health University of California, Davis(University of California System)	This work was supported by the Canine Health Foundation (#01488-A) and the Center for Companion Animal Health University of California, Davis (# 2009-54-F/M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin K, 2010, J AM ANIM HOSP ASSOC, V46, P285, DOI 10.5326/0460285; Beauvais W, 2012, J SMALL ANIM PRACT, V53, P314, DOI 10.1111/j.1748-5827.2011.01220.x; CONCANNON PW, 1993, J REP FER S, P3; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; COX DR, 1972, J R STAT SOC B, V34, P187; de la Riva GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055937; Diesel G, 2010, VET REC, V166, P455, DOI 10.1136/vr.b4798; Dobson Jane M, 2013, ISRN Vet Sci, V2013, P941275, DOI 10.1155/2013/941275; Duerr FM, 2007, JAVMA-J AM VET MED A, V231, P1688, DOI 10.2460/javma.231.11.1688; Duval JM, 1999, J AM VET MED ASSOC, V215, P811; Fields MJ, 2004, BIOL REPROD, V71, P1412, DOI 10.1095/biolreprod.104.027201; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Hart BL, 2001, J AM VET MED ASSOC, V219, P51, DOI 10.2460/javma.2001.219.51; Hart BL, 1988, PERFECT PUPPY CHOOSE; Hoffman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061082; Kasstrom H, 1975, Acta Radiol Suppl, V344, P135; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kustritz MVR, 2007, JAVMA-J AM VET MED A, V231, P1665, DOI 10.2460/javma.231.11.1665; PRYMAK C, 1988, J AM VET MED ASSOC, V193, P706; Reichler IM, 2008, VET DERMATOL, V19, P77, DOI 10.1111/j.1365-3164.2008.00652.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; Sallander M, 2001, ACTA VET SCAND, V42, P71, DOI 10.1186/1751-0147-42-71; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; Teske E, 2002, MOL CELL ENDOCRINOL, V197, P251, DOI 10.1016/S0303-7207(02)00261-7; Trevejo R, 2011, JAVMA-J AM VET MED A, V238, P898, DOI 10.2460/javma.238.7.898; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Villamil JA, 2009, J CANCER EPIDEMIOL, V2009, DOI [10.1155/2009/591753, 10.1155/2009/747803]; Ware WA, 1999, J VET INTERN MED, V13, P95, DOI 10.1892/0891-6640(1999)013&lt;0095:CTID&gt;2.3.CO;2; White CR, 2011, J AM ANIM HOSP ASSOC, V47, P210, DOI 10.5326/JAAHA-MS-5621; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Zink MC, 2014, JAVMA-J AM VET MED A, V244, P309, DOI 10.2460/javma.244.3.309	33	66	66	2	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102241	10.1371/journal.pone.0102241	http://dx.doi.org/10.1371/journal.pone.0102241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020045	gold, Green Published			2022-12-27	WOS:000339618600057
J	Alkema, L; New, JR; Pedersen, J; You, DZ				Alkema, Leontine; New, Jin Rou; Pedersen, Jon; You, Danzhen		UN Inter-Agcy Grp Child Mortality	Child Mortality Estimation 2013: An Overview of Updates in Estimation Methods by the United Nations Inter-Agency Group for Child Mortality Estimation	PLOS ONE			English	Article								Background: In September 2013, the United Nations Inter-agency Group for Child Mortality Estimation (UN IGME) published an update of the estimates of the under-five mortality rate (U5MR) and under-five deaths for all countries. Compared to the UN IGME estimates published in 2012, updated data inputs and a new method for estimating the U5MR were used. Methods: We summarize the new U5MR estimation method, which is a Bayesian B-spline Bias-reduction model, and highlight differences with the previously used method. Differences in UN IGME U5MR estimates as published in 2012 and those published in 2013 are presented and decomposed into differences due to the updated database and differences due to the new estimation method to explain and motivate changes in estimates. Findings: Compared to the previously used method, the new UN IGME estimation method is based on a different trend fitting method that can track (recent) changes in U5MR more closely. The new method provides U5MR estimates that account for data quality issues. Resulting differences in U5MR point estimates between the UN IGME 2012 and 2013 publications are small for the majority of countries but greater than 10 deaths per 1,000 live births for 33 countries in 2011 and 19 countries in 1990. These differences can be explained by the updated database used, the curve fitting method as well as accounting for data quality issues. Changes in the number of deaths were less than 10% on the global level and for the majority of MDG regions. Conclusions: The 2013 UN IGME estimates provide the most recent assessment of levels and trends in U5MR based on all available data and an improved estimation method that allows for closer-to-real-time monitoring of changes in the U5MR and takes account of data quality issues.	[Alkema, Leontine; New, Jin Rou] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Alkema, Leontine] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Pedersen, Jon] Fafo Inst Appl Int Studies, Oslo, Norway; [You, Danzhen] United Nations Childrens Fund, New York, NY USA	National University of Singapore; National University of Singapore; UNICEF	Alkema, L (corresponding author), Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore.	alkema@nus.edu.sg	Alkema, Leontine/K-1585-2013; Gerland, Patrick/F-7390-2013	Alkema, Leontine/0000-0001-8806-5957; Mathers, Colin/0000-0002-0617-6731; Gerland, Patrick/0000-0002-2082-3122	National University of Singapore [R-155-000-099-133, R-155-000-146-112]; UNICEF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007242] Funding Source: NIH RePORTER	National University of Singapore(National University of Singapore); UNICEF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the National University of Singapore grants R-155-000-099-133 and R-155-000-146-112 and UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema L, 2013, ARXIV13091602STATAP; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001355; [Anonymous], WHOHISHSIGHE20133; [Anonymous], 2012, LEV TRENDS CHILD MOR; [Anonymous], 2013, MILL DEV GOALS REP 2; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Centre for Research on the Epidemiology of Disasters (CRED), 2012, EMDAT CRED INT DIS D; Child Trends, 2013, FAM LIF DIFF CENTR S; Currie ID, 2002, STAT MODEL, V2, P333, DOI 10.1191/1471082x02st039ob; Eilers PHC, 2010, WIRES COMPUT STAT, V2, P637, DOI 10.1002/wics.125; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Eilers PHC, 1999, J R STAT SOC C, P300; Guillot M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001299; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Oestergaard MZ, 2013, INT J EPIDEMIOL, V42, P645, DOI 10.1093/ije/dyt059; Pedersen J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001289; Plummer M., 2003, P 3 INT WORKSH DISTR; Price M., 2013, TECHNICAL REPORT; R Foundation for Statistical Computing R Core Team, 2014, LANG ENV STAT COMP; Sawyer CC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001287; Silva R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001296; Sullivan JM, 2008, ASSESSMENT CREDIBILI; UN Inter-agency Group for Child Mortality Estimation, 2013, ANN RAT RED 5 MORT E; UN Inter-agency Group for Child Mortality Estimation, 2012, ANN RAT RED 5 MORT E; UN Inter-agency Group for Child Mortality Estimation, 2013, COUNTR SPEC METH NOT; United Nations, 2011, WORLD POP PROSP 2010; United Nations, 2013, WORLD POP AG 2013; Walker N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001298	30	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101112	10.1371/journal.pone.0101112	http://dx.doi.org/10.1371/journal.pone.0101112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013954	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400017
J	Guan, XM; Bidlack, FB; Stokes, N; Bartlett, JD				Guan, Xiaomu; Bidlack, Felicitas B.; Stokes, Nicole; Bartlett, John D.			E-Cadherin Can Replace N-Cadherin during Secretory-Stage Enamel Development	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; VASCULAR MORPHOGENESIS; RAT INCISOR; AMELOBLASTS; EXPRESSION; LEADS; AMELOGENESIS; JUNCTIONS; ADHESION	Background: N-cadherin is a cell-cell adhesion molecule and deletion of N-cadherin in mice is embryonic lethal. During the secretory stage of enamel development, E-cadherin is down-regulated and N-cadherin is specifically up-regulated in ameloblasts when groups of ameloblasts slide by one another to form the rodent decussating enamel rod pattern. Since N-cadherin promotes cell migration, we asked if N-cadherin is essential for ameloblast cell movement during enamel development. Methodology/Principal Findings: The enamel organ, including its ameloblasts, is an epithelial tissue and for this study a mouse strain with N-cadherin ablated from epithelium was generated. Enamel from wild-type (WT) and N-cadherin conditional knockout (cKO) mice was analyzed. mu CT and scanning electron microscopy showed that thickness, surface structure, and prism pattern of the cKO enamel looked identical to WT. No significant difference in hardness was observed between WT and cKO enamel. Interestingly, immunohistochemistry revealed the WT and N-cadherin cKO secretory stage ameloblasts expressed approximately equal amounts of total cadherins. Strikingly, E-cadherin was not normally down-regulated during the secretory stage in the cKO mice suggesting that E-cadherin can compensate for the loss of N-cadherin. Previously it was demonstrated that bone morphogenetic protein-2 (BMP2) induces E- and N-cadherin expression in human calvaria osteoblasts and we show that the N-cadherin cKO enamel organ expressed significantly more BMP2 and significantly less of the BMP antagonist Noggin than did WT enamel organ. Conclusions/Significance: The E- to N-cadherin switch at the secretory stage is not essential for enamel development or for forming the decussating enamel rod pattern. E- cadherin can substitute for N-cadherin during these developmental processes. Bmp2 expression may compensate for the loss of N-cadherin by inducing or maintaining E-cadherin expression when E- cadherin is normally down-regulated. Notably, this is the first demonstration of a natural endogenous increase in E-cadherin expression due to N-cadherin ablation in a healthy developing tissue.	[Guan, Xiaomu; Bidlack, Felicitas B.; Bartlett, John D.] Dept Mineralized Tissue Biol, Cambridge, MA 02142 USA; [Guan, Xiaomu; Bidlack, Felicitas B.; Bartlett, John D.] Harvard Univ, Sch Dent Med, Forsyth Inst, Cambridge, MA 02138 USA; [Stokes, Nicole] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Howard Hughes Medical Institute; Rockefeller University	Bartlett, JD (corresponding author), Dept Mineralized Tissue Biol, Cambridge, MA 02142 USA.	jbartlett@forsyth.org	Bartlett, John/L-9832-2017	Bartlett, John/0000-0003-2052-6299; Bidlack, Felicitas/0000-0001-8105-223X	National Institute of Dental and Craniofacial Research of the National Institutes of Health [R01DE016276]; National Institutes of Health [1S10RR027553-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016276] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number R01DE016276 (JDB). The Forsyth Institute micro-CT Core is partly supported by National Institutes of Health grant 1S10RR027553-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012703; Brieher WM, 2013, CURR OPIN CELL BIOL, V25, P39, DOI 10.1016/j.ceb.2012.10.010; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Guan X, 2013, J DENT RES, V92, P1123, DOI 10.1177/0022034513506581; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Libusova L, 2010, DEVELOPMENT, V137, P2297, DOI 10.1242/dev.048488; Luo Y, 2001, DEVELOPMENT, V128, P459; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Luo Y, 2006, DEV BIOL, V299, P517, DOI 10.1016/j.ydbio.2006.09.003; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; NISHIKAWA S, 1988, EUR J CELL BIOL, V47, P222; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piven OO, 2011, EXP BIOL MED, V236, P816, DOI 10.1258/ebm.2011.010362; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Radice GL, 2013, PROG MOL BIOL TRANSL, V116, P263, DOI 10.1016/B978-0-12-394311-8.00012-1; REITH EJ, 1973, ARCH ORAL BIOL, V18, P445, DOI 10.1016/0003-9969(73)90170-2; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; RISNES S, 1979, ARCH ORAL BIOL, V24, P299, DOI 10.1016/0003-9969(79)90092-X; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102153	10.1371/journal.pone.0102153	http://dx.doi.org/10.1371/journal.pone.0102153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014356	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400072
J	Guimier, A; Ferrand, S; Pierron, G; Couturier, J; Janoueix-Lerosey, I; Combaret, V; Mosseri, V; Thebaud, E; Gambart, M; Plantaz, D; Marabelle, A; Coze, C; Rialland, X; Fasola, S; Lapouble, E; Freneaux, P; Peuchmaur, M; Michon, J; Delattre, O; Schleiermacher, G				Guimier, Anne; Ferrand, Sandrine; Pierron, Gaelle; Couturier, Jerome; Janoueix-Lerosey, Isabelle; Combaret, Valerie; Mosseri, Veronique; Thebaud, Estelle; Gambart, Marion; Plantaz, Dominique; Marabelle, Aurelien; Coze, Carole; Rialland, Xavier; Fasola, Sylvie; Lapouble, Eve; Freneaux, Paul; Peuchmaur, Michel; Michon, Jean; Delattre, Olivier; Schleiermacher, Gudrun			Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN	PLOS ONE			English	Article							ACTIVATING MUTATIONS; GENE AMPLIFICATION; SOLID TUMORS; ALK KINASE; ARRAY-CGH; MDM2; EXPRESSION; AMPLICONS; PATTERN; CANCER	Background: Somatically acquired genomic alterations with MYCN amplification (MNA) are key features of neuroblastoma (NB), the most common extra-cranial malignant tumour of childhood. Little is known about the frequency, clinical characteristics and outcome of NBs harbouring genomic amplification(s) distinct from MYCN. Methods: Genomic profiles of 1100 NBs from French centres studied by array-CGH were re-examined specifically to identify regional amplifications. Patients were included if amplifications distinct from the MYCN locus were seen. A subset of NBs treated at Institut Curie and harbouring MNA as determined by array-CGH without other amplification was also studied. Clinical and histology data were retrospectively collected. Results: In total, 56 patients were included and categorised into 3 groups. Group 1 (n = 8) presented regional amplification(s) without MNA. Locus 12q13-14 was a recurrent amplified region (4/8 cases). This group was heterogeneous in terms of INSS stages, primary localisations and histology, with atypical clinical features. Group 2 (n = 26) had MNA as well as other regional amplifications. These patients shared clinical features of those of a group of NBs MYCN amplified (Group 3, n = 22). Overall survival for group 1 was better than that of groups 2 and 3 (5 year OS: 87.5%+/- 11% vs 34.9%+/- 7%, log-rank p<0.05). Conclusion: NBs harbouring regional amplification(s) without MNA are rare and seem to show atypical features in clinical presentation and genomic profile. Further high resolution genetic explorations are justified in this heterogeneous group, especially when considering these alterations as predictive markers for targeted therapy.	[Guimier, Anne; Michon, Jean; Schleiermacher, Gudrun] Inst Curie, Dept Pediat, Paris, France; [Ferrand, Sandrine; Pierron, Gaelle; Couturier, Jerome; Lapouble, Eve] Inst Curie, Unite Genet Somat, Paris, France; [Janoueix-Lerosey, Isabelle; Delattre, Olivier; Schleiermacher, Gudrun] INSERM, Inst Curie, U830, Lab Genet & Biol Canc, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translationnelle, F-69373 Lyon, France; [Mosseri, Veronique] Inst Curie, Serv Biostat, Paris, France; [Thebaud, Estelle] CHU Nantes, Serv Hematooncol Pediat, F-44035 Nantes 01, France; [Gambart, Marion] CHU Toulouse, Serv Hematooncol Pediat, Toulouse, France; [Plantaz, Dominique] CHU Grenoble, Serv Hematooncol Pediat, F-38043 Grenoble, France; [Marabelle, Aurelien] Ctr Lutte Canc Leon Berard, Inst Hematol & Oncol Pediat, Lyon, France; [Coze, Carole] Aix Marseille Univ, Marseille, France; [Coze, Carole] Hop Enfants La Timone, APHM, Serv Hematooncol Pediat, Marseille, France; [Rialland, Xavier] CHU Angers, Serv Hematooncol Pediat, Angers, France; [Fasola, Sylvie] Hop Trousseau, Serv Hematooncol Pediat, F-75571 Paris, France; [Freneaux, Paul] Inst Curie, Anat Pathol Lab, Paris, France; [Peuchmaur, Michel] Hop Univ Robert Debre, AP HP, Serv Pathol, Paris, France; [Peuchmaur, Michel] Univ Paris 07, Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Nantes Universite; CHU de Nantes; CHU de Toulouse; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Schleiermacher, G (corresponding author), Inst Curie, Dept Pediat, Paris, France.	gudrun.schleiermacher@curie.net	GAMBART, Marion/AAR-4551-2020; Schleiermacher, Gudrun/AAN-4711-2021; marabelle, aurelien/AAP-3791-2021; Janoueix-Lerosey, Isabelle/G-1758-2018	Schleiermacher, Gudrun/0000-0002-0133-5879; marabelle, aurelien/0000-0002-5816-3019; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Guimier, Anne/0000-0002-4759-0621; delattre, olivier/0000-0002-8730-2276	Annenberg foundation; Institut National de la Sante et de la Recherche Medicale; Ligue Nationale contre le Cancer (Equipe labellisee);  [PHRC AOM 02014];  [PHRC IC2007-09]	Annenberg foundation; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); ; 	This study was partly supported by the Annenberg foundation. This work was also supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale contre le Cancer (Equipe labellisee) and the PHRC AOM 02014 and PHRC IC2007-09. The construction of the BAC/PAC array was supported by grants from the Carte d'Identite des Tumeurs program of the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Berner JM, 1996, GENE CHROMOSOME CANC, V17, P254, DOI 10.1002/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO;2-2; Bielle F, 2012, AM J SURG PATHOL, V36, P1141, DOI 10.1097/PAS.0b013e31825a6895; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Carr J, 2007, CANCER GENET CYTOGEN, V172, P127, DOI 10.1016/j.cancergencyto.2006.08.012; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; CORVI R, 1995, ONCOGENE, V10, P1081; Fix A, 2004, GENE CHROMOSOME CANC, V40, P266, DOI 10.1002/gcc.20041; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mejia-Guerrero S, 2010, GENE CHROMOSOME CANC, V49, P518, DOI 10.1002/gcc.20761; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Molenaar JJ, 2003, GENE CHROMOSOME CANC, V36, P242, DOI 10.1002/gcc.10166; Mosse YP, 2007, GENE CHROMOSOME CANC, V46, P936, DOI 10.1002/gcc.20477; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Reifenberger G, 1996, CANCER RES, V56, P5141; Rubie H, 1997, J CLIN ONCOL, V15, P1171, DOI 10.1200/JCO.1997.15.3.1171; Ryan SL, 2012, ACTA NEUROPATHOL, V123, P501, DOI 10.1007/s00401-011-0923-y; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2012, BRIT J CANCER, V107, P1418, DOI 10.1038/bjc.2012.375; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Schwab M, 1999, SEMIN CANCER BIOL, V9, P319, DOI 10.1006/scbi.1999.0126; Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj.onc.1205304; Slack A, 2005, CANCER LETT, V228, P21, DOI 10.1016/j.canlet.2005.01.050; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; Su WT, 2004, CANCER GENET CYTOGEN, V154, P131, DOI 10.1016/j.cancergencyto.2004.02.009; Tomioka N, 2008, ONCOGENE, V27, P441, DOI 10.1038/sj.onc.1210661; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Wang LL, 2013, CANCER-AM CANCER SOC, V119, P3718, DOI 10.1002/cncr.28251; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51	42	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101990	10.1371/journal.pone.0101990	http://dx.doi.org/10.1371/journal.pone.0101990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013904	Green Submitted, gold, Green Published			2022-12-27	WOS:000339378400051
J	Halasa, T; Boklund, A				Halasa, Tariq; Boklund, Anette			The Impact of Resources for Clinical Surveillance on the Control of a Hypothetical Foot-and-Mouth Disease Epidemic in Denmark	PLOS ONE			English	Article							CONTROL STRATEGIES; SIMULATION-MODEL; VACCINATION; SPREAD	The objectives of this study were to assess whether current surveillance capacity is sufficient to fulfill EU and Danish regulations to control a hypothetical foot-and-mouth disease (FMD) epidemic in Denmark, and whether enlarging the protection and/or surveillance zones could minimize economic losses. The stochastic spatial simulation model DTU-DADS was further developed to simulate clinical surveillance of herds within the protection and surveillance zones and used to model spread of FMD between herds. A queuing system was included in the model, and based on daily surveillance capacity, which was 450 herds per day, it was decided whether herds appointed for surveillance would be surveyed on the current day or added to the queue. The model was run with a basic scenario representing the EU and Danish regulations, which includes a 3 km protection and 10 km surveillance zone around detected herds. In alternative scenarios, the protection zone was enlarged to 5 km, the surveillance zone was enlarged to 15 or 20 km, or a combined enlargement of the protection and surveillance zones was modelled. Sensitivity analysis included changing surveillance capacity to 200, 350 or 600 herds per day, frequency of repeated visits for herds in overlapping surveillance zones from every 14 days to every 7, 21 and 30 days, and the size of the zones combined with a surveillance capacity increased to 600 herds per day. The results showed that the default surveillance capacity is sufficient to survey herds on time. Extra resources for surveillance did not improve the situation, but fewer resources could result in larger epidemics and costs. Enlarging the protection zone was a better strategy than the basic scenario. Despite that enlarging the surveillance zone might result in shorter epidemic duration, and lower number of affected herds, it resulted frequently in larger economic losses.	[Halasa, Tariq; Boklund, Anette] Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Copenhagen, Denmark	Technical University of Denmark	Halasa, T (corresponding author), Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Copenhagen, Denmark.	tahbh@vet.dtu.dk	Boklund, Anette/HGE-8502-2022	Boklund, Anette/0000-0001-6359-3403; Halasa, Tariq/0000-0003-1112-0254	Danish Veterinary Authorities	Danish Veterinary Authorities	This study was funded by the Danish Veterinary Authorities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I., 2002, FOOT MOUTH DIS 2001; [Anonymous], 2003, OFF J EUR UNION L, V306, P46; Backer JA, 2012, PREV VET MED, V107, P27, DOI 10.1016/j.prevetmed.2012.05.012; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Boklund A, 2013, PREV VET MED, V111, P206, DOI 10.1016/j.prevetmed.2013.05.008; Boklund A, 2009, PREV VET MED, V90, P180, DOI 10.1016/j.prevetmed.2009.04.008; Cox SJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008051; Danish Contingency Plan, 2004, MUND OG KLOV BER OP, V19, P2860; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Halasa T, 2013, PREV VET MED, V112, P194, DOI 10.1016/j.prevetmed.2013.09.003; Halasa T, 2011, PREV VET MED, V98, P1, DOI 10.1016/j.prevetmed.2010.08.005; Halasa T, 2014, PLOS ONE, DOI [10.1371/journalpone.0092521., DOI 10.1371/JOURNALPONE.0092521]; Hutber AM, 2006, RES VET SCI, V81, P31, DOI 10.1016/j.rvsc.2005.09.014; Junker F., 2009, OECD FOOD AGR FISHER, DOI [10.1787/18156797, DOI 10.1787/221275827814]; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Martinez-Lopez B, 2010, PREV VET MED, V96, P19, DOI 10.1016/j.prevetmed.2010.05.015; Pendell D. L., 2007, Journal of Agricultural and Applied Economics, V39, P19; Perez AM, 2004, PREV VET MED, V65, P217, DOI 10.1016/j.prevetmed.2004.08.002; R Core Team, 2016, R FDN STAT COMP; Velthuis AGJ, 2007, PREV VET MED, V82, P262, DOI 10.1016/j.prevetmed.2007.05.023; Ward MP, 2009, PREV VET MED, V88, P286, DOI 10.1016/j.prevetmed.2008.12.006	23	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102480	10.1371/journal.pone.0102480	http://dx.doi.org/10.1371/journal.pone.0102480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014351	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400097
J	Widmann, M; Pleiss, J				Widmann, Michael; Pleiss, Juergen			Protein Variants Form a System of Networks: Microdiversity of IMP Metallo-Beta-Lactamases	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANCIENT GENES; SCHEME	Genome and metagenome sequencing projects support the view that only a tiny portion of the total protein microdiversity in the biosphere has been sequenced yet, while the vast majority of existing protein variants is still unknown. By using a network approach, the microdiversity of 42 metallo-beta-lactamases of the IMP family was investigated. In the networks, the nodes are formed by the variants, while the edges correspond to single mutations between pairs of variants. The 42 variants were assigned to 7 separate networks. By analyzing the networks and their relationships, the structure of sequence space was studied and existing, but still unknown, functional variants were predicted. The largest network consists of 10 variants with IMP-1 in its center and includes two ubiquitous mutations, V67F and S262G. By relating the corresponding pairs of variants, the networks were integrated into a single system of networks. The largest network also included a quartet of variants: IMP-1, two single mutants, and the respective double mutant. The existence of quartets indicates that if two mutations resulted in functional enzymes, the double mutant may also be active and stable. Therefore, quartet construction from triplets was applied to predict 15 functional variants. Further functional mutants were predicted by applying the two ubiquitous mutations in all networks. In addition, since the networks are separated from each other by 10-15 mutations on average, it is expected that a subset of the theoretical intermediates are functional, and therefore are supposed to exist in the biosphere. Finally, the network analysis helps to distinguish between epistatic and additive effects of mutations; while the presence of correlated mutations indicates a strong interdependency between the respective positions, the mutations V67F and S262G are ubiquitous and therefore background independent.	[Widmann, Michael; Pleiss, Juergen] Univ Stuttgart, Inst Tech Biochem, D-70174 Stuttgart, Germany	University of Stuttgart	Pleiss, J (corresponding author), Univ Stuttgart, Inst Tech Biochem, D-70174 Stuttgart, Germany.	Juergen.Pleiss@itb.uni-stuttgart.de			Deutsche Forschungsgemeinschaft [FOR1296]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MW and JP are grateful to the Deutsche Forschungsgemeinschaft (FOR1296) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dryden DTF, 2008, J R SOC INTERFACE, V5, P953, DOI 10.1098/rsif.2008.0085; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitch WM, 1997, J MOL EVOL, V44, pS65, DOI 10.1007/PL00000059; Gabor E, 2012, J MOL BIOL, V418, P16, DOI 10.1016/j.jmb.2012.02.015; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Holmes B, 2004, NEW SCI, V184, P6; Kuipers RKP, 2009, PROTEINS, V76, P608, DOI 10.1002/prot.22374; Maughan H, 2002, MOL BIOL EVOL, V19, P1637, DOI 10.1093/oxfordjournals.molbev.a004227; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Nakhleh L, 2005, 2005 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P93, DOI 10.1109/CSB.2005.47; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; Oelschlaeger P, 2008, J INORG BIOCHEM, V102, P2043, DOI 10.1016/j.jinorgbio.2008.05.007; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; Page MGP, 2010, ANTIMICROB AGENTS CH, V54, P2291, DOI 10.1128/AAC.01525-09; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Widmann M, 2012, ANTIMICROB AGENTS CH, V56, P3481, DOI 10.1128/AAC.00255-12; Wright GD, 2012, TRENDS MICROBIOL, V20, P157, DOI 10.1016/j.tim.2012.01.002	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101813	10.1371/journal.pone.0101813	http://dx.doi.org/10.1371/journal.pone.0101813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013948	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400037
J	Wyllie, AL; Chu, MLJN; Schellens, MHB; Gastelaars, JVE; Jansen, MD; van der Ende, A; Bogaert, D; Sanders, EAM; Trzcinski, K				Wyllie, Anne L.; Chu, Mei Ling J. N.; Schellens, Marielle H. B.; Gastelaars, Jody van Engelsdorp; Jansen, Marc D.; van der Ende, Arie; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof			Streptococcus pneumoniae in Saliva of Dutch Primary School Children	PLOS ONE			English	Article							PNEUMOCOCCAL CARRIAGE; MULTIPLEX PCR; CONJUGATE VACCINE; INVASIVE DISEASE; SEROTYPES; COLONIZATION; COMPETITION; VIRULENCE; REPLACEMENT; STRAINS	While nasopharyngeal sampling is the gold standard for the detection of Streptococcus pneumoniae carriage, historically seen, saliva sampling also seems highly sensitive for pneumococcal detection. We investigated S. pneumoniae carriage in saliva from fifty schoolchildren by conventional and molecular methods. Saliva was first culture-enriched for pneumococci, after which, DNA was extracted from all bacterial growth and tested by quantitative-PCR (qPCR) for pneumococcus-specific genes lytA and piaA. Next, serotype composition of the samples was determined by serotype-specific qPCRs, conventional-PCRs (cPCR) and sequencing of cPCR amplicons. Although only 2 (4%) of 50 samples were positive by conventional diagnostic culture, 44 (88%) were positive for pneumococci by qPCR. In total, we detected the presence of at least 81 pneumococcal strains representing 20 serotypes in samples from 44 carriers with 23 carriers (52%) positive for multiple (up to 6) serotypes. The number of serotypes detected per sample correlated with pneumococcal abundance. This study shows that saliva could be used as a tool for future pneumococcal surveillance studies. Furthermore, high rates of pneumococcal carriage and co-carriage of multiple pneumococcal strains together with a large number of serotypes in circulation suggests a ubiquitous presence of S. pneumoniae in saliva of school-aged children. Our results also suggest that factors promoting pneumococcal carriage within individual hosts may weaken competitive interactions between S. pneumoniae strains.	[Wyllie, Anne L.; Chu, Mei Ling J. N.; Schellens, Marielle H. B.; Gastelaars, Jody van Engelsdorp; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof] Univ Med Ctr Utrecht, Wilhelminas Children Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands; [Jansen, Marc D.] Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Trzcinski, K (corresponding author), Univ Med Ctr Utrecht, Wilhelminas Children Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands.	K.Trzcinski@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019	Trzcinski, Krzysztof/0000-0002-5433-8846; Wyllie, Anne/0000-0001-6015-0279; Bogaert, Debby/0000-0003-2651-7000; van der Ende, Arie/0000-0003-1298-3086; Jansen, Marc/0000-0001-7567-8519	Wilhelmina Children's Hospital of the University Medical Centre Utrecht	Wilhelmina Children's Hospital of the University Medical Centre Utrecht	This study was supported by internal funds from Wilhelmina Children's Hospital of the University Medical Centre Utrecht. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auranen K, 2013, VACCINE, V32, P159, DOI 10.1016/j.vaccine.2013.06.105; Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Benton KA, 1997, INFECT IMMUN, V65, P1237, DOI 10.1128/IAI.65.4.1237-1244.1997; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Griffith F., 1927, J HYG LOND, V64, P129; GUNDEL M., 1933, Zeitschrift fur Hygiene und Infektionskrankheiten, V114, P678, DOI 10.1007/BF02183676; Heffron R, 1979, PNEUMOCOCCUS CARRIER, P342; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Krone CL, 2013, LANCET RESP MED, V2600, P1; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; Mehtala J, 2013, EPIDEMIOLOGY, V24, P522, DOI 10.1097/EDE.0b013e318294be89; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Rosenau MJ, 1926, AM J HYG, V6, P463, DOI 10.1093/oxfordjournals.aje.a120022; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Trzcinski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060520; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Verhagen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089541; Walsh RL, 2011, MBIO, V2, DOI 10.1128/mBio.00092-11; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; White B, 1938, ISOLATION PNEUMOCOCC, P30; White B, 1938, CARRIER STATE BIOL P, P230	41	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102045	10.1371/journal.pone.0102045	http://dx.doi.org/10.1371/journal.pone.0102045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013895	Green Submitted, gold, Green Published			2022-12-27	WOS:000339378400058
J	Andries, K; Villellas, C; Coeck, N; Thys, K; Gevers, T; Vranckx, L; Lounis, N; de Jong, BC; Koul, A				Andries, Koen; Villellas, Cristina; Coeck, Nele; Thys, Kim; Gevers, Tom; Vranckx, Luc; Lounis, Nacer; de Jong, Bouke C.; Koul, Anil			Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline	PLOS ONE			English	Article							DRUG-RESISTANCE; ATP SYNTHASE; EFFLUX; INHIBITOR; EMERGENCE; VERAPAMIL; TMC207; 1ST	Bedaquiline (BDQ), an ATP synthase inhibitor, is the first drug to be approved for treatment of multi-drug resistant tuberculosis in decades. In vitro resistance to BDQ was previously shown to be due to target-based mutations. Here we report that non-target based resistance to BDQ, and cross-resistance to clofazimine (CFZ), is due to mutations in Rv0678, a transcriptional repressor of the genes encoding the MmpS5-MmpL5 efflux pump. Efflux-based resistance was identified in paired isolates from patients treated with BDQ, as well as in mice, in which it was confirmed to decrease bactericidal efficacy. The efflux inhibitors verapamil and reserpine decreased the minimum inhibitory concentrations of BDQ and CFZ in vitro, but verapamil failed to increase the bactericidal effect of BDQ in mice and was unable to reverse efflux-based resistance in vivo. Cross-resistance between BDQ and CFZ may have important clinical implications.	[Andries, Koen; Villellas, Cristina; Thys, Kim; Gevers, Tom; Vranckx, Luc; Lounis, Nacer; Koul, Anil] Janssen Pharmaceut, Dept Infect Dis, B-2340 Beerse, Belgium; [Coeck, Nele; de Jong, Bouke C.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Johnson & Johnson; Janssen Pharmaceuticals; Institute of Tropical Medicine (ITM)	Andries, K (corresponding author), Janssen Pharmaceut, Dept Infect Dis, B-2340 Beerse, Belgium.	kandries@its.jnj.com	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675	Janssen; Baekeland PhD scholarship from the Flemish Institute for Scientific Technology [IWT 130308]	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Baekeland PhD scholarship from the Flemish Institute for Scientific Technology	BdJ received funds from Janssen for drug susceptibility testing on isolates from clinical studies on bedaquiline. NC is funded by a Baekeland PhD scholarship from the Flemish Institute for Scientific Technology (IWT 130308). The funder provided support in the form of salaries for NC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cohen J, 2013, SCIENCE, V339, P130, DOI 10.1126/science.339.6116.130; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Gupta S, 2014, ANTIMICROB AGENTS CH, V58, P574, DOI 10.1128/AAC.01462-13; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Hartkoorn RC, 2014, ANTIMICROB AGENTS CH, V58, P2979, DOI 10.1128/AAC.00037-14; Huitric E, 2010, ANTIMICROB AGENTS CH, V54, P1022, DOI 10.1128/AAC.01611-09; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4369; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11; Segala E, 2012, ANTIMICROB AGENTS CH, V56, P2326, DOI 10.1128/AAC.06154-11; Williams K, 2012, ANTIMICROB AGENTS CH, V56, P3114, DOI 10.1128/AAC.00384-12; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	24	229	243	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102135	10.1371/journal.pone.0102135	http://dx.doi.org/10.1371/journal.pone.0102135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010492	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800074
J	Boyd, NF; Li, Q; Melnichouk, O; Huszti, E; Martin, LJ; Gunasekara, A; Mawdsley, G; Yaffe, MJ; Minkin, S				Boyd, Norman F.; Li, Qing; Melnichouk, Olga; Huszti, Ella; Martin, Lisa J.; Gunasekara, Anoma; Mawdsley, Gord; Yaffe, Martin J.; Minkin, Salomon			Evidence That Breast Tissue Stiffness Is Associated with Risk of Breast Cancer	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MAMMOGRAPHIC DENSITY; QUANTITATIVE-ANALYSIS; ELASTOGRAPHY; PROGRESSION; ARCHITECTURE; MALIGNANCY; SYMMETRY	Background: Evidence from animal models shows that tissue stiffness increases the invasion and progression of cancers, including mammary cancer. We here use measurements of the volume and the projected area of the compressed breast during mammography to derive estimates of breast tissue stiffness and examine the relationship of stiffness to risk of breast cancer. Methods: Mammograms were used to measure the volume and projected areas of total and radiologically dense breast tissue in the unaffected breasts of 362 women with newly diagnosed breast cancer (cases) and 656 women of the same age who did not have breast cancer (controls). Measures of breast tissue volume and the projected area of the compressed breast during mammography were used to calculate the deformation of the breast during compression and, with the recorded compression force, to estimate the stiffness of breast tissue. Stiffness was compared in cases and controls, and associations with breast cancer risk examined after adjustment for other risk factors. Results: After adjustment for percent mammographic density by area measurements, and other risk factors, our estimate of breast tissue stiffness was significantly associated with breast cancer (odds ratio = 1.21, 95% confidence interval = 1.03, 1.43, p = 0.02) and improved breast cancer risk prediction in models with percent mammographic density, by both area and volume measurements. Conclusion: An estimate of breast tissue stiffness was associated with breast cancer risk and improved risk prediction based on mammographic measures and other risk factors. Stiffness may provide an additional mechanism by which breast tissue composition is associated with risk of breast cancer and merits examination using more direct methods of measurement.	[Boyd, Norman F.; Li, Qing; Melnichouk, Olga; Huszti, Ella; Martin, Lisa J.; Minkin, Salomon] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada; [Gunasekara, Anoma; Mawdsley, Gord; Yaffe, Martin J.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Boyd, NF (corresponding author), Ontario Canc Inst, Campbell Family Inst Breast Canc Res, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	boyd@uhnres.utoronto.ca		Shestakovska, Olga/0000-0002-4175-4680; Mawdsley, Gord/0000-0001-6957-8060	Canadian Breast Cancer Research Alliance; Ontario Ministry of Health and Long Term Care; Lau Chair in Breast Cancer Research; Tory Chair in Cancer Research	Canadian Breast Cancer Research Alliance; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Lau Chair in Breast Cancer Research; Tory Chair in Cancer Research	This work was supported by a grant from the Canadian Breast Cancer Research Alliance and by the Ontario Ministry of Health and Long Term Care. Dr. Boyd was supported by the Lau Chair in Breast Cancer Research and Dr. Yaffe by the Tory Chair in Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Boyd N, 2009, CANCER EPIDEM BIOMAR, V18, P1754, DOI 10.1158/1055-9965.EPI-09-0107; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2010, JNCI-J NATL CANCER I, V102, P1224, DOI 10.1093/jnci/djq239; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Byng JW, 1996, EUR J CANCER PREV, V5, P319, DOI 10.1097/00008469-199610000-00003; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Hagios C, 1998, PHILOS T R SOC B, V353, P857, DOI 10.1098/rstb.1998.0250; Hennessey S, 2014, CANCER CAUSE CONTROL, V25, P491, DOI 10.1007/s10552-014-0351-0; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Lorenzen J, 2002, ROFO-FORTSCHR RONTG, V174, P830, DOI 10.1055/s-2002-32690; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Pawluczyk O, 2003, MED PHYS, V30, P352, DOI 10.1118/1.1539038; Pawluczyk O, 2001, MED PHYS, V28, P438, DOI 10.1118/1.1359244; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P43, DOI 10.1158/1055-9965.EPI-06-0738; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wojcinski S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-159; Wojcinski S, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-35; Yaffe MJ, 2009, MED PHYS, V36, P5437, DOI 10.1118/1.3250863; Zangani D, 1999, DIFFERENTIATION, V64, P91, DOI 10.1046/j.1432-0436.1999.6420091.x	26	84	86	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100937	10.1371/journal.pone.0100937	http://dx.doi.org/10.1371/journal.pone.0100937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010427	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800008
J	Folias, AE; Penaranda, C; Su, AL; Bluestone, JA; Hebrok, M				Folias, Alexandra E.; Penaranda, Cristina; Su, Anthony L.; Bluestone, Jeffrey A.; Hebrok, Matthias			Aberrant Innate Immune Activation following Tissue Injury Impairs Pancreatic Regeneration	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; DUCTAL ADENOCARCINOMA; MACROPHAGES; CELLS; MICE; INFLAMMATION; KIDNEY; CANCER; REPAIR; RISK	Normal tissue architecture is disrupted following injury, as resident tissue cells become damaged and immune cells are recruited to the site of injury. While injury and inflammation are critical to tissue remodeling, the inability to resolve this response can lead to the destructive complications of chronic inflammation. In the pancreas, acinar cells of the exocrine compartment respond to injury by transiently adopting characteristics of progenitor cells present during embryonic development. This process of de-differentiation creates a window where a mature and stable cell gains flexibility and is potentially permissive to changes in cellular fate. How de-differentiation can turn an acinar cell into another cell type (such as a pancreatic beta-cell), or a cell with cancerous potential (as in cases of deregulated Kras activity) is of interest to both the regenerative medicine and cancer communities. While it is known that inflammation and acinar de-differentiation increase following pancreatic injury, it remains unclear which immune cells are involved in this process. We used a combination of genetically modified mice, immunological blockade and cellular characterization to identify the immune cells that impact pancreatic regeneration in an in vivo model of pancreatitis. We identified the innate inflammatory response of macrophages and neutrophils as regulators of pancreatic regeneration. Under normal conditions, mild innate inflammation prompts a transient de-differentiation of acinar cells that readily dissipates to allow normal regeneration. However, non-resolving inflammation developed when elevated pancreatic levels of neutrophils producing interferon-c increased iNOS levels and the pro-inflammatory response of macrophages. Pancreatic injury improved following in vivo macrophage depletion, iNOS inhibition as well as suppression of iNOS levels in macrophages via interferon-c blockade, supporting the impairment in regeneration and the development of chronic inflammation arises from aberrant activation of the innate inflammatory response. Collectively these studies identify targetable inflammatory factors that can be used to influence the development of non-resolving inflammation and pancreatic regeneration following injury.	[Folias, Alexandra E.; Penaranda, Cristina; Su, Anthony L.; Bluestone, Jeffrey A.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94115 USA.	mhebrok@diabetes.ucsf.edu		Su, Anthony/0000-0002-5280-6423; Penaranda, Cristina/0000-0002-2595-2863	Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation [3-2011-95]; Ruth L. Kirschstein National Research Service Award [5 T32 DK07418]; NIH [R21 AI107328-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107328, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Leona M. and Harry B. Helmsley Charitable Trust (http://helmsleytrust.org/) supported work in the laboratory of M.H. A.E.F. was supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation (3-2011-95; http://jdrf.org/) and the Ruth L. Kirschstein National Research Service Award (5 T32 DK07418; https://www.nidcd.nih.gov/). An NIH Exploratory/Developmental Research Grant Award (R21 AI107328-01A1; http://nih.gov/) supported work in the laboratory of J.A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Frossard JL, 2011, J CLIN PATHOL, V64, P387, DOI 10.1136/jcp.2010.088500; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gandolfo MT, 2009, KIDNEY INT, V76, P717, DOI 10.1038/ki.2009.259; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; GU DL, 1993, DEVELOPMENT, V118, P33; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kinsey GR, 2010, KIDNEY INT, V77, P771, DOI 10.1038/ki.2010.12; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Ray A, 2010, J VIS EXP; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Saeki K, 2012, GASTROENTEROLOGY, V142, P1010, DOI 10.1053/j.gastro.2011.12.054; Sakai Y, 2003, GASTROENTEROLOGY, V124, P725, DOI 10.1053/gast.2003.50099; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Sandoval D, 1996, GASTROENTEROLOGY, V111, P1081, DOI 10.1016/S0016-5085(96)70077-X; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Viebahn CS, 2010, J HEPATOL, V53, P500, DOI 10.1016/j.jhep.2010.04.010	46	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102125	10.1371/journal.pone.0102125	http://dx.doi.org/10.1371/journal.pone.0102125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010227	Green Published, gold			2022-12-27	WOS:000338763800072
J	Azmi, IJ; Khajanchi, BK; Akter, F; Hasan, TN; Shahnaij, M; Akter, M; Banik, A; Sultana, H; Hossain, MA; Ahmed, MK; Faruque, SM; Talukder, KA				Azmi, Ishrat J.; Khajanchi, Bijay K.; Akter, Fatema; Hasan, Trisheeta N.; Shahnaij, Mohammad; Akter, Mahmuda; Banik, Atanu; Sultana, Halima; Hossain, Mohammad A.; Ahmed, Mohammad K.; Faruque, Shah M.; Talukder, Kaisar A.			Fluoroquinolone Resistance Mechanisms of Shigella flexneri Isolated in Bangladesh	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; ESCHERICHIA-COLI STRAINS; DNA GYRASE; DYSENTERIAE TYPE-1; ANTIMICROBIAL RESISTANCE; DETERMINING REGION; NALIDIXIC-ACID; MUTATIONS; SEROTYPES; CHINA	Objective: To investigate the prevalence and mechanisms of fluoroquinolone resistance in Shigella species isolated in Bangladesh and to compare with similar strains isolated in China. Methods: A total of 3789 Shigella isolates collected from Clinical Microbiology Laboratory of icddr, b, during 2004-2010 were analyzed for antibiotic susceptibility. Analysis of plasmids, plasmid-mediated quinolone-resistance genes, PFGE, and sequencing of genes of the quinolone-resistance-determining regions (QRDR) were conducted in representative strains isolated in Bangladesh and compared with strains isolated in Zhengding, China. In addition, the role of efflux-pump was studied by using the efflux-pump inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP). Results: Resistance to ciprofloxacin in Shigella species increased from 0% in 2004 to 44% in 2010 and S. flexneri was the predominant species. Of Shigella spp, ciprofloxacin resistant (Cip(R)) strains were mostly found among S. flexneri (8.3%), followed by S. sonnei (1.5%). Within S. flexneri (n = 2181), 14.5% were resistance to ciprofloxacin of which serotype 2a was predominant (96%). MIC of ciprofloxacin, norfloxacin, and ofloxacin were 6-32 mg/L, 8-32 mg/L, and 8-24 mg/L, respectively in S. flexneri 2a isolates. Sequencing of QRDR genes of resistant isolates showed double mutations in gyrA gene (Ser(83) Leu, Asp(87) Asn/Gly) and single mutation in parC gene (Ser(80) Ile). A difference in amino acid substitution at position 87 was found between strains isolated in Bangladesh (Asp(87) Asn) and China (Asp(87) Gly) except for one. A novel mutation at position 211 (His -> Tyr) in gyrA gene was detected only in the Bangladeshi strains. Susceptibility to ciprofloxacin was increased by the presence of CCCP indicating the involvement of energy dependent active efflux pumps. A single PFGE type was found in isolates from Bangladesh and China suggesting their genetic relatedness. Conclusions: Emergence of fluoroquinolone resistance in Shigella undermines a major challenge in current treatment strategies which needs to be followed up by using empirical therapeutic strategies.	[Azmi, Ishrat J.; Khajanchi, Bijay K.; Akter, Fatema; Hasan, Trisheeta N.; Shahnaij, Mohammad; Akter, Mahmuda; Banik, Atanu; Sultana, Halima; Hossain, Mohammad A.; Faruque, Shah M.; Talukder, Kaisar A.] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh; [Ahmed, Mohammad K.] Inst Publ Hlth, Drug Testing Lab, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Talukder, KA (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, GPO Box 128, Dhaka 1000, Bangladesh.	kaisar@icddrb.org	Shahnaij, Mohammad/GMX-3978-2022	Mohammad, Shahnaij/0000-0002-3693-7239; Faruque, Shah/0000-0002-7006-622X	icddr,b's core donors; Government of Bangladesh through IHP-HNPRP; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b's core donors; Government of Bangladesh through IHP-HNPRP; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by the icddr,b's core donors and Government of Bangladesh through IHP-HNPRP. icddr,b acknowledges with gratitude the commitment of Government of Bangladesh through IHP-HNPRP to its research efforts. icddr, b also gratefully acknowledges the following donors which provide unrestricted support: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Cho H, 2001, J MICROBIOL, V39, P62; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Ding J, 1999, Zhonghua Nei Ke Za Zhi, V38, P550; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Dutta S, 2002, EPIDEMIOL INFECT, V129, P235, DOI 10.1017/S0950268802007240; Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380, DOI 10.1128/AAC.40.10.2380; Friedman SM, 2001, ANTIMICROB AGENTS CH, V45, P2378, DOI 10.1128/AAC.45.8.2378-2380.2001; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Jacoby GA, 2003, ANTIMICROB AGENTS CH, V47, P559, DOI 10.1128/AAC.47.2.559-562.2003; Kim JY, 2008, CLIN MICROBIOL INFEC, V14, P760, DOI 10.1111/j.1469-0691.2008.02033.x; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; MUNSHI MH, 1987, LANCET, V2, P419; Oonaka K, 1998, Kansenshogaku Zasshi, V72, P365; Pichel M, 2012, FOODBORNE PATHOG DIS, V9, P5; Piddock L J, 1995, Drugs, V49 Suppl 2, P29; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Pournaras S, 2005, J ANTIMICROB CHEMOTH, V56, P761, DOI 10.1093/jac/dki296; RAHMAN M, 1994, ANTIMICROB AGENTS CH, V38, P2488, DOI 10.1128/AAC.38.10.2488; Sack RB, 1997, CLIN INFECT DIS, V24, pS102, DOI 10.1093/clinids/24.Supplement_1.S102; Salam MA, 1998, LANCET, V352, P522, DOI 10.1016/S0140-6736(97)11457-X; Talukder KA, 2006, CURR MICROBIOL, V52, P108, DOI 10.1007/s00284-005-0140-9; Talukder KA, 2004, J ANTIMICROB CHEMOTH, V54, P730, DOI 10.1093/jac/dkh425; Talukder KA, 2003, J CLIN MICROBIOL, V41, P5053, DOI 10.1128/JCM.41.11.5053-5058.2003; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Talukder KA, 2001, J CLIN MICROBIOL, V39, P3757, DOI 10.1128/JCM.39.10.3757-3759.2001; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Truong QC, 1997, ANTIMICROB AGENTS CH, V41, P85, DOI 10.1128/AAC.41.1.85; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; Vila J, 1996, ANTIMICROB AGENTS CH, V40, P491, DOI 10.1128/AAC.40.2.491; Vito R, 2003, J ANTIMICROB CHEMOTH, V52, P605; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Wang H, 2001, ANTIMICROB AGENTS CH, V45, P1515, DOI 10.1128/AAC.45.5.1515-1521.2001; Wang MG, 2004, ANTIMICROB AGENTS CH, V48, P1295, DOI 10.1128/AAC.48.4.1295-1299.2004; Wang XY, 2005, AM J TROP MED HYG, V73, P416, DOI 10.4269/ajtmh.2005.73.416; WEISSMAN JB, 1975, LANCET, V1, P88	43	34	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102533	10.1371/journal.pone.0102533	http://dx.doi.org/10.1371/journal.pone.0102533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028972	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600081
J	Qin, JB; Yang, TB; Xiao, SY; Tan, HZ; Feng, TJ; Fu, HL				Qin, Jiabi; Yang, Tubao; Xiao, Shuiyuan; Tan, Hongzhuan; Feng, Tiejian; Fu, Hanlin			Reported Estimates of Adverse Pregnancy Outcomes among Women with and without Syphilis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CONGENITAL-SYPHILIS; MATERNAL SYPHILIS; ANTENATAL SYPHILIS; RISK-FACTORS; PREVENTION; MORTALITY; TANZANIA; SHENZHEN; CHINA	Background: To estimate probability of adverse pregnancy outcomes (APOs) among women with and without syphilis through a systematic review of published literatures. Methodology/Principal Findings: Chinese and English literatures were searched for studies assessing pregnancy outcomes in the presence of maternal syphilis through August 2013. The prevalence estimates were summarized and analyzed by meta-analysis. Fifty-four literatures involving 11398 syphilitic women and 43342 non-syphilitic women were included from 4187 records initially found. Among untreated mothers with syphilis, pooled estimates were 76.8% for all APOs, 36.0% for congenital syphilis, 23.2% for preterm, 23.4% for low birth weight, 26.4% for stillbirth or fetal loss, 14.9% for miscarriage and 16.2% for neonatal deaths. Among syphilitic mother receiving treatment only in the late trimester (>28 weeks), pooled estimates were 64.4% for APOs, 40.6% for congenital syphilis, 17.6% for preterm, 12.4% for low birth weight, and 21.3% for stillbirth or fetal loss. Among syphilitic mothers with high titers (>= 1: 8), pooled estimates were 42.8% for all APOs, 25.8% for congenital syphilis, 15.1% for preterm, 9.4% for low birth weight, 14.6% for stillbirth or fetal loss and 16.0% for neonatal deaths. Among non-syphilitic mothers, the pooled estimates were 13.7% for all APOs, 7.2% for preterm birth, 4.5% for low birth weight, 3.7% for stillbirth or fetal loss, 2.3% for miscarriage and 2.0% for neonatal death. Begg's rank correlation test indicated little evidence of publication bias (P>0.10). Substantial heterogeneity was found across studies in the estimates of all adverse outcomes for both women with syphilis (I-2 = 93.9%; P<0.0001) and women without syphilis (I-2 = 94.8%; P<0.0001). Conclusions/Significance: Syphilis continues to be an important cause of substantial perinatal morbidity and mortality, which reminds that policy-makers charged with resource allocation that the elimination of mother-to-child transmission of syphilis is a public health priority.	[Qin, Jiabi; Yang, Tubao; Tan, Hongzhuan; Fu, Hanlin] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Xiao, Shuiyuan] Cent South Univ, Dept Social Med, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Feng, Tiejian] Shenzhen Ctr Chron Dis Control & Prevent, Dept Dermatol & Venereal Dis, Shenzhen, Peoples R China	Central South University; Central South University	Qin, JB (corresponding author), Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China.	qinjiabi123@163.com; yangtb@xysm.net			Fundamental Research Funds for Central South University [2012zzts029]; Hunan Province Innovation Projects of China [CX2012B076]; Program of Prevention of Mother-to-Children Transmission of Syphilis in Shenzhen, China	Fundamental Research Funds for Central South University; Hunan Province Innovation Projects of China; Program of Prevention of Mother-to-Children Transmission of Syphilis in Shenzhen, China	JBQ was supported by the Fundamental Research Funds for Central South University (2012zzts029) and the Hunan Province Innovation Projects (CX2012B076) of China. This work was also supported by the Program of Prevention of Mother-to-Children Transmission of Syphilis in Shenzhen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SM, 2004, B WORLD HEALTH ORGAN, V82, P433; Cao DH, 2012, CHINA MODERN DOCTOR, V50, P49; Chen GuoJu, 2012, Chinese Journal of Dermatovenereology, V26, P321; Chen JH, 2010, CHIN J PRACTICAL PRE, V17, P1815; China Ministry of Health, 2010, NOT MIN HLTH ISS NAT; Cui L, 2013, CHIN J CLIN RATIONAL, V6, P85; Dai Y, 2011, CHIN J CLIN MED PRAC, V15, P142; Deng JF, 2012, MED INNOVATION CHINA, V9, P31; Deperthes BD, 2004, B WORLD HEALTH ORGAN, V82, P410; Fang SN, 2003, CHIN J PUBLIC HLTH, V19, P546; Gao H, 2006, J GUANGDONG MED COLL, V24, P596; Gao JM, 2009, CHIN J BIRTH HLTH HE, V17, P81; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Harman NB, 1917, STAYING PLAGUE; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; HIRA SK, 1990, GENITOURIN MED, V66, P159; Huang ZM, 2009, CHIN TROPICAL MED, V9, P1408; INGRAHAM N R Jr, 1950, Acta Derm Venereol Suppl (Stockh), V31, P60; Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798; Kuang YB, 2004, CHIN MODERN HOSP, V4, P49; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Lago EG, 2004, SEX TRANSM DIS, V31, P33, DOI 10.1097/01.OLQ.0000105003.72411.FB; Li HS, 2012, MATERN CHILD HLTH J, V27, P1496; Li Li, 2009, Maternal and Child Health Care of China, V24, P4087; Li Q, 2005, MATERN CHILD HLTH J, V20, P1477; Li TH, 2010, INNER MONGOLIA MED J, V42, P1053; Li Z, 2012, GUIDE CHINA MED, V10, P227; Li Zhen, 2011, China Tropical Medicine, V11, P1383; Lin XH, 2002, CHIN J HLTH BIRTH CH, V13, P3; Liu JB, 2010, SEX TRANSM INFECT, V86, P292, DOI 10.1136/sti.2009.037549; Lu J, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P456; Luo ZZ, 2011, CHIN J PRACTICAL PRE, V18, P1625; MCDERMOTT J, 1993, B WORLD HEALTH ORGAN, V71, P773; MCFARLIN BL, 1995, MIDWIFERY, V11, P55, DOI 10.1016/0266-6138(95)90067-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Pan P, 2012, CHIN TROPICAL MED, V12, P725; Qin JB, 2014, EUR J CLIN MICROBIOL, V33, P221, DOI 10.1007/s10096-013-1948-z; Qin JB, 2014, SEX TRANSM DIS, V41, P13, DOI 10.1097/OLQ.0000000000000062; Saloojee H, 2004, B WORLD HEALTH ORGAN, V82, P424; Santis M. de, 2012, Infectious Diseases in Obstetrics and Gynecology, V2012, P430585, DOI 10.1155/2012/430585; Shi Jing, 2013, Chinese Journal of Dermatovenereology, V27, P274; Shuang JY, 2010, J SHANXI COLL TRADIT, V11, P63; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun LL, 2008, CHIN J BIRTH HLTH HE, V16, P81; Temmerman M, 2000, SEX TRANSM INFECT, V76, P117, DOI 10.1136/sti.76.2.117; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Tikhonova L, 2003, SEX TRANSM INFECT, V79, P106, DOI 10.1136/sti.79.2.106; WAMMOCK VS, 1950, AM J OBSTET GYNECOL, V59, P806; Wang CX, 2006, MED J CHINESE PEOPLE, V17, P212; Wang HB, 2003, J TONGJI U MED SCI, V24, P449; Wang W, 2011, J CLIN NEUROSCI, V18, P24, DOI 10.1016/j.jocn.2010.06.008; Wang Xun, 2007, China Tropical Medicine, V7, P962; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; Wei HP, 2013, J HAINAN MED U, V19, P381; World Health Organization, 2007, GLOB EL CONG SYPH RA; Wu FY, 2009, J ZHEJIANG U TRADITI, V33, P833; Wu FY, 2013, CHINESE FOREIGN MED, V11, P128; Xu Y, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P460; Xu YX, 2004, CHIN MODERN PREVENTI, V31, P411; Xu ZongYan, 2012, Chinese Journal of Dermatovenereology, V26, P720; Xu ZY, 2013, J JILIN U, V1, P33; Xuan QS, 2006, CHIN J PERINAT MED, V9, P400; Ye GR, 2010, J MILITARY SURG SW C, V12, P1059; Yuan XQ, 2011, GUIDE CHINA MED, V9, P135; Zhang Xiao-min, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P682; Zheng RQ, 2006, CHIN MODERN PREVENTI, V33, P1035; Zhou GJ, 2009, ANHUI MED J, V30, P308; Zhou Hua, 2006, Zhonghua Pifuke Zazhi, V39, P681; Zhu LP, 2010, INT J INFECT DIS, V14, pE45, DOI 10.1016/j.ijid.2009.09.009	73	51	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102203	10.1371/journal.pone.0102203	http://dx.doi.org/10.1371/journal.pone.0102203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025232	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400050
J	Vishal, LA; Nazeer, Y; Ravishankaran, R; Mahalakshmi, N; Kaliraj, P				Vishal, Lawrence Ansel; Nazeer, Y.; Ravishankaran, Rajendran; Mahalakshmi, Natarajan; Kaliraj, Perumal			Evaluation of Rapid Blood Sample Collection in the Detection of Circulating Filarial Antigens for Epidemiological Survey by rWbSXP-1 Capture Assay	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI ANTIGEN; LYMPHATIC FILARIASIS; ESCHERICHIA-COLI; FIELD-EVALUATION; DIAGNOSIS; INFECTION; ANTIBODY; MICROFILAREMIA; INDIVIDUALS; FILTRATION	Background: Lymphatic filariasis is a neglected tropical disease leading to profound disfiguring causing socio economic burden in the tropics. Current diagnosis strategies available during field surveys and epidemics are based on traditional microscopic detections and a few antigen/antibody assays. We have compared different sampling methodologies and standardized the highly sensitive and reliable rWbSXP-1 antigen detection assay to our new sampling methodology. Methodology: Samples collected as serum, whole blood, whole blood on filter paper and whole blood on microscopic slides from patients belonging to various clinical groups of filariasis [endemic normal(EN), chronic pathology(CP), microfilaraemic(MF) and non-endemic normal(NEN)] were collected and standardized the rWbSXP-1 antigen detection assay using monoclonal antibody raised against rWbSXP-1 protein. The whole blood collected on microscopic slide based sampling method was employed in the field and the presence of circulating filarial antigen (CFA) was assessed using the rWbSXP-1 assay. Principal Findings: The sampling methods were compared and no significant difference was observed for the detection of CFA (MF, P = 0.304, EN, P = 0.675, CP, P = 0.5698, NEN, P = 0.4494). Further the optimized sampling method was utilized to collect the 1106 samples from Polur, Tiruvannamalai. The rWbSXP-1 assay gave 98 antigen positive results whereas the microscopic method gave only 17. Conclusions: Four sampling methodologies were analyzed and the new sampling methodology of whole blood collected on microscopic slide was found to be convenient for the detection of CFA using rWbSXP-1 antigen detection assay. The 1106 samples from Polur were collected using the new method. The rWbSXP-1 antigen assay perceived a 7.32% increased result which was read as false negatives on the conventional microscopic staining method. This new sampling methodology coupled with the rWbSXP-1 antigen assay can be used in epidemiological surveys for lymphatic filariasis and the same sampling methodology can be expanded to other antigen based high affinity assays.	[Vishal, Lawrence Ansel; Nazeer, Y.; Ravishankaran, Rajendran; Mahalakshmi, Natarajan; Kaliraj, Perumal] Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai	Kaliraj, P (corresponding author), Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India.	kaliraj55@yahoo.co.in		Sharif, Nazeer/0000-0001-6732-3662; Lawrance, Ansel Vishal/0000-0002-2795-1303	Indian Council of Medical Research [80/810/13-ECDI]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The research was funded by Indian Council of Medical Research vide the Senior Research Fellowship granted to Mr. Ansel Vishal L. File No: 80/810/13-ECDI, url: www.icmr.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Rahman Rohana, 2007, Filaria J, V6, P10; Baskar LKV, 2004, MICROBIOL IMMUNOL, V48, P519, DOI 10.1111/j.1348-0421.2004.tb03547.x; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; CHANTEAU S, 1994, J INFECT DIS, V170, P247, DOI 10.1093/infdis/170.1.247; CLSI (formerly NCCLS), 2000, M15A CLSI NCCLS, P15; Garcia-Meras Lydia, 2007, DIAGNOSTIC MED PARAS, P15; Gyapong JO, 1998, T ROY SOC TROP MED H, V92, P407, DOI 10.1016/S0035-9203(98)91068-9; HARLOW E, 1998, USING ANTIBODIES LAB; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hoti SL, 2002, NATL MED J INDIA, V15, P263; Jamail M, 2005, TROP MED INT HEALTH, V10, P99, DOI 10.1111/j.1365-3156.2004.01334.x; Janardhan S, 2007, J IND MICROBIOL BIOT, V34, P675, DOI 10.1007/s10295-007-0243-3; Jawaharlal JP, 2013, DIAGN MICROBIOL INFE; Lammie Patrick J, 2004, Filaria J, V3, P9, DOI 10.1186/1475-2883-3-9; Mahalakshmi N, 2013, PARASITOL RES, V112, P3203, DOI 10.1007/s00436-013-3496-y; MCMAHON JE, 1979, ANN TROP MED PARASIT, V73, P457, DOI 10.1080/00034983.1979.11687285; OTTESEN EA, 1982, AM J TROP MED HYG, V31, P953, DOI 10.4269/ajtmh.1982.31.953; Pandey V, 2011, CLIN CHIM ACTA, V412, P1867, DOI 10.1016/j.cca.2011.06.029; Pandiaraja P, 2010, EXP PARASITOL, V125, P236, DOI 10.1016/j.exppara.2010.01.027; Ravichandran M, 1997, PARASITE IMMUNOL, V19, P69, DOI 10.1046/j.1365-3024.1997.d01-185.x; Rocha A, 2004, MEM I OSWALDO CRUZ, V99, P101, DOI 10.1590/S0074-02762004000100018; Sabesan S, 2010, J POSTGRAD MED, V56, P232, DOI 10.4103/0022-3859.68650; SANTHANAM S, 1989, TROP MED PARASITOL, V40, P440; SINGH J, 1956, Indian J Malariol, V10, P117; Southgate B A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P19, DOI 10.1016/0035-9203(84)90310-9; Suba S., 2000, Biomedical Research (Aligarh), V11, P321; Tisch DJ, 2008, AM J TROP MED HYG, V78, P289, DOI 10.4269/ajtmh.2008.78.289; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER P, 1993, TROP MED PARASITOL, V44, P45; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; Weil GJ, 2013, AM J TROP MED HYG, V89, P11, DOI 10.4269/ajtmh.13-0089; Weil GJ, 2011, ACTA TROP, V120, pS19, DOI 10.1016/j.actatropica.2010.04.010; Weil GJ, 1996, AM J TROP MED HYG, V55, P333, DOI 10.4269/ajtmh.1996.55.333; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; World Health Organisation Division of Tropical Disease, 1998, WHOCTDFIL974	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102260	10.1371/journal.pone.0102260	http://dx.doi.org/10.1371/journal.pone.0102260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025711	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400055
J	Zhang, CL; Yu, ZQ; Li, XP; Xu, YJ; Liu, D				Zhang, Chengliang; Yu, Zaoqin; Li, Xiping; Xu, Yanjiao; Liu, Dong			Chronopharmacodynamics and Chronopharmacokinetics of Pethidine in Mice	PLOS ONE			English	Article							MEPERIDINE; MORPHINE; TOLERANCE; PHARMACOKINETICS; DISPOSITION; AGONISTS; PLASMA; RHYTHM; PAIN; TIME	Background: Many studies have demonstrated that the pharmacokinetics and pharmacodynamics of analgesic drugs vary according to the circadian time of drug administration. This study aims at determining whether the analgesic effect and pharmacokinetics of pethidine in male BALB/c mice are influenced by administration time. Methods: A hot-plate test was used to evaluate the analgesic effect after pethidine (20 mg/kg) or saline injection at different dosing times. Mouse blood samples were collected at different intervals after dosing at 9: 00 am and 9: 00 pm, and were determined via liquid chromatography-tandem mass spectrometry (LC-MS/MS). Results: A significant 24-h rhythm was observed in the latency to thermal response at 30 min after dosing, with the peak during the dark phase and the nadir during the light phase. Tolerance to analgesic effect was produced after chronic pethidine injection at 9: 00 am or 9: 00 pm, and the recovery from tolerance was faster during the dark phase. The peak concentration (C-max) and area under the concentration-time curve (AUC) of pethidine and its metabolite norpethidine were significantly higher during the dark phase than during the light phase, but the total serum clearance (CL/F) exhibited the opposite trend. The rhythm of drug plasma concentration was positively correlated with the analgesic effect. Conclusion: These results suggest that the pharmacodynamics and pharmacokinetics of pethidine in mice vary significantly according to the dosing time, which implies that the time of administration should be considered in the rational clinical use of pethidine to maximise analgesia and minimise the adverse effects.	[Zhang, Chengliang; Yu, Zaoqin; Li, Xiping; Xu, Yanjiao; Liu, Dong] Huazhong Univ Sci & Technol, Dept Pharm, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yu, Zaoqin] China Pharmaceut Univ, Coll Pharmacol, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China	Huazhong University of Science & Technology; China Pharmaceutical University	Liu, D (corresponding author), Huazhong Univ Sci & Technol, Dept Pharm, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	ld2069@outlook.com	Zhang, Cheng/GRS-8698-2022					Boom Merel, 2010, J Pain Res, V3, P183, DOI 10.2147/JPR.S13616; Boulamery A, 2007, CHRONOBIOL INT, V24, P961, DOI 10.1080/07420520701648309; Bruguerolle B, 2007, ADV DRUG DELIVER REV, V59, P883, DOI 10.1016/j.addr.2006.06.001; Clark Richard F., 1995, Journal of Emergency Medicine, V13, P797, DOI 10.1016/0736-4679(95)02002-0; CLARKE JM, 1976, LANCET, V2, P508, DOI 10.1016/S0140-6736(76)90801-1; Cui Y, 2005, CHRONOBIOL INT, V22, P515, DOI 10.1081/CBI-200062397; DAHLSTROM BE, 1979, DRUG METAB DISPOS, V7, P108; DANZIGER LH, 1994, PHARMACOTHERAPY, V14, P235; DEGAUTE JP, 1991, HYPERTENSION, V18, P199, DOI 10.1161/01.HYP.18.2.199; EBERT B, 1995, NEUROSCI LETT, V187, P165, DOI 10.1016/0304-3940(95)11364-3; Erstad BL, 1997, ANN PHARMACOTHER, V31, P23, DOI 10.1177/106002809703100102; FRANCE CP, 1990, J PHARMACOL EXP THER, V254, P626; Fu CY, 2007, BEHAV BRAIN RES, V184, P39, DOI 10.1016/j.bbr.2007.06.019; Hashimoto T, 2006, ANESTHESIOLOGY, V105, P574, DOI 10.1097/00000542-200609000-00023; HUMMEL T, 1995, CHRONOBIOL INT, V12, P62, DOI 10.3109/07420529509064501; KAIKO RF, 1983, ANN NEUROL, V13, P180, DOI 10.1002/ana.410130213; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kanasaki Y, 2012, J PHARMACOL SCI, V120, P112, DOI 10.1254/jphs.12059FP; Kennaway DJ, 1998, J CLIN ENDOCR METAB, V83, P1013, DOI 10.1210/jc.83.3.1013; Koczmara Christine, 2005, Dynamics, V16, P8; Latta Kenneth S, 2002, Am J Ther, V9, P53, DOI 10.1097/00045391-200201000-00010; Liu Xiao-ping, 2001, Yaoxue Xuebao, V36, P561; Liu YW, 2011, J PHARMACOL SCI, V115, P196, DOI 10.1254/jphs.10284FP; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; Paech MJ, 2008, ANESTH ANALG, V106, P278, DOI 10.1213/01.ane.0000287650.75027.11; PARONIS CA, 1992, J PHARMACOL EXP THER, V262, P1; Ramirez J, 2004, DRUG METAB DISPOS, V32, P930; RITSCHEL WA, 1983, INT J CLIN PHARM TH, V21, P218; STEVENS CW, 1989, J PHARMACOL EXP THER, V251, P216; Tabuchi M, 2005, CANCER RES, V65, P8448, DOI 10.1158/0008-5472.CAN-05-1161; Ushijima K, 2005, J PHARMACOL EXP THER, V315, P764, DOI 10.1124/jpet.105.088849; Vranken JH, 2005, ACTA ANAESTH SCAND, V49, P665, DOI 10.1111/j.1399-6576.2005.00667.x; Weed MR, 2006, PHARMACOL BIOCHEM BE, V84, P487, DOI 10.1016/j.pbb.2006.06.012; Yamakura T, 1999, ANESTHESIOLOGY, V91, P1053, DOI 10.1097/00000542-199910000-00026; Yillar D. O., 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P159; Yoshida M, 2003, J PHARMACOL EXP THER, V305, P1200, DOI 10.1124/jpet.103.049031; Zhang CL, 2013, J ANAL TOXICOL, V37, P351, DOI 10.1093/jat/bkt043	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102054	10.1371/journal.pone.0102054	http://dx.doi.org/10.1371/journal.pone.0102054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025283	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400040
J	Zuo, PY; Chen, XL; Liu, YW; Xiao, CL; Liu, CY				Zuo, Pei-Yuan; Chen, Xing-Lin; Liu, Yu-Wei; Xiao, Chang-Liang; Liu, Cheng-Yun			Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis	PLOS ONE			English	Article							PHASE-III TRIAL; ARTERIAL THROMBOEMBOLIC EVENTS; DOUBLE-BLIND; PLUS BEVACIZUMAB; COLORECTAL-CANCER; PLACEBO; CHEMOTHERAPY; COMBINATION; PACLITAXEL; OVARIAN	Arterial ischemia and hemorrhage are associated with bevacizumab, an inhibitor of vascular endothelial growth factor that is widely used to treat many types of cancers. As specific types of arterial ischemia and hemorrhage, cerebrovascular events such as central nervous system (CNS) ischemic events and CNS hemorrhage are serious adverse events. However, increased cerebrovascular events have not been uniformly reported by previous studies. New randomized controlled trials (RCTs) have been reported in recent years and we therefore conducted an up-to-date meta-analysis of RCTs to fully characterize the risk of cerebrovascular events with bevacizumab. We searched the databases of PubMed, Web of Science, and the American Society of Clinical Oncology conferences to identify relevant clinical trials up to February 2014. Eligible studies included prospective RCTs that directly compared patients with cancer treated with and without bevacizumab. A total of 12,917 patients from 17 RCTs were included in our analysis. Patients treated with bevacizumab had a significantly increased risk of cerebrovascular events compared with patients treated with control medication, with a relative risk of 3.28 (95% CI, 1.97-5.48). The risks of CNS ischemic events and CNS hemorrhage were increased compared with control, with RRs of 3.22 (95% CI, 1.71-6.07) and 3.09 (95% CI, 1.36-6.99), respectively. Risk varied with the bevacizumab dose, with RRs of 3.97 (95% CI, 2.15-7.36) and 1.96 (95% CI, 0.76-5.06) at 5 and 2.5 mg/kg/week, respectively. Higher risks were observed in patients with metastatic colorectal cancer (RR, 6.42; 95% CI, 1.76-35.57), and no significant risk was observed in other types of tumors. In conclusion, the addition of bevacizumab significantly increased the risk of cerebrovascular events compared with controls, including CNS ischemic events and CNS hemorrhage. The risk may vary with bevacizumab dose and tumor type.	[Zuo, Pei-Yuan; Chen, Xing-Lin; Liu, Yu-Wei; Xiao, Chang-Liang; Liu, Cheng-Yun] Huazhong Univ Sci & Technol, Minist Hlth, Key Lab Geriatr, Dept Geriatr,Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Liu, CY (corresponding author), Huazhong Univ Sci & Technol, Minist Hlth, Key Lab Geriatr, Dept Geriatr,Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China.	lcyun@medmail.com.cn		Chen, Xinglin/0000-0002-5820-9224	National Natural Science Foundation of China [81370468]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (No81370468). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Allegra CJ, 2009, J CLIN ONCOL, V27, P3385, DOI 10.1200/JCO.2009.21.9220; Becker J, 2010, CLIN CANCER RES, V16, P1431, DOI 10.1158/1078-0432.CCR-09-1936; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Carden CP, 2008, NEURO-ONCOLOGY, V10, P624, DOI 10.1215/15228517-2008-010; Chen XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067120; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ebbers HC, 2013, DRUG DISCOV TODAY, V18, P872, DOI 10.1016/j.drudis.2013.05.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Hapani S, 2010, ONCOLOGY-BASEL, V79, P27, DOI 10.1159/000314980; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Kim KB, 2012, J CLIN ONCOL, V30, P34, DOI 10.1200/JCO.2011.34.6270; Kindler HL, 2007, J THORAC ONCOL, V2, pS374, DOI 10.1097/01.JTO.0000283221.63767.ba; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Letarte N, 2013, CANCER CHEMOTH PHARM, V71, P1561, DOI 10.1007/s00280-013-2155-4; Meade MO, 1997, ANN INTERN MED, V127, P531, DOI 10.7326/0003-4819-127-7-199710010-00005; Meyerhardt JA, 2012, J CLIN ONCOL, V30, P608, DOI 10.1200/JCO.2011.38.9650; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Narita Y, 2013, JPN J CLIN ONCOL, V43, P587, DOI 10.1093/jjco/hyt051; Okines AFC, 2013, ANN ONCOL, V24, P702, DOI 10.1093/annonc/mds533; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Price TJ, 2012, ANN ONCOL, V23, P1531, DOI 10.1093/annonc/mdr488; Ranpura V, 2010, AM J HYPERTENS, V23, P460, DOI 10.1038/ajh.2010.25; Ranpura V, 2010, ACTA ONCOL, V49, P287, DOI 10.3109/02841860903524396; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Schutz FAB, 2011, ANN ONCOL, V22, P1404, DOI 10.1093/annonc/mdq587; Seet RCS, 2011, NEUROCRIT CARE, V15, P421, DOI 10.1007/s12028-011-9552-5; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	38	53	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102484	10.1371/journal.pone.0102484	http://dx.doi.org/10.1371/journal.pone.0102484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025282	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400079
J	Condette, CJ; Khorsi-Cauet, H; Morliere, P; Zabijak, L; Reygner, J; Bach, V; Gay-Queheillard, J				Condette, Claire Joly; Khorsi-Cauet, Hafida; Morliere, Patrice; Zabijak, Luciane; Reygner, Julie; Bach, Veronique; Gay-Queheillard, Jerome			Increased Gut Permeability and Bacterial Translocation after Chronic Chlorpyrifos Exposure in Rats	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; TIGHT JUNCTION; BARRIER FUNCTION; DISRUPTION; EPITHELIUM; DAMAGE; MODEL; TIME; OXON	The epithelium's barrier function is crucial for maintaining homeostasis and preventing the passage of food antigens and luminal bacteria. This function is essentially subserved by tight junctions (TJs), multiprotein complexes located in the most apical part of the lateral membrane. Some gastrointestinal disease states are associated with elevated intestinal permeability to macromolecules. In a study on rats, we determined the influence of chronic, daily ingestion of chlorpyrifos (CPF, a pesticide that crosses the placental barrier) during pre- and postnatal periods on intestinal permeability and TJ characteristics in the pups. Fluorescein isothiocyanate (FITC)-dextran was used as a marker of paracellular transport and mucosal barrier dysfunction. Pups were gavaged with FITC-dextran solution and blood samples were collected every 30 min for 400 min and analyzed spectrofluorimetrically. At sacrifice, different intestinal segments were resected and prepared for analysis of the transcripts (qPCR) and localization (using immunofluorescence) of ZO-1, occludin and claudins (scaffolding proteins that have a role in the constitution of TJs). In rats that had been exposed to CPF in utero and after birth, we observed a progressive increase in FITC-dextran passage across the epithelial barrier from 210 to 325 min at day 21 after birth (weaning) but not at day 60 (adulthood). At both ages, there were significant changes in intestinal TJ gene expression, with downregulation of ZO-1 and occludin and upregulation of claudins 1 and 4. In some intestinal segments, there were changes in the cellular localization of ZO-1 and claudin 4 immunostaining. Lastly, bacterial translocation to the spleen was also observed. The presence of CPF residues in food may disturb epithelial homeostasis in rats. Changes in TJ protein expression and localization may be involved in gut barrier dysfunction in this model. Uncontrolled passage of macromolecules and bacteria across the intestinal epithelium may be a risk factor for digestive inflammatory diseases.	[Condette, Claire Joly; Khorsi-Cauet, Hafida; Reygner, Julie; Bach, Veronique; Gay-Queheillard, Jerome] Jules Verne Univ Picardy, Fac Med, Peritox Lab, Ineris EA4285 UMI01, Amiens, France; [Morliere, Patrice] Jules Verne Univ Picardy, Fac Med, INSERMU1088, Amiens, France; [Morliere, Patrice] Amiens Univ Hosp, Human Biol Ctr, Biochem Lab, Amiens, France; [Zabijak, Luciane] Jules Verne Univ Picardy, EA4666, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Gay-Queheillard, J (corresponding author), Jules Verne Univ Picardy, Fac Med, Peritox Lab, Ineris EA4285 UMI01, Amiens, France.	jerome.gay@u-picardie.fr	Khorsi-Cauet, Hafida/AFO-7669-2022; Bach, Veronique/AAD-5958-2022		French Ministry of Research; Picardy Regional Council	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Picardy Regional Council(Region Hauts-de-France)	Sources of financial support: The French Ministry of Research and the Picardy Regional Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 2011, NUTRIENTS, V3, P104, DOI 10.3390/nu3010104; Bolles HG, 1999, J AGR FOOD CHEM, V47, P1817, DOI 10.1021/jf980962d; Boudry G, 2011, PEDIATR RES, V69, P4, DOI 10.1203/PDR.0b013e3181fc9d13; Cameron HL, 2007, NEUROGASTROENT MOTIL, V19, P47, DOI 10.1111/j.1365-2982.2006.00845.x; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Carroll IM, 2013, WORLD J GASTROENTERO, V19, P7531, DOI 10.3748/wjg.v19.i43.7531; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; COCHRAN RC, 1995, FOOD CHEM TOXICOL, V33, P165, DOI 10.1016/0278-6915(94)00124-7; Cook TJ, 2003, TOXICOLOGY, V184, P125, DOI 10.1016/S0300-483X(02)00555-3; De Lisle RC, 2013, CELL TISSUE RES; Du MH, 2013, WORLD J GASTROENTERO, V19, P5988, DOI 10.3748/wjg.v19.i36.5988; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Fries W, 1999, LAB INVEST, V79, P49; Gearhart DA, 2007, TOXICOL APPL PHARM, V218, P20, DOI 10.1016/j.taap.2006.10.008; Gebbers JO, 2004, ANN NY ACAD SCI, V1029, P337, DOI 10.1196/annals.1309.015; Gibson PR, 1996, INFLAMM BOWEL DIS, V2, P279, DOI 10.1002/ibd.3780020412; Grigoryan H, 2009, TOXICOL APPL PHARM, V240, P143, DOI 10.1016/j.taap.2009.07.015; Grootjans J, 2010, WORLD J GASTRO SURG, V2, P61, DOI 10.4240/wjgs.v2.i3.61; Hamada K, 2013, CANCER CHEMOTH PHARM, V72, P757, DOI 10.1007/s00280-013-2238-2; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Jarvinen KM, 2013, PEDIAT ALLERG IMM-UK, V24, P589, DOI 10.1111/pai.12106; Joly C, 2013, ENVIRON SCI POLLUT R, V20, P2726, DOI 10.1007/s11356-012-1283-4; Joly Condette C, J PEDIAT GASTR UNPUB; Lennette E., 1985, MANUAL CLIN MICROBIO, Vfourth; Liu J, 2002, TOXICOL APPL PHARM, V178, P102, DOI 10.1006/taap.2001.9326; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Medina M, 2014, GUT, V63, P116, DOI 10.1136/gutjnl-2012-304119; Maurissen JPJ, 2000, TOXICOL SCI, V57, P250, DOI 10.1093/toxsci/57.2.250; Mazzon E, 2002, GUT, V51, P507, DOI 10.1136/gut.51.4.507; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Tirelli V, 2007, TOXICOL IN VITRO, V21, P308, DOI 10.1016/j.tiv.2006.08.015; Yajima M, 2001, J PEDIATR GASTR NUTR, V33, P592, DOI 10.1097/00005176-200111000-00015; Yeh TH, 2011, BIOMATERIALS, V32, P6164, DOI 10.1016/j.biomaterials.2011.03.056; Yu Q, 2012, J DAIRY SCI, V95, P5580, DOI 10.3168/jds.2012-5540; Zhang Y, 2012, BIOCHEM BIOPH RES CO, V428, P321, DOI 10.1016/j.bbrc.2012.10.056	37	65	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102217	10.1371/journal.pone.0102217	http://dx.doi.org/10.1371/journal.pone.0102217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019507	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600054
J	Faisal, MN; Hoffmann, J; El-Kholy, S; Kallsen, K; Wagner, C; Bruchhaus, I; Fink, C; Roeder, T				Faisal, Muhammad N.; Hoffmann, Julia; El-Kholy, Samar; Kallsen, Kimberley; Wagner, Christina; Bruchhaus, Iris; Fink, Christine; Roeder, Thomas			Transcriptional Regionalization of the Fruit Fly's Airway Epithelium	PLOS ONE			English	Article							TRACHEAL SYSTEM; DROSOPHILA; EXPRESSION; ASTHMA; GENES; MORPHOGENESIS; ACTIVATION; OCTOPAMINE; BEHAVIOR; GROWTH	Although airway epithelia are primarily devoted to gas exchange, they have to fulfil a number of different tasks including organ maintenance and the epithelial immune response to fight airborne pathogens. These different tasks are at least partially accomplished by specialized cell types in the epithelium. In addition, a proximal to distal gradient mirroring the transition from airflow conduction to real gas exchange, is also operative. We analysed the airway system of larval Drosophila melanogaster with respect to region-specific expression in the proximal to distal axis. The larval airway system is made of epithelial cells only. We found differential expression between major trunks of the airways and more distal ones comprising primary, secondary and terminal ones. A more detailed analysis was performed using DNA-microarray analysis to identify cohorts of genes that are either predominantly expressed in the dorsal trunks or in the primary/secondary/terminal branches of the airways. Among these differentially expressed genes are especially those involved in signal transduction. Wnt-signalling associated genes for example are predominantly found in secondary/terminal airways. In addition, some G-protein coupled receptors are differentially expressed between both regions of the airways, exemplified by those activated by octopamine or tyramine, the invertebrate counterparts of epinephrine and norepinephrine. Whereas the OAMB is predominantly found in terminal airway regions, the oct beta bR has higher expression levels in dorsal trunks. In addition, we observed a significant association of both, genes predominantly expressed in dorsal trunks or in primary to terminal branches branches with those regulated by hypoxia. Taken together, this observed differential expression is indicative for a proximal to distal transcriptional regionalization presumably reflecting functional differences in these parts of the fly's airway system.	[Faisal, Muhammad N.; Hoffmann, Julia; El-Kholy, Samar; Kallsen, Kimberley; Fink, Christine; Roeder, Thomas] Univ Kiel, Dept Mol Physiol, Kiel, Germany; [Kallsen, Kimberley; Wagner, Christina] Res Ctr Borstel, Prior Area Allergy & Asthma, Borstel, Germany; [Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; [Roeder, Thomas] ARCN, German Ctr Lung Res DZL, Lubeck, Germany	University of Kiel; Forschungszentrum Borstel; Bernhard Nocht Institut fur Tropenmedizin	Roeder, T (corresponding author), Univ Kiel, Dept Mol Physiol, Kiel, Germany.	troeder@zoologie.uni-kiel.de	Wagner, Christina/M-7796-2018; Roeder, Thomas/B-9016-2011; faisal, M/GQB-4757-2022; Fink, Christine/ABF-7102-2021	Roeder, Thomas/0000-0002-3489-3834; Fink, Christine/0000-0003-0083-2168; Faisal, Muhammad/0000-0001-6448-9325	German Research Foundation [SFB TR22]	German Research Foundation(German Research Foundation (DFG))	We would like to thank the German Research Foundation for financial support (SFB TR22 Teilprojekt A7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-265; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Cardoso WV, 2000, DEV DYNAM, V219, P121, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1053>3.3.CO;2-8; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Clark AC, 2004, J NEUROSCI, V24, P4283, DOI 10.1523/JNEUROSCI.4938-03.2004; Costantino BFB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000102; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Gervais L, 2011, DEVELOPMENT, V138, P1269, DOI 10.1242/dev.059188; Hashimoto S, 2012, J CELL SCI, V125, P932, DOI 10.1242/jcs.092734; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Kida H, 2008, AM J PATHOL, V172, P1542, DOI 10.2353/ajpath.2008.071052; LIEDTKE CM, 1989, AM J PHYSIOL, V257, pL125, DOI 10.1152/ajplung.1989.257.2.L125; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Pitsouli C, 2010, DEVELOPMENT, V137, P3615, DOI 10.1242/dev.056408; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Roeder T, 2002, MICROSC RES TECHNIQ, V56, P237, DOI 10.1002/jemt.10027; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Roeder T, 2012, ADV EXP MED BIOL, V710, P37, DOI 10.1007/978-1-4419-5638-5_5; Roeder T, 2009, AM J RESP CRIT CARE, V179, P979, DOI 10.1164/rccm.200811-1777PP; Ruhle H, 1932, Z WISS ZOOL ABT A, V141, P159; Salathe Matthias, 2002, Journal of Allergy and Clinical Immunology, V110, pS275, DOI 10.1067/mai.2002.129412; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Seiler F, 2013, J IMMUNOL, V190, P1603, DOI 10.4049/jimmunol.1200596; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Terakado M, 2011, AM J PHYSIOL-LUNG C, V300, pL56, DOI 10.1152/ajplung.00159.2010; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wagner C, 2009, FASEB J, V23, P2045, DOI 10.1096/fj.08-114223; Wagner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-446; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Wegener C, 2011, J NEUROCHEM, V118, P581, DOI 10.1111/j.1471-4159.2010.07130.x; Wegener C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r131; Whitten J, 1957, Q J MICROSC SCI, V98; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102534	10.1371/journal.pone.0102534	http://dx.doi.org/10.1371/journal.pone.0102534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020150	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600092
J	Yamanaka, K; Tomioka, H; Kawasaki, S; Noda, Y; Yamagata, B; Iwanami, A; Mimura, M				Yamanaka, Kaori; Tomioka, Hiroi; Kawasaki, Shingo; Noda, Yumiko; Yamagata, Bun; Iwanami, Akira; Mimura, Masaru			Effect of Parietal Transcranial Magnetic Stimulation on Spatial Working Memory in Healthy Elderly Persons - Comparison of Near Infrared Spectroscopy for Young and Elderly	PLOS ONE			English	Article							HEMISPHERIC-ASYMMETRY; EPISODIC MEMORY; OLDER ADULTS; HUMAN BRAIN; COGNITION; MODELS; NIRS	In a previous study, we succeeded in improving the spatial working memory (WM) performance in healthy young persons by applying transcranial magnetic stimulation (TMS) to the parietal cortex and simultaneously measuring the oxygenated hemoglobin (oxy-Hb) level using near-infrared spectroscopy (NIRS). Since an improvement in WM was observed when TMS was applied to the right parietal cortex, the oxy-Hb distribution seemed to support a model of hemispheric asymmetry (HA). In the present study, we used the same study design to evaluate healthy elderly persons and investigated the effect of TMS on WM performance in the elderly, comparing the results with those previously obtained from young persons. The application of TMS did not affect WM performance (both reaction time and accuracy) of 38 elderly participants (mean age = 72.5 years old). To investigate the reason for this result, we conducted a three-way ANOVA examining oxy-Hb in both young and elderly participants. For the right parietal TMS site in the elderly, TMS significantly decreased the oxy-Hb level during WM performance; this result was the opposite of that observed in young participants. An additional three-way ANOVA was conducted for each of the 52 channels, and a P value distribution map was created. The P value maps for the young participants showed a clearly localized TMS effect for both the WM and control task, whereas the P map for the elderly participants showed less significant channels and localization. Further analysis following the time course revealed that right-side parietal TMS had almost no effect on the frontal cortex in the elderly participants. This result can most likely be explained by age-related differences in HA arising from the over-recruitment of oxy-Hb, differentiation in the parietal cortex, and age-related alterations of the frontal-parietal networks.	[Yamanaka, Kaori; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Tomioka, Hiroi; Noda, Yumiko; Yamagata, Bun; Iwanami, Akira] Showa Univ, Sch Med, Dept Neuropsychiat, Tokyo 142, Japan; [Kawasaki, Shingo] Hitachi Med Corp, Applicat Dev Off, Opt Topog Grp, Tokyo, Japan	Keio University; Showa University; Hitachi Limited	Yamanaka, K (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	kaoriymnk@yahoo.co.jp			Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Backman L, 2011, NEUROBIOL AGING, V32, P1849, DOI 10.1016/j.neurobiolaging.2009.10.018; Bergvall U, 1986, Acta Radiol Suppl, V369, P205; Bledowski C, 2009, J NEUROSCI, V29, P13735, DOI 10.1523/JNEUROSCI.2547-09.2009; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Craik FI, 2003, NEUROSCI BIOBEHAV R, V36, P1729; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Hertzog C, 2003, PSYCHOL AGING, V18, P755, DOI 10.1037/0882-7974.18.4.755; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Kaiser S, 2010, NEUROSCI LETT, V469, P65, DOI 10.1016/j.neulet.2009.11.045; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; McEvoy LK, 2001, COGNITIVE BRAIN RES, V11, P363, DOI 10.1016/S0926-6410(01)00009-X; Muri RM, 2000, NEUROPSYCHOLOGIA, V38, P1105, DOI 10.1016/S0028-3932(00)00030-0; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Piefke M, 2010, NEUROBIOL AGING; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Thomason ME, 2009, J COGNITIVE NEUROSCI, V21, P316, DOI 10.1162/jocn.2008.21028; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Yamanaka K, 2010, CEREB CORTEX, V20, P1037, DOI 10.1093/cercor/bhp163; Zung WW, 1975, MEASUREMENT DEPRESSI; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	35	10	10	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102306	10.1371/journal.pone.0102306	http://dx.doi.org/10.1371/journal.pone.0102306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019944	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600064
J	Baraz, R; Cisterne, A; Saunders, PO; Hewson, J; Thien, M; Weiss, J; Basnett, J; Bradstock, KF; Bendall, LJ				Baraz, Rana; Cisterne, Adam; Saunders, Philip O.; Hewson, John; Thien, Marilyn; Weiss, Jocelyn; Basnett, Jordan; Bradstock, Kenneth F.; Bendall, Linda J.			mTOR Inhibition by Everolimus in Childhood Acute Lymphoblastic Leukemia Induces Caspase-Independent Cell Death	PLOS ONE			English	Article							5'-UNTRANSLATED REGION; PROGRAMMED NECROSIS; RAD001 EVEROLIMUS; MAMMALIAN TARGET; ER STRESS; B-LINEAGE; APOPTOSIS; RAPAMYCIN; AUTOPHAGY; ACTIVATION	Increasingly, anti-cancer medications are being reported to induce cell death mechanisms other than apoptosis. Activating alternate death mechanisms introduces the potential to kill cells that have defects in their apoptotic machinery, as is commonly observed in cancer cells, including in hematological malignancies. We, and others, have previously reported that the mTOR inhibitor everolimus has pre-clinical efficacy and induces caspase-independent cell death in acute lymphoblastic leukemia cells. Furthermore, everolimus is currently in clinical trial for acute lymphoblastic leukemia. Here we characterize the death mechanism activated by everolimus in acute lymphoblastic leukemia cells. We find that cell death is caspase-independent and lacks the morphology associated with apoptosis. Although mitochondrial depolarization is an early event, permeabilization of the outer mitochondrial membrane only occurs after cell death has occurred. While morphological and biochemical evidence shows that autophagy is clearly present it is not responsible for the observed cell death. There are a number of features consistent with paraptosis including morphology, caspase-independence, and the requirement for new protein synthesis. However in contrast to some reports of paraptosis, the activation of JNK signaling was not required for everolimus-induced cell death. Overall in acute lymphoblastic leukemia cells everolimus induces a cell death that resembles paraptosis.	[Baraz, Rana; Cisterne, Adam; Saunders, Philip O.; Hewson, John; Thien, Marilyn; Weiss, Jocelyn; Basnett, Jordan; Bendall, Linda J.] Univ Sydney, Westmead Millennium Inst, Ctr Canc Res, Westmead, NSW, Australia; [Bradstock, Kenneth F.] Westmead Hosp, Dept Haematol, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Bendall, LJ (corresponding author), Univ Sydney, Westmead Millennium Inst, Ctr Canc Res, Westmead, NSW, Australia.	linda.bendall@sydney.edu.au	Cisterne, Adam/HGA-8311-2022		Leukemia and Lymphoma Society of the USA [6105-08]; University of Sydney; National Health and Medical Research Council (NHMRC) [1042305]; Cancer Institute NSW [12/CDF/2-03]	Leukemia and Lymphoma Society of the USA(Leukemia and Lymphoma Society); University of Sydney(University of Sydney); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	This work has been supported by grant funding from the Leukemia and Lymphoma Society of the USA (No. 6105-08), PS was supported by a University of Sydney Postgraduate Award and LB by fellowships from the National Health and Medical Research Council (NHMRC, No. 1042305) and Cancer Institute NSW (No. 12/CDF/2-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Bertrand FE, 2005, LEUKEMIA, V19, P98, DOI 10.1038/sj.leu.2403560; Boumber Y, 2012, FINAL REPORT PHASE 1; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Brown VI, 2003, P NATL ACAD SCI USA, V100, P15113, DOI 10.1073/pnas.2436348100; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Crazzolara R, 2009, AUTOPHAGY, V5, P727, DOI 10.4161/auto.5.5.8507; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Das G., 2012, COLD SPRING HARB PER, V4; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Gokbuget N, 2009, SEMIN HEMATOL, V46, P64, DOI 10.1053/j.seminhematol.2008.09.003; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Higgins GC, 2012, FREE RADICAL BIO MED, V53, P1960, DOI 10.1016/j.freeradbiomed.2012.08.586; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Kantarjian HM, 2000, J CLIN ONCOL, V18, P547, DOI 10.1200/JCO.2000.18.3.547; Khan NI, 2008, LEUKEMIA LYMPHOMA, V49, P710, DOI 10.1080/10428190701861660; Kolesnichenko M, 2012, CELL CYCLE, V11, P2391, DOI 10.4161/cc.20683; Ling YH, 2011, CLIN CANCER RES, V17, P5353, DOI 10.1158/1078-0432.CCR-10-1948; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Pospelova TV, 2012, CELL CYCLE, V11, P2402, DOI 10.4161/cc.20882; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; SALVARIS E, 1992, LEUKEMIA RES, V16, P655, DOI 10.1016/0145-2126(92)90016-Z; Saunders P. O., 2012, ONCOGENE; Saunders P, 2011, HAEMATOL-HEMATOL J, V96, P69, DOI 10.3324/haematol.2010.026997; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Sun QR, 2010, J CELL PHYSIOL, V222, P421, DOI 10.1002/jcp.21982; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Teachey DT, 2008, BLOOD, V112, P2020, DOI 10.1182/blood-2008-02-137141; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Tseng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036006; WADA M, 1993, BLOOD, V82, P3163; Wang G, 2012, INT J NANOMED, V7, P271, DOI 10.2147/IJN.S26935; Wang L, 2004, LEUKEMIA RES, V28, P733, DOI 10.1016/j.leukres.2003.10.033; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226	46	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102494	10.1371/journal.pone.0102494	http://dx.doi.org/10.1371/journal.pone.0102494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014496	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400098
J	Rojas, JM; Moreno, H; Valcarcel, F; Pena, L; Sevilla, N; Martin, V				Rojas, Jose M.; Moreno, Hector; Valcarcel, Felix; Pena, Lourdes; Sevilla, Noemi; Martin, Veronica			Vaccination with Recombinant Adenoviruses Expressing the Peste des Petits Ruminants Virus F or H Proteins Overcomes Viral Immunosuppression and Induces Protective Immunity against PPRV Challenge in Sheep	PLOS ONE			English	Article							RINDERPEST VIRUS; RESPONSES; VECTORS; ANTIBODY; GOATS; IMMUNIZATION; INDUCTION; INFECTION; EFFICACY; VACCINES	Peste des petits ruminants (PPR) is a highly contagious disease of small ruminants caused by the Morbillivirus peste des petits ruminants virus (PPRV). Two recombinant replication-defective human adenoviruses serotype 5 (Ad5) expressing either the highly immunogenic fusion protein (F) or hemagglutinin protein (H) from PPRV were used to vaccinate sheep by intramuscular inoculation. Both recombinant adenovirus vaccines elicited PPRV-specific B- and T-cell responses. Thus, neutralizing antibodies were detected in sera from immunized sheep. In addition, we detected a significant antigen specific T-cell response in vaccinated sheep against two different PPRV strains, indicating that the vaccine induced heterologous T cell responses. Importantly, no clinical signs and undetectable virus shedding were observed after virulent PPRV challenge in vaccinated sheep. These vaccines also overcame the T cell immunosuppression induced by PPRV in control animals. The results indicate that these adenovirus constructs could be a promising alternative to current vaccine strategies for the development of PPRV DIVA vaccines.	[Rojas, Jose M.; Moreno, Hector; Valcarcel, Felix; Pena, Lourdes; Sevilla, Noemi; Martin, Veronica] Ctr Invest Sanidad Anim CISA INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Martin, V (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Madrid, Spain.	veronica.martin@inia.es	Martin, Veronica/M-9641-2019; Rojas, José M/J-7406-2012; Valcarcel, Felix/Y-3386-2019; Moreno, Hector/AAA-6283-2020; Martín, Verónica/H-2776-2015; Sevilla, Noemi/K-8648-2014; Rojas, José Manuel/X-2903-2019	Martin, Veronica/0000-0003-1486-1656; Rojas, José M/0000-0002-4055-3967; Valcarcel, Felix/0000-0001-5609-0496; Martín, Verónica/0000-0003-1486-1656; Sevilla, Noemi/0000-0003-0118-0376; Rojas, José Manuel/0000-0002-4055-3967; Moreno, Hector/0000-0002-2615-8514	Ministerio de Ciencia e Innovacion [RyC-2010-06516, AGL-2011-25025, AGL2009-07353, RTA2010-00094-C03-03]; NADIR Integrating Activities 7th EU program [228394]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NADIR Integrating Activities 7th EU program	This work was funded by grant numbers RyC-2010-06516 and AGL-2011-25025 (VM); AGL2009-07353 (NS) and RTA2010-00094-C03-03 (FV) from Ministerio de Ciencia e Innovacion (http://www.mineco.gob.es/portal/site/mineco/idi) and 228394-NADIR Integrating Activities 7th EU program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar M, 2012, VIRUS RES, V167, P43, DOI 10.1016/j.virusres.2012.03.018; Babiuk LA, 2000, J BIOTECHNOL, V83, P105, DOI 10.1016/S0168-1656(00)00314-X; Baron MD, 2011, BIOLOGY OF PARAMYXOVIRUSES, P293; BARRETT T, 1989, VIROLOGY, V170, P11, DOI 10.1016/0042-6822(89)90346-2; Berhe G, 2003, J VIROL, V77, P1571, DOI 10.1128/JVI.77.2.1571-1577.2003; Butler D, 2013, NATURE, V499, P264, DOI 10.1038/499264a; CHARLTON KM, 1992, ARCH VIROL, V123, P169, DOI 10.1007/BF01317147; Chen WY, 2010, VACCINE, V28, P4742, DOI 10.1016/j.vaccine.2010.04.102; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Cruz PE, 2006, BIOTECHNOL PROGR, V22, P568, DOI 10.1021/bp050294y; Das SC, 2000, J VIROL, V74, P9039, DOI 10.1128/JVI.74.19.9039-9047.2000; DHAR D, 1990, PHYS REV LETT, V64, P1613, DOI 10.1103/PhysRevLett.64.1613; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; El Harrak M, 2012, J CLIN MICROBIOL, V50, P3738, DOI 10.1128/JCM.01785-12; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Ferreira TB, 2005, J BIOTECHNOL, V119, P272, DOI 10.1016/j.jbiotec.2005.03.009; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Herbert R, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-24; Hu RL, 2007, VACCINE, V25, P5301, DOI 10.1016/j.vaccine.2007.05.024; Hu RL, 2006, MICROBES INFECT, V8, P1090, DOI 10.1016/j.micinf.2005.11.007; Jaiswal S, 2003, J VIROL, V77, P12907, DOI 10.1128/JVI.77.23.12907-12913.2003; Lameiro MH, 2006, J BIOTECHNOL, V126, P152, DOI 10.1016/j.jbiotec.2006.04.030; Lefevre P C, 1990, Rev Sci Tech, V9, P935; LIBEAU G, 1995, RES VET SCI, V58, P50, DOI 10.1016/0034-5288(95)90088-8; Liu Y, 2008, VACCINE, V26, P5368, DOI 10.1016/j.vaccine.2008.08.001; Lund BT, 2000, J GEN VIROL, V81, P2137, DOI 10.1099/0022-1317-81-9-2137; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Mayr GA, 1999, VIROLOGY, V263, P496, DOI 10.1006/viro.1999.9940; Munir M., 2012, SEROLOGICAL DIAGNOSI, DOI DOI 10.5772/36464; Ozkul A, 2002, EMERG INFECT DIS, V8, P708; Pope RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055830; PREVEC L, 1989, J GEN VIROL, V70, P429, DOI 10.1099/0022-1317-70-2-429; PREVEC L, 1990, J INFECT DIS, V161, P27, DOI 10.1093/infdis/161.1.27; Qin JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037170; Rajak KK, 2005, COMP IMMUNOL MICROB, V28, P287, DOI 10.1016/j.cimid.2005.08.002; Riyesh Thachamvally, 2011, Virologica Sinica, V26, P324, DOI 10.1007/s12250-011-3205-x; Rojas JM, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-30; Rojas JM, 2014, VACCINE, V32, P393, DOI 10.1016/j.vaccine.2013.11.033; Saravanan P, 2008, BIOLOGICALS, V36, P1, DOI 10.1016/j.biologicals.2007.03.005; Schneider-Schaulies J, 2008, ADV VIRUS RES, V71, P173, DOI 10.1016/S0065-3527(08)00004-3; Sen A, 2010, EXPERT REV VACCINES, V9, P785, DOI [10.1586/erv.10.74, 10.1586/ERV.10.74]; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Sun Y, 2010, RES VET SCI, V88, P77, DOI 10.1016/j.rvsc.2009.06.005; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; TAYLOR WP, 1979, RES VET SCI, V27, P321, DOI 10.1016/S0034-5288(18)32800-5; Truong T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087145; Wang Y, 2013, VET IMMUNOL IMMUNOP, V154, P1, DOI 10.1016/j.vetimm.2013.05.002	47	41	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101226	10.1371/journal.pone.0101226	http://dx.doi.org/10.1371/journal.pone.0101226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013961	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400022
J	Su, XD; Zhang, ZY; Qu, XY; Tian, YQ; Zhang, GZ				Su, Xudong; Zhang, Zhaoyan; Qu, Xinye; Tian, Yaqiang; Zhang, Guangzhen			Hemoglobin A1c for Diagnosis of Postpartum Abnormal Glucose Tolerance among Women with Gestational Diabetes Mellitus: Diagnostic Meta-Analysis	PLOS ONE			English	Article							TESTS; A(1C)	Objective: To evaluate the accuracy of glycosylated hemoglobin A1c (HbA1c) for the diagnosis of postpartum abnormal glucose tolerance among women with gestational diabetes mellitus (GDM). Methods: After a systematic review of related studies, the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and other measures about the accuracy of HbA1c in the diagnosis of postpartum abnormal glucose tolerance were pooled using random-effects models. The summary receiver operating characteristic (SROC) curve was used to summarize the overall test performance. Results: Six studies met our inclusion criteria. The pooled results on SEN, SPE, PLR, NLR, and DOR were 0.36 (95% CI 0.23-0.52), 0.85 (95% CI 0.73-0.92), 2.4 (95% CI 1.6-3.6), 0.75 (95% CI 0.63-0.88) and 3 (95% CI 2-5). The area under the summary receiver operating characteristic (SROC) curve was 0.67 with a Q value of 0.63. Conclusions: Measurement of HbA1c alone is not a sensitive test to detect abnormal glucose tolerance in women with prior GDM.	[Su, Xudong; Tian, Yaqiang; Zhang, Guangzhen] Liaocheng Peoples Hosp, Dept Endocrinol, Liaocheng, Peoples R China; [Zhang, Zhaoyan; Qu, Xinye] Women & Children Hosp, Dept Obstet & Gynaecol, Liaocheng, Peoples R China		Zhang, GZ (corresponding author), Liaocheng Peoples Hosp, Dept Endocrinol, Liaocheng, Peoples R China.	sxd0080@sina.com						Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Ferrara A, 2009, DIABETES CARE, V32, P269, DOI 10.2337/dc08-1184; Garcia de Guadiana Romualdo Luis, 2012, Endocrinol Nutr, V59, P362, DOI 10.1016/j.endonu.2012.04.002; Gingras V, 2013, J OBSTET GYNAECOL CA, V35, P810, DOI 10.1016/S1701-2163(15)30837-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Picon MJ, 2012, DIABETES CARE, V35, P1648, DOI 10.2337/dc11-2111; Katreddy MV, 2013, WORLD J DIABETES, V4, P76, DOI 10.4239/wjd.v4.i3.76; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim C, 2011, DIABETES CARE, V34, P1949, DOI 10.2337/dc11-0269; Megia A, 2012, BJOG-INT J OBSTET GY, V119, P891, DOI 10.1111/j.1471-0528.2012.03325.x; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Russell MA, 2006, OBSTET GYNECOL, V108, P1456, DOI 10.1097/01.AOG.0000245446.85868.73; Shah BR, 2011, BJOG-INT J OBSTET GY, V118, P1484, DOI 10.1111/j.1471-0528.2011.03083.x; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	18	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102144	10.1371/journal.pone.0102144	http://dx.doi.org/10.1371/journal.pone.0102144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014072	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400070
J	Zhang, DZ; Lau, KM; Chan, ESY; Wang, G; Szeto, CC; Wong, K; Choy, RKW; Ng, CF				Zhang, Ding-Zuan; Lau, Kin-Mang; Chan, Eddie S. Y.; Wang, Gang; Szeto, Cheuk-Chun; Wong, Kenneth; Choy, Richard K. W.; Ng, Chi-Fai			Cell-Free Urinary MicroRNA-99a and MicroRNA-125b Are Diagnostic Markers for the Non-Invasive Screening of Bladder Cancer	PLOS ONE			English	Article							FREE DNA; TUMOR; PROLIFERATION; BIOMARKERS; EXPRESSION; GROWTH; GENES; SERUM; RISK	Background: Evidence implicated the diagnostic significance of microRNAs in whole urine/urine sediments in urothelial carcinoma of the bladder (UCB). However, the contaminated blood cells in patients with haematouria significantly altered the expression profiles of urinary microRNA, influencing the test accuracy. Methods: MicroRNA profiles of the urine supernatants of UCB patients and controls without any malignancy and profiles of malignant and corresponding normal mucosa tissues from the patients were determined by microRNA microarray and compared to identify differentially expressed microRNAs. The differential expression was verified in the tissues of an independent patient cohort by RT-qPCR. The diagnostic significance of selected microRNAs as biomarkers in the urine supernatant was investigated in the expanded cohorts. Results: MicroRNA-99a and microRNA-125b were down-regulated in the urine supernatants of UCB patients. The degree of down-regulation was associated with the tumor grade. A diagnostic model was developed using a combined index of the levels of microRNA-99a and microRNA-125b in the urine supernatant with a sensitivity of 86.7%, a specificity of 81.1% and a positive predicted value (PPV) of 91.8%. Discriminating between high-and low-grade UCB, the model using the level of microRNA-125b alone exhibited a sensitivity of 81.4%, a specificity of 87.0% and a PPV of 93.4%. Conclusions: The results revealed a unique microRNA expression signature in the urine supernatants of UCB patients for the development of molecular diagnostic tests. An effective cell-free urinary microRNA-based model was developed using a combined index of the levels of microRNA-99a and microRNA-125b to detect UCB with good discriminating power, high sensitivity and high specificity.	[Zhang, Ding-Zuan; Chan, Eddie S. Y.; Ng, Chi-Fai] Chinese Univ Hong Kong, Dept Surg, Div Urol, Hong Kong, Hong Kong, Peoples R China; [Lau, Kin-Mang] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Wang, Gang; Szeto, Cheuk-Chun] Chinese Univ Hong Kong, Dept Med & Therapeut, Div Nephrol, Hong Kong, Hong Kong, Peoples R China; [Wong, Kenneth; Choy, Richard K. W.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Ng, CF (corresponding author), Chinese Univ Hong Kong, Dept Surg, Div Urol, Hong Kong, Hong Kong, Peoples R China.	ngcf@surgery.cuhk.edu.hk	Ng, Chi-Fai/E-5134-2011; Chi-fai, NG/AAV-8270-2021; Szeto, Cheuk Chun/N-4954-2015; Choy, Richard/AAW-8230-2020	Ng, Chi-Fai/0000-0002-1723-9646; Szeto, Cheuk Chun/0000-0002-8898-8505; Choy, Richard/0000-0002-3616-6200; Lau, Kin-Mang/0000-0001-5888-1937	Chinese University of Hong Kong [2009.1.096]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was supported by the Direct Grant for Research (2009.1.096), The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Chang HW, 2007, INT J BIOL MARKER, V22, P287, DOI 10.1177/172460080702200408; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman GD, 1996, CANCER EPIDEM BIOMAR, V5, P993; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hansel DE, 2010, AM J PATHOL, V176, P3062, DOI 10.2353/ajpath.2010.090872; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mostofi F, 1999, HISTOLOGICAL TYPING; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Parker J, 2011, THESCIENTIFICWORLDJO, V11, P1103, DOI 10.1100/tsw.2011.104; Satge D, 2009, UROL INT, V82, P296, DOI 10.1159/000209361; Schroeder GL, 2004, J UROLOGY, V172, P1123, DOI 10.1097/01.ju.0000134347.14643.ab; Snowdon J, 2012, CUAJ-CAN UROL ASSOC, V15, P1; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Szarvas T, 2007, ONCOL REP, V18, P405; Timberg G, 1997, SCAND J UROL NEPHROL, V31, P337, DOI 10.3109/00365599709030616; Tzai TS, 2003, UROLOGY, V62, P378, DOI 10.1016/S0090-4295(03)00344-3; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Wang G, 2010, J RHEUMATOL, V37, P2516, DOI 10.3899/jrheum.100308; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Zancan M, 2005, INT J BIOL MARKER, V20, P134, DOI 10.1177/172460080502000209; Zhao AH, 2012, J GENET GENOMICS, V39, P29, DOI 10.1016/j.jgg.2011.12.003	35	191	192	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100793	10.1371/journal.pone.0100793	http://dx.doi.org/10.1371/journal.pone.0100793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014919	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400011
J	Cao, HP; Deterding, LJ; Blackshear, PJ				Cao, Heping; Deterding, Leesa J.; Blackshear, Perry J.			Identification of a Major Phosphopeptide in Human Tristetraprolin by Phosphopeptide Mapping and Mass Spectrometry	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA; GENE-EXPRESSION; RECOMBINANT TRISTETRAPROLIN; TTP; BINDING; MOUSE; PHOSPHORYLATION; DEADENYLATION	Tristetraprolin/zinc finger protein 36 (TTP/ZFP36) binds and destabilizes some pro-inflammatory cytokine mRNAs. TTP-deficient mice develop a profound inflammatory syndrome due to excessive production of pro-inflammatory cytokines. TTP expression is induced by various factors including insulin and extracts from cinnamon and green tea. TTP is highly phosphorylated in vivo and is a substrate for several protein kinases. Multiple phosphorylation sites are identified in human TTP, but it is difficult to assign major vs. minor phosphorylation sites. This study aimed to generate additional information on TTP phosphorylation using phosphopeptide mapping and mass spectrometry (MS). Wild-type and site-directed mutant TTP proteins were expressed in transfected human cells followed by in vivo radiolabeling with [P-32]-orthophosphate. Histidine-tagged TTP proteins were purified with Ni-NTA affinity beads and digested with trypsin and lysyl endopeptidase. The digested peptides were separated by C-18 column with high performance liquid chromatography. Wild-type and all mutant TTP proteins were localized in the cytosol, phosphorylated extensively in vivo and capable of binding to ARE-containing RNA probes. Mutant TTP with S-90 and S-93 mutations resulted in the disappearance of a major phosphopeptide peak. Mutant TTP with an S-197 mutation resulted in another major phosphopeptide peak being eluted earlier than the wildtype. Additional mutations at S-186, S-296 and T-271 exhibited little effect on phosphopeptide profiles. MS analysis identified the peptide that was missing in the S-90 and S-93 mutant protein as LGPELSPSPTSPTATSTTPSR (corresponding to amino acid residues 83-103 of human TTP). MS also identified a major phosphopeptide associated with the first zinc-finger region. These analyses suggest that the tryptic peptide containing S-90 and S-93 is a major phosphopeptide in human TTP.	[Cao, Heping] ARS, USDA, So Reg Res Ctr, New Orleans, LA 70124 USA; [Deterding, Leesa J.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Cao, HP (corresponding author), ARS, USDA, So Reg Res Ctr, New Orleans, LA 70124 USA.	Heping.Cao@ars.usda.gov	Blackshear, Perry J./C-6206-2019; Cao, Heping/AAC-1666-2021	Blackshear, Perry J./0000-0002-9561-8529; Cao, Heping/0000-0002-0958-1468	United States Department of Agriculture-Agriculture Research Service Quality and Utilization of Agricultural Products Research Program 306 [CRIS 6435-41000-102-00D]; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080, ZIAES103206] Funding Source: NIH RePORTER	United States Department of Agriculture-Agriculture Research Service Quality and Utilization of Agricultural Products Research Program 306; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by United States Department of Agriculture-Agriculture Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-102-00D and the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Cao HP, 2008, PROTEIN J, V27, P163, DOI 10.1007/s10930-007-9119-7; Cao H, 2008, BIOTECHNOL PROGR, V24, P326, DOI 10.1021/bp070269n; Cao H, 2008, J NUTR, V138, P833, DOI 10.1093/jn/138.5.833; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Cao HP, 2011, J AGR FOOD CHEM, V59, P2739, DOI 10.1021/jf103527x; Cao HP, 2009, BIOTECHNOL PROGR, V25, P461, DOI 10.1002/btpr.121; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Deterding LJ, 1998, J BIOL CHEM, V273, P12863, DOI 10.1074/jbc.273.21.12863; Dixon DA, 2004, CURR PHARM DESIGN, V10, P635, DOI 10.2174/1381612043453171; Dvorak CMT, 2005, VET IMMUNOL IMMUNOP, V105, P301, DOI 10.1016/j.vetimm.2005.02.006; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; KANEDA N, 1992, GENE, V118, P289, DOI 10.1016/0378-1119(92)90202-Z; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Suswam EA, 2013, J NEURO-ONCOL, V113, P195, DOI 10.1007/s11060-013-1112-8; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; Twizere JC, 2003, J NATL CANCER I, V95, P1846, DOI 10.1093/jnci/djg118; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, P499	46	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100977	10.1371/journal.pone.0100977	http://dx.doi.org/10.1371/journal.pone.0100977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010646	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800010
J	Padmaraj, D; Pande, R; Miller, JH; Wosik, J; Zagozdzon-Wosik, W				Padmaraj, Divya; Pande, Rohit; Miller, John H., Jr.; Wosik, Jarek; Zagozdzon-Wosik, Wanda			Mitochondrial Membrane Studies Using Impedance Spectroscopy with Parallel pH Monitoring	PLOS ONE			English	Article							INTERNAL MEMBRANES; BIOLOGICAL CELLS; ELECTRIC-FIELDS; PROTON GRADIENT; OUTER-MEMBRANE; MODEL; FCCP; CANCER; SIMULATION; GENERATION	A biological microelectromechanical system (BioMEMS) device was designed to study complementary mitochondrial parameters important in mitochondrial dysfunction studies. Mitochondrial dysfunction has been linked to many diseases, including diabetes, obesity, heart failure and aging, as these organelles play a critical role in energy generation, cell signaling and apoptosis. The synthesis of ATP is driven by the electrical potential across the inner mitochondrial membrane and by the pH difference due to proton flux across it. We have developed a tool to study the ionic activity of the mitochondria in parallel with dielectric measurements (impedance spectroscopy) to gain a better understanding of the properties of the mitochondrial membrane. This BioMEMS chip includes: 1) electrodes for impedance studies of mitochondria designed as two-and four-probe structures for optimized operation over a wide frequency range and 2) ion-sensitive field effect transistors for proton studies of the electron transport chain and for possible monitoring other ions such as sodium, potassium and calcium. We have used uncouplers to depolarize the mitochondrial membrane and disrupt the ionic balance. Dielectric spectroscopy responded with a corresponding increase in impedance values pointing at changes in mitochondrial membrane potential. An electrical model was used to describe mitochondrial sample's complex impedance frequency dependencies and the contribution of the membrane to overall impedance changes. The results prove that dielectric spectroscopy can be used as a tool for membrane potential studies. It can be concluded that studies of the electrochemical parameters associated with mitochondrial bioenergetics may render significant information on various abnormalities attributable to these organelles.	[Padmaraj, Divya; Pande, Rohit; Wosik, Jarek; Zagozdzon-Wosik, Wanda] Univ Houston, Elect & Comp Engn Dept, Houston, TX 77004 USA; [Padmaraj, Divya; Pande, Rohit; Miller, John H., Jr.; Wosik, Jarek] Univ Houston, Texas Ctr Superconduct, Houston, TX USA; [Miller, John H., Jr.] Univ Houston, Dept Phys, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston	Zagozdzon-Wosik, W (corresponding author), Univ Houston, Elect & Comp Engn Dept, Houston, TX 77004 USA.	wwosik@uh.edu	Miller, John J/GZG-5663-2022	Miller, John/0000-0001-9329-5810	NIH: NHLBI [R21CA133153]; NIH: NCI [R21CA133153, 3 R21 CA133153-03S1]; State of Texas through the Texas Center for Superconductivity at the University of Houston; Norman Hackerman Advanced Research Program; NATIONAL CANCER INSTITUTE [R21CA133153] Funding Source: NIH RePORTER	NIH: NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH: NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); State of Texas through the Texas Center for Superconductivity at the University of Houston; Norman Hackerman Advanced Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support by grant R21CA133153 (NIH: NHLBI & NCI) and by ARRA supplement 3 R21 CA133153-03S1 (NIH: NCI). Additional support was provided by the State of Texas through the Texas Center for Superconductivity at the University of Houston and the Norman Hackerman Advanced Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Chung WY, 2006, MICROELECTRON J, V37, P1105, DOI 10.1016/j.mejo.2006.05.001; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200; Ellappan P, 2005, J ELECTROSTAT, V63, P297, DOI 10.1016/j.elstat.2004.11.007; Feeney CJ, 2003, J NEUROSCI METH, V125, P13, DOI 10.1016/S0165-0270(03)00027-X; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; FRICKE HUGO, 1933, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOL, V1, P117; Gowrishankar TR, 2003, P NATL ACAD SCI USA, V100, P3203, DOI 10.1073/pnas.0636434100; GRATTAROLA M, 1993, IEEE T BIO-MED ENG, V40, P35, DOI 10.1109/10.204769; HEYTLER PG, 1962, BIOCHEM BIOPH RES CO, V7, P272, DOI 10.1016/0006-291X(62)90189-4; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jack J, 1983, ELECT CURRENT FLOW E; Kadenbach B, 2011, MITOCHONDRION, V11, P700, DOI 10.1016/j.mito.2011.06.001; Kadenbach B, 2010, BBA-GEN SUBJECTS, V1800, P205, DOI 10.1016/j.bbagen.2009.04.019; Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Lemeshko VV, 2002, BIOPHYS J, V82, P684, DOI 10.1016/S0006-3495(02)75431-3; Lin JH, 2005, P ANN INT IEEE EMBS, P7608, DOI 10.1109/IEMBS.2005.1616273; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Morgan H, 2007, J PHYS D APPL PHYS, V40, P61, DOI 10.1088/0022-3727/40/1/S10; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Padmaraj D, 2011, BIOSENS BIOELECTRON, V29, P13, DOI 10.1016/j.bios.2011.06.050; Park KS, 2002, PFLUG ARCH EUR J PHY, V443, P344, DOI 10.1007/s004240100703; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Prodan E, 2008, BIOPHYS J, V95, P4174, DOI 10.1529/biophysj.108.137042; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Talbot J, 2007, J PHYSIOL-LONDON, V579, P783, DOI 10.1113/jphysiol.2006.126383; To MS, 2010, ARCH BIOCHEM BIOPHYS, V495, P152, DOI 10.1016/j.abb.2010.01.004; Tomaszewski D., 2007, J TELECOMMUNICATIONS, V2007, P55; Treuer L, 1998, MOL PHARM, V53, P734; Vajrala V, 2008, BIOPHYS J, V94, P2043, DOI 10.1529/biophysj.107.114611; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; Yao CG, 2008, IEEE T BIO-MED ENG, V55, P1792, DOI 10.1109/TBME.2008.919887; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	42	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101793	10.1371/journal.pone.0101793	http://dx.doi.org/10.1371/journal.pone.0101793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010497	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800041
J	Wu, BB; Wang, GQ; Wu, J; Fu, Q; Liu, CM				Wu, Binbin; Wang, Guoqiang; Wu, Jin; Fu, Qing; Liu, Changming			Sources of Heavy Metals in Surface Sediments and an Ecological Risk Assessment from Two Adjacent Plateau Reservoirs	PLOS ONE			English	Article							QUALITY GUIDELINES; GUIZHOU PROVINCE; RIVER SEDIMENTS; WATER; POLLUTION; GROUNDWATER; MERCURY; CONTAMINATION; GEOCHEMISTRY; SOUTHWEST	The concentrations of heavy metals (mercury (Hg), cadmium (Cd), lead (Pb), chromium (Cr), copper (Cu) and arsenic (As)) in surface water and sediments were investigated in two adjacent drinking water reservoirs (Hongfeng and Baihua Reservoirs) on the Yunnan-Guizhou Plateau in Southwest China. Possible pollution sources were identified by spatial and statistical analyses. For both reservoirs, Cd was most likely from industrial activities, and As was from lithogenic sources. For the Hongfeng Reservoir, Pb, Cr and Cu might have originated from mixed sources (traffic pollution and residual effect of former industrial practices), and the sources of Hg included the inflows, which were different for the North (industrial activities) and South (lithogenic origin) Lakes, and atmospheric deposition resulting from coal combustion. For the Baihua Reservoir, the Hg, Cr and Cu were primarily derived from industrial activities, and the Pb originated from traffic pollution. The Hg in the Baihua Reservoir might also have been associated with coal combustion pollution. An analysis of ecological risk using sediment quality guidelines showed that there were moderate toxicological risks for sediment-dwelling organisms in both reservoirs, mainly from Hg and Cr. Ecological risk analysis using the Hakanson index suggested that there was a potential moderate to very high ecological risk to humans from fish in both reservoirs, mainly because of elevated levels of Hg and Cd. The upstream Hongfeng Reservoir acts as a buffer, but remains an important source of Cd, Cu and Pb and a moderately important source of Cr, for the downstream Baihua Reservoir. This study provides a replicable method for assessing aquatic ecosystem health in adjacent plateau reservoirs.	[Wu, Binbin; Wang, Guoqiang; Wu, Jin; Liu, Changming] Beijing Normal Univ, Coll Water Sci, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China; [Fu, Qing] Chinese Res Inst Environm Sci, Beijing, Peoples R China	Beijing Normal University; Chinese Research Academy of Environmental Sciences	Wang, GQ (corresponding author), Beijing Normal Univ, Coll Water Sci, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China.	wanggq@bnu.edu.cn	WU, JIN/AAE-9081-2019	Wang, Guoqiang/0000-0002-3976-1056	Beijing Higher Education Young Elite Teacher Project [YETP0275]; Program for New Century Excellent Talents in University [NCET-12-0058]; Fundamental Research Funds for the Central Universities [2012LZD10]	Beijing Higher Education Young Elite Teacher Project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Beijing Higher Education Young Elite Teacher Project (Grant No. YETP0275), the Program for New Century Excellent Talents in University (Grant No. NCET-12-0058) and the Fundamental Research Funds for the Central Universities (Grant No. 2012LZD10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, WATER SA, V31, P95; Bai JH, 2011, ECOL MODEL, V222, P301, DOI 10.1016/j.ecolmodel.2009.12.002; Bai JH, 2009, STOCH ENV RES RISK A, V23, P341, DOI 10.1007/s00477-008-0219-5; [白占国 Bai Zhanguo], 2002, [地球化学, Geochimica], V31, P113; Bhavsar Satyendra P., 2010, Integrated Environmental Assessment and Management, V6, P641, DOI 10.1002/ieam.102; Chabukdhara M, 2012, CHEMOSPHERE, V87, P945, DOI 10.1016/j.chemosphere.2012.01.055; Farkas A, 2007, CHEMOSPHERE, V68, P761, DOI 10.1016/j.chemosphere.2006.12.099; Feng XB, 2010, ENVIRON SCI TECHNOL, V44, P3363, DOI 10.1021/es9039488; Feng XB, 2009, ENVIRON POLLUT, V157, P2970, DOI 10.1016/j.envpol.2009.06.002; Feng XB, 2009, ENVIRON POLLUT, V157, P2594, DOI 10.1016/j.envpol.2009.05.024; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hakanson L., 1983, PRINCIPLES LAKE SEDI; Han GL, 2004, CHEM GEOL, V204, P1, DOI 10.1016/j.chemgeo.2003.09.009; [何邵麟 He Shaolin], 2012, [物探与化探, Geophysical and Geochemical Exploration], V36, P273; HE T, 2007, BIOGEOCHEMICAL CYCLI; He TR, 2008, ENVIRON POLLUT, V154, P56, DOI 10.1016/j.envpol.2007.11.013; Huang XF, 2008, STUDIES CHARACTERIST; Huang XianFei, 2008, Research of Environmental Sciences, V21, P18; Ingersoll CG, 1996, J GREAT LAKES RES, V22, P602, DOI 10.1016/S0380-1330(96)70984-X; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Lang YC, 2006, APPL GEOCHEM, V21, P887, DOI 10.1016/j.apgeochem.2006.03.005; Larrose A, 2010, APPL GEOCHEM, V25, P1912, DOI 10.1016/j.apgeochem.2010.10.007; LARSEN B, 1989, MAR POLLUT BULL, V20, P556, DOI 10.1016/0025-326X(89)90356-1; Li XD, 2000, APPL GEOCHEM, V15, P567, DOI 10.1016/S0883-2927(99)00072-4; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; Liu F, 2011, ENVIRON CHEM, V30, P440; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Liu Y, 2007, WATER SA, V33, P305; Long ER, 2006, ENVIRON SCI TECHNOL, V40, P1726, DOI 10.1021/es058012d; Loska K, 2003, CHEMOSPHERE, V51, P723, DOI 10.1016/S0045-6535(03)00187-5; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; NEPA: National Environmental Protection Agency (Presently known as MEP; Ministry of Environmental Protection), 1994, ATL SOIL ENV BACKGR; Persaud D, 1993, GUIDELINES PROTECTIO, P27; Singh KP, 2005, J HYDROL, V312, P14, DOI 10.1016/j.jhydrol.2005.01.021; Smith SL, 1996, J GREAT LAKES RES, V22, P624, DOI 10.1016/S0380-1330(96)70985-1; Sophocleous M, 2002, HYDROGEOL J, V10, P52, DOI 10.1007/s10040-001-0170-8; State Environmental Protection Administration (SEPA), 2000, REP STAT ENV CHIN; Swartz RC, 1999, ENVIRON TOXICOL CHEM, V18, P780, DOI 10.1002/etc.5620180426; [田林锋 Tian Linfeng], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P885; Uluturhan E, 2007, WATER RES, V41, P1185, DOI 10.1016/j.watres.2006.11.044; Wang B, 2005, B ENVIRON CONTAM TOX, V74, P227, DOI 10.1007/s00128-004-0574-y; Wang FS, 2011, APPL GEOCHEM, V26, pS375, DOI 10.1016/j.apgeochem.2011.03.065; Wang FS, 2011, ATMOS ENVIRON, V45, P3827, DOI 10.1016/j.atmosenv.2011.04.014; Wang Y, 2001, J HYDROL, V246, P223, DOI 10.1016/S0022-1694(01)00376-6; Word JQ, 2005, USE OF SEDIMENT: QUALITY GUIDELINES AND RELATED TOOLS FOR THE ASSESSMENT OF CONTAMINATED SEDIMENTS, P121; Yan HY, 2008, SCI TOTAL ENVIRON, V407, P497, DOI 10.1016/j.scitotenv.2008.08.043; Yi YJ, 2011, ENVIRON POLLUT, V159, P2575, DOI 10.1016/j.envpol.2011.06.011; [曾艳 Zeng Yan], 2010, [地球与环境, Earth and Environment], V38, P470; Zhu ZM, 2013, J HAZARD MATER, V246, P189, DOI 10.1016/j.jhazmat.2012.12.024	50	75	77	5	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102101	10.1371/journal.pone.0102101	http://dx.doi.org/10.1371/journal.pone.0102101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010771	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800068
J	O'Callaghan, JP; Kelly, KA; VanGilder, RL; Sofroniew, MV; Miller, DB				O'Callaghan, James P.; Kelly, Kimberly A.; VanGilder, Reyna L.; Sofroniew, Michael V.; Miller, Diane B.			Early Activation of STAT3 Regulates Reactive Astrogliosis Induced by Diverse Forms of Neurotoxicity	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; UP-REGULATION; SUBSTITUTED AMPHETAMINES; MICROGLIAL ACTIVATION; QUANTITATIVE ASPECTS; SIGNALING PATHWAY; BRAIN; INFLAMMATION; LIPOPOLYSACCHARIDE; ASTROCYTES	Astrogliosis, a cellular response characterized by astrocytic hypertrophy and accumulation of GFAP, is a hallmark of all types of central nervous system (CNS) injuries. Potential signaling mechanisms driving the conversion of astrocytes into "reactive'' phenotypes differ with respect to the injury models employed and can be complicated by factors such as disruption of the blood-brain barrier (BBB). As denervation tools, neurotoxicants have the advantage of selective targeting of brain regions and cell types, often with sparing of the BBB. Previously, we found that neuroinflammation and activation of the JAK2-STAT3 pathway in astrocytes precedes up regulation of GFAP in the MPTP mouse model of dopaminergic neurotoxicity. Here we show that multiple mechanistically distinct mouse models of neurotoxicity (MPTP, AMP, METH, MDA, MDMA, KA, TMT) engender the same neuroinflammatory and STAT3 activation responses in specific regions of the brain targeted by each neurotoxicant. The STAT3 effects seen for TMT in the mouse could be generalized to the rat, demonstrating cross-species validity for STAT3 activation. Pharmacological antagonists of the neurotoxic effects blocked neuroinflammatory responses, pSTAT3(tyr705) and GFAP induction, indicating that damage to neuronal targets instigated astrogliosis. Selective deletion of STAT3 from astrocytes in STAT3 conditional knockout mice markedly attenuated MPTP-induced astrogliosis. Monitoring STAT3 translocation in GFAP-positive cells indicated that effects of MPTP, METH and KA on pSTAT3(tyr705) were localized to astrocytes. These findings strongly implicate the STAT3 pathway in astrocytes as a broadly triggered signaling pathway for astrogliosis. We also observed, however, that the acute neuroinflammatory response to the known inflammogen, LPS, can activate STAT3 in CNS tissue without inducing classical signs of astrogliosis. Thus, acute phase neuroinflammatory responses and neurotoxicity-induced astrogliosis both signal through STAT3 but appear to do so through different modules, perhaps localized to different cell types.	[O'Callaghan, James P.; Kelly, Kimberly A.; Miller, Diane B.] NIOSH, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [VanGilder, Reyna L.] W Virginia Univ, Sch Pharm, Morgantown, WV 26506 USA; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	O'Callaghan, JP (corresponding author), NIOSH, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA.	Jdo5@cdc.gov	Kelly, Kimberly/J-9834-2012; Sofroniew, Michael/ABE-8857-2020	Kelly, Kimberly/0000-0002-1146-3137; 	Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health	Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was funded by intramural funds from the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; AL-amri JS, 2013, INDIAN J EXP BIOL, V51, P357; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bengmark S, 2004, CLIN NUTR, V23, P1256, DOI 10.1016/j.clnu.2004.07.016; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; BROCK TO, 1987, J NEUROSCI, V7, P931; Buttini M, 1996, NEUROCHEM INT, V29, P25, DOI 10.1016/0197-0186(95)00141-7; Chen E, 2013, CURR MOL MED, V13, P1474; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Datta SC, 2008, J NEUROSCI METH, V175, P119, DOI 10.1016/j.jneumeth.2008.08.007; Dawn B, 2004, CARDIOVASC RES, V64, P61, DOI 10.1016/j.cardiores.2004.05.011; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; DiNapoli VA, 2010, NEUROSCIENCE, V170, P633, DOI 10.1016/j.neuroscience.2010.07.011; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; FULLER TA, 1981, NEUROBEH TOXICOL TER, V3, P355; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gautron L, 2002, NEUROSCIENCE, V112, P717, DOI 10.1016/S0306-4522(02)00115-X; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ifuku M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-197; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Kelly KA, 2012, J NEUROCHEM, V122, P995, DOI 10.1111/j.1471-4159.2012.07864.x; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Little AR, 2002, NEUROSCIENCE, V115, P307, DOI 10.1016/S0306-4522(02)00359-7; Meddahi A, 2002, J BIOMED MATER RES, V62, P525, DOI 10.1002/jbm.10283; MILLER DB, 1994, J PHARMACOL EXP THER, V270, P752; Miscia S, 2002, CELL GROWTH DIFFER, V13, P13; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; O'Callaghan James P, 2002, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1208s11; O'Callaghan JP, 2010, METABOLISM, V59, pS21, DOI 10.1016/j.metabol.2010.07.011; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; O'Callaghan JP, 2004, J NEUROSCI METH, V135, P159, DOI 10.1016/j.jneumeth.2003.12.006; OCALLAGHAN JP, 1990, BRAIN RES, V521, P73, DOI 10.1016/0006-8993(90)91526-M; OCALLAGHAN JP, 1994, J PHARMACOL EXP THER, V270, P741; OCALLAGHAN JP, 1991, NEUROTOXICOL TERATOL, V13, P275, DOI 10.1016/0892-0362(91)90073-6; OCALLAGHAN JP, 1995, NEUROCHEM INT, V26, P115, DOI 10.1016/0197-0186(94)00106-5; OCALLAGHAN JP, 1993, ANN NY ACAD SCI, V679, P195, DOI 10.1111/j.1749-6632.1993.tb18299.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Rivest S, 2000, P SOC EXP BIOL MED, V223, P22, DOI 10.1046/j.1525-1373.2000.22304.x; Scharf MT, 2008, J NEUROCHEM, V105, P833, DOI 10.1111/j.1471-4159.2007.05182.x; Sedgewick J, 2013, IMAGE INTEGRITY SCI; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Stella N, 2012, SCIENCE, V338, P1303, DOI 10.1126/science.1232331; Takeda K, 1998, J IMMUNOL, V161, P4652; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Nguyen T, 2013, J COAT TECHNOL RES, V10, P1, DOI 10.1007/s11998-012-9455-1; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Turner RC, 2012, NEUROLOGICAL DISORDE, P27; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Xia HS, 2002, ULTRASON SONOCHEM, V9, P151, DOI 10.1016/S1350-4177(01)00118-3; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	77	95	96	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102003	10.1371/journal.pone.0102003	http://dx.doi.org/10.1371/journal.pone.0102003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025494	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400034
J	Pedergnana, V; Syx, L; Cobat, A; Guergnon, J; Brice, P; Ferme, C; Carde, P; Hermine, O; Le-Pendeven, C; Amiel, C; Taoufik, Y; Alcais, A; Theodorou, I; Besson, C; Abel, L				Pedergnana, Vincent; Syx, Laurene; Cobat, Aurelie; Guergnon, Julien; Brice, Pauline; Ferme, Christophe; Carde, Patrice; Hermine, Olivier; Le-Pendeven, Catherine; Amiel, Corinne; Taoufik, Yassine; Alcais, Alexandre; Theodorou, Ioannis; Besson, Caroline; Abel, Laurent			Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens	PLOS ONE			English	Article							LIKELIHOOD-BINOMIAL METHOD; QUANTITATIVE TRAITS; HODGKINS LYMPHOMA; RELATIVES; SIBSHIPS	Over 95% of the adult population worldwide is infected with Epstein-Barr virus (EBV). EBV infection is associated with the development of several cancers, including Hodgkin lymphoma (HL). Elevated levels of anti-EBV antibodies have been associated with increased risk of HL. There is growing evidence that genetic factors control the levels of antibodies against EBV antigens. Here, we conducted linkage and association studies to search for genetic factors influencing either anti-viral capsid antigen (VCA) or anti-Epstein Barr nuclear antigen-1 (EBNA-1) IgG levels in a unique cohort of 424 individuals of European origin from 119 French families recruited through a Hodgkin lymphoma (HL) patient. No major locus controlling anti-VCA antibody levels was identified. However, we found that the HLA region influenced anti-EBNA-1 IgG titers. Refined association studies in this region identified a cluster of HLA class II variants associated with anti-EBNA-1 IgG titers (e.g. p = 5x10-5 for rs9268403). The major allele of rs9268403 conferring a predisposition to high anti-EBNA-1 antibody levels was also associated with an increased risk of HL (p = 0.02). In summary, this study shows that HLA class II variants influenced anti-EBNA-1 IgG titers in a European population. It further shows the role of the same variants in the risk of HL.	[Pedergnana, Vincent; Syx, Laurene; Cobat, Aurelie; Alcais, Alexandre; Abel, Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, Paris, France; [Pedergnana, Vincent; Syx, Laurene; Cobat, Aurelie; Alcais, Alexandre; Abel, Laurent] Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, Paris, France; [Guergnon, Julien; Theodorou, Ioannis] Univ Paris 06, INSERM, Lab Immun & Infect, UMR S 945,Grp Hosp Pitie Salpetriere,AP HP, Paris, France; [Brice, Pauline] Hop St Louis, Serv Oncohematol, Paris, France; [Ferme, Christophe; Carde, Patrice] Hop Gustave Roussy, Dept Med, Villejuif, France; [Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol, Paris, France; [Le-Pendeven, Catherine; Amiel, Corinne] Hop Tenon, AP HP, Lab Virol, F-75970 Paris, France; [Taoufik, Yassine; Besson, Caroline] CHU Bicetre, AP HP, Serv Hematol & Immunol Biol, Le Kremlin Bicetre, France; [Taoufik, Yassine; Besson, Caroline] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Taoufik, Yassine; Besson, Caroline] INSERM, U1012, F-94275 Le Kremlin Bicetre, France; [Abel, Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Rockefeller University	Besson, C (corresponding author), CHU Bicetre, AP HP, Serv Hematol & Immunol Biol, Le Kremlin Bicetre, France.	caroline.besson@bct.aphp.fr; laurent.abel@inserm.fr	Hermine, Olivier/Q-7072-2018; Besson, Caroline/H-4648-2018; Alcais, Alexandre/J-5882-2017; Abel, Laurent/H-8888-2017; Cobat, Aurélie/H-4722-2017	Besson, Caroline/0000-0003-4364-7173; Alcais, Alexandre/0000-0002-1012-2226; Abel, Laurent/0000-0001-7016-6493; Cobat, Aurélie/0000-0001-7209-6257; Hermine, Olivier/0000-0003-2574-3874; Pedergnana, Vincent/0000-0002-7852-5339	Association pour la Recherche contre le Cancer; Ligue Nationale contre le cancer; Fondation de France; Inserm	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the Association pour la Recherche contre le Cancer, Ligue Nationale contre le cancer, Fondation de France, and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 1999, GENET EPIDEMIOL, V17, P102, DOI 10.1002/(SICI)1098-2272(1999)17:2<102::AID-GEPI2>3.0.CO;2-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Besson C, 2006, J CLIN MICROBIOL, V44, P47, DOI 10.1128/JCM.44.1.47-50.2006; Besson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000406; Besson C, 2009, J INFECT DIS, V199, P1121, DOI 10.1086/597424; Cobat A, 2014, GENET EPIDE IN PRESS; Cobat A, 2011, GENET EPIDEMIOL, V35, P46, DOI 10.1002/gepi.20548; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	15	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102501	10.1371/journal.pone.0102501	http://dx.doi.org/10.1371/journal.pone.0102501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025336	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400080
J	Shiino, T; Hattori, J; Yokomaku, Y; Iwatani, Y; Sugiura, W				Shiino, Teiichiro; Hattori, Junko; Yokomaku, Yoshiyuki; Iwatani, Yasumasa; Sugiura, Wataru		Japanese Drug Resistance HIV-1	Phylodynamic Analysis Reveals CRF01_AE Dissemination between Japan and Neighboring Asian Countries and the Role of Intravenous Drug Use in Transmission	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV TYPE-1; SUBTYPE E; SEXUAL TRANSMISSION; RESISTANT HIV-1; MEN MSM; EPIDEMIOLOGY; CHINA; PROGRESSION; PREVALENCE	Background: One major circulating HIV-1 subtype in Southeast Asian countries is CRF01_AE, but little is known about its epidemiology in Japan. We conducted a molecular phylodynamic study of patients newly diagnosed with CRF01_AE from 2003 to 2010. Methods: Plasma samples from patients registered in Japanese Drug Resistance HIV-1 Surveillance Network were analyzed for protease-reverse transcriptase sequences; all sequences undergo subtyping and phylogenetic analysis using distance-matrix-based, maximum likelihood and Bayesian coalescent Markov Chain Monte Carlo (MCMC) phylogenetic inferences. Transmission clusters were identified using interior branch test and depth-first searches for sub-tree partitions. Times of most recent common ancestor (tMRCAs) of significant clusters were estimated using Bayesian MCMC analysis. Results: Among 3618 patient registered in our network, 243 were infected with CRF01_AE. The majority of individuals with CRF01_AE were Japanese, predominantly male, and reported heterosexual contact as their risk factor. We found 5 large clusters with >= 5 members and 25 small clusters consisting of pairs of individuals with highly related CRF01_AE strains. The earliest cluster showed a tMRCA of 1996, and consisted of individuals with their known risk as heterosexual contacts. The other four large clusters showed later tMRCAs between 2000 and 2002 with members including intravenous drug users (IVDU) and non-Japanese, but not men who have sex with men (MSM). In contrast, small clusters included a high frequency of individuals reporting MSM risk factors. Phylogenetic analysis also showed that some individuals infected with HIV strains spread in East and South-eastern Asian countries. Conclusions: Introduction of CRF01_AE viruses into Japan is estimated to have occurred in the 1990s. CFR01_AE spread via heterosexual behavior, then among persons connected with non-Japanese, IVDU, and MSM. Phylogenetic analysis demonstrated that some viral variants are largely restricted to Japan, while others have a broad geographic distribution.	[Shiino, Teiichiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Hattori, Junko; Yokomaku, Yoshiyuki; Iwatani, Yasumasa; Sugiura, Wataru] Nagoya Med Ctr, Dept Infect Dis & Immunol, Clin Res Ctr, Nagoya, Aichi, Japan; [Iwatani, Yasumasa; Sugiura, Wataru] Nagoya Univ, Dept AIDS Res, Grad Sch Med, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); Nagoya Medical Center; Nagoya University	Sugiura, W (corresponding author), Nagoya Med Ctr, Dept Infect Dis & Immunol, Clin Res Ctr, Nagoya, Aichi, Japan.	wsugiura@nnh.hosp.go.jp	Iwatani, Yasumasa/A-8675-2016	Iwatani, Yasumasa/0000-0001-9269-4828	Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MH, 2012, J VIROL, V86, P12402, DOI 10.1128/JVI.00262-12; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beyrer C, 1998, AIDS RES HUM RETROV, V14, P1687, DOI 10.1089/aid.1998.14.1687; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Drummond A, 2001, MOL BIOL EVOL, V18, P1365, DOI 10.1093/oxfordjournals.molbev.a003920; Drummond A, 2000, MOL BIOL EVOL, V17, P1807, DOI 10.1093/oxfordjournals.molbev.a026281; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Gatanaga H, 2007, ANTIVIR RES, V75, P75, DOI 10.1016/j.antiviral.2006.11.012; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Infectious Diseases Surveillance Center, 2011, IASR, V32, P282; Kato S, 2003, AIDS RES HUM RETROV, V19, P1057, DOI 10.1089/088922203322588431; Kihara M, 1997, J ACQ IMMUN DEF SYND, V14, pS3, DOI 10.1097/00042560-199700002-00002; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Kusagawa S, 1999, AIDS RES HUM RETROV, V15, P91, DOI 10.1089/088922299311772; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau KA, 2007, AIDS REV, V9, P218; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Menu E, 1996, AIDS RES HUM RETROV, V12, P629, DOI 10.1089/aid.1996.12.629; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nerurkar VR, 1997, CELL MOL BIOL, V43, P959; Nylander JAA., 2004, BIOINFORMATICS; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; OU CY, 1992, AIDS RES HUM RETROV, V8, P1471, DOI 10.1089/aid.1992.8.1471; Porter KR, 1997, J ACQ IMMUN DEF SYND, V14, P1, DOI 10.1097/00042560-199701010-00001; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNGASS, 2012, NAT COMM POL INSTR N; Wang WH, 2008, AIDS RES HUM RETROV, V24, P1245, DOI 10.1089/aid.2008.0095; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; WENIGER BG, 1994, AIDS, V8, pS13; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yamanaka T, 1997, AIDS RES HUM RETROV, V13, P317, DOI 10.1089/aid.1997.13.317; Ye JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054238; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1	51	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102633	10.1371/journal.pone.0102633	http://dx.doi.org/10.1371/journal.pone.0102633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025900	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400096
J	Tran, BX; Ohinmaa, A; Kuhle, S; Johnson, JA; Veugelers, PJ				Tran, Bach Xuan; Ohinmaa, Arto; Kuhle, Stefan; Johnson, Jeffrey A.; Veugelers, Paul J.			Life Course Impact of School-Based Promotion of Healthy Eating and Active Living to Prevent Childhood Obesity	PLOS ONE			English	Article							ASSESSING COST-EFFECTIVENESS; BODY-MASS INDEX; PHYSICAL-ACTIVITY; FOLLOW-UP; ADULTHOOD; OVERWEIGHT; TRAJECTORIES; INTERVENTIONS; CONSEQUENCES; PARTICIPANTS	Background: The Alberta Project Promoting active Living and healthy Eating in Schools (APPLE Schools) is a comprehensive school health program that is proven feasible and effective in preventing obesity among school aged children. To support decision making on expanding this program, evidence on its long-term health and economic impacts is particularly critical. In the present study we estimate the life course impact of the APPLE Schools programs in terms of future body weights and avoided health care costs. Method: We modeled growth rates of body mass index (BMI) using longitudinal data from the National Population Health Survey collected between 1996-2008. These growth rate characteristics were used to project BMI trajectories for students that attended APPLE Schools and for students who attended control schools (141 randomly selected schools) in the Canadian province of Alberta. Results: Throughout the life course, the prevalence of overweight (including obesity) was 1.2% to 2.8% (1.7 on average) less among students attending APPLE Schools relative to their peers attending control schools. The life course prevalence of obesity was 0.4% to 1.4% (0.8% on average) less among APPLE Schools students. If the APPLE Schools program were to be scaled up, the potential cost savings would be $33 to 82 million per year for the province of Alberta, or $150 to 330 million per year for Canada. Conclusions: These projected health and economic benefits seem to support broader implementation of school-based health promotion programs.	[Tran, Bach Xuan; Ohinmaa, Arto; Johnson, Jeffrey A.; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Kuhle, Stefan] Dalhousie Univ, Dept Pediat Obstet & Gynecol, Halifax, NS, Canada	University of Alberta; Dalhousie University	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	paul.veugelers@ualberta.ca	Kuhle, Stefan/X-5815-2019	Kuhle, Stefan/0000-0001-9417-3727; Veugelers, Paul/0000-0001-8996-0822; Johnson, Jeffrey/0000-0001-8290-2857	Alberta Health; University of Alberta; Canadian Institutes for Health Research [FRN: 91061]; Heart and Stroke Foundation of Canada; Canadian Population Health Initiative; Canadian Institutes for Health Research; Alberta Innovates Health Solutions (AIHS); Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; AIHS; Alberta Innovates [201300671] Funding Source: researchfish	Alberta Health; University of Alberta(University of Alberta); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Population Health Initiative; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; AIHS; Alberta Innovates	The Provincial evaluation was funded through a contract with Alberta Health. The APPLE Schools program was funded through a donation to the School of Public Health at the University of Alberta. The research was funded by an operating grant by the Canadian Institutes for Health Research (FRN: 91061), Heart and Stroke Foundation of Canada and Canadian Population Health Initiative, and through Canadian Institutes for Health Research and Alberta Innovates Health Solutions (AIHS) postdoctoral fellowships to Dr. Bach Tran, and a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention and AIHS Health Scholarship to Dr. Paul J. Veugelers. Dr. J. A. Johnson is a Centennial Professor at the University of Alberta and a Senior Health Scholar with AIHS. All interpretations and opinions in the present study are those of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman-Farinelli MA, 2007, MED J AUSTRALIA, V187, P314, DOI 10.5694/j.1326-5377.2007.tb01253.x; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; [Anonymous], 2008, AHIP COVER; Asakawa K, 2012, J HEALTH ECON, V31, P207, DOI 10.1016/j.jhealeco.2011.10.002; Atkinson W, 2008, AHIP COVER, V49, P32; Atkinson William, 2008, AHIP Cover, V49, P26; Brown HS, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-47; Ng C, 2012, AM J HUM BIOL, V24, P170, DOI 10.1002/ajhb.22216; Carter R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-419; Dietz WH, 2005, NEW ENGL J MED, V352, P2100, DOI 10.1056/NEJMcp043052; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Fung C, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-27; Greening L, 2011, OBESITY, V19, P1213, DOI 10.1038/oby.2010.329; Guyer B, 2009, ACAD PEDIATR, V9, P142, DOI 10.1016/j.acap.2008.12.007; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Katzmarzyk PT, 2004, CAN J PUBLIC HEALTH, V95, P16, DOI 10.1007/BF03403627; Kuhle S, 2011, THESIS U ALBERTA; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Lhachimi SK, 2013, OBES REV, V14, P523, DOI 10.1111/obr.12029; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; McAuley KA, 2010, OBESITY, V18, P131, DOI 10.1038/oby.2009.148; Moodie M, 2011, J PHYS ACT HEALTH, V8, P503, DOI 10.1123/jpah.8.4.503; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Saha AK, 2011, INDIAN J PEDIATR, V78, P1349, DOI 10.1007/s12098-011-0489-7; Starc G, 2011, PUBLIC HEALTH NUTR, V14, P49, DOI 10.1017/S1368980010000741; Tran Bach Xuan, 2013, Cost Eff Resour Alloc, V11, P3, DOI 10.1186/1478-7547-11-3; Trasande L, 2011, EXPERT REV PHARM OUT, V11, P47, DOI 10.1586/ERP.10.86; Venn AJ, 2007, MED J AUSTRALIA, V186, P458, DOI 10.5694/j.1326-5377.2007.tb00997.x; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Veugelers PJ, 2005, AM J PUBLIC HEALTH, V95, P432, DOI 10.2105/AJPH.2004.045898; Wang LY, 2010, J ADOLESCENT HEALTH, V46, P467, DOI 10.1016/j.jadohealth.2009.11.204; Wang LY, 2008, J SCHOOL HEALTH, V78, P619, DOI 10.1111/j.1746-1561.2008.00357.x; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wu JF, 2013, PEDIATR NEONATOL, V54, P71, DOI 10.1016/j.pedneo.2013.01.002; Zenzen W, 2009, J PEDIATR HEALTH CAR, V23, P242, DOI 10.1016/j.pedhc.2008.04.008	37	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102242	10.1371/journal.pone.0102242	http://dx.doi.org/10.1371/journal.pone.0102242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025581	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400054
J	Jin, YZ; Zhang, C; Liu, W; Qi, HY; Chen, H; Cao, SX				Jin, Yazhong; Zhang, Chong; Liu, Wei; Qi, Hongyan; Chen, Hao; Cao, Songxiao			The Cinnamyl Alcohol Dehydrogenase Gene Family in Melon (Cucumis melo L.): Bioinformatic Analysis and Expression Patterns	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; LOBLOLLY-PINE; CAD GENES; LIGNIFICATION; PLANT; PROMOTER; ETHYLENE; SORGHUM	Cinnamyl alcohol dehydrogenase (CAD) is a key enzyme in lignin biosynthesis. However, little was known about CADs in melon. Five CAD-like genes were identified in the genome of melons, namely CmCAD1 to CmCAD5. The signal peptides analysis and CAD proteins prediction showed no typical signal peptides were found in all CmCADs and CmCAD proteins may locate in the cytoplasm. Multiple alignments implied that some motifs may be responsible for the high specificity of these CAD proteins, and may be one of the key residues in the catalytic mechanism. The phylogenetic tree revealed seven groups of CAD and melon CAD genes fell into four main groups. CmCAD1 and CmCAD2 belonged to the bona fide CAD group, in which these CAD genes, as representative from angiosperms, were involved in lignin synthesis. Other CmCADs were distributed in group II, V and VII, respectively. Semi-quantitative PCR and real time qPCR revealed differential expression of CmCADs, and CmCAD5 was expressed in different vegetative tissues except mature leaves, with the highest expression in flower, while CmCAD2 and CmCAD5 were strongly expressed in flesh during development. Promoter analysis revealed several motifs of CAD genes involved in the gene expression modulated by various hormones. Treatment of abscisic acid (ABA) elevated the expression of CmCADs in flesh, whereas the transcript levels of CmCAD1 and CmCAD5 were induced by auxin (IAA); Ethylene induced the expression of CmCADs, while 1-MCP repressed the effect, apart from CmCAD4. Taken together, these data suggested that CmCAD4 may be a pseudogene and that all other CmCADs may be involved in the lignin biosynthesis induced by both abiotic and biotic stresses and in tissue-specific developmental lignification through a CAD genes family network, and CmCAD2 may be the main CAD enzymes for lignification of melon flesh and CmCAD5 may also function in flower development.	[Jin, Yazhong; Zhang, Chong; Liu, Wei; Qi, Hongyan; Chen, Hao; Cao, Songxiao] Shenyang Agr Univ, Key Lab Protected Hort, Educ Minist, Shenyang, Liaoning, Peoples R China; [Jin, Yazhong; Zhang, Chong; Liu, Wei; Qi, Hongyan; Chen, Hao; Cao, Songxiao] Shenyang Agr Univ, Dept Hort, Shenyang, Liaoning, Peoples R China; [Jin, Yazhong] Heilongjiang Bayi Agr Univ, Coll Agr, Daqing, Heilong Jiang, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University; Heilongjiang Bayi Agricultural University	Qi, HY (corresponding author), Shenyang Agr Univ, Key Lab Protected Hort, Educ Minist, Shenyang, Liaoning, Peoples R China.	hyqiaaa@126.com			National Natural Science Foundation of China [31272154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (31272154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-100; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Bedon F, 2009, PLANT CELL REP, V28, P787, DOI 10.1007/s00299-009-0688-0; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Boudet AM, 2000, PLANT PHYSIOL BIOCH, V38, P81, DOI 10.1016/S0981-9428(00)00166-2; Bukh C, 2012, J EXP BOT, V63, P6223, DOI 10.1093/jxb/ers275; Chantreau M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-159; Cheng H, 2013, MOL BIOL REP, V40, P707, DOI 10.1007/s11033-012-2111-0; Damiani I, 2005, PLANT MOL BIOL, V59, P753, DOI 10.1007/s11103-005-0947-6; Deng WW, 2013, J PLANT PHYSIOL, V170, P272, DOI 10.1016/j.jplph.2012.10.010; Domon JM, 2013, PHYTOCHEMISTRY, V85, P51, DOI 10.1016/j.phytochem.2012.09.001; Frost CJ, 2008, NEW PHYTOL, V178, P835, DOI 10.1111/j.1469-8137.2008.02420.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; GALLIANO H, 1993, PLANT MOL BIOL, V23, P145, DOI 10.1007/BF00021427; GOFFNER D, 1992, PLANTA, V188, P48, DOI [10.1007/BF01160711, 10.1007/BF00198938]; Guo DM, 2010, J MOL EVOL, V71, P202, DOI 10.1007/s00239-010-9378-3; HALPIN C, 1994, PLANT J, V6, P339, DOI 10.1046/j.1365-313X.1994.06030339.x; Hirano K, 2012, PLANT CELL REP, V31, P91, DOI 10.1007/s00299-011-1142-7; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Jordi G. M., 2012, PNAS, P12054; Kaur H, 2012, PLANT PHYSIOL, V159, P1545, DOI 10.1104/pp.112.196717; Kim SJ, 2004, P NATL ACAD SCI USA, V101, P1455, DOI 10.1073/pnas.0307987100; Kim SJ, 2007, PHYTOCHEMISTRY, V68, P1957, DOI 10.1016/j.phytochem.2007.02.032; Kim YH, 2010, PLANT CELL REP, V29, P779, DOI 10.1007/s00299-010-0864-2; Latreche K, 2011, PHYSIOL MOL PLANT P, V76, P144, DOI 10.1016/j.pmpp.2011.08.001; LAUVERGEAT V, 1995, BIOCHEMISTRY-US, V34, P12426, DOI 10.1021/bi00038a041; Li XJ, 2009, PLANT MOL BIOL, V69, P685, DOI 10.1007/s11103-008-9448-8; Ma QH, 2010, J EXP BOT, V61, P2735, DOI 10.1093/jxb/erq107; MACKAY JJ, 1995, MOL GEN GENET, V247, P537, DOI 10.1007/BF00290344; MCKIE JH, 1993, BIOCHIM BIOPHYS ACTA, V1202, P61, DOI 10.1016/0167-4838(93)90063-W; OMALLEY DM, 1992, PLANT PHYSIOL, V98, P1364, DOI 10.1104/pp.98.4.1364; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Saathoff AJ, 2012, APPL BIOCHEM BIOTECH, V168, P1086, DOI 10.1007/s12010-012-9843-0; Saathoff AJ, 2011, BIOENERG RES, V4, P120, DOI 10.1007/s12155-010-9106-2; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Saidi MN, 2013, PLANT SCI, V211, P8, DOI 10.1016/j.plantsci.2013.06.008; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Shan LL, 2008, PLANTA, V227, P1243, DOI 10.1007/s00425-008-0696-2; Singh RK, 2010, PHYTOCHEMISTRY, V71, P1485, DOI 10.1016/j.phytochem.2010.05.024; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Tesniere C, 2004, J EXP BOT, V55, P2235, DOI 10.1093/jxb/erh244; Tobias CM, 2005, PLANTA, V220, P678, DOI 10.1007/s00425-004-1385-4; Trabucco GM, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-61; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tronchet M, 2010, MOL PLANT PATHOL, V11, P83, DOI [10.1111/j.1364-3703.2009.00578.x, 10.1111/j.1364-3703.2009.00578.X]; Verries C, 2004, PLANT SCI, V167, P1067, DOI 10.1016/j.plantsci.2004.06.003; Wang YY, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-251; Youn B, 2006, ORG BIOMOL CHEM, V4, P1687, DOI 10.1039/b601672c; Zhang KW, 2006, PLANT PHYSIOL, V140, P972, DOI 10.1104/pp.105.073007; Zhang LB, 2010, FOOD CHEM, V123, P32, DOI 10.1016/j.foodchem.2010.03.122	53	24	26	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101730	10.1371/journal.pone.0101730	http://dx.doi.org/10.1371/journal.pone.0101730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019207	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600025
J	Raveendran, VV; Smith, DD; Tan, XY; Sweeney, ME; Reed, GA; Flynn, CA; Tawfik, OW; Milne, G; Dileepan, KN				Raveendran, Vineesh V.; Smith, Donald D.; Tan, Xiaoyu; Sweeney, Matthew E.; Reed, Gregory A.; Flynn, Colleen A.; Tawfik, Ossama W.; Milne, Ginger; Dileepan, Kottarappat N.			Chronic Ingestion of H1-Antihistamines Increase Progression of Atherosclerosis in Apolipoprotein E-/- Mice	PLOS ONE			English	Article							ARTERY ENDOTHELIAL-CELLS; APOE-DEFICIENT MICE; E-NULL MICE; LESION FORMATION; THROMBOXANE A(2); MAST-CELLS; HISTAMINE; EXPRESSION; ATHEROGENESIS; PERMEABILITY	Although increased serum histamine levels and H1R expression in the plaque are seen in atherosclerosis, it is not known whether H1R activation is a causative factor in the development of the disease, or is a host defense response to atherogenic signals. In order to elucidate how pharmacological inhibition of histamine receptor 1 (H1R) signaling affects atherogenesis, we administered either cetirizine (1 and 4 mg/kg. b.w) or fexofenadine (10 and 40 mg/kg. b.w) to ApoE(-/-) mice maintained on a high fat diet for three months. Mice ingesting a low dose of cetirizine or fexofenadine had significantly higher plaque coverage in the aorta and cross-sectional lesion area at the aortic root. Surprisingly, the higher doses of cetirizine or fexofenadine did not enhance atherosclerotic lesion coverage over the controls. The low dose of fexofenadine, but not cetirizine, increased serum LDL cholesterol. Interestingly, the expression of iNOS and eNOS mRNA was increased in aortas of mice on high doses of cetirizine or fexofenadine. This may be a compensatory nitric oxide (NO)-mediated vasodilatory mechanism that accounts for the lack of increase in the progression of atherosclerosis. Although the administration of cetirizine did not alter blood pressure between the groups, there was a positive correlation between blood pressure and lesion/media ratio at the aortic root in mice receiving the low dose of cetirizine. However, this association was not observed in mice treated with the high dose of cetirizine or either doses of fexofenadine. The macrophages or T lymphocytes densities were not altered by low doses of H1-antihistamines, whereas, high doses decreased the number of macrophages but not T lymphocytes. The number of mast cells was decreased only in mice treated with low dose of fexofenadine. These results demonstrate that chronic ingestion of low therapeutic doses of cetirizine or fexofenadine enhance progression of atherosclerosis.	[Raveendran, Vineesh V.; Smith, Donald D.; Tan, Xiaoyu; Sweeney, Matthew E.; Dileepan, Kottarappat N.] Univ Kansas, Med Ctr, Dept Med, Div Allergy Clin Immunol & Rheumatol, Kansas City, KS 66103 USA; [Reed, Gregory A.; Flynn, Colleen A.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Tawfik, Ossama W.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Milne, Ginger] Vanderbilt Univ, Med Ctr, Nashville, TN USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Vanderbilt University	Dileepan, KN (corresponding author), Univ Kansas, Med Ctr, Dept Med, Div Allergy Clin Immunol & Rheumatol, Kansas City, KS 66103 USA.	kdileepan@kumc.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X	National Institutes of Health [R01-HL070101, 3R01-HL070101-04S1]; Joseph and Elizabeth Carey Arthritis Fund; Audrey E. Smith Medical Research Fund from KU Endowment Association; Department of Internal Medicine Research Office; Research Institute at the University of Kansas Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joseph and Elizabeth Carey Arthritis Fund; Audrey E. Smith Medical Research Fund from KU Endowment Association; Department of Internal Medicine Research Office; Research Institute at the University of Kansas Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants R01-HL070101 and 3R01-HL070101-04S1, the Joseph and Elizabeth Carey Arthritis Fund and the Audrey E. Smith Medical Research Fund from KU Endowment Association and Department of Internal Medicine Research Office, and Lied Grant from the Research Institute at the University of Kansas Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON JB, 1994, HUM PATHOL, V25, P154, DOI 10.1016/0046-8177(94)90271-2; Benarroch EE, 2010, NEUROLOGY, V75, P1472, DOI 10.1212/WNL.0b013e3181f884b1; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; CHALDAKOV GN, 1995, HUM PATHOL, V26, P1286, DOI 10.1016/0046-8177(95)90209-0; Church DS, 2011, WORLD ALLERGY ORGAN, V4, pS22, DOI 10.1097/WOX.0b013e3181f385d9; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Deml KF, 2009, MOL PHARMACOL, V76, P1019, DOI 10.1124/mol.109.058651; Flynn CA, 2011, RAPID COMMU IN PRESS; GILL DS, 1989, METABOLISM, V38, P243, DOI 10.1016/0026-0495(89)90082-6; HARMAN D, 1969, J ATHEROSCLER RES, V10, P77, DOI 10.1016/S0368-1319(69)80084-0; Jin H, 2006, EUR J PHARMACOL, V529, P136, DOI 10.1016/j.ejphar.2005.10.060; Jutel A, 2006, CHEM IMMUNOL ALLERGY, V91, P174; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Leurs R, 2002, CLIN EXP ALLERGY, V32, P489, DOI 10.1046/j.0954-7894.2002.01314.x; Li Y, 2001, MICROVASC RES, V61, P253, DOI 10.1006/mvre.2001.2304; Ludewig B, 2004, P NATL ACAD SCI USA, V101, P11529, DOI 10.1073/pnas.0404612101; OWENS GK, 1979, ATHEROSCLEROSIS, V34, P365, DOI 10.1016/0021-9150(79)90061-3; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Raveendran VV, 2011, IMMUNOLOGY, V132, P578, DOI 10.1111/j.1365-2567.2010.03403.x; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; Sakata Y, 1996, AM J CARDIOL, V77, P1121, DOI 10.1016/S0002-9149(96)00147-6; Smith DD, 2010, J PHYSIOL PHARMACOL, V61, P309; Smith DD, 2012, AM J PHYSIOL-HEART C, V302, pH2612, DOI 10.1152/ajpheart.00879.2011; TAKAGISHI T, 1995, AM J PATHOL, V146, P981; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Tan X, 2007, J IMMUNOL, V179, P7899, DOI 10.4049/jimmunol.179.11.7899; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; Villablanca A, 2004, ARTERIOSCL THROM VAS, V24, P1055, DOI 10.1161/01.ATV.0000130467.65290.d4; Vimala Raveendran V, 2014, AM J PHYSIOL-GASTR L; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Yarnal J R, 1975, J Am Osteopath Assoc, V74, P561; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102165	10.1371/journal.pone.0102165	http://dx.doi.org/10.1371/journal.pone.0102165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020133	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600050
J	Adelman, MW; Kurbatova, E; Wang, YF; Leonard, MK; White, N; McFarland, DA; Blumberg, HM				Adelman, Max W.; Kurbatova, Ekaterina; Wang, Yun F.; Leonard, Michael K.; White, Nancy; McFarland, Deborah A.; Blumberg, Henry M.			Cost Analysis of a Nucleic Acid Amplification Test in the Diagnosis of Pulmonary Tuberculosis at an Urban Hospital with a High Prevalence of TB/HIV	PLOS ONE			English	Article							SKIN-TEST CONVERSION; MYCOBACTERIUM-TUBERCULOSIS; UNITED-STATES; INFECTION; RISK	Introduction: The Centers for Disease Control and Prevention has recommended using a nucleic acid amplification test NAAT) for diagnosing pulmonary tuberculosis (TB) but there is a lack of data on NAAT cost-effectiveness. Methods: We conducted a prospective cohort study that included all patients with an AFB smear-positive respiratory specimen at Grady Memorial Hospital in Atlanta, GA, USA between January 2002 and June 2008. We determined the sensitivity, specificity, and positive and negative predictive value of a commercially available and FDA-approved NAAT (amplified MTD, Gen-Probe) compared to the gold standard of culture. A cost analysis was performed and included costs related to laboratory tests, hospital charges, anti-TB medications, and contact investigations. Average cost per patient was calculated under two conditions: (1) using a NAAT on all AFB smear-postive respiratory specimens and (2) not using a NAAT. One-way sensitivity analyses were conducted to determine sensitivity of cost difference to reasonable ranges of model inputs. Results: During a 6 1/2 year study period, there were 1,009 patients with an AFB smear-positive respiratory specimen at our public urban hospital. We found the NAAT to be highly sensitive (99.6%) and specific (99.1%) on AFB smear-positive specimens compared to culture. Overall, the positive predictive value (PPV) of an AFB smear-positive respiratory specimen for culture-confirmed TB was 27%. The PPV of an AFB smear-positive respiratory specimen for culture-confirmed TB was significantly higher for HIV-uninfected persons compared to those who were HIV-seropositive (152/271 [56%] vs. 85/445 [19%]; RR = 2.94, 95% CI 2.36-3.65, p<0.001). The cost savings of using the NAAT was $2,003 per AFB smear-positive case. Conclusions: Routine use of the NAAT on AFB smear-positive respiratory specimens was highly cost-saving in our setting at a U.S. urban public hospital with a high prevalence of TB and HIV because of the low PPV of an AFB smear for culture-confirmed TB.	[Adelman, Max W.] Emory Univ, Sch Med, Atlanta, GA USA; [Kurbatova, Ekaterina; Leonard, Michael K.; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Kurbatova, Ekaterina; McFarland, Deborah A.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Wang, Yun F.] Grady Mem Hosp, Clin Microbiol Lab, Atlanta, GA USA; [Wang, Yun F.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [White, Nancy; Blumberg, Henry M.] Grady Mem Hosp, Dept Epidemiol, Atlanta, GA USA; [Blumberg, Henry M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Rollins School Public Health	Blumberg, HM (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	henry.m.blumberg@emory.edu	McFarland, Deborah A/P-1907-2018; Adelman, Max/HHZ-5271-2022; Blumberg, Henry/W-2156-2019	McFarland, Deborah A/0000-0002-0019-5165; Adelman, Max/0000-0002-9277-6046; Blumberg, Henry/0000-0002-3110-2443	Georgia Department of Public Health [PH-10100210-88]; National Institutes of Health (NIH) National Center for Advancing Translational Sciences [UL1TR000454, TL1TR000456]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, TL1TR000456] Funding Source: NIH RePORTER	Georgia Department of Public Health; National Institutes of Health (NIH) National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Georgia Department of Public Health (Contract PH-10100210-88) and by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (UL1TR000454 and TL1TR000456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, UPD GUID US NUCL AC; [Anonymous], 2005, GUID INV CONT PERS I; Billinger ME, 2009, EMERG INFECT DIS, V15, P1562, DOI 10.3201/eid1510.090196; BLUMBERG HM, 1995, ANN INTERN MED, V122, P658, DOI 10.7326/0003-4819-122-9-199505010-00003; Blumberg HM, 1998, CLIN INFECT DIS, V27, P826, DOI 10.1086/514963; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Dowdy DW, 2003, J CLIN MICROBIOL, V41, P948, DOI 10.1128/JCM.41.3.948-953.2003; Guerra RL, 2008, J CLIN MICROBIOL, V46, P3811, DOI 10.1128/JCM.01682-08; Hughes R, 2012, RESP MED, V106, P300, DOI 10.1016/j.rmed.2011.10.005; Larsen NM, 2002, CLIN INFECT DIS, V35, P796, DOI 10.1086/342333; Leonard MK, 2006, AM J INFECT CONTROL, V34, P69, DOI 10.1016/j.ajic.2005.09.003; Millman AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079669; Moore DF, 2005, DIAGN MICR INFEC DIS, V52, P247, DOI 10.1016/j.diagmicrobio.2005.02.014; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; Park PH, 2013, INT J TUBERC LUNG D, V17, P759, DOI 10.5588/ijtld.12.0739; Parrish NM, 2011, J CLIN MICROBIOL, V49, P772, DOI 10.1128/JCM.02451-10; Sotir MJ, 1999, CLIN INFECT DIS, V29, P1138, DOI 10.1086/313453; Sprinson JE, 2003, INT J TUBERC LUNG D, V7, pS363; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC; Wright PW, 1998, J CLIN MICROBIOL, V36, P1046, DOI 10.1128/JCM.36.4.1046-1049.1998	20	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100649	10.1371/journal.pone.0100649	http://dx.doi.org/10.1371/journal.pone.0100649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014783	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400010
J	Chatani, E; Tsuchisaka, Y; Masuda, Y; Tsenkova, R				Chatani, Eri; Tsuchisaka, Yutaro; Masuda, Yuki; Tsenkova, Roumiana			Water Molecular System Dynamics Associated with Amyloidogenic Nucleation as Revealed by Real Time Near Infrared Spectroscopy and Aquaphotomics	PLOS ONE			English	Article							INSULIN; FIBRILLATION; HYDRATION; CLUSTERS; FIBRILS; BETA(2)-MICROGLOBULIN; MECHANISM; KINETICS; VIEW	The formation of amyloid fibrils proceeds via a nucleation-dependent mechanism in which nucleation phase is generally associated with a high free energy resulting in the rate-limiting step. On the basis of this kinetic feature, the nucleation is one of the most crucial phases controlling the pathogenesis of amyloidoses, but little is known about the details of how protein molecules and surrounding environment vary at this stage. Here, we applied near infrared (NIR) spectral monitoring of water structural changes in real time during the nucleation-dependent fibrillation of insulin. Whilst multivariate spectral analysis in the 2050-2350 nm spectral region indicated cross-beta formation, characteristic transformations of water structure have been detected in the spectral region 1300-1600 nm corresponding to the first overtone of water OH stretching vibrations. Furthermore, specific water spectral patterns (aquagrams) related to different water molecular conformations have been found along the course of protein nucleation and aggregation. Right in the beginning, dissociation of hydrogen-bonded network in bulk water and coinstantaneous protein and ion hydration were observed, followed by water hydrogen-bonded networks development, presumably forcing the nucleation. These specific transformations of water spectral pattern could be used further as a biomarker for early non-invasive diagnosis of amyloidoses prior to explosive amplification and deposits of amyloid fibrils.	[Chatani, Eri; Masuda, Yuki] Kobe Univ, Dept Chem, Grad Sch Sci, Kobe, Hyogo, Japan; [Tsuchisaka, Yutaro; Tsenkova, Roumiana] Kobe Univ, Dept Environm Informat & Bioprod Engn, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Chatani, E (corresponding author), Kobe Univ, Dept Chem, Grad Sch Sci, Kobe, Hyogo, Japan.	chatani@crystal.kobe-u.ac.jp; rtsen@kobe-u.ac.jp	Tsenkova, Roumiana/ABB-7980-2021	Tsenkova, Roumiana/0000-0002-9733-7587	MEXT KAKENHI [25440071]; Naito Foundation; Kobe University Innovation Center	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation(Naito Memorial Foundation); Kobe University Innovation Center	This work was supported, in part, by MEXT KAKENHI Grant Number 25440071, Grant from the Naito Foundation for E.C., and Kobe University Innovation Center Grant for R.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; [Anonymous], 2001, NEAR INFRARED TECHNO; Baftizadeh F, 2012, J AM CHEM SOC, V134, P3886, DOI 10.1021/ja210826a; Bekard IB, 2009, BIOPHYS J, V97, P2521, DOI 10.1016/j.bpj.2009.07.064; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Brovchenko I, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/155105; Chatani E, 2005, BBA-PROTEINS PROTEOM, V1753, P64, DOI 10.1016/j.bbapap.2005.08.002; Chatani E, 2014, J BIOL CHEM, V289, P10399, DOI 10.1074/jbc.M113.520874; Chong SH, 2012, P NATL ACAD SCI USA, V109, P7636, DOI 10.1073/pnas.1120646109; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Hazy E, 2011, BIOPHYS J, V101, P2260, DOI 10.1016/j.bpj.2011.08.052; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Jinendra B, 2010, BIOCHEM BIOPH RES CO, V397, P685, DOI 10.1016/j.bbrc.2010.06.007; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Kinoshita K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00856; Krone MG, 2008, J AM CHEM SOC, V130, P11066, DOI 10.1021/ja8017303; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Maeda H., 1995, J NEAR INFRARED SPEC, V3, P191, DOI [10.1255/jnirs.69, DOI 10.1255/JNIRS.69]; Miyazawa M., 1998, J NEAR INFRARED SPEC, V6, P253, DOI [10.1255/jnirs.204, DOI 10.1255/JNIRS.204]; Murayama K, 2002, BIOPOLYMERS, V67, P394, DOI 10.1002/bip.10142; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Ozaki Y, 2002, APPL CHEM; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Robert P, 1999, APPL SPECTROSC, V53, P226, DOI 10.1366/0003702991946361; SADLER AJ, 1984, ANAL BIOCHEM, V138, P44, DOI 10.1016/0003-2697(84)90766-8; Sasahara K, 2005, J MOL BIOL, V352, P700, DOI 10.1016/j.jmb.2005.07.033; Takeuchi M, 2009, J NEAR INFRARED SPEC, V17, P373, DOI 10.1255/jnirs.843; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Tsenkova R, 2001, J ANIM SCI, V79, P2550; Tsenkova R., 2010, SPECTROSC EUR, V22, P6; Tsenkova RN, 2004, BIOCHEM BIOPH RES CO, V325, P1005, DOI 10.1016/j.bbrc.2004.10.135; Tsenkova R, 2009, J NEAR INFRARED SPEC, V17, P303, DOI 10.1255/jnirs.869; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Walton JH, 2011, BIOPHYS J, V100, P2302, DOI 10.1016/j.bpj.2011.03.029; Weber JM, 2000, SCIENCE, V287, P2461, DOI 10.1126/science.287.5462.2461; Wei DQ, 1997, J CHEM PHYS, V106, P6086, DOI 10.1063/1.473607; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wu Y, 2000, BBA-MOL CELL RES, V1497, P27, DOI 10.1016/S0167-4889(00)00043-4; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Yuan B, 2003, APPL SPECTROSC, V57, P1223, DOI 10.1366/000370203769699072	47	38	40	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101997	10.1371/journal.pone.0101997	http://dx.doi.org/10.1371/journal.pone.0101997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013915	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400053
J	Jagadapillai, R; Mellen, NM; Sachleben, LR; Gozal, E				Jagadapillai, Rekha; Mellen, Nicholas M.; Sachleben, Leroy R., Jr.; Gozal, Evelyne			Ceftriaxone Preserves Glutamate Transporters and Prevents Intermittent Hypoxia-Induced Vulnerability to Brain Excitotoxic Injury	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; ISCHEMIC TOLERANCE; STROKE; ASTROCYTES; INDUCTION; MECHANISM; RELEASE; DISEASE; EXPRESSION; CULTURES	Hypoxia alters cellular metabolism and although the effects of sustained hypoxia (SH) have been extensively studied, less is known about chronic intermittent hypoxia (IH), commonly associated with cardiovascular morbidity and stroke. We hypothesize that impaired glutamate homeostasis after chronic IH may underlie vulnerability to stroke-induced excitotoxicity. P16 organotypic hippocampal slices, cultured for 7 days were exposed for 7 days to IH (alternating 2 min 5% O-2 - 15 min 21% O-2), SH (5% O-2) or RA (21% O-2), then 3 glutamate challenges. The first and last exposures were intended as a metabolic stimulus (200 mu M glutamate, 15 min); the second emulated excitotoxicity (10 mM glutamate, 10 min). GFAP, MAP2, and EAAT1, EAAT2 glutamate transporters expression were assessed after exposure to each hypoxic protocol. Additionally, cell viability was determined at baseline and after each glutamate challenge, in presence or absence of ceftriaxone that increases glutamate transporter expression. GFAP and MAP2 decreased after 7 days IH and SH. Long-term IH but not SH decreased EAAT1 and EAAT2. Excitotoxic glutamate challenge decreased cell viability and the following 200 mu M exposure further increased cell death, particularly in IH-exposed slices. Ceftriaxone prevented glutamate transporter decrease and improved cell viability after IH and excitotoxicity. We conclude that IH is more detrimental to cell survival and glutamate homeostasis than SH. These findings suggest that impaired regulation of extracellular glutamate levels is implicated in the increased brain susceptibility to excitotoxic insult after long-term IH.	[Jagadapillai, Rekha; Mellen, Nicholas M.; Sachleben, Leroy R., Jr.; Gozal, Evelyne] Univ Louisville, Dept Pediat, KCHRI, Louisville, KY 40292 USA; [Gozal, Evelyne] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Mellen, Nicholas M.; Gozal, Evelyne] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Gozal, E (corresponding author), Univ Louisville, Dept Pediat, KCHRI, Louisville, KY 40292 USA.	evelyne.gozal@louisville.edu			University of Louisville Department of Pediatrics Pilot Research Grant (PRG) Program;  [NIH-RR15576];  [NIH-RR031159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031159, P20RR015576] Funding Source: NIH RePORTER	University of Louisville Department of Pediatrics Pilot Research Grant (PRG) Program; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH-RR15576, NIH-RR031159 grants and by the University of Louisville Department of Pediatrics Pilot Research Grant (PRG) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Martinez-Garcia MA, 2009, AM J RESP CRIT CARE, V180, P36, DOI 10.1164/rccm.200808-1341OC; Arnaud C, 2011, AM J RESP CRIT CARE, V184, P724, DOI 10.1164/rccm.201012-2033OC; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; Calvin AD, 2009, NAT CLIN PRACT CARD, V6, P90, DOI 10.1038/ncpcardio1418; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dronne MA, 2007, BRAIN RES, V1138, P231, DOI 10.1016/j.brainres.2006.12.062; Foster GE, 2007, EXP PHYSIOL, V92, P51, DOI 10.1113/expphysiol.2006.035204; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Gegelashvili G, 1996, NEUROREPORT, V8, P261, DOI 10.1097/00001756-199612200-00052; Gong SJ, 2012, NEUROCHEM RES, V37, P527, DOI 10.1007/s11064-011-0639-3; Gozal E, 2005, AM J PHYSIOL-CELL PH, V288, pC535, DOI 10.1152/ajpcell.00270.2004; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Kato M, 2009, CIRC J, V73, P1363, DOI 10.1253/circj.CJ-09-0364; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Lavie L, 2005, NEUROL CLIN, V23, P1059, DOI 10.1016/j.ncl.2005.05.005; Lavie L, 2009, EUR RESPIR J, V33, P1467, DOI 10.1183/09031936.00086608; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu YX, 2012, GLIA, V60, P112, DOI 10.1002/glia.21252; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan S, 2009, POSTGRAD MED J, V85, P693, DOI 10.1136/thx.2008.105577; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Schurr A, 2001, NEUROSCI LETT, V307, P151, DOI 10.1016/S0304-3940(01)01937-1; Serebrovskaya TV, 2008, EXP BIOL MED, V233, P627, DOI 10.3181/0710-MR-267; Shi YF, 2009, SLEEP MED, V10, P717, DOI 10.1016/j.sleep.2008.08.006; Somers V K, 1992, Clin Auton Res, V2, P171, DOI 10.1007/BF01818958; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Vega C, 2006, J NEUROCHEM, V97, P872, DOI 10.1111/j.1471-4159.2006.03790.x; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1352, DOI 10.1038/sj.jcbfm.9600441; Zheng SR, 2011, NEPHRON EXP NEPHROL, V119, pE21, DOI 10.1159/000327586	48	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100230	10.1371/journal.pone.0100230	http://dx.doi.org/10.1371/journal.pone.0100230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014412	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400007
J	Lange, Y; Ye, J; Steck, TL				Lange, Yvonne; Ye, Jin; Steck, Theodore L.			Essentially All Excess Fibroblast Cholesterol Moves from Plasma Membranes to Intracellular Compartments	PLOS ONE			English	Article							NONVESICULAR STEROL TRANSPORT; CULTURED HUMAN-FIBROBLASTS; ENDOPLASMIC-RETICULUM; FOAM CELLS; HOMEOSTASIS; MOVEMENT; PHOSPHOLIPIDS; PROTEINS; BINDING; PHOSPHATIDYLCHOLINE	It has been shown that modestly increasing plasma membrane cholesterol beyond its physiological set point greatly increases the endoplasmic reticulum and mitochondrial pools, thereby eliciting manifold feedback responses that return cell cholesterol to its resting state. The question arises whether this homeostatic mechanism reflects the targeting of cell surface cholesterol to specific intracellular sites or its general equilibration among the organelles. We now show that human fibroblast cholesterol can be increased as much as two-fold from 2-hydroxypropyl-beta-cyclodextrin without changing the size of the cell surface pool. Rather, essentially all of the added cholesterol disperses rapidly among cytoplasmic membranes, increasing their overall cholesterol content by as much as five-fold. We conclude that the level of plasma membrane cholesterol is normally at capacity and that even small increments above this physiological set point redistribute essentially entirely to intracellular membranes, perhaps down their chemical activity gradients.	[Lange, Yvonne; Ye, Jin] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Steck, Theodore L.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Rush University; University of Chicago	Lange, Y (corresponding author), Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA.	ylange@rush.edu	Lange, Yvonne/A-7794-2009; Steck, Theodore/GWM-4373-2022	Steck, Theodore/0000-0002-8391-9244	Commonwealth Scientific and Industrial Research Organisation (CSIRO); CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program, Marine Biodiversity Hub; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R55HL028448, R01HL028448] Funding Source: NIH RePORTER	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program, Marine Biodiversity Hub; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship. HP was supported by a CSIRO Office of the Executive Chief Postdoctoral Award. BDB's time on this paper was supported by the Australia Governments' National Environmental Research Program, Marine Biodiversity Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2007, BIOPHYS J, V92, P1125, DOI 10.1529/biophysj.106.088427; Bach D, 2003, BBA-BIOMEMBRANES, V1610, P187, DOI 10.1016/S0005-2736(03)00017-8; Brown AJ, 2012, EUR J LIPID SCI TECH, V114, P617, DOI 10.1002/ejlt.201100295; Brzustowicz MR, 2002, BIOPHYS J, V82, P285, DOI 10.1016/S0006-3495(02)75394-0; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; ECHEVARRIA F, 1990, J BIOL CHEM, V265, P8484; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Johnson BB, 2012, BIOCHEMISTRY-US, V51, P3373, DOI 10.1021/bi3003132; Kellner-Weibel G, 1999, ARTERIOSCL THROM VAS, V19, P1891, DOI 10.1161/01.ATV.19.8.1891; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lange Y, 1999, J LIPID RES, V40, P2264; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lange Y, 2013, BIOCHEMISTRY-US, V52, P6950, DOI 10.1021/bi400862q; Lange Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030051; Lange Y, 2009, J LIPID RES, V50, P1881, DOI 10.1194/jlr.M900116-JLR200; Lange Y, 2009, BIOCHEMISTRY-US, V48, P8505, DOI 10.1021/bi900951r; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Lopez CA, 2013, SCI REPORTS, V3, P1; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; McConnell HM, 2003, BBA-BIOMEMBRANES, V1610, P159, DOI 10.1016/S0005-2736(03)00015-4; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; MURPHY RF, 1984, CYTOMETRY, V5, P275, DOI 10.1002/cyto.990050310; OHNOIWASHITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1109, P81, DOI 10.1016/0005-2736(92)90190-W; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Olsen BN, 2013, BIOPHYS J, V105, P1838, DOI 10.1016/j.bpj.2013.08.042; Olsen BN, 2011, BIOPHYS J, V100, P948, DOI 10.1016/j.bpj.2010.12.3728; Pitchiaya S, 2013, METHODS, V63, P188, DOI 10.1016/j.ymeth.2013.05.028; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; SLOTTE JP, 1992, BIOCHIM BIOPHYS ACTA, V1123, P326, DOI 10.1016/0005-2760(92)90014-M; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Steck TL, 1970, METHOD CANCER RES, V5, P93; TANGIRALA RK, 1994, J LIPID RES, V35, P93; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wustner D, 2012, CURR PHARM BIOTECHNO, V13, P303, DOI 10.2174/138920112799095301; Wustner D, 2002, J BIOL CHEM, V277, P30325, DOI 10.1074/jbc.M202626200; Ziblat R, 2010, J AM CHEM SOC, V132, P9920, DOI 10.1021/ja103975g; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993	52	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e98482	10.1371/journal.pone.0098482	http://dx.doi.org/10.1371/journal.pone.0098482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014655	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400002
J	Okumura, K; Saito, M; Isogai, E; Aoto, Y; Hachiya, T; Sakakibara, Y; Katsuragi, Y; Hirose, S; Kominami, R; Goitsuka, R; Nakamura, T; Wakabayashi, Y				Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Aoto, Yoshimasa; Hachiya, Tsuyoshi; Sakakibara, Yasubumi; Katsuragi, Yoshinori; Hirose, Satoshi; Kominami, Ryo; Goitsuka, Ryo; Nakamura, Takuro; Wakabayashi, Yuichi			Meis1 Regulates Epidermal Stem Cells and Is Required for Skin Tumorigenesis	PLOS ONE			English	Article							MALIGNANT PROGRESSION; GENE-EXPRESSION; INITIATION; PROMOTION; CANCER; PROTEINS; TUMORS; CARCINOGENESIS; NEUROBLASTOMA; CARCINOMAS	Previous studies have shown that Meis1 plays an important role in blood development and vascular homeostasis, and can induce blood cancers, such as leukemia. However, its role in epithelia remains largely unknown. Here, we uncover two roles for Meis1 in the epidermis: as a critical regulator of epidermal homeostasis in normal tissues and as a proto-oncogenic factor in neoplastic tissues. In normal epidermis, we show that Meis1 is predominantly expressed in the bulge region of the hair follicles where multipotent adult stem cells reside, and that the number of these stem cells is reduced when Meis1 is deleted in the epidermal tissue of mice. Mice with epidermal deletion of Meis1 developed significantly fewer DMBA/TPA-induced benign and malignant tumors compared with wild-type mice, suggesting that Meis1 plays a role in both tumor development and malignant progression. This is consistent with the observation that Meis1 expression increases as tumors progress from benign papillomas to malignant carcinomas. Interestingly, we found that Meis1 localization was altered to neoplasia development. Instead of being localized to the stem cell region, Meis1 is localized to more differentiated cells in tumor tissues. These findings suggest that, during the transformation from normal to neoplastic tissues, a functional switch occurs in Meis1.	[Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Wakabayashi, Yuichi] Chiba Canc Ctr, Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, Chiba 2608717, Japan; [Aoto, Yoshimasa; Hachiya, Tsuyoshi; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Bioinfomat Lab, Yokohama, Kanagawa 223, Japan; [Katsuragi, Yoshinori; Hirose, Satoshi; Kominami, Ryo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata, Japan; [Goitsuka, Ryo] Tokyo Univ Sci, Res Inst Biol Sci, Div Dev & Aging, Noda, Chiba 278, Japan; [Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan	Chiba Cancer Center; Keio University; Niigata University; Tokyo University of Science; Japanese Foundation for Cancer Research	Wakabayashi, Y (corresponding author), Chiba Canc Ctr, Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, 666-2 Nitonacho, Chiba 2608717, Japan.	yuichi_wakabayashi@chiba-cc.jp	Hachiya, Tsuyoshi/AAM-8691-2021; Hirose, Satoshi/CAF-1500-2022	Hachiya, Tsuyoshi/0000-0002-5274-3266; Hirose, Satoshi/0000-0001-7825-501X	MEXT's program under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [23241066] Funding Source: KAKEN	MEXT's program under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Amornphimoltham P, 2008, CLIN CANCER RES, V14, P8094, DOI 10.1158/1078-0432.CCR-08-0703; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen JL, 2012, CLIN CANCER RES, V18, P4291, DOI 10.1158/1078-0432.CCR-12-0373; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Darwiche N, 2007, ONCOGENE, V26, P6885, DOI 10.1038/sj.onc.1210491; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fernandez P, 2004, ONCOGENE, V23, P5084, DOI 10.1038/sj.onc.1207665; Geerts D, 2005, CANCER LETT, V228, P43, DOI 10.1016/j.canlet.2005.01.047; GLICK AB, 1994, GENE DEV, V8, P2429, DOI 10.1101/gad.8.20.2429; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Hirayama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089885; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Indra AK, 2000, HORM RES, V54, P296, DOI 10.1159/000053275; Jones TA, 2000, EUR J CANCER, V36, P2368, DOI 10.1016/S0959-8049(00)00332-4; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Maeda R, 2001, ONCOGENE, V20, P1329, DOI 10.1038/sj.onc.1204250; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Matsumoto T, 2003, CANCER RES, V63, P4819; Morris RJ, 1997, CANCER RES, V57, P3436; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; MORRIS RJ, 1986, CANCER RES, V46, P3061; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Niessen MT, 2013, J CELL BIOL, V202, P887, DOI 10.1083/jcb.201307001; Okumura K, 2012, CARCINOGENESIS, V33, P2260, DOI 10.1093/carcin/bgs250; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Rundhaug JE, 1997, MOL CARCINOGEN, V20, P125, DOI 10.1002/(SICI)1098-2744(199709)20:1<125::AID-MC14>3.0.CO;2-3; Rundhaug JE, 2007, MOL CARCINOGEN, V46, P981, DOI 10.1002/mc.20340; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Spieker N, 2001, GENOMICS, V71, P214, DOI 10.1006/geno.2000.6408; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wilker E, 2005, MOL CARCINOGEN, V44, P137, DOI 10.1002/mc.20132; YUSPA SH, 1994, J INVEST DERMATOL, V103, pS90, DOI 10.1111/1523-1747.ep12399255	51	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102111	10.1371/journal.pone.0102111	http://dx.doi.org/10.1371/journal.pone.0102111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013928	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400067
J	Vosselman, MJ; Vijgen, GHEJ; Kingma, BRM; Brans, B; Lichtenbelt, WDV				Vosselman, Maarten J.; Vijgen, Guy H. E. J.; Kingma, Boris R. M.; Brans, Boudewijn; Lichtenbelt, Wouter D. van Marken			Frequent Extreme Cold Exposure and Brown Fat and Cold-Induced Thermogenesis: A Study in a Monozygotic Twin	PLOS ONE			English	Article							ADIPOSE-TISSUE ACTIVITY; NONSHIVERING THERMOGENESIS; ADAPTIVE THERMOGENESIS; UNCOUPLING PROTEIN-1; ADULT HUMANS; MILD COLD; TEMPERATURE; DECREASE; GENES; FINNS	Introduction: Mild cold acclimation is known to increase brown adipose tissue (BAT) activity and cold-induced thermogenesis (CIT) in humans. We here tested the effect of a lifestyle with frequent exposure to extreme cold on BAT and CIT in a Dutch man known as 'the Iceman', who has multiple world records in withstanding extreme cold challenges. Furthermore, his monozygotic twin brother who has a 'normal' sedentary lifestyle without extreme cold exposures was measured. Methods: The Iceman (subject A) and his brother (subject B) were studied during mild cold (13 degrees C) and thermoneutral conditions (31 degrees C). Measurements included BAT activity and respiratory muscle activity by [F-18]FDG-PET/CT imaging and energy expenditure through indirect calorimetry. In addition, body temperatures, cardiovascular parameters, skin perfusion, and thermal sensation and comfort were measured. Finally, we determined polymorphisms for uncoupling protein-1 and beta 3-adrenergic receptor. Results: Subjects had comparable BAT activity (A: 1144 SUVtotal and B: 1325 SUVtotal), within the range previously observed in young adult men. They were genotyped with the polymorphism for uncoupling protein-1 (G/G). CIT was relatively high (A: 40.1% and B: 41.9%), but unlike during our previous cold exposure tests in young adult men, here both subjects practiced a g-Tummo like breathing technique, which involves vigorous respiratory muscle activity. This was confirmed by high [F-18]FDG-uptake in respiratory muscle. Conclusion: No significant differences were found between the two subjects, indicating that a lifestyle with frequent exposures to extreme cold does not seem to affect BAT activity and CIT. In both subjects, BAT was not higher compared to earlier observations, whereas CIT was very high, suggesting that g-Tummo like breathing during cold exposure may cause additional heat production by vigorous isometric respiratory muscle contraction. The results must be interpreted with caution given the low subject number and the fact that both participants practised the g-Tummo like breathing technique.	[Vosselman, Maarten J.; Kingma, Boris R. M.; Lichtenbelt, Wouter D. van Marken] Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Brans, Boudewijn] Maastricht Univ, Med Ctr, Dept Nucl Med, Maastricht, Netherlands; [Vijgen, Guy H. E. J.] Erasmus MC, Dept Surg GV, Rotterdam, Netherlands	Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Lichtenbelt, WDV (corresponding author), Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands.	markenlichtenbelt@maastrichtuniversity.nl	Kingma, Boris/AAK-4492-2020	Kingma, Boris/0000-0001-5961-0215; Vijgen, Guy/0000-0002-6011-753X	Netherlands Organization for Scientific Research [TOP 91209037]; EU [HEALTH-F2-2011-278373]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This work is partly financed by the Netherlands Organization for Scientific Research (TOP 91209037 to W.D.vM.L.), and by the EU FP7 project DIABAT (HEALTH-F2-2011-278373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens E, 2006, THERMAL AND MOISTURE TRANSPORT IN FIBROUS MATERIALS, P560, DOI 10.1533/9781845692261.3.560; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BLIGH J, 1973, Journal of Applied Physiology, V35, P941; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; DAVIS TR, 1961, J APPL PHYSIOL, V16, P1011, DOI 10.1152/jappl.1961.16.6.1011; Esterbauer H, 1998, J LIPID RES, V39, P834; Kildeso J, 1999, SCAND J WORK ENV HEA, V25, P361, DOI 10.5271/sjweh.446; Kingma BRM, 2011, ACTA PHYSIOL, V203, P419, DOI 10.1111/j.1748-1716.2011.02336.x; Kox M, 2012, PSYCHOSOM MED, V74, P489, DOI 10.1097/PSY.0b013e3182583c6d; Kozhevnikov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058244; Lichtenbelt WDV, 2002, AM J PHYSIOL-ENDOC M, V282, pE1077, DOI 10.1152/ajpendo.00020.2001; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Nagai N, 2011, INT J OBESITY, V35, P1050, DOI 10.1038/ijo.2010.261; Peters R M, 1969, Ann Thorac Surg, V7, P51; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Tiwari AK, 2009, J DIABETES COMPLICAT, V23, P102, DOI 10.1016/j.jdiacomp.2007.10.003; Valve R, 1998, DIABETOLOGIA, V41, P357, DOI 10.1007/s001250050915; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; van Ooijen AMJ, 2005, BRIT J NUTR, V93, P387, DOI 10.1079/BJN20041362; van Rooijen BD, 2013, INVEST RADIOL, V48, P708, DOI 10.1097/RLI.0b013e31829363b8; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Wijers SLJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001777; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125	29	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101653	10.1371/journal.pone.0101653	http://dx.doi.org/10.1371/journal.pone.0101653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014028	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400029
J	Mizukami, T; Momose, H; Kuramitsu, M; Takizawa, K; Araki, K; Furuhata, K; Ishii, KJ; Hamaguchi, I; Yamaguchi, K				Mizukami, Takuo; Momose, Haruka; Kuramitsu, Madoka; Takizawa, Kazuya; Araki, Kumiko; Furuhata, Keiko; Ishii, Ken J.; Hamaguchi, Isao; Yamaguchi, Kazunari			System Vaccinology for the Evaluation of Influenza Vaccine Safety by Multiplex Gene Detection of Novel Biomarkers in a Preclinical Study and Batch Release Test	PLOS ONE			English	Article							IMMUNE-RESPONSE; TOXICITY; PATTERNS; VIRUS	Vaccines are beneficial and universal tools to prevent infectious disease. Thus, safety of vaccines is strictly evaluated in the preclinical phase of trials and every vaccine batch must be tested by the National Control Laboratories according to the guidelines published by each country. Despite many vaccine production platforms and methods, animal testing for safety evaluation is unchanged thus far. We recently developed a systems biological approach to vaccine safety evaluation where identification of specific biomarkers in a rat pre-clinical study evaluated the safety of vaccines for pandemic H5N1 influenza including Irf7, Lgals9, Lgalsbp3, Cxcl11, Timp1, Tap2, Psmb9, Psme1, Tapbp, C2, Csf1, Mx2, Zbp1, Ifrd1, Trafd1, Cxcl9, beta 2m, Npc1, Ngfr and Ifi47. The current study evaluated whether these 20 biomarkers could evaluate the safety, batch-to-batch and manufacturer-to-manufacturer consistency of seasonal trivalent influenza vaccine using a multiplex gene detection system. When we evaluated the influenza HA vaccine (HAv) from four different manufactures, the biomarker analysis correlated to findings from conventional animal use tests, such as abnormal toxicity test. In addition, sensitivity of toxicity detection and differences in HAvs were higher and more accurate than with conventional methods. Despite a slight decrease in body weight caused by HAv from manufacturer B that was not statistically significant, our results suggest that HAv from manufacturer B is significantly different than the other HAvs tested with regard to Lgals3bp, Tapbp, Lgals9, Irf7 and C2 gene expression in rat lungs. Using the biomarkers confirmed in this study, we predicted batch-to-batch consistency and safety of influenza vaccines within 2 days compared with the conventional safety test, which takes longer. These biomarkers will facilitate the future development of new influenza vaccines and provide an opportunity to develop in vitro methods of evaluating batch-to-batch consistency and vaccine safety as an alternative to animal testing.	[Mizukami, Takuo; Momose, Haruka; Kuramitsu, Madoka; Takizawa, Kazuya; Araki, Kumiko; Furuhata, Keiko; Hamaguchi, Isao; Yamaguchi, Kazunari] Natl Inst Infect Dis, Dept Safety Res Blood & Biol, Lab Blood & Vaccine safety, Tokyo, Japan; [Ishii, Ken J.] Natl Inst Biomed Innovat NIBIO, Lab Adjuvant Innovat, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, WPI Immunol Frontier Res Ctr WPI IFREC, Lab Vaccine Sci, Osaka, Japan	National Institute of Infectious Diseases (NIID); Osaka University	Hamaguchi, I (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol, Lab Blood & Vaccine safety, Tokyo, Japan.	130hama@nih.go.jp	Ishii, Ken J/B-1685-2012; Mizukami, Takuo/F-9248-2016	Ishii, Ken J/0000-0002-6728-3872; Mizukami, Takuo/0000-0001-6105-6049	Ministry of Health, Labor, and Welfare of Japan [201132001, 201208036]; Grants-in-Aid for Scientific Research [25860798] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from Ministry of Health, Labor, and Welfare of Japan (201132001 and 201208036, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Ato M, 2013, VACCINE, V31, P2184, DOI 10.1016/j.vaccine.2013.02.016; Baylor NW., 2012, VACCINES EXPERT CONS, V6th, P1427; Brennan FR, 2005, VACCINE, V23, P3210, DOI 10.1016/j.vaccine.2004.11.072; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Couch Robert B., 1997, Journal of Infectious Diseases, V176, pS38, DOI 10.1086/514173; Even-Or O, 2013, EXPERT REV VACCINES, V12, P1095, DOI 10.1586/14760584.2013.825445; Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299; Hamaguchi I, 2008, VACCINE, V26, P4686, DOI 10.1016/j.vaccine.2008.06.086; Hamaguchi I, 2007, VACCINE, V25, P3355, DOI 10.1016/j.vaccine.2006.12.059; KUROKAWA M, 1961, JPN J MED SCI BIOL, V14, P249, DOI 10.7883/yoken1952.14.249; Mizukami T, 2008, VACCINE, V26, P2270, DOI 10.1016/j.vaccine.2008.02.031; Mizukami T, 2009, BIOLOGICALS, V37, P8, DOI 10.1016/j.biologicals.2008.07.007; Momose H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/361841; Momose H, 2010, JPN J INFECT DIS, V63, P25; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Offit PA, 2012, VACCINES, P1464; Plotkin SL, 2012, VACCINES, P1; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Verdier F, 2001, VACCINE, V20, pS21, DOI 10.1016/S0264-410X(01)00308-5; Wang IM, 2012, MICROB BIOTECHNOL, V5, P177, DOI 10.1111/j.1751-7915.2011.00317.x; WHO, 2020, PAND INFL RISK MAN W; Wolf JJ, 2010, METHODS MOL BIOL, V626, P29, DOI 10.1007/978-1-60761-585-9_3; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Wood JM., 1998, TXB INFLUENZA, P317; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	28	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101835	10.1371/journal.pone.0101835	http://dx.doi.org/10.1371/journal.pone.0101835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010690	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800044
J	Rohrl, C; Eigner, K; Fruhwurth, S; Stangl, H				Roehrl, Clemens; Eigner, Karin; Fruhwuerth, Stefanie; Stangl, Herbert			Bile Acids Reduce Endocytosis of High-Density Lipoprotein (HDL) in HepG2 Cells	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; SELECTIVE LIPID UPTAKE; SR-BI; SCAVENGER RECEPTOR; NUCLEAR RECEPTOR; PARTICLE UPTAKE; SECRETION; IDENTIFICATION; EXPRESSION	High-density lipoprotein (HDL) transports lipids to hepatic cells and the majority of HDL-associated cholesterol is destined for biliary excretion. Cholesterol is excreted into the bile directly or after conversion to bile acids, which are also present in the plasma as they are effectively reabsorbed through the enterohepatic cycle. Here, we provide evidence that bile acids affect HDL endocytosis. Using fluorescent and radiolabeled HDL, we show that HDL endocytosis was reduced in the presence of high concentrations of taurocholate, a natural non-cell-permeable bile acid, in human hepatic HepG2 and HuH7 cells. In contrast, selective cholesteryl-ester (CE) uptake was increased. Taurocholate exerted these effects extracellularly and independently of HDL modification, cell membrane perturbation or blocking of endocytic trafficking. Instead, this reduction of endocytosis and increase in selective uptake was dependent on SR-BI. In addition, cell-permeable bile acids reduced HDL endocytosis by farnesoid X receptor (FXR) activation: chenodeoxycholate and the non-steroidal FXR agonist GW4064 reduced HDL endocytosis, whereas selective CE uptake was unaltered. Reduced HDL endocytosis by FXR activation was independent of SR-BI and was likely mediated by impaired expression of the scavenger receptor cluster of differentiation 36 (CD36). Taken together we have shown that bile acids reduce HDL endocytosis by transcriptional and non-transcriptional mechanisms. Further, we suggest that HDL endocytosis and selective lipid uptake are not necessarily tightly linked to each other.	[Roehrl, Clemens; Eigner, Karin; Fruhwuerth, Stefanie; Stangl, Herbert] Med Univ Vienna, Dept Med Chem, Ctr Pathobiochem & Genet, Vienna, Austria	Medical University of Vienna	Stangl, H (corresponding author), Med Univ Vienna, Dept Med Chem, Ctr Pathobiochem & Genet, Vienna, Austria.	herbert.stangl@meduniwien.ac.at	Stangl, Herbert/AAT-4379-2021; Stangl, Herbert/R-9441-2019	Stangl, Herbert/0000-0002-7288-7320; Rohrl, Clemens/0000-0002-1192-0748	Austrian Science Fund (FWF) [P25763-B13, P22838-B13]; DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Institute of Medical Chemistry at the Medical University of Vienna; Austrian Science Fund (FWF) [P 22838] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Institute of Medical Chemistry at the Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are funded by the Austrian Science Fund (FWF) projects: P25763-B13 (to Clemens Rohrl) and P22838-B13 (to Herbert Stangl). Stefanie Fruhwurth is a recipient of a DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Institute of Medical Chemistry at the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ANGELIN B, 1982, J CLIN INVEST, V70, P724, DOI 10.1172/JCI110668; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Camarota LM, 2004, J BIOL CHEM, V279, P27599, DOI 10.1074/jbc.M402946200; Chao F, 2010, ATHEROSCLEROSIS, V213, P443, DOI 10.1016/j.atherosclerosis.2010.09.016; Claudel T, 2002, J CLIN INVEST, V109, P961; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; GLOMSET JA, 1968, J LIPID RES, V9, P155; Goffinet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095807; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hambruch E, 2012, J PHARMACOL EXP THER, V343, P556, DOI 10.1124/jpet.112.196519; Harder CJ, 2006, J LIPID RES, V47, P492, DOI 10.1194/jlr.M500444-JLR200; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Kovacs WJ, 2009, J BIOL CHEM, V284, P7232, DOI 10.1074/jbc.M809064200; Krieger M, 1986, Methods Enzymol, V129, P227; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036; Li F, 1996, BIOCHEMISTRY-US, V35, P6657, DOI 10.1021/bi952313q; Li GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035895; LIANG D, 1993, HEPATOLOGY, V18, P1162; Liu B, 2002, J BIOL CHEM, V277, P34125, DOI 10.1074/jbc.M204265200; Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Malerod L, 2005, BIOCHEM BIOPH RES CO, V336, P1096, DOI 10.1016/j.bbrc.2005.08.237; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Meyer JM, 2013, CURR OPIN LIPIDOL, V24, P386, DOI 10.1097/MOL.0b013e3283638042; Nieland TJF, 2005, BBA-MOL CELL BIOL L, V1734, P44, DOI 10.1016/j.bbalip.2005.02.007; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; PLESNER L, 1995, INT REV CYTOL, V158, P141; Rohrl C, 2013, BBA-MOL CELL BIOL L, V1831, P1626, DOI [10.1016/j.bbalip.2013.07.014, 10.1016/j.bbalip2013.07.014]; Rohrl C, 2012, CURR PHARM BIOTECHNO, V13, P331, DOI 10.2174/138920112799095338; Rohrl C, 2010, HISTOCHEM CELL BIOL, V133, P261, DOI 10.1007/s00418-009-0672-3; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SCHWARTZ CC, 1978, SCIENCE, V200, P62, DOI 10.1126/science.204996; Serhan N, 2013, BBA-MOL CELL BIOL L, V1831, P719, DOI 10.1016/j.bbalip.2012.12.006; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Sirvent A, 2004, J LIPID RES, V45, P2110, DOI 10.1194/jlr.M400221-JLR200; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3086, DOI 10.1073/pnas.83.10.3086; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899	43	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102026	10.1371/journal.pone.0102026	http://dx.doi.org/10.1371/journal.pone.0102026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010412	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800062
J	Spencer, M; Yang, L; Adu, A; Finlin, BS; Zhu, BB; Shipp, LR; Rasouli, N; Peterson, CA; Kern, PA				Spencer, Michael; Yang, Lin; Adu, Akosua; Finlin, Brian S.; Zhu, Beibei; Shipp, Lindsey R.; Rasouli, Neda; Peterson, Charlotte A.; Kern, Philip A.			Pioglitazone Treatment Reduces Adipose Tissue Inflammation through Reduction of Mast Cell and Macrophage Number and by Improving Vascularity	PLOS ONE			English	Article							INSULIN SENSITIVITY; SKELETAL-MUSCLE; FATTY-ACIDS; OBESITY; ADIPONECTIN; ACTIVATION; METFORMIN; THIAZOLIDINEDIONES; EXPRESSION; SECRETION	Context and Objective: Adipose tissue in insulin resistant subjects contains inflammatory cells and extracellular matrix components. This study examined adipose pathology of insulin resistant subjects who were treated with pioglitazone or fish oil. Design, Setting and Participants: Adipose biopsies were examined from nine insulin resistant subjects before/after treatment with pioglitazone 45 mg/day for 12 weeks and also from 19 subjects who were treated with fish oil (1,860 mg EPA, 1,500 mg DHA daily). These studies were performed in a clinical research center setting. Results: Pioglitazone treatment increased the cross-sectional area of adipocytes by 18% (p = 0.01), and also increased capillary density without affecting larger vessels. Pioglitazone treatment decreased total adipose macrophage number by 26%, with a 56% decrease in M1 macrophages and an increase in M2 macrophages. Mast cells were more abundant in obese versus lean subjects, and were decreased from 24 to 13 cells/mm(2) (p = 0.02) in patients treated with pioglitazone, but not in subjects treated with FO. Although there were no changes in total collagen protein, pioglitazone increased the amount of elastin protein in adipose by 6-fold. Conclusion: The PPAR gamma agonist pioglitazone increased adipocyte size yet improved other features of adipose, increasing capillary number and reducing mast cells and inflammatory macrophages. The increase in elastin may better permit adipocyte expansion without triggering cell necrosis and an inflammatory reaction.	[Spencer, Michael; Adu, Akosua; Finlin, Brian S.; Zhu, Beibei; Shipp, Lindsey R.; Kern, Philip A.] Univ Kentucky, Dept Med, Div Endocrinol, Lexington, KY 40506 USA; [Spencer, Michael; Adu, Akosua; Finlin, Brian S.; Zhu, Beibei; Shipp, Lindsey R.; Kern, Philip A.] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Lexington, KY USA; [Yang, Lin] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA; [Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Lexington, KY USA; [Rasouli, Neda] Univ Colorado, Div Endocrinol, Denver, CO 80202 USA; [Rasouli, Neda] Eastern Colorado Vet Hlth Care Syst, Denver, CO USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Colorado System; University of Colorado Denver	Kern, PA (corresponding author), Univ Kentucky, Dept Med, Div Endocrinol, Lexington, KY 40506 USA.	philipkern@uky.edu	Adu, Akosua/AAY-3285-2021	Adu, Akosua/0000-0001-9615-970X; Rasouli, Neda/0000-0003-1269-3580	VA Merit grant; CTSA grant [UL1TR000117]; COBRE [P20RR021954];  [DK80327];  [DK71349]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080327, R01DK071349] Funding Source: NIH RePORTER	VA Merit grant; CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); COBRE; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: DK80327 (P. K.), DK71349 (C. P. and P. K.), A VA Merit grant (N.R.), CTSA grant UL1TR000117, and COBRE P20RR021954. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Bodles AM, 2006, J LIPID RES, V47, P2080, DOI 10.1194/jlr.M600235-JLR200; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Ciaraldi TP, 2002, DIABETES, V51, P30, DOI 10.2337/diabetes.51.1.30; Consoli A, 2005, LUPUS, V14, P794, DOI 10.1191/0961203305lu2223oa; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Di Cataldo S, 2010, COMPUT METH PROG BIO, V100, P1, DOI 10.1016/j.cmpb.2010.02.002; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Divoux A, 2012, J CLIN ENDOCR METAB, V97, pE1677, DOI 10.1210/jc.2012-1532; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610; Gupta AK, 2009, J DIABETES COMPLICAT; Itoh M, 2007, ARTERIOSCLER THROMB; Klimcakova E, 2011, DIABETOLOGIA, V54, P876, DOI 10.1007/s00125-010-2014-3; Koenen TB, 2009, J CLIN ENDOCR METAB, V94, P4453, DOI 10.1210/jc.2009-0517; Koppaka S, 2013, DIABETES, V62, P1843, DOI 10.2337/db12-0868; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee BC, 2013, BIOCH BIOPHYS ACTA; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; McLaughlin TM, 2010, OBESITY, V18, P926, DOI 10.1038/oby.2009.380; Miyazaki Y, 2002, DIABETES CARE, V25, P517, DOI 10.2337/diacare.25.3.517; Mula J, 2013, J APPL PHYSIOL, V114, P148, DOI 10.1152/japplphysiol.01022.2012; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Rasouli N, 2006, AM J PHYSIOL-ENDOC M, V290, pE42, DOI 10.1152/ajpendo.00240.2005; Rasouli N, 2005, AM J PHYSIOL-ENDOC M, V288, pE930, DOI 10.1152/ajpendo.00522.2004; Rasouli N, 2006, AM J PHYSL ENDOCRINO; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Rasouli N, 2007, AM J PHYSIOL-ENDOC M, V292, pE359, DOI 10.1152/ajpendo.00221.2006; Rasouli N, 2012, PHARMACOGENET GENOM, V22, P484, DOI 10.1097/FPC.0b013e328352a72e; Shadid S, 2003, DIABETES CARE, V26, P3148, DOI 10.2337/diacare.26.11.3148; Smith SR, 2006, ADIPOCYTES, V2, P11; Smolle J, 1996, ANAL QUANT CYTOL, V18, P323; Spencer M, 2013, DIABETES, V62, P1709, DOI 10.2337/db12-1042; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Teranishi T, 2007, METABOLISM, V56, P1418, DOI 10.1016/j.metabol.2007.06.005; Tonelli J, 2004, DIABETES, V53, P1621, DOI 10.2337/diabetes.53.6.1621; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Unal R, 2010, J CLIN ENDOCRINOL ME; Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P14, DOI 10.1016/j.bbadis.2010.12.012	51	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102190	10.1371/journal.pone.0102190	http://dx.doi.org/10.1371/journal.pone.0102190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010722	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800078
J	Wang, SM; Chen, IC; Liao, YT; Liu, CC				Wang, Shih-Min; Chen, I-Chun; Liao, Yu-Ting; Liu, Ching-Chuan			The Clinical Correlation of Regulatory T Cells and Cyclic Adenosine Monophosphate in Enterovirus 71 Infection	PLOS ONE			English	Article							SELECTIVE PHOSPHODIESTERASE INHIBITORS; 71-INDUCED PULMONARY-EDEMA; BRAIN-STEM ENCEPHALITIS; CARDIOPULMONARY BYPASS; CYTOKINE PRODUCTION; UP-REGULATION; MILRINONE; LYMPHOCYTES; CHILDREN; KEY	Background: Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection. Objective: This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment. Study Design: Patients < 18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined. Results: Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4(+)CD25(+)Foxp3(+) and CD4(+)Foxp3(+) T cells compared with patients with HFMD or BE. The expression frequency of CD4(-)CD8(-) was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4(+)Foxp3(+) increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment. Conclusions: These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.	[Wang, Shih-Min] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Emergency Med, Tainan, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Pediat, Tainan, Taiwan; [Wang, Shih-Min; Liao, Yu-Ting; Liu, Ching-Chuan] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chen, I-Chun] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Wang, SM (corresponding author), Natl Cheng Kung Univ & Hosp, Coll Med, Dept Emergency Med, Tainan, Taiwan.	pedwang@mail.ncku.edu.tw; liucc@mail.ncku.edu.tw			National Science Council, Taiwan [NSC 98-2314-B-006-002-MY3, NSC 101-2314-B-006-014-MY3]; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	This study was supported by grants from the National Science Council, Taiwan (NSC 98-2314-B-006-002-MY3, NSC 101-2314-B-006-014-MY3); and the Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Carulli G, 2004, ACTA HAEMATOL-BASEL, V111, P163, DOI 10.1159/000076526; Chi CY, 2013, CRIT CARE MED, V41, P1754, DOI 10.1097/CCM.0b013e31828a2a85; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Dekkers BGJ, 2013, PHARMACOL THERAPEUT, V137, P248, DOI 10.1016/j.pharmthera.2012.10.006; Fu Dan, 2009, Zhonghua Er Ke Za Zhi, V47, P829; Glavas NA, 2001, P NATL ACAD SCI USA, V98, P6319, DOI 10.1073/pnas.101131098; Hayashida N, 1999, ANN THORAC SURG, V68, P1661, DOI 10.1016/S0003-4975(99)00716-X; Hentschel T, 2007, ANESTHESIOLOGY, V106, P124, DOI 10.1097/00000542-200701000-00021; HOWELL RE, 1995, J PHARMACOL EXP THER, V275, P703; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; La Cava A, 2008, AUTOIMMUN REV, V8, P83, DOI 10.1016/j.autrev.2008.08.002; Lamarche Y, 2005, J THORAC CARDIOV SUR, V130, P83, DOI 10.1016/j.jtcvs.2004.09.011; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mathiot ND, 2001, AIDS RES HUM RETROV, V17, P977, DOI 10.1089/088922201750290096; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SCHMIDT J, 1995, IMMUNOPHARMACOLOGY, V30, P191, DOI 10.1016/0162-3109(95)00022-L; Shipley JB, 1996, AM J MED SCI, V311, P286, DOI 10.1097/00000441-199606000-00011; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; STROBER S, 1989, J IMMUNOL, V143, P1118; Szczypka M, 2010, PHARMACOL REP, V62, P1148, DOI 10.1016/S1734-1140(10)70377-7; Vendetti S, 2002, J IMMUNOL, V169, P6231, DOI 10.4049/jimmunol.169.11.6231; Vendetti S, 2006, J LEUKOCYTE BIOL, V80, P880, DOI 10.1189/jlb.0106072; Wang SM, 2012, EUR J CLIN MICROBIOL, V31, P1219, DOI 10.1007/s10096-011-1432-6; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2014, EXPERT REV ANTI-INFE, V12, P447, DOI 10.1586/14787210.2014.895666; Wang SM, 2005, PEDIATR PULM, V39, P219, DOI 10.1002/ppul.20157; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Yang KD, 2001, J INFECT DIS, V183, P850, DOI 10.1086/319255; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102025	10.1371/journal.pone.0102025	http://dx.doi.org/10.1371/journal.pone.0102025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010330	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800061
J	Arilla, M; Rosell, J; Blasco, R; Dominguez-Rodrigo, M; Pickering, TR				Arilla, Maite; Rosell, Jordi; Blasco, Ruth; Dominguez-Rodrigo, Manuel; Pickering, Travis Rayne			The "Bear" Essentials: Actualistic Research on Ursus arctos arctos in the Spanish Pyrenees and Its Implications for Paleontology and Archaeology	PLOS ONE			English	Article							MULTIPLE CARNIVORE TAXA; PESTERA CU OASE; SPOTTED HYENA; NATIONAL-PARK; CAVE BEARS; FLK ZINJ; MULTIVARIATE APPROACH; TAPHONOMIC ANALYSIS; BONE ACCUMULATIONS; MARK FREQUENCIES	Neotaphonomic studies of large carnivores are used to create models in order to explain the formation of terrestrial vertebrate fossil faunas. The research reported here adds to the growing body of knowledge on the taphonomic consequences of large carnivore behavior in temperate habitats and has important implications for paleontology and archaeology. Using photo-and videotrap data, we were able to describe the consumption of 17 ungulate carcasses by wild brown bears (Ursus arctos arctos) ranging the Spanish Pyrenees. Further, we analyzed the taphonomic impact of these feeding bouts on the bones recovered from those carcasses. The general sequence of consumption that we charted starts with separation of a carcass's trunk; viscera are generally eaten first, followed by musculature of the humerus and femur. Long limb bones are not broken open for marrow extraction. Bears did not transport carcasses or carcass parts from points of feeding and did not disperse bones appreciably (if at all) from their anatomical positions. The general pattern of damage that resulted from bear feeding includes fracturing, peeling, crenulation, tooth pitting and scoring of axial and girdle elements and furrowing of the upper long limb bones. As predicted from observational data, the taphonomic consequences of bear feeding resemble those of other non-durophagus carnivores, such as felids, and are distinct from those of durophagus carnivores, such as hyenids. Our results have paleontological and archaeological relevance. Specifically, they may prove useful in building analogical models for interpreting the formation of fossil faunas for which bears are suspected bone accumulators and/or modifiers. More generally, our comparative statistical analyses draw precise quantitative distinctions between bone damage patterns imparted respectively by durophagus (modelled here primarily by spotted hyenas [Crocuta crocuta] and wolves [Canis lupus]) and non-durophagus (modelled here by brown bears and lions [Panthera leo]) carnivorans.	[Arilla, Maite; Rosell, Jordi] Univ Rovira & Virgili, Area Prehist, E-43007 Tarragona, Spain; [Arilla, Maite; Rosell, Jordi] Inst Catala Palaeoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Blasco, Ruth] Gibraltar Museum, Gibraltar, Gibraltar, England; [Dominguez-Rodrigo, Manuel] Museo Origenes, IDEA Inst Evoluc Africa, Madrid, Spain; [Dominguez-Rodrigo, Manuel] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Pickering, Travis Rayne] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Pickering, Travis Rayne] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Pickering, Travis Rayne] Transvaal Museum, Plio Pleistocene Palaeontol Sect, Dept Vertebrates, Ditsong Natl Museum Nat Hist, ZA-0001 Pretoria, South Africa	Universitat Rovira i Virgili; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Complutense University of Madrid; University of Wisconsin System; University of Wisconsin Madison; University of Witwatersrand	Blasco, R (corresponding author), Gibraltar Museum, Gibraltar, Gibraltar, England.	rblascolopez@gmail.com	Blasco, Ruth/AAG-8200-2019; Rosell, Jordi/G-8705-2015	Blasco, Ruth/0000-0001-9804-739X; Rosell, Jordi/0000-0002-6758-6291; Arilla, Maite/0000-0001-5994-678X	Ministerio de Ciencia e Innovacion [CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717, HAR2010-18952-C02-01]; Generalitat de Catalunya; EU	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); EU(European Commission)	This research was supported with funding from the Ministerio de Ciencia e Innovacion, project nos. CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717, HAR2010-18952-C02-01. Ruth Blasco is a Beatriu de Pinos-A post-doctoral research fellowship from Generalitat de Catalunya and COFUND Marie Curie Actions, EU-FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2012, ARCHAEOL ANTHROP SCI, V4, P209, DOI 10.1007/s12520-012-0093-4; [Anonymous], 2004, ESPAC TIEMPO FORMA S, DOI DOI 10.5944/ETFI.16-17.2003.4751; Arroyo ABM, 2009, J ARCHAEOL SCI, V36, P284, DOI 10.1016/j.jas.2008.09.007; Bachler E, 1940, ALPINE PALAOLITHIKUM; Bachler E, 1923, JB ST GALLISCHEN NAT, V59, P79; Baquedano E, 2012, J ARCHAEOL SCI, V39, P1728, DOI 10.1016/j.jas.2012.01.010; Bergounioux F.M., 1958, HUNDERT JAHRE NEANDE, P151; Binford L.R., 1981, BONES ANCIENT MEN MO; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; BUNGE M, 1981, INT J GEN SYST, V7, P221, DOI 10.1080/03081078108934823; BUNN HT, 1988, J ANTHROPOL ARCHAEOL, V7, P412, DOI 10.1016/0278-4165(88)90004-9; Camaros E, 2013, J ARCHAEOL SCI, V40, P1361, DOI 10.1016/j.jas.2012.09.037; Christiansen P, 1999, ANN ZOOL FENN, V36, P93; Costamagno S, 2008, ANN PALEONTOL, V94, P245, DOI 10.1016/j.annpal.2008.09.003; Couturier MAJ, 1954, OURS BRUN URSUS ARCO; d'Errico F., 1998, EC PREHISTORIQUE COM, P85; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; de Ruiter DJ, 2000, J ARCHAEOL SCI, V27, P665, DOI 10.1006/jasc.1999.0470; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; Dienes I., 1968, STATION PALEOLITHIQU, P111; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dominguez-Rodrigo Manuel, 2012, Journal of Taphonomy, V10, P147; Dominguez-Rodrigo M, 2014, QUATERN INT, V322, P32, DOI 10.1016/j.quaint.2013.09.042; Dominguez-Rodrigo Manuel, 2010, Journal of Taphonomy, V8, P155; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Egeland Amy G., 2008, Journal of Taphonomy, V6, P275; Elgmork K, 1995, WILDLIFE BIOL, V1, P239, DOI 10.2981/wlb.1995.0029; Faith JT, 2007, J ARCHAEOL SCI, V34, P872, DOI 10.1016/j.jas.2006.08.007; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; Fosse P, 2000, OURS HOMME, V100, P1; Gargett R.H., 1996, CAVE BEARS MODERN HU; Gidna A, 2013, J ARCHAEOL SCI, V40, P1903, DOI 10.1016/j.jas.2012.11.023; Gidna AO, 2014, QUATERN INT, V322, P167, DOI 10.1016/j.quaint.2013.08.059; Grandal-d'Anglade A, 2010, CR PALEVOL, V9, P31, DOI 10.1016/j.crpv.2009.10.003; Grandal-dAnglade A., 2005, MITT KOMM QUARTARFOR, V14, P41; HAYNES G, 1982, ARCTIC, V35, P266; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hill A., 1989, BONE MODIFICATION, P169; Kerbis-Peterhans J C, 1990, ROLE PORCUPINES LEOP; KOBY F.-ED, 1949, REV SUISSE ZOOL, V56, P675; KRUUK H., 1967, MAMMALIA, V31, P1, DOI 10.1515/mamm.1967.31.1.1; Kuhn BF, 2009, J ARCHAEOL SCI, V36, P297, DOI 10.1016/j.jas.2008.09.008; Kurten B, 1976, CAVE BEAR STORY LIFE; la Grange A, 2009, J STAT SOFTW, V30, P1; Lansing SW, 2009, PALEOBIOLOGY, V35, P289, DOI 10.1666/08009.1; Maguire J.M., 1980, Palaeontologia Africana, V23, P75; Mazza P., 1995, ASPECTS DENT BIOL PA, P147; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Patou-Mathis M, 1988, ANTHROPOZOOLOGICA, P17; Pickering TR, 1997, J ARCHAEOL SCI, V24, P1115, DOI 10.1006/jasc.1996.0191; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; Pickering Travis Rayne, 2011, Journal of Taphonomy, V9, P117; Pinto AC, 2002, TAPHONOMY PALAEOCOLO; Pinto AC, 2005, TAFONOMIA PALEOECOLO; Pinto Ana C., 2004, Revue de Paleobiologie, V23, P845; Pinto Llona A.C., 2001, Cadernos Laboratorio Xeoloxico de Laxe, V26, P423; Pinto-Llona AC, 2013, PALAEOGEOGR PALAEOCL, V370, P41, DOI 10.1016/j.palaeo.2012.11.017; Pobiner BL, 2007, J HUM EVOL, V52, P614, DOI 10.1016/j.jhevol.2006.11.007; Prendergast Mary E., 2008, Journal of Taphonomy, V6, P301; Quiles J, 2006, CR PALEVOL, V5, P927, DOI 10.1016/j.crpv.2006.09.005; Rabal-Garces R, 2012, LETHAIA, V45, P96, DOI 10.1111/j.1502-3931.2011.00260.x; Richards MP, 2008, P NATL ACAD SCI USA, V105, P600, DOI 10.1073/pnas.0711063105; Robert I, 2002, J ARCHAEOL SCI, V29, P763, DOI 10.1006/jasc.2001.0778; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Sala N, 2013, J ARCHAEOL SCI, V40, P1389, DOI 10.1016/j.jas.2012.10.018; Saladie P, 2013, INT J OSTEOARCHAEOL, V23, P13, DOI 10.1002/oa.1237; Schaller G. B., 1972, SERENGETI LION; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Skinner J.D., 1980, Palaeontologia Africana, V23, P99; Skinner JD, 1998, J ARCHAEOL SCI, V25, P69, DOI 10.1006/jasc.1997.0200; Smith DL, 2010, PALAIOS, V25, P318, DOI 10.2110/palo.2009.p09-115r; Stiner M.C., 1998, EC PREHISTORIQUE COM, P73; Stiner MC, 1998, J HUM EVOL, V34, P303, DOI 10.1006/jhev.1997.0198; Stiner MC., 1996, GEOARCHAEOLOGY, V11, P279, DOI [10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:4<279::AID-GEA1>3.0.CO;2-Z]; SUTCLIFFE AJ, 1970, NATURE, V227, P1110, DOI 10.1038/2271110a0; Tappen M, 2000, AM J PHYS ANTHROPOL, V113, P217, DOI 10.1002/1096-8644(200010)113:2<217::AID-AJPA6>3.0.CO;2-G; Torres T., 1984, THESIS ESCUELA TECNI; Torres T, 2007, J HUM EVOL, V52, P1, DOI 10.1016/j.jhevol.2006.07.013; Weaver TD, 2011, J ARCHAEOL SCI, V38, P2420, DOI 10.1016/j.jas.2011.05.009; White T.D., 1992, PREHISTORIC CANNIBAL; Yravedra Jose, 2011, Journal of Taphonomy, V9, P37	87	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102457	10.1371/journal.pone.0102457	http://dx.doi.org/10.1371/journal.pone.0102457			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029167	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600074
J	Buckley, S; Usai, D; Jakob, T; Radini, A; Hardy, K				Buckley, Stephen; Usai, Donatella; Jakob, Tina; Radini, Anita; Hardy, Karen			Dental Calculus Reveals Unique Insights into Food Items, Cooking and Plant Processing in Prehistoric Central Sudan	PLOS ONE			English	Article							CYPERUS-ROTUNDUS; MASS-SPECTROMETRY; ISOTOPIC EVIDENCE; PYROLYSIS-GC/MS; ESSENTIAL OIL; TOOTH WEAR; ANTIOXIDANT; TUBERS; STARCH; HISTORY	Accessing information on plant consumption before the adoption of agriculture is challenging. However, there is growing evidence for use of locally available wild plants from an increasing number of pre-agrarian sites, suggesting broad ecological knowledge. The extraction of chemical compounds and microfossils from dental calculus removed from ancient teeth offers an entirely new perspective on dietary reconstruction, as it provides empirical results on material that is already in the mouth. Here we present a suite of results from the multi-period Central Sudanese site of Al Khiday. We demonstrate the ingestion in both pre-agricultural and agricultural periods of Cyperus rotundus tubers. This plant is a good source of carbohydrates and has many useful medicinal and aromatic qualities, though today it is considered to be the world's most costly weed. Its ability to inhibit Streptococcus mutans may have contributed to the unexpectedly low level of caries found in the agricultural population. Other evidence extracted from the dental calculus includes smoke inhalation, dry (roasting) and wet (heating in water) cooking, a second plant possibly from the Triticaceae tribe and plant fibres suggestive of raw material preparation through chewing.	[Buckley, Stephen; Radini, Anita] Univ York, BioArCh, York YO10 5DD, N Yorkshire, England; [Usai, Donatella] Ist Italiano Africa & Oriente, Rome, Italy; [Usai, Donatella] Ctr Studi Sudanese & Subsahariani, Treviso, Italy; [Jakob, Tina] Univ Durham, Dept Archaeol, Durham, England; [Radini, Anita] Univ Leicester, Sch Archaeol & Ancient Hist, ULAS, Leicester, Leics, England; [Hardy, Karen] Univ Autonoma Barcelona, Dept Prehist, ICREA Catalan Inst Res & Adv Studies, Bellaterra, Spain	University of York - UK; Durham University; University of Leicester; Autonomous University of Barcelona; ICREA	Hardy, K (corresponding author), Univ Autonoma Barcelona, Dept Prehist, ICREA Catalan Inst Res & Adv Studies, Bellaterra, Spain.	khardy@icrea.cat	Hardy, Karen/R-6909-2018; Usai, Donatella/AAY-4536-2020	Hardy, Karen/0000-0003-1127-2397; Usai, Donatella/0000-0001-9379-9015; Jakob, Tina/0000-0002-6584-1834	Istituto Italiano per l'Africa e l'Oriente, Centro Studi Sudanesi e Sub-Sahariani; Spanish Ministry of Science and Innovation [HAR2012-35376]; ICREA Funding Source: Custom	Istituto Italiano per l'Africa e l'Oriente, Centro Studi Sudanesi e Sub-Sahariani; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	Archaeological fieldwork was funded by The Italian Minister of Foreign Affairs, Istituto Italiano per l'Africa e l'Oriente, Centro Studi Sudanesi e Sub-Sahariani. The equipment used belongs to Pharos Research (UK) and Spanish Ministry of Science and Innovation research project (grant number HAR2012-35376). The research described in this submission was unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; ANERUD A, 1991, J CLIN PERIODONTOL, V18, P160; Bamgbose AM, 2003, BIORESOURCE TECHNOL, V89, P245, DOI 10.1016/S0960-8524(03)00074-9; Bocherens H, 2009, VERTEBR PALEOBIOL PA, P241, DOI 10.1007/978-1-4020-9699-0_19; Bonfiglioli B, 2004, INT J OSTEOARCHAEOL, V14, P448, DOI 10.1002/oa.726; Collins MJ, 2011, P NATL ACAD SCI USA, V108, pE145, DOI 10.1073/pnas.1103241108; Crawford J, 2007, PROGR AFRICAN ARCHAE, P105; De Natale A, 2007, J ETHNOPHARMACOL, V109, P295, DOI 10.1016/j.jep.2006.07.038; Dudgeon JV, 2014, INT J OSTEOARCHAEOL, V24, P634, DOI 10.1002/oa.2249; Duke J.A., 1987, MED PLANTS CHINA; El Shafie AGAI, 2011, J AFR EARTH SCI, V60, P13, DOI 10.1016/j.jafrearsci.2011.01.004; Eshed V, 2006, AM J PHYS ANTHROPOL, V130, P145, DOI 10.1002/ajpa.20362; Fahmy AG, 2005, VEG HIST ARCHAEOBOT, V14, P287, DOI 10.1007/s00334-004-0058-3; Fahmy AG, 2003, FOOD FUEL FIELDS PRO, P95; Farah EA, 1999, J GEOSCIENCES, V2, P45; Greenwood PF, 2004, ORG GEOCHEM, V35, P331, DOI 10.1016/j.orggeochem.2003.10.013; Gribble GW, 1996, PURE APPL CHEM, V68, P1699, DOI 10.1351/pac199668091699; Hardy K, 2013, ANTIQUITY, V87, P873, DOI 10.1017/S0003598X00049528; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Hardy K, 2009, J ARCHAEOL SCI, V36, P248, DOI 10.1016/j.jas.2008.09.015; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hershkovitz I, 1997, J HUM EVOL, V33, P507, DOI 10.1006/jhev.1997.0149; Hillman GC., 1989, PREHISTORY WADI KUBB, P162; Hillson S, 2005, CAMBRIDGE MANUAL ARC; HINTON RJ, 1981, AM J PHYS ANTHROPOL, V54, P555, DOI 10.1002/ajpa.1330540409; Holm L. G., 1977, WORLDS WORST WEEDS D; Huffman Michael A., 2007, P677; Humphrey LT, 2014, P NATL ACAD SCI USA, V111, P954, DOI 10.1073/pnas.1318176111; Jakob T, 2010, 4 CATARACT IN PRESS; Judd M, 2012, BRIT ARCHAEOLOGICAL, V2; Kaal J, 2008, ORG GEOCHEM, V39, P1415, DOI 10.1016/j.orggeochem.2008.06.011; Kaal J, 2008, J ARCHAEOL SCI, V35, P2133, DOI 10.1016/j.jas.2008.01.013; Kaal J, 2008, QUATERNARY RES, V69, P56, DOI 10.1016/j.yqres.2007.10.005; Kaal J, 2009, J ANAL APPL PYROL, V85, P408, DOI 10.1016/j.jaap.2008.11.007; Kilani S, 2005, ENVIRON TOXICOL PHAR, V20, P478, DOI 10.1016/j.etap.2005.05.012; Kilani S, 2008, CHEM BIODIVERS, V5, P729, DOI 10.1002/cbdv.200890069; Kilani-Jaziri S, 2011, S AFR J BOT, V77, P767, DOI 10.1016/j.sajb.2011.03.015; Lago JHG, 2006, J BRAZIL CHEM SOC, V17, P1334, DOI 10.1590/S0103-50532006000700021; Lario J, 1997, QUATERNARY SCI REV, V16, P583, DOI 10.1016/S0277-3791(96)00053-4; Latz Peter, 1995, BUSHFIRES BUSHTUCKER; Lee-Thorp J, 2012, P NATL ACAD SCI USA, V109, P20369, DOI 10.1073/pnas.1204209109; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; LUKACS JR, 1988, AM J PHYS ANTHROPOL, V76, P377, DOI 10.1002/ajpa.1330760310; Manniche Lise, 1989, ANCIENT EGYPTIAN HER; Meena AK, 2010, INT J PHARM CLIN RES, V2, P20; Mekem Sonwa M, 2000, THESIS U HAMBURG; Mercuri AM, 2007, PROGR AFRICAN ARCHAE, P87; Molnar P, 2008, AM J PHYS ANTHROPOL, V136, P423, DOI 10.1002/ajpa.20824; Moore AMT, 2000, VILLAGE EUPHRATES FO, pxvii; Nagulendran K. R., 2007, E-J CHEM, V4, P440, DOI [10.1155/2007/903496, DOI 10.1155/2007/903496]; Najah AM, 2012, AL MUSTANSIRIYAH J P, V11, P85; National Research Council, 1996, LOST CROPS AFR; NEGBI M, 1992, ECON BOT, V46, P64, DOI 10.1007/BF02985255; Pal D. K., 2006, Indian Journal of Pharmaceutical Sciences, V68, P256; Puratchikody A., 2006, Indian Journal of Pharmaceutical Sciences, V68, P97; Raut NA, 2006, FITOTERAPIA, V77, P585, DOI 10.1016/j.fitote.2006.09.006; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Robyt J.F., 1968, STARCH ITS DERIVATIV, P431; RYAN AS, 1989, J HUM EVOL, V18, P235, DOI 10.1016/0047-2484(89)90051-1; SALAMA RB, 1987, J AFR EARTH SCI, V6, P899, DOI 10.1016/0899-5362(87)90049-2; Salvatori S, 2011, AFR ARCHAEOL REV, V28, P177, DOI 10.1007/s10437-011-9095-3; Schnorr S, 2013, AM J PHYS ANTHROPOL, V150, P244; Schoeninger MJ, 2001, J FOOD COMPOS ANAL, V14, P15, DOI 10.1006/jfca.2000.0961; SHAMSI SRA, 1986, INDIAN J EXP BIOL, V24, P449; SIMMONDS PG, 1970, APPL MICROBIOL, V20, P567, DOI 10.1128/AEM.20.4.567-572.1970; Sonwa MM, 2001, PHYTOCHEMISTRY, V58, P799, DOI 10.1016/S0031-9422(01)00301-6; STOLLER EW, 1987, WEED TECHNOL, V1, P66, DOI 10.1017/S0890037X0002916X; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; THEBTARANONTH C, 1995, PHYTOCHEMISTRY, V40, P125, DOI 10.1016/0031-9422(95)00260-E; Uddin SJ, 2006, FITOTERAPIA, V77, P134, DOI 10.1016/j.fitote.2004.11.011; Usai D, 2010, 4 CATARACT IN PRESS; VANLOON WMGM, 1991, J ANAL APPL PYROL, V20, P275, DOI 10.1016/0165-2370(91)80078-M; VINCENT AS, 1985, WORLD ARCHAEOL, V17, P131, DOI 10.1080/00438243.1985.9979958; Volpato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043949; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Wesolowski V, 2010, J ARCHAEOL SCI, V37, P1326, DOI 10.1016/j.jas.2009.12.037; WILLIAMS MA, 1973, GEOGR J, V139, P498, DOI 10.2307/1795032; Wrangham R, 2009, AM J PHYS ANTHROPOL, V140, P630, DOI 10.1002/ajpa.21122; Yang XY, 2012, J ARCHAEOL SCI, V39, P247, DOI 10.1016/j.jas.2011.09.001; Yazdanparast R, 2007, J MED FOOD, V10, P667, DOI 10.1089/jmf.2006.090; Yu HH, 2007, AM J CHINESE MED, V35, P497, DOI 10.1142/S0192415X07005016	81	66	68	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100808	10.1371/journal.pone.0100808	http://dx.doi.org/10.1371/journal.pone.0100808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028938	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000341306600008
J	Helajarvi, H; Rosenstrom, T; Pahkala, K; Kahonen, M; Lehtimaki, T; Heinonen, OJ; Oikonen, M; Tammelin, T; Viikari, JSA; Raitakari, OT				Helajarvi, Harri; Rosenstrom, Tom; Pahkala, Katja; Kahonen, Mika; Lehtimaki, Terho; Heinonen, Olli J.; Oikonen, Mervi; Tammelin, Tuija; Viikari, Jorma S. A.; Raitakari, Olli T.			Exploring Causality between TV Viewing and Weight Change in Young and Middle-Aged Adults. The Cardiovascular Risk in Young Finns Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ALL-CAUSE MORTALITY; BODY-MASS INDEX; SEDENTARY BEHAVIORS; DISEASE RISK; PHYSICAL-ACTIVITY; SITTING TIME; OBESITY; ASSOCIATION; MARKERS	Background: Television viewing time (TV time) is associated with increased weight and obesity, but it is unclear whether this relation is causal. Methods and Results: We evaluated changes in TV time, waist circumference (waist) and body mass index (BMI) in participants of the population-based Cardiovascular Risk in Young Finns study (761 women, 626 men aged 33-50 years in 2011). Waist and BMI were measured, and TV time was self-reported in 2001, 2007, and 2011. Changes in waist and BMI between 2001 and 2011 were studied a) for the whole group, b) in groups with constantly low (<= 1 h/d), moderate (1-3 h/d), or high (>= 3 h/d) TV time, and c) in groups with >= 1 hour in-/decrease in daily TV time between 2001 and 2011. BMIs in 1986 were also evaluated. We explored the causal relationship of TV time with waist and BMI by classical temporality criterion and recently introduced causal-discovery algorithms (pairwise causality measures). Both methods supported the hypothesis that TV time is causative to weight gain, and no evidence was found for reverse or bidirectional causality. Constantly low TV time was associated with less pronounced increase in waist and BMI, and waist and BMI increase was lower with decreased TV time (P<0.05). The increase in waist and BMI was at least 2-fold in the high TV time group compared to the low TV time group (P<0.05). Adjustment for age, sex, BMI/waist in 2001, physical activity, energy intake, or smoking did not change the results. Conclusions: In young and middle-aged adults, constantly high TV time is temporally antecedent to BMI and waist increase.	[Helajarvi, Harri; Pahkala, Katja; Heinonen, Olli J.] Univ Turku, Dept Physiol, Paavo Nurmi Ctr, Turku, Finland; [Helajarvi, Harri; Pahkala, Katja; Heinonen, Olli J.] Univ Turku, Dept Hlth & Phys Act, Paavo Nurmi Ctr, Turku, Finland; [Rosenstrom, Tom] Univ Helsinki, Unit Personal Work & Hlth Psychol, Helsinki, Finland; [Pahkala, Katja; Oikonen, Mervi; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Fimlab Labs, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tammelin, Tuija] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Viikari, Jorma S. A.] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Helsinki; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku	Helajarvi, H (corresponding author), Univ Turku, Dept Physiol, Paavo Nurmi Ctr, Turku, Finland.	harri.helajarvi@utu.fi	Pahkala, Katja/D-7449-2013; Pahkala, Katja/GPX-7471-2022; Raitakari, Olli/AAQ-7389-2021; Lehtimäki, Terho/AAD-1094-2022; Heinonen, Olli/AAG-7298-2019	Pahkala, Katja/0000-0001-9338-4397; Lehtimäki, Terho/0000-0002-2555-4427; Heinonen, Olli/0000-0002-1722-1729; Kahonen, Mika/0000-0002-4510-7341; Rosenstrom, Tom/0000-0001-8277-3776	Academy of Finland [126925, 121584, 124282, 129378, 117797, 41071]; Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation	The Young Finns Study has been financially supported by the Academy of Finland: grants 126925, 121584, 124282, 129378, 117797, and 41071; the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation, Sigrid Juselius Foundation, Tampere Tuberculosis Foundation and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Dunstan DW, 2011, CURR OPIN CARDIOL, V26, P412, DOI 10.1097/HCO.0b013e3283496605; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Finnpanel website, RES TV AUD MEAS VIEW; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hansen ALS, 2012, DIABETIC MED, V29, P918, DOI 10.1111/j.1464-5491.2012.03656.x; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Heinonen I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002901; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoyer PO, 2008, INT J APPROX REASON, V49, P362, DOI 10.1016/j.ijar.2008.02.006; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Latouche C, 2013, J APPL PHYSIOL, V114, P453, DOI 10.1152/japplphysiol.00978.2012; Luckner H, 2011, EUR J PUBLIC HEALTH, V4, P491; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Otten JJ, 2009, ARCH INTERN MED, V169, P2109, DOI 10.1001/archinternmed.2009.430; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; R Core Team, 2012, R LANG ENV STAT COMP; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rosenstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050841; Saunders TJ, 2013, METABOLISM, V62, P1423, DOI 10.1016/j.metabol.2013.05.010; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shimizu S, 2011, J MACH LEARN RES, V12, P1225; Stamatakis E, 2012, DIABETOLOGIA, V55, P311, DOI 10.1007/s00125-011-2358-3; Stamatakis E, 2009, BRIT J NUTR, V101, P765, DOI 10.1017/S0007114508035939; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Wahi G, 2011, ARCH PEDIAT ADOL MED, V165, P979, DOI 10.1001/archpediatrics.2011.122; Wijndaele K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020058; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	41	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101860	10.1371/journal.pone.0101860	http://dx.doi.org/10.1371/journal.pone.0101860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028965	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600025
J	Pinskaya, M; Ghavi-Helm, Y; Mariotte-Labarre, S; Morillon, A; Soutourina, J; Werner, M				Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Morillon, Antonin; Soutourina, Julie; Werner, Michel			PHD and TFIIS- Like Domains of the Bye1 Transcription Factor Determine Its Multivalent Genomic Distribution	PLOS ONE			English	Article							ESS1 PROLYL ISOMERASE; ELONGATION-FACTOR TFIIS; EXPRESSION; INITIATION; BINDING; METHYLATION; TERMINATION; INDUCTION; COMPLEXES; COMPONENT	The BYpass of Ess1 (Bye1) protein is a putative S. cerevisiae transcription factor homologous to the human cancer-associated PHF3/DIDO family of proteins. Bye1 contains a Plant Homeodomain (PHD) and a TFIIS-like domain. The Bye1 PHD finger interacts with tri-methylated lysine 4 of histone H3 (H3K4me3) while the TFIIS-like domain binds to RNA polymerase (Pol) II. Here, we investigated the contribution of these structural features to Bye1 recruitment to chromatin as well as its function in transcriptional regulation. Genome-wide analysis of Bye1 distribution revealed at least two distinct modes of association with actively transcribed genes: within the core of Pol II- and Pol III-transcribed genes concomitant with the presence of the TFIIS transcription factor and, additionally, with promoters of a subset of Pol II-transcribed genes. Specific loss of H3K4me3 abolishes Bye1 association to gene promoters, but doesn't affect its binding within gene bodies. Genetic interactions suggested an essential role of Bye1 in cell fitness under stress conditions compensating the absence of TFIIS. Furthermore, BYE1 deletion resulted in the attenuation of GAL genes expression upon galactose-mediated induction indicating its positive role in transcription regulation. Together, these findings point to a bimodal role of Bye1 in regulation of Pol II transcription. It is recruited via its PHD domain to H3K4 tri-methylated promoters at early steps of transcription. Once Pol II is engaged into elongation, Bye1 binds directly to the transcriptional machinery, modulating its progression along the gene.	[Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Soutourina, Julie; Werner, Michel] iBiTec S CEA, FRE3377, Gif Sur Yvette, France; [Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Soutourina, Julie; Werner, Michel] CNRS, FRE3377, Gif Sur Yvette, France; [Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Soutourina, Julie; Werner, Michel] Univ Paris 11, FRE3377, Gif Sur Yvette, France; [Pinskaya, Marina; Morillon, Antonin] Univ Paris 06, ncRNA, Inst Curie, Ctr Rech,CNRS,UMR3244, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Pinskaya, M (corresponding author), iBiTec S CEA, FRE3377, Gif Sur Yvette, France.	marina.pinskaya@curie.fr; michel.werner@cea.fr	Soutourina, Julie/F-8305-2014; Morillon, Antonin/M-4751-2017; Werner, Michel/B-7316-2009	Soutourina, Julie/0000-0001-5218-2350; Morillon, Antonin/0000-0002-0575-5264; Ghavi-Helm, Yad/0000-0003-2397-9576; Pinskaya, Marina/0000-0003-1992-0264; Werner, Michel/0000-0002-2965-5858	"Contrat de Formation par la Recherche" from the CEA; "Plasticity and Integrity of genome" from the CEA; ERC "EpincRNA" starting grant	"Contrat de Formation par la Recherche" from the CEA; "Plasticity and Integrity of genome" from the CEA; ERC "EpincRNA" starting grant	YG and MP were supported by a "Contrat de Formation par la Recherche" and "Plasticity and Integrity of genome, respectively, from the CEA. MP and AM benefited a financial support from ERC "EpincRNA" starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Fischer U, 2001, CYTOGENET CELL GENET, V94, P131, DOI 10.1159/000048804; Futterer A, 2005, J CLIN INVEST, V115, P2351, DOI 10.1172/JCI24177; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gatchalian J, 2013, CELL REP, V4, P148, DOI 10.1016/j.celrep.2013.06.014; Ghavi-Helm Y, 2008, GENE DEV, V22, P1934, DOI 10.1101/gad.471908; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kinkelin K, 2013, P NATL ACAD SCI USA, V110, P15277, DOI 10.1073/pnas.1311010110; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042965; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Trachana V, 2007, P NATL ACAD SCI USA, V104, P2691, DOI 10.1073/pnas.0611132104; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WERNER M, 1993, J BIOL CHEM, V268, P20721; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Wu XY, 2003, GENETICS, V165, P1687	35	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102464	10.1371/journal.pone.0102464	http://dx.doi.org/10.1371/journal.pone.0102464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029256	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600075
J	Villacis, RAR; Silveira, SM; Barros, MC; Marchi, FA; Domingues, MAC; Scapulatempo-Neto, C; Aguiar, S; Lopes, A; Cunha, IW; Rogatto, SR				Villacis, Rolando A. R.; Silveira, Sara M.; Barros-Filho, Mateus C.; Marchi, Fabio A.; Domingues, Maria A. C.; Scapulatempo-Neto, Cristovam; Aguiar, Samuel, Jr.; Lopes, Ademar; Cunha, Isabela W.; Rogatto, Silvia R.			Gene Expression Profiling in Leiomyosarcomas and Undifferentiated Pleomorphic Sarcomas: SRC as a New Diagnostic Marker	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; CANCER; CLASSIFICATION; PREDICTION; PATTERNS; TUMORS	Background: Undifferentiated Pleomorphic Sarcoma (UPS) and high-grade Leiomyosarcoma (LMS) are soft tissue tumors with an aggressive clinical behavior, frequently developing local recurrence and distant metastases. Despite several gene expression studies involving soft tissue sarcomas, the potential to identify molecular markers has been limited, mostly due to small sample size, in-group heterogeneity and absence of detailed clinical data. Materials and Methods: Gene expression profiling was performed for 22 LMS and 22 UPS obtained from untreated patients. To assess the relevance of the gene signature, a meta-analysis was performed using five published studies. Four genes (BAD, MYOCD, SRF and SRC) selected from the gene signature, meta-analysis and functional in silico analysis were further validated by quantitative PCR. In addition, protein-protein interaction analysis was applied to validate the data. SRC protein immunolabeling was assessed in 38 UPS and 52 LMS. Results: We identified 587 differentially expressed genes between LMS and UPS, of which 193 corroborated with other studies. Cluster analysis of the data failed to discriminate LMS from UPS, although it did reveal a distinct molecular profile for retroperitoneal LMS, which was characterized by the over-expression of smooth muscle-specific genes. Significantly higher levels of expression for BAD, SRC, SRF, and MYOCD were confirmed in LMS when compared with UPS. SRC was the most value discriminator to distinguish both sarcomas and presented the highest number of interaction in the in silico protein-protein analysis. SRC protein labeling showed high specificity and a positive predictive value therefore making it a candidate for use as a diagnostic marker in LMS. Conclusions: Retroperitoneal LMS presented a unique gene signature. SRC is a putative diagnostic marker to differentiate LMS from UPS.	[Villacis, Rolando A. R.; Silveira, Sara M.; Barros-Filho, Mateus C.; Rogatto, Silvia R.] AC Camargo Canc Ctr, Res Ctr CIPE, Neogene Lab, Sao Paulo, Brazil; [Marchi, Fabio A.] Univ Sao Paulo, Interinst Grad Program Bioinformat, Math & Stat Inst, Sao Paulo, Brazil; [Domingues, Maria A. C.] UNESP Sao Paulo State Univ, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Aguiar, Samuel, Jr.; Lopes, Ademar] AC Camargo Canc Ctr, Dept Pelv Surg, Sao Paulo, Brazil; [Cunha, Isabela W.] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil; [Rogatto, Silvia R.] UNESP Sao Paulo State Univ, Sch Med, Dept Urol, Sao Paulo, Brazil	A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade Estadual Paulista; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade Estadual Paulista	Rogatto, SR (corresponding author), AC Camargo Canc Ctr, Res Ctr CIPE, Neogene Lab, Sao Paulo, Brazil.	silvia.rogatto@cipe.accamargo.org.br	Filho, Mateus C Barros/J-1544-2015; Marchi, Fabio A/N-9288-2018; Lopes, Ademar/G-8526-2014; Cunha, Isabela/H-3013-2012; Junior, Samuel Aguiar/A-7388-2011; Rogatto, Silvia R/E-6535-2012	Filho, Mateus C Barros/0000-0003-3893-5269; Marchi, Fabio A/0000-0001-5815-8423; Lopes, Ademar/0000-0002-8317-3817; Cunha, Isabela/0000-0002-2029-5139; Junior, Samuel Aguiar/0000-0003-3476-727X; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Villacis, Rolando/0000-0003-3851-2696; Rogatto, Silvia/0000-0003-4637-5687; Custodio Domingues, Maria Aparecida/0000-0002-4023-3410	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Pesquisa (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Beck AH, 2010, ONCOGENE, V29, P845, DOI 10.1038/onc.2009.381; Boccardo E, 2010, CARCINOGENESIS, V31, P521, DOI 10.1093/carcin/bgp333; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Carneiro A, 2009, LAB INVEST, V89, P668, DOI 10.1038/labinvest.2009.18; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dickson BC, 2013, HUM PATHOL, V44, P1125, DOI 10.1016/j.humpath.2012.10.001; Fletcher CD., 2002, WHO CLASSIFICATION T; Gibault L, 2011, J PATHOL, V223, P64, DOI 10.1002/path.2787; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Guillou L, 2010, VIRCHOWS ARCH, V456, P201, DOI 10.1007/s00428-009-0853-4; Italiano A, 2013, CLIN CANCER RES, V19, P1190, DOI 10.1158/1078-0432.CCR-12-2970; Kresse SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015378; Larramendy ML, 2008, CANCER GENET CYTOGEN, V187, P1, DOI 10.1016/j.cancergencyto.2008.06.005; Mills AM, 2011, AM J SURG PATHOL, V35, P583, DOI 10.1097/PAS.0b013e318211abd6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nielsen TO, 2010, J CLIN ONCOL, V28, P1796, DOI 10.1200/JCO.2009.26.1917; Perot G, 2009, CANCER RES, V69, P2269, DOI 10.1158/0008-5472.CAN-08-1443; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Cirilo PDR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057901; Robin YM, 2013, MODERN PATHOL, V26, P502, DOI 10.1038/modpathol.2012.192; Silveira SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067643; Sioletic S, 2013, HISTOPATHOLOGY, V62, P287, DOI 10.1111/j.1365-2559.2012.04348.x; Toro JR, 2006, INT J CANCER, V119, P2922, DOI 10.1002/ijc.22239; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; West RB, 2010, ADV ANAT PATHOL, V17, P366, DOI 10.1097/PAP.0b013e3181ec7428	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102281	10.1371/journal.pone.0102281	http://dx.doi.org/10.1371/journal.pone.0102281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028927	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600056
J	Burkard, C; Bloyet, LM; Wicht, O; van Kuppeveld, FJ; Rottier, PJM; de Haan, CAM; Bosch, BJ				Burkard, Christine; Bloyet, Louis-Marie; Wicht, Oliver; van Kuppeveld, Frank J.; Rottier, Peter J. M.; de Haan, Cornelis A. M.; Bosch, Berend Jan			Dissecting Virus Entry: Replication-Independent Analysis of Virus Binding, Internalization, and Penetration Using Minimal Complementation of beta-Galactosidase	PLOS ONE			English	Article							VESICULAR STOMATITIS; ELECTRON-MICROSCOPY; SENSITIVE DETECTION; INFLUENZA-VIRUS; CORONAVIRUS; FUSION; CELLS; ASSAY; PROTEIN; ENDOCYTOSIS	Studies of viral entry into host cells often rely on the detection of post-entry parameters, such as viral replication or the expression of a reporter gene, rather than on measuring entry per se. The lack of assays to easily detect the different steps of entry severely hampers the analysis of this key process in virus infection. Here we describe novel, highly adaptable viral entry assays making use of minimal complementation of the E. coli beta-galactosidase in mammalian cells. Enzyme activity is reconstituted when a small intravirion peptide (alpha-peptide) is complementing the inactive mutant form Delta M15 of beta-galactosidase. The method allows to dissect and to independently detect binding, internalization, and fusion of viruses during host cell entry. Here we use it to confirm and extend current knowledge on the entry process of two enveloped viruses: vesicular stomatitis virus (VSV) and murine hepatitis coronavirus (MHV).	[Burkard, Christine; Bloyet, Louis-Marie; Wicht, Oliver; van Kuppeveld, Frank J.; Rottier, Peter J. M.; de Haan, Cornelis A. M.; Bosch, Berend Jan] Univ Utrecht, Dept Infect Dis & Immunol, Div Virol, Fac Vet Med, Utrecht, Netherlands	Utrecht University	Bosch, BJ (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Div Virol, Fac Vet Med, Utrecht, Netherlands.	b.j.bosch@uu.nl	Bloyet, Louis-Marie/AAB-6244-2022; Bosch, Berend/ABD-8740-2021; Wicht, Oliver/L-8714-2013	Bloyet, Louis-Marie/0000-0002-5648-3190; Wicht, Oliver/0000-0003-3266-8075; Tait-Burkard, Christine/0000-0002-0471-3230; de Haan, Cornelis/0000-0002-4459-9874; van Kuppeveld, Frank/0000-0001-5800-749X	EU [235649]	EU(European Commission)	Support was provided by the EU Seventh Framework Program (Virus Entry, project 235649, to PJMR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHEN YD, 1989, BIOPHYS CHEM, V34, P283, DOI 10.1016/0301-4622(89)80065-1; de Haan Cornelis A. M., 2008, V454, P229, DOI 10.1007/978-1-59745-181-9_17; DUNNEBACKE TH, 1969, J VIROL, V4, P505, DOI 10.1128/JVI.4.4.505-513.1969; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Ewers H, 2012, METHOD ENZYMOL, V506, P63, DOI 10.1016/B978-0-12-391856-7.00028-7; Fero M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000455; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kolokoltsov AA, 2004, J VIROL, V78, P5124, DOI 10.1128/JVI.78.10.5124-5132.2004; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Laliberte JP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002446; LANGLEY KE, 1975, P NATL ACAD SCI USA, V72, P1254, DOI 10.1073/pnas.72.4.1254; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; LOWY RJ, 1990, P NATL ACAD SCI USA, V87, P1850, DOI 10.1073/pnas.87.5.1850; MADSHUS IH, 1987, J CELL PHYSIOL, V131, P14, DOI 10.1002/jcp.1041310104; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; Matula P, 2009, CYTOM PART A, V75A, P309, DOI 10.1002/cyto.a.20662; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; MESSING J, 1977, P NATL ACAD SCI USA, V74, P3642, DOI 10.1073/pnas.74.9.3642; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Raviv Y, 2002, VIROLOGY, V293, P243, DOI 10.1006/viro.2001.1237; Rodriguez LL, 2002, VIRUS RES, V85, P211, DOI 10.1016/S0168-1702(02)00026-6; Roingeard P, 2008, BIOL CELL, V100, P491, DOI 10.1042/BC20070173; ROTTIER PJM, 1981, J VIROL, V40, P350, DOI 10.1128/JVI.40.2.350-357.1981; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; Schickli JH, 1997, J VIROL, V71, P9499, DOI 10.1128/JVI.71.12.9499-9507.1997; SCHLEGEL R, 1981, BIOCHEM BIOPH RES CO, V102, P992, DOI 10.1016/0006-291X(81)91636-3; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; SUMMERS MD, 1971, J ULTRA MOL STRUCT R, V35, P606, DOI 10.1016/S0022-5320(71)80014-X; Tani H, 2007, J VIROL, V81, P8601, DOI 10.1128/JVI.00608-07; Tscherne DM, 2010, J VIROL METHODS, V163, P336, DOI 10.1016/j.jviromet.2009.10.020; VENNEMA H, 1990, J VIROL, V64, P339, DOI 10.1128/JVI.64.1.339-346.1990; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; Wolf MC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-119; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101762	10.1371/journal.pone.0101762	http://dx.doi.org/10.1371/journal.pone.0101762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025332	Green Published, gold			2022-12-27	WOS:000339992400021
J	Jen, CP; Amstislavskaya, TG; Kuo, CC; Chen, YH				Jen, Chun-Ping; Amstislavskaya, Tamara G.; Kuo, Chen-Chi; Chen, Yu-Hung			Protein Preconcentration Using Nanofractures Generated by Nanoparticle-Assisted Electric Breakdown at Junction Gaps	PLOS ONE			English	Article							SAMPLE PRECONCENTRATION; STACKING; DEVICE	Sample preconcentration is an important step that increases the accuracy of subsequent detection, especially for samples with extremely low concentrations. Due to the overlapping of electrical double layers in the nanofluidic channel, the concentration polarization effect can be generated by applying an electric field. Therefore, a nonlinear electrokinetic flow is induced, which results in the fast accumulation of proteins in front of the induced ionic depletion zone, the so-called exclusion-enrichment effect. Nanofractures were created in this work to preconcentrate proteins via the exclusion-enrichment effect. The protein sample was driven by electroosmotic flow and accumulated at a specific location. The preconcentration chip for proteins was fabricated using simple standard soft lithography with a polydimethylsiloxane replica. Nanofractures were formed by utilizing nanoparticle-assisted electric breakdown. The proposed method for nanofracture formation that utilizes nanoparticle deposition at the junction gap between microchannels greatly decreases the required electric breakdown voltage. The experimental results indicate that a protein sample with an extremely low concentration of 1 nM was concentrated to 1.5x10(4)-fold in 60 min using the proposed chip.	[Jen, Chun-Ping; Kuo, Chen-Chi] Natl Chung Cheng Univ, Dept Mech Engn, Chiayi, Taiwan; [Jen, Chun-Ping; Kuo, Chen-Chi] Natl Chung Cheng Univ, Adv Inst Mfg High Tech Innovat, Chiayi, Taiwan; [Amstislavskaya, Tamara G.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Chen, Yu-Hung] Natl Cheng Kung Univ, Dept Med, Tainan 70101, Taiwan; [Chen, Yu-Hung] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan	National Chung Cheng University; National Chung Cheng University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; National Cheng Kung University; National Cheng Kung University	Jen, CP (corresponding author), Natl Chung Cheng Univ, Dept Mech Engn, Chiayi, Taiwan.	imecpj@ccu.edu.tw; second@mail.ncku.edu.tw	Jen, Chun-Ping/P-3275-2018; Amstislavskaya, Tamara G/K-4149-2018; Chen, Yu-Hung/GLU-7365-2022; Chen, Yu-Hung/F-4167-2010	Jen, Chun-Ping/0000-0001-5558-5817; Chen, Yu-Hung/0000-0003-3524-629X; 	National Science Council of the Republic of China, Taiwan [NSC 101-2221-E-194-027, NSC 102-2221-E-194-001]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council of the Republic of China, Taiwan, for its financial support of this research under grants NSC 101-2221-E-194-027 and NSC 102-2221-E-194-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAUDHURY MK, 1991, LANGMUIR, V7, P1013, DOI 10.1021/la00053a033; Chiang PJ, 2014, MICROELECTRON ENG, V115, P39, DOI 10.1016/j.mee.2013.10.024; Chun HG, 2010, ANAL CHEM, V82, P6287, DOI 10.1021/ac101297t; Duan CH, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4794973; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008; Hayt W.H., 1989, ENG ELECTROMAGNETICS, V5th ed.; Hofmann O, 1999, ANAL CHEM, V71, P678, DOI 10.1021/ac9806660; Jung B, 2006, ANAL CHEM, V78, P2319, DOI 10.1021/ac051659w; Kim SM, 2006, ANAL CHEM, V78, P4779, DOI 10.1021/ac060031y; Kim SJ, 2008, ANAL CHEM, V80, P3507, DOI 10.1021/ac800157q; Ko SH, 2011, LAB CHIP, V11, P1351, DOI 10.1039/c0lc00349b; Lee JH, 2008, LAB CHIP, V8, P596, DOI 10.1039/b717900f; Lee JH, 2007, ANAL CHEM, V79, P6868, DOI 10.1021/ac071162h; Lichtenberg J, 2001, ELECTROPHORESIS, V22, P258, DOI 10.1002/1522-2683(200101)22:2<258::AID-ELPS258>3.0.CO;2-4; Lin CC, 2011, MICROFLUID NANOFLUID, V10, P481, DOI 10.1007/s10404-010-0661-9; Liu V, 2010, LAB CHIP, V10, P1485, DOI 10.1039/b923214a; Mao P, 2005, LAB CHIP, V5, P837, DOI 10.1039/b502809d; Pu QS, 2004, NANO LETT, V4, P1099, DOI 10.1021/nl0494811; Ross D, 2002, ANAL CHEM, V74, P2556, DOI 10.1021/ac025528w; Song S, 2004, ANAL CHEM, V76, P4589, DOI 10.1021/ac0497151; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Wang YC, 2005, ANAL CHEM, V77, P4293, DOI 10.1021/ac050321z; Wu DP, 2009, LAB CHIP, V9, P1890, DOI 10.1039/b823409d; Yu H, 2008, LAB CHIP, V8, P1496, DOI 10.1039/b802778a	25	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102050	10.1371/journal.pone.0102050	http://dx.doi.org/10.1371/journal.pone.0102050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025205	gold, Green Published			2022-12-27	WOS:000339992400038
J	Kamthan, M; Nalla, VK; Ruhela, D; Kamthan, A; Maiti, P; Datta, A				Kamthan, Mohan; Nalla, Vijaya Kumar; Ruhela, Deepa; Kamthan, Ayushi; Maiti, Protiti; Datta, Asis			Characterization of a Putative Spindle Assembly Checkpoint Kinase Mps1, Suggests Its Involvement in Cell Division, Morphogenesis and Oxidative Stress Tolerance in Candida albicans	PLOS ONE			English	Article							POLE BODY DUPLICATION; SPECIFICITY PROTEIN-KINASES; BREAST-CANCER CELLS; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL INSTABILITY; MITOTIC CHECKPOINT; FILAMENTOUS GROWTH; PATHOGENIC YEAST; BUDDING YEAST; CYCLE ARREST	In Saccharomyces cerevisiae MPS1 is one of the major protein kinase that governs the spindle checkpoint pathway. The S. cerevisiae structural homolog of opportunistic pathogen Candida albicans CaMPS1, is indispensable for the cell viability. The essentiality of Mps1 was confirmed by Homozygote Trisome test. To determine its biological function in this pathogen conditional mutant was generated through regulatable MET3 promoter. Examination of heterozygous and conditional (+ Met/Cys) mps1 mutants revealed a mitosis specific arrest phenotype, where mutants showed large buds with undivided nuclei. Flowcytometry analysis revealed abnormal ploidy levels in mps1mutant. In presence of anti-microtubule drug Nocodazole, mps1 mutant showed a dramatic loss of viability suggesting a role of Mps1 in Spindle Assembly Checkpoint (SAC) activation. These mutants were also defective in microtubule organization. Moreover, heterozygous mutant showed defective in-vitro yeast to hyphae morphological transition. Growth defect in heterozygous mutant suggest haploinsufficiency of this gene. qRT PCR analysis showed around 3 fold upregulation of MPS1 in presence of serum. This expression of MPS1 is dependent on Efg1and is independent of other hyphal regulators like Ras1 and Tpk2. Furthermore, mps1 mutants were also sensitive to oxidative stress. Heterozygous mps1 mutant did not undergo morphological transition and showed 5-Fold reduction in colony forming units in response to macrophage. Thus, the vital checkpoint kinase, Mps1 besides cell division also has a role in morphogenesis and oxidative stress tolerance, in this pathogenic fungus.	[Kamthan, Mohan; Ruhela, Deepa; Kamthan, Ayushi; Maiti, Protiti; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India; [Nalla, Vijaya Kumar] Univ Delhi, Dept Microbiol, Bhaskaracharya Coll, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Bhaskaracharya College of Applied Sciences; University of Delhi	Datta, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	asis_datta@rediffmail.com		Kamthan, Mohan/0000-0001-8859-4699	Department of Biotechnology, the Ministry of Science and Technology, Government of India	Department of Biotechnology, the Ministry of Science and Technology, Government of India	This work was supported by the Department of Biotechnology, the Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Bachewich C, 2005, MOL MICROBIOL, V57, P942, DOI 10.1111/j.1365-2958.2005.04727.x; Bai C, 2002, MOL MICROBIOL, V45, P31, DOI 10.1046/j.1365-2958.2002.02995.x; Barelle CJ, 2003, EUKARYOT CELL, V2, P398, DOI 10.1128/EC.2.3.398-410.2003; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Chen CY, 1998, MICROBIOL-UK, V144, P2941, DOI 10.1099/00221287-144-11-2941; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Daum JR, 2000, CURR BIOL, V10, P1375, DOI 10.1016/S0960-9822(00)00780-6; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Finley KR, 2008, J CELL SCI, V121, P466, DOI 10.1242/jcs.015172; Fisk HA, 2004, CELL CYCLE, V3, P439; FONZI WA, 1993, GENETICS, V134, P717; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; He XW, 1998, J CELL SCI, V111, P1635; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jemaa M, 2013, CELL DEATH DIFFER, V20, P1532, DOI 10.1038/cdd.2013.105; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; ODDS FC, 1994, J MED VET MYCOL, V32, P1; Russell K D, 2005, CURR BIOL, V15, P1070; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanyal K, 2002, P NATL ACAD SCI USA, V99, P12969, DOI 10.1073/pnas.162488299; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; Tsuda K, 2011, BIOCHEM BIOPH RES CO, V409, P418, DOI 10.1016/j.bbrc.2011.05.010; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Watanabe S, 2008, EMBO J, V27, P1085, DOI 10.1038/emboj.2008.32; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101517	10.1371/journal.pone.0101517	http://dx.doi.org/10.1371/journal.pone.0101517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025778	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400016
J	Scheuring, I				Scheuring, Istvan			Diffusive Public Goods and Coexistence of Cooperators and Cheaters on a 1D Lattice	PLOS ONE			English	Article							EVOLUTIONARY GAME; BIOFILM STRUCTURE; SOCIAL EVOLUTION; GROUP SELECTION; SNOWDRIFT GAME; KIN SELECTION; NEIGHBORHOOD; DEFECTION; DISCRETE; ALTRUISM	Many populations of cells cooperate through the production of extracellular materials. These materials (enzymes, siderophores) spread by diffusion and can be applied by both the cooperator and cheater (non-producer) cells. In this paper the problem of coexistence of cooperator and cheater cells is studied on a 1D lattice where cooperator cells produce a diffusive material which is beneficial to the individuals according to the local concentration of this public good. The reproduction success of a cell increases linearly with the benefit in the first model version and increases non-linearly (saturates) in the second version. Two types of update rules are considered; either the cooperative cell stops producing material before death (death-production-birth, DpB) or it produces the common material before it is selected to die (production-death-birth, pDB). The empty space is occupied by its neighbors according to their replication rates. By using analytical and numerical methods I have shown that coexistence of the cooperator and cheater cells is possible although atypical in the linear version of this 1D model if either DpB or pDB update rule is assumed. While coexistence is impossible in the non-linear model with pDB update rule, it is one of the typical behaviors in case of the non-linear model with DpB update rule.	Dept Plant Systemat Ecol & Theoret Biol, MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH)	Scheuring, I (corresponding author), Dept Plant Systemat Ecol & Theoret Biol, MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Pazmany P Setany 1-C, H-1117 Budapest, Hungary.	scheurin@caesar.elte.hu	Scheuring, Istvan/A-5368-2011	Scheuring, Istvan/0000-0002-8108-8897	Hungarian National Science Foundation (OTKA) [100296, 100299]; Hungarian Academy of Science (MTA)	Hungarian National Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Science (MTA)	The work is supported by the Hungarian National Science Foundation (OTKA, Grant no. 100296 and 100299). The production cost of the paper is covered by Hungarian Academy of Science (MTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2013, ELIFE, V2, DOI 10.7554/eLife.01169; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Archetti M, 2013, EVOL APPL, V6, P1146, DOI 10.1111/eva.12092; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Archetti M, 2009, J THEOR BIOL, V261, P475, DOI 10.1016/j.jtbi.2009.08.018; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bahmra KS, 2010, PARTIAL DIFFERENTIAL; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Borenstein DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063304; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Czaran T, 2000, GEOMETRY ECOLOGICAL; Damore JA, 2012, J THEOR BIOL, V299, P31, DOI 10.1016/j.jtbi.2011.03.008; Debarre F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4409; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Fuqua C., 2002, MODERN MICROBIAL GEN, P362; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Grafen A, 2008, J THEOR BIOL, V252, P694, DOI 10.1016/j.jtbi.2008.01.021; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; Julou T, 2013, P NATL ACAD SCI USA, V110, P12577, DOI 10.1073/pnas.1301428110; Kerenyi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057947; Killingback T, 1996, P ROY SOC B-BIOL SCI, V263, P1135, DOI 10.1098/rspb.1996.0166; Konnyu B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-204; Kummerli R, 2010, P NATL ACAD SCI USA, V107, P18921, DOI 10.1073/pnas.1011154107; Kun A, 2006, BEHAV ECOL, V17, P633, DOI 10.1093/beheco/ark009; Lehmann L, 2007, P NATL ACAD SCI USA, V104, P6736, DOI 10.1073/pnas.0700662104; MOTRO U, 1991, J THEOR BIOL, V151, P145, DOI 10.1016/S0022-5193(05)80358-3; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szamado S, 2008, J THEOR BIOL, V253, P221, DOI 10.1016/j.jtbi.2008.02.037; Szathmary E, 1995, MAJOR TRANSITIONS EV; van Veelen M, 2009, J THEOR BIOL, V259, P589, DOI 10.1016/j.jtbi.2009.04.019; Vasarhelyi Z, 2013, BIOSYSTEMS, V113, P81, DOI 10.1016/j.biosystems.2013.05.003; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Xavier JB, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.16	51	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100769	10.1371/journal.pone.0100769	http://dx.doi.org/10.1371/journal.pone.0100769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025985	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400006
J	Zhai, HH; Pan, JC; Pang, E; Bai, B				Zhai, Haohan; Pan, Jianchao; Pang, En; Bai, Bo			Lavage with Allicin in Combination with Vancomycin Inhibits Biofilm Formation by Staphylococcus epidermidis in a Rabbit Model of Prosthetic Joint Infection	PLOS ONE			English	Article							SEPTIC ARTHRITIS; IRRIGATION; MANAGEMENT; DIAGNOSIS; ARTHROPLASTY; DEBRIDEMENT; PREVENTION; EFFICACY; THERAPY	Background and Aim: The present anti-infection strategy for prosthetic joint infections (PJI) includes the use of antibiotics and surgical treatments, but the bacterial eradication rates are still low. One of the major challenges is the formation of biofilm causing poor bacterial eradication. Recently it has been reported that allicin (diallyl thiosulphinate), an antibacterial principle of garlic, can inhibit bacteria adherence and prevent biofilm formation in vitro. However, whether allicin could inhibit biofilm formation in vivo is unknown. The aim of this study was to investigate the effects of allicin on biofilm formation, and whether allicin could potentiate the bactericidal effect of vancomycin in a rabbit PJI model. Methods: A sterile stainless-steel screw with a sterile ultra-high molecular weight polyethylene washer was inserted into the lateral femoral condyle of the right hind knee joint of rabbit, and 1 mL inoculum containing 10(4) colony-forming units of Staphylococcus epidermidis was inoculated into the knee joint (n = 32). Fourteen days later, rabbits randomly received one of the following 4 treatments using continuous lavages: normal saline, vancomycin (20 mcg/mL), allicin (4 mg/L), or allicin (4 mg/L) plus vancomycin (20 mcg/mL). Three days later, the washer surface biofilm formation was examined by scanning electron microscopy (SEM). The bacterial counts within the biofilm of implanted screws were determined by bacterial culture. Results: The lowest number of viable bacterial counts of Staphylococcus epidermidis recovered from the biofilm was in the rabbits treated with allicin plus vancomycin (P < 0.01 vs. all other groups). The biofilm formation was significantly reduced or undetectable by SEM in rabbits receiving allicin or allicin plus vancomycin. Conclusion: Intra-articular allicincan inhibit biofilm formation and enhance the bactericidal effect of vancomycin on implant surface in vivo. Allicin in combination with vancomycin may be a useful anti-infection strategy for the treatment of PJI.	[Zhai, Haohan; Pan, Jianchao; Bai, Bo] Guangzhou Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China; [Pang, En] Kingmed Diagnost Ctr Co Ltd, Dept Microbiol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Bai, B (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China.	drbobai@126.com						Arciola CR, 2011, INT J ARTIF ORGANS, V34, P727, DOI 10.5301/IJAO.2011.8784; Bahrs C, 2003, J SURG RES, V112, P26, DOI 10.1016/S0022-4804(03)00150-1; Barrett J, 2005, J BONE JOINT SURG AM, V87A, P1965, DOI 10.2106/JBJS.D.02440; Beswick AD, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-18; Bradbury T, 2009, J ARTHROPLASTY, V24, P101, DOI 10.1016/j.arth.2009.04.028; Brown NM, 2012, J ARTHROPLASTY, V27, P27, DOI 10.1016/j.arth.2011.03.034; Chaudhry H, 2014, CLIN ORTHOP RELAT R, V472, P22, DOI 10.1007/s11999-013-3333-8; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Craig MR, 2005, J ORTHOP RES, V23, P1100, DOI 10.1016/j.orthres.2005.03.007; Cruz-Villalon G, 2011, J APPL MICROBIOL, V110, P723, DOI 10.1111/j.1365-2672.2010.04929.x; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Dodwell ER, 2013, CURR OPIN PEDIATR, V25, P58, DOI 10.1097/MOP.0b013e32835c2b42; Fujimura S, 2009, J ORTHOP SCI, V14, P658, DOI 10.1007/s00776-009-1366-3; Gallo Jiri, 2003, Biomedical Papers (Olomouc), V147, P27; Haerdi-Landerer MC, 2010, VET J, V184, P14, DOI 10.1016/j.tvjl.2009.02.013; Iarikov D, 2012, CLIN INFECT DIS, V55, P1474, DOI 10.1093/cid/cis735; Isiklar ZU, 1996, CLIN ORTHOP RELAT R, P184; Kirr R, 2006, ZBL CHIR, V131, pS79, DOI 10.1055/s-2005-921501; Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; LETTIN AWF, 1990, J BONE JOINT SURG BR, V72, P220, DOI 10.1302/0301-620X.72B2.2312559; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Malloy KM, 2009, ORTHOPEDICS, V32, P499, DOI 10.3928/01477447-20090527-18; Manadan Augustine M, 2004, Am J Ther, V11, P412, DOI 10.1097/01.mph.0000087296.80768.1e; Meijer MC, 2000, J VET MED A, V47, P351, DOI 10.1046/j.1439-0442.2000.00290.x; MELLASCHMIDT C, 1989, CHIRURG, V60, P791; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Odum SM, 2011, J ARTHROPLASTY, V26, P114, DOI 10.1016/j.arth.2011.03.031; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; PARISIEN JS, 1992, CLIN ORTHOP RELAT R, P243; Parvizi Javad, 2012, J Bone Joint Surg Am, V94, pe104, DOI 10.2106/JBJS.K.01417; Parvizi J, 2009, CLIN ORTHOP RELAT R, V467, P1732, DOI 10.1007/s11999-009-0857-z; Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103; Peel TN, 2012, CURR OPIN INFECT DIS, V25, P670, DOI 10.1097/QCO.0b013e32835915db; Perez-Giraldo C, 2003, J APPL MICROBIOL, V95, P709, DOI 10.1046/j.1365-2672.2003.02030.x; Sampedro MF, 2010, SPINE, V35, P1218, DOI 10.1097/BRS.0b013e3181c3b2f3; Shuman EK, 2012, INFECT DIS CLIN N AM, V26, P29, DOI 10.1016/j.idc.2011.09.011; Tsumura H, 2005, INT ORTHOP, V29, P113, DOI 10.1007/s00264-004-0626-2; Vos LM, 2013, J OROFAC PAIN, V27, P171, DOI 10.11607/jop.1007; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x; Zmistowski B, 2011, J ARTHROPLASTY, V26, P104, DOI 10.1016/j.arth.2011.03.044	45	35	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102760	10.1371/journal.pone.0102760	http://dx.doi.org/10.1371/journal.pone.0102760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025650	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400104
J	Attucks, OC; Jasmer, KJ; Hannink, M; Kassis, J; Zhong, ZP; Gupta, S; Victory, SF; Guzel, M; Polisetti, DR; Andrews, R; Mjalli, AMM; Kostura, MJ				Attucks, Otis C.; Jasmer, Kimberly J.; Hannink, Mark; Kassis, Jareer; Zhong, Zhenping; Gupta, Suparna; Victory, Sam F.; Guzel, Mustafa; Polisetti, Dharma Rao; Andrews, Robert; Mjalli, Adnan M. M.; Kostura, Matthew J.			Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity	PLOS ONE			English	Article							TRANSCRIPTION REPRESSOR BACH1; OXIDATIVE STRESS; MYOCARDIAL PROTECTION; CYSTEINE RESIDUES; GENETIC ABLATION; NRF2 ACTIVATION; BINDING-SITES; UP-REGULATION; ACID-ESTERS; MICE	Oxidative stress is generated by reactive oxygen species (ROS) produced in response to metabolic activity and environmental factors. Increased oxidative stress is associated with the pathophysiology of a broad spectrum of inflammatory diseases. Cellular response to excess ROS involves the induction of antioxidant response element (ARE) genes under control of the transcriptional activator Nrf2 and the transcriptional repressor Bach1. The development of synthetic small molecules that activate the protective anti-oxidant response network is of major therapeutic interest. Traditional small molecules targeting ARE-regulated gene activation (e.g., bardoxolone, dimethyl fumarate) function by alkylating numerous proteins including Keap1, the controlling protein of Nrf2. An alternative is to target the repressor Bach1. Bach1 has an endogenous ligand, heme, that inhibits Bach1 binding to ARE, thus allowing Nrf2-mediated gene expression including that of heme-oxygenase-1 (HMOX1), a well described target of Bach1 repression. In this report, normal human lung fibroblasts were used to screen a collection of synthetic small molecules for their ability to induce HMOX1. A class of HMOX1-inducing compounds, represented by HPP-4382, was discovered. These compounds are not reactive electrophiles, are not suppressed by N-acetyl cysteine, and do not perturb either ROS or cellular glutathione. Using RNAi, we further demonstrate that HPP-4382 induces HMOX1 in an Nrf2-dependent manner. Chromatin immunoprecipitation verified that HPP-4382 treatment of NHLF cells reciprocally coordinated a decrease in binding of Bach1 and an increase of Nrf2 binding to the HMOX1 E2 enhancer. Finally we show that HPP-4382 can inhibit Bach1 activity in a reporter assay that measures transcription driven by the human HMOX1 E2 enhancer. Our results suggest that HPP-4382 is a novel activator of the antioxidant response through the modulation of Bach1 binding to the ARE binding site of target genes.	[Attucks, Otis C.; Kassis, Jareer; Zhong, Zhenping; Gupta, Suparna; Victory, Sam F.; Guzel, Mustafa; Polisetti, Dharma Rao; Andrews, Robert; Mjalli, Adnan M. M.; Kostura, Matthew J.] TransTech Pharma LLC, High Point, NC 27265 USA; [Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO USA; [Hannink, Mark] Univ Missouri, Life Sci Ctr, Columbia, MO USA; [Jasmer, Kimberly J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kostura, MJ (corresponding author), TransTech Pharma LLC, High Point, NC 27265 USA.	matthew.j.kostura@gmail.com	Jasmer, Kimberly/V-2522-2019	Jasmer, Kimberly/0000-0002-8669-428X; Kostura, Matthew/0000-0001-7940-7492; Guzel, Prof. Mustafa/0000-0002-1423-0435	High Point Pharmaceuticals LLC.	High Point Pharmaceuticals LLC.	The research described in this manuscript was funded by High Point Pharmaceuticals LLC. The funder did have a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Botros FT, 2005, KIDNEY INT, V68, P2745, DOI 10.1111/j.1523-1755.2005.00745.x; Burgess A, 2010, HYPERTENSION, V56, P1124, DOI 10.1161/HYPERTENSIONAHA.110.151423; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Elmarakby AA, 2012, AM J PHYSIOL-RENAL, V302, pF791, DOI 10.1152/ajprenal.00472.2011; Harusato A, 2009, J PHYSIOL PHARMACOL, V60, P149; Harusato A, 2011, FREE RADICAL RES, V45, P717, DOI 10.3109/10715762.2011.574287; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; Iida A, 2009, TOHOKU J EXP MED, V217, P223, DOI 10.1620/tjem.217.223; Inoue M, 2011, J CLIN BIOCHEM NUTR, V48, P161, DOI 10.3164/jcbn.09-122GFR; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Johns DG, 2009, EUR J PHARMACOL, V606, P109, DOI 10.1016/j.ejphar.2008.12.030; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kondo K, 2013, AM J PHYSIOL-ENDOC M, V305, pE641, DOI 10.1152/ajpendo.00120.2013; Kruger AL, 2006, J PHARMACOL EXP THER, V319, P1144, DOI 10.1124/jpet.106.107482; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Stec DE, 2008, AM J HYPERTENS, V21, P189, DOI 10.1038/ajh.2007.29; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tanimoto T, 2009, FREE RADICAL BIO MED, V46, P1119, DOI 10.1016/j.freeradbiomed.2009.01.017; Vanella L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt176; Vera T, 2008, HYPERTENSION, V52, P660, DOI 10.1161/HYPERTENSIONAHA.108.114884; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Watari Y, 2008, HYPERTENS RES, V31, P783, DOI 10.1291/hypres.31.783; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Yore MM, 2011, PLOS ONE, DOI [10.1371/journal.pone0022862, DOI 10.1371/J0URNAL.P0NE0022862]; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	51	31	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101044	10.1371/journal.pone.0101044	http://dx.doi.org/10.1371/journal.pone.0101044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019514	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600010
J	Gao, JJ; Yan, Q; Liu, S; Yang, XS				Gao, Jiujiao; Yan, Qiu; Liu, Shuai; Yang, Xuesong			Knockdown of EpCAM Enhances the Chemosensitivity of Breast Cancer Cells to 5-fluorouracil by Downregulating the Antiapoptotic Factor Bcl-2	PLOS ONE			English	Article							MAPK SIGNALING PATHWAYS; IN-VITRO; FAMILY; GROWTH; EXPRESSION; APOPTOSIS; PROTEINS; SURVIVAL; ARREST	Resistance to fluoropyrimidine-based chemotherapy is the main reason for the failure of cancer treatment, and drug resistance is associated with an inability of tumor cells to undergo apoptosis in response to treatment. Alterations in the expression of epithelial cell adhesion molecule (EpCAM) affect the sensitivity or resistance of tumor cells to anticancer treatment and the activity of intracellular signaling pathways. However, the role of EpCAM in the induction of apoptosis in breast cancer cells remains unclear. Here, we investigated the effect of EpCAM gene knockdown on chemosensitivity to 5-fluorouracil (5-FU) in MCF-7 cells and explored the underlying mechanisms. Our results showed that knockdown of EpCAM promoted apoptosis, inhibited cell proliferation and caused cell-cycle arrest. EpCAM knockdown enhanced the cytotoxic effect of 5-FU, promoting apoptosis by downregulating the expression of the anti-apoptotic protein Bcl-2 and upregulating the expression of the pro-apoptotic proteins Bax, and caspase3 via the ERK1/2 and JNK MAPK signaling pathways in MCF-7 cells. These results indicate that knockdown of EpCAM may have a tumor suppressor effect and suggest EpCAM as a potential target for the treatment of breast cancer.	[Gao, Jiujiao; Yan, Qiu; Liu, Shuai; Yang, Xuesong] Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Peoples R China	Dalian Medical University	Yang, XS (corresponding author), Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Peoples R China.	yxmsnow@126.com			Major State basic Research Development Program of China [2012CB822103]; National Natural Science Foundation of China [30800195, 31070729, 31270866]; National Natural Science Foundation of Liaoning Province [2013023046]	Major State basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Liaoning Province	This work was supported by grants from the Major State basic Research Development Program of China (2012CB822103), the National Natural Science Foundation of China (No.: 30800195, 31070729 and 31270866) and the National Natural Science Foundation of Liaoning Province (NO.2013023046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyagari VN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-61; Barille-Nion S, 2012, ANTICANCER RES, V32, P4225; Bugalho A, 2013, CLIN LUNG CANC; Chow LWC, 2013, EXPERT OPIN INV DRUG, V22, P299, DOI 10.1517/13543784.2013.766715; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Fan Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004131; Ferguson JE, 2014, J MED FOOD; Flatmark K, 2013, INT J CANCER, V133, P1497, DOI 10.1002/ijc.28158; Fu Q, 2013, J ZHEJIANG UNIV-SC B, V14, P8, DOI 10.1631/jzus.B1200189; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Geng M, 2013, INT J CLIN EXP PATHO, V6, P2554; Geng ZM, 2013, ONCOL REP, V30, P793, DOI 10.3892/or.2013.2539; Gostner JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-45; Hall C, 2013, CLIN GENITOURIN CANC, V11, P10, DOI 10.1016/j.clgc.2012.09.002; Hardwick JM, 2012, TRENDS CELL BIOL, V22, P318, DOI 10.1016/j.tcb.2012.03.005; He LC, 2013, TOXICOLOGY, V312, P36, DOI 10.1016/j.tox.2013.07.013; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Liljefors M, 2004, INT J ONCOL, V25, P703; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lund K, 2014, MABS, V6; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Ni J, 2013, INT J BIOCHEM CELL B, V45, P2736, DOI 10.1016/j.biocel.2013.09.008; Nunna S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087703; Ogawa K, 2014, ANN SURG ONCOL, V21, P1314, DOI 10.1245/s10434-013-3430-7; Ohno S, 2013, BREAST CANC RES TREA; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Qu C, 2013, MOL CELL BIOCH; Russo F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-56; Sorrentino MF, 2012, CARDIOL J, V19, P453, DOI 10.5603/CJ.2012.0084; Takahashi K, 2013, INT J ONCOL, V43, P1985, DOI 10.3892/ijo.2013.2135; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Yang D, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-105	37	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102590	10.1371/journal.pone.0102590	http://dx.doi.org/10.1371/journal.pone.0102590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019346	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600095
J	Kylaniemi, MK; Kaukonen, R; Myllyviita, J; Rasool, O; Lahesmaa, R				Kylaniemi, Minna K.; Kaukonen, Riina; Myllyviita, Johanna; Rasool, Omid; Lahesmaa, Riitta			The Regulation and Role of c-FLIP in Human Th Cell Differentiation	PLOS ONE			English	Article							NF-KAPPA-B; INHIBITORY PROTEIN EXPRESSION; INTERFERON-GAMMA; UP-REGULATION; LYMPHOCYTE-ACTIVATION; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; SUBUNIT EXPRESSION; GENE-EXPRESSION; DEATH	The early differentiation of T helper (Th) cells is a tightly controlled and finely balanced process, which involves several factors including cytokines, transcription factors and co-stimulatory molecules. Recent studies have shown that in addition to the regulation of apoptosis, caspase activity is also needed for Th cell proliferation and activation and it might play a role in Th cell differentiation. The isoforms of the cellular FLICE inhibitory protein (c-FLIP) are regulators of CASPASE-8 activity and the short isoform, c-FLIPS, has been shown to be up-regulated by IL-4, the Th2 driving cytokine. In this work, we have studied the expression and functional role of three c-FLIP isoforms during the early Th cell differentiation. Only two of the isoforms, c-FLIPS and c-FLIPL, were detected at the protein level although c-FLIPR was expressed at the mRNA level. The knockdown of c-FLIPL led to enhanced Th1 differentiation and elevated IL-4 production by Th2 cells, whereas the knockdown of c-FLIPS diminished GATA3 expression and IL-4 production by Th2 cells. In summary, our results provide new insight into the role of c-FLIP proteins in the early differentiation of human Th cells.	[Kylaniemi, Minna K.; Kaukonen, Riina; Myllyviita, Johanna; Rasool, Omid; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kylaniemi, Minna K.; Kaukonen, Riina; Myllyviita, Johanna; Rasool, Omid; Lahesmaa, Riitta] Abo Akad Univ, Turku, Finland; [Kylaniemi, Minna K.] Abo Akad Univ, Natl Doctoral Programme Informat & Struct Biol, Turku, Finland	University of Turku; Abo Akademi University; Abo Akademi University	Lahesmaa, R (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	riitta.lahesmaa@btk.fi		Kylaniemi, Minna/0000-0001-7374-9862	Centre of Excellence in Molecular Systems Immunology and Physiology Research [250114]; The Academy of Finland; European Union [201106]; The Sigrid Juselius Foundation; Hospital District of Southwest Finland; Waldemar von Frenckell's foundation	Centre of Excellence in Molecular Systems Immunology and Physiology Research; The Academy of Finland(Academy of Finland); European Union(European Commission); The Sigrid Juselius Foundation(Sigrid Juselius Foundation); Hospital District of Southwest Finland; Waldemar von Frenckell's foundation	This work was sponsored by the Centre of Excellence in Molecular Systems Immunology and Physiology Research, no. 250114, The Academy of Finland, European Union FP7 Grant Systems Biology of T cell activation in health and disease, no. 201106, The Sigrid Juselius Foundation (www.sigridjuselius.fi), Hospital District of Southwest Finland, Waldemar von Frenckell's foundation (http://www.foundationweb.net/frenckell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Corn RA, 2003, J IMMUNOL, V171, P1816, DOI 10.4049/jimmunol.171.4.1816; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dohrman A, 2005, J IMMUNOL, V175, P311, DOI 10.4049/jimmunol.175.1.311; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Hinshaw-Makepeace J, 2008, EUR J IMMUNOL, V38, P54, DOI 10.1002/eji.200636956; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kang K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-4; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; Kirchhoff S, 2000, J IMMUNOL, V165, P6293, DOI 10.4049/jimmunol.165.11.6293; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lawless VA, 2000, J IMMUNOL, V165, P6803, DOI 10.4049/jimmunol.165.12.6803; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lund RJ, 2003, EUR J IMMUNOL, V33, P1105, DOI 10.1002/eji.200323899; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nishikomori R, 2002, J IMMUNOL, V169, P4388, DOI 10.4049/jimmunol.169.8.4388; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Rautajoki KJ, 2007, MOL CELL PROTEOMICS, V6, P238, DOI 10.1074/mcp.M600290-MCP200; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehra S, 2005, J IMMUNOL, V174, P3440, DOI 10.4049/jimmunol.174.6.3440; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tai TS, 2004, CELL DEATH DIFFER, V11, P69, DOI 10.1038/sj.cdd.4401316; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tripathi P, 2012, IMMUNOL CELL BIOL, V90, P676, DOI 10.1038/icb.2011.87; Tseveleki V, 2004, J IMMUNOL, V173, P6619, DOI 10.4049/jimmunol.173.11.6619; Ueffing N, 2008, BLOOD, V112, P690, DOI 10.1182/blood-2008-02-141382; Ueffing N, 2009, BLOOD, V114, P572, DOI 10.1182/blood-2009-02-204230; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wu WF, 2004, J IMMUNOL, V172, P4724, DOI 10.4049/jimmunol.172.8.4724; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yeh JH, 1998, J EXP MED, V188, P1795, DOI 10.1084/jem.188.10.1795; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Zhang J, 2009, INT J BIOCHEM CELL B, V41, P1678, DOI 10.1016/j.biocel.2009.02.008; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	63	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102022	10.1371/journal.pone.0102022	http://dx.doi.org/10.1371/journal.pone.0102022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019384	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600036
J	del Campo, M; Sagredo, A; del Campo, L; Villalobo, A; Ferrer, M				del Campo, Marta; Sagredo, Ana; del Campo, Lara; Villalobo, Antonio; Ferrer, Mercedes			Time-Dependent Effect of Orchidectomy on Vascular Nitric Oxide and Thromboxane A(2) Release. Functional Implications to Control Cell Proliferation through Activation of the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							ACETYLCHOLINE-INDUCED RELAXATION; ARTERY SMOOTH-MUSCLE; PROTEIN-KINASE; ENDOTHELIAL DYSFUNCTION; MESENTERIC-ARTERIES; SEX-HORMONES; INCREASES; TESTOSTERONE; PROSTANOIDS; ANDROGENS	This study analyzes whether the release of nitric oxide (NO) and thromboxane A(2) (TXA(2)) depends on the time lapsed since gonadal function is lost, and their correlation with the proliferation of vascular smooth muscle cells (VSMC) mediated by the epidermal growth factor receptor (EGFR). For this purpose, aortic and mesenteric artery segments from control and 6-weeks or 5-months orchidectomized rats were used to measure NO and TXA(2) release. The results showed that the basal and acetylcholine (ACh)-induced NO release were decreased 6 weeks post-orchidectomy both in aorta and mesenteric artery, but were recovered 5 months thereafter up to levels similar to those found in arteries from control rats. The basal and ACh-induced TXA(2) release increased in aorta and mesenteric artery 6 weeks post-orchidectomy, and was maintained at high levels 5 months thereafter. Since we previously observed that orchidectomy, which decreased testosterone level, enlarged the muscular layer of mesenteric arteries, the effect of testosterone on VSMC proliferation was analyzed. The results showed that treatment of cultured VSMC with testosterone downregulated mitogenic signaling pathways initiated by the ligand-dependent activation of the EGFR. In contrast, the EGFR pathways were constitutively active in mesenteric arteries of long-term orchidectomized rats. Thus, the exposure of mesenteric arteries from control rats to epidermal growth factor (EGF) induced the activation of EGFR signaling pathways. However, the addition of EGF to arteries from orchidectomized rats failed to induce a further activation of these pathways. In conclusion, this study shows that the release of NO depends on the time lapsed since the gonadal function is lost, while the release of TXA(2) is already increased after short periods post-orchidectomy. The alterations in these signaling molecules could contribute to the constitutive activation of the EGFR and its downstream signaling pathways after long period post-orchidectomy enhancing the proliferation of the vascular muscular layer.	[del Campo, Marta; Sagredo, Ana; del Campo, Lara; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [del Campo, Lara; Ferrer, Mercedes] Hosp La Paz, Inst Invest Sanit IdIPAZ, Madrid, Spain; [del Campo, Marta; Villalobo, Antonio] CSIC, Inst Invest Biomed, Madrid, Spain; [del Campo, Marta; Villalobo, Antonio] Univ Autonoma Madrid, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	mercedes.ferrer@uam.es	Villalobo, Antonio/K-2902-2017; Parra, Mercedes Ferrer/AAE-1746-2020; del Campo Milan, Marta/K-5405-2016; Villalobo, Antonio/O-9621-2019; Ferrer, Mercedes/E-3556-2018; del Campo Milán, Lara/ABD-4219-2021; del Campo, Lara/A-8317-2015	Parra, Mercedes Ferrer/0000-0002-4670-7146; del Campo Milan, Marta/0000-0003-2808-3699; Villalobo, Antonio/0000-0002-4200-374X; del Campo Milán, Lara/0000-0002-0394-116X; del Campo, Lara/0000-0002-0394-116X	Fondo de Investigaciones Sanitarias [PI1100406]; Fondo Europeo de Desarrollo Regional; Secretaria de Estado de Investigacion, Desarrollo e Innovacion [SAF2011-23494]; Consejeria de Educacion de la Comunidad de Madrid [S2011/BMD-2349]; European Commission [PITN-GA-2011-289033]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional(European Commission); Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Consejeria de Educacion de la Comunidad de Madrid; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants to M.F. from the Fondo de Investigaciones Sanitarias (PI1100406) and Fondo Europeo de Desarrollo Regional, and grants to A.V. from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (SAF2011-23494), the Consejeria de Educacion de la Comunidad de Madrid (S2011/BMD-2349), and the European Commission (contract PITN-GA-2011-289033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4; Ba ZF, 2001, ARCH SURG-CHICAGO, V136, P1158, DOI 10.1001/archsurg.136.10.1158; Blanco-Rivero J, 2006, J VASC RES, V43, P101, DOI 10.1159/000089791; Blanco-Rivero J, 2005, J VASC RES, V42, P526, DOI 10.1159/000088342; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2006, J ENDOCRINOL, V190, P771, DOI 10.1677/joe.1.06887; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Cao Jian, 2010, Chinese Medical Sciences Journal, V25, P44; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cutini PH, 2012, J STEROID BIOCHEM, V132, P322, DOI 10.1016/j.jsbmb.2012.08.001; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo L, 2013, CLIN SCI, V124, P719, DOI 10.1042/CS20120700; Estrada C, 1997, BIOCHEM J, V326, P369, DOI 10.1042/bj3260369; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; Fernandez-Martinez AB, 2013, BBA-MOL CELL RES, V1833, P2029, DOI 10.1016/j.bbamcr.2013.04.013; Ferrer M, 1998, ENDOTHELIUM-NEW YORK, V6, P133, DOI 10.3109/10623329809072200; Formoso G, 2006, MOL ENDOCRINOL, V20, P1153, DOI 10.1210/me.2005-0266; Gallet C, 2003, BIOCHEM J, V371, P733, DOI 10.1042/BJ20021030; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; Gonzales RJ, 2004, AM J PHYSIOL-HEART C, V286, pH552, DOI 10.1152/ajpheart.00663.2003; Gonzales RJ, 2005, AM J PHYSIOL, V286, P552; Guder G, 2010, HEART, V96, P504, DOI 10.1136/hrt.2009.181065; Jones TH, 2010, TRENDS ENDOCR REV, V24, P313; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Matz RL, 2000, BRIT J PHARMACOL, V131, P303, DOI 10.1038/sj.bjp.0703568; MORINELLI TA, 1994, J BIOL CHEM, V269, P5693; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Myers SI, 1996, PROSTAG LEUKOTR ESS, V54, P403, DOI 10.1016/S0952-3278(96)90023-X; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Perusquia M, 2012, VASC PHARMACOL, V56, P176, DOI 10.1016/j.vph.2012.01.008; Perusquia M, 2010, AM J PHYSIOL-HEART C, V298, pH1301, DOI 10.1152/ajpheart.00753.2009; Sagredo A, 2011, JOINT M EUR SOC MICR; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Shimokawa H, 1998, J Atheroscler Thromb, V4, P118; Simoncini T, 2003, ENDOCRINOLOGY, V144, P3449, DOI 10.1210/en.2003-0044; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Villalobo A, 2007, DYN CELL BIOL, V1, P60; Wang Y, 2014, J ATHEROSCLER THROMB, V21, P204, DOI 10.5551/jat.19448; Wynne FL, 2003, J ENDOCRINOL INVEST, V26, P181, DOI 10.1007/BF03345150; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719; Yu J, 2012, BIOCHEM BIOPH RES CO, V424, P538, DOI 10.1016/j.bbrc.2012.06.151	51	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102523	10.1371/journal.pone.0102523	http://dx.doi.org/10.1371/journal.pone.0102523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013941	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400101
J	Finlay, MC; Ahmed, AK; Sugrue, A; Bhar-Amato, J; Quarta, G; Pantazis, A; Ciaccio, EJ; Syrris, P; Sen-Chowdhry, S; Ben-Simon, R; Chow, AW; Lowe, MD; Segal, OR; McKenna, WJ; Lambiase, PD				Finlay, Malcolm C.; Ahmed, Akbar K.; Sugrue, Alan; Bhar-Amato, Justine; Quarta, Giovanni; Pantazis, Antonis; Ciaccio, Edward J.; Syrris, Petros; Sen-Chowdhry, Srijita; Ben-Simon, Ron; Chow, Anthony W.; Lowe, Martin D.; Segal, Oliver R.; McKenna, William J.; Lambiase, Pier D.			Dynamic Conduction and Repolarisation Changes in Early Arrhythmogenic Right Ventricular Cardiomyopathy versus Benign Outflow Tract Ectopy Demonstrated by High Density Mapping & Paced Surface ECG Analysis	PLOS ONE			English	Article							T-WAVE; MUTATIONS; DYSPLASIA/CARDIOMYOPATHY; ABNORMALITIES; ELECTROGRAMS; TACHYCARDIA; DISEASE; STIMULATION; RESTITUTION; VALIDATION	The concealed phase of arrhythmogenic right ventricular cardiomyopathy (ARVC) may initially manifest electrophysiologically. No studies have examined dynamic conduction/repolarization kinetics to distinguish benign right ventricular outflow tract ectopy (RVOT ectopy) from ARVC's early phase. We investigated dynamic endocardial electrophysiological changes that differentiate early ARVC disease expression from RVOT ectopy. Methods: 22 ARVC (12 definite based upon family history and mutation carrier status, 10 probable) patients without right ventricular structural anomalies underwent high-density non-contact mapping of the right ventricle. These were compared to data from 14 RVOT ectopy and 12 patients with supraventricular tachycardias and normal hearts. Endocardial & surface ECG conduction and repolarization parameters were assessed during a standard S1-S2 restitution protocol. Results: Definite ARVC without RV structural disease could not be clearly distinguished from RVOT ectopy during sinus rhythm or during steady state pacing. Delay in Activation Times at coupling intervals just above the ventricular effective refractory period (VERP) increased in definite ARVC (43 +/- 20 ms) more than RVOT ectopy patients (36 +/- 14 ms, p = 0.03) or Normals (25 +/- 16 ms, p = 0.008) and a progressive separation of the repolarisation time curves between groups existed. Repolarization time increases in the RVOT were also greatest in ARVC (definite ARVC: 18620 ms; RVOT ectopy: 5 +/- 14, Normal: 1 +/- 18, p, 0.05). Surface ECG correlates of these intracardiac measurements demonstrated an increase of greater than 48 ms in stimulus to surface ECG J-point pre-ERP versus steady state, with an 88% specificity and 68% sensitivity in distinguishing definite ARVC from the other groups. This technique could not distinguish patients with genetic predisposition to ARVC only (probable ARVC) from controls. Conclusions: Significant changes in dynamic conduction and repolarization are apparent in early ARVC before detectable RV structural abnormalities, and were present to a lesser degree in probable ARVC patients. Investigation of dynamic electrophysiological parameters may be useful to identify concealed ARVC in patients without disease pedigrees by using endocardial electrogram or paced ECG parameters.	[Finlay, Malcolm C.; Ahmed, Akbar K.; Sugrue, Alan; Bhar-Amato, Justine; Quarta, Giovanni; Pantazis, Antonis; Syrris, Petros; Sen-Chowdhry, Srijita; Ben-Simon, Ron; Chow, Anthony W.; Lowe, Martin D.; Segal, Oliver R.; McKenna, William J.; Lambiase, Pier D.] UCL, Inst Cardiovasc Sci, London, England; [Ciaccio, Edward J.] Columbia Univ, Dept Med, New York, NY USA	University of London; University College London; Columbia University	Lambiase, PD (corresponding author), UCL, Inst Cardiovasc Sci, London, England.	pier.lambiase@uclh.nhs.uk	Sugrue, Alan/AAN-8589-2021; Lambiase, Pier/L-8534-2019; SYRRIS, PETROS/C-1703-2008; McKenna, William J/C-3243-2008; Finlay, Malcolm/Q-2363-2015	Lambiase, Pier/0000-0002-9055-9267; SYRRIS, PETROS/0000-0002-2363-8758; McKenna, William J/0000-0001-7994-2460; Finlay, Malcolm/0000-0001-6403-9340	Heart Research UK [RG2582]; Wellcome Trust Research Training Fellowship; British Heart Foundation Project [BHF-PG/05/112]; University College London Hospital Biomedicine National Institute of Health Research, Educational Grant; St Jude Medical and the Stephen Lyness Research Fund;  [WT093879MA]; British Heart Foundation [FS/10/011/27881] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10230] Funding Source: researchfish	Heart Research UK; Wellcome Trust Research Training Fellowship(Wellcome Trust); British Heart Foundation Project(British Heart Foundation); University College London Hospital Biomedicine National Institute of Health Research, Educational Grant; St Jude Medical and the Stephen Lyness Research Fund; ; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Heart Research UK, Grant no. RG2582; http://www. heartresearch. org. uk/(to JB); Wellcome Trust Research Training Fellowship, Grant no. WT093879MA; http://www. wellcome. ac. uk/(to MF); British Heart Foundation Project, Grant no. BHF-PG/05/112; www. bhf. org. uk (to PL); University College London Hospital Biomedicine National Institute of Health Research, Educational Grant, St Jude Medical and the Stephen Lyness Research Fund (to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avella A, 2010, HEART RHYTHM, V7, P828, DOI 10.1016/j.hrthm.2010.01.016; Cerrone M., 2013, CIRCULATION; Cerrone M, 2012, CARDIOVASC RES, V95, P460, DOI 10.1093/cvr/cvs218; Ciaccio EJ, 2000, CIRCULATION, V102, P464; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; Corrado D, 2010, CIRCULATION, V122, P1144, DOI 10.1161/CIRCULATIONAHA.109.913871; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; de Bakker JMT, 2010, CIRC-ARRHYTHMIA ELEC, V3, P204, DOI 10.1161/CIRCEP.109.904763; Delmar M, 2012, PEDIATR CARDIOL, V33, P975, DOI 10.1007/s00246-012-0257-0; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; FRANZ MR, 1987, CIRCULATION, V75, P379, DOI 10.1161/01.CIR.75.2.379; Gomes J, 2012, EUR HEART J, V33, P1942, DOI 10.1093/eurheartj/ehr472; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Haqqani HM, 2012, CIRC-ARRHYTHMIA ELEC, p[6, 1123]; Imai K., 2009, ZELIG EVERYONES STAT; Kawara T, 2001, CIRCULATION, V104, P3069, DOI 10.1161/hc5001.100833; Lambiase PD, 2009, CIRCULATION, V120, P106, DOI 10.1161/CIRCULATIONAHA.108.771401; Lambiase PD, 2004, HEART, V90, P44, DOI 10.1136/heart.90.1.44; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Pinheiro J., 2019, NLME LINEAR NONLINEA; Potse M, 2007, ANATOL J CARDIOL, V7, P164; Potse M, 2009, AM J PHYSIOL-HEART C, V297, pH792, DOI 10.1152/ajpheart.00064.2009; Quarta G, 2010, HEART, V96, P516, DOI 10.1136/hrt.2009.182949; Saffitz JE, 2009, HEART RHYTHM, V6, pS62, DOI 10.1016/j.hrthm.2009.03.003; Santangeli P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P632, DOI 10.1161/CIRCEP.110.958116; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Schilling RJ, 1998, CIRCULATION, V98, P887, DOI 10.1161/01.CIR.98.9.887; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Tandri H, 2009, HEART RHYTHM, V6, P769, DOI 10.1016/j.hrthm.2009.02.031; Team RCD, 2010, R LANG ENV STAT COMP; THERNEAU TM, 2010, RPART RECURSIVE PART, P1; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; Yue AM, 2004, CIRCULATION, V110, P1343, DOI 10.1161/01.CIR.0000141734.43393.BE	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e99125	10.1371/journal.pone.0099125	http://dx.doi.org/10.1371/journal.pone.0099125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014132	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400005
J	Leuenberger, T; Pfueller, CF; Luessi, F; Bendix, I; Paterka, M; Prozorovski, T; Treue, D; Luenstedt, S; Herz, J; Siffrin, V; Infante-Duarte, C; Zipp, F; Waiczies, S				Leuenberger, Tina; Pfueller, Caspar F.; Luessi, Felix; Bendix, Ivo; Paterka, Magdalena; Prozorovski, Timour; Treue, Denise; Luenstedt, Sarah; Herz, Josephine; Siffrin, Volker; Infante-Duarte, Carmen; Zipp, Frauke; Waiczies, Sonia			Modulation of Dendritic Cell Immunobiology via Inhibition of 3-Hydroxy-3-Methylglutaryl-CoA (HMG-CoA) Reductase	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; REGULATORY T-CELLS; HEMATOPOIETIC PROGENITOR CELLS; STEADY-STATE; IN-VITRO; SIMVASTATIN TREATMENT; INTERFERON BETA-1A; CONTROLLED-TRIAL; ATORVASTATIN; TOLERANCE	The maturation status of dendritic cells determines whether interacting T cells are activated or if they become tolerant. Previously we could induce T cell tolerance by applying a 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitor (HMGCRI) atorvastatin, which also modulates MHC class II expression and has therapeutic potential in autoimmune disease. Here, we aimed at elucidating the impact of this therapeutic strategy on T cell differentiation as a consequence of alterations in dendritic cell function. We investigated the effect of HMGCRI during differentiation of peripheral human monocytes and murine bone marrow precursors to immature DC in vitro and assessed their phenotype. To examine the stimulatory and tolerogenic capacity of these modulated immature dendritic cells, we measured proliferation and suppressive function of CD4+ T cells after stimulation with the modulated immature dendritic cells. We found that an HMGCRI, atorvastatin, prevents dendrite formation during the generation of immature dendritic cells. The modulated immature dendritic cells had a diminished capacity to take up and present antigen as well as to induce an immune response. Of note, the consequence was an increased capacity to differentiate naive T cells towards a suppressor phenotype that is less sensitive to proinflammatory stimuli and can effectively inhibit the proliferation of T effector cells in vitro. Thus, manipulation of antigen-presenting cells by HMGCRI contributes to an attenuated immune response as shown by promotion of T cells with suppressive capacities.	[Leuenberger, Tina; Luessi, Felix; Paterka, Magdalena; Siffrin, Volker; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Rhine Main Neurosci Network Rmn2, Dept Neurol,Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany; [Leuenberger, Tina; Paterka, Magdalena; Luenstedt, Sarah; Siffrin, Volker; Zipp, Frauke] Max Delbrueck Ctr Mol Med Berlin Buch, Berlin, Germany; [Pfueller, Caspar F.] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Bendix, Ivo; Herz, Josephine] Univ Hosp Essen, Dept Pediat Neonatol 1, Essen, Germany; [Prozorovski, Timour] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Treue, Denise] Charite, Inst Pathol, D-13353 Berlin, Germany; [Infante-Duarte, Carmen] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Waiczies, Sonia] Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany	Johannes Gutenberg University of Mainz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Heinrich Heine University Dusseldorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Luessi, F (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Rhine Main Neurosci Network Rmn2, Dept Neurol,Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany.	luessi@uni-mainz.de	Siffrin, Volker/AAR-3632-2021; Waiczies, Sonia/H-4181-2012; Zipp, Frauke/C-9968-2015	Waiczies, Sonia/0000-0002-9916-9572; Zipp, Frauke/0000-0002-1231-1928; Infante Duarte, Carmen/0000-0003-3005-351X; Siffrin, Volker/0000-0002-1532-2868; Treue, Denise/0000-0002-0657-5505; Bendix, Ivo/0000-0002-9751-3640	Deutsche Forschungsgemeinschaft (DFG) [SFB-TRR 43, SFB 650, GRK1258]; Johannes Gutenberg-University Mainz (JGU)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Johannes Gutenberg-University Mainz (JGU)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) to F. Z. (SFB-TRR 43 and SFB 650) and to T. L. and J. H. (GRK1258), and the Johannes Gutenberg-University Mainz (JGU) to F. L. (MAIFOR-grant and grant from the "Inneruniversitare Forschungsforderung (Stufe I)''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Birnbaum G, 2008, NEUROLOGY, V71, P1390, DOI 10.1212/01.wnl.0000319698.40024.1c; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Chataway J, 2014, LANCET; Cools N, 2007, J LEUKOCYTE BIOL, V82, P1365, DOI 10.1189/jlb.0307166; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hugues S, 2010, SEMIN IMMUNOPATHOL, V32, P227, DOI 10.1007/s00281-010-0211-2; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Johansson SM, 2008, IMMUNOLOGY, V123, P491, DOI 10.1111/j.1365-2567.2007.02714.x; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kamm CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086663; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laman JD, 1997, IMMUNOL TODAY, V18, P272, DOI 10.1016/S0167-5699(97)80022-9; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Legge KL, 2002, J EXP MED, V196, P217, DOI 10.1084/jem.20011061; Li XL, 2013, MOL CELL NEUROSCI, V56, P85, DOI 10.1016/j.mcn.2013.03.005; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Rudick RA, 2009, NEUROLOGY, V72, P1989, DOI 10.1212/WNL.0b013e3181a92b96; Scheffold A, 2007, NAT IMMUNOL, V8, P1285, DOI 10.1038/ni1207-1285; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sorensen PS, 2011, LANCET NEUROL, V10, P691, DOI 10.1016/S1474-4422(11)70144-2; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Togha M, 2010, MULT SCLER J, V16, P848, DOI 10.1177/1352458510369147; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Waiczies S, 2005, J IMMUNOL, V174, P5630, DOI 10.4049/jimmunol.174.9.5630; Waiczies S, 2007, J IMMUNOL, V179, P6024, DOI 10.4049/jimmunol.179.9.6024; Weber MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-29; Xu H, 2014, J NEUROIMMUNOL, V269, P28, DOI 10.1016/j.jneuroim.2014.02.002; Yates SF, 2007, J IMMUNOL, V179, P967, DOI 10.4049/jimmunol.179.2.967; Yilmaz A, 2004, ATHEROSCLEROSIS, V172, P85, DOI 10.1016/j.atherosclerosis.2003.10.002; Yilmaz A, 2006, J LEUKOCYTE BIOL, V79, P529, DOI 10.1189/jlb.0205064; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zhang Y, 1999, BLOOD, V93, P1208, DOI 10.1182/blood.V93.4.1208.404k05_1208_1220; Zhang Y, 1997, BLOOD, V90, P4842, DOI 10.1182/blood.V90.12.4842.4842_4842_4853	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100871	10.1371/journal.pone.0100871	http://dx.doi.org/10.1371/journal.pone.0100871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013913	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000339378400014
J	Fernandez-Banares, F; Carrasco, A; Garcia-Puig, R; Rosinach, M; Gonzalez, C; Alsina, M; Loras, C; Salas, A; Viver, JM; Esteve, M				Fernandez-Banares, Fernando; Carrasco, Anna; Garcia-Puig, Roger; Rosinach, Merce; Gonzalez, Clarisa; Alsina, Montserrat; Loras, Carme; Salas, Antonio; Viver, Josep M.; Esteve, Maria			Intestinal Intraepithelial Lymphocyte Cytometric Pattern Is More Accurate than Subepithelial Deposits of Anti-Tissue Transglutaminase IgA for the Diagnosis of Celiac Disease in Lymphocytic Enteritis	PLOS ONE			English	Article							GLUTEN-SENSITIVE ENTEROPATHY; FLOW-CYTOMETRY; HELICOBACTER-PYLORI; T-LYMPHOCYTES; ANTIBODIES; CHILDREN; MUCOSA; CELLS; ANTIGLIADIN; DUODENOSIS	Background & Aims: An increase in CD3+TCR gamma delta+ and a decrease in CD3- intraepithelial lymphocytes (IEL) is a characteristic flow cytometric pattern of celiac disease (CD) with atrophy. The aim was to evaluate the usefulness of both CD IEL cytometric pattern and anti-TG2 IgA subepithelial deposit analysis (CD IF pattern) for diagnosing lymphocytic enteritis due to CD. Methods: Two-hundred and five patients (144 females) who underwent duodenal biopsy for clinical suspicion of CD and positive celiac genetics were prospectively included. Fifty had villous atrophy, 70 lymphocytic enteritis, and 85 normal histology. Eight patients with non-celiac atrophy and 15 with lymphocytic enteritis secondary to Helicobacter pylori acted as control group. Duodenal biopsies were obtained to assess both CD IEL flow cytometric (complete or incomplete) and IF patterns. Results: Sensitivity of IF, and complete and incomplete cytometric patterns for CD diagnosis in patients with positive serology (Marsh 1+3) was 92%, 85 and 97% respectively, but only the complete cytometric pattern had 100% specificity. Twelve seropositive and 8 seronegative Marsh 1 patients had a CD diagnosis at inclusion or after gluten free-diet, respectively. CD cytometric pattern showed a better diagnostic performance than both IF pattern and serology for CD diagnosis in lymphocytic enteritis at baseline (95% vs 60% vs 60%, p = 0.039). Conclusions: Analysis of the IEL flow cytometric pattern is a fast, accurate method for identifying CD in the initial diagnostic biopsy of patients presenting with lymphocytic enteritis, even in seronegative patients, and seems to be better than anti-TG2 intestinal deposits.	[Fernandez-Banares, Fernando; Carrasco, Anna; Rosinach, Merce; Loras, Carme; Viver, Josep M.; Esteve, Maria] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Gastroenterol, CIBERehd, Terrassa, Barcelona, Spain; [Garcia-Puig, Roger] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Pediat, Terrassa, Barcelona, Spain; [Gonzalez, Clarisa; Salas, Antonio] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Pathol, CIBERehd, Terrassa, Barcelona, Spain; [Alsina, Montserrat] CATLAB, Dept Immunol, Viladecavalls, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Mutua Terrassa; University of Barcelona	Fernandez-Banares, F (corresponding author), Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Gastroenterol, CIBERehd, Terrassa, Barcelona, Spain.	ffbanares@mutuaterrassa.es		Carrasco, Anna/0000-0001-8810-1583; Fernandez-Banares, Fernando/0000-0002-1489-504X; ESTEVE, MARIA/0000-0001-7716-0027; ESTEVE, MARIA/0000-0002-3178-7008; LORAS ALASTRUEY, CARME/0000-0002-4035-3316	Instituto de Salud Carlos III (Ministry of Health, Spain) [PI10/00892]	Instituto de Salud Carlos III (Ministry of Health, Spain)(Instituto de Salud Carlos IIISpanish Government)	The study was sponsored by a grant from the Instituto de Salud Carlos III (PI10/00892, Ministry of Health, Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz I, 2010, ALIMENT PHARM THER, V32, P1392, DOI 10.1111/j.1365-2036.2010.04477.x; Calleja S, 2011, DIGEST DIS SCI, V56, P2042, DOI 10.1007/s10620-010-1534-5; Camarero C, 2000, ACTA PAEDIATR, V89, P285, DOI 10.1080/080352500750028410; Carroccio A, 2006, CLIN CHEM, V52, P1175, DOI 10.1373/clinchem.2005.061366; Catassi C, 2010, AM J MED, V123, P691, DOI 10.1016/j.amjmed.2010.02.019; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; CHORZELSKI TP, 1984, BRIT J DERMATOL, V111, P395, DOI 10.1111/j.1365-2133.1984.tb06601.x; Eiras P, 1998, CYTOMETRY, V34, P95, DOI 10.1002/(SICI)1097-0320(19980415)34:2<95::AID-CYTO6>3.0.CO;2-B; Farre C., 2002, THESIS U BARCELONA; Forne M, 2000, AM J GASTROENTEROL, V95, P2200, DOI 10.1111/j.1572-0241.2000.02303.x; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jarvinen TT, 2003, AM J GASTROENTEROL, V98, P1332, DOI 10.1016/S0002-9270(03)00230-2; Kakar S, 2003, AM J GASTROENTEROL, V98, P2027, DOI 10.1016/S0002-9270(03)00542-2; Kokkonen J, 2000, SCAND J GASTROENTERO, V35, P1137, DOI 10.1080/003655200750056592; Koskinen O, 2010, J CLIN GASTROENTEROL, V44, P483, DOI 10.1097/MCG.0b013e3181b64557; KUTLU T, 1993, GUT, V34, P208, DOI 10.1136/gut.34.2.208; Leon F, 2003, GASTROENTEROLOGY, V125, P345, DOI 10.1016/S0016-5085(03)00886-2; Leon F, 2011, J IMMUNOL METHODS, V363, P177, DOI 10.1016/j.jim.2010.09.002; Lindfors K, 2011, INT REV IMMUNOL, V30, P185, DOI 10.3109/08830185.2011.595854; Maglio M, 2011, DIGEST LIVER DIS, V43, P604, DOI 10.1016/j.dld.2011.01.015; MAKI M, 1991, GUT, V32, P1412, DOI 10.1136/gut.32.11.1412; Marine M, 2011, ALIMENT PHARM THER, V33, P477, DOI 10.1111/j.1365-2036.2010.04543.x; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Olivencia Palomar Pilar, 2008, Gastroenterol Hepatol, V31, P555, DOI 10.1157/13128293; Rosinach M, 2012, DIGEST LIVER DIS, V44, P643, DOI 10.1016/j.dld.2012.03.006; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Salmi TT, 2010, DIGEST LIVER DIS, V42, P28, DOI 10.1016/j.dld.2009.04.004; Santaolalla R, 2008, ALIMENT PHARM THER, V27, P820, DOI 10.1111/j.1365-2036.2008.03652.x; SAVILAHTI E, 1990, PEDIATR RES, V28, P579, DOI 10.1203/00006450-199012000-00005; Tosco A, 2013, CLIN EXP IMMUNOL, V171, P69, DOI 10.1111/j.1365-2249.2012.04673.x; Tosco A, 2008, J PEDIATR GASTR NUTR, V47, P293, DOI 10.1097/MPG.0b013e3181677067; TREJDOSIEWICZ LK, 1991, CLIN EXP IMMUNOL, V84, P440; Tursi A, 2001, AM J GASTROENTEROL, V96, P1507; Verbeek WHM, 2008, AM J GASTROENTEROL, V103, P3152, DOI 10.1111/j.1572-0241.2008.02213.x; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15; Wahab PJ, 2001, AM J GASTROENTEROL, V96, P1464, DOI 10.1111/j.1572-0241.2001.03812.x; Walker MM, 2011, HISTOPATHOLOGY, V59, P166, DOI 10.1111/j.1365-2559.2010.03680.x	39	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101249	10.1371/journal.pone.0101249	http://dx.doi.org/10.1371/journal.pone.0101249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010214	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800017
J	Josowitz, R; Lu, J; Falce, C; D'Souza, SL; Wu, M; Cohen, N; Dubois, NC; Zhao, Y; Sobie, EA; Fishman, GI; Gelb, BD				Josowitz, Rebecca; Lu, Jia; Falce, Christine; D'Souza, Sunita L.; Wu, Meng; Cohen, Ninette; Dubois, Nicole C.; Zhao, Yong; Sobie, Eric A.; Fishman, Glenn I.; Gelb, Bruce D.			Identification and Purification of Human Induced Pluripotent Stem Cell-Derived Atrial-Like Cardiomyocytes Based on Sarcolipin Expression	PLOS ONE			English	Article							MATURATION; PHARMACOLOGY; SELECTION; PROTEIN; MUSCLE	The use of human stem cell-derived cardiomyocytes to study atrial biology and disease has been restricted by the lack of a reliable method for stem cell-derived atrial cell labeling and purification. The goal of this study was to generate an atrial-specific reporter construct to identify and purify human stem cell-derived atrial-like cardiomyocytes. We have created a bacterial artificial chromosome (BAC) reporter construct in which fluorescence is driven by expression of the atrial-specific gene sarcolipin (SLN). When purified using flow cytometry, cells with high fluorescence specifically express atrial genes and display functional calcium handling and electrophysiological properties consistent with atrial cardiomyocytes. Our data indicate that SLN can be used as a marker to successfully monitor and isolate hiPSC-derived atrial-like cardiomyocytes. These purified cells may find many applications, including in the study of atrial-specific pathologies and chamber-specific lineage development.	[Josowitz, Rebecca; Wu, Meng; Dubois, Nicole C.; Zhao, Yong; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Lu, Jia; Fishman, Glenn I.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA; [Falce, Christine; Sobie, Eric A.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [D'Souza, Sunita L.; Dubois, Nicole C.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Wu, Meng; Cohen, Ninette; Zhao, Yong; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Fishman, Glenn I.] NYU, Sch Med, Dept Med, New York, NY USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai	Gelb, BD (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.	bruce.gelb@mssm.edu	Wu, Meng/J-8515-2016	Wu, Meng/0000-0001-5512-9651; Fishman, Glenn/0000-0002-2366-8527	Empire State Stem Cell Fund through New York State Department of Health [NYSTEM N08T-020, NYSTEM N11G-032]; National Institutes of Health [R01 HL113499, R01 HL105983, R01 HL076230]; American Heart Association [12PRE12060254]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105983, R01HL076230, R01HL113499] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM N08T-020, http://stemcell.ny.gov/) to BDG; National Institutes of Health (R01 HL113499, https://www.nhlbi.nih.gov/) to BDG; American Heart Association (12PRE12060254, https://my.americanheart.org) to RJ; Empire State Stem Cell Fund through New York State Department of Health (NYSTEM N11G-032, http://stemcell.ny.gov/) to GIF; National Institutes of Health (R01 HL105983, https://www.nhlbi.nih.gov/) to GIF; and National Institutes of Health (R01 HL076230, https://www.nhlbi.nih.gov/) to EAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bootman MD, 2011, BBA-MOL CELL RES, V1813, P922, DOI 10.1016/j.bbamcr.2011.01.030; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Don CW, 2013, J CELL MOL MED, V17, P1355, DOI 10.1111/jcmm.12147; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Hatem SN, 2010, J MOL CELL CARDIOL, V48, P90, DOI 10.1016/j.yjmcc.2009.08.029; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Small EM, 2004, TRENDS CARDIOVAS MED, V14, P13, DOI 10.1016/j.tcm.2003.09.005; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; VARRO A, 1993, ACTA PHYSIOL SCAND, V149, P133, DOI 10.1111/j.1748-1716.1993.tb09605.x; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Willems E, 2011, CIRC RES, V109, P360, DOI 10.1161/CIRCRESAHA.111.249540; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558	31	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101316	10.1371/journal.pone.0101316	http://dx.doi.org/10.1371/journal.pone.0101316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010565	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800020
J	Rabeony, H; Petit-Paris, I; Garnier, J; Barrault, C; Pedretti, N; Guilloteau, K; Jegou, JF; Guillet, G; Huguier, V; Lecron, JC; Bernard, FX; Morel, F				Rabeony, Hanitriniaina; Petit-Paris, Isabelle; Garnier, Julien; Barrault, Christine; Pedretti, Nathalie; Guilloteau, Karline; Jegou, Jean-Francois; Guillet, Gerard; Huguier, Vincent; Lecron, Jean-Claude; Bernard, Francois-Xavier; Morel, Franck			Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1 alpha, TNF alpha and Oncostatin M	PLOS ONE			English	Article							CYTOKINE PRODUCTION; T-LYMPHOCYTES; EXPRESSION; PSORIASIS; EPIDERMIS; PERTURBATION; MECHANISMS; DEFENSE; DISEASE; GENES	Keratinocyte differentiation program leading to an organized epidermis plays a key role in maintaining the first line of defense of the skin. Epidermal integrity is regulated by a tight communication between keratinocytes and leucocytes, particularly under cytokine control. Imbalance of the cytokine network leads to inflammatory diseases such as psoriasis. Our attempt to model skin inflammation showed that the combination of IL-17A, IL-22, IL-1 alpha, OSM and TNF alpha (Mix M5) synergistically increases chemokine and antimicrobial-peptide expression, recapitulating some features of psoriasis. Other characteristics of psoriasis are acanthosis and down-regulation of keratinocyte differentiation markers. Our aim was to characterize the specific roles of these cytokines on keratinocyte differentiation, and to compare with psoriatic lesion features. All cytokines decrease keratinocyte differentiation markers, but IL-22 and OSM were the most powerful, and the M5 strongly synergized the effects. In addition, IL-22 and OSM induced epidermal hyperplasia in vitro and M5 induced epidermal thickening and decreased differentiation marker expression in a mouse model, as observed in human psoriatic skin lesions. This study highlights the precise role of cytokines in the skin inflammatory response. IL-22 and OSM more specifically drive epidermal hyperplasia and differentiation loss while IL-1 alpha, IL-17A and TNF alpha were more involved in the activation of innate immunity.	[Rabeony, Hanitriniaina; Petit-Paris, Isabelle; Guilloteau, Karline; Jegou, Jean-Francois; Lecron, Jean-Claude; Bernard, Francois-Xavier; Morel, Franck] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, Equipe Accueil 4331, Poitiers, France; [Petit-Paris, Isabelle; Lecron, Jean-Claude] Ctr Hosp Univ Poitiers, Lab Immunol & Inflammat, Poitiers, France; [Garnier, Julien; Barrault, Christine; Pedretti, Nathalie; Bernard, Francois-Xavier] BIOalternatives, Gencay, France; [Guillet, Gerard] Ctr Hosp Univ Poitiers, Serv Dermatol, Poitiers, France; [Huguier, Vincent] Ctr Hosp Univ Poitiers, Serv Chirurg Plast, Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Morel, F (corresponding author), Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, Equipe Accueil 4331, Poitiers, France.	f.morel@univ-poitiers.fr	Morel, Franck/AAI-4274-2021	Morel, Franck/0000-0003-3812-9304; LECRON, Jean-Claude/0000-0003-3990-5213; Rabeony, Hanitriniaina/0000-0001-6470-0514; Jegou, Jean-Francois/0000-0002-9703-5976	Poitiers University Hospital (PHRC); "La Ligue contre le cancer"; "Association Nationale de Recherche et de la Technologie"; "le conseil regional de la region Poitou-Charentes"	Poitiers University Hospital (PHRC); "La Ligue contre le cancer"(Ligue nationale contre le cancer); "Association Nationale de Recherche et de la Technologie"; "le conseil regional de la region Poitou-Charentes"(Region Nouvelle-Aquitaine)	This study was supported by grants from a clinical research program from Poitiers University Hospital (PHRC), "La Ligue contre le cancer", "Association Nationale de Recherche et de la Technologie" and from "le conseil regional de la region Poitou-Charentes". H. Rabeony is supported by "le conseil regional de la region Poitou-Charentes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 1999, J IMMUNOL, V162, P494; Bernard Francois-Xavier, 2012, J Allergy (Cairo), V2012, P718725, DOI 10.1155/2012/718725; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kupetsky EA, 2013, CYTOKINE, V61, P704, DOI 10.1016/j.cyto.2012.12.027; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	30	71	76	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101937	10.1371/journal.pone.0101937	http://dx.doi.org/10.1371/journal.pone.0101937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010647	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800053
J	Dezzutti, CS; Russo, J; Wang, L; Abebe, KZ; Li, J; Friend, DR; McGowan, IM; Rohan, LC				Dezzutti, Charlene S.; Russo, Julie; Wang, Lin; Abebe, Kaleab Z.; Li, Jie; Friend, David R.; McGowan, Ian M.; Rohan, Lisa C.			Development of HIV-1 Rectal-Specific Microbicides and Colonic Tissue Evaluation	PLOS ONE			English	Article							CD4(+) T-CELLS; VAGINAL GEL; IMMUNODEFICIENCY-VIRUS; TOPICAL MICROBICIDES; IN-VITRO; EX-VIVO; LYMPHOID FOLLICLES; CONTROLLED-TRIAL; UNITED-STATES; DC-SIGN	The gastrointestinal tract is structurally and functionally different from the vagina. Thus, the paradigm of topical microbicide development and evaluation has evolved to include rectal microbicides (RMs). Our interest was to create unique RM formulations to safely and effectively deliver antiretroviral drugs to mucosal tissue. RMs were designed to include those that spread and coat all surfaces of the rectum and distal colon rapidly (liquid) and those that create a deformable, erodible barrier and remain localized at the administration site (gel). Tenofovir (TFV) (1%) was formulated as an aqueous thermoreversible fluid and a carbopol-based aqueous hydrogel. Lipid-based liquid and gel formulations were prepared for UC781 (0.1%) using isopropyl myristate and GTCC (Caprylic/Capric Triglycerides), respectively. Formulations were characterized for pH, viscosity, osmolality, and drug content. Pre-clinical testing incorporated ex vivo colonic tissue obtained through surgical resections and flexible sigmoidoscopy (flex sig). As this was the first time using tissue from both sources side-by-side, the ability to replicate HIV-1 was compared. Efficacy of the RM formulations was tested by applying the products with HIV-1 directly to polarized colonic tissue and following viral replication. Safety of the formulations was determined by MTT assay and histology. All products had a neutral pH and were isoosmolar. While HIV-1(BaL) and HIV-1(JR-CSF) alone and in the presence of semen had similar replication trends between surgically resected and flex sig tissues, the magnitude of viral replication was significantly better in flex sig tissues. Both TFV and UC781 formulations protected the colonic tissue, regardless of tissue source, from HIV-1 and retained tissue viability and architecture. Our in vitro and ex vivo results show successful formulation of unique RMs. Moreover, the results of flex sig and surgically resected tissues were comparable suggesting the incorporation of both in pre-clinical testing algorithms.	[Dezzutti, Charlene S.; Russo, Julie; Wang, Lin; McGowan, Ian M.; Rohan, Lisa C.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Dezzutti, Charlene S.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Abebe, Kaleab Z.; Li, Jie] Univ Pittsburgh, Dept Med, Div Gen Internal Med, Pittsburgh, PA USA; [Friend, David R.] CONRAD, Arlington, VA USA; [McGowan, Ian M.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Rohan, Lisa C.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dezzutti, CS (corresponding author), Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	cdezzutti@mwri.magee.edu	M, Ian/AAP-1032-2021; M, i/HCI-9242-2022; Abebe, Kaleab/K-4400-2019	M, Ian/0000-0002-6470-8476; Abebe, Kaleab/0000-0002-3644-8419; Dezzutti, Charlene/0000-0001-5902-5841	U.S. National Institutes of Health (NIH), Division of AIDS - Combination HIV Antiviral Rectal Microbicide (CHARM) Program [U19 AI082637]; amfAR [106749-41-RGMC]; U.S. NIH; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Development; National Institute of Mental Health - the Microbicide Trials Network [UM1 AI068633, UM1 AI106707]; CONRAD; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082637, UM1AI106707, UM1AI068633] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), Division of AIDS - Combination HIV Antiviral Rectal Microbicide (CHARM) Program; amfAR; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health - the Microbicide Trials Network; CONRAD(United States Agency for International Development (USAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health (NIH), Division of AIDS - Combination HIV Antiviral Rectal Microbicide (CHARM) Program (U19 AI082637), to CSD, LCR, DF, and IMM. Additional funding was from amfAR (#106749-41-RGMC) to CSD and from the U.S. NIH, the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Development, and the National Institute of Mental Health - the Microbicide Trials Network (UM1 AI068633 and UM1 AI106707) to CSD, LCR, and IMM. Co-author, David R. Friend, is an employee of CONRAD which provided the drug substance used for manufacture of the rectal microbicide gels. CONRAD is also holder of the IND for the vaginal TFV 1% gel that is in clinical trial and provided the salary for author DRF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Anderson DJ, 2010, AIDS, V24, P1, DOI 10.1097/QAD.0b013e328333acfb; [Anonymous], 2011, GLOB HIV AIDS RESP; Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; Balandya E, 2010, J IMMUNOL, V185, P7596, DOI 10.4049/jimmunol.1002846; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Buckheit RW, 2012, CURR HIV RES, V10, P97, DOI 10.2174/157016212799304698; Denison FC, 1999, MOL HUM REPROD, V5, P220, DOI 10.1093/molehr/5.3.220; Dezzutti CS, 2013, CURR HIV-AIDS REP, V10, P12, DOI 10.1007/s11904-012-0148-2; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gorbach PM, 2009, SEX TRANSM DIS, V36, P193, DOI 10.1097/OLQ.0b013e3181901ccf; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Introini A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003148; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Koboziev I, 2010, ANN NY ACAD SCI, V1207, pE86, DOI 10.1111/j.1749-6632.2010.05711.x; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Lackman-Smith CS, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-22; LANGMAN JM, 1992, J CLIN GASTROENTEROL, V14, P81; LANGMAN JM, 1986, J ANAT, V149, P189; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; OCONNOR TJ, 1995, INT J STD AIDS, V6, P267, DOI 10.1177/095646249500600409; Politch JA, 2007, HUM REPROD, V22, P2928, DOI 10.1093/humrep/dem281; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Schwartz JL, 2008, SEX TRANSM DIS, V35, P414, DOI 10.1097/OLQ.0b013e318162c4d8; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wang L, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-12; WOLTERSEVERHARDT E, 1986, FERTIL STERIL, V46, P114; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	55	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102585	10.1371/journal.pone.0102585	http://dx.doi.org/10.1371/journal.pone.0102585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025306	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400091
J	Conde-Jaldon, M; Montes-Cano, MA; Garcia-Lozano, JR; Ortiz-Fernandez, L; Ortego-Centeno, N; Gonzalez-Leon, R; Espinosa, G; Grana-Gil, G; Sanchez-Burson, J; Gonzalez-Gay, MA; Barnosi-Marin, AC; Solans, R; Fanlo, P; Carballeira, MR; Camps, T; Castaneda, S; Martin, J; Gonzalez-Escribano, MF				Conde-Jaldon, Marta; Antonio Montes-Cano, Marco; Raul Garcia-Lozano, Jose; Ortiz-Fernandez, Lourdes; Ortego-Centeno, Norberto; Gonzalez-Leon, Rocio; Espinosa, Gerard; Grana-Gil, Genaro; Sanchez-Burson, Juan; Angel Gonzalez-Gay, Miguel; Celia Barnosi-Marin, Ana; Solans, Roser; Fanlo, Patricia; Rodriguez Carballeira, Monica; Camps, Teresa; Castaneda, Santos; Martin, Javier; Francisca Gonzalez-Escribano, Maria			Epistatic Interaction of ERAP1 and HLA-B in Behcet Disease: A Replication Study in the Spanish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MHC CLASS-I; ANKYLOSING-SPONDYLITIS SUSCEPTIBILITY; GENETIC ASSOCIATION; ENDOPLASMIC-RETICULUM; CHINESE POPULATION; LOCI; IDENTIFICATION; PSORIASIS; AMINOPEPTIDASE	Behcet's disease (BD) is a multifactorial disorder associated with the HLA region. Recently, the ERAP1 gene has been proposed as a susceptibility locus with a recessive model and with epistatic interaction with HLA-B51. ERAP1 trims peptides in the endoplasmic reticulum to optimize their length for MHC-I binding. Polymorphisms in this gene have been related with the susceptibility to other immune-mediated diseases associated to HLA class I. Our aim was, the replication in the Spanish population of the association described in the Turkish population between ERAP1 (rs17482078) and BD. Additionally, in order to improve the understanding of this association we analyzed four additional SNPs (rs27044, rs10050860, rs30187 and rs2287987) associated with other diseases related to HLA class I and the haplotype blocks in this gene region. According to our results, frequencies of the homozygous genotypes for the minor alleles of all the SNPs were increased among patients and the OR values were higher in the subgroup of patients with the HLA-B risk factors, although differences were not statistically significant. Moreover, the presence of the same mutation in both chromosomes increased the OR values from 4.51 to 10.72 in individuals carrying the HLA-B risk factors. Therefore, although they were not statistically significant, our data were consistent with an association between ERAP1 and BD as well as with an epistatic interaction between ERAP1 and HLA-B in the Spanish population.	[Conde-Jaldon, Marta; Antonio Montes-Cano, Marco; Raul Garcia-Lozano, Jose; Ortiz-Fernandez, Lourdes; Francisca Gonzalez-Escribano, Maria] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Serv Inmunol,IBiS, Seville, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Serv Med Interna, Granada, Spain; [Gonzalez-Leon, Rocio] Hosp Univ Virgen del Rocio, Serv Med Interna, Seville, Spain; [Espinosa, Gerard] Hosp Clin Barcelona, Serv Enfermedades Autoinmunes, Barcelona, Spain; [Grana-Gil, Genaro] CHU A Coruna, Serv Reumatol, La Coruna, Spain; [Sanchez-Burson, Juan] Hosp Valme, Serv Reumatol, Seville, Spain; [Angel Gonzalez-Gay, Miguel] Hosp Marques de Valdecilla, Serv Reumatol, Santander, Spain; [Celia Barnosi-Marin, Ana] Hosp Torrecardenas, Serv Med Interna, Almeria, Spain; [Solans, Roser] Hosp Valle De Hebron, Serv Med Interna, Barcelona, Spain; [Fanlo, Patricia] Hosp Virgen del Camino, Serv Med Interna, Pamplona, Spain; [Rodriguez Carballeira, Monica] Hosp Univ Mutua Terrassa, Med Interna Unitat Malalties Autoimmunes & Sistem, Barcelona, Spain; [Camps, Teresa] Hosp Carlos Haya, Serv Med Interna, Malaga, Spain; [Castaneda, Santos] Hosp Princesa, Serv Reumatol, Madrid, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario San Cecilio; Virgen del Rocio University Hospital; University of Barcelona; Hospital Clinic de Barcelona; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Valme; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Torrecardenas; Hospital Universitari Vall d'Hebron; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Mutua Terrassa; Hospital Carlos Haya; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Montes-Cano, MA (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Serv Inmunol,IBiS, Seville, Spain.	marcoa.montes.sspa@juntadeandalucia.es	Ortiz-Fernández, Lourdes/AAA-6647-2020; Carballeir, Monica Rodriguez/AAQ-8337-2021; Martin, Javier/B-8141-2008; Espinosa, Gerard/AAV-2751-2020; Ortiz-Fernández, Lourdes/GOJ-7451-2022; González-Gay, Miguel A./B-2306-2008; Martín, Javier/AAV-5209-2021; Centeno, Norberto Ortego/C-4793-2019; IBIS, EPIDEMIOLOGIA/O-8791-2015; Martín, María/HDL-9512-2022; Espinosa, Gerard/J-2603-2016; González-Escribano, María Francisca/X-5554-2019; Ortiz-Fernández, Lourdes/C-3937-2015	Ortiz-Fernández, Lourdes/0000-0002-0247-4280; Carballeir, Monica Rodriguez/0000-0002-8802-0238; Martin, Javier/0000-0002-2202-0622; Espinosa, Gerard/0000-0003-1336-0163; González-Gay, Miguel A./0000-0002-7924-7406; Centeno, Norberto Ortego/0000-0003-2325-0937; Espinosa, Gerard/0000-0003-1336-0163; Ortiz-Fernández, Lourdes/0000-0002-0247-4280	Fondo de Investigaciones Sanitarias [10/1701]; Fondos FEDER; Plan Andaluz de Investigacion [CTS-0197, CTS-180]; Red Enfermedades Inflamatorias y Reumaticas [RD08/0075/0013]; Consejeria de Salud de la Junta de Andalucia [0260/08];  [FI11/00547]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fondos FEDER(European Commission); Plan Andaluz de Investigacion; Red Enfermedades Inflamatorias y Reumaticas; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); 	This work was supported by Fondo de Investigaciones Sanitarias (10/1701), Fondos FEDER, Plan Andaluz de Investigacion (CTS-0197 and CTS-180), Red Enfermedades Inflamatorias y Reumaticas (RD08/0075/0013) and Consejeria de Salud de la Junta de Andalucia (0260/08). LOF is the recipient of a fellowship (FI11/00547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Montes-Cano MA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4328; Bettencourt BF, 2013, RHEUMATOLOGY, V52, P2168, DOI 10.1093/rheumatology/ket269; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen R, 2012, RHEUMATOL INT, V32, P909, DOI 10.1007/s00296-010-1712-y; Choi CB, 2010, ANN RHEUM DIS, V69, P582, DOI 10.1136/ard.2008.105296; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Fei YP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2695; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Kadi A, 2013, ANN RHEUM DIS, V72, P608, DOI 10.1136/annrheumdis-2012-201783; Karasneh J, 2005, ARTHRITIS RHEUM-US, V52, P1836, DOI 10.1002/art.21060; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kone-Paut I, 1999, J PEDIATR-US, V135, P89, DOI 10.1016/S0022-3476(99)70333-1; Lee YH, 2011, INFLAMM RES, V60, P999, DOI 10.1007/s00011-011-0374-x; Lysell J, 2013, J INVEST DERMATOL, V133, P411, DOI 10.1038/jid.2012.280; Maksymowych WP, 2009, ARTHRITIS RHEUM, V60, P1317, DOI 10.1002/art.24467; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pazar B, 2010, J RHEUMATOL, V37, P379, DOI 10.3899/jrheum.090806; Pimentel-Santos FM, 2009, CLIN EXP RHEUMATOL, V27, P800; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SILMAN AJ, 1990, LANCET, V335, P1078; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Tsui FWL, 2010, ANN RHEUM DIS, V69, P733, DOI 10.1136/ard.2008.103804; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436	41	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102100	10.1371/journal.pone.0102100	http://dx.doi.org/10.1371/journal.pone.0102100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019531	Green Published, gold			2022-12-27	WOS:000339618600046
J	Lv, MM; Zhu, XY; Zhong, SL; Chen, WX; Hu, Q; Ma, TF; Zhang, J; Zhang, XH; Tang, JH; Zhao, JH				Lv, Mengmeng; Zhu, Xingya; Zhong, Shanliang; Chen, Weixian; Hu, Qing; Ma, Tengfei; Zhang, Jun; Zhang, Xiaohui; Tang, Jinhai; Zhao, Jianhua			Radial Scars and Subsequent Breast Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							COMPLEX SCLEROSING LESION; SCREENING-PROGRAM; DISEASE; WOMEN; CARCINOMA; BIOPSIES; HEALTH; BIAS	Background: The relationship between radial scars and breast cancer is unclear, as the results of different studies are inconsistent. We aim to solve the controversy and assess the breast cancer risk of radial scars. Methods: Case-control or cohort studies about radial scars and breast cancer risk published in PubMed, Web of Science and the Cochrane Library from 2000 to 2013 were searched. Heterogeneity for the eligible data was assessed and a pooled odds ratio (OR) with 95% confidence interval (CI) was calculated. Results: Five observational studies involving 2521 cases and 20290 controls were included in our study. From pooled analysis, radial scars were found to have a 1.33 fold increased risk of breast cancer, but which was not significant (P = 0.138). Sample size contributed to heterogeneity. In subgroup analysis, the results pooled from studies with sample size >2000 show that presence of radial scars was associated with 1.6 times breast cancer risk compared to absence of radial scars. Radial scars increased the risk of breast cancer among women with proliferative disease without atypia, but no significant association between radial scars and carcinoma was noted among women with atypical hyperplasia. Conclusions: Radial scars tend to be associated with an increased breast cancer risk. Radial scars should be considered among women with proliferative disease without atypia, while atypical hyperplasia is still the primary concern among women with both radial scars and atypical hyperplasia.	[Lv, Mengmeng; Chen, Weixian; Hu, Qing; Zhang, Jun; Tang, Jinhai] Nanjing Med Univ, Canc Inst Jiangsu Prov, Dept Gen Surg, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Lv, Mengmeng; Zhu, Xingya] Nanjing Med Univ, Clin Sch 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Xingya] Nanjing Med Univ, Gulou Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Zhong, Shanliang; Ma, Tengfei; Zhang, Xiaohui; Zhao, Jianhua] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Ctr Clin Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Tang, JH (corresponding author), Nanjing Med Univ, Canc Inst Jiangsu Prov, Dept Gen Surg, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China.	jss_zlyy@163.com; jsslcjyzx@126.com		Zhong, Shanliang/0000-0001-8200-0511				Aroner SA, 2013, BREAST CANCER RES TR, V139, P277, DOI 10.1007/s10549-013-2535-9; AZAVEDO E, 1992, EUR J RADIOL, V15, P18, DOI 10.1016/0720-048X(92)90196-G; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berg JC, 2008, BREAST CANCER RES TR, V108, P167, DOI 10.1007/s10549-007-9605-9; Bunting DM, 2011, EJSO-EUR J SURG ONC, V37, P709, DOI 10.1016/j.ejso.2011.04.011; Cohen MA, 2000, AM J ROENTGENOL, V174, P1075, DOI 10.2214/ajr.174.4.1741075; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DouglasJones AG, 1997, HISTOPATHOLOGY, V30, P214, DOI 10.1046/j.1365-2559.1997.d01-600.x; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fasih T, 2005, EJSO-EUR J SURG ONC, V31, P1125, DOI 10.1016/j.ejso.2005.04.004; FISHER ER, 1979, AM J CLIN PATHOL, V71, P240; FROUGE C, 1995, RADIOLOGY, V195, P623, DOI 10.1148/radiology.195.3.7753984; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Iqbal M, 2002, HUM PATHOL, V33, P715, DOI 10.1053/hupa.2002.125375; Jacobs TW, 2002, HUM PATHOL, V33, P29, DOI 10.1053/hupa.2002.30190; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Kabat GC, 2010, CANCER CAUSE CONTROL, V21, P821, DOI 10.1007/s10552-010-9508-7; King TA, 2000, AM J SURG, V180, P428, DOI 10.1016/S0002-9610(00)00506-7; Linell F, 1980, Acta Pathol Microbiol Scand Suppl, P1; Manfrin E, 2008, BREAST CANCER RES TR, V107, P371, DOI 10.1007/s10549-007-9569-9; MANTEL N, 1959, J NATL CANCER I, V22, P719; NIELSEN M, 1985, HISTOPATHOLOGY, V9, P287, DOI 10.1111/j.1365-2559.1985.tb02446.x; NIELSEN M, 1987, CANCER, V59, P1019, DOI 10.1002/1097-0142(19870301)59:5<1019::AID-CNCR2820590528>3.0.CO;2-N; Patterson JA, 2004, EJSO, V30, P1065, DOI 10.1016/j.ejso.2004.08.004; Sanders ME, 2006, CANCER-AM CANCER SOC, V106, P1453, DOI 10.1002/cncr.21730; Schnitt SJ, 2003, AM J SURG PATHOL, V27, P836, DOI 10.1097/00000478-200306000-00017; Shaaban AM, 2002, AM J SURG PATHOL, V26, P421, DOI 10.1097/00000478-200204000-00003; SLOANE JP, 1993, HISTOPATHOLOGY, V23, P225, DOI 10.1111/j.1365-2559.1993.tb01194.x; WELLINGS SR, 1984, HUM PATHOL, V15, P475, DOI 10.1016/S0046-8177(84)80083-0; Worsham MJ, 2007, BREAST J, V13, P115, DOI 10.1111/j.1524-4741.2007.00388.x; Worsham MJ, 2009, BREAST CANCER RES TR, V118, P1, DOI 10.1007/s10549-008-0198-8	32	5	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102503	10.1371/journal.pone.0102503	http://dx.doi.org/10.1371/journal.pone.0102503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019286	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600087
J	Yin, J; Wang, LM; Tang, WF; Wang, X; Lv, L; Shao, AZ; Shi, YJ; Ding, GW; Chen, SC; Gu, HY				Yin, Jun; Wang, Liming; Tang, Weifeng; Wang, Xu; Lv, Lu; Shao, Aizhong; Shi, Yijun; Ding, Guowen; Chen, Suocheng; Gu, Haiyong			RANK rs1805034 T > C Polymorphism Is Associated with Susceptibility of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; B LIGAND RANKL; INHIBITS PROSTATE-CANCER; BONE-MINERAL DENSITY; BREAST-CANCER; RECEPTOR ACTIVATOR; CELL FUNCTION; ZOLEDRONIC ACID; TUMOR-GROWTH; OSTEOPROTEGERIN	Esophageal cancer remains the sixth leading cause of cancer associated death and eighth most common cancer worldwide. Genetic factors, such as single nucleotide polymorphisms (SNPs), may contribute to the carcinogenesis of esophageal cancer. Here, we conducted a hospital based case-control study to evaluate the genetic susceptibility of functional SNPs on the development of esophageal cancer. A total of 629 esophageal squamous cell carcinoma (ESCC) cases and 686 controls were enrolled for this study. The OPG rs3102735 T>C, rs2073618 G>C, RANK rs1805034 T>C, RANKL rs9533156 T>C and rs2277438 A>G were determined by ligation detection reaction method. Our findings suggested that RANK rs1805034 T>C is associated with the susceptibility of ESCC, which is more evident in male and elder (>= 63) patients. Our study provides the first evidence that functional polymorphisms RANK rs1805034 T>C may be an indicator for individual susceptibility to ESCC. However, further larger studies among different ethnic populations are warranted to verify our conclusion.	[Yin, Jun; Tang, Weifeng; Wang, Xu; Lv, Lu; Shao, Aizhong; Shi, Yijun; Ding, Guowen; Chen, Suocheng; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Wang, Liming] Jiangsu Univ, Affiliated Peoples Hosp, Dept Chemotherapy, Inst Canc, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Yin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China.	yin912@126.com; chensuocheng@sina.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81370001, 81101889, 81000028, 81300037]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; "333" Elitist Training Program of Jiangsu [BRA2013135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); "333" Elitist Training Program of Jiangsu	This study was supported in part by National Natural Science Foundation of China (81370001, 81101889, 81000028, 81300037), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), The "333" Elitist Training Program of Jiangsu (BRA2013135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Assmann G, 2010, J RHEUMATOL, V37, P900, DOI 10.3899/jrheum.091110; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bonifaci N, 2011, BREAST CANCER RES TR, V129, P947, DOI 10.1007/s10549-011-1546-7; Brown JM, 2001, UROLOGY, V57, P611, DOI 10.1016/S0090-4295(00)01122-5; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Chu LW, 2010, CANCER EPIDEM BIOMAR, V19, P1848, DOI 10.1158/1055-9965.EPI-10-0101; Chung PYJ, 2010, J BONE MINER RES, V25, P2316, DOI 10.1002/jbmr.162; DESTEFANI E, 1993, EUR J CANCER, V29A, P763, DOI 10.1016/S0959-8049(05)80363-6; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng XS, 2014, ASIAN PAC J CANCER P, V15, P1981, DOI 10.7314/APJCP.2014.15.5.1981; Fisher JL, 2006, CANCER RES, V66, P3620, DOI 10.1158/0008-5472.CAN-05-3119; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Good CR, 2002, J SURG ONCOL, V79, P174, DOI 10.1002/jso.10067; Hsu YH, 2006, HUM GENET, V118, P568, DOI 10.1007/s00439-005-0062-4; Huang CH, 2011, RHEUMATOLOGY, V50, P359, DOI 10.1093/rheumatology/keq306; Huang L, 2002, J CLIN PATHOL, V55, P877, DOI 10.1136/jcp.55.11.877; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jorgensen HL, 2004, J BONE MINER METAB, V22, P132, DOI 10.1007/s00774-003-0461-3; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Katz J, 2011, INT J ORAL MAX SURG, V40, P605, DOI 10.1016/j.ijom.2011.02.002; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee CH, 2007, EUR J CANCER, V43, P1188, DOI 10.1016/j.ejca.2007.01.039; McGonigle JS, 2009, ANGIOGENESIS, V12, P35, DOI 10.1007/s10456-008-9127-z; Ney JT, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-40; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pitocco D, 2009, DIABETES CARE, V32, P1694, DOI 10.2337/dc09-0243; Quinn JE, 2005, PROSTATE CANCER P D, V8, P253, DOI 10.1038/sj.pcan.4500815; Rhee EJ, 2010, ENDOCR J, V57, P541, DOI 10.1507/endocrj.K10E-015; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Taylor PR, 2003, J NATL CANCER I, V95, P1414, DOI 10.1093/jnci/djg044; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Whang PG, 2005, J ORTHOP RES, V23, P1475, DOI 10.1016/j.orthres.2005.05.004; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080570; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685; Zhang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021835	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101705	10.1371/journal.pone.0101705	http://dx.doi.org/10.1371/journal.pone.0101705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019155	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600024
J	Boczek, T; Lisek, M; Ferenc, B; Kowalski, A; Stepinski, D; Wiktorska, M; Zylinska, L				Boczek, Tomasz; Lisek, Malwina; Ferenc, Bozena; Kowalski, Antoni; Stepinski, Dariusz; Wiktorska, Magdalena; Zylinska, Ludmila			Plasma Membrane Ca2+-ATPase Isoforms Composition Regulates Cellular pH Homeostasis in Differentiating PC12 Cells in a Manner Dependent on Cytosolic Ca2+ Elevations	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ASCITES TUMOR MITOCHONDRIA; CYCLOSPORINE-A; CALCIUM-TRANSPORT; BRAIN; INHIBITION; NEURONS; DEPOLARIZATION; ACTIVATION; INTRAMITOCHONDRIAL	Plasma membrane Ca2+-ATPase (PMCA) by extruding Ca2+ outside the cell, actively participates in the regulation of intracellular Ca2+ concentration. Acting as Ca2+/H+ counter-transporter, PMCA transports large quantities of protons which may affect organellar pH homeostasis. PMCA exists in four isoforms (PMCA1-4) but only PMCA2 and PMCA3, due to their unique localization and features, perform more specialized function. Using differentiated PC12 cells we assessed the role of PMCA2 and PMCA3 in the regulation of intracellular pH in steady-state conditions and during Ca2+ overload evoked by 59 mM KCl. We observed that manipulation in PMCA expression elevated pH(mito) and pH(cyto) but only in PMCA2-downregulated cells higher mitochondrial pH gradient (Delta pH) was found in steady-state conditions. Our data also demonstrated that PMCA2 or PMCA3 knock-down delayed Ca2+ clearance and partially attenuated cellular acidification during KCl-stimulated Ca2+ influx. Because SERCA and NCX modulated cellular pH response in neglectable manner, and all conditions used to inhibit PMCA prevented KCl-induced pH drop, we considered PMCA2 and PMCA3 as mainly responsible for transport of protons to intracellular milieu. In steady-state conditions, higher TMRE uptake in PMCA2-knockdown line was driven by plasma membrane potential (Psi(p)). Nonetheless, mitochondrial membrane potential (Psi(m)) in this line was dissipated during Ca2+ overload. Cyclosporin and bongkrekic acid prevented Psi(m) loss suggesting the involvement of Ca2+-driven opening of mitochondrial permeability transition pore as putative underlying mechanism. The findings presented here demonstrate a crucial role of PMCA2 and PMCA3 in regulation of cellular pH and indicate PMCA membrane composition important for preservation of electrochemical gradient.	[Boczek, Tomasz; Lisek, Malwina; Ferenc, Bozena; Kowalski, Antoni; Zylinska, Ludmila] Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland; [Kowalski, Antoni] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Stepinski, Dariusz] Univ Lodz, Dept Cytophysiol, PL-90131 Lodz, Poland; [Wiktorska, Magdalena] Med Univ Lodz, Dept Mol Cell Mech, Lodz, Poland	Medical University Lodz; Aarhus University; University of Lodz; Medical University Lodz	Boczek, T (corresponding author), Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland.	tomasz.boczek@umed.lodz.pl	Zylinska, Ludmila/A-1205-2008; Zylinska, Ludmila/ABE-9113-2020	Zylinska, Ludmila/0000-0002-3876-8942; Zylinska, Ludmila/0000-0002-3876-8942; Lisek, Malwina/0000-0003-3438-2396; Boczek, Tomasz/0000-0002-7654-9011; Kowalski, Antoni/0000-0002-0936-7373; Wiktorska, Magdalena/0000-0001-7346-0380	Medical University of Lodz [503/6-086-02/503-01]; National Science Centre [UMO-2012/05/D/NZ4/02982]	Medical University of Lodz; National Science Centre(National Science Centre, Poland)	This work was supported by Medical University of Lodz grant no. 503/6-086-02/503-01 and, in part, by National Science Centre grant (to TB) based on decision UMO-2012/05/D/NZ4/02982. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BENHAM CD, 1992, J PHYSIOL-LONDON, V455, P567, DOI 10.1113/jphysiol.1992.sp019316; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Boczek T, 2012, CELL CALCIUM, V52, P433, DOI 10.1016/j.ceca.2012.08.002; Boczek T, 2012, MOL CELL BIOCHEM, V360, P89, DOI 10.1007/s11010-011-1047-3; BOGUCKA K, 1995, BBA-BIOENERGETICS, V1228, P261, DOI 10.1016/0005-2728(94)00188-B; Bolshakov AP, 2008, CELL CALCIUM, V43, P602, DOI 10.1016/j.ceca.2007.10.005; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Burette A, 2007, J COMP NEUROL, V500, P1127, DOI 10.1002/cne.21237; Carafoli E, 2000, CALCIUM HOMEOSTASIS; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Csordas G, 2003, J BIOL CHEM, V278, P42273, DOI 10.1074/jbc.M305248200; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Fakira Amanda Kathleen, 2010, World J Biol Chem, V1, P103, DOI 10.4331/wjbc.v1.i5.103; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; Haak LL, 2002, J NEUROCHEM, V80, P405, DOI 10.1046/j.0022-3042.2001.00727.x; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; HANSFORD RG, 1967, BIOCHEM BIOPH RES CO, V27, P686, DOI 10.1016/S0006-291X(67)80090-1; HANSFORD RG, 1985, REV PHYSIOL BIOCH P, V102, P1, DOI 10.1007/BFb0034084; Hillman DE, 1996, NEUROSCIENCE, V72, P315, DOI 10.1016/0306-4522(95)00518-8; Holton Mary Louisa, 2010, World J Biol Chem, V1, P201, DOI 10.4331/wjbc.v1.i6.201; Jacobson J, 2002, J CELL SCI, V115, P1175; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kip SN, 2006, HIPPOCAMPUS, V16, P20, DOI 10.1002/hipo.20129; Krohn AJ, 1999, J NEUROSCI, V19, P7394, DOI 10.1523/JNEUROSCI.19-17-07394.1999; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; Lehotsky J, 2002, FRONT BIOSCI, V7, P53; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Mata AM, 2005, BRAIN RES REV, V49, P398, DOI 10.1016/j.brainresrev.2004.11.004; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MORENOSANCHEZ R, 1988, BIOCHEM J, V256, P403, DOI 10.1042/bj2560403; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; NICHOLLS DG, 1978, BIOCHEM J, V170, P511, DOI 10.1042/bj1700511; O'Reilly CM, 2004, AM J PHYSIOL-CELL PH, V286, pC1139, DOI 10.1152/ajpcell.00371.2003; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Perry SW, 2005, J IMMUNOL, V174, P4333, DOI 10.4049/jimmunol.174.7.4333; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; Pitter JG, 2002, CELL CALCIUM, V31, P97, DOI 10.1054/ceca.2001.0264; Poburko D, 2012, PFLUG ARCH EUR J PHY, V464, P19, DOI 10.1007/s00424-012-1106-y; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Pytlowany M, 2008, ACTA BIOCHIM POL, V55, P339, DOI 10.18388/abp.2008_3081; REYNOLDS EE, 1982, BIOCHEMISTRY-US, V21, P4795, DOI 10.1021/bi00262a042; ROMAN I, 1981, MEMBRANE BIOCHEM, V4, P1, DOI 10.3109/09687688109065419; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Schuchmann S, 2000, J NEUROPHYSIOL, V83, P1710, DOI 10.1152/jn.2000.83.3.1710; Souayah N, 2008, EXP NEUROL, V214, P341, DOI 10.1016/j.expneurol.2008.09.002; STAHL WL, 1992, MOL BRAIN RES, V16, P223, DOI 10.1016/0169-328X(92)90229-5; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vergun O, 2005, BBA-BIOENERGETICS, V1709, P127, DOI 10.1016/j.bbabio.2005.07.006; VILLALOBO A, 1980, J BIOL CHEM, V255, P2457; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; ZACHARIAS DA, 1995, MOL BRAIN RES, V28, P263, DOI 10.1016/0169-328X(94)00215-Z; Zaidi A, 1998, NEUROBIOL AGING, V19, P487, DOI 10.1016/S0197-4580(98)00078-5; Zhdanov AV, 2010, BBA-BIOENERGETICS, V1797, P1627, DOI 10.1016/j.bbabio.2010.06.006; Zylinska L, 2007, ANN NY ACAD SCI, V1099, P254, DOI 10.1196/annals.1387.008	75	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102352	10.1371/journal.pone.0102352	http://dx.doi.org/10.1371/journal.pone.0102352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014339	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400088
J	Higo, N; Ogawa, K; Minemura, J; Xu, BJ; Nozawa, T; Ogata, T; Ara, K; Yano, K; Miyake, Y				Higo, Naoki; Ogawa, Ken-ichiro; Minemura, Juichi; Xu, Bujie; Nozawa, Takayuki; Ogata, Taiki; Ara, Koji; Yano, Kazuo; Miyake, Yoshihiro			Interpersonal Similarity between Body Movements in Face-To-Face Communication in Daily Life	PLOS ONE			English	Article								Individuals are embedded in social networks in which they communicate with others in their daily lives. Because smooth face-to-face communication is the key to maintaining these networks, measuring the smoothness of such communication is an important issue. One indicator of smoothness is the similarity of the body movements of the two individuals concerned. A typical example noted in experimental environments is the interpersonal synchronization of body movements such as nods and gestures during smooth face-to-face communication. It should therefore be possible to estimate quantitatively the smoothness of face-to-face communication in social networks through measurement of the synchronization of body movements. However, this is difficult because social networks, which differ from disciplined experimental environments, are open environments for the face-to-face communication between two individuals. In such open environments, their body movements become complicated by various external factors and may follow unstable and nonuniform patterns. Nevertheless, we consider there to be some interaction during face-to-face communication that leads to the interpersonal synchronization of body movements, which can be seen through the interpersonal similarity of body movements. The present study aims to clarify such interaction in terms of body movements during daily face-to-face communication in real organizations of more than 100 people. We analyzed data on the frequency of body movement for each individual during face-to-face communication, as measured by a wearable sensor, and evaluated the degree of interpersonal similarity of body movements between two individuals as their frequency difference. Furthermore, we generated uncorrelated data by resampling the data gathered and compared these two data sets statistically to distinguish the effects of actual face-to-face communication from those of the activities accompanying the communication. Our results confirm an interpersonal similarity of body movements between two individuals in face-to-face communication, for all the organizations studied, and suggest that some body interaction is behind this similarity.	[Higo, Naoki; Ogawa, Ken-ichiro; Minemura, Juichi; Xu, Bujie; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Nozawa, Takayuki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Ogata, Taiki] Univ Tokyo, Ctr Engn, Kashiwa, Chiba, Japan; [Ara, Koji; Yano, Kazuo] Hitachi Ltd, Ctr Res Lab, Tokyo, Japan	Tokyo Institute of Technology; Tohoku University; University of Tokyo; Hitachi Limited	Ogawa, K (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	ogawa@dis.titech.ac.jp	Nozawa, Takayuki/Y-9610-2019	Nozawa, Takayuki/0000-0001-6300-4373; Ogata, Taiki/0000-0002-0590-598X	Homo Contribuens Research and Development Institute [0004]	Homo Contribuens Research and Development Institute	This work was supported, in part, by the Homo Contribuens Research and Development Institute (Grant No. 0004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	Akitomi T., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P814, DOI 10.1109/PASSAT/SocialCom.2011.65; Ara Koji, 2011, 2011 16th Asia and South Pacific Design Automation Conference, ASP-DAC 2011, P567, DOI 10.1109/ASPDAC.2011.5722254; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; CONDON WS, 1967, J PSYCHIAT RES, V5, P221, DOI 10.1016/0022-3956(67)90004-0; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Condon WS., 1971, PERCEPTION LANGUAGE, P150; Daibo I, 1982, SOC PSYCH 22 INT C P, P188; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Mattarazzo JD, 1972, INTERVIEW RES ITS AN; Mehrabian A., 1971, SILENT MESSAGE; Ono E, 2012, 2012 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P912, DOI 10.1109/SII.2012.6427358; Paradiso JA, 2010, PERS UBIQUIT COMPUT, V14, P137, DOI 10.1007/s00779-009-0239-2; Pentland A, 2010, AM SCI, V98, P204, DOI 10.1511/2010.84.203; Pentland AP, 2010, HONEST SIGNALS WE SH; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Tsuji S., 2009, 6 INT C NETW SENS SY, P1, DOI DOI 10.1109/INSS.2009.5409930; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176	23	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102019	10.1371/journal.pone.0102019	http://dx.doi.org/10.1371/journal.pone.0102019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014021	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400056
J	Hijaz, F; Killiny, N				Hijaz, Faraj; Killiny, Nabil			Collection and Chemical Composition of Phloem Sap from Citrus sinensis L. Osbeck (Sweet Orange)	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; AMINO-ACID-COMPOSITION; GREENING DISEASE; TCA CYCLE; METABOLISM; JUICES; DERIVATIZATION; MYOINOSITOL; BACTERIUM; COMPLEX	Through utilizing the nutrient-rich phloem sap, sap feeding insects such as psyllids, leafhoppers, and aphids can transmit many phloem-restricted pathogens. On the other hand, multiplication of phloem-limited, uncultivated bacteria such as Candidatus Liberibacter asiaticus (CLas) inside the phloem of citrus indicates that the sap contains all the essential nutrients needed for the pathogen growth. The phloem sap composition of many plants has been studied; however, to our knowledge, there is no available data about citrus phloem sap. In this study, we identified and quantified the chemical components of phloem sap from pineapple sweet orange. Two approaches (EDTA enhanced exudation and centrifugation) were used to collect phloem sap. The collected sap was derivatized with methyl chloroformate (MCF), N-methyl-N-[tert-butyl dimethylsilyl]-trifluroacetamide (MTBSTFA), or trimethylsilyl (TMS) and analyzed with GC-MS revealing 20 amino acids and 8 sugars. Proline, the most abundant amino acid, composed more than 60% of the total amino acids. Tryptophan, tyrosine, leucine, isoleucine, and valine, which are considered essential for phloem sap-sucking insects, were also detected. Sucrose, glucose, fructose, and inositol were the most predominant sugars. In addition, seven organic acids including succinic, fumaric, malic, maleic, threonic, citric, and quinic were detected. All compounds detected in the EDTA-enhanced exudate were also detected in the pure phloem sap using centrifugation. The centrifugation technique allowed estimating the concentration of metabolites. This information expands our knowledge about the nutrition requirement for citrus phloem-limited bacterial pathogen and their vectors, and can help define suitable artificial media to culture them.	[Hijaz, Faraj; Killiny, Nabil] Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL 33850 USA	State University System of Florida; University of Florida	Killiny, N (corresponding author), Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL 33850 USA.	nabilkilliny@ufl.edu		Hijaz, Faraj/0000-0002-8079-161X; Killiny, Nabil/0000-0002-3895-6943	citrus research and development foundation [00085011]	citrus research and development foundation	This work was supported by grant (contract # 00085011) from citrus research and development foundation to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid G, 2009, GENE, V439, P1, DOI 10.1016/j.gene.2009.03.007; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Bursell E., 1981, P135; BYRNE DN, 1990, J INSECT PHYSIOL, V36, P433, DOI 10.1016/0022-1910(90)90061-J; CANDY DJ, 1967, BIOCHEM J, V103, P666, DOI 10.1042/bj1030666; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; Castle WS, 2013, INCIDENCE HLB COMMER; Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010; Chen WP, 2010, J CHROMATOGR B, V878, P2199, DOI 10.1016/j.jchromb.2010.06.027; Chen XT, 2009, INT J FOOD SCI NUTR, V60, P116, DOI 10.1080/09637480802695649; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; DADD RH, 1967, J INSECT PHYSIOL, V13, P763, DOI 10.1016/0022-1910(67)90125-4; DERENOBALES M, 1987, TRENDS BIOCHEM SCI, V12, P364, DOI 10.1016/0968-0004(87)90167-8; Dinant S, 2010, CR BIOL, V333, P504, DOI 10.1016/j.crvi.2010.03.008; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Gholami M, 2004, ACTA HORTIC, P143, DOI 10.17660/ActaHortic.2004.640.16; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gou Zhiheng, 2012, Zoological Research, V33, pE75, DOI 10.3724/SP.J.1141.2012.E05-06E75; Graham JH, 2008, P M INT RES C HUANGL; Guelette BS, 2012, J EXP BOT, V63, P3603, DOI 10.1093/jxb/ers028; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Ham TaeHo, 2012, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V57, P144, DOI 10.7740/kjcs.2012.57.2.144; Hasib A, 2001, SCI ALIMENT, V21, P555, DOI 10.3166/sda.21.555-562; Hunter Wayne B., 1999, International Journal of Ecology and Environmental Sciences, V25, P259; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Karadeniz Feryal, 2004, Turkish Journal of Agriculture and Forestry, V28, P267; Komor E, 1996, J EXP BOT, V47, P1155, DOI 10.1093/jxb/47.Special_Issue.1155; Lee HS, 2000, J LIQ CHROMATOGR R T, V23, P2123, DOI 10.1081/JLC-100100476; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Madey E, 2002, PLANTA, V214, P625, DOI 10.1007/s004250100649; Merchant A, 2010, J EXP BOT, V61, P1785, DOI 10.1093/jxb/erq045; MOORE S, 1968, J BIOL CHEM, V243, P6281; Nation J. L., 2002, INSECT PHYSL BIOCH, DOI DOI 10.1017/CBO9781107415324.004; Nour V, 2010, NOT BOT HORTI AGROBO, V38, P44; Nowak H, 2010, OECOLOGIA, V163, P973, DOI 10.1007/s00442-010-1652-y; OHSHIMA T, 1990, PLANT CELL PHYSIOL, V31, P735; Parker JK, 2014, PHYTOPATHOLOGY, V104, P15, DOI 10.1094/PHYTO-05-13-0119-R; Raveh E, 2005, SCI HORTIC-AMSTERDAM, V103, P317, DOI 10.1016/j.scienta.2004.06.007; Rennenberg H, 1996, J EXP BOT, V47, P1491, DOI 10.1093/jxb/47.10.1491; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; Sobolevsky TG, 2003, J SEP SCI, V26, P1474, DOI 10.1002/jssc.200301492; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Thompson SN, 1995, BBA-GEN SUBJECTS, V1245, P376, DOI 10.1016/0304-4165(95)00107-7; Valle EM, 1998, PLANT CELL PHYSIOL, V39, P458, DOI 10.1093/oxfordjournals.pcp.a029391; van Bel AJE, 2008, J EXP BOT, V59, P261, DOI 10.1093/jxb/erm294; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Vinuelas J, 2011, MOL MICROBIOL, V81, P1271, DOI 10.1111/j.1365-2958.2011.07760.x; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Waterfield N, 2010, CURR BIOL, V20, pR13, DOI 10.1016/j.cub.2009.11.018; ZYREN J, 1985, J ASSOC OFF ANA CHEM, V68, P672	56	106	109	5	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101830	10.1371/journal.pone.0101830	http://dx.doi.org/10.1371/journal.pone.0101830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014027	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400039
J	Jo, Y; Labrique, AB; Lefevre, AE; Mehl, G; Pfaff, T; Walker, N; Friberg, IK				Jo, Youngji; Labrique, Alain B.; Lefevre, Amnesty E.; Mehl, Garrett; Pfaff, Teresa; Walker, Neff; Friberg, Ingrid K.			Using the Lives Saved Tool (LiST) to Model mHealth Impact on Neonatal Survival in Resource-Limited Settings	PLOS ONE			English	Article							HEALTH-CARE; MOBILE PHONES; CHILD HEALTH; INTEGRATED MANAGEMENT; NATIONAL CAUSES; ANTENATAL CARE; MORTALITY; INTERVENTION; COMMUNICATION; INFORMATION	While the importance of mHealth scale-up has been broadly emphasized in the mHealth community, it is necessary to guide scale up efforts and investment in ways to help achieve the mortality reduction targets set by global calls to action such as the Millennium Development Goals, not merely to expand programs. We used the Lives Saved Tool (LiST)-an evidence-based modeling software-to identify priority areas for maternal and neonatal health services, by formulating six individual and combined interventions scenarios for two countries, Bangladesh and Uganda. Our findings show that skilled birth attendance and increased facility delivery as targets for mHealth strategies are likely to provide the biggest mortality impact relative to other intervention scenarios. Although further validation of this model is desirable, tools such as LiST can help us leverage the benefit of mHealth by articulating the most appropriate delivery points in the continuum of care to save lives.	[Jo, Youngji; Labrique, Alain B.; Lefevre, Amnesty E.; Walker, Neff; Friberg, Ingrid K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Jo, Youngji; Labrique, Alain B.; Lefevre, Amnesty E.; Pfaff, Teresa] Johns Hopkins Univ, Global mHlth Initiat, Baltimore, MD USA; [Mehl, Garrett] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Pfaff, Teresa] Johns Hopkins Sch Nursing, Dept Community Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; World Health Organization; Johns Hopkins University	Labrique, AB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	alabriqu@gmail.com	LeFevre, Amnesty E/A-3162-2019	LeFevre, Amnesty E/0000-0001-8437-7240; Labrique, Alain/0000-0003-2502-7819	WHO mHealth Technical and Evidence Review Group (mTERG); Johns Hopkins University Global mHealth Initiative	WHO mHealth Technical and Evidence Review Group (mTERG); Johns Hopkins University Global mHealth Initiative	Funding for this work was provided as part of a contract in support of the WHO mHealth Technical and Evidence Review Group (mTERG) and by the Johns Hopkins University Global mHealth Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2012, PAK J MED SCI, V28, P800; Ahsan A, 2013, ICTD 13 P 6 INT C IN, V2; Al-Abdullah T, 2009, CAN J EMERG MED, V11, P139; Amouzou A, 2010, INT J EPIDEMIOL, V39, P186, DOI 10.1093/ije/dyq034; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Bryce J, 2010, INT J EPIDEMIOL, V39, P40, DOI 10.1093/ije/dyq020; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; Chib A, 2010, J COMPUT-MEDIAT COMM, V15, P500, DOI 10.1111/j.1083-6101.2010.01515.x; Coleman J, 2013, J MOBILE TECHNOLOGY, V2, P9, DOI DOI 10.7309/jmtm.2.4S.7; Curioso WH, 2005, DESIGN IMPLEMENTATIO; DeRenzi B, 2008, E IMCI IMPROVING PED; DeRenzi B, 2011, FRAMEWORK CASE BASED, P377; DeRenzi B, 2011, MT SINAI J MED, V78, P406, DOI 10.1002/msj.20256; Engle KL, MOBILE PHONE INTERVE; Fairbrother G, 2009, PEDIATRICS, V123, pS61, DOI 10.1542/peds.2008-1755B; Fiordelli M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2430; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Healthcare Innovation Technology, 2013, EV MOTECH RES IMP MH; Hsieh SH, 2010, J MED SYST, V34, P519, DOI 10.1007/s10916-009-9265-x; Huq L., 2012, INT J SOCIO ANTHRO, V4, P226, DOI [10.5897/IJSA11.134, DOI 10.5897/IJSA11.134]; International Telecommunication Union (ITU), WORLD 2013 ICT FACTS; Kaewkungwal J, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-69; Krasovec K, 2004, INT J GYNECOL OBSTET, V85, pS14, DOI 10.1016/ijgo.2004.02.007; Labrique A, 2013, INT J MED INFORM, V82, P467, DOI 10.1016/j.ijmedinf.2012.11.016; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Li M, 2012, OBES RES CLIN PRACT, V6, P55; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lund S, 2012, BJOG-INT J OBSTET GY, V119, P1256, DOI 10.1111/j.1471-0528.2012.03413.x; Lund S, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2941; Lund S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-29; Mechael PN, 2008, SEARCH SCALABLE MHEA; mHealth Alliance, 2012, MOB ALL MAT ACT MAMA; Mitchell M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-95; Mitchell M, 2012, J HEALTH COMMUN, V17, P118, DOI 10.1080/10810730.2011.649105; Mobile Alliance for Maternal Action (MAMA), WHAT IS MAMA; Mobile Technology for Community Health in Ghana (MOTECH), 2011, WHAT IT IS WHAT GRAM; Musoke M, 2002, INDIGENOUS KNOWLEDGE, V4, P1; Needs S, 2013, MHEALTH MNCH STATE E, P1; Ngabo F, 2012, PAN AFR MED J, V13; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Speciale AM, 2013, J MIDWIFERY WOM HEAL, V58, P76, DOI 10.1111/j.1542-2011.2012.00243.x; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Tesfaye S, 2014, J MIDWIFERY WOM HEAL, V59, pS55, DOI 10.1111/jmwh.12168; The Earth Institute Columbia University, 2010, BARR GAPS AFF MHEALT; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UNICEF, MOB TECHN COMM CAS M; UNICEF, UG INN; United Nation, 2012, MILL DEV GOALS REP; United States Agency for International Development (USAID), MHEALTH COMP; USAID, LIST MAN; Walker CLF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000428; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; WHO mHealth Alliance, 2013, WHORHR1316; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; World Health Organization, 2001, TECHN CONS IN PRESS; World Health Organization, 2011, MHEALTHNEW HOR HLTH, V3	64	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102224	10.1371/journal.pone.0102224	http://dx.doi.org/10.1371/journal.pone.0102224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014008	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400077
J	Ward, N; Moreno-Hagelsieb, G				Ward, Natalie; Moreno-Hagelsieb, Gabriel			Quickly Finding Orthologs as Reciprocal Best Hits with BLAT, LAST, and UBLAST: How Much Do We Miss?	PLOS ONE			English	Article							PROTEIN DATABASE SEARCHES; COMPLETE GENOME SEQUENCE; MICROBIAL GENOMES; PSI-BLAST; BACTERIAL; IDENTIFICATION; ANNOTATION; PREDICTION; ACCURACY; SERVER	Reciprocal Best Hits (RBH) are a common proxy for orthology in comparative genomics. Essentially, a RBH is found when the proteins encoded by two genes, each in a different genome, find each other as the best scoring match in the other genome. NCBI's BLAST is the software most usually used for the sequence comparisons necessary to finding RBHs. Since sequence comparison can be time consuming, we decided to compare the number and quality of RBHs detected using algorithms that run in a fraction of the time as BLAST. We tested BLAT, LAST and UBLAST. All three programs ran in a hundredth to a 25th of the time required to run BLAST. A reduction in the number of homologs and RBHs found by the faster algorithms compared to BLAST becomes apparent as the genomes compared become more dissimilar, with BLAT, a program optimized for quickly finding very similar sequences, missing both the most homologs and the most RBHs. Though LAST produced the closest number of homologs and RBH to those produced with BLAST, UBLAST was very close, with either program producing between 0.6 and 0.8 of the RBHs as BLAST between dissimilar genomes, while in more similar genomes the differences were barely apparent. UBLAST ran faster than LAST, making it the best option among the programs tested.	[Ward, Natalie; Moreno-Hagelsieb, Gabriel] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University	Moreno-Hagelsieb, G (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada.	gmoreno@wlu.ca		Moreno-Hagelsieb, Gabriel/0000-0002-2457-4450	Wilfrid Laurier University; Natural Sciences and Engineering Research Council of Canada (NSERC)	Wilfrid Laurier University; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research supported by Wilfrid Laurier University and by a Discovery grant to GMH by The Natural Sciences and Engineering Research Council of Canada (NSERC). Wilfrid Laurier University provided funds for equipment. The Discovery grant from Natural Sciences and Engineering Research Council of Canada (NSERC) provided funds for equipment and publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrasiabi C, 2013, NUCLEIC ACIDS RES, V41, pW242, DOI 10.1093/nar/gkt399; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen IMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054859; Chen X, 2012, PLOS COMPUTATIONAL B; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dutilh BE, 2007, BIOINFORMATICS, V23, P815, DOI 10.1093/bioinformatics/btm015; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gattiker A, 2003, COMPUT BIOL CHEM, V27, P49, DOI 10.1016/S1476-9271(02)00094-4; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Janga SC, 2004, NUCLEIC ACIDS RES, V32, P5392, DOI 10.1093/nar/gkh882; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Moreno-Hagelsieb G, 2013, BIOINFORMATICS, V29, P947, DOI 10.1093/bioinformatics/btt064; Moreno-Hagelsieb Gabriel, 2002, Bioinformatics, V18 Suppl 1, pS329; Nakaya A, 2013, NUCLEIC ACIDS RES, V41, pD353, DOI 10.1093/nar/gks1239; Ohno S., 1970, EVOLUTION GENE DUPLI; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Thomas PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002386; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Whiteside MD, 2013, NUCLEIC ACIDS RES, V41, pD366, DOI 10.1093/nar/gks1241; Yu YK, 2006, NUCLEIC ACIDS RES, V34, P5966, DOI 10.1093/nar/gkl731	49	91	94	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101850	10.1371/journal.pone.0101850	http://dx.doi.org/10.1371/journal.pone.0101850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013894	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400042
J	Liang, Z; Xie, Y; Dominguez, JA; Breed, ER; Yoseph, BP; Burd, EM; Farris, AB; Davidson, NO; Coopersmith, CM				Liang, Zhe; Xie, Yan; Dominguez, Jessica A.; Breed, Elise R.; Yoseph, Benyam P.; Burd, Eileen M.; Farris, Alton B.; Davidson, Nicholas O.; Coopersmith, Craig M.			Intestine-Specific Deletion of Microsomal Triglyceride Transfer Protein Increases Mortality in Aged Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GUT EPITHELIAL APOPTOSIS; PSEUDOMONAS-AERUGINOSA; IMPROVES SURVIVAL; BARRIER FUNCTION; MURINE MODEL; MUCOSAL BARRIER; CECAL LIGATION; SEVERE SEPSIS; MUCUS LAYER	Background: Mice with conditional, intestine-specific deletion of microsomal triglyceride transfer protein (Mttp-IKO) exhibit a complete block in chylomicron assembly together with lipid malabsorption. Young (8-10 week) Mttp-IKO mice have improved survival when subjected to a murine model of Pseudomonas aeruginosa-induced sepsis. However, 80% of deaths in sepsis occur in patients over age 65. The purpose of this study was to determine whether age impacts outcome in Mttp-IKO mice subjected to sepsis. Methods: Aged (20-24 months) Mttp-IKO mice and WT mice underwent intratracheal injection with P. aeruginosa. Mice were either sacrificed 24 hours post-operatively for mechanistic studies or followed seven days for survival. Results: In contrast to young septic Mttp-IKO mice, aged septic Mttp-IKO mice had a significantly higher mortality than aged septic WT mice (80% vs. 39%, p = 0.005). Aged septic Mttp-IKO mice exhibited increased gut epithelial apoptosis, increased jejunal Bax/Bcl-2 and Bax/Bcl-XL ratios yet simultaneously demonstrated increased crypt proliferation and villus length. Aged septic Mttp-IKO mice also manifested increased pulmonary myeloperoxidase levels, suggesting increased neutrophil infiltration, as well as decreased systemic TNF alpha compared to aged septic WT mice. Conclusions: Blocking intestinal chylomicron secretion alters mortality following sepsis in an age-dependent manner. Increases in gut apoptosis and pulmonary neutrophil infiltration, and decreased systemic TNF alpha represent potential mechanisms for why intestine-specific Mttp deletion is beneficial in young septic mice but harmful in aged mice as each of these parameters are altered differently in young and aged septic WT and Mttp-IKO mice.	[Liang, Zhe; Breed, Elise R.; Yoseph, Benyam P.; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA; [Liang, Zhe; Breed, Elise R.; Yoseph, Benyam P.; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Xie, Yan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Dominguez, Jessica A.] Bastyr Univ Calif, Dept Basic Sci, San Diego, CA USA; [Burd, Eileen M.; Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University; Washington University (WUSTL); Emory University	Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA.	cmcoop3@emory.edu	Farris, Alton Brad/S-6041-2017; Breed, Elise/G-2547-2017	Farris, Alton Brad/0000-0001-5534-7763; Breed, Elise/0000-0001-6468-8463; Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health [GM072808, GM104323, GM095442, GM66202, HL-38180, DK-56260, DK-52574]; Shock Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK056260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066202, R01GM072808, R01GM104323, T32GM095442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shock Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from National Institutes of Health (GM072808, GM104323, GM095442, GM66202, HL-38180, DK-56260, DK-52574) and the Shock Society Early Career Investigator Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Babrowski T, 2013, SURGERY, V153, P36, DOI 10.1016/j.surg.2012.06.022; Badami CD, 2008, SHOCK, V30, P680, DOI 10.1097/SHK.0b013e318173edd1; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Cao ZY, 2014, J PROTEOME RES, V13, P422, DOI 10.1021/pr400814s; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087; Chang M, 2012, SHOCK, V37, P297, DOI 10.1097/SHK.0b013e318240b59b; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Chen MM, 2014, EXP GERONTOL, VS0531-5565, DOI [10.1016/j.ex-ger.2013.12.010, DOI 10.1016/J.EX-GER.2013.12.010]; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Deitch EA, 2011, SHOCK, V36, P177, DOI 10.1097/SHK.0b013e3182205c30; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Dominguez JA, 2013, CRIT CARE MED, V41, pE275, DOI 10.1097/CCM.0b013e31828a44ed; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Dominguez JA, 2010, CRIT CARE CLIN, V26, P549, DOI 10.1016/j.ccc.2010.04.005; Drechsler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051457; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Fang JF, 2010, SHOCK, V34, P291, DOI 10.1097/SHK.0b013e3181ceef5e; Fink D, 2011, J TRAUMA, V71, P1575, DOI 10.1097/TA.0b013e31821cb7e5; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Fink Mitchell P, 2003, Curr Opin Crit Care, V9, P143, DOI 10.1097/00075198-200304000-00011; Fishman JE, 2013, AM J PHYSIOL-GASTR L, V304, pG57, DOI 10.1152/ajpgi.00170.2012; Fox AC, 2012, SHOCK, V38, P508, DOI 10.1097/SHK.0b013e31826e47e8; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Geng YX, 2013, INFLAMMATION, V36, P670, DOI 10.1007/s10753-012-9591-x; Gomez CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/475139; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Lanza-Jacoby S, 2003, J ENDOTOXIN RES, V9, P341, DOI 10.1179/096805103225002782; Lu Q, 2011, J TRAUMA, V70, P630, DOI 10.1097/TA.0b013e3181e1221b; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; McConnell KW, 2010, CRIT CARE MED, V38, P223, DOI 10.1097/CCM.0b013e3181b4a76b; Mittal A, 2010, SHOCK, V34, P140, DOI 10.1097/SHK.0b013e3181cd8631; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; MURACA M, 1993, J HEPATOL, V17, P141, DOI 10.1016/S0168-8278(05)80028-5; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Osuchowski MF, 2012, J IMMUNOL, V189, P4648, DOI 10.4049/jimmunol.1201806; Ott J, 2011, PROSTAG LEUKOTR ESS, V85, P267, DOI 10.1016/j.plefa.2011.04.011; Peltz ED, 2009, SURGERY, V146, P347, DOI 10.1016/j.surg.2009.02.022; Perrone EE, 2012, SHOCK, V38, P68, DOI 10.1097/SHK.0b013e318259abdb; Qin XF, 2008, SHOCK, V29, P372, DOI 10.1097/shk.0b013e3181453f4e; Qiu P, 2011, EXPERT OPIN INV DRUG, V20, P1555, DOI 10.1517/13543784.2011.623125; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Reino DC, 2012, SHOCK, V38, P107, DOI 10.1097/SHK.0b013e318257123a; Romanowski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030119; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Sambol JT, 2009, J APPL PHYSIOL, V106, P57, DOI 10.1152/japplphysiol.90937.2008; Sarin EL, 2004, J TRAUMA, V57, P950, DOI 10.1097/01.TA.0000149493.95859.6C; Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Tucsek Z, 2013, J GERONTOL A-BIOL, V68, P652, DOI 10.1093/gerona/gls232; Turnbull IR, 2004, SHOCK, V22, P364, DOI 10.1097/01.shk.0000142552.77473.7d; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Watkins AC, 2008, J TRAUMA, V64, P126, DOI 10.1097/TA.0b013e3181574a8a; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2012, ARTERIOSCL THROM VAS, V32, P1624, DOI 10.1161/ATVBAHA.112.246066; Yamamoto K, 2002, AM J PATHOL, V161, P1805, DOI 10.1016/S0002-9440(10)64457-4; Yang JX, 2013, SURGERY, V153, P52, DOI 10.1016/j.surg.2012.04.002; Yoseph BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062792; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051	81	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101828	10.1371/journal.pone.0101828	http://dx.doi.org/10.1371/journal.pone.0101828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010671	Green Published, gold			2022-12-27	WOS:000338763800043
J	Yoshii, H; Yanagihara, K; Imaseki, H; Hamano, T; Yamanishi, H; Inagaki, M; Sakai, Y; Sugiura, N; Kurihara, O; Sakai, K				Yoshii, Hiroshi; Yanagihara, Kouta; Imaseki, Hitoshi; Hamano, Tsuyoshi; Yamanishi, Hirokuni; Inagaki, Masayo; Sakai, Yasuhiro; Sugiura, Nobuyuki; Kurihara, Osamu; Sakai, Kazuo			Methodology Using a Portable X-Ray Fluorescence Device for On-Site and Rapid Evaluation of Heavy-Atom Contamination in Wounds: A Model Study for Application to Plutonium Contamination	PLOS ONE			English	Article							IN-VIVO; WHOLE-BLOOD; XRF MEASUREMENT; IRON; BONE; LEAD; ZN; FE; CU	Workers decommissioning the Fukushima-Daiichi nuclear power plant damaged from the Great East Japan Earthquake and resulting tsunami are at risk of injury with possible contamination from radioactive heavy atoms including actinides, such as plutonium. We propose a new methodology for on-site and rapid evaluation of heavy-atom contamination in wounds using a portable X-ray fluorescence (XRF) device. In the present study, stable lead was used as the model contaminant substitute for radioactive heavy atoms. First, the wound model was developed by placing a liquid blood phantom on an epoxy resin wound phantom contaminated with lead. Next, the correlation between the concentration of contaminant and the XRF peak intensity was formulated considering the thickness of blood exiting the wound. Methods to determine the minimum detection limit (MDL) of contaminants at any maximal equivalent dose to the wound by XRF measurement were also established. For example, in this system, at a maximal equivalent dose of 16.5 mSv to the wound and blood thickness of 0.5 mm, the MDL value for lead was 1.2 ppm (3.1 nmol). The radioactivity of Pu-239 corresponding to 3.1 nmol is 1.7 kBq, which is lower than the radioactivity of Pu-239 contaminating puncture wounds in previous severe accidents. In conclusion, the established methodology could be beneficial for future development of a method to evaluate plutonium contamination in wounds. Highlights: Methodology for evaluation of heavy-atom contamination in a wound was established. A portable Xray fluorescence device enables on-site, rapid and direct evaluation. This method is expected to be used for evaluation of plutonium contamination in wounds.	[Yoshii, Hiroshi; Yanagihara, Kouta; Imaseki, Hitoshi; Hamano, Tsuyoshi; Kurihara, Osamu; Sakai, Kazuo] Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Chiba 260, Japan; [Yanagihara, Kouta; Sakai, Yasuhiro] Toho Univ, Dept Phys, Fac Sci, Funabashi, Chiba 274, Japan; [Yamanishi, Hirokuni; Inagaki, Masayo] Kinki Univ, Atom Energy Res Inst, Higashiosaka, Osaka 577, Japan; [Sugiura, Nobuyuki] Nucl Safety Res Assoc, Radiat Environm Effects Res Ctr, Minato Ku, Shinbashi, Tokyo, Japan	National Institutes for Quantum Science & Technology; Toho University; Japan Atomic Energy Agency; Kindai University (Kinki University)	Yoshii, H (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Chiba 260, Japan.	yoshii@nirs.go.jp						BORJESSON J, 1995, PHYS MED BIOL, V40, P413, DOI 10.1088/0031-9155/40/3/006; Bradley DA, 2000, J RADIOANAL NUCL CH, V244, P213, DOI 10.1023/A:1006757424682; Carbaugh EH, 2010, HEALTH PHYS, V99, P483, DOI 10.1097/HP.0b013e3181d96381; CHRISTOFFERSSON JO, 1983, PHYS MED BIOL, V28, P1135, DOI 10.1088/0031-9155/28/10/005; Deslattes RD, 2003, REV MOD PHYS, V75, P35, DOI 10.1103/RevModPhys.75.35; Estevam M, 2013, HEALTH PHYS, V104, P132, DOI 10.1097/HP.0b013e3182667721; Fleming DEB, 2007, PHYS MED BIOL, V52, pN459, DOI 10.1088/0031-9155/52/19/N04; GENICOT JL, 1995, APPL RADIAT ISOTOPES, V46, P199, DOI 10.1016/0969-8043(94)00115-G; Gherase MR, 2010, APPL RADIAT ISOTOPES, V68, P743, DOI 10.1016/j.apradiso.2009.09.037; Helmer OM, 1934, J BIOL CHEM, V104, P157; ICRP, 2007, ANN ICRP, V37, P98; International Atomic Energy Agency, 2005, SER MED PROBL ALW HA, P53; IYENGAR GV, 1987, BIOL TRACE ELEM RES, V12, P263, DOI 10.1007/BF02796686; Jenkins R, 1999, XRAY FLUORESCENCE SP, p[153, 175]; King LS, 1942, J EXP MED, V76, P325, DOI 10.1084/jem.76.4.325; Moreno MA, 1999, SCI TOTAL ENVIRON, V229, P209, DOI 10.1016/S0048-9697(99)00074-1; National Council on Radiation protection and Measurement, 2006, 156 NCRP, P118; Nie HL, 2006, PHYS MED BIOL, V51, P351, DOI 10.1088/0031-9155/51/2/011; Nie HL, 2004, PHYS MED BIOL, V49, pN325, DOI 10.1088/0031-9155/49/19/N02; Nie LH, 2011, PHYS MED BIOL, V56, pN39, DOI 10.1088/0031-9155/56/3/N01; O'Meara JM, 1998, APPL RADIAT ISOTOPES, V49, P713, DOI 10.1016/S0969-8043(97)00091-2; O'Meara JM, 2000, APPL RADIAT ISOTOPES, V53, P639, DOI 10.1016/S0969-8043(00)00244-X; Saha GB, 1993, PHYS RADIOBIOLOGY NU, P11; Schadilov AE, 2010, HEALTH PHYS, V99, P560, DOI 10.1097/HP.0b013e3181c34989; Teng WF, 2008, BIOL TRACE ELEM RES, V121, P243, DOI 10.1007/s12011-007-8047-x; TRUDNOWSKI RJ, 1974, CLIN CHEM, V20, P615	26	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101966	10.1371/journal.pone.0101966	http://dx.doi.org/10.1371/journal.pone.0101966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010749	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800055
J	Afonso, P; McGinty, N; Machete, M				Afonso, Pedro; McGinty, Niall; Machete, Miguel			Dynamics of Whale Shark Occurrence at Their Fringe Oceanic Habitat	PLOS ONE			English	Article							RHINCODON-TYPUS; NORTH-ATLANTIC; CLIMATE-CHANGE; NURSERY AREAS; INDIAN-OCEAN; ECOLOGY; CONSERVATION; OSCILLATION; FISHERIES; BYCATCH	Studies have shown that the whale shark (Rhincodon typus), a vulnerable large filter feeder, seasonally aggregates at highly productive coastal sites and that individuals can perform large, trans-boundary migrations to reach these locations. Yet, the whereabouts of the whale shark when absent from these sites and the potential oceanographic and biological drivers involved in shaping their present and future habitat use, including that located at the fringes of their suitable oceanic habitat, are largely unknown. We analysed a 16-year (1998-2013) observer dataset from the pole-and-line tuna fishery across the Azores (mid-North Atlantic) and used GAM models to investigate the spatial and temporal patterns of whale shark occurrence in relation to oceanographic features. Across this period, the whale shark became a regular summer visitor to the archipelago after a sharp increase in sighting frequency seen in 2008. We found that SST helps predicting their occurrence in the region associated to the position of the seasonal 22 degrees C isotherm, showing that the Azores are at a thermal boundary for this species and providing an explanation for the post 2007 increase. Within the region, whale shark detections were also higher in areas of increased bathymetric slope and closer to the seamounts, coinciding with higher chla biomass, a behaviour most probably associated to increased feeding opportunities. They also showed a tendency to be clustered around the southernmost island of Santa Maria. This study shows that the region integrates the oceanic habitat of adult whale shark and suggests that an increase in its relative importance for the Atlantic population might be expected in face of climate change.	[Afonso, Pedro; McGinty, Niall] Univ Azores, IMAR Inst Marine Res, Dept Oceanog & Fisheries, Horta, Portugal; [Machete, Miguel] LARSyS Lab Robot & Syst Engn & Sci, Lisbon, Portugal; [McGinty, Niall] Univ Iceland, Dept Life & Hlth Sci, MARICE Marine Acad Res Iceland, Reykjavik, Iceland	Universidade dos Acores; University of Iceland	Afonso, P (corresponding author), Univ Azores, IMAR Inst Marine Res, Dept Oceanog & Fisheries, Horta, Portugal.	afonso@uac.pt	Afonso, Pedro/B-7815-2013	Afonso, Pedro/0000-0002-4618-2589	Portuguese Foundation for Science and Technology/Ministry of Education and Science (FCT/MCTES-MEC) through Ciencia POPH/QREN; LARSyS Strategic Project [PEst/OE/EEI/LA00009/2011]; MADE project [EU/FP7-KBBE-2007-1]	Portuguese Foundation for Science and Technology/Ministry of Education and Science (FCT/MCTES-MEC) through Ciencia POPH/QREN; LARSyS Strategic Project; MADE project	This research was partially supported by the Portuguese Foundation for Science and Technology/Ministry of Education and Science (FCT/MCTES-MEC) through individual support to P. A. (Ciencia 2008/POPH/QREN) and the LARSyS Strategic Project (PEst/OE/EEI/LA00009/2011) 2011-2012, and by the MADE project (EU/FP7-KBBE-2007-1) through individual support to N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amande MJ, 2010, AQUAT LIVING RESOUR, V23, P353, DOI 10.1051/alr/2011003; [Anonymous], 2010, R LANG ENV STAT COMP; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bashmachnikov I, 2004, P SOC PHOTO-OPT INS, V5569, P148, DOI 10.1117/12.565596; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Brunnschweiler JM, 2011, AM FISHERIES SOC S, V76, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardenas-Palomo N, 2010, REV BIOL TROP, V58, P399; Clarke M.R., 1995, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V13A, P53; Clarke M.R., 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P41; Compagno LJV, 2001, SHARKS WORLD ANNOT; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Granadeiro JP, 1998, MAR ECOL PROG SER, V166, P267, DOI 10.3354/meps166267; Henson SA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005139; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Ketchum JT, 2013, ENVIRON BIOL FISH, V96, P779, DOI 10.1007/s10641-012-0071-9; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Leterme SC, 2005, LIMNOL OCEANOGR, V50, P1244, DOI 10.4319/lo.2005.50.4.1244; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; Martinez E, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006836; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Norman B, 2005, IUCN 2012 IUCN RED L; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pravin P, 2000, CURR SCI INDIA, V79, P310; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Romanov EV, 2002, FISH B-NOAA, V100, P90; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Sequeira AMM, 2013, J FISH BIOL, V82, P367, DOI 10.1111/jfb.12017; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; Sequeira AMM, 2014, GLOBAL CHANGE BIOL, V20, P778, DOI 10.1111/gcb.12343; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V382, P77, DOI 10.1016/j.jembe.2009.10.015; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wiafe G, 2008, ICES J MAR SCI, V65, P318, DOI 10.1093/icesjms/fsn042; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; Wolfson F.H., 1986, P208; Yochanan K, 2010, J CLIMATE, V23, P5610; ZWEIG MH, 1993, CLIN CHEM, V39, P561	44	26	27	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102060	10.1371/journal.pone.0102060	http://dx.doi.org/10.1371/journal.pone.0102060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028929	Green Submitted, gold, Green Published			2022-12-27	WOS:000341306600032
J	Kim, SC; Park, SW; Ryoo, I; Jung, SC; Yun, TJ; Choi, SH; Kim, JH; Sohn, CH				Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho			Contrast-Enhanced FLAIR (Fluid-Attenuated Inversion Recovery) for Evaluating Mild Traumatic Brain Injury	PLOS ONE			English	Article							DIFFUSE AXONAL INJURY; HEAD-INJURY; SUBDURAL-HEMATOMA; MR; MENINGES; SEQUELAE; RESECTION; SPACE; SITE	Purpose: To evaluate whether adding a contrast-enhanced fluid-attenuated inversion recovery (FLAIR) sequence to routine magnetic resonance imaging (MRI) can detect additional abnormalities in the brains of symptomatic patients with mild traumatic brain injury. Materials and Methods: Fifty-four patients with persistent symptoms following mild closed head injury were included in our retrospective study (M:F = 32: 22, mean age: 59.8 +/- 16.4, age range: 26-84 years). All MRI examinations were obtained within 14 days after head trauma (mean: 3.2 +/- 4.1 days, range: 0.2-14 days). Two neuroradiologists recorded (1) the presence of traumatic brain lesions on MR images with and without contrast-enhanced FLAIR images and (2) the pattern and location of meningeal enhancement depicted on contrast-enhanced FLAIR images. The number of additional traumatic brain lesions diagnosed with contrast-enhanced FLAIR was recorded. Correlations between meningeal enhancement and clinical findings were also evaluated. Results: Traumatic brain lesions were detected on routine image sequences in 25 patients. Three additional cases of brain abnormality were detected with the contrast-enhanced FLAIR images. Meningeal enhancement was identified on contrast-enhanced FLAIR images in 9 cases while the other routine image sequences showed no findings of traumatic brain injury. Overall, the additional contrast-enhanced FLAIR images revealed more extensive abnormalities than routine imaging in 37 cases (p<0.001). In multivariate logistic regression analysis, subdural hematoma and posttraumatic loss of consciousness showed a significant association with meningeal enhancement on contrast-enhanced FLAIR images, with odds ratios 13.068 (95% confidence interval 2.037 to 83.852), and 15.487 (95% confidence interval 2.545 to 94.228), respectively. Conclusion: Meningeal enhancement on contrast-enhanced FLAIR images can help detect traumatic brain lesions as well as additional abnormalities not identified on routine unenhanced MRI. Therefore contrast-enhanced FLAIR MR imaging is recommended when a contrast MR study is indicated in a patient with a symptomatic prior closed mild head injury.	[Kim, Soo Chin; Park, Sun-Won] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea; [Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ryoo, Inseon] Korea Univ, Guro Hosp, Dept Radiol, Seoul, South Korea; [Jung, Seung Chai] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital	Park, SW (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea.	swpark8802@gmail.com	Sohn, ChulHo/AAV-4565-2021	Choi, Seung Hong/0000-0002-0412-2270				Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Atkinson JLD, 2003, J MAGN RESON IMAGING, V17, P484, DOI 10.1002/jmri.10275; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BURKE JW, 1990, RADIOLOGY, V174, P99, DOI 10.1148/radiology.174.1.2294579; Dolinskas CA, 1998, AM J NEURORADIOL, V19, P419; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; ELSTER AD, 1990, RADIOLOGY, V174, P93, DOI 10.1148/radiology.174.1.2294578; Ercan N, 2004, AM J NEURORADIOL, V25, P761; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fukuoka H, 2010, AM J NEURORADIOL, V31, P868, DOI 10.3174/ajnr.A1937; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Goo HW, 2003, PEDIATR RADIOL, V33, P843, DOI 10.1007/s00247-003-1057-8; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Henegar MM, 1996, J NEUROSURG, V84, P174, DOI 10.3171/jns.1996.84.2.0174; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rapana A, 1997, CLIN NEUROL NEUROSUR, V99, P124, DOI 10.1016/S0303-8467(96)00585-9; Romano Valerie A., 1994, Journal of Emergency Medicine, V12, P369, DOI 10.1016/0736-4679(94)90280-1; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sato N, 1997, RADIOLOGY, V204, P839, DOI 10.1148/radiology.204.3.9280269; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Soman S, 2013, AM J NEURORADIOL, V34, P2092, DOI 10.3174/ajnr.A3595; SZE G, 1993, AM J ROENTGENOL, V160, P727, DOI 10.2214/ajr.160.4.8456653; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	33	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102229	10.1371/journal.pone.0102229	http://dx.doi.org/10.1371/journal.pone.0102229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028975	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600049
J	Rosler, TW; Matusch, A; Librizzi, D; Arias-Carrion, O; Freundlieb, N; Hoeffken, H; Oertel, WH; Depboylu, C; Hoglinger, GU				Roesler, Thomas W.; Matusch, Andreas; Librizzi, Damiano; Arias-Carrion, Oscar; Freundlieb, Nils; Hoeffken, Helmut; Oertel, Wolfgang H.; Depboylu, Candan; Hoeglinger, Guenter U.			Diesterified Derivatives of 5-Iodo-2 '-Deoxyuridine as Cerebral Tumor Tracers	PLOS ONE			English	Article							FLUORINATED THYMIDINE DERIVATIVES; IMAGING CELL-PROLIFERATION; BRAIN-TUMORS; IODODEOXYURIDINE; GLIOMAS; ANALOG; MOUSE; PET	With the aim to develop beneficial tracers for cerebral tumors, we tested two novel 5-iodo-2'-deoxyuridine (IUdR) derivatives, diesterified at the deoxyribose residue. The substances were designed to enhance the uptake into brain tumor tissue and to prolong the availability in the organism. We synthesized carrier added 5-[I-125]iodo-3',5'-di-O-acetyl-2'-deoxyuridine (Ac-2[I-125]IUdR), 5-[I-125]iodo-3',5'-di-O-pivaloyl-2'-deoxyuridine (Piv(2)[I-125]IUdR) and their respective precursor molecules for the first time. HPLC was used for purification and to determine the specific activities. The iodonucleoside tracer were tested for their stability against human thymidine phosphorylase. DNA integration of each tracer was determined in 2 glioma cell lines (Gl261, CRL2397) and in PC12 cells in vitro. In mice, we measured the relative biodistribution and the tracer uptake in grafted brain tumors. Ac-2[I-125]IUdR, Piv(2)[I-125]IUdR and [I-125]IUdR (control) were prepared with labeling yields of 31-47% and radiochemical purities of >99% (HPLC). Both diesterified iodonucleoside tracers showed a nearly 100% resistance against degradation by thymidine phosphorylase. Ac-2[I-125]IUdR and Piv(2)[I-125]IUdR were specifically integrated into the DNA of all tested tumor cell lines but to a less extend than the control [I-125]IUdR. In mice, 24 h after i.p. injection, brain radioactivity uptakes were in the following order Piv(2)[I-125]IUdR > Ac-2[I-125]IUdR>[I-125]IUdR. For Ac-2[I-125]IUdR we detected lower amounts of radioactivities in the thyroid and stomach, suggesting a higher stability toward deiodination. In mice bearing unilateral graft-induced brain tumors, the uptake ratios of tumor-bearing to healthy hemisphere were 51, 68 and 6 for [I-125]IUdR, Ac-2[I-125]IUdR and Piv(2)[I-125]IUdR, respectively. Esterifications of both deoxyribosyl hydroxyl groups of the tumor tracer IUdR lead to advantageous properties regarding uptake into brain tumor tissue and metabolic stability.	[Roesler, Thomas W.; Matusch, Andreas; Arias-Carrion, Oscar; Freundlieb, Nils; Oertel, Wolfgang H.; Depboylu, Candan; Hoeglinger, Guenter U.] Univ Marburg, Dept Neurol, Marburg, Germany; [Roesler, Thomas W.; Hoeglinger, Guenter U.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Matusch, Andreas] Res Ctr Julich, Inst Neurosci & Med INM 2, Julich, Germany; [Librizzi, Damiano; Hoeffken, Helmut] Univ Marburg, Dept Nucl Med, Marburg, Germany; [Arias-Carrion, Oscar; Hoeglinger, Guenter U.] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Freundlieb, Nils] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Brain Imaging & Neurostimulat BINS Lab, Hamburg, Germany	Philipps University Marburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Research Center Julich; Philipps University Marburg; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rosler, TW (corresponding author), Univ Marburg, Dept Neurol, Marburg, Germany.	thomas.roesler@dzne.de	Arias-Carrion, Oscar/A-4248-2018; Höglinger, Günter U/F-2388-2015	Arias-Carrion, Oscar/0000-0002-9982-7571; Höglinger, Günter U/0000-0001-7587-6187	Else Kroner-Fresenius Foundation [P35/08//A75/07]; German Research Foundation (DFG) [HO2402/6-1]	Else Kroner-Fresenius Foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	This project was funded by the Else Kroner-Fresenius Foundation P35/08//A75/07. Gunter U. Hoglinger was supported by the German Research Foundation (DFG, HO2402/6-1). Wolfgang H. Oertel is senior research professor of the Charitable Hertie Foundation, Frankfurt/Main, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSMAN JI, 1970, CANCER RES, V30, P2394; Blasberg RG, 2000, CANCER RES, V60, P624; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; FOULON CF, 1995, APPL RADIAT ISOTOPES, V46, P1039, DOI 10.1016/0969-8043(95)00214-X; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gosh MK, 1992, PHARM RES, V9, P1173; HUGHES WL, 1964, FED PROC, V23, P640; Jacobs AH, 2005, J NUCL MED, V46, P1948; KAWAGUCHI T, 1985, CHEM PHARM BULL, V33, P1652; Langen KJ, 1997, J NUCL MED, V38, P517; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Larock RC, 2005, TETRAHEDRON, V61, P11427, DOI 10.1016/j.tet.2005.08.065; Machein MR, 2003, BRAIN PATHOL, V13, P582; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; PRUSOFF WH, 1959, BIOCHIM BIOPHYS ACTA, V32, P295, DOI 10.1016/0006-3002(59)90597-9; PRUSOFF WH, 1960, BIOCHEM PHARMACOL, V3, P110, DOI 10.1016/0006-2952(60)90027-7; QUACKENBUSH RC, 1988, CELL TISSUE KINET, V21, P381, DOI 10.1111/j.1365-2184.1988.tb00797.x; Toyohara J, 2003, NUCL MED BIOL, V30, P687, DOI 10.1016/S0969-8051(03)00081-7; Toyohara J, 2002, J NUCL MED, V43, P1218; Toyohara J, 2006, NUCL MED BIOL, V33, P751, DOI 10.1016/j.nucmedbio.2006.06.003; Toyohara J, 2006, NUCL MED BIOL, V33, P765, DOI 10.1016/j.nucmedbio.2006.06.001	21	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102397	10.1371/journal.pone.0102397	http://dx.doi.org/10.1371/journal.pone.0102397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028935	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600072
J	Aparna, V; Dineshkumar, K; Mohanalakshmi, N; Velmurugan, D; Hopper, W				Aparna, Vasudevan; Dineshkumar, Kesavan; Mohanalakshmi, Narasumani; Velmurugan, Devadasan; Hopper, Waheeta			Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation	PLOS ONE			English	Article							P-GLYCOPROTEIN; RESISTANCE; DOCKING; BERBERINE; PRODUCTS; PROTEIN; ASSAY; SITE	Pseudomonas aeruginosa and Escherichia coli are resistant to wide range of antibiotics rendering the treatment of infections very difficult. A main mechanism attributed to the resistance is the function of efflux pumps. MexAB-OprM and AcrAB-TolC are the tripartite efflux pump assemblies, responsible for multidrug resistance in P. aeruginosa and E. coli respectively. Substrates that are more susceptible for efflux are predicted to have a common pharmacophore feature map. In this study, a new criterion of excluding compounds with efflux substrate-like features was used, thereby refining the selection process and enriching the inhibitor identification process. An in-house database of phytochemicals was created and screened using high-throughput virtual screening against AcrB and MexB proteins and filtered by matching with the common pharmacophore models (AADHR, ADHNR, AAHNR, AADHN, AADNR, AAADN, AAADR, AAANR, AAAHN, AAADD and AAADH) generated using known efflux substrates. Phytochemical hits that matched with any one or more of the efflux substrate models were excluded from the study. Hits that do not have features similar to the efflux substrate models were docked using XP docking against the AcrB and MexB proteins. The best hits of the XP docking were validated by checkerboard synergy assay and ethidium bromide accumulation assay for their efflux inhibition potency. Lanatoside C and diadzein were filtered based on the synergistic potential and validated for their efflux inhibition potency using ethidium bromide accumulation study. These compounds exhibited the ability to increase the accumulation of ethidium bromide inside the bacterial cell as evidenced by these increase in fluorescence in the presence of the compounds. With this good correlation between in silico screening and positive efflux inhibitory activity in vitro, the two compounds, lanatoside C and diadzein could be promising efflux pump inhibitors and effective to use in combination therapy against drug resistant strains of P. aeruginosa and E. coli.	[Aparna, Vasudevan; Dineshkumar, Kesavan; Mohanalakshmi, Narasumani; Hopper, Waheeta] SRM Univ, Dept Bioinformat, Sch Bioengn, Fac Engn & Technol, Kattankulathur, Tamil Nadu, India; [Velmurugan, Devadasan] Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras, Tamil Nadu, India	SRM Institute of Science & Technology Chennai; University of Madras	Hopper, W (corresponding author), SRM Univ, Dept Bioinformat, Sch Bioengn, Fac Engn & Technol, Kattankulathur, Tamil Nadu, India.	hod.bioinfo@ktr.srmuniv.ac.in	Hopper, Waheeta/P-8453-2016; Kesavan, Dinesh Kumar/AAW-1831-2020	Hopper, Waheeta/0000-0001-6912-4835; Kumar Kesavan, Dinesh/0000-0003-2906-8386	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; SRM University, India	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); SRM University, India	This study was supported by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, for funding the research and SRM University, India for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askoura M, 2011, LIBYAN J MED, V6, DOI 10.3402/ljm.v6i0.5870; Ball AR, 2006, ACS CHEM BIOL, V1, P594, DOI 10.1021/cb600238x; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Chung SY, 2005, ARCH PHARM RES, V28, P823, DOI 10.1007/BF02977349; CLSI, 2012, M100S22 CLSI; Coldham NG, 2010, J ANTIMICROB CHEMOTH, V65, P1655, DOI 10.1093/jac/dkq169; Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Hirakata Y, 2009, INT J ANTIMICROB AG, V34, P343, DOI 10.1016/j.ijantimicag.2009.06.007; Jatana N, 2013, J MOL GRAPH MODEL, V39, P145, DOI 10.1016/j.jmgm.2012.10.010; Kumar A, 2008, J ANTIMICROB CHEMOTH, V61, P1270, DOI 10.1093/jac/dkn088; Lechner D, 2008, J ANTIMICROB CHEMOTH, V62, P345, DOI 10.1093/jac/dkn178; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Melero CP, 2000, MOLECULES, V5, P51, DOI 10.3390/50100051; Nakashima R, 2013, NATURE, V500, P102, DOI 10.1038/nature12300; Nelson Mark L., 2002, Current Medicinal Chemistry - Anti-Infective Agents, V1, P35, DOI 10.2174/1568012023355054; Peach ML, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-6; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; POISSON J, 1954, CR HEBD ACAD SCI, V238, P1607; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schrodinger, 2011, VERS 9 2; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460; Stermitz FR, 2001, BIOCHEM SYST ECOL, V29, P793, DOI 10.1016/S0305-1978(01)00025-4; Stermitz FR, 2000, J NAT PROD, V63, P1146, DOI 10.1021/np990639k; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Vasudevan A., 2014, INT J PHARM PHARM SC, V6, P84; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Zhang Z, 2010, WORLD J GASTROENTERO, V16, P1279, DOI 10.3748/wjg.v16.i10.1279	35	72	76	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101840	10.1371/journal.pone.0101840	http://dx.doi.org/10.1371/journal.pone.0101840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025665	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400024
J	Fuhrmann, A; Li, JL; Chien, S; Engler, AJ				Fuhrmann, Alexander; Li, Julie; Chien, Shu; Engler, Adam J.			Cation Type Specific Cell Remodeling Regulates Attachment Strength	PLOS ONE			English	Article							INTEGRIN-MEDIATED ADHESION; QUANTITATIVE MEASUREMENTS; DIVALENT-CATIONS; BINDING; FIBRONECTIN; AFFINITY; MATRIX; FIBROBLASTS; MAGNESIUM; DYNAMICS	Single-molecule experiments indicate that integrin affinity is cation-type-dependent, but in spread cells integrins are engaged in complex focal adhesions (FAs), which can also regulate affinity. To better understand cation-type-dependent adhesion in fully spread cells, we investigated attachment strength by application of external shear. While cell attachment strength is indeed modulated by cations, the regulation of integrin-mediated adhesion is also exceedingly complex, cell specific, and niche dependent. In the presence of magnesium only, fibroblasts and fibrosarcoma cells remodel their cytoskeleton to align in the direction of applied shear in an alpha(5)-integrin/fibronectin-dependent manner, which allows them to withstand higher shear. In the presence of calcium or on collagen in modest shear, fibroblasts undergo piecewise detachment but fibrosarcoma cells exhibit increased attachment strength. These data augment the current understanding of force-mediated detachment by suggesting a dynamic interplay in situ between cell adhesion and integrins depending on local niche cation conditions.	[Fuhrmann, Alexander; Li, Julie; Chien, Shu; Engler, Adam J.] Univ Calif San Diego, Dept Bioengn, Inst Engn Med, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Dept Med, Inst Engn Med, La Jolla, CA 92093 USA; [Chien, Shu; Engler, Adam J.] Sanford Consortium Regenerat Med, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Engler, AJ (corresponding author), Univ Calif San Diego, Dept Bioengn, Inst Engn Med, La Jolla, CA 92093 USA.	aengler@ucsd.edu	Engler, Adam/AAF-4016-2019	Engler, Adam/0000-0003-1642-5380	 [DP02OD006460];  [U54CA143803];  [BC121670P1]; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006460] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DP02OD006460, U54CA143803, BC121670P1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2012, BIOCHEM BIOPH RES CO, V421, P245, DOI 10.1016/j.bbrc.2012.03.145; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Chen JB, 2010, J CELL PHYSIOL, V223, P68, DOI 10.1002/jcp.22010; Chen Y, 2013, P NATL ACAD SCI USA, V110, pE2352, DOI 10.1073/pnas.1221637110; CONFORTI G, 1994, CELL ADHES COMMUN, V1, P279, DOI 10.3109/15419069409097260; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013; Engler AJ, 2009, J CELL SCI, V122, P1647, DOI 10.1242/jcs.040824; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006; Gabriele E, 1997, CELL GROWTH DIFFER, V8, P1339; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lange T S, 1995, Exp Dermatol, V4, P130, DOI 10.1111/j.1600-0625.1995.tb00236.x; LANGE TS, 1994, EXP CELL RES, V214, P381, DOI 10.1006/excr.1994.1271; Lee AM, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4748811; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Lomakina EB, 2004, BIOPHYS J, V86, P1223, DOI 10.1016/S0006-3495(04)74196-X; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MARTZ E, 1980, J CELL BIOL, V84, P584, DOI 10.1083/jcb.84.3.584; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Noria S, 2004, AM J PATHOL, V164, P1211, DOI 10.1016/S0002-9440(10)63209-9; Patterson KC, 2013, BIOPHYS J, V105, P40, DOI 10.1016/j.bpj.2013.05.052; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Schinagl RM, 1999, J ORTHOP RES, V17, P121, DOI 10.1002/jor.1100170118; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; SELTZER MH, 1970, CANCER RES, V30, P615; Sherwood L, 2004, HUMAN PHYSL CELLS SY; Spillmann C, 2002, ANN BIOMED ENG, V30, P1002, DOI 10.1114/1.1511241; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; TAKEICHI M, 1974, DEV BIOL, V39, P336; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535	44	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102424	10.1371/journal.pone.0102424	http://dx.doi.org/10.1371/journal.pone.0102424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014042	Green Published, gold			2022-12-27	WOS:000339378400095
J	Wei, W; Xin, HH; Roy, B; Dai, JB; Miao, YG; Gao, GJ				Wei, Wei; Xin, Huhu; Roy, Bhaskar; Dai, Junbiao; Miao, Yungen; Gao, Guanjun			Heritable Genome Editing with CRISPR/Cas9 in the Silkworm, Bombyx mori	PLOS ONE			English	Article							GUIDED CAS9 NUCLEASE; CAENORHABDITIS-ELEGANS; TARGETED MUTAGENESIS; HUMAN-CELLS; URIC-ACID; RNA; DROSOPHILA; SYSTEMS; GENES; TRANSFORMATION	We report the establishment of an efficient and heritable gene mutagenesis method in the silkworm Bombyx mori using modified type II clustered regularly interspaced short palindromic repeats (CRISPR) with an associated protein (Cas9) system. Using four loci Bm-ok, BmKMO, BmTH, and Bmtan as candidates, we proved that genome alterations at specific sites could be induced by direct microinjection of specific guide RNA and Cas9-mRNA into silkworm embryos. Mutation frequencies of 16.7-35.0% were observed in the injected generation, and DNA fragments deletions were also noted. Bm-ok mosaic mutants were used to test for mutant heritability due to the easily determined translucent epidermal phenotype of Bm-ok-disrupted cells. Two crossing strategies were used. In the first, injected Bm-ok moths were crossed with wild-type moths, and a 28.6% frequency of germline mutation transmission was observed. In the second strategy, two Bm-ok mosaic mutant moths were crossed with each other, and 93.6% of the offsprings appeared mutations in both alleles of Bm-ok gene (compound heterozygous). In summary, the CRISPR/Cas9 system can act as a highly specific and heritable gene-editing tool in Bombyx mori.	[Wei, Wei; Roy, Bhaskar; Dai, Junbiao; Gao, Guanjun] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Xin, Huhu; Miao, Yungen] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China	Tsinghua University; Zhejiang University	Miao, YG (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	miaoyg@zju.edu.cn; gaogu@mail.tsinghua.edu.cn	Dai, Junbiao/AAB-8328-2021	Dai, Junbiao/0000-0002-5299-4700	National Natural Science Foundation of China [31171278, 31271542, 31372374/C1703]; National Basic Research Program of China [2012CB114601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (31171278, 31271542, 31372374/C1703) and the National Basic Research Program of China (2012CB114601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; BUCKNER JS, 1990, J INSECT PHYSIOL, V36, P219, DOI 10.1016/0022-1910(90)90106-P; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Katic I, 2013, GENETICS, V195, P1173, DOI 10.1534/genetics.113.155754; KIKKAWA H, 1953, ADV GENET, V5, P107, DOI 10.1016/S0065-2660(08)60407-1; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Seitz V, 2003, DEV COMP IMMUNOL, V27, P207, DOI 10.1016/S0145-305X(02)00097-6; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tamura Toshiki, 2007, Journal of Insect Biotechnology and Sericology, V76, P155; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xiao A, 2014, BIOINFORMATICS; Yamao M, 1999, GENE DEV, V13, P511, DOI 10.1101/gad.13.5.511; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhao AC, 2012, INSECT SCI, V19, P172, DOI 10.1111/j.1744-7917.2011.01422.x	32	60	74	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101210	10.1371/journal.pone.0101210	http://dx.doi.org/10.1371/journal.pone.0101210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013902	Green Submitted, gold, Green Published			2022-12-27	WOS:000339378400021
J	Wen, J; Schulman, KA				Wen, Jin; Schulman, Kevin A.			Can Team-Based Care Improve Patient Satisfaction? A Systematic Review of Randomized Controlled Trials	PLOS ONE			English	Review							HEALTH MAINTENANCE ORGANIZATION; OUTPATIENT GERIATRIC EVALUATION; PHYSICIAN ASSISTANTS; NURSE-PRACTITIONERS; FOLLOW-UP; MANAGEMENT; MULTIDISCIPLINARY; QUALITY; INTERVENTION; DEPRESSION	Background: Team-based approaches to patient care are a relatively recent innovation in health care delivery. The effectiveness of these approaches on patient outcomes has not been well documented. This paper reports a systematic review of the relationship between team-based care and patient satisfaction. Methods: We searched MEDLINE, EMBASE, Cochrane Library, CINAHL, and PSYCHOINFO for eligible studies dating from inception to October 8, 2012. Eligible studies reported (1) a randomized controlled trial, (2) interventions including both team-based care and non-team-based care (or usual care), and (3) outcomes including an assessment of patient satisfaction. Articles with different settings between intervention and control were excluded, as were trial protocols. The reference lists of retrieved papers were also evaluated for inclusion. Results: The literature search yielded 319 citations, of which 77 were screened for further full-text evaluation. Of these, 27 articles were included in the systematic review. The 26 trials with a total of 15,526 participants were included in this systematic review. The pooling result of dichotomous data (number of studies: 10) showed that team-based care had a positive effect on patient satisfaction compared with usual care (odds ratio, 2.09; 95% confidence interval, 1.54 to 2.84); however, combined continuous data (number of studies: 7) demonstrated that there was no significant difference in patient satisfaction between team-based care and usual care (standardized mean difference, -0.02; 95% confidence interval, -0.40 to 0.36). Conclusions: Some evidence showed that team-based care is better than usual care in improving patient satisfaction. However, considering the pooling result of continuous data, along with the suboptimal quality of included trials, further large-scale and high-quality randomized controlled trials comparing team-based care and usual care are needed.	[Wen, Jin] Sichuan Univ, West China Hosp, Inst Hosp Management, Dept Hosp Management & Hlth Policy, Chengdu 610064, Peoples R China; [Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27708 USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Sichuan University; Duke University; Duke University	Schulman, KA (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27708 USA.	kevin.schulman@duke.edu			Duke Clinical Research Institute; China Medical Board; Institute of International Education; Skhuan University Scholarship Fund	Duke Clinical Research Institute; China Medical Board; Institute of International Education; Skhuan University Scholarship Fund	This work was supported internally by the Duke Clinical Research Institute. Dr. Wen was supported by the China Medical Board, the Institute of International Education, and the Skhuan University Scholarship Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abri Rashid, 2014, Oman Med J, V29, P3, DOI 10.5001/omj.2014.02; Bausch B, 2009, EUR RESPIR J, V34, P1060, DOI 10.1183/09031936.00159108; Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Byng R, 2004, BRIT J GEN PRACT, V54, P259; Coleman EA, 1999, J AM GERIATR SOC, V47, P775, DOI 10.1111/j.1532-5415.1999.tb03832.x; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; DeBehnke D, 2002, AM J EMERG MED, V20, P267, DOI 10.1053/ajem.2002.34199; Ell K, 2011, PSYCHIAT SERV, V62, P162, DOI 10.1176/ps.62.2.pss6202_0162; Fihn SD, 2011, ARCH INTERN MED, V171, P1471, DOI 10.1001/archinternmed.2011.372; Friese CR, 2010, J ONCOL PRACT, V6, P312, DOI 10.1200/JOP.2010.000039; Gade G, 2008, J PALLIAT MED, V11, P180, DOI 10.1089/jpm.2007.0055; Garcia-Ayrnerich J, 2007, RESP MED, V101, P1462, DOI 10.1016/j.rmed.2007.01.012; Garety PA, 2006, BRIT J PSYCHIAT, V188, P37, DOI 10.1192/bjp.bp.104.007286; Gish RG, 2012, EXPERT REV GASTROENT, V6, P173, DOI [10.1586/egh.11.105, 10.1586/EGH.11.105]; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hinkel JM, 2010, J ONCOL PRACT, V6, P182, DOI 10.1200/JOP.777001; HUGHES SL, 1992, HEALTH SERV RES, V26, P801; Hunkeler EM, 2006, BMJ-BRIT MED J, V332, P259, DOI 10.1136/bmj.38683.710255.BE; Hunt JS, 2008, J GEN INTERN MED, V23, P1966, DOI 10.1007/s11606-008-0791-x; Johnson S, 2005, BRIT MED J, V331, P599, DOI 10.1136/bmj.38519.678148.8F; Litaker David, 2003, J Interprof Care, V17, P223, DOI 10.1080/1356182031000122852; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Mitchell P, 2012, NAM PERSPECT, DOI DOI 10.31478/201210C; Nolte J., 2005, ENHANCING INTERDISCI; Pape GA, 2011, ARCH INTERN MED, V171, P1480, DOI 10.1001/archinternmed.2011.417; Prakash Bhanu, 2010, J Cutan Aesthet Surg, V3, P151, DOI 10.4103/0974-2077.74491; Preen DB, 2005, INT J QUAL HEALTH C, V17, P43, DOI 10.1093/intqhc/mzi002; Rilling WS, 2002, J VASC INTERV RADIOL, V13, pS259, DOI 10.1016/S1051-0443(07)61794-1; Rost K, 2001, J GEN INTERN MED, V16, P143, DOI 10.1111/j.1525-1497.2001.00537.x; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; Scott F, 2005, NUTRITION, V21, P1071, DOI 10.1016/j.nut.2005.03.004; Scott JC, 2004, J AM GERIATR SOC, V52, P1463, DOI 10.1111/j.1532-5415.2004.52408.x; Scottish Intercollegiate Guidelines Network, 2013, SEARCH FILT; Smelt AFH, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514819; Smith PC, 2004, HEALTH AFFAIR, V23, P112, DOI 10.1377/hlthaff.23.3.112; Smith S, 2004, FAM PRACT, V21, P39, DOI 10.1093/fampra/cmh109; Speight J, 2005, VALUE HEALTH, V8, pS6, DOI 10.1111/j.1524-4733.2005.00071.x; Steglitz J, 2012, TRANSL BEHAV MED, V2, P260, DOI 10.1007/s13142-012-0154-3; Tijhuis GJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P525, DOI 10.1002/art.10665; Toseland RW, 1996, MED CARE, V34, P624, DOI 10.1097/00005650-199606000-00011; Turnbull D, 1996, LANCET, V348, P213; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; White CN, 2010, J ONCOL PRACT, V6, pE31, DOI 10.1200/JOP.2010.000100; WILLIAMS ME, 1987, J AM GERIATR SOC, V35, P1071, DOI 10.1111/j.1532-5415.1987.tb04923.x; Yellen E, 2002, J NURS CARE QUAL, V16, P23, DOI 10.1097/00001786-200207000-00005; ZIMMER JG, 1985, AM J PUBLIC HEALTH, V75, P134, DOI 10.2105/AJPH.75.2.134	47	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100603	10.1371/journal.pone.0100603	http://dx.doi.org/10.1371/journal.pone.0100603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014674	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400009
J	Creason, AL; Vandeputte, OM; Savory, EA; Davis, EW; Putnam, ML; Hu, ED; Swader-Hines, D; Mol, A; Baucher, M; Prinsen, E; Zdanowska, M; Givan, SA; El Jaziri, M; Loper, JE; Mahmud, T; Chang, JH				Creason, Allison L.; Vandeputte, Olivier M.; Savory, Elizabeth A.; Davis, Edward W., II; Putnam, Melodie L.; Hu, Erdong; Swader-Hines, David; Mol, Adeline; Baucher, Marie; Prinsen, Els; Zdanowska, Magdalena; Givan, Scott A.; El Jaziri, Mondher; Loper, Joyce E.; Mahmud, Taifo; Chang, Jeff H.			Analysis of Genome Sequences from Plant Pathogenic Rhodococcus Reveals Genetic Novelties in Virulence Loci	PLOS ONE			English	Article							TRANSFER-RNA; ISOPRENOID BIOSYNTHESIS; CYTOKININ BIOSYNTHESIS; FASCIANS; IDENTIFICATION; PATHWAY; PROTEIN; EVOLUTION; SELECTION; AGROBACTERIUM	Members of Gram-positive Actinobacteria cause economically important diseases to plants. Within the Rhodococcus genus, some members can cause growth deformities and persist as pathogens on a wide range of host plants. The current model predicts that phytopathogenic isolates require a cluster of three loci present on a linear plasmid, with the fas operon central to virulence. The Fas proteins synthesize, modify, and activate a mixture of growth regulating cytokinins, which cause a hormonal imbalance in plants, resulting in abnormal growth. We sequenced and compared the genomes of 20 isolates of Rhodococcus to gain insights into the mechanisms and evolution of virulence in these bacteria. Horizontal gene transfer was identified as critical but limited in the scale of virulence evolution, as few loci are conserved and exclusive to phytopathogenic isolates. Although the fas operon is present in most phytopathogenic isolates, it is absent from phytopathogenic isolate A21d2. Instead, this isolate has a horizontally acquired gene chimera that encodes a novel fusion protein with isopentyltransferase and phosphoribohydrolase domains, predicted to be capable of catalyzing and activating cytokinins, respectively. Cytokinin profiling of the archetypal D188 isolate revealed only one activate cytokinin type that was specifically synthesized in a fas-dependent manner. These results suggest that only the isopentenyladenine cytokinin type is synthesized and necessary for Rhodococcus phytopathogenicity, which is not consistent with the extant model stating that a mixture of cytokinins is necessary for Rhodococcus to cause leafy gall symptoms. In all, data indicate that only four horizontally acquired functions are sufficient to confer the trait of phytopathogenicity to members of the genetically diverse clade of Rhodococcus.	[Creason, Allison L.; Savory, Elizabeth A.; Davis, Edward W., II; Putnam, Melodie L.; Hu, Erdong; Swader-Hines, David; Loper, Joyce E.; Chang, Jeff H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Creason, Allison L.; Davis, Edward W., II; Loper, Joyce E.; Mahmud, Taifo; Chang, Jeff H.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Vandeputte, Olivier M.; Mol, Adeline; Baucher, Marie; El Jaziri, Mondher] Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium; [Prinsen, Els; Zdanowska, Magdalena] Univ Antwerp, Dept Biol, Lab Plant Growth & Dev, B-2020 Antwerp, Belgium; [Givan, Scott A.] Univ Missouri, Informat Res Core Facil, Columbia, MO USA; [Loper, Joyce E.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR USA; [Mahmud, Taifo] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Chang, Jeff H.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Universite Libre de Bruxelles; University of Antwerp; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); Oregon State University; Oregon State University	Chang, JH (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	changj@science.oregonstate.edu	Prinsen, Els/M-8973-2016; Mahmud, Taifo/A-1492-2015	Prinsen, Els/0000-0003-4320-1585; Mahmud, Taifo/0000-0001-9639-526X; Givan, Scott/0000-0002-0630-8589; Davis, Edward/0000-0003-1229-4272; Creason, Allison/0000-0001-5724-1276; Chang, Jeff/0000-0002-1833-0695; Savory, Elizabeth/0000-0002-6016-9962; Baucher, Marie/0000-0002-2404-8573; Loper, Joyce/0000-0003-3501-5969	Agricultural Research Foundation; USDA (United States Department of Agriculture) NIFA (National Institute of Food and Agriculture) [2013-67012-21139]; Provost's Distinguished Graduate Fellowship by Oregon State University; National Science Foundation [DGE-1314109]; Society of American Florists; USDA-ARS (Agricultural Research Service); FRS-FNRS; Fonds David et Alice Van Buuren (Belgium)	Agricultural Research Foundation; USDA (United States Department of Agriculture) NIFA (National Institute of Food and Agriculture); Provost's Distinguished Graduate Fellowship by Oregon State University; National Science Foundation(National Science Foundation (NSF)); Society of American Florists; USDA-ARS (Agricultural Research Service); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds David et Alice Van Buuren (Belgium)	This work is supported by a grant from the Agricultural Research Foundation awarded to JHC. EAS is supported by USDA (United States Department of Agriculture) NIFA (National Institute of Food and Agriculture) post-doctoral fellowship #2013-67012-21139. EWD is supported by a Provost's Distinguished Graduate Fellowship awarded by Oregon State University. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1314109 to EWD. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the National Science Foundation. This work is also supported in part by the Society of American Florists and a cooperative agreement with USDA-ARS (Agricultural Research Service) awarded to MLP. OMV is a Post-doctoral Researcher of the FRS-FNRS (Fonds de la Recherche Scientifique, Belgium) and supported by grants from FRS-FNRS and the Fonds David et Alice Van Buuren (Belgium). MB is a Senior Research Associate of the FRS-FNRS (Fonds de la Recherche Scientifique, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AKIYOSHI DE, 1987, J BACTERIOL, V169, P4242, DOI 10.1128/jb.169.9.4242-4248.1987; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell KS, 1998, J APPL MICROBIOL, V85, P195; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Chen HP, 2012, APPL ENVIRON MICROB, V78, P7798, DOI 10.1128/AEM.02120-12; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cornelis K, 2001, MOL PLANT MICROBE IN, V14, P599, DOI 10.1094/MPMI.2001.14.5.599; CRESPI M, 1994, J BACTERIOL, V176, P2492, DOI 10.1128/JB.176.9.2492-2501.1994; CRESPI M, 1992, EMBO J, V11, P795, DOI 10.1002/j.1460-2075.1992.tb05116.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Day WA, 2001, INFECT IMMUN, V69, P7471, DOI 10.1128/IAI.69.12.7471-7480.2001; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; EINSET JW, 1977, BIOCHEM BIOPH RES CO, V79, P1117, DOI 10.1016/0006-291X(77)91121-4; Francis I, 2012, MOL PLANT MICROBE IN, V25, P637, DOI 10.1094/MPMI-08-11-0215; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gurtler V, 2004, FEMS MICROBIOL REV, V28, P377, DOI 10.1016/j.femsre.2004.01.001; Herbig A, 2012, BIOINFORMATICS, V28, pI7, DOI 10.1093/bioinformatics/bts217; Hjerde E, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00055-13; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jeon WB, 2006, PROTEINS, V65, P1051, DOI 10.1002/prot.21166; Joshi MV, 2007, MOL PLANT MICROBE IN, V20, P751, DOI 10.1094/MPMI-20-7-0751; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Konishi M, 2014, MAR BIOTECHNOL, V16, P484, DOI 10.1007/s10126-014-9568-x; Krall L, 2002, FEBS LETT, V527, P315, DOI 10.1016/S0014-5793(02)03258-1; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Maes T, 2001, MOL MICROBIOL, V42, P13, DOI 10.1046/j.1365-2958.2001.02615.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MATSUBARA S, 1968, PLANT PHYSIOL, V43, P451, DOI 10.1104/pp.43.3.451; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Na KS, 2005, J BIOSCI BIOENG, V99, P378, DOI 10.1263/jbb.99.378; Parmley JL, 2007, J MOL EVOL, V64, P646, DOI 10.1007/s00239-006-0207-7; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Pertry I, 2009, P NATL ACAD SCI USA, V106, P929, DOI 10.1073/pnas.0811683106; Pertry I, 2010, MOL PLANT MICROBE IN, V23, P1164, DOI 10.1094/MPMI-23-9-1164; Putnam ML, 2007, PLANT DIS, V91, P1064, DOI 10.1094/PDIS-91-9-1064; R Core Team, 2021, R LANGUAGE ENV STAT; Rajaonson S, 2011, ENVIRON MICROBIOL, V13, P1236, DOI 10.1111/j.1462-2920.2011.02424.x; RATHBONE MP, 1972, PLANTA, V108, P93, DOI 10.1007/BF00386072; Redig P, 1996, PLANT PHYSIOL, V112, P141, DOI 10.1104/pp.112.1.141; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Sakakibara H, 2005, P NATL ACAD SCI USA, V102, P9972, DOI 10.1073/pnas.0500793102; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekine M, 2006, ENVIRON MICROBIOL, V8, P334, DOI 10.1111/j.1462-2920.2005.00899.x; Soisson SM, 1997, SCIENCE, V276, P421, DOI 10.1126/science.276.5311.421; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stes E, 2011, ANNU REV PHYTOPATHOL, V49, P69, DOI 10.1146/annurev-phyto-072910-095217; Sugawara H, 2008, P NATL ACAD SCI USA, V105, P2734, DOI 10.1073/pnas.0707374105; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; Temmerman W, 2000, J BACTERIOL, V182, P5832, DOI 10.1128/JB.182.20.5832-5840.2000; Vandeputte O, 2005, APPL ENVIRON MICROB, V71, P1169, DOI 10.1128/AEM.71.3.1169-1177.2005; Vereecke D, 2002, J BACTERIOL, V184, P1112, DOI 10.1128/jb.184.4.1112-1120.2002; Vereecke D, 2000, PLANTA, V210, P241, DOI 10.1007/PL00008131; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; von Bargen K, 2009, FEMS MICROBIOL REV, V33, P870, DOI 10.1111/j.1574-6976.2009.00181.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yanai I, 2002, GENOME BIOL, V3; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101	92	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101996	10.1371/journal.pone.0101996	http://dx.doi.org/10.1371/journal.pone.0101996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010934	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800057
J	Eletsky, A; Michalska, K; Houliston, S; Zhang, Q; Daily, MD; Xu, XH; Cui, H; Yee, A; Lemak, A; Wu, B; Garcia, M; Burnet, MC; Meyer, KM; Aryal, UK; Sanchez, O; Ansong, C; Xiao, R; Acton, TB; Adkins, JN; Montelione, GT; Joachimiak, A; Arrowsmith, CH; Savchenko, A; Szyperski, T; Cort, JR				Eletsky, Alexander; Michalska, Karolina; Houliston, Scott; Zhang, Qi; Daily, Michael D.; Xu, Xiaohui; Cui, Hong; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Burnet, Meagan C.; Meyer, Kristen M.; Aryal, Uma K.; Sanchez, Octavio; Ansong, Charles; Xiao, Rong; Acton, Thomas B.; Adkins, Joshua N.; Montelione, Gaetano T.; Joachimiak, Andrzej; Arrowsmith, Cheryl H.; Savchenko, Alexei; Szyperski, Thomas; Cort, John R.			Structural and Functional Characterization of DUF1471 Domains of Salmonella Proteins SrfN, YdgH/SssB, and YahO	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; SOLUTION NMR STRUCTURE; VIRULENCE FACTORS; RESONANCE ASSIGNMENTS; MULTIDIMENSIONAL NMR; QUALITY ASSESSMENT; BIOFILM FORMATION; RCS PHOSPHORELAY; STRESS-RESPONSE; FORCE-FIELD	Bacterial species in the Enterobacteriaceae typically contain multiple paralogues of a small domain of unknown function (DUF1471) from a family of conserved proteins also known as YhcN or BhsA/McbA. Proteins containing DUF1471 may have a single or three copies of this domain. Representatives of this family have been demonstrated to play roles in several cellular processes including stress response, biofilm formation, and pathogenesis. We have conducted NMR and X-ray crystallographic studies of four DUF1471 domains from Salmonella representing three different paralogous DUF1471 subfamilies: SrfN, YahO, and SssB/YdgH (two of its three DUF1471 domains: the N-terminal domain I (residues 21-91), and the C-terminal domain III (residues 244-314)). Notably, SrfN has been shown to have a role in intracellular infection by Salmonella Typhimurium. These domains share less than 35% pairwise sequence identity. Structures of all four domains show a mixed alpha+beta fold that is most similar to that of bacterial lipoprotein RcsF. However, all four DUF1471 sequences lack the redox sensitive cysteine residues essential for RcsF activity in a phospho-relay pathway, suggesting that DUF1471 domains perform a different function(s). SrfN forms a dimer in contrast to YahO and SssB domains I and III, which are monomers in solution. A putative binding site for oxyanions such as phosphate and sulfate was identified in SrfN, and an interaction between the SrfN dimer and sulfated polysaccharides was demonstrated, suggesting a direct role for this DUF1471 domain at the host-pathogen interface.	[Eletsky, Alexander; Zhang, Qi; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Michalska, Karolina; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA; [Houliston, Scott; Xu, Xiaohui; Cui, Hong; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Houliston, Scott; Xu, Xiaohui; Cui, Hong; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Daily, Michael D.; Burnet, Meagan C.; Meyer, Kristen M.; Aryal, Uma K.; Sanchez, Octavio; Ansong, Charles; Adkins, Joshua N.; Cort, John R.] Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08855 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Savchenko, Alexei] Univ Toronto, Banting & Best Dept Med Res, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Michalska, Karolina; Xu, Xiaohui; Cui, Hong; Joachimiak, Andrzej; Savchenko, Alexei] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Eletsky, Alexander; Houliston, Scott; Zhang, Qi; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.; Arrowsmith, Cheryl H.; Szyperski, Thomas] Northeast Struct Genom Consortium, Piscataway, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; United States Department of Energy (DOE); Argonne National Laboratory; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory	Cort, JR (corresponding author), Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA.	john.cort@pnnl.gov		Zhang, Qi/0000-0002-7482-0875; Arrowsmith, Cheryl/0000-0002-4971-3250; Montelione, Gaetano/0000-0002-9440-3059; Joachimiak, Andrzej/0000-0003-2535-6209	US National Institutes of Health [NIAID Y1-AI-8401, NIGMS PSI-Biology GM094623, GM094597, GM094585]; Natural Sciences and Engineering Research Council of Canada [372475-10]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI008401, R01AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094623, U54GM094597, U54GM094585] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the US National Institutes of Health (nih.gov) grants NIAID Y1-AI-8401 (J.N.A.) and NIGMS PSI-Biology GM094623 (J.N.A.), GM094597 (G.T.M. and T.S., NESG), and GM094585 (A.J., MCSG), the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) grant 372475-10 (C.H.A), and the U.S. Department of Energy, Office of Biological and Environmental Research (science.energy.gov), contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; [Anonymous], PYMOL MOL GRAPHICS S; Ansong C, 2013, P NATL ACAD SCI USA, V110, P10153, DOI 10.1073/pnas.1221210110; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cort JR, 2008, J MOL BIOL, V382, P692, DOI 10.1016/j.jmb.2008.07.022; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng KP, 2011, APPL ENVIRON MICROB, V77, P3952, DOI 10.1128/AEM.02420-10; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eletsky Alexander, 2012, Journal of Structural and Functional Genomics, V13, P1, DOI 10.1007/s10969-011-9121-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; Jansson M, 1996, J BIOMOL NMR, V7, P131; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lopez CA, 2009, J CHEM THEORY COMPUT, V5, P3195, DOI 10.1021/ct900313w; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Manes NP, 2007, MOL CELL PROTEOMICS, V6, P717, DOI 10.1074/mcp.M600282-MCP200; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Osborne SE, 2009, P NATL ACAD SCI USA, V106, P3982, DOI 10.1073/pnas.0811669106; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rogov VV, 2011, J BIOL CHEM, V286, P18775, DOI 10.1074/jbc.M111.230185; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; Rudd KE, 1998, ELECTROPHORESIS, V19, P536, DOI 10.1002/elps.1150190413; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salazar JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057272; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki M, 2008, J BIOL CHEM, V283, P25936, DOI 10.1074/jbc.M803773200; Wang SY, 2010, APPL ENVIRON MICROB, V76, P5013, DOI 10.1128/AEM.00823-10; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Weber MM, 2010, MICROBIOL-SGM, V156, P139, DOI 10.1099/mic.0.031468-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; Yoon H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-100; Yoon H, 2011, INFECT IMMUN, V79, P2182, DOI 10.1128/IAI.01277-10; Zhang XS, 2008, ISME J, V2, P615, DOI 10.1038/ismej.2008.24; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	74	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101787	10.1371/journal.pone.0101787	http://dx.doi.org/10.1371/journal.pone.0101787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010333	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800039
J	Figliolini, F; Cantaluppi, V; De Lena, M; Beltramo, S; Romagnoli, R; Salizzoni, M; Melzi, R; Nano, R; Piemonti, L; Tetta, C; Biancone, L; Camussi, G				Figliolini, Federico; Cantaluppi, Vincenzo; De Lena, Michela; Beltramo, Silvia; Romagnoli, Renato; Salizzoni, Mauro; Melzi, Raffaella; Nano, Rita; Piemonti, Lorenzo; Tetta, Ciro; Biancone, Luigi; Camussi, Giovanni			Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets	PLOS ONE			English	Article							VEGF-A; GENE-EXPRESSION; MICROVESICLES; PROLIFERATION; DIFFERENTIATION; MEMBRANE; VASCULARIZATION; ANGIOGENESIS; MASS	The cross-talk between beta cells and endothelium plays a key role in islet physiopathology and in the revascularization process after islet transplantation. However, the molecular mechanisms involved in this cross-talk are not fully elucidated. Extracellular vesicles (EVs) are secreted membrane nanoparticles involved in inter-cellular communication through the transfer of proteins and nucleic acids. The aims of this study were: 1) isolation and characterization of EVs from human islets; 2) evaluation of the pro-angiogenic effect of islet-derived EVs on human islet endothelial cells (IECs). EVs were isolated by ultracentrifugation from conditioned medium of human islets and characterized by nanotrack analysis (Nanosight), FACS, western blot, bioanalyzer, mRNA/microRNA RT-PCR array. On IECs, we evaluated EV-induced insulin mRNA transfer, proliferation, resistance to apoptosis, in vitro angiogenesis, migration, gene and protein profiling. EVs sized 236 +/- 54 nm, expressed different surface molecules and islet-specific proteins (insulin, C-peptide, GLP1R) and carried several mRNAs (VEGFa, eNOS) and microRNAs (miR-27b, miR-126, miR-130 and miR-296) involved in beta cell function, insulin secretion and angiogenesis. Purified EVs were internalized into IECs inducing insulin mRNA expression, protection from apoptosis and enhancement of angiogenesis. Human islets release biologically active EVs able to shuttle specific mRNAs and microRNAs (miRNAs) into target endothelial cells. These results suggest a putative role for islet-derived EVs in beta cell-endothelium cross-talk and in the neoangiogenesis process which is critical for engraftment of transplanted islets.	[Figliolini, Federico; Cantaluppi, Vincenzo; De Lena, Michela; Beltramo, Silvia; Biancone, Luigi; Camussi, Giovanni] Univ Turin, Dept Med Sci, Turin, Italy; [Romagnoli, Renato; Salizzoni, Mauro] Univ Turin, Liver Transplantat Ctr, Turin, Italy; [Melzi, Raffaella; Nano, Rita; Piemonti, Lorenzo] Ist Sci San Raffaele, Diabet Res Inst HSR DRI, I-20132 Milan, Italy; [Tetta, Ciro] Fresenius Med Care, Bad Homburg, Germany	University of Turin; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Camussi, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	giovanni.camussi@unito.it	Melzi, Raffaella/AAN-3825-2020; Cantaluppi, Vincenzo/K-8531-2016; Piemonti, Lorenzo/P-7605-2017; Camussi, Giovanni/J-7624-2016; Nano, Rita/AAC-1934-2019; Romagnoli, Renato/AAB-9311-2019; Figliolini, Federico/AAQ-4983-2021	Cantaluppi, Vincenzo/0000-0002-4120-3555; Piemonti, Lorenzo/0000-0002-2172-2198; Camussi, Giovanni/0000-0003-2795-232X; Nano, Rita/0000-0003-4520-8481; Romagnoli, Renato/0000-0001-8340-8885; Salizzoni, Mauro/0000-0002-5480-8705; BIANCONE, Luigi/0000-0002-7700-6350; Figliolini, Federico/0000-0002-6142-2261	Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project; Local University Grants	Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project(Regione Piemonte); Local University Grants	This work was supported by Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project (GC) and Local University Grants (VC, LB and GC). The sponsors did not contribute to the design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Alvarez ML, 2012, DIABETES RES CLIN PR; Ansa-Addo EA, 2010, J IMMUNOL, V185, P5236, DOI 10.4049/jimmunol.1001656; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Camussi G, 2013, CURR MOL MED, V13, P58, DOI 10.2174/156652413804486304; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Crawford LA, 2009, MOL ENDOCRINOL, V23, P324, DOI 10.1210/me.2008-0045; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Deregibus MC, 2010, HISTOL HISTOPATHOL, V25, P397, DOI 10.14670/HH-25.397; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Golocheikine A, 2010, TRANSPLANTATION, V90, P725, DOI 10.1097/TP.0b013e3181ef8a63; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Jabs N, 2008, EXP CLIN ENDOCR DIAB, V116, pS46, DOI 10.1055/s-2008-1081486; Jiang FX, 1999, DIABETES, V48, P722, DOI 10.2337/diabetes.48.4.722; Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6; Johansson A, 2009, TRANSPL INT, V22, P1182, DOI 10.1111/j.1432-2277.2009.00939.x; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Johansson M, 2006, J ANAT, V208, P191, DOI 10.1111/j.1469-7580.2006.00520.x; Jorfi S, 2013, BIOCHEM SOC T, V41, P293, DOI 10.1042/BST20120273; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Vasir B, 2001, TRANSPLANTATION, V71, P924, DOI 10.1097/00007890-200104150-00018; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035	38	69	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102521	10.1371/journal.pone.0102521	http://dx.doi.org/10.1371/journal.pone.0102521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028931	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600080
J	Heard, D; Bobashev, GV; Morris, RJ				Heard, Daniel; Bobashev, Georgiy V.; Morris, Robert J.			Reducing the Complexity of an Agent-Based Local Heroin Market Model	PLOS ONE			English	Article							DRUG MARKETS; STATISTICS	This project explores techniques for reducing the complexity of an agent-based model ( ABM). The analysis involved a model developed from the ethnographic research of Dr. Lee Hoffer in the Larimer area heroin market, which involved drug users, drug sellers, homeless individuals and police. The authors used statistical techniques to create a reduced version of the original model which maintained simulation fidelity while reducing computational complexity. This involved identifying key summary quantities of individual customer behavior as well as overall market activity and replacing some agents with probability distributions and regressions. The model was then extended to allow external market interventions in the form of police busts. Extensions of this research perspective, as well as its strengths and limitations, are discussed.	[Heard, Daniel] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA; [Bobashev, Georgiy V.; Morris, Robert J.] RTI Int, Res Triangle Pk, NC USA	Duke University; Research Triangle Institute	Heard, D (corresponding author), Duke Univ, Dept Stat Sci, Durham, NC 27708 USA.	dph11@stat.duke.edu			NIDA [R01DA025163-01A1]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025163] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work has been funded by a grant R01DA025163-01A1 from NIDA (Hoffer and Bobashev PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre BE, 2011, CONTEMP SOC SCI, V6, P415, DOI 10.1080/21582041.2011.609380; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Baldwin B, 2013, HEROINS DEADLY  0717; Bouchard M, 2005, J DRUG ISSUES, V35, P733, DOI 10.1177/002204260503500404; Burden R. L., 2010, NUMERICAL ANAL; Cox DD, 2008, BIOMETRIKA, V95, P621, DOI 10.1093/biomet/asn021; Curtis R, 2000, ILLEGAL DRUG MARKETS, P241; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Gilbert N., 1999, SIMULATION SOCIAL SC; Hoffer L, 2011, COMPUTATIONAL NEUROS, P313; Hoffer L.D., 2006, JUNKIE BUSINESS EVOL; Hoffer LD, 2009, AM J COMMUN PSYCHOL, V44, P273, DOI 10.1007/s10464-009-9268-2; Karayanakis N., 1993, COMPUTER ASSISTED SI; Leger D, 2013, US TODAY        0723; May T, 2004, ADDICT RES THEORY, V12, P549, DOI 10.1080/16066350412331323119; McKenna SM, 1995, 1 INT C DIG POW SYST, P3; Perez P, 2006, SMART INFRASTRUCTURE, P193; Rahmandad H, 2012, SYST DYNAM REV, V28, P396, DOI 10.1002/sdr.1481; Ritter A, 2005, AUSTR ILLICIT DRUG M; Seelye KW, 2013, NY TIMES        0718; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Wellek S., 2003, TESTING STAT HYPOTHE; Zou Y, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066106	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102263	10.1371/journal.pone.0102263	http://dx.doi.org/10.1371/journal.pone.0102263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025132	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400057
J	Kaur, H; Jajodia, A; Grover, S; Baghel, R; Gupta, M; Jain, S; Kukreti, R				Kaur, Harpreet; Jajodia, Ajay; Grover, Sandeep; Baghel, Ruchi; Gupta, Meenal; Jain, Sanjeev; Kukreti, Ritushree			Genetic Variations of PIP4K2A Confer Vulnerability to Poor Antipsychotic Response in Severely Ill Schizophrenia Patients	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; NEUROTROPHIC FACTOR; DISEQUILIBRIUM TESTS; HAPLOTYPE BLOCKS; ENZYME-ACTIVITY; SINGLE MARKER; BDNF GENE; ASSOCIATION; POPULATION; VARIANTS	Literature suggests that disease severity and neurotransmitter signaling pathway genes can accurately identify antipsychotic response in schizophrenia patients. However, putative role of signaling molecules has not been tested in schizophrenia patients based on severity of illness, despite its biological plausibility. In the present study we investigated the possible association of polymorphisms from five candidate genes RGS4, SLC6A3, PIP4K2A, BDNF, PI4KA with response to antipsychotic in variably ill schizophrenia patients. Thus in present study, a total 53 SNPs on the basis of previous reports and functional grounds were examined for their association with antipsychotic response in 423 schizophrenia patients segregated into low and high severity groups. Additionally, haplotype, diplotype, multivariate logistic regression and multifactor-dimensionality reduction (MDR) analyses were performed. Furthermore, observed associations were investigated in atypical monotherapy (n = 355) and risperidone (n = 260) treated subgroups. All associations were estimated as odds ratio (OR) and 95% confidence interval (CI) and test for multiple corrections was applied. Single locus analysis showed significant association of nine variants from SLC6A3, PIP4K2A and BDNF genes with incomplete antipsychotic response in schizophrenia patients with high severity. We identified significant association of six marker diplotype ATTGCT/ATTGCT (rs746203-rs10828317-rs7094131-rs2296624-rs11013052-rs1409396) of PIP4K2A gene in incomplete responders (corrected p-value = 0.001; adjusted-OR = 3.19, 95%-CI = 1.46-6.98) with high severity. These associations were further observed in atypical monotherapy and risperidone sub-groups. MDR approach identified gene-gene interaction among BDNF_rs7103411-BDNF_rs1491851-SLC6A3_rs40184 in severely ill incomplete responders (OR = 7.91, 95%-CI = 4.08-15.36). While RGS4_rs2842026-SLC6A3_rs2975226 interacted synergistically in incomplete responders with low severity (OR = 4.09, 95%-CI = 2.09-8.02). Our findings provide strong evidence that diplotype ATTGCT/ATTGCT of PIP4K2A gene conferred approximately three-times higher incomplete responsiveness towards antipsychotics in severely ill patients. These results are consistent with the known role of phosphatidyl-inositol-signaling elements in antipsychotic action and outcome. Findings have implication for future molecular genetic studies as well as personalized medicine. However more work is warranted to elucidate underlying causal biological pathway.	[Kaur, Harpreet; Jajodia, Ajay; Grover, Sandeep; Baghel, Ruchi; Gupta, Meenal; Kukreti, Ritushree] CSIR Inst Genom & Integrat Biol, Delhi, India; [Jain, Sanjeev] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bengaluru, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); National Institute of Mental Health & Neurosciences - India	Kukreti, R (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	ritus@igib.res.in	Kaur, Harpreet/ABH-9527-2020	Kaur, Harpreet/0000-0002-2836-7053; Grover, Sandeep/0000-0003-2615-4916; jain, sanjeev/0000-0002-9508-351X	Council of Scientific and Industrial Research [BSC0123]; Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR)	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Financial support from the BSC0123 project (Council of Scientific and Industrial Research) is duly acknowledged. HK, RB are thankful to Indian Council of Medical Research (ICMR) and AJ, SG, MG are thankful to Council of Scientific and Industrial Research (CSIR) for providing senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Abou Jamra R, 2006, AM J MED GENET B, V141B, P663, DOI 10.1002/ajmg.b.30358; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Anttila S, 2005, J NEURAL TRANSM, V112, P885, DOI 10.1007/s00702-004-0233-9; Bakker SC, 2007, GENES BRAIN BEHAV, V6, P113, DOI 10.1111/j.1601-183X.2006.00234.x; Bannon MJ, 2001, EUR NEUROPSYCHOPHARM, V11, P449, DOI 10.1016/S0924-977X(01)00122-5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chen L, 2009, SCHIZOPHR RES, V113, P34, DOI 10.1016/j.schres.2009.06.001; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Clarke JH, 2013, PSYCHOPHARMACOLOGY, V230, P329, DOI 10.1007/s00213-013-3299-y; CONN PJ, 1986, J NEUROSCI, V6, P3669; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dominguez E, 2007, SCHIZOPHR RES, V90, P123, DOI 10.1016/j.schres.2006.09.022; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Fedorenko OY, 2013, ZH NEVROL PSIKHIATR, V113, P58; Fedorenko O, 2008, PSYCHOPHARMACOLOGY, V199, P47, DOI 10.1007/s00213-008-1095-x; Fedorenko O, 2009, PSYCHOPHARMACOLOGY, V206, P429, DOI 10.1007/s00213-009-1621-5; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Gupta M, 2009, PHARMACOGENOMICS, V10, P385, DOI 10.2217/14622416.10.3.385; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Haro JM, 2005, ACTA PSYCHIAT SCAND, V111, P220, DOI 10.1111/j.1600-0447.2004.00450.x; He ZD, 2007, SCHIZOPHR RES, V94, P359, DOI 10.1016/j.schres.2007.04.013; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Huang SY, 2010, SCHIZOPHR RES, V116, P68, DOI 10.1016/j.schres.2009.10.004; Jeong SH, 2004, PROG NEURO-PSYCHOPH, V28, P975, DOI 10.1016/j.pnpbp.2004.05.015; Jha P, 2012, INFECT GENET EVOL, V12, P142, DOI 10.1016/j.meegid.2011.11.001; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jungerius BJ, 2008, MOL PSYCHIATR, V13, P1060, DOI 10.1038/sj.mp.4002080; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Kirov G, 2005, J CLIN INVEST, V115, P1440, DOI 10.1172/JCI24759; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lipska BK, 2006, HUM MOL GENET, V15, P2804, DOI 10.1093/hmg/ddl222; Luoni A, 2014, PHARMACOL RES, V80, P1, DOI 10.1016/j.phrs.2013.11.008; Mas S, 2009, PROG NEURO-PSYCHOPH, V33, P1064, DOI 10.1016/j.pnpbp.2009.06.001; McGuffin P, 2004, PSYCHIAT PRAX, V31, pS189, DOI 10.1055/s-2004-834565; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Pae CU, 2012, NEUROPSYCHOBIOLOGY, V65, P1, DOI 10.1159/000327605; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Saggers-Gray L, 2008, AM J MED GENET B, V147B, P1310, DOI 10.1002/ajmg.b.30736; Sakata K, 2014, NEUROSCIENCE, V260, P265, DOI 10.1016/j.neuroscience.2013.12.013; Schwab SG, 2006, MOL PSYCHIATR, V11, P837, DOI 10.1038/sj.mp.4001864; Sjoholm H, 2004, PSYCHOPHARMACOLOGY, V173, P27, DOI 10.1007/s00213-003-1700-y; Sotnikova Tatyana D., 2006, CNS & Neurological Disorders-Drug Targets, V5, P45, DOI 10.2174/187152706784111579; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Talkowski ME, 2008, HUM MOL GENET, V17, P747, DOI 10.1093/hmg/ddm347; Thiselton DL, 2010, AM J MED GENET B, V153B, P323, DOI 10.1002/ajmg.b.30982; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; UNDIE AS, 1992, NEUROBIOL AGING, V13, P505, DOI 10.1016/0197-4580(92)90079-D; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Watanabe Y, 2013, PSYCHIAT CLIN NEUROS, V67, P123, DOI 10.1111/pcn.12018; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Xu MQ, 2010, EUR J HUM GENET, V18, P707, DOI 10.1038/ejhg.2009.238; Zai GCM, 2012, PROG NEURO-PSYCHOPH, V39, P96, DOI 10.1016/j.pnpbp.2012.05.014; Zandi PP, 2010, CLIN LAB MED, V30, P931, DOI 10.1016/j.cll.2010.07.004	69	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102556	10.1371/journal.pone.0102556	http://dx.doi.org/10.1371/journal.pone.0102556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025909	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400086
J	Khsheibun, R; Paperna, T; Volkowich, A; Lejbkowicz, I; Avidan, N; Miller, A				Khsheibun, Rana; Paperna, Tamar; Volkowich, Anat; Lejbkowicz, Izabella; Avidan, Nili; Miller, Ariel			Gene Expression Profiling of the Response to Interferon Beta in Epstein-Barr-Transformed and Primary B Cells of Patients with Multiple Sclerosis	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-4; IFN-BETA; DIAGNOSTIC-CRITERIA; RECEPTOR; LINES; GROWTH; AUTOIMMUNITY; ACTIVATION; ANTIBODIES; INFECTION	The effects of interferon-beta (IFN-beta), one of the key immunotherapies used in multiple sclerosis (MS), on peripheral blood leukocytes and T cells have been extensively studied. B cells are a less abundant leukocyte type, and accordingly less is known about the B cell-specific response to IFN-beta. To identify gene expression changes and pathways induced by IFN-beta in B cells, we studied the in vitro response of human Epstein Barr-transformed B cells (lymphoblast cell lines-LCLs), and validated our results in primary B cells. LCLs were derived from an MS patient repository. Whole genome expression analysis identified 115 genes that were more than two-fold differentially up-regulated following IFN-beta exposure, with over 50 previously unrecognized as IFN-beta response genes. Pathways analysis demonstrated that IFN-beta affected LCLs in a similar manner to other cell types by activating known IFN-beta canonical pathways. Additionally, IFN-beta increased the expression of innate immune response genes, while down-regulating many B cell receptor pathway genes and genes involved in adaptive immune responses. Novel response genes identified herein, NEXN, DDX60L, IGFBP4, and HAPLN3, B cell receptor pathway genes, CD79B and SYK, and lymphocyte activation genes, LAG3 and IL27RA, were validated as IFN-beta response genes in primary B cells. In this study new IFN-beta response genes were identified in B cells, with possible implications to B cell-specific functions. The study's results emphasize the applicability of LCLs for studies of human B cell drug response. The usage of LCLs from patient-based repositories may facilitate future studies of drug response in MS and other immune-mediated disorders with a B cell component.	[Khsheibun, Rana; Paperna, Tamar; Lejbkowicz, Izabella; Avidan, Nili; Miller, Ariel] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Volkowich, Anat; Miller, Ariel] Carmel Hosp, Div Neuroimmunol, Haifa, Israel; [Volkowich, Anat; Miller, Ariel] Carmel Hosp, Multiple Sclerosis Ctr, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center; Clalit Health Services; Carmel Medical Center	Miller, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel.	millera@tx.technion.ac.il		Miller, Ariel/0000-0001-5843-6841	National Multiple Sclerosis Society of the United States of America [RG 3520A1/1]; Wolfson Family Charitable Trust; Sacta-Rashi Foundation; Technion's Vice-President for Research funds; E. & S. Kronovet Fund for Medical Research; American Technion Society; Association Technion France; Israeli Ministry of Science and Technology fellowship for Arabs, Druze and Cherkessians; Gerald and Una Yakatan Fellowship; Sondra and Robert Berk Fellowship	National Multiple Sclerosis Society of the United States of America(National Multiple Sclerosis Society); Wolfson Family Charitable Trust; Sacta-Rashi Foundation; Technion's Vice-President for Research funds; E. & S. Kronovet Fund for Medical Research; American Technion Society; Association Technion France; Israeli Ministry of Science and Technology fellowship for Arabs, Druze and Cherkessians; Gerald and Una Yakatan Fellowship; Sondra and Robert Berk Fellowship	This work was supported by the National Multiple Sclerosis Society of the United States of America (RG 3520A1/1 to AM); and the Wolfson Family Charitable Trust, the Sacta-Rashi Foundation, the Technion's Vice-President for Research funds, the E. & S. Kronovet Fund for Medical Research, the American Technion Society, and the Association Technion France (to AM). RK was a recipient of the following fellowships: Israeli Ministry of Science and Technology fellowship for Arabs, Druze and Cherkessians, Gerald and Una Yakatan Fellowship, and Sondra and Robert Berk Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVICH C, 1994, CYTOKINE, V6, P414, DOI 10.1016/1043-4666(94)90066-3; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Bolotin E, 2014, HUM MOL GENET, V23, P1202, DOI 10.1093/hmg/ddt512; Buchwalder PA, 2000, J INTERF CYTOK RES, V20, P857, DOI 10.1089/10799900050163226; Buck D, 2011, J NEUROL, V258, P1747, DOI 10.1007/s00415-011-6101-2; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Casiraghi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002715; Chesik D, 2006, EUR J NEUROSCI, V24, P1645, DOI 10.1111/j.1460-9568.2006.05034.x; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Comabella M, 2011, CURR NEUROL NEUROSCI, V11, P484, DOI 10.1007/s11910-011-0211-1; Croze E, 2013, PHARMACOGENOMICS J, V13, P443, DOI 10.1038/tpj.2012.27; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Disanto G, 2012, HUM MOL GENET, V21, P3575, DOI 10.1093/hmg/dds189; Disanto G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032281; Dorner M, 2008, J VIROL, V82, P4400, DOI 10.1128/JVI.02630-07; Durai R, 2006, INT J ONCOL, V28, P1317; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Hecker M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029648; Henig N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062366; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Khan OA, 1998, NEUROLOGY, V51, P738, DOI 10.1212/WNL.51.3.738; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Krumbholz M, 2008, BRAIN, V131, P1455, DOI 10.1093/brain/awn077; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel I, 2012, J CELL MOL MED, V16, P765, DOI 10.1111/j.1582-4934.2011.01380.x; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller A, 2008, J NEUROL SCI, V274, P68, DOI 10.1016/j.jns.2008.07.028; Min JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022070; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Monson NL, 2008, CURR OPIN NEUROL, V21, pS3, DOI 10.1097/01.wco.0000313358.53553.c7; Morag A, 2013, J MOL NEUROSCI, V49, P554, DOI 10.1007/s12031-012-9852-z; Morag A, 2011, PHARMACOGENOMICS, V12, P171, DOI 10.2217/PGS.10.185; Morag A, 2010, PHARMACOGENOMICS, V11, P327, DOI [10.2217/pgs.10.27, 10.2217/PGS.10.27]; Ohtsuka T, 1998, J CELL BIOL, V143, P1227, DOI 10.1083/jcb.143.5.1227; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Poovassery JS, 2012, J IMMUNOL, V189, P1757, DOI 10.4049/jimmunol.1200624; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramgolam VS, 2011, J IMMUNOL, V186, P4518, DOI 10.4049/jimmunol.1000271; Rogge L, 1998, J IMMUNOL, V161, P6567; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sanders AR, 2013, HUM MOL GENET, V22, P5001, DOI 10.1093/hmg/ddt350; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Sierro S, 2011, EXPERT OPIN THER TAR, V15, P91, DOI 10.1517/14712598.2011.540563; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; Squassina A, 2013, PHARMACOL RES, V73, P1, DOI 10.1016/j.phrs.2013.04.004; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; Weber MS, 2011, BBA-MOL BASIS DIS, V1812, P239, DOI 10.1016/j.bbadis.2010.06.009; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Wroblewski JM, 2002, J IMMUNOL METHODS, V264, P19, DOI 10.1016/S0022-1759(01)00565-8; Yoshimoto T, 2004, J IMMUNOL, V173, P2479, DOI 10.4049/jimmunol.173.4.2479; Zhou R, 2004, J MOL ENDOCRINOL, V32, P349, DOI 10.1677/jme.0.0320349	77	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102331	10.1371/journal.pone.0102331	http://dx.doi.org/10.1371/journal.pone.0102331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025430	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400064
J	Manka, P; Olliges, V; Bechmann, LP; Schlattjan, M; Jochum, C; Treckmann, JW; Saner, FH; Gerken, G; Syn, WK; Canbay, A				Manka, Paul; Olliges, Verena; Bechmann, Lars P.; Schlattjan, Martin; Jochum, Christoph; Treckmann, Juergen W.; Saner, Fuat H.; Gerken, Guido; Syn, Wing-Kin; Canbay, Ali			Low Levels of Blood Lipids Are Associated with Etiology and Lethal Outcome in Acute Liver Failure	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE; REGENERATION; PATTERNS	Background/Aims: Emerging data links different aspects of lipid metabolism to liver regeneration. In patients with acute liver failure (ALF), low levels of lipids may correlate with disease severity. Thus, we determined whether there is an etiology-specific link between lipid levels in patients suffering from ALF and aimed to investigate an effect of lipid levels on the prognosis of ALF. Methods: In this retrospective single center study, we reviewed 89 consecutive ALF patients, who met the criteria of the "Acute Liver Failure Study Group''. Patient characteristics, clinical data and laboratory parameters were individually analyzed at admission and correlated with the patients' outcome after a four week follow up. Possible endpoints were either discharge, or death or liver transplantation. Results: High-density lipoprotein (HDL), cholesterol and triglyceride levels were significantly lower in patients who died or required a liver transplant. HDL levels were significantly higher in patients with ALF caused by acetaminophen intoxication, compared to fulminant HBV infection or drug induced liver injury. HDL levels correlated with hepatic injury by ALT levels, and Albumin, and inversely correlated with the MELD score, INR, and bilirubin. Conclusion: In our cohort of patients with ALF, we could show that HDL and cholesterol are suppressed. In addition novel etiology specific patterns between acteminophen and non-acteminophen induced liver failure were detected for serum lipid components. Further studies are needed to address the role of cholesterol and lipid metabolism and the according pathways in different etiologies of ALF.	[Manka, Paul; Olliges, Verena; Bechmann, Lars P.; Schlattjan, Martin; Jochum, Christoph; Gerken, Guido; Canbay, Ali] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Treckmann, Juergen W.; Saner, Fuat H.] Univ Duisburg Essen, Univ Hosp, Dept Gen Visceral & Transplantat Surg, Essen, Germany; [Syn, Wing-Kin] Fdn Liver Res, Inst Hepatol, London, England; [Syn, Wing-Kin] Barts Hlth NHS Trust, Dept Hepatol, London, England	University of Duisburg Essen; University of Duisburg Essen; University of London; University College London; Barts Health NHS Trust	Canbay, A (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany.	ali.canbay@uni-due.de	Manka, Paul/AAN-1261-2021; Manka, Paul/ABH-2421-2020; Jochum, Christoph/AAC-5402-2020; Syn, Wing-Kin/AAB-8406-2020; Saner, Fuat H/W-8024-2019; Bechmann, Lars/AAZ-7141-2020; Canbay, Ali/AAL-9620-2020	Manka, Paul/0000-0001-8589-7280; Canbay, Ali/0000-0001-6069-7899; Bechmann, Lars/0000-0003-3487-9810	Deutsche Forschungsgemeinschaft (DFG) [CA267/8-1, CA267/13-1, BE3967/3-1]; Wilhelm Laupitz Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (DFG grant CA267/8-1 and CA267/13-1 to AC and DFG grant BE3967/3-1 to LPB), and the Wilhelm Laupitz Foundation to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisqueta L, 2013, BBA-MOL CELL BIOL L, V1831, P1357, DOI 10.1016/j.bbalip.2013.04.015; Barylski M, 2014, BEST PRACT RES CL EN, V28, P453, DOI 10.1016/j.beem.2013.11.001; BAUMBERGER C, 1991, PATHOBIOLOGY, V59, P378, DOI 10.1159/000163681; Best J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00258; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; Delgado-Coello B, 2011, LIVER INT, V31, P1271, DOI 10.1111/j.1478-3231.2011.02542.x; Etogo-Asse FE, 2012, LIVER INT, V32, P523, DOI [10.1111/j.1478-3231.2012.02758.x, 10.1111/j.1478-3231.2011.02657.x]; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Galbois A, 2009, HEPATOLOGY, V49, P175, DOI 10.1002/hep.22582; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; Hadem J, 2012, CLIN GASTROENTEROL H, V10, P664, DOI 10.1016/j.cgh.2012.02.016; Hoover-Plow J, 2013, METABOLISM, V62, P479, DOI 10.1016/j.metabol.2012.07.024; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Liu ML, 2012, ARTERIOSCL THROM VAS, V32, P2113, DOI 10.1161/ATVBAHA.112.255471; MILLER JP, 1990, BAILLIERE CLIN ENDOC, V4, P807; Sydor S, 2013, LAB INVEST, V93, P20, DOI 10.1038/labinvest.2012.142; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Wang GQ, 2004, MOL CELL BIOCHEM, V262, P41, DOI 10.1023/B:MCBI.0000038214.52184.82	19	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102351	10.1371/journal.pone.0102351	http://dx.doi.org/10.1371/journal.pone.0102351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025159	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400067
J	Ballesteros, Y; Polidori, C; Tormos, J; Banos-Picon, L; Asis, JD				Ballesteros, Yolanda; Polidori, Carlo; Tormos, Jose; Banos-Picon, Laura; Daniel Asis, Josep			Complex-to-Predict Generational Shift between Nested and Clustered Organization of Individual Prey Networks in Digger Wasps	PLOS ONE			English	Article							STIZUS-CONTINUUS HYMENOPTERA; GRASSHOPPER-HUNTING WASP; INTRASPECIFIC COMPETITION; RESOURCE USE; NICHE WIDTH; DIET SPECIALIZATION; PONERINE ANT; SEA OTTERS; FEEDING SPECIALIZATION; SPECIES COEXISTENCE	Although diet has traditionally been considered to be a property of the species or populations as a whole, there is nowadays extensive knowledge that individual specialization is widespread among animal populations. Nevertheless, the factors determining the shape of interactions within food webs remain largely undiscovered, especially in predatory insects. We used an aggregation of the digger wasp Bembix merceti to 1) analyse patterns of individual prey use across three flying seasons in a network-based context; and 2) test the effect of four potential factors that might explain network topologies (wasp mass, nest spatial distribution, simultaneous nest-provisioning, prey availability). Inter-individual diet variation was found in all three years, under different predator-prey network topologies: Individuals arranged in dietary clusters and displayed a checkerboard pattern in 2009, but showed nestedness in 2008 and 2010. Network topologies were not fully explained by the tested factors. Larger females consumed a higher proportion of the total number of prey species captured by the population as a whole, in such a way that nested patterns may arise from mass-dependent prey spectrum width. Conversely, individuals with similar body mass didn't form clusters. Nested patterns seemed to be associated with a greater availability of the main prey species (a proxy for reduced intra-specific competition). Thus, according with theory, clusters seemed to appear when competition increased. On the other hand, the nests of the individuals belonging to a given cluster were not more closely located, and neither did individuals within a cluster provision their nests simultaneously. Thus, a female-female copying behaviour during foraging was unlikely. In conclusion, wasp populations can maintain a considerable individual variation across years under different food web organizations. The tested factors only partially accounted for the shift in network properties, and new analyses should be carried out to elucidate how diet network topologies arise in wasp populations.	[Ballesteros, Yolanda; Tormos, Jose; Banos-Picon, Laura; Daniel Asis, Josep] Univ Salamanca, Fac Biol, Dept Zool, E-37008 Salamanca, Spain; [Polidori, Carlo] Museo Nacl Ciencias Nat CSIC, Dept Biodiversidad & Biol Evolut, Madrid, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Ballesteros, Y (corresponding author), Univ Salamanca, Fac Biol, Dept Zool, E-37008 Salamanca, Spain.	ballesteros.y@outlook.com	Baños-Picón, Laura/A-7675-2017; Asís, Josep D/K-5623-2014; Polidori, Carlo/G-4382-2010; Tormos, José/K-5643-2014	Baños-Picón, Laura/0000-0003-0500-8231; Asís, Josep D/0000-0001-8134-1875; Polidori, Carlo/0000-0003-4834-0752; Tormos, José/0000-0002-0568-4486	Junta de Castilla y Leon [SA094A09, SA010A06]; MICINN [CGL2010-16730]; Universidad de Salamanca-Santander Bank grant; post-doctoral contract within the Program JAE-Doc "Junta para la Ampliacion de Estudios''; Spanish Research Council (CSIC); FSE	Junta de Castilla y Leon(Junta de Castilla y Leon); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Universidad de Salamanca-Santander Bank grant; post-doctoral contract within the Program JAE-Doc "Junta para la Ampliacion de Estudios''; Spanish Research Council (CSIC); FSE(European Social Fund (ESF))	This work was supported by the Projects SA094A09 and SA010A06 (Junta de Castilla y Leon) and CGL2010-16730 (MICINN). YB was funded by a Universidad de Salamanca-Santander Bank grant. CP was funded by a post-doctoral contract within the Program JAE-Doc "Junta para la Ampliacion de Estudios,'' funded by the Spanish Research Council (CSIC) and the FSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBOGBA C, 1992, INSECT SOC, V39, P455, DOI 10.1007/BF01240629; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Asis JD, 2011, BEHAVIOUR, V148, P191, DOI 10.1163/000579510X551651; ASIS JD, 1988, ENTOMOL NEWS, V99, P199; Asis JD, 2004, J NAT HIST, V38, P1799, DOI 10.1080/0022293031000156295; Asis JD, 2014, ETHOLOGY, V120, P340, DOI 10.1111/eth.12208; Ballesteros Y, 2012, ANN SOC ENTOMOL FR, V48, P281, DOI 10.1080/00379271.2012.10697777; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2009, EVOL ECOL RES, V11, P1217; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; Diamond J.M., 1975, P342; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Durell SEALD, 2000, BIOL REV, V75, P503; ENDO T, 1994, ECOL RES, V9, P225, DOI 10.1007/BF02347498; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Evans HE., 2007, SAND WASPS NATURAL H; GOSSCUSTARD JD, 1988, J ANIM ECOL, V57, P827, DOI 10.2307/5095; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; GWYNNE DT, 1983, ANN ENTOMOL SOC AM, V76, P434, DOI 10.1093/aesa/76.3.434; Hagbery J, 2012, NATURWISSENSCHAFTEN, V99, P821, DOI 10.1007/s00114-012-0964-7; Heino J, 2005, FRESHWATER BIOL, V50, P567, DOI 10.1111/j.1365-2427.2005.01346.x; Kendall BE, 2003, CONSERV BIOL, V17, P1170, DOI 10.1046/j.1523-1739.2003.02411.x; Krasnov BR, 2005, ECOGRAPHY, V28, P475, DOI 10.1111/j.0906-7590.2005.04238.x; Lankau RA, 2009, AM NAT, V174, pE40, DOI 10.1086/600083; Leadbeater E, 2008, P ROY SOC B-BIOL SCI, V275, P1669, DOI 10.1098/rspb.2008.0270; LEWIS AC, 1986, SCIENCE, V232, P863, DOI 10.1126/science.232.4752.863; Lichstein JW, 2007, AM NAT, V170, P807, DOI 10.1086/522937; Lomnicki A., 1988, POPULATION ECOLOGY I, DOI 10.12987/9780691209616; Masello JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067714; Moleon M, 2012, J ANIM ECOL, V81, P1154, DOI 10.1111/j.1365-2656.2012.02006.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Nieh James C., 2009, P266; Okuyama T, 2008, ECOL RES, V23, P665, DOI 10.1007/s11284-007-0425-5; Partridge L., 1985, P207; PERSSON L, 1985, OECOLOGIA, V67, P338, DOI 10.1007/BF00384938; PIELOU EC, 1972, J THEOR BIOL, V34, P337, DOI 10.1016/0022-5193(72)90166-X; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Polidori C, 2005, EUR J ENTOMOL, V102, P801, DOI 10.14411/eje.2005.111; Polidori C, 2011, PREDATION HYMENOPTER, P101; Polidori C, 2008, ANIM BEHAV, V75, P1651, DOI 10.1016/j.anbehav.2007.10.018; Polidori C, 2013, OIKOS, V122, P385, DOI 10.1111/j.1600-0706.2012.20387.x; Polidori C, 2012, POPUL ECOL, V54, P443, DOI 10.1007/s10144-012-0322-9; Polidori C, 2010, BIOL J LINN SOC, V99, P544, DOI 10.1111/j.1095-8312.2009.01397.x; Polidori C, 2009, J NAT HIST, V43, P2985, DOI 10.1080/00222930903383511; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; Poulin R, 2002, INT J PARASITOL, V32, P1235, DOI 10.1016/S0020-7519(02)00109-1; Provencher JF, 2012, MAR ECOL PROG SER, V454, P171, DOI 10.3354/meps09299; Punzo F, 2005, J NEW YORK ENTOMOL S, V113, P222, DOI 10.1664/0028-7199(2005)113[0222:EAHBOT]2.0.CO;2; Raveret-Richter M., 2000, ANNU REV ENTOMOL, V45, P121, DOI [10.1146/annurev.ento.45.1.121, DOI 10.1146/ANNUREV.ENTO.45.1.121]; Santoro D, 2011, J ANIM ECOL, V80, P1123, DOI 10.1111/j.1365-2656.2011.01874.x; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; SCHATZ B, 1995, SOCIOBIOLOGY, V26, P269; Schatz B, 1999, J INSECT BEHAV, V12, P641, DOI 10.1023/A:1020927703689; SMITH TB, 1990, ECOLOGY, V71, P1246, DOI 10.2307/1938261; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Swanson BO, 2003, ECOLOGY, V84, P1441, DOI 10.1890/02-0353; Tinker MT, 2012, ECOL LETT, V15, P475, DOI 10.1111/j.1461-0248.2012.01760.x; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Ulrich W, 2004, OIKOS, V107, P603, DOI 10.1111/j.0030-1299.2004.12981.x; WERNER TK, 1987, P NATL ACAD SCI USA, V84, P5506, DOI 10.1073/pnas.84.15.5506	77	3	3	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102325	10.1371/journal.pone.0102325	http://dx.doi.org/10.1371/journal.pone.0102325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019164	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600067
J	Duong, T; Kim, J; Ruley, HE; Jo, D				Duong, Tam; Kim, Jaetaek; Ruley, H. Earl; Jo, Daewoong			Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals	PLOS ONE			English	Article							PROTECTS DOPAMINERGIC-NEURONS; UBIQUITIN LIGASE ACTIVITY; NUCLEAR IMPORT INHIBITOR; MOUSE MODEL; ANTITUMOR-ACTIVITY; MOLECULAR-MECHANISMS; INDUCED TOXICITY; ALPHA-SYNUCLEIN; L-DOPA; DELIVERY	Parkinson's disease (PD) is a neurodegenerative disorder of complex etiology characterized by the selective loss of dopaminergic neurons, particularly in the substantia nigra. Parkin, a tightly regulated E3 ubiquitin ligase, promotes the survival of dopaminergic neurons in both PD and Parkinsonian syndromes induced by acute exposures to neurotoxic agents. The present study assessed the potential of cell-permeable parkin (CP-Parkin) as a neuroprotective agent. Cellular uptake and tissue penetration of recombinant, enzymatically active parkin was markedly enhanced by the addition of a hydrophobic macromolecule transduction domain (MTD). The resulting CP-Parkin proteins (HPM13 and PM10) suppressed dopaminergic neuronal toxicity in cells and mice exposed to 6-hydroxydopamine (6-OHDH) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). These included enhanced survival and dopamine expression in cultured CATH. a and SH-SY5Y neuronal cells; and protection against MPTP-induced damage in mice, notably preservation of tyrosine hydroxylase-positive cells with enhanced dopamine expression in the striatum and midbrain, and preservation of gross motor function. These results demonstrate that CP-Parkin proteins can compensate for intrinsic limitations in the parkin response and provide a therapeutic strategy to augment parkin activity in vivo.	[Duong, Tam; Jo, Daewoong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea; [Kim, Jaetaek] Chung Ang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 156756, South Korea; [Ruley, H. Earl] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Jo, Daewoong] ProCell Therapeut Inc, ProCell R&D Inst, Seoul, South Korea	Chonnam National University; Chung Ang University; Chung Ang University Hospital; Vanderbilt University	Jo, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA.	dae-woong.jo@vanderbilt.edu	Kim, Jaetaek/AAE-7147-2020	Kim, Jaetaek/0000-0001-5247-0408	Ministry of Education, Science and Technology, Republic of Korea [KRF-2006-331-E00102]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant of the Rising Professor Support Program (KRF-2006-331-E00102 to D.J.) of Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthe manuscript.	Ahn EH, 2013, FREE RADICAL BIO MED, V55, P36, DOI 10.1016/j.freeradbiomed.2012.11.008; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fischer PM, 2007, MED RES REV, V27, P755, DOI 10.1002/med.20093; Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jeong HJ, 2012, MOL CELLS, V33, P471, DOI 10.1007/s10059-012-2255-8; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Joshi RL, 2011, FEBS LETT, V585, P1573, DOI 10.1016/j.febslet.2011.05.006; Kim DW, 2010, FREE RADICAL BIO MED, V48, P969, DOI 10.1016/j.freeradbiomed.2010.01.023; Kim MJ, 2012, BIOCHIMIE, V94, P2448, DOI 10.1016/j.biochi.2012.07.005; Kim MJ, 2010, J NEUROL SCI, V298, P64, DOI 10.1016/j.jns.2010.08.016; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lee YP, 2012, FEBS J, V279, P1929, DOI 10.1111/j.1742-4658.2012.08574.x; Lim J, 2013, BIOMATERIALS, V34, P6261, DOI 10.1016/j.biomaterials.2013.05.011; Lim J, 2013, CLIN CANCER RES, V19, P680, DOI 10.1158/1078-0432.CCR-12-2692; Lim J, 2012, MOL THER, V20, P1540, DOI 10.1038/mt.2012.102; Lim J, 2011, CANCER RES, V71, P7216, DOI 10.1158/0008-5472.CAN-11-2015; Lipski J, 2011, PROG NEUROBIOL, V94, P389, DOI 10.1016/j.pneurobio.2011.06.005; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu DY, 2004, J BIOL CHEM, V279, P19239, DOI 10.1074/jbc.M313442200; Liu XY, 2000, J BIOL CHEM, V275, P16774; Liu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000093; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Luthra PM, 2009, J NEUROSCI METH, V178, P284, DOI 10.1016/j.jneumeth.2008.12.019; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Masserano JM, 1996, MOL PHARMACOL, V50, P1309; Moore DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013235; Nagel F, 2008, J NEUROCHEM, V105, P853, DOI 10.1111/j.1471-4159.2007.05204.x; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Ramamoorthy A, 2007, BIOCHEMISTRY-US, V46, P965, DOI 10.1021/bi061895g; Rosen KM, 2006, J BIOL CHEM, V281, P12809, DOI 10.1074/jbc.M512649200; Sohn EJ, 2012, BBA-GEN SUBJECTS, V1820, P1647, DOI 10.1016/j.bbagen.2012.06.012; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Surmeier DJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009290; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Trempe JF, 2013, SCIENCE; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Walden H, 2012, CELL MOL LIFE SCI, V69, P3053, DOI 10.1007/s00018-012-0978-5; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0	53	5	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102517	10.1371/journal.pone.0102517	http://dx.doi.org/10.1371/journal.pone.0102517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019626	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600089
J	Hofstra, JM; Coenen, MJH; Schijvenaars, MMVAP; Berden, JHM; van der Vlag, J; Hoefsloot, LH; Knoers, NVAM; Wetzels, JFM; Nijenhuis, T				Hofstra, Julia M.; Coenen, Marieke J. H.; Schijvenaars, Mascha M. V. A. P.; Berden, Jo H. M.; van der Vlag, Johan; Hoefsloot, Lies H.; Knoers, Nine V. A. M.; Wetzels, Jack F. M.; Nijenhuis, Tom			TRPC6 Single Nucleotide Polymorphisms and Progression of Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE INJURY; RECEPTOR; ACTIVATION; ASSOCIATION; COMPLEMENT; EXPRESSION; MUTATION; ANTIGEN; MARKERS	Background: Activating mutations in the Transient Receptor Potential channel C6 (TRPC6) cause autosomal dominant focal segmental glomerular sclerosis (FSGS). TRPC6 expression is upregulated in renal biopsies of patients with idiopathic membranous glomerulopathy (iMN) and animal models thereof. In iMN, disease progression is characterized by glomerulosclerosis. In addition, a context-dependent TRPC6 overexpression was recently suggested in complement-mediated podocyte injury in e. g. iMN. Hence, we hypothesized that genetic variants in TRPC6 might affect susceptibility to development or progression of iMN. Methods & Results: Genomic DNA was isolated from blood samples of 101 iMN patients and 292 controls. By direct sequencing of the entire TRPC6 gene, 13 single nucleotide polymorphisms (SNPs) were identified in the iMN cohort, two of which were causing an amino acid substitution (rs3802829; Pro15Ser and rs36111323, Ala404Val). No statistically significant differences in genotypes or allele frequencies between patients and controls were observed. Clinical outcome in patients was determined (remission n = 26, renal failure n = 46, persistent proteinuria n = 29, follow-up median 80 months {range 51-166}). The 13 identified SNPs showed no association with remission or renal failure. There were no differences in genotypes or allele frequencies between patients in remission and progressors. Conclusions: Our data suggest that TRPC6 polymorphisms do not affect susceptibility to iMN, or clinical outcome in iMN.	[Hofstra, Julia M.; Berden, Jo H. M.; van der Vlag, Johan; Wetzels, Jack F. M.; Nijenhuis, Tom] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [Coenen, Marieke J. H.; Schijvenaars, Mascha M. V. A. P.; Hoefsloot, Lies H.; Knoers, Nine V. A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Nijenhuis, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands.	Tom.Nijenhuis@Radboudumc.nl	Hofstra, Julia/A-4171-2015; Wetzels, Jack F.M./A-1720-2014; Coenen, Marieke/A-2159-2010; Van der Vlag, Johan/E-4636-2010; Schijvenaars, Mascha/P-8712-2015; Nijenhuis, Tom/L-4547-2015; Nijenhuis, Tom/ABE-5194-2021; Berden, J.H.M./H-8009-2014	Wetzels, Jack F.M./0000-0002-0650-6921; Coenen, Marieke/0000-0001-8796-2031; Van der Vlag, Johan/0000-0001-7843-5918; Nijenhuis, Tom/0000-0002-4375-7236; Nijenhuis, Tom/0000-0002-4375-7236; 	Dutch Kidney Foundation [OW08, KJPB 07.0001]; Genzyme Renal Innovations Program (GRIP); Dutch Diabetes Fund [2009.80.118]	Dutch Kidney Foundation; Genzyme Renal Innovations Program (GRIP)(Sanofi-AventisGenzyme Corporation); Dutch Diabetes Fund	Financial support was provided by a Dutch Kidney Foundation grant (OW08) for J.M.H and J.F. M. W., a Kolff Career Stimulation Grant from the Dutch Kidney Foundation (KJPB 07.0001), a grant from the Genzyme Renal Innovations Program (GRIP) and a Ruby Diabetes Research Grant from the Dutch Diabetes Fund (2009.80.118) for T.N. http://www. nierstichting.nl http://www.genzyme.com/Responsibility/Grants-and-Giving.aspx http://www.diabetesfonds.nl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Branten AJW, 2005, J AM SOC NEPHROL, V16, P169, DOI 10.1681/ASN.2004040287; BROOKS RC, 1989, J BIOL CHEM, V264, P20147; Chen WC, 2010, RENAL FAILURE, V32, P666, DOI 10.3109/0886022X.2010.485289; Cheng WR, 2011, NEPHROL DIAL TRANSPL, V26, P2544, DOI 10.1093/ndt/gfq768; Coenen MJH, 2013, J AM SOC NEPHROL, V24, P677, DOI 10.1681/ASN.2012070730; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; GLASSOCK RJ, 1992, NEPHROL DIAL TRANSPL, V7, P64; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Heeringa SF, 2007, NEPHROL DIAL TRANSPL, V22, P2201, DOI 10.1093/ndt/gfm188; Hofstra JM, 2012, NETH J MED, V70, P109; Hofstra JM, 2013, NAT REV NEPHROL, V9, P443, DOI 10.1038/nrneph.2013.125; Hofstra JM, 2013, NEPHROL DIAL TRANSPL, V28, P1830, DOI 10.1093/ndt/gfs572; Hofstra JM, 2012, NEPHROL DIAL TRANSPL, V27, P6, DOI 10.1093/ndt/gfr371; JONES DB, 1957, AM J PATHOL, V33, P313; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Kistler AD, 2013, J BIOL CHEM, V288, P36598, DOI 10.1074/jbc.M113.488122; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Ma H, 2013, SEMIN NEPHROL, V33, P531, DOI 10.1016/j.semnephrol.2013.08.004; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ronco P, 2012, NAT REV NEPHROL, V8, P203, DOI 10.1038/nrneph.2012.35; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Sonneveld R, 2013, AM J PATHOL, V182, P1196, DOI 10.1016/j.ajpath.2012.12.011; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; van den Brand JAJG, 2012, CLIN J AM SOC NEPHRO, V7, P1242, DOI 10.2215/CJN.00670112; van den Brand JAJG, 2011, CLIN J AM SOC NEPHRO, V6, P2846, DOI 10.2215/CJN.04020411; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhang H, 2009, EXP BIOL MED, V234, P1029, DOI 10.3181/0901-RM-11	36	4	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102065	10.1371/journal.pone.0102065	http://dx.doi.org/10.1371/journal.pone.0102065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019165	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600042
J	Mian, C; Ceccato, F; Barollo, S; Watutantrige-Fernando, S; Albiger, N; Regazzo, D; de Lazzari, P; Pennelli, G; Rotondi, S; Nacamulli, D; Pelizzo, MR; Jaffrain-Rea, ML; Grimaldi, F; Occhi, G; Scaroni, C				Mian, Caterina; Ceccato, Filippo; Barollo, Susi; Watutantrige-Fernando, Sara; Albiger, Nora; Regazzo, Daniela; de Lazzari, Paola; Pennelli, Gianmaria; Rotondi, Sandra; Nacamulli, Davide; Pelizzo, Maria Rosa; Jaffrain-Rea, Marie-Lise; Grimaldi, Franco; Occhi, Gianluca; Scaroni, Carla			AHR Over-Expression in Papillary Thyroid Carcinoma: Clinical and Molecular Assessments in a Series of Italian Acromegalic Patients with a Long-Term Follow-Up	PLOS ONE			English	Article							PITUITARY-ADENOMA PREDISPOSITION; INTERACTING PROTEIN MUTATIONS; HYDROCARBON RECEPTOR AHR; CANCER INCIDENCE; AIP MUTATIONS; PREVALENCE; MORTALITY; NEOPLASMS; CONSENSUS; DISEASES	Aim: Acromegaly reportedly carries an increased risk of malignant and benign thyroid tumors, with a prevalence of thyroid cancer of around 3-7%. Germline mutations in the aryl-hydrocarbon receptor (AHR) interacting protein (AIP) have been identified in familial forms of acromegaly. The molecular and endocrine relationships between follicular thyroid growth and GH-secreting pituitary adenoma have yet to be fully established. Our aim was to study the prevalence of differentiated thyroid cancer (DTC) in acromegaly, focusing on the role of genetic events responsible for the onset of thyroid cancer. Methods: Germline mutations in the AIP gene were assessed in all patients; BRAF and H-N-K RAS status was analyzed by direct sequencing in thyroid specimens, while immunohistochemistry was used to analyze the protein expression of AIP and AHR. A set of PTCs unrelated to acromegaly was also studied. Results: 12 DTCs (10 papillary and 2 follicular carcinomas) were identified in a cohort of 113 acromegalic patients. No differences in GH/IGF-1 levels or disease activity emerged between patients with and without DTC, but the former were older and more often female. BRAF V600E was found in 70% of the papillary thyroid cancers; there were no RAS mutations. AIP protein expression was similar in neoplastic and normal cells, while AHR protein was expressed more in PTCs carrying BRAF mutations than in normal tissue, irrespective of acromegaly status. Conclusions: The prevalence of DTC in acromegaly is around 11% and endocrinologists should bear this in mind, especially when examining elderly female patients with uninodular goiter. The DTC risk does not seem to correlate with GH/IGF-1 levels, while it may be associated with BRAF mutations and AHR over-expression. Genetic or epigenetic events probably play a part in promoting thyroid carcinoma.	[Mian, Caterina; Ceccato, Filippo; Barollo, Susi; Watutantrige-Fernando, Sara; Albiger, Nora; Regazzo, Daniela; de Lazzari, Paola; Nacamulli, Davide; Occhi, Gianluca; Scaroni, Carla] Univ Hosp Padua, Dept Med, Endocrinol Unit, Padua, Italy; [Pennelli, Gianmaria] Univ Hosp Padua, Dept Med, Pathol Unit 2, Padua, Italy; [Rotondi, Sandra; Jaffrain-Rea, Marie-Lise] Univ Aquila, Dept Clin & Biotechnol Sci, I-67100 Laquila, Italy; [Pelizzo, Maria Rosa] Univ Hosp Padua, Dept Surg, Surg Pathol Unit, Padua, Italy; [Jaffrain-Rea, Marie-Lise] Univ Aquila, Dept Neurol Sci, Neuromed Inst, I-67100 Laquila, Italy; [Grimaldi, Franco] Univ Hosp Santa Maria Misericordia, Endocrinol & Metab Unit, Udine, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of L'Aquila; University of Padua; Azienda Ospedaliera - Universita di Padova; University of L'Aquila; Hospital Santa Maria della Misericordia	Mian, C (corresponding author), Univ Hosp Padua, Dept Med, Endocrinol Unit, Padua, Italy.	caterina.mian@unipd.it	Ceccato, Filippo/K-1316-2018; Dagdelen, Selcuk/A-9432-2017; Occhi, Gianluca/AAJ-1125-2020; Regazzo, Daniela/X-3139-2019; Jaffrain-Rea, Marie-Lise/D-1129-2009; Occhi, Gianluca/S-5872-2019; Grimaldi, Franco/AAK-5748-2020; Rea, Marie Lise Jaffrain/AAK-9443-2021; Pennelli, Gianmaria/J-9937-2016; Scaroni, Carla/G-3853-2017	Ceccato, Filippo/0000-0003-1456-8716; Dagdelen, Selcuk/0000-0002-0513-1750; Regazzo, Daniela/0000-0002-1942-7202; Jaffrain-Rea, Marie-Lise/0000-0002-5916-8997; Occhi, Gianluca/0000-0003-4065-4677; Rea, Marie Lise Jaffrain/0000-0002-5916-8997; Pennelli, Gianmaria/0000-0003-0210-165X; Scaroni, Carla/0000-0001-9396-3815; MIAN, CATERINA/0000-0003-2615-8001; Watutantrige Fernando, Sara/0000-0001-7056-0423				Baldys-Waligorska A, 2010, ENDOKRYNOL POL, V61, P29; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; dos Santos MCC, 2013, PITUITARY, V16, P109, DOI 10.1007/s11102-012-0383-y; Ceccato F, 2011, J ENDOCRINOL INVEST, V34, P353, DOI [10.1007/BF03347459, 10.3275/7145]; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Colao A, 2007, J CLIN ENDOCR METAB, V92, P3854, DOI 10.1210/jc.2006-2551; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dagdelen S, 2014, PITUITARY, V17, P299, DOI 10.1007/s11102-013-0501-5; Duong Cuong V, 2012, Endocr Relat Cancer, V19, P805, DOI 10.1530/ERC-12-0251; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernando SW, 2013, EUR J CLIN NUTR, V67, P366, DOI 10.1038/ejcn.2013.44; Gasperi M, 2002, J ENDOCRINOL INVEST, V25, P240, DOI 10.1007/BF03343997; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; Gullu BE, 2010, PITUITARY, V13, P242, DOI 10.1007/s11102-010-0224-9; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Herrmann BL, 2004, EXP CLIN ENDOCR DIAB, V112, P225, DOI 10.1055/s-2004-817967; Jaffrain-Rea ML, 2013, ENDOCR-RELAT CANCER, V20, P753, DOI 10.1530/ERC-12-0322; Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094; Jenkins PJ, 2006, CLIN ENDOCRINOL, V64, P115, DOI 10.1111/j.1365-2265.2005.02404.x; Kurimoto M, 2008, ENDOCR J, V55, P67, DOI 10.1507/endocrj.K07E-010; Loeper S, 2008, REV ENDOCR METAB DIS, V9, P41, DOI 10.1007/s11154-007-9063-z; Melmed S, 2013, PITUITARY, V16, P294, DOI 10.1007/s11102-012-0420-x; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; MINUTO F, 1989, J CLIN ENDOCR METAB, V68, P621, DOI 10.1210/jcem-68-3-621; Occhi G, 2010, EUR J ENDOCRINOL, V163, P369, DOI 10.1530/EJE-10-0327; ONODA N, 1992, EUR J CANCER, V28A, P1904, DOI 10.1016/0959-8049(92)90033-X; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Pardi E, 2013, J CLIN ENDOCR METAB, V98, P2800, DOI 10.1210/jc.2012-4029; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Pennelli G, 2011, THYROID, V21, P1393, DOI 10.1089/thy.2011.0120; Popovic V, 1998, CLIN ENDOCRINOL, V49, P441, DOI 10.1046/j.1365-2265.1998.00536.x; Raitila A, 2007, ENDOCR-RELAT CANCER, V14, P901, DOI 10.1677/ERC-07-0025; Raitila A, 2009, J ENDOCRINOL INVEST, V32, P426, DOI 10.1007/BF03346480; Reiners C, 2014, NAT REV ENDOCRINOL, V10, P69, DOI 10.1038/nrendo.2013.247; Roger P, 1998, J CLIN ENDOCR METAB, V66, P1158; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; Tita P, 2005, CLIN ENDOCRINOL, V63, P161, DOI 10.1111/j.1365-2265.2005.02316.x; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Watutantrige-Fernando S, 2018, THYROID, V28, P96, DOI 10.1089/thy.2017.0248	39	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101560	10.1371/journal.pone.0101560	http://dx.doi.org/10.1371/journal.pone.0101560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019383	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600018
J	Vidal, BD; Ghiraldini, FG; Mello, MLS				Vidal, Benedicto de Campos; Ghiraldini, Flavia Gerelli; Mello, Maria Luiza S.			Changes in Liver Cell DNA Methylation Status in Diabetic Mice Affect Its FT-IR Characteristics	PLOS ONE			English	Article							CYTOSINE METHYLATION; INFRARED-SPECTRA; LASER-RAMAN; BINDING; SITES	Background: Lower levels of cytosine methylation have been found in the liver cell DNA from non-obese diabetic (NOD) mice under hyperglycemic conditions. Because the Fourier transform-infrared (FT-IR) profiles of dry DNA samples are differently affected by DNA base composition, single-stranded form and histone binding, it is expected that the methylation status in the DNA could also affect its FT-IR profile. Methodology/Principal Findings: The DNA FT-IR signatures obtained from the liver cell nuclei of hyperglycemic and normoglycemic NOD mice of the same age were compared. Dried DNA samples were examined in an IR microspectroscope equipped with an all-reflecting objective (ARO) and adequate software. Conclusions/Significance: Changes in DNA cytosine methylation levels induced by hyperglycemia in mouse liver cells produced changes in the respective DNA FT-IR profiles, revealing modifications to the vibrational intensities and frequencies of several chemical markers, including v(as) -CH3 stretching vibrations in the 5-methylcytosine methyl group. A smaller band area reflecting lower energy absorbed in the DNA was found in the hyperglycemic mice and assumed to be related to the lower levels of -CH3 groups. Other spectral differences were found at 1700-1500 cm(-1) and in the fingerprint region, and a slight change in the DNA conformation at the lower DNA methylation levels was suggested for the hyperglycemic mice. The changes that affect cytosine methylation levels certainly affect the DNA-protein interactions and, consequently, gene expression in liver cells from the hyperglycemic NOD mice.	[Vidal, Benedicto de Campos; Ghiraldini, Flavia Gerelli; Mello, Maria Luiza S.] Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Mello, MLS (corresponding author), Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil.	mlsmello@unicamp.br	Vidal, Benedicto/I-3227-2012; de Campos Vidal, Benedicto/ABH-6617-2020; Mello, Maria Luiza Silveira/D-9158-2012	Vidal, Benedicto/0000-0003-1629-5619; de Campos Vidal, Benedicto/0000-0003-0285-1653; Mello, Maria Luiza Silveira/0000-0003-1629-5619	Sao Paulo State Research Foundation (FAPESP) [201050015-6]; Brazilian National Council for Research and Development (CNPq) [301943/2009-5, 475261/2012-7]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grant no. 201050015-6 from the Sao Paulo State Research Foundation (FAPESP) and grants no. 301943/2009-5 and 475261/2012-7 from the Brazilian National Council for Research and Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Anastassopoulou J, 2009, VIB SPECTROSC, V51, P270, DOI 10.1016/j.vibspec.2009.07.005; Arakawa H, 2001, BIOPHYS J, V81, P1580, DOI 10.1016/S0006-3495(01)75812-2; Banyay M, 2002, J MOL BIOL, V324, P667, DOI 10.1016/S0022-2836(02)01104-X; Bird B, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-8; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; Damasceno NB, 2013, 59 C BRAS GEN AG LIN, P57; Eglinton G, 1970, INTRO SPECTROSCOPY M, V1, p[129, 139]; Flett MSC, 1970, INTRO SPECTROSCOPIC, V1, P109; Fox JJ, 1940, PROC R SOC LON SER-A, V175, P0208, DOI 10.1098/rspa.1940.0053; Franchini DM, 2012, ANNU REV GENET, V46, P419, DOI 10.1146/annurev-genet-110711-155451; FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P673, DOI 10.1107/S0365110X53001939; Ghiraldini FG, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-19; Ghiraldini FG, 2012, CYTOM PART A, V81A, P755, DOI 10.1002/cyto.a.22102; Ghiraldini FG, 2013, MOL BIOL CELL, V24, P2467, DOI 10.1091/mbc.E13-04-0186; Hembram KPSS, 2009, MAT SCI ENG C-BIO S, V29, P1093, DOI 10.1016/j.msec.2008.09.021; Kelly JG, 2011, J BIOPHOTONICS, V4, P345, DOI 10.1002/jbio.201000085; Kurtz DM, 2000, J LIPID RES, V41, P2063; KYOGOKU Y, 1961, J MOL BIOL, V3, P741, DOI 10.1016/S0022-2836(61)80078-8; MATHLOUTHI M, 1986, CARBOHYD RES, V146, P1, DOI 10.1016/0008-6215(86)85019-4; Mello MLS, 2014, MICRON, V61, P49, DOI 10.1016/j.micron.2014.02.003; Mello MLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043169; MOHAN S, 1993, ASIAN J CHEM, V5, P243; Mukai T, 2006, LIVER INT, V26, P1006, DOI 10.1111/j.1478-3231.2006.01322.x; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; REDI CA, 1990, CHROMOSOMA, V99, P11, DOI 10.1007/BF01737284; Reusch W, 1999, VIRTUAL TEXT ORGANIC; Shimanouchi T., 1964, ADVANCES CHEMICAL PH, V7, P435; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Vargason JM, 2000, NAT STRUCT BIOL, V7, P758; Vargason JM, 2001, P NATL ACAD SCI USA, V98, P7265, DOI 10.1073/pnas.121176898; Vargason JM, 2002, THESIS OREGON STATE; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yang PY, 2012, APOPTOSIS, V17, P154, DOI 10.1007/s10495-011-0666-1; Yang Y, 2003, DIABETOLOGIA, V46, P1447, DOI 10.1007/s00125-003-1218-1; Yugami H, 1996, SOLID STATE IONICS, V85, P319, DOI 10.1016/0167-2738(96)00076-8; Zelig U, 2011, BBA-GEN SUBJECTS, V1810, P827, DOI 10.1016/j.bbagen.2011.06.010	38	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102295	10.1371/journal.pone.0102295	http://dx.doi.org/10.1371/journal.pone.0102295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019512	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600062
J	Zhang, Y; Peng, L; Kan, HD; Xu, JM; Chen, RJ; Liu, Y; Wang, WB				Zhang, Yue; Peng, Li; Kan, Haidong; Xu, Jianming; Chen, Renjie; Liu, Yuan; Wang, Weibing			Effects of Meteorological Factors on Daily Hospital Admissions for Asthma in Adults: A Time-Series Analysis	PLOS ONE			English	Article							DIURNAL TEMPERATURE-RANGE; CLIMATE-CHANGE; AIR-POLLUTION; CHILDHOOD ASTHMA; COLD TEMPERATURE; HEAT WAVES; MORTALITY; PREVALENCE; SYMPTOMS; DISEASE	Background: There is limited evidence for the impacts of meteorological changes on asthma hospital admissions in adults in Shanghai, China. Objectives: To quantitatively evaluate the short-term effects of daily mean temperature on asthma hospital admissions. Methods: Daily hospital admissions for asthma and daily mean temperatures between January 2005 and December 2012 were analyzed. After controlling for secular and seasonal trends, weather, air pollution and other confounding factors, a Poisson generalized additive model (GAM) combined with a distributed lag non-linear model were used to explore the associations between temperature and hospital admissions for asthma. Results: During the study periods, there were 15,678 hospital admissions for asthma by residents of Shanghai, an average 5.6 per day. Pearson correlation analysis found a significant negative correlation (r = -0.174, P<0.001) between asthma hospitalizations and daily mean temperature (DMT). The DMT effect on asthma increased below the median DMT, with lower temperatures associated with a higher risk of hospital admission for asthma. Generally, the cold effect appeared to be relatively acute, with duration lasting several weeks, while the hot effect was short-term. The relative risk of asthma hospital admissions associated with cold temperature (the 25th percentile of temperature relative to the median temperature) was 1.20 (95% confidence interval [CI], 1.01 similar to 1.41) at lag0-14. However, warmer temperatures were not associated with asthma hospital admissions. Conclusions: Cold temperatures may trigger asthmatic attacks. Effective strategies are needed to protect populations at risk from the effects of cold.	[Zhang, Yue; Kan, Haidong; Chen, Renjie; Liu, Yuan; Wang, Weibing] Fudan Univ, Minist Educ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhang, Yue; Kan, Haidong; Chen, Renjie; Liu, Yuan; Wang, Weibing] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Kan, Haidong; Wang, Weibing] Fudan Univ, Fudan Tyndall Ctr, Shanghai 200433, Peoples R China; [Peng, Li; Xu, Jianming] Shanghai Ctr Urban Environm Meteorol, Shanghai, Peoples R China; [Peng, Li; Xu, Jianming] Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, WB (corresponding author), Fudan Univ, Minist Educ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	wwb@fudan.edu.cn	Kan, Haidong/AGU-0328-2022		Global Environment Change Research in Fudan University [EZH1829007/003]; Chinese Meteorological Administration [GYHY201206027]; Chinese National Science Foundation [30800937]; program of Key Discipline Construction of Public Health of Shanghai [12GWZX0101]	Global Environment Change Research in Fudan University; Chinese Meteorological Administration; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); program of Key Discipline Construction of Public Health of Shanghai	This study was funded by the Global Environment Change Research in Fudan University (Grant No. EZH1829007/003), the Chinese Meteorological Administration (Grant No. GYHY201206027), Chinese National Science Foundation (30800937) and the program of Key Discipline Construction of Public Health of Shanghai (Grant No. 12GWZX0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, AM J EMERG MED, V27, P153, DOI 10.1016/j.ajem.2008.01.013; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Amoah A S, 2012, Ghana Med J, V46, P23; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Beggs PJ, 2010, INT J ENV RES PUB HE, V7, P3006, DOI 10.3390/ijerph7083006; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; Buckley JP, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-55; Cao JS, 2009, SCI TOTAL ENVIRON, V407, P5531, DOI 10.1016/j.scitotenv.2009.07.021; Chan-Yeung M, 2002, EUR RESPIR J, V19, P853, DOI 10.1183/09031936.02.00250602; Chen RJ, 2010, J HAZARD MATER, V181, P234, DOI 10.1016/j.jhazmat.2010.05.002; D'Amato G, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-12; D'Amato G, 2011, MULTIDISCIP RESP MED, V6, P28, DOI 10.1186/2049-6958-6-1-28; Donaldson GC, 1999, EUR RESPIR J, V13, P844, DOI 10.1034/j.1399-3003.1999.13d25.x; Epton MJ, 1997, THORAX, V52, P528, DOI 10.1136/thx.52.6.528; Europe WHOROf, 2006, AIR QUAL GUID GLOB U; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Grineski SE, 2011, ENVIRON RES, V111, P1148, DOI 10.1016/j.envres.2011.06.007; Guo YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042232; Guo YM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-36; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Guo YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016511; Hajat S, 2002, INT J EPIDEMIOL, V31, P825, DOI 10.1093/ije/31.4.825; Hales S, 1998, ENVIRON HEALTH PERSP, V106, P607, DOI 10.2307/3434236; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; Li MC, 2011, J ALLERGY CLIN IMMUN, V128, P626, DOI 10.1016/j.jaci.2011.04.032; Lim YH, 2012, SCI TOTAL ENVIRON, V417, P55, DOI 10.1016/j.scitotenv.2011.12.048; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Makinen TM, 2009, RESP MED, V103, P456, DOI 10.1016/j.rmed.2008.09.011; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Michelozzi P, 2006, J EPIDEMIOL COMMUN H, V60, P417, DOI 10.1136/jech.2005.040857; Reid CE, 2009, ECOHEALTH, V6, P458, DOI 10.1007/s10393-009-0261-x; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051567; Son J-Y, 2014, INT J BIOMETEOROL, P1; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Vutcovici M, 2014, INT J BIOMETEOROL, V58, P843, DOI 10.1007/s00484-013-0664-9; Wang MZ, 2013, SCI TOTAL ENVIRON, V456, P370, DOI 10.1016/j.scitotenv.2013.03.023; WHO, 2005, AIR QUAL GUID GLOB U; Xu ZW, 2013, OCCUP ENVIRON MED, V70, P730, DOI 10.1136/oemed-2013-101538; Xu ZW, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-12; Yang J, 2012, ENV HLTH, V11, P1; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279	46	52	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102475	10.1371/journal.pone.0102475	http://dx.doi.org/10.1371/journal.pone.0102475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019158	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600085
J	Brust, H; Lehmann, T; D'Hulst, C; Fettke, J				Brust, Henrike; Lehmann, Tanja; D'Hulst, Christophe; Fettke, Joerg			Analysis of the Functional Interaction of Arabidopsis Starch Synthase and Branching Enzyme Isoforms Reveals that the Cooperative Action of SSI and BEs Results in Glucans with Polymodal Chain Length Distribution Similar to Amylopectin	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AMYLOSE-EXTENDER MUTATION; BIOSYNTHETIC-ENZYMES; MAIZE ENDOSPERM; RICE ENDOSPERM; ESCHERICHIA-COLI; RESERVE STARCH; WHEAT STARCHES; LEAF STARCH; ZEA-MAYS	Starch synthase (SS) and branching enzyme (BE) establish the two glycosidic linkages existing in starch. Both enzymes exist as several isoforms. Enzymes derived from several species were studied extensively both in vivo and in vitro over the last years, however, analyses of a functional interaction of SS and BE isoforms are missing so far. Here, we present data from in vitro studies including both interaction of leaf derived and heterologously expressed SS and BE isoforms. We found that SSI activity in native PAGE without addition of glucans was dependent on at least one of the two BE isoforms active in Arabidopsis leaves. This interaction is most likely not based on a physical association of the enzymes, as demonstrated by immunodetection and native PAGE mobility analysis of SSI, BE2, and BE3. The glucans formed by the action of SSI/BEs were analysed using leaf protein extracts from wild type and be single mutants (Atbe2 and Atbe3 mutant lines) and by different combinations of recombinant proteins. Chain length distribution (CLD) patterns of the formed glucans were irrespective of SSI and BE isoforms origin and still independent of assay conditions. Furthermore, we show that all SS isoforms (SSI-SSIV) were able to interact with BEs and form branched glucans. However, only SSI/BEs generated a polymodal distribution of glucans which was similar to CLD pattern detected in amylopectin of Arabidopsis leaf starch. We discuss the impact of the SSI/BEs interplay for the CLD pattern of amylopectin.	[Brust, Henrike; Lehmann, Tanja; Fettke, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [D'Hulst, Christophe] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	University of Potsdam; Universite de Lille - ISITE; Universite de Lille	Brust, H (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	henbrust@uni-potsdam.de	D'HULST, Christophe/B-2072-2012; D'Hulst, Christophe/AAX-2809-2020; Brust, Henrike/AAM-7193-2021	D'HULST, Christophe/0000-0002-5556-9099; D'Hulst, Christophe/0000-0002-5556-9099; Fettke, Joerg/0000-0003-0137-7611				Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Bertoft E, 2004, CARBOHYD POLYM, V57, P211, DOI 10.1016/j.carbpol.2004.04.015; Bertoft E, 2011, INT J BIOL MACROMOL, V49, P441, DOI 10.1016/j.ijbiomac.2011.04.014; Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Broberg S, 2000, CARBOHYD POLYM, V43, P285, DOI 10.1016/S0144-8617(00)00152-1; Brust H., 2013, Journal of Applied Glycoscience, V60, P3, DOI 10.5458/jag.jag.JAG-2012_018; BURTON RA, 1995, PLANT J, V7, P3, DOI 10.1046/j.1365-313X.1995.07010003.x; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; Chauhan F, 2013, STARCH-STARKE, V65, P191, DOI 10.1002/star.201200132; Commuri PD, 2001, PLANT J, V25, P475, DOI 10.1046/j.1365-313x.2001.00955.x; Crofts N, 2012, PLANT SCI, V193, P62, DOI 10.1016/j.plantsci.2012.05.006; Cuevas RP, 2010, CARBOHYD POLYM, V81, P120, DOI 10.1016/j.carbpol.2010.02.004; Delvalle D, 2005, PLANT J, V43, P398, DOI 10.1111/j.1365-313X.2005.02462.x; Dumez S, 2006, PLANT CELL, V18, P2694, DOI 10.1105/tpc.105.037671; Fettke J, 2012, ESSENTIAL REV EXPT B, V5, P309; Fettke J, 2012, J EXP BOT, V63, P3011, DOI 10.1093/jxb/ers014; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Fujita N., 2008, Journal of Applied Glycoscience, V55, P167, DOI 10.5458/jag.55.167; Fujita N, 2007, PLANT PHYSIOL, V144, P2009, DOI 10.1104/pp.107.102533; Gao M, 1997, PLANT PHYSIOL, V114, P69, DOI 10.1104/pp.114.1.69; Gerard C, 2000, CARBOHYD RES, V326, P130, DOI 10.1016/S0008-6215(00)00025-2; Gomand SV, 2010, FOOD HYDROCOLLOID, V24, P307, DOI 10.1016/j.foodhyd.2009.10.008; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; Hanashiro I, 1996, CARBOHYD RES, V283, P151, DOI 10.1016/0008-6215(95)00408-4; HANASHIRO I, 2004, J APPL GLYCOSCI, V51, P217; HAWKER JS, 1974, ARCH BIOCHEM BIOPHYS, V160, P530, DOI 10.1016/0003-9861(74)90430-5; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Jobling SA, 2002, NAT BIOTECHNOL, V20, P295, DOI 10.1038/nbt0302-295; Kalinga DN, 2013, STARCH-STARKE, V65, P791, DOI 10.1002/star.201200240; Keeling PL, 2010, ANNU REV FOOD SCI T, V1, P271, DOI 10.1146/annurev.food.102308.124214; Konik-Rose C, 2007, THEOR APPL GENET, V115, P1053, DOI 10.1007/s00122-007-0631-0; Franco CML, 2010, BRAZ ARCH BIOL TECHN, V53, P443, DOI 10.1590/S1516-89132010000200025; Li ZY, 2011, J EXP BOT, V62, P5217, DOI 10.1093/jxb/err239; Lin QH, 2012, PLANT PHYSIOL, V158, P679, DOI 10.1104/pp.111.189704; Liu FS, 2012, BIOCHEM J, V448, P373, DOI 10.1042/BJ20120573; Liu FS, 2012, J EXP BOT, V63, P1167, DOI 10.1093/jxb/err341; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; McMaugh SJ, 2014, J EXP BOT, V65, P2189, DOI 10.1093/jxb/eru095; Morell MK, 2003, PLANT J, V34, P172, DOI 10.1046/j.1365-313X.2003.01712.x; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; PEAT S, 1952, J CHEM SOC, P4546; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; POLLOCK C, 1980, ARCH BIOCHEM BIOPHYS, V204, P578, DOI 10.1016/0003-9861(80)90070-3; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Sawada T, 2009, PLANT CELL PHYSIOL, V50, P1062, DOI 10.1093/pcp/pcp058; Senoura T, 2004, BIOSCI BIOTECH BIOCH, V68, P1949, DOI 10.1271/bbb.68.1949; Stitt M, 1989, METHOD ENZYMOL, V174, P971; Szydlowski N, 2011, J EXP BOT, V62, P4547, DOI 10.1093/jxb/err172; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Tetlow IJ, 2012, STARCH ORIGINS STRUC, V5, P115; Tetlow IJ, 2012, ESSENTIAL REV EXPT B, V5, P144; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Vrinten PL, 2012, CARBOHYD POLYM, V89, P1250, DOI 10.1016/j.carbpol.2012.04.029; WAFFENSCHMIDT S, 1987, ANAL BIOCHEM, V165, P337, DOI 10.1016/0003-2697(87)90278-8; Yamamori M, 2000, THEOR APPL GENET, V101, P21, DOI 10.1007/s001220051444; Yandeau-Nelson MD, 2011, PLANT PHYSIOL, V156, P479, DOI 10.1104/pp.111.174094; Yasui T, 2005, STARCH-STARKE, V57, P521, DOI 10.1002/star.200500426; Yasushi YB, 2002, CARBOHYD POLYM, V47, P159; Yoo SH, 2002, CARBOHYD POLYM, V49, P297, DOI 10.1016/S0144-8617(01)00338-1; Zhang XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-96; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zhang XL, 2004, PLANT MOL BIOL, V54, P865, DOI 10.1007/s11103-004-0312-1	75	24	25	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102364	10.1371/journal.pone.0102364	http://dx.doi.org/10.1371/journal.pone.0102364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014622	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400090
J	Talukder, ZI; Gong, L; Hulke, BS; Pegadaraju, V; Song, QJ; Schultz, Q; Qi, LL				Talukder, Zahirul I.; Gong, Li; Hulke, Brent S.; Pegadaraju, Venkatramana; Song, Qijian; Schultz, Quentin; Qi, Lili			A High-Density SNP Map of Sunflower Derived from RAD-Sequencing Facilitating Fine-Mapping of the Rust Resistance Gene R-12	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FERTILITY RESTORATION GENE; HELIANTHUS-ANNUUS L.; SEGREGATION DISTORTION LOCI; MARKER-ASSISTED SELECTION; QUANTITATIVE TRAIT LOCI; CONSENSUS LINKAGE MAP; SCLEROTINIA-SCLEROTIORUM; DOWNY MILDEW; DNA MARKERS	A high-resolution genetic map of sunflower was constructed by integrating SNP data from three F-2 mapping populations (HA 89/RHA 464, B-line/RHA 464, and CR 29/RHA 468). The consensus map spanned a total length of 1443.84 cM, and consisted of 5,019 SNP markers derived from RAD tag sequencing and 118 publicly available SSR markers distributed in 17 linkage groups, corresponding to the haploid chromosome number of sunflower. The maximum interval between markers in the consensus map is 12.37 cM and the average distance is 0.28 cM between adjacent markers. Despite a few shortdistance inversions in marker order, the consensus map showed high levels of collinearity among individual maps with an average Spearman's rank correlation coefficient of 0.972 across the genome. The order of the SSR markers on the consensus map was also in agreement with the order of the individual map and with previously published sunflower maps. Three individual and one consensus maps revealed the uneven distribution of markers across the genome. Additionally, we performed fine mapping and marker validation of the rust resistance gene R12, providing closely linked SNP markers for marker-assisted selection of this gene in sunflower breeding programs. This high resolution consensus map will serve as a valuable tool to the sunflower community for studying marker-trait association of important agronomic traits, marker assisted breeding, map-based gene cloning, and comparative mapping.	[Talukder, Zahirul I.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Gong, Li] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; [Hulke, Brent S.; Qi, Lili] USDA ARS, No Crop Sci Lab, Fargo, ND 58105 USA; [Pegadaraju, Venkatramana; Schultz, Quentin] BioDiagnostics Inc, River Falls, WI USA; [Song, Qijian] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA	North Dakota State University Fargo; North Dakota State University Fargo; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Qi, LL (corresponding author), USDA ARS, No Crop Sci Lab, Fargo, ND 58105 USA.	lili.qi@ars.usda.gov	Qi, LI/AAF-3389-2019; Hulke, Brent/GZG-4449-2022	Talukder, Zahirul/0000-0002-7429-5329	National Sunflower Association-SNP Consortium; public-private partnership between the non-profit National Sunflower Association; public researchers at United States Department of Agriculture (USDA); USDA-ARS CRIS Project [5442-21000-039-00D]	National Sunflower Association-SNP Consortium; public-private partnership between the non-profit National Sunflower Association; public researchers at United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); USDA-ARS CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by the National Sunflower Association-SNP Consortium, a public-private partnership between the non-profit National Sunflower Association, public researchers at United States Department of Agriculture (USDA), and private seed companies, and the USDA-ARS CRIS Project No. 5442-21000-039-00D. Venkatramana Pegadaraju and Quentin Schultz have competing commercial interests as employees of BioDiagnostics, Inc., a for-profit company that has provided some financial assistance to this project and also has a commercial interest in the data generated with the chip because it increases the value of their services to their customers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bachlava E, 2011, THEOR APPL GENET, V122, P1211, DOI 10.1007/s00122-010-1525-0; BERRY ST, 1995, THEOR APPL GENET, V91, P195, DOI 10.1007/BF00220877; Bert PF, 2004, THEOR APPL GENET, V109, P865, DOI 10.1007/s00122-004-1701-1; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Bohra A, 2012, THEOR APPL GENET, V125, P1325, DOI 10.1007/s00122-012-1916-5; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Cloutier S, 2012, THEOR APPL GENET, V125, P685, DOI 10.1007/s00122-012-1860-4; FAO, 2010, FAO AGR HDB; Faris JD, 1998, GENETICS, V149, P319; Feng JH, 2008, THEOR APPL GENET, V117, P241, DOI 10.1007/s00122-008-0769-4; Fusari CM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-7; Galeano CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028135; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Gedil MA, 2001, GENOME, V44, P213, DOI 10.1139/gen-44-2-213; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; Gong L, 2013, THEOR APPL GENET, V126, P93, DOI 10.1007/s00122-012-1962-z; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; Herve D, 2001, J EXP BOT, V52, P1857, DOI 10.1093/jexbot/52.362.1857; Hulke BS, 2010, J PLANT REGIST, V4, P249, DOI 10.3198/jpr2010.02.0114crg; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Isobe S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-57; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jan CC, 1998, THEOR APPL GENET, V96, P15, DOI 10.1007/s001220050703; Kane NC, 2011, BOTANY, V89, P429, DOI [10.1139/B11-032, 10.1139/b11-032]; Khan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047864; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Kumar LS, 1999, BIOTECHNOL ADV, V17, P143, DOI 10.1016/S0734-9750(98)00018-4; Lawson WR, 1998, MOL BREEDING, V4, P227, DOI 10.1023/A:1009667112088; Li HB, 2010, MOL GENET GENOMICS, V284, P319, DOI 10.1007/s00438-010-0570-3; Li X, 2010, GENOME, V53, P939, DOI 10.1139/G10-054; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Liu Z, 2012, THEOR APPL GENET, V125, P121, DOI 10.1007/s00122-012-1820-z; Liu Z, 2012, MOL BREEDING, V29, P275, DOI 10.1007/s11032-011-9563-0; Lombard V, 2001, THEOR APPL GENET, V103, P491, DOI 10.1007/s001220100560; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Micic Z, 2005, THEOR APPL GENET, V110, P1490, DOI 10.1007/s00122-005-1984-x; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Mulpuri S, 2009, THEOR APPL GENET, V119, P795, DOI 10.1007/s00122-009-1089-z; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pan QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052777; Pegadaraju V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-556; Qi LL, 2012, MOL BREEDING, V30, P745, DOI 10.1007/s11032-011-9659-6; Qi LL, 2012, THEOR APPL GENET, V125, P921, DOI 10.1007/s00122-012-1883-x; Qi LL, 2011, THEOR APPL GENET, V123, P351, DOI 10.1007/s00122-011-1588-6; Qi LL, 2011, PHYTOPATHOLOGY, V101, P241, DOI 10.1094/PHYTO-06-10-0162; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Remington DL, 1999, THEOR APPL GENET, V98, P1279, DOI 10.1007/s001220051194; RIESEBERG LH, 1993, HEREDITY, V70, P285, DOI 10.1038/hdy.1993.41; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Ronicke S, 2005, PHYTOPATHOLOGY, V95, P834, DOI 10.1094/PHYTO-95-0834; Schnabel U, 2008, PLANT BREEDING, V127, P587, DOI 10.1111/j.1439-0523.2008.01516.x; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Talukder ZI, 2014, THEOR APPL GENET, V127, P193, DOI 10.1007/s00122-013-2210-x; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Varshney RK, 2006, TRENDS BIOTECHNOL, V24, P490, DOI 10.1016/j.tibtech.2006.08.006; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wills DM, 2007, GENETICS, V176, P2589, DOI 10.1534/genetics.107.075333; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yu JK, 2003, CROP SCI, V43, P367, DOI 10.2135/cropsci2003.0367; Yue B, 2008, PHYTOPATHOLOGY, V98, P926, DOI 10.1094/PHYTO-98-8-0926; Yue B, 2010, PLANT BREEDING, V129, P24, DOI 10.1111/j.1439-0523.2009.01661.x; Zhu CS, 2007, THEOR APPL GENET, V114, P295, DOI 10.1007/s00122-006-0432-x	74	57	58	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e98628	10.1371/journal.pone.0098628	http://dx.doi.org/10.1371/journal.pone.0098628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014030	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400004
J	Fairhall, SL; Albi, A; Melcher, D				Fairhall, Scott L.; Albi, Angela; Melcher, David			Temporal Integration Windows for Naturalistic Visual Sequences	PLOS ONE			English	Article							UNIVERSAL CONSTANT; RECEPTIVE WINDOWS; MOTION; SEGMENTATION; PERCEPTION; HIERARCHY; COGNITION; SPEECH	There is increasing evidence that the brain possesses mechanisms to integrate incoming sensory information as it unfolds over time-periods of 2-3 seconds. The ubiquity of this mechanism across modalities, tasks, perception and production has led to the proposal that it may underlie our experience of the subjective present. A critical test of this claim is that this phenomenon should be apparent in naturalistic visual experiences. We tested this using movie-clips as a surrogate for our day-to-day experience, temporally scrambling them to require (re-) integration within and beyond the hypothesized 2-3 second interval. Two independent experiments demonstrate a step-wise increase in the difficulty to follow stimuli at the hypothesized 2-3 second scrambling condition. Moreover, only this difference could not be accounted for by low-level visual properties. This provides the first evidence that this 2-3 second integration window extends to complex, naturalistic visual sequences more consistent with our experience of the subjective present.	[Fairhall, Scott L.; Albi, Angela; Melcher, David] Univ Trento, Ctr Mind Brain Sci, Trento, Italy	University of Trento	Fairhall, SL (corresponding author), Univ Trento, Ctr Mind Brain Sci, Trento, Italy.	Scott.fairhall@unitn.it	Fairhall, Scott/AAT-9126-2021; Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X	European Research Council under the European Union/ERC [313658]	European Research Council under the European Union/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 313658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058149; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; ELBERT T, 1991, PSYCHOPHYSIOLOGY, V28, P648, DOI 10.1111/j.1469-8986.1991.tb01009.x; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Howell DC., 2012, STAT METHODS PSYCHOL; Kagerer FA, 2002, NEUROPSYCHOLOGIA, V40, P357, DOI 10.1016/S0028-3932(01)00111-7; Kiss M, 2008, ACTA NEUROBIOL EXP, V68, P204; Kolers P. A., 1972, ASPECTS MOTION PERCE; Kortum P, 2010, HUM FACTORS, V52, P105, DOI 10.1177/0018720810366020; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; MacDorman K. F., 2006, SUBJECTIVE RATINGS R, P25; Mach E., 1965, MACH BANDS QUANTITAT, P253; MATES J, 1994, J COGNITIVE NEUROSCI, V6, P332, DOI 10.1162/jocn.1994.6.4.332; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Messaris P., 1994, VISUAL LITERACY IMAG; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Occelli V, 2011, PSYCHON B REV, V18, P429, DOI 10.3758/s13423-011-0070-4; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Poppel E, 2009, PHILOS T R SOC B, V364, P1887, DOI 10.1098/rstb.2009.0015; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Salt Barry, 1983, FILM STYLE TECHNOLOG; SCHLEIDT M, 1987, NATURWISSENSCHAFTEN, V74, P289, DOI 10.1007/BF00366417; Vandenbroucke ARE, 2011, NEUROPSYCHOLOGIA, V49, P1559, DOI 10.1016/j.neuropsychologia.2010.12.044; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; VOLLRATH M, 1992, NATURWISSENSCHAFTEN, V79, P479, DOI 10.1007/BF01139205; Wang HX, 2012, J VISION, V12, DOI [10.1167/12.1.16, 10.1167/12.6.26]; Wertheimer Max, 1912, EXPT STUDIEN SEHEN B; Wutz A, 2014, J NEUROSCI, V34, P1554, DOI 10.1523/JNEUROSCI.3187-13.2014; Wutz A, 2013, ATTEN PERCEPT PSYCHO, V75, P921, DOI 10.3758/s13414-013-0454-9; Zacks Jeffrey M., 2011, ART SENSES, P435	35	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102248	10.1371/journal.pone.0102248	http://dx.doi.org/10.1371/journal.pone.0102248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010517	Green Published, gold			2022-12-27	WOS:000338763800085
J	Garijo, R; Hernandez-Alonso, P; Rivas, C; Diallo, JS; Sanjuan, R				Garijo, Raquel; Hernandez-Alonso, Pablo; Rivas, Carmen; Diallo, Jean-Simon; Sanjuan, Rafael			Experimental Evolution of an Oncolytic Vesicular Stomatitis Virus with Increased Selectivity for p53-Deficient Cells	PLOS ONE			English	Article							RNA VIRUS; INNATE IMMUNITY; INFECTED-CELLS; BREAST-CANCER; LEADER RNA; HOST; ADAPTATION; VIROTHERAPY; P53; GLYCOPROTEIN	Experimental evolution has been used for various biotechnological applications including protein and microbial cell engineering, but less commonly in the field of oncolytic virotherapy. Here, we sought to adapt a rapidly evolving RNA virus to cells deficient for the tumor suppressor gene p53, a hallmark of cancer cells. To achieve this goal, we established four independent evolution lines of the vesicular stomatitis virus (VSV) in p53-knockout mouse embryonic fibroblasts (p53-/- MEFs) under conditions favoring the action of natural selection. We found that some evolved viruses showed increased fitness and cytotoxicity in p53-/- cells but not in isogenic p53+/+ cells, indicating gene-specific adaptation. However, full-length sequencing revealed no obvious or previously described genetic changes associated with oncolytic activity. Half-maximal effective dose (EC50) assays in mouse p53-positive colon cancer (CT26) and p53-deficient breast cancer (4T1) cells indicated that the evolved viruses were more effective against 4T1 cells than the parental virus or a reference oncolytic VSV (M Delta 51), but showed no increased efficacy against CT26 cells. In vivo assays using 4T1 syngeneic tumor models showed that one of the evolved lines significantly delayed tumor growth compared to mice treated with the parental virus or untreated controls, and was able to induce transient tumor suppression. Our results show that RNA viruses can be specifically adapted typical cancer features such as p53 inactivation, and illustrate the usefulness of experimental evolution for oncolytic virotherapy.	[Garijo, Raquel; Hernandez-Alonso, Pablo; Sanjuan, Rafael] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Garijo, Raquel; Diallo, Jean-Simon] Ottawa Hosp Res Inst, Ctr Innovat Canc Res, Ottawa, ON, Canada; [Rivas, Carmen] Ctr Nacl Biotecnol, Dept Biol Mol & Celular, Madrid, Spain; [Rivas, Carmen] Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Santiago De Compostela, Spain; [Rivas, Carmen] Univ Santiago de Compostela, IDIS, Santiago De Compostela, Spain; [Sanjuan, Rafael] Univ Valencia, Dept Genet, Valencia, Spain	University of Valencia; University of Ottawa; Ottawa Hospital Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Valencia	Sanjuan, R (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain.	rafael.sanjuan@uv.es	Sanjuan, Rafael/A-4248-2015; Rivas, Carmen/AAB-6278-2019; Hernandez-Alonso, Pablo/Q-1090-2018; Rivas, Carmen/L-3162-2017; Diallo, Jean-Simon/G-4465-2017	Rivas, Carmen/0000-0002-0518-7199; Hernandez-Alonso, Pablo/0000-0002-9977-8976; Rivas, Carmen/0000-0002-0518-7199; Diallo, Jean-Simon/0000-0002-4862-2795; Sanjuan, Rafael/0000-0002-1844-545X	Spanish Ministerio de Economia y Competitividad [BFU2011-25271]; European Research Council [ERC-2011-StG- 281191-VIRMUT]; Terry Fox Research Institute [201201TFF-271514-TFF-AYDP-29782]; Lotte & John Hecht Memorial Foundation Innovation of the Canadian Cancer Society [2012-701460]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Terry Fox Research Institute; Lotte & John Hecht Memorial Foundation Innovation of the Canadian Cancer Society	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (www.mineco.es; BFU2011-25271) and the European Research Council (erc.europa.eu; ERC-2011-StG- 281191-VIRMUT) to R. S., and from the Terry Fox Research Institute (www.tfri.ca; 201201TFF-271514-TFF-AYDP-29782) and The Lotte & John Hecht Memorial Foundation Innovation of the Canadian Cancer Society (www.msfhr.org; 2012-701460) to J-S.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, INFECT GENET EVOL, V8, P806, DOI 10.1016/j.meegid.2008.07.010; Alemany R, 2013, CLIN TRANSL ONCOL, V15, P182, DOI 10.1007/s12094-012-0951-7; Belshaw R, 2008, TRENDS ECOL EVOL, V23, P188, DOI 10.1016/j.tree.2007.11.010; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Bull JJ, 2001, ANNU REV ECOL SYST, V32, P183, DOI 10.1146/annurev.ecolsys.32.081501.114020; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cuevas JM, 2009, J EVOLUTION BIOL, V22, P2041, DOI 10.1111/j.1420-9101.2009.01817.x; Cuevas JM, 2002, GENETICS, V162, P533; DaPoian AT, 1996, P NATL ACAD SCI USA, V93, P8268, DOI 10.1073/pnas.93.16.8268; Diallo JS, 2010, MOL THER, V18, P1123, DOI 10.1038/mt.2010.67; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Ebert O, 2005, CANCER GENE THER, V12, P350, DOI 10.1038/sj.cgt.7700794; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Faul EJ, 2009, VIRUSES-BASEL, V1, P832, DOI 10.3390/v1030832; Furio V, 2012, J VIROL, V86, P12228, DOI 10.1128/JVI.00755-12; Gao YH, 2006, J VIROL, V80, P8603, DOI 10.1128/JVI.00142-06; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; GRINNELL BW, 1983, J VIROL, V48, P88, DOI 10.1128/JVI.48.1.88-101.1983; Hastie E, 2012, J GEN VIROL, V93, P2529, DOI 10.1099/vir.0.046672-0; Heiber JF, 2011, J VIROL, V85, P10440, DOI 10.1128/JVI.05408-11; Hunt KK, 2007, GENE THERAPY CANC; Janelle V, 2011, J VIROL, V85, P6513, DOI 10.1128/JVI.02484-10; Jha BK, 2013, MOL THER, V21, P1749, DOI 10.1038/mt.2013.112; Kuhn I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002409; KURILLA MG, 1982, P NATL ACAD SCI-BIOL, V79, P5240, DOI 10.1073/pnas.79.17.5240; Le Boeuf F, 2010, MOL THER, V18, P888, DOI 10.1038/mt.2010.44; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Marcos-Villar L, 2013, CELL CYCLE, V12, P2809, DOI 10.4161/cc.25868; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Novella IS, 2004, J MOL BIOL, V342, P1415, DOI 10.1016/j.jmb.2004.08.003; Oldstone MBA, 2010, VIRUS PLAGUES HIST; Pagan I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000786; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Rainwater-Lovett K, 2007, J GEN VIROL, V88, P2042, DOI 10.1099/vir.0.82644-0; Remold SK, 2008, MOL BIOL EVOL, V25, P1138, DOI 10.1093/molbev/msn059; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Simon D., 2013, EVOLUTIONARY OPTIMIZ; Socha RD, 2013, FEBS J, V280, P5582, DOI 10.1111/febs.12354; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Turner PE, 2000, GENETICS, V156, P1465; Uil TG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1258; Walker JD, 2011, J VIROL, V85, P7363, DOI 10.1128/JVI.00098-11; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; Wollmann G, 2005, J VIROL, V79, P6005, DOI 10.1128/JVI.79.10.6005-6022.2005; Wollmann G, 2013, J VIROL, V87, P6644, DOI 10.1128/JVI.03311-12; Wu L, 2008, HUM GENE THER, V19, P635, DOI 10.1089/hum.2007.163; Yan W, 2003, J VIROL, V77, P2640, DOI 10.1128/JVI.77.4.2640-2650.2003; Zhang Z, 2012, CANCER GENE THER, V19, P630, DOI 10.1038/cgt.2012.41	57	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102365	10.1371/journal.pone.0102365	http://dx.doi.org/10.1371/journal.pone.0102365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010337	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800094
J	Palmyre, A; Lee, J; Ryklin, G; Camarata, T; Selig, MK; Duchemin, AL; Nowak, P; Arnaout, MA; Drummond, IA; Vasilyev, A				Palmyre, Aurelien; Lee, Jeongeun; Ryklin, Gennadiy; Camarata, Troy; Selig, Martin K.; Duchemin, Anne-Laure; Nowak, Paul; Arnaout, M. Amin; Drummond, Iain A.; Vasilyev, Aleksandr			Collective Epithelial Migration Drives Kidney Repair after Acute Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CELL-MIGRATION; ZEBRAFISH; MORPHOGENESIS; REGENERATION; GENES	Acute kidney injury (AKI) is a common and significant medical problem. Despite the kidney's remarkable regenerative capacity, the mortality rate for the AKI patients is high. Thus, there remains a need to better understand the cellular mechanisms of nephron repair in order to develop new strategies that would enhance the intrinsic ability of kidney tissue to regenerate. Here, using a novel, laser ablation-based, zebrafish model of AKI, we show that collective migration of kidney epithelial cells is a primary early response to acute injury. We also show that cell proliferation is a late response of regenerating kidney epithelia that follows cell migration during kidney repair. We propose a computational model that predicts this temporal relationship and suggests that cell stretch is a mechanical link between migration and proliferation, and present experimental evidence in support of this hypothesis. Overall, this study advances our understanding of kidney repair mechanisms by highlighting a primary role for collective cell migration, laying a foundation for new approaches to treatment of AKI.	[Palmyre, Aurelien; Lee, Jeongeun; Camarata, Troy; Duchemin, Anne-Laure; Arnaout, M. Amin; Drummond, Iain A.; Vasilyev, Aleksandr] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Selig, Martin K.; Vasilyev, Aleksandr] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lee, Jeongeun; Ryklin, Gennadiy; Nowak, Paul; Vasilyev, Aleksandr] NYIT COM, Dept Biomed Sci, Old Westbury, NY USA; [Arnaout, M. Amin] Harvard Univ, Sch Med, Dept Dev & Regenerat Biol, Boston, MA USA; [Drummond, Iain A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; New York Institute Technology; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vasilyev, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.	avasilye@nyit.edu		Palmyre, Aurelien/0000-0002-5470-4367; Duchemin, Anne-Laure/0000-0002-2897-0821; Camarata, Troy/0000-0002-7628-2716	HSCI Pilot Grant [K08DK082782, R03DK097443];  [DK053093];  [DK071041];  [DK070263];  [DK088327];  [DK48549];  [DK007540]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071041, T32DK007540, R01DK070263, R03DK097443, K08DK082782, R01DK048549, R01DK053093, R01DK088327] Funding Source: NIH RePORTER	HSCI Pilot Grant; ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	K08DK082782, R03DK097443, HSCI Pilot Grant (A. V.); DK053093, DK071041, DK070263 (I. A. D.), and DK088327, DK48549 and DK007540 (M. A. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Blanco MT, 2012, J CELL SCI, V125, P5984, DOI 10.1242/jcs.109066; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Cosentino C. C., 2010, J VIS EXP; Cosentino CC, 2013, J AM SOC NEPHROL, V24, P943, DOI 10.1681/ASN.2012111055; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Esson ML, 2002, ANN INTERN MED, V137, P744, DOI 10.7326/0003-4819-137-9-200211050-00010; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Hellman NE, 2010, P NATL ACAD SCI USA, V107, P18499, DOI 10.1073/pnas.1005998107; Hentschel DM, 2005, AM J PHYSIOL-RENAL, V288, pF923, DOI 10.1152/ajprenal.00386.2004; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Johnson CS, 2011, JOVE-J VIS EXP, DOI 10.3791/2845; Korzh V, 2011, ZEBRAFISH, V8, P23, DOI 10.1089/zeb.2011.0689; Lameire N, 2008, LANCET, V372, P1863, DOI 10.1016/S0140-6736(08)61794-8; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rodriguez-Diaz A, 2008, HFSP J, V2, P220, DOI 10.2976/1.2955565; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Takakura A, 2009, HUM MOL GENET, V18, P2523, DOI 10.1093/hmg/ddp147; TOBACK FG, 1992, KIDNEY INT, V41, P226, DOI 10.1038/ki.1992.32; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vasilyev A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039992; Vasilyev Aleksandr, 2012, Methods Mol Biol, V886, P55, DOI 10.1007/978-1-61779-851-1_6; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Yasuda H, 2010, THER APHER DIAL, V14, P541, DOI 10.1111/j.1744-9987.2010.00826.x	35	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101304	10.1371/journal.pone.0101304	http://dx.doi.org/10.1371/journal.pone.0101304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010471	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800019
J	Liang, YY; Chen, MY; Hua, YJ; Chen, S; Zheng, LS; Cao, X; Peng, LX; Xie, P; Huang, BJ; Sun, R; Wang, L; Xiang, YQ; Guo, X; Qian, CN				Liang, Ying-Ying; Chen, Ming-Yuan; Hua, Yi-Jun; Chen, Shi; Zheng, Li-Sheng; Cao, Xue; Peng, Li-Xia; Xie, Ping; Huang, Bi-Jun; Sun, Rui; Wang, Lin; Xiang, Yan-Qun; Guo, Xiang; Qian, Chao-Nan			Downregulation of Ras Association Domain Family Member 6 (RASSF6) Underlies the Treatment Resistance of Highly Metastatic Nasopharyngeal Carcinoma Cells	PLOS ONE			English	Article							EMERGING TREATMENT OPTIONS; CANCER STEM-CELLS; TUMOR-SUPPRESSOR; BREAST-CANCER; CISPLATIN SENSITIVITY; HIPPO PATHWAY; LYMPH-NODE; APOPTOSIS; EXPRESSION; PROTEIN	Radiation and cisplatin-based chemotherapy are major treatments for nasopharyngeal carcinoma (NPC). However, a major impediment for further improving the cure rate is the development of treatment resistance with an undetermined molecular mechanism in metastatic NPC cells. Our established, highly metastatic NPC cells have been reported to be more resistant to cisplatin chemotherapy. In the present study, we found that Ras association domain family member 6 (RASSF6) was downregulated in highly metastatic cells but upregulated in low metastatic cells in comparison to their parental cell line. Ectopic-expression of RASSF6 enhanced the sensitivity of highly metastatic NPC cells to cisplatin or radiation by enhancing apoptosis. RASSF6 depletion conversely reduced treatment sensitivity by decreasing the apoptosis rate. Overexpression of RASSF6 in highly metastatic NPC cells could enhance the phosphorylation of JNK when exposed to cisplatin or radiation treatment, while knocking down RASSF6 in low metastatic NPC cells could reduce the level of phospho-JNK when exposed to the same treatments. The activation of JNK signaling by RASSF6 and its subsequent sensitivity to apoptosis in NPC cells could be inhibited by applying the JNK inhibitor SP600125. In conclusion, the downregulation of RASSF6 in highly metastatic NPC cells contributed to their treatment resistance, and over-expression of RASSF6 conferred treatment sensitivity to highly metastatic NPC cells by activating JNK signaling. RASSF6 could be a valuable molecular marker for identifying sensitive metastatic NPC tumors during cisplatin treatment or radiotherapy.	[Liang, Ying-Ying; Zheng, Li-Sheng; Cao, Xue; Peng, Li-Xia; Xie, Ping; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Ying-Ying; Zheng, Li-Sheng; Cao, Xue; Peng, Li-Xia; Xie, Ping; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Ming-Yuan; Hua, Yi-Jun; Sun, Rui; Wang, Lin; Xiang, Yan-Qun; Guo, Xiang; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Shi] Sun Yat Sen Univ, Dept Gastroesophageal Surg, Affliated Hosp 6, Gastrointestinal & Anal Hosp, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qian, CN (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	qianchn@sysucc.org.cn	Huang, Bi-Jun/GSD-2430-2022; Chen, Ming/GVU-8412-2022		National Natural Science Foundation of China [81030043, 81272340]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81030043 and No. 81272340) for these authors: Chao-Nan Qian, Li-Xia Peng, Shi Chen, Ying-Ying Liang, and Xue Cao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Akino K, 2005, GASTROENTEROLOGY, V129, P156, DOI 10.1053/j.gastro.2005.03.051; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Burger H, 2011, DRUG RESIST UPDATE, V14, P22, DOI 10.1016/j.drup.2010.12.002; Duru N, 2013, J CANC RES CLIN ONCO; El Kamar FG, 2003, ONCOLOGIST, V8, P18, DOI 10.1634/theoncologist.8-1-18; Ferrari P, 2013, BIOMED PHARMACOTHER, V67, P543, DOI 10.1016/j.biopha.2013.03.006; Furukawa T, 2000, ANTICANCER RES, V20, P3657; Gebauer G, 2000, INT J ONCOL, V16, P321; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Iwasa H, 2013, J BIOL CHEM; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kitagawa D, 2006, EMBO J, V25, P3286, DOI 10.1038/sj.emboj.7601212; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu RY, 2013, MOL CANCER THER, V12, P2157, DOI 10.1158/1535-7163.MCT-12-1190; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Ma BBY, 2008, CANCER SCI, V99, P1311, DOI 10.1111/j.1349-7006.2008.00836.x; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Moshnikova A, 2006, J BIOL CHEM, V281, P8143, DOI 10.1074/jbc.M511837200; MS Wu, 2013, MOL CANC THER; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Reu FJ, 2006, CANCER RES, V66, P2785, DOI 10.1158/0008-5472.CAN-05-2303; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Sarmiento MP, 2013, CHIN J CANC; Spratt DE, 2012, ONCOTARGETS THER, V5, P297, DOI 10.2147/OTT.S28032; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Vermorken JB, 2010, ANN ONCOL, V21, P252, DOI 10.1093/annonc/mdq453; Withanage K, 2012, J BIOCHEM, V152, P111, DOI 10.1093/jb/mvs056; Zhang Linjie, 2002, Zhonghua Zhongliu Zazhi, V24, P430; Zhang L, 2013, DRUG DES DEV THER, V7, P37, DOI 10.2147/DDDT.S30753	37	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100843	10.1371/journal.pone.0100843	http://dx.doi.org/10.1371/journal.pone.0100843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028967	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600009
J	Michalowska, M; Winiarczyk, S; Adaszek, L; Lopuszynski, W; Gradzki, Z; Salmons, B; Gunzburg, WH				Michalowska, Monika; Winiarczyk, Stanislaw; Adaszek, Lukasz; Lopuszynski, Wojciech; Gradzki, Zbigniew; Salmons, Brian; Guenzburg, Walter H.			Phase I/II Clinical Trial of Encapsulated, Cytochrome P450 Expressing Cells as Local Activators of Cyclophosphamide to Treat Spontaneous Canine Tumours	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR EXPRESSION; MAMMARY-TUMORS; PANCREATIC-CARCINOMA; IFOSFAMIDE; CHEMOTHERAPY; RECURRENCE; INJECTION; ESTROGEN; PROTOCOL; THERAPY	Based upon promising preclinical studies, a clinical trial was performed in which encapsulated cells overexpressing cytochrome P450 enzyme isoform 2B1 were implanted around malignant mammary tumours arising spontaneously in dogs. The dogs were then given cyclophosphamide, one of the standard chemotherapeutic agents used for the treatment of mammary tumours. The dogs were assessed for a number of clinical parameters as well as for reduction in tumour size. The treatment was well tolerated with no evidence of adverse reactions or side effects being associated with the administration of the encapsulated cells. Reductions in tumour size of more than 50% were observed for 6 out of the 11 tumours analysed while 5 tumours showing minor responses, i.e. stable disease. In contrast, the tumours that received cyclophosphamide alone showed only stable disease. Taken together, this data suggests that encapsulated cytochrome P450 expressing cells combined with chemotherapy may be useful in the local treatment of a number of dog mammary tumours and support the performance of further clinical studies to evaluate this new treatment.	[Michalowska, Monika; Winiarczyk, Stanislaw; Adaszek, Lukasz; Gradzki, Zbigniew] Univ Life Sci, Fac Vet Med, Dept Epizootiol & Clin Infect Dis, Lublin, Poland; [Lopuszynski, Wojciech] Univ Life Sci, Fac Vet Med, Dept Pathol Anat, Lublin, Poland; [Salmons, Brian] Austrianova, Centros, Singapore; [Guenzburg, Walter H.] Univ Vet Med, Inst Virol, Dept Pathobiol, Vienna, Austria	University of Veterinary Medicine Vienna	Adaszek, L (corresponding author), Univ Life Sci, Fac Vet Med, Dept Epizootiol & Clin Infect Dis, Lublin, Poland.	ukaszek0@wp.pl	Salmons, Brian/E-3001-2010; Gunzburg, Walter/ABI-6076-2020; Grądzki, Zbigniew/R-6589-2018	Salmons, Brian/0000-0002-9490-9447; Gunzburg, Walter/0000-0001-8907-1021; Grądzki, Zbigniew/0000-0002-5390-3225; Adaszek, Lukasz/0000-0003-0261-2695; Lopuszynski, Wojciech/0000-0002-9875-5449				Alenza MDP, 2001, J AM VET MED ASSOC, V219, P1110, DOI 10.2460/javma.2001.219.1110; Armeanu S, 2001, J MICROENCAPSUL, V18, P491; BRODEY RS, 1983, J AM ANIM HOSP ASSOC, V19, P61; Cassali GD, 2007, CYTOPATHOLOGY, V18, P191, DOI 10.1111/j.1365-2303.2007.00412.x; Chen L, 1996, CANCER RES, V56, P1331; Dautzenberg H, 1999, ANN NY ACAD SCI, V875, P46, DOI 10.1111/j.1749-6632.1999.tb08493.x; de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200; DONNAY I, 1995, AM J VET RES, V56, P1188; Elmslie RE, 2008, J VET INTERN MED, V22, P1373, DOI 10.1111/j.1939-1676.2008.0179.x; Gordon A, 1997, Clin Oncol (R Coll Radiol), V9, P338, DOI 10.1016/S0936-6555(05)80069-X; Gunzburg WH, 1999, ANN NY ACAD SCI, V880, P326, DOI 10.1111/j.1749-6632.1999.tb09536.x; Kammertoens T, 2000, CANCER GENE THER, V7, P629, DOI 10.1038/sj.cgt.7700139; Karayannopoulou M, 2001, J VET MED A, V48, P85, DOI 10.1046/j.1439-0442.2001.00336.x; Karle P, 2001, CANCER GENE THER, V8, P220, DOI 10.1038/sj.cgt.7700290; Karle P, 1998, ADV EXP MED BIOL, V451, P97; Kroger JC, 2003, PANCREATOLOGY, V3, P55, DOI 10.1159/000069147; Lohr M, 2005, NEOPLASIA, V7, P17, DOI 10.1593/neo.04445; Lohr M, 2002, CANCER CHEMOTH PHARM, V49, pS21, DOI 10.1007/s00280-002-0448-0; Lohr M, 1998, GENE THER, V5, P1070, DOI 10.1038/sj.gt.3300671; Lohr M, 2001, LANCET, V357, P1591, DOI 10.1016/S0140-6736(00)04749-8; Lohr M, 1999, J MOL MED, V77, P393, DOI 10.1007/s001090050366; Loscher W, 1994, GRUNDLAGEN PHARMAKOT, P398; Marconato L, 2008, VET COMP ONCOL, V6, P90, DOI 10.1111/j.1476-5829.2007.00143.x; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Misdorp W, 1999, WHO INT HISTOLOGICAL, P18; Munson Linda, 2007, Breast Dis, V28, P7; NEMOTO K, 1994, BRIT J HAEMATOL, V87, P572, DOI 10.1111/j.1365-2141.1994.tb08314.x; Novosad CA, 2003, CLIN TECH SMALL AN P, V18, P107, DOI 10.1053/svms.2003.36625; OWEN LN, 1979, INVEST CELL PATHOL, V2, P257; Pelegrin M, 2000, HUM GENE THER, V11, P1407, DOI 10.1089/10430340050057486; Pelegrin M, 1998, HUM GENE THER, V9, P2165, DOI 10.1089/hum.1998.9.15-2165; Saller RM, 2002, J GENE MED, V4, P150, DOI 10.1002/jgm.257; Salmons B, 2003, J GASTROENTEROL, V38, P78; Salmons B, 2010, ADV EXP MED BIOL, V670, P92; Sorenmo K, 2003, VET CLIN N AM-SMALL, V33, P573, DOI 10.1016/S0195-5616(03)00020-2; STANGE J, 1993, BIOMAT ARTIF CELL IM, V21, P343, DOI 10.3109/10731199309117372; Stratmann N, 2008, VET SURG, V37, P82, DOI 10.1111/j.1532-950X.2007.00351.x; UCKERT W, 2003, METH MOLEC MED, V90, P345; Winiarczyk S, 2002, J MOL MED-JMM, V80, P610, DOI 10.1007/s00109-002-0356-0; Zenker I, 2010, VET REC, V167, P744, DOI 10.1136/vr.c5081	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102061	10.1371/journal.pone.0102061	http://dx.doi.org/10.1371/journal.pone.0102061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028963	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600033
J	Suari, Y; Brenner, S				Suari, Yair; Brenner, Steve			RGB Plots as a Tool for the Simultaneous Visualization of Multiple Data Layers in a Two Dimensional Space	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; MEDITERRANEAN-SEA; RATIO	Visualization of multidimensional data helps in understanding complex systems and environments. We present here a red, green, blue (RGB) visualization method that can serve to display environmental properties. The saturation of each color is used to represent the concentration of a given property. The implementation of that figure is illustrated through visualization of three dissolved inorganic nutrient concentrations along a vertical transect of the Mediterranean, as well as through a vertical time series of three phytoplankton group cell numbers. The RGB figures show well known properties of the water column. In addition, they reveal some lesser-known properties, such as regions in shallow water in which the ratio of phosphorus and silica to nitrogen is high, and a deep eukariotic phytoplankton community. Visualization of such data is usually performed with three separate contour or surface plots, and occasionally two properties are presented as an overlay in a single figure. The RGB figure offers a better way to visualize the interactions among the three separate plots than is commonly available.	[Suari, Yair; Brenner, Steve] Bar Ilan Univ, Dept Geog & Environm, Ramat Gan, Israel	Bar Ilan University	Suari, Y (corresponding author), Ruppin Acad Ctr, Sch Marine Sci & Marine Environm, Michmoret, Israel.	yairsuari@gmail.com		Suari, Yair/0000-0002-7632-2423	European Commission through the Sixth Framework Program European Coastal Sea Operational Observing and Forecasting System (ECOOP) [36355]	European Commission through the Sixth Framework Program European Coastal Sea Operational Observing and Forecasting System (ECOOP)	This research was supported by the European Commission through the Sixth Framework Program European Coastal Sea Operational Observing and Forecasting System (ECOOP) Contract Number 36355. The sampling cruises were supported by Andreas Weill and Eco-Ocean Association of Herzlyia, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; AZOV Y, 1991, MAR POLLUT BULL, V23, P225, DOI 10.1016/0025-326X(91)90679-M; Bouman HA, 2011, ENV MICROBIOL REP, V3, P473, DOI 10.1111/j.1758-2229.2011.00241.x; Brown M, 2002, VLIZ SPECIAL PUBLICA, P10; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Kaye NR, 2012, GEOSCI MODEL DEV, V5, P245, DOI 10.5194/gmd-5-245-2012; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Kurzweil R, 2004, ALAN TURING: LIFE AND LEGACY OF A GREAT THINKER, P381; Marie D, 1999, APPL ENV MICROBIOL; MATLAB, 2012, MATLAB; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Pahlow M, 2005, MAR ECOL PROG SER, V287, P33, DOI 10.3354/meps287033; Redfield A. C., 1934, PROPORTIONS ORGANIC, P176; Roederer M, 2008, CYTOM A; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Saadatinejad MR, 2011, J GEOPHYS ENG, V8, P412, DOI 10.1088/1742-2132/8/3/002; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Smol J.P., 2010, DIATOMS APPL ENV EAR; Sommer U, 2002, HYDROBIOLOGIA, V484, P11, DOI 10.1023/A:1021340601986; The free encyclopedia, 2014, RGB COL MOD; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102903	10.1371/journal.pone.0102903	http://dx.doi.org/10.1371/journal.pone.0102903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028934	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600104
J	Sustr, V; Chronakova, A; Semanova, S; Tajovsky, K; Simek, M				Sustr, Vladimir; Chronakova, Alica; Semanova, Stanislava; Tajovsky, Karel; Simek, Miloslav			Methane Production and Methanogenic Archaea in the Digestive Tracts of Millipedes (Diplopoda)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; SYMBIOTIC METHANOGENS; ECOLOGICAL DIVERSITY; SOIL; COMMUNITY; BACTERIA; GUT; ENVIRONMENTS; PHYLOGENY	Methane production by intestinal methanogenic Archaea and their community structure were compared among phylogenetic lineages of millipedes. Tropical and temperate millipedes of 35 species and 17 families were investigated. Species that emitted methane were mostly in the juliform orders Julida, Spirobolida, and Spirostreptida. The irregular phylogenetic distribution of methane production correlated with the presence of the methanogen-specific mcrA gene. The study brings the first detailed survey of methanogens' diversity in the digestive tract of millipedes. Sequences related to Methanosarcinales, Methanobacteriales, Methanomicrobiales and some unclassified Archaea were detected using molecular profiling (DGGE). The differences in substrate preferences of the main lineages of methanogenic Archaea found in different millipede orders indicate that the composition of methanogen communities may reflect the differences in available substrates for methanogenesis or the presence of symbiotic protozoa in the digestive tract. We conclude that differences in methane production in the millipede gut reflect differences in the activity and proliferation of intestinal methanogens rather than an absolute inability of some millipede taxa to host methanogens. This inference was supported by the general presence of methanogenic activity in millipede faecal pellets and the presence of the 16S rRNA gene of methanogens in all tested taxa in the two main groups of millipedes, the Helminthophora and the Pentazonia.	[Sustr, Vladimir; Chronakova, Alica; Semanova, Stanislava; Tajovsky, Karel; Simek, Miloslav] Biol Ctr AS CR, Inst Soil Biol, Vvi, Ceske Budejovice, Czech Republic; [Semanova, Stanislava; Simek, Miloslav] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Sustr, V (corresponding author), Biol Ctr AS CR, Inst Soil Biol, Vvi, Ceske Budejovice, Czech Republic.	sustr@upb.cas.cz	Šimek, Miloslav/G-1532-2014; Tajovsky, Karel/G-2815-2014; Šustr, Vladimír/G-1495-2014; Chronakova, Alica/G-1422-2014; Chroňáková, Alica/AAS-1476-2020	Chronakova, Alica/0000-0002-3316-6862; Chroňáková, Alica/0000-0002-3316-6862	Czech Science Foundation [526/09/1570]	Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by the Czech Science Foundation (Spots of methane production and consumption in terrestrial ecosystems: key for understanding methane turmover, No 526/09/1570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Website of the Czech Science Foundation: http://www.gacr.cz/.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; BIGNELL DE, 1984, J INSECT PHYSIOL, V30, P169, DOI 10.1016/0022-1910(84)90122-7; Bijnen FGC, 1996, APPL OPTICS, V35, P5357, DOI 10.1364/AO.35.005357; BREZNAK JA, 1982, ANNU REV MICROBIOL, V36, P323, DOI 10.1146/annurev.mi.36.100182.001543; Brune A, 2010, MICROBIOL MONOGR, V19, P81, DOI 10.1007/978-3-642-13615-3_6; Byzov BA, 2006, SOIL BIOL, P89; CRUDEN DL, 1987, ANNU REV MICROBIOL, V41, P617, DOI 10.1146/annurev.mi.41.100187.003153; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; Dighe AS, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-20; Dlugokencky EJ, 2011, PHILOS T R SOC A, V369, P2058, DOI 10.1098/rsta.2010.0341; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; EHHALT DH, 1974, TELLUS, V26, P58, DOI 10.1111/j.2153-3490.1974.tb01952.x; Embley TM, 1998, NATURE, V396, P517, DOI 10.1038/24994; Enghoff Henrik, 1992, Berichte des Naturwissenschaftlich-Medizinischen Vereins in Innsbruck Supplementum, V10, P47; Environmental Protection Agency (EPA United States), 2010, 430R10001 EPA; FERRY JG, 1992, CRIT REV BIOCHEM MOL, V27, P473, DOI 10.3109/10409239209082570; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; GIJZEN HJ, 1991, APPL ENVIRON MICROB, V57, P1630, DOI 10.1128/AEM.57.6.1630-1634.1991; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HACKSTEIN JHP, 1994, P NATL ACAD SCI USA, V91, P5441, DOI 10.1073/pnas.91.12.5441; Hackstein JHP, 2010, MICROBIOL MONOGR, V19, P13, DOI 10.1007/978-3-642-13615-3_2; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hara Kurt, 2002, Microbes and Environments, V17, P185, DOI 10.1264/jsme2.17.185; HOFFMAN RL, 1969, ECOLOGY, V50, P1096, DOI 10.2307/1936905; Hopkin P.S., 1992, BIOL MILLIPEDES; Jamali H, 2011, AGR FOREST METEOROL, V151, P1471, DOI 10.1016/j.agrformet.2010.06.009; Kim SY, 2008, SOIL BIOL BIOCHEM, V40, P2874, DOI 10.1016/j.soilbio.2008.08.004; Knapp BA, 2009, PEDOBIOLOGIA, V52, P325, DOI 10.1016/j.pedobi.2008.11.005; Koubova A, 2012, EUR J SOIL BIOL, V48, P32, DOI 10.1016/j.ejsobi.2011.09.007; Kusar D, 2010, FEMS MICROBIOL ECOL, V74, P623, DOI 10.1111/j.1574-6941.2010.00980.x; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Makkar H.P.S., 2007, MEASURING METHANE PR; MAYER HP, 1990, FEMS MICROBIOL ECOL, V73, P103; Mikhajlova EV, 2004, GOLOVATCH PENSOFT SE; Morozova D, 2007, ORIGINS LIFE EVOL B, V37, P189, DOI 10.1007/s11084-006-9024-7; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; Mwabvu T, 2010, ZOOTAXA, P1; Ohkuma M, 1999, FEMS MICROBIOL LETT, V171, P147, DOI 10.1111/j.1574-6968.1999.tb13425.x; OHKUMA M, 1995, FEMS MICROBIOL LETT, V134, P45, DOI 10.1111/j.1574-6968.1995.tb07912.x; Orsolya O, 2002, EUR J SOIL BIOL, V38, P67, DOI 10.1016/S1164-5563(01)01128-1; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; PETERS V, 1995, APPL ENVIRON MICROB, V61, P1673, DOI 10.1128/AEM.61.4.1673-1676.1995; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; RASMUSSEN RA, 1983, NATURE, V301, P700, DOI 10.1038/301700a0; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Rosenberg J, 1995, VERHANDLUGEN WESTDEU, P67; Sarmiento BF, 2011, METHOD ENZYMOL, V494, P43, DOI 10.1016/B978-0-12-385112-3.00003-2; SIMEK M, 1995, SOIL BIOL BIOCHEM, V27, P1227, DOI 10.1016/0038-0717(95)00037-F; Sprenger WW, 2000, INT J SYST EVOL MICR, V50, P1989, DOI 10.1099/00207713-50-6-1989; Stoev Pavel, 2008, Steenstrupia, V30, P47; Sustr V, 2009, SOIL BIOL BIOCHEM, V41, P1684, DOI 10.1016/j.soilbio.2009.05.007; Tokura M, 2000, FEMS MICROBIOL ECOL, V33, P233, DOI 10.1111/j.1574-6941.2000.tb00745.x; Tree of Life Web Project, 2002, DIPL MILL VERS 01 JA; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; Watanabe T, 2004, FEMS MICROBIOL LETT, V232, P153, DOI 10.1016/S0378-1097(04)00045-X; Wilkinson J. M., 2012, UK Vet: Livestock, V17, P33; ZINDER SH, 1985, INT J SYST BACTERIOL, V35, P522, DOI 10.1099/00207713-35-4-522	61	12	12	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102659	10.1371/journal.pone.0102659	http://dx.doi.org/10.1371/journal.pone.0102659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028969	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600089
J	Al-khattawi, A; Alyami, H; Townsend, B; Ma, XH; Mohammed, AR				Al-khattawi, Ali; Alyami, Hamad; Townsend, Bill; Ma, Xianghong; Mohammed, Afzal R.			Evidence-Based Nanoscopic and Molecular Framework for Excipient Functionality in Compressed Orally Disintegrating Tablets	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; MICROCRYSTALLINE CELLULOSE; PARTICLE-SIZE; SOLID-STATE; COMPACTION PROPERTIES; PUNCH VELOCITY; CRYSTAL HABIT; THEOPHYLLINE; ADHESION; BEHAVIOR	The work investigates the adhesive/cohesive molecular and physical interactions together with nanoscopic features of commonly used orally disintegrating tablet (ODT) excipients microcrystalline cellulose (MCC) and D-mannitol. This helps to elucidate the underlying physico-chemical and mechanical mechanisms responsible for powder densification and optimum product functionality. Atomic force microscopy (AFM) contact mode analysis was performed to measure nano-adhesion forces and surface energies between excipient-drug particles (6-10 different particles per each pair). Moreover, surface topography images (100 nm(2)-10 mu m(2)) and roughness data were acquired from AFM tapping mode. AFM data were related to ODT macro/microscopic properties obtained from SEM, FTIR, XRD, thermal analysis using DSC and TGA, disintegration testing, Heckel and tabletability profiles. The study results showed a good association between the adhesive molecular and physical forces of paired particles and the resultant densification mechanisms responsible for mechanical strength of tablets. MCC micro roughness was 3 times that of D-mannitol which explains the high hardness of MCC ODTs due to mechanical interlocking. Hydrogen bonding between MCC particles could not be established from both AFM and FTIR solid state investigation. On the contrary, D-mannitol produced fragile ODTs due to fragmentation of surface crystallites during compression attained from its weak crystal structure. Furthermore, AFM analysis has shown the presence of extensive micro fibril structures inhabiting nano pores which further supports the use of MCC as a disintegrant. Overall, excipients (and model drugs) showed mechanistic behaviour on the nano/micro scale that could be related to the functionality of materials on the macro scale.	[Al-khattawi, Ali; Alyami, Hamad; Mohammed, Afzal R.] Aston Univ, Aston Sch Pharm, Birmingham B4 7ET, W Midlands, England; [Townsend, Bill; Ma, Xianghong] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England; [Al-khattawi, Ali; Townsend, Bill; Ma, Xianghong; Mohammed, Afzal R.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England	Aston University; Aston University; Aston University	Mohammed, AR (corresponding author), Aston Univ, Aston Sch Pharm, Birmingham B4 7ET, W Midlands, England.	a.u.r.mohammed@aston.ac.uk		Ma, Xianghong/0000-0003-4957-2942; Al-khattawi, Ali/0000-0002-2498-2817; Mohammed, Afzal-Ur-Rahman/0000-0002-5212-3040; Alyami, Hamad/0000-0003-3513-4976	Aston University through a Post graduate overseas bursary awarded	Aston University through a Post graduate overseas bursary awarded	The work was funded by Aston University through a Post graduate overseas bursary awarded to Ali Al-Khattawi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson A, 1999, DRUG DEV IND PHARM, V25, P753, DOI 10.1081/DDC-100102235; Al-Khattawi A, 2014, CURR DRUG DELIV, V11, P486, DOI 10.2174/1567201811666140323201650; Al-khattawi A, 2013, EXPERT OPIN DRUG DEL, V10, P651, DOI 10.1517/17425247.2013.769955; ALDERBORN G, 1988, ACTA PHARM SUEC, V25, P31; ALDERBORN G, 2008, PHARM POWDER COMPACT, V1; AMIDON GE, 1995, PHARMACEUT RES, V12, P923, DOI 10.1023/A:1016233725612; Burger A, 2000, J PHARM SCI-US, V89, P457, DOI 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO;2-G; Busignies V, 2006, EUR J PHARM BIOPHARM, V64, P66, DOI 10.1016/j.ejpb.2006.03.004; BUTT HJ, 1991, BIOPHYS J, V60, P1438, DOI 10.1016/S0006-3495(91)82180-4; Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176; Chattoraj S, 2010, CRYSTENGCOMM, V12, P2466, DOI 10.1039/c000614a; Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005; Convention USP, 2005, DISINTEGRATION, V701; Davies MJ, 2011, INT J PHARMACEUT, V421, P1, DOI 10.1016/j.ijpharm.2011.09.004; Di Martino P, 2002, J CRYST GROWTH, V243, P345, DOI 10.1016/S0022-0248(02)01523-3; Eve JK, 2002, INT J PHARMACEUT, V238, P17, DOI 10.1016/S0378-5173(02)00055-8; Fox CD, 1963, DRUG COSMET IND, V92, P161; Garekani HA, 2001, DRUG DEV IND PHARM, V27, P803, DOI 10.1081/DDC-100107243; Gohel MC., 2007, AAPS PHARMSCITECH, V8, pE94, DOI [10.1208/pt0801013, DOI 10.1208/PT0801013]; Gonnissen Y, 2007, EUR J PHARM BIOPHARM, V67, P220, DOI 10.1016/j.ejpb.2006.12.021; Grierson DS, 2005, J ADHES SCI TECHNOL, V19, P291, DOI 10.1163/1568561054352685; Hancock BC, 1997, J PHARM SCI, V86, P1, DOI 10.1021/js9601896; HECKEL RW, 1961, T METALL SOC AIME, V221, P671; Herting MG, 2007, INT J PHARM, V338, P110, DOI 10.1016/j.ijpharm.2007.01.035; Hinterstoisser B, 2003, BIOMACROMOLECULES, V4, P1232, DOI 10.1021/bm030017k; HUTTENRA.R, 1971, PHARMAZIE, V26, P645; Inghelbrecht S, 1998, INT J PHARM, V161, P215, DOI 10.1016/S0378-5173(97)00356-6; Janardhnan S, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/279610; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kaialy W, 2010, COLLOID SURFACE B, V79, P345, DOI 10.1016/j.colsurfb.2010.04.016; KAREHILL PG, 1990, INT J PHARM, V64, P35, DOI 10.1016/0378-5173(90)90176-5; KAREHILL PG, 1990, INT J PHARM, V61, P251, DOI 10.1016/0378-5173(90)90216-Q; LAM KK, 1992, POWDER TECHNOL, V73, P117, DOI 10.1016/0032-5910(92)80072-5; LIANG CY, 1959, J POLYM SCI, V37, P385, DOI 10.1002/pol.1959.1203713209; MARSHALL PV, 1993, POWDER TECHNOL, V74, P171, DOI 10.1016/0032-5910(93)87009-D; NESIC M, 1990, ACTA PHARM JUGOSL, V40, P545; Oh SY, 2005, CARBOHYD RES, V340, P2376, DOI 10.1016/j.carres.2005.08.007; Pather SI, 1998, INT J PHARM, V164, P1, DOI 10.1016/S0378-5173(97)00348-7; Picker KM, 1999, EUR J PHARM BIOPHARM, V48, P27, DOI 10.1016/S0939-6411(99)00009-0; Picker KM, 2002, J PHARM SCI-US, V91, P342, DOI 10.1002/jps.10018; Pifferi G, 1999, FARMACO, V54, P1, DOI 10.1016/S0014-827X(98)00101-3; RICHMAN MD, 1965, J PHARM SCI, V54, P447, DOI 10.1002/jps.2600540323; Roberts CJ, 2005, EUR J PHARM SCI, V24, P153, DOI 10.1016/j.ejps.2004.11.002; ROBERTS RJ, 1985, J PHARM PHARMACOL, V37, P377, DOI 10.1111/j.2042-7158.1985.tb03019.x; ROBERTS RJ, 1987, INT J PHARM, V36, P205, DOI 10.1016/0378-5173(87)90157-8; ROMERO AJ, 1993, INT J PHARMACEUT, V99, P125, DOI 10.1016/0378-5173(93)90354-I; Seton L, 2010, CRYST GROWTH DES, V10, P3879, DOI 10.1021/cg100165t; Soh JLP, 2013, PHARM DEV TECHNOL, V18, P172, DOI 10.3109/10837450.2012.685658; Sonnergaard JM, 1999, INT J PHARM, V193, P63, DOI 10.1016/S0378-5173(99)00319-1; Suihko E, 2001, INT J PHARM, V217, P225, DOI 10.1016/S0378-5173(01)00607-X; Suihko E, 1997, INT J PHARM, V158, P47, DOI 10.1016/S0378-5173(97)00239-1; SUZUKI E, 1989, CHEM PHARM BULL, V37, P493; Szczesniak L, 2008, CELLULOSE, V15, P445, DOI 10.1007/s10570-007-9192-2; van Veen B, 2000, INT J PHARM, V203, P71, DOI 10.1016/S0378-5173(00)00450-6; Whelan MR, 2002, J PHARMACEUT BIOMED, V30, P1355, DOI 10.1016/S0731-7085(02)00394-1; YORK P, 1983, INT J PHARMACEUT, V14, P1, DOI 10.1016/0378-5173(83)90111-4; Yoshinari T, 2003, INT J PHARM, V258, P121, DOI 10.1016/S0378-5173(03)00157-1; Yvonne P., 2012, DRUG DELIV LETT, V2, P195	58	10	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101369	10.1371/journal.pone.0101369	http://dx.doi.org/10.1371/journal.pone.0101369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025427	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000339992400013
J	Francis, SC; Ao, TT; Vanobberghen, FM; Chilongani, J; Hashim, R; Andreasen, A; Watson-Jones, D; Changalucha, J; Kapiga, S; Hayes, RJ				Francis, Suzanna C.; Ao, Trong T.; Vanobberghen, Fiona M.; Chilongani, Joseph; Hashim, Ramadhan; Andreasen, Aura; Watson-Jones, Deborah; Changalucha, John; Kapiga, Saidi; Hayes, Richard J.			Epidemiology of Curable Sexually Transmitted Infections among Women at Increased Risk for HIV in Northwestern Tanzania: Inadequacy of Syndromic Management	PLOS ONE			English	Article							FEMALE SEX WORKERS; CHLAMYDIA-TRACHOMATIS INFECTION; SIMPLEX-VIRUS TYPE-2; TRICHOMONAS-VAGINALIS; BACTERIAL VAGINOSIS; DISEASES; TRANSMISSION; ACQUISITION; SYPHILIS; COHORT	Background: Curable, non-viral pathogens account for a significant burden of sexually transmitted infections (STIs), and there is established evidence that STIs increase both HIV acquisition and transmission. We investigated the prevalence, trends, and factors associated with Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Treponema pallidum, and the performance of syndromic management, among a cohort of women working in bars, hotels, and other food and recreational facilities near large-scale mines in northwestern Tanzania. Methods: HIV-negative women aged 18-44 years (N = 966) were enrolled and followed for 12 months in a microbicides feasibility study. We collected sociodemographic and behavioural data, performed clinical examinations, and tested for STIs, at enrolment and 3-monthly. Risk factors for STIs were investigated using logistic regression models with random effects. Sensitivity, specificity and predictive values of syndromic management were calculated. Results: At enrolment, the prevalences of C. trachomatis, N. gonorrhoeae, T. vaginalis, and high-titre active syphilis were 111/956 (12%), 42/955 (4%), 184/945 (19%) and 46/965 (5%), respectively. There were significant decreases over time for C. trachomatis and T. vaginalis (OR trend per month: 0.94 [95% CI 0.91, 0.97]; and 0.95 [0.93, 0.98], respectively; both p < 0.001). The majority of these infections were not diagnosed by the corresponding syndrome; therefore, most participants were not treated at the diagnosis visit. Syndromic management was poorly predictive of laboratory-diagnosed infections. We identified a number of risk factors for STIs, including low educational level, some sexual behaviours, and ever having been pregnant. Conclusions: This analysis demonstrates that the prevalences of curable STIs are high among women who work in food and recreational facilities in northwestern Tanzania. Most of these infections are missed by syndromic management. Accurate and affordable rapid-point-of-care tests and innovative interventions are needed to reduce the burden of STIs in this population which is at increased risk for HIV.	[Francis, Suzanna C.; Ao, Trong T.; Vanobberghen, Fiona M.; Kapiga, Saidi; Hayes, Richard J.] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England; [Francis, Suzanna C.; Ao, Trong T.; Vanobberghen, Fiona M.; Chilongani, Joseph; Hashim, Ramadhan; Andreasen, Aura; Watson-Jones, Deborah; Kapiga, Saidi] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Chilongani, Joseph; Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania; [Andreasen, Aura; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	Francis, SC (corresponding author), Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Keppel St, London WC1E 7HT, England.	suzanna.francis@lshtm.ac.uk		Francis, Suzanna Carter/0000-0002-3724-4813; Kapiga, Saidi/0000-0003-1753-4060; Andreasen, Aura/0000-0003-0664-7342; Hayes, Richard/0000-0002-1729-9892	European and Developing Countries Clinical Trials Partnership [CT_ct_05_32070_002]; Medical Research Council (MRC); Department for International Development (DFID) [G0901756, G1002369, G0700837]; MRC [G0901756, G0700837, G0701039, G1002369] Funding Source: UKRI; Medical Research Council [G0700837, G1002369, MR/K012126/1, G0701039, G0901756] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support was provided by the European and Developing Countries Clinical Trials Partnership (project code: CT_ct_05_32070_002) and from the Medical Research Council (MRC) and Department for International Development (DFID) with S. Kapiga (G0901756), S. C. Francis (G1002369), R.J. Hayes, and F. Vanobberghen (G0700837) receiving MRC & DFID support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M., 2001, GUIDELINES MANAGEMEN; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Celum Connie L, 2010, Top HIV Med, V18, P138; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Das A, 2013, SEX TRANSM INFECT, V89, P5, DOI 10.1136/sextrans-2012-050472; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Duncan S, 2012, NEW ENGL J MED, V366, P2136, DOI 10.1056/NEJMc1203138; Duncan S, 2011, SEX TRANSM INFECT, V87, P231, DOI 10.1136/sti.2010.048777; Feldblum PJ, 2010, SEX TRANSM DIS, V37, P594, DOI 10.1097/OLQ.0b013e3181e15f0b; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Heffron R, 2011, LANCET INFECT DIS, V3099, P1; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Johnson HL, 2011, SEX TRANSM DIS, V38, P167, DOI 10.1097/OLQ.0b013e3181f2e85f; Kapiga S, 2009, SEX TRANSM DIS, V36, P199, DOI 10.1097/OLQ.0b013e318191ba01; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Lagace-Wiens PRS, 2012, SEX TRANSM DIS, V39, P332, DOI 10.1097/OLQ.0b013e318248a85f; Mahony JB, 2001, J CLIN MICROBIOL, V39, P1429, DOI 10.1128/JCM.39.4.1429-1435.2001; Masese L, 2013, SEX TRANSM DIS, V40, P221, DOI 10.1097/OLQ.0b013e318272fe45; Mavedzenge SN, 2010, SEX TRANSM DIS, V37, P460, DOI 10.1097/OLQ.0b013e3181cfcc4b; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Ministry of Health and Social Welfare, 2007, NAT GUID MAN SEX TRA; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Moodley P, 2002, CLIN INFECT DIS, V34, P519, DOI 10.1086/338399; Moodley P, 2002, J INFECT DIS, V185, P69, DOI 10.1086/338027; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nye MB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.005; Peeling RW, 2006, NAT REV MICROBIOL, V4, P909, DOI 10.1038/nrmicro1555; Pettifor A, 2009, CONTRACEPTION, V80, P555, DOI 10.1016/j.contraception.2009.06.007; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; Schmid G, 2005, PREVALENCE INCIDENCE; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; Taylor-Robinson D, 2012, INT J STD AIDS, V23, P18, DOI 10.1258/ijsa.2011.011066; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Vallely A, 2007, SEX TRANSM DIS, V34, P638, DOI 10.1097/OLQ.0b013e3180325120; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	49	34	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101221	10.1371/journal.pone.0101221	http://dx.doi.org/10.1371/journal.pone.0101221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025338	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000339992400011
J	Hu, ZQ; Yang, RC				Hu, Zhiqiu; Yang, Rong-Cai			Marker-Based Estimation of Genetic Parameters in Genomics	PLOS ONE			English	Article							WIDE ASSOCIATION; MOLECULAR MARKERS; MISSING HERITABILITY; QUANTITATIVE INHERITANCE; POPULATION-STRUCTURE; NATURAL-POPULATIONS; MIXED MODELS; HUMAN HEIGHT; PREDICTION; TRAITS	Linear mixed model (LMM) analysis has been recently used extensively for estimating additive genetic variances and narrow-sense heritability in many genomic studies. While the LMM analysis is computationally less intensive than the Bayesian algorithms, it remains infeasible for large-scale genomic data sets. In this paper, we advocate the use of a statistical procedure known as symmetric differences squared (SDS) as it may serve as a viable alternative when the LMM methods have difficulty or fail to work with large datasets. The SDS procedure is a general and computationally simple method based only on the least squares regression analysis. We carry out computer simulations and empirical analyses to compare the SDS procedure with two commonly used LMM-based procedures. Our results show that the SDS method is not as good as the LMM methods for small data sets, but it becomes progressively better and can match well with the precision of estimation by the LMM methods for data sets with large sample sizes. Its major advantage is that with larger and larger samples, it continues to work with the increasing precision of estimation while the commonly used LMM methods are no longer able to work under our current typical computing capacity. Thus, these results suggest that the SDS method can serve as a viable alternative particularly when analyzing 'big' genomic data sets.	[Hu, Zhiqiu; Yang, Rong-Cai] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Yang, Rong-Cai] Alberta Agr & Rural Dev, Edmonton, AB, Canada	University of Alberta	Yang, RC (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	rong-cai.yang@ales.ualberta.ca		Hu, Zhiqiu/0000-0001-5600-4236; Yang, Rong-Cai/0000-0002-3607-7822	Natural Sciences and Engineering Research Council of Canada [NSERC OGP0183983]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is supported in part by the Natural Sciences and Engineering Research Council of Canada (NSERC OGP0183983) to R-CY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; GRIMES LW, 1980, J ANIM SCI, V50, P632, DOI 10.2527/jas1980.504634x; Harville DA., 1998, TECHNOMETRICS, V40, P164, DOI DOI 10.1080/00401706.1998.10485214; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Henderson C. R, 1984, APPL LINEAR MODELS A; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hill WG, 2014, GENETICS, V196, P1, DOI 10.1534/genetics.112.147850; Jiang R, 2009, 2009 INTERNATIONAL JOINT CONFERENCE ON BIOINFORMATICS, SYSTEMS BIOLOGY AND INTELLIGENT COMPUTING, PROCEEDINGS, P70, DOI 10.1109/IJCBS.2009.32; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KOCH GG, 1968, TECHNOMETRICS, V10, P551, DOI 10.2307/1267108; Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01815; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Lynch M, 1999, GENETICS, V152, P1753; Lynch M., 1998, GENETICS ANAL QUANTI; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Macdonald SJ, 2005, GENETICS, V171, P1741, DOI 10.1534/genetics.105.045344; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCallum BD, 2008, CAN J PLANT SCI, V88, P649, DOI 10.4141/CJPS07159; Meuwissen THE, 2001, GENETICS, V157, P1819; Mousseau TA, 1998, HEREDITY, V80, P218, DOI 10.1046/j.1365-2540.1998.00269.x; R Core Team, 2012, R LANG ENV STAT COMP; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 2000, MOL ECOL, V9, P1195, DOI 10.1046/j.1365-294x.2000.00971.x; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stringer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068913; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Thomas SC, 2005, PHILOS T R SOC B, V360, P1457, DOI 10.1098/rstb.2005.1675; Venables WN., 2002, MODERN APPL STAT S 4; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yung LS, 2011, BIOINFORMATICS, V27, P1309, DOI 10.1093/bioinformatics/btr114; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6; Zhang YM, 2008, THEOR APPL GENET, V117, P683, DOI 10.1007/s00122-008-0809-0; Zhang YM, 2009, GENETICA, V136, P311, DOI 10.1007/s10709-008-9313-3; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	53	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102715	10.1371/journal.pone.0102715	http://dx.doi.org/10.1371/journal.pone.0102715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025305	Green Submitted, gold, Green Published			2022-12-27	WOS:000339992400101
J	Jansson, S; Bendahl, PO; Grabau, DA; Falck, AK; Ferno, M; Aaltonen, K; Ryden, L				Jansson, Sara; Bendahl, Par-Ola; Grabau, Dorthe Aamand; Falck, Anna-Karin; Ferno, Marten; Aaltonen, Kristina; Ryden, Lisa			The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFR alpha, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GLIOBLASTOMA-MULTIFORME; TISSUE MICROARRAYS; TARGETED THERAPIES; RANDOMIZED-TRIAL; FOLLOW-UP; BASAL; PHENOTYPE; AMPLIFICATION; SUNITINIB	Background: Triple-negative breast cancer (TNBC) is a heterogeneous subgroup of breast cancer with poor prognosis and no targeted therapy available. Receptor tyrosine kinases (RTKs) are emerging targets in anticancer therapy and many RTK-inhibiting drugs are currently being developed. The aim of this study was to elucidate if there is a correlation between the protein expression of three RTKs c-KIT, VEGFR2 and PDGFR alpha, their gene copy number, and prognosis in TNBC compared to non-TNBC. Methods: Tumor tissue samples from patients diagnosed with primary breast cancer were stained with immunohistochemistry (IHC) for protein assessment, and with fluorescence in situ hybridization (FISH) for gene copy number determination. Breast cancer mortality (BCM), measured from the date of surgery to death, was used as endpoint. Results: The cohort included 464 patients, out of which 34 (7.3%) had a TNBC. High expression of the three RTKs was more common in TNBC compared to non-TNBC: c-KIT 49% vs. 10% (P<0.001), PDGFR alpha 32% vs. 19% (P = 0.07) and VEGFR2 32% vs. 6% (P<0.001). The odds ratio (OR) of c-KIT, VEGFR2 and PDGFR alpha positivity, adjusted for tumor characteristics, was 6.8, 3.6 and 1.3 times higher for TNBC than for non-TNBC. 73.5% of the TNBC had high expression of at least one of the three investigated receptors, compared to 30.0% of the non-TNBC (P<0.001). Survival analysis showed no significant difference in BCM for TNBC patients with high vs. low c-KIT, PDGFR alpha or VEGFR2 protein expression. 193 (42%) tumors were evaluated with FISH. No correlation was seen between increased gene copy number and TNBC, or between increased gene copy number and high protein expression of the RTK. Conclusion: c-KIT, VEGFR2 and PDGFR alpha show higher protein expression in TNBC compared to non-TNBC. Further investigation clarifying the importance of these RTKs in TNBC is encouraged, as they are possible targets for anticancer therapy.	[Jansson, Sara; Bendahl, Par-Ola; Grabau, Dorthe Aamand; Ferno, Marten; Aaltonen, Kristina] Lund Univ, Div Oncol & Pathol, Dept Clin Sci, Lund, Sweden; [Falck, Anna-Karin] Hosp Helsingborg, Dept Surg, Helsingborg, Sweden; [Ryden, Lisa] Skane Univ Hosp, Dept Clin Sci Lund, Div Surg, Lund, Sweden	Lund University; Helsingborgs Hospital; Lund University; Skane University Hospital	Jansson, S (corresponding author), Lund Univ, Div Oncol & Pathol, Dept Clin Sci, Lund, Sweden.	sara.jansson@med.lu.se			Swedish Cancer Society; Swedish Research Council; Swedish Medical Association; Gunnar Nilsson Cancer Foundation; Mrs. Berta Kamprad Foundation; Stig and Ragna Gorthons Stiftelse; University Hospital of Lund Research Foundation; Skane Country Council's Research and Development Foundation; National Health Service	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Association; Gunnar Nilsson Cancer Foundation; Mrs. Berta Kamprad Foundation; Stig and Ragna Gorthons Stiftelse; University Hospital of Lund Research Foundation; Skane Country Council's Research and Development Foundation; National Health Service	The work was supported by Swedish Cancer Society, Swedish Research Council, Swedish Medical Association, the Gunnar Nilsson Cancer Foundation, the Mrs. Berta Kamprad Foundation, Stig and Ragna Gorthons Stiftelse, the University Hospital of Lund Research Foundation, Skane Country Council's Research and Development Foundation and Governmental Funding of Clinical Research within the National Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Brown LA, 2007, J MOL HISTOL, V38, P151, DOI 10.1007/s10735-006-9069-y; Burford A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071777; Burstein HJ, 2008, J CLIN ONCOL, V26, P1810, DOI 10.1200/JCO.2007.14.5375; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; de Ruijter TC, 2011, J CANCER RES CLIN, V137, P183, DOI 10.1007/s00432-010-0957-x; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dhakal HP, 2012, HISTOPATHOLOGY, V61, P350, DOI 10.1111/j.1365-2559.2012.04223.x; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Falck AK, 2013, BREAST CANCER RES TR, V140, P93, DOI 10.1007/s10549-013-2617-8; Falck AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-403; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hahtola S, 2008, GENE CHROMOSOME CANC, V47, P107, DOI 10.1002/gcc.20513; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Holtkamp N, 2007, NEURO-ONCOLOGY, V9, P291, DOI 10.1215/15228517-2007-009; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Johansson I, 2012, GENE CHROMOSOME CANC, V51, P375, DOI 10.1002/gcc.21922; Kashiwagi S, 2013, BRIT J SURG, V100, P490, DOI 10.1002/bjs.9021; Kozloff M, 2010, ANN ONCOL, V21, P1436, DOI 10.1093/annonc/mdp565; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Nassar A, 2012, BREAST J, V18, P399, DOI 10.1111/j.1524-4741.2012.01279.x; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nupponen NN, 2008, MODERN PATHOL, V21, P265, DOI 10.1038/modpathol.3800989; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Ryden L, 2010, BREAST CANCER RES TR, V120, P491, DOI 10.1007/s10549-010-0758-6; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tibes R, 2005, ANNU REV PHARMACOL, V45, P357, DOI 10.1146/annurev.pharmtox.45.120403.100124; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Zietsch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011858	45	29	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102176	10.1371/journal.pone.0102176	http://dx.doi.org/10.1371/journal.pone.0102176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025175	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400048
J	Manicam, C; Pitz, S; Brochhausen, C; Grus, FH; Pfeiffer, N; Gericke, A				Manicam, Caroline; Pitz, Susanne; Brochhausen, Christoph; Grus, Franz H.; Pfeiffer, Norbert; Gericke, Adrian			Effective Melanin Depigmentation of Human and Murine Ocular Tissues: An Improved Method for Paraffin and Frozen Sections	PLOS ONE			English	Article							DILUTE HYDROGEN-PEROXIDE; UVEAL MELANOMA; CILIARY BODY; PATHOLOGY; IMMUNOHISTOCHEMISTRY; CYTOSKELETON; LESIONS; CELLS; EYE; DOG	Purpose: The removal of excessive melanin pigments that obscure ocular tissue morphology is important to address scientific questions and for differential diagnosis of ocular tumours based on histology. Thus, the goal of the present study was to establish an effective and fast melanin bleaching method for paraffin and frozen mouse and human ocular tissues. Methods: Paraffin-embedded and frozen ocular specimens from mice and human donors were subjected to bleaching employing two methods. The first employed potassium permanganate (KMnO4) with oxalic acid, and the second 10% hydrogen peroxide (H2O2). To determine optimal bleaching conditions, depigmentation was carried out at various incubation times. The effect of diluents used for 10% H2O2 was assessed using phosphate-buffered saline (PBS), and deionized water. Three different slide types and two fixatives, which were ice-cold acetone with 80% methanol, and 4% paraformaldehyde (PFA) were used to determine the optimal conditions for better tissue adherence during bleaching. All tissues were stained in hematoxylin and eosin for histological evaluation. Results: Optimal bleaching was achieved using warm 10% H2O2 diluted in PBS at 65 degrees C for 120 minutes. Chromium-gelatin-coated slides prevented tissue detachment. Adherence of cryosections was also improved with post-fixation using 4% PFA and overnight air-drying at RT after cryosectioning. Tissue morphology was preserved under these conditions. Conversely, tissues bleached in KMnO4/oxalic acid demonstrated poor depigmentation with extensive tissue damage. Conclusions: Warm dilute H2O2 at 65 degrees C for 120 minutes rapidly and effectively bleached both cryo-and paraffin sections of murine and human ocular tissues.	[Manicam, Caroline; Pitz, Susanne; Grus, Franz H.; Pfeiffer, Norbert; Gericke, Adrian] Johannes Gutenberg Univ Mainz, Dept Ophthalmol, Univ Med Ctr, Mainz, Germany; [Brochhausen, Christoph] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Manicam, C (corresponding author), Johannes Gutenberg Univ Mainz, Dept Ophthalmol, Univ Med Ctr, Mainz, Germany.	cmjc_82@yahoo.com	Pfeiffer, Norbert/AAO-7586-2020		Gertraud Maria Rzehulka Foundation; internal grant from the University Medical Center [MAIFOR2013-2014]	Gertraud Maria Rzehulka Foundation; internal grant from the University Medical Center	This study was supported by a grant from the Gertraud Maria Rzehulka Foundation and an internal grant from the University Medical Center (MAIFOR2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal RT, 2006, CURR EYE RES, V31, P57, DOI 10.1080/02713680500478535; Alexander RA, 1996, BRIT J BIOMED SCI, V53, P170; ALEXANDER RA, 1986, MED LAB SCI, V43, P121; Ansorge M, 1996, PIGM CELL RES, V9, P142, DOI 10.1111/j.1600-0749.1996.tb00102.x; BOMANJI J, 1987, BRIT J OPHTHALMOL, V71, P647, DOI 10.1136/bjo.71.9.647; Chesterman W, 1958, Q J MICROSCOPICAL SC, V3, P65; FLUGELKOCH C, 1994, INVEST OPHTH VIS SCI, V35, P4268; FOSS AJE, 1995, BRIT J BIOMED SCI, V52, P22; FRANGIONI G, 1986, STAIN TECHNOL, V61, P239, DOI 10.3109/10520298609109944; FUCHS U, 1991, INVEST OPHTH VIS SCI, V32, P3178; FUCHS U, 1992, AM J PATHOL, V141, P169; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P639, DOI 10.1111/j.1751-1097.2008.00316.x; JEBB AH, 1977, STAIN TECHNOL, V52, P315, DOI 10.3109/10520297709116805; Kivela T, 1995, BRIT J BIOMED SCI, V52, P325; KIVELA T, 1992, J HISTOCHEM CYTOCHEM, V40, P1517, DOI 10.1177/40.10.1382090; Kligora CJ, 1999, MODERN PATHOL, V12, P1143; KORYTOWSKI W, 1990, J BIOL CHEM, V265, P12410; Li LXL, 1999, HISTOCHEM J, V31, P237; Liu CH, 2013, APPL IMMUNOHISTO M M, V21, P275, DOI 10.1097/PAI.0b013e31826d81db; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Momose M, 2011, PATHOL INT, V61, P345, DOI 10.1111/j.1440-1827.2011.02667.x; Mudhar HS, 2013, BRIT J OPHTHALMOL, V97, P924, DOI 10.1136/bjophthalmol-2013-303291; Orchard GE, 2007, BRIT J BIOMED SCI, V64, P89, DOI 10.1080/09674845.2007.11978097; Orchard GE, 1998, AM J DERMATOPATH, V20, P357, DOI 10.1097/00000372-199808000-00006; Roels S, 1999, J COMP PATHOL, V121, P13, DOI 10.1053/jcpa.1998.0291; Seagle BLL, 2005, P NATL ACAD SCI USA, V102, P8978, DOI 10.1073/pnas.0501971102; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Sompuram SR, 2004, AM J CLIN PATHOL, V121, P190, DOI 10.1309/BRN7CTX1E84NWWPL; Thurby C, 2009, J HISTOTECHNOL, V32, P198, DOI 10.1179/his.2009.32.4.198; Toivonen P, 2012, ACTA OPHTHALMOL, V90, P341, DOI 10.1111/j.1755-3768.2010.01985.x; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; van de Sandt RROM, 2003, VET OPHTHALMOL, V6, P273, DOI 10.1111/j.1463-5224.2003.00306.x	32	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102512	10.1371/journal.pone.0102512	http://dx.doi.org/10.1371/journal.pone.0102512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025426	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400082
J	Zou, HX; Pang, QY; Lin, LD; Zhang, AQ; Li, N; Lin, YQ; Li, LM; Wu, QQ; Yan, XF				Zou, Hui-Xi; Pang, Qiu-Ying; Lin, Li-Dong; Zhang, Ai-Qin; Li, Nan; Lin, Yan-Qing; Li, Lu-Min; Wu, Qin-Qin; Yan, Xiu-Feng			Behavior of the Edible Seaweed Sargassum fusiforme to Copper Pollution: Short-Term Acclimation and Long-Term Adaptation	PLOS ONE			English	Article							CLAM RUDITAPES-PHILIPPINARUM; INDUCED OXIDATIVE STRESS; BROWN ALGA; NITRATE REDUCTASE; D-ASPARTATE; DIFFERENTIAL RESPONSES; METABOLIC-RESPONSES; NITROGEN-METABOLISM; ANTIOXIDANT ENZYMES; HIZIKIA-FUSIFORMIS	Aquatic agriculture in heavy-metal-polluted coastal areas faces major problems due to heavy metal transfer into aquatic organisms, leading to various unexpected changes in nutrition and primary and/or secondary metabolism. In the present study, the dual role of heavy metal copper (Cu) played in the metabolism of photosynthetic organism, the edible seaweed Sargassum fusiforme, was evaluated by characterization of biochemical and metabolic responses using both H-1 NMR and GC-MS techniques under acute (47 mu M, 1 day) and chronic stress (8 mu M, 7 days). Consequently, photosynthesis may be seriously inhibited by acute Cu exposure, resulting in decreasing levels of carbohydrates, e. g., mannitol, the main products of photosynthesis. Ascorbate may play important roles in the antioxidant system, whose content was much more seriously decreased under acute than that under chronic Cu stress. Overall, these results showed differential toxicological responses on metabolite profiles of S. fusiforme subjected to acute and chronic Cu exposures that allowed assessment of impact of Cu on marine organisms.	[Zou, Hui-Xi; Li, Nan; Lin, Yan-Qing; Li, Lu-Min; Wu, Qin-Qin; Yan, Xiu-Feng] Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China; [Pang, Qiu-Ying; Lin, Li-Dong; Zhang, Ai-Qin] Northeast Forest Univ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Harbin, Peoples R China	Wenzhou University; Northeast Forestry University - China	Yan, XF (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China.	yanxiufeng@wzu.edu.cn	Zou, Hui-Xi/GPS-6496-2022	Zou, Hui-Xi/0000-0002-8141-8059; Yan, Xiufeng/0000-0001-5127-494X	Zhejiang Provincial Natural Science Foundation of China [LQ13C030005]; Natural Science Foundation of China [31270541]; Plan for Qianjiang Talent of Zhejiang [QJD1202014]; Program for Wenzhou Science & Technology Innovative Research Team of China [C20120007-08]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for Qianjiang Talent of Zhejiang; Program for Wenzhou Science & Technology Innovative Research Team of China	This material is based upon work funded by Zhejiang Provincial Natural Science Foundation of China (LQ13C030005, http://www.zjnsf.gov.cn), Natural Science Foundation of China (31270541, http://www.nsfc.gov.cn), Plan for Qianjiang Talent of Zhejiang (QJD1202014), and Program for Wenzhou Science & Technology Innovative Research Team of China (C20120007-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K., 1987, PHOTOINHIBITION, P227; Barding GA, 2013, J PROTEOME RES, V12, P898, DOI 10.1021/pr300953k; Barding GA, 2012, J PROTEOME RES, V11, P320, DOI 10.1021/pr200919b; Bischoff K., 2012, SEAWEED BIOL, P109, DOI [10.1007/978-3-642-28451-9_6, DOI 10.1007/978-3-642-28451-9_6]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burzynski M, 1997, ACTA PHYSIOL PLANT, V19, P3, DOI 10.1007/s11738-997-0015-8; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Chen CL, 2013, PLANT J, V75, P891, DOI 10.1111/tpj.12262; Collen J, 1999, J PHYCOL, V35, P62, DOI 10.1046/j.1529-8817.1999.3510062.x; Contreras L, 2005, J PHYCOL, V41, P1184, DOI 10.1111/j.1529-8817.2005.00151.x; Contreras L, 2009, AQUAT TOXICOL, V94, P94, DOI 10.1016/j.aquatox.2009.06.004; Diaz J, 2001, PLANT SCI, V161, P179, DOI 10.1016/S0168-9452(01)00410-1; Doubnerova V, 2011, PLANT SCI, V180, P575, DOI 10.1016/j.plantsci.2010.12.005; Dowling VA, 2006, PROTEOMICS, V6, P5597, DOI 10.1002/pmic.200600274; Dunn WB, 2013, METABOLOMICS, V9, pS44, DOI 10.1007/s11306-012-0434-4; Fan JH, 1996, ASTRON ASTROPHYS SUP, V116, P409, DOI 10.1051/aas:1996124; Fang J, 2004, B ENVIRON CONTAM TOX, V73, P583, DOI 10.1007/s00128-004-0468-z; Farag MA, 2012, PHYTOCHEMISTRY, V76, P60, DOI 10.1016/j.phytochem.2011.12.010; Fernandez E, 2008, EUKARYOT CELL, V7, P555, DOI 10.1128/EC.00431-07; FLYNN KJ, 1989, J PLANKTON RES, V11, P165, DOI 10.1093/plankt/11.1.165; Fontaine JX, 2006, PLANT CELL PHYSIOL, V47, P410, DOI 10.1093/pcp/pcj008; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Funakoshi M, 2008, FEBS J, V275, P1188, DOI 10.1111/j.1742-4658.2008.06279.x; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Gonzalez A, 2010, PLANT CELL ENVIRON, V33, P1627, DOI 10.1111/j.1365-3040.2010.02169.x; Gouia H, 2000, PLANT PHYSIOL BIOCH, V38, P629, DOI 10.1016/S0981-9428(00)00775-0; HARRISON WG, 1977, B MAR SCI, V27, P44; Hassan HM, 1990, STRESS RESPONSES PLA, P178; Iwamoto K, 2005, MAR BIOTECHNOL, V7, P407, DOI 10.1007/s10126-005-0029-4; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Kawamitsu Y, 1999, MAR BIOL, V133, P361, DOI 10.1007/s002270050475; Kunhikrishnan A, 2013, J HAZARD MATER, V261, P784, DOI 10.1016/j.jhazmat.2012.10.015; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu XL, 2011, ECOTOXICOLOGY, V20, P1422, DOI 10.1007/s10646-011-0699-9; Liu XL, 2011, ENVIRON TOXICOL PHAR, V31, P323, DOI 10.1016/j.etap.2010.12.003; Llorens N, 2000, PLANT SCI, V160, P159, DOI 10.1016/S0168-9452(00)00379-4; Luna CM, 1997, PHYSIOL PLANTARUM, V101, P103, DOI 10.1034/j.1399-3054.1997.1010114.x; Macfarlane GR, 2001, MAR POLLUT BULL, V42, P233, DOI 10.1016/S0025-326X(00)00147-8; Mellado M, 2012, PLANT PHYSIOL BIOCH, V51, P102, DOI 10.1016/j.plaphy.2011.10.007; NAGAHISA E, 1994, FISHERIES SCI, V60, P777, DOI 10.2331/fishsci.60.777; Niu JF, 2010, CHIN J OCEANOL LIMN, V28, P26, DOI 10.1007/s00343-010-9120-4; Okamoto OK, 2001, ARCH ENVIRON CON TOX, V40, P18; OVERNELL J, 1975, MAR BIOL, V29, P99; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Pang SJ, 2008, AQUAC RES, V39, P1408, DOI 10.1111/j.1365-2109.2008.02010.x; Pelletreau K. N., 2008, P121, DOI 10.1007/978-3-540-74181-7_6; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Purohit PV, 2004, OMICS, V8, P118, DOI 10.1089/1536231041388348; Ratkevicius N, 2003, PLANT CELL ENVIRON, V26, P1599, DOI 10.1046/j.1365-3040.2003.01073.x; REED RH, 1985, PHYCOLOGIA, V24, P35, DOI 10.2216/i0031-8884-24-1-35.1; Ritter A, 2010, PROTEOMICS, V10, P2074, DOI 10.1002/pmic.200900004; Romanowska E, 2002, PHYSIOLOGY AND BIOCHEMISTRY OF METAL TOXICITY AND TOLERANCE IN PLANTS, P257; Shen B, 1997, PLANT PHYSIOL, V113, P1177, DOI 10.1104/pp.113.4.1177; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; SMITH TA, 1971, BIOL REV, V46, P201, DOI 10.1111/j.1469-185X.1971.tb01182.x; SUNDA WG, 1983, LIMNOL OCEANOGR, V28, P924, DOI 10.4319/lo.1983.28.5.0924; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; van Lipzig MMH, 2005, CHEM RES TOXICOL, V18, P1691, DOI 10.1021/tx0501233; Wickens G, 2001, ECON BOT, P127; Wu HF, 2005, J INORG BIOCHEM, V99, P644, DOI 10.1016/j.jinorgbio.2004.11.021; Wu HF, 2013, J PLANT GROWTH REGUL, V32, P353, DOI 10.1007/s00344-012-9305-5; Wu HF, 2013, ECOTOX ENVIRON SAFE, V90, P1, DOI 10.1016/j.ecoenv.2012.02.022; Wu HF, 2012, ECOTOXICOLOGY, V21, P2363, DOI 10.1007/s10646-012-0992-2; Wu HF, 2012, ECOTOX ENVIRON SAFE, V85, P64, DOI 10.1016/j.ecoenv.2012.03.016; Wu HF, 2011, MAR DRUGS, V9, P1566, DOI 10.3390/md9091566; Wu HF, 2011, ENVIRON TOXICOL CHEM, V30, P806, DOI 10.1002/etc.446; Wu TM, 2009, AQUAT TOXICOL, V94, P275, DOI 10.1016/j.aquatox.2009.07.010; Wu TM, 2008, PHYCOLOGIA, V47, P346, DOI 10.2216/PH07-77.1; Xie XJ, 2014, PHYCOLOGIA, V53, P10, DOI 10.2216/13-161.1; Xu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037438; Yokoyama T, 2011, BIOSCI BIOTECH BIOCH, V75, P1481, DOI 10.1271/bbb.110184; Zeier J, 2013, PLANT CELL ENVIRON, V36, P2085, DOI 10.1111/pce.12122; Zhang L, 2011, ENVIRON TOXICOL PHAR, V32, P218, DOI 10.1016/j.etap.2011.05.006; Zhang LB, 2011, MAR ENVIRON RES, V72, P33, DOI 10.1016/j.marenvres.2011.04.002; Zhu XF, 2011, BOT MAR, V54, P431, DOI 10.1515/BOT.2011.054	77	13	13	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101960	10.1371/journal.pone.0101960	http://dx.doi.org/10.1371/journal.pone.0101960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025229	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400029
J	Higashi, K; Imamura, M; Fudo, S; Uemura, T; Saiki, R; Hoshino, T; Toida, T; Kashiwagi, K; Igarashi, K				Higashi, Kyohei; Imamura, Masataka; Fudo, Satoshi; Uemura, Takeshi; Saiki, Ryotaro; Hoshino, Tyuji; Toida, Toshihiko; Kashiwagi, Keiko; Igarashi, Kazuei			Identification of Functional Amino Acid Residues Involved in Polyamine and Agmatine Transport by Human Organic Cation Transporter 2	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; RECOGNITION SITE; PROTEIN; PUTRESCINE; EXCRETION; ANTIPORTER; SPERMIDINE; CADAVERINE; PERMEASE; OCT2	Polyamine (putrescine, spermidine and spermine) and agmatine uptake by the human organic cation transporter 2 (hOCT2) was studied using HEK293 cells transfected with pCMV6-XL4/hOCT2. The Km values for putrescine and spermidine were 7.50 and 6.76 mM, and the Vmax values were 4.71 and 2.34 nmol/min/mg protein, respectively. Spermine uptake by hOCT2 was not observed at pH 7.4, although it inhibited both putrescine and spermidine uptake. Agmatine was also taken up by hOCT2, with Km value: 3.27 mM and a Vmax value of 3.14 nmol/min/mg protein. Amino acid residues involved in putrescine, agmatine and spermidine uptake by hOCT2 were Asp(427), Glu(448), Glu(456), Asp(475), and Glu(516). In addition, Glu(524) and Glu(530) were involved in putrescine and spermidine uptake activity, and Glu(528) and Glu(540) were weakly involved in putrescine uptake activity. Furthermore, Asp(551) was also involved in the recognition of spermidine. These results indicate that the recognition sites for putrescine, agmatine and spermidine on hOCT2 strongly overlap, consistent with the observation that the three amines are transported with similar affinity and velocity. A model of spermidine binding to hOCT2 was constructed based on the functional amino acid residues.	[Higashi, Kyohei; Imamura, Masataka; Fudo, Satoshi; Uemura, Takeshi; Saiki, Ryotaro; Hoshino, Tyuji; Toida, Toshihiko; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Saiki, Ryotaro; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chiba, Japan; [Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba, Japan	Chiba University; Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan.	iga16077@faculty.chiba-u.jp		Igarashi, Kazuei/0000-0003-3751-3187; Higashi, Kyohei/0000-0002-2622-4825; Fudo, Satoshi/0000-0001-9925-5131	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Fujita M, 2012, P NATL ACAD SCI USA, V109, P6343, DOI 10.1073/pnas.1121406109; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; Higashi K, 2004, J BIOCHEM, V136, P533, DOI 10.1093/jb/mvh150; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, AMINO ACIDS, V31, P477, DOI 10.1007/s00726-006-0264-7; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; KAKINUMA Y, 1987, ARCH BIOCHEM BIOPHYS, V259, P171, DOI 10.1016/0003-9861(87)90483-8; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pelis RM, 2007, AM J PHYSIOL-RENAL, V292, pF1583, DOI 10.1152/ajprenal.00496.2006; Pelis RM, 2006, J BIOL CHEM, V281, P35272, DOI 10.1074/jbc.M606561200; Sala-Rabanal M, 2013, MOL PHARMACEUT, V10, P1450, DOI 10.1021/mp400024d; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Tachihara K, 2005, J BIOL CHEM, V280, P12637, DOI 10.1074/jbc.M410778200; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Terui Y, 2014, AMINO ACIDS, V46, P661, DOI 10.1007/s00726-013-1517-x; Tomitori H, 2012, AMINO ACIDS, V42, P733, DOI 10.1007/s00726-011-0989-9; Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Winter TN, 2011, MOL PHARMACEUT, V8, P133, DOI 10.1021/mp100180a; Yokoo S, 2008, DRUG METAB DISPOS, V36, P2299, DOI 10.1124/dmd.108.023168; Zhang XH, 2005, J BIOL CHEM, V280, P34813, DOI 10.1074/jbc.M506342200	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102234	10.1371/journal.pone.0102234	http://dx.doi.org/10.1371/journal.pone.0102234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019617	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600055
J	Faller, J; Scherer, R; Costa, U; Opisso, E; Medina, J; Muller-Putz, GR				Faller, Josef; Scherer, Reinhold; Costa, Ursula; Opisso, Eloy; Medina, Josep; Mueller-Putz, Gernot R.			A Co-Adaptive Brain-Computer Interface for End Users with Severe Motor Impairment	PLOS ONE			English	Article							EEG; COMMUNICATION; PATIENT; IMAGERY; RHYTHMS	Co-adaptive training paradigms for event-related desynchronization (ERD) based brain-computer interfaces (BCI) have proven effective for healthy users. As of yet, it is not clear whether co-adaptive training paradigms can also benefit users with severe motor impairment. The primary goal of our paper was to evaluate a novel cue-guided, co-adaptive BCI training paradigm with severely impaired volunteers. The co-adaptive BCI supports a non-control state, which is an important step toward intuitive, self-paced control. A secondary aim was to have the same participants operate a specifically designed self-paced BCI training paradigm based on the auto-calibrated classifier. The co-adaptive BCI analyzed the electroencephalogram from three bipolar derivations (C3, Cz, and C4) online, while the 22 end users alternately performed right hand movement imagery (MI), left hand MI and relax with eyes open (non-control state). After less than five minutes, the BCI auto-calibrated and proceeded to provide visual feedback for the MI task that could be classified better against the non-control state. The BCI continued to regularly recalibrate. In every calibration step, the system performed trial-based outlier rejection and trained a linear discriminant analysis classifier based on one auto-selected logarithmic band-power feature. In 24 minutes of training, the co-adaptive BCI worked significantly (p = 0.01) better than chance for 18 of 22 end users. The self-paced BCI training paradigm worked significantly (p = 0.01) better than chance in 11 of 20 end users. The presented co-adaptive BCI complements existing approaches in that it supports a non-control state, requires very little setup time, requires no BCI expert and works online based on only two electrodes. The preliminary results from the self-paced BCI paradigm compare favorably to previous studies and the collected data will allow to further improve self-paced BCI systems for disabled users.	[Faller, Josef; Scherer, Reinhold; Mueller-Putz, Gernot R.] Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria; [Costa, Ursula; Opisso, Eloy; Medina, Josep] UAB, Neurorehab Univ Inst, Guttmann Inst, Barcelona, Spain; [Opisso, Eloy; Medina, Josep] Germans Trias & Pujol Found, Hlth Sci Res Inst, Barcelona, Spain	Graz University of Technology; Autonomous University of Barcelona	Scherer, R (corresponding author), Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria.	reinhold.scherer@tugraz.at	Faller, Josef/ABG-2374-2020	Faller, Josef/0000-0001-7814-9292; Scherer, Reinhold/0000-0003-3407-9709; Muller-Putz, Gernot/0000-0002-0087-3720	FP7 EU Research Project BrainAble [247447]; FP7 EU Research Project BackHome [288566]	FP7 EU Research Project BrainAble; FP7 EU Research Project BackHome	This work was supported by the FP7 EU Research Projects BrainAble (No. 247447; http://www.brainable.org/) and BackHome (No. 288566; http://www.backhome-fp7.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-34; Billinger M., 2012, PRACTICAL BRAIN COMP, P333, DOI [10.1007/978-3-642-29746-5_17, DOI 10.1007/978-3-642-29746-5_17]; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Blankertz B., 2006, CLIN NEUROPHYSIOL, V113, P108, DOI DOI 10.1109/MSP.2008.4408441; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Conradi J., 2009, INT J BIOELECTROMAGN, V11, P65; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Daly I, 2013, CLIN NEUROPHYSIOL, V124, P1787, DOI 10.1016/j.clinph.2013.02.118; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; Faller J, 2013, I IEEE EMBS C NEUR E, P977, DOI 10.1109/NER.2013.6696099; Faller J, 2012, 34 ANN INT C IEEE EN; Faller J, 2013, P BCI M 2013 AS CA U; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Friedrich EVC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076214; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; Grosse-Wentrup M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025004; Jatzev S, 2008, P 4 INT BCI WORKSH T; Kreilinger A, 2013, IEEE INTELL SYST APP, V28, P28; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Kus R, 2012, IEEE T NEUR SYS REH, V20, P823, DOI 10.1109/TNSRE.2012.2214789; Leeb R, 2013, ARTIF INTELL MED, V59, P121, DOI 10.1016/j.artmed.2013.08.004; Lotte F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00568; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Millan JD, 2004, ARTIF INTELL, V159, P241, DOI 10.1016/j.artint.2004.05.008; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2003, CLIN NEUROPHYSIOL, V114, P399, DOI 10.1016/S1388-2457(02)00387-5; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Obermaier B, 2003, IEEE T NEUR SYS REH, V11, P422, DOI 10.1109/TNSRE.2003.816866; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; Pfurtscheller G, 2009, Comput Intell Neurosci, P104180, DOI 10.1155/2009/104180; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pichiorri F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025020; Pokorny C, 2013, ARTIF INTELL MED, V59, P81, DOI 10.1016/j.artmed.2013.07.003; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Rohm M, 2013, P 4 TOBI WORKSH 2013, P19; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Scherer Reinhold, 2007, Comput Intell Neurosci, P79826, DOI 10.1155/2007/79826; Vidaurre C, 2006, IEEE T BIO-MED ENG, V53, P1214, DOI 10.1109/TBME.2006.873542; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	48	35	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101168	10.1371/journal.pone.0101168	http://dx.doi.org/10.1371/journal.pone.0101168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014055	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400019
J	Lu, JJ; Tan, DY; Baskin, JM; Baskin, CC				Lu, Juan J.; Tan, Dun Y.; Baskin, Jerry M.; Baskin, Carol C.			Germination Season and Watering Regime, but Not Seed Morph, Affect Life History Traits in a Cold Desert Diaspore-Heteromorphic Annual	PLOS ONE			English	Article							WEED DIPLOTAXIS ERUCOIDES; ARABIDOPSIS-THALIANA; PHENOTYPIC PLASTICITY; EVOLUTIONARY ECOLOGY; NATURAL-SELECTION; FLOWERING TIME; BRASSICACEAE; RESPONSES; DATE; CHARACTERS	Seed morph, abiotic conditions and time of germination can affect plant fitness, but few studies have tested their combined effects on plasticity of plant life history traits. Thus, we tested the hypothesis that seed morph, germination season and watering regime influence phenotypic expression of post-germination life history traits in the diaspore-heteromorphic cold desert winter annual/spring ephemeral Diptychocarpus strictus. The two seed morphs were sown in watered and non-watered plots in late summer, and plants derived from them were watered or not-watered throughout the study. Seed morph did not affect phenology, growth and morphology, survival, dry mass accumulation and allocation or silique and seed production. Seeds in watered plots germinated in autumn (AW) and spring (SW) but only in spring for non-watered plots (SNW). A high percentage of AW, SW and SNW plants survived and reproduced, but flowering date and flowering period of autumn- vs. spring-germinated plants differed. Dry mass also differed with germination season/watering regime (AW > SW > SNW). Number of siliques and seeds increased with plant size (AW > SW > SNW), whereas percent dry mass allocated to reproduction was higher in small plants: SNW > SW > AW. Thus, although seed morph did not affect the expression of life history traits, germination season and watering regime significantly affected phenology, plant size and accumulation and allocation of biomass to reproduction. Flexibility throughout the life cycle of D. strictus is an adaptation to the variation in timing and amount of rainfall in its cold desert habitat.	[Lu, Juan J.; Tan, Dun Y.; Baskin, Jerry M.; Baskin, Carol C.] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Grassland Resources & Ecol, Urumqi, Peoples R China; [Lu, Juan J.; Tan, Dun Y.; Baskin, Jerry M.; Baskin, Carol C.] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Minist Educ, Key Lab Western Arid Reg Grassland Resources & Ec, Urumqi, Peoples R China; [Baskin, Jerry M.; Baskin, Carol C.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA	Xinjiang Agricultural University; Xinjiang Agricultural University; University of Kentucky; University of Kentucky	Tan, DY (corresponding author), Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Grassland Resources & Ecol, Urumqi, Peoples R China.	tandunyan@163.com; ccbask0@uky.edu			National Science Foundation of China [31160093, U1130301, 41361011]; Chinese Ministry of Education [213038A]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Science Foundation of China (31160093, U1130301, 41361011) and the Key Project of Chinese Ministry of Education (No. 213038A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZX, 1995, FLORA XINJIANGENSIS, V2, P171; Angert AL, 2010, AM J BOT, V97, P405, DOI 10.3732/ajb.0900242; ARONSON J, 1993, OECOLOGIA, V93, P336, DOI 10.1007/BF00317875; BASKIN JM, 1984, B TORREY BOT CLUB, V111, P329, DOI 10.2307/2995914; BASKIN JM, 1972, AM MIDL NAT, V88, P318, DOI 10.2307/2424357; CHEPLICK GP, 1992, J ECOL, V80, P567, DOI 10.2307/2260699; de Casas RR, 2012, NEW PHYTOL, V194, P868, DOI 10.1111/j.1469-8137.2012.04097.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Dubois J, 2012, ANN BOT-LONDON, V110, P1245, DOI 10.1093/aob/mcs203; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Lu JJ, 2012, OIKOS, V121, P357, DOI 10.1111/j.1600-0706.2011.19800.x; Lu JJ, 2010, ANN BOT-LONDON, V105, P999, DOI 10.1093/aob/mcq041; Mandak B, 2005, FLORA, V200, P516, DOI 10.1016/j.flora.2005.06.003; Mandak Bohumil, 1997, Preslia (Prague), V69, P129; MARKS M, 1981, OIKOS, V36, P326, DOI 10.2307/3544630; Nordborg M, 1999, AM J BOT, V86, P470, DOI 10.2307/2656807; Penfield S, 2012, PHILOS T R SOC B, V367, P291, DOI 10.1098/rstb.2011.0186; Sans FX, 1997, CAN J BOT, V75, P86, DOI 10.1139/b97-011; SANS FX, 1994, CAN J BOT, V72, P10, DOI 10.1139/b94-003; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sokal R.R., 2012, BIOMETRY; SZAREK SR, 1982, AM MIDL NAT, V108, P338, DOI 10.2307/2425494; VANROOYEN MW, 1992, J ARID ENVIRON, V22, P51, DOI 10.1016/S0140-1963(18)30656-6; VENABLE DL, 1985, AM NAT, V126, P577, DOI 10.1086/284440; VENABLE DL, 1987, ECOLOGY, V68, P65, DOI 10.2307/1938805; Venable DL, 1985, J ECOL, V73, P113; Wang XQ, 2006, CHINESE SCI BULL, V51, P110, DOI 10.1007/s11434-006-8214-z; [魏文寿 Wei Wenshou], 2003, [中国沙漠, Journal of Desert Research], V23, P101; Zhou DW, 2005, CAN J BOT, V83, P28, DOI [10.1139/b04-148, 10.1139/B04-148]	31	29	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102018	10.1371/journal.pone.0102018	http://dx.doi.org/10.1371/journal.pone.0102018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013967	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400055
J	Morimoto, N; de Leon, MSP; Zollikofer, CPE				Morimoto, Naoki; de Leon, Marcia S. Ponce; Zollikofer, Christoph P. E.			Phenotypic Variation in Infants, Not Adults, Reflects Genotypic Variation among Chimpanzees and Bonobos	PLOS ONE			English	Article							Q(ST)-F-ST COMPARISONS; GENE FLOW; LOCOMOTOR BEHAVIOR; STABILIZING SELECTION; POPULATION-STRUCTURE; DIAPHYSEAL STRUCTURE; QUANTITATIVE TRAIT; NATURAL-SELECTION; PAN-PANISCUS; G MATRIX	Studies comparing phenotypic variation with neutral genetic variation in modern humans have shown that genetic drift is a main factor of evolutionary diversification among populations. The genetic population history of our closest living relatives, the chimpanzees and bonobos, is now equally well documented, but phenotypic variation among these taxa remains relatively unexplored, and phenotype-genotype correlations are not yet documented. Also, while the adult phenotype is typically used as a reference, it remains to be investigated how phenotype-genotye correlations change during development. Here we address these questions by analyzing phenotypic evolutionary and developmental diversification in the species and subspecies of the genus Pan. Our analyses focus on the morphology of the femoral diaphysis, which represents a functionally constrained element of the locomotor system. Results show that during infancy phenotypic distances between taxa are largely congruent with non-coding (neutral) genotypic distances. Later during ontogeny, however, phenotypic distances deviate from genotypic distances, mainly as an effect of heterochronic shifts between taxon-specific developmental programs. Early phenotypic differences between Pan taxa are thus likely brought about by genetic drift while late differences reflect taxon-specific adaptations.	[Morimoto, Naoki] Kyoto Univ, Grad Sch Sci, Lab Phys Anthropol, Kyoto, Japan; [de Leon, Marcia S. Ponce; Zollikofer, Christoph P. E.] Univ Zurich, Inst Anthropol, Zurich, Switzerland	Kyoto University; University of Zurich	Morimoto, N (corresponding author), Kyoto Univ, Grad Sch Sci, Lab Phys Anthropol, Kyoto, Japan.	morimoto@anthro.zool.kyoto-u.ac.jp; zolli@aim.uzh.ch		Morimoto, Naoki/0000-0002-8367-4777	Swiss National Science Foundation [3100A0-109344/1]; Japan Society for Promotion of Science [251133]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Swiss National Science Foundation (no. 3100A0-109344/1) and Japan Society for Promotion of Science Research Fellowship for Young Scientists (no. 251133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Ackermann RR, 2004, P NATL ACAD SCI USA, V101, P17946, DOI 10.1073/pnas.0405919102; ATCHLEY WR, 1984, AM NAT, V123, P519, DOI 10.1086/284220; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Betti L, 2010, AM J PHYS ANTHROPOL, V141, P76, DOI 10.1002/ajpa.21115; Bolter DR, 2011, AM J PHYS ANTHROPOL, V145, P647, DOI 10.1002/ajpa.21517; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bourne GH, 1971, CHIMPANZEE, V4; Bourne GH, 1969, CHIMPANZEE, V1; Brommer JE, 2011, J EVOLUTION BIOL, V24, P1160, DOI 10.1111/j.1420-9101.2011.02268.x; Carlson K, 2008, INT J PRIMATOL, V29, P1401, DOI 10.1007/s10764-008-9297-y; Carlson KJ, 2006, J HUM EVOL, V50, P394, DOI 10.1016/j.jhevol.2005.10.004; Carlson KJ, 2005, AM J PHYS ANTHROPOL, V127, P312, DOI 10.1002/ajpa.20124; Carlson KJ, 2008, INTEGR COMP BIOL, V48, P385, DOI 10.1093/icb/icn066; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Champneys F, 1871, J Anat Physiol, V6, P176; Chapuis E, 2008, GENETICS, V180, P2151, DOI 10.1534/genetics.108.092452; Charmantier A, 2006, P ROY SOC B-BIOL SCI, V273, P225, DOI 10.1098/rspb.2005.3294; Collard M, 2000, P NATL ACAD SCI USA, V97, P5003, DOI 10.1073/pnas.97.9.5003; Crass E, 1952, THESIS U WISCONSIN; de Leon MSP, 2007, VERTEBR PALEOBIOL PA, P71; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Doran D. M., 1996, GREAT APE SOC; Doran DM, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P14, DOI 10.1017/CBO9780511606397.004; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P83, DOI 10.1002/ajpa.1330910106; Edelaar P, 2011, MOL ECOL, V20, P4830, DOI 10.1111/j.1365-294X.2011.05333.x; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Geiger M, 2013, J EVOLUTIONARY BIOL, V20, P12279; Gonder MK, 2006, INT J PRIMATOL, V27, P1103, DOI 10.1007/s10764-006-9063-y; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunz P, 2005, DEV PRIMATOL; Gunz P, 2012, J HUM EVOL, V62, P300, DOI 10.1016/j.jhevol.2011.11.013; Haller BC, 2014, EVOLUTION, V68, P483, DOI 10.1111/evo.12275; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Hawks J, 2013, ANNU REV ANTHROPOL, V42, P433, DOI 10.1146/annurev-anthro-092412-155548; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Kalinowski ST, 2002, MOL ECOL, V11, P1263, DOI 10.1046/j.1365-294X.2002.01520.x; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Koyabu D, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-21; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leinonen T, 2006, J EVOLUTION BIOL, V19, P1803, DOI 10.1111/j.1420-9101.2006.01182.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Lesser KJ, 2006, AGING CELL, V5, P293, DOI 10.1111/j.1474-9726.2006.00219.x; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; LYNCH M, 1989, EVOLUTION, V43, P1, DOI 10.1111/j.1558-5646.1989.tb04203.x; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Martin G, 2008, GENETICS, V180, P2135, DOI 10.1534/genetics.107.080820; McGrew MC, 1996, GREAT APE SOC; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Merila J, 1997, EVOLUTION, V51, P946, DOI 10.1111/j.1558-5646.1997.tb03675.x; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Morgan TJ, 2005, HEREDITY, V94, P518, DOI 10.1038/sj.hdy.6800652; Morimoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041980; Morimoto N, 2011, ANAT REC, V294, P1433, DOI 10.1002/ar.21424; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Palagi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052767; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penin X, 2002, AM J PHYS ANTHROPOL, V118, P50, DOI 10.1002/ajpa.10044; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Puymerail L, 2013, COMPTES RENDUS PALEV; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Relethford JH, 1997, HUM BIOL, V69, P443; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Relethford JH, 2004, AM J HUM BIOL, V16, P379, DOI 10.1002/ajhb.20045; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Roseman CC, 2007, BIOESSAYS, V29, P1185, DOI 10.1002/bies.20678; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; Saether SA, 2007, J EVOLUTION BIOL, V20, P1563, DOI 10.1111/j.1420-9101.2007.01328.x; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; Sanchez M, 2012, EMBRYOS IN DEEP TIME: THE ROCK RECORD OF BIOLOGICAL DEVELOPMENT, P1, DOI 10.1525/california/9780520271937.001.0001; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Shaw KL, 2011, GENETICA, V139, P649, DOI 10.1007/s10709-011-9562-4; SHEA BT, 1983, AM J PHYS ANTHROPOL, V62, P275, DOI 10.1002/ajpa.1330620307; SHEA BT, 1983, SCIENCE, V222, P521, DOI 10.1126/science.6623093; SIGMON BA, 1974, J HUM EVOL, V3, P161, DOI 10.1016/0047-2484(74)90197-3; Slate J, 2013, EVOLUTION, V67, P1251, DOI 10.1111/evo.12060; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Smith HF, 2007, AM J PHYS ANTHROPOL, V134, P312, DOI 10.1002/ajpa.20671; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Specht M, 2007, VISUAL COMPUT, V23, P743, DOI 10.1007/s00371-007-0156-1; SPITZE K, 1993, GENETICS, V135, P367; STERN JT, 1972, AM J PHYS ANTHROPOL, V36, P315, DOI 10.1002/ajpa.1330360303; Storz JF, 2002, MOL ECOL, V11, P2537, DOI 10.1046/j.1365-294X.2002.01636.x; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; von Cramon-Taubadel N, 2009, EVOL ANTHROPOL, V18, P237, DOI 10.1002/evan.20233; Wagner GP, 1996, GENETICS, V143, P617; Weaver TD, 2008, P NATL ACAD SCI USA, V105, P4645, DOI 10.1073/pnas.0709079105; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Wilson LAB, 2011, J EXP ZOOL PART B, V316B, P50, DOI 10.1002/jez.b.21380; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wright S., 1978, EVOLUTION GENETIC PO; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI; Zollikofer CPE, 2001, HOM EVOLUT CLIMAT CH, V2, P50	123	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102074	10.1371/journal.pone.0102074	http://dx.doi.org/10.1371/journal.pone.0102074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013970	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000339378400064
J	Li, MY; Wetzel-Strong, SE; Hua, XY; Tilley, SL; Oswald, E; Krummel, MF; Caron, KM				Li, Manyu; Wetzel-Strong, Sarah E.; Hua, Xiaoyang; Tilley, Stephen L.; Oswald, Erin; Krummel, Matthew F.; Caron, Kathleen M.			Deficiency of RAMP1 Attenuates Antigen-Induced Airway Hyperresponsiveness in Mice	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; ACTIVITY MODIFYING PROTEINS; CALCITONIN-GENE; HYDROPS-FETALIS; RECEPTOR; EXPRESSION; LACKING; ASTHMA; POTENT; CELLS	Asthma is a chronic inflammatory disease affecting the lung, characterized by breathing difficulty during an attack following exposure to an environmental trigger. Calcitonin gene-related peptide (CGRP) is a neuropeptide that may have a pathological role in asthma. The CGRP receptor is comprised of two components, which include the G-protein coupled receptor, calcitonin receptor-like receptor (CLR), and receptor activity-modifying protein 1 (RAMP1). RAMPs, including RAMP1, mediate ligand specificity in addition to aiding in the localization of receptors to the cell surface. Since there has been some controversy regarding the effect of CGRP on asthma, we sought to determine the effect of CGRP signaling ablation in an animal model of asthma. Using gene-targeting techniques, we generated mice deficient for RAMP1 by excising exon 3. After determining that these mice are viable and overtly normal, we sensitized the animals to ovalbumin prior to assessing airway resistance and inflammation after methacholine challenge. We found that mice lacking RAMP1 had reduced airway resistance and inflammation compared to wildtype animals. Additionally, we found that a 50% reduction of CLR, the G-protein receptor component of the CGRP receptor, also ameliorated airway resistance and inflammation in this model of allergic asthma. Interestingly, the loss of CLR from the smooth muscle cells did not alter the airway resistance, indicating that CGRP does not act directly on the smooth muscle cells to drive airway hyperresponsiveness. Together, these data indicate that signaling through RAMP1 and CLR plays a role in mediating asthma pathology. Since RAMP1 and CLR interact to form a receptor for CGRP, our data indicate that aberrant CGRP signaling, perhaps on lung endothelial and inflammatory cells, contributes to asthma pathophysiology. Finally, since RAMP-receptor interfaces are pharmacologically tractable, it may be possible to develop compounds targeting the RAMP1/CLR interface to assist in the treatment of asthma.	[Li, Manyu; Wetzel-Strong, Sarah E.; Caron, Kathleen M.] Univ N Carolina, Dept Cell Biol, Chapel Hill, NC 27599 USA; [Li, Manyu; Wetzel-Strong, Sarah E.; Caron, Kathleen M.] Univ N Carolina, Dept Physiol, Chapel Hill, NC USA; [Caron, Kathleen M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Hua, Xiaoyang; Tilley, Stephen L.] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA; [Oswald, Erin; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco	Caron, KM (corresponding author), Univ N Carolina, Dept Cell Biol, Chapel Hill, NC 27599 USA.	kathleen_Caron@med.unc.edu	Hua, Xiaoyang/T-5252-2019	Caron, Kathleen/0000-0002-7033-9232; Wetzel-Strong, Sarah/0000-0001-5560-2330; Hua, Xiaoyang/0000-0001-6414-7712	National Institutes of Health/National Heart Lung and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases [HD060860, DK99156];  [2U19A1077439-06];  [P01 HL024136]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060860] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099156] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health/National Heart Lung and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases HD060860 and DK99156 to KMC, as well as 2U19A1077439-06 and P01 HL024136 to MFK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2011, NATL HLTH STAT REPOR, V1-14; Aoki-Nagase T, 2002, AM J PHYSIOL-LUNG C, V283, pL963, DOI 10.1152/ajplung.00130.2002; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bonner K, 2013, J ALLERGY CLIN IMMUN, V132, P942, DOI 10.1016/j.jaci.2013.04.015; Bonner K, 2010, J ALLERGY CLIN IMMUN, V126, P1277, DOI 10.1016/j.jaci.2010.08.013; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dakhama A, 2002, AM J RESP CRIT CARE, V165, P1137, DOI 10.1164/ajrccm.165.8.2109058; Fraser NJ, 1999, MOL PHARMACOL, V55, P1054, DOI 10.1124/mol.55.6.1054; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Kay AB, 2007, ALLERGY, V62, P495, DOI 10.1111/j.1398-9995.2007.01342.x; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Potaczek DP, 2013, PEDIAT ALLERG IMM-UK, V24, P441, DOI 10.1111/pai.12083; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Salvatore CA, 2008, J PHARMACOL EXP THER, V324, P416, DOI 10.1124/jpet.107.130344; Simms J, 2009, BIOCHEMISTRY-US, V48, P198, DOI 10.1021/bi801869n; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Tang YM, 1998, J NEUROIMMUNOL, V84, P207, DOI 10.1016/S0165-5728(97)00257-9; Tilley SL, 2007, J IMMUNOL, V178, P3208, DOI 10.4049/jimmunol.178.5.3208; Toru H, 1996, INT IMMUNOL, V8, P1367; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Wetzel-Strong SE, 2014, DEV DYNAM, V243, P243, DOI 10.1002/dvdy.24065; Wootten D, 2013, BRIT J PHARMACOL, V168, P822, DOI 10.1111/j.1476-5381.2012.02202.x; Yamamoto H, 2007, J APPL PHYSIOL, V102, P2361, DOI 10.1152/japplphysiol.00615.2006	35	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102356	10.1371/journal.pone.0102356	http://dx.doi.org/10.1371/journal.pone.0102356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010197	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800093
J	Sakamoto, JM; Goddard, J; Rasgon, JL				Sakamoto, Joyce M.; Goddard, Jerome; Rasgon, Jason L.			Population and Demographic Structure of Ixodes scapularis Say in the Eastern United States	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; BLACKLEGGED TICK; LYME-DISEASE; ACARI IXODIDAE; GEOGRAPHICAL VARIATION; BORRELIA-BURGDORFERI; EVOLUTIONARY HISTORY; PRINCIPAL VECTOR; DAMMINI ACARI; IDENTIFICATION	Introduction: The most significant vector of tick-borne pathogens in the United States is Ixodes scapularis Say (the blacklegged tick). Previous studies have identified significant genetic, behavioral and morphological differences between northern vs. southern populations of this tick. Because tick-borne pathogens are dependent on their vectors for transmission, a baseline understanding of the vector population structure is crucial to determining the risks and epidemiology of pathogen transmission. Methods: We investigated population genetic variation of I. scapularis populations in the eastern United States using a multilocus approach. We sequenced and analyzed the mitochondrial COI and 16S genes and three nuclear genes (serpin2, ixoderin B and lysozyme) from wild specimens. Results: We identified a deep divergence (3-7%) in I. scapularis COI gene sequences from some southern specimens, suggesting we had sampled a different Ixodes species. Analysis of mitochondrial 16S rRNA sequences did not support this hypothesis and indicated that all specimens were I. scapularis. Phylogenetic analysis and analysis of molecular variance (AMOVA) supported significant differences between northern vs. southern populations. Demographic analysis suggested that northern populations had experienced a bottleneck/expansion event sometime in the past, possibly associated with Pleistocene glaciation events. Conclusions: Similar to other studies, our data support the division of northern vs. southern I. scapularis genetic lineages, likely due to differences in the demographic histories between these geographic regions. The deep divergence identified in some COI gene sequences highlights a potential hazard of relying solely on COI for species identification ("barcoding") and population genetics in this important vector arthropod.	[Sakamoto, Joyce M.; Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Sakamoto, Joyce M.; Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Goddard, Jerome] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Mississippi State University	Sakamoto, JM (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jms1198@psu.edu		Rasgon, Jason/0000-0002-4050-8429	Huck Institutes of the Life Sciences	Huck Institutes of the Life Sciences	This research was supported by funds from the Huck Institutes of the Life Sciences to JMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2009, GENETICS, V183, P249, DOI 10.1534/genetics.109.104042; APPERSON CS, 1993, EXP APPL ACAROL, V17, P719; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Black WC, 2009, INSECT MOL BIOL, V18, P705, DOI 10.1111/j.1365-2583.2009.00925.x; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P531; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Durden LA, 2002, EXP APPL ACAROL, V26, P257, DOI 10.1023/A:1021199914816; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; FU YX, 1993, GENETICS, V133, P693; Goddard J, 2006, J VECTOR ECOL, V31, P421, DOI 10.3376/1081-1710(2006)31[421:NROIIS]2.0.CO;2; Goddard Jerome, 2002, J Agromedicine, V8, P25, DOI 10.1300/J096v08n02_06; Goltz L, 2013, SYST APPL ACAROL-UK, V18, P212, DOI 10.11158/saa.18.3.2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Hutcheson HJ, 1998, EXP APPL ACAROL, V22, P51, DOI 10.1023/A:1006085424796; HUTCHESON HJ, 1995, J MED ENTOMOL, V32, P827, DOI 10.1093/jmedent/32.6.827; Keirans JE, 1996, J MED ENTOMOL, V33, P297, DOI 10.1093/jmedent/33.3.297; Kempf F, 2009, MOL ECOL, V18, P4450, DOI 10.1111/j.1365-294X.2009.04356.x; McCoy KD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00057; MCLAIN DK, 1995, HEREDITY, V75, P303, DOI 10.1038/hdy.1995.139; McLain DK, 2001, HEREDITY, V86, P234, DOI 10.1046/j.1365-2540.2001.00835.x; MCLAIN DK, 1995, J MED ENTOMOL, V32, P353, DOI 10.1093/jmedent/32.3.353; Mechai S, 2013, J MED ENTOMOL, V50, P560, DOI 10.1603/ME12178; Norris DE, 1996, J MED ENTOMOL, V33, P78, DOI 10.1093/jmedent/33.1.78; Noureddine R, 2011, INT J PARASITOL, V41, P183, DOI 10.1016/j.ijpara.2010.08.010; OLIVER JH, 1993, J MED ENTOMOL, V30, P54, DOI 10.1093/jmedent/30.1.54; Oliver JH, 1996, J PARASITOL, V82, P926, DOI 10.2307/3284201; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poucher KL, 1999, J PARASITOL, V85, P623, DOI 10.2307/3285734; Qiu WG, 2002, GENETICS, V160, P833; Rasgon JL, 2006, P ROY SOC B-BIOL SCI, V273, P1603, DOI 10.1098/rspb.2006.3493; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RICH SM, 1995, P NATL ACAD SCI USA, V92, P6284, DOI 10.1073/pnas.92.14.6284; Rich SM, 1997, INSECT MOL BIOL, V6, P123, DOI 10.1111/j.1365-2583.1997.tb00080.x; Rounds MA, 2012, J MED ENTOMOL, V49, P843, DOI 10.1603/ME12038; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Scarpassa VM, 2011, AM J TROP MED HYG, V85, P857, DOI 10.4269/ajtmh.2011.11-0150; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; SPIELMAN A, 1979, J MED ENTOMOL, V15, P218, DOI 10.1093/jmedent/15.3.218; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Zee J, 2013, TICKS TICK-BORNE DIS, V4, P63, DOI 10.1016/j.ttbdis.2012.07.005; Venkatesan M, 2007, MOL BIOL EVOL, V24, P1208, DOI 10.1093/molbev/msm040; WESSON DM, 1993, P NATL ACAD SCI USA, V90, P10221, DOI 10.1073/pnas.90.21.10221; Wolff JN, 2013, HEREDITY, V110, P57, DOI 10.1038/hdy.2012.60; Xiong HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073329	60	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101389	10.1371/journal.pone.0101389	http://dx.doi.org/10.1371/journal.pone.0101389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025532	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400014
J	Wilson, HB; Meijaard, E; Venter, O; Ancrenaz, M; Possingham, HP				Wilson, Howard B.; Meijaard, Erik; Venter, Oscar; Ancrenaz, Marc; Possingham, Hugh P.			Conservation Strategies for Orangutans: Reintroduction versus Habitat Preservation and the Benefits of Sustainably Logged Forest	PLOS ONE			English	Article							IMPACT; SUMATRA; RESERVE; WILD	The Sumatran orangutan is currently listed by the IUCN as critically endangered and the Bornean species as endangered. Unless effective conservation measures are enacted quickly, most orangutan populations without adequate protection face a dire future. Two main strategies are being pursued to conserve orangutans: (i) rehabilitation and reintroduction of excaptive or displaced individuals; and (ii) protection of their forest habitat to abate threats like deforestation and hunting. These strategies are often mirrored in similar programs to save other valued and endangered mega-fauna. Through GIS analysis, collating data from across the literature, and combining this information within a modelling and decision analysis framework, we analysed which strategy or combination of strategies is the most cost-effective at maintaining wild orangutan populations, and under what conditions. We discovered that neither strategy was optimal under all circumstances but was dependent on the relative cost per orangutan, the timescale of management concern, and the rate of deforestation. Reintroduction, which costs twelve times as much per animal as compared to protection of forest, was only a cost-effective strategy at very short timescales. For time scales longer than 10-20 years, forest protection is the more cost-efficient strategy for maintaining wild orangutan populations. Our analyses showed that a third, rarely utilised strategy is intermediate: introducing sustainable logging practices and protection from hunting in timber production forest. Maximum long-term cost-efficiency is achieved by working in conservation forest. However, habitat protection involves addressing complex conservation issues and conflicting needs at the landscape level. We find a potential resolution in that well-managed production forests could achieve intermediate conservation outcomes. This has broad implications for sustaining biodiversity more generally within an economically productive landscape. Insights from this analysis should provide a better framework to prioritize financial investments, and facilitate improved integration between the organizations that implement these strategies.	[Wilson, Howard B.; Meijaard, Erik; Venter, Oscar; Possingham, Hugh P.] Univ Queensland, Australian Res Council Ctr Excellence Environm De, Sch Biol Sci, Brisbane, Qld, Australia; [Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Venter, Oscar] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Australia; [Venter, Oscar] James Cook Univ, Sch Marine & Trop Biol, Cairns, Australia; [Ancrenaz, Marc] Kinabatangan Orangutan Conservat Project, Sandakan, Malaysia	University of Queensland; People & Nature Consulting International; James Cook University; James Cook University	Wilson, HB (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Environm De, Sch Biol Sci, Brisbane, Qld, Australia.	h.wilson1@uq.edu.au	Venter, Oscar/ABE-1477-2021; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Meijaard, Erik/A-2687-2016	Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Meijaard, Erik/0000-0001-8685-3685	Centre for Applied Environmental Decision Analysis, a Commonwealth Environmental Research Facility Hub - Australian Government Department of Environment, Water, Heritage and the Arts	Centre for Applied Environmental Decision Analysis, a Commonwealth Environmental Research Facility Hub - Australian Government Department of Environment, Water, Heritage and the Arts	This work was supported by the Centre for Applied Environmental Decision Analysis, a Commonwealth Environmental Research Facility Hub funded by the Australian Government Department of Environment, Water, Heritage and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Applegate GB, 2002, APPL REDUCED IMPACT; Aveling R., 1982, Oryx, V16, P263; BOS, 2008, IND AUD REP FIN STAT; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Davis JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075373; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Gaveau DLA, 2012, CONSERV LETT, V5, P142, DOI 10.1111/j.1755-263X.2011.00220.x; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Grundmann E, 2006, SOC SCI INFORM, V45, P265, DOI 10.1177/0539018406063643; Hartig F, 2008, BIOL CONSERV, V141, P2625, DOI 10.1016/j.biocon.2008.07.028; Husson Simon J., 2009, P77; Jepson P, 2002, NAT AREA J, V22, P28; Lagan P, 2007, ECOL RES, V22, P414, DOI 10.1007/s11284-007-0362-3; LardeuxGilloux I, 1995, NEGLECTED APE, P61; Linkie M, 2008, CONSERV BIOL, V22, P683, DOI 10.1111/j.1523-1739.2008.00906.x; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; McQuistan C. I., 2006, PROT AR FUND IND STU; Meijaard E, 2012, ANN NY ACAD SCI, V1249, P29, DOI 10.1111/j.1749-6632.2011.06288.x; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Pressey RL, 2004, ECOL LETT, V7, P1035, DOI 10.1111/j.1461-0248.2004.00672.x; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Rijksen HD, 1999, OUR VANISHING RELATI; Rijksen HD, 1982, ORANGUTAN ITS BIOL C, P317; Ruslandi, 2011, FRONT ECOL ENVIRON, V9, P542, DOI 10.1890/11.WB.030; Russon Anne E., 2009, P327; Singleton I., 2004, ORANGUTAN POPULATION; Soehartono Tonny., 2007, STRATEGI DAN RENCANA; Tutin CEG, 2001, CONSERV BIOL, V15, P1247, DOI 10.1046/j.1523-1739.2001.00046.x; Venter O, 2013, CONSERV LETT, V6, P116, DOI 10.1111/j.1755-263X.2012.00287.x; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wilson HB, 2011, ECOL LETT, V14, P886, DOI 10.1111/j.1461-0248.2011.01652.x	38	28	29	4	265	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102174	10.1371/journal.pone.0102174	http://dx.doi.org/10.1371/journal.pone.0102174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025134	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000339992400047
J	Avsaroglu, B; Bronk, G; Gordon-Messer, S; Ham, J; Bressan, DA; Haber, JE; Kondev, J				Avsaroglu, Baris; Bronk, Gabriel; Gordon-Messer, Susannah; Ham, Jungoh; Bressan, Debra A.; Haber, James E.; Kondev, Jane			Effect of Chromosome Tethering on Nuclear Organization in Yeast	PLOS ONE			English	Article							GENOME ORGANIZATION; CHROMATIN FIBER; GENE-EXPRESSION; DYNAMICS; REVEALS; DNA; TERRITORIES; FLEXIBILITY; PRINCIPLES; PERIPHERY	Interphase chromosomes in Saccharomyces cerevisiae are tethered to the nuclear envelope at their telomeres and to the spindle pole body (SPB) at their centromeres. Using a polymer model of yeast chromosomes that includes these interactions, we show theoretically that telomere attachment to the nuclear envelope is a major determinant of gene positioning within the nucleus only for genes within 10 kb of the telomeres. We test this prediction by measuring the distance between the SPB and the silent mating locus (HML) on chromosome III in wild-type and mutant yeast strains that contain altered chromosome-tethering interactions. In wild-type yeast cells we find that disruption of the telomere tether does not dramatically change the position of HML with respect to the SPB, in agreement with theoretical predictions. Alternatively, using a mutant strain with a synthetic tether that localizes an HML-proximal site to the nuclear envelope, we find a significant change in the SPB-HML distance, again as predicted by theory. Our study quantifies the importance of tethering at telomeres on the organization of interphase chromosomes in yeast, which has been shown to play a significant role in determining chromosome function such as gene expression and recombination.	[Avsaroglu, Baris; Bronk, Gabriel; Kondev, Jane] Brandeis Univ, Dept Phys, Waltham, MA 02254 USA; [Gordon-Messer, Susannah; Ham, Jungoh; Bressan, Debra A.; Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Gordon-Messer, Susannah; Ham, Jungoh; Bressan, Debra A.; Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Gordon-Messer, Susannah] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	Brandeis University; Brandeis University; Brandeis University; Brandeis University	Avsaroglu, B (corresponding author), Brandeis Univ, Dept Phys, Waltham, MA 02254 USA.	baris@brandeis.edu			NSF grants [MRSEC 0820492, DMR-1206146]; NIH grant [GM20056]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R37GM020056] Funding Source: NIH RePORTER	NSF grants(National Science Foundation (NSF)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grants MRSEC 0820492 and DMR-1206146, and by the NIH grant GM20056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Albert B, 2013, J CELL BIOL, V202, P201, DOI 10.1083/jcb.201208186; Albert B, 2012, BBA-GENE REGUL MECH, V1819, P468, DOI 10.1016/j.bbagrm.2011.12.010; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bassett A, 2009, CURR OPIN GENET DEV, V19, P159, DOI 10.1016/j.gde.2009.02.010; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Belmont AS, 1989, CHROMOSOMA; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Brickner Jason H, 2004, PLoS Biol, V2, pe342; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Cockell MM, 1999, CURR BIOL, V9, pR575, DOI 10.1016/S0960-9822(99)80359-5; Cremer T, 2006, EUR J HISTOCHEM, V50, P161; de Gennes P. G., 1979, SCALING CONCEPTS POL; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Gehlen LR, 2006, J PHYS-CONDENS MAT, V18, pS245, DOI 10.1088/0953-8984/18/14/S09; GEHLEN LR, 2012, DO NOT DISTRIBUTE, V3, P370; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Hajjoul H, 2013, GENOME RES, V23, P1829, DOI 10.1101/gr.157008.113; Hoze N, 2013, MOL BIOL CELL, V24, P1791, DOI 10.1091/mbc.E13-01-0031; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Jin QW, 2000, J CELL SCI, V113, P1903; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Marvin ME, 2009, GENETICS, V183, P453, DOI 10.1534/genetics.109.106682; Marvin ME, 2009, GENETICS, V183, P441, DOI 10.1534/genetics.109.106674; Marvin ME, 2009, GENETICS, V183, p1SI; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; PETERLIN A, 1953, NATURE, V171, P259, DOI 10.1038/171259b0; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Rabl C, 1885, MORPHOL JB, V10, P214; Rippe K, 2012, GENOME ORGANIZATION AND FUNCTION IN THE CELL NUCLEUS, P1; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Therizols P, 2010, P NATL ACAD SCI USA, V107, P2025, DOI 10.1073/pnas.0914187107; Tjong H, 2012, GENOME RES, V22, P1295, DOI 10.1101/gr.129437.111; Tokuda N, 2012, BIOPHYS J, V102, P296, DOI 10.1016/j.bpj.2011.12.005; UCHIDA M, 2011, QUANTITATIVE ANAL YE, V28, P227; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Wong H, 2012, CURR BIOL, V22, P1881, DOI 10.1016/j.cub.2012.07.069; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	84	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102474	10.1371/journal.pone.0102474	http://dx.doi.org/10.1371/journal.pone.0102474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020108	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600084
J	Budding, AE; Grasman, ME; Eck, A; Bogaards, JA; Vandenbroucke-Grauls, CMJE; van Bodegraven, AA; Savelkoul, PHM				Budding, Andries E.; Grasman, Matthijs E.; Eck, Anat; Bogaards, Johannes A.; Vandenbroucke-Grauls, Christina M. J. E.; van Bodegraven, Adriaan A.; Savelkoul, Paul H. M.			Rectal Swabs for Analysis of the Intestinal Microbiota	PLOS ONE			English	Article							STORAGE-CONDITIONS; EXTRACTION; DNA; BACTERIAL	The composition of the gut microbiota is associated with various disease states, most notably inflammatory bowel disease, obesity and malnutrition. This underlines that analysis of intestinal microbiota is potentially an interesting target for clinical diagnostics. Currently, the most commonly used sample types are feces and mucosal biopsy specimens. Because sampling method, storage and processing of samples impact microbiota analysis, each sample type has its own limitations. An ideal sample type for use in routine diagnostics should be easy to obtain in a standardized fashion without perturbation of the microbiota. Rectal swabs may satisfy these criteria, but little is known about microbiota analysis on these sample types. In this study we investigated the characteristics and applicability of rectal swabs for gut microbiota profiling in a clinical routine setting in patients presenting with various gastro-intestinal disorders. We found that rectal swabs appeared to be a convenient means of sampling the human gut microbiota. Swabs can be performed on demand, whenever a patient presents; swab-derived microbiota profiles are reproducible, whether they are gathered at home by patients or by medical professionals in an outpatient setting and may be ideally suited for clinical diagnostics and large-scale studies.	[Budding, Andries E.; Eck, Anat; Vandenbroucke-Grauls, Christina M. J. E.; Savelkoul, Paul H. M.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Grasman, Matthijs E.; van Bodegraven, Adriaan A.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Bogaards, Johannes A.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van Bodegraven, Adriaan A.] ORBIS Med Ctr, Dept Internal Med Gastroenterol & Geriatr, Sittard Geleen, Netherlands; [Savelkoul, Paul H. M.] Maastricht Univ Med Ctr, Dept Med Microbiol, Maastricht, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Orbis Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC)	Budding, AE (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	d.budding@vumc.nl	van Bodegraven, Ad/ABG-4367-2020; van Bodegraven, Ad A/L-3180-2013; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Budding, Andries/0000-0001-5128-5411; Bogaards, Johannes/0000-0002-3389-5141				Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Cuiv PO, 2011, MICROB ECOL, V61, P353, DOI 10.1007/s00248-010-9771-x; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Nylund L, 2010, J MICROBIOL METH, V83, P231, DOI 10.1016/j.mimet.2010.09.003; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sloan LM, 2004, J CLIN MICROBIOL, V42, P2636, DOI 10.1128/JCM.42.6.2636-2643.2004; SYED SA, 1972, APPL MICROBIOL, V24, P638, DOI 10.1128/AEM.24.4.638-644.1972; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414	16	87	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101344	10.1371/journal.pone.0101344	http://dx.doi.org/10.1371/journal.pone.0101344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020051	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600013
J	Cui, YY; Xu, H; Wu, HH; Qi, J; Shi, J; Li, YQ				Cui, Yuan-Yuan; Xu, Hao; Wu, Huang-Hui; Qi, Jian; Shi, Juan; Li, Yun-Qing			Spatio-Temporal Expression and Functional Involvement of Transient Receptor Potential Vanilloid 1 in Diabetic Mechanical Allodynia in Rats	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; IMMUNOHISTOCHEMICALLY IDENTIFIED NEURONS; PRIMARY SENSORY NEURONS; SPINAL NERVE LIGATION; CAPSAICIN RECEPTOR; INFLAMMATORY PAIN; THERMAL HYPERALGESIA; NEUROPATHIC PAIN; DRG NEURONS; TRPV1	Diabetic neuropathic pain (DNP) is one of the most common clinical manifestations of diabetes mellitus (DM), which is characterized by prominent mechanical allodynia (DMA). However, the molecular mechanism underlying it has not fully been elucidated. In this study, we examined the spatio-temporal expression of a major nociceptive channel protein transient receptor potential vanilloid 1 (TRPV1) and analyzed its functional involvement by intrathecal (i.t.) application of TRPV1 antagonists in streptozocin (STZ)-induced DMA rat models. Western blot and immunofluorescent staining results showed that TRPV1 protein level was significantly increased in the soma of the dorsal root ganglion (DRG) neurons on 14 days after STZ treatment (DMA 14 d), whereas those in spinal cord and skin (mainly from the central and peripheral processes of DRG neurons) had already been enhanced on DMA 7 d to peak on DMA 14 d. qRT-PCR experiments confirmed that TRPV1 mRNA level was significantly up-regulated in the DRG on DMA 7 d, indicating a preceding translation of TRPV1 protein in the soma but preferential distribution of this protein to the processes under the DMA conditions. Cell counting assay based on double immunostaining suggested that increased TRPV1-immunoreactive neurons were likely to be small-sized and CGRP-ergic. Finally, single or multiple intrathecal applications of non-specific or specific TRPV1 antagonists, ruthenium red and capsazepine, at varying doses, effectively alleviated DMA, although the effect of the former was more prominent and long-lasting. These results collectively indicate that TRPV1 expression dynamically changes during the development of DMA and this protein may play important roles in mechanical nociception in DRG neurons, presumably through facilitating the release of CGRP.	[Cui, Yuan-Yuan; Xu, Hao; Qi, Jian; Shi, Juan; Li, Yun-Qing] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Cui, Yuan-Yuan; Xu, Hao; Qi, Jian; Shi, Juan; Li, Yun-Qing] Fourth Mil Med Univ, Preclin Sch Med, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Cui, Yuan-Yuan] Xian Med Univ, Inst Basic Med Sci, Xian, Peoples R China; [Cui, Yuan-Yuan] Xian Med Univ, Lab Cell Biol & Translat Med, Xian, Peoples R China; [Wu, Huang-Hui] Fujian Med Univ, Fuzhou Gen Hosp, Dept Anesthesiol, Fuzhou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University; Xi'an Medical University; Fujian Medical University	Shi, J (corresponding author), Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China.	shixjuan@fmmu.edu.cn; deptanat@fmmu.edu.cn			National Natural Science Foundation of China [30971123, 31010103909, 31071012, 81371239]; Shaanxi Provincial Education Department [2013JK0757]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Education Department	National Natural Science Foundation of China (Nos. 30971123, 31010103909, 31071012, 81371239) and Scientific Research Program Funded by Shaanxi Provincial Education Department (Program No. 2013JK0757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Bennett DLH, 2001, NEUROSCIENTIST, V7, P13, DOI 10.1177/107385840100700105; Bishnoi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-52; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Ciura S, 2006, J NEUROSCI, V26, P9069, DOI 10.1523/JNEUROSCI.0877-06.2006; Daly D, 2007, J PHYSIOL-LONDON, V583, P663, DOI 10.1113/jphysiol.2007.139147; De Petrocellis Luciano, 2013, Recent Pat CNS Drug Discov, V8, P180; Engle MP, 2012, J COMP NEUROL, V520, P1663, DOI 10.1002/cne.23005; Gerke MB, 2002, ANAT RECORD, V268, P105, DOI 10.1002/ar.10144; Hammond DL, 2004, J COMP NEUROL, V475, P575, DOI 10.1002/cne.20209; Hara T, 2013, PAIN, V154, P882, DOI 10.1016/j.pain.2013.02.023; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Holzer P, 2009, DIGEST DIS, V27, P24, DOI 10.1159/000268118; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Ivanusic JJ, 2009, J COMP NEUROL, V517, P276, DOI 10.1002/cne.22160; Jakkamsetti V, 2013, NEURON, V80, P72, DOI 10.1016/j.neuron.2013.07.020; Kasama S, 2007, EUR J NEUROSCI, V25, P2956, DOI 10.1111/j.1460-9568.2007.05584.x; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Ma WY, 2005, PAIN, V113, P386, DOI 10.1016/j.pain.2004.11.018; Mandadi S, 2008, CURR NEUROPHARMACOL, V6, P21, DOI 10.2174/157015908783769680; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morioka N, 2002, J NEUROCHEM, V80, P989, DOI 10.1046/j.0022-3042.2002.00722.x; Morrow Thomas J, 2004, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0918s29; Murthy Kalyani, 2005, Endocr Pract, V11, P331; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Pabbidi RM, 2008, MOL PHARMACOL, V73, P995, DOI 10.1124/mol.107.041707; Palazzo E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-66; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Pierre MS, 2009, EXP BRAIN RES, V196, P31, DOI 10.1007/s00221-009-1808-3; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; Sekino Y, 2014, EUR J PAIN, V18, P639, DOI 10.1002/j.1532-2149.2013.00412.x; Shinoda M, 2008, J PAIN, V9, P687, DOI 10.1016/j.jpain.2008.02.007; Smart D, 2001, EUR J PHARMACOL, V417, P51, DOI 10.1016/S0014-2999(01)00901-3; Sugimoto Y, 2013, J PHARMACOL SCI, V123, P256, DOI 10.1254/jphs.13088FP; Sun W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039647; Tang ZY, 2009, J NEUROTRAUM, V26, P289, DOI 10.1089/neu.2008.0506; Tominaga M, 2000, JPN J PHARMACOL, V83, P20, DOI 10.1254/jjp.83.20; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Ugawa S, 2005, MOL BRAIN RES, V136, P125, DOI 10.1016/j.molbrainres.2005.01.010; Veves A, 2008, PAIN MED, V9, P660, DOI 10.1111/j.1526-4637.2007.00347.x; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Wu HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092374; Xiao LZ, 2013, PAIN MED, V14, P276, DOI 10.1111/pme.12017; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	52	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102052	10.1371/journal.pone.0102052	http://dx.doi.org/10.1371/journal.pone.0102052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020137	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600041
J	Danielsen, AK; Okholm, C; Pommergaard, HC; Burcharth, J; Rosenberg, J				Danielsen, Anne Kjaergaard; Okholm, Cecilie; Pommergaard, Hans-Christian; Burcharth, Jakob; Rosenberg, Jacob			Number of Published Randomized Controlled Multi Center Trials Testing Pharmacological Interventions or Devices Is Increasing in Both Medical and Surgical Specialties	PLOS ONE			English	Article							SPONSORSHIP; CHALLENGES; SURGERY; IMPACT	Background: In general, there is a need for testing new interventions in large randomized controlled trials. Depending on the research question it may be advantageous to establish multicenter studies as a way of organizing clinical trials in order to increase study power. Main Objectives: The object of this study was to investigate the development in the organization of multicenter studies, the distribution of studies within different clinical specialties, across continents, and investigate the differences related to testing various interventions. Methods and Materials: A literature search was done in MEDLINE for multicenter studies published in 1995, 2000, 2005, and 2010, respectively. Data extraction identified data related to clinical specialties, interventions, participating patients, departments, countries, and continents. Results: The number of multicenter studies increased from 112 in 1995 to 1,273 in 2010, with a larger share of multicenter studies being performed in Europe and North America. The pharmacological interventions were primarily being tested in medical studies followed by the device tests predominantly in surgical studies. The number of included patients as well as the number of participating departments increased during the time span, though the increase in studies was most evident in Europe and North America compared with the rest of the world.	[Danielsen, Anne Kjaergaard] Metropolitan Univ Coll, Fac Hlth & Technol, Dept Nursing, Copenhagen, Denmark; [Okholm, Cecilie; Pommergaard, Hans-Christian; Burcharth, Jakob; Rosenberg, Jacob] Univ Copenhagen, Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Danielsen, AK (corresponding author), Metropolitan Univ Coll, Fac Hlth & Technol, Dept Nursing, Copenhagen, Denmark.	anne.k.danielsen@gmail.com	Burcharth, Jakob/S-9147-2019; Pommergaard, Hans-Christian/GSN-8028-2022	Burcharth, Jakob/0000-0001-8367-7831; Pommergaard, Hans-Christian/0000-0001-7068-1946; Rosenberg, Jacob/0000-0002-0063-1086; Danielsen, Anne/0000-0003-0507-0887				Ali UA, 2013, ANN SURG, V258, P199, DOI 10.1097/SLA.0b013e31829c7795; Barnard KD, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-63; Chung KC, 2010, PLAST RECONSTR SURG, V126, P515, DOI 10.1097/PRS.0b013e3181df64fa; Costello A, 2000, BRIT MED J, V321, P827, DOI 10.1136/bmj.321.7264.827; Dane A, 2011, PHARM STAT, V10, P454, DOI 10.1002/pst.518; Diener MK, 2009, SURGERY, V146, P444, DOI 10.1016/j.surg.2009.02.016; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Horton R, 1997, LANCET, V349, P1411, DOI 10.1016/S0140-6736(05)63721-X; Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576; Knebel P, 2012, LANGENBECK ARCH SURG, V397, P611, DOI 10.1007/s00423-012-0922-z; Perlis CS, 2005, J AM ACAD DERMATOL, V52, P967, DOI 10.1016/j.jaad.2005.01.020; Rosenberg J, 2012, COLORECTAL DIS, V14, P266, DOI 10.1111/j.1463-1318.2011.02896.x; Roumiantseva D, 2013, CONTEMP CLIN TRIALS, V34, P348, DOI 10.1016/j.cct.2013.01.004; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f936; Wente MN, 2003, DIGEST SURG, V20, P263, DOI 10.1159/000071183	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101383	10.1371/journal.pone.0101383	http://dx.doi.org/10.1371/journal.pone.0101383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020129	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600014
J	Sellami, H; Znazen, A; Sellami, A; Mnif, H; Louati, N; Ben Zarrouk, S; Keskes, L; Rebai, T; Gdoura, R; Hammami, A				Sellami, Hanen; Znazen, Abir; Sellami, Afifa; Mnif, Hela; Louati, Nour; Ben Zarrouk, Soumaya; Keskes, Leila; Rebai, Tarek; Gdoura, Radhouane; Hammami, Adnene			Molecular Detection of Chlamydia trachomatis and Other Sexually Transmitted Bacteria in Semen of Male Partners of Infertile Couples in Tunisia: The Effect on Semen Parameters and Spermatozoa Apoptosis Markers	PLOS ONE			English	Article							REAL-TIME PCR; UREAPLASMA-UREALYTICUM INFECTIONS; ASYMPTOMATIC MALE PARTNERS; POLYMERASE-CHAIN-REACTION; SPERM DNA FRAGMENTATION; EJACULATED HUMAN SPERM; MYCOPLASMA-HOMINIS; GENITAL-TRACT; MITOCHONDRIAL-FUNCTION; CHROMATIN INTEGRITY	This study was undertaken to determine the prevalence of Chlamydia trachomatis, Mycoplasmas, and Ureaplasmas in semen samples of the male partners of infertile couples and to investigate whether Chlamydia trachomatis could initiate apoptosis in human spermatozoa. A total of 85 males partners of infertile couples undergoing routine semen analysis according to World Health Organization guidelines were included. Specimens were examined for the presence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Ureaplasma parvum by Real time PCR (qPCR). Semen specimens were analysed for the appearance of apoptotic markers (sperm DNA fragmentation, activated caspase 3 levels, mitochondrial membrane potential (Delta Psi m)) using flow cytometry. C. trachomatis, N. gonorrhoeae, U. urealyticum, M genitalium were detected in semen samples of 13 (15.2%), 5 (5.8%), 5 (5.8%) and 3 (3.5%) male partners of infertile couples, respectively. M. hominis and U. parvum were detected in semen sample of only one patient (1.1%). The semen of infertile men positive for C. trachomatis showed lower mean of semen count and lower rapid progressive motility (category [a]) of spermatozoa compared to uninfected men with statistically significances (p = 0.02 and p = 0.04, respectively). Flow cytometry analyses demonstrated a significant increase of the mean rate of semen with low Delta Psi m and caspase 3 activation of infertile men positive for C. trachomatis compared to uninfected men (p = 0.006 and p = 0.001, respectively). DNA fragmentation was also increased in sperm of infertile men positive for C. trachomatis compared to uninfected men but without statistical significances (p = 0.62). Chlamydial infection was associated to loss of Delta Psi m and caspase 3activation. Thus, C. trachomatis infection could be incriminated in apoptosis induction of spermatozoa. These effects may explain the negative direct impact of C. trachomatis infection on sperm fertilizing ability.	[Sellami, Hanen; Znazen, Abir; Hammami, Adnene] Habib Bourguiba Univ Hosp Sfax, Dept Microbiol & Res Lab Microorganismes & Pathol, Sfax, Tunisia; [Sellami, Afifa; Ben Zarrouk, Soumaya; Keskes, Leila; Rebai, Tarek] Univ Sfax, Fac Med Sfax, Histol Embryol Res Unit, Sfax, Tunisia; [Mnif, Hela; Louati, Nour] Sfax Reg Ctr Blood Transfus, Sfax, Tunisia; [Gdoura, Radhouane] Univ Sfax, Sci Fac Sfax, Unit Res Toxicol Microbiol Environm & Hlth, Sfax, Tunisia	Universite de Sfax; Hopital Habib Bourguiba; Universite de Sfax; Universite de Sfax; Universite de Sfax	Znazen, A (corresponding author), Habib Bourguiba Univ Hosp Sfax, Dept Microbiol & Res Lab Microorganismes & Pathol, Sfax, Tunisia.	abir.znazen@rns.tn	Gdoura, Radhouane/AAD-6486-2022; Gdoura, Radhouane/I-6865-2018	Gdoura, Radhouane/0000-0003-1140-3780; SELLAMI, Hanen/0000-0001-5479-1707; Keskes, Leila/0000-0002-8420-139X	research laboratory "MPH'' Habib Bourguiba University Hospital of Sfax Tunisia	research laboratory "MPH'' Habib Bourguiba University Hospital of Sfax Tunisia	The work was financed by the research laboratory "MPH'' Habib Bourguiba University Hospital of Sfax Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusarah EA, 2013, DIAGN MICR INFEC DIS, V77, P283, DOI 10.1016/j.diagmicrobio.2013.05.018; Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Al-Mously N, 2009, FERTIL STERIL, V92, P1606, DOI 10.1016/j.fertnstert.2008.08.128; Al-Sweih NA, 2012, J ANDROL, V33, P1323, DOI 10.2164/jandrol.111.013821; BORNMAN MS, 1990, ANDROLOGIA, V22, P118; Cengiz T., 1997, International Urology and Nephrology, V29, P687, DOI 10.1007/BF02552187; CUSTO GM, 1989, ARCH ANDROLOGY, V23, P243, DOI 10.3109/01485018908986847; Motrich RD, 2006, J INFECTION, V53, P175, DOI 10.1016/j.jinf.2005.11.007; Datcu R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-480; de Barbeyrac B, 2006, EUR J OBSTET GYN R B, V129, P46, DOI 10.1016/j.ejogrb.2006.02.014; DEJONG Z, 1990, EUR UROL, V18, P127; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Domes T, 2012, FERTIL STERIL, V97, P299, DOI 10.1016/j.fertnstert.2011.11.024; Eggert-Kruse W, 2003, FERTIL STERIL, V80, P660, DOI 10.1016/S0015-0282(03)00761-1; Eley A, 2005, HUM REPROD, V20, P2601, DOI 10.1093/humrep/dei082; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; GALDIERO F, 1994, FEMS MICROBIOL LETT, V115, P197, DOI 10.1016/0378-1097(94)90013-2; Gallegos G, 2008, FERTIL STERIL, V90, P328, DOI 10.1016/j.fertnstert.2007.06.035; Garner DL, 1999, MOL REPROD DEV, V53, P222, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;222::AID-MRD11&gt;3.0.CO;2-L; Gdoura R, 2008, J ANDROL, V29, P198, DOI 10.2164/jandrol.107.003566; Gdoura R, 2001, EUR J CONTRACEP REPR, V6, P102, DOI 10.1080/713604209; Gdoura R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-129; Gewies A, 2003, BRIT J CANCER, V89, P1574, DOI 10.1038/sj.bjc.6601297; GORCZYCA W, 1993, EXP CELL RES, V207, P202, DOI 10.1006/excr.1993.1182; Gravance CG, 2000, THERIOGENOLOGY, V53, P1691, DOI 10.1016/S0093-691X(00)00308-3; Habermann B, 1999, J EUR ACAD DERMATOL, V12, P25, DOI 10.1016/S0926-9959(98)00092-0; Hamdad-Daoudi F, 2004, J MED MICROBIOL, V53, P985, DOI 10.1099/jmm.0.45641-0; Hjelmevoll SO, 2006, J MOL DIAGN, V8, P574, DOI 10.2353/jmoldx.2006.060024; Hosseinzadeh S, 2003, J MED MICROBIOL, V52, P193, DOI 10.1099/jmm.0.04836-0; Hosseinzadeh S, 2001, HUM REPROD, V16, P293, DOI 10.1093/humrep/16.2.293; Hosseinzadeh S, 2004, J ANDROL, V25, P104; Hosseinzadeh S, 2000, INFECT IMMUN, V68, P4872, DOI 10.1128/IAI.68.9.4872-4876.2000; Idahl A, 2004, HUM REPROD, V19, P1121, DOI 10.1093/humrep/deh155; Jakiel Grzegorz, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P61; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Jalal H, 2013, INT J MOL EPIDEMIOL, V4, P167; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Keck C, 1998, HUM REPROD UPDATE, V4, P891, DOI 10.1093/humupd/4.6.891; Knox CL, 2003, FERTIL STERIL, V80, P921, DOI 10.1016/S0015-0282(03)01125-7; La Vignera S, 2011, INT J ANDROL, V34, pE330, DOI 10.1111/j.1365-2605.2011.01200.x; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Liu JJ, 2014, UROLOGY, V83, P795, DOI 10.1016/j.urology.2013.11.009; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Ochsendorf FR, 2008, ANDROLOGIA, V40, P72, DOI 10.1111/j.1439-0272.2007.00825.x; Ochsendorf FR, 1999, J EUR ACAD DERMATOL, V12, P143, DOI 10.1111/j.1468-3083.1999.tb01005.x; Paasch U, 2004, FERTIL STERIL, V81, P802, DOI 10.1016/j.fertnstert.2003.09.030; Paasch U, 2003, J ANDROL, V24, P246; Paavonen J, 1999, HUM REPROD UPDATE, V5, P433, DOI 10.1093/humupd/5.5.433; Pajovic B, 2013, ANDROLOGIA, V45, P266, DOI 10.1111/and.12004; Pannekoek Y, 2000, J MED MICROBIOL, V49, P697, DOI 10.1099/0022-1317-49-8-697; Pascual A, 2010, INT J MICROBIOL, V2010; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Reichart M, 2000, BIOL REPROD, V63, P1041, DOI 10.1095/biolreprod63.4.1041; Rosemond A, 2006, PATHOL BIOL, V54, P125, DOI 10.1016/j.patbio.2005.09.004; Rowe P.J., 2000, WHO MANUAL STANDARDI; Rybar R, 2012, ANDROLOGIA, V44, P410, DOI 10.1111/j.1439-0272.2011.01198.x; Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586; Sakkas Denny, 2003, Reprod Biomed Online, V7, P428; Satta A, 2006, HUM REPROD, V21, P134, DOI 10.1093/humrep/dei269; Schuffner A, 2002, J ANDROL, V23, P194; Schulz M, 2010, FERTIL STERIL, V94, P619, DOI 10.1016/j.fertnstert.2009.01.140; Sellami H, 2011, J ANDROL, V32, P86, DOI 10.2164/jandrol.109.009183; Shen HM, 2002, HUM REPROD, V17, P1266, DOI 10.1093/humrep/17.5.1266; Taylor SL, 2004, MOL HUM REPROD, V10, P825, DOI 10.1093/molehr/gah099; Vancutsem E, 2011, J MOL DIAGN, V13, P206, DOI 10.1016/j.jmoldx.2010.10.007; Veznik Z, 2004, ACTA OBSTET GYN SCAN, V83, P656, DOI 10.1111/j.0001-6349.2004.00542.x; Vigil P, 2002, ANDROLOGIA, V34, P155, DOI 10.1046/j.1439-0272.2002.00472.x; Villegas J, 2005, APOPTOSIS, V10, P105, DOI 10.1007/s10495-005-6065-8; VOGELS WHM, 1993, J CLIN MICROBIOL, V31, P1103, DOI 10.1128/JCM.31.5.1103-1107.1993; Wang Y, 2006, ASIAN J ANDROL, V8, P562, DOI 10.1111/j.1745-7262.2006.00190.x; Weidner W, 1996, INFECTION, V24, P309, DOI 10.1007/BF01743366; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Witkin SS, 2002, BEST PRACT RES CL OB, V16, P865, DOI 10.1053/beog.2002.0326; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yoshida T, 2002, J CLIN MICROBIOL, V40, P105, DOI 10.1128/JCM.40.1.105-110.2002	76	41	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e98903	10.1371/journal.pone.0098903	http://dx.doi.org/10.1371/journal.pone.0098903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019616	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600001
J	Stea, TH; Andersen, LF; Paulsen, G; Hetlelid, KJ; Lohne-Seiler, H; Adnanes, S; Bjornsen, T; Salvesen, S; Berntsen, S				Stea, Tonje H.; Andersen, Lene F.; Paulsen, Goran; Hetlelid, Ken J.; Lohne-Seiler, Hilde; Adnanes, Svanhild; Bjornsen, Thomas; Salvesen, Svein; Berntsen, Sveinung			Validation of a Pre-Coded Food Diary Used among 60-80 Year Old Men: Comparison of Self-Reported Energy Intake with Objectively Recorded Energy Expenditure	PLOS ONE			English	Article							DOUBLY LABELED WATER; DIETARY PATTERNS; ADULTS; MORTALITY; ADOLESCENTS; POPULATION; CHILDREN; VALIDITY; QUALITY; WOMEN	Objective: To validate energy intake (EI) estimated from a pre-coded food diary (PFD) against energy expenditure (EE) measured with a valid physical activity monitor (SenseWear Pro(3) Armband) and to evaluate whether misreporting was associated with overweight/obesity in a group of elderly men. Methods: Forty-seven healthy Norwegian men, 60-80 years old, completed the study. As this study was part of a larger intervention study, cross-sectional data were collected at both baseline and post-test. Participants recorded their food intake for four consecutive days using food diaries and wore SenseWear Pro(3) Armband (SWA) during the same period. Only participants with complete data sets at both baseline and post-test were included in the study. Results: The group average EI was 17% lower at baseline and 18% lower at post-test compared to measured EE. Mean difference from Bland-Altman plot for EI and EE was -1.5 MJ/day (+/- 1.96 SD: -7.0, 4.0 MJ/day) at baseline and -1.6 MJ/day (-6.6, 3.4 MJ/day) at post-test. The intraclass correlation coefficient (ICC) was 0.30 (95% CI: 0.02, 0.54, p = 0.018) at baseline and 0.34 (0.06, 0.57, p = 0.009) at post-test. Higher values of underreporting was shown among overweight/obese compared to normal weight participants at both baseline and post-test (p <= 0.001), respectively. Conclusions: The results indicate that the PFD could be a useful tool for estimating energy intake in normal weight elderly men. On the other hand, the PFD seems to be less suitable for estimating energy intake in overweight/obese elderly men.	[Stea, Tonje H.; Hetlelid, Ken J.; Lohne-Seiler, Hilde; Adnanes, Svanhild; Bjornsen, Thomas; Salvesen, Svein; Berntsen, Sveinung] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Andersen, Lene F.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Paulsen, Goran] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway	University of Agder; University of Oslo; Norwegian School of Sport Sciences	Stea, TH (corresponding author), Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway.	tonje.h.stea@uia.no	Paulsen, Goran/ABG-6995-2020; Andersen, Lene/ABC-1337-2021	Bjornsen, Thomas/0000-0002-4010-8038	Smartfish(R) company; Regional Research Founds, Agder [222933]	Smartfish(R) company; Regional Research Founds, Agder	The present study was supported by grants from the Smartfish (R) company and Regional Research Founds, Agder [grant number 222933]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration on Aging Administration for Community Living U.S. Department of Health and Human Services, 2013, PROF OLD AM 2013; Andersen LF, 2005, PUBLIC HEALTH NUTR, V8, P1315, DOI 10.1079/PHN2005751; Andersen LF, 2003, EUR J CLIN NUTR, V57, P279, DOI 10.1038/sj.ejcn.1601519; Australian Government, 2010, 2010 INT REP AUSTR 2; Bazelmans C, 2007, PUBLIC HEALTH NUTR, V10, P185, DOI 10.1017/S1368980007246774; Berntsen S, 2010, BRIT J SPORT MED, V44, P657, DOI 10.1136/bjsm.2008.048868; Biltoft-Jensen A, 2009, BRIT J NUTR, V102, P1838, DOI 10.1017/S0007114509991292; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boeing H, 2013, EUR J CLIN NUTR, V67, P424, DOI 10.1038/ejcn.2013.47; Ford Dara Wheeler, 2013, Journal of Nutrition in Gerontology and Geriatrics, V32, P85, DOI 10.1080/21551197.2013.779622; Forrestal SG, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2010.00270.x; Granic A, 2013, J EPIDEMIOL COMMUN H, V67, P578, DOI 10.1136/jech-2012-201780; Hsiao PY, 2013, J NUTR HEALTH AGING, V17, P566, DOI 10.1007/s12603-013-0014-y; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Johansson G, 2001, PUBLIC HEALTH NUTR, V4, P919, DOI 10.1079/PHN2001124; Kretsch MJ, 1999, J AM DIET ASSOC, V99, P300, DOI 10.1016/S0002-8223(99)00078-4; Kyle UG, 2002, CURR OPIN CLIN NUTR, V5, P427, DOI 10.1097/00075197-200207000-00012; Lillegaard ITL, 2005, BRIT J NUTR, V94, P998, DOI 10.1079/BJN20051587; Lillegaard ITL, 2005, EUR J CLIN NUTR, V59, P611, DOI 10.1038/sj.ejcn.1602119; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Long JD, 2010, WORLDV EVID-BASED NU, V7, P191, DOI 10.1111/j.1741-6787.2009.00173.x; Luhrmann PM, 2001, NUTRITION, V17, P912, DOI 10.1016/S0899-9007(01)00664-5; Meng X, 2013, J NUTR HEALTH AGING, V17, P112, DOI 10.1007/s12603-012-0382-8; Nielsen BM, 2009, J NUTR, V139, P2337, DOI 10.3945/jn.109.112599; Overby N.C.A., 2002, UNGKOST 2000 NATL RE; Overby NC, 2004, PUBLIC HEALTH NUTR, V7, P285, DOI 10.1079/PHN2003515; Volp ACP, 2011, NUTR HOSP, V26, P430, DOI [10.3305/nh.2011.26.3.5181, 10.1590/S0212-16112011000300002]; Rothenberg EM, 2009, EUR J CLIN NUTR, V63, pS64, DOI 10.1038/ejcn.2008.67; Shahar DR, 2010, J AM COLL NUTR, V29, P14, DOI 10.1080/07315724.2010.10719812; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; The Norwegian Food Safety Authority The Norwegian Directorate of Health The University of Oslo, 2013, NORW FOOD COMP TABL; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; WHO, 2004, GLOB DAT BOD MASS IN; World Health Organization, 2013, EUR HLTH REP 2012 CH	37	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102029	10.1371/journal.pone.0102029	http://dx.doi.org/10.1371/journal.pone.0102029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019949	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600039
J	Xu, TD; Wu, X; Chen, QP; Zhu, SS; Liu, Y; Pan, DF; Chen, XH; Li, DY				Xu, Tongda; Wu, Xin; Chen, Qiuping; Zhu, Shasha; Liu, Yang; Pan, Defeng; Chen, Xiaohu; Li, Dongye			The Anti-Apoptotic and Cardioprotective Effects of Salvianolic Acid A on Rat Cardiomyocytes following Ischemia/Reperfusion by DUSP-Mediated Regulation of the ERK1/2/JNK Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MAP KINASE PHOSPHATASES; MYOCARDIAL-ISCHEMIA; SIGNALING PATHWAYS; CELL-SURVIVAL; C-JUN; INHIBITION; ERK; PROTECTS; CANCER	The purpose of this study was to observe the effects of salvianolic acid A (SAA) pretreatment on the myocardium during ischemia/reperfusion (I/R) and to illuminate the interrelationships among dual specificity protein phosphatase (DUSP) 2/4/16, ERK1/2 and JNK pathways during myocardial I/R, with the ultimate goal of elucidating how SAA exerts cardioprotection against I/R injury (IRI). Wistar rats were divided into the following six groups: control group (CON), I/R group, SAA+I/R group, ERK1/2 inhibitor PD098059+I/R group (PD+I/R), PD+SAA+I/R group, and JNK inhibitor SP600125+I/R group (SP+I/R). The cardioprotective effects of SAA on the myocardium during I/R were investigated with a Langendorff device. Heart rate (HR), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), maximum rate of ventricular pressure rise and fall (+/- dp/dt(max)), myocardial infarction areas (MIA), lactate dehydrogenase (LDH), and cardiomyocytes apoptosis were monitored. To determine the crosstalk betwee JNK and ERK1/2 via DUSP2/4/16 with SAA pretreatment, siRNA-DUSP2/4/16 were performed. The expression levels of Bcl-2, Bax, caspase 3, p-JNK, p-ERK1/2 and DUSP2/4/16 in cardiomyocytes were assayed by Western blot. Our results showed that LDH, MIA and cell apoptosis were decreased, and various parameters of heart function were improved by SAA pretreatment and SP application. In the I/R group, the expression levels of p-ERK1/2 and DUSP4/16 were not significantly different compared with the CON group, however, the protein expression levels of p-ERK1/2, Bcl-2 and DUSP4/16 were higher, while p-JNK, Bax, caspase 3 and DUSP2 levels were reduced among the SAA+I/R, PD+SAA+I/R and SP+I/R groups. The above indices were not significantly different between the SAA+I/R and SP+I/R groups. Compared with the SAA+I/R group, p-ERK1/2 was increased and p-JNK was decreased in the SAA+si-DUSP2+I/R, however, p-ERK was downregulated and p-JNK was upregulated in SAA+si-DUSP4+I/R group. SAA exerts an anti-apoptotic role against myocardial IRI by inhibiting DUSP2-mediated JNK dephosphorylation and activating DUSP4/16-mediated ERK1/2 phosphorylation.	[Xu, Tongda; Wu, Xin; Chen, Qiuping; Zhu, Shasha; Liu, Yang; Pan, Defeng; Li, Dongye] Xuzhou Med Coll, Res Inst Cardiovasc Dis, Xuzhou, Jiangsu, Peoples R China; [Xu, Tongda; Chen, Xiaohu; Li, Dongye] Nanjing Tradit Chinese Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University	Chen, XH (corresponding author), Nanjing Tradit Chinese Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China.	chenxiaohu2001@aliyun.com; ldy@xzmc.edu.cn	李, 东野/AAY-6410-2020; 李, 东/GYA-4703-2022	Xu, Tongda/0000-0002-5594-3992	Ministry of Education of China [20123237110006]	Ministry of Education of China(Ministry of Education, China)	This work was supported by Doctoral Fund of Ministry of Education of China (Grant No. 20123237110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Fan H, 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/508938; Fang F, 2011, PHARMACOLOGY, V88, P149, DOI 10.1159/000330068; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; Hu XL, 2013, ARCH DERMATOL RES, V305, P433, DOI 10.1007/s00403-013-1334-9; Hu ZY, 2009, CLIN EXP PHARMACOL P, V36, P776, DOI 10.1111/j.1440-1681.2009.05138.x; Jiang BH, 2009, PLANTA MED, V75, P1286, DOI 10.1055/s-0029-1185669; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Krstic A, 2012, J BIOL REG HOMEOS AG, V26, P641; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Masuda K, 2010, BIOCHEM BIOPH RES CO, V393, P201, DOI 10.1016/j.bbrc.2010.01.097; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Ottani A, 2010, EUR J PHARMACOL, V637, P124, DOI 10.1016/j.ejphar.2010.03.052; Pan HJ, 2011, J CARDIOVASC PHARM, V58, P535, DOI 10.1097/FJC.0b013e31822de355; Qiao ZY, 2011, MOLECULES, V16, P10002, DOI 10.3390/molecules161210002; Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sun Q, 2009, EXP BIOL MED, V234, P1212, DOI 10.3181/0812-RM-349; Tao JP, 2011, AM J PHYSIOL-HEART C, V301, pH1471, DOI 10.1152/ajpheart.00097.2011; Verma YK, 2013, APOPTOSIS, V18, P212, DOI 10.1007/s10495-012-0780-8; Wang XY, 2011, J ETHNOPHARMACOL, V135, P662, DOI 10.1016/j.jep.2011.03.070; Wang XJ, 2005, J ETHNOPHARMACOL, V97, P441, DOI 10.1016/j.jep.2004.11.036; Wei XL, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-37; Wiejak J, 2012, CELL SIGNAL, V24, P1690, DOI 10.1016/j.cellsig.2012.04.016; Yin XL, 2011, AM J CHINESE MED, V39, P853, DOI 10.1142/S0192415X11009251; Yue TL, 2005, DIABETES, V54, P554, DOI 10.2337/diabetes.54.2.554; Zhai CL, 2012, ACTA PHARMACOL SIN, V33, P1477, DOI 10.1038/aps.2012.112	32	63	71	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102292	10.1371/journal.pone.0102292	http://dx.doi.org/10.1371/journal.pone.0102292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019380	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600061
J	Lange, M; Fiedler, M; Bankwitz, D; Osburn, W; Viazov, S; Brovko, O; Zekri, AR; Khudyakov, Y; Nassal, M; Pumpens, P; Pietschmann, T; Timm, J; Roggendorf, M; Walker, A				Lange, Milena; Fiedler, Melanie; Bankwitz, Dorothea; Osburn, William; Viazov, Sergei; Brovko, Olena; Zekri, Abdel-Rahman; Khudyakov, Yury; Nassal, Michael; Pumpens, Paul; Pietschmann, Thomas; Timm, Joerg; Roggendorf, Michael; Walker, Andreas			Hepatitis C Virus Hypervariable Region 1 Variants Presented on Hepatitis B Virus Capsid-Like Particles Induce Cross-Neutralizing Antibodies	PLOS ONE			English	Article							HEPADNAVIRUS CORE PROTEINS; THERAPEUTIC VACCINES; CELL ENTRY; DISPLAY; INFECTION; ANTIGEN; EPITOPES; CARRIER; SURFACE; MIMOTOPES	Hepatitis C virus (HCV) infection is still a serious global health burden. Despite improved therapeutic options, a preventative vaccine would be desirable especially in undeveloped countries. Traditionally, highly conserved epitopes are targets for antibody-based prophylactic vaccines. In HCV-infected patients, however, neutralizing antibodies are primarily directed against hypervariable region I (HVRI) in the envelope protein E2. HVRI is the most variable region of HCV, and this heterogeneity contributes to viral persistence and has thus far prevented the development of an effective HVRI-based vaccine. The primary goal of an antibody-based HCV vaccine should therefore be the induction of cross-reactive HVRI antibodies. In this study we approached this problem by presenting selected cross-reactive HVRI variants in a highly symmetric repeated array on capsid-like particles (CLPs). SplitCore CLPs, a novel particulate antigen presentation system derived from the HBV core protein, were used to deliberately manipulate the orientation of HVRI and therefore enable the presentation of conserved parts of HVRI. These HVRI-CLPs induced high titers of cross-reactive antibodies, including neutralizing antibodies. The combination of only four HVRI CLPs was sufficient to induce antibodies cross-reactive with 81 of 326 (24.8%) naturally occurring HVRI peptides. Most importantly, HVRI CLPs with AS03 as an adjuvant induced antibodies with a 10-fold increase in neutralizing capability. These antibodies were able to neutralize infectious HCVcc isolates and 4 of 19 (21%) patient-derived HCVpp isolates. Taken together, these results demonstrate that the induction of at least partially cross-neutralizing antibodies is possible. This approach might be useful for the development of a prophylactic HCV vaccine and should also be adaptable to other highly variable viruses.	[Lange, Milena; Fiedler, Melanie; Viazov, Sergei; Brovko, Olena; Timm, Joerg; Roggendorf, Michael; Walker, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Bankwitz, Dorothea; Pietschmann, Thomas] TWINCORE, Div Expt Virol, Hannover, Germany; [Osburn, William] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Zekri, Abdel-Rahman] Natl Canc Inst, Virol & Immunol Unit, Cairo, Egypt; [Khudyakov, Yury] Ctr Dis Control & Prevent, Atlanta, GA USA; [Nassal, Michael] Univ Hosp Freiburg, Dept Internal Med 2, Freiburg, Germany; [Pumpens, Paul] Latvian Biomed Res & Study Ctr, Dept Recombinant Biotechnol, Riga, Latvia	University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research; Johns Hopkins University; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; Centers for Disease Control & Prevention - USA; University of Freiburg; Latvian Biomedical Research & Study Centre	Walker, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	Andreas.Walker@uni-due.de	Pietschmann, Thomas/E-9241-2015; Zekri, Abdel-Rahman N/A-3768-2008; Pumpens, Paul/A-2163-2008; Nassal, Michael/U-4529-2019; Timm, Jörg/P-7652-2019	Pietschmann, Thomas/0000-0001-5138-6239; Nassal, Michael/0000-0003-2204-9158; Timm, Jörg/0000-0001-7799-3045; Pietschmann, Thomas/0000-0001-6789-4422; Zekri, Abdel-Rahman/0000-0003-3939-0416; Walker, Andreas/0000-0002-8736-0863	Deutsche Forschungsgemeinschaft [Fi768/6-1, KFO 117/2]; German federal ministry of education and research; YEAL-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German federal ministry of education and research(Federal Ministry of Education & Research (BMBF)); YEAL-Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de; grant number Fi768/6-1 within the Priority program KFO 117/2) and the German federal ministry of education and research (www.bmbf.de; grant number EGY08/068). ML received a scholarship from the YEAL-Stiftung (http://www.yael-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameiss K, 2010, VACCINE, V28, P6704, DOI 10.1016/j.vaccine.2010.07.083; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Barnes E, SCI TRANSL MED, V4; Barouch DH, NATURE; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Belnap DM, 2003, P NATL ACAD SCI USA, V100, P10884, DOI 10.1073/pnas.1834404100; BICHKO V, 1993, MOL IMMUNOL, V30, P221, DOI 10.1016/0161-5890(93)90051-C; Billaud JN, 2007, VACCINE, V25, P1593, DOI 10.1016/j.vaccine.2006.11.013; Billaud JN, 2005, J VIROL, V79, P13656, DOI 10.1128/JVI.79.21.13656-13666.2005; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottcher B, 2006, J MOL BIOL, V356, P812, DOI 10.1016/j.jmb.2005.11.053; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Campo DS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00267; Conaty S, 2004, VACCINE, V22, P3214, DOI 10.1016/j.vaccine.2003.08.050; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477; Fournillier A, 2013, J INFECT DIS, V208, P1008, DOI 10.1093/infdis/jit267; Geldmacher A, 2005, VACCINE, V23, P3973, DOI 10.1016/j.vaccine.2005.02.025; Gregson AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001556; Guan M, 2012, J BIOL CHEM, V287, P35631, DOI 10.1074/jbc.M112.382341; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; HERZENBERG LA, 1980, NATURE, V285, P664, DOI 10.1038/285664a0; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; KUMAR U, 1994, GASTROENTEROLOGY, V106, P1072, DOI 10.1016/0016-5085(94)90770-6; Law JLM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059776; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Meunier JC, 2011, J INFECT DIS, V204, P1186, DOI 10.1093/infdis/jir511; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Mondelli MU, 2003, J BIOSCIENCES, V28, P305, DOI 10.1007/BF02970149; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; Nassal M, 2008, INT J MED MICROBIOL, V298, P135, DOI 10.1016/j.ijmm.2007.08.002; Oliveira GA, 2005, INFECT IMMUN, V73, P3587, DOI 10.1128/IAI.73.6.3587-3597.2005; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Puntoriero G, 1998, EMBO J, V17, P3521, DOI 10.1093/emboj/17.13.3521; Ray R, 2010, J INFECT DIS, V202, P862, DOI 10.1086/655902; Roccasecca R, 2001, Int Rev Immunol, V20, P289, DOI 10.3109/08830180109043040; Roccasecca R, 2001, MOL IMMUNOL, V38, P485, DOI 10.1016/S0161-5890(01)00084-0; Sallberg M, 2002, INTERVIROLOGY, V45, P350, DOI 10.1159/000067928; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Skamel C, 2006, J BIOL CHEM, V281, P17474, DOI 10.1074/jbc.M513571200; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; Vieyres G, 2011, J GEN VIROL, V92, P494, DOI 10.1099/vir.0.028092-0; Vogel M, 2005, FEBS LETT, V579, P5211, DOI 10.1016/j.febslet.2005.08.044; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Walker A, 2011, NATURE SCI REPORTS, V1; Walker A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00005; Walker A, 2008, J BIOL CHEM, V283, P33508, DOI 10.1074/jbc.M805211200; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zibert A, 1997, J VIROL, V71, P4123, DOI 10.1128/JVI.71.5.4123-4127.1997; ZIBERT A, 1995, VIROLOGY, V208, P653, DOI 10.1006/viro.1995.1196; Zucchelli S, 2001, HEPATOLOGY, V33, P692, DOI 10.1053/jhep.2001.22175	75	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102235	10.1371/journal.pone.0102235	http://dx.doi.org/10.1371/journal.pone.0102235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014219	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400079
J	Lee, JH; Choi, SS; Kim, HW; Xiong, WC; Min, CK; Lee, SJ				Lee, Jae Ho; Choi, Sung Sook; Kim, Hae Won; Xiong, Wen Cheng; Min, Churl K.; Lee, Sang Jin			Neogenin as a Receptor for Early Cell Fate Determination in Preimplantation Mouse Embryos	PLOS ONE			English	Article							MOLECULAR-BIOLOGY; STEM-CELLS; TROPHECTODERM; BLASTOMERES; EXPRESSION; NETRIN-1; TEAD4; DCC; SPECIFICATION; APOPTOSIS	The first cell lineage determination in embryos takes place when two cell populations are set apart, each differentiating into the trophectoderm (TE) and inner cell mass (ICM), respectively. It is widely believed that position/polarity cues play a key role in triggering this differentiation, but it remains unclear how extracellular cues are transduced into cell fate determination. Here, we provide evidence that supports that neogenin is implicated in relaying extracellular cues into the first cell fate determination in preimplantation mouse embryos. A polarized and transient distribution of neogenin was manifested in early blastomeres. Neogenin up-regulation by its overexpression accelerated ICM development in the blastocyst concomitant with the activation of the ICM-specific transcription factors Oct3/4, Sox2, and Nanog while its depletion by small hairpin RNAs (shRNAs) caused a developmental abnormality of poorly endowed ICM accompanied by the deactivation of Oct3/4, Sox2, and Nanog. Treatment with netrin-1 among neogenin ligands further impaired both embryonic development and ICM formation while repulsive guidance molecule c (RGMc) led to opposite consequences, enhancing ICM formation. From this study, we propose a model whereby neogenin interprets its own expression level to control the first cell fate determination in response to extracellular cues.	[Lee, Jae Ho; Kim, Hae Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Lee, Jae Ho; Kim, Hae Won] Dankook Univ, WCU Res Ctr, Cheonan, South Korea; [Choi, Sung Sook] Sahmyook Univ, Dept Pharmacol, Seoul, South Korea; [Kim, Hae Won] Dankook Univ, Sch Dent, Dept Dent Biomat, Cheonan, South Korea; [Xiong, Wen Cheng] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA; [Min, Churl K.] Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea; [Lee, Sang Jin] Sahmyook Univ, Dept Anim Biotechnol, Seoul, South Korea	Dankook University; Dankook University; Sahmyook University; Dankook University; University System of Georgia; Augusta University; Ajou University; Sahmyook University	Min, CK (corresponding author), Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea.	minc@ajou.ac.kr; leesj@syu.ac.kr	Knowles, Jonathan Campbell/B-9019-2008	Knowles, Jonathan Campbell/0000-0003-3917-3446	Sahmyook University Research Fund; Priority Research Centers Program [2009-0093829]; World Class University Program [R31-10069]	Sahmyook University Research Fund; Priority Research Centers Program; World Class University Program	This work was supported by a grant of the 2012 Sahmyook University Research Fund to S.J.L.; and the Priority Research Centers Program (Grant No. 2009-0093829) and World Class University Program (Grant No. R31-10069) to H.W.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; FLEMING TP, 1985, J EMBRYOL EXP MORPH, V89, P175; Ilic D, 1997, J CELL SCI, V110, P401; Jiang Y, 2003, DEV BIOL, V258, P364, DOI 10.1016/S0012-1606(03)00136-2; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Milla LA, 2014, INT J CANCER, V134, P21, DOI 10.1002/ijc.28330; Morris SA, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130104; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Roperch JP, 2008, CANCER RES, V68, P8231, DOI 10.1158/0008-5472.CAN-08-1483; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Severyn CJ, 2009, BIOCHEM J, V422, P393, DOI 10.1042/BJ20090978; Son TW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.94; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tajbakbsh S, 2009, ANNU REV CELL DEV BI, V25, P671, DOI 10.1146/annurev.cellbio.24.110707.175415; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tsuchiya A, 2007, BRAIN RES, V1159, P1, DOI 10.1016/j.brainres.2006.12.096; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016; ZIOMEK CA, 1982, DEV BIOL, V91, P440, DOI 10.1016/0012-1606(82)90050-1	33	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101989	10.1371/journal.pone.0101989	http://dx.doi.org/10.1371/journal.pone.0101989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013897	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400050
J	Zekavati, A; Nasir, A; Alcaraz, A; Aldrovandi, M; Marsh, P; Norton, JD; Murphy, JJ				Zekavati, Anna; Nasir, Asghar; Alcaraz, Amor; Aldrovandi, Maceler; Marsh, Phil; Norton, John D.; Murphy, John J.			Post-Transcriptional Regulation of BCL2 mRNA by the RNA-Binding Protein ZFP36L1 in Malignant B Cells	PLOS ONE			English	Article							LYMPHOCYTIC-LEUKEMIA CELLS; EARLY RESPONSE GENE; EXPRESSION PROFILES; INDUCE APOPTOSIS; TRISTETRAPROLIN; NUCLEOLIN; FAMILY; DIFFERENTIATION; STABILIZATION; INVOLVEMENT	The human ZFP36 zinc finger protein family consists of ZFP36, ZFP36L1, and ZFP36L2. These proteins regulate various cellular processes, including cell apoptosis, by binding to adenine uridine rich elements in the 3' untranslated regions of sets of target mRNAs to promote their degradation. The pro-apoptotic and other functions of ZFP36 family members have been implicated in the pathogenesis of lymphoid malignancies. To identify candidate mRNAs that are targeted in the proapoptotic response by ZFP36L1, we reverse-engineered a gene regulatory network for all three ZFP36 family members using the 'maximum information coefficient' (MIC) for target gene inference on a large microarray gene expression dataset representing cells of diverse histological origin. Of the three inferred ZFP36L1 mRNA targets that were identified, we focussed on experimental validation of mRNA for the pro-survival protein, BCL2, as a target for ZFP36L1. RNA electrophoretic mobility shift assay experiments revealed that ZFP36L1 interacted with the BCL2 adenine uridine rich element. In murine BCL1 leukemia cells stably transduced with a ZFP36L1 ShRNA lentiviral construct, BCL2 mRNA degradation was significantly delayed compared to control lentiviral expressing cells and ZFP36L1 knockdown in different cell types (BCL1, ACHN, Ramos), resulted in increased levels of BCL2 mRNA levels compared to control cells. 3' untranslated region luciferase reporter assays in HEK293T cells showed that wild type but not zinc finger mutant ZFP36L1 protein was able to downregulate a BCL2 construct containing the BCL2 adenine uridine rich element and removal of the adenine uridine rich core from the BCL2 3' untranslated region in the reporter construct significantly reduced the ability of ZFP36L1 to mediate this effect. Taken together, our data are consistent with ZFP36L1 interacting with and mediating degradation of BCL2 mRNA as an important target through which ZFP36L1 mediates its pro-apoptotic effects in malignant B-cells.	[Zekavati, Anna; Nasir, Asghar; Aldrovandi, Maceler; Murphy, John J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Alcaraz, Amor; Murphy, John J.] Univ Westminster, Dept Biomed Sci, London W1R 8AL, England; [Marsh, Phil] Kings Coll London, Div Endocrinol, London WC2R 2LS, England; [Norton, John D.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of London; King's College London; University of Westminster; University of London; King's College London; University of Essex	Murphy, JJ (corresponding author), Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England.	j.murphy@westminster.ac.uk	Aldrovandi, Maceler/D-4322-2014	Aldrovandi, Maceler/0000-0002-4386-0719	government of Pakistan PhD Studentship	government of Pakistan PhD Studentship	AN was supported by a government of Pakistan PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Baou M, 2009, LEUKEMIA, V23, P986, DOI 10.1038/leu.2008.340; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA QF, 1995, ONCOGENE, V10, P487; MA QF, 1994, ONCOGENE, V9, P3329; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; MURPHY JJ, 1990, BIOCHIM BIOPHYS ACTA, V1049, P261; Nasir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052187; Ning ZQ, 1996, EUR J IMMUNOL, V26, P2356, DOI 10.1002/eji.1830261013; NING ZQ, 1995, BIOCHEM BIOPH RES CO, V215, P23, DOI 10.1006/bbrc.1995.2429; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Pospisilova H, 2007, LEUKEMIA, V21, P2079, DOI 10.1038/sj.leu.2404739; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Renault TT, 2013, ANN NY ACAD SCI, V1285, P59, DOI 10.1111/nyas.12045; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Treguer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054550; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vignudelli T, 2010, MOL BIOL CELL, V21, P3340, DOI 10.1091/mbc.E10-01-0040	44	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102625	10.1371/journal.pone.0102625	http://dx.doi.org/10.1371/journal.pone.0102625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014217	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400105
J	Allen, ML; Elbroch, LM; Wilmers, CC; Wittmer, HU				Allen, Maximilian L.; Elbroch, L. Mark; Wilmers, Christopher C.; Wittmer, Heiko U.			Trophic Facilitation or Limitation? Comparative Effects of Pumas and Black Bears on the Scavenger Community	PLOS ONE			English	Article							GUILD; FOOD; YELLOWSTONE; COMPETITION; PREDATION; CARCASSES; CARRION; PREY	Scavenging is a widespread behaviour and an important process influencing food webs and ecological communities. Large carnivores facilitate the movement of energy across trophic levels through the scavenging and decomposition of their killed prey, but competition with large carnivores is also likely to constrain acquisition of carrion by scavengers. We used an experimental approach based on motion-triggered video cameras at black-tailed deer (Odocoileus hemionus columbianus) carcasses to measure the comparative influences of two large carnivores in the facilitation and limitation of carrion acquisition by scavengers. We found that pumas (Puma concolor) and black bears (Ursus americanus) had different effects on their ecological communities. Pumas, as a top-level predator, facilitated the consumption of carrion by scavengers, despite significantly reducing their observed sum feeding times (165.7 min +/- 21.2 SE at puma kills 264.3 min +/- 30.1 SE at control carcasses). In contrast, black bears, as the dominant scavenger in the system, limited consumption of carrion by scavengers as evidenced by the observed reduction of scavenger species richness recorded at carcasses where they were present (mean = 2.33 +/- 0.28 SE), compared to where they were absent (mean = 3.28 +/- 0.23 SE). Black bears also had large negative effects on scavenger sum feeding times (88.5 min +/- 19.8 SE at carcasses where bears were present, 372.3 min +/- 50.0 SE at carcasses where bears were absent). In addition, we found that pumas and black bears both increased the nestedness (a higher level of order among species present) of the scavenger community. Our results suggest that scavengers have species-specific adaptions to exploit carrion despite large carnivores, and that large carnivores influence the structure and composition of scavenger communities. The interactions between large carnivores and scavengers should be considered in future studies of food webs and ecological communities.	[Allen, Maximilian L.; Wittmer, Heiko U.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Elbroch, L. Mark] Panthera, New York, NY USA; [Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA	Victoria University Wellington; University of California System; University of California Santa Cruz	Allen, ML (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	Maximilian.Allen@vuw.ac.nz	Allen, Maximilian/ABG-9307-2020; Wittmer, Heiko U/D-4172-2015	Allen, Maximilian/0000-0001-8976-889X; Wittmer, Heiko U/0000-0002-8861-188X	University of California Davis; California Department of Fish and Wildlife; Victoria University of Wellington tuition scholarship	University of California Davis(University of California System); California Department of Fish and Wildlife; Victoria University of Wellington tuition scholarship	The University of California Davis, and the California Department of Fish and Wildlife generously provided financial support for the project. M. Allen was supported by a Victoria University of Wellington tuition scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2014, CAN J ZOOL, V92, P397, DOI 10.1139/cjz-2013-0284; Allen M.L., 2014, THESIS VICTORIA U WE; ANGERBJORN A, 1991, J ANIM ECOL, V60, P705, DOI 10.2307/5307; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Begon M., 2009, ECOLOGY INDIVIDUALS; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cortes-Avizanda A, 2012, ECOLOGY, V93, P2570, DOI 10.1890/12-0221.1; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Elbroch LM, 2013, J MAMMAL, V94, P259, DOI 10.1644/12-MAMM-A-041.1; Elbroch LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053595; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Houston DC, 1995, SERENGETI DYNAMICS E, P263; Hunter JS, 2007, AFR J ECOL, V45, P275, DOI 10.1111/j.1365-2028.2006.00702.x; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; MATHEWS NE, 1988, CAN J ZOOL, V66, P1241, DOI 10.1139/z88-179; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; Murphy KM, 1998, URSUS-SERIES, V10, P55; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Olson ZH, 2012, OIKOS, V121, P77, DOI 10.1111/j.1600-0706.2011.19771.x; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; R Core Team, 2021, R LANGUAGE ENV STAT; Ruth Toni K., 2010, P163; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHWARTZ CC, 1991, WILDLIFE MONOGR, P1; Sebastian-Gonzalez E, 2013, IBIS, V155, P881, DOI 10.1111/ibi.12079; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sokal R.R., 1987, INTRO BIOSTATISTICS, V2nd; Svoboda NJ, 2011, URSUS, V22, P91, DOI 10.2192/URSUS-D-10-00024.1; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; WATSON J, 1992, J ANIM ECOL, V61, P543, DOI 10.2307/5609; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	41	43	44	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102257	10.1371/journal.pone.0102257	http://dx.doi.org/10.1371/journal.pone.0102257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010629	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800086
J	Chrol-Cannon, J; Jin, YC				Chrol-Cannon, Joseph; Jin, Yaochu			On the Correlation between Reservoir Metrics and Performance for Time Series Classification under the Influence of Synaptic Plasticity	PLOS ONE			English	Article							COMPUTATION; CHAOS; EDGE	Reservoir computing provides a simpler paradigm of training recurrent networks by initialising and adapting the recurrent connections separately to a supervised linear readout. This creates a problem, though. As the recurrent weights and topology are now separated from adapting to the task, there is a burden on the reservoir designer to construct an effective network that happens to produce state vectors that can be mapped linearly into the desired outputs. Guidance in forming a reservoir can be through the use of some established metrics which link a number of theoretical properties of the reservoir computing paradigm to quantitative measures that can be used to evaluate the effectiveness of a given design. We provide a comprehensive empirical study of four metrics; class separation, kernel quality, Lyapunov's exponent and spectral radius. These metrics are each compared over a number of repeated runs, for different reservoir computing set-ups that include three types of network topology and three mechanisms of weight adaptation through synaptic plasticity. Each combination of these methods is tested on two time-series classification problems. We find that the two metrics that correlate most strongly with the classification performance are Lyapunov's exponent and kernel quality. It is also evident in the comparisons that these two metrics both measure a similar property of the reservoir dynamics. We also find that class separation and spectral radius are both less reliable and less effective in predicting performance.	[Chrol-Cannon, Joseph; Jin, Yaochu] Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England	University of Surrey	Jin, YC (corresponding author), Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England.	yaochu.jin@surrey.ac.uk	Jin, Yaochu/B-3776-2012; Jin, Yaochu/GRY-7004-2022	Jin, Yaochu/0000-0003-1100-0631; Jin, Yaochu/0000-0003-1100-0631	Engineering and Physical Sciences Research Council through University of Surrey	Engineering and Physical Sciences Research Council through University of Surrey	JCC was supported by Engineering and Physical Sciences Research Council's Doctoral Training Grant through University of Surrey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chrol-Cannon J, 2014, BIOSYSTEMS; Chrol-Cannon J., 2012, 2012 INT JOINT C NEU, P1; Gibbons TE, 2010, IEEE IJCNN; Goodman E, 2006, IEEE IJCNN, P3848; Hebb Donald O., 1949, ORG BEHAV; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jaeger H, 2005, IEEE IJCNN, P1460; Jaeger H, 2007, 10 JAC U BREM; Jaeger H., 2002, 152 GMD GERM NAT RES; Jaeger H., 2001, TECH REP 148, V148; Joshi P, 2009, LECT NOTES COMPUT SC, V5768, P239, DOI 10.1007/978-3-642-04274-4_25; Kudo M, 1999, PATTERN RECOGN LETT, V20, P1103, DOI 10.1016/S0167-8655(99)00077-X; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Lukosevicius M, 2012, KUNSTL INTELL, V26, P365, DOI 10.1007/s13218-012-0204-5; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Norton D, 2010, NEUROCOMPUTING, V73, P2893, DOI 10.1016/j.neucom.2010.08.005; Norton D, 2006, IEEE IJCNN, P4243; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Xue FZ, 2013, NEUROCOMPUTING, V122, P324, DOI 10.1016/j.neucom.2013.06.019; Yin J, 2012, IEEE T AUTON MENT DE, V4, P273, DOI 10.1109/TAMD.2012.2182765	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101792	10.1371/journal.pone.0101792	http://dx.doi.org/10.1371/journal.pone.0101792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010415	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800040
J	Dally, S; Rupp, S; Lemuth, K; Hartmann, SC; Hiller, E; Bailer, SM; Knabbe, C; Weile, J				Dally, Simon; Rupp, Steffen; Lemuth, Karin; Hartmann, Stefan C.; Hiller, Ekkehard; Bailer, Susanne M.; Knabbe, Cornelius; Weile, Jan			Single-Stranded DNA Catalyzes Hybridization of PCR-Products to Microarray Capture Probes	PLOS ONE			English	Article							OLIGONUCLEOTIDE; STABILITY; SIGNAL	Since its development, microarray technology has evolved to a standard method in the biotechnological and medical field with a broad range of applications. Nevertheless, the underlying mechanism of the hybridization process of PCR-products to microarray capture probes is still not completely understood, and several observed phenomena cannot be explained with current models. We investigated the influence of several parameters on the hybridization reaction and identified ssDNA to play a major role in the process. An increase of the ssDNA content in a hybridization reaction strongly enhanced resulting signal intensities. A strong influence could also be observed when unlabeled ssDNA was added to the hybridization reaction. A reduction of the ssDNA content resulted in a massive decrease of the hybridization efficiency. According to these data, we developed a novel model for the hybridization mechanism. This model is based on the assumption that single stranded DNA is necessary as catalyst to induce the hybridization of dsDNA. The developed hybridization model is capable of giving explanations for several yet unresolved questions regarding the functionality of microarrays. Our findings not only deepen the understanding of the hybridization process, but also have immediate practical use in data interpretation and the development of new microarrays.	[Dally, Simon; Knabbe, Cornelius; Weile, Jan] Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany; [Dally, Simon; Rupp, Steffen; Lemuth, Karin; Hartmann, Stefan C.; Hiller, Ekkehard; Bailer, Susanne M.] Fraunhofer Inst Interfacial Engn & Biotechnol, Dept Mol Biotechnol, Stuttgart, Germany	Ruhr University Bochum; Fraunhofer Gesellschaft	Weile, J (corresponding author), Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	jweile@hdz-nrw.de			European Union [241446]; German Federal Ministry for Education and Research [01EZ1113B]	European Union(European Commission); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241446 (project 'Antiresdev'), and by the German Federal Ministry for Education and Research under grant agreement no 01EZ1113B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chizhikov V, 2001, APPL ENVIRON MICROB, V67, P3258, DOI 10.1128/AEM.67.7.3258-3263.2001; Dally S, 2013, ANTIMICROBIAL AGENTS; Gharaibeh RZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014464; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Kim KT, 2011, MOL CELLS, V32, P367, DOI 10.1007/s10059-011-0121-8; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Peytavi R, 2005, BIOTECHNIQUES, V39, P89, DOI 10.2144/05391RR01; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; Pozhitkov AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1122; Reynaldo LP, 2000, J MOL BIOL, V297, P511, DOI 10.1006/jmbi.2000.3573; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Stedtfeld RD, 2007, APPL ENVIRON MICROB, V73, P380, DOI 10.1128/AEM.01785-06; Trapp C, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-20; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06	15	0	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102338	10.1371/journal.pone.0102338	http://dx.doi.org/10.1371/journal.pone.0102338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025686	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400065
J	Hettich, MM; Matthes, F; Ryan, DP; Griesche, N; Schroder, S; Dorn, S; Krauss, S; Ehninger, D				Hettich, Moritz M.; Matthes, Frank; Ryan, Devon P.; Griesche, Nadine; Schroeder, Susanne; Dorn, Stephanie; Krauss, Sybille; Ehninger, Dan			The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex	PLOS ONE			English	Article							AMYLOID-PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PHOSPHATASE 2A; OPITZ-SYNDROME; UBIQUITIN LIGASE; INSULIN; TAU; TRANSLATION; BETA; PHOSPHORYLATION	Alzheimer's disease (AD), the most common form of dementia in the elderly, is characterized by two neuropathological hallmarks: senile plaques, which are composed of A beta peptides, and neurofibrillary tangles, which are composed of hyperphosphorylated TAU protein. Diabetic patients with dysregulated insulin signalling are at increased risk of developing AD. Further, several animal models of diabetes show increased A beta expression and hyperphosphorylated tau. As we have shown recently, the anti-diabetic drug metformin is capable of dephosphorylating tau at AD-relevant phospho-sites. Here, we investigated the effect of metformin on the main amyloidogenic enzyme BACE1 and, thus, on the production of A beta peptides, the second pathological hallmark of AD. We find similar results in cultures of primary neurons, a human cell line model of AD and in vivo in mice. We show that treatment with metformin decreases BACE1 protein expression by interfering with an mRNA-protein complex that contains the ubiquitin ligase MID1, thereby reducing BACE1 activity. Together with our previous findings these results indicate that metformin may target both pathological hallmarks of AD and may be of therapeutic value for treating and/or preventing AD.	[Hettich, Moritz M.; Matthes, Frank; Ryan, Devon P.; Griesche, Nadine; Schroeder, Susanne; Dorn, Stephanie; Krauss, Sybille; Ehninger, Dan] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Krauss, S (corresponding author), Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Bonn, Germany.	sybille.krauss@dzne.de; dan.ehninger@dzne.de	Krauss, Sybille/L-5328-2016	Matthes, Frank/0000-0002-5115-8831; Ryan, Devon/0000-0002-8549-0971; Krauss, Sybille/0000-0002-5653-9289	Else Kroner-Fresenius-Stiftung [2012_A304]	Else Kroner-Fresenius-Stiftung	This work was supported by the Else Kroner-Fresenius-Stiftung (2012_A304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alzheimer A, 1995, Clin Anat, V8, P429; Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Aranda-Orgilles B, 2011, J BIOL CHEM, V286, P39945, DOI 10.1074/jbc.M111.224451; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Deng Y, 2013, EUR J NEUROSCI, V37, P1962, DOI 10.1111/ejn.12235; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Kickstein E., 2010, P NATL ACAD SCI US; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krauss S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2514; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; O'Neill C, 2012, BIOCHEM SOC T, V40, P721, DOI 10.1042/BST20120080; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Southan Christopher, 2013, Frontiers in Genetics, V4, P293, DOI 10.3389/fgene.2013.00293; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	36	55	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102420	10.1371/journal.pone.0102420	http://dx.doi.org/10.1371/journal.pone.0102420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025689	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400074
J	Tong, DL; Boocock, DJ; Dhondalay, GKR; Lemetre, C; Ball, GR				Tong, Dong Ling; Boocock, David J.; Dhondalay, Gopal Krishna R.; Lemetre, Christophe; Ball, Graham R.			Artificial Neural Network Inference (ANNI): A Study on Gene-Gene Interaction for Biomarkers in Childhood Sarcomas	PLOS ONE			English	Article							TROPONIN-T; REGULATORY NETWORKS; EWINGS-SARCOMA; ESTROGEN-RECEPTOR; EXPRESSION; IDENTIFICATION; PROTEIN; MICROARRAY; ALGORITHM; MUTATION	Objective To model the potential interaction between previously identified biomarkers in children sarcomas using artificial neural network inference (ANNI). Method: To concisely demonstrate the biological interactions between correlated genes in an interaction network map, only 2 types of sarcomas in the children small round blue cell tumors (SRBCTs) dataset are discussed in this paper. A backpropagation neural network was used to model the potential interaction between genes. The prediction weights and signal directions were used to model the strengths of the interaction signals and the direction of the interaction link between genes. The ANN model was validated using Monte Carlo cross-validation to minimize the risk of over-fitting and to optimize generalization ability of the model. Results: Strong connection links on certain genes (TNNT1 and FNDC5 in rhabdomyosarcoma (RMS); FCGRT and OLFM1 in Ewing's sarcoma (EWS)) suggested their potency as central hubs in the interconnection of genes with different functionalities. The results showed that the RMS patients in this dataset are likely to be congenital and at low risk of cardiomyopathy development. The EWS patients are likely to be complicated by EWS-FLI fusion and deficiency in various signaling pathways, including Wnt, Fas/Rho and intracellular oxygen. Conclusions: The ANN network inference approach and the examination of identified genes in the published literature within the context of the disease highlights the substantial influence of certain genes in sarcomas.	[Tong, Dong Ling; Boocock, David J.; Ball, Graham R.] Nottingham Trent Univ, John van Geest Canc Res Ctr, Sch Sci & Technol, Nottingham, England; [Dhondalay, Gopal Krishna R.] Univ London Imperial Coll Sci Technol & Med, NHLI, Imperial Ctr Translat & Expt Med, London, England; [Lemetre, Christophe] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10021 USA	Nottingham Trent University; Imperial College London; Memorial Sloan Kettering Cancer Center	Ball, GR (corresponding author), Nottingham Trent Univ, John van Geest Canc Res Ctr, Sch Sci & Technol, Nottingham, England.	graham.ball@ntu.ac.uk	Dhondalay, Gopal Krishna Ramadas/A-3369-2014; Boocock, David/I-4666-2015	Dhondalay, Gopal Krishna Ramadas/0000-0002-1020-0175; Boocock, David/0000-0002-7333-3549; Ball, Graham/0000-0001-5828-7129; Tong, Dong/0000-0002-6363-7960	John and Lucille van Geest Foundation	John and Lucille van Geest Foundation	This research is funded by the John and Lucille van Geest Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abdelaziz AI, 2005, ADV EXP MED BIOL, V565, P283; Albert R, 2004, LECT NOTES PHYS, V650, P459; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Breidthardt T, 2012, CLIN J AM SOC NEPHRO, V7, P1285, DOI 10.2215/CJN.00460112; Cheng L, 2011, IEEE T NEURAL NETWOR, V22, P714, DOI 10.1109/TNN.2011.2109735; Chipman KC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-17; Christley S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006799; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Czuchlewski DR, 2008, AM J CLIN PATHOL, V130, P957, DOI 10.1309/AJCP12HIRWSRQLAN; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dhondalay G. K., 2011, Proceedings of the 2011 International Conference on Machine Learning and Cybernetics (ICMLC 2011), P727, DOI 10.1109/ICMLC.2011.6016771; Djavan B, 2002, J CLIN ONCOL, V20, P921, DOI 10.1200/JCO.20.4.921; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Geryk-Hall M, 2009, CURR ONCOL REP, V11, P446, DOI 10.1007/s11912-009-0061-z; Giacomantonio CE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000936; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gunther F, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-87; Gupta A, 2013, RECENT PATENTS ENDOC, V7, P138, DOI 10.2174/1872214811307020007; Hartemink AJ, 2002, IEEE INTELL SYST, V17, P37, DOI 10.1109/MIS.2002.999218; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kodithuwakku SP, 2012, LAB INVEST, V92, P256, DOI 10.1038/labinvest.2011.148; Krebs S, 2007, P NATL ACAD SCI USA, V104, P6746, DOI 10.1073/pnas.0607721104; Lancashire LJ, 2010, BREAST CANCER RES TR, V120, P83, DOI 10.1007/s10549-009-0378-1; Lancashire LJ, 2008, ARTIF INTELL MED, V43, P99, DOI 10.1016/j.artmed.2008.03.001; Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012; Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Lemetre C, 2010, ARTIFICIAL NEURAL NE; Lemetre C, 2009, LECT NOTES COMPUT SC, V5517, P877, DOI 10.1007/978-3-642-02478-8_110; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li XD, 2010, J CELL BIOCHEM, V111, P933, DOI 10.1002/jcb.22782; Liu WB, 2012, MOL BIOL REP, V39, P4401, DOI 10.1007/s11033-011-1228-x; Lopes DN, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/479242; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Maraziotis IA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-140; Martinez-Abrain A, 2008, ACTA OECOL, V34, P9, DOI 10.1016/j.actao.2008.02.004; Matharoo-Ball B, 2007, J PROTEOME RES, V6, P3321, DOI 10.1021/pr070124b; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Morgan MJ, 1999, BIOCHEM BIOPH RES CO, V255, P245, DOI 10.1006/bbrc.1999.0179; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; O'Neill MC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-13; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Parkinson NJ, 2008, NEUROMUSCULAR DISORD, V18, P394, DOI 10.1016/j.nmd.2008.01.006; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Pianta TJ, 2012, NEPHROLOGY, V17, P636, DOI 10.1111/j.1440-1797.2012.01625.x; Rajwanshi A, 2009, J CYTOL, V26, P1, DOI 10.4103/0970-9371.54861; Ram R, 2009, LECT N BIOINFORMAT, V5780, P293, DOI 10.1007/978-3-642-04031-3_26; RIMOKH R, 1993, BLOOD, V81, P136; Sainz-Jaspeado M, 2010, MOL CANCER RES, V8, P1489, DOI 10.1158/1541-7786.MCR-10-0060; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sengupta A, 2011, INT J ONCOL, V38, P1259, DOI 10.3892/ijo.2011.963; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stock M, 2004, J BONE MINER RES, V19, P959, DOI 10.1359/jbmr.2004.19.6.959; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Tong DL, 2009, P 4 IAPR INT C PATT, P1; Tong DL, 2011, ARTIF INTELL MED, V53, P47, DOI 10.1016/j.artmed.2011.06.008; Tong DL, 2010, INT J MACH LEARN CYB, V1, P75, DOI 10.1007/s13042-010-0004-x; Tong DL, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-6, P1082, DOI 10.1109/ICMLC.2009.5212372; Uren A, 2004, PEDIATR BLOOD CANCER, V43, P243, DOI 10.1002/pbc.20124; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Wu ZZ, 2011, J CELL PHYSIOL, V226, P2415, DOI 10.1002/jcp.22589; Xu R, 2004, P ANN INT IEEE EMBS, V26, P2905; Xu R, 2006, LECT NOTES COMPUT SC, V3973, P648	80	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102483	10.1371/journal.pone.0102483	http://dx.doi.org/10.1371/journal.pone.0102483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025207	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400078
J	Tramm, N; Oppenheimer, N; Nagy, S; Efrati, E; Biron, D				Tramm, Nora; Oppenheimer, Naomi; Nagy, Stanislav; Efrati, Efi; Biron, David			Why Do Sleeping Nematodes Adopt a Hockey-Stick-Like Posture?	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; DYNAMICS; MUSCLE; MECHANICS; LETHARGUS; GENETICS; CIRCUIT; CALCIUM; ATPASE	A characteristic posture is considered one of the behavioral hallmarks of sleep, and typically includes functional features such as support for the limbs and shielding of sensory organs. The nematode C. elegans exhibits a sleep-like state during a stage termed lethargus, which precedes ecdysis at the transition between larval stages. A hockey-stick-like posture is commonly observed during lethargus. What might its function be? It was previously noted that during lethargus, C. elegans nematodes abruptly rotate about their longitudinal axis. Plausibly, these `` flips'' facilitate ecdysis by assisting the disassociation of the old cuticle from the new one. We found that body-posture during lethargus was established using a stereotypical motor program and that body bends during lethargus quiescence were actively maintained. Moreover, flips occurred almost exclusively when the animals exhibited a single body bend, preferentially in the anterior or mid section of the body. We describe a simple biomechanical model that imposes the observed lengths of the longitudinally directed body-wall muscles on an otherwise passive elastic rod. We show that this minimal model is sufficient for generating a rotation about the anterior-posterior body axis. Our analysis suggests that posture during lethargus quiescence may serve a developmental role in facilitating flips and that the control of body wall muscles in anterior and posterior body regions are distinct.	[Tramm, Nora; Oppenheimer, Naomi; Efrati, Efi; Biron, David] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Tramm, Nora; Oppenheimer, Naomi; Efrati, Efi; Biron, David] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Nagy, Stanislav; Biron, David] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Biron, D (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.	dbiron@uchicago.edu	Nagy, Stanislav/GXW-2342-2022; Nagy, Stanislav/T-5247-2017		NSF GRFP [DGE-0638477]; Simons fellowship; Burroughs Wellcome Fund; Searle Scholars Program; National Science Foundation [PHYS-1066293]	NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Simons fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Searle Scholars Program; National Science Foundation(National Science Foundation (NSF))	This work was supported by NSF GRFP #DGE-0638477 (N.T), Simons fellowship (E. E), Burroughs Wellcome Fund (D. B), Searle Scholars Program (D. B). This work was supported in part by the National Science Foundation under Grant No. PHYS-1066293 and the hospitality of the Aspen Center for Physics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2008, ANNU REV GENET, V42, P361, DOI 10.1146/annurev.genet.42.110807.091541; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Audoly B., 2010, ELASTICITY GEOMETRY; Backholm M, 2013, P NATL ACAD SCI USA, V110, P4528, DOI 10.1073/pnas.1219965110; BRENNER S, 1974, GENETICS, V77, P71; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; Fang-Yen C, 2010, P NATL ACAD SCI USA, V107, P20323, DOI 10.1073/pnas.1003016107; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hall D.H., 2007, C ELEGANS ATLAS; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; ISHII N, 1989, SCIENCE, V243, P1367, DOI 10.1126/science.2922614; Iwanir S, 2013, SLEEP, V36, P385, DOI 10.5665/sleep.2456; JEWELL BR, 1959, J PHYSIOL-LONDON, V149, P154, DOI 10.1113/jphysiol.1959.sp006332; Karbowski J, 2008, J COMPUT NEUROSCI, V24, P253, DOI 10.1007/s10827-007-0054-6; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Loomis AL, 1938, J NEUROPHYSIOL, V1, P413, DOI 10.1152/jn.1938.1.5.413; McDONNELL J, 1946, Br J Phys Med, V9, P46; Nagy S, 2013, ELIFE, V2, DOI 10.7554/eLife.00782; Nelson MD, 2013, CURR OPIN NEUROBIOL, V23, P824, DOI 10.1016/j.conb.2013.02.015; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Park SJ, 2007, P NATL ACAD SCI USA, V104, P17376, DOI 10.1073/pnas.0702138104; Perseghin P, 2012, TRANSFUSION, P1; Petzold BC, 2011, BIOPHYS J, V100, P1977, DOI 10.1016/j.bpj.2011.02.035; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Schwarz J, 2012, WORM, V1, P0; Singh K, 2011, CURR BIOL, V21, P825, DOI 10.1016/j.cub.2011.04.010; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Sobel I., 1973, PATTERN CLASSIFICATI, P271; Struik D. J., 1988, LECT CLASSICAL DIFFE; Sznitman J, 2010, BIOPHYS J, V98, P617, DOI 10.1016/j.bpj.2009.11.010; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; Von Stetina SE, 2005, INT REV NEUROBIOL, V69, P125, DOI 10.1016/S0074-7742(05)69005-8; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	39	16	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101162	10.1371/journal.pone.0101162	http://dx.doi.org/10.1371/journal.pone.0101162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025212	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400009
J	Furrow, RE				Furrow, Robert E.			Epigenetic Inheritance, Epimutation, and the Response to Selection	PLOS ONE			English	Article							DNA METHYLATION; POPULATIONS; EVOLUTION	There has been minimal theoretical exploration of the role of epigenetic variation in the response to natural selection. Using a population genetic model, I derive formulae that characterize the response of epigenetic variation to selection over multiple generations. Unlike genetic models in which mutation rates are assumed to be low relative to the strength of selection, the response to selection decays quickly due to a rapid lowering of parent-offspring epiallelic correlation. This effect is separate from the slowing response caused by a reduction in epigenetic variation. These results suggest that epigenetic variation may be less responsive to natural selection than is genetic variation, even in cases where levels of heritability appear similar.	Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Furrow, RE (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	rfurrow@stanford.edu		Furrow, Robert/0000-0001-5732-5613				Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Cropley JE, 2012, P ROY SOC B-BIOL SCI, V279, P2347, DOI 10.1098/rspb.2011.2646; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Day T, 2011, AM NAT, V178, pE18, DOI 10.1086/660911; Geoghegan JL, 2012, THEOR POPUL BIOL, V81, P232, DOI 10.1016/j.tpb.2011.08.001; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Hirsch S, 2012, Cold Spring Harb Symp Quant Biol, V77, P97, DOI 10.1101/sqb.2013.77.014605; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Jablonka E, 1998, TRENDS ECOL EVOL, V13, P206, DOI 10.1016/S0169-5347(98)01344-5; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Klironomos FD, 2013, BIOESSAYS, V35, P571, DOI 10.1002/bies.201200169; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Lim HN, 2007, NAT GENET, V39, P269, DOI 10.1038/ng1956; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Liu S, 2012, MOL GENET GENOMICS, V287, P643, DOI 10.1007/s00438-012-0704-x; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Silveira AB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003437; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Stumpf MPH, 2002, P NATL ACAD SCI USA, V99, P15234, DOI 10.1073/pnas.232546899; Tal O, 2010, GENETICS, V184, P1037, DOI 10.1534/genetics.109.112466; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x	29	17	18	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101559	10.1371/journal.pone.0101559	http://dx.doi.org/10.1371/journal.pone.0101559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019291	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600017
J	Wrenshall, LE; Clabaugh, SE; Cool, DR; Arumugam, P; Grunwald, WC; Smith, DR; Liu, GC; Miller, JD				Wrenshall, Lucile E.; Clabaugh, Suzanne E.; Cool, David R.; Arumugam, Prakash; Grunwald, William C.; Smith, Deandra R.; Liu, Gino C.; Miller, John D.			Identification of a Cytotoxic Form of Dimeric Interleukin-2 in Murine Tissues	PLOS ONE			English	Article							CELL-DEATH; MELANOMA-CELLS; LYMPHOCYTES-T; CROSS-LINKING; IL-2; OLIGODENDROCYTES; TRANSGLUTAMINASE; EXPRESSION; HEPARANASE; RECEPTOR	Interleukin-2 (IL-2) is a multi-faceted cytokine, known for promoting proliferation, survival, and cell death depending on the cell type and state. For example, IL-2 facilitates cell death only in activated T cells when antigen and IL-2 are abundant. The availability of IL-2 clearly impacts this process. Our laboratory recently demonstrated that IL-2 is retained in blood vessels by heparan sulfate, and that biologically active IL-2 is released from vessel tissue by heparanase. We now demonstrate that heparanase digestion also releases a dimeric form of IL-2 that is highly cytotoxic to cells expressing the IL-2 receptor. These cells include "traditional'' IL-2 receptor-bearing cells such as lymphocytes, as well as those less well known for IL-2 receptor expression, such as epithelial and smooth muscle cells. The morphologic changes and rapid cell death induced by dimeric IL-2 imply that cell death is mediated by disruption of membrane permeability and subsequent necrosis. These findings suggest that IL-2 has a direct and unexpectedly broad influence on cellular homeostatic mechanisms in both immune and non-immune systems.	[Wrenshall, Lucile E.; Clabaugh, Suzanne E.; Arumugam, Prakash; Liu, Gino C.; Miller, John D.] Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA; [Cool, David R.; Grunwald, William C.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Smith, Deandra R.] Univ Nebraska, Eppley Inst Res Canc, Omaha, NE 68182 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; University of Nebraska System	Wrenshall, LE (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA.	lucile.wrenshall@wright.edu			Miami Valley Hospital Foundation; NIH [R21 HL102589-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102589] Funding Source: NIH RePORTER	Miami Valley Hospital Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the following: 1. Miami Valley Hospital Foundation www.mvhfoundation.org; 2. NIH grant #R21 HL102589-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONRADT HS, 1988, BIOCHEM BIOPH RES CO, V150, P97, DOI 10.1016/0006-291X(88)90491-3; deGaldeano AG, 1996, TUMOR BIOL, V17, P155, DOI 10.1159/000217978; Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867; EITAN S, 1992, P NATL ACAD SCI USA, V89, P5442, DOI 10.1073/pnas.89.12.5442; EITAN S, 1993, SCIENCE, V261, P106, DOI 10.1126/science.8100369; EIZENBERG O, 1995, EMBO J, V14, P1136, DOI 10.1002/j.1460-2075.1995.tb07097.x; Gerritsma JSJ, 1997, J AM SOC NEPHROL, V8, P1510; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; Koul S, 2014, AM J PHYSL RENAL PHY; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Miller JD, 2008, IMMUNOL CELL BIOL, V86, P192, DOI 10.1038/sj.icb.7100128; Miller JD, 2012, IMMUNOL CELL BIOL, V90, P159, DOI 10.1038/icb.2011.45; Murthy SNP, 2000, P NATL ACAD SCI USA, V97, P44, DOI 10.1073/pnas.97.1.44; Pillet AH, 2008, EUR CYTOKINE NETW, V19, P49, DOI 10.1684/ecn.2008.0120; Reinecker H, HUMAN INTESTINAL EPI; RIMOLDI D, 1993, ANTICANCER RES, V13, P555; Snow AL, 2010, IMMUNOL REV, V236, P68, DOI 10.1111/j.1600-065X.2010.00917.x; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Zambricki E, 2005, AM J TRANSPLANT, V5, P2623, DOI 10.1111/j.1600-6143.2005.01075.x; Zheng LX, 1998, J IMMUNOL, V160, P763; ZURAWSKI SM, 1993, EMBO J, V12, P5113, DOI 10.1002/j.1460-2075.1993.tb06206.x	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102191	10.1371/journal.pone.0102191	http://dx.doi.org/10.1371/journal.pone.0102191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019288	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600052
J	Zhu, JE; Wu, XR; Yuan, SJ; Qian, D; Nan, Q; An, LZ; Xiang, Y				Zhu, Jingen; Wu, Xiaorong; Yuan, Shunjie; Qian, Dong; Nan, Qiong; An, Lizhe; Xiang, Yun			Annexin5 Plays a Vital Role in Arabidopsis Pollen Development via Ca2+-Dependent Membrane Trafficking	PLOS ONE			English	Article							ACTIN-BINDING PROTEINS; TUBE TIP GROWTH; PLANT ANNEXINS; F-ACTIN; DIFFERENTIAL EXPRESSION; PROTEOMIC ANALYSIS; BREFELDIN-A; ENDOPLASMIC-RETICULUM; PHOSPHOLIPID-BINDING; POLARIZED GROWTH	The regulation of pollen development and pollen tube growth is a complicated biological process that is crucial for sexual reproduction in flowering plants. Annexins are widely distributed from protists to higher eukaryotes and play multiple roles in numerous cellular events by acting as a putative "linker" between Ca2+ signaling, the actin cytoskeleton and the membrane, which are required for pollen development and pollen tube growth. Our recent report suggested that downregulation of the function of Arabidopsis annexin 5 (Ann5) in transgenic Ann5-RNAi lines caused severely sterile pollen grains. However, little is known about the underlying mechanisms of the function of Ann5 in pollen. This study demonstrated that Ann5 associates with phospholipid membrane and this association is stimulated by Ca2+ in vitro. Brefeldin A (BFA) interferes with endomembrane trafficking and inhibits pollen germination and pollen tube growth. Both pollen germination and pollen tube growth of Ann5-overexpressing plants showed increased resistance to BFA treatment, and this effect was regulated by calcium. Overexpression of Ann5 promoted Ca2+-dependent cytoplasmic streaming in pollen tubes in vivo in response to BFA. Lactrunculin (LatB) significantly prohibited pollen germination and tube growth by binding with high affinity to monomeric actin and preferentially targeting dynamic actin filament arrays and preventing actin polymerization. Overexpression of Ann5 did not affect pollen germination or pollen tube growth in response to LatB compared with wild-type, although Ann5 interacts with actin filaments in a manner similar to some animal annexins. In addition, the sterile pollen phenotype could be only partially rescued by Ann5 mutants at Ca2+-binding sites when compared to the complete recovery by wild-type Ann5. These data demonstrated that Ann5 is involved in pollen development, germination and pollen tube growth through the promotion of endomembrane trafficking modulated by calcium. Our results provide reliable molecular mechanisms that underlie the function of Ann5 in pollen.	[Zhu, Jingen; Wu, Xiaorong; Yuan, Shunjie; Qian, Dong; Nan, Qiong; An, Lizhe; Xiang, Yun] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China	Lanzhou University	Xiang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	xiangy@lzu.edu.cn	; Yang, Xiaoming/GRJ-9483-2022	Xiang, Yun/0000-0002-5178-0700; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2014CB954200-03]; National Natural Science Foundation of China [30800079, 31270326]; Program for New Century Excellent Talents in University [NCET-13-0264]; Natural Science Foundation for Distinguished Yong Scholars of Gansu Province [2013GS10064]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation for Distinguished Yong Scholars of Gansu Province	This work was supported by the National Basic Research Program (2014CB954200-03), the National Natural Science Foundation of China (30800079 and 31270326), the Program for New Century Excellent Talents in University (NCET-13-0264), and the Natural Science Foundation for Distinguished Yong Scholars of Gansu Province (2013GS10064) to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Arboledas D, 1997, FEBS LETT, V416, P217, DOI 10.1016/S0014-5793(97)01207-6; Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Bai SY, 2010, J EXP BOT, V61, P1089, DOI 10.1093/jxb/erp373; Bassani M, 2004, PLANT MOL BIOL, V56, P367, DOI 10.1007/s11103-004-3474-y; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7970, DOI 10.1021/bi00246a014; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bianco L, 2009, J PROTEOMICS, V72, P586, DOI 10.1016/j.jprot.2008.11.019; BLACKBOURN HD, 1992, PLANT PHYSIOL, V99, P864, DOI 10.1104/pp.99.3.864; BOUSTEAD CM, 1989, FEBS LETT, V244, P456, DOI 10.1016/0014-5793(89)80582-4; Breton G, 2000, PLANT CELL PHYSIOL, V41, P177, DOI 10.1093/pcp/41.2.177; Buitink J, 2006, PLANT J, V47, P735, DOI 10.1111/j.1365-313X.2006.02822.x; Cai G, 2009, J EXP BOT, V60, P495, DOI 10.1093/jxb/ern321; Calvert CM, 1996, PLANT CELL, V8, P333, DOI 10.1105/tpc.8.2.333; Campanoni P, 2007, J EXP BOT, V58, P65, DOI 10.1093/jxb/erl059; Cantero A, 2006, PLANT PHYSIOL BIOCH, V44, P13, DOI 10.1016/j.plaphy.2006.02.002; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Cheung AY, 2001, SCIENCE, V293, P1441, DOI 10.1126/science.1065051; CLARK GB, 1992, PLANTA, V187, P1, DOI 10.1007/BF00201617; Clark GB, 2005, PLANTA, V220, P621, DOI 10.1007/s00425-004-1374-7; Clark GB, 2001, PLANT PHYSIOL, V126, P1072, DOI 10.1104/pp.126.3.1072; Clark Greg, 2005, Gravit Space Biol Bull, V18, P113; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dabitz N, 2005, BIOCHEMISTRY-US, V44, P16292, DOI 10.1021/bi0516226; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Fu Y, 2010, J INTEGR PLANT BIOL, V52, P131, DOI 10.1111/j.1744-7909.2010.00922.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gorecka KM, 2007, PLANT CELL PHYSIOL, V48, P792, DOI 10.1093/pcp/pcm046; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Helling D, 2006, PLANT CELL, V18, P3519, DOI 10.1105/tpc.106.047373; Hepler PK, 2012, TRENDS PLANT SCI, V17, P32, DOI 10.1016/j.tplants.2011.10.007; Hill WG, 2003, J GEN PHYSIOL, V121, P413, DOI 10.1085/jgp.200308803; Hofmann A, 2002, PROTEIN SCI, V11, P2033, DOI 10.1110/ps.4770102; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Hoshino D, 2004, PLANTA, V219, P867, DOI 10.1007/s00425-004-1285-7; Hu SQ, 2000, PLANT J, V24, P127, DOI 10.1046/j.1365-313x.2000.00852.x; Huh SM, 2010, PLANT CELL PHYSIOL, V51, P1499, DOI 10.1093/pcp/pcq111; Hwang JU, 2005, MOL BIOL CELL, V16, P5385, DOI 10.1091/mbc.E05-05-0409; Jacob R, 2004, J BIOL CHEM, V279, P3680, DOI 10.1074/jbc.C300503200; Jia HL, 2013, J BIOL CHEM, V288, P32277, DOI 10.1074/jbc.M113.483594; KACHAR B, 1988, J CELL BIOL, V106, P1545, DOI 10.1083/jcb.106.5.1545; Konopka-Postupolska D, 2007, PROTOPLASMA, V230, P203, DOI 10.1007/s00709-006-0234-7; Konrad KR, 2011, CURR OPIN PLANT BIOL, V14, P721, DOI 10.1016/j.pbi.2011.09.005; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; Proust J, 1999, PLANT MOL BIOL, V39, P361, DOI 10.1023/A:1006199814795; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Roy SJ, 1999, PLANT J, V19, P379, DOI 10.1046/j.1365-313X.1999.00515.x; RUTTEN TLM, 1993, EUR J CELL BIOL, V61, P247; Santoni V, 1998, PLANT J, V16, P633, DOI 10.1046/j.1365-313x.1998.00335.x; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; SMALLWOOD M, 1990, BIOCHEM J, V270, P157, DOI 10.1042/bj2700157; Soler M, 2007, PLANT PHYSIOL, V144, P419, DOI 10.1104/pp.106.094227; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Staiger CJ, 2010, J EXP BOT, V61, P1969, DOI 10.1093/jxb/erq012; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Verchot-Lubicz J, 2010, PROTOPLASMA, V240, P99, DOI 10.1007/s00709-009-0088-x; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; WENG XW, 1993, PROTEIN SCI, V2, P448; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yamamoto Y, 2003, PLANT CELL PHYSIOL, V44, P1192, DOI 10.1093/pcp/pcg147; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Zhang CH, 2002, PROTOPLASMA, V219, P59, DOI 10.1007/s007090200006; Zhang Y, 2010, PLANT PHYSIOL, V152, P2200, DOI 10.1104/pp.109.142349; Zhao LN, 2013, PLANT CELL, V25, P649, DOI 10.1105/tpc.112.103184; Zhu JG, 2014, MOL PLANT, V7, P751, DOI 10.1093/mp/sst171	83	34	37	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102407	10.1371/journal.pone.0102407	http://dx.doi.org/10.1371/journal.pone.0102407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019283	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600078
J	Furugaki, K; Cui, L; Kunisawa, Y; Osada, K; Shinkai, K; Tanaka, M; Kataoka, K; Nakano, K				Furugaki, Kouichi; Cui, Lin; Kunisawa, Yumi; Osada, Kensuke; Shinkai, Kentaro; Tanaka, Masao; Kataoka, Kazunori; Nakano, Kenji			Intraperitoneal Administration of a Tumor-Associated Antigen SART3, CD40L, and GM-CSF Gene-Loaded Polyplex Micelle Elicits a Vaccine Effect in Mouse Tumor Models	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; COLONY-STIMULATING FACTOR; CANCER-PATIENTS; DENDRITIC CELLS; PERITONEAL DISSEMINATION; SART3-DERIVED PEPTIDES; PEGYLATED POLYPLEX; PANCREATIC-CANCER; IMMUNE ACTIVATION; BLOCK-COPOLYMER	Polyplex micelles have demonstrated biocompatibility and achieve efficient gene transfection in vivo. Here, we investigated a polyplex micelle encapsulating genes encoding the tumor-associated antigen squamous cell carcinoma antigen recognized by T cells-3 (SART3), adjuvant CD40L, and granulocyte macrophage colony-stimulating factor (GM-CSF) as a DNA vaccine platform in mouse tumor models with different types of major histocompatibility antigen complex (MHC). Intraperitoneally administrated polyplex micelles were predominantly found in the lymph nodes, spleen, and liver. Compared with mock controls, the triple gene vaccine significantly prolonged the survival of mice harboring peritoneal dissemination of CT26 colorectal cancer cells, of which long-term surviving mice showed complete rejection when re-challenged with CT26 tumors. Moreover, the DNA vaccine inhibited the growth and metastasis of subcutaneous CT26 and Lewis lung tumors in BALB/c and C57BL/6 mice, respectively, which represent different MHC haplotypes. The DNA vaccine highly stimulated both cytotoxic T lymphocyte and natural killer cell activities, and increased the infiltration of CD11c(+) DCs and CD4(+)/CD8a(+) T cells into tumors. Depletion of CD4(+) or CD8a(+) T cells by neutralizing antibodies deteriorated the anti-tumor efficacy of the DNA vaccine. In conclusion, a SART3/CD40L+GM-CSF gene-loaded polyplex micelle can be applied as a novel vaccine platform to elicit tumor rejection immunity regardless of the recipient MHC haplotype.	[Furugaki, Kouichi; Cui, Lin; Kunisawa, Yumi; Nakano, Kenji] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Furugaki, Kouichi; Shinkai, Kentaro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Osada, Kensuke; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Tokyo, Japan; [Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol, Tokyo, Japan	Kyushu University; Kyushu University; University of Tokyo; University of Tokyo	Nakano, K (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan.	kenakano@med.kyushu-u.ac.jp	Osada, Kensuke/V-3322-2017; Kataoka, Kazunori/K-7108-2012	Osada, Kensuke/0000-0001-9557-6851; Kataoka, Kazunori/0000-0002-8591-413X	Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Special Coordination Funds for Promoting Science and Technology (from Japan)	Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology (from Japan)	This work was supported in part by Grants-in-Aid for Scientific Research (to K.N.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and by the Special Coordination Funds for Promoting Science and Technology (SCF funding program Grants-in-Aid for Scientific Research from Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BM, 2012, CANCER LETT, V325, P155, DOI 10.1016/j.canlet.2012.07.012; Barth RJ, 2010, CLIN CANCER RES, V16, P5548, DOI 10.1158/1078-0432.CCR-10-2138; Berzofsky JA, 2012, SEMIN ONCOL, V39, P348, DOI 10.1053/j.seminoncol.2012.02.002; Chen QX, 2012, BIOMATERIALS, V33, P4722, DOI 10.1016/j.biomaterials.2012.03.017; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Dessureault S, 2005, J SURG RES, V125, P173, DOI 10.1016/j.jss.2004.11.036; Furugaki K, 2010, BLOOD, V115, P653, DOI 10.1182/blood-2007-08-109009; Harada K, 2000, JPN J CANCER RES, V91, P239, DOI 10.1111/j.1349-7006.2000.tb00937.x; HIRANO K, 1985, J PHARM SCI, V74, P915, DOI 10.1002/jps.2600740902; Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072; Ito M, 2000, INT J CANCER, V88, P633, DOI 10.1002/1097-0215(20001115)88:4<633::AID-IJC18>3.3.CO;2-E; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0; Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306; Kumagai M, 2012, J CONTROL RELEASE, V160, P542, DOI 10.1016/j.jconrel.2012.03.021; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Lazoura E, 2005, CURR MED CHEM, V12, P1481, DOI 10.2174/0929867054039017; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; LU L, 1994, J EXP MED, V179, P1823, DOI 10.1084/jem.179.6.1823; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Mackiewicz J, 2009, EUR J PHARMACOL, V625, P84, DOI 10.1016/j.ejphar.2009.09.069; Minami T, 2007, CANCER IMMUNOL IMMUN, V56, P689, DOI 10.1007/s00262-006-0216-9; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Ohgidani M, 2013, J CONTROL RELEASE, V167, P238, DOI 10.1016/j.jconrel.2013.02.006; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Shevchenko I, 2013, INT J CANCER, V133, P98, DOI 10.1002/ijc.27990; Slingluff CL, 2010, J IMMUNOTHER, V33, P630, DOI 10.1097/CJI.0b013e3181e311ac; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Takahashi N, 2012, CANCER SCI, V103, P150, DOI 10.1111/j.1349-7006.2011.02106.x; Tongu M, 2013, CANCER IMMUNOL IMMUN, V62, P383, DOI 10.1007/s00262-012-1343-0; Uchida S, 2012, MOL THER, V20, P1196, DOI 10.1038/mt.2012.20; Un K, 2010, HUM GENE THER, V21, P65, DOI 10.1089/hum.2009.106; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Vonderheide RH, 2013, CLIN CANCER RES, V19, P1035, DOI 10.1158/1078-0432.CCR-12-2064; Wang WS, 2009, INT IMMUNOL, V21, P1065, DOI 10.1093/intimm/dxp072; Wang Y, 2002, BLOOD, V100, P569, DOI 10.1182/blood.V100.2.569; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yang D, 1999, CANCER RES, V59, P4056; Zarei S, 2009, BLOOD, V113, P6658, DOI 10.1182/blood-2008-06-161075; Zhang M, 2005, GENE THER, V12, P1049, DOI 10.1038/sj.gt.3302490	43	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101854	10.1371/journal.pone.0101854	http://dx.doi.org/10.1371/journal.pone.0101854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013909	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400044
J	McGuffey, JE; Wei, B; Bernert, JT; Morrow, JC; Xia, BY; Wang, LQ; Blount, BC				McGuffey, James E.; Wei, Binnian; Bernert, John T.; Morrow, John C.; Xia, Baoyun; Wang, Lanqing; Blount, Benjamin C.			Validation of a LC-MS/MS Method for Quantifying Urinary Nicotine, Six Nicotine Metabolites and the Minor Tobacco Alkaloids-Anatabine and Anabasine-in Smokers' Urine	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PRESSURE CHEMICAL-IONIZATION; ELECTROSPRAY-IONIZATION; HUMAN PLASMA; ANALYTE RESPONSE; ION SUPPRESSION; MS-MS; BIOMARKERS; LC/MS/MS; COTININE	Tobacco use is a major contributor to premature morbidity and mortality. The measurement of nicotine and its metabolites in urine is a valuable tool for evaluating nicotine exposure and for nicotine metabolic profiling-i.e., metabolite ratios. In addition, the minor tobacco alkaloids-anabasine and anatabine-can be useful for monitoring compliance in smoking cessation programs that use nicotine replacement therapy. Because of an increasing demand for the measurement of urinary nicotine metabolites, we developed a rapid, low-cost method that uses isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) for simultaneously quantifying nicotine, six nicotine metabolites, and two minor tobacco alkaloids in smokers' urine. This method enzymatically hydrolyzes conjugated nicotine (primarily glucuronides) and its metabolites. We then use acetone pretreatment to precipitate matrix components (endogenous proteins, salts, phospholipids, and exogenous enzyme) that may interfere with LC-MS/MS analysis. Subsequently, analytes (nicotine, cotinine, hydroxycotinine, norcotinine, nornicotine, cotinine N-oxide, nicotine 1'-N-oxide, anatabine, and anabasine) are chromatographically resolved within a cycle time of 13.5 minutes. The optimized assay produces linear responses across the analyte concentrations typically found in urine collected from daily smokers. Because matrix ion suppression may influence accuracy, we include a discussion of conventions employed in this procedure to minimize matrix interferences. Simplicity, low cost, low maintenance combined with high mean metabolite recovery (76-99%), specificity, accuracy (0-10% bias) and reproducibility (2-9% C.V.) make this method ideal for large high through-put studies.	[McGuffey, James E.; Wei, Binnian; Bernert, John T.; Morrow, John C.; Xia, Baoyun; Wang, Lanqing; Blount, Benjamin C.] Ctr Dis Control & Prevent, Tobacco & Volatiles Branch, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	McGuffey, JE (corresponding author), Ctr Dis Control & Prevent, Tobacco & Volatiles Branch, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.	jem4@cdc.gov	; Wei, Binnian/H-2746-2014	Wei, Binnian/0000-0001-8076-1202; Wei, Binnian/0000-0003-0465-9964	U.S. Food and Drug Administration Center for Tobacco Products; Centers for Disease Control and Prevention	U.S. Food and Drug Administration Center for Tobacco Products; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded through an interagency agreement between the U.S. Food and Drug Administration Center for Tobacco Products and the Centers for Disease Control and Prevention. The FDA had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. The authors are employed by the CDC, who provided all elements involved in the study design, data collection, analysis, and preparation of the manuscript for publication.	Alzweiri M, 2008, TALANTA, V74, P1060, DOI 10.1016/j.talanta.2007.07.037; Annesley TM, 2000, J AM SOC SPECTRUN, P942; ANSTALL HB, 1965, CLIN CHEM, V11, P741; Ashri NY, 2011, BIOANALYSIS, V3, P2003, DOI [10.4155/bio.11.201, 10.4155/BIO.11.201]; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Benowitz NL, 1999, J PHARMACOL EXP THER, V291, P1196; Benowitz NL, 2002, J NATL CANCER I, V94, P108, DOI 10.1093/jnci/94.2.108; Berg JZ, 2010, J PHARMACOL EXP THER, V332, P202, DOI 10.1124/jpet.109.159855; Bernert JT, 2005, J ANAL TOXICOL, V29, P814, DOI 10.1093/jat/29.8.814; Bloor WR, 1929, J BIOL CHEM, V82, P273; Boyd EM, 1935, J BIOL CHEM, V110, P61; Buhrman DL, 1996, J AM SOC MASS SPECTR, V7, P1099, DOI 10.1016/S1044-0305(96)00072-4; Choi BK, 2001, J CHROMATOGR A, V907, P337, DOI 10.1016/S0021-9673(00)01052-9; Constantopoulos TL, 1999, J AM SOC MASS SPECTR, V10, P625, DOI 10.1016/S1044-0305(99)00031-8; Dams R, 2003, J AM SOC MASS SPECTR, V14, P1290, DOI 10.1016/S1044-0305(03)00574-9; Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424; Ebbert JO, 2007, NICOTINE TOB RES, V9, P43, DOI 10.1080/14622200601078285; Fan Z, 2008, CHROMATOGRAPHIA, V68, P623, DOI 10.1365/s10337-008-0729-9; Hecht SS, 2010, CHEM RES TOXICOL, V23, P1001, DOI 10.1021/tx100056m; Hoofnagle AN, 2006, AM J CLIN PATHOL, V126, P880, DOI 10.1309/LQ8U3UL956ET324X; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; HUTCHINSON J, 1998, J CHROMATOGR B, V708, P87; Jacob P, 2002, CANCER EPIDEM BIOMAR, V11, P1668; King R, 2000, J AM SOC MASS SPECTR, V11, P942, DOI 10.1016/S1044-0305(00)00163-X; Lerman C, 2006, CLIN PHARMACOL THER, V79, P600, DOI 10.1016/j.clpt.2006.02.006; Liang HR, 2003, RAPID COMMUN MASS SP, V17, P2815, DOI 10.1002/rcm.1268; Little JL, 2006, J CHROMATOGR B, V833, P219, DOI 10.1016/j.jchromb.2006.02.011; Malaiyandi V, 2006, CANCER EPIDEM BIOMAR, V15, P1812, DOI 10.1158/1055-9965.EPI-05-0723; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Matuszewski BK, 1998, ANAL CHEM, V70, P882, DOI 10.1021/ac971078+; Mei H, 2003, RAPID COMMUN MASS SP, V17, P97, DOI 10.1002/rcm.876; Miller EI, 2010, J CHROMATOGR B, V878, P725, DOI 10.1016/j.jchromb.2009.12.018; Muller C, 2002, J CHROMATOGR B, V773, P47, DOI 10.1016/S1570-0232(02)00142-3; Nakajima Miki, 2005, Drug Metab Pharmacokinet, V20, P227, DOI 10.2133/dmpk.20.227; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Polson C, 2003, J CHROMATOGR B, V785, P263, DOI 10.1016/S1570-0232(02)00914-5; Rainville PD, 2012, J PHARMACEUT BIOMED, V59, P138, DOI 10.1016/j.jpba.2011.10.021; Rangiah K, 2011, BIOANALYSIS, V3, P745, DOI 10.4155/BIO.11.42; Schuhmacher J, 2003, RAPID COMMUN MASS SP, V17, P1950, DOI 10.1002/rcm.1139; Shin HS, 2002, J CHROMATOGR B, V769, P177, DOI 10.1016/S1570-0232(02)00007-7; Sinclair RG, 1942, J BIOL CHEM, V142, P659; Taylor JK, 1987, QUALITY ASSURANCE CH; Tomlinson AJ, 2003, RAPID COMMUN MASS SP, V17, P909, DOI 10.1002/rcm.1001; Wang S, 2007, J PHARMACEUT BIOMED, V43, P701, DOI 10.1016/j.jpba.2006.08.010; Xia YQ, 2009, RAPID COMMUN MASS SP, V23, P2125, DOI 10.1002/rcm.4121; Xu X, 2004, CLIN CHEM, V50, P2323, DOI 10.1373/clinchem.2004.038489	46	44	45	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101816	10.1371/journal.pone.0101816	http://dx.doi.org/10.1371/journal.pone.0101816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013964	gold, Green Published			2022-12-27	WOS:000339378400038
J	Backes, C; Leidinger, P; Keller, A; Hart, M; Meyer, T; Meese, E; Hecksteden, A				Backes, Christina; Leidinger, Petra; Keller, Andreas; Hart, Martin; Meyer, Tim; Meese, Eckart; Hecksteden, Anne			Blood Born miRNAs Signatures that Can Serve as Disease Specific Biomarkers Are Not Significantly Affected by Overall Fitness and Exercise	PLOS ONE			English	Article							CIRCULATING MICRORNA; GENE-EXPRESSION; PERIPHERAL-BLOOD; CANCER-DIAGNOSIS; AEROBIC EXERCISE; LUNG-CANCER; PROFILES; SERUM; HEALTH; CELLS	Blood born micro(mi) RNA expression pattern have been reported for various human diseases with signatures specific for diseases. To evaluate these biomarkers, it is mandatory to know possible changes of miRNA signatures in healthy individuals under different physiological conditions. We analyzed the miRNA expression in peripheral blood of elite endurance athletes and moderatly active controls. Blood drawing was done before and after exhaustive exercise in each group. After Benjamini-Hochberg adjustment we did not find any miRNA with significant p-values when comparing miRNA expression between the different groups. We found, however, 24 different miRNAs with an expression fold change of minimum 1.5 in at least one of the comparisons (athletes before vs after exercise, athletes before exercise vs controls and athletes after exercise vs controls). The observed changes are not significant in contrast to the expression changes of the blood born miRNA expression reported for many human diseases. These data support the idea of disease associated miRNA patterns useful as biomarkers that are not readily altered by physiological conditions.	[Backes, Christina; Leidinger, Petra; Hart, Martin; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, Homburg, Germany; [Keller, Andreas] Univ Saarland, Dept Clin Bioinformat, Saarbrucken, Germany; [Meyer, Tim; Hecksteden, Anne] Univ Saarland, Inst Sports & Prevent Med, Saarbrucken, Germany	Saarland University; Saarland University; Saarland University	Backes, C (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, Homburg, Germany.	c.backes@mx.uni-saarland.de	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895	DFG	DFG(German Research Foundation (DFG))	This work was supported in part by DFG grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Buttner P, 2007, J APPL PHYSIOL, V102, P26, DOI 10.1152/japplphysiol.00066.2006; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; ElSharawy A, 2012, AGING CELL, V11, P607, DOI 10.1111/j.1474-9726.2012.00824.x; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gotte M, 2010, Minerva Ginecol, V62, P559; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hochberg Y, 1988, BIOMETRIKA, V75, P185, DOI DOI 10.1093/BIOMET/75.4.800; Keller A, 2011, NAT METH; Keller A, 2014, MULT SCLER J, V20, P295, DOI 10.1177/1352458513496343; Keller A, 2011, RNA BIOL, V8, P506, DOI 10.4161/rna.8.3.14994; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lawrie CH, 2013, BLOOD REV, V27, P143, DOI 10.1016/j.blre.2013.04.002; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li SC, 2013, MODERN PATHOL, V26, P685, DOI 10.1038/modpathol.2012.216; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Pritchard CC, 2011, CANC PREV RES PHILA; Radom-Aizik S, 2008, J APPL PHYSIOL, V104, P236, DOI 10.1152/japplphysiol.00872.2007; Radom-Aizik S, 2012, CTS-CLIN TRANSL SCI, V5, P32, DOI 10.1111/j.1752-8062.2011.00384.x; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Ratert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039309; Schmitt J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-379; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Yin Yu, 2010, Zhonghua Nan Ke Xue, V16, P599	40	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102183	10.1371/journal.pone.0102183	http://dx.doi.org/10.1371/journal.pone.0102183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010680	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800077
J	Oliveira, AB; Fatore, FM; Paulovich, FV; Oliveira, ON; Leite, VBP				Oliveira, Antonio B., Jr.; Fatore, Francisco M.; Paulovich, Fernando V.; Oliveira, Osvaldo N., Jr.; Leite, Vitor B. P.			Visualization of Protein Folding Funnels in Lattice Models	PLOS ONE			English	Article							FREE-ENERGY LANDSCAPE; POTENTIAL-ENERGY; TRANSITION-STATE; DYNAMICS; KINETICS; PATHWAYS; DETERMINES; MECHANISMS; SURFACE	Protein folding occurs in a very high dimensional phase space with an exponentially large number of states, and according to the energy landscape theory it exhibits a topology resembling a funnel. In this statistical approach, the folding mechanism is unveiled by describing the local minima in an effective one-dimensional representation. Other approaches based on potential energy landscapes address the hierarchical structure of local energy minima through disconnectivity graphs. In this paper, we introduce a metric to describe the distance between any two conformations, which also allows us to go beyond the one-dimensional representation and visualize the folding funnel in 2D and 3D. In this way it is possible to assess the folding process in detail, e. g., by identifying the connectivity between conformations and establishing the paths to reach the native state, in addition to regions where trapping may occur. Unlike the disconnectivity maps method, which is based on the kinetic connections between states, our methodology is based on structural similarities inferred from the new metric. The method was developed in a 27-mer protein lattice model, folded into a 3x3x3 cube. Five sequences were studied and distinct funnels were generated in an analysis restricted to conformations from the transition-state to the native configuration. Consistent with the expected results from the energy landscape theory, folding routes can be visualized to probe different regions of the phase space, as well as determine the difficulty in folding of the distinct sequences. Changes in the landscape due to mutations were visualized, with the comparison between wild and mutated local minima in a single map, which serves to identify different trapping regions. The extension of this approach to more realistic models and its use in combination with other approaches are discussed.	[Oliveira, Antonio B., Jr.; Leite, Vitor B. P.] Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Paulo, Brazil; [Fatore, Francisco M.; Paulovich, Fernando V.] Univ Sao Paulo, Inst Ciencias Matemat & Comp, Sao Paulo, Brazil; [Oliveira, Osvaldo N., Jr.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Leite, VBP (corresponding author), Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Paulo, Brazil.	vleite@sjrp.unesp.br	Paulovich, Fernando/G-1329-2010; Oliveira, Osvaldo N./A-1714-2008	Paulovich, Fernando/0000-0002-2316-760X; Oliveira, Osvaldo N./0000-0002-5399-5860; Oliveira Junior, Antonio Bento/0000-0003-1955-3556	FAPESP (Brazil); CNPq (Brazil); CAPES (Brazil); nBioNet network (Brazil)	FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); nBioNet network (Brazil)	This work was supported by FAPESP, CNPq, CAPES and nBioNet network (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, J CHEM PHYS, V101, P6052, DOI 10.1063/1.467320; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Becker OM, 1997, J MOL STRUC-THEOCHEM, V398, P507, DOI 10.1016/S0166-1280(97)00080-8; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chahine J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.168101; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Choi S.S., 2010, J SYST CYBERN INFORM, V8, P43; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Cox T. F., 2010, MULTIDIMENSIONAL SCA; Dickson A, 2013, J AM CHEM SOC, V135, P4729, DOI 10.1021/ja311077u; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dima RI, 1999, P NATL ACAD SCI USA, V96, P4904, DOI 10.1073/pnas.96.9.4904; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Doye JPK, 1999, J CHEM PHYS, V111, P8417, DOI 10.1063/1.480217; Doye JPK, 1999, J CHEM PHYS, V110, P6896, DOI 10.1063/1.478595; Evans DA, 2003, J CHEM PHYS, V119, P9947, DOI 10.1063/1.1616515; Garstecki P, 1999, PHYS REV E, V60, P3219, DOI 10.1103/PhysRevE.60.3219; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Klimov DK, 1998, J CHEM PHYS, V109, P4119, DOI 10.1063/1.477012; Krivov SV, 2002, J CHEM PHYS, V117, P10894, DOI 10.1063/1.1517606; Kurnik M, 2012, P NATL ACAD SCI USA, V109, P5705, DOI 10.1073/pnas.1118640109; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lee CL, 2003, J CHEM PHYS, V118, P959, DOI 10.1063/1.1527672; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Levinthal C., 1968, EXTRAIT J CHIMIE PHY, V65; Miller MA, 1999, J CHEM PHYS, V111, P6610, DOI 10.1063/1.480011; Miller MA, 1999, PHYS REV E, V60, P3701, DOI 10.1103/PhysRevE.60.3701; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Noe F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2714539; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Otzen DE, 1999, P NATL ACAD SCI USA, V96, P11746, DOI 10.1073/pnas.96.21.11746; Potoyan DA, 2011, J AM CHEM SOC, V133, P7405, DOI 10.1021/ja1111964; Prada-Gracia D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000415; Rao F, 2004, J MOL BIOL, V342, P299, DOI 10.1016/j.jmb.2004.06.063; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; SOCCI ND, 1995, J CHEM PHYS, V103, P4732, DOI 10.1063/1.470610; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tejada E., 2003, Information Visualization, V2, P218, DOI 10.1057/palgrave.ivs.9500054; Thirumalai D, 2010, ANNU REV BIOPHYS, V39, P159, DOI 10.1146/annurev-biophys-051309-103835; Wales D., 2003, ENERGY LANDSCAPES AP; Wales DJ, 2006, J PHYS CHEM B, V110, P20765, DOI 10.1021/jp0680544; Wales DJ, 2006, INT REV PHYS CHEM, V25, P237, DOI 10.1080/01442350600676921; Wales DJ, 2012, PHILOS T R SOC A, V370, P2877, DOI 10.1098/rsta.2011.0208; Wales DJ, 2010, CURR OPIN STRUC BIOL, V20, P3, DOI 10.1016/j.sbi.2009.12.011; Wales DJ, 2004, J CHEM PHYS, V121, P10284, DOI 10.1063/1.1810471; Wales DJ, 2004, MOL PHYS, V102, P891, DOI 10.1080/00268970410001703363; Wales DJ, 1998, NATURE, V394, P758, DOI 10.1038/29487; Wales DJ, 2002, MOL PHYS, V100, P3285, DOI 10.1080/00268970210162691; Wang J, 2012, P NATL ACAD SCI USA, V109, P15763, DOI 10.1073/pnas.1212842109; Ware C., 2001, INFORM DESIGN J, V10; Zheng WW, 2013, J PHYS CHEM B, V117, P12769, DOI 10.1021/jp401911h; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119	59	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100861	10.1371/journal.pone.0100861	http://dx.doi.org/10.1371/journal.pone.0100861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010343	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800007
J	Huang, MY; Yang, W; Wu, Y; Jiang, J; Gao, Y; Chen, Y; Feng, QJ; Chen, WF; Lu, ZT				Huang, Meiyan; Yang, Wei; Wu, Yao; Jiang, Jun; Gao, Yang; Chen, Yang; Feng, Qianjin; Chen, Wufan; Lu, Zhentai			Content-Based Image Retrieval Using Spatial Layout Information in Brain Tumor T1-Weighted Contrast-Enhanced MR Images	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; LESIONS	This study aims to develop content-based image retrieval (CBIR) system for the retrieval of T1-weighted contrast-enhanced MR (CE-MR) images of brain tumors. When a tumor region is fed to the CBIR system as a query, the system attempts to retrieve tumors of the same pathological category. The bag-of-visual-words (BoVW) model with partition learning is incorporated into the system to extract informative features for representing the image contents. Furthermore, a distance metric learning algorithm called the Rank Error-based Metric Learning (REML) is proposed to reduce the semantic gap between low-level visual features and high-level semantic concepts. The effectiveness of the proposed method is evaluated on a brain T1-weighted CE-MR dataset with three types of brain tumors (i.e., meningioma, glioma, and pituitary tumor). Using the BoVW model with partition learning, the mean average precision (mAP) of retrieval increases beyond 4.6% with the learned distance metrics compared with the spatial pyramid BoVW method. The distance metric learned by REML significantly outperforms three other existing distance metric learning methods in terms of mAP. The mAP of the CBIR system is as high as 91.8% using the proposed method, and the precision can reach 93.1% when the top 10 images are returned by the system. These preliminary results demonstrate that the proposed method is effective and feasible for the retrieval of brain tumors in T1-weighted CE-MR Images.	[Huang, Meiyan; Yang, Wei; Wu, Yao; Jiang, Jun; Gao, Yang; Feng, Qianjin; Chen, Wufan; Lu, Zhentai] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Chen, Yang] Southeast Univ, Lab Image Sci & Technol, Key Lab Comp Network & Informat Integrat, Minist Educ, Nanjing, Jiangsu, Peoples R China	Southern Medical University - China; Southeast University - China	Feng, QJ (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.	qianjinfeng08@gmail.com	feng, qianjin/GNM-7856-2022; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; Jiang, Jun/0000-0003-1147-3666	National Basic Research Program of China (973 Program) [2010CB732505]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAI14B02]; National Natural Science Foundation of China [81101109, 31371009]; National High Technology Research and Development Program of China (863 Program) [2012AA02A616]; Program of Pearl River Young Talents of Science and Technology in Guangzhou [2013J2200065, 2012J2200041]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program of Pearl River Young Talents of Science and Technology in Guangzhou	This work was supported by the National Basic Research Program of China (973 Program) (http://www.973.gov.cn/) under grant (No. 2010CB732505), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (http://kjzc.jhgl.org/) under grant (No. 2012BAI14B02), the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grant (No. 81101109 and No. 31371009), the National High Technology Research and Development Program of China (863 Program) (http://www.863.gov.cn/) under grant (No. 2012AA02A616), Program of Pearl River Young Talents of Science and Technology in Guangzhou (http://www.gzsi.gov.cn/) under grant (No. 2013J2200065), and Program of Pearl River Young Talents of Science and Technology in Guangzhou (http://www.gzsi.gov.cn/) under grant (No. 2012J2200041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antel SB, 2003, NEUROIMAGE, V19, P1748, DOI 10.1016/S1053-8119(03)00226-X; Avni U, 2011, IEEE T MED IMAGING, V30, P733, DOI 10.1109/TMI.2010.2095026; Bagci U, 2012, IEEE T MED IMAGING, V31, P777, DOI 10.1109/TMI.2011.2180920; Bagci U, 2010, PATTERN RECOGN LETT, V31, P315, DOI 10.1016/j.patrec.2009.09.010; Bosch A, 2006, MODELING CLASSIFYING, P1552; Burges C.J., 2006, P NEUR INF PROC SYST; Chang H, 2007, IMAGE VISION COMPUT, V25, P695, DOI 10.1016/j.imavis.2006.05.013; Chaplot S, 2006, BIOMED SIGNAL PROCES, V1, P86, DOI 10.1016/j.bspc.2006.05.002; Chen MH, 2013, IEEE T INFORM THEORY, V59, P6301, DOI 10.1109/TIT.2013.2268923; Chu WW, 1998, IEEE T KNOWL DATA EN, V10, P872, DOI 10.1109/69.738355; de Oliveira JEE, 2010, COMPUT METH PROG BIO, V99, P289, DOI 10.1016/j.cmpb.2010.01.005; Dube S, 2006, CONTENT BASED IMAGE, P3337; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Frome A., 2006, NIPS, P417; Guan H, 2009, BRIDGING SEMANTIC GA; Harada T, 2011, PROC CVPR IEEE, P1617, DOI 10.1109/CVPR.2011.5995691; Huang HK, 2005, COMPUT MED IMAG GRAP, V29, P195, DOI 10.1016/j.compmedimag.2004.09.008; Huang KZ, 2011, KNOWL INF SYST, V28, P25, DOI 10.1007/s10115-010-0313-0; Huang MY, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/280538; Iakovidis DK, 2009, IEEE T INF TECHNOL B, V13, P442, DOI 10.1109/TITB.2008.923144; Jegou H, 2010, INT J COMPUT VISION, V87, P316, DOI 10.1007/s11263-009-0285-2; Jiang J, 2013, COMPUT MED IMAG GRAP, V37, P512, DOI 10.1016/j.compmedimag.2013.05.007; Jiang YN, 2012, LECT NOTES COMPUT SC, V7573, P730, DOI 10.1007/978-3-642-33709-3_52; Kloppel S, 2011, NEUROIMAGE, V57, P416, DOI 10.1016/j.neuroimage.2011.04.053; Lahmiri S, 2011, BRAIN MRI CLASSIFICA, P1; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Liu C, 2003, PROC CVPR IEEE, P587; Moustakas J, 2005, IEEE INT C MULT EXP; Muller H, 2004, INT J MED INFORM, V73, P1, DOI 10.1016/j.ijmedinf.2003.11.024; Nazari Mina Rafi, 2010, INT J COMPUTER APPL, V7, P33, DOI DOI 10.5120/1327-1636; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Petrakis EGM, 1997, IEEE T KNOWL DATA EN, V9, P435, DOI 10.1109/69.599932; Rahman MM, 2008, COMPUT MED IMAG GRAP, V32, P95, DOI 10.1016/j.compmedimag.2007.10.001; Robinson GP, 1996, COMPUT MED IMAG GRAP, V20, P209, DOI 10.1016/S0895-6111(96)00014-6; Rudin C, 2009, J MACH LEARN RES, V10, P2233; Sharma G, 2011, LEARNING DISCRIMINAT; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Wu JX, 2011, IEEE T PATTERN ANAL, V33, P1489, DOI 10.1109/TPAMI.2010.224; Xing E., 2002, ADV NEURAL INFORM PR, V15, P505, DOI DOI 10.5555/2968618.2968683; Yang L, 2010, IEEE T PATTERN ANAL, V32, P30, DOI 10.1109/TPAMI.2008.273; Yang W, 2012, J DIGIT IMAGING, V25, P708, DOI 10.1007/s10278-012-9495-1; Yang W, 2012, MED PHYS, V39, P6929, DOI 10.1118/1.4754305; Yang Y, 2011, IEEE I CONF COMP VIS, P1465, DOI 10.1109/ICCV.2011.6126403; Zhang YD, 2011, EXPERT SYST APPL, V38, P10049, DOI 10.1016/j.eswa.2011.02.012	48	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102754	10.1371/journal.pone.0102754	http://dx.doi.org/10.1371/journal.pone.0102754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028970	Green Published, gold			2022-12-27	WOS:000341306600097
J	Amiot, A; Mansour, H; Baumgaertner, I; Delchier, JC; Tournigand, C; Furet, JP; Carrau, JP; Canoui-Poitrine, F; Sobhani, I				Amiot, Aurelien; Mansour, Hicham; Baumgaertner, Isabelle; Delchier, Jean-Charles; Tournigand, Christophe; Furet, Jean-Pierre; Carrau, Jean-Pierre; Canoui-Poitrine, Florence; Sobhani, Iradj		CRC Grp Val De Marne	The Detection of the Methylated Wif-1 Gene Is More Accurate than a Fecal Occult Blood Test for Colorectal Cancer Screening	PLOS ONE			English	Article							DNA METHYLATION; COLON-CANCER; MORTALITY; MARKER; RISK	Background: The clinical benefit of guaiac fecal occult blood tests (FOBT) is now well established for colorectal cancer screening. Growing evidence has demonstrated that epigenetic modifications and fecal microbiota changes, also known as dysbiosis, are associated with CRC pathogenesis and might be used as surrogate markers of CRC. Patients and Methods: We performed a cross-sectional study that included all consecutive subjects that were referred (from 2003 to 2007) for screening colonoscopies. Prior to colonoscopy, effluents (fresh stools, sera-S and urine-U) were harvested and FOBTs performed. Methylation levels were measured in stools, S and U for 3 genes (Wif1, ALX-4, and Vimentin) selected from a panel of 63 genes; Kras mutations and seven dominant and subdominant bacterial populations in stools were quantified. Calibration was assessed with the Hosmer-Lemeshow chi-square, and discrimination was determined by calculating the C-statistic (Area Under Curve) and Net Reclassification Improvement index. Results: There were 247 individuals (mean age 60.8612.4 years, 52% of males) in the study group, and 90 (36%) of these individuals were patients with advanced polyps or invasive adenocarcinomas. A multivariate model adjusted for age and FOBT led to a C-statistic of 0.83 [0.77-0.88]. After supplementary sequential (one-by-one) adjustment, Wif-1 methylation (S or U) and fecal microbiota dysbiosis led to increases of the C-statistic to 0.90 [0.84-0.94] (p = 0.02) and 0.81 [0.74-0.86] (p = 0.49), respectively. When adjusted jointly for FOBT and Wif-1 methylation or fecal microbiota dysbiosis, the increase of the C-statistic was even more significant (0.91 and 0.85, p < 0.001 and p = 0.10, respectively). Conclusion: The detection of methylated Wif-1 in either S or U has a higher performance accuracy compared to guaiac FOBT for advanced colorectal neoplasia screening. Conversely, fecal microbiota dysbiosis detection was not more accurate. Blood and urine testing could be used in those individuals reluctant to undergo stool testing.	[Amiot, Aurelien; Delchier, Jean-Charles; Sobhani, Iradj] Henri Mondor Hosp, AP HP, Dept Gastroenterol, Creteil, France; [Amiot, Aurelien; Delchier, Jean-Charles; Tournigand, Christophe; Canoui-Poitrine, Florence; Sobhani, Iradj] Univ Paris Est Creteil, Creteil, France; [Amiot, Aurelien; Mansour, Hicham; Canoui-Poitrine, Florence; Sobhani, Iradj] Lab Invest Clin EA 4393 EC2M3, Creteil, France; [Mansour, Hicham] King Abdullah Univ Sci & Technol, Biosci Core Labs, Thuwal, Saudi Arabia; [Baumgaertner, Isabelle; Tournigand, Christophe] Henri Mondor Hosp, AP HP, Dept Oncol, Creteil, France; [Delchier, Jean-Charles] INRA, MICALIS Inst, Commensals & Probiot Host Interact Lab, Jouy En Josas, France; [Carrau, Jean-Pierre] CPAM, Lab Anal, Paris, France; [Canoui-Poitrine, Florence] Henri Mondor Hosp, AP HP, Dept Publ Hlth, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); King Abdullah University of Science & Technology; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Sobhani, I (corresponding author), Henri Mondor Hosp, AP HP, Dept Gastroenterol, Creteil, France.	iradj.sobhani@hmn.aphp.fr	Canoui-Poitrine, Florence/R-4474-2018; Tournigand, Christophe/Q-2831-2018; AMIOT, Aurélien/ABL-6373-2022	Canoui-Poitrine, Florence/0000-0001-9970-6051; 	Canceropole Ile de France, CoMiCa project; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa project; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa 2007-2010 project, (Charles Debray association-ACD); LNCC (French National League against Cancer), CCR INSERM Promotion (2004-2006). The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baylin SB, 1998, ADV CANCER RES, V72, P141; Boyle P, 2002, BRIT MED BULL, V64, P1, DOI 10.1093/bmb/64.1.1; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Grady WM, 2001, CANCER RES, V61, P900; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lengauer C, 2003, SCIENCE, V300, P442, DOI 10.1126/science.1084468; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lieberman D, 2009, CURR OPIN GASTROEN, V25, P422, DOI 10.1097/MOG.0b013e32832d1e2a; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansour H, 2009, Patent No. [WO 2009095596 A2, 2009095596]; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Muller HM, 2004, LANCET, V363, P1283, DOI 10.1016/S0140-6736(04)16002-9; O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Polakis P, 2000, GENE DEV, V14, P1837; Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Sobhani I, 2011, GUT, V60, pA1; Sobhani I, 2013, THER ADV GASTROENTER, V6, P215, DOI 10.1177/1756283X12473674; Sobhani I, 2011, DIS COLON RECTUM, V54, P876, DOI 10.1007/DCR.0b013e31820fd2bc; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	41	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e99233	10.1371/journal.pone.0099233	http://dx.doi.org/10.1371/journal.pone.0099233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025467	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400002
J	Dong, J; Shi, F; Li, H; Zhang, XM; Hu, XZ; Gong, J				Dong, Jun; Shi, Fei; Li, Han; Zhang, Xiaoming; Hu, Xiaozhong; Gong, Jun			SSU rDNA Sequence Diversity and Seasonally Differentiated Distribution of Nanoplanktonic Ciliates in Neritic Bohai and Yellow Seas as Revealed by T-RFLP	PLOS ONE			English	Article							OPERATIONAL TAXONOMIC UNITS; RIBOSOMAL-RNA GENE; SPATIAL-DISTRIBUTION; MEDITERRANEAN SEA; ANNUAL CYCLE; MARINE; COMMUNITIES; OLIGOTRICH; SUMMER; POLYMORPHISMS	Nanociliates have been frequently found to be important players in the marine microbial loop, however, little is known about their diversity and distribution in coastal ecosystems. We investigated the molecular diversity and distribution patterns of nanoplanktonic oligotrich and choreotrich (OC) ciliates in surface water of three neritic basins of northern China, the South Yellow Sea (SYS), North Yellow Sea (NYS), and Bohai Sea (BS) in June and November 2011. SSU rRNA gene clone libraries generated from three summertime samples (sites B38, B4 and H8) were analyzed and revealed a large novel ribotype diversity, of which many were low-abundant phylotypes belonging to the subclass Oligotrichia, but divergent from described morphospecies. Based on the data of terminal-restriction fragment length polymorphism (T-RFLP) analysis of all 35 samples, we found that the T-RF richness was generally higher in the SYS than in the BS, and negatively correlated with the molar ratio of P to Si. Overall, multidimensional scaling and permutational multivariate analysis of variance of the community turnover demonstrated a distinct seasonal pattern but no basin-to-basin differentiation across all samples. Nevertheless, significant community differences among basins were recognized in the winter dataset. Mantel tests showed that the environmental factors, P: Si ratio, water temperature and concentration of dissolved oxygen (DO), determined the community across all samples. However, both biogeographic distance and environment shaped the community in winter, with DO being the most important physicochemical factor. Our results indicate that the stoichiometric ratio of P: Si is a key factor, through which the phytoplankton community may be shaped, resulting in a cascade effect on the diversity and community composition of OC nanociliates in the N-rich, Si-limited coastal surface waters, and that the Yellow Sea Warm Current drives the nanociliate community, and possibly the microbial food webs, in the coastal ecosystem in winter.	[Dong, Jun; Hu, Xiaozhong] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Dong, Jun; Shi, Fei; Li, Han; Gong, Jun] Chinese Acad Sci, Lab Microbial Ecol & Matter Cycles, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Zhang, Xiaoming; Gong, Jun] S China Normal Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; South China Normal University	Gong, J (corresponding author), Chinese Acad Sci, Lab Microbial Ecol & Matter Cycles, Yantai Inst Coastal Zone Res, Yantai, Peoples R China.	jgong@yic.ac.cn	Gong, Jun/B-1580-2008	Gong, Jun/0000-0002-4402-1263	One Hundred Talent Program of CAS; National Natural Science Foundation of China [41176143]; Strategic Priority Research Program of CAS [XDA11020403]; Natural Science Foundation for Distinguished Young Scholars of Shandong [JQ201210]; Yantai Double Hundred Talent Plan	One Hundred Talent Program of CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS; Natural Science Foundation for Distinguished Young Scholars of Shandong; Yantai Double Hundred Talent Plan	This work was supported by the One Hundred Talent Program of CAS, the National Natural Science Foundation of China (No. 41176143), the Strategic Priority Research Program of CAS (No. XDA11020403), the Natural Science Foundation for Distinguished Young Scholars of Shandong (No. JQ201210), and the Yantai Double Hundred Talent Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatha S, 2005, EUR J PROTISTOL, V41, P65, DOI 10.1016/j.ejop.2004.09.005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson M.J., 2008, PERMANOVA PRIMER GUI; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Bachy C, 2012, PROTIST, V163, P873, DOI 10.1016/j.protis.2012.01.001; Balzano S, 2012, ISME J, V6, P1480, DOI 10.1038/ismej.2011.213; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Carlsson P, 1999, AQUAT MICROB ECOL, V18, P55, DOI 10.3354/ame018055; Caron DA, 1999, J PHYCOL, V35, P824, DOI 10.1046/j.1529-8817.1999.3540824.x; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Caron DA, 2009, AQUAT MICROB ECOL, V57, P227, DOI 10.3354/ame01352; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Claessens M, 2008, AQUAT MICROB ECOL, V53, P181, DOI 10.3354/ame01243; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Doherty M, 2010, APPL ENVIRON MICROB, V76, P3924, DOI 10.1128/AEM.01604-09; Doherty M, 2010, ENVIRON MICROBIOL, V12, P886, DOI 10.1111/j.1462-2920.2009.02133.x; Dolan J. R., 2012, BIOL ECOLOGY TINTINN, P214; Dolan JR, 1999, DEEP-SEA RES PT I, V46, P2025, DOI 10.1016/S0967-0637(99)00043-6; Dolan JR, 1995, DEEP-SEA RES PT I, V42, P1965, DOI 10.1016/0967-0637(95)00092-5; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenchel T., 1987, ECOLOGY PROTOZOA, P1, DOI 10.1007/978-3-662-06817-5; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Gong J, 2005, AQUAT MICROB ECOL, V39, P159, DOI 10.3354/ame039159; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim DY, 2012, J MICROBIOL METH, V91, P527, DOI 10.1016/j.mimet.2012.09.026; Kim YO, 1997, MAR BIOL, V128, P207, DOI 10.1007/s002270050084; Liu WW, 2011, SYST BIODIVERS, V9, P247, DOI 10.1080/14772000.2011.605812; Liu WW, 2011, J EUKARYOT MICROBIOL, V58, P43, DOI 10.1111/j.1550-7408.2010.00519.x; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; Mironova E, 2012, J PLANKTON RES, V34, P208, DOI 10.1093/plankt/fbr095; MONTAGNES D J S, 1987, Marine Microbial Food Webs, V2, P83; MONTAGNES DJS, 1989, J PLANKTON RES, V11, P193, DOI 10.1093/plankt/11.2.193; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Nylander JAA., 2004, BIOINFORMATICS; Perez MT, 2000, DEEP-SEA RES PT I, V47, P479, DOI 10.1016/S0967-0637(99)00099-0; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; Pitta P, 2001, AQUAT MICROB ECOL, V24, P297, DOI 10.3354/ame024297; Pitta P, 2000, MAR ECOL PROG SER, V194, P269, DOI 10.3354/meps194269; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; RASSOULZADEGAN F, 1986, LIMNOL OCEANOGR, V31, P1010, DOI 10.4319/lo.1986.31.5.1010; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Setala O, 2003, AQUAT MICROB ECOL, V32, P287, DOI 10.3354/ame032287; SHERR EB, 1986, LIMNOL OCEANOGR, V31, P177, DOI 10.4319/lo.1986.31.1.0177; SHERR EB, 1987, NATURE, V325, P710, DOI 10.1038/325710a0; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tamura M, 2011, AQUAT MICROB ECOL, V64, P51, DOI 10.3354/ame01509; Tang QS, 2003, LAR MAR ECOSYST, V12, P121; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; WARWICK RM, 1991, J MAR BIOL ASSOC UK, V71, P225, DOI 10.1017/S0025315400037528; Zhang CX, 2008, CHIN J OCEANOL LIMN, V26, P81, DOI 10.1007/s00343-008-0081-9; Zhang Wu-chang, 2002, Chinese Journal of Oceanology and Limnology, V20, P135	64	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102640	10.1371/journal.pone.0102640	http://dx.doi.org/10.1371/journal.pone.0102640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025156	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400097
J	Huang, JS; Dang, JB; Borchert, GM; Eilbeck, K; Zhang, H; Xiong, M; Jiang, WJ; Wu, H; Blake, JA; Natale, DA; Tan, M				Huang, Jingshan; Dang, Jiangbo; Borchert, Glen M.; Eilbeck, Karen; Zhang, He; Xiong, Min; Jiang, Weijian; Wu, Hao; Blake, Judith A.; Natale, Darren A.; Tan, Ming			OMIT: Dynamic, Semi-Automated Ontology Development for the microRNA Domain	PLOS ONE			English	Article							TOOL; UNIFICATION; INFORMATION; PREDICTION; TARGETS	As a special class of short non-coding RNAs, microRNAs (a. k. a. miRNAs or miRs) have been reported to perform important roles in various biological processes by regulating respective target genes. However, significant barriers exist during biologists' conventional miR knowledge discovery. Emerging semantic technologies, which are based upon domain ontologies, can render critical assistance to this problem. Our previous research has investigated the construction of a miR ontology, named Ontology for MIcroRNA Target Prediction (OMIT), the very first of its kind that formally encodes miR domain knowledge. Although it is unavoidable to have a manual component contributed by domain experts when building ontologies, many challenges have been identified for a completely manual development process. The most significant issue is that a manual development process is very labor-intensive and thus extremely expensive. Therefore, we propose in this paper an innovative ontology development methodology. Our contributions can be summarized as: (i) We have continued the development and critical improvement of OMIT, solidly based on our previous research outcomes. (ii) We have explored effective and efficient algorithms with which the ontology development can be seamlessly combined with machine intelligence and be accomplished in a semi-automated manner, thus significantly reducing large amounts of human efforts. A set of experiments have been conducted to thoroughly evaluate our proposed methodology.	[Huang, Jingshan; Zhang, He; Xiong, Min; Jiang, Weijian; Wu, Hao] Univ S Alabama, Sch Comp, Mobile, AL 36688 USA; [Dang, Jiangbo] Siemens Corp, Corp Technol, Princeton, NJ USA; [Borchert, Glen M.] Univ S Alabama, Dept Biol, Mobile, AL 36688 USA; [Eilbeck, Karen] Univ Utah, Sch Med, Salt Lake City, UT USA; [Blake, Judith A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Natale, Darren A.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA	University of South Alabama; Siemens AG; University of South Alabama; Utah System of Higher Education; University of Utah; Jackson Laboratory; Georgetown University; University of South Alabama	Huang, JS (corresponding author), Univ S Alabama, Sch Comp, Mobile, AL 36688 USA.	huang@southalabama.edu	Tan, Ming/ABD-5847-2021; Natale, Darren A/AAE-9303-2019	Tan, Ming/0000-0003-2007-9898; Natale, Darren A/0000-0001-5809-9523; Eilbeck, Karen/0000-0002-0831-6427; borchert, glen/0000-0002-6182-7154; Blake, Judith/0000-0001-8522-334X	NIH [R01-CA149646]; Vincent F. Kilborn, Jr. Cancer Research Foundation; NSF by Division of Molecular and Cellular Biosciences [1350064]; NSF EPSCoR program; NATIONAL CANCER INSTITUTE [R01CA149646, U01CA180982, P30CA034196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vincent F. Kilborn, Jr. Cancer Research Foundation; NSF by Division of Molecular and Cellular Biosciences; NSF EPSCoR program(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ming Tan's lab is funded by NIH Grant R01-CA149646 and The Vincent F. Kilborn, Jr. Cancer Research Foundation. Glen M. Borchert was supported by NSF CAREER grant 1350064 awarded by Division of Molecular and Cellular Biosciences, with co-funding provided by the NSF EPSCoR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre E, 2000, P ONT LEARN WORKSH O; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auer S, 2006, LECT NOTES COMPUT SC, V4273, P736; Balakrishna M, 2010, P 7 INT C LANG RES E, P19; Bao J, 2006, P AAAI 2006 FALL S S; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Biebow B, 1999, P 11 EUR WORKSH KNOW, P49; Bittner T, 2004, P GMDS, P199; Bohring H., 2005, LEIPZ INFORM TAGE LI, V72, P147; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cho M, 2006, 8th International Conference on Advanced Communication Technology, Vols 1-3, pU1573; Cimiano P., 2006, ONTOLOGY LEARNING PO; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; Courtot M, 2011, APPL ONTOL, V6, P23, DOI 10.3233/AO-2011-0087; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Enright A, 2003, NUCL ACIDS RES, V5; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gasevic D, 2004, 2004 2ND INTERNATIONAL IEEE CONFERENCE INTELLIGENT SYSTEMS, VOLS 1 AND 2, PROCEEDINGS, P485; Gennari JH, 2003, INT J HUM-COMPUT ST, V58, P89, DOI 10.1016/S1071-5819(02)00127-1; Grenon P, 2004, STUD HEALTH TECHNOL, V102, P20; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grun D, 2006, CURR BIOL, V16, P460; Hu H, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P1233; Huang J., 2012, P BHI WORKSH 2012 IE, P16; Huang J, 2010, P 1 ACM INT C BIOINF, P472; Huang JS, 2011, PHARM RES-DORDR, V28, P3101, DOI 10.1007/s11095-011-0573-8; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khan LF, 2002, PROC INT C TOOLS ART, P122, DOI 10.1109/TAI.2002.1180796; Kietz J, 2000, P 12 EUR WORKSH KNOW; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kong H, 2006, P 8 INT C ADV COMM T; Krebs J. E., 2014, LEWINS GENES, VXI; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu ZX, 2013, J BIOL CHEM, V288, P4334, DOI 10.1074/jbc.M112.419168; Lonsdale D, 2005, P 5 INT C KNOWL MAN; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; McGuinness Deborah L, 2001, ONTOLOGY DEV; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Mitchell T.M, 2003, MACH LEARN; Moldovan D., 2000, FLAIRS-2000. Proceedings of the Thirteenth International Florida Artificial Intelligence Research Society Conference, P224; Natale DA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S1; Nobecourt J, 2000, P WORKSH ONT TEXT JU; Pinto HS, 2004, KNOWL INF SYST, V6, P441, DOI 10.1007/s10115-003-0138-1; Pivk A, 2006, AI COMMUN, V19, P83; Ratsch E, 2003, COMP FUNCT GENOM, V4, P85, DOI 10.1002/cfg.244; Reeves GA, 2008, BIOINFORMATICS, V24, P2767, DOI 10.1093/bioinformatics/btn528; Reference Genome Group of the Gene Ontology Consortium, 2009, PLOS COMPUT BIOL, V5; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B., 2004, P FOIS 2004 INT C FO, P73; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Sure Y, 2002, LECT NOTES COMPUT SC, V2342, P221; Townsend C, 2010, P 9 INT C ONT DAT AP, P1162; Tsang J, 2005, MOL CELL, V38, P140; Uschold M, 1996, KNOWL ENG REV, V11, P93, DOI 10.1017/S0269888900007797; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wachter T, 2010, BIOINFORMATICS, V26, pi88, DOI 10.1093/bioinformatics/btq188; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wilson J., 2008, MOL BIOL CELL; Xiang Zuoshuang, 2010, BMC Res Notes, V3, P175, DOI 10.1186/1756-0500-3-175; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	67	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100855	10.1371/journal.pone.0100855	http://dx.doi.org/10.1371/journal.pone.0100855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025130	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400007
J	Wu, CL; Qu, XH; Mao, YQ; Li, HW; Dai, KR; Liu, FX; Zhu, ZA				Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Dai, Kerong; Liu, Fengxiang; Zhu, Zhenan			Utility of Intraoperative Frozen Section in the Diagnosis of Periprosthetic Joint Infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RESECTION ARTHROPLASTY; HIP	Purpose: Intraoperative frozen section (FS) is an effective diagnostic test for periprosthetic joint infection (PJI). We evaluated the diagnostic characteristics of single- and multiplex-site intraoperative FS, and evaluated the results of single-site FS combined with those of C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) for assessing PJI. Methods: We studied 156 painful joint arthroplasties in 152 consecutive patients presenting for revision total joint arthroplasty due to PJI. Receiver operating characteristic analysis was used to determine the optimal cutoff values for CRP level, ESR, and intraoperative FS histopathology. Sensitivity, specificity, positive and negative predictive values, and accuracy of the diagnostic tests were assessed using a 2x2 table. Results: We investigated the diagnostic utility of polymorphonuclear leukocyte number (PMN) per high-power field (HPF) on FS. Our data showed that 5 PMNs per HPF is a suitable diagnostic threshold, with a high accuracy in single-and multiplex-site FS. Five PMNs in any 1 of 5 sites had the highest sensitivity of 0.86 and a specificity of 0.96. Five PMNs in every 1 of 5 sites had greater diagnostic utility, with a specificity of 1; however, the sensitivity of this measure fell to 0.62. Five PMNs in single-site FS had a sensitivity of 0.70 and a specificity of 0.94. Five PMNs in single-site FS or CRP level >= 15 mg/L increased the sensitivity to 0.92; however, the specificity decreased to 0.79. Conclusion: Compared with single-site FS, any 1 positive site on multiplex-site FS may improve sensitivity, while every 1 positive site on multiplex-site FS may improve specificity. Five PMNs in any 1 of 5 sites on FS has excellent utility for the diagnosis of PJI. Additional systematic large-scale studies are needed to verify this result.	[Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Dai, Kerong; Liu, Fengxiang; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, FX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	liu_fengxiang@163.com; zhenan_zhu@126.com	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890	National Natural Science Foundation of China [81171729]; Major Basic Research of Science and Technology Commission of Shanghai Municipality [11DJ1400303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81171729) and Major Basic Research of Science and Technology Commission of Shanghai Municipality (Grant No. 11DJ1400303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alijanipour P, 2013, CLIN ORTHOP RELAT RE; Athanasou NA, 1997, J BONE JOINT SURG AM, V79A, P1433, DOI 10.2106/00004623-199709000-00021; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; Banit DM, 2002, CLIN ORTHOP RELAT R, P230, DOI 10.1097/00003086-200208000-00026; Bori G, 2009, ARCH ORTHOP TRAUM SU, V129, P591, DOI 10.1007/s00402-008-0679-6; Bozic KJ, 2013, J ARTHROPLASTY; Buttaro MA, 2010, CLIN ORTHOP RELAT R, V468, P3263, DOI 10.1007/s11999-010-1451-0; Costa Christopher R, 2012, Am J Orthop (Belle Mead NJ), V41, P160; Fink B, 2013, CLIN ORTHOP RELAT R, V471, P956, DOI 10.1007/s11999-012-2474-5; Ghanem E, 2009, INT J INFECT DIS, V13, pE444, DOI 10.1016/j.ijid.2009.02.017; Ghanem E, 2009, CLIN ORTHOP RELAT R, V467, P1699, DOI 10.1007/s11999-009-0742-9; Liao YY, 2010, J BONE JOINT SURG AM, V92A, P1314; MIRRA JM, 1976, CLIN ORTHOP RELAT R, P221; Muller Michael, 2008, J Orthop Surg Res, V3, P31, DOI 10.1186/1749-799X-3-31; Parvizi Javad, 2012, J Bone Joint Surg Am, V94, pe104, DOI 10.2106/JBJS.K.01417; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P1401, DOI 10.1007/s11999-011-1822-1; Parvizi J, 2010, J AM ACAD ORTHOP SUR, V18, P771, DOI 10.5435/00124635-201012000-00007; Piper KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009358; Schwartz AJ, 2012, J ARTHROPLASTY, V27, P46, DOI 10.1016/j.arth.2012.03.033; Shukla SK, 2010, J ARTHROPLASTY, V25, P87, DOI 10.1016/j.arth.2010.05.006; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Tohtz SW, 2010, CLIN ORTHOP RELAT R, V468, P762, DOI 10.1007/s11999-009-1102-5; Tsaras G, 2012, J BONE JOINT SURG AM, V94A, P1700, DOI 10.2106/JBJSJ.00756; Ueng SW, 2013, CLIN ORTHOP RELAT R, DOI [10.1007/s11999-11013-13007-11996, DOI 10.1007/S11999-11013-13007-11996]; Wong YC, 2005, J ARTHROPLASTY, V20, P1015, DOI 10.1016/j.arth.2004.08.003; Zhao X, 2013, J ARTHROPLASTY, V28, P913, DOI 10.1016/j.arth.2012.10.015	27	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102346	10.1371/journal.pone.0102346	http://dx.doi.org/10.1371/journal.pone.0102346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025886	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400066
J	Zhao, SY; Zhang, HG; Cao, DY; Liu, Y; Li, XH				Zhao, Shanyu; Zhang, Haigang; Cao, Dayan; Liu, Ya; Li, Xiaohui			Lipopolysaccharide Exposure during Pregnancy Leads to Aortic Dysfunction in Offspring Rats	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; DIET-INDUCED OBESITY; CARDIOVASCULAR-DISEASE; ANGIOTENSIN-II; PRENATAL EXPOSURE; BLOOD-PRESSURE; CONNEXIN EXPRESSION; PROTEIN RESTRICTION; ENDOTHELIAL-CELLS	Background: Prenatal exposure to Lipopolysaccharide (LPS) produces hypertension in adult offspring rats. The present study was to explore the effects of prenatal inflammation on morphological and functional changes in the aorta from offspring rats and to further assess its susceptibility to cardiovascular diseases. Methods and Results: Pregnant rats were treated intraperitoneally on gestation Days 8, 10 and 12 with saline, LPS (0.79 mg/kg), or pyrrolidine dithiocarbamate (PDTC, 100 mg/kg)+LPS, respectively. Aortic ring reactivity and histopathological alteration were analyzed in offspring at the age of 12 weeks. The detections of connexin (Cx) 37, Cx40, Cx43, and Cx45, including immunofluorescent patterns, protein levels and mRNA expression in the aorta, were performed as well. Furthermore, the expressions of Nuclear factor (NF)-kappa B (p65), I kappa B alpha, phospho-I kappa B alpha and I kappa B beta were determined. The results showed that prenatal LPS exposure leads to morphological abnormalities and impaired aortic reactivity in offspring. Prenatal LPS exposure also decreased the protein and mRNA expression of Cx37 in the aorta from offspring rats. NF-kappa B and phospho-I kappa B alpha levels were both increased, IkBa level, however, was decreased in the aorta of offspring from the maternal LPS exposure compared to the controls. Simultaneously, PDTC treatment markedly reversed the action of LPS. Conclusions: Decreased expression of Cx37 contributed to the aortic dysfunction of prenatal LPS exposure offspring, which should be associated with NF-kappa B activation.	[Zhao, Shanyu; Cao, Dayan; Liu, Ya; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China; [Zhao, Shanyu; Cao, Dayan; Liu, Ya; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Dept Pharmaceut, Chongqing, Peoples R China; [Zhang, Haigang] Third Mil Med Univ, Dept Pharmacol, Coll Pharm, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Liu, Y (corresponding author), Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China.	liuya1979@gmail.com; liphsub@gmail.com	Zhao, Shanyu/AAM-2055-2021	Zhao, Shanyu/0000-0002-8863-7019; cao, dayan/0000-0001-7648-3668	National Natural Science Foundation of China [81373420, 81273507, 81072630]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NO 81373420,81273507,81072630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BEVAN JA, 1972, AGENTS ACTIONS, V2, P257, DOI 10.1007/BF02087051; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Christ GJ, 1996, CIRC RES, V79, P631, DOI 10.1161/01.RES.79.4.631; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Daviglus Martha L, 2006, Am J Cardiovasc Drugs, V6, P87, DOI 10.2165/00129784-200606020-00003; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Haefliger JA, 1999, ARTERIOSCL THROM VAS, V19, P1615, DOI 10.1161/01.ATV.19.7.1615; Hampton T, 2004, JAMA-J AM MED ASSOC, V292, P1285, DOI 10.1001/jama.292.11.1285; Hao XQ, 2010, INFLAMMATION, V33, P408, DOI 10.1007/s10753-010-9199-y; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; He Xiao-yan, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P853; Isakson BE, 2006, ARTERIOSCL THROM VAS, V26, P2216, DOI 10.1161/01.ATV.0000237608.19055.53; Jobs A, 2012, HYPERTENSION, V60, P1422, DOI 10.1161/HYPERTENSIONAHA.112.201194; Keelan JA, 2009, J IMMUNOL, V183, P5270, DOI 10.4049/jimmunol.0802660; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; Liao WQ, 2008, CLIN EXP PHARMACOL P, V35, P1413, DOI 10.1111/j.1440-1681.2008.05062.x; Liu JH, 2009, FEBS J, V276, P4598, DOI 10.1111/j.1742-4658.2009.07165.x; McKinnon RL, 2006, CARDIOVASC RES, V69, P236, DOI 10.1016/j.cardiores.2005.09.003; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Nijdam ME, 2008, AM J HYPERTENS, V21, P388, DOI 10.1038/ajh.2007.89; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Olzinski AR, 2005, CARDIOVASC RES, V66, P170, DOI 10.1016/j.cardiores.2004.12.021; Palinski W, 2008, CIRCULATION, V117, P341, DOI 10.1161/CIRCULATIONAHA.107.750133; Palinski W, 2009, J CARDIOVASC TRANSL, V2, P277, DOI 10.1007/s12265-009-9108-7; Pfenniger A, 2010, ARTERIOSCL THROM VAS, V30, P827, DOI 10.1161/ATVBAHA.109.200816; Plum A, 2000, CURR BIOL, V10, P1083, DOI 10.1016/S0960-9822(00)00690-4; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Salminen A, 2008, PEDIATR RES, V63, P280, DOI 10.1203/PDR.0b013e318163a8b2; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Simon AM, 2003, J CELL SCI, V116, P2223, DOI 10.1242/jcs.00429; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Tang EHC, 2008, J PHARMACOL EXP THER, V327, P148, DOI 10.1124/jpet.108.140046; Tsai SH, 2013, CARDIOVASC RES, V100, P501, DOI 10.1093/cvr/cvt230; Tsukuda K, 2012, J AM SOC HYPERTENS, V6, P324, DOI 10.1016/j.jash.2012.07.001; van Vliet LS, 2007, ARTERIOSCLER THROMB, V27, P2228; Velten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024544; Wagner C, 2010, KIDNEY INT, V78, P762, DOI 10.1038/ki.2010.257; Wei YL, 2007, ACTA PHARMACOL SIN, V28, P651, DOI 10.1111/j.1745-7254.2007.00593.x; Weisbrod RM, 2013, HYPERTENSION, V62, P1105, DOI 10.1161/HYPERTENSIONAHA.113.01744; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yeh HI, 2000, J HISTOCHEM CYTOCHEM, V48, P1377, DOI 10.1177/002215540004801008; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251; Zhao SY, 2014, ZHONGHUA XIN XUE GUA, V42; Zhou JZ, 2013, MOL MED REP, V8, P95, DOI 10.3892/mmr.2013.1498	50	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102273	10.1371/journal.pone.0102273	http://dx.doi.org/10.1371/journal.pone.0102273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025169	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400058
J	Brabrand, M; Hallas, J; Knudsen, T				Brabrand, Mikkel; Hallas, Jesper; Knudsen, Torben			Nurses and Physicians in a Medical Admission Unit Can Accurately Predict Mortality of Acutely Admitted Patients: A Prospective Cohort Study	PLOS ONE			English	Article							EARLY WARNING SCORE; CRITICAL ILLNESS; PROGNOSTICATION; SURVIVAL; JUDGMENT	Background: There exist several risk stratification systems for predicting mortality of emergency patients. However, some are complex in clinical use and others have been developed using suboptimal methodology. The objective was to evaluate the capability of the staff at a medical admission unit (MAU) to use clinical intuition to predict in-hospital mortality of acutely admitted patients. Methods: This is an observational prospective cohort study of adult patients (15 years or older) admitted to a MAU at a regional teaching hospital. The nursing staff and physicians predicted in-hospital mortality upon the patients' arrival. We calculated discriminatory power as the area under the receiver-operating-characteristic curve (AUROC) and accuracy of prediction (calibration) by Hosmer-Lemeshow goodness-of-fit test. Results: We had a total of 2,848 admissions (2,463 patients). 89 (3.1%) died while admitted. The nursing staff assessed 2,404 admissions and predicted mortality in 1,820 (63.9%). AUROC was 0.823 (95% CI: 0.762-0.884) and calibration poor. Physicians assessed 738 admissions and predicted mortality in 734 (25.8% of all admissions). AUROC was 0.761 (95% CI: 0.657-0.864) and calibration poor. AUROC and calibration increased with experience. When nursing staff and physicians were in agreement (+/- 5%), discriminatory power was very high, 0.898 (95% CI: 0.773-1.000), and calibration almost perfect. Combining an objective risk prediction score with staff predictions added very little. Conclusions: Using only clinical intuition, staff in a medical admission unit has a good ability to identify patients at increased risk of dying while admitted. When nursing staff and physicians agreed on their prediction, discriminatory power and calibration were excellent.	[Brabrand, Mikkel; Knudsen, Torben] Hosp South West Denmark, Dept Med, Esbjerg, Denmark; [Brabrand, Mikkel; Knudsen, Torben] Univ Southern Denmark, Inst Reg Hlth Res, Ctr South Western Denmark, Esbjerg, Denmark; [Hallas, Jesper] Univ Southern Denmark, Res Unit Clin Pharmacol, Odense, Denmark	University of Southern Denmark; University of Southern Denmark	Brabrand, M (corresponding author), Hosp South West Denmark, Dept Med, Esbjerg, Denmark.	mbrabrand@health.sdu.dk	Knudsen, Torben/V-6176-2018; Brabrand, Mikkel/F-7276-2011	Knudsen, Torben/0000-0003-0726-0115; Brabrand, Mikkel/0000-0002-3340-8251	Sydvestjysk Sygehus; University of Southern Denmark; Danish Society for Internal Medicine (The AB Foundation); The Karola Jorgensen Research Foundation; The Edith and Vagn Hedegaard Jensens Foundation; The Johs. M. Klein and Wife Scholarship	Sydvestjysk Sygehus; University of Southern Denmark; Danish Society for Internal Medicine (The AB Foundation); The Karola Jorgensen Research Foundation; The Edith and Vagn Hedegaard Jensens Foundation; The Johs. M. Klein and Wife Scholarship	This study was supported by unrestricted grants from Sydvestjysk Sygehus, University of Southern Denmark, Danish Society for Internal Medicine (The AB Foundation), The Karola Jorgensen Research Foundation, The Edith and Vagn Hedegaard Jensens Foundation, and The Johs. M. Klein and Wife Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabrand M, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-8; Buurman BM, 2008, J GEN INTERN MED, V23, P1883, DOI 10.1007/s11606-008-0741-7; CHARLSON ME, 1986, J CHRON DIS, V39, P439, DOI 10.1016/0021-9681(86)90111-6; Danis M, 1997, CRIT CARE MED, V25, P887; Duckitt RW, 2007, BRIT J ANAESTH, V98, P769, DOI 10.1093/bja/aem097; Fullerton JN, 2012, RESUSCITATION, V83, P557, DOI 10.1016/j.resuscitation.2012.01.004; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Kellett J, 2008, EUR J INTERN MED, V19, P155, DOI 10.1016/j.ejim.2007.09.002; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Levine SD, 2006, J EMERG MED, V31, P1, DOI 10.1016/j.jemermed.2005.08.007; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Prytherch DR, 2005, RESUSCITATION, V66, P203, DOI 10.1016/j.resuscitation.2005.02.011; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Sinuff T, 2006, CRIT CARE MED, V34, P878, DOI 10.1097/01.CCM.0000201881.58644.41; Twomey F, 2008, AM J HOSP PALLIAT ME, V25, P139, DOI 10.1177/1049909107312594; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511	20	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101739	10.1371/journal.pone.0101739	http://dx.doi.org/10.1371/journal.pone.0101739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019354	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600026
J	Fink, G; Sudfeld, CR; Danaei, G; Ezzati, M; Fawzi, WW				Fink, Guenther; Sudfeld, Christopher R.; Danaei, Goodarz; Ezzati, Majid; Fawzi, Wafaie W.			Scaling-Up Access to Family Planning May Improve Linear Growth and Child Development in Low and Middle Income Countries	PLOS ONE			English	Article							TEENAGE MOTHERHOOD; HEALTH SURVEYS; MATERNAL AGE; BIRTH COHORT; OUTCOMES; PREGNANCY; INFANT; FERTILITY; MORTALITY; CONTRACEPTION	Background: A large literature has indicated a robust association between birth spacing and child survival, but evidence on the association of birth timing with physical growth in low and middle income countries (LMICs) remains limited. Methods and Results: Data from 153 cross-sectional Demographic and Health Surveys (DHS) across 61 LMICs conducted between 1990 and 2011 were combined to assess the association of birth timing with child stunting (height-for-age z-score <-2). A total of 623,789 children of birth order 1-5 contributed to the maternal age analysis, while the birth spacing dataset consisted of 584,226 children of birth order 2 and higher. Compared to 27-34 year old mothers, maternal age under 18 years was associated with a relative stunting risk of 1.35 (95% CI: 1.29-1.40) for firstborn children, whereas the relative risk was 1.24 (95% CI: 1.19-1.29) for mothers aged 18-19 years. The association of young maternal age with stunting was significantly greater for urban residents and those in the top 50% of household wealth. Birth intervals less than 12 months and 12-23 months had relative risks for stunting of 1.09 (95% CI: 1.06-1.12) and 1.06 (95% CI: 1.05-1.06) as compared to a 24-35 month inter-pregnancy interval, respectively. The strength of both teenage pregnancy and short birth interval associations showed substantial variation across WHO region. We estimate that 8.6% (6.9-10.3%) of stunted cases in the South Asian DHS sample would have been averted by jointly eliminating teen pregnancies and birth intervals less than 24 months, while only 3.6% (1.5-5.7%) of stunting cases would have prevented in the Middle East and North Africa sample. Conclusions: Postponing the age of first birth and increasing inter-pregnancy intervals has the potential to significantly reduce the prevalence of stunting and improve child development in LMICs.	[Fink, Guenther; Sudfeld, Christopher R.; Danaei, Goodarz; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Dept Epidemiol, London, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Dept Biostat, London, England	Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; Imperial College London	Fink, G (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	gfink@hsph.harvard.edu	Sudfeld, Christopher/AAW-3856-2021; Danaei, Goodarz/B-6085-2008	Sudfeld, Christopher/0000-0002-3203-3638; 	Grand Challenges Canada through the Saving Brains Project; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056] Funding Source: researchfish	Grand Challenges Canada through the Saving Brains Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by Grand Challenges Canada through the Saving Brains Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari R., 2003, ADULTHOOD EXPLORING, P62; Alam N, 2000, J BIOSOC SCI, V32, P229, DOI 10.1017/S0021932000002297; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Alvergne A, 2013, AM J HUM BIOL, V25, P107, DOI 10.1002/ajhb.22348; Bloom DE, 2010, URB DEV MULT PERSP; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Coyne CA, 2013, TWIN RES HUM GENET, V16, P679, DOI 10.1017/thg.2013.23; Guimarae AMDN, 2013, REV SAUDE PUBL, V47, P11, DOI 10.1590/S0034-89102013000100003; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Finlay JE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000226; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gupta N, 2008, EUR J OBSTET GYN R B, V137, P165, DOI 10.1016/j.ejogrb.2007.06.013; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; ICF International, 2012, DEM HLTH SURV SAMPL; Kar BR, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-31; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Mayor S, 2004, BRIT MED J, V328, P1152, DOI 10.1136/bmj.328.7449.1152-a; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Reynolds HW, 2006, INT FAM PLAN PERSPEC, V32, P6, DOI 10.1363/3200606; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Rutstein SO, 2008, 41 DHS; Scally G, 2002, INT J EPIDEMIOL, V31, P554, DOI 10.1093/ije/31.3.554; SENDEROWITZ J, 1985, POPUL BULL, V40, P1; Shaw M, 2006, SOC SCI MED, V62, P2526, DOI 10.1016/j.socscimed.2005.10.007; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; StataCorp, 2011, STAT STAT SOFTW REL; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Stewart CP, 2007, MATERN CHILD NUTR, V3, P174, DOI 10.1111/j.1740-8709.2007.00097.x; UNICEF, 1990, STRAT IMPR NUTR CHIL; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; WHO, 2006, ANTR SOFTW ASS GROWT; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World B., 2012, WORLD BANK SE4ALL DA; World Health Organization, 2011, WHO GUID PREV EARL P; Yen S, 2013, PEDIATR ANN, V42, P21, DOI 10.3928/00904481-20130128-08; Zabin LS, 1998, STUD FAMILY PLANN, V29, P210, DOI 10.2307/172160; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102391	10.1371/journal.pone.0102391	http://dx.doi.org/10.1371/journal.pone.0102391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1PC	25020132	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600075
J	Papadimitropoulos, A; Piccinini, E; Brachat, S; Braccini, A; Wendt, D; Barbero, A; Jacobi, C; Martin, I				Papadimitropoulos, Adam; Piccinini, Elia; Brachat, Sophie; Braccini, Alessandra; Wendt, David; Barbero, Andrea; Jacobi, Carsten; Martin, Ivan			Expansion of Human Mesenchymal Stromal Cells from Fresh Bone Marrow in a 3D Scaffold-Based System under Direct Perfusion	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; EX-VIVO; PROGENITOR CELLS; CULTURE; DIFFERENTIATION; GROWTH; PROLIFERATION; NICHE	Mesenchymal stromal/stem cell (MSC) expansion in conventional monolayer culture on plastic dishes (2D) leads to progressive loss of functionality and thus challenges fundamental studies on the physiology of skeletal progenitors, as well as translational applications for cellular therapy and molecular medicine. Here we demonstrate that 2D MSC expansion can be entirely bypassed by culturing freshly isolated bone marrow nucleated cells within 3D porous scaffolds in a perfusion-based bioreactor system. The 3D-perfusion system generated a stromal tissue that could be enzymatically treated to yield CD45- MSC. As compared to 2D-expanded MSC (control), those derived from 3D-perfusion culture after the same time (3 weeks) or a similar extent of proliferation (7-8 doublings) better maintained their progenitor properties, as assessed by a 4.3-fold higher clonogenicity and the superior differentiation capacity towards all typical mesenchymal lineages. Transcriptomic analysis of MSC from 5 donors validated the robustness of the process and indicated a reduced inter-donor variability and a significant upregulation of multipotency-related gene clusters following 3D-perfusion-as compared to 2D-expansion. Interestingly, the differences in functionality and transcriptomics between MSC expanded in 2D or under 3D-perfusion were only partially captured by cytofluorimetric analysis using conventional surface markers. The described system offers a multidisciplinary approach to study how factors of a 3D engineered niche regulate MSC function and, by streamlining conventional labor-intensive processes, is prone to automation and scalability within closed bioreactor systems.	[Papadimitropoulos, Adam; Piccinini, Elia; Braccini, Alessandra; Wendt, David; Barbero, Andrea; Martin, Ivan] Univ Basel, Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Surg, Basel, Switzerland; [Papadimitropoulos, Adam; Piccinini, Elia; Braccini, Alessandra; Wendt, David; Barbero, Andrea; Martin, Ivan] Univ Basel, Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Biomed, Basel, Switzerland; [Brachat, Sophie; Jacobi, Carsten] Novartis Inst Biomed Res, Basel, Switzerland	University of Basel; University of Basel; Novartis	Martin, I (corresponding author), Univ Basel, Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Surg, Basel, Switzerland.	ivan.martin@usb.ch	Martin, Ivan/K-9286-2016	Lemire-Brachat, Sophie/0000-0002-3398-8225; Barbero, Andrea/0000-0001-5252-789X; Martin, Ivan/0000-0001-6493-0432	Novartis AG, Basel, Switzerland; European Union (OPHIS) [FP7-NMP-2009-SMALL-3-246373]; Novartis AG	Novartis AG, Basel, Switzerland; European Union (OPHIS); Novartis AG	The authors would like to acknowledge Novartis AG, Basel, Switzerland and the European Union (OPHIS; #FP7-NMP-2009-SMALL-3-246373) for financial support. The funding organization (Novartis AG) provided financial support i) in the form of authors' salaries (SBrachat and CJacobi) where their specific roles have been articulated in the 'author contributions' section and ii) for the research materials.	Almeida-Porada G, 2000, BLOOD, V95, P3620, DOI 10.1182/blood.V95.11.3620.011k02_3620_3627; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Augello A, 2010, EUR CELLS MATER, V20, P121; Baksh D, 2005, BLOOD, V106, P3012, DOI 10.1182/blood-2005-01-0433; Baksh D, 2003, EXP HEMATOL, V31, P723, DOI 10.1016/S0301-472X(03)00106-1; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bocelli-Tyndall C, 2009, ANN RHEUM DIS, V68, P1352, DOI 10.1136/ard.2008.094003; Bocelli-Tyndall C, 2010, ARTHRITIS RHEUM-US, V62, P3815, DOI 10.1002/art.27736; Braccini A, 2005, STEM CELLS, V23, P1066, DOI 10.1634/stemcells.2005-0002; Chen X, 2006, STEM CELLS, V24, P2052, DOI 10.1634/stemcells.2005-0591; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Di Maggio N, 2012, STEM CELLS, V30, P1455, DOI 10.1002/stem.1106; Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041; Diederichs S, 2009, BIOTECHNOL PROGR, V25, P1762, DOI 10.1002/btpr.258; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Eipers PG, 2000, EXP HEMATOL, V28, P815, DOI 10.1016/S0301-472X(00)00183-1; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Frauenschuh S, 2007, BIOTECHNOL PROGR, V23, P187, DOI 10.1021/bp060155w; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Louca D, 2013, SCI REP-UK, V3, DOI [10.1038/srep02047, 10.1038/srep02128]; Martin I, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008558; Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muraglia A, 2000, J CELL SCI, V113, P1161; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810, DOI 10.1152/ajpcell.1997.273.3.C810; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prewitz MC, 2013, NAT METHODS, V10, P788, DOI [10.1038/nmeth.2523, 10.1038/NMETH.2523]; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reichardt Anne, 2013, Open Biomed Eng J, V7, P50, DOI 10.2174/1874120701307010050; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scaglione S, 2006, BIOTECHNOL BIOENG, V93, P181, DOI 10.1002/bit.20677; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759; Yang Y, 2007, BIOMATERIALS, V28, P3110, DOI 10.1016/j.biomaterials.2007.03.015; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; Zhang ZL, 2009, BONE MARROW TRANSPL, V43, P69, DOI 10.1038/bmt.2008.260; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	60	63	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102359	10.1371/journal.pone.0102359	http://dx.doi.org/10.1371/journal.pone.0102359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020062	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600074
J	Roy, V; Iken, K; Archambault, P				Roy, Virginie; Iken, Katrin; Archambault, Philippe			Environmental Drivers of the Canadian Arctic Megabenthic Communities	PLOS ONE			English	Article							BEAUFORT SEA; BARENTS SEA; MEGAFAUNAL ASSEMBLAGES; EPIBENTHIC MEGAFAUNA; BENTHIC ECOLOGY; ORGANIC-MATTER; WATER POLYNYA; CHUKCHI SEAS; NORTH WATER; CARBON FLUX	Environmental gradients and their influence on benthic community structure vary over different spatial scales; yet, few studies in the Arctic have attempted to study the influence of environmental gradients of differing spatial scales on megabenthic communities across continental-scales. The current project studied for the first time how megabenthic community structure is related to several environmental factors over 2000 km of the Canadian Arctic, from the Beaufort Sea to northern Baffin Bay. Faunal trawl samples were collected between 2007 and 2011 at 78 stations from 30 to 1000 m depth and patterns in biomass, density, richness, diversity, and taxonomic composition were examined in relation to indirect/spatial gradients (e.g., depth), direct gradients (e. g., bottom oceanographic variables), and resource gradients (e. g., food supply proxies). Six benthic community types were defined based on their biomass-based taxonomic composition. Their distribution was significantly, but moderately, associated with large-scale (100-1000 km) environmental gradients defined by depth, physical water properties (e.g., bottom salinity), and meso-scale (10-100 km) environmental gradients defined by substrate type (hard vs. soft) and sediment organic carbon content. We did not observe a strong decline of bulk biomass, density and richness with depth or a strong increase of those community characteristics with food supply proxies, contrary to our hypothesis. We discuss how local-to meso-scale environmental conditions, such as bottom current regimes and polynyas, sustain biomass-rich communities at specific locations in oligotrophic and in deep regions of the Canadian Arctic. This study demonstrates the value of considering the scales of variability of environmental gradients when interpreting their relevance in structuring of communities.	[Roy, Virginie; Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Iken, Katrin] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA	University of Quebec; University of Alaska System; University of Alaska Fairbanks	Roy, V (corresponding author), Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada.	virginie.m.roy@gmail.com		Archambault, Philippe/0000-0001-5986-6149	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche nature et technologies du Quebec (FQRNT); Institut des sciences de la mer de Rimouski (ISMER) through Post Graduate Scholarships; Canadian Healthy Oceans Network (CHONe); Quebec-Ocean; ArcticNet; CHONe	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche nature et technologies du Quebec (FQRNT); Institut des sciences de la mer de Rimouski (ISMER) through Post Graduate Scholarships; Canadian Healthy Oceans Network (CHONe); Quebec-Ocean; ArcticNet; CHONe	Financial support was received by the Natural Sciences and Engineering Research Council of Canada (NSERC), by Fonds de recherche nature et technologies du Quebec (FQRNT), by Institut des sciences de la mer de Rimouski (ISMER) through Post Graduate Scholarships to VR and by stipends from the Canadian Healthy Oceans Network (CHONe) and Quebec-Ocean, and through grants to PA from ArcticNet and CHONe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE WG, 1995, J GEOPHYS RES-OCEANS, V100, P4411, DOI 10.1029/94JC01982; Ambrose WG, 2001, MAR BIOL, V139, P937; [Anonymous], 2010, SEA IC CLIM ATL NO C; Appeltans W., 2013, **NON-TRADITIONAL**; Ardyna M, 2011, MAR ECOL PROG SER, V442, P37, DOI 10.3354/meps09378; Arrigo KR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018978; Bailey JNL, 2013, MAR GEOL, V341, P1, DOI 10.1016/j.margeo.2013.04.017; Barber DG, 2007, ELSEV OCEANOGR SERIE, V74, P1, DOI 10.1016/S0422-9894(06)74001-6; Belanger S, 2013, BIOGEOSCIENCES, V10, P4087, DOI 10.5194/bg-10-4087-2013; Belt ST, 2013, ORG GEOCHEM, V62, P33, DOI 10.1016/j.orggeochem.2013.07.002; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Blanchard AL, 2014, DEEP-SEA RES PT II, V102, P132, DOI 10.1016/j.dsr2.2013.09.022; Blanchard AL, 2013, CONT SHELF RES, V67, P67, DOI 10.1016/j.csr.2013.04.031; Blanchard AL, 2013, CONT SHELF RES, V67, P52, DOI 10.1016/j.csr.2013.04.021; Bluhm BA, 2009, AQUAT BIOL, V7, P269, DOI 10.3354/ab00198; Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Carroll ML, 2012, POLAR BIOL, V35, P1259, DOI 10.1007/s00300-012-1171-x; Carroll ML, 2008, DEEP-SEA RES PT II, V55, P2340, DOI 10.1016/j.dsr2.2008.05.022; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cochrane SKJ, 2009, J SEA RES, V61, P222, DOI 10.1016/j.seares.2009.01.003; Conlan K, 2013, J MARINE SYST, V127, P76, DOI 10.1016/j.jmarsys.2013.07.013; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Curtis M.A., 1975, Polar Record, VNo. 111, P595; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Darnis G, 2012, CLIMATIC CHANGE, V115, P179, DOI 10.1007/s10584-012-0483-8; Denisenko SG, 2003, MAR ECOL PROG SER, V258, P109, DOI 10.3354/meps258109; DFO, 2009, 2009056 DFO CAN SCI; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Eleftheriou A., 2005, METHODS STUDY MARINE, V3rd ed, DOI DOI 10.1111/maec.12189; FISSEL DB, 1982, ARCTIC, V35, P180; Forest A, 2013, BIOGEOSCIENCES, V10, P2833, DOI 10.5194/bg-10-2833-2013; Forest A, 2011, PROG OCEANOGR, V91, P410, DOI 10.1016/j.pocean.2011.05.002; Goni MA, 2013, J GEOPHYS RES-OCEANS, V118, P4017, DOI 10.1002/jgrc.20286; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; Gorley C.K., 2006, GETTING STARTED PRIM; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Grebmeier Jacqueline M., 1995, Coastal and Estuarine Studies, V49, P231; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; GREBMEIER JM, 1995, J GEOPHYS RES-OCEANS, V100, P4439, DOI 10.1029/94JC02198; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; HAGERMAN L, 1988, MAR ECOL PROG SER, V47, P55, DOI 10.3354/meps047055; Hamel D, 2002, DEEP-SEA RES PT II, V49, P5277, DOI 10.1016/S0967-0645(02)00190-X; Hannah CG, 2009, ARCTIC, V62, P83; Hargrave BT, 2002, DEEP-SEA RES PT II, V49, P5227, DOI 10.1016/S0967-0645(02)00187-X; Holte B, 1998, POLAR BIOL, V19, P375, DOI 10.1007/s003000050262; Howell SEL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004730; Howell SEL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037681; JENKS GF, 1971, ANN ASSOC AM GEOGR, V61, P217, DOI 10.1111/j.1467-8306.1971.tb00779.x; Jones DOB, 2007, MAR BIOL RES, V3, P191, DOI 10.1080/17451000701455287; Jorgensen LL, 1999, POLAR BIOL, V22, P395, DOI 10.1007/s003000050435; Kenchington E, 2011, 2011071 DFO CAN SCI, V2011; Klages M, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P139; Klein B, 2002, DEEP-SEA RES PT II, V49, P4983, DOI 10.1016/S0967-0645(02)00174-1; Kuzyk ZZA, 2009, MAR GEOL, V264, P190, DOI 10.1016/j.margeo.2009.05.006; LABARBERA M, 1984, AM ZOOL, V24, P71; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Link H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074077; Link H, 2011, POLAR BIOL, V34, P2025, DOI 10.1007/s00300-011-1046-6; Lubinsky I, 1972, THESIS MCGILL U MONT; Magen C, 2010, ESTUAR COAST SHELF S, V86, P31, DOI 10.1016/j.ecss.2009.09.009; Mayer M, 1996, MAR ECOL PROG SER, V143, P151, DOI 10.3354/meps143151; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McLaughlin F.A., 2004, SEA 14, P1211; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Melling H, 2001, ATMOS OCEAN, V39, P301, DOI 10.1080/07055900.2001.9649683; Metaxas A, 2001, CAN J FISH AQUAT SCI, V58, P86, DOI 10.1139/cjfas-58-1-86; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Morata N, 2008, MAR ECOL PROG SER, V371, P47, DOI 10.3354/meps07677; O'Brien MC, 2006, CONT SHELF RES, V26, P41, DOI 10.1016/j.csr.2005.09.007; Piepenburg D, 1997, MAR ECOL PROG SER, V147, P63, DOI 10.3354/meps147063; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg D, 1996, MAR BIOL, V125, P321, DOI 10.1007/BF00346313; Piepenburg D, 1996, POLAR BIOL, V16, P431, DOI 10.1007/BF02390425; Piepenburg D, 1997, J MARINE SYST, V10, P467, DOI 10.1016/S0924-7963(96)00050-4; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Ravelo AM, 2013, DEEP SEA RES 2, DOI [10.1016/j.dsr2.2013.07.017i, DOI 10.1016/J.DSR2.2013.07.017I]; Renaud PE, 2007, J EXP MAR BIOL ECOL, V349, P248, DOI 10.1016/j.jembe.2007.05.021; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Riaux-Gobin C, 1993, HDB METHODS AQUATIC, P369, DOI DOI 10.1201/9780203752746-43; Rozanska M, 2009, MAR ECOL PROG SER, V386, P43, DOI 10.3354/meps08092; Sallon A, 2011, POLAR BIOL, V34, P1989, DOI 10.1007/s00300-011-1055-5; Schmid MK, 2006, PROG OCEANOGR, V71, P314, DOI 10.1016/j.pocean.2006.09.002; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Snelgrove P. V. R, 2001, ENCY OCEAN SCI, P748; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Soltwedel T, 2009, DEEP-SEA RES PT I, V56, P1856, DOI 10.1016/j.dsr.2009.05.012; Soreide JE, 2013, MAR BIOL RES, V9, P831, DOI 10.1080/17451000.2013.775457; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stein R, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P169; Stein R., 2004, ORGANIC CARBON CYCLE, P24, DOI DOI 10.1007/978-3-642-18912-8_7; Stirling I, 1997, J MARINE SYST, V10, P9, DOI 10.1016/S0924-7963(96)00054-1; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; THOMSON DH, 1982, ARCTIC, V35, P61; Tremblay JE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048825; Tremblay JE, 2007, ELSEV OCEANOGR SERIE, V74, P239, DOI 10.1016/S0422-9894(06)74008-9; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wassmann P, 1998, HYDROBIOLOGIA, V363, P29; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; Wei CL, 2012, DEEP-SEA RES PT I, V69, P82, DOI 10.1016/j.dsr.2012.07.008; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wetzel MA, 2005, HELGOLAND MAR RES, V59, P206, DOI 10.1007/s10152-005-0220-z; Williams WJ, 2008, J MAR RES, V66, P645, DOI 10.1357/002224008787536808; Zajac RN, 1998, HYDROBIOLOGIA, V375-76, P227, DOI 10.1023/A:1017032200173	114	46	47	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e100900	10.1371/journal.pone.0100900	http://dx.doi.org/10.1371/journal.pone.0100900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019385	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600009
J	Dominguez, F; Moreno-Moya, JM; Lozoya, T; Romero, A; Martinez, S; Monterde, M; Gurrea, M; Ferri, B; Nunez, MJ; Simon, C; Pellicer, A				Dominguez, Francisco; Manuel Moreno-Moya, Juan; Lozoya, Teresa; Romero, Ainhoa; Martinez, Sebastian; Monterde, Mercedes; Gurrea, Marta; Ferri, Blanca; Jose Nunez, Maria; Simon, Carlos; Pellicer, Antonio			Embryonic miRNA Profiles of Normal and Ectopic Pregnancies	PLOS ONE			English	Article							HUMAN FALLOPIAN-TUBE; MICRORNA EXPRESSION; MUC1; EPIGENETICS; TARGETS	Our objective was to investigate the miRNA profile of embryonic tissues in ectopic pregnancies (EPs) and controlled abortions (voluntary termination of pregnancy; VTOP). Twenty-three patients suffering from tubal EP and twenty-nine patients with a normal ongoing pregnancy scheduled for a VTOP were recruited. Embryonic tissue samples were analyzed by miRNA microarray and further validated by real time PCR. Microarray studies showed that four miRNAs were differentially downregulated (hsa-mir-196b, hsa-mir-30a, hsa-mir-873, and hsa-mir-337-3p) and three upregulated (hsa-mir-1288, hsa-mir-451, and hsa-mir-223) in EP compared to control tissue samples. Hsa-miR-196, hsa-miR-223, and hsa-miR-451 were further validated by real time PCR in a wider population of EP and control samples. We also performed a computational analysis to identify the gene targets and pathways which might be modulated by these three differentially expressed miRNAs. The most significant pathways found were the mucin type O-glycan biosynthesis and the ECM-receptor-interaction pathways. We also checked that the dysregulation of these three miRNAs was able to alter the expression of the gene targets in the embryonic tissues included in these pathways such as GALNT13 and ITGA2 genes. In conclusion, analysis of miRNAs in ectopic and eutopic embryonic tissues shows different expression patterns that could modify pathways which are critical for correct implantation, providing new insights into the understanding of ectopic implantation in humans.	[Dominguez, Francisco; Manuel Moreno-Moya, Juan; Martinez, Sebastian; Simon, Carlos; Pellicer, Antonio] Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain; [Lozoya, Teresa; Romero, Ainhoa; Monterde, Mercedes; Gurrea, Marta; Ferri, Blanca; Jose Nunez, Maria; Pellicer, Antonio] Hosp Univ LaFe, Valencia, Spain; [Dominguez, Francisco] INCLIVA Biomed Res, Valencia, Spain		Dominguez, F (corresponding author), Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain.	francisco.dominguez@ivi.es	Pellicer, Antonio/AAA-6005-2020; Simon, Carlos/G-2186-2014; Dominguez, Francisco/AAA-7260-2020; MARTINEZ, ANTONIO PELLICER/C-4832-2015	Pellicer, Antonio/0000-0002-8254-863X; Simon, Carlos/0000-0003-0902-9531; Dominguez, Francisco/0000-0002-7620-8081; 	Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme - FEDER [CP13/00075]	Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme - FEDER	FD's participation in this work was supported by the Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme (CP13/00075) co-founded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe W, 2013, HUM REPROD; Al-Azemi M, 2009, HUM REPROD, V24, P2582, DOI 10.1093/humrep/dep233; Altmae S, 2012, REPROD SCI; [Anonymous], 1995, JAMA, V273, P533; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bozdag G, 2011, J OBSTET GYNAECOL, V31, P666, DOI 10.3109/01443615.2011.594916; Brown JK, 2011, CURR OPIN OBSTET GYN, V23, P221, DOI 10.1097/GCO.0b013e3283481212; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041080; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fylstra D L, 1998, Obstet Gynecol Surv, V53, P320, DOI 10.1097/00006254-199805000-00024; Gilabert-Estelles J, 2012, CURR MED CHEM, V19, P2406, DOI 10.2174/092986712800269362; Horne AW, 2009, J CLIN ENDOCR METAB, V94, P5146, DOI 10.1210/jc.2009-1476; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1681; Lozoya T, 2014, PLOS ONE, V31, P9; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Manfe V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059390; Moreno-Moya JM, 2014, MOL HUM REPROD, V20, P550, DOI 10.1093/molehr/gau010; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Refaat B, 2012, FERTIL STERIL, V97, P1115, DOI 10.1016/j.fertnstert.2012.02.035; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Salih SM, 2004, AM J OBSTET GYNECOL, V190, P1404, DOI 10.1016/j.ajog.2004.01.066; Sha AG, 2011, FERTIL STERIL, V96, P150, DOI 10.1016/j.fertnstert.2011.04.072; Shaw JLV, 2010, HUM REPROD UPDATE, V16, P432, DOI 10.1093/humupd/dmp057; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wilkins-Haug L, 2009, CURR OPIN OBSTET GYN, V21, P201, DOI 10.1097/GCO.0b013e32832d7b95	34	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102185	10.1371/journal.pone.0102185	http://dx.doi.org/10.1371/journal.pone.0102185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013942	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400075
J	Waltz, X; Baillot, M; Connes, P; Bocage, B; Renaudeau, D				Waltz, Xavier; Baillot, Michelle; Connes, Philippe; Bocage, Bruno; Renaudeau, David			Effects of Hydration Level and Heat Stress on Thermoregulatory Responses, Hematological and Blood Rheological Properties in Growing Pigs	PLOS ONE			English	Article							HIGH-TEMPERATURE	Heat stress is one of the major limiting factors of production efficiency in the swine industry. The aims of the present study were 1) to observe if hemorheological and hematological parameters could be associated to physiological acclimation during the first days of heat stress exposure and 2) to determine if water restriction could modulate the effect of thermal heat stress on physiological, hematological and hemorheological parameters. Twelve Large White male pigs were divided into an ad libitum and a water restricted group. All pigs were submitted to one week at 24 degrees C (D-7 to D-1). Then, at D0, temperature was progressively increased until 32 degrees C and maintained during one week (D1 to D7). We performed daily measurements of water and feed intake. Physiological (i.e., skin temperature, rectal temperature, respiratory rate), hematological and hemorheological parameters were measured on D-6, D-5, D0, D1, D2 and D7. Water restriction had no effect on physiological, hematological and hemorheological parameters. The first days of heat stress caused an increase in the three physiological parameters followed by a reduction of these parameters suggesting a successful acclimation of pigs to heat stress. We showed an increase in hematocrit, red blood cell aggregation and red blood cell aggregation strength during heat stress. Further, we observed an important release of reticulocytes, an increase of red blood cell deformability and a reduction of feed intake and blood viscosity under heat stress. This study suggests that physiological acute adaptation to heat stress is accompanied by large hematological and hemorheological changes.	[Waltz, Xavier; Connes, Philippe] UMR Inserm 1134, F-97159 Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Connes, Philippe] Univ Antilles Guyane, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Baillot, Michelle; Connes, Philippe] Univ Antilles Guyane, Dept Physiol, Lab ACTES, EA 3596, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Connes, Philippe] PRES Sorbonne Paris Cite, Lab Excellence GR Ex, Paris, France; [Connes, Philippe] Inst Univ France, Paris, France; [Bocage, Bruno; Renaudeau, David] INRA, UR 143, Unite Rech Zootech, Petit Bourg, France; [Renaudeau, David] INRA, UMR 1348, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; Institut Universitaire de France; INRAE; INRAE	Connes, P (corresponding author), UMR Inserm 1134, F-97159 Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Connes, Philippe/J-7835-2019; WALTZ, Xavier/M-3606-2016	Connes, Philippe/0000-0002-9232-0268; WALTZ, Xavier/0000-0002-0838-290X; Philippe, Connes/0000-0001-8449-7998	INRA (PigChange project); INRA (PigChange project)	INRA (PigChange project); INRA (PigChange project)	The present study has been funded by INRA (PigChange project 2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Collin A, 2001, EXP PHYSIOL, V86, P83, DOI 10.1113/eph8602102; Collin A, 2001, ANIM SCI, V72, P519, DOI 10.1017/S1357729800052048; Grau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056759; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Jung F, 2011, CLIN HEMORHEOL MICRO, V48, P129, DOI 10.3233/CH-2011-1392; Mount L. E., 1975, Livestock Production Science, V2, P381, DOI 10.1016/0301-6226(75)90121-9; Pearce SC, 2013, J ANIM SCI, V91, P2108, DOI 10.2527/jas.2012-5738; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Rampling MW, 2004, BIORHEOLOGY, V41, P91; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Renaudeau D, 2010, J ANIM SCI, V88, P3715, DOI 10.2527/jas.2009-2169; Renaudeau D, 2006, ANIM RES, V55, P209, DOI 10.1051/animres:2006012; Simmonds MJ, 2013, J GERIATR CARDIOL, V10, P291, DOI 10.3969/j.issn.1671-5411.2013.03.010; Tikhomirova IA, 2011, CLIN HEMORHEOL MICRO, V49, P295, DOI 10.3233/CH-2011-1480; Uyuklu M, 2009, CLIN HEMORHEOL MICRO, V41, P269, DOI 10.3233/CH-2009-1178; WALTZ X, 2013, CLIN HEMORHEOL MICRO; Zhou WT, 1999, J THERM BIOL, V24, P193, DOI 10.1016/S0306-4565(99)00011-X	18	8	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102537	10.1371/journal.pone.0102537	http://dx.doi.org/10.1371/journal.pone.0102537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013960	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400102
J	Hu, SL; Zhao, FR; Hu, Q; Chen, WX				Hu, Shi-Ling; Zhao, Feng-Rong; Hu, Qin; Chen, Wei-Xian			Meta-Analysis Assessment of GP210 and SP100 for the Diagnosis of Primary Biliary Cirrhosis	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; ANTINUCLEAR ANTIBODIES; AUTOANTIBODIES; PROTEINS; GLYCOPROTEIN; PREVALENCE; ENVELOPE; TESTS; POLYPEPTIDE; GUIDELINES	Purpose: To conduct a systematic review of included studies assessing the association of GP210 and SP100 with the risk of primary biliary cirrhosis (PBC) using meta-analysis. Methods: Five databases, the Cochrane Library, MEDLINE, VIP, CNKI, WANFANG were used to detect the role of GP210 and SP100 in diagnosis of PBC. Approximately 13,000 participants from several countries were included in this analysis. Meta-DiSc statistical software was used for analysis. Results: 25 studies on GP210 and 21 studies on SP100 were included in the meta-analysis. The DOR, sensitivity, specificity of GP210 in diagnosis of PBC were 24.854 (11.957-51.660), 0.272 (0.257-0.288), 0.985 (0.982-0.988), respectively, and they were 9.133 (4.739-17.600), 0.231 (0.213-0.249), 0.977 (0.973-0.981) for SP100. Conclusion: Our meta-analysis indicated both GP210 and SP100 had high specificity but low sensitivity in diagnosis of PBC.	[Hu, Shi-Ling; Hu, Qin; Chen, Wei-Xian] Chongqing Med Univ, Hosp 2, Dept Lab Med, Chongqing, Peoples R China; [Zhao, Feng-Rong] Youyang Peoples Hosp, Dept Gynecol & Obstet, Chongqing, Peoples R China	Chongqing Medical University	Chen, WX (corresponding author), Chongqing Med Univ, Hosp 2, Dept Lab Med, Chongqing, Peoples R China.	chenweixian75@163.com			National Natural Science Foundation of China [81171628]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The reported work was supported by research grants from National Natural Science Foundation of China (81171628). The website is https://isis.nsfc.gov.cn/egrantweb/. WXC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assassi S, 2009, J RHEUMATOL, V36, P2250, DOI 10.3899/jrheum.090340; Bandin O, 1996, HEPATOLOGY, V23, P1020; Bauer A, 2007, J CLIN LAB ANAL, V21, P227, DOI 10.1002/jcla.20170; Bogdanos DP, 2003, DIGEST LIVER DIS, V35, P801, DOI 10.1016/S1590-8658(03)00466-3; Du HH, 2013, CHINESE J LIVER DIS, V5, P19, DOI [10.3969/j.issn.1674-7380.2013.01.004, DOI 10.3969/J.ISSN.1674-7380.2013.01.004]; Gao LX, 2008, CLIN EXP MED, V8, P9, DOI 10.1007/s10238-008-0150-6; Granito A, 2010, AM J GASTROENTEROL, V105, P125, DOI 10.1038/ajg.2009.596; GREBER UF, 1990, EMBO J, V9, P1495, DOI 10.1002/j.1460-2075.1990.tb08267.x; Hu CJ, 2010, WORLD J GASTROENTERO, V16, P3616, DOI 10.3748/wjg.v16.i29.3616; Hu CJ, 2011, DIGEST DIS SCI, V56, P3357, DOI 10.1007/s10620-011-1756-1; Hu SL, 2014, CLIN CHEM LAB MED, V52, P1533, DOI 10.1515/cclm-2013-0926; Imura-Kumada S, 2012, MOD RHEUMATOL, V22, P892, DOI 10.1007/s10165-012-0607-z; Invernizzi P, 2005, SEMIN LIVER DIS, V25, P298, DOI 10.1055/s-2005-916321; Itoh S, 1998, J GASTROEN HEPATOL, V13, P257, DOI 10.1111/j.1440-1746.1998.01553.x; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71; Kinoshita H, 1999, LIVER, V19, P122, DOI 10.1111/j.1478-3231.1999.tb00021.x; Kumar Y, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-1; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Liu HY, 2010, J AUTOIMMUN, V35, P436, DOI 10.1016/j.jaut.2010.09.005; [刘妍 LIU Yan], 2009, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V27, P256; LOZANO F, 1988, HEPATOLOGY, V8, P930, DOI 10.1002/hep.1840080438; Lu JianXi, 2011, China Tropical Medicine, V11, P1303; Marasini B, 2001, ANN RHEUM DIS, V60, P1046, DOI 10.1136/ard.60.11.1046; Milkiewicz P, 2009, CLIN GASTROENTEROL H, V7, P1355, DOI 10.1016/j.cgh.2009.07.012; Miyachi K, 2003, J AUTOIMMUN, V20, P247, DOI 10.1016/S0896-8411(03)00033-7; Muratori L, 2008, CLIN LIVER DIS, V12, P261, DOI 10.1016/j.cld.2008.02.009; Muratori P, 2003, AM J GASTROENTEROL, V98, P431, DOI 10.1016/S0002-9270(02)05925-7; Nakamura M, 2005, J HEPATOL, V42, P386, DOI 10.1016/j.jhep.2004.11.016; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; NICKOWITZ RE, 1994, GASTROENTEROLOGY, V106, P193, DOI 10.1016/S0016-5085(94)95333-3; Peng WH, 2012, SHANDONG MED J, V52, P17; Saito Hironobu, 2012, Fukushima J Med Sci, V58, P107; Sakauchi F, 2005, J EPIDEMIOL, V15, P24, DOI 10.2188/jea.15.24; Scagliusi P, 1984, Minerva Med, V75, P161; Shao J, 2005, WORLD CHINESE J DIGE, V13, P1478; STERNSDORF T, 1995, SCAND J IMMUNOL, V42, P257, DOI 10.1111/j.1365-3083.1995.tb03652.x; Stinton LM, 2011, CLIN EXP IMMUNOL, V163, P147, DOI 10.1111/j.1365-2249.2010.04288.x; SZOSTECKI C, 1990, J IMMUNOL, V145, P4338; Tang YM, 2011, J CLIN HEPATOL, V14, P132, DOI [10.3969/j.issn.1672-5069.2011.02.018, DOI 10.3969/J.ISSN.1672-5069.2011.02.018]; TARTAKOVSKY F, 1995, HEPATOLOGY, V21, P495, DOI 10.1016/0270-9139(95)90112-4; Tozzoli R, 2002, AM J CLIN PATHOL, V117, P316; VANDEWATER J, 1989, NEW ENGL J MED, V320, P1377, DOI 10.1056/NEJM198905253202104; WALKER JG, 1965, LANCET, V1, P827; Watt FE, 2004, QJM-INT J MED, V97, P397, DOI 10.1093/qjmed/hch078; Wesierska-Gadek J, 2006, HEPATOLOGY, V43, P1135, DOI 10.1002/hep.21172; Wesierska-Gadek Jozefa, 1996, Human Antibodies and Hybridomas, V7, P167; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Worman HJ, 2003, AUTOIMMUN REV, V2, P211, DOI 10.1016/S1568-9972(03)00013-2; WOZNIAK RW, 1989, J CELL BIOL, V108, P2083, DOI 10.1083/jcb.108.6.2083; [武剑 Wu Jian], 2012, [中国现代医学杂志, China Journal of Modern Medicine], V22, P55; Xiao Hua, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P209; Zuchner D, 1997, HEPATOLOGY, V26, P1123	53	22	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101916	10.1371/journal.pone.0101916	http://dx.doi.org/10.1371/journal.pone.0101916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010534	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800052
J	Kleinmintz, OM; Goldstein, P; Mayseless, N; Abecasis, D; Shamay-Tsoory, SG				Kleinmintz, Oded M.; Goldstein, Pavel; Mayseless, Naama; Abecasis, Donna; Shamay-Tsoory, Simone G.			Expertise in Musical Improvisation and Creativity: The Mediation of Idea Evaluation	PLOS ONE			English	Article							THINKING	The current study explored the influence of musical expertise, and specifically training in improvisation on creativity, using the framework of the twofold model, according to which creativity involves a process of idea generation and idea evaluation. Based on the hypothesis that a strict evaluation phase may have an inhibiting effect over the generation phase, we predicted that training in improvisation may have a "releasing effect'' on the evaluation system, leading to greater creativity. To examine this hypothesis, we compared performance among three groups - musicians trained in improvisation, musicians not trained in improvisation, and non-musicians - on divergent thinking tasks and on their evaluation of creativity. The improvisation group scored higher on fluency and originality compared to the other two groups. Among the musicians, evaluation of creativity mediated how experience in improvisation was related to originality and fluency scores. It is concluded that deliberate practice of improvisation may have a "releasing effect'' on creativity.	[Kleinmintz, Oded M.; Goldstein, Pavel; Mayseless, Naama; Shamay-Tsoory, Simone G.] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel; [Goldstein, Pavel] Univ Haifa, Dept Stat, IL-31999 Haifa, Israel; [Abecasis, Donna] Univ Haifa, Grad Sch Creat Arts Therapies, IL-31999 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa	Kleinmintz, OM (corresponding author), Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel.	odedklin@gmail.com		Kleinmintz, Oded M./0000-0002-2919-8781	Israeli Science Foundation (ISF) [1194/13]	Israeli Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Israeli Science Foundation (ISF) grant number 1194/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WM, 2005, IMPACT IMPROVISATION; Amabile TM, 2012, J CREATIVE BEHAV, V46, P3, DOI 10.1002/jocb.001; Antonietti A., 2011, OPEN ED J, V4, P80, DOI DOI 10.2174/1874920801104010080; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; BASADUR M, 1982, ORGAN BEHAV HUM PERF, V30, P41, DOI 10.1016/0030-5073(82)90233-1; Chiu CY, 2010, MANAGE ORGAN REV, V6, P447, DOI 10.1111/j.1740-8784.2010.00194.x; Corrigall KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00222; Csikszentmihalyi M., 1988, SOC CULTURE PERSON S; EDWARDS D, 1987, BIOMETRICS, V43, P913, DOI 10.2307/2531545; Elliott DJ, 1995, INT J MUSIC EDUC, P3; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P1, DOI 10.2277/ 0521600812; Ericsson KA, 1996, ROAD EXCELLENCE ACQU; Fink A, 2011, PERS INDIV DIFFER, V51, P754, DOI 10.1016/j.paid.2011.06.024; Fink A, 2009, NEUROIMAGE, V46, P854, DOI 10.1016/j.neuroimage.2009.02.036; Finke R.A., 1992, CREATIVE COGNITION T; Getzels J.W., 1976, CREATIVE VISION LONG; Gibson C, 2009, BRAIN COGNITION, V69, P162, DOI 10.1016/j.bandc.2008.07.009; Guilford J. P., 1978, ALTERNATE USES MANUA; Hallam E., 2007, CREATIVITY CULTURAL; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1093/her/cyl085; Hennessey BA, 2010, ANNU REV PSYCHOL, V61, P569, DOI 10.1146/annurev.psych.093008.100416; Hickey M, 2009, INT J MUSIC EDUC, V27, P285, DOI 10.1177/0255761409345442; Karakelle S, 2009, THINK SKILLS CREAT, V4, P124, DOI 10.1016/j.tsc.2009.05.002; Kemp A.E., 1996, MUSICAL TEMPERAMENT; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Koutsoupidou T, 2009, PSYCHOL MUSIC, V37, P251, DOI 10.1177/0305735608097246; Kowatari Y, 2009, HUM BRAIN MAPP, V30, P1678, DOI 10.1002/hbm.20633; Kurman J, 2003, J CROSS CULT PSYCHOL, V34, P24, DOI 10.1177/0022022102239153; Lewis C, 2013, THINKING SKILLS CREA; Mayseless N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00502; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P1258, DOI 10.1037/0022-3514.52.6.1258; MEYER L. B., 1989, STYLE MUSIC THEORY H; Miller BL, 2000, BRIT J PSYCHIAT, V176, P458, DOI 10.1192/bjp.176.5.458; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Niu WH, 2001, INT J PSYCHOL, V36, P225, DOI 10.1080/00207590143000036; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RHODES M, 1961, PHI DELTA KAPPAN, V42, P305; Runco M.A., 1997, EMINENT CREATIVITY E; Sawyer K, 2012, VOCAT LEARN, V5, P59, DOI 10.1007/s12186-011-9066-5; Sawyer R.K., 2012, EXPLAINING CREATIVIT, V2nd ed; Sawyer RK, 2000, J AESTHET ART CRITIC, V58, P149, DOI 10.2307/432094; Schellenberg EG, 2006, J EDUC PSYCHOL, V98, P457, DOI 10.1037/0022-0663.98.2.457; SCHMIDT T, 1975, EDUC THEATRE J, V27, P111, DOI 10.2307/3206346; Seeley WW, 2008, BRAIN, V131, P39, DOI 10.1093/brain/awm270; Shamay-Tsoory SG, 2011, NEUROPSYCHOLOGIA, V49, P178, DOI 10.1016/j.neuropsychologia.2010.11.020; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Silvia P. J., 2008, PSYCHOL AESTHET CREA, V2, P139, DOI [DOI 10.1037/1931-3896.2.3.139, 10.1037/1931-3896.2.3.139]; Silvia P.J., 2008, PSYCHOL AESTHET CREA, V2, P68, DOI [10.1037/1931-3896.2.2.68, DOI 10.1037/1931-3896.2.2.68]; Silvia PJ, 2011, THINK SKILLS CREAT, V6, P24, DOI 10.1016/j.tsc.2010.06.001; Sowden PT, 2014, THINK REASONING, P1; Sternberg R.J., 1999, HDB CREAT, V1, P3; Thompson WF, 2009, MUSIC FEELING UNDERS; Torrance, 2008, TORRANCE TESTS CREAT; Torrance EP, 1974, TORRANCE TESTS CREAT; Zachary R, 1986, SHIPLEY I LIVING SCA	56	33	34	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101568	10.1371/journal.pone.0101568	http://dx.doi.org/10.1371/journal.pone.0101568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK9RG	25010334	Green Published, gold			2022-12-27	WOS:000338763800028
J	Rendleman, J; Antipin, Y; Reva, B; Adaniel, C; Przybylo, JA; Dutra-Clarke, A; Hansen, N; Heguy, A; Huberman, K; Borsu, L; Paltiel, O; Ben-Yehuda, D; Brown, JR; Freedman, AS; Sander, C; Zelenetz, A; Klein, RJ; Shao, YZ; Lacher, M; Vijai, J; Offit, K; Kirchhoff, T				Rendleman, Justin; Antipin, Yevgeniy; Reva, Boris; Adaniel, Christina; Przybylo, Jennifer A.; Dutra-Clarke, Ana; Hansen, Nichole; Heguy, Adriana; Huberman, Kety; Borsu, Laetitia; Paltiel, Ora; Ben-Yehuda, Dina; Brown, Jennifer R.; Freedman, Arnold S.; Sander, Chris; Zelenetz, Andrew; Klein, Robert J.; Shao, Yongzhao; Lacher, Mortimer; Vijai, Joseph; Offit, Kenneth; Kirchhoff, Tomas			Genetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOME-WIDE ASSOCIATION; B-CELL LYMPHOMA; TELANGIECTASIA-MUTATED GENE; DOUBLE-STRAND BREAKS; FOLLICULAR LYMPHOMA; ATM MUTATIONS; CANCER SUSCEPTIBILITY; XRCC1 POLYMORPHISMS; CHINESE POPULATION	Molecular and genetic evidence suggests that DNA repair pathways may contribute to lymphoma susceptibility. Several studies have examined the association of DNA repair genes with lymphoma risk, but the findings from these reports have been inconsistent. Here we provide the results of a focused analysis of genetic variation in DNA repair genes and their association with the risk of non-Hodgkin's lymphoma (NHL). With a population of 1,297 NHL cases and 1,946 controls, we have performed a two-stage case/control association analysis of 446 single nucleotide polymorphisms (SNPs) tagging the genetic variation in 81 DNA repair genes. We found the most significant association with NHL risk in the ATM locus for rs227060 (OR = 1.27, 95% CI: 1.13-1.43, p = 6.77x10(-5)), which remained significant after adjustment for multiple testing. In a subtype-specific analysis, associations were also observed for the ATM locus among both diffuse large B-cell lymphomas (DLBCL) and small lymphocytic lymphomas (SLL), however there was no association observed among follicular lymphomas (FL). In addition, our study provides suggestive evidence of an interaction between SNPs in MRE11A and NBS1 associated with NHL risk (OR = 0.51, 95% CI: 0.34-0.77, p = 0.0002). Finally, an imputation analysis using the 1,000 Genomes Project data combined with a functional prediction analysis revealed the presence of biologically relevant variants that correlate with the observed association signals. While the findings generated here warrant independent validation, the results of our large study suggest that ATM may be a novel locus associated with the risk of multiple subtypes of NHL.	[Rendleman, Justin; Adaniel, Christina; Shao, Yongzhao; Kirchhoff, Tomas] NYU, NYU Sch Med, New York, NY 10012 USA; [Antipin, Yevgeniy; Reva, Boris; Przybylo, Jennifer A.; Dutra-Clarke, Ana; Hansen, Nichole; Heguy, Adriana; Huberman, Kety; Borsu, Laetitia; Sander, Chris; Zelenetz, Andrew; Klein, Robert J.; Lacher, Mortimer; Vijai, Joseph; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Paltiel, Ora; Ben-Yehuda, Dina] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel; [Brown, Jennifer R.; Freedman, Arnold S.] Harvard Univ, Dana Farber Canc Ctr, Boston, MA 02115 USA	New York University; Memorial Sloan Kettering Cancer Center; Hebrew University of Jerusalem; Harvard University; Dana-Farber Cancer Institute	Kirchhoff, T (corresponding author), NYU, NYU Sch Med, New York, NY 10012 USA.	Tomas.Kirchhoff@nyumc.org	Heguy, Adriana/GPP-3907-2022; Rendleman, Justin/ABI-2137-2020; Klein, Robert/ABI-7857-2020; Reva, Boris/AAB-8932-2022; Joseph, Vijai/J-9158-2013	Klein, Robert/0000-0003-3539-5391; Rendleman, Justin/0000-0001-8152-7127; Kirchhoff, Tomas/0000-0002-9055-2364; Joseph, Vijai/0000-0002-7933-151X	Leukemia and Lymphoma Society [TRP 6202-09]; Lymphoma Foundation; Filomena M. D'Agostino Foundation; Okonow-Lipton Fund; National Institutes of Health [K23 CA115682]; Anbinder Fund; NATIONAL CANCER INSTITUTE [P30CA016087, K23CA115682, P30CA008748] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lymphoma Foundation; Filomena M. D'Agostino Foundation; Okonow-Lipton Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anbinder Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by Translational Research Grant from Leukemia and Lymphoma Society (TRP 6202-09, awarded to Tomas Kirchhoff). Funding support was also provided by the Lymphoma Foundation and the Filomena M. D'Agostino Foundation (both to Kenneth Offit). Further support was also provided by the Okonow-Lipton Fund (Jennifer R. Brown) and the National Institutes of Health (K23 CA115682, Jennifer R. Brown). Jennifer R. Brown is a Scholar of the American Society of Hematology as well as a Scholar in Clinical Research of the Leukemia and Lymphoma Society. MSKCC Sequenom facility is supported by the Anbinder Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1183, DOI 10.1098/rspb.2010.1920; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baris S, 2009, PEDIATR HEMAT ONCOL, V26, P467, DOI [10.1080/08880010903096201, 10.3109/08880010903096201]; Bassaganyas L, 2013, LEUKEMIA, V27, P2376, DOI 10.1038/leu.2013.127; Bednarski JJ, 2012, ADV IMMUNOL, V116, P175, DOI 10.1016/B978-0-12-394300-2.00006-5; Berndt SI, 2013, NAT GENET; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bullrich F, 1999, CANCER RES, V59, P24; Camacho E, 2002, BLOOD, V99, P238, DOI 10.1182/blood.V99.1.238; Chang ET, 2005, J NATL CANCER I, V97, P1466, DOI 10.1093/jnci/dji293; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; de Miranda NFCC, 2011, ANN NY ACAD SCI, V1246, P50, DOI 10.1111/j.1749-6632.2011.06322.x; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Economopoulou P, 2011, LEUKEMIA LYMPHOMA, V52, P567, DOI 10.3109/10428194.2010.551155; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Gallagher DJ, 2010, CLIN CANCER RES, V16, P2819, DOI 10.1158/1078-0432.CCR-10-0028; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gronbaek K, 2002, BLOOD, V100, P1430, DOI 10.1182/blood-2002-02-0382; Gumy-Pause F, 2004, LEUKEMIA, V18, P238, DOI 10.1038/sj.leu.2403221; Hill DA, 2006, BLOOD, V108, P3161, DOI 10.1182/blood-2005-01-026690; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kals M, 2005, YEAST, V22, P213, DOI 10.1002/yea.1204; Kanehisa M, 2000, POSTGENOME INFORMATI; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Kim IS, 2010, CANCER GENET CYTOGEN, V196, P31, DOI 10.1016/j.cancergencyto.2009.08.008; Kirchhoff T, 2009, CANCER EPIDEM BIOMAR, V18, P2468, DOI 10.1158/1055-9965.EPI-09-0151; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kumar V, 2011, J HUM GENET, V56, P436, DOI 10.1038/jhg.2011.35; Liu J, 2009, CANCER GENET CYTOGEN, V191, P67, DOI 10.1016/j.cancergencyto.2009.01.015; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Olshen AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-14; Ostrer H, 2013, HUM GENET, V132, P119, DOI 10.1007/s00439-012-1235-6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Schuetz JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-117; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Shen M, 2007, HAEMATOLOGICA, V92, P1180, DOI 10.3324/haematol.11324; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Shen M, 2010, BRIT J HAEMATOL, V151, P239, DOI 10.1111/j.1365-2141.2010.08364.x; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Siddiqui Rina, 2004, Curr Oncol Rep, V6, P380, DOI 10.1007/s11912-004-0064-8; Sipahimalani P, 2007, INT J CANCER, V121, P1967, DOI 10.1002/ijc.22888; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Smedby KE, 2006, CANCER EPIDEM BIOMAR, V15, P258, DOI 10.1158/1055-9965.EPI-05-0583; Stankovic T, 2002, BLOOD, V99, P300, DOI 10.1182/blood.V99.1.300; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tan DEK, 2013, NAT GENET, V45, P804, DOI 10.1038/ng.2666; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Worrillow L, 2009, CANCER EPIDEMIOL, V33, P257, DOI 10.1016/j.canep.2009.08.002; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	69	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101685	10.1371/journal.pone.0101685	http://dx.doi.org/10.1371/journal.pone.0101685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010664	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800032
J	Essone, PN; Chegou, NN; Loxton, AG; Stanley, K; Kriel, M; van der Spuy, G; Franken, KL; Ottenhoff, TH; Walzl, G				Essone, Paulin N.; Chegou, Novel N.; Loxton, Andre G.; Stanley, Kim; Kriel, Magdalena; van der Spuy, Gian; Franken, Kees L.; Ottenhoff, Tom H.; Walzl, Gerhard			Host Cytokine Responses Induced after Overnight Stimulation with Novel M-tuberculosis Infection Phase-Dependent Antigens Show Promise as Diagnostic Candidates for TB Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PULMONARY TUBERCULOSIS; SERUM; BIOMARKER; URINE; ASSAY; DOSR; HIV	Background: We previously identified Mycobacterium tuberculosis (M.tb) antigen-induced host markers that showed promise as TB diagnostic candidates in 7-day whole blood culture supernatants. The aim of the present study was to evaluate the utility of these markers further, and cross-compare results with short-term antigen stimulated and unstimulated culture supernatants. Methods: We recruited 15 culture confirmed TB cases and 15 non-TB cases from a high-TB endemic community in Cape Town, South Africa into a pilot case-control study from an on-going larger study. Blood samples collected from study participants were stimulated with 4 M.tb antigens that were previously identified as promising (ESAT6/CFP10 (early secreted), Rv2029c (latency), Rv2032 (latency) and Rv2389c (rpf)) in a 7-day or overnight culture assay. Supernatants were also collected form the standard QuantiFERON In Tube (QFT-IT) test. The levels of 26 host markers were evaluated in the three culture supernatants using the Luminex platform. Results: The unstimulated levels of CRP, Serum amyloid P (SAP) and serum amyloid A (SAA) and ESAT-6/CFP-10 specific IP-10 and SAA were amongst the best discriminatory markers in all 3 assays, ascertaining TB with AUC of 72-84%. Four-marker models accurately classified up to 92%, 100% and 100% of study participants in the overnight, 7-day and Quantiferon culture supernatants, respectively, after leave-one-out cross validation. Conclusion: Unstimulated and antigen-specific levels of CRP, SAA, IP-10, MMP-2 and sCD40L hold promise as diagnostic candidates for TB disease in short-term stimulation assays. Larger studies are required to validate these findings but the data suggest that antigen-specific cytokine production and in particular mutimarker biosignatures might contribute to future diagnostic strategies.	[Essone, Paulin N.; Chegou, Novel N.; Loxton, Andre G.; Stanley, Kim; Kriel, Magdalena; van der Spuy, Gian; Walzl, Gerhard] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Essone, Paulin N.; Chegou, Novel N.; Loxton, Andre G.; Stanley, Kim; Kriel, Magdalena; van der Spuy, Gian; Walzl, Gerhard] Univ Stellenbosch, MRC Ctr TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Franken, Kees L.; Ottenhoff, Tom H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Walzl, G (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa.	gwalzl@sun.ac.za	Franken, Kees/ABA-7095-2021; van der Spuy, Gian/AAY-7701-2020; Walzl, Gerhard/N-6371-2016	Franken, Kees/0000-0002-4747-6060; van der Spuy, Gian/0000-0002-9067-5903; Walzl, Gerhard/0000-0003-2487-125X; Loxton, Andre/0000-0003-0659-9803; Chegou, Novel N/0000-0002-8690-1699	EDCTP [IP. 09.32040.011]; EC FP7 NEWTBVAC contract [HEALTH.F3.2009 241745]; EC FP7 EURIPRED contract [INFRASTRUCTURES.2012.1 312661]; EC FP7 VACTRAIN; "Agence nationale des bourses du Gabon''	EDCTP; EC FP7 NEWTBVAC contract; EC FP7 EURIPRED contract; EC FP7 VACTRAIN; "Agence nationale des bourses du Gabon''(French National Research Agency (ANR))	The authors acknowledge the EDCTP (grant IP. 09.32040.011), EC FP7 NEWTBVAC contract no. HEALTH.F3.2009 241745, EC FP7 EURIPRED contract no. INFRASTRUCTURES.2012.1 312661 and EC FP7 VACTRAIN (the text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information). Paulin Essone is funded by "Agence nationale des bourses du Gabon''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2007, ANN NY ACAD SCI, V1098, P437, DOI 10.1196/annals.1384.016; dos Anjos BL, 2010, CLIN CHEM LAB MED, V48, P493, DOI 10.1515/CCLM.2010.110; Dosanjh DPS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028754; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Fujiwara H, 2011, J SURG ONCOL, V103, P62, DOI 10.1002/jso.21751; Kanoh Y, 2013, ONCOL REP, V29, P469, DOI 10.3892/or.2012.2123; Kashino SS, 2008, CLIN EXP IMMUNOL, V153, P56, DOI 10.1111/j.1365-2249.2008.03672.x; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Kirwan DE, 2012, AM J TROP MED HYG, V87, P197, DOI 10.4269/ajtmh.2012.12-0107; Lin MY, 2008, BIOL CHEM, V389, P497, DOI 10.1515/BC.2008.057; MAASILTA P, 1989, INFECTION, V17, P13, DOI 10.1007/BF01643491; Noh S, 2011, HEPATO-GASTROENTEROL, V58, P2015, DOI 10.5754/hge11209; Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED; Phalane KG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/981984; Riano F, 2012, TUBERCULOSIS, V92, P148, DOI 10.1016/j.tube.2011.12.005; Safranek J, 2009, ANTICANCER RES, V29, P2513; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Verweij KE, 2010, INT J TUBERC LUNG D, V14, P1127; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2011, US TUB INT GAMM REL; Wu X, 2008, J APPL MICROBIOL, V105, P1121, DOI 10.1111/j.1365-2672.2008.03850.x; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	36	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102584	10.1371/journal.pone.0102584	http://dx.doi.org/10.1371/journal.pone.0102584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025278	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400090
J	Lawrence, BJ; Gasson, N; Kane, R; Bucks, RS; Loftus, AM				Lawrence, Blake J.; Gasson, Natalie; Kane, Robert; Bucks, Romola S.; Loftus, Andrea M.			Activities of Daily Living, Depression, and Quality of Life in Parkinson's Disease	PLOS ONE			English	Article							BRAZILIAN PATIENTS; DETERMINANTS; CRITIQUE; THERAPY; ANXIETY; SCALES	This study examined whether activities of daily living (ADL) mediate the relationship between depression and health-related quality of life (HR-QOL) in people with Parkinson's disease (PD). A cross-sectional, correlational research design examined data from 174 participants who completed the Geriatric Depression Scale (GDS-15), Parkinson's Disease Questionnaire-39 (PDQ-39), and Unified Parkinson's Disease Rating Scale-section 2 (UPDRS-section 2 [ADL]). Multiple Regression Analysis (MRA) was used to examine the mediator model. Depression and ADL significantly (p<.001) predicted HR-QOL, and depression significantly (p<.001) predicted ADL. Whilst ADL did not impact on the relationship between depression and HR-QOL, there was a significant (p<.001) indirect effect of depression on HR-QOL via ADL, suggesting both direct and indirect (via ADL) effects of depression on HR-QOL. The magnitude of this effect was moderate (R-2=.13). People with PD who report depression also experience greater difficulty completing ADL, which impacts upon their HR-QOL. It is recommended that clinicians adopt a multidisciplinary approach to care by combining pharmacological treatments with psycho/occupational therapy, thereby alleviating the heterogeneous impact of motor and non-motor symptoms on HR-QOL in people with PD.	[Lawrence, Blake J.; Gasson, Natalie; Kane, Robert; Loftus, Andrea M.] Curtin Univ, Sch Psychol & Speech Pathol, Curtin Neurosci Lab, Perth, WA 6845, Australia; [Gasson, Natalie; Bucks, Romola S.; Loftus, Andrea M.] Curtin Univ, Parkinsons Ctr ParkC, Perth, WA 6845, Australia; [Bucks, Romola S.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	Curtin University; Curtin University; University of Western Australia	Lawrence, BJ (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Curtin Neurosci Lab, Perth, WA 6845, Australia.	blake.lawrence@postgrad.curtin.edu.au	Bucks, Romola Starr/B-9164-2011; Lawrence, Blake/C-6069-2016	Bucks, Romola Starr/0000-0002-4207-4724; Lawrence, Blake/0000-0002-8772-8226; Gasson, Natalie/0000-0001-6265-9095; Loftus, Andrea/0000-0001-8782-7024	Australian Research Council; Edith Cowan University's Office of Research and Innovation; Parkinson's Association of WA; McCusker Charitable Foundation; Parkinson's Young Onset Support Group (WA); Royal Freshwater Bay Yacht Club	Australian Research Council(Australian Research Council); Edith Cowan University's Office of Research and Innovation; Parkinson's Association of WA; McCusker Charitable Foundation; Parkinson's Young Onset Support Group (WA); Royal Freshwater Bay Yacht Club	All funding for ParkC has been received from the Australian Research Council, Edith Cowan University's Office of Research and Innovation, Parkinson's Association of WA, The McCusker Charitable Foundation, Parkinson's Young Onset Support Group (WA) and the Royal Freshwater Bay Yacht Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Carod-Artal FJ, 2008, PARKINSONISM RELAT D, V14, P102, DOI 10.1016/j.parkreldis.2007.06.011; Carod-Artal FJ, 2007, MOVEMENT DISORD, V22, P1408, DOI 10.1002/mds.21408; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dissanayaka NNW, 2011, J AFFECT DISORDERS, V132, P82, DOI 10.1016/j.jad.2011.01.021; Dobkin Roseanne DeFronzo, 2008, Expert Rev Neurother, V8, P27, DOI 10.1586/14737175.8.1.27; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Ishihara L, 2006, ACTA NEUROL SCAND, V113, P211, DOI 10.1111/j.1600-0404.2006.00579.x; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Kleiner-Fisman G, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-91; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Martinez-Martin P, 2003, MOVEMENT DISORD, V18, P985, DOI 10.1002/mds.10479; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; Meek C, 2010, BRIT J OCCUP THER, V73, P178, DOI 10.4276/030802210X12706313444027; Pagonabarraga J, 2010, ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 2: H-P, P405; Papapetropoulos S, 2006, CLIN NEUROL NEUROSUR, V108, P465, DOI 10.1016/j.clineuro.2005.08.002; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Piccinni A, 2012, COMPR PSYCHIAT, V53, P727, DOI 10.1016/j.comppsych.2011.11.002; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Quelhas R, 2009, J NEUROPSYCH CLIN N, V21, P413, DOI 10.1176/appi.neuropsych.21.4.413; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Wichowicz HM, 2006, EUR PSYCHIAT, V21, P516, DOI 10.1016/j.eurpsy.2006.01.012	30	48	49	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102294	10.1371/journal.pone.0102294	http://dx.doi.org/10.1371/journal.pone.0102294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025280	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400061
J	Chen, F; Kumar, S; Yu, YF; Aggarwal, S; Gross, C; Wang, YS; Chakraborty, T; Verin, AD; Catravas, JD; Lucas, R; Black, SM; Fulton, DJR				Chen, Feng; Kumar, Sanjiv; Yu, Yanfang; Aggarwal, Saurabh; Gross, Christine; Wang, Yusi; Chakraborty, Trinad; Verin, Alexander D.; Catravas, John D.; Lucas, Rudolf; Black, Stephen M.; Fulton, David J. R.			PKC-Dependent Phosphorylation of eNOS at T495 Regulates eNOS Coupling and Endothelial Barrier Function in Response to G(+) -Toxins	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; ACUTE LUNG INJURY; MICROVASCULAR PERMEABILITY; SUPEROXIDE ANION; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL PNEUMONIA; VASCULAR-PERMEABILITY; PORE FORMATION; PNEUMOLYSIN	Gram positive (G(+)) infections make up similar to 50% of all acute lung injury cases which are characterized by extensive permeability edema secondary to disruption of endothelial cell (EC) barrier integrity. A primary cause of increased permeability are cholesterol-dependent cytolysins (CDCs) of G(+)-bacteria, such as pneumolysin (PLY) and listeriolysin-O (LLO) which create plasma membrane pores, promoting Ca2+-influx and activation of PKC alpha. In human lung microvascular endothelial cells (HLMVEC), pretreatment with the nitric oxide synthase (NOS) inhibitor, ETU reduced the ability of LLO to increase microvascular cell permeability suggesting an endothelial nitric oxide synthase (eNOS)-dependent mechanism. LLO stimulated superoxide production from HLMVEC and this was prevented by silencing PKC alpha or NOS inhibition suggesting a link between these pathways. Both LLO and PLY stimulated eNOS T495 phosphorylation in a PKC-dependent manner. Expression of a phosphomimetic T495D eNOS (human isoform) resulted in increased superoxide and diminished nitric oxide (NO) production. Transduction of HLMVEC with an active form of PKC alpha resulted in the robust phosphorylation of T495 and increased peroxynitrite production, indicative of eNOS uncoupling. To determine the mechanisms underlying eNOS uncoupling, HLMVEC were stimulated with LLO and the amount of hsp90 and caveolin-1 bound to eNOS determined. LLO stimulated the dissociation of hsp90, and in particular, caveolin-1 from eNOS. Both hsp90 and caveolin-1 have been shown to influence eNOS uncoupling and a peptide mimicking the scaffolding domain of caveolin-1 blocked the ability of PKC alpha to stimulate eNOS-derived superoxide. Collectively, these results suggest that the G(+) pore-forming toxins promote increased EC permeability via activation of PKC alpha, phosphorylation of eNOS-T495, loss of hsp90 and caveolin-1 binding which collectively promote eNOS uncoupling and the production of barrier disruptive superoxide.	[Chen, Feng] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China; [Chen, Feng; Kumar, Sanjiv; Yu, Yanfang; Aggarwal, Saurabh; Gross, Christine; Wang, Yusi; Verin, Alexander D.; Lucas, Rudolf; Black, Stephen M.; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30901 USA; [Lucas, Rudolf; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol, Augusta, GA USA; [Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, D-35390 Giessen, Germany; [Catravas, John D.] Old Dominion Univ, Norfolk, VA USA	Nanjing Medical University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Justus Liebig University Giessen; Old Dominion University	Fulton, DJR (corresponding author), Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30901 USA.	dfulton@gru.edu	Lucas, Rudolf/ABA-3011-2020; Chen, Feng/E-1133-2011	Lucas, Rudolf/0000-0003-3805-8868	National Institutes of Health [RO1 HL085827, P01 HL101902-01A1, R01HL092446, R01HL094609]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085827, P01HL101902, R01HL092446, R01HL094609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1 HL085827, P01 HL101902-01A1 (DJRF), R01HL092446 (DF), R01HL094609 (RL) and by a Postdoctoral Fellowship from the AHA (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANTHRAMAN A, 1983, RESPIRATION, V44, P153, DOI 10.1159/000194542; Bonev BB, 2001, J BIOL CHEM, V276, P5714, DOI 10.1074/jbc.M005126200; Cai L, 2014, AM J PHYSL LUNG CELL; Catravas JD, 2010, VASCUL PHARM; Chatterjee A, 2008, AM J PHYSIOL-LUNG C, V294, pL755, DOI 10.1152/ajplung.00350.2007; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chiasson VL, 2011, J PHARMACOL EXP THER, V337, P718, DOI 10.1124/jpet.110.178095; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536; DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Ferro TJ, 1997, AM J PHYSIOL-LUNG C, V272, pL979, DOI 10.1152/ajplung.1997.272.5.L979; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 2005, J BIOL CHEM, V280, P35943, DOI 10.1074/jbc.M504606200; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; GUICE KS, 1989, ANN SURG, V210, P740, DOI 10.1097/00000658-198912000-00008; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Karuppiah K, 2011, AM J PHYSIOL-HEART C, V301, pH903, DOI 10.1152/ajpheart.00936.2010; Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064; KUROSE I, 1995, CIRC RES, V76, P30, DOI 10.1161/01.RES.76.1.30; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Lucas R, 2012, AM J RESP CELL MOL, V47, P445, DOI 10.1165/rcmb.2011-0332OC; McElroy MC, 1997, AM J PHYSIOL-LUNG C, V272, pL631, DOI 10.1152/ajplung.1997.272.4.L631; McQuaid KE, 1997, EXP PHYSIOL, V82, P369, DOI 10.1113/expphysiol.1997.sp004032; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Qian J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00347; Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; RUBINS JB, 1994, INFECT IMMUN, V62, P3829, DOI 10.1128/IAI.62.9.3829-3836.1994; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; SOUTHAN GJ, 1995, BRIT J PHARMACOL, V114, P510, DOI 10.1111/j.1476-5381.1995.tb13256.x; Sprague RS, 1998, J PHARMACOL EXP THER, V284, P443; Stringaris AK, 2002, NEUROBIOL DIS, V11, P355, DOI 10.1006/nbdi.2002.0561; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sugimoto M, 2007, BIOCHEM BIOPH RES CO, V361, P462, DOI 10.1016/j.bbrc.2007.07.030; Sun X, 2014, AM J RESP CELL MOL B; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tanita T, 1999, SURG TODAY, V29, P755, DOI 10.1007/BF02482321; TERADA LS, 1992, P NATL ACAD SCI USA, V89, P3362, DOI 10.1073/pnas.89.8.3362; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987; Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9; Witzenrath M, 2007, CRIT CARE MED, V35, P1756, DOI 10.1097/01.CCM.0000269212.84709.23; Wright JK, 1999, ARCH SURG-CHICAGO, V134, P293, DOI 10.1001/archsurg.134.3.293; Xiong C, 2010, VASCUL PHARM; Xiong CL, 2010, VASC PHARMACOL, V52, P207, DOI 10.1016/j.vph.2009.12.010; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	66	43	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e99823	10.1371/journal.pone.0099823	http://dx.doi.org/10.1371/journal.pone.0099823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020117	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600004
J	Li, CP; Lai, QL; Li, GZ; Liu, Y; Sun, FQ; Shao, ZZ				Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze			Multilocus Sequence Analysis for the Assessment of Phylogenetic Diversity and Biogeography in Hyphomonas Bacteria from Diverse Marine Environments	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; MICROBIAL DIVERSITY; SPECIES DEFINITION; ANALYSIS REVEALS; SP NOV.; SEDIMENT; STRAINS; WATER; HYPHOMICROBIUM; PROSTHECATE	Hyphomonas, a genus of budding, prosthecate bacteria, are primarily found in the marine environment. Seven type strains, and 35 strains from our collections of Hyphomonas, isolated from the Pacific Ocean, Atlantic Ocean, Arctic Ocean, South China Sea and the Baltic Sea, were investigated in this study using multilocus sequence analysis (MLSA). The phylogenetic structure of these bacteria was evaluated using the 16S rRNA gene, and five housekeeping genes (leuA, clpA, pyrH, gatA and rpoD) as well as their concatenated sequences. Our results showed that each housekeeping gene and the concatenated gene sequence all yield a higher taxonomic resolution than the 16S rRNA gene. The 42 strains assorted into 12 groups. Each group represents an independent species, which was confirmed by virtual DNA-DNA hybridization (DDH) estimated from draft genome sequences. Hyphomonas MLSA interspecies and intraspecies boundaries ranged from 93.3% to 96.3%, similarity calculated using a combined DDH and MLSA approach. Furthermore, six novel species (groups I, II, III, IV, V and XII) of the genus Hyphomonas exist, based on sequence similarities of the MLSA and DDH values. Additionally, we propose that the leuA gene (93.0% sequence similarity across our dataset) alone could be used as a fast and practical means for identifying species within Hyphomonas. Finally, Hyphomonas' geographic distribution shows that strains from the same area tend to cluster together as discrete species. This study provides a framework for the discrimination and phylogenetic analysis of the genus Hyphomonas for the first time, and will contribute to a more thorough understanding of the biological and ecological roles of this genus.	[Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] State Key Lab Breeding Base Marine Genet Resource, Xiamen, Peoples R China; [Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] Third Inst State Ocean Adm, Key Lab Marine Genet Resources, Xiamen, Peoples R China; [Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] Collaborat Innovat Ctr Marine Biol Resources, Xiamen, Peoples R China; [Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] Key Lab Marine Genet Resources Fujian Prov, Xiamen, Peoples R China		Shao, ZZ (corresponding author), State Key Lab Breeding Base Marine Genet Resource, Xiamen, Peoples R China.	shaozz@163.com		Liu, Yang/0000-0002-2362-9501	COMRA program [DY125-15-R-01]; Public Welfare Project of SOA [201005032]; National Infrastructure of Natural Resources for Science and Technology Program of China [NIMR-2013-9]	COMRA program; Public Welfare Project of SOA; National Infrastructure of Natural Resources for Science and Technology Program of China	This work was financially supported by COMRA program (No. DY125-15-R-01), Public Welfare Project of SOA (201005032) and National Infrastructure of Natural Resources for Science and Technology Program of China (No. NIMR-2013-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; Balboa S, 2013, SYST APPL MICROBIOL, V36, P183, DOI 10.1016/j.syapm.2012.12.004; Bolt F, 2010, J CLIN MICROBIOL, V48, P4177, DOI 10.1128/JCM.00274-10; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Coulon F, 2007, ENVIRON MICROBIOL, V9, P177, DOI 10.1111/j.1462-2920.2006.01126.x; Curtis SM, 2012, SYST APPL MICROBIOL, V35, P441, DOI 10.1016/j.syapm.2012.08.001; de la Haba RR, 2012, INT J SYST EVOL MICR, V62, P520, DOI 10.1099/ijs.0.032938-0; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gray ND, 2007, ISME J, V1, P596, DOI 10.1038/ismej.2007.74; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; Hara A, 2003, ENVIRON MICROBIOL, V5, P746, DOI 10.1046/j.1468-2920.2003.00468.x; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lai OL, 2009, INT J SYST EVOL MICR, V59, P1278, DOI 10.1099/ijs.0.003889-0; Laranjo M, 2012, SYST APPL MICROBIOL, V35, P359, DOI 10.1016/j.syapm.2012.06.002; LEIFSON E, 1964, ANTON VAN LEE J M S, V30, P249, DOI 10.1007/BF02046730; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079417, 10.1371/journal.pone.0082678, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0075318, 10.1371/journal.pone.0080097]; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maeda R, 2009, FEMS MICROBIOL LETT, V292, P203, DOI 10.1111/j.1574-6968.2009.01497.x; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Meier-Kolthoff JP, 2013, ARCH MICROBIOL, V195, P413, DOI 10.1007/s00203-013-0888-4; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mo S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-24; MOORE RL, 1984, INT J SYST BACTERIOL, V34, P71, DOI 10.1099/00207713-34-1-71; MOORE RL, 1981, ANNU REV MICROBIOL, V35, P567, DOI 10.1146/annurev.mi.35.100181.003031; Nzoue A, 2009, SYST APPL MICROBIOL, V32, P400, DOI 10.1016/j.syapm.2009.06.002; Oakley BB, 2010, ISME J, V4, P488, DOI 10.1038/ismej.2009.146; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Poindexter JS, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P72, DOI 10.1007/0-387-30745-1_4; PONGRATZ E., 1957, SCHWEIZ ZEITSCHR ALLG PATH U BAKT, V20, P593; Rebollar EA, 2012, ENVIRON MICROBIOL, V14, P2323, DOI 10.1111/j.1462-2920.2012.02784.x; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rivas R, 2009, SYST APPL MICROBIOL, V32, P101, DOI 10.1016/j.syapm.2008.12.005; Rong XY, 2009, SYST APPL MICROBIOL, V32, P314, DOI 10.1016/j.syapm.2009.05.003; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tamura T, 2012, ANTON LEEUW INT J G, V102, P481, DOI 10.1007/s10482-012-9780-5; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Thompson FL, 2007, APPL ENVIRON MICROB, V73, P4279, DOI 10.1128/AEM.00020-07; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Vinuesa P, 2008, APPL ENVIRON MICROB, V74, P6987, DOI 10.1128/AEM.00875-08; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Wang BJ, 2008, ENVIRON MICROBIOL, V10, P1948, DOI 10.1111/j.1462-2920.2008.01611.x; Wang BJ, 2010, INT J SYST EVOL MICR, V60, P1289, DOI 10.1099/ijs.0.012930-0; Wang Jianning, 2012, Weishengwu Xuebao, V52, P1011; Wang LT, 2007, INT J SYST EVOL MICR, V57, P1846, DOI 10.1099/ijs.0.64685-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Weiner RM, 2000, INT J SYST EVOL MICR, V50, P459, DOI 10.1099/00207713-50-2-459; WEINER RM, 1985, INT J SYST BACTERIOL, V35, P237, DOI 10.1099/00207713-35-3-237; WEINER RM, 1980, CAN J MICROBIOL, V26, P1366, DOI 10.1139/m80-226; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Zhang F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00760	60	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101394	10.1371/journal.pone.0101394	http://dx.doi.org/10.1371/journal.pone.0101394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019154	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600015
J	Nelson, AE; Forbes, AA				Nelson, Amanda E.; Forbes, Andrew A.			Urban Land Use Decouples Plant-Herbivore-Parasitoid Interactions at Multiple Spatial Scales	PLOS ONE			English	Article							HABITAT; RESPONSES; HOST; DISPERSAL; CONSEQUENCES; BIODIVERSITY; POPULATIONS; DIVERSITY; LOCATION; SERVICES	Intense urban and agricultural development alters habitats, increases fragmentation, and may decouple trophic interactions if plants or animals cannot disperse to needed resources. Specialist insects represent a substantial proportion of global biodiversity and their fidelity to discrete microhabitats provides a powerful framework for investigating organismal responses to human land use. We sampled site occupancy and densities for two plant-herbivore-parasitoid systems from 250 sites across a 360 km(2) urban/agricultural landscape to ask whether and how human development decouples interactions between trophic levels. We compared patterns of site occupancy, host plant density, herbivory and parasitism rates of insects at two trophic levels with respect to landcover at multiple spatial scales. Geospatial analyses were used to identify landcover characters predictive of insect distributions. We found that herbivorous insect densities were decoupled from host tree densities in urban landcover types at several spatial scales. This effect was amplified for the third trophic level in one of the two insect systems: despite being abundant regionally, a parasitoid species was absent from all urban/suburban landcover even where its herbivore host was common. Our results indicate that human land use patterns limit distributions of specialist insects. Dispersal constraints associated with urban built development are specifically implicated as a limiting factor.	[Nelson, Amanda E.; Forbes, Andrew A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Nelson, AE (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	amanda-nelson@uiowa.edu		Nelson, Amanda/0000-0003-3868-5271; Forbes, Andrew/0000-0001-8332-6652	University of Iowa Department of Biology	University of Iowa Department of Biology	We wish to thank Stephen Hendrix and Christopher Patrick for helpful comments on early versions of this manuscript. George Malanson and Dale Zimmerman were instrumental in formulation of experimental designs. We thank four anonymous reviewers for comments and suggestions that greatly improved our manuscript. We extend thanks to numerous undergraduate research assistants, especially Katherine Weldon, Benjamin Worrell, and Francis Waisath, for help with field collections, insect husbandry, and data entry. We are also grateful for generous support from the University of Iowa Department of Biology and many private and public landowners in Johnson County, IA.	Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2005, EXPLORING SPATIAL DA; Bergerot B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011294; BOLLER EF, 1976, ANNU REV ENTOMOL, V21, P223, DOI 10.1146/annurev.en.21.010176.001255; BUSH GL, 1969, AM NAT, V103, P669, DOI 10.1086/282634; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Coladonato M., 1991, FIRE EFFECTS INFORM; Daoust SP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00300.1; Di Giulio M, 2009, J ENVIRON MANAGE, V90, P2959, DOI 10.1016/j.jenvman.2009.05.002; Doncaster CP, 1997, AM NAT, V150, P425, DOI 10.1086/286074; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Granchietti A, 2012, BIOL CONTROL, V61, P7, DOI 10.1016/j.biocontrol.2011.10.015; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Holt Robert D., 1996, P313; HUNTER AF, 1991, OIKOS, V60, P275, DOI 10.2307/3545068; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jenkinson GL, 1969, HIST LAKE MACBRIDE S; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kruess A, 2003, ECOGRAPHY, V26, P283, DOI 10.1034/j.1600-0587.2003.03402.x; LANDSBERG J, 1995, AUST J ECOL, V20, P299, DOI 10.1111/j.1442-9993.1995.tb00542.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Luck M, 2002, LANDSCAPE ECOL, V17, P327, DOI 10.1023/A:1020512723753; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Meehan TD, 2013, J INSECT CONSERV, V17, P411, DOI 10.1007/s10841-012-9523-y; Muesebeck C., 1980, USDA TECHNICAL B, V1617; Myers SW, 2006, ENVIRON ENTOMOL, V35, P219, DOI 10.1603/0046-225X-35.2.219; O'Rourke ME, 2011, ECOL APPL, V21, P1782, DOI 10.1890/10-0241.1; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Piechnik DA, 2013, ACTA OECOL, V47, P85, DOI 10.1016/j.actao.2012.11.002; PROKOPY RJ, 1984, AM SCI, V72, P41; Quilici Serge, 2012, Insects, V3, P1220, DOI 10.3390/insects3041220; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Rousset F, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P266; Rull J, 2011, ANN ENTOMOL SOC AM, V104, P202, DOI 10.1603/AN10095; Schnitzler FR, 2011, ECOL ENTOMOL, V36, P241, DOI 10.1111/j.1365-2311.2011.01266.x; Senger SE, 2007, ENTOMOL EXP APPL, V123, P91, DOI 10.1111/j.1570-7458.2007.00529.x; Smith RF, 2009, J N AM BENTHOL SOC, V28, P1022, DOI 10.1899/08-176.1; Stelinski LL, 2004, FLA ENTOMOL, V87, P124, DOI 10.1653/0015-4040(2004)087[0124:FOQAOT]2.0.CO;2; Strevens CMJ, 2011, J ANIM ECOL, V80, P282, DOI 10.1111/j.1365-2656.2010.01768.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Uchytil R.J., 1991, FIRE EFFECTS INFORM; USDA-NASS, 2011, CROPSCAPE; USDA-NRCS, 2005, SOIL SURV GEOG DAT; Vinatier F, 2013, LANDSCAPE ECOL, V28, P217, DOI 10.1007/s10980-012-9822-4; Wharton R.A., 1978, Journal of the Washington Academy of Sciences, V68, P147; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	57	19	21	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102127	10.1371/journal.pone.0102127	http://dx.doi.org/10.1371/journal.pone.0102127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019962	gold, Green Published			2022-12-27	WOS:000339618600048
J	Barbosa, AJB; Sampaio, I; Schneider, H; Santos, S				Barreto Barbosa, Andressa Jisely; Sampaio, Iracilda; Schneider, Horacio; Santos, Simoni			Molecular Phylogeny of Weakfish Species of the Stellifer Group (Sciaenidae, Perciformes) of the Western South Atlantic Based on Mitochondrial and Nuclear Data	PLOS ONE			English	Article							MACRODON-ANCYLODON SCIAENIDAE; CAETE RIVER ESTUARY; GENETIC-DIVERGENCE; COASTAL WATERS; FISH; TELEOSTEI; AMERICA; REEF; PHYLOGEOGRAPHY; POPULATIONS	The phylogenetic relationships within the Stellifer group of weakfishes (Stellifer, Odontoscion, Ophioscion, and Bairdiella) were evaluated using 2723 base pairs comprising sequences of nuclear (rhodopsin, TMO-4C4, RAG-1) and mitochondrial (16S rRNA and COI) markers obtained from specimens of nine species. Our results indicate a close relationship between Bairdiella and Odontoscion, and also that the genus Stellifer is not monophyletic, but rather that it consists of two distinct lineages, one clade containing S. microps/S. naso/S. brasiliensis and the other, S. rastrifer/S. stellifer/Stellifer sp. B, which is closer to Ophioscion than the former clade. The O. punctatissimus populations from the northern and southern Brazilian coast were also highly divergent in both nuclear (0.8% for rhodopsin and 0.9% for RAG-1) and mitochondrial sequences (2.2% for 16S rRNA and 7.3% for COI), which we conclude is consistent with the presence of two distinct species. The morphological similarities of the members of the Stellifer group is reinforced by the molecular data from both the present study and previous analyses, which have questioned the taxonomic status of the Stellifer group. If, on the one hand, the group is in fact composed of four genera (Stellifer, Ophioscion, Odontoscion, and Bairdiella), one of the two Stellifer clades should be reclassified as a new genus. However, if the close relationship and the reduced genetic divergence found within the group is confirmed in a more extensive study, including representatives of additional taxa, this, together with the morphological evidence, would support downgrading the whole group to a single genus. Obviously, these contradictory findings reinforce the need for a more systematic taxonomic revision of the Stellifer group as a whole.	[Barreto Barbosa, Andressa Jisely; Sampaio, Iracilda; Schneider, Horacio; Santos, Simoni] Fed Univ Para, Lab Genet & Mol Biol, Inst Coastal Studies IECOS, Braganca, Para, Brazil	Universidade Federal do Para	Santos, S (corresponding author), Fed Univ Para, Lab Genet & Mol Biol, Inst Coastal Studies IECOS, Braganca, Para, Brazil.	simoni@ufpa.br	Schneider, Horacio/J-7131-2012; SAMPAIO, IRACILDA/J-6514-2012	Schneider, Horacio/0000-0002-5987-6395; SAMPAIO, IRACILDA/0000-0002-2137-4656	Brazilian National Council for Scientific and Technological Development (CNPq); CNPq [306233/2009-6, 478027/2007-9]; FAPESPA; PROPESP/UFPA; FADESP;  [APP064/2011]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); PROPESP/UFPA; FADESP; 	This study was part of the MS dissertation of AJBB, which was financed by the Brazilian National Council for Scientific and Technological Development (CNPq). This research was also funded by CNPq (Grants 306233/2009-6 to IS; 478027/2007-9 to SS; and 306233/2009-6 to HS), APP064/2011 to IS, FAPESPA (PRONEX 2007 to HS), PROPESP/UFPA (http://www.propesp.ufpa.br), and FADESP (https://www.fadesp.org.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar SSC, 2012, THESIS U FEDERAL PAR; [Anonymous], 1993, FAO SPECIES IDENTIFI; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Barleta-Bergan A, 2002, ESTUAR COAST SHELF S, V54, P193, DOI 10.1006/ecss.2001.0842; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Barletta M, 2003, MAR ECOL PROG SER, V256, P217, DOI 10.3354/meps256217; Barletta-Bergan A, 2002, J FISH BIOL, V61, P33, DOI [10.1006/jfbi.2002.2065, 10.1111/j.1095-8649.2002.tb01759.x]; Barletta-Bergan Audrey, 2009, Open Fish Science Journal, V2, P15; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Brunner PC, 2001, EVOLUTION, V55, P573, DOI 10.1554/0014-3820(2001)055[0573:HPOACS]2.0.CO;2; Carvalho-Filho A., 1999, PEIXES COSTA BRASILE; Carvalho-Filho Alfredo, 2010, Zootaxa, V2519, P48; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; CASTRO B. M. F., 1998, SEA, P209; CHAO L N, 1978, NOAA (National Oceanic and Atmospheric Administration) Technical Report NMFS (National Marine Fisheries Service) Circular, P1; Chen DL, 2010, MOL PHYLOGENET EVOL, V55, P1167, DOI 10.1016/j.ympev.2010.01.039; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cooke GM, 2012, J BIOGEOGR, V39, P724, DOI 10.1111/j.1365-2699.2011.02635.x; da Costa AJG, 2011, J COASTAL RES, P1960; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farias IP, 2000, J EXP ZOOL, V288, P76, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;76::AID-JEZ8&gt;3.0.CO;2-P; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Figueiredo J.L., 2003, CAT LOGO ESP CIES PE, P9; Grunwald C, 2002, MOL ECOL, V11, P1885, DOI 10.1046/j.1365-294X.2002.01575.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Lakra WS, 2009, MOL BIOL REP, V36, P831, DOI 10.1007/s11033-008-9252-1; Leray M, 2010, EVOLUTION, V64, P1218, DOI 10.1111/j.1558-5646.2009.00917.x; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Lopez JA, 2004, COPEIA, P449, DOI 10.1643/CG-03-087R1; Menezes NA, 1980, MAN PEIXES MARINHOS; Musilova Zuzana, 2009, Vertebrate Zoology, V59, P131; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Palumbi Stephen R., 1996, P205; Planes S, 2001, EVOLUTION, V55, P2263; Pombo M, 2012, BRAZ J OCEANOGR, V60, P271, DOI 10.1590/S1679-87592012000300001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2008, FIGTREE V 1 4 0; Rambaut A, 2007, TRACER V 1 4; RAMSEY PR, 1987, COPEIA, P682; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2008, MOL PHYLOGENET EVOL, V48, P918, DOI 10.1016/j.ympev.2008.05.024; Rodrigues JL, 2011, BRAZ J BIOL, V71, P991, DOI 10.1590/S1519-69842011000500019; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos S, 2003, GENET MOL BIOL, V26, P151, DOI 10.1590/S1415-47572003000200008; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Santos S, 2013, MOL PHYLOGENET EVOL, V66, P423, DOI 10.1016/j.ympev.2012.09.020; SASAKI K, 1989, Memoirs of the Faculty of Fisheries Hokkaido University, V36, P1; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Stepien CA, 2001, EVOLUTION, V55, P1852, DOI 10.1111/j.0014-3820.2001.tb00834.x; Streelman JT, 1997, P ROY SOC B-BIOL SCI, V264, P1011, DOI 10.1098/rspb.1997.0140; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinas J, 2010, J BIOGEOGR, V37, P557, DOI 10.1111/j.1365-2699.2009.02225.x; Vinson C, 2004, GENET MOL BIOL, V27, P174, DOI 10.1590/S1415-47572004000200008; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	61	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102250	10.1371/journal.pone.0102250	http://dx.doi.org/10.1371/journal.pone.0102250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25020128	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400082
J	Canuel, M; Abdous, B; Belanger, D; Gosselin, P				Canuel, Magalie; Abdous, Belkacem; Belanger, Diane; Gosselin, Pierre			Development of Composite Indices to Measure the Adoption of Pro-Environmental Behaviours across Canadian Provinces	PLOS ONE			English	Article							ENGLISH; ATTITUDES; VALUES; FAMILY; IMPACT	Objective: The adoption of pro-environmental behaviours reduces anthropogenic environmental impacts and subsequent human health effects. This study developed composite indices measuring adoption of pro-environmental behaviours at the household level in Canada. Methods: The 2007 Households and the Environment Survey conducted by Statistics Canada collected data on Canadian environmental behaviours at households' level. A subset of 55 retained questions from this survey was analyzed by Multiple Correspondence Analysis (MCA) to develop the index. Weights attributed by MCA were used to compute scores for each Canadian province as well as for socio-demographic strata. Scores were classified into four categories reflecting different levels of adoption of pro-environmental behaviours. Results: Two indices were finally created: one based on 23 questions related to behaviours done inside the dwelling and a second based on 16 questions measuring behaviours done outside of the dwelling. British Columbia, Quebec, Prince-Edward-Island and Nova-Scotia appeared in one of the two top categories of adoption of pro-environmental behaviours for both indices. Alberta, Saskatchewan, Manitoba and Newfoundland-and- Labrador were classified in one of the two last categories of pro-environmental behaviours adoption for both indices. Households with a higher income, educational attainment, or greater number of persons adopted more indoor pro-environmental behaviours, while on the outdoor index, they adopted fewer such behaviours. Households with low-income fared better on the adoption of outdoors pro-environmental behaviours. Conclusion: MCA was successfully applied in creating Indoor and Outdoor composite Indices of pro-environmental behaviours. The Indices cover a good range of environmental themes and the analysis could be applied to similar surveys worldwide (as baseline weights) enabling temporal trend comparison for recurring themes. Much more than voluntary measures, the study shows that existing regulations, dwelling type, households composition and income as well as climate are the major factors determining pro-environmental behaviours.	[Canuel, Magalie; Gosselin, Pierre] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Abdous, Belkacem; Belanger, Diane; Gosselin, Pierre] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Abdous, Belkacem] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Belanger, Diane; Gosselin, Pierre] Inst Natl Rech Sci, Ctr Eau Terre Environm, Quebec City, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Laval University; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS)	Canuel, M (corresponding author), Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada.	magalie.canuel@inspq.qc.ca			Quebec government	Quebec government	This study was funded by the Green Fund for Action 21 of the 2006-2012 Climate Change Action Plan of the Quebec government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GREEN HOUS BEH OV 20; [Anonymous], EN EFF TRENDS CAN 19; Asselin LM., 2002, COMPOSITE INDICATOR; Atiles J. H., 2003, Southern Rural Sociology, V19, P97; Babooram A, 2008, ENVIROSTATS, V2, P7; BAER DE, 1984, CAN J SOCIOL, V9, P405, DOI 10.2307/3340527; Baillargeon J.P, 1994, RECH SOCIOGRAPH, V35, P255; BChydro, 2013, BUY BUILD RENT EFF H; Birrell C, 2008, ENVIROSTATS, V2, P19; Blumenberg E, 2010, TRANSPORTATION, V37, P429, DOI 10.1007/s11116-010-9262-4; Bohon SA, 2008, POPUL RES POLICY REV, V27, P273, DOI 10.1007/s11113-008-9075-8; Bonsal B, 2013, DROUGHTS; Canada mortgage and Housing Corporation, 2013, RED EN COST; Charreire H, 2010, INT J OBESITY, V34, P1293, DOI 10.1038/ijo.2010.39; Corbeil J. P, 2012, LINGUISTIC CHARACTER; CORTINOVIS I, 1993, SOC SCI MED, V36, P1087, DOI 10.1016/0277-9536(93)90127-P; Dossa LH, 2011, HUM ECOL, V39, P569, DOI 10.1007/s10745-011-9421-z; Environment Canada, 2011, OTT MUN WAT US REP; Environment Canada, 2013, WIS WAT US; Environment Canada, 2010, WAT CLIM CHANG; Environment Canada, 2013, AMM EM; Esty D. C., 2005, 2005 ENV SUSTAINABIL; Gibbons WD, 2008, ENVIROSTATS, V2, P8; Gibson KL, 2008, J SOC PSYCHOL, V148, P133, DOI 10.3200/SOCP.148.2.133-166; Greenacre M, 2010, PACKAGE CA SIMPLE MU; Greenacre M., 2007, CORRES ANAL PRACTICE; Hardie D, 2009, RURAL SMALL TOWN CAN, V7, P1; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Human Resources and Skills Development Canada, 2007, WHAT DIFF DOES LEARN; Kinkead J, 2006, ANAL CANADIAN OTHER; Kollmuss A., 2012, ENVIRON EDUC RES, V8, P239, DOI DOI 10.1080/13504620220145401; Lopez A, 2007, J WILDLIFE MANAGE, V71, P1275, DOI 10.2193/2006-480; Lynch MF, 2007, ENVIROSTATS, V1, P9; Mainieri T, 1997, J SOC PSYCHOL, V137, P189, DOI 10.1080/00224549709595430; Mekis E, 2011, ATMOS OCEAN, V49, P163, DOI 10.1080/07055900.2011.583910; Melgar N, 2013, ENV BEHAV DO PERSONA; Milito AC, 2008, ENVIROSTATS, V2, P3; Ministere du Developpement durable de l'Environnement de la Faune et des Parcs, 2011, PEST MAN COD HIGHL; Munro A, 2010, RECYCLING CANADIAN H; Mustapha I., 2013, ENVIROSTATS, V7, P1; Mustapha I, 2012, 16201X STAT CANADAOT; Nardo M., 2005, HDB CONSTRUCTING COM, P17, DOI [10.1787/533411815016, DOI 10.1787/533411815016]; Nelligan T, 2008, ENVIROSTATS, V2, P17; Oaks, 2012, PROV TERR WAT EFF CO; Price CE, 2012, POPUL RES POLICY REV, V31, P119, DOI 10.1007/s11113-011-9216-3; Reynaud A, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004195; *STAT CAN, 2008, HUM ACT ENV ANN STAT; Statistics Canada, 2010, MICR US GUID HOUS EN; Statistics Canada, 2009, 11526X STAT CAN; Statistics Canada, 2011, CANSIM TABL 027 0017; Statistics Canada, 2011, IMM CAN PORTR FOR BO; Stewart D., 2007, FOCUS GROUPS; Todd A, 2014, CHALLENGES, V5, P138; U.S. Environmental Protection Agency, 1998, WASH DC WAT CONS PLA; Wu Z, 1996, J COMP FAM STUD, V27, P437, DOI 10.3138/jcfs.27.3.437; Xiao CY, 2010, POPUL ENVIRON, V32, P88, DOI 10.1007/s11111-010-0115-z; Young N, 2012, CAN J SOCIOL, V37, P25, DOI 10.29173/cjs9733	57	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101569	10.1371/journal.pone.0101569	http://dx.doi.org/10.1371/journal.pone.0101569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25013929	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000339378400028
J	Corchado, S; Lopez-Cortes, LF; Rivero-Juarez, A; Torres-Cornejo, A; Rivero, A; Marquez-Coello, M; Giron-Gonzalez, JA				Corchado, Sara; Lopez-Cortes, Luis F.; Rivero-Juarez, Antonio; Torres-Cornejo, Almudena; Rivero, Antonio; Marquez-Coello, Mercedes; Giron-Gonzalez, Jose-Antonio			Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients	PLOS ONE			English	Article							INTERFERON PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; PEGYLATED INTERFERON; GENOTYPE 1; VIRAL KINETICS; HIV; TELAPREVIR; INFECTION; MANAGEMENT; SERUM	Objective: To establish the role of liver fibrosis as a predictive tool of response to pegylated interferon alpha (Peg-IFN) and ribavirin (RBV) treatment in human immunodeficiency (HIV)/hepatitis C virus (HCV) coinfected patients, in addition to recognized predictive factors (HCV load, HCV genotype, IL-28B polymorphism). Patients and Methods: A sample of 267 HIV/HCV coinfected patients was treated with Peg-IFN and RBV. Predictive factors of rapid (RVR) and sustained (SVR) virological response were analyzed. Independent variables were age, sex, IL28B, -238 TNF-alpha and -592 IL-10 polymorphisms, HCV genotype, HCV-RNA levels, significant fibrosis or cirrhosis and CD4+ T cell count. Results: Patients infected by HCV genotype 1 (n = 187) showed RVR and SVR in 12% and 39% of cases, respectively. The parameters associated with RVR were IL28B genotype CC and plasma HCV-RNA levels <600000 IU/ml. Advanced liver fibrosis was negatively associated with SVR in patients without RVR. A SVR was obtained in 42% of subjects with HCV genotype 4, and the independent factors associated with SVR were IL28B genotype CC and an HCV-RNA <600000 IU/ml. A SVR was obtained in 66% of patients with HCV genotypes 2/3; in this case, the independent parameter associated with SVR was the absence of significant liver fibrosis. TNF-alpha and IL-10 polymorphisms were not associated with SVR, although a significantly higher percentage of -238 TNF-alpha genotype GG was detected in patients with significant liver fibrosis. Conclusions: In HIV/HCV coinfected patients with HCV genotypes 1 or 4, RVR, mainly influenced by genotype IL28B and HCV-RNA levels, reliably predicted SVR after 4 weeks of therapy with Peg-IFN plus RBV. In patients infected by HCV genotype 3, an elevated relapse rate compromised the influence of RVR on SVR. Relapses were related to the presence of advanced liver fibrosis. Liver cirrhosis was associated with a -238 TNF-alpha polymorphism in these patients.	[Corchado, Sara; Marquez-Coello, Mercedes; Giron-Gonzalez, Jose-Antonio] Hosp Univ Puerta del Mar, Unidad Enfermedades Infecciosas, Cadiz, Spain; [Lopez-Cortes, Luis F.; Torres-Cornejo, Almudena] Univ Seville, CSIC, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Seville, Spain; [Rivero-Juarez, Antonio; Rivero, Antonio] Reina Sofia Univ Hosp, Maimonides Inst Res Biomed Cordoba, Cordoba, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Giron-Gonzalez, JA (corresponding author), Hosp Univ Puerta del Mar, Unidad Enfermedades Infecciosas, Cadiz, Spain.	joseantonio.giron@uca.es	Girón-González, José-Antonio/H-3990-2014; Girón-González, José-Antonio/AAG-4199-2020; Rivero, Antonio/ABE-5294-2020; IBIS, VIH/O-8856-2015; Lopez.Cortes, Luis Fernando/W-8323-2019; Rivero-Juarez, Antonio/E-4528-2019	Girón-González, José-Antonio/0000-0002-7482-5828; Girón-González, José-Antonio/0000-0002-7482-5828; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Rivero, Antonio/0000-0001-5005-8268; Marquez-Coello, Mercedes/0000-0003-3948-6258; Rivero-Juarez, Antonio/0000-0002-5813-6889; Rivero Roman, Antonio/0000-0002-8643-4250	Consejeria de Salud, Junta de Andalucia [PI-0076/2008, PI-0157/2011, PI-0430/2012]; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III [PI 08/0869, PI 11/00605]; Intensificacion de la Actividad Investigadora en el S.N.S, Instituto de Salud Carlos III; Intensificacion de la Actividad Investigadora en el Servicio Andaluz de Salud, Junta de Andalucia	Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Intensificacion de la Actividad Investigadora en el S.N.S, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Intensificacion de la Actividad Investigadora en el Servicio Andaluz de Salud, Junta de Andalucia(Junta de Andalucia)	This work has been performed with grants of the "Consejeria de Salud, Junta de Andalucia (PI-0076/2008, PI-0157/2011 and PI-0430/2012), and "Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (PI 08/0869 and PI 11/00605)''. JA Giron-Gonzalez has a grant for "Intensificacion de la Actividad Investigadora en el S.N.S, Instituto de Salud Carlos III'', 2011, and a grant for "Intensificacion de la Actividad Investigadora en el Servicio Andaluz de Salud, Junta de Andalucia'', 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agencia Espanola del Medicamento y Productos Sanitarios, 2014, CRT REC GEN TRAT CON; Bataller R, 2003, HEPATOLOGY, V37, P493, DOI 10.1053/jhep.2003.50127; Brau N, 2005, SEMIN LIVER DIS, V25, P33, DOI 10.1055/s-2005-864780; Chang MH, 2012, CLIN THER, V34, P2021, DOI 10.1016/j.clinthera.2012.08.009; Corchado S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066619; Crespo M, 2007, AIDS, V21, P477, DOI 10.1097/QAD.0b013e328012b5ba; Dieterich D, 2013, 20 C RETR OPP INF AT; Fabris C, 1998, J INTERF CYTOK RES, V18, P705, DOI 10.1089/jir.1998.18.705; Foster GR, 2013, J HEPATOL, V58, P488, DOI 10.1016/j.jhep.2012.11.013; Friedman SL, 1997, J GASTROENTEROL, V32, P424, DOI 10.1007/BF02934504; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giron-Gonzalez JA, 2005, SCAND J GASTROENTERO, V40, P217, DOI 10.1080/00365520510011470; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Jonsson JR, 2008, HEPATOLOGY, V48, P80, DOI 10.1002/hep.22311; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Kwo PY, 2012, LIVER INT, V32, P39, DOI 10.1111/j.1478-3231.2011.02709.x; Laguno M, 2004, AIDS, V18, pF27, DOI 10.1097/00002030-200409030-00003; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Mandorfer M, 2013, AIDS, V27, P2707, DOI 10.1097/01.aids.0000432460.44593.ef; Mangia A, 2004, CYTOKINE, V25, P103, DOI 10.1016/j.cyto.2003.10.005; Marin-Serrano E, 2006, J VIRAL HEPATITIS, V13, P230, DOI 10.1111/j.1365-2893.2005.00679.x; Martel-Laferriere V, 2014, J CLIN GASTROENTEROL, V48, P106, DOI 10.1097/MCG.0000000000000010; Martin-Carbonero L, 2008, AIDS, V22, P15, DOI 10.1097/QAD.0b013e3282f1da99; Medrano J, 2010, CLIN INFECT DIS, V51, P1209, DOI 10.1086/656811; Mira JA, 2007, ANTIVIR THER, V12, P1225; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Mira JA, 2012, AIDS, V26, P1721, DOI 10.1097/QAD.0b013e3283568884; Moreno A, 2006, J VIRAL HEPATITIS, V13, P466, DOI 10.1111/j.1365-2893.2005.00710.x; Moreno A, 2004, ANTIVIR THER, V9, P133; Naggie S, 2014, 21 C RETR OPP INF BO; Neukam K, 2013, J INFECTION, V67, P59, DOI 10.1016/j.jinf.2013.03.010; Neukam K, 2012, J HEPATOL, V56, P788, DOI 10.1016/j.jhep.2011.11.008; Nunez M, 2007, JAIDS-J ACQ IMM DEF, V45, P439, DOI 10.1097/QAI.0b013e318061b5d9; Payan C, 2007, GUT, V56, P1111, DOI 10.1136/gut.2006.106690; Perry CM, 2012, DRUGS, V72, P619, DOI 10.2165/11208370-000000000-00000; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Rivero-Juarez A, 2012, J ANTIMICROB CHEMOTH, V67, P202, DOI 10.1093/jac/dkr439; Rodriguez-Inigo E, 2005, J MOL DIAGN, V7, P535, DOI 10.1016/S1525-1578(10)60585-5; Seden K, 2011, CURR OPIN HIV AIDS, V6, P514, DOI 10.1097/COH.0b013e32834b54dc; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Soriano V, 2004, AIDS RES HUM RETROV, V20, P351, DOI 10.1089/088922204323048096; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Zhu Y, 2013, WORLD J GASTROENTERO, V19, P8963, DOI 10.3748/wjg.v19.i47.8963	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101760	10.1371/journal.pone.0101760	http://dx.doi.org/10.1371/journal.pone.0101760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013899	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400034
J	Harel, BT; Pietrzak, RH; Snyder, PJ; Thomas, E; Mayes, LC; Maruff, P				Harel, Brian T.; Pietrzak, Robert H.; Snyder, Peter J.; Thomas, Elizabeth; Mayes, Linda C.; Maruff, Paul			The Development of Associate Learning in School Age Children	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TESTING AUTOMATED BATTERY; SHORT-TERM-MEMORY; WORKING-MEMORY; PARKINSONS-DISEASE; NEUROPSYCHOLOGICAL FUNCTION; COMPUTERIZED ASSESSMENT; STRATEGIC COMPONENTS; EXECUTIVE FUNCTION; PHONEME AWARENESS	Associate learning is fundamental to the acquisition of knowledge and plays a critical role in the everyday functioning of the developing child, though the developmental course is still unclear. This study investigated the development of visual associate learning in 125 school age children using the Continuous Paired Associate Learning task. As hypothesized, younger children made more errors than older children across all memory loads and evidenced decreased learning efficiency as memory load increased. Results suggest that age-related differences in performance largely reflect continued development of executive function in the context of relatively developed memory processes.	[Harel, Brian T.] CogState Ltd, New Haven, CT 06510 USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Snyder, Peter J.] Brown Univ, Dept Neurol, Alpert Med Sch, Providence, RI 02912 USA; [Thomas, Elizabeth] Univ Melbourne, Sch Behav Sci Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Mayes, Linda C.] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA; [Maruff, Paul] CogState Ltd, Melbourne, Vic, Australia	Yale University; Brown University; University of Melbourne; Yale University; CogState Limited	Harel, BT (corresponding author), CogState Ltd, New Haven, CT 06510 USA.	bharel@cogstate.com	Snyder, Peter J./W-2609-2019; Maruff, Paul/ABA-1673-2020; Maruff, Paul/AAD-2454-2021	Maruff, Paul/0000-0002-6947-9537; Snyder, Peter/0000-0003-0555-4654	CogState, Ltd	CogState, Ltd	No current funding sources for this study. Authors Brian T. Harel and Paul Maruff are employed by CogState, Ltd. CogState, Ltd provided support in the form of salaries for authors BTH and PM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achim AM, 2005, NEUROIMAGE, V24, P1113, DOI 10.1016/j.neuroimage.2004.10.036; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley AD, 2011, NEUROPSYCHOLOGIA, V49, P1393, DOI 10.1016/j.neuropsychologia.2010.12.042; BEUHRING T, 1987, J EXP CHILD PSYCHOL, V44, P377, DOI 10.1016/0022-0965(87)90041-5; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Cho W, 2011, PSYCHOPHARMACOLOGY, V218, P513, DOI 10.1007/s00213-011-2344-y; Collie A, 2007, CONTEMP CLIN TRIALS, V28, P391, DOI 10.1016/j.cct.2006.10.010; Conklin HM, 2007, DEV NEUROPSYCHOL, V31, P103, DOI 10.1207/s15326942dn3101_6; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2006, J MEM LANG, V55, P274, DOI 10.1016/j.jml.2006.04.002; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 2003, TRENDS COGN SCI, V7, P427, DOI 10.1016/j.tics.2003.08.008; Gitten JC, 2006, CHILD NEUROPSYCHOL, V12, P39, DOI 10.1080/09297040500205579; Halford GS, 2007, TRENDS COGN SCI, V11, P236, DOI 10.1016/j.tics.2007.04.001; Harel BT, 2011, NEUROPSYCHOLOGY, V25, P752, DOI 10.1037/a0024237; Harel BT, 2013, PSYCHOPHARMACOLOGY B; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Hulme C, 2007, J EXP CHILD PSYCHOL, V96, P150, DOI 10.1016/j.jecp.2006.09.002; Hund AM, 2003, DEV PSYCHOL, V39, P939, DOI 10.1037/0012-1649.39.6.939; Hund AM, 2002, J EXP CHILD PSYCHOL, V82, P200, DOI 10.1016/S0022-0965(02)00004-8; Jansen-Osmann P, 2007, EXP PSYCHOL, V54, P236, DOI 10.1027/1618-3169.54.3.236; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Levine B, 1997, NEUROPSYCHOLOGY, V11, P367, DOI 10.1037/0894-4105.11.3.367; Lim YY, 2013, J ALZHEIMERS DIS, V33, P1167, DOI 10.3233/JAD-121771; Litt RA, 2013, J EXP CHILD PSYCHOL, V115, P137, DOI 10.1016/j.jecp.2012.11.012; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Luciana M, 2003, J CHILD PSYCHOL PSYC, V44, P649, DOI 10.1111/1469-7610.00152; Manenti R, 2010, NEUROSCIENCE, V166, P501, DOI 10.1016/j.neuroscience.2009.12.037; Matthews K, 2008, J AFFECT DISORDERS, V111, P113, DOI 10.1016/j.jad.2008.02.003; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Meulenbroek O, 2010, BRAIN RES, V1315, P100, DOI 10.1016/j.brainres.2009.12.011; O'Donnell J, 2011, J CLIN EXP NEUROPSYC, V33, P1069, DOI 10.1080/13803395.2011.596821; PASCUALL.J, 1970, ACTA PSYCHOL, V32, P301, DOI 10.1016/0001-6918(70)90108-3; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Pentland LM, 2003, BRAIN COGNITION, V52, P144, DOI 10.1016/S0278-2626(03)00079-4; Petrides M, 1997, NEUROPSYCHOLOGIA, V35, P989, DOI 10.1016/S0028-3932(97)00026-2; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; PETRIDES M, 1990, NEUROPSYCHOLOGIA, V28, P137, DOI 10.1016/0028-3932(90)90096-7; Pietrzak RH, 2012, HUM PSYCHOPHARM CLIN, V27, P549, DOI 10.1002/hup.2263; Pillon B, 1998, NEUROPSYCHOLOGIA, V36, P1, DOI 10.1016/S0028-3932(97)00102-4; Pirogovsky E, 2009, DEVELOPMENTAL SCI, V12, P1054, DOI 10.1111/j.1467-7687.2009.00857.x; Postle BR, 1997, NEUROPSYCHOLOGIA, V35, P1413, DOI 10.1016/S0028-3932(97)00054-7; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; Rhodes SM, 2005, PSYCHOL MED, V35, P1109, DOI 10.1017/S0033291705004599; Riggs KJ, 2006, J EXP CHILD PSYCHOL, V95, P18, DOI 10.1016/j.jecp.2006.03.009; Riggs KJ, 2011, J EXP CHILD PSYCHOL, V108, P802, DOI 10.1016/j.jecp.2010.11.006; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Shing YL, 2008, J EXP PSYCHOL GEN, V137, P495, DOI 10.1037/0096-3445.137.3.495; Shing YL, 2010, NEUROSCI BIOBEHAV R, V34, P1080, DOI 10.1016/j.neubiorev.2009.11.002; Simmering V.R., 2012, FRONT PSYCHOL, V3, P567, DOI DOI 10.3389/FPSYG.2012.00567; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Thomas E, 2011, CHILD NEUROPSYCHOL, V17, P599, DOI 10.1080/09297049.2011.567980; Visu-Petra L, 2007, J INTELL DISABIL RES, V51, P942, DOI 10.1111/j.1365-2788.2007.01002.x; Warmington M, 2012, SCI STUD READ, V16, P45, DOI 10.1080/10888438.2010.534832; Windfuhr KL, 2001, J EXP CHILD PSYCHOL, V80, P160, DOI 10.1006/jecp.2000.2625; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	62	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101750	10.1371/journal.pone.0101750	http://dx.doi.org/10.1371/journal.pone.0101750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014755	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400033
J	Lee, M; Kim, W; Choi, Y; Kim, S; Kim, D; Yu, SJ; Lee, JH; Kim, HY; Jung, YJ; Kim, BG; Kim, YJ; Yoon, JH; Lee, KL; Lee, HS				Lee, Minjong; Kim, Won; Choi, Yunhee; Kim, Sunhee; Kim, Donghee; Yu, Su Jong; Lee, Jeong-Hoon; Kim, Hwi Young; Jung, Yong Jin; Kim, Byeong Gwan; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Kook Lae; Lee, Hyo-Suk			Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis	PLOS ONE			English	Article							DISEASE; MODELS; POLYMORPHISMS; PATHOGENESIS; MANAGEMENT; ADH2	The accurate prognostic stratification of alcoholic hepatitis (AH) is essential for individualized therapeutic decisions. The aim of this study was to develop a new prognostic model to predict liver-related mortality in Asian AH patients. We conducted a hospital-based, retrospective cohort study using 308 patients with AH between 1999 and 2011 (a derivation cohort) and 106 patients with AH between 2005 and 2012 (a validation cohort). The Cox proportional hazards model was constructed to select significant predictors of liver-related death from the derivation cohort. A new prognostic model was internally validated using a bootstrap sampling method. The discriminative performance of this new model was compared with those of other prognostic models using a concordance index in the validation cohort. Bilirubin, prothrombin time, creatinine, potassium at admission, and a spontaneous change in bilirubin levels from day 0 to day 7 (SCBL) were incorporated into a model for AH to grade the severity in an Asian patient cohort (MAGIC). For risk stratification, four risk groups were identified with cutoff scores of 29, 37, and 46 based on the different survival probabilities (P < 0.001). In addition, MAGIC showed better discriminative performance for liver-related mortality than any other scoring system in the validation cohort. MAGIC can accurately predict liver-related mortality in Asian patients hospitalized for AH. Therefore, SCBL may help us decide whether patients with AH urgently require corticosteroid treatment.	[Lee, Minjong; Yu, Su Jong; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Kook Lae; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Minjong; Yu, Su Jong; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Kook Lae; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Won; Kim, Hwi Young; Jung, Yong Jin; Kim, Byeong Gwan; Lee, Kook Lae] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Choi, Yunhee; Kim, Sunhee] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Kim, Donghee] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Dept Internal Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, W (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	drwon1@snu.ac.kr	Kim, Won/H-6940-2019; Lee, Jeong-Hoon/Q-1055-2018; Kim, Donghee/C-4288-2013	Kim, Won/0000-0002-2926-1007; Lee, Jeong-Hoon/0000-0002-0315-2080; Kim, Yoon Jun/0000-0001-9141-7773; Kim, Donghee/0000-0003-1919-6800; Yoon, Jung-Hwan/0000-0002-9128-3610; , minjong/0000-0002-3159-5444; Yu, Su Jong/0000-0001-8888-7977	Korean Association	Korean Association	This study was supported by the 2012 Korean Association for the Study of the Liver Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dominguez M, 2008, AM J GASTROENTEROL, V103, P2747, DOI 10.1111/j.1572-0241.2008.02104.x; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; Elphick DA, 2007, AM J GASTROENTEROL, V102, P780, DOI 10.1111/j.1572-0241.2006.01034.x; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Forrest EH, 2012, J HEPATOL, V56, P1427, DOI 10.1016/j.jhep.2011.12.028; GOEDDE HW, 1992, HUM GENET, V88, P344; Haber PS, 2003, J GASTROEN HEPATOL, V18, P1332, DOI 10.1046/j.1440-1746.2003.03217.x; HARDISON WG, 1966, NEW ENGL J MED, V275, P61, DOI 10.1056/NEJM196607142750201; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Konishi T, 2003, ALCOHOL ALCOHOLISM, V38, P93, DOI 10.1093/alcalc/agg021; Laine C, 2000, J SUBST ABUSE, V12, P271, DOI 10.1016/S0899-3289(00)00054-7; Leise MD, 2011, GASTROENTEROLOGY, V140, P1952, DOI 10.1053/j.gastro.2011.02.017; Li You-Min, 2005, Hepatobiliary Pancreat Dis Int, V4, P170; Louvet A, 2013, J HEPATOL, V58, pS52, DOI 10.1016/S0168-8278(13)60119-1; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mathurin P, 1996, GASTROENTEROLOGY, V110, P1847, DOI 10.1053/gast.1996.v110.pm8964410; Mathurin P, 2003, HEPATOLOGY, V38, P1363, DOI 10.1016/j.hep.2003.09.038; McCullough AJ, 1998, AM J GASTROENTEROL, V93, P2022; McCullough AJ, 2011, J DIGEST DIS, V12, P257, DOI 10.1111/j.1751-2980.2010.00470.x; Rongey C, 2006, WORLD J GASTROENTERO, V12, P6909, DOI 10.3748/wjg.v12.i43.6909; Saito H, 2004, HEPATOL RES, V30, P193, DOI 10.1016/j.hepres.2004.08.016; SAVOLAINEN VT, 1993, ALCOHOL CLIN EXP RES, V17, P1112, DOI 10.1111/j.1530-0277.1993.tb05673.x; Singal AK, 2011, GASTROENTEROL CLIN N, V40, P611, DOI 10.1016/j.gtc.2011.06.008; Stewart SH, 2002, ARCH INTERN MED, V162, P2236, DOI 10.1001/archinte.162.19.2236; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vidal F, 2004, J HEPATOL, V41, P744, DOI 10.1016/j.jhep.2003.06.003	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100870	10.1371/journal.pone.0100870	http://dx.doi.org/10.1371/journal.pone.0100870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013906	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400013
J	Liu, B; Ouyang, ZG; Zhang, YF; Li, XH; Hong, YB; Huang, L; Liu, SX; Zhang, HJ; Li, DY; Song, FM				Liu, Bo; Ouyang, Zhigang; Zhang, Yafen; Li, Xiaohui; Hong, Yongbo; Huang, Lei; Liu, Shixia; Zhang, Huijuan; Li, Dayong; Song, Fengming			Tomato NAC Transcription Factor SlSRN1 Positively Regulates Defense Response against Biotic Stress but Negatively Regulates Abiotic Stress Response	PLOS ONE			English	Article							FACTOR GENE FAMILY; COMPREHENSIVE ANALYSIS; DROUGHT RESISTANCE; GRAIN-YIELD; HYPERSENSITIVE RESPONSE; PHYTOPHTHORA-INFESTANS; PATHOGEN RESISTANCE; FUNCTIONAL-ANALYSIS; LEAF SENESCENCE; DOMAIN PROTEIN	Biotic and abiotic stresses are major unfavorable factors that affect crop productivity worldwide. NAC proteins comprise a large family of transcription factors that play important roles in plant growth and development as well as in responses to biotic and abiotic stresses. In a virus-induced gene silencing-based screening to identify genes that are involved in defense response against Botrytis cinerea, we identified a tomato NAC gene SlSRN1 (Solanum lycopersicum Stress-related NAC1). SlSRN1 is a plasma membrane-localized protein with transactivation activity in yeast. Expression of SlSRN1 was significantly induced by infection with B. cinerea or Pseudomonas syringae pv. tomato (Pst) DC3000, leading to 6-8 folds higher than that in the mock-inoculated plants. Expression of SlSRN1 was also induced by salicylic acid, jasmonic acid and 1-amino cyclopropane-1-carboxylic acid and by drought stress. Silencing of SlSRN1 resulted in increased severity of diseases caused by B. cinerea and Pst DC3000. However, silencing of SlSRN1 resulted in increased tolerance against oxidative and drought stresses. Furthermore, silencing of SlSRN1 accelerated accumulation of reactive oxygen species but attenuated expression of defense genes after infection by B. cinerea. Our results demonstrate that SlSRN1 is a positive regulator of defense response against B. cinerea and Pst DC3000 but is a negative regulator for oxidative and drought stress response in tomato.	[Liu, Bo; Ouyang, Zhigang; Zhang, Yafen; Li, Xiaohui; Hong, Yongbo; Huang, Lei; Liu, Shixia; Zhang, Huijuan; Li, Dayong; Song, Fengming] Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Song, FM (corresponding author), Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	fmsong@zju.edu.cn			National Basic Research Program of China [2009CB119005]; National Key Technology R & D Program of China [2011BAD12B04]; National High-Tech R D Program [2012AA101504]; Research Fund for the Doctoral Program of Higher Education of China [20120101110070]	National Basic Research Program of China(National Basic Research Program of China); National Key Technology R & D Program of China(National Key Technology R&D Program); National High-Tech R D Program(National High Technology Research and Development Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China (2009CB119005), the National Key Technology R & D Program of China (2011BAD12B04), the National High-Tech R & D Program (No. 2012AA101504) and the Research Fund for the Doctoral Program of Higher Education of China (20120101110070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; Bollhoner B, 2012, J EXP BOT, V63, P1081, DOI 10.1093/jxb/err438; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Chen X, 2014, PLANT CELL PHYSIOL, V55, P604, DOI 10.1093/pcp/pct204; Chen YJ, 2013, PLANT MOL BIOL, V83, P577, DOI 10.1007/s11103-013-0109-1; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Han QQ, 2012, MOL BIOL REP, V39, P1713, DOI 10.1007/s11033-011-0911-2; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hendelman A, 2013, J EXP BOT, V64, P5497, DOI 10.1093/jxb/ert324; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang WZ, 2013, NEW PHYTOL, V197, P1214, DOI 10.1111/nph.12096; Hussey SG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00325; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Kim HS, 2012, NUCLEIC ACIDS RES, V40, P9182, DOI 10.1093/nar/gks683; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kuzniak E, 2005, PLANTA, V222, P192, DOI 10.1007/s00425-005-1514-8; Kuzniak E, 2004, J EXP BOT, V55, P605, DOI 10.1093/jxb/erh076; Le Henanff G, 2013, J EXP BOT, V64, P4877, DOI 10.1093/jxb/ert277; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Ma NN, 2013, PHYSIOL PLANTARUM, V149, P474, DOI 10.1111/ppl.12049; McLellan H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003670; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Oh SK, 2005, PLANTA, V222, P876, DOI 10.1007/s00425-005-0030-1; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Orellana S, 2010, PLANT CELL ENVIRON, V33, P2191, DOI 10.1111/j.1365-3040.2010.02220.x; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Ricachenevsky FK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00226; Saga H, 2012, MOL PLANT MICROBE IN, V25, P684, DOI 10.1094/MPMI-09-11-0244; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Shahnejat-Bushehri S, 2012, PLANT SIGNAL BEHAV, V7, P1518, DOI 10.4161/psb.22092; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Sun Li-Jun, 2012, Yichuan, V34, P993, DOI 10.3724/SP.J.1005.2012.00993; Sun LJ, 2013, PLANT MOL BIOL, V81, P41, DOI 10.1007/s11103-012-9981-3; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Virk N, 2013, ACTA PHYSIOL PLANT, V35, P1211, DOI 10.1007/s11738-012-1160-2; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yang RC, 2011, MOL BIOL REP, V38, P857, DOI 10.1007/s11033-010-0177-0; Yoshii M, 2010, PLANT J, V61, P804, DOI 10.1111/j.1365-313X.2009.04107.x; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhu MK, 2014, PLANT CELL PHYSIOL, V55, P119, DOI 10.1093/pcp/pct162	86	53	60	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102067	10.1371/journal.pone.0102067	http://dx.doi.org/10.1371/journal.pone.0102067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010573	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800064
J	Muller, S; Kruger, B; Lange, F; Bock, CN; Nizze, H; Glass, A; Ibrahim, SM; Jaster, R				Mueller, Sarah; Krueger, Burkhard; Lange, Falko; Bock, Cristin N.; Nizze, Horst; Glass, Aenne; Ibrahim, Saleh M.; Jaster, Robert			The mtDNA nt7778 G/T Polymorphism Augments Formation of Lymphocytic Foci but Does Not Aggravate Cerulein-Induced Acute Pancreatitis in Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE PANCREATITIS; FREE-RADICALS; ORGANELLAR DYSFUNCTION; MULTIPLE-SCLEROSIS; MRL/MP-MOUSE; ACINAR-CELLS; MITOCHONDRIAL; PATHOGENESIS; INFLAMMATION	A polymorphism in the ATP synthase 8 (ATP8) gene of the murine mitochondrial genome, G-to-T transversion at position 7778, has been suggested to increase susceptibility to multiple autoimmune diseases, including autoimmune pancreatitis (AIP). The polymorphism also induces mitochondrial reactive oxygen species generation, secretory dysfunction and beta-cell mass adaptation. Here, we have used two conplastic mouse strains, C57BL/6N-mtAKR/J (B6-mtAKR; nt7778 G; control) and C57BL/6N-mtFVB/N (B6-mtFVB; nt7778 T), to address the question if the polymorphism also affects the course of cerulein-induced acute pancreatitis in mice. Therefore, two age groups of mice (3 and 12-month-old, respectively) were subjected to up to 7 injections of the secretagogue cerulein (50 mu g/kg body weight) at hourly intervals. Disease severity was assessed at time points from 3 hours to 7 days based on pancreatic histopathology, serum levels of alpha-amylase and activities of myeloperoxidase (MPO) in lung tissue. A comparison of cerulein-induced pancreatic tissue damage and increases of alpha-amylase and MPO activities showed no differences between the age-matched groups of both strains. Interestingly, histological evaluation of pancreatic tissue of both untreated and cerulein-treated B6-mtAKR and B6-mtFVB mice also revealed the presence of infiltrates of immune cells surrounding ducts and vessels; a finding that is compatible with an early stage of AIP. After recovery from cerulein-induced pancreatitis (day 7 after the injections), 12-month-old B6-mtFVB mice but not B6-mtAKR mice displayed aggravated lymphocytic lesions. A comparison of 12-month-old mice with other age groups of both strains revealed that lymphocytic foci were largely absent in 3-month-old mice, while 24-month-old mice were more affected. Together, our data suggest that the mtDNA nt7778 G/T polymorphism does not aggravate cerulein-induced acute pancreatitis. Autoimmune-like lesions, however, may progress faster if additional tissue damage occurs.	[Mueller, Sarah; Lange, Falko; Bock, Cristin N.; Jaster, Robert] Univ Med Rostock, Div Gastroenterol, Dept Med 2, Rostock, Germany; [Krueger, Burkhard] Univ Med Rostock, Div Med Biol, Rostock, Germany; [Lange, Falko] Univ Med Rostock, Oscar Langendorff Inst Physiol, Rostock, Germany; [Nizze, Horst] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Glass, Aenne] Univ Med Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Lubeck	Jaster, R (corresponding author), Univ Med Rostock, Div Gastroenterol, Dept Med 2, Rostock, Germany.	jaster@med.uni-rostock.de	Ibrahim, Saleh/AAO-9541-2020	Lange, Falko/0000-0001-8782-5205; Ibrahim, Saleh/0000-0001-7827-2290	Bundesministerium fur Bildung und Forschung [0315892A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (0315892A, GERONTOSYS program, http://www.bmbf.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahari SE, 2007, CELL MOL NEUROBIOL, V27, P695, DOI 10.1007/s10571-007-9160-2; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Eipel C, 2011, LIFE SCI, V88, P343, DOI 10.1016/j.lfs.2010.12.011; Fitzner B, 2009, PANCREATOLOGY, V9, P233, DOI 10.1159/000199434; Gimsa U, 2009, ANN NY ACAD SCI, V1153, P131, DOI 10.1111/j.1749-6632.2008.03960.x; Gukovskaya AS, 2004, PANCREATOLOGY, V4, P567, DOI 10.1159/000082182; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; HAYASHI Y, 1989, CLIN EXP IMMUNOL, V78, P120; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Jonsen A, 2009, LUPUS, V18, P309, DOI 10.1177/0961203308097477; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; KANNO H, 1992, CLIN EXP IMMUNOL, V89, P68; Kruger B, 1998, LAB INVEST, V78, P763; Larsson NG, 2001, TRENDS MOL MED, V7, P578, DOI 10.1016/S1471-4914(01)02167-0; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Lorentz K, 1998, CLIN CHEM LAB MED, V36, P185, DOI 10.1515/CCLM.1998.034; Maleth J, 2013, ACTA PHYSIOL, V207, P226, DOI 10.1111/apha.12037; Maleth J, 2011, GUT, V60, P136, DOI 10.1136/gut.2009.192153; Mathews CE, 2005, DIABETOLOGIA, V48, P261, DOI 10.1007/s00125-004-1644-8; Muller S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094494; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Okamura D, 2012, AGING CELL, V11, P760, DOI 10.1111/j.1474-9726.2012.00841.x; Park BK, 2003, WORLD J GASTROENTERO, V9, P2266; RUTLEDGE PL, 1987, GASTROENTEROLOGY, V93, P41, DOI 10.1016/0016-5085(87)90311-8; SANFEY H, 1984, ANN SURG, V200, P405, DOI 10.1097/00000658-198410000-00003; Sorg H, 2008, AM J PHYSIOL-GASTR L, V295, pG1274, DOI 10.1152/ajpgi.90341.2008; Takahashi H, 2012, AGING CELL, V11, P305, DOI 10.1111/j.1474-9726.2011.00787.x; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Vyshkina T, 2008, CLIN IMMUNOL, V129, P31, DOI 10.1016/j.clim.2008.07.011; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296; Wu BU, 2013, GASTROENTEROLOGY, V144, P1272, DOI 10.1053/j.gastro.2013.01.075; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29; Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102266	10.1371/journal.pone.0102266	http://dx.doi.org/10.1371/journal.pone.0102266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010670	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800087
J	Shatwell, T; Kohler, J; Nicklisch, A				Shatwell, Tom; Koehler, Jan; Nicklisch, Andreas			Temperature and Photoperiod Interactions with Phosphorus-Limited Growth and Competition of Two Diatoms	PLOS ONE			English	Article							STEADY-STATE GROWTH; BLUE-GREEN-ALGA; PHYTOPLANKTON GROWTH; ENVIRONMENTAL-FACTORS; PHOSPHATE-UPTAKE; EUKARYOTIC MICROALGAE; OSCILLATORIA-REDEKEI; LIGHT-INTENSITY; KINETICS; LIMITATION	In lakes, trophic change and climate change shift the relationship between nutrients and physical factors, like temperature and photoperiod, and interactions between these factors should affect the growth of phytoplankton species differently. We therefore determined the relationship between P-limited specific growth rates and P-quota (biovolume basis) of Stephanodiscus minutulus and Nitzschia acicularis (diatoms) at or near light saturation in axenic, semi-continuous culture at 10, 15 and 20 degrees C and at 6, 9 and 12 h d(-1) photoperiod. Photoperiod treatments were performed at constant daily light exposure to allow comparison. Under these conditions, we also performed competition experiments and estimated relative P-uptake rates of the species. Temperature strongly affected P-limited growth rates and relative P uptake rates, whereas photoperiod only affected maximum growth rates. S. minutulus used internal P more efficiently than N. acicularis. N. acicularis was the superior competitor for P due to a higher relative uptake rate and its superiority increased with increasing temperature and photoperiod. S. minutulus conformed to the Droop relationship but N. acicularis did not. A model with a temperature-dependent normalised half-saturation coefficient adequately described the factor interactions of both species. The temperature dependence of the quota model reflected each species' specific adaptation to its ecological niche. The results demonstrate that increases in temperature or photoperiod can partially compensate for a decrease in P-quota under moderately limiting conditions, like during spring in temperate lakes. Thus warming may counteract de-eutrophication to some degree and a relative shift in growth factors can influence the phytoplankton species composition.	[Shatwell, Tom] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecohydrol, Berlin, Germany; [Koehler, Jan; Nicklisch, Andreas] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecosyst Res, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Shatwell, T (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecohydrol, Berlin, Germany.	shatwell@igb-berlin.de	Shatwell, Tom/K-2937-2013; Shatwell, Tom/ABF-1308-2020; Köhler, Jan/C-2633-2014	Shatwell, Tom/0000-0002-4520-7916; Shatwell, Tom/0000-0002-4520-7916; Köhler, Jan/0000-0003-1894-2912	Nafog grant from the federal state of Berlin	Nafog grant from the federal state of Berlin	This work was funded by a Nafog grant to TS from the federal state of Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN G, 1988, HYDROBIOLOGIA, V170, P191, DOI 10.1007/BF00024905; AHLGREN G, 1987, OIKOS, V49, P177, DOI 10.2307/3566025; Andersen T., 1997, PELAGIC NUTR CYCLES; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; AZAD HS, 1970, ENVIRON SCI TECHNOL, V4, P737, DOI 10.1021/es60044a008; BROWN EJ, 1979, J PHYCOL, V15, P305, DOI 10.1111/j.1529-8817.1979.tb02643.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; BUTTON DK, 1978, DEEP-SEA RES, V25, P1163, DOI 10.1016/0146-6291(78)90011-5; CAPERON J, 1972, DEEP-SEA RES, V19, P601, DOI 10.1016/0011-7471(72)90089-7; CASTENHOLZ RW, 1964, PHYSIOL PLANTARUM, V17, P951, DOI 10.1111/j.1399-3054.1964.tb08222.x; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V10, P317; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V11, P13, DOI 10.3109/10408418409105902; Darley W.M., 1977, BOTANICAL MONOGRAPHS, P198; DEV, 2007, 38405 DEV DIN 21; Dickman EM, 2006, OECOLOGIA, V149, P676, DOI 10.1007/s00442-006-0473-5; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; Ducobu H, 1998, J PHYCOL, V34, P467, DOI 10.1046/j.1529-8817.1998.340467.x; FALKNER G, 1995, J PHYCOL, V31, P745, DOI 10.1111/j.0022-3646.1995.00745.x; Flynn KJ, 2008, J PLANKTON RES, V30, P423, DOI 10.1093/plankt/fbn007; Flynn KJ, 2008, OCEANOGR MAR BIOL, V46, P1, DOI 10.1201/9781420065756.ch1; Flynn KJ, 2002, J PHYCOL, V38, P961, DOI 10.1046/j.1529-8817.2002.t01-1-01235.x; FOY R H, 1976, British Phycological Journal, V11, P151; FOY RH, 1993, EUR J PHYCOL, V28, P203, DOI 10.1080/09670269300650311; FUHS GW, 1969, J PHYCOL, V5, P312, DOI 10.1111/j.1529-8817.1969.tb02620.x; GIBSON CE, 1983, BRIT PHYCOL J, V18, P39, DOI 10.1080/00071618300650051; GIBSON CE, 1987, BRIT PHYCOL J, V22, P187, DOI 10.1080/00071618700650231; Giersdorf K, 1988, EINFLUSS LICHT TEMPE, P117; GOLDMAN JC, 1977, LIMNOL OCEANOGR, V22, P932, DOI 10.4319/lo.1977.22.5.0932; GOLDMAN JC, 1979, MICROB ECOL, V5, P153, DOI 10.1007/BF02013523; GOTHAM IJ, 1981, J PHYCOL, V17, P257, DOI 10.1111/j.1529-8817.1981.tb00848.x; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P341, DOI 10.4319/lo.1989.34.2.0341; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; HEALEY FP, 1973, J PHYCOL, V9, P383, DOI 10.1111/j.0022-3646.1973.00383.x; HEALEY FP, 1980, MICROBIAL ECOL, V5, P281, DOI 10.1007/BF02020335; HEALEY FP, 1985, J PHYCOL, V21, P134, DOI 10.1111/j.0022-3646.1985.00134.x; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jeppesen E., 2010, CLIMATE CHANGE IMPAC, P119, DOI DOI 10.1002/9781444327397.CH6; KILHAM P, 1986, LIMNOL OCEANOGR, V31, P1169, DOI 10.4319/lo.1986.31.6.1169; Kirillin G, 2010, BOREAL ENVIRON RES, V15, P279; Klausmeier CA, 2008, ECOL RES, V23, P479, DOI 10.1007/s11284-008-0470-8; Klausmeier CA, 2004, LIMNOL OCEANOGR, V49, P1463, DOI 10.4319/lo.2004.49.4_part_2.1463; KOHL JG, 1991, PROC INT ASSOC THE 4, V24, P2652; Kohler J, 2005, FRESHWATER BIOL, V50, P1639, DOI 10.1111/j.1365-2427.2005.01430.x; LEHMAN JT, 1975, LIMNOL OCEANOGR, V20, P343, DOI 10.4319/lo.1975.20.3.0343; Litchman E, 2004, LIMNOL OCEANOGR, V49, P1457, DOI 10.4319/lo.2004.49.4_part_2.1457; Litchman E, 2003, FRESHWATER BIOL, V48, P2141, DOI 10.1046/j.1365-2427.2003.01157.x; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Nicklisch A, 1998, J PLANKTON RES, V20, P105, DOI 10.1093/plankt/20.1.105; Nicklisch A, 1999, INT REV HYDROBIOL, V84, P233; Nicklisch A, 2008, J PLANKTON RES, V30, P75, DOI 10.1093/plankt/fbm099; Nicklisch A, 2009, EUR J PHYCOL, V44, P297, DOI 10.1080/09670260802578518; OLSEN Y, 1989, J PHYCOL, V25, P486, DOI 10.1111/j.1529-8817.1989.tb00254.x; PAASCHE E, 1968, PHYSIOL PLANTARUM, V21, P66, DOI 10.1111/j.1399-3054.1968.tb07231.x; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; R Core Team, 2021, R LANGUAGE ENV STAT; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P649, DOI 10.4319/lo.1981.26.4.0649; Riegman R, 2000, J PHYCOL, V36, P87, DOI 10.1046/j.1529-8817.2000.99023.x; RIEGMAN R, 1985, ARCH MICROBIOL, V142, P72, DOI 10.1007/BF00409240; Rinke K, 2010, FRESHWATER BIOL, V55, P1674, DOI 10.1111/j.1365-2427.2010.02401.x; ROLOFF B, 1993, ARCH HYDROBIOL, V126, P405; Schreiber U., 1993, Progress in Botany, V54, P151; Shatwell T, 2008, GLOBAL CHANGE BIOL, V14, P2194, DOI 10.1111/j.1365-2486.2008.01630.x; Shatwell T, 2013, J PLANKTON RES, V35, P957, DOI 10.1093/plankt/fbt058; Shatwell T, 2012, LIMNOL OCEANOGR, V57, P541, DOI 10.4319/lo.2012.57.2.0541; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; SOMMER U, 1994, LIMNOL OCEANOGR, V39, P1680, DOI 10.4319/lo.1994.39.7.1680; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1995, LINKING SPECIES & ECOSYSTEMS, P240; TEMPEST DW, 1965, J GEN MICROBIOL, V41, P267, DOI 10.1099/00221287-41-2-267; Thompson P, 1999, J PHYCOL, V35, P1215, DOI 10.1046/j.1529-8817.1999.3561215.x; Tilman D., 1982, Monographs in Population Biology, pi; VANDONK E, 1990, J PHYCOL, V26, P40; WERNICKE P, 1986, INT REV GES HYDROBIO, V71, P297, DOI 10.1002/iroh.19860710302	74	13	13	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102367	10.1371/journal.pone.0102367	http://dx.doi.org/10.1371/journal.pone.0102367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010420	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800095
J	Yan, H; Fan, SX; Guo, CX; Hu, J; Dong, L				Yan, Hai; Fan, Shuxin; Guo, Chenxiao; Hu, Jie; Dong, Li			Quantifying the Impact of Land Cover Composition on Intra-Urban Air Temperature Variations at a Mid-Latitude City	PLOS ONE			English	Article							URBAN HEAT-ISLAND; TROPICAL CITY; GREEN AREAS; VEGETATION; CLIMATE; PARKS; COMFORT; STREET; CITIES; CANYON	The effects of land cover on urban-rural and intra-urban temperature differences have been extensively documented. However, few studies have quantitatively related air temperature to land cover composition at a local scale which may be useful to guide landscape planning and design. In this study, the quantitative relationships between air temperature and land cover composition at a neighborhood scale in Beijing were investigated through a field measurement campaign and statistical analysis. The results showed that the air temperature had a significant positive correlation with the coverage of man-made surfaces, but the degree of correlation varied among different times and seasons. The different land cover types had different effects on air temperature, and also had very different spatial extent dependence: with increasing buffer zone size (from 20 to 300 m in radius), the correlation coefficient of different land cover types varied differently, and their relative impacts also varied among different times and seasons. At noon in summer, similar to 37% of the variations in temperature were explained by the percentage tree cover, while similar to 87% of the variations in temperature were explained by the percentage of building area and the percentage tree cover on summer night. The results emphasize the key role of tree cover in attenuating urban air temperature during daytime and nighttime in summer, further highlighting that increasing vegetation cover could be one effective way to ameliorate the urban thermal environment.	[Yan, Hai; Fan, Shuxin; Guo, Chenxiao; Dong, Li] Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China; [Yan, Hai] Zhejiang Agr & Forestry Univ, Sch Landscape Architecture, Linan, Zhejiang, Peoples R China; [Hu, Jie] Tsinghua Univ, Sch Architecture, Beijing 100084, Peoples R China; [Hu, Jie] Beijing Tsinghua Urban Planning & Design Inst, Res Ctr Landscape Architecture, Beijing, Peoples R China	Beijing Forestry University; Zhejiang A&F University; Tsinghua University	Dong, L (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China.	dongli@bjfu.edu.cn						Ali-Toudert F, 2006, BUILD ENVIRON, V41, P94, DOI 10.1016/j.buildenv.2005.01.013; BARRADAS VL, 1991, INT J BIOMETEOROL, V35, P24, DOI 10.1007/BF01040959; Buyantuyev A, 2010, LANDSCAPE ECOL, V25, P17, DOI 10.1007/s10980-009-9402-4; Cao X, 2010, LANDSCAPE URBAN PLAN, V96, P224, DOI 10.1016/j.landurbplan.2010.03.008; Chang CR, 2007, LANDSCAPE URBAN PLAN, V80, P386, DOI 10.1016/j.landurbplan.2006.09.005; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Giridharan R, 2008, BUILD ENVIRON, V43, P1583, DOI 10.1016/j.buildenv.2007.10.003; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hamada S, 2010, URBAN FOR URBAN GREE, V9, P15, DOI 10.1016/j.ufug.2009.10.002; HENRY JA, 1987, LANDSCAPE URBAN PLAN, V14, P21, DOI 10.1016/0169-2046(87)90003-X; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Jansson C, 2007, THEOR APPL CLIMATOL, V89, P185, DOI 10.1007/s00704-006-0259-z; JAUREGUI E, 1991, ENERG BUILDINGS, V15, P457; Jonsson P, 2004, INT J CLIMATOL, V24, P1307, DOI 10.1002/joc.1064; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kruger E, 2007, BUILD ENVIRON, V42, P1685, DOI 10.1016/j.buildenv.2006.02.019; Li XM, 2012, LANDSCAPE ECOL, V27, P887, DOI 10.1007/s10980-012-9731-6; Mackey CW, 2012, BUILD ENVIRON, V49, P348, DOI 10.1016/j.buildenv.2011.08.004; Ng E, 2012, BUILD ENVIRON, V47, P256, DOI 10.1016/j.buildenv.2011.07.014; NUNEZ M, 1977, J APPL METEOROL, V16, P11, DOI 10.1175/1520-0450(1977)016<0011:TEBOAU>2.0.CO;2; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; OKE TR, 1989, PHILOS T ROY SOC B, V324, P335, DOI 10.1098/rstb.1989.0051; Oliveira S, 2011, BUILD ENVIRON, V46, P2186, DOI 10.1016/j.buildenv.2011.04.034; Peng SS, 2012, ENVIRON SCI TECHNOL, V46, P696, DOI 10.1021/es2030438; Rizwan AM, 2008, J ENVIRON SCI, V20, P120, DOI 10.1016/S1001-0742(08)60019-4; Saaroni H, 2000, LANDSCAPE URBAN PLAN, V48, P1, DOI 10.1016/S0169-2046(99)00075-4; Shashua-Bar L, 2000, ENERG BUILDINGS, V31, P221, DOI 10.1016/S0378-7788(99)00018-3; Spronken-Smith RA, 1998, INT J REMOTE SENS, V19, P2085, DOI 10.1080/014311698214884; Stewart ID, 2011, INT J CLIMATOL, V31, P200, DOI 10.1002/joc.2141; Sun CY, 2011, THEOR APPL CLIMATOL, V106, P433, DOI 10.1007/s00704-011-0444-6; Sun CY, 2009, THEOR APPL CLIMATOL, V98, P323, DOI 10.1007/s00704-009-0120-2; Sun RH, 2012, LANDSCAPE URBAN PLAN, V105, P27, DOI 10.1016/j.landurbplan.2011.11.018; UN, 2011, WORLD POPULATION PRO; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Weng QH, 2004, REMOTE SENS ENVIRON, V89, P467, DOI 10.1016/j.rse.2003.11.005; Wong NH, 2007, BUILD ENVIRON, V42, P2949, DOI 10.1016/j.buildenv.2006.06.004; Wong NH, 2005, HABITAT INT, V29, P547, DOI 10.1016/j.habitatint.2004.04.008; Wong NH, 2009, J URBAN PLAN D-ASCE, V136, P261; Yokobori T, 2009, CLIM RES, V39, P61, DOI 10.3354/cr00800; Yokohari M, 2001, LANDSCAPE URBAN PLAN, V53, P17, DOI 10.1016/S0169-2046(00)00123-7; Yu C, 2006, ENERG BUILDINGS, V38, P105, DOI 10.1016/j.enbuild.2005.04.003; Yu M, 2013, CLIMATIC CHANGE, V120, P123, DOI 10.1007/s10584-013-0788-2; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	43	31	31	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102124	10.1371/journal.pone.0102124	http://dx.doi.org/10.1371/journal.pone.0102124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010134	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800071
J	Gaveau, DLA; Sloan, S; Molidena, E; Yaen, H; Sheil, D; Abram, NK; Ancrenaz, M; Nasi, R; Quinones, M; Wielaard, N; Meijaard, E				Gaveau, David L. A.; Sloan, Sean; Molidena, Elis; Yaen, Husna; Sheil, Doug; Abram, Nicola K.; Ancrenaz, Marc; Nasi, Robert; Quinones, Marcela; Wielaard, Niels; Meijaard, Erik			Four Decades of Forest Persistence, Clearance and Logging on Borneo	PLOS ONE			English	Article							TROPICAL FORESTS; LOGGED FORESTS; CONSERVATION; BIODIVERSITY; DEFORESTATION; MAMMALS; MODELS; TIMBER	The native forests of Borneo have been impacted by selective logging, fire, and conversion to plantations at unprecedented scales since industrial-scale extractive industries began in the early 1970s. There is no island-wide documentation of forest clearance or logging since the 1970s. This creates an information gap for conservation planning, especially with regard to selectively logged forests that maintain high conservation potential. Analysing LANDSAT images, we estimate that 75.7% (558,060 km(2)) of Borneo's area (737,188 km(2)) was forested around 1973. Based upon a forest cover map for 2010 derived using ALOS-PALSAR and visually reviewing LANDSAT images, we estimate that the 1973 forest area had declined by 168,493 km(2) (30.2%) in 2010. The highest losses were recorded in Sabah and Kalimantan with 39.5% and 30.7% of their total forest area in 1973 becoming non-forest in 2010, and the lowest in Brunei and Sarawak (8.4%, and 23.1%). We estimate that the combined area planted in industrial oil palm and timber plantations in 2010 was 75,480 km(2), representing 10% of Borneo. We mapped 271,819 km of primary logging roads that were created between 1973 and 2010. The greatest density of logging roads was found in Sarawak, at 0.89 km km(-2), and the lowest density in Brunei, at 0.18 km km(- 2). Analyzing MODIS-based tree cover maps, we estimate that logging operated within 700 m of primary logging roads. Using this distance, we estimate that 266,257 km(2) of 1973 forest cover has been logged. With 389,566 km(2) (52.8%) of the island remaining forested, of which 209,649 km(2) remains intact. There is still hope for biodiversity conservation in Borneo. Protecting logged forests from fire and conversion to plantations is an urgent priority for reducing rates of deforestation in Borneo.	[Gaveau, David L. A.; Molidena, Elis; Yaen, Husna; Sheil, Doug; Nasi, Robert; Meijaard, Erik] Ctr Int Forestry Res, Bogor, Indonesia; [Sloan, Sean] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Sheil, Doug] Norwegian Univ Life Sci NMBU, Dept Ecol & Nat Resource Management INA, As, Norway; [Abram, Nicola K.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc; Meijaard, Erik] People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia; [Ancrenaz, Marc] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] Kinabatangan Orang Utan Conservat Programme, HUTAN, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] Chester Zoo, North England Zool Soc, Chester, Cheshire, England; [Quinones, Marcela; Wielaard, Niels] SarVision, Wageningen, Netherlands; [Meijaard, Erik] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	CGIAR; Center for International Forestry Research (CIFOR); James Cook University; Norwegian University of Life Sciences; University of Kent; People & Nature Consulting International; University of Queensland	Gaveau, DLA (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.	d.gaveau@cgiar.org	Sheil, Douglas/A-3867-2015; Nasi, Robert/P-2382-2019; Sheil, Douglas/N-3291-2019; Nasi, Robert/A-3549-2015; Meijaard, Erik/A-2687-2016; Sloan, Sean/A-8630-2012; Abram, Nicola/K-2060-2014	Sheil, Douglas/0000-0002-1166-6591; Nasi, Robert/0000-0001-9739-3135; Nasi, Robert/0000-0001-9739-3135; Meijaard, Erik/0000-0001-8685-3685; Sloan, Sean/0000-0002-7834-0203; Abram, Nicola/0000-0003-1886-7297	Arcus foundation; CGIAR Research Program on Forests, Trees, and Agroforestry	Arcus foundation; CGIAR Research Program on Forests, Trees, and Agroforestry	This work was funded by the Arcus foundation and the CGIAR Research Program on Forests, Trees, and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NK, 2014, ECOSYSTEM S IN PRESS; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; ARONOFF S, 1982, PHOTOGRAMM ENG REM S, V48, P1309; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Billand A., 2008, PRODUCTION FORETS CO; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; Bryan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069679; Butler R, 2013, TROPICAL RAINFOREST; Carlson KM, 2012, NATURE CLIMATE CHANG; Casson A, 2000, HESITANT BOOM INDONE; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Edwards DP, 2013, SCIENCE, V339, P646, DOI 10.1126/science.339.6120.646-b; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; FOODY GM, 1992, PHOTOGRAMM ENG REM S, V58, P1459; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Giam X, 2011, BIOL CONSERVATION; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Goldammer JG, 1990, IMPACT DROUGHTS FORE, P11; Hoekman DH, 2010, IEEE J-STARS, V3, P605, DOI 10.1109/JSTARS.2010.2070059; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Matricardi E, 2001, BSRSI RES ADV 2003 2; McKinnon K, 1996, ECOLOGY KALIMANTAN; Meijaard E, 2008, ECOL RES, V23, P21, DOI 10.1007/s11284-007-0342-7; Meijaard E, 2007, NATURE, V446, P974, DOI 10.1038/446974a; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Meijaard Erik, 2005, RESEARCH-CHINA; Ministry of Forestry, 2011, FOR STAT IND; Ministry of Forestry, 2011, LANDC MAP 2009 2010; Ministry of Forestry, 2000, LANDC MAP 2000; Monteiro AL, 2003, INT J REMOTE SENS, V24, P151, DOI 10.1080/01431160305008; Ngidang D., 2002, ASIA PACIFIC VIEWPOI, V43, P157, DOI DOI 10.1111/1467-8373.00171; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Putz FE, 2012, CONSERVATION LETT; Rulequest, 2007, DAT MIN TOOLS SEE5; Satriastanti FE, 2012, JAKARTA POST; Shearman PL, 2009, BIOTROPICA, V41, P379, DOI 10.1111/j.1744-7429.2009.00495.x; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Souza C, 2000, INT J REMOTE SENS, V21, P173, DOI 10.1080/014311600211064; Souza Jr C, 2013, DEGRADATION MONITORI; Thomlinson JR, 1999, REMOTE SENS ENVIRON, V70, P16, DOI 10.1016/S0034-4257(99)00055-3; Townshead J.R.G., 2011, VEGETATION CONTINUOU; USGS, 2013, GLOB LAND SURV; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Walsh RPD, 1999, PHILOS T R SOC B, V354, P1869, DOI 10.1098/rstb.1999.0528; Wells J.A., 2013, FORESTS FLOODS PEOPL; Wilson K, 2010, MEANJIN, V69, P20	51	240	250	3	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101654	10.1371/journal.pone.0101654	http://dx.doi.org/10.1371/journal.pone.0101654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029192	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000341306600019
J	Lobato, FL; Barneche, DR; Siqueira, AC; Liedke, AMR; Lindner, A; Pie, MR; Bellwood, DR; Floeter, SR				Lobato, Fabio L.; Barneche, Diego R.; Siqueira, Alexandre C.; Liedke, Ana M. R.; Lindner, Alberto; Pie, Marcio R.; Bellwood, David R.; Floeter, Sergio R.			Diet and Diversification in the Evolution of Coral Reef Fishes	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; DAMSELFISHES POMACENTRIDAE; ANTIPREDATORY DEFENSES; MOLECULAR PHYLOGENIES; HERBIVOROUS FISHES; BAYESIAN-INFERENCE; CARIBBEAN SPONGES; FAMILY LABRIDAE; RED-SEA; RATES	The disparity in species richness among evolutionary lineages is one of the oldest and most intriguing issues in evolutionary biology. Although geographical factors have been traditionally thought to promote speciation, recent studies have underscored the importance of ecological interactions as one of the main drivers of diversification. Here, we test if differences in species richness of closely related lineages match predictions based on the concept of density-dependent diversification. As radiation progresses, ecological niche-space would become increasingly saturated, resulting in fewer opportunities for speciation. To assess this hypothesis, we tested whether reef fish niche shifts toward usage of low-quality food resources (i.e. relatively low energy/protein per unit mass), such as algae, detritus, sponges and corals are accompanied by rapid net diversification. Using available molecular information, we reconstructed phylogenies of four major reef fish clades (Acanthuroidei, Chaetodontidae, Labridae and Pomacentridae) to estimate the timing of radiations of their subclades. We found that the evolution of species-rich clades was associated with a switch to low quality food in three of the four clades analyzed, which is consistent with a density-dependent model of diversification. We suggest that ecological opportunity may play an important role in understanding the diversification of reef-fish lineages.	[Lobato, Fabio L.; Siqueira, Alexandre C.; Liedke, Ana M. R.; Lindner, Alberto; Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Barneche, Diego R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Pie, Marcio R.] Univ Fed Parana, Setor Ciencias Biol, BR-80060000 Curitiba, Parana, Brazil; [Bellwood, David R.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Universidade Federal de Santa Catarina (UFSC); Macquarie University; Universidade Federal do Parana; James Cook University; James Cook University	Floeter, SR (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil.	sergio.floeter@ufsc.br	Lindner, Alberto/E-1946-2013; Siqueira, Alexandre C./AAJ-5987-2020; Floeter, S. R./B-1438-2012	Siqueira, Alexandre C./0000-0001-7970-4024; Floeter, S. R./0000-0002-3201-6504; Barneche, Diego/0000-0002-4568-2362; Lindner, Alberto/0000-0003-3288-0885	Microsoft Corporation; CNPq [304897/2012-4, 309472/2011-3]; Australian Research Council	Microsoft Corporation(Microsoft); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Australian Research Council(Australian Research Council)	This work benefited from the Computational Biology Service Unit - Cornell University (CBSU Web Computing Interface), funded by Microsoft Corporation. Marcio R. Pie and Sergio R. Floeter were supported by CNPq (http://www.cnpq.br/) (MRP: 304897/2012-4; SRF: 309472/2011-3). David R. Bellwood was supported by the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; [Anonymous], 2020, CATALOG FISHES; Bannikov A.F., 1990, Studi e Ricerche sui Giacimenti Terziari di Bolca, V6, P133; Bannikov AF, 2004, STUDI RICERCHE GIACI, V13, P55; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bellwood D.R., 1990, Studi e Ricerche sui Giacimenti Terziari di Bolca, V6, P149; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Bellwood DR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4144; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2004, MOL PHYLOGENET EVOL, V33, P140, DOI 10.1016/j.ympev.2004.04.015; Bellwood DR, 1998, CORAL REEFS, V17, P187, DOI 10.1007/s003380050114; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; BOWEN SH, 1995, ECOLOGY, V76, P899, DOI 10.2307/1939355; BREY T, 1988, J EXP MAR BIOL ECOL, V117, P271, DOI 10.1016/0022-0981(88)90062-7; Brey T, 2010, J SEA RES, V64, P334, DOI 10.1016/j.seares.2010.05.002; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V106, P57, DOI 10.3354/meps106057; Burns E, 2003, MAR ECOL PROG SER, V252, P115, DOI 10.3354/meps252115; Burns E, 2003, MAR ECOL PROG SER, V252, P105, DOI 10.3354/meps252105; Choat J.H., 1991, P39; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 2012, BIOL J LINN SOC, V107, P529, DOI 10.1111/j.1095-8312.2012.01959.x; Clements KD, 2004, MOL PHYLOGENET EVOL, V32, P575, DOI 10.1016/j.ympev.2004.02.003; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Cowman PF, 2009, MOL PHYLOGENET EVOL, V52, P621, DOI 10.1016/j.ympev.2009.05.015; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elliott JP, 2003, J FISH BIOL, V63, P1598, DOI 10.1111/j.1095-8649.2003.00272.x; Espeland M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-254; Ferreira CEL, 1998, J FISH BIOL, V53, P222, DOI 10.1006/jfbi.1998.0824; Ferry-Graham LA, 2001, J MORPHOL, V248, P120, DOI 10.1002/jmor.1024; Fessler JL, 2007, MOL PHYLOGENET EVOL, V45, P50, DOI 10.1016/j.ympev.2007.05.018; Floeter SR, 2004, J FISH BIOL, V64, P1680, DOI 10.1111/j.0022-1112.2004.00428.x; Frederich B, 2013, AM NAT, V181, P94, DOI 10.1086/668599; Harmelin-Vivien Mireille L., 2002, P265, DOI 10.1016/B978-012615185-5/50016-5; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hay M.E., 1991, P96; Hoey AS, 2012, P ROY SOC B-BIOL SCI, V279, P2426, DOI 10.1098/rspb.2011.2679; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Horn MH, 1998, PHYSL FISHES, P41; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones RS, 1968, MICRONESICA, V4, P310; Kazancioglu E, 2009, P ROY SOC B-BIOL SCI, V276, P3439, DOI 10.1098/rspb.2009.0876; Klanten SO, 2004, MOL PHYLOGENET EVOL, V32, P221, DOI 10.1016/j.ympev.2003.11.008; Konow N, 2008, BIOL J LINN SOC, V93, P545, DOI 10.1111/j.1095-8312.2007.00893.x; Kotrschal K, 1988, J ZOOLOG SYST EVOL R, V26, P51; Kramer MJ, 2013, CORAL REEFS, V32, P575, DOI 10.1007/s00338-013-1009-1; Kuiter R. H., 2010, LABRIDAE FISHES WRAS; Kuiter R. H., 2002, BUTTERFLYFISHES BANN; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Maddison WP, 2011, MESQUITE MODULAR SYS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Meylan A, 1991, NEW PERSPECTIVES SPO, P472; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paul Valerie J., 1992, P164; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Price SA, 2010, EVOLUTION, V64, P3057, DOI 10.1111/j.1558-5646.2010.01036.x; PURCELL SW, 1993, ENVIRON BIOL FISH, V37, P139, DOI 10.1007/BF00000589; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A, 2013, TRACER VERSION 1 6; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ricklefs RE, 2003, P ROY SOC B-BIOL SCI, V270, P2285, DOI 10.1098/rspb.2003.2489; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Ruber L, 2005, EVOLUTION, V59, P1119; Sanderson MJ, 1996, AM J BOT, V83, P1488, DOI 10.2307/2446103; SANDERSON MJ, 1994, SOC GEN PHY, V49, P13; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Smith LL, 2008, MOL PHYLOGENET EVOL, V49, P136, DOI 10.1016/j.ympev.2008.06.008; Streelman JT, 2002, EVOLUTION, V56, P961; Tang KL, 1999, MOL PHYLOGENET EVOL, V11, P415, DOI 10.1006/mpev.1998.0596; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P419, DOI 10.1666/0094-8373(2000)026<0419:DHATAO>2.0.CO;2; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; White JW, 2010, ECOLOGY, V91, P1949, DOI 10.1890/09-0298.1; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279	94	37	38	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102094	10.1371/journal.pone.0102094	http://dx.doi.org/10.1371/journal.pone.0102094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029229	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341306600035
J	Piszczek, J; Mamdani, M; Antoniou, T; Juurlink, DN; Gomes, T				Piszczek, Jolanta; Mamdani, Muhammad; Antoniou, Tony; Juurlink, David N.; Gomes, Tara			The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men	PLOS ONE			English	Article							MIDDLE-AGED MEN; BODY-COMPOSITION; TIME-SERIES; TRENDS; ENDOCRINE; AUSTRALIA; MORTALITY; STRENGTH	Background: Despite a lack of data describing the long-term efficacy and safety of testosterone replacement therapy (TRT), prescribing of testosterone to older men has increased with the availability of topical formulations. The magnitude of this increase and the impact of formulary restrictions on testosterone prescribing are poorly characterized. Methods: We conducted a time series analysis using the linked health administrative records of men aged 66 years or older in Ontario, Canada between January 1, 1997 and March 31, 2012. We used interventional autoregressive integrated moving average models to examine the impact of a restrictive drug reimbursement policy on testosterone prescribing and examined the demographic profile of men initiating testosterone in the final 2 years of the study period. Results: A total of 28,477 men were dispensed testosterone over the study period. Overall testosterone prescribing declined 27.9% in the 6 months following the implementation of the restriction policy (9.5 to 6.9 men per 1000 eligible; p<0.01). However, the overall decrease was temporary and testosterone use exceeded pre-policy levels by the end of the study period (11.0 men per 1000 eligible), largely driven by prescriptions for topical testosterone (4.8 men per 1000 eligible). Only 6.3% of men who initiated testosterone had a documented diagnosis of hypogonadism, the main criteria for TRT reimbursement according to the new policy. Conclusion: Government-imposed restrictions did not influence long-term prescribing of testosterone to older men. By 2012, approximately 1 in every 90 men aged 66 or older was being treated with TRT, most with topical formulations.	[Piszczek, Jolanta; Mamdani, Muhammad; Antoniou, Tony; Gomes, Tara] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mamdani, Muhammad; Juurlink, David N.; Gomes, Tara] ICES, Toronto, ON, Canada; [Antoniou, Tony] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.] Sunnybrook Hlth Sci Ctr, Dept Med, Div Clin Pharmacol & Toxicol, Toronto, ON M4N 3M5, Canada; [Mamdani, Muhammad] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mamdani, Muhammad; Gomes, Tara] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gomes, T (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.	gomest@smh.ca		Gomes, Tara/0000-0002-1468-1965	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC; Ontario HIV Treatment Network	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC; Ontario HIV Treatment Network	This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund and the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario MOHLTC. Tony Antoniou is funded by a post-doctoral fellowship from the Ontario HIV Treatment Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results, and conclusions are those of the authors, and no endorsement by Ontario's Ministry of Health and Long-term Care or by the Institute for Clinical Evaluative Sciences is intended or should be inferred.	Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Braun SR, 2013, JAMA INTERN MED, V173, P1458, DOI 10.1001/jamainternmed.2013.6892; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Dobs AS, 1990, J CLIN ENDOCR METAB, V84, P3469; Edelstein Daniel, 2006, Expert Opin Emerg Drugs, V11, P685, DOI 10.1517/14728214.11.4.685; Eggertson L, 2011, CAN MED ASSOC J, V183, pE1161, DOI 10.1503/cmaj.109-4000; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Gomes Tara, 2011, Open Med, V5, pe13; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Handelsman DJ, 2012, MED J AUSTRALIA, V196, P642, DOI 10.5694/mja11.11277; Handelsman DJ, 2004, MED J AUSTRALIA, V181, P419, DOI 10.5694/j.1326-5377.2004.tb06364.x; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM321, DOI 10.1093/gerona/57.5.M321; Kermode-Scott B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5501; Liverman KT, 2004, TESTOSTERONE AGING C; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Mamdani M, 2007, AM J MED, V120, P893, DOI 10.1016/j.amjmed.2007.02.028; Marshall BL, 2009, MED STUDIES, V1, P249, DOI DOI 10.1007/S12376-009-0019-3; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Quail JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-146; Schoenfeld MJ, 2013, J SEX MED, V10, P1401, DOI 10.1111/jsm.12114; Schwartz L, 2013, JAMA INTERN MED, V173, P1; Shores MM, 2009, J CLIN PSYCHIAT, V70, P1009, DOI 10.4088/JCP.08m04478; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Szeinbach SL, 2012, PATIENT PREFER ADHER, V6, P631, DOI 10.2147/PPA.S35840; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Weeks C., 2012, GLOBE MAIL; Weir MA, 2012, J ONCOL PRACT, V8, P179, DOI 10.1200/JOP.2011.000287	35	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e98003	10.1371/journal.pone.0098003	http://dx.doi.org/10.1371/journal.pone.0098003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029014	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600002
J	Salmi, R; Hammerschmidt, K; Doran-Sheehy, DM				Salmi, Roberta; Hammerschmidt, Kurt; Doran-Sheehy, Diane M.			Individual Distinctiveness in Call Types of Wild Western Female Gorillas	PLOS ONE			English	Article							SPEAR-NOSED BATS; VOCAL REPERTOIRE; ACOUSTIC STRUCTURE; CONTACT CALLS; LOWLAND GORILLAS; GEOGRAPHIC VARIATIONS; SAGUINUS-OEDIPUS; MACACA-SYLVANUS; SEX-DIFFERENCES; SOCIAL-FACTORS	Individually distinct vocalizations play an important role in animal communication, allowing call recipients to respond differentially based on caller identity. However, which of the many calls in a species' repertoire should have more acoustic variability and be more recognizable is less apparent. One proposed hypothesis is that calls used over long distances should be more distinct because visual cues are not available to identify the caller. An alternative hypothesis proposes that close calls should be more recognizable because of their importance in social interactions. To examine which hypothesis garners more support, the acoustic variation and individual distinctiveness of eight call types of six wild western gorilla (Gorilla gorilla) females were investigated. Acoustic recordings of gorilla calls were collected at the Mondika Research Center (Republic of Congo). Acoustic variability was high in all gorilla calls. Similar high inter-individual variation and potential for identity coding (PIC) was found for all call types. Discriminant function analyses confirmed that all call types were individually distinct (although for call types with lowest sample size - hum, grumble and scream - this result cannot be generalized), suggesting that neither the distance at which communication occurs nor the call social function alone can explain the evolution of identity signaling in western gorilla communication.	[Salmi, Roberta] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Salmi, Roberta] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA; [Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Doran-Sheehy, Diane M.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA	University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Deutsches Primatenzentrum (DPZ); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Salmi, R (corresponding author), Univ Georgia, Dept Anthropol, Athens, GA 30602 USA.	roberta.salmi@gmail.com	salmi, roberta/AAD-6267-2021; Doran-Sheehy, Diane/GXV-9571-2022	Salmi, Roberta/0000-0001-5745-2014	Leakey Foundation; Wildlife Direct and Richard Leakey; Primate Action Fund; Primate Conservation Inc.; Sigma Xi; Stony Brook University	Leakey Foundation; Wildlife Direct and Richard Leakey; Primate Action Fund; Primate Conservation Inc.; Sigma Xi; Stony Brook University	The Leakey Foundation, Wildlife Direct and Richard Leakey, the Primate Action Fund, Primate Conservation Inc., Sigma Xi, and Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; Berg KS, 2011, ANIM BEHAV, V81, P241, DOI 10.1016/j.anbehav.2010.10.012; Bergman TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3045, DOI 10.1098/rspb.2010.0580; Bezerra BM, 2010, INT J PRIMATOL, V31, P759, DOI 10.1007/s10764-010-9427-1; Blumstein DT, 1997, ANIM BEHAV, V53, P143, DOI 10.1006/anbe.1996.0285; Bouchet H, 2012, J COMP PSYCHOL, V126, P45, DOI 10.1037/a0025018; Bouchet H, 2010, AM J PRIMATOL, V72, P360, DOI 10.1002/ajp.20791; Boughman JW, 1997, BEHAV ECOL SOCIOBIOL, V40, P61, DOI 10.1007/s002650050316; Boughman JW, 1998, ANIM BEHAV, V55, P1717, DOI 10.1006/anbe.1997.0721; Briefer E, 2011, APPL ANIM BEHAV SCI, V133, P175, DOI 10.1016/j.applanim.2011.05.012; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020329; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charrier I, 2001, POLAR BIOL, V24, P378, DOI 10.1007/s003000100231; Charrier I, 2003, ANIM BEHAV, V65, P543, DOI 10.1006/anbe.2003.2073; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Clay Z, 2011, ETHOLOGY, V117, P1158, DOI 10.1111/j.1439-0310.2011.01975.x; CLEVELAND J, 1982, Z TIERPSYCHOL, V58, P231; Crockford C, 2004, ETHOLOGY, V110, P221, DOI 10.1111/j.1439-0310.2004.00968.x; Crockford C, 2007, ANIM BEHAV, V73, P885, DOI 10.1016/j.anbehav.2006.10.016; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Digweed SM, 2007, AM J PRIMATOL, V69, P829, DOI 10.1002/ajp.20398; Doran-Sheehy DM, 2007, AM J PRIMATOL, V69, P1354, DOI 10.1002/ajp.20442; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; Evans CS, 2007, BIOL LETTERS, V3, P8, DOI 10.1098/rsbl.2006.0561; Fichtel C, 2002, ETHOLOGY, V108, P763, DOI 10.1046/j.1439-0310.2002.00816.x; Fischer J, 2004, ANIM BEHAV, V67, P655, DOI 10.1016/j.anbehav.2003.08.006; Fischer J, 2002, FOLIA PRIMATOL, V73, P32, DOI 10.1159/000060417; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ANIM BEHAV, V61, P925, DOI 10.1006/anbe.2000.1687; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fischer J, 2013, AM J PRIMATOL, V75, P643, DOI 10.1002/ajp.22153; Fugate JMB, 2008, AM J PRIMATOL, V70, P594, DOI 10.1002/ajp.20533; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Ghazanfar AA, 2007, NATURE, V448, P535, DOI 10.1038/448535a; Griebel U., 2008, EVOLUTION COMMUNICAT, P9, DOI [DOI 10.7551/MITPRESS/9780262151214.003.0002, 10.7551/mitpress/7650.003.0006, DOI 10.7551/MITPRESS/7650.003.0006]; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hammerschmidt K., 1994, P287; HAMMERSCHMIDT K, 1995, BEHAVIOUR, V132, P381, DOI 10.1163/156853995X00621; Harcourt AH, 1996, BEHAVIOUR, V133, P827, DOI 10.1163/156853996X00260; HARCOURT AH, 1993, BEHAVIOUR, V124, P89, DOI 10.1163/156853993X00524; Harcourt AH, 2007, GORILLA SOC CONFLICT, Vxviii; HAUSER MD, 1991, ETHOLOGY, V89, P29; HAUSER MD, 1992, J ACOUST SOC AM, V91, P2175, DOI 10.1121/1.403676; Hawkins ER, 2010, J ACOUST SOC AM, V128, P924, DOI 10.1121/1.3459837; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoffmann LS, 2012, ADV EXP MED BIOL, V730, P141, DOI 10.1007/978-1-4419-7311-5_31; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Jansen DAWAM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-97; Jouventin P, 2002, ANIM BEHAV, V64, P747, DOI 10.1006/anbe.2002.4002; Klecka W. R., 1980, DISCRIMINANT ANAL; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; Koren L, 2011, BEHAV ECOL SOCIOBIOL, V65, P675, DOI 10.1007/s00265-010-1069-y; Kreiman J., 1997, TALKER VARIABILITY S, P85; Leavesley AJ, 2005, ANIM BEHAV, V70, P365, DOI 10.1016/j.anbehav.2004.10.017; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Leliveld LMC, 2011, J ACOUST SOC AM, V129, P2278, DOI 10.1121/1.3559680; Lemasson A, 2011, J ACOUST SOC AM, V129, P3341, DOI 10.1121/1.3569704; Lemasson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045106; Lemasson A, 2011, ADV INTERACT STUD, V1, P39; Levrero F, 2013, AM J PRIMATOL, V75, P324, DOI 10.1002/ajp.22108; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Maciej P, 2013, BEHAV ECOL SOCIOBIOL, V67, P61, DOI 10.1007/s00265-012-1425-1; Maciej P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023015; Magliocca F, 1999, AM J PRIMATOL, V48, P1, DOI 10.1002/(SICI)1098-2345(1999)48:1<1::AID-AJP1>3.0.CO;2-2; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MARLER P, 1967, SCIENCE, V157, P769, DOI 10.1126/science.157.3790.769; Marler P., 1976, GROWING POINTS ETHOL, P239; Mathevon N, 2010, BMC BIOL, V10, P3; Miller CT, 2012, J COMP PHYSIOL A, V198, P337, DOI 10.1007/s00359-012-0712-7; Mitani JC, 1996, INT J PRIMATOL, V17, P569, DOI 10.1007/BF02735192; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; OCKLEFORD EM, 1988, EARLY HUM DEV, V18, P27, DOI 10.1016/0378-3782(88)90040-0; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Owren MJ, 2003, J COMP PSYCHOL, V117, P380, DOI 10.1037/0735-7036.117.4.380; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; PALOMBIT RA, 1992, INT J PRIMATOL, V13, P183, DOI 10.1007/BF02547840; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Pollard KA, 2011, BEHAV ECOL, V22, P93, DOI 10.1093/beheco/arq179; Pollard KA, 2011, CURR BIOL, V21, P413, DOI 10.1016/j.cub.2011.01.051; Price T, 2009, BEHAVIOUR, V146, P871, DOI 10.1163/156853908X396610; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Rendall D, 1998, J ACOUST SOC AM, V103, P602, DOI 10.1121/1.421104; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Rendall D, 2009, J ACOUST SOC AM, V125, P1792, DOI 10.1121/1.3068453; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; ROBINSON J G, 1981, Primates, V22, P161, DOI 10.1007/BF02382607; ROBISSON P, 1993, ETHOLOGY, V94, P279; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; Seyfarth RM, 2003, ANN NY ACAD SCI, V1000, P32, DOI 10.1196/annals.1280.004; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Snowdon Charles T., 1997, P234, DOI 10.1017/CBO9780511758843.012; SNOWDON CT, 1980, ANIM BEHAV, V28, P717, DOI 10.1016/S0003-3472(80)80131-X; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Spillmann B, 2010, ETHOLOGY, V116, P385, DOI 10.1111/j.1439-0310.2010.01744.x; Theis KR, 2007, BEHAVIOUR, V144, P557, DOI 10.1163/156853907780713046; van Schaik CP, 2003, LIFE HIST COGNITIVE, P5; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Venables WN., 2002, MODERN APPL STAT S 4; WATTS DP, 1989, ETHOLOGY, V81, P1; Watts DP, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P351; Watts DP, 1997, BEHAVIOUR, V134, P23, DOI 10.1163/156853997X00269; Weiss DJ, 2001, J COMP PSYCHOL, V115, P258, DOI 10.1037/0735-7036.115.3.258; West B. T., 2006, LINEAR MIXED MODELS, P180; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203	117	19	19	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101940	10.1371/journal.pone.0101940	http://dx.doi.org/10.1371/journal.pone.0101940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029238	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600027
J	Brown, HR; Zeidman, P; Smittenaar, P; Adams, RA; McNab, F; Rutledge, RB; Dolan, RJ				Brown, Harriet R.; Zeidman, Peter; Smittenaar, Peter; Adams, Rick A.; McNab, Fiona; Rutledge, Robb B.; Dolan, Raymond J.			Crowdsourcing for Cognitive Science - The Utility of Smartphones	PLOS ONE			English	Article							STOP; TASK; MODEL	By 2015, there will be an estimated two billion smartphone users worldwide. This technology presents exciting opportunities for cognitive science as a medium for rapid, large-scale experimentation and data collection. At present, cost and logistics limit most study populations to small samples, restricting the experimental questions that can be addressed. In this study we investigated whether the mass collection of experimental data using smartphone technology is valid, given the variability of data collection outside of a laboratory setting. We presented four classic experimental paradigms as short games, available as a free app and over the first month 20,800 users submitted data. We found that the large sample size vastly outweighed the noise inherent in collecting data outside a controlled laboratory setting, and show that for all four games canonical results were reproduced. For the first time, we provide experimental validation for the use of smartphones for data collection in cognitive science, which can lead to the collection of richer data sets and a significant cost reduction as well as provide an opportunity for efficient phenotypic screening of large populations.	[Brown, Harriet R.; Zeidman, Peter; Smittenaar, Peter; Adams, Rick A.; McNab, Fiona; Rutledge, Robb B.; Dolan, Raymond J.] Univ Oxford, Oxford Ctr Human Brain Act, Oxford, England; [McNab, Fiona] Univ Birmingham, Sch Psychol, London, England	University of Oxford; University of Birmingham	Brown, HR (corresponding author), Univ Oxford, Oxford Ctr Human Brain Act, Oxford, England.	harriet.brown.09@ucl.ac.uk	Adams, Rick/M-7640-2015	Adams, Rick/0000-0002-7661-8881; Zeidman, Peter/0000-0003-3610-6619; Feldman, Harriet/0000-0002-2365-1805; Dolan, Ray/0000-0001-9356-761X; Rutledge, Robb/0000-0001-7337-5039	Wellcome Trust [101252/Z/13/Z, 091593/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust Engaging Science: Brain Awareness Week Award, 101252/Z/13/Z. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2008, PSYCHOL SCI, V19, P1146, DOI 10.1111/j.1467-9280.2008.02216.x; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bichero S, 2012, GLOBAL SMARTPHONE IN; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Buck E, 2012, LEARNING OPENGL ES I; Cabrera PJ, 2010, BEGINNING IPHONE GAM; Chandler J, 2013, BEHAV RES METHODS; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Clery D, 2011, SCIENCE, V333, P173, DOI 10.1126/science.333.6039.173; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dufau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024974; Gazzaley A, 2005, NAT NEUROSCI, V8, P1791, DOI 10.1038/nn1205-1791c; Kalanthroff E, 2013, CONSCIOUS COGN, V22, P413, DOI 10.1016/j.concog.2013.01.010; KANE MJ, 1994, PSYCHOL AGING, V9, P103, DOI 10.1037/0882-7974.9.1.103; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; Mcnab F, 2014, J EXP PSYCHOL HUMAN, V40, P960, DOI 10.1037/a0036013; mittenaar P, 2014, PLOS ONE, V9; Park HL, 2003, INT J GERIATR PSYCH, V18, P1121, DOI 10.1002/gps.1023; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; Rabbitt P, 2009, Q J EXP PSYCHOL, V62, P1859, DOI 10.1080/17470210802633461; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205	29	53	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100662	10.1371/journal.pone.0100662	http://dx.doi.org/10.1371/journal.pone.0100662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025865	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400005
J	Fang, L; Xu, Z; Wang, GS; Ji, FY; Mei, CX; Liu, J; Wu, GM				Fang, Li; Xu, Zhi; Wang, Guan-song; Ji, Fu-yun; Mei, Chun-xia; Liu, Juan; Wu, Guo-ming			Directed Evolution of an LBP/CD14 Inhibitory Peptide and Its Anti-Endotoxin Activity	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; LPS BINDING-PROTEIN; GRAM-NEGATIVE BACTERIA; ACUTE LUNG INJURY; INFLAMMATORY RESPONSES; ANTI-CD14 ANTIBODY; SEPTIC SHOCK; SOLUBLE CD14; IN-VITRO; LBP	Background: LPS-binding protein (LBP) and its ligand CD14 are located upstream of the signaling pathway for LPS-induced inflammation. Blocking LBP and CD14 binding might prevent LPS-induced inflammation. In previous studies, we obtained a peptide analog (MP12) for the LBP/ CD14 binding site and showed that this peptide analog had anti-endotoxin activity. In this study, we used in vitro directed evolution for this peptide analog to improve its in vivo and in vitro anti-endotoxin activity. Methods: We used error-prone PCR (ep-PCR) and induced mutations in the C-terminus of LBP and attached the PCR products to T7 phages to establish a mutant phage display library. The positive clones that competed with LBP for CD14 binding was obtained by screening. We used both in vivo and in vitro experiments to compare the anti-endotoxin activities of a polypeptide designated P1 contained in a positive clone and MP12. Results: 11 positive clones were obtained from among target phages. Sequencing showed that 9 positive clones had a threonine (T) to methionine (M) mutation in amino acid 287 of LBP. Compared to polypeptide MP12, polypeptide P1 significantly inhibited LPS-induced TNF-alpha expression and NF-kappa B activity in U937 cells (P < 0.05). Compared to MP12, P1 significantly improved arterial oxygen pressure, an oxygenation index, and lung pathology scores in LPS-induced ARDS rats (P < 0.05). Conclusion: By in vitro directed evolution of peptide analogs for the LBP/ CD14 binding site, we established a new polypeptide (P1) with a threonine (T)-to-methionine (M) mutation in amino acid 287 of LBP. This polypeptide had high anti-endotoxin activity in vitro and in vivo, which suggested that amino acid 287 in the C-terminus of LBP may play an important role in LBP binding with CD14.	[Fang, Li; Xu, Zhi; Wang, Guan-song; Ji, Fu-yun; Mei, Chun-xia; Liu, Juan; Wu, Guo-ming] Third Mil Med Univ, Inst Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University	Wu, GM (corresponding author), Third Mil Med Univ, Inst Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China.	cg2014fl@163.com		Xu, Zhi/0000-0003-1199-6635; Wang, Guansong/0000-0002-5184-0777	National Natural Science Foundation of China [30971189, 81070053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (30971189,81070053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana MD, 2003, J ENDOTOXIN RES, V9, P281, DOI 10.1177/09680519030090050301; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; CHEN KQ, 1993, P NATL ACAD SCI USA, V90, P5618, DOI 10.1073/pnas.90.12.5618; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fortin PD, 2005, J BIOL CHEM, V280, P42307, DOI 10.1074/jbc.M510456200; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hardin AO, 2006, BIOCHEM BIOPH RES CO, V342, P547, DOI 10.1016/j.bbrc.2006.02.005; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Heumann D, 2003, J ENDOTOXIN RES, V9, P381, DOI 10.1179/0963805103225003312; Heumann D, 2001, J ENDOTOXIN RES, V7, P439, DOI 10.1177/09680519010070060701; Hristova M, 2003, INFLAMM RES, V52, P1, DOI 10.1007/s000110300007; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Kitchens RL, 2003, J ENDOTOXIN RES, V9, P113, DOI 10.1179/096805103125001504; Lamping N, 1996, J IMMUNOL, V157, P4648; Le Roy D, 1999, J IMMUNOL, V162, P7454; MARTIN TR, 1994, J LEUKOCYTE BIOL, V56, P1; Olszyna DP, 2003, EUR CYTOKINE NETW, V14, P158; Parsons PE, 2000, CLIN CHEST MED, V21, P467, DOI 10.1016/S0272-5231(05)70159-3; Patel HJ, 2003, J IMMUNOL, V170, P2663, DOI 10.4049/jimmunol.170.5.2663; SCHUMANN RR, 1992, RES IMMUNOL, V143, P11, DOI 10.1016/0923-2494(92)80074-U; Sohn EJ, 2007, VET RES, V38, P95, DOI 10.1051/vetres:2006052; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Su X, 2004, INTENS CARE MED, V30, P133, DOI 10.1007/s00134-003-2001-y; TAYLOR AH, 1995, J BIOL CHEM, V270, P17934, DOI 10.1074/jbc.270.30.17934; THEOFAN G, 1994, J IMMUNOL, V152, P3623; Tobias PS, 1999, CLIN INFECT DIS, V28, P476, DOI 10.1086/515163; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Verbon A, 2001, J IMMUNOL, V166, P3599, DOI 10.4049/jimmunol.166.5.3599; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Xu Z, 2009, INFLAMM RES, V58, P45, DOI 10.1007/s00011-008-8178-3; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	36	13	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101406	10.1371/journal.pone.0101406	http://dx.doi.org/10.1371/journal.pone.0101406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025695	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400015
J	Mascarenhas, P; Fatela, B; Barahona, I				Mascarenhas, Paulo; Fatela, Bruno; Barahona, Isabel			Effect of Diabetes Mellitus Type 2 on Salivary Glucose - A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Review							ADULTS	Background: Early screening of type 2 diabetes mellitus (DM) is essential for improved prognosis and effective delay of clinical complications. However, testing for high glycemia often requires invasive and painful blood testing, limiting its large-scale applicability. We have combined new, unpublished data with published data comparing salivary glucose levels in type 2 DM patients and controls and/or looked at the correlation between salivary glucose and glycemia/HbA1c to systematically review the effectiveness of salivary glucose to estimate glycemia and HbA1c. We further discuss salivary glucose as a biomarker for large-scale screening of diabetes or developing type 2 DM. Methods and Findings: We conducted a meta-analysis of peer-reviewed published articles that reported data regarding mean salivary glucose levels and/or correlation between salivary glucose levels and glycemia or HbA1c for type 2 DM and non-diabetic individuals and combined them with our own unpublished results. Our global meta-analysis of standardized mean differences on salivary glucose levels shows an overall large positive effect of type 2 DM over salivary glucose (Hedge's g = 1.37). The global correlation coefficient (r) between salivary glucose and glycemia was large (r = 0.49), with subgroups ranging from medium (r = 0.30 in non-diabetics) to very large (r = 0.67 in diabetics). Meta-analysis of the global correlation between salivary glucose and HbA1c showed an overall association of medium strength (r = 0.37). Conclusions: Our systematic review reports an overall meaningful salivary glucose concentration increase in type 2 DM and a significant overall relationship between salivary glucose concentration and associated glycemia/HbA1c values, with the strength of the correlation increasing for higher glycemia/HbA1c values. These results support the potential of salivary glucose levels as a biomarker for type 2 DM, providing a less painful/invasive method for screening type 2 DM, as well as for monitoring blood glucose levels in large cohorts of DM patients.	[Mascarenhas, Paulo; Barahona, Isabel] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, Monte De Caparica, Portugal; [Fatela, Bruno] Ctr Hosp Setubal CHS, Serv Anal Clin, Setubal, Portugal	Instituto Superior de Ciencias da Saude Egas Moniz	Barahona, I (corresponding author), Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, Monte De Caparica, Portugal.	ibarahona@egasmoniz.edu.pt	barahona, isabel/J-6877-2012; , Paulo/ADF-8017-2022	barahona, isabel/0000-0002-2654-0983; , Paulo/0000-0002-6584-1199	Egas Moniz grant [EMIB 2003-01]	Egas Moniz grant	This work was supported by Egas Moniz grant # EMIB 2003-01 (http://www.egasmoniz.com.pt/pt-pt.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikshyeet P, 2012, DIABETES METAB SYNDR, V5, P149, DOI 10.2147/DMSO.S32112; Agrawal RP, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000266; Al-zahawi S.M., 2012, J BAGH COLL DENT, V24, P123; Amer S, 2001, Pak J Pharm Sci, V14, P33; Aydin S, 2007, J BIOCHEM MOL BIOL, V40, P29; Bakianian Vaziri P, 2010, J Dent (Tehran), V7, P13; Bernardi Maria Jose, 2007, Oral Health Prev Dent, V5, P73; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Carda Carmen, 2006, Med Oral Patol Oral Cir Bucal, V11, pE309; Coe R, 2002, PRESENTATION TO THE; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; DARWAZEH AMG, 1991, J ORAL PATHOL MED, V20, P280, DOI 10.1111/j.1600-0714.1991.tb00928.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FICARA AJ, 1975, J PERIODONTAL RES, V10, P171, DOI 10.1111/j.1600-0765.1975.tb00022.x; Genco Robert J, 2012, J Am Dent Assoc, V143, p3S; Hammer GP, 2009, DTSCH ARZTEBL INT, V106, P664, DOI 10.3238/arztebl.2009.0664; Hashemipour M, 2000, IRAN J ENDOCRINOL ME, V2, P221; Headrick TC, 2010, STATISTICAL SIMULATI; Hegde A, 2010, BIOMED RES-INDIA, V21, P252; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Jurysta C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/430426; Lasisi T J, 2012, Ann Ib Postgrad Med, V10, P25; Lasisi T J, 2012, Niger J Physiol Sci, V27, P79; Mahdavi S.O., 2012, IRAN J DIABETES OBES, V4, P127; MANDEL ID, 1980, CRC CR REV CL LAB SC, V12, P321, DOI 10.3109/10408368009108733; Manjrekar PA, 2012, J CLIN DIAGN RES, V6, P770; MURRAH VA, 1985, J ORAL PATHOL MED, V14, P236, DOI 10.1111/j.1600-0714.1985.tb00487.x; Panchbhai Arati S, 2012, J Oral Maxillofac Res, V3, pe3, DOI 10.5037/jomr.2012.3303; Panchbhai Arati S, 2010, J Oral Sci, V52, P359; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; R Core Team, 2018, R LANG ENV STAT COMP; Rao PV, 2009, J PROTEOME RES, V8, P239, DOI 10.1021/pr8003776; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; REUTERVING CO, 1987, DIABETES METAB, V13, P457; Rosenthal R, 1984, APPLIED SOCIAL SCIEN, V6; Scott DA, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-48; Ship JA, 2003, J AM DENT ASSOC, V134, p4S; So CF, 2012, MED DEVICES-EVID RES, V5, P45, DOI 10.2147/MDER.S28134; Soares MSM, 2009, MED ORAL PATOL ORAL, V14, pE510; Valdez Rodolfo, 2009, J Diabetes Sci Technol, V3, P722; Vasconcelos Ana Carolina U, 2010, J Oral Sci, V52, P293; Vashist Praveen, 2011, Indian J Community Med, V36, P247, DOI 10.4103/0970-0218.91324; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Yamaguchi M, 1998, IEEE ENG MED BIOL, V17, P59, DOI 10.1109/51.677170	45	50	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101706	10.1371/journal.pone.0101706	http://dx.doi.org/10.1371/journal.pone.0101706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025218	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400019
J	Al-Daghri, NM; Guerini, FR; Al-Attas, OS; Alokail, MS; Alkharfy, KM; Draz, HM; Agliardi, C; Costa, AS; Saulle, I; Mohammed, AK; Biasin, M; Clerici, M				Al-Daghri, Nasser M.; Guerini, Franca R.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Draz, Hossam M.; Agliardi, Cristina; Costa, Andrea S.; Saulle, Irma; Mohammed, Abdul Khader; Biasin, Mara; Clerici, Mario			Vitamin D Receptor Gene Polymorphisms Are Associated with Obesity and Inflammosome Activity	PLOS ONE			English	Article							TYPE-2 DIABETIC SUBJECTS; CARDIOVASCULAR-DISEASE; CIRCULATING ENDOTOXIN; INSULIN-RESISTANCE; IMMUNE ACTIVATION; LIVER-DISEASE; GLUCOSE; INFLAMMATION; LIPOPOLYSACCHARIDE; ADIPOCYTES	To explore the mechanisms underlying the suggested role of the vitamin D/vitamin D receptor (VDR) complex in the pathogenesis of obesity we performed genetic and immunologic analyses in obese and non-obese Saudi individuals without other concomitant chronic diseases. Genomic DNA was genotyped for gene single nucleotide polymorphisms (SNPs) of VDR by allelic discrimination in 402 obese (body mass index -BMI >= 30 kg/m2) and 489 non-obese (BMI<30 kg/m2) Saudis. Q-PCR analyses were performed using an ABI Prism 7000 Sequence Detection System. The inflammosome pathway was analysed by PCR, cytokines and plasma lipopolysaccaride (LPS) concentrations with ELISA assays. Results showed that the VDR SNPs rs731236 (G) (TaqI) and rs1544410 (T) (Bsm-I) minor allele polymorphisms are significantly more frequent in obese individuals (p = 0.009, beta = 0.086 and p = 0.028, beta = 0.072, respectively). VDR haplotypes identified are positively (GTA) (p = 0.008, beta = 1.560); or negatively (ACC) (p = 0.044, beta = 0.766) associated with obesity and higher BMI scores. The GTA "risk" haplotype was characterized by an up-regulation of inflammosome components, a higher production of proinflammatory cytokines (p<0.05) and a lower VDR expression. Plasma LPS concentration was also increased in GTA obese individuals (p<0.05), suggesting an alteration of gut permeability leading to microbial translocation. Data herein indicate that polymorphisms affecting the vitamin D/VDR axis play a role in obesity that is associated with an ongoing degree of inflammation, possibly resulting from alterations of gut permeability and microbial translocation. These results could help the definition of VDR fingerprints that predict an increased risk of developing obesity and might contribute to the identification of novel therapeutic strategies for this metabolic condition.	[Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Draz, Hossam M.; Mohammed, Abdul Khader; Clerici, Mario] King Saud Univ, Coll Sci, Biomarkers Res Program, Dept Biochem, Riyadh 11451, Saudi Arabia; [Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.] King Saud Univ, Coll Sci, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh 11451, Saudi Arabia; [Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia; [Guerini, Franca R.; Agliardi, Cristina; Costa, Andrea S.; Clerici, Mario] ONLUS, Don Gnocchi Fdn, Milan, Italy; [Guerini, Franca R.; Agliardi, Cristina; Costa, Andrea S.; Clerici, Mario] Univ Milan, Milan, Italy; [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia; [Draz, Hossam M.] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada; [Saulle, Irma; Biasin, Mara; Clerici, Mario] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy	King Saud University; King Saud University; King Saud University; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Milan; King Saud University; University of Quebec; Institut national de la recherche scientifique (INRS); University of Milan	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Sci, Biomarkers Res Program, Dept Biochem, Riyadh 11451, Saudi Arabia.	aldaghri2011@gmail.com	Al-Daghri, Nasser/G-7736-2011; Al-Daghri, Nasser/A-8360-2011; biasin, mara/G-7426-2012; Al-okail, Majed S/E-5565-2016; Agliardi, Cristina/K-1401-2016; Costa, Andrea Saul/R-2586-2017; Costa, Andrea Saul/Z-5611-2019	Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; biasin, mara/0000-0003-3671-4235; Al-okail, Majed S/0000-0001-8147-3499; Agliardi, Cristina/0000-0003-2022-3386; Costa, Andrea Saul/0000-0002-7353-157X; Costa, Andrea Saul/0000-0002-7353-157X; Saulle, Irma/0000-0002-8600-2503; Clerici, Mario/0000-0001-5920-6191; Draz, Hossam/0000-0002-7351-3339; Mohammed, Abdul Khader/0000-0002-8774-0014	College of Science Research Center, King Saud University, Riyadh, Saudi Arabia	College of Science Research Center, King Saud University, Riyadh, Saudi Arabia(King Saud University)	This project has been funded by the College of Science Research Center, King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2012, J IMMUNOL, V188, P1325, DOI 10.4049/jimmunol.1101954; Alkharfy KM, 2013, METAB SYNDR RELAT D, V11, P283, DOI 10.1089/met.2012.0068; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; Dee Anne, 2014, BMC Res Notes, V7, P242, DOI 10.1186/1756-0500-7-242; Dixon AN, 2008, INT J CLIN PRACT, V62, P1124, DOI 10.1111/j.1742-1241.2008.01800.x; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Eleftheriadis T, 2010, INT UROL NEPHROL, V42, P181, DOI 10.1007/s11255-009-9541-1; Habib SS, 2013, BIOMED ENVIRON SCI, V26, P94, DOI 10.3967/0895-3988.2013.02.003; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hofer U, 2009, SEMIN IMMUNOPATHOL, V31, P257, DOI 10.1007/s00281-009-0158-3; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P1771, DOI 10.1002/mnfr.201200383; Miller MA, 2009, ATHEROSCLEROSIS, V203, P494, DOI 10.1016/j.atherosclerosis.2008.06.018; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Schuch NJ, 2009, ARQ BRAS ENDOCRINOL, V53, P625, DOI 10.1590/S0004-27302009000500015; Suganami Takayoshi, 2013, Nihon Rinsho, V71, P225; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z; Wong KE, 2011, J BIOL CHEM, V286, P33804, DOI 10.1074/jbc.M111.257568; Yang LN, 2011, CELL IMMUNOL, V271, P173, DOI 10.1016/j.cellimm.2011.06.017; Ye WZ, 2001, EUR J ENDOCRINOL, V145, P181, DOI 10.1530/eje.0.1450181	32	61	65	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102141	10.1371/journal.pone.0102141	http://dx.doi.org/10.1371/journal.pone.0102141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020064	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600049
J	Bozdaganyan, ME; Orekhov, PS; Shaytan, AK; Shaitan, KV				Bozdaganyan, Marine E.; Orekhov, Philipp S.; Shaytan, Alexey K.; Shaitan, Konstantin V.			Comparative Computational Study of Interaction of C-60-Fullerene and Tris-Malonyl-C-60-Fullerene Isomers with Lipid Bilayer: Relation to Their Antioxidant Effect	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; FULLERENE DERIVATIVES; C-60; TRANSLOCATION; CELLS; CARBOXYFULLERENES; MECHANISMS; SIMULATION; MEMBRANES; TOOL	Oxidative stress induced by excessive production of reactive oxygen species (ROS) has been implicated in the etiology of many human diseases. It has been reported that fullerenes and some of their derivatives-carboxyfullerenes-exhibits a strong free radical scavenging capacity. The permeation of C-60-fullerene and its amphiphilic derivatives-C-3-tris-malonic-C-60-fullerene (C-3) and D-3-tris-malonyl-C-60-fullerene (D3)-through a lipid bilayer mimicking the eukaryotic cell membrane was studied using molecular dynamics (MD) simulations. The free energy profiles along the normal to the bilayer composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) for C-60, C-3 and D-3 were calculated. We found that C-60 molecules alone or in clusters spontaneously translocate to the hydrophobic core of the membrane and stay inside the bilayer during the whole period of simulation time. The incorporation of cluster of fullerenes inside the bilayer changes properties of the bilayer and leads to its deformation. In simulations of the tris-malonic fullerenes we discovered that both isomers, C-3 and D-3, adsorb at the surface of the bilayer but only C-3 tends to be buried in the area of the lipid headgroups forming hydrophobic contacts with the lipid tails. We hypothesize that such position has implications for ROS scavenging mechanism in the specific cell compartments.	[Bozdaganyan, Marine E.; Orekhov, Philipp S.; Shaytan, Alexey K.; Shaitan, Konstantin V.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia	Lomonosov Moscow State University	Shaitan, KV (corresponding author), Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia.	k.v.shaitan@molsim.org	Shaytan, Alexey K/D-7306-2012; Bozdaganyan, Marine/ABH-3544-2020; Bozdaganyan, Marine/ABF-2126-2020; Orekhov, Philipp/V-5214-2017	Shaytan, Alexey K/0000-0003-0312-938X; Orekhov, Philipp/0000-0003-4078-4762	Russian Foundation for Basic Research [13-04-01570a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research, http://www.rfbr.ru/rffi/eng, Grant #13-04-01570a. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; [Anonymous], INTERACTIONS; Bedrov D, 2008, J PHYS CHEM B, V112, P2078, DOI 10.1021/jp075149c; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bosi S, 2003, EUR J MED CHEM, V38, P913, DOI 10.1016/j.ejmech.2003.09.005; Corona-Morales AA, 2003, J NEUROSCI RES, V71, P121, DOI 10.1002/jnr.10456; D'Rozario RSG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115102; Ding HM, 2012, ACS NANO, V6, P1230, DOI 10.1021/nn2038862; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiedler SL, 2010, BIOPHYS J, V99, P144, DOI 10.1016/j.bpj.2010.03.039; Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X; Fumelli C, 2000, J INVEST DERMATOL, V115, P835, DOI 10.1046/j.1523-1747.2000.00140.x; Harhaji L, 2007, EUR J PHARMACOL, V568, P89, DOI 10.1016/j.ejphar.2007.04.041; HEDBERG K, 1991, SCIENCE, V254, P410, DOI 10.1126/science.254.5030.410; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang YL, 1998, EUR J BIOCHEM, V254, P38, DOI 10.1046/j.1432-1327.1998.2540038.x; Kamat JP, 2000, TOXICOLOGY, V155, P55, DOI 10.1016/S0300-483X(00)00277-8; Kraszewski S, 2011, ACS NANO, V5, P8571, DOI 10.1021/nn201952c; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Levtsova O. V., 2011, Biofizika, V56, P242; Lin AMY, 1999, J NEUROCHEM, V72, P1634, DOI 10.1046/j.1471-4159.1999.721634.x; Lin AMY, 2002, NEUROSCI RES, V43, P317, DOI 10.1016/S0168-0102(02)00056-1; Marchesan S, 2005, BIOORG MED CHEM LETT, V15, P3615, DOI 10.1016/j.bmcl.2005.05.069; Minozzi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023187; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pronk S., 2013, BIOINFORMATICS; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Qiao R, 2007, NANO LETT, V7, P614, DOI 10.1021/nl062515f; Straface E, 1999, FEBS LETT, V454, P335, DOI 10.1016/S0014-5793(99)00812-1; TOCANNE JF, 1994, PROG LIPID RES, V33, P203, DOI 10.1016/0163-7827(94)90027-2; VANBUUREN AR, 1993, J PHYS CHEM-US, V97, P9206, DOI 10.1021/j100138a023; Wang IC, 1999, J MED CHEM, V42, P4614, DOI 10.1021/jm990144s; Wong-Ekkabut J, 2008, NAT NANOTECHNOL, V3, P363, DOI 10.1038/nnano.2008.130	38	29	30	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102487	10.1371/journal.pone.0102487	http://dx.doi.org/10.1371/journal.pone.0102487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019215	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600086
J	Many, AM; Brown, AMC				Many, Alexander M.; Brown, Anthony M. C.			Both Canonical and Non-Canonical Wnt Signaling Independently Promote Stem Cell Growth in Mammospheres	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; TYROSINE KINASE ROR2; N-TERMINAL KINASE; TRANSGENIC MICE; SELF-RENEWAL; TGF-BETA; STEM/PROGENITOR CELLS; RECEPTOR; PROTEINS; INDUCE	The characterization of mammary stem cells, and signals that regulate their behavior, is of central importance in understanding developmental changes in the mammary gland and possibly for targeting stem-like cells in breast cancer. The canonical Wnt/beta-catenin pathway is a signaling mechanism associated with maintenance of self-renewing stem cells in many tissues, including mammary epithelium, and can be oncogenic when deregulated. Wnt1 and Wnt3a are examples of ligands that activate the canonical pathway. Other Wnt ligands, such as Wnt5a, typically signal via non-canonical, beta-cateninin-dependent, pathways that in some cases can antagonize canonical signaling. Since the role of non-canonical Wnt signaling in stem cell regulation is not well characterized, we set out to investigate this using mammosphere formation assays that reflect and quantify stem cell properties. Ex vivo mammosphere cultures were established from both wild-type and Wnt1 transgenic mice and were analyzed in response to manipulation of both canonical and non-canonical Wnt signaling. An increased level of mammosphere formation was observed in cultures derived from MMTV-Wnt1 versus wild-type animals, and this was blocked by treatment with Dkk1, a selective inhibitor of canonical Wnt signaling. Consistent with this, we found that a single dose of recombinant Wnt3a was sufficient to increase mammosphere formation in wild-type cultures. Surprisingly, we found that Wnt5a also increased mammosphere formation in these assays. We confirmed that this was not caused by an increase in canonical Wnt/beta-catenin signaling but was instead mediated by non-canonical Wnt signals requiring the receptor tyrosine kinase Ror2 and activity of the Jun N-terminal kinase, JNK. We conclude that both canonical and non-canonical Wnt signals have positive effects promoting stem cell activity in mammosphere assays and that they do so via independent signaling mechanisms.	[Many, Alexander M.; Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA	Cornell University	Brown, AMC (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA.	amcbrown@med.cornell.edu			New York Stem Cell Science [C024286]; National Institutes of Health [R25 CA105012, R01 CA123238]; Strang Cancer Prevention Institute; NATIONAL CANCER INSTITUTE [R01CA123238, R25CA105012] Funding Source: NIH RePORTER	New York Stem Cell Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Strang Cancer Prevention Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by New York Stem Cell Science (http://stemcell.ny.gov/) grant C024286 (AB and AM), National Institutes of Health (http://www.nih.gov/) grant R25 CA105012 (AM), Strang Cancer Prevention Institute, and National Institutes of Health grant R01 CA123238 (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Alexander CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008037; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dong QX, 2013, STEM CELL RES, V10, P396, DOI 10.1016/j.scr.2013.01.007; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jonsson M, 2002, CANCER RES, V62, P409; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067811; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Many AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2631; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pavlovich AL, 2011, EXP CELL RES, V317, P1872, DOI 10.1016/j.yexcr.2011.03.017; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	87	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101800	10.1371/journal.pone.0101800	http://dx.doi.org/10.1371/journal.pone.0101800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019931	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600029
J	Ravva, SV; Sarreal, CZ; Mandrell, RE				Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.			Strain Differences in Fitness of Escherichia coli O157:H7 to Resist Protozoan Predation and Survival in Soil	PLOS ONE			English	Article							BIOFILM FORMATION; ACID RESISTANCE; DAIRY LAGOONS; WASTE-WATER; O157-H7; CURLI; GROWTH; ADHERENCE; BACTERIA; IDENTIFICATION	Escherichia coli O157:H7 (EcO157) associated with the 2006 spinach outbreak appears to have persisted as the organism was isolated, three months after the outbreak, from environmental samples in the produce production areas of the central coast of California. Survival in harsh environments may be linked to the inherent fitness characteristics of EcO157. This study evaluated the comparative fitness of outbreak-related clinical and environmental strains to resist protozoan predation and survive in soil from a spinach field in the general vicinity of isolation of strains genetically indistinguishable from the 2006 outbreak strains. Environmental strains from soil and feral pig feces survived longer (11 to 35 days for 90% decreases, D-value) with Vorticella microstoma and Colpoda aspera, isolated previously from dairy wastewater; these D-values correlated (P<0.05) negatively with protozoan growth. Similarly, strains from cow feces, feral pig feces, and bagged spinach survived significantly longer in soil compared to clinical isolates indistinguishable by 11-loci multi-locus variable-number tandem-repeat analysis. The curli-positive (C+) phenotype, a fitness trait linked with attachment in ruminant and human gut, decreased after exposure to protozoa, and in soils only C- cells remained after 7 days. The C+ phenotype correlated negatively with D-values of EcO157 exposed to soil (r(s) = -0.683; P = 0.036), Vorticella (rs = -0.465; P = 0.05) or Colpoda (r(s) = -0.750; P = 0.0001). In contrast, protozoan growth correlated positively with C+ phenotype (Vorticella, r(s) = 0.730, P = 0.0004; Colpoda, r(s) = 0.625, P = 0.006) suggesting a preference for consumption of C+ cells, although they grew on C- strains also. We speculate that the C- phenotype is a selective trait for survival and possibly transport of the pathogen in soil and water environments.	[Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA 94710 USA	United States Department of Agriculture (USDA)	Ravva, SV (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA 94710 USA.	subbarao.ravva@ars.usda.gov	Mandrell, Robert E/O-9814-2018		U.S. Department of Agriculture (USDA), Agricultural Research Service CRIS project [5325-42000-046]; National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2006-55212-16927, 2007-35212-18239]	U.S. Department of Agriculture (USDA), Agricultural Research Service CRIS project; National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	The work was funded by the U.S. Department of Agriculture (USDA), Agricultural Research Service CRIS project 5325-42000-046 and partly by the National Research Initiative Competitive Grant nos. 2006-55212-16927 and 2007-35212-18239 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery LM, 2004, SOIL BIOL BIOCHEM, V36, P2101, DOI 10.1016/j.soilbio.2004.05.018; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Berry ED, 2005, J ENVIRON QUAL, V34, P656, DOI 10.2134/jeq2005.0656; Biscola FT, 2011, APPL ENVIRON MICROB, V77, P2201, DOI 10.1128/AEM.01920-10; Brzuszkiewicz E, 2009, GENOME DYNAM, V6, P110, DOI 10.1159/000235766; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; CASIDA LE, 1989, APPL ENVIRON MICROB, V55, P1857, DOI 10.1128/AEM.55.8.1857-1859.1989; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Cookson AL, 2002, INT J MED MICROBIOL, V292, P195, DOI 10.1078/1438-4221-00203; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2010, APPL ENVIRON MICROB, V76, P3398, DOI 10.1128/AEM.02373-09; Desmarchelier PM, 1998, J CLIN MICROBIOL, V36, P1801, DOI 10.1128/JCM.36.6.1801-1804.1998; Fratamico PM, 2000, J FOOD PROTECT, V63, P1032, DOI 10.4315/0362-028X-63.8.1032; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; GURIJALA KR, 1990, APPL ENVIRON MICROB, V56, P1631, DOI 10.1128/AEM.56.6.1631-1635.1990; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jenkins MB, 2011, ENVIRON SCI TECHNOL, V45, P1853, DOI 10.1021/es1032019; Jones DL, 1999, SOIL USE MANAGE, V15, P76, DOI 10.1111/j.1475-2743.1999.tb00069.x; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Mandrell R. E., 2009, MICROBIAL SAFETY FRE, P5; Newsome AL, 1998, APPL ENVIRON MICROB, V64, P1688; Oh DH, 2009, J FOOD PROTECT, V72, P503, DOI 10.4315/0362-028X-72.3.503; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x; Ravva SV, 2007, APPL ENVIRON MICROB, V73, P2191, DOI 10.1128/AEM.02213-06; Ravva SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054782; Ravva SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015671; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; SCHEUERMAN PR, 1988, ARCH MICROBIOL, V150, P320, DOI 10.1007/BF00408301; Seo S, 2012, APPL ENVIRON MICROB, V78, P5882, DOI 10.1128/AEM.01095-12; Topp E, 2003, FEMS MICROBIOL ECOL, V44, P303, DOI 10.1016/S0168-6496(03)00055-2; Uhlich GA, 2002, INFECT IMMUN, V70, P395, DOI 10.1128/IAI.70.1.395-399.2002; Wang GD, 1998, J FOOD PROTECT, V61, P662, DOI 10.4315/0362-028X-61.6.662	36	8	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102412	10.1371/journal.pone.0102412	http://dx.doi.org/10.1371/journal.pone.0102412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019377	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600079
J	Nishiyama, K; Hirai, K				Nishiyama, Keiji; Hirai, Keisuke			The Melatonin Agonist Ramelteon Induces Duration-Dependent Clock Gene Expression through cAMP Signaling in Pancreatic INS-1 beta-Cells	PLOS ONE			English	Article							INSULIN-SECRETION; PARS TUBERALIS; SUPRACHIASMATIC NUCLEI; RAT-1 FIBROBLASTS; MESSENGER-RNA; RECEPTOR MT1; SENSITIZATION; METABOLISM; ISLETS; PHOSPHORYLATION	Prolonged exposure to melatonin improves glycemic control in animals. Although glucose metabolism is controlled by circadian clock genes, little is known about the role of melatonin signaling and its duration in the regulation of clock gene expression in pancreatic beta-cells. Activation of MT1 and MT2 melatonin receptors inhibits cAMP signaling, which mediates clock gene expression. Therefore, this study investigated exposure duration-dependent alterations in cAMP element-binding protein (CREB) phosphorylation and clock gene expression that occur during and after exposure to ramelteon, a selective melatonin agonist used to treat insomnia. In rat INS-1 cells, a pancreatic beta-cell line endogenously expressing melatonin receptors, ramelteon persistently decreased CREB phosphorylation during the treatment period (2-14 h), whereas the subsequent washout induced an enhancement of forskolin-stimulated CREB phosphorylation in a duration and concentration-dependent manner. This augmentation was blocked by forskolin or the melatonin receptor antagonist luzindole. Similarly, gene expression analyses of 7 clock genes revealed the duration dependency of the effects of ramelteon on Rev-erb alpha and Bmal1 expression through melatonin receptor-mediated cAMP signaling; longer exposure times (14 h) resulted in greater increases in the expression and signaling of Rev-erb alpha, which is related to b-cell functions. Interestingly, this led to amplified oscillatory Rev-erb alpha and Bmal1 expression after agonist washout and forskolin stimulation. These results provide new insights into the duration-dependent effects of ramelteon on clock gene expression in INS-1 cells and may improve the understanding of its effect in vivo. The applicability of these results to pancreatic islets awaits further investigation.	[Nishiyama, Keiji; Hirai, Keisuke] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, CNS Drug Discovery Unit, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Hirai, K (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, CNS Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	keisuke.hirai@takeda.com			Takeda Pharmaceutical Company Ltd.	Takeda Pharmaceutical Company Ltd.(Takeda Pharmaceutical Company Ltd)	This study was supported by Takeda Pharmaceutical Company Ltd. The publication steering committee of Takeda Pharmaceutical Company Ltd. played a role in the decision to publish. One of the authors (K. H.), a senior director of Takeda, is a member of the committee and is responsible for the decision on the present publication. The funder provided support in the form of salaries for authors KN and KH, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript.	Agez L, 2007, NEUROSCIENCE, V144, P522, DOI 10.1016/j.neuroscience.2006.09.030; Agez L, 2009, J PINEAL RES, V46, P95, DOI 10.1111/j.1600-079X.2008.00636.x; Agil A, 2012, J PINEAL RES, V52, P203, DOI 10.1111/j.1600-079X.2011.00928.x; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Barrett P, 2012, J PINEAL RES, V52, P376, DOI 10.1111/j.1600-079X.2011.00963.x; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bazwinsky-Wutschke I, 2012, J PINEAL RES, V53, P344, DOI 10.1111/j.1600-079X.2012.01004.x; Alonso-Vale MIC, 2008, J PINEAL RES, V45, P422, DOI 10.1111/j.1600-079X.2008.00610.x; Dardente H, 2003, MOL BRAIN RES, V114, P101, DOI 10.1016/S0169-328X(03)00134-7; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Garfinkel D, 2011, DIABETES METAB SYNDR, V4, P307, DOI 10.2147/DMSO.S23904; Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Imbesi M, 2009, J PINEAL RES, V46, P87, DOI 10.1111/j.1600-079X.2008.00634.x; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Muhlbauer E, 2012, J PINEAL RES, V52, P446, DOI 10.1111/j.1600-079X.2012.00959.x; Muhlbauer E, 2007, J PINEAL RES, V42, P105, DOI 10.1111/j.1600-079X.2006.00399.x; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Schwartz WJ, 2005, NEUROSCI LETT, V385, P87, DOI 10.1016/j.neulet.2005.05.018; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Uchikawa O, 2002, J MED CHEM, V45, P4222, DOI 10.1021/jm0201159; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; Von Gall C, 2005, ANN NY ACAD SCI, V1040, P508, DOI 10.1196/annals.1327.105; Wagner GC, 2007, EUR J NEUROSCI, V25, P485, DOI 10.1111/j.1460-9568.2006.05291.x; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022; Witt-Enderby PA, 2000, CELL MOTIL CYTOSKEL, V46, P28, DOI 10.1002/(SICI)1097-0169(200005)46:1<28::AID-CM4>3.0.CO;2-5; Witt-Enderby PA, 1998, ENDOCRINOLOGY, V139, P3064, DOI 10.1210/en.139.7.3064; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Xiang S, 2012, BREAST CANCER-BASIC, V6, P137, DOI 10.4137/BCBCR.S9673; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X	46	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102073	10.1371/journal.pone.0102073	http://dx.doi.org/10.1371/journal.pone.0102073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013953	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400063
J	Loudon, JE; Grobler, JP; Sponheimer, M; Moyer, K; Lorenz, JG; Turner, TR				Loudon, James E.; Grobler, J. Paul; Sponheimer, Matt; Moyer, Kimberly; Lorenz, Joseph G.; Turner, Trudy R.			Using the Stable Carbon and Nitrogen Isotope Compositions of Vervet Monkeys (Chlorocebus pygerythrus) to Examine Questions in Ethnoprimatology	PLOS ONE			English	Article							CERCOPITHECUS-AETHIOPS; BONE-COLLAGEN; 4 SITES; HAIR; DIET; DELTA-N-15; RATIOS; VARIABILITY; DELTA-C-13; PATTERNS	This study seeks to understand how humans impact the dietary patterns of eight free-ranging vervet monkey (Chlorocebus pygerythrus) groups in South Africa using stable isotope analysis. Vervets are omnivores that exploit a wide range of habitats including those that have been anthropogenically-disturbed. As humans encroach upon nonhuman primate landscapes, human-nonhuman primate interconnections become increasingly common, which has led to the rise of the field of ethnoprimatology. To date, many ethnoprimatological studies have examined human-nonhuman primate associations largely in qualitative terms. By using stable carbon (delta C-13) and nitrogen (delta N-15) isotope analysis, we use quantitative data to understand the degree to which humans impact vervet monkey dietary patterns. Based on initial behavioral observations we placed the eight groups into three categories of anthropogenic disturbance (low, mid, and high). Using delta C-13 and delta N-15 values we estimated the degree to which each group and each anthropogenically-disturbed category was consuming C-4 plants (primarily sugar cane, corn, or processed foods incorporating these crops). delta C-13 values were significantly different between groups and categories of anthropogenic-disturbance. delta N-15 values were significantly different at the group level. The two vervet groups with the highest consumption of C-4 plants inhabited small nature reserves, appeared to interact with humans only sporadically, and were initially placed in the mid level of anthropogenic-disturbance. However, further behavioral observations revealed that the high delta C-13 values exhibited by these groups were linked to previously unseen raiding of C-4 crops. By revealing these cryptic feeding patterns, this study illustrates the utility of stable isotopes analysis for some ethnoprimatological questions.	[Loudon, James E.] E Carolina Univ, Dept Anthropol, Greenville, NC 27858 USA; [Loudon, James E.; Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Grobler, J. Paul; Turner, Trudy R.] Univ Orange Free State, Dept Genet, Bloemfontein, South Africa; [Moyer, Kimberly] Univ Colorado, Denver, CO 80202 USA; [Lorenz, Joseph G.] Cent Washington Univ, Dept Anthropol, Ellensburg, WI USA; [Turner, Trudy R.] Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA	University of North Carolina; East Carolina University; University of Colorado System; University of Colorado Boulder; University of the Free State; University of Colorado System; University of Colorado Denver; University of Wisconsin System; University of Wisconsin Milwaukee	Loudon, JE (corresponding author), E Carolina Univ, Dept Anthropol, Greenville, NC 27858 USA.	loudonj@ecu.edu	; Sponheimer, Matt/A-6075-2013	Grobler, Paul/0000-0002-5913-7031; Sponheimer, Matt/0000-0002-8743-1123	National Science Foundation [BCS 0938969]; National Institutes of Health [R01RR016300]; Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR016300] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Science Foundation (BCS 0938969); National Institutes of Health (R01RR016300); The Fulbright Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Cardini A, 2013, J BIOGEOGR, V40, P370, DOI 10.1111/j.1365-2699.2012.02783.x; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Codron D, 2005, S AFR J SCI, V101, P245; Codron D, 2008, BIOL J LINN SOC, V94, P755, DOI 10.1111/j.1095-8312.2008.01028.x; Codron J, 2013, J QUATERNARY SCI, V28, P301, DOI 10.1002/jqs.2614; Cramer JD, 2013, AM J PRIMATOL, V75, P752, DOI 10.1002/ajp.22156; Crowley BE, 2012, INT J PRIMATOL, V33, P673, DOI 10.1007/s10764-012-9582-7; DRACOPOLI NC, 1983, AM J PHYS ANTHROPOL, V61, P39, DOI 10.1002/ajpa.1330610105; Fourie NH, 2008, AM J PHYS ANTHROPOL, V135, P121, DOI 10.1002/ajpa.20713; Fuentes A., 2002, PRIMATES FACE FACE; Fuentes A, 2012, ANNU REV ANTHROPOL, V41, P101, DOI 10.1146/annurev-anthro-092611-145808; Fuentes A, 2010, AM J PRIMATOL, V72, P841, DOI 10.1002/ajp.20844; Gonedele Bi Sery, 2009, Primate Conservation, V24, P91; Grobler JP, 2010, S AFR J WILDL RES, V40, P163, DOI 10.3957/056.040.0208; GROBLER P., 2006, ECOLOGICAL ENV ANTHR, V2, P12; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Jones-Engel Lisa, 2011, P295; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; Loudon JE, 2007, AM J PHYS ANTHROPOL, V133, P978, DOI 10.1002/ajpa.20605; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Murphy BP, 2006, FUNCT ECOL, V20, P1062, DOI 10.1111/j.1365-2435.2006.01186.x; O'Regan HJ, 2008, J HUM EVOL, V55, P617, DOI 10.1016/j.jhevol.2008.05.001; Pampush JD., 2010, THESIS U WISCONSIN M; RICHARD AF, 1989, INT J PRIMATOL, V10, P569, DOI 10.1007/BF02739365; Riley E. P., 2006, ECOLOGICAL ENV ANTHR, V2, P75; Riley EP, 2011, PRIMATES PERSPECTIVE, P676; Riley EP, 2013, TECH ECOL CONSERVAT, P128; Sandberg PA, 2012, AM J PRIMATOL, V74, P969, DOI 10.1002/ajp.22053; Schoeninger MJ, 1997, AM J PHYS ANTHROPOL, V103, P69, DOI 10.1002/(SICI)1096-8644(199705)103:1<69::AID-AJPA5>3.0.CO;2-8; Schoeninger MJ, 1998, OECOLOGIA, V113, P222, DOI 10.1007/s004420050372; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schurr MR, 2012, PRIMATES, V53, P31, DOI 10.1007/s10329-011-0268-0; SCHWARCZ HP, 1985, J ARCHAEOL SCI, V12, P187, DOI 10.1016/0305-4403(85)90020-2; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Sponheimer M, 2001, OECOLOGIA, V126, P153, DOI 10.1007/s004420000498; Sponheimer M, 2009, AM J PHYS ANTHROPOL, V140, P661, DOI 10.1002/ajpa.21111; Struhsaker TT, 1967, KENYA ECOLOGY, V48, P892; TAPPEN NC, 1960, CURR ANTHROPOL, V1, P91, DOI 10.1086/200088; TURNER TR, 1994, FOLIA PRIMATOL, V63, P177, DOI 10.1159/000156815; Turner TR, 1997, AM J PHYS ANTHROPOL, V103, P19, DOI 10.1002/(SICI)1096-8644(199705)103:1<19::AID-AJPA3>3.0.CO;2-8; TURNER TR, 1981, AM J PHYS ANTHROPOL, V55, P225, DOI 10.1002/ajpa.1330550211; VOGEL JC, 1978, S AFR J SCI, V74, P298	47	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100758	10.1371/journal.pone.0100758	http://dx.doi.org/10.1371/journal.pone.0100758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010211	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800006
J	Quesada-Romero, L; Mena-Ulecia, K; Tiznado, W; Caballero, J				Quesada-Romero, Luisa; Mena-Ulecia, Karel; Tiznado, William; Caballero, Julio			Insights into the Interactions between Maleimide Derivates and GSK3 beta Combining Molecular Docking and QSAR	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SUBSTITUTED PYRAZOLE DERIVATIVES; B-RAF KINASE; PANCREATIC-CANCER; CELL-SURVIVAL; ACTIVE-SITE; INHIBITORS; GSK-3-BETA; DYNAMICS; 3-BETA	Many protein kinase (PK) inhibitors have been reported in recent years, but only a few have been approved for clinical use. The understanding of the available molecular information using computational tools is an alternative to contribute to this process. With this in mind, we studied the binding modes of 77 maleimide derivates inside the PK glycogen synthase kinase 3 beta (GSK3 beta) using docking experiments. We found that the orientations that these compounds adopt inside GSK3 beta binding site prioritize the formation of hydrogen bond (HB) interactions between the maleimide group and the residues at the hinge region (residues Val135 and Asp133), and adopt propeller-like conformations (where the maleimide is the propeller axis and the heterocyclic substituents are two slanted blades). In addition, quantitative structure-activity relationship (QSAR) models using CoMSIA methodology were constructed to explain the trend of the GSK3 beta inhibitory activities for the studied compounds. We found a model to explain the structure-activity relationship of non-cyclic maleimide (NCM) derivatives (54 compounds). The best CoMSIA model (training set included 44 compounds) included steric, hydrophobic, and HB donor fields and had a good Q(2) value of 0.539. It also predicted adequately the most active compounds contained in the test set. Furthermore, the analysis of the plots of the steric CoMSIA field describes the elements involved in the differential potency of the inhibitors that can be considered for the selection of suitable inhibitors.	[Quesada-Romero, Luisa; Caballero, Julio] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Mena-Ulecia, Karel; Tiznado, William] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Santiago, Chile	Universidad de Talca; Universidad Andres Bello	Caballero, J (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile.	jcaballero@utalca.cl	Tiznado, william/G-7479-2014; Caballero, Julio/G-3654-2014	Tiznado, william/0000-0002-6061-8879; Caballero, Julio/0000-0003-0182-1444; KAREL, MENA-ULECIA/0000-0001-6651-511X; Quesada Romero, Luisa/0000-0002-7607-4853	Fondecyt, Chile [1130141]	Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the grant no. 1130141 (J.C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate-Morales J, 2010, J CHEM INF MODEL, V50, P110, DOI 10.1021/ci900302z; Alzate-Morales JH, 2010, J CHEM INF MODEL, V50, P1101, DOI 10.1021/ci100049h; [Anonymous], 1699, SYBYL VERS 7 3; [Anonymous], 2011, SUIT 2011 LIGPREP VE; Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; Bruce L., 1993, J COMPUT AID MOL DES, V7, P587; Caballero J, 2012, EUR J MED CHEM, V58, P272, DOI 10.1016/j.ejmech.2012.10.020; Caballero J, 2012, MED CHEM RES, V21, P1912, DOI 10.1007/s00044-011-9714-1; Caballero J, 2012, CURR PHARM DESIGN, V18, P2946, DOI 10.2174/138161212800672705; Caballero J, 2011, J CHEM INF MODEL, V51, P2920, DOI 10.1021/ci200306w; Caballero J, 2011, CHEM BIOL DRUG DES, V78, P631, DOI 10.1111/j.1747-0285.2011.01186.x; Caballero J, 2011, J COMPUT AID MOL DES, V25, P349, DOI 10.1007/s10822-011-9425-1; Darrington RS, 2012, INT J CANCER, V131, pE872, DOI 10.1002/ijc.27620; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fang JS, 2011, J CHEM INF MODEL, V51, P1431, DOI 10.1021/ci2001154; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gaisina IN, 2009, J MED CHEM, V52, P1853, DOI 10.1021/jm801317h; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kozikowski AP, 2007, J AM CHEM SOC, V129, P8328, DOI 10.1021/ja068969w; Kuo GH, 2003, J MED CHEM, V46, P4021, DOI 10.1021/jm030115o; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; Ojha PK, 2011, CHEMOMETR INTELL LAB, V107, P194, DOI 10.1016/j.chemolab.2011.03.011; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Zhang HC, 2007, BIOORG MED CHEM LETT, V17, P2863, DOI 10.1016/j.bmcl.2007.02.059; Zhang HC, 2003, BIOORG MED CHEM LETT, V13, P3049, DOI 10.1016/S0960-894X(03)00644-9	36	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102212	10.1371/journal.pone.0102212	http://dx.doi.org/10.1371/journal.pone.0102212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010341	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800083
J	Zeynalov, E; Rezvani, N; Miyazaki, C; Liu, XG; Littleton-Kearney, MT				Zeynalov, Emil; Rezvani, Niloofar; Miyazaki, Chikao; Liu, Xiaoguang; Littleton-Kearney, Marguerite T.			Reproductive Senescence Blunts Response of Estrogen Receptor-alpha Expression to Estrogen Treatment in Rat Post-Ischemic Cerebral Microvessels	PLOS ONE			English	Article							FEMALE RATS; VASCULAR ACTIONS; BLOOD-VESSELS; PIAL ARTERY; STROKE; AGE; BRAIN; SEX; DEPRIVATION; THERAPY	Background: Several studies demonstrate that estrogen treatment improves cerebral blood flow in ischemic brain regions of young ovariectomized (OVX) rats. Estrogen receptor-alpha (ER-alpha) may mediate estrogen's beneficial actions via its effects on the cerebral microvasculature. However, estrogen-derived benefit may be attenuated in aged, reproductively senescent (RS) rats. Our goal was to determine the effects of aging, estrogen deprivation and estrogen repletion with oral conjugated estrogens (CE) on postischemic cerebral microvascular protein expression of ER-alpha and ER-beta. Methods: Fisher-344 (n = 37) female rats were randomly divided into the following groups: OVX, OVX CE-treated, RS untreated, and RS CE-treated. After 30 days pretreatment with CE (0.01 mg/kg) rats were subjected to 15 min. transient global cerebral ischemia. Non-ischemic naive, OVX and RS rats were used as controls. Expression of ER-alpha and ER-beta in isolated cortical cerebral microvessels (20 to 100 mu m in diameter) was assessed using Western blot and immunohistochemistry techniques. Results: Age and reproductive status blunted nonischemic ER-alpha expression in microvessels of OVX rats (0.31 +/- 0.05) and RS rats (0.33 +/- 0.06) compared to naive rats (0.45 +/- 0.02). Postischemic microvascular expression of ER-alpha in OVX rats (0.01 +/- 0.0) was increased by CE treatment (0.04 +/- 0.01). Expression of ER-alpha in microvessels of RS rats (0.03 +/- 0.02) was unaffected by CE treatment (0.01 +/- 0.02). Western blot data are presented as a ratio of ER-alpha or ER-beta proteins to beta-actin and. Oral CE treatment had no effect on ER-beta expression in postischemic microvessels of OVX and RS rats. Statistical analysis was performed by One-Way ANOVA and a Newman-Keuls or Student's post-hoc test. Conclusion: Chronic treatment with CE increases ER-alpha but not ER-beta expression in cerebral microvessels of OVX rats. Aging appears to reduce the normal ability of estrogen to increase ER-alpha expression in postischemic cerebral microvessels.	[Zeynalov, Emil; Rezvani, Niloofar; Littleton-Kearney, Marguerite T.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Miyazaki, Chikao; Liu, Xiaoguang] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Zeynalov, E (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	emil.zeynalov@healthonecares.com			National Institutes of Health (NIH) [R01NR005339]; Ruth L. Kirshstein National Research Service Award; NIH [GM075774-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005339] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirshstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by National Institutes of Health (NIH) grant R01NR005339, the Ruth L. Kirshstein National Research Service Award, and NIH Clinician-Scientist Award T-32, ID No: GM075774-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell Cheryl, 2009, Curr Treat Options Cardiovasc Med, V11, P241; Geary GG, 1998, BRIT J PHARMACOL, V123, P1533, DOI 10.1038/sj.bjp.0701761; Jesmin S, 2003, J CEREBR BLOOD F MET, V23, P181, DOI 10.1097/01.WCB.0000043341.09; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Li M, 2009, MICROCIRCULATION, V16, P403, DOI 10.1080/10739680902827738; Littleton-Kearney MT, 2005, J CEREBR BLOOD F MET, V25, P421, DOI 10.1038/sj.jcbfm.9600052; Lobo RA, 2007, CLIMACTERIC, V10, P27, DOI 10.1080/13697130701550903; LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193; Macrae IM, 2006, BIOCHEM SOC T, V34, P1362, DOI 10.1042/BST0341362; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Mendelsohn ME, 2002, AM J CARDIOL, V90, p3F, DOI 10.1016/S0002-9149(02)02418-9; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Murata T, 2013, STROKE, V44, P779, DOI 10.1161/STROKEAHA.112.678177; Ospina JA, 2003, AM J PHYSIOL-HEART C, V285, pH241, DOI 10.1152/ajpheart.00018.2003; Pinna C, 2008, HYPERTENSION, V51, P1210, DOI 10.1161/HYPERTENSIONAHA.107.106807; Qin XY, 2005, J CEREBR BLOOD F MET, V25, P1041, DOI 10.1038/sj.jcbfm.9600105; Razmara A, 2008, J PHARMACOL EXP THER, V325, P782, DOI 10.1124/jpet.107.134072; RODEGHIERO F, 1990, RES CLIN LAB, V20, P143; Sandoval KE, 2011, MICROVASC RES, V81, P198, DOI 10.1016/j.mvr.2010.12.007; SASS B, 1975, J NATL CANCER I, V54, P1449, DOI 10.1093/jnci/54.6.1449; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Sharma N, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn298; Smiley DA, 2009, CURR MED CHEM, V16, P1863, DOI 10.2174/092986709788186093; Sohrabji F, 2005, ANN NY ACAD SCI, V1052, P75, DOI 10.1196/annals.1347.006; Sone K, 2007, EXP ANIM TOKYO, V56, P139, DOI 10.1538/expanim.56.139; Stirone C, 2003, AM J PHYSIOL-ENDOC M, V284, pE184, DOI 10.1152/ajpendo.00165.2002; Thakur M, 2008, BIOGERONTOLOGY, V9, P467, DOI 10.1007/s10522-008-9166-2; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; Vehkavaara S, 2000, CIRCULATION, V102, P2687, DOI 10.1161/01.CIR.102.22.2687; Wilson ME, 2002, MECH AGEING DEV, V123, P593, DOI 10.1016/S0047-6374(01)00406-7; Wynne FL, 2004, HYPERTENSION, V43, P405, DOI 10.1161/01.HYP.0000111833.82664.0c; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102194	10.1371/journal.pone.0102194	http://dx.doi.org/10.1371/journal.pone.0102194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010766	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800079
J	Cui, JH; Du, XL; Liu, H; Hu, GC; Lv, GP; Xu, BH; Yang, XR; Li, W; Cui, ZG				Cui, Jinghua; Du, Xiaoli; Liu, Hui; Hu, Guangchun; Lv, Guoping; Xu, Baohong; Yang, Xiaorong; Li, Wei; Cui, Zhigang			The Genotypic Characterization of Cronobacter spp. Isolated in China	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII; INFANT FORMULA; GENUS; TURICENSIS; INFECTION; OUTBREAK; PROPOSAL; MILK; NOV.; FOOD	Cronobacter spp. (Enterobacter sakazakii) is an important pathogen contaminating powdered infant formula (PIF). To describe the genotypic diversity of Cronobacter isolated in China, we identified the isolates using fusA allele sequencing, and subtyped all of the isolates using pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and multiple-locus variable-number tandem-repeat analysis (MLVA). A total of 105 isolates were identified, which included C. sakazakii (58 isolates), C. malonaticus (30 isolates), C. dublinensis (11 isolates), C. turicensis (5 isolates), and C. muytjensii (1 isolate). These isolates were showed to have 85 PFGE-patterns, 71 sequence types (STs), and 55 MLVA-patterns. Comparisons among the three molecular subtyping methods revealed that the PFGE method was the most distinguishable tool in identifying clusters of Cronobacter spp. through DNA fingerprinting, and MLST method came second. However, ESTR-1, ESTR-2, ESTR-3, and ESTR-4 were not effective loci for subtyping Cronobacter spp. such that the MLVA method requires further improvement.	[Cui, Jinghua; Du, Xiaoli; Li, Wei; Cui, Zhigang] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liu, Hui; Hu, Guangchun] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Peoples R China; [Lv, Guoping; Xu, Baohong] Shijiazhuang Municipal Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China; [Yang, Xiaorong] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Cui, ZG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	cuizhigang@icdc.cn			National Science and Technology Key Project, China [2012ZX10004-215]	National Science and Technology Key Project, China	This study was supported by the National Science and Technology Key Project, China (No. 2012ZX10004-215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSENI A, 1987, J HOSP INFECT, V9, P143, DOI 10.1016/0195-6701(87)90052-1; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Brady C, 2013, SYST APPL MICROBIOL, V36, P309, DOI 10.1016/j.syapm.2013.03.005; Brengi SP, 2012, FOODBORNE PATHOG DIS, V9, P861, DOI 10.1089/fpd.2012.1161; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Edelson-Mammel SG, 2005, J FOOD PROTECT, V68, P1900, DOI 10.4315/0362-028X-68.9.1900; El-Sharoud WM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-24; Farber JM, 2004, LANCET, V363, P5, DOI 10.1016/S0140-6736(03)15244-0; Friedemann M, 2009, EUR J CLIN MICROBIOL, V28, P1297, DOI 10.1007/s10096-009-0779-4; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; GALLAGHER PG, 1991, PEDIATR RADIOL, V21, P135, DOI 10.1007/BF02015629; Gosney MA, 2006, EUR J INTERN MED, V17, P185, DOI 10.1016/j.ejim.2005.11.010; Grim CJ, 2012, APPL ENVIRON MICROB, V78, P6035, DOI 10.1128/AEM.01457-12; Iversen C, 2004, INT J FOOD MICROBIOL, V96, P133, DOI 10.1016/j.ijfoodmicro.2004.01.024; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Joseph S, 2013, MOL CELL PROBE, V27, P137, DOI 10.1016/j.mcp.2013.02.002; Joseph S, 2012, INT J SYST EVOL MICR, V62, P1277, DOI 10.1099/ijs.0.032292-0; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Kim JB, 2008, YONSEI MED J, V49, P1017, DOI 10.3349/ymj.2008.49.6.1017; Kim JB, 2011, J MICROBIOL BIOTECHN, V21, P509, DOI 10.4014/jmb.1007.07059; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Mullane NR, 2008, APPL ENVIRON MICROB, V74, P1223, DOI 10.1128/AEM.01726-07; Mullane NR, 2007, INT J FOOD MICROBIOL, V116, P73, DOI 10.1016/j.ijfoodmicro.2006.12.036; Proudy I, 2008, J APPL MICROBIOL, V104, P26, DOI 10.1111/j.1365-2672.2007.03526.x; See KC, 2007, AGE AGEING, V36, P595, DOI 10.1093/ageing/afm092; Seo KH, 2005, J FOOD PROTECT, V68, P59, DOI 10.4315/0362-028X-68.1.59; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	29	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102179	10.1371/journal.pone.0102179	http://dx.doi.org/10.1371/journal.pone.0102179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029018	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600042
J	DosSantos, MF; Martikainen, IK; Nascimento, TD; Love, TM; DeBoer, MD; Schambra, HM; Bikson, M; Zubieta, JK; DaSilva, AF				DosSantos, Marcos F.; Martikainen, Ilkka K.; Nascimento, Thiago D.; Love, Tiffany M.; DeBoer, Misty D.; Schambra, Heidi M.; Bikson, Marom; Zubieta, Jon-Kar; DaSilva, Alexandre F.			Building up Analgesia in Humans via the Endogenous mu-Opioid System by Combining Placebo and Active tDCS: A Preliminary Report	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; MEDIAL PREFRONTAL CORTEX; MOTOR CORTEX; PERIAQUEDUCTAL GRAY; NEUROPATHIC PAIN; BACK-PAIN; BRAIN; MODULATION; ANTICIPATION	Transcranial Direct Current Stimulation (tDCS) is a method of non-invasive brain stimulation that has been frequently used in experimental and clinical pain studies. However, the molecular mechanisms underlying tDCS-mediated pain control, and most important its placebo component, are not completely established. In this pilot study, we investigated in vivo the involvement of the endogenous mu-opioid system in the global tDCS-analgesia experience. Nine healthy volunteers went through positron emission tomography (PET) scans with [C-11] carfentanil, a selective m-opioid receptor (MOR) radiotracer, to measure the central MOR activity during tDCS in vivo (non-displaceable binding potential, BPND) - one of the main analgesic mechanisms in the brain. Placebo and real anodal primary motor cortex (M1/2mA) tDCS were delivered sequentially for 20 minutes each during the PET scan. The initial placebo tDCS phase induced a decrease in MOR BPND in the periaqueductal gray matter (PAG), precuneus, and thalamus, indicating activation of endogenous mu-opioid neurotransmission, even before the active tDCS. The subsequent real tDCS also induced MOR activation in the PAG and precuneus, which were positively correlated to the changes observed with placebo tDCS. Nonetheless, real tDCS had an additional MOR activation in the left prefrontal cortex. Although significant changes in the MOR BPND occurred with both placebo and real tDCS, significant analgesic effects, measured by improvements in the heat and cold pain thresholds, were only observed after real tDCS, not the placebo tDCS. This study gives preliminary evidence that the analgesic effects reported with M1-tDCS, can be in part related to the recruitment of the same endogenous MOR mechanisms induced by placebo, and that such effects can be purposely optimized by real tDCS.	[DosSantos, Marcos F.; Martikainen, Ilkka K.; Nascimento, Thiago D.; DeBoer, Misty D.; DaSilva, Alexandre F.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [DosSantos, Marcos F.; Martikainen, Ilkka K.; Nascimento, Thiago D.; DeBoer, Misty D.; DaSilva, Alexandre F.] Univ Michigan, Sch Dent, MCOHR, Ann Arbor, MI 48109 USA; [Martikainen, Ilkka K.; Love, Tiffany M.; Zubieta, Jon-Kar; DaSilva, Alexandre F.] Univ Michigan, Translat Neuroimaging Lab, MBNI, Ann Arbor, MI 48109 USA; [Schambra, Heidi M.] Columbia Univ, Dept Neurol, New York, NY USA; [Schambra, Heidi M.] Columbia Univ, Dept Rehabil & Regenerat Med, New York, NY USA; [Bikson, Marom] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; Columbia University; City University of New York (CUNY) System; City College of New York (CUNY)	DaSilva, AF (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	adasilva@umich.edu	DosSantos, Marcos/AAR-7308-2020; Zubieta, Jon-Kar/AAB-5565-2022; Nascimento, Thiago/GNH-3833-2022; Love, Tiffany/W-8427-2019; DosSantos, Marcos/E-8913-2014	DosSantos, Marcos/0000-0002-5997-9693; Nascimento, Thiago/0000-0003-0910-9005; Love, Tiffany/0000-0001-9299-3190; DosSantos, Marcos/0000-0002-5997-9693	Michigan Institute for Clinical & Health Research Clinical Trial Planning Program/CTSA, University of Michigan [UL1RR024986]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; University of Michigan, Ann Arbor, United States of America; Swedish Cultural Foundation in Finland, Helsinki, Finland; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER	Michigan Institute for Clinical & Health Research Clinical Trial Planning Program/CTSA, University of Michigan; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Michigan, Ann Arbor, United States of America; Swedish Cultural Foundation in Finland, Helsinki, Finland; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the following grants: Dr. DaSilva, the principal investigator of the study, was supported by Michigan Institute for Clinical & Health Research Clinical Trial Planning Program/CTSA high-tech funding UL1RR024986, University of Michigan. Dr. Santos was also supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil, and by the University of Michigan, Ann Arbor, United States of America. Dr. Martikainen was supported by the Swedish Cultural Foundation in Finland, Helsinki, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Amer Assoc Electrodiagnost Med, 2004, MUSCLE NERVE, V29, P734, DOI 10.1002/mus.20053; Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; DANNALS RF, 1985, INT J APPL RADIAT IS, V36, P303, DOI 10.1016/0020-708X(85)90089-4; DaSilva AF, 2012, HEADACHE; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; DaSilva AFM, 2007, NEUROREPORT, V18, P301, DOI 10.1097/WNR.0b013e32801776bb; de Andrade DC, 2011, PAIN, V152, P320, DOI 10.1016/j.pain.2010.10.032; DosSantos Marcos Fabio, 2012, Front Psychiatry, V3, P93, DOI 10.3389/fpsyt.2012.00093; Essick GK, 2004, J OROFAC PAIN, V18, P345; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Harris RE, 2009, NEUROIMAGE, V47, P1077, DOI 10.1016/j.neuroimage.2009.05.083; Jewett DM, 2001, NUCL MED BIOL, V28, P733, DOI 10.1016/S0969-8051(01)00226-8; Jin CW, 2013, NMR BIOMED, V26, P58, DOI 10.1002/nbm.2819; Johnson S, 2006, PAIN, V123, P187, DOI 10.1016/j.pain.2006.02.030; Jurgens TP, 2012, EUR J PAIN, V16, P1251, DOI 10.1002/j.1532-2149.2012.00135.x; Kano M, 2013, AM J PHYSL GASTROINT; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Leppa M, 2006, NEUROIMAGE, V31, P661, DOI 10.1016/j.neuroimage.2005.12.019; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Luedtke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048857; Maarrawi J, 2007, NEUROLOGY, V69, P827, DOI 10.1212/01.wnl.0000269783.86997.37; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Maleki N, 2013, NMR BIOMED; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; MINOSHIMA S, 1993, J NUCL MED, V34, P322; Moloney TM, 2013, NEUROSCI LETT, V534, P289, DOI 10.1016/j.neulet.2012.11.049; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; O'Connell NE, 2013, CLIN J PAIN, V29, P26, DOI 10.1097/AJP.0b013e318247ec09; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; O'Connell NE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub2; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schestatsky P, 2011, ARQ NEURO-PSIQUIAT, V69, P943, DOI 10.1590/S0004-282X2011000700019; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Stagg CJ, 2013, J NEUROSCI, V33, P11425, DOI 10.1523/JNEUROSCI.3887-12.2013; Summers J, 2004, NEUROSCI LETT, V368, P197, DOI 10.1016/j.neulet.2004.07.008; Taylor JJ, 2013, NEUROPSYCHOPHARMACOL; Taylor JJ, 2012, PAIN, V153, P1219, DOI 10.1016/j.pain.2012.02.030; Villamar MF, 2013, JOVE-J VIS EXP, DOI 10.3791/50309; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Wrigley PJ, 2013, PAIN, V154, P2178, DOI 10.1016/j.pain.2013.06.045; Wu D, 2013, EXP BRAIN RES; YARNITSKY D, 1994, J NEUROL SCI, V125, P39, DOI 10.1016/0022-510X(94)90239-9; Youssef AM, 2013, PAIN; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x; Zyloney CE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-80	69	52	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102350	10.1371/journal.pone.0102350	http://dx.doi.org/10.1371/journal.pone.0102350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029273	Green Published, gold			2022-12-27	WOS:000341306600068
J	Edmonds, MD; Eischen, CM				Edmonds, Mick D.; Eischen, Christine M.			Differences in miRNA Expression in Early Stage Lung Adenocarcinomas that Did and Did Not Relapse	PLOS ONE			English	Article							COMPARING CANCER TISSUES; MICRORNA EXPRESSION; TUMOR MICROENVIRONMENT; GENE-EXPRESSION; CELL CARCINOMA; FREE SURVIVAL; SIGNATURE; METAANALYSIS; MIGRATION; INVASION	Relapse of adenocarcinoma, the most common non-small cell lung cancer (NSCLC), is a major clinical challenge to improving survival. To gain insight into the early molecular events that contribute to lung adenocarcinoma relapse, and taking into consideration potential cell type specificity, we used stringent criteria for sample selection. We measured miRNA expression only from flash frozen stage I lung adenocarcinomas, excluding other NSCLC subtypes. We compared miRNA expression in lung adenocarcinomas that relapsed within two years to those that did not relapse within three years after surgical resection prior to adjuvant therapy. The most significant differences in mRNA expression for recurrent tumors compared to non-recurrent tumors were decreases in miR-106b*, -187, -205, -449b, -774* and increases in miR-151-3p, let-7b, miR-215, -520b, and -512-3p. A unique comparison between adjacent normal lung tissue from relapse and non-relapse groups revealed dramatically different miRNA expression, suggesting dysregulation of miRNA in the environment around the tumor. To assess patient-to-patient variability, miRNA levels in the tumors were normalized to levels in matched adjacent normal lung tissue. This analysis revealed a different set of significantly altered miRNA in tumors that recurred compared to tumors that did not. Together our analyses elucidated miRNA not previously linked to lung adenocarcinoma that likely have important roles in its development and progression. Our results also highlight the differences in miRNA expression in normal lung tissue in adenocarcinomas that do and do not recur. Most notably, our data identified those miRNA that distinguish early stage tumors likely to relapse prior to treatment and miRNA that could be further studied for use as biomarkers for prognosis, patient monitoring, and/or treatment decisions.	[Edmonds, Mick D.; Eischen, Christine M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA	Vanderbilt University	Eischen, CM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	christine.eischen@vanderbilt.edu			American Cancer Society-Kirby Foundations Fund Postdoctoral Fellowship [PF-13-088-01-CSM]; Vanderbilt-Ingram Cancer Center Thoracic Program from the National Center for Advancing Translational Sciences [CTSA UL1TR000445]; National Cancer Institute [P50CA090949, P30CA068485]; Vanderbilt Department of Pathology, Microbiology and Immunology; NATIONAL CANCER INSTITUTE [P50CA090949, T32CA119925, P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	American Cancer Society-Kirby Foundations Fund Postdoctoral Fellowship; Vanderbilt-Ingram Cancer Center Thoracic Program from the National Center for Advancing Translational Sciences; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Department of Pathology, Microbiology and Immunology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the American Cancer Society-Kirby Foundations Fund Postdoctoral Fellowship PF-13-088-01-CSM (MDE), the Vanderbilt-Ingram Cancer Center Thoracic Program, CTSA UL1TR000445 from the National Center for Advancing Translational Sciences, National Cancer Institute P50CA090949 SPORE in Lung Cancer, National Cancer Institute P30CA068485 Cancer Center Support Grant that supports the Vanderbilt Technologies for Advanced Genomic Analysis and Research Design, and the Vanderbilt Department of Pathology, Microbiology and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Cazzoli R, 2013, J THORAC ONCOL, V8, P1156, DOI 10.1097/JTO.0b013e318299ac32; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chu TH, 2013, CANCER LETT, V337, P115, DOI 10.1016/j.canlet.2013.05.032; Edmonds MD, 2009, CELL CYCLE, V8, P2673, DOI 10.4161/cc.8.17.9303; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fassina A, 2011, CHEST, V140, P1305, DOI 10.1378/chest.11-0708; Fuse M, 2012, J HUM GENET, V57, P691, DOI 10.1038/jhg.2012.95; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gao B, 2013, BIOMED PHARMACOTHER; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Graves EE, 2010, SEMIN RADIAT ONCOL, V20, P156, DOI 10.1016/j.semradonc.2010.01.003; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P424, DOI [10.1093/abbs/gms018, 10.1093/abbs/gms018.]; Huang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072615; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Jia AY, 2013, AM J PATHOL, V182, P1171, DOI 10.1016/j.ajpath.2013.01.006; Jiang L, 2010, BMC CANCER, V10, P318; Jiang LL, 2013, CANCER INVEST, V31, P538, DOI 10.3109/07357907.2013.820314; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Liang Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-61; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Markou A, 2013, LUNG CANCER, V81, P388, DOI 10.1016/j.lungcan.2013.05.007; Mitra R, 2014, REPRODUCIBLE COMBINA; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mulrane L, 2012, CLIN CANCER RES, V18, P6702, DOI 10.1158/1078-0432.CCR-12-1420; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Nadal E, 2013, CLIN CANCER RES, V19, P6842, DOI 10.1158/1078-0432.CCR-13-0736; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Rani S, 2013, CANCER BIOL THER, V14; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Roa WH, 2012, CLIN INVEST MED, V35, pE271, DOI 10.25011/cim.v35i5.18700; Schneider S, 2006, PHARMACOGENET GENOM, V16, P555, DOI 10.1097/01.fpc.0000220563.44724.6d; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Trevino V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016492; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wu XF, 2013, CANCER PREV RES, V6, P196, DOI 10.1158/1940-6207.CAPR-12-0276; Xing LX, 2010, MODERN PATHOL, V23, P1157, DOI 10.1038/modpathol.2010.111; Xu M, 2013, ONCOL REP, V30, P1398, DOI 10.3892/or.2013.2548; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang QH, 2013, GENE, V527, P26, DOI 10.1016/j.gene.2013.06.006; Zhao J, 2013, BIOCHEM BIOPH RES CO, V438, P439, DOI 10.1016/j.bbrc.2013.07.095; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	62	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101802	10.1371/journal.pone.0101802	http://dx.doi.org/10.1371/journal.pone.0101802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028925	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600024
J	Forsdahl, S; Kiselev, Y; Hogseth, R; Mjelle, JE; Mikkola, I				Forsdahl, Siri; Kiselev, Yury; Hogseth, Rune; Mjelle, Janne E.; Mikkola, Ingvild			Pax6 Regulates the Expression of Dkk3 in Murine and Human Cell Lines, and Altered Responses to Wnt Signaling Are Shown in FlpIn-3T3 Cells Stably Expressing Either the Pax6 or the Pax6(5a) Isoform	PLOS ONE			English	Article							PAIRED DOMAIN; BETA-CATENIN; SEQUENCE RECOGNITION; MOUSE TELENCEPHALON; CRYSTALLIN GENE; DNA-BINDING; PROTEINS; IDENTIFICATION; REIC/DKK-3; DIFFERENTIATION	Pax6 is a transcription factor important for early embryo development. It is expressed in several cancer cell lines and tumors. In glioblastoma, PAX6 has been shown to function as a tumor suppressor. Dickkopf 3 (Dkk3) is well established as a tumor suppressor in several tumor types, but not much is known about the regulation of its expression. We have previously found that Pax6 and Pax6(5a) increase the expression of the Dkk3 gene in two stably transfected mouse fibroblast cell lines. In this study the molecular mechanism behind this regulation is looked at. Western blot and reverse transcriptase quantitative PCR (RT-qPCR) confirmed higher level of Dkk3 expression in both Pax6 and Pax6(5a) expressing cell lines compared to the control cell line. By the use of bioinformatics and electrophoretic mobility shift assay (EMSA) we have mapped a functional Pax6 binding site in the mouse Dkk3 promoter. The minimal Dkk3 promoter fragment required for transcriptional activation by Pax6 and Pax6(5a) was a 200 bp region just upstream of the transcriptional start site. Mutation of the evolutionary conserved binding site in this region abrogated transcriptional activation and binding of Pax6/Pax6(5a) to the mouse Dkk3 promoter. Since the identified Pax6 binding site in this promoter is conserved, RT-qPCR and Western blot were used to look for regulation of Dkk3/REIC expression in human cell lines. Six of eight cell lines tested showed changes in Dkk3/REIC expression after PAX6 siRNA knockdown. Interestingly, we observed that the Pax6/Pax6(5a) expressing mouse fibroblast cell lines were less responsive to canonical Wnt pathway stimulation than the control cell line when TOP/FOP activity and the levels of active beta-catenin and GSK3-beta Ser9 phosphorylation were measured after LiCl stimulation.	[Forsdahl, Siri; Kiselev, Yury; Hogseth, Rune; Mjelle, Janne E.; Mikkola, Ingvild] UiT Artic Univ Norway, Res Grp Pharmacol, Dept Pharm, Tromso, Norway; [Kiselev, Yury] UiT Artic Univ Norway, Norwegian Translat Canc Res Ctr, Dept Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Mikkola, I (corresponding author), UiT Artic Univ Norway, Res Grp Pharmacol, Dept Pharm, Tromso, Norway.	ingvild.mikkola@uit.no		Mikkola, Ingvild/0000-0001-6442-7626; Kiselev, Yury/0000-0002-6753-8572	Norwegian Research Council [160293]; University of Tromso, Norway; University Hospital of North Norway	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Tromso, Norway; University Hospital of North Norway	This work was funded by the Norwegian Research Council (grant#160293) for I. M, a PhD position funded by the University of Tromso, Norway, for S. F, and a post doc position funded by the University Hospital of North Norway for Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSLEN LA, 1988, ANTICANCER RES, V8, P797; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; CVEKL A, 1994, MOL CELL BIOL, V14, P7363, DOI 10.1128/MCB.14.11.7363; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Davis J, 2011, INVEST OPHTH VIS SCI, V52, P4158, DOI 10.1167/iovs.10-6726; De Brouwer S, 2012, INT J CANCER, V130, P2591, DOI 10.1002/ijc.26295; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Fujii M, 2011, J MOL HISTOL, V42, P499, DOI 10.1007/s10735-011-9357-z; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Grocott T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1269; Haug BH, 2011, CARCINOGENESIS, V32, P1005, DOI 10.1093/carcin/bgr073; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Jung IL, 2010, INT J MOL MED, V26, P33, DOI 10.3892/ijmm_00000431; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kobayashi K, 2002, GENE, V282, P151, DOI 10.1016/S0378-1119(01)00838-1; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Nakamura RE, 2007, BMC CELL BIOL, V8, P52; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tsuji T, 2001, BIOCHEM BIOPH RES CO, V289, P257, DOI 10.1006/bbrc.2001.5972; Tudzarova S, 2010, EMBO J, V29, P3381, DOI 10.1038/emboj.2010.201; Ueno K, 2011, MOL CARCINOGEN, V50, P449, DOI 10.1002/mc.20729; Valdora F, 2013, INT J MOL SCI, V14, P7492, DOI 10.3390/ijms14047492; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Zhang K, 2010, INT J ONCOL, V37, P1495, DOI 10.3892/ijo_00000802; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880	51	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102559	10.1371/journal.pone.0102559	http://dx.doi.org/10.1371/journal.pone.0102559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029272	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600084
J	Regnier, S; Malcolm, W; Allen, F; Wright, J; Bezlyak, V				Regnier, Stephane; Malcolm, William; Allen, Felicity; Wright, Jonathan; Bezlyak, Vladimir			Efficacy of Anti-VEGF and Laser Photocoagulation in the Treatment of Visual Impairment due to Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							QUALITY-OF-LIFE; INTRAVITREAL RANIBIZUMAB; DEFERRED LASER; RETINOPATHY; TRIAL; TRIAMCINOLONE; BEVACIZUMAB; MANAGEMENT; PEGAPTANIB; PAIRWISE	Objective: Compare the efficacy of ranibizumab, aflibercept, laser, and sham in the first-line treatment of diabetic macular edema (DME) to inform technology assessments such as those conducted by the UK National Institute for Health and Care Excellence (NICE). Data sources: MEDLINE, Embase, Cochrane Library, congress abstracts, ClinicalTrials.gov registry and Novartis data on file. Inclusion criteria: Studies reporting 6- or 12-month results of randomized controlled trials (RCTs) evaluating at least two of ranibizumab 0.5 mg pro re nata, aflibercept 2.0 mg bi-monthly, laser photocoagulation or sham. Study quality was assessed based on likelihood of bias in selection, attrition, detection and performance. Outcome measure: Improvement in best-corrected visual acuity (BCVA) measured as the proportion of patients gaining >= 10 letters on the Early Treatment Diabetic Retinopathy Study scale. The outcome was chosen following acceptance by NICE of a Markov model with 10-letter health states in the assessment of ranibizumab for DME. Meta-analysis: Bayesian network meta-analyses with fixed and random effects adjusted for differences in baseline BCVA or central retinal thickness. Results: The analysis included 1,978 patients from eight RCTs. The random effects model adjusting for baseline BCVA was the best model based on total residual. The efficacy of ranibizumab was numerically, but not statistically, superior to aflibercept (odds ratio [OR] 1.59; 95% credible interval [CrI], 0.61-5.37). Ranibizumab and aflibercept were statistically superior to laser monotherapy with ORs of 5.50 (2.73-13.16) and 3.45 (1.62-6.84) respectively. The probability that ranibizumab is the most efficacious treatment was 73% compared with 14% for aflibercept, 12% for ranibizumab plus laser, and 0% for laser. Limitations: Three of the eight RCTs included are not yet published. The models did not adjust for all potential effect modifiers. Conclusion: Ranibizumab was non-significantly superior to aflibercept and both anti-VEGF therapies had statistically superior efficacy to laser.	[Regnier, Stephane; Bezlyak, Vladimir] Novartis Pharma AG, Basel, Switzerland; [Malcolm, William; Allen, Felicity] Novartis Pharmaceut UK Ltd, Frimley, Surrey, England; [Wright, Jonathan] Numerus Ltd, Wokingham, England	Novartis; Novartis	Regnier, S (corresponding author), Novartis Pharma AG, Basel, Switzerland.	stephane.regnier@novartis.com		Regnier, Stephane/0000-0002-1994-4648	Novartis Pharma AG	Novartis Pharma AG	This study was funded by Novartis Pharma AG. The funder provided support in the form of salaries for authors SR, WM, FA and VB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Novartis Pharma AG and Genentech, Inc. reviewed the manuscript before submission. Third-party medical writing assistance, but not editorial content sufficient to meet International Committee of Medical Journal Editors (ICMJE) authorship criteria, was funded by Novartis Pharma AG.	Ahmadian L, 2008, OPHTHAL EPIDEMIOL, V15, P345, DOI 10.1080/09286580802227402; American Academy of Ophthalmology Retina Panel, 2008, PREF PRACT PATT GUID; [Anonymous], 2012, DIAB RET GUID; Bandello F, 2014, OPHTHALMIC RES, V51, P88, DOI 10.1159/000356693; Bandello F, 2012, EYE, V26, P485, DOI 10.1038/eye.2011.337; Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610; Boscia F, 2010, DRUGS, V70, P2171, DOI 10.2165/11538130-000000000-00000; Bressler NM, 2009, ARCH OPHTHALMOL-CHIC, V127, P13, DOI 10.1001/archophthalmol.2008.562; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Csaky KG, 2008, INVEST OPHTH VIS SCI, V49, P479, DOI 10.1167/iovs.07-1132; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; Davidov E, 2009, GRAEF ARCH CLIN EXP, V247, P267, DOI 10.1007/s00417-008-0960-y; Delcourt C, PREVALENCE DIA UNPUB; Diabetic Retinopathy Clinical Research Network*, 2013, JAMA Ophthalmol, V131, P283, DOI 10.1001/jamaophthalmol.2013.2015; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Do DV, 2013, JAMA OPHTHALMOL, V131, P139, DOI 10.1001/2013.jamaophthalmol.91; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; FERRIS FL, 1987, OPHTHALMOLOGY, V94, P761; Ford JA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5182; Ford JA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002269; Frampton JE, 2012, DRUGS, V72, P509, DOI 10.2165/11208410-000000000-00000; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Ip MS, 2012, ARCH OPHTHALMOL-CHIC, V130, P1145, DOI 10.1001/archophthalmol.2012.1043; Jain A, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/689276; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Lamoureux EL, 2010, OPHTHALMOLOGY, V117, P757, DOI 10.1016/j.ophtha.2009.09.035; Loftus JV, 2011, INVEST OPHTH VIS SCI, V52, P7498, DOI 10.1167/iovs.11-7613; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Margolis MK, 2002, PHARMACOECONOMICS, V20, P791, DOI 10.2165/00019053-200220120-00001; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Matza LS, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-95; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; National Institute for Health and Care Excellence, 2013, MAC OED DIAB PEG SOD; National Institute for Health and Care Excellence.Single Technology Appraisal, 2010, SINGL TECHN APPR RAN; Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2175, DOI 10.1016/j.ophtha.2009.04.023; Ollendorf DA, 2013, INT J TECHNOL ASSESS, V29, P392, DOI 10.1017/S0266462313000500; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Poku E, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-74; Nguyen QD, 2012, INVEST OPHTH VIS SCI, V53, P7666, DOI 10.1167/iovs.12-9961; Regeneron, 2013, IR C CALL EYLEA AFL; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sultan MB, 2011, OPHTHALMOLOGY, V118, P1107, DOI 10.1016/j.ophtha.2011.02.045; The National Institute for Health and Care Excellence, 2012, GUID MAN 2012; The Scottish Intercollegiate Guidelines Network (SIGN), METH GUID; Virgili G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007419.pub3; Wang HY, 2012, CURR EYE RES, V37, P661, DOI 10.3109/02713683.2012.675616; Welton NJ., 2012, EVIDENCE SYNTHESIS D; Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group, 2014, OPHTHALMOLOGY; Yilmaz MB, 2012, RETINAVITREUS, V20, P265; Yilmaz T, 2011, ACTA OPHTHALMOL, V89, P709, DOI 10.1111/j.1755-3768.2010.01918.x; Zechmeister-Koss I, 2012, BRIT J OPHTHALMOL, V96, P167, DOI 10.1136/bjophthalmol-2011-300674	58	41	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102309	10.1371/journal.pone.0102309	http://dx.doi.org/10.1371/journal.pone.0102309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029255	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600059
J	Franchini, DM; Chan, CF; Morgan, H; Incorvaia, E; Rangam, G; Dean, W; Santos, F; Reik, W; Petersen-Mahrt, SK				Franchini, Don-Marc; Chan, Chun-Fung; Morgan, Hugh; Incorvaia, Elisabetta; Rangam, Gopinath; Dean, Wendy; Santos, Fatima; Reik, Wolf; Petersen-Mahrt, Svend K.			Processive DNA Demethylation via DNA Deaminase-Induced Lesion Resolution	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION; MISMATCH-REPAIR; EPIGENETIC MEMORY; MAMMALIAN-CELLS; AID DEFICIENCY; IN-VITRO; 5-METHYLCYTOSINE	Base modifications of cytosine are an important aspect of chromatin biology, as they can directly regulate gene expression, while DNA repair ensures that those modifications retain genome integrity. Here we characterize how cytosine DNA deaminase AID can initiate DNA demethylation. In vitro, AID initiated targeted DNA demethylation of methyl CpGs when in combination with DNA repair competent extracts. Mechanistically, this is achieved by inducing base alterations at or near methyl-cytosine, with the lesion being resolved either via single base substitution or a more efficient processive polymerase dependent repair. The biochemical findings are recapitulated in an in vivo transgenic targeting assay, and provide the genetic support of the molecular insight into DNA demethylation. This targeting approach supports the hypothesis that mCpG DNA demethylation can proceed via various pathways and mCpGs do not have to be targeted to be demethylated.	[Franchini, Don-Marc; Incorvaia, Elisabetta; Rangam, Gopinath; Petersen-Mahrt, Svend K.] IFOM Fdn Inst FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy; [Franchini, Don-Marc; Rangam, Gopinath; Petersen-Mahrt, Svend K.] London Res Inst, Clare Hall Labs, DNA Editing Lab, S Mimms, Herts, England; [Chan, Chun-Fung; Morgan, Hugh; Dean, Wendy; Santos, Fatima; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England	IFOM - FIRC Institute of Molecular Oncology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Petersen-Mahrt, SK (corresponding author), IFOM Fdn Inst FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy.	svend.petersen-mahrt@ifom.eu	Rangam, Gopinath/J-8832-2019; Franchini, Don Marc/A-5203-2015; Reik, Wolf/I-6794-2012; Dean, Wendy/GSE-3948-2022	Rangam, Gopinath/0000-0001-5081-5804; Franchini, Don Marc/0000-0002-2562-5643; Dean, Wendy/0000-0001-9441-5044; Reik, Wolf/0000-0003-0216-9881; Santos, Fatima/0000-0002-3854-4084	Biotechnology and Biological Sciences Research Council, UK; MRC - Medical Research Council, UK; Network of Excellence - The Epigenome, EU; Cell Centric, UK; CJ Martin Fellowship; NHMRC Early Career Fellowships, Australia; London Research Institute - Cancer Research UK postdoctoral fellowships, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare, Italy; London Research Institute - Cancer Research UK core funding, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare core funding, Italy; DIVA - Discover Validation of Anticancer drugs, Lombardi, Italy; AIRC - Italian Association for Cancer research [13149]; BBSRC [BBS/E/B/000C0403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0403] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC - Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Network of Excellence - The Epigenome, EU; Cell Centric, UK; CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowships, Australia(National Health and Medical Research Council (NHMRC) of Australia); London Research Institute - Cancer Research UK postdoctoral fellowships, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare, Italy; London Research Institute - Cancer Research UK core funding, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare core funding, Italy; DIVA - Discover Validation of Anticancer drugs, Lombardi, Italy; AIRC - Italian Association for Cancer research(Fondazione AIRC per la ricerca sul cancro); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	W.R. was supported by Biotechnology and Biological Sciences Research Council, UK, MRC - Medical Research Council, UK, Network of Excellence - The Epigenome, EU, and Cell Centric, UK. H. M. was supported by a CJ Martin Fellowship, NHMRC Early Career Fellowships, Australia. G. R. was supported by London Research Institute - Cancer Research UK postdoctoral fellowships, UK. D. M. F. was supported by London Research Institute - Cancer Research UK postdoctoral fellowships, UK, and IFOM - Fondazione Istituto FIRC di Oncologia Molecolare fellowships, Italy. E. I. was supported by an IFOM - Fondazione Istituto FIRC di Oncologia Molecolare, Italy. S. K. P. M. was supported by London Research Institute - Cancer Research UK core funding, UK, IFOM - Fondazione Istituto FIRC di Oncologia Molecolare core funding, Italy, DIVA - Discover Validation of Anticancer drugs, Lombardi, Italy, and AIRC - Italian Association for Cancer research - 13149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Chow JC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000604; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Fraenkel S, 2007, NAT IMMUNOL, V8, P715, DOI 10.1038/ni1476; Franchini DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082097; Franchini DM, 2012, ANNU REV GENET, V46, P419, DOI 10.1146/annurev-genet-110711-155451; Fritz EL, 2013, NAT IMMUNOL, V14, P749, DOI 10.1038/ni.2616; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He Y-F, 2011, SCIENCE; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munoz DP, 2013, P NATL ACAD SCI USA, V110, pE2977, DOI 10.1073/pnas.1301021110; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; NYCE J, 1986, NUCLEIC ACIDS RES, V14, P4353, DOI 10.1093/nar/14.10.4353; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; Schmitz KM, 2012, SEMIN IMMUNOL, V24, P241, DOI 10.1016/j.smim.2012.07.001; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Willmann KL, 2012, J EXP MED, V209, P2099, DOI 10.1084/jem.20112145; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	55	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e97754	10.1371/journal.pone.0097754	http://dx.doi.org/10.1371/journal.pone.0097754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025377	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400001
J	Li, S; Flisikowska, T; Kurome, M; Zakhartchenko, V; Kessler, B; Saur, D; Kind, A; Wolf, E; Flisikowski, K; Schnieke, A				Li, Shun; Flisikowska, Tatiana; Kurome, Mayuko; Zakhartchenko, Valeri; Kessler, Barbara; Saur, Dieter; Kind, Alexander; Wolf, Eckhard; Flisikowski, Krzysztof; Schnieke, Angelika			Dual Fluorescent Reporter Pig for Cre Recombination: Transgene Placement at the ROSA26 Locus	PLOS ONE			English	Article							IN-VIVO; EXPRESSION; MOUSE; CELLS; IDENTIFICATION; TRANSDUCTION; MODELS; STRAIN; MICE	We are extending the Cre/loxP site-specific recombination system to pigs, focussing on conditional and tissue-specific expression of oncogenic mutations to model human cancers. Identifying the location, pattern and extent of Cre recombination in vivo is an important aspect of this technology. Here we report pigs with a dual fluorochrome cassette under the control of the strong CAG promoter that switches expression after Cre-recombination, from membrane-targeted tandem dimer Tomato to membrane-targeted green fluorescent protein. The reporter cassette was placed at the porcine ROSA26 locus by conventional gene targeting using primary mesenchymal stem cells, and animals generated by nuclear transfer. Gene targeting efficiency was high, and analysis of foetal organs and primary cells indicated that the reporter is highly expressed and functional. Cre reporter pigs will provide a multipurpose indicator of Cre recombinase activity, an important new tool for the rapidly expanding field of porcine genetic modification.	[Li, Shun; Flisikowska, Tatiana; Kind, Alexander; Flisikowski, Krzysztof; Schnieke, Angelika] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany; [Kurome, Mayuko; Zakhartchenko, Valeri; Kessler, Barbara; Wolf, Eckhard] Univ Munich, Oberschleissheim, Germany; [Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar 2, D-80290 Munich, Germany	Technical University of Munich; University of Munich; Technical University of Munich	Schnieke, A (corresponding author), Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany.	schnieke@wzw.tum.de	Flisikowska, Tatiana/I-9043-2014; Saur, Dieter/O-8355-2015	Flisikowska, Tatiana/0000-0003-0481-117X; Saur, Dieter/0000-0001-5874-0210; Wolf, Eckhard/0000-0002-0430-9510; Schnieke, Angelika/0000-0002-5761-9635; Zakhartchenko, Valeri/0000-0002-5974-9759	Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN971/3-1, WO 685/16-1]; China Scholarship Council [2011699005]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	This work was supported financially by the Deutsche Forschungsgemeinschaft (German Research Foundation) through grant number SCHN971/3-1, WO 685/16-1. Shun Li would like to thank the China Scholarship Council for financial support for his PhD study (No. 2011699005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besenfelder U, 1997, THERIOGENOLOGY, V47, P1051, DOI 10.1016/S0093-691X(97)00062-9; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Flisikowska T, 2013, TRANSGENIC RES, V22, P673, DOI 10.1007/s11248-013-9720-9; FLOTTE TR, 1995, GENE THER, V2, P29; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Iverson SV, 2011, HEPATOLOGY, V54, P655, DOI 10.1002/hep.24398; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Kurome M, 2006, TRANSGENIC RES, V15, P229, DOI 10.1007/s11248-006-0004-5; Leuchs S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043323; Li L, 2009, BIOCHEM BIOPH RES CO, V382, P232, DOI 10.1016/j.bbrc.2009.02.146; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Munst Bernhard, 2009, J Vis Exp, DOI 10.3791/1627; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	23	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102455	10.1371/journal.pone.0102455	http://dx.doi.org/10.1371/journal.pone.0102455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025770	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400075
J	Chi, ZX; Liu, RT; You, H; Ma, SS; Cui, H; Zhang, Q				Chi, Zhenxing; Liu, Rutao; You, Hong; Ma, Shanshan; Cui, Hao; Zhang, Qiang			Probing the In Vitro Cytotoxicity of the Veterinary Drug Oxytetracycline	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; OXOLINIC ACID; BLOOD; TETRACYCLINES; TOXICITY; ERYTHROCYTE; GLUTATHIONE; MECHANISM; MEMBRANES	The study investigated the effect of oxytetracycline (OTC) on the anti-oxidative defense system, the structure (hemolysis rate and morphology) and function (ATP enzyme activity) of human red blood cells (hRBCs) to investigate the possible toxic mechanism of OTC to hRBCs. The experimental results indicate that OTC can cause a decline in the function of the antioxidant defense system of hRBCs, resulting in oxidative stress. OTC can bring about morphological changes to hRBCs, and further leads to hemolysis, when the concentration of OTC is over 8x10(-5) M (about 164 mu g/ml). At a low OTC concentration, below 4x10(-5) M (82 mu g/ml), OTC can enhance the activity of ATP enzyme of hRBCs, known as hormesis. However, at a high concentration, above 4x10(-5) M (about 82 mu g/ml), the ATP enzymatic activity was inhibited, affecting the function of hRBCs. The estalished mechanism of toxicity of OTC to hRBCs can facilitate a deeper understanding of the toxicity of OTC in vivo.	[Chi, Zhenxing; You, Hong] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China; [Chi, Zhenxing; You, Hong; Ma, Shanshan; Cui, Hao; Zhang, Qiang] Harbin Inst Technol Weihai, Sch Marine Sci & Technol, Weihai, Peoples R China; [Liu, Rutao] Shandong Univ, Sch Environm Sci & Engn, Jinan 250100, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Shandong University	Chi, ZX (corresponding author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China.	Zhenxingchi@gmail.com	YOU, Hong/G-6189-2012; Chi, Zhenxing/AAX-2123-2021	YOU, Hong/0000-0001-9454-1681; chi, zhen xing/0000-0001-7513-1580	State Key Laboratory of Urban Water Resource and Environment, HIT [2013DX09]; China Postdoctoral Science Foundation [2013M540297]; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.2014126]; NSFC [21277081]; Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China [708058]; Independent innovation program of Jinan [201202083]; Independent innovation foundation of Shandong University natural science projects [2012DX002]	State Key Laboratory of Urban Water Resource and Environment, HIT; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology(Harbin Institute of Technology); NSFC(National Natural Science Foundation of China (NSFC)); Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China(Ministry of Education, China); Independent innovation program of Jinan; Independent innovation foundation of Shandong University natural science projects	State Key Laboratory of Urban Water Resource and Environment, HIT (2013DX09); China Postdoctoral Science Foundation funded project (2013M540297); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology (HIT.NSRIF.2014126); NSFC (21277081); The Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (708058); Independent innovation program of Jinan (201202083); Independent innovation foundation of Shandong University natural science projects (2012DX002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATURE, V272, P552; Aruoma OI, 1998, J AM OIL CHEM SOC, V75, P199, DOI 10.1007/s11746-998-0032-9; Ben Othmen L, 2008, PROG NEURO-PSYCHOPH, V32, P155, DOI 10.1016/j.pnpbp.2007.08.003; BLOBEL H., 1960, JOUR AMER VET MED ASSOC, V137, P701; Boleas S, 2005, J HAZARD MATER, V122, P233, DOI 10.1016/j.jhazmat.2005.03.003; Brentnall C, 2013, RES VET SCI, V94, P687, DOI 10.1016/j.rvsc.2013.01.012; CANTLEY LC, 1978, NATURE, V272, P552, DOI 10.1038/272552a0; Chi ZX, 2010, J HAZARD MATER, V180, P741, DOI 10.1016/j.jhazmat.2010.04.110; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Das S, 2000, CURR SCI INDIA, V78, P486; de Campos HH, 2006, CLIMACTERIC, V9, P312, DOI 10.1080/13697130600871947; DEJONGE HR, 1973, BIOCHEM PHARMACOL, V22, P2659, DOI 10.1016/0006-2952(73)90127-5; Dinsmore RP, 1996, J AM VET MED ASSOC, V209, P1753; Doi AM, 1998, J VET PHARMACOL THER, V21, P364, DOI 10.1046/j.1365-2885.1998.00162.x; GABLER WL, 1991, RES COMMUN CHEM PATH, V72, P39; Gao N, 2007, ELECTROPHORESIS, V28, P3966, DOI 10.1002/elps.200700124; GIRARDI C, 1990, PHARMACOL RES, V22, P79, DOI 10.1016/1043-6618(90)90703-G; Gokalp O, 2006, MOL CELL BIOCHEM, V290, P55, DOI 10.1007/s11010-006-9157-z; Ferreira CSG, 2007, ECOTOX ENVIRON SAFE, V67, P452, DOI 10.1016/j.ecoenv.2006.10.006; Hammer M, 1998, APPL OPTICS, V37, P7410, DOI 10.1364/AO.37.007410; Herken H, 2001, MOL PSYCHIATR, V6, P66, DOI 10.1038/sj.mp.4000789; Hill A, 2007, BRIT J HAEMATOL, V137, P181, DOI 10.1111/j.1365-2141.2007.06554.x; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; HOBUSCH D, 1971, EXP PATHOL-JENA, V5, P298; Jiao SJ, 2008, J ENVIRON SCI, V20, P806, DOI 10.1016/S1001-0742(08)62130-0; Kong WD, 2007, ENVIRON POLLUT, V147, P187, DOI 10.1016/j.envpol.2006.08.016; Li KX, 2008, CHEMOSPHERE, V72, P473, DOI 10.1016/j.chemosphere.2008.02.008; Li Zhao-li, 2006, Journal of Ecology and Rural Environment, V22, P84; Lin YS, 2010, J AM CHEM SOC, V132, P4834, DOI 10.1021/ja910846q; Loke ML, 2003, J CHROMATOGR B, V783, P11, DOI 10.1016/S1570-0232(02)00468-3; Lorenzo C, 1999, INT J PANCREATOL, V26, P181, DOI 10.1385/IJGC:26:3:181; Lunden T, 1998, FISH SHELLFISH IMMUN, V8, P217, DOI 10.1006/fsim.1998.0142; Manrique-Moreno M, 2010, BIOPHYS CHEM, V147, P53, DOI 10.1016/j.bpc.2009.12.010; Mates JM, 1999, BLOOD CELL MOL DIS, V25, P103, DOI 10.1006/bcmd.1999.0234; Mecocci P, 2000, FREE RADICAL BIO MED, V28, P1243, DOI 10.1016/S0891-5849(00)00246-X; NOUWS JFM, 1983, VET QUART, V5, P165, DOI 10.1080/01652176.1983.9693891; Omoregie E, 2002, J WORLD AQUACULT SOC, V33, P377, DOI 10.1111/j.1749-7345.2002.tb00514.x; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Parmentier C, 1999, ELECTROPHORESIS, V20, P2938; [曲甍甍 Qu Mengmeng], 2004, [农业环境科学学报, Journal of Agro-environment science], V23, P240; Reja A, 1996, VET HUM TOXICOL, V38, P344; Rigos G, 2004, AQUAT TOXICOL, V69, P281, DOI 10.1016/j.aquatox.2004.05.009; Roncada P, 2000, J VET PHARMACOL THER, V23, P281, DOI 10.1046/j.1365-2885.2000.00260.x; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Roversi FM, 2006, CLIN CHIM ACTA, V364, P316, DOI 10.1016/j.cca.2005.07.022; SELWYN MJ, 1970, EUR J BIOCHEM, V14, P120, DOI 10.1111/j.1432-1033.1970.tb00268.x; Shcharbin D, 2010, J CONTROL RELEASE, V141, P110, DOI 10.1016/j.jconrel.2009.09.030; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Skaper SD, 1997, FREE RADICAL BIO MED, V22, P669, DOI 10.1016/S0891-5849(96)00383-8; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Sun YC, 2002, J CONTROL RELEASE, V85, P125, DOI 10.1016/S0168-3659(02)00286-9; Suwalsky M, 2009, J INORG BIOCHEM, V103, P797, DOI 10.1016/j.jinorgbio.2009.02.009; Uno K, 1996, AQUACULTURE, V143, P33, DOI 10.1016/0044-8486(95)01225-7; Mamani MCV, 2009, FOOD CHEM, V117, P545, DOI 10.1016/j.foodchem.2009.04.032; Virolainen NE, 2008, J AGR FOOD CHEM, V56, P11065, DOI 10.1021/jf801797z; Wadsworth RM, 2008, EXP PHYSIOL, V93, P155, DOI 10.1113/expphysiol.2007.038687; WENNMALM A, 1992, BRIT J PHARMACOL, V106, P507, DOI 10.1111/j.1476-5381.1992.tb14365.x; Xiong J, 2013, J PHYS C SER, V418, P1; Ye ZQ, 2007, ANAL CHEM, V79, P1135, DOI 10.1021/ac060972a; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k	60	21	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102334	10.1371/journal.pone.0102334	http://dx.doi.org/10.1371/journal.pone.0102334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019386	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600070
J	Dai, CL; Yan, ZH; You, Q; Du, MY; Zhao, MW				Dai, Caili; Yan, Zhihu; You, Qing; Du, Mingyong; Zhao, Mingwei			Formation of Worm-Like Micelles in Mixed N-Hexadecyl-N-Methylpyrrolidinium Bromide-Based Cationic Surfactant and Anionic Surfactant Systems	PLOS ONE			English	Article							CETYLTRIMETHYLAMMONIUM BROMIDE; VISCOELASTIC PROPERTIES; RHEOLOGICAL BEHAVIOR; NMR-SPECTROSCOPY; IONIC LIQUIDS; BICELLES; DYNAMICS	Through the descriptive and rheological characterization of worm-like micelles formed by N-hexadecyl-N-methylpyrrolidinium bromide and sodium laurate, the formation and properties of the worm-like micelles were affected by the concentrations of sodium laurate and temperature. Additionally, cryogenic transmission electron microscopy images further validated the formation of worm-like micelles.	[Dai, Caili; Yan, Zhihu; Du, Mingyong; Zhao, Mingwei] China Univ Petr Huadong, Sch Petr Engn, Qingdao, Shandong, Peoples R China; [You, Qing] China Univ Geosci, Sch Energy Resources, Beijing, Peoples R China	China University of Petroleum; China University of Geosciences	Zhao, MW (corresponding author), China Univ Petr Huadong, Sch Petr Engn, Qingdao, Shandong, Peoples R China.	zhaomingwei@upc.edu.cn	Du, Mingyong/O-6384-2017	Du, Mingyong/0000-0001-7006-2125; Dai, Cai li/0000-0002-7477-8865	National Natural Science Foundation of China [51174221, 21303268]; Program for New Century Excellent Talents in University [20110226]; China Postdoctoral Science Foundation [2013T60689]; National Ministry of Education [20120133110010]; Fundamental Research Funds for the Central Universities [14CX02041A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was sponsored by the National Natural Science Foundation of China (number 51174221, 21303268), the Program for New Century Excellent Talents in University (number 20110226), China Postdoctoral Science Foundation funded project (number 2013T60689), Doctoral Fund from National Ministry of Education (number 20120133110010) and the Fundamental Research Funds for the Central Universities (number 14CX02041A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya DP, 2004, PHYS CHEM CHEM PHYS, V6, P1627, DOI 10.1039/b312940c; Ali AA, 1999, COLLOID POLYM SCI, V277, P270; Anderson VJ, 2006, RHEOLOGY REV, V2006, P217; CANDAU SJ, 1988, J COLLOID INTERF SCI, V122, P430, DOI 10.1016/0021-9797(88)90377-3; CANDAU SJ, 1985, J COLLOID INTERF SCI, V105, P521, DOI 10.1016/0021-9797(85)90327-3; Cates ME, 2006, ADV PHYS, V55, P799, DOI 10.1080/00018730601082029; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Chu ZL, 2013, CHEM SOC REV, V42, P7174, DOI 10.1039/c3cs35490c; Davies TS, 2006, J AM CHEM SOC, V128, P6669, DOI 10.1021/ja060021e; Dong B, 2008, COLLOID SURFACE A, V317, P666, DOI 10.1016/j.colsurfa.2007.12.001; Dong B, 2007, LANGMUIR, V23, P4178, DOI 10.1021/la0633029; Dvinskikh S, 2006, J AM CHEM SOC, V128, P6326, DOI 10.1021/ja061153a; Dvinskikh SV, 2007, J AM CHEM SOC, V129, P794, DOI 10.1021/ja065536k; Dvinskikh SV, 2007, J MAGN RESON, V184, P228, DOI 10.1016/j.jmr.2006.10.004; Geng F, 2010, PROCESS BIOCHEM, V45, P306, DOI 10.1016/j.procbio.2009.10.001; GRANEK R, 1992, J CHEM PHYS, V96, P4758, DOI 10.1063/1.462787; HOFFMANN H, 1992, LANGMUIR, V8, P2140, DOI 10.1021/la00045a013; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Kumar R, 2007, LANGMUIR, V23, P12849, DOI 10.1021/la7028559; Li J, 2012, COLLOID SURFACE A, V396, P16, DOI 10.1016/j.colsurfa.2011.12.019; Lin Z, 1996, LANGMUIR, V12, P1729, DOI 10.1021/la950570q; Lu T, 2008, J PHYS CHEM B, V112, P2909, DOI 10.1021/jp0766205; Magid LJ, 1998, J PHYS CHEM B, V102, P4064, DOI 10.1021/jp9730961; Moitzi C, 2005, J PHYS CHEM B, V109, P16161, DOI 10.1021/jp0441691; Pei XM, 2011, J COLLOID INTERF SCI, V356, P176, DOI 10.1016/j.jcis.2010.12.065; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; REHAGE H, 1991, MOL PHYS, V74, P933, DOI 10.1080/00268979100102721; Shi LJ, 2012, RSC ADV, V2, P11922, DOI 10.1039/c2ra21467a; SHIKATA T, 1987, LANGMUIR, V3, P1081, DOI 10.1021/la00078a035; Shrestha RG, 2007, J COLLOID INTERF SCI, V311, P276, DOI 10.1016/j.jcis.2007.02.050; Shrestha RG, 2009, COLLOID SURFACE A, V332, P103, DOI 10.1016/j.colsurfa.2008.09.002; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Xu J, 2008, ANGEW CHEM, V120, P7982; Yamamoto K, 2009, LANGMUIR, V25, P7010, DOI 10.1021/la900200s; Zhao MW, 2011, PHYS CHEM CHEM PHYS, V13, P1332, DOI 10.1039/c0cp00342e	35	10	10	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102539	10.1371/journal.pone.0102539	http://dx.doi.org/10.1371/journal.pone.0102539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019152	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600093
J	Tonnessen, E; Sylta, O; Haugen, TA; Hem, E; Svendsen, IS; Seiler, S				Tonnessen, Espen; Sylta, Oystein; Haugen, Thomas A.; Hem, Erlend; Svendsen, Ida S.; Seiler, Stephen			The Road to Gold: Training and Peaking Characteristics in the Year Prior to a Gold Medal Endurance Performance	PLOS ONE			English	Article							INTENSITY DISTRIBUTION; AEROBIC POWER; ELITE MALE; DURATION; TAPER; COMPETITION; ADAPTATION; CYCLISTS; RUNNERS; TOUR	Purpose: To describe training variations across the annual cycle in Olympic and World Champion endurance athletes, and determine whether these athletes used tapering strategies in line with recommendations in the literature. Methods: Eleven elite XC skiers and biathletes (4 male; 28 +/- 1 yr, 85 +/- 5 mL. min(-1). kg(-1) (V) over dotO(2max), 7 female, 25 +/- 4 yr, 73 +/- 3 mL.min(-1).kg(-1) (V) over dotO(2max) reported one year of day-to-day training leading up to the most successful competition of their career. Training data were divided into periodization and peaking phases and distributed into training forms, intensity zones and endurance activity forms. Results: Athletes trained similar to 800 h/500 sessions.year(-1), including similar to 500 h. year(-1) of sport-specific training. Ninety-four percent of all training was executed as aerobic endurance training. Of this, similar to 90% was low intensity training (LIT, below the first lactate threshold) and 10% high intensity training (HIT, above the first lactate threshold) by time. Categorically, 23% of training sessions were characterized as HIT with primary portions executed at or above the first lactate turn point. Training volume and specificity distribution conformed to a traditional periodization model, but absolute volume of HIT remained stable across phases. However, HIT training patterns tended to become more polarized in the competition phase. Training volume, frequency and intensity remained unchanged from pre-peaking to peaking period, but there was a 32 +/- 15% (P<.01) volume reduction from the preparation period to peaking phase. Conclusions: The annual training data for these Olympic and World champion XC skiers and biathletes conforms to previously reported training patterns of elite endurance athletes. During the competition phase, training became more sport-specific, with 92% performed as XC skiing. However, they did not follow suggested tapering practice derived from short-term experimental studies. Only three out of 11 athletes took a rest day during the final 5 days prior to their most successful competition.	[Tonnessen, Espen; Haugen, Thomas A.; Hem, Erlend] Norwegian Olymp Federat, Oslo, Norway; [Sylta, Oystein; Seiler, Stephen] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway; [Svendsen, Ida S.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England	University of Agder; Loughborough University	Tonnessen, E (corresponding author), Norwegian Olymp Federat, Oslo, Norway.	espen.tonnessen@olympiatoppen.no	Haugen, Thomas/AAQ-5280-2021; Haugen, Thomas/I-9580-2015	Haugen, Thomas/0000-0001-5929-0389				Billat V, 2003, MED SCI SPORT EXER, V35, P297, DOI 10.1249/01.MSS.0000053556.59992.A9; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Bompa T.O., 2009, PERIODIZATION THEORY, VFifth; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86; Esteve-Lanao J, 2007, J STRENGTH COND RES, V21, P943, DOI 10.1519/00124278-200708000-00048; Fiskerstrand A, 2004, SCAND J MED SCI SPOR, V14, P303, DOI 10.1046/j.1600-0838.2003.370.x; FOSTER C, 1995, EUR J APPL PHYSIOL O, V70, P367, DOI 10.1007/BF00865035; Gao J., 2008, J BEIJING SPORT U, V31, P832; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; Guellich A, 2009, INT J SPORT PHYSIOL, V4, P448, DOI 10.1123/ijspp.4.4.448; HICKSON RC, 1985, J APPL PHYSIOL, V58, P492, DOI 10.1152/jappl.1985.58.2.492; HICKSON RC, 1982, J APPL PHYSIOL, V53, P225, DOI 10.1152/jappl.1982.53.1.225; HOUMARD JA, 1994, MED SCI SPORT EXER, V26, P624; Ingham SA, 2012, INT J SPORT PHYSIOL, V7, P193, DOI 10.1123/ijspp.7.2.193; Karp J R, 2008, NEW STUDIES ATHLETIC, V23, P31; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Le Meur Y, 2012, SCI SPORT, V27, P77, DOI 10.1016/j.scispo.2011.06.013; Losnegard T, 2013, J STRENGTH COND RES, V27, P1780, DOI 10.1519/JSC.0b013e31827368f6; Lucia A, 1999, INT J SPORTS MED, V20, P167, DOI 10.1055/s-2007-971112; Lucia A, 2003, MED SCI SPORT EXER, V35, P872, DOI 10.1249/01.MSS.0000064999.82036.B4; Matwejew, 1975, PERIODISIERUNG SPORT; McNeely E, 2007, STRENGTH COND J, V29, P18; Mujika I, 1995, Can J Appl Physiol, V20, P395; Mujika I, 1998, INT J SPORTS MED, V19, P439, DOI 10.1055/s-2007-971942; Mujika I, 2003, MED SCI SPORT EXER, V35, P1182, DOI 10.1249/01.MSS.0000074448.73931.11; Mujika I, 2002, INT J SPORTS MED, V23, P582, DOI 10.1055/s-2002-35526; Mujika I, 2010, SCAND J MED SCI SPOR, V20, P24, DOI 10.1111/j.1600-0838.2010.01189.x; Mujika I, 2002, INT J SPORTS MED, V23, P367, DOI 10.1055/s-2002-33146; Mujika I, 2013, INT J SPORT IN PRESS; Neal CM, 2011, J SPORT SCI, V29, P1515, DOI 10.1080/02640414.2011.596217; NSF, 1985, TREN LANGR; NSF, 1992, TREN LANGR; NSSF, 1991, TREN SKISK; Orie J, 2014, INT J SPORT PHYSIOL, V9, P93, DOI 10.1123/IJSPP.2013-0427; Pyne DB, 2009, J SPORT SCI, V27, P195, DOI 10.1080/02640410802509136; Ronnestad BR, 2010, EUR J APPL PHYSIOL, V110, P1269, DOI 10.1007/s00421-010-1622-4; Sandbakk O, 2011, SCAND J MED SCI SPOR, V21, pE9, DOI 10.1111/j.1600-0838.2010.01117.x; Sandbakk O, 2014, INT J SPORT PHYSIOL, V9, P117, DOI [10.1123/ijspp.2013-0373, 10.1123/IJSPP.2013-0373]; Schumacher YO, 2002, MED SCI SPORT EXER, V34, P1029; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Seiler S, 2009, SPORTSCIENCE, V13, P1; Seiler S, 2010, INT J SPORT PHYSIOL, V5, P276, DOI 10.1123/ijspp.5.3.276; SHEPLEY B, 1992, J APPL PHYSIOL, V72, P706, DOI 10.1152/jappl.1992.72.2.706; Siewierski M., 2010, POL J SPORT TOUR, V17, P227; Steinacker JM, 1998, MED SCI SPORT EXER, V30, P1158, DOI 10.1097/00005768-199807000-00022; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P100, DOI 10.1123/IJSPP.2013-0298; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P85, DOI [10.1123/ijspp.2013-0203, 10.1123/IJSPP.2013-0203]; TANAKA H, 1994, SPORTS MED, V18, P330, DOI 10.2165/00007256-199418050-00005; Thomas L, 2005, MED SCI SPORT EXER, V37, P1615, DOI 10.1249/01.mss.0000177461.94156.4b; Tjelta Leif Inge, 2013, IJASS(International Journal of Applied Sports Sciences), V25, P11; Tjelta LI, 2014, INT J SPORTS SCI COA, V9, P139, DOI 10.1260/1747-9541.9.1.139; Tonnessen E., 2009, HVORFOR BLE BESTE BE; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Yu HJ, 2012, INT J SPORT PHYSIOL, V7, P103, DOI 10.1123/ijspp.7.2.103; Zapico AG, 2007, J SPORT MED PHYS FIT, V47, P191	57	126	129	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101796	10.1371/journal.pone.0101796	http://dx.doi.org/10.1371/journal.pone.0101796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019608	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600028
J	Belzer, C; Gerber, GK; Roeselers, G; Delaney, M; DuBois, A; Liu, Q; Belavusava, V; Yeliseyev, V; Houseman, A; Onderdonk, A; Cavanaugh, C; Bry, L				Belzer, Clara; Gerber, Georg K.; Roeselers, Guus; Delaney, Mary; DuBois, Andrea; Liu, Qing; Belavusava, Vera; Yeliseyev, Vladimir; Houseman, Andres; Onderdonk, Andrew; Cavanaugh, Colleen; Bry, Lynn			Dynamics of the Microbiota in Response to Host Infection	PLOS ONE			English	Article							CITROBACTER-RODENTIUM INFECTION; GENE-EXPRESSION DATA; MUCOSAL INFECTION; GUT MICROBIOME; MICE; INFLAMMATION; DIVERSITY; SEQUENCES; PATHOGEN; COLITIS	Longitudinal studies of the microbiota are important for discovering changes in microbial communities that affect the host. The complexity of these ecosystems requires rigorous integrated experimental and computational methods to identify temporal signatures that promote physiologic or pathophysiologic responses in vivo. Employing a murine model of infectious colitis with the pathogen Citrobacter rodentium, we generated a 2-month time-series of 16S rDNA gene profiles, and quantitatively cultured commensals, from multiple intestinal sites in infected and uninfected mice. We developed a computational framework to discover time-varying signatures for individual taxa, and to automatically group signatures to identify microbial sub-communities within the larger gut ecosystem that demonstrate common behaviors. Application of this model to the 16S rDNA dataset revealed dynamic alterations in the microbiota at multiple levels of resolution, from effects on systems-level metrics to changes across anatomic sites for individual taxa and species. These analyses revealed unique, time-dependent microbial signatures associated with host responses at different stages of colitis. Signatures included a Mucispirillum OTU associated with early disruption of the colonic surface mucus layer, prior to the onset of symptomatic colitis, and members of the Clostridiales and Lactobacillales that increased with successful resolution of inflammation, after clearance of the pathogen. Quantitative culture data validated findings for predominant species, further refining and strengthening model predictions. These findings provide new insights into the complex behaviors found within host ecosystems, and define several time-dependent microbial signatures that may be leveraged in studies of other infectious or inflammatory conditions.	[Belzer, Clara; Gerber, Georg K.; Delaney, Mary; DuBois, Andrea; Liu, Qing; Belavusava, Vera; Yeliseyev, Vladimir; Onderdonk, Andrew; Bry, Lynn] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Belzer, Clara; Gerber, Georg K.; Onderdonk, Andrew; Bry, Lynn] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gerber, Georg K.; Delaney, Mary; DuBois, Andrea; Liu, Qing; Belavusava, Vera; Yeliseyev, Vladimir; Onderdonk, Andrew; Bry, Lynn] Harvard Univ, Brigham & Womens Hosp, Ctr Clin & Translat Metagenom, Harvard Digest Dis Ctr,Med Sch, Boston, MA 02115 USA; [Roeselers, Guus; Cavanaugh, Colleen] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Houseman, Andres] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Bry, L (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	lbry@partners.org	Roeselers, Guus/J-2971-2012; Belzer, Clara/P-6500-2018; Young, Richard A/F-6495-2012	Roeselers, Guus/0000-0002-4725-6105; Belzer, Clara/0000-0001-6922-836X; Young, Richard A/0000-0001-8855-8647; Onderdonk, Andrew/0000-0001-8998-8972; Houseman, Eugene Andres/0000-0003-0703-1830; Bry, Lynn/0000-0002-8792-8527	Harvard Digestive Diseases Center (NIH) [P30-DK034854, R01-HD061916]; Netherlands Organization for Scientific Research, NWO; Stanley L. Robbins Memorial Research award; Harvard Catalyst; Harvard Clinical and Translational Science Center [UL1 RR 025758]; Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Harvard Digestive Diseases Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research, NWO(Netherlands Organization for Scientific Research (NWO)); Stanley L. Robbins Memorial Research award; Harvard Catalyst; Harvard Clinical and Translational Science Center; Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work supported by a pilot feasibility grant from the Harvard Digestive Diseases Center (NIH Award #P30-DK034854; CMC, LB), R01-HD061916 (LB, CB), Rubicon grant from the Netherlands Organization for Scientific Research, NWO (GR), Stanley L. Robbins Memorial Research award (GKG), and Harvard Catalyst, The Harvard Clinical and Translational Science Center (AH; NIH Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Bar-Joseph Z, 2003, P NATL ACAD SCI USA, V100, P10146, DOI 10.1073/pnas.1732547100; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bishop AL, 2007, MICROBES INFECT, V9, P1316, DOI 10.1016/j.micinf.2007.06.006; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chen CC, 2005, PEDIATR RES, V58, P1185, DOI 10.1203/01.pdr.0000183660.39116.83; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Gerber GK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002624; Ghosh S, 2011, AM J PHYSIOL-GASTR L, V301, pG39, DOI 10.1152/ajpgi.00509.2010; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HINTZ HF, 1978, J ANIM SCI, V46, P1803, DOI 10.2527/jas1978.4661803x; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Johnson-Henry KC, 2005, J INFECT DIS, V191, P2106, DOI 10.1086/430318; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Murray PR, 2010, TOPLEY WILSONS MICRO; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	44	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e95534	10.1371/journal.pone.0095534	http://dx.doi.org/10.1371/journal.pone.0095534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014551	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400001
J	Francois, C; Jaillet, F; Takerkart, S; Schon, D				Francois, Clement; Jaillet, Florent; Takerkart, Sylvain; Schoen, Daniele			Faster Sound Stream Segmentation in Musicians than in Nonmusicians	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MUSICAL EXPERIENCE; BRAIN-STEM; STATISTICAL REGULARITIES; SPEECH SEGMENTATION; CONDUCTION APHASIA; ARCUATE FASCICULUS; WORD-FREQUENCY; LANGUAGE; PITCH	The musician's brain is considered as a good model of brain plasticity as musical training is known to modify auditory perception and related cortical organization. Here, we show that music-related modifications can also extend beyond motor and auditory processing and generalize (transfer) to speech processing. Previous studies have shown that adults and newborns can segment a continuous stream of linguistic and non-linguistic stimuli based only on probabilities of occurrence between adjacent syllables, tones or timbres. The paradigm classically used in these studies consists of a passive exposure phase followed by a testing phase. By using both behavioural and electrophysiological measures, we recently showed that adult musicians and musically trained children outperform nonmusicians in the test following brief exposure to an artificial sung language. However, the behavioural test does not allow for studying the learning process per se but rather the result of the learning. In the present study, we analyze the electrophysiological learning curves that are the ongoing brain dynamics recorded as the learning is taking place. While musicians show an inverted U shaped learning curve, nonmusicians show a linear learning curve. Analyses of Event-Related Potentials (ERPs) allow for a greater understanding of how and when musical training can improve speech segmentation. These results bring evidence of enhanced neural sensitivity to statistical regularities in musicians and support the hypothesis of positive transfer of training effect from music to sound stream segmentation in general.	[Francois, Clement] Inst Biomed Res Bellvitge, Cognit & Brain Plast Unit, Barcelona, Spain; [Francois, Clement] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Jaillet, Florent; Takerkart, Sylvain] Aix Marseille Univ, Inst Neurosci Timone, Unite Mixte Rech 7289, CNRS, Marseille, France; [Schoen, Daniele] Aix Marseille Univ, Inst Neurosci Syst Unite 1106, INSERM, Marseille, France	University of Barcelona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Schon, D (corresponding author), Aix Marseille Univ, Inst Neurosci Syst Unite 1106, INSERM, Marseille, France.	daniele.schon@univ-amu.fr	Schön, Daniele/B-2484-2013; François, Clément/F-7133-2013	Schön, Daniele/0000-0003-4472-4150; François, Clément/0000-0003-2271-6942; Jaillet, Florent/0000-0003-3781-9514	French National Research Agency [ANR-09-BLAN-0310]; FYSSEN foundation	French National Research Agency(French National Research Agency (ANR)); FYSSEN foundation	This study has been supported by the French National Research Agency (ANR-09-BLAN-0310 to D. Schon, http://www.agence-nationale-recherche.fr/). At the time of the submission C. Francois is in a postdoctoral stay at the University of Barcelona funded by the FYSSEN foundation (http://www.fondationfyssen.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; Anderson JM, 1999, BRAIN LANG, V70, P1, DOI 10.1006/brln.1999.2135; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; BENSON DF, 1973, ARCH NEUROL-CHICAGO, V28, P339, DOI 10.1001/archneur.1973.00490230075011; Bidebnan GM, 2010, BRAIN RES, V1355, P112, DOI 10.1016/j.brainres.2010.07.100; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chobert J, 2011, J COGNITIVE NEUROSCI, V23, P3874, DOI 10.1162/jocn_a_00088; Cunillera T, 2006, BRAIN RES, V1123, P168, DOI 10.1016/j.brainres.2006.09.046; Cunillera T, 2009, NEUROIMAGE, V48, P541, DOI 10.1016/j.neuroimage.2009.06.069; DAMASIO H, 1980, BRAIN, V103, P337, DOI 10.1093/brain/103.2.337; De Diego Balaguer Ruth, 2007, PLoS One, V2, pe1175, DOI 10.1371/journal.pone.0001175; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Federmeier KD, 2000, BRAIN LANG, V71, P62, DOI 10.1006/brln.1999.2213; Francois C, 2014, HEARING RES, V308, P122, DOI 10.1016/j.heares.2013.08.018; Francois C, 2013, CEREB CORTEX, V23, P2038, DOI 10.1093/cercor/bhs180; Francois C, 2012, ANN NY ACAD SCI, V1252, P108, DOI 10.1111/j.1749-6632.2011.06395.x; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Francois C, 2010, NEUROREPORT, V21, P928, DOI 10.1097/WNR.0b013e32833ddd5e; George EM, 2011, NEUROPSYCHOLOGIA, V49, P1083, DOI 10.1016/j.neuropsychologia.2011.02.001; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Halwani GF, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00156; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Larrouy-Maestri P, 2013, MUSIC SCI, V17, P217, DOI 10.1177/1029864912473470; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Lopez-Barroso D, 2011, CEREB CORTEX, V21, P2742, DOI 10.1093/cercor/bhr064; Loui P, 2009, J NEUROSCI, V29, P454, DOI 10.1523/JNEUROSCI.4503-08.2009; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Makeig S, 1996, ADV NEUR IN, V8, P145; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P294, DOI 10.1162/jocn.2010.21413; McNealy K, 2006, J NEUROSCI, V26, P7629, DOI 10.1523/JNEUROSCI.5501-05.2006; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Milovanou R, 2008, BRAIN RES, V1194, P81, DOI 10.1016/j.brainres.2007.11.042; Milovanov R, 2009, NEUROSCI LETT, V460, P161, DOI 10.1016/j.neulet.2009.05.063; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Oechslin MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.076.2009; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Paraskevopoulos E, 2012, NEUROPSYCHOLOGIA, V50, P341, DOI 10.1016/j.neuropsychologia.2011.12.007; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Rodriguez-Fornells A, 2012, ANN NY ACAD SCI, V1252, P282, DOI 10.1111/j.1749-6632.2011.06425.x; Rodriguez-Fornells A, 2009, PHILOS T R SOC B, V364, P3711, DOI 10.1098/rstb.2009.0130; Rugg M., 1995, ELECTROPHYSIOLOGY MI; Russeler J, 2001, NEUROSCI LETT, V308, P33, DOI 10.1016/S0304-3940(01)01977-2; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Saffran JR, 2001, P NATL ACAD SCI USA, V98, P12874, DOI 10.1073/pnas.231498898; Sanders LD, 2002, NAT NEUROSCI, V5, P700, DOI 10.1038/nn873; Sanders LD, 2009, NEUROPSYCHOLOGIA, V47, P1183, DOI 10.1016/j.neuropsychologia.2008.11.005; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin A, 2005, NEUROREPORT, V16, P1781, DOI 10.1097/01.wnr.0000185017.29316.63; Shook A, 2013, AM J PSYCHOL, V126, P95, DOI 10.5406/amerjpsyc.126.1.0095; Skoe E, 2013, NEUROSCIENCE, V243, P104, DOI 10.1016/j.neuroscience.2013.03.009; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Tierney AT, 2008, EMPIR MUSICOL REV, V3, P178, DOI 10.18061/1811/35989; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tillmann B, 2004, J EXP PSYCHOL LEARN, V30, P1131, DOI 10.1037/0278-7393.30.5.1131; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Tremblay P, 2013, NEUROIMAGE, V66, P318, DOI 10.1016/j.neuroimage.2012.10.055; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; YOUNG MP, 1992, PSYCHOPHYSIOLOGY, V29, P664, DOI 10.1111/j.1469-8986.1992.tb02044.x	76	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101340	10.1371/journal.pone.0101340	http://dx.doi.org/10.1371/journal.pone.0101340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014068	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400024
J	Murugesan, GR; Romero, LF; Persia, ME				Murugesan, Ganapathi R.; Romero, Luis F.; Persia, Michael E.			Effects of Protease, Phytase and a Bacillus sp. Direct-Fed Microbial on Nutrient and Energy Digestibility, Ileal Brush Border Digestive Enzyme Activity and Cecal Short-Chain Fatty Acid Concentration in Broiler Chickens	PLOS ONE			English	Article							APPARENT METABOLIZABLE ENERGY; SUBTILIS VAR. NATTO; GROWTH-PERFORMANCE; SOYBEAN-MEAL; FEED RESTRICTION; LIVE PERFORMANCE; YOUNG BROILERS; AMINO-ACIDS; DIETS; SUPPLEMENTATION	Two experiments were conducted to determine the effects of protease and phytase (PP) and a Bacillus sp. direct-fed microbial (DFM) on dietary energy and nutrient utilization in broiler chickens. In the first experiment, Ross 308 broiler chicks were fed diets supplemented with PP and DFM in a 262 factorial arrangement. The 4 diets (control (CON), CON + PP, CON + DFM, and CON + PP + DFM) were fed from 15-21 days of age. In Experiment 1, significant interaction (P <= 0.01) between PP and DFM on the apparent ileal digestibility coefficient for starch, crude protein, and amino acid indicated that both additives increased the digestibility. Both additives increased the nitrogen retention coefficient with a significant interaction (P <= 0.01). Although no interaction was observed, significant main effects (P <= 0.01) for nitrogen-corrected apparent ME (AMEn) for PP or DFM indicated an additive response. In a follow-up experiment, Ross 308 broiler chicks were fed the same experimental diets from 1-21 days of age. Activities of ileal brush border maltase, sucrase, and L-alanine aminopeptidase were increased (P <= 0.01) by PP addition, while a trend (P = 0.07) for increased sucrase activity was observed in chickens fed DFM, in Experiment 2. The proportion of cecal butyrate was increased (P <= 0.01) by DFM addition. Increased nutrient utilization and nitrogen retention appear to involve separate but complementary mechanisms for PP and DFM, however AMEn responses appear to have separate and additive mechanisms.	[Murugesan, Ganapathi R.; Persia, Michael E.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Romero, Luis F.] DuPont Ind Biosci, Danisco Anim Nutr, Marlborough, England	Iowa State University	Persia, ME (corresponding author), Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	mpersia@vt.edu		Murugesan, Raj/0000-0002-1285-2126	Danisco Animal Nutrition - DuPont Industrial Biosciences	Danisco Animal Nutrition - DuPont Industrial Biosciences	The experiments were funded by Danisco Animal Nutrition - DuPont Industrial Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aacc, 2011, J AACC INT; Aoac, 2006, J AOAC INT; Apata DF, 2008, J SCI FOOD AGR, V88, P1253, DOI 10.1002/jsfa.3214; Aviagen, 2011, ROSS 308 PER STAND M; Cherbut C, 2003, P NUTR SOC, V62, P95, DOI 10.1079/PNS2002213; COLLINGTON GK, 1990, BRIT J NUTR, V64, P59, DOI 10.1079/BJN19900009; Colombatto D, 2009, J ANIM SCI, V87, P1097, DOI 10.2527/jas.2008-1262; Cowieson AJ, 2008, BRIT POULTRY SCI, V49, P37, DOI 10.1080/00071660701812989; Cowieson AJ, 2009, WORLD POULTRY SCI J, V65, P609, DOI 10.1017/S0043933909000427; DAHLQVIST A, 1964, ANAL BIOCHEM, V7, P18, DOI 10.1016/0003-2697(64)90115-0; Douglas MW, 2000, J APPL POULTRY RES, V9, P74, DOI 10.1093/japr/9.1.74; Fritts CA, 2000, J APPL POULTRY RES, V9, P149, DOI 10.1093/japr/9.2.149; Fujiwara K, 2009, J POULT SCI, V46, P116, DOI 10.2141/jpsa.46.116; Ghazi S, 2002, BRIT POULTRY SCI, V43, P70, DOI 10.1080/00071660120109935; Hooge DM, 2004, J APPL POULTRY RES, V13, P222, DOI 10.1093/japr/13.2.222; Jin LZ, 2000, POULTRY SCI, V79, P886, DOI 10.1093/ps/79.6.886; Kocher A, 2003, J APPL POULTRY RES, V12, P275, DOI 10.1093/japr/12.3.275; Kumprecht I, 1998, CZECH J ANIM SCI, V43, P327; Lemme A, 2004, WORLD POULTRY SCI J, V60, P423, DOI 10.1079/WPS200426; LEONE JL, 1973, J ASSOC OFF ANA CHEM, V56, P535; Li LL, 2008, J SCI FOOD AGR, V88, P35, DOI 10.1002/jsfa.2910; Liu N, 2009, ARCH ANIM NUTR, V63, P292, DOI 10.1080/17450390903020422; Lopez G, 2005, POULTRY SCI, V84, P1069, DOI 10.1093/ps/84.7.1069; MAROUX S, 1973, BIOCHIM BIOPHYS ACTA, V321, P282, DOI 10.1016/0005-2744(73)90083-1; Marsman GJP, 1997, POULTRY SCI, V76, P864, DOI 10.1093/ps/76.6.864; Mathlouthi N, 2011, INT J POULT SCI, V10; Meng X, 2005, POULTRY SCI, V84, P1242, DOI 10.1093/ps/84.8.1242; Murugesan GR, 2013, POULTRY SCI, V92, P1238, DOI 10.3382/ps.2012-02719; Olukosi OA, 2008, BRIT J NUTR, V99, P682, DOI 10.1017/S0007114507815807; Pinheiro DF, 2004, POULTRY SCI, V83, P1544, DOI 10.1093/ps/83.9.1544; Ravindran V, 2000, BRIT POULTRY SCI, V41, P193, DOI 10.1080/00071660050022263; Saartchit J, 1990, POULTRY SCI, V69, P1966; Samanya M, 2002, COMP BIOCHEM PHYS A, V133, P95, DOI 10.1016/S1095-6433(02)00121-6; SANTOSO U, 1995, BRIT J NUTR, V74, P523, DOI 10.1079/BJN19950155; Santoso U, 2001, ASIAN AUSTRAL J ANIM, V14, P333; SAS Institute Inc, 2012, SAS; Scott M. L., 1982, NUTR CHICKEN, V3rd; Shirley RB, 2003, POULTRY SCI, V82, P671, DOI 10.1093/ps/82.4.671; Wang ZR, 2005, POULTRY SCI, V84, P875, DOI 10.1093/ps/84.6.875; Yu B, 2007, ANIM FEED SCI TECH, V134, P283, DOI 10.1016/j.anifeedsci.2006.09.017; Zanella I, 1999, POULTRY SCI, V78, P561, DOI 10.1093/ps/78.4.561; Zhou Y, 2009, POULTRY SCI, V88, P316, DOI 10.3382/ps.2008-00231	42	33	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101888	10.1371/journal.pone.0101888	http://dx.doi.org/10.1371/journal.pone.0101888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013936	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400045
J	Pena-Soler, E; Fernandez, FJ; Lopez-Estepa, M; Garces, F; Richardson, AJ; Quintana, JF; Rudd, KE; Coll, M; Vega, MC				Pena-Soler, Esther; Fernandez, Francisco J.; Lopez-Estepa, Miguel; Garces, Fernando; Richardson, Andrew J.; Quintana, Juan F.; Rudd, Kenneth E.; Coll, Miquel; Cristina Vega, M.			Structural Analysis and Mutant Growth Properties Reveal Distinctive Enzymatic and Cellular Roles for the Three Major L-Alanine Transaminases of Escherichia coli	PLOS ONE			English	Article							HISTIDINOL-PHOSPHATE AMINOTRANSFERASE; DOUBLE SUBSTRATE RECOGNITION; ASPARTATE-AMINOTRANSFERASE; PYRIDOXAL 5'-PHOSPHATE; CRYSTAL-STRUCTURES; ENZYMES; MECHANISM; GLUTAMATE; MITOCHONDRIAL; REFINEMENT	In order to maintain proper cellular function, the metabolism of the bacterial microbiota presents several mechanisms oriented to keep a correctly balanced amino acid pool. Central components of these mechanisms are enzymes with alanine transaminase activity, pyridoxal 5'-phosphate-dependent enzymes that interconvert alanine and pyruvate, thereby allowing the precise control of alanine and glutamate concentrations, two of the most abundant amino acids in the cellular amino acid pool. Here we report the 2.11-A crystal structure of full-length AlaA from the model organism Escherichia coli, a major bacterial alanine aminotransferase, and compare its overall structure and active site composition with detailed atomic models of two other bacterial enzymes capable of catalyzing this reaction in vivo, AlaC and valine-pyruvate aminotransferase (AvtA). Apart from a narrow entry channel to the active site, a feature of this new crystal structure is the role of an active site loop that closes in upon binding of substrate-mimicking molecules, and which has only been previously reported in a plant enzyme. Comparison of the available structures indicates that beyond superficial differences, alanine aminotransferases of diverse phylogenetic origins share a universal reaction mechanism that depends on an array of highly conserved amino acid residues and is similarly regulated by various unrelated motifs. Despite this unifying mechanism and regulation, growth competition experiments demonstrate that AlaA, AlaC and AvtA are not freely exchangeable in vivo, suggesting that their functional repertoire is not completely redundant thus providing an explanation for their independent evolutionary conservation.	[Pena-Soler, Esther; Fernandez, Francisco J.; Lopez-Estepa, Miguel; Quintana, Juan F.; Cristina Vega, M.] CSIC, Ctr Invest Biol, Spanish Natl Res Council, Madrid, Spain; [Pena-Soler, Esther; Coll, Miquel] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Coll, Miquel] Inst Biol Mol Barcelona IBMB CSIC, Barcelona, Spain; [Garces, Fernando] Scripps Res Inst, La Jolla, CA 92037 USA; [Richardson, Andrew J.; Rudd, Kenneth E.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Scripps Research Institute; University of Miami	Vega, MC (corresponding author), CSIC, Ctr Invest Biol, Spanish Natl Res Council, Madrid, Spain.	cvega@cib.csic.es	Peña, Esther/AAB-8217-2019; Coll, Miquel/L-5999-2014; Fernandez, Francisco J./C-3647-2011; Vega, M. Cristina/C-3640-2011	Coll, Miquel/0000-0003-4471-8674; Pena, Esther/0000-0003-2750-0614; Fernandez, Francisco J./0000-0002-5015-1849; Vega, M. Cristina/0000-0003-0628-8378	Spanish Ministry of Economy and Competitiveness [PET2008_0101, BIO2009-11184, BFU2010-22260-C02-02, BFU2008-02372/BMC, CSD 2006-23, BFU2011-22588]; Generalitat de Catalunya [SGR2009-1309]; European Commission [279039]; US National Institutes of Health [1-R01-GM58560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058560] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Spanish Ministry of Economy and Competitiveness (grants PET2008_0101, BIO2009-11184 and BFU2010-22260-C02-02 to MCV and BFU2008-02372/ BMC, CSD 2006-23 and BFU2011-22588 to MC), the Generalitat de Catalunya (grant SGR2009-1309 to MC), the European Commission (Framework Programme 7 (FP7) projects ComplexINC No. 279039 to MCV), and the US National Institutes of Health (grant 1-R01-GM58560 to KER and AJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cho BK, 2012, NAT CHEM BIOL, V8, P65, DOI 10.1038/nchembio.710; Cook PD, 2007, BIOCHEMISTRY-US, V46, P14215, DOI 10.1021/bi701686s; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duff SMG, 2012, ARCH BIOCHEM BIOPHYS, V528, P90, DOI 10.1016/j.abb.2012.06.006; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez FJ, 2004, J BIOL CHEM, V279, P21478, DOI 10.1074/jbc.M400291200; Fernandez FJ, 2012, BBA-PROTEINS PROTEOM, V1824, P339, DOI 10.1016/j.bbapap.2011.10.016; GEHRING H, 1984, BIOCHEMISTRY-US, V23, P6335, DOI 10.1021/bi00321a007; Glinghammar B, 2009, INT J MOL MED, V23, P621, DOI 10.3892/ijmm_00000173; Goto M, 2003, BIOCHEMISTRY-US, V42, P3725, DOI 10.1021/bi026722f; Graber R, 1999, J BIOL CHEM, V274, P31203, DOI 10.1074/jbc.274.44.31203; Griswold WR, 2011, J AM CHEM SOC, V133, P14823, DOI 10.1021/ja2061006; Haruyama K, 2001, BIOCHEMISTRY-US, V40, P4633, DOI 10.1021/bi002769u; Hayashi H, 1998, BIOCHEMISTRY-US, V37, P15076, DOI 10.1021/bi981517e; Hayashi H, 2003, BBA-PROTEINS PROTEOM, V1647, P103, DOI 10.1016/S1570-9639(03)00068-2; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Islam MM, 2005, BIOCHEMISTRY-US, V44, P8218, DOI 10.1021/bi050071g; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim SH, 2010, J BACTERIOL, V192, P5304, DOI 10.1128/JB.00738-10; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Kleywegt Gerard J, 2007, Methods Mol Biol, V364, P255; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liangpunsakul S, 2005, AM J MED SCI, V329, P111, DOI 10.1097/00000441-200503000-00001; MALASHKEVICH VN, 1993, BIOCHEMISTRY-US, V32, P13451, DOI 10.1021/bi00212a010; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S; Mizuguchi H, 2003, BBA-PROTEINS PROTEOM, V1647, P321, DOI 10.1016/S1570-9639(03)00082-7; Mizuguchi H, 2001, BIOCHEMISTRY-US, V40, P353, DOI 10.1021/bi001403e; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Ouchi T, 2009, BIOCHEM BIOPH RES CO, V388, P21, DOI 10.1016/j.bbrc.2009.07.096; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; WANG MD, 1987, J BACTERIOL, V169, P5610, DOI 10.1128/jb.169.12.5610-5614.1987; WANG MD, 1987, J BACTERIOL, V169, P4228, DOI 10.1128/jb.169.9.4228-4234.1987; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Watanabe N, 2008, J MOL BIOL, V384, P1314, DOI 10.1016/j.jmb.2008.10.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Zhou JD, 2011, METHODS MOL BIOL, V765, P3, DOI 10.1007/978-1-61779-197-0_1; Zhou W, SE COLLABOR IN PRESS	59	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102139	10.1371/journal.pone.0102139	http://dx.doi.org/10.1371/journal.pone.0102139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014014	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000339378400069
J	Shen, YC; Weng, SF; Wang, JJ; Tien, KJ				Shen, Yuan-Chi; Weng, Shih-Feng; Wang, Jhi-Joung; Tien, Kai-Jen			Erectile Dysfunction and Risk of End Stage Renal Disease Requiring Dialysis: A Nationwide Population-Based Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; SEXUAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; PREVALENCE; MEN; HYPERTENSION; PREDICTOR; SEVERITY	Background: Previous studies have suggested that erectile dysfunction (ED) is an independent risk factor for macrovascular disease. Very few studies have evaluated the relationship between ED and risk of end stage renal disease (ESRD) requiring dialysis. Methods: A random sample of 1,000,000 individuals from Taiwan's National Health Insurance database was collected. We selected the control group by matching the subjects and controls by age, diabetes, hypertension, coronary heart disease, hyperlipidemia, area of residence, monthly income and index date. We identified 3985 patients with newly-diagnosed ED between 2000 and 2008 and compared them with a matched cohort of 23910 patients without ED. All patients were tracked from the index date to identify which patients subsequently developed a need for dialysis. Results: The incidence rates of dialysis in the ED cohort and comparison groups were 10.85 and 9.06 per 10000 person-years, respectively. Stratified by age, the incidence rate ratio for dialysis was greater in ED patients aged <50 years (3.16, 95% CI: 1.62-6.19, p = 0.0008) but not in aged 50-64 (0.94, 95% CI: 0.52-1.69, p = 0.8397) and those aged >= 65 (0.69, 95% CI: 0.32-1.52, p = 0.3594). After adjustment for patient characteristics and medial comorbidities, the adjusted HR for dialysis remained greater in ED patients aged <50 years (adjusted HR: 2.08, 95% CI: 1.05-4.11, p<0.05). The log-rank test revealed that ED patients <50-years-old had significantly higher cumulative incidence rates of dialysis than those without (p = 0.0004). Conclusion: Patients with ED, especially younger patients, are at an increased risk for ESRD requiring dialysis later in life.	[Shen, Yuan-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan; [Shen, Yuan-Chi] Cheng Shiu Univ, Kaohsiung, Taiwan; [Weng, Shih-Feng; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Tien, Kai-Jen] Chi Mei Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Tainan, Taiwan; [Tien, Kai-Jen] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan	Chang Gung Memorial Hospital; Cheng Shiu University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Tien, KJ (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Tainan, Taiwan.	cmmctkj@gmail.com		Weng, Shih-Feng/0000-0001-8684-3487				Aversa A, 2010, INT J UROL, V17, P38, DOI 10.1111/j.1442-2042.2009.02426.x; Bellinghieri G, 2008, J NEPHROL, V21, pS113; Blumentals W A, 2003, Aging Male, V6, P217, DOI 10.1080/13685530312331309752; Chew KK, 2010, J SEX MED, V7, P192, DOI 10.1111/j.1743-6109.2009.01576.x; Chuang YC, 2012, J SEX MED, V9, P1055, DOI 10.1111/j.1743-6109.2011.02586.x; Hermans MP, 2009, DIABETES METAB, V35, P484, DOI 10.1016/j.diabet.2009.06.003; Hwang TIS, 2010, J SEX MED, V7, P2817, DOI 10.1111/j.1743-6109.2010.01837.x; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Ma RCW, 2008, J AM COLL CARDIOL, V51, P2045, DOI 10.1016/j.jacc.2008.02.051; Marumo K, 2001, INT J UROL, V8, P53, DOI 10.1046/j.1442-2042.2001.00258.x; McKinlay JB, 2000, INT J IMPOT RES, V12, pS6, DOI 10.1038/sj.ijir.3900567; Navaneethan SD, 2010, AM J KIDNEY DIS, V56, P670, DOI 10.1053/j.ajkd.2010.06.016; O'Leary MP, 2006, J UROLOGY, V175, P1058, DOI 10.1016/S0022-5347(05)00418-0; Ponholzer A, 2005, EUR UROL, V48, P512, DOI 10.1016/j.eururo.2005.05.014; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; RECKELHOFF JF, 1993, AM J PHYSIOL, V265, pR1126, DOI 10.1152/ajpregu.1993.265.5.R1126; Salem S, 2009, J SEX MED, V6, P3425, DOI 10.1111/j.1743-6109.2009.01515.x; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Siu SC, 2001, DIABETIC MED, V18, P732, DOI 10.1046/j.0742-3071.2001.00557.x; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Uhlig K, 2002, TRADITIONAL CARDIAC, P118; Viigimaa M, 2011, J HYPERTENS, V29, P403, DOI 10.1097/HJH.0b013e328342c659; Weinberg AE, 2013, J SEX MED, V10, P3102, DOI 10.1111/jsm.12318; Yamasaki H, 2004, DIABETES RES CLIN PR, V66, pS173, DOI 10.1016/j.diabres.2003.09.019; Zoccali C, 2011, KIDNEY INT SUPPL, V1, P2, DOI 10.1038/kisup.2011.4	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102055	10.1371/journal.pone.0102055	http://dx.doi.org/10.1371/journal.pone.0102055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013905	Green Submitted, gold, Green Published			2022-12-27	WOS:000339378400059
J	Chen, MN; Li, X; Yang, QL; Chi, XY; Pan, LJ; Chen, N; Yang, Z; Wang, T; Wang, MA; Yu, SL				Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin			Dynamic Succession of Soil Bacterial Community during Continuous Cropping of Peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; MICROBIAL COMMUNITIES; YIELD DECLINE; LAND-USE; PLANT; DIVERSITY; MICROORGANISMS; POPULATIONS; MANAGEMENT; AGGREGATION	Plant health and soil fertility are affected by plant-microbial interactions in soils. Peanut is an important oil crop worldwide and shows considerable adaptability, but growth and yield are negatively affected by continuous cropping. In this study, 16S rRNA gene clone library analyses were used to study the succession of soil bacterial communities under continuous peanut cultivation. Six libraries were constructed for peanut over three continuous cropping cycles and during its seedling and pod-maturing growth stages. Cluster analyses indicated that soil bacterial assemblages obtained from the same peanut cropping cycle were similar, regardless of growth period. The diversity of bacterial sequences identified in each growth stage library of the three peanut cropping cycles was high and these sequences were affiliated with 21 bacterial groups. Eight phyla: Acidobacteria, Actinobacteria, Bacteroidetes, Chloroflexi, Gemmatimonadetes, Planctomycetes, Proteobacteria and Verrucomicrobia were dominant. The related bacterial phylotypes dynamic changed during continuous cropping progress of peanut. This study demonstrated that the bacterial populations especially the beneficial populations were positively selected. The simplification of the beneficial microbial communities such as the phylotypes of Alteromonadales, Burkholderiales, Flavobacteriales, Pseudomonadales, Rhizobiales and Rhodospirillales could be important factors contributing to the decline in peanut yield under continuous cropping. The microbial phylotypes that did not successively changed with continuous cropping, such as populations related to Rhizobiales and Rhodospirillales, could potentially resist stress due to continuous cropping and deserve attention. In addition, some phylotypes, such as Acidobacteriales, Chromatiales and Gemmatimonadales, showed a contrary tendency, their abundance or diversity increased with continuous peanut cropping progress. Some bacterial phylotypes including Acidobacteriales, Burkholderiales, Bdellovibrionales, and so on, also were affected by plant age.	[Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China		Yu, SL (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	yshanlin1956@163.com		Li, Xiao/0000-0002-0505-1654	China Agriculture Research System [C ARS-14]; National Natural Science Foundation of China [31000728, 31100205, 31200211]; Natural Science Fund of Shandong Province [ZR2011CQ 036, ZR2012586 CQ031]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2010NY023]; Qingdao Municipal Science and Technology Plan Project [11-2-4-9-(3)-jic, 11-2-3-26-nsh, 12-1-4-11-(2)-jch]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shandong Province; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from China Agriculture Research System (C ARS-14), the National Natural Science Foundation of China (31000728; 31100205; 31200211), the Natural Science Fund of Shandong Province (ZR2011CQ 036; ZR2012586 CQ031), the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2010NY023), Qingdao Municipal Science and Technology Plan Project (11-2-4-9-(3)-jic; 11-2-3-26-nsh; 12-1-4-11-(2)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2013, SOIL BIOL BIOCHEM, V57, P144, DOI 10.1016/j.soilbio.2012.09.003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avidano L, 2005, APPL SOIL ECOL, V30, P21, DOI 10.1016/j.apsoil.2005.01.003; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Caesar-TonThat T, 2010, EUR J SOIL BIOL, V46, P119, DOI 10.1016/j.ejsobi.2009.12.004; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dobermann A, 2000, AGRON J, V92, P633, DOI 10.2134/agronj2000.924633x; Ehteshami S M R, 2007, Pak J Biol Sci, V10, P3585, DOI 10.3923/pjbs.2007.3585.3591; Elmer WH, 2011, PLANT DIS, V95, P960, DOI 10.1094/PDIS-10-10-0741; Fabra A, 2010, CRIT REV MICROBIOL, V36, P179, DOI 10.3109/10408410903584863; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Guan XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-820; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; JOHNSON NC, 1992, AGRON J, V84, P387, DOI 10.2134/agronj1992.00021962008400030007x; Kandeler E, 2006, SOIL BIOL BIOCHEM, V38, P2448, DOI 10.1016/j.soilbio.2006.02.021; Kihara J, 2012, APPL SOIL ECOL, V58, P12, DOI 10.1016/j.apsoil.2012.03.004; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Li XG, 2014, SOIL BIOL BIOCHEM, V72, P11, DOI 10.1016/j.soilbio.2014.01.019; Li YG, 2012, APPL MECH MATER, V108, P127, DOI 10.4028/www.scientific.net/AMM.108.127; Liddycoat SM, 2009, CAN J MICROBIOL, V55, P388, DOI [10.1139/w08-144, 10.1139/W08-144]; Lithourgidis AS, 2006, EUR J AGRON, V25, P208, DOI 10.1016/j.eja.2006.05.003; Liu JS, 2013, OMEGA-INT J MANAGE S, V41, P3, DOI 10.1016/j.omega.2010.12.006; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nayyar A, 2009, APPL SOIL ECOL, V43, P115, DOI 10.1016/j.apsoil.2009.06.008; Picard C, 2000, APPL ENVIRON MICROB, V66, P948, DOI 10.1128/AEM.66.3.948-955.2000; Pliego C, 2011, PLANT SOIL, V340, P505, DOI 10.1007/s11104-010-0615-8; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rasche F, 2006, J APPL ECOL, V43, P555, DOI 10.1111/j.1365-2664.2006.01169.x; Reichardt W, 1997, APPL ENVIRON MICROB, V63, P233, DOI 10.1128/AEM.63.1.233-238.1997; Saharan BC, 2011, LIFE SCI MED RES, V21, P1, DOI DOI 10.4172/2157-7471.1000266; Sharma KK, 2006, METH MOL B, V343, P347; Spaepen S, 2009, ADV BOT RES, V51, P283, DOI 10.1016/S0065-2296(09)51007-5; Sudini H, 2011, PHYTOPATHOLOGY, V101, P819, DOI 10.1094/PHYTO-11-10-0310; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2	47	41	54	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101355	10.1371/journal.pone.0101355	http://dx.doi.org/10.1371/journal.pone.0101355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010658	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800021
J	Kalamida, D; Karagounis, IV; Giatromanolaki, A; Koukourakis, MI				Kalamida, Dimitra; Karagounis, Ilias V.; Giatromanolaki, Alexandra; Koukourakis, Michael I.			Important Role of Autophagy in Endothelial Cell Response to Ionizing Radiation	PLOS ONE			English	Article							CANCER-CELLS; PATHWAY	Objectives: Vasculature damage is an important contributor to the side-effects of radiotherapy. The aim of this study is to provide insights into the radiobiology of the autophagic response of endothelial cells. Methods and Materials: Human umbilical vascular endothelial cells (HUVEC) were exposed to 2 Gy of ionizing radiation (IR) and studied using confocal microscopy and western blot analysis, at 4 and 8 days post-irradiation. The role of autophagy flux in HUVEC radio-sensitivity was also examined. Results: IR-induced accumulation of LC3A+, LC3B+ and p62 cytoplasmic vacuoles, while in double immunostaining with lysosomal markers (LAMP2a and CathepsinD) repression of the autophagolysosomal flux was evident. Autophagy-related proteins (ATF4, HIF1 alpha, HIF2 alpha, Beclin1) were, however, induced excluding an eventual repressive effect of radiation on autophagy initiating protein expression. Exposure of HUVEC to SMER28, an mTOR-independent inducer of autophagy, enhanced proLC3 and LC3A, B-I protein expression and accelerated the autophagic flux. Pre-treatment of HUVEC with SMER28 protected against the blockage of autophagic flux induced by IR and conferred radio-resistance. Suppression of LC3A/LC3B proteins with siRNAs resulted in radio-sensitization. Conclusions: The current data provide a rationale for the development of novel radioprotection policies targeting the autophagic pathway.	[Kalamida, Dimitra; Karagounis, Ilias V.; Koukourakis, Michael I.] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis, Greece; [Kalamida, Dimitra; Karagounis, Ilias V.; Giatromanolaki, Alexandra; Koukourakis, Michael I.] Univ Gen Hosp Alexandroupolis, Alexandroupolis, Greece; [Giatromanolaki, Alexandra] Democritus Univ Thrace, Dept Pathol, Alexandroupolis, Greece	Democritus University of Thrace; Democritus University of Thrace	Koukourakis, MI (corresponding author), Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis, Greece.	targ@her.forthnet.gr	Karagounis, Ilias V/A-6497-2013	Karagounis, Ilias V/0000-0003-1642-1996	TRAINING AND LIFELONG LEARNING - ARISTEIA project [520]; ESPA; GGET [12605/26.09.2012]	TRAINING AND LIFELONG LEARNING - ARISTEIA project; ESPA; GGET	The study has been funded by the TRAINING AND LIFELONG LEARNING - ARISTEIA project, code no 520, ESPA 2007-2013, GGET decision number 12605/26.09.2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou I, 2013, BIOCHEM BIOPH RES CO, V431, P456, DOI 10.1016/j.bbrc.2012.12.146; BAKER DG, 1989, CANCER INVEST, V7, P287, DOI 10.3109/07357908909039849; Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Dumont FJ, 2012, CURR CANCER DRUG TAR, V12, P899; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Gorbunov NV, 2009, J PATHOL, V219, P242, DOI 10.1002/path.2591; Ito H, 2005, INT J ONCOL, V26, P1401; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang N, 2013, CELL SIGNAL, V25, P2530, DOI 10.1016/j.cellsig.2013.08.010; Paglin S, 2001, CANCER RES, V61, P439; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; Quarmby S, 1999, INT J CANCER, V82, P385, DOI 10.1002/(SICI)1097-0215(19990730)82:3<385::AID-IJC12>3.0.CO;2-5; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zachari MA, 2014, DOSE RESPON IN PRESS; Zhao Y, 2012, J CELL PHYSIOL, V227, P639, DOI 10.1002/jcp.22768; Zois CE, 2011, BIOCHEM BIOPH RES CO, V404, P552, DOI 10.1016/j.bbrc.2010.12.024; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	22	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102408	10.1371/journal.pone.0102408	http://dx.doi.org/10.1371/journal.pone.0102408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010689	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800099
J	Renaud, ENC; van Bueren, ETL; Myers, JR; Paulo, MJ; van Eeuwijk, FA; Zhu, N; Juvik, JA				Renaud, Erica N. C.; van Bueren, Edith T. Lammerts; Myers, James R.; Paulo, Maria Joao; van Eeuwijk, Fred A.; Zhu, Ning; Juvik, John A.			Variation in Broccoli Cultivar Phytochemical Content under Organic and Conventional Management Systems: Implications in Breeding for Nutrition	PLOS ONE			English	Article							GLUCOSINOLATE-MYROSINASE SYSTEM; LUNG-CANCER RISK; CRUCIFEROUS VEGETABLES; BETA-CAROTENE; ASCORBIC-ACID; VITAMIN-C; SELENIUM FERTILIZATION; SEASONAL-VARIATION; CROPPING SYSTEMS; WINTER-WHEAT	Organic agriculture requires cultivars that can adapt to organic crop management systems without the use of synthetic pesticides as well as genotypes with improved nutritional value. The aim of this study encompassing 16 experiments was to compare 23 broccoli cultivars for the content of phytochemicals associated with health promotion grown under organic and conventional management in spring and fall plantings in two broccoli growing regions in the US (Oregon and Maine). The phytochemicals quantified included: glucosinolates (glucoraphanin, glucobrassicin, neoglucobrassin), tocopherols (delta-, gamma-, alpha-tocopherol) and carotenoids (lutein, zeaxanthin, beta-carotene). For glucoraphanin (17.5%) and lutein (13%), genotype was the major source of total variation; for glucobrassicin, region (36%) and the interaction of location and season (27.5%); and for neoglucobrassicin, both genotype (36.8%) and its interactions (34.4%) with season were important. For delta- and gamma-tocopherols, season played the largest role in the total variation followed by location and genotype; for total carotenoids, genotype (8.41-13.03%) was the largest source of variation and its interactions with location and season. Overall, phytochemicals were not significantly influenced by management system. We observed that the cultivars with the highest concentrations of glucoraphanin had the lowest for glucobrassicin and neoglucobrassicin. The genotypes with high concentrations of glucobrassicin and neoglucobrassicin were the same cultivars and were early maturing F-1 hybrids. Cultivars highest in tocopherols and carotenoids were open pollinated or early maturing F-1 hybrids. We identified distinct locations and seasons where phytochemical performance was higher for each compound. Correlations among horticulture traits and phytochemicals demonstrated that glucoraphanin was negatively correlated with the carotenoids and the carotenoids were correlated with one another. Little or no association between phytochemical concentration and date of cultivar release was observed, suggesting that modern breeding has not negatively influenced the level of tested compounds. We found no significant differences among cultivars from different seed companies.	[Renaud, Erica N. C.; van Bueren, Edith T. Lammerts] Wageningen Univ, Wageningen UR Plant Breeding, Plant Sci Grp, NL-6700 AP Wageningen, Netherlands; [Myers, James R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Paulo, Maria Joao; van Eeuwijk, Fred A.] Wageningen Univ, Plant Sci Grp, NL-6700 AP Wageningen, Netherlands; [Zhu, Ning; Juvik, John A.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	Wageningen University & Research; Oregon State University; Wageningen University & Research; University of Illinois System; University of Illinois Urbana-Champaign	Renaud, ENC (corresponding author), Wageningen Univ, Wageningen UR Plant Breeding, Plant Sci Grp, NL-6700 AP Wageningen, Netherlands.	E.Renaud@enzazaden.com		Caldas Paulo, Maria Joao/0000-0002-4180-0763	Seeds of Change; Wageningen University; University of Illinois; Oregon State University	Seeds of Change; Wageningen University(European Commission); University of Illinois; Oregon State University	Funding was provided by Seeds of Change (www.seedsofchange.com) and monetary funding from Wageningen University, University of Illinois and Oregon State University. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires A, 2011, MOLECULES, V16, P6816, DOI 10.3390/molecules16086816; Aldrich HT, 2010, J SCI FOOD AGR, V90, P2548, DOI 10.1002/jsfa.4116; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Baresel JP, 2008, EUPHYTICA, V163, P347, DOI 10.1007/s10681-008-9718-1; Benbrook C, 2009, HORTSCIENCE, V44, P12, DOI 10.21273/HORTSCI.44.1.12; Bjorkman M, 2011, PHYTOCHEMISTRY, V72, P538, DOI 10.1016/j.phytochem.2011.01.014; Bosetti C, 2012, ANN ONCOL, V23, P2198, DOI 10.1093/annonc/mdr604; Bourn D, 2002, CRIT REV FOOD SCI, V42, P1, DOI 10.1080/10408690290825439; Brandt K, 2011, CRIT REV PLANT SCI, V30, P177, DOI 10.1080/07352689.2011.554417; Brown AF, 2002, J AM SOC HORTIC SCI, V127, P807, DOI 10.21273/JASHS.127.5.807; CARLSON DG, 1987, J AM SOC HORTIC SCI, V112, P173; CECCARELLI S, 1994, EUPHYTICA, V77, P205, DOI 10.1007/BF02262633; Ceccarelli S, 1996, EUPHYTICA, V92, P203, DOI 10.1007/BF00022846; Charron CS, 2005, J SCI FOOD AGR, V85, P671, DOI 10.1002/jsfa.1880; Charron CS, 2005, J SCI FOOD AGR, V85, P682, DOI 10.1002/jsfa.2031; Chassy AW, 2006, J AGR FOOD CHEM, V54, P8244, DOI 10.1021/jf060950p; Crozier A., 2006, PLANT SECONDARY META; Davis D, 2004, J AM COLL NUTR, V23, P1; de Ponti T, 2012, AGR SYST, V108, P1, DOI 10.1016/j.agsy.2011.12.004; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Farnham MW, 2011, CROP SCI, V51, P2721, DOI 10.2135/cropsci2010.09.0556; Farnham MW, 2009, HORTSCIENCE, V44, P1248, DOI 10.21273/HORTSCI.44.5.1248; Farnham MW, 2005, HORTSCIENCE, V40, P50, DOI 10.21273/HORTSCI.40.1.50; Farnham MW, 2004, PLANT BREEDING, V123, P60, DOI 10.1046/j.0179-9541.2003.00912.x; Faulkner K, 1998, CARCINOGENESIS, V19, P605, DOI 10.1093/carcin/19.4.605; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Goldstein W, 2012, ORGANIC CROP BREEDIN; Hale AL, 2007, THEOR APPL GENET, V115, P351, DOI 10.1007/s00122-007-0569-2; HANSEN M, 1995, J AM SOC HORTIC SCI, V120, P1069, DOI 10.21273/JASHS.120.6.1069; Harker FR, 2004, FOOD QUAL PREFER, V15, P91, DOI 10.1016/S0950-3293(03)00035-1; Herr I, 2010, CANCER TREAT REV, V36, P377, DOI 10.1016/j.ctrv.2010.01.002; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Hunter D, 2011, CRIT REV FOOD SCI, V51, P571, DOI 10.1080/10408391003721701; Hussain A, 2010, INT J ENV RES PUB HE, V7, P3442, DOI 10.3390/ijerph7093442; Ibrahim KE, 2009, J AGR FOOD CHEM, V57, P4636, DOI 10.1021/jf900260d; Jones H, 2010, J AGR SCI-CAMBRIDGE, V148, P303, DOI 10.1017/S0021859610000146; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Keck Anna-Sigrid, 2004, Integr Cancer Ther, V3, P5, DOI 10.1177/1534735403261831; Khoo HE, 2011, MOLECULES, V16, P1710, DOI 10.3390/molecules16021710; Kim HS, 2011, J AM SOC HORTIC SCI, V136, P239, DOI 10.21273/JASHS.136.4.239; Kirk AP, 2012, PLANT BREEDING, V131, P687, DOI 10.1111/j.1439-0523.2012.02006.x; Kirsh VA, 2007, JNCI-J NATL CANCER I, V99, P1200, DOI 10.1093/jnci/djm065; Koh E, 2009, J FOOD COMPOS ANAL, V22, P637, DOI 10.1016/j.jfca.2009.01.019; Koh E, 2012, J AGR FOOD CHEM, V60, P3144, DOI 10.1021/jf300051f; Kopsell DA, 2004, HORTSCIENCE, V39, P361, DOI 10.21273/HORTSCI.39.2.361; Kopsell DA, 2006, TRENDS PLANT SCI, V11, P499, DOI 10.1016/j.tplants.2006.08.006; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Kritchevsky SB, 1999, J NUTR, V129, P5, DOI 10.1093/jn/129.1.5; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1576, DOI 10.1021/jf9810158; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Kushad MM, 1999, J AGR FOOD CHEM, V47, P1541, DOI 10.1021/jf980985s; Lam TK, 2010, CANCER EPIDEM BIOMAR, V19, P2534, DOI 10.1158/1055-9965.EPI-10-0475; Loschenberger F, 2008, EUPHYTICA, V163, P469, DOI 10.1007/s10681-008-9709-2; Lorenzana RE, 2008, CROP SCI, V48, P903, DOI 10.2135/cropsci2007.08.0465; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Martinez-Ballesta M. Carmen, 2008, Phytochemistry Reviews, V7, P251, DOI 10.1007/s11101-007-9071-3; Mayne ST, 1996, FASEB J, V10, P690, DOI 10.1096/fasebj.10.7.8635686; Meyer M, 2008, EUR FOOD RES TECHNOL, V226, P1429, DOI 10.1007/s00217-007-0674-0; Mithen R, 2003, THEOR APPL GENET, V106, P727, DOI 10.1007/s00122-002-1123-x; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI [10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V, 10.1002/(SICI)1097-0010(20000515)80:7&lt;967::AID-JSFA597&gt;3.0.CO;2-V]; MOZAFAR A, 1993, J PLANT NUTR, V16, P2479, DOI 10.1080/01904169309364698; MUNGER HM, 1979, HORTSCIENCE, V14, P247; Murphy KM, 2008, EUPHYTICA, V163, P381, DOI 10.1007/s10681-008-9681-x; Murphy KM, 2007, FIELD CROP RES, V102, P172, DOI 10.1016/j.fcr.2007.03.011; Naguib A. E. M., 2012, Journal of the Saudi Society of Agricultural Sciences, V11, P135; Osman AM, 2008, EUPHYTICA, V163, P511, DOI 10.1007/s10681-008-9700-y; Pek Z, 2012, HORTSCIENCE, V47, P1646, DOI 10.21273/HORTSCI.47.11.1646; Picchi V, 2012, FOOD CHEM, V130, P501, DOI 10.1016/j.foodchem.2011.07.036; Przystalski M, 2008, EUPHYTICA, V163, P417, DOI 10.1007/s10681-008-9715-4; Renaud ENC, 2014, CROP SCI, DOI [10.2135/cropsci201, DOI 10.2135/CROPSCI201]; Robbins RJ, 2005, J MED FOOD, V8, P204, DOI 10.1089/jmf.2005.8.204; Rosa EAS, 2001, HORTSCIENCE, V36, P56, DOI 10.21273/HORTSCI.36.1.56; Saba A, 2003, FOOD QUAL PREFER, V14, P637, DOI 10.1016/S0950-3293(02)00188-X; Schonhof I, 2004, NAHRUNG, V48, P25, DOI 10.1002/food.200300329; Schonhof I, 2007, J PLANT NUTR SOIL SC, V170, P65, DOI 10.1002/jpln.200620639; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Stolz H, 2011, NJAS-WAGEN J LIFE SC, V58, P67, DOI 10.1016/j.njas.2010.10.002; Tiwari U, 2013, FOOD RES INT, V50, P497, DOI 10.1016/j.foodres.2011.09.007; Traka MH, 2013, NEW PHYTOL, V198, P1085, DOI 10.1111/nph.12232; Troxell-Alrich H, 2011, J AGROCROP SCI, V2, P1; Vallejo F, 2003, EUR FOOD RES TECHNOL, V216, P395, DOI 10.1007/s00217-003-0664-9; Vallejo F, 2003, J SCI FOOD AGR, V83, P307, DOI 10.1002/jsfa.1320; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Vlachostergios DN, 2008, EUPHYTICA, V163, P449, DOI 10.1007/s10681-008-9712-7; Wang JS, 2012, FOOD CHEM, V133, P735, DOI 10.1016/j.foodchem.2012.01.085; Wang LI, 2004, CANCER CAUSE CONTROL, V15, P977, DOI 10.1007/s10552-004-1093-1; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Wunderlich SM, 2008, INT J FOOD SCI NUTR, V59, P34, DOI 10.1080/09637480701453637; Xu CJ, 2010, J FOOD AGRIC ENVIRON, V8, P179; Zhao X, 2006, HORTTECHNOLOGY, V16, P449, DOI 10.21273/HORTTECH.16.3.0449	93	25	26	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e95683	10.1371/journal.pone.0095683	http://dx.doi.org/10.1371/journal.pone.0095683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028959	Green Published, gold			2022-12-27	WOS:000341306600001
J	Schneider, A; Wubken, M; Linde, K; Buhner, M				Schneider, Antonius; Wuebken, Magdalena; Linde, Klaus; Buehner, Markus			Communicating and Dealing with Uncertainty in General Practice: The Association with Neuroticism	PLOS ONE			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; DECISION-MAKING; PRIMARY-CARE; PHYSICIANS REACTIONS; PERSONALITY; VALIDATION; SCALES; PRACTITIONERS; PERSPECTIVE; HEURISTICS	Background: Diagnostic reasoning in primary care setting where presented problems and patients are mostly unselected appears as a complex process. The aim was to develop a questionnaire to describe how general practitioners (GPs) deal with uncertainty to gain more insight into the decisional process. The association of personality traits with medical decision making was investigated additionally. Methods: Raw items were identified by literature research and focus group. Items were improved by interviewing ten GPs with thinking-aloud-method. A personal case vignette related to a complex and uncertainty situation was introduced. The final questionnaire was administered to 228 GPs in Germany. Factorial validity was calculated with explorative and confirmatory factor analysis. The results of the Communicating and Dealing with Uncertainty (CoDU) - questionnaire were compared with the scales of the 'Physician Reaction to Uncertainty' (PRU) questionnaire and with the personality traits which were determined with the Big Five Inventory (BFI-K). Results: The items could be assigned to four scales with varying internal consistency, namely 'communicating uncertainty' (Cronbach alpha 0.79), 'diagnostic action' (0.60), 'intuition' (0.39) and 'extended social anamnesis' (0.69). Neuroticism was positively associated with all PRU scales 'anxiety due to uncertainty' (Pearson correlation 0.487), 'concerns about bad outcomes' (0.488), 'reluctance to disclose uncertainty to patients' (0.287), 'reluctance to disclose mistakes to physicians' (0.212) and negatively associated with the CoDU scale 'communicating uncertainty' (-0.242) (p<0.01 for all). 'Extraversion' (0.146; p<0.05), 'agreeableness' (0.145, p<0.05), 'conscientiousness' (0.168, p<0.05) and 'openness to experience' (0.186, p<0.01) were significantly positively associated with 'communicating uncertainty'. 'Extraversion' (0.162), 'consciousness' (0.158) and 'openness to experience' (0.155) were associated with 'extended social anamnesis' (p<0.05). Conclusion: The questionnaire allowed describing the diagnostic decision making process of general practitioners in complex situations. Personality traits are associated with diagnostic reasoning and communication with patients, which might be important for medical education and quality improvement purposes.	[Schneider, Antonius; Wuebken, Magdalena; Linde, Klaus] Tech Univ Munich, Klinikum Rechts Isar, Inst Gen Practice, D-80290 Munich, Germany; [Buehner, Markus] Univ Munich, Dept Psychol, Munich, Germany	Technical University of Munich; University of Munich	Schneider, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Gen Practice, D-80290 Munich, Germany.	antonius.schneider@tum.de		Linde, Klaus/0000-0002-2902-970X				Allison JJ, 1998, MED DECIS MAKING, V18, P320, DOI 10.1177/0272989X9801800310; Andre M, 2003, FAM PRACT, V20, P514, DOI 10.1093/fampra/cmg503; Baliatsas C, 2014, J PSYCHOSOM RES, V76, P405, DOI 10.1016/j.jpsychores.2014.02.008; Borges NJ, 2002, J CAREER ASSESSMENT, V10, P362, DOI 10.1177/10672702010003006; Chamorro-Premuzic T, 2012, PERSONALITY INDIVIDU, V41, P419; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Elstein AS, 1999, ACAD MED, V74, P791, DOI 10.1097/00001888-199907000-00012; Gask L, 2011, J PSYCHOSOM RES, V71, P325, DOI 10.1016/j.jpsychores.2011.05.008; GERRITY MS, 1992, AM J SOCIOL, V97, P1022, DOI 10.1086/229860; Gerrity MS, 1995, MOTIV EMOTION, V19, P175, DOI 10.1007/BF02250510; Ghosh AK, 2005, J LAB CLIN MED, V145, P171, DOI 10.1016/j.lab.2005.02.006; Graham EK, 2012, J GERONTOL B-PSYCHOL, V67, P545, DOI 10.1093/geronb/gbr149; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; Hall KH, 2002, MED EDUC, V36, P216, DOI 10.1046/j.1365-2923.2002.01140.x; Heine SJ, 2009, ANNU REV PSYCHOL, V60, P369, DOI 10.1146/annurev.psych.60.110707.163655; Hewson MG, 1996, J GEN INTERN MED, V11, P481, DOI 10.1007/BF02599044; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; KNOTTNERUS JA, 1991, FAM PRACT, V8, P305, DOI 10.1093/fampra/8.4.305; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; Lievens F, 2009, J APPL PSYCHOL, V94, P1514, DOI 10.1037/a0016137; Marewski Julian N, 2012, Dialogues Clin Neurosci, V14, P77; Murdock KW, 2013, J INDIVID DIFFER, V34, P97, DOI 10.1027/1614-0001/a000104; O'Riordan Margaret, 2011, Qual Prim Care, V19, P175; Hartman TCO, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-68; Rammstedt B, 2005, DIAGNOSTICA, V51, P195, DOI 10.1026/0012-1924.51.4.195; RAVETZ JR, 1987, KNOWLEDGE, V9, P87, DOI 10.1177/107554708700900104; Schneider A, 2013, DTSCH ARZTEBL INT, V110, P653, DOI 10.3238/arztebl.2013.0653; Schneider A, 2010, J EVAL CLIN PRACT, V16, P431, DOI 10.1111/j.1365-2753.2010.01464.x; Schneider A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-81; SHROUT PE, 1989, J CLIN EPIDEMIOL, V42, P69, DOI 10.1016/0895-4356(89)90027-9; Stolper CF, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wheling P, 2013, WISSEN GRENZE UMGANG, P43; WILLIS GB, 1991, APPL COGNITIVE PSYCH, V5, P251, DOI 10.1002/acp.2350050307; WONCA, 2013, EUR DEF GEN PRACT FA	37	8	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102780	10.1371/journal.pone.0102780	http://dx.doi.org/10.1371/journal.pone.0102780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029276	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600100
J	Chen, L; Keitany, GJ; Peng, XH; Gibson, C; Mohar, I; Vignali, M; Crispe, IN; Huang, FS; Wang, RB				Chen, Lin; Keitany, Gladys J.; Peng, Xiaohong; Gibson, Claire; Mohar, Isaac; Vignali, Marissa; Crispe, Ian N.; Huang, Fusheng; Wang, Ruobing			Identification of Pre-Erythrocytic Malaria Antigens That Target Hepatocytes for Killing In Vivo and Contribute to Protection Elicited by Whole-Parasite Vaccination	PLOS ONE			English	Article							YOELII CIRCUMSPOROZOITE PROTEIN; T-CELL IMMUNITY; PHASE 2A TRIAL; PLASMODIUM-BERGHEI; NAIVE ADULTS; LIVER-STAGES; IMMUNIZATION; FALCIPARUM; RESPONSES; SPOROZOITES	Pre-erythrocytic malaria vaccines, including those based on whole-parasite approaches, have shown protective efficacy in animal and human studies. However few pre-erythocytic antigens other than the immunodominant circumsporozoite protein (CSP) have been studied in depth with the goal of developing potent subunit malaria vaccines that are suited for use in endemic areas. Here we describe a novel technique to identify pre-erythrocytic malaria antigens that contribute to protection elicited by whole-parasite vaccination in the mouse model. Our approach combines immunization with genetically attenuated parasites and challenge with DNA plasmids encoding for potential protective pre-erythrocytic malaria antigens as luciferase fusions by hydrodynamic tail vein injection. After optimizing the technique, we first showed that immunization with Pyfabb/f(-), a P. yoelii genetically attenuated parasite, induces killing of CSP-presenting hepatocytes. Depletion of CD8(+) but not CD4(+) T cells diminished the killing of CSP-expressing hepatocytes, indicating that killing is CD8(+) T cell-dependent. Finally we showed that the use of heterologous prime/boost immunization strategies that use genetically attenuated parasites and DNA vaccines enabled the characterization of a novel pre-erythrocytic antigen, Tmp21, as a contributor to Pyfabb/f(-) induced protection. This technique will be valuable for identification of potentially protective liver stage antigens and has the potential to contribute to the understanding of immunity elicited by whole parasite vaccination, as well as the development of effective subunit malaria vaccines.	[Chen, Lin; Peng, Xiaohong; Huang, Fusheng] Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China; [Chen, Lin; Keitany, Gladys J.; Peng, Xiaohong; Gibson, Claire; Vignali, Marissa; Wang, Ruobing] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Mohar, Isaac; Crispe, Ian N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Crispe, Ian N.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Wang, Ruobing] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Army Medical University; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Huang, FS (corresponding author), Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China.	fushenghster@gmail.com; ruobing.wang@seattlebiomed.org		Vignali, Marissa/0000-0002-7319-3371	National Institutes of Health [R01AI076498]; Bill and Melinda Gates Foundation [OPP1016829]; National Natural Science Foundation of China [30972570]; Seattle BioMed; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seattle BioMed; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant R01AI076498 to R. W., Bill and Melinda Gates Foundation grant OPP1016829 to R. W., National Natural Science Foundation of China #30972570 to F. H., and by Seattle BioMed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MAL VACC TECHN ROADM; Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Cabrera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070842; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Cockburn IA, 2014, INFECT IMMUN, V82, P1460, DOI 10.1128/IAI.01500-13; Cockburn IA, 2013, P NATL ACAD SCI USA, V110, P9090, DOI 10.1073/pnas.1303858110; Cooney LA, 2013, INFECT IMMUN, V81, P4171, DOI 10.1128/IAI.00871-13; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Epstein JE, 2013, CURR OPIN INFECT DIS, V26, P420, DOI 10.1097/QCO.0000000000000002; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Franke ED, 1997, J IMMUNOL, V159, P3424; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Miller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060820; Mishra S, 2011, VACCINE, V29, P7335, DOI 10.1016/j.vaccine.2011.07.081; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Obeng-Adjei N, CANC GENE THER, V20, P652; Rai U, 2012, BIOMOLECULES, V2, P23, DOI 10.3390/biom2010023; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Wang RB, 2005, EUR J IMMUNOL, V35, P1859, DOI 10.1002/eji.200425807; Wang RB, 1998, INFECT IMMUN, V66, P4193; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102225	10.1371/journal.pone.0102225	http://dx.doi.org/10.1371/journal.pone.0102225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025375	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400052
J	Galanter, WL; Bryson, ML; Falck, S; Rosenfield, R; Laragh, M; Shrestha, N; Schiff, GD; Lambert, BL				Galanter, William L.; Bryson, Michelle L.; Falck, Suzanne; Rosenfield, Rachel; Laragh, Marci; Shrestha, Neeha; Schiff, Gordon D.; Lambert, Bruce L.			Indication Alerts Intercept Drug Name Confusion Errors during Computerized Entry of Medication Orders	PLOS ONE			English	Article							VISUAL-PERCEPTION; TRIAL	Background: Confusion between similar drug names is a common cause of potentially harmful medication errors. Interventions to prevent these errors at the point of prescribing have had limited success. The purpose of this study is to measure whether indication alerts at the time of computerized physician order entry (CPOE) can intercept drug name confusion errors. Methods and Findings: A retrospective observational study of alerts provided to prescribers in a public, tertiary hospital and ambulatory practice with medication orders placed using CPOE. Consecutive patients seen from April 2006 through February 2012 were eligible if a clinician received an indication alert during ordering. A total of 54,499 unique patients were included. The computerized decision support system prompted prescribers to enter indications when certain medications were ordered without a coded indication in the electronic problem list. Alerts required prescribers either to ignore them by clicking OK, to place a problem in the problem list, or to cancel the order. Main outcome was the proportion of indication alerts resulting in the interception of drug name confusion errors. Error interception was determined using an algorithm to identify instances in which an alert triggered, the initial medication order was not completed, and the same prescriber ordered a similar-sounding medication on the same patient within 5 minutes. Similarity was defined using standard text similarity measures. Two clinicians performed chart review of all cases to determine whether the first, non-completed medication order had a documented or non-documented, plausible indication for use. If either reviewer found a plausible indication, the case was not considered an error. We analyzed 127,458 alerts and identified 176 intercepted drug name confusion errors, an interception rate of 0.14+/-6.01%. Conclusions: Indication alerts intercepted 1.4 drug name confusion errors per 1000 alerts. Institutions with CPOE should consider using indication prompts to intercept drug name confusion errors.	[Galanter, William L.; Falck, Suzanne; Laragh, Marci] UIC, Dept Med, Chicago, IL 60607 USA; [Galanter, William L.; Bryson, Michelle L.] UIC, Dept Pharm Practice, Chicago, IL USA; [Rosenfield, Rachel] Univ Illinois, Coll Med, Chicago, IL USA; [Shrestha, Neeha] UIC, Dept Pharm Adm, Chicago, IL USA; [Schiff, Gordon D.] Harvard Univ, Dept Med, Boston, MA 02115 USA; [Lambert, Bruce L.] Northwestern Univ, Dept Commun Studies, Chicago, IL 60611 USA; [Lambert, Bruce L.] Northwestern Univ, Ctr Commun & Hlth, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; Harvard University; Northwestern University; Northwestern University	Galanter, WL (corresponding author), UIC, Dept Med, Chicago, IL 60607 USA.	BillG@uic.edu		Galanter, William/0000-0001-7811-5391	Agency for Healthcare Research and Quality [U19HS021093]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021093] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by grant number U19HS021093 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspden P, 2007, PREVENTING MED ERROR; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Cina JL, 2006, JT COMM J QUAL PATIE, V32, P73, DOI 10.1016/S1553-7250(06)32010-7; Cohen M.R., 2007, MED ERRORS; Darker IT, 2011, ERGONOMICS, V54, P21, DOI 10.1080/00140139.2010.535022; Falck S, INT J MED I IN PRESS; Filik R, 2010, DRUG SAFETY, V33, P677, DOI 10.2165/11532360-000000000-00000; Flynn Elizabeth Allan, 2003, J Am Pharm Assoc (Wash), V43, P191; Galanter W, 2013, J AM MED INFORM ASSN, V20, P477, DOI 10.1136/amiajnl-2012-001555; Galanter WL, 2010, INT J MED INFORM, V79, P332, DOI 10.1016/j.ijmedinf.2008.05.005; Galanter WL, 2005, J AM MED INFORM ASSN, V12, P269, DOI 10.1197/jamia.M1727; HICKS RW, 2008, MEDMARX DATA REPORT; Institute for Safe Medication Practices (ISMP), 2010, ISMPS LIST CONF DRUG; Irwin A, 2013, HUM FACTORS, V55, P253, DOI 10.1177/0018720812457565; Kondrak G, 2006, ARTIF INTELL MED, V36, P29, DOI 10.1016/j.artmed.2005.07.005; Lambert BL, 2005, DRUG SAFETY, V28, P495, DOI 10.2165/00002018-200528060-00003; Lambert BL, 1999, MED CARE, V37, P1214, DOI 10.1097/00005650-199912000-00005; Lambert BL, 2008, MEDMARX DATA REPORT, P10; Poon EG, 2010, NEW ENGL J MED, V362, P1698, DOI 10.1056/NEJMsa0907115; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; US FDA, 2014, GUID IND BEST PRACT; Walton SM, 2011, APPL CLIN INFORM, V2, P94, DOI 10.4338/ACI-2010-11-RA-0072	22	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101977	10.1371/journal.pone.0101977	http://dx.doi.org/10.1371/journal.pone.0101977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025346	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400032
J	Edri, S; Tuller, T				Edri, Shlomit; Tuller, Tamir			Quantifying the Effect of Ribosomal Density on mRNA Stability	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSLATION INITIATION; GENE-EXPRESSION; HALF-LIFE; YEAST; DECAY; DEGRADATION	Gene expression is a fundamental cellular process by which proteins are eventually synthesized based on the information coded in the genes. This process includes four major steps: transcription of the DNA segment corresponding to a gene to mRNA molecules, the degradation of the mRNA molecules, the translation of mRNA molecules to proteins by the ribosome and the degradation of the proteins. We present an innovative quantitative study of the interaction between the gene translation stage and the mRNA degradation stage using large scale genomic data of S. cerevisiae, which include measurements of mRNA levels, mRNA half-lives, ribosomal densities and protein abundances, for thousands of genes. The reported results support the conjecture that transcripts with higher ribosomal density, which is related to the translation stage, tend to have elevated half-lives, and we suggest a novel quantitative estimation of the strength of this relation. Specifically, we show that on average, an increase of 78% in ribosomal density yields an increase of 25% in mRNA half-life, and that this relation between ribosomal density and mRNA half-life is not function specific. In addition, our analyses demonstrate that ribosomal density along the entire ORF, and not in specific locations, has a significant effect on the transcript half-life. Finally, we show that the reported relation cannot be explained by different expression levels among genes. A plausible explanation for the reported results is that ribosomes tend to protect the mRNA molecules from the exosome complexes degrading them; however, additional non-mutually exclusive possible explanations for the reported relation and experiments for their verifications are discussed in the paper.	[Edri, Shlomit; Tuller, Tamir] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel	Tel Aviv University	Tuller, T (corresponding author), Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	tamirtul@post.tau.ac.il		Tuller, Tamir/0000-0003-4194-7068; Edri, Shlomit/0000-0001-5377-1595	Israel Cancer Research Fund (ICRF); German-Israeli Foundation (GIF)	Israel Cancer Research Fund (ICRF); German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	The study was partially supported by the Israel Cancer Research Fund (ICRF) and German-Israeli Foundation (GIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Dana A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002755; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pedersen M, 2011, J MOL BIOL, V407, P35, DOI 10.1016/j.jmb.2011.01.025; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Roy B, 2013, TRENDS GENETICS; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Shalgi R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r86; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shirley RL, 1998, J CELL SCI, V111, P3129; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Tourriere H, 2002, BIOCHIMIE, V84, P821, DOI 10.1016/S0300-9084(02)01445-1; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zur H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003136	47	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102308	10.1371/journal.pone.0102308	http://dx.doi.org/10.1371/journal.pone.0102308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020060	gold, Green Published			2022-12-27	WOS:000339618600065
J	M'Dahoma, S; Bourgoin, S; Kayser, V; Barthelemy, S; Chevarin, C; Chali, F; Orsal, D; Hamon, M				M'Dahoma, Said; Bourgoin, Sylvie; Kayser, Valerie; Barthelemy, Sandrine; Chevarin, Caroline; Chali, Farah; Orsal, Didier; Hamon, Michel			Spinal Cord Transection-Induced Allodynia in Rats - Behavioral, Physiopathological and Pharmacological Characterization	PLOS ONE			English	Article							CENTRAL NEUROPATHIC PAIN; DORSAL-HORN NEURONS; TACTILE ALLODYNIA; MICROGLIAL ACTIVATION; NEUROTROPHIC FACTOR; LOCOMOTOR FUNCTION; INJURY; RECEPTOR; MODEL; STIMULATION	In humans, spinal cord lesions induce not only major motor and neurovegetative deficits but also severe neuropathic pain which is mostly resistant to classical analgesics. Better treatments can be expected from precise characterization of underlying physiopathological mechanisms. This led us to thoroughly investigate (i) mechanical and thermal sensory alterations, (ii) responses to acute treatments with drugs having patent or potential anti-allodynic properties and (iii) the spinal/ganglion expression of transcripts encoding markers of neuronal injury, microglia and astrocyte activation in rats that underwent complete spinal cord transection (SCT). SCT was performed at thoracic T8-T9 level under deep isoflurane anaesthesia, and SCT rats were examined for up to two months post surgery. SCT induced a marked hyper-reflexia at hindpaws and strong mechanical and cold allodynia in a limited (6 cm(2)) cutaneous territory just rostral to the lesion site. At this level, pressure threshold value to trigger nocifensive reactions to locally applied von Frey filaments was 100-fold lower in SCT-versus sham-operated rats. A marked up-regulation of mRNAs encoding ATF3 (neuronal injury) and glial activation markers (OX-42, GFAP, P2x4, P2x7, TLR4) was observed in spinal cord and/or dorsal root ganglia at T6-T11 levels from day 2 up to day 60 post surgery. Transcripts encoding the proinflammatory cytokines IL-1 beta, IL-6 and TNF-alpha were also markedly but differentially up-regulated at T6-T11 levels in SCT rats. Acute treatment with ketamine (50 mg/kg i.p.), morphine (3-10 mg/kg s.c.) and tapentadol (10-20 mg/kg i.p.) significantly increased pressure threshold to trigger nocifensive reaction in the von Frey filaments test, whereas amitriptyline, pregabalin, gabapentin and clonazepam were ineffective. Because all SCT rats developed long lasting, reproducible and stable allodynia, which could be alleviated by drugs effective in humans, thoracic cord transection might be a reliable model for testing innovative therapies aimed at reducing spinal cord lesion-induced central neuropathic pain.	[M'Dahoma, Said; Bourgoin, Sylvie; Kayser, Valerie; Barthelemy, Sandrine; Chevarin, Caroline; Hamon, Michel] Univ Paris 05, INSERM, U894, Ctr Psychiat & Neurosci, Paris, France; [M'Dahoma, Said; Bourgoin, Sylvie; Kayser, Valerie; Barthelemy, Sandrine; Chevarin, Caroline; Hamon, Michel] Fac Med Pierre & Marie Curie, Paris, France; [Chali, Farah; Orsal, Didier] Univ Paris 06, CNRS, UMR 7101, Lab Neurobiol Signaux Intercellulaires, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	M'Dahoma, S (corresponding author), Univ Paris 05, INSERM, U894, Ctr Psychiat & Neurosci, Paris, France.	said.mdahoma@yahoo.fr	Chevarin, Caroline/M-1438-2015		Institut National de la Sante et de la Recherche Medicale (INSERM); University Pierre and Marie Curie (UPMC); Agence Nationale de la Recherche [ANR 11BSV4 017 04]; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Ministere de la Recherche et de l'Enseignement Superieur (France)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Pierre and Marie Curie (UPMC); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Ministere de la Recherche et de l'Enseignement Superieur (France)	This research has been supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), University Pierre and Marie Curie (UPMC), Agence Nationale de la Recherche (Contract ANR 11BSV4 017 04, TrkBDNFarmod), and Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME, Contract "M.Hamon, 2010-2011''). Said M'Dahoma was supported by fellowships from the Ministere de la Recherche et de l'Enseignement Superieur (France) during performance of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguggia M, 2013, NEUROL SCI, V34, pS37, DOI 10.1007/s10072-013-1382-0; Amaya-Castellanos E, 2011, PHARMACOL BIOCHEM BE, V99, P591, DOI 10.1016/j.pbb.2011.06.005; Antri M, 2005, NEUROSCI LETT, V384, P162, DOI 10.1016/j.neulet.2005.04.062; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; ATTAL N, 1990, PAIN, V41, P235, DOI 10.1016/0304-3959(90)90022-6; Baastrup C, 2011, BRAIN RES, V1370, P129, DOI 10.1016/j.brainres.2010.11.008; Baastrup C, 2010, PAIN, V151, P670, DOI 10.1016/j.pain.2010.08.024; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bennett AD, 2000, BRAIN RES, V859, P72, DOI 10.1016/S0006-8993(99)02483-X; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Bryce TN, 2012, SPINAL CORD, V50, P413, DOI 10.1038/sc.2011.156; CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8; Carlton SM, 2009, PAIN, V147, P265, DOI 10.1016/j.pain.2009.09.030; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Chen YH, 2009, J NEUROSCI RES, V87, P418, DOI 10.1002/jnr.21860; Colpaert FC, 2004, EUR J PHARMACOL, V497, P29, DOI 10.1016/j.ejphar.2004.06.026; Constandil L, 2012, J PAIN, V13, P579, DOI 10.1016/j.jpain.2012.03.008; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Crown ED, 2006, EXP NEUROL, V199, P397, DOI 10.1016/j.expneurol.2006.01.003; Densmore VS, 2010, PAIN, V151, P184, DOI 10.1016/j.pain.2010.07.007; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; FENOLLOSA P, 1993, PARAPLEGIA, V31, P722, DOI 10.1038/sc.1993.114; Finnerup NB, 2014, J PAIN, V15, P40, DOI 10.1016/j.jpain.2013.09.008; Finnerup NB, 2001, SPINAL CORD, V39, P256, DOI 10.1038/sj.sc.3101161; Gao TL, 2013, J NEUROSCI METH, V212, P317, DOI 10.1016/j.jneumeth.2012.11.008; Garrison MK, 2011, EXP NEUROL, V227, P104, DOI 10.1016/j.expneurol.2010.09.019; Genovese T, 2009, J NEUROCHEM, V108, P1360, DOI 10.1111/j.1471-4159.2009.05899.x; Graziano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054350; Guptarak J, 2013, PAIN, V154, P1115, DOI 10.1016/j.pain.2013.03.026; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Gwak YS, 2006, J NEUROTRAUM, V23, P1111, DOI 10.1089/neu.2006.23.1111; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hajebrahimi Z, 2008, NEUROSCI LETT, V441, P261, DOI 10.1016/j.neulet.2008.06.046; HOLE K, 1993, PAIN, V53, P247, DOI 10.1016/0304-3959(93)90220-J; Hoschouer EL, 2010, PAIN, V148, P328, DOI 10.1016/j.pain.2009.11.023; Hubscher CH, 2008, J NEUROTRAUM, V25, P1241, DOI 10.1089/neu.2008.0515; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Humanes-Valera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069655; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Jung JI, 2008, KOREAN J PHYSIOL PHA, V12, P299, DOI 10.4196/kjpp.2008.12.6.299; Kayser V, 2002, BRIT J PHARMACOL, V137, P1287, DOI 10.1038/sj.bjp.0704979; Kayser V, 2010, PHARM PAIN, P185, DOI [10.1007/s11724-017-0486-3, DOI 10.1007/S11724-017-0486-3]; Kayser V, 2007, PAIN, V130, P235, DOI 10.1016/j.pain.2006.11.015; Kayser V, 2011, EUR J PAIN, V15, P451, DOI 10.1016/j.ejpain.2010.09.012; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kim JY, 2013, J KOREAN MED SCI, V28, P295, DOI 10.3346/jkms.2013.28.2.295; Kim K, 2013, J CLIN NEUROSCI, V20, P804, DOI 10.1016/j.jocn.2012.07.009; Latremoliere A, 2008, J NEUROSCI, V28, P8489, DOI 10.1523/JNEUROSCI.2552-08.2008; LOTTA S, 1991, PARAPLEGIA, V29, P247, DOI 10.1038/sc.1991.35; Marchand F, 2009, EUR J PAIN, V13, P673, DOI 10.1016/j.ejpain.2008.08.001; Marcillo A, 2012, EXP NEUROL, V233, P687, DOI 10.1016/j.expneurol.2011.06.008; McCleane GJ, 2003, ANESTH ANALG, V97, P1474, DOI 10.1213/01.ANE.0000085640.69855.51; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nakae A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939023; Niesters M, 2012, EXPERT OPIN DRUG MET, V8, P1409, DOI 10.1517/17425255.2012.712686; Norrbrink C, 2009, CLIN J PAIN, V25, P177, DOI 10.1097/AJP.0b013e31818a744d; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Ramsey JBG, 2010, J NEUROTRAUM, V27, P1709, DOI 10.1089/neu.2010.1382; Rekand T, 2010, ACTA NEUROL SCAND, V122, P62, DOI 10.1111/j.1600-0404.2010.01378.x; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Santos-Nogueira E, 2012, J NEUROTRAUM, V29, P898, DOI 10.1089/neu.2010.1700; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh R, 2011, INDIAN J ORTHOP, V45, P141, DOI 10.4103/0019-5413.77134; Suzuki R, 2004, BRAIN RES, V1019, P68, DOI 10.1016/j.brainres.2004.05.108; Tian DS, 2007, BRAIN RES, V1154, P206, DOI 10.1016/j.brainres.2007.04.005; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Tzellos TG, 2008, EUR J CLIN PHARMACOL, V64, P851, DOI 10.1007/s00228-008-0523-5; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; Vanelderen P, 2013, REGION ANESTH PAIN M, V38, P124, DOI 10.1097/AAP.0b013e31827d611b; Wallin J, 2002, EUR J PAIN-LONDON, V6, P261, DOI 10.1053/eujp.2002.0329; Wang JG, 2005, ANESTHESIOLOGY, V102, P152, DOI 10.1097/00000542-200501000-00024; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Yasuda T, 1999, JPN J PHARMACOL, V79, P65, DOI 10.1254/jjp.79.65; Yezierski R P, 2000, Prog Brain Res, V129, P429; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	85	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102027	10.1371/journal.pone.0102027	http://dx.doi.org/10.1371/journal.pone.0102027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019623	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600038
J	Sang, SW; Yin, WW; Bi, P; Zhang, HL; Wang, CG; Liu, XB; Chen, B; Yang, WZ; Liu, QY				Sang, Shaowei; Yin, Wenwu; Bi, Peng; Zhang, Honglong; Wang, Chenggang; Liu, Xiaobo; Chen, Bin; Yang, Weizhong; Liu, Qiyong			Predicting Local Dengue Transmission in Guangzhou, China, through the Influence of Imported Cases, Mosquito Density and Climate Variability	PLOS ONE			English	Article							AEDES-AEGYPTI; HEMORRHAGIC-FEVER; GUANGDONG PROVINCE; PUERTO-RICO; TEMPERATURE; INFECTIONS; OUTBREAK; INDEXES; EPIDEMIOLOGY; THAILAND	Introduction: Each year there are approximately 390 million dengue infections worldwide. Weather variables have a significant impact on the transmission of Dengue Fever (DF), a mosquito borne viral disease. DF in mainland China is characterized as an imported disease. Hence it is necessary to explore the roles of imported cases, mosquito density and climate variability in dengue transmission in China. The study was to identify the relationship between dengue occurrence and possible risk factors and to develop a predicting model for dengue's control and prevention purpose. Methodology and Principal Findings: Three traditional suburbs and one district with an international airport in Guangzhou city were selected as the study areas. Autocorrelation and cross-correlation analysis were used to perform univariate analysis to identify possible risk factors, with relevant lagged effects, associated with local dengue cases. Principal component analysis (PCA) was applied to extract principal components and PCA score was used to represent the original variables to reduce multi-collinearity. Combining the univariate analysis and prior knowledge, time-series Poisson regression analysis was conducted to quantify the relationship between weather variables, Breteau Index, imported DF cases and the local dengue transmission in Guangzhou, China. The goodness-of-fit of the constructed model was determined by pseudo-R-2, Akaike information criterion (AIC) and residual test. There were a total of 707 notified local DF cases from March 2006 to December 2012, with a seasonal distribution from August to November. There were a total of 65 notified imported DF cases from 20 countries, with forty-six cases (70.8%) imported from Southeast Asia. The model showed that local DF cases were positively associated with mosquito density, imported cases, temperature, precipitation, vapour pressure and minimum relative humidity, whilst being negatively associated with air pressure, with different time lags. Conclusions: Imported DF cases and mosquito density play a critical role in local DF transmission, together with weather variables. The establishment of an early warning system, using existing surveillance datasets will help to control and prevent dengue in Guangzhou, China.	[Sang, Shaowei; Wang, Chenggang; Liu, Xiaobo; Chen, Bin; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Sang, Shaowei; Yin, Wenwu; Zhang, Honglong; Liu, Xiaobo; Yang, Weizhong; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Bi, Peng] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia; [Wang, Chenggang] Shandong Univ Tradit Chinese Med, Dept Prevent Med, Coll Basic Med Sci, Jinan, Shandong, Peoples R China; [Chen, Bin] Xiamen Entry Exit Inspect & Quarantine Bur, Xiamen, Peoples R China; [Sang, Shaowei; Liu, Xiaobo; Liu, Qiyong] WHO Collaborating Ctr Vector Surveillance & Manag, Beijing, Peoples R China; [Liu, Qiyong] Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld 4111, Australia; [Sang, Shaowei; Wang, Chenggang; Liu, Qiyong] Shandong Univ, Climate Change & Hlth Ctr, Jinan 250100, Peoples R China; [Sang, Shaowei; Liu, Xiaobo; Liu, Qiyong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Adelaide; Shandong University of Traditional Chinese Medicine; Griffith University; Shandong University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yangwz@chinacdc.cn; liuqiyong@icdc.cn	Smith, Gary B/A-8235-2013	Bi, Peng/0000-0002-3238-3427	National Basic Research Program of China (973 Program) [2012CB955504]; National Natural Science Foundation of China (NSFC) [81273139]; Special Research Program for Health [201202006]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Research Program for Health	The study was supported by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955504); The National Natural Science Foundation of China (NSFC) (Grant No. 81273139); The Special Research Program for Health (Grant No. 201202006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Banu S, 2011, TROP MED INT HEALTH, V16, P598, DOI 10.1111/j.1365-3156.2011.02734.x; Bi P, 2008, J INFECTION, V57, P317, DOI 10.1016/j.jinf.2008.08.004; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Fan J, 2013, EPIDEMIOL INFECT, V142, P1; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Li ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-132; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83; Pham HV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-172; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Rohani A, 2009, SE ASIAN J TROP MED, V40, P942; Roriz-Cruz M, 2010, B WORLD HEALTH ORGAN, V88, P244, DOI 10.2471/BLT.10.076935; Rosa-Freitas Maria Goreti, 2006, Rev Panam Salud Publica, V20, P256, DOI 10.1590/S1020-49892006000900006; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Schreiber KV, 2001, INT J BIOMETEOROL, V45, P81, DOI 10.1007/s004840100090; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Scott TW, 2003, WAG UR FRON, V2, P187; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sulaiman S, 1996, J AM MOSQUITO CONTR, V12, P494; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; Wang C, 2013, ASIA-PAC POWER ENERG; Wang C, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-9; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wilder-Smith A, 2012, PAEDIATR INT CHILD H, V32, P28, DOI 10.1179/2046904712Z.00000000050; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504	47	71	73	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102755	10.1371/journal.pone.0102755	http://dx.doi.org/10.1371/journal.pone.0102755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019967	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600099
J	Smieja, M; Warszycki, D; Tabor, J; Bojarski, AJ				Smieja, Marek; Warszycki, Dawid; Tabor, Jacek; Bojarski, Andrzej J.			Asymmetric Clustering Index in a Case Study of 5-HT1A Receptor Ligands	PLOS ONE			English	Article							DERIVATIVES	The automatic clustering of chemical compounds is an important branch of chemoinformatics. In this paper the Asymmetric Clustering Index (A(CI)) is proposed to assess how well an automatically created partition reflects the reference. The asymmetry allows for a distinction between the fixed reference and the numerically constructed partition. The introduced index is applied to evaluate the quality of hierarchical clustering procedures for 5-HT1A receptor ligands. We find that the most appropriate combination of parameters for the hierarchical clustering of compounds with a determined activity for this biological target is the Klekota Roth fingerprint combined with the complete linkage function and the Buser similarity metric.	[Smieja, Marek; Tabor, Jacek] Jagiellonian Univ, Fac Math & Comp Sci, Krakow, Poland; [Warszycki, Dawid; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences	Smieja, M (corresponding author), Jagiellonian Univ, Fac Math & Comp Sci, Krakow, Poland.	marek.smieja@uj.edu.pl	Bojarski, Andrzej/GSO-0213-2022		Polish Ministry of Science and Higher Education [IP2012 055972]; Polish-Norwegian Research Programme, Norwegian Financial Mechanism in the frame of Project PLATFORMex [Pol-Nor/198887/73/2013]; National Centre of Science, Poland [2011/01/B/ST6/01887]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish-Norwegian Research Programme, Norwegian Financial Mechanism in the frame of Project PLATFORMex; National Centre of Science, Poland	The work of first author was supported by Polish Ministry of Science and Higher Education from the budget for science in the years 2013-2015 [IP2012 055972]. The work of second and fourth authors was supported by the Polish-Norwegian Research Programme operated by the National Centre for Research and Development under the Norwegian Financial Mechanism 2009-2014 in the frame of Project PLATFORMex [Pol-Nor/198887/73/2013]. The work of the third author was supported by the National Centre of Science, Poland [2011/01/B/ST6/01887]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown N, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459353; Caliendo G, 2005, CURR MED CHEM, V12, P1721, DOI 10.2174/0929867054367220; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011; Ewing T, 2006, J CHEM INF MODEL, V46, P2423, DOI 10.1021/ci060155b; Fred ALN, 2003, PROC CVPR IEEE, P128; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; HALL LH, 1995, J CHEM INF COMP SCI, V35, P1039, DOI 10.1021/ci00028a014; Heikamp K, 2011, J CHEM INF MODEL, V51, P1831, DOI 10.1021/ci200199u; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479; Lopez-Rodriguez ML, 2002, CURR MED CHEM, V9, P443, DOI 10.2174/0929867023371030; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; MURTAGH F, 1983, COMPUT J, V26, P354, DOI 10.1093/comjnl/26.4.354; Oh SJ, 2001, CURR MED CHEM, V8, P999, DOI 10.2174/0929867013372599; Olivier B, 1999, Prog Drug Res, V52, P103; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Todeschini R, 2012, J CHEM INF MODEL, V52, P2884, DOI [10.1021/ci300261r, 10.1021/ci30026tr]; Wagner D, 2007, COMP CLUSTERINGS OVE; Warszycki D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084510; Willett P, 2005, J MED CHEM, V48, P4183, DOI 10.1021/jm0582165; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102069	10.1371/journal.pone.0102069	http://dx.doi.org/10.1371/journal.pone.0102069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019251	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600043
J	Voorn, EL; Brehm, MA; Beelen, A; de Haan, A; Nollet, F; Gerrits, KHL				Voorn, Eric L.; Brehm, Merel A.; Beelen, Anita; de Haan, Arnold; Nollet, Frans; Gerrits, Karin H. L.			Reliability of Contractile Properties of the Knee Extensor Muscles in Individuals with Post-Polio Syndrome	PLOS ONE			English	Article							QUADRICEPS FEMORIS MUSCLE; MAXIMAL VOLUNTARY; FATIGUE; STRENGTH; ENDURANCE; POLIOMYELITIS; PERFORMANCE; DISABILITY; VARIABLES; EXERCISE	Objective: To assess the reliability of contractile properties of the knee extensor muscles in 23 individuals with post-polio syndrome (PPS) and 18 age-matched healthy individuals. Methods: Contractile properties of the knee extensors were assessed from repeated electrically evoked contractions on 2 separate days, with the use of a fixed dynamometer. Reliability was determined for fatigue resistance, rate of torque development (MRTD), and early and late relaxation time (RT50 and RT25), using the intraclass correlation coefficient (ICC) and standard error of measurement (SEM, expressed as % of the mean). Results: In both groups, reliability for fatigue resistance was good, with high ICCs (>0.90) and small SEM values (PPS: 7.1%, healthy individuals: 7.0%). Reliability for contractile speed indices varied, with the best values found for RT50 (ICCs>0.82, SEM values <2.8%). We found no systematic differences between test and retest occasions, except for RT50 in healthy subjects (p = 0.016). Conclusions: In PPS and healthy individuals, the reliability of fatigue resistance, as obtained from electrically evoked contractions is high. The reliability of contractile speed is only moderate, except for RT50 in PPS, demonstrating high reliability. Significance: This was the first study to examine the reliability of electrically evoked contractile properties in individuals with PPS. Our results demonstrate its potential to study mechanisms underlying muscle fatigue in PPS and to evaluate changes in contractile properties over time in response to interventions or from natural course.	[Voorn, Eric L.; Brehm, Merel A.; Beelen, Anita; Nollet, Frans] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [Voorn, Eric L.; de Haan, Arnold; Gerrits, Karin H. L.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Voorn, EL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.l.voorn@amc.uva.nl	Brehm, Merel-Anne/K-8638-2017; Brehm, Merel-Anne/AAK-7419-2020	Brehm, Merel-Anne/0000-0002-3425-4661; Brehm, Merel-Anne/0000-0002-3425-4661; Voorn, Eric/0000-0003-0807-2124	Prinses Beatrix Spierfonds (PBF); Dutch Public Fund for Neuromuscular Disorders; Netherlands Organization for Health Research and Development [ZonMW 89000003]; Department of Rehabilitation AMC	Prinses Beatrix Spierfonds (PBF); Dutch Public Fund for Neuromuscular Disorders; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Department of Rehabilitation AMC	This study was supported by the Prinses Beatrix Spierfonds (PBF); The Dutch Public Fund for Neuromuscular Disorders, The Netherlands Organization for Health Research and Development (ID: ZonMW 89000003) and the Department of Rehabilitation AMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre JC, 1997, ARCH PHYS MED REHAB, V78, P681, DOI 10.1016/S0003-9993(97)90073-3; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen GM, 2004, MUSCLE NERVE, V30, P172, DOI 10.1002/mus.20094; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; Burnley M, 2009, J APPL PHYSIOL, V106, P975, DOI 10.1152/japplphysiol.91474.2008; de Ruiter CJ, 2004, J APPL PHYSIOL, V97, P1693, DOI 10.1152/japplphysiol.00230.2004; de Vet H. C. W., 2011, MEASUREMENT IN MEDIC; Ernstoff B, 1996, ARCH PHYS MED REHAB, V77, P843, DOI 10.1016/S0003-9993(96)90268-3; Euser AM, 2008, J CLIN EPIDEMIOL, V61, P978, DOI 10.1016/j.jclinepi.2007.11.003; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Gerrits HL, 2001, CLIN PHYSIOL, V21, P105, DOI 10.1046/j.1365-2281.2001.00293.x; GRIMBY G, 1994, PHYS THER, V74, P415, DOI 10.1093/ptj/74.5.415; Grimby G, 1998, MUSCLE NERVE, V21, P1428, DOI 10.1002/(SICI)1097-4598(199811)21:11<1428::AID-MUS10>3.3.CO;2-D; HALSTEAD LS, 1991, ORTHOPEDICS, V14, P1209; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Hildegunn L, 2007, PHYSIOTHER RES INT, V12, P39, DOI DOI 10.1002/PRI.352; Hunter S, 1998, J GERONTOL A-BIOL, V53, pB204, DOI 10.1093/gerona/53A.3.B204; Ivanyi B, 1996, MUSCLE NERVE, V19, P738, DOI 10.1002/(SICI)1097-4598(199606)19:6<738::AID-MUS8>3.0.CO;2-B; Koopman FS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-8; LEE J, 1989, COMPUT BIOL MED, V19, P61, DOI 10.1016/0010-4825(89)90036-X; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Luciano CA, 1996, MUSCLE NERVE, V19, P1413, DOI 10.1002/(SICI)1097-4598(199611)19:11<1413::AID-MUS5>3.3.CO;2-3; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; March of Dimes, 2000, INTERNATIONAL CONFER; MCDONNELL MK, 1987, PHYS THER, V67, P941, DOI 10.1093/ptj/67.6.941; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Morris MG, 2008, J SPORT SCI MED, V7, P431; Nollet F, 1999, ARCH PHYS MED REHAB, V80, P136, DOI 10.1016/S0003-9993(99)90110-7; SNYDERMACKLER L, 1993, MED SCI SPORT EXER, V25, P783, DOI 10.1249/00005768-199307000-00005; Voorn EL, 2013, NEUROMUSCULAR DISORD, V23, P892, DOI 10.1016/j.nmd.2013.06.372; [No title captured]	33	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101660	10.1371/journal.pone.0101660	http://dx.doi.org/10.1371/journal.pone.0101660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019943	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600021
J	Chavez-Dozal, AA; Gorman, C; Lostroh, CP; Nishiguchi, MK				Chavez-Dozal, Alba A.; Gorman, Clayton; Lostroh, C. Phoebe; Nishiguchi, Michele K.			Gene-Swapping Mediates Host Specificity among Symbiotic Bacteria in a Beneficial Symbiosis	PLOS ONE			English	Article							VIBRIO-FISCHERI; SEPIOLID SQUID; NEISSERIA-GONORRHOEAE; ADHERENCE; CELL; PILC	Environmentally acquired beneficial associations are comprised of a wide variety of symbiotic species that vary both genetically and phenotypically, and therefore have differential colonization abilities, even when symbionts are of the same species. Strain variation is common among conspecific hosts, where subtle differences can lead to competitive exclusion between closely related strains. One example where symbiont specificity is observed is in the sepiolid squid-Vibrio mutualism, where competitive dominance exists among V. fischeri isolates due to subtle genetic differences between strains. Although key symbiotic loci are responsible for the establishment of this association, the genetic mechanisms that dictate strain specificity are not fully understood. We examined several symbiotic loci (lux-bioluminescence, pil = pili, and msh-mannose sensitive hemagglutinin) from mutualistic V. fischeri strains isolated from two geographically distinct squid host species (Euprymna tasmanica-Australia and E. scolopes-Hawaii) to determine whether slight genetic differences regulated host specificity. Through colonization studies performed in naive squid hatchlings from both hosts, we found that all loci examined are important for specificity and host recognition. Complementation of null mutations in non-native V. fischeri with loci from the native V. fischeri caused a gain in fitness, resulting in competitive dominance in the non-native host. The competitive ability of these symbiotic loci depended upon the locus tested and the specific squid species in which colonization was measured. Our results demonstrate that multiple bacterial genetic elements can determine V. fischeri strain specificity between two closely related squid hosts, indicating how important genetic variation is for regulating conspecific beneficial interactions that are acquired from the environment.	[Chavez-Dozal, Alba A.; Gorman, Clayton; Nishiguchi, Michele K.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Lostroh, C. Phoebe] Colorado Coll, Dept Biol, Colorado Springs, CO 80903 USA	New Mexico State University; Colorado College	Nishiguchi, MK (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	nish@nmsu.edu		Lostroh, Phoebe/0000-0002-7956-9536	NMSU National Institutes of Health (NIH) RISE [NIH NIGMS R25GM061222]; NASA (NMSGC) fellowships; NMSU NIH MARC program [NIH-GM0007667-34]; National Science Foundation (NSF); NIH [NSF IOS-0744498, NIH NIAID1SC1AI081659-01, NIH ARRA-3SC1AI081659-02S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI081659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007667, R25GM061222] Funding Source: NIH RePORTER	NMSU National Institutes of Health (NIH) RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA (NMSGC) fellowships; NMSU NIH MARC program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.A.C-D. was supported by NMSU National Institutes of Health (NIH) RISE to the doctorate (NIH NIGMS R25GM061222) and NASA (NMSGC) fellowships. C.G. was supported by the NMSU NIH MARC program (NIH-GM0007667-34). Support for the research was through National Science Foundation (NSF) and NIH awards (NSF IOS-0744498, NIH NIAID1SC1AI081659-01 and NIH ARRA-3SC1AI081659-02S1) to M.K.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyakumar DS, 2009, FEMS MICROBIOL LETT, V299, P65, DOI 10.1111/j.1574-6968.2009.01732.x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Browne-Silva J, 2008, INT J SYST EVOL MICR, V58, P1292, DOI 10.1099/ijs.0.65370-0; Castle W, 2013, THESIS NEW MEXICO ST; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Gaida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017782; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Naughton LM, 2009, APPL ENVIRON MICROB, V75, P2802, DOI 10.1128/AEM.01698-08; Nishiguchi MK, 2002, MICROB ECOL, V44, P10, DOI 10.1007/BF03036870; Nyholm SV, 2008, VIE MILIEU, V58, P175; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Pollack-Berti A, 2010, ENVIRON MICROBIOL, V12, P2302, DOI 10.1111/j.1462-2920.2010.02250.x; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; Soto W, 2012, EVOLUTION, V66, P1308, DOI 10.1111/j.1558-5646.2011.01547.x; Soto W, 2014, MICROB ECOL, V67, P700, DOI 10.1007/s00248-013-0356-3; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Urbanczyk H, 2008, J BACTERIOL, V190, P3494, DOI 10.1128/JB.00101-08; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	27	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101691	10.1371/journal.pone.0101691	http://dx.doi.org/10.1371/journal.pone.0101691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014649	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400032
J	Calvino-Cancela, M; Mendez-Rial, R; Reguera-Salgado, J; Martin-Herrero, J				Calvino-Cancela, Maria; Mendez-Rial, Roi; Reguera-Salgado, Javier; Martin-Herrero, Julio			Alien Plant Monitoring with Ultralight Airborne Imaging Spectroscopy	PLOS ONE			English	Article							CLASSIFICATION; COMMUNITIES; INVASIONS	Effective management of invasive plants requires a precise determination of their distribution. Remote sensing techniques constitute a promising alternative to field surveys and hyperspectral sensors (also known as imaging spectrometers, with a large number of spectral bands and high spectral resolution) are especially suitable when very similar categories are to be distinguished (e.g. plant species). A main priority in the development of this technology is to lower its cost and simplify its use, so that its demonstrated aptitude for many environmental applications can be truly realized. With this aim, we have developed a system for hyperspectral imaging (200 spectral bands in the 380-1000 nm range and circa 3 nm spectral resolution) operated on board ultralight aircraft (namely a gyrocopter), which allows a drastic reduction of the running costs and operational complexity of image acquisition, and also increases the spatial resolution of the images (circa 5-8 pixels/m(2) at circa 65 km/h and 300 m height). The detection system proved useful for the species tested (Acacia melanoxylon, Oxalis pes-caprae, and Carpobrotus aff. edulis and acinaciformis), with user's and producer's accuracy always exceeding 90%. The detection accuracy reported corresponds to patches down to 0.125 m(2) (50% of pixels 0.5x0.5 m in size), a very small size for many plant species, making it very effective for initial stages of invasive plant spread. In addition, its low operating costs, similar to those of a 4WD ground vehicle, facilitate frequent image acquisition. Acquired images constitute a permanent record of the status of the study area, with great amount of information that can be analyzed in the future for other purposes, thus greatly facilitating the monitoring of natural areas at detailed spatial and temporal scales for improved management.	[Calvino-Cancela, Maria] Univ Vigo, Dept Ecol & Anim Biol, Vigo 36310, Galicia, Spain; [Mendez-Rial, Roi; Reguera-Salgado, Javier; Martin-Herrero, Julio] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Galicia, Spain	Universidade de Vigo; Universidade de Vigo	Calvino-Cancela, M (corresponding author), Univ Vigo, Dept Ecol & Anim Biol, Vigo 36310, Galicia, Spain.	maria@uvigo.es	Martin-Herrero, Julio/D-3827-2009	Martin-Herrero, Julio/0000-0003-1109-6338; Mendez-Rial, Roi/0000-0002-9991-0316; Calvino-Cancela, Maria/0000-0002-7833-4671	Organismo Autonomo de Parques Nacionales; Ministerio de Medio Ambiente y Medio Rural y Marino [023/2008]; ERDF; Xunta de Galicia Consolidation of Research Units [2009/062]; AtlanTIC	Organismo Autonomo de Parques Nacionales; Ministerio de Medio Ambiente y Medio Rural y Marino(Spanish Government); ERDF(European Commission); Xunta de Galicia Consolidation of Research Units; AtlanTIC	This work was partially supported by the Organismo Autonomo de Parques Nacionales, Ministerio de Medio Ambiente y Medio Rural y Marino (023/2008), ERDF, Xunta de Galicia Consolidation of Research Units (2009/062), and AtlanTIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens C, 2011, WEED SCI, V59, P145, DOI 10.1614/WS-D-10-00094.1; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Burkart A, 2014, IEEE SENS J, V14, P62, DOI 10.1109/JSEN.2013.2279720; Calvino-Cancela M, 2007, ECOSCIENCE, V14, P529, DOI 10.2980/1195-6860(2007)14[529:EPTEOA]2.0.CO;2; Camps-Valls G, 2004, IEEE T GEOSCI REMOTE, V42, P1530, DOI 10.1109/TGRS.2004.827262; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Emry DJ, 2011, J APPL ECOL, V48, P1391, DOI 10.1111/j.1365-2664.2011.02050.x; Giardino C, 2007, REMOTE SENS ENVIRON, V109, P183, DOI 10.1016/j.rse.2006.12.017; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jorgensen RH, 2009, FLORA, V204, P289, DOI 10.1016/j.flora.2008.03.002; KLINKHAMER PGL, 1992, FUNCT ECOL, V6, P308, DOI 10.2307/2389522; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lass LW, 2005, WEED SCI, V53, P242, DOI 10.1614/WS-04-044R2; Leishman J., 2002, PRINCIPLES HELICOPTE, V2nd; Lucas R, 2008, REMOTE SENS ENVIRON, V112, P2088, DOI 10.1016/j.rse.2007.10.011; Mack Richard N., 2005, SCOPE, V63, P179; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin-Herrero J, 2007, IEEE T GEOSCI REMOTE, V45, P1386, DOI 10.1109/TGRS.2007.894569; Mendez-Rial R, 2012, IEEE GEOSCI REMOTE S, V9, P214, DOI 10.1109/LGRS.2011.2164050; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Panetta FD, 2005, DIVERS DISTRIB, V11, P435, DOI 10.1111/j.1366-9516.2005.00179.x; Peerbhay KY, 2013, ISPRS J PHOTOGRAMM, V79, P19, DOI 10.1016/j.isprsjprs.2013.01.013; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Reguera-Salgado J, 2012, INT GEOSCI REMOTE SE, P4086, DOI 10.1109/IGARSS.2012.6350729; Reguera-Salgado J, 2012, IEEE T GEOSCI REMOTE, V50, P4409, DOI 10.1109/TGRS.2012.2192938; Sanz-Elorza M., 2001, Lazaroa, V22, P121; Scholkopf B., 1997, SUPPORT VECTOR LEARN; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Underwood EC, 2007, ENVIRON MANAGE, V39, P63, DOI 10.1007/s00267-005-0228-9; Vapnik V., 2013, NATURE STAT LAERNING; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x	37	19	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102381	10.1371/journal.pone.0102381	http://dx.doi.org/10.1371/journal.pone.0102381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010601	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800097
J	Cheng, D; He, QF				Cheng, Dan; He, Qingfang			PfsR Is a Key Regulator of Iron Homeostasis in Synechocystis PCC 6803	PLOS ONE			English	Article							CHLOROPHYLL-BINDING-PROTEIN; SYNECHOCOCCUS SP PCC7942; SP STRAIN PCC-7120; OXIDATIVE STRESS; SP PCC-6803; PHOTOSYSTEM-I; ISIA GENE; TETRAPYRROLE BIOSYNTHESIS; ELECTRON-TRANSPORT; ESCHERICHIA-COLI	Iron is an essential cofactor in numerous cellular processes. The iron deficiency in the oceans affects the primary productivity of phytoplankton including cyanobacteria. In this study, we examined the function of PfsR, a TetR family transcriptional regulator, in iron homeostasis of the cyanobacterium Synechocystis PCC 6803. Compared with the wild type, the pfsR deletion mutant displayed stronger tolerance to iron limitation and accumulated significantly more chlorophyll a, carotenoid, and phycocyanin under iron-limiting conditions. The mutant also maintained more photosystem I and photosystem II complexes than the wild type after iron deprivation. In addition, the activities of photosystem I and photosystem II were much higher in pfsR deletion mutant than in wild-type cells under iron-limiting conditions. The transcripts of pfsR were enhanced by iron limitation and inactivation of the gene affected pronouncedly expression of fut genes (encoding a ferric iron transporter), feoB (encoding a ferrous iron transporter), bfr genes (encoding bacterioferritins), ho genes (encoding heme oxygenases), isiA (encoding a chlorophyll-binding protein), and furA (encoding a ferric uptake regulator). The iron quota in pfsR deletion mutant cells was higher than in wild-type cells both before and after exposure to iron limitation. Electrophoretic mobility shift assays showed that PfsR bound to its own promoter and thereby autoregulated its own expression. These data suggest that PfsR is a critical regulator of iron homeostasis.	[Cheng, Dan; He, Qingfang] Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	He, QF (corresponding author), Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA.	qfhe@ualr.edu		Cheng, Dan/0000-0001-5302-950X	U.S. National Science Foundation [MCB 1120153]; National Natural Science Foundation of China [31270102]; Shandong Province "Taishan Scholar" Foundation [tshw20091014]	U.S. National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province "Taishan Scholar" Foundation	This work was supported by U.S. National Science Foundation (http://www.nsf.gov/) [grant number MCB 1120153]; National Natural Science Foundation of China (http://www.nsfc.gov.cn/) [grant number 31270102]; and Shandong Province "Taishan Scholar" Foundation (http://www.shandong.gov.cn/) [grant number tshw20091014]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrizhiyevskaya EG, 2002, BBA-BIOENERGETICS, V1556, P265, DOI 10.1016/S0005-2728(02)00371-7; Aspinwall CL, 2004, FEBS LETT, V574, P126, DOI 10.1016/j.febslet.2004.08.016; Babykin M. M., 2003, Genetika, V39, P25; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Bibby TS, 2001, J BIOL CHEM, V276, P43246, DOI 10.1074/jbc.M106541200; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Cheng Y, 2006, J BACTERIOL, V188, P4822, DOI 10.1128/JB.00258-06; Choudhary M, 2007, ECOTOX ENVIRON SAFE, V66, P204, DOI 10.1016/j.ecoenv.2006.02.002; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; ENTSCH B, 1983, MAR BIOL, V73, P17, DOI 10.1007/BF00396281; FALK S, 1995, PHOTOSYNTH RES, V45, P51, DOI 10.1007/BF00032235; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; FERREIRA F, 1994, J APPL PHYCOL, V6, P199, DOI 10.1007/BF02186073; Fraser JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059861; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Ghassemian M, 1996, MICROBIOL-SGM, V142, P1469, DOI 10.1099/13500872-142-6-1469; Gonzalez A, 2012, ENVIRON MICROBIOL, V14, P3175, DOI 10.1111/j.1462-2920.2012.02897.x; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hernandez JA, 2004, FEMS MICROBIOL LETT, V236, P275, DOI 10.1016/j.femsle.2004.05.050; Hernandez-Prieto MA, 2012, G3-GENES GENOM GENET, V2, P1475, DOI 10.1534/g3.112.003863; Houot L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-350; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Jantaro S, 2006, J BIOL CHEM, V281, P30865, DOI 10.1074/jbc.M606252200; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Karapetyan NV, 2008, PHOTOSYNTH RES, V97, P195, DOI 10.1007/s11120-008-9336-8; Kashiyama Y, 2012, P NATL ACAD SCI USA, V109, P17328, DOI 10.1073/pnas.1207347109; Katoh H, 2000, J BACTERIOL, V182, P6523, DOI 10.1128/JB.182.22.6523-6524.2000; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; Kirik I. A., 2003, Molekulyarnaya Biologiya (Moscow), V37, P1035; Kunert A, 2003, FEMS MICROBIOL LETT, V227, P255, DOI 10.1016/S0378-1097(03)00689-X; Latifi A, 2005, J BACTERIOL, V187, P6596, DOI 10.1128/JB.187.18.6596-6598.2005; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Martin-Luna B, 2011, J PLANT PHYSIOL, V168, P2244, DOI 10.1016/j.jplph.2011.08.006; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Michel KP, 2003, PHOTOSYNTH RES, V75, P71, DOI 10.1023/A:1022459919040; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Nefedova L. N., 2003, Genetika, V39, P336; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; OQUIST G, 1974, PHYSIOL PLANTARUM, V31, P55, DOI 10.1111/j.1399-3054.1974.tb03677.x; Pareja E, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-29; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; SANDMANN G, 1990, PHOTOSYNTH RES, V26, P119, DOI 10.1007/BF00047083; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; Sandstrom S, 2002, PHYSIOL PLANTARUM, V116, P255, DOI 10.1034/j.1399-3054.2002.1160216.x; Sandstrom S, 2001, PHOTOCHEM PHOTOBIOL, V74, P431, DOI 10.1562/0031-8655(2001)074<0431:CTIGPF>2.0.CO;2; Sevilla E, 2011, MICROBIOL-SGM, V157, P3398, DOI 10.1099/mic.0.048231-0; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Shinar G, 2006, P NATL ACAD SCI USA, V103, P3999, DOI 10.1073/pnas.0506610103; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Stekel DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-6; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Sukrong S, 2012, MOL PLANT, V5, P1310, DOI 10.1093/mp/sss065; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Wall ME, 2003, J MOL BIOL, V332, P861, DOI 10.1016/S0022-2836(03)00948-3; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010432; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; Yilmaz M, 2010, PHOTOSYNTH RES, V103, P47, DOI 10.1007/s11120-009-9506-3; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	78	8	9	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101743	10.1371/journal.pone.0101743	http://dx.doi.org/10.1371/journal.pone.0101743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010795	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800035
J	Couldrey, C; Brauning, R; Bracegirdle, J; Maclean, P; Henderson, HV; McEwan, JC				Couldrey, Christine; Brauning, Rudiger; Bracegirdle, Jeremy; Maclean, Paul; Henderson, Harold V.; McEwan, John C.			Genome-Wide DNA Methylation Patterns and Transcription Analysis in Sheep Muscle	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; CPG; ISLANDS; TISSUES	DNA methylation plays a central role in regulating many aspects of growth and development in mammals through regulating gene expression. The development of next generation sequencing technologies have paved the way for genome-wide, high resolution analysis of DNA methylation landscapes using methodology known as reduced representation bisulfite sequencing (RRBS). While RRBS has proven to be effective in understanding DNA methylation landscapes in humans, mice, and rats, to date, few studies have utilised this powerful method for investigating DNA methylation in agricultural animals. Here we describe the utilisation of RRBS to investigate DNA methylation in sheep Longissimus dorsi muscles. RRBS analysis of similar to 1% of the genome from Longissimus dorsi muscles provided data of suitably high precision and accuracy for DNA methylation analysis, at all levels of resolution from genome-wide to individual nucleotides. Combining RRBS data with mRNAseq data allowed the sheep Longissimus dorsi muscle methylome to be compared with methylomes from other species. While some species differences were identified, many similarities were observed between DNA methylation patterns in sheep and other more commonly studied species. The RRBS data presented here highlights the complexity of epigenetic regulation of genes. However, the similarities observed across species are promising, in that knowledge gained from epigenetic studies in human and mice may be applied, with caution, to agricultural species. The ability to accurately measure DNA methylation in agricultural animals will contribute an additional layer of information to the genetic analyses currently being used to maximise production gains in these species.	[Couldrey, Christine; Maclean, Paul; Henderson, Harold V.] AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand; [Brauning, Rudiger; McEwan, John C.] AgResearch Ltd, Invermay Agr Ctr, Puddle Alley, Mosgiel, New Zealand; [Bracegirdle, Jeremy] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand	Couldrey, C (corresponding author), AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand.	Christine.Couldrey@agresearch.co.nz	McEwan, John/A-1143-2008	McEwan, John/0000-0003-4801-6207; Bracegirdle, Jeremy/0000-0002-9471-4527; Henderson, Harold/0000-0001-9660-5298; Maclean, Paul/0000-0001-8898-8276; Brauning, Rudiger/0000-0001-5068-9166	AgResearch	AgResearch	This work was supported by AgResearch internal funding (AgResearch research and capability fund - emerging leaders grant). This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Couldrey C, 2011, CELL REPROGRAM, V13, P171, DOI 10.1089/cell.2010.0065; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doherty R, 2014, FRONTIERS GENETICS, DOI [10.3389/fgene.2014, DOI 10.3389/FGENE.2014]; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Fass J, 2010, TRIMBWASTYLE PL; Goddard ME, 2010, GENET RES, V92, P413, DOI 10.1017/S0016672310000613; Hartung T, 2012, EPIGENETICS-US, V7, P421, DOI 10.4161/epi.19565; Kosaki K, 1997, AM J MED GENET, V73, P308; LEWIS J, 1991, FEBS LETT, V285, P155, DOI 10.1016/0014-5793(91)80795-5; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrook J., 2002, MOL CLONING LAB MANU; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	22	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101853	10.1371/journal.pone.0101853	http://dx.doi.org/10.1371/journal.pone.0101853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010796	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800046
J	Sun, YY; Xu, RD; Chen, LN; Kong, RQ; Hu, XP				Sun, Yuanyuan; Xu, Rudan; Chen, Lina; Kong, Ruiqing; Hu, Xiaopeng			A Novel Fractal Coding Method Based on M-J Sets	PLOS ONE			English	Article							IMAGE COMPRESSION; CLASSIFICATION; SEARCH; SCHEME	In this paper, we present a novel fractal coding method with the block classification scheme based on a shared domain block pool. In our method, the domain block pool is called dictionary and is constructed from fractal Julia sets. The image is encoded by searching the best matching domain block with the same BTC (Block Truncation Coding) value in the dictionary. The experimental results show that the scheme is competent both in encoding speed and in reconstruction quality. Particularly for large images, the proposed method can avoid excessive growth of the computational complexity compared with the traditional fractal coding algorithm.	[Sun, Yuanyuan; Xu, Rudan; Kong, Ruiqing; Hu, Xiaopeng] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China; [Chen, Lina] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China	Dalian University of Technology; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Sun, YY (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China.	syuan@dlut.edu.cn			National Natural Science Foundation of China [61103147, 61075018, 61070098, 61272523]; National Key Project of Science and Technology of China [2011ZX05039-003-4]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (No. 61103147, 61075018, 61070098, 61272523, http://www.nsfc.gov.cn), the National Key Project of Science and Technology of China (No. 2011ZX05039-003-4, http://www.most.gov.cn) and the Fundamental Research Funds for the Central Universities (No. DUT12JB06, http://www.dlut.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnsley M., 1992, FRACTAL IMAGE COMPRE; Barnsley M. F., 1988, VIS COMM IM PROC 88, P122; Baviskar AG, 2012, ADV COMPUTER SCI ENG, V166, P353; Chen HN, 2010, IMAGE VISION COMPUT, V28, P518, DOI 10.1016/j.imavis.2009.08.007; DELP EJ, 1979, IEEE T COMMUN, V27, P1335, DOI 10.1109/TCOM.1979.1094560; Douda S., 2011, ELECT LETT COMPUTER, V10, P11; Duh DJ, 2005, IMAGE VISION COMPUT, V23, P1115, DOI 10.1016/j.imavis.2005.05.013; Jacquin AE, 1990, AC SPEECH SIGN PROC, P2225; Jacquin AE, 1992, IEEE T IMAGE PROCESS, V1, P18, DOI 10.1109/83.128028; Jaferzadeh K, 2012, IET IMAGE PROCESS, V6, P1024, DOI 10.1049/iet-ipr.2011.0181; Li ZH, 2010, APPL MECH MAT, V34, P1360; Lin YL, 2011, COMPUT MATH APPL, V62, P310, DOI 10.1016/j.camwa.2011.05.011; Linde Y Buzo A, 1980, IEEE T COMMUN, V28, P702; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Ozawa K, 2008, IMAGE VISION COMPUT, V26, P622, DOI 10.1016/j.imavis.2007.07.012; Pi MH, 2005, IEEE T MULTIMEDIA, V7, P597, DOI 10.1109/TMM.2005.846796; Schwartz WR, 2011, INT J IMAGE GRAPH, V11, P571, DOI 10.1142/S0219467811004251; Sze CJ, 1996, IMAGE VISION COMPUT, V14, P401, DOI 10.1016/0262-8856(95)01074-2; Tong CS, 2001, IEEE T IMAGE PROCESS, V10, P1269, DOI 10.1109/83.941851; Truong TK, 2004, CHAOS SOLITON FRACT, V22, P1071, DOI 10.1016/j.chaos.2004.03.015; Wang JJ, 2013, IEEE T IMAGE PROCESS, V22, P3690, DOI 10.1109/TIP.2013.2268977; Wohlberg B, 1999, IEEE T IMAGE PROCESS, V8, P1716, DOI 10.1109/83.806618	22	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101697	10.1371/journal.pone.0101697	http://dx.doi.org/10.1371/journal.pone.0101697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010686	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800033
J	Warnke, P; Warning, L; Podbielski, A				Warnke, Philipp; Warning, Liesa; Podbielski, Andreas			Some Are More Equal - A Comparative Study on Swab Uptake and Release of Bacterial Suspensions	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PORT-A-CUL; TRANSPORT-SYSTEMS; ANAEROBIC-BACTERIA; NEISSERIA-GONORRHOEAE; NASAL CARRIAGE; HOSPITAL ADMISSION; MICROBIAL ECOLOGY; FLOCKED SWABS; UNITED-STATES	Objectives: Swabs are widely used to collect samples for microbiological analyses from various clinical settings. They vary by material, size, and structure of the tip. This study investigates the uptake and release capacities for liquid and bacteria. Methods: Five swabs were analyzed for their uptake and release capacities of Staphylococcus aureus and Staphylococcus epidermidis suspensions. Two approaches were investigated providing volume-restricted and unrestricted amounts of bacterial suspensions to mimic various clinical situations. Volume and bacterial uptake and release were measured in milligrams and by counting colony forming units (CFU), respectively. Results: Volume uptake and release in the unrestricted setting varied highly significant between 239.6 mg and 88.7 mg (p<0.001) and between 65.2 mg and 2.2 mg (p<0.001), respectively. In the volume-restricted setting the complete volume was absorbed by all swabs, volume release could only be detected for flocked swabs (2.7 mg; p<0.001). Highest amount of CFU release was detected for the MWE Dryswab in the unrestricted setting for both S. aureus and S. epidermidis with 1544 CFU and 553 CFU, respectively, lowest release for the Sarstedt neutral swab with 32 CFU and 17 CFU, respectively (p<0.001). In the volume-restricted setting MWE Sigma-Swab released the highest bacterial amount with 135 CFU S. aureus and 55 CFU S. epidermidis, respectively, the lowest amount was released by Mast Mastaswab with 2 CFU S. aureus and 1 CFU S. epidermidis, respectively (p<0.001). Within the range of the utilized bacterial concentrations, uptake/release ratios were identical for the particular swab types and independent of the bacterial species. Conclusions: The influence of the swab type on subsequent diagnostic results is often underestimated. Uptake and release of the investigated bacteria vary significantly between different swab types and sampling conditions. For best diagnostic outcome swabs should be chosen according to the examined situation and the swab performance profile.	[Warnke, Philipp; Warning, Liesa; Podbielski, Andreas] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany	University of Rostock	Warnke, P (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de						Abu-Diab A, 2008, J CLIN MICROBIOL, V46, P2414, DOI 10.1128/JCM.00369-08; Barber S, 1998, PATHOLOGY, V30, P179, DOI 10.1080/00313029800169196; BROOK I, 1987, J CLIN MICROBIOL, V25, P2020, DOI 10.1128/JCM.25.10.2020-2022.1987; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Citron DM, 2000, J CLIN MICROBIOL, V38, P892, DOI 10.1128/JCM.38.2.892-894.2000; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Dalmaso Giblerto, 2008, PDA J Pharm Sci Technol, V62, P191; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Drake C, 2005, J CLIN MICROBIOL, V43, P1301, DOI 10.1128/JCM.43.3.1301-1303.2005; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Farhat SE, 2001, J CLIN MICROBIOL, V39, P2958, DOI 10.1128/JCM.39.8.2958-2960.2001; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hernes SS, 2011, EUR J CLIN MICROBIOL, V30, P159, DOI 10.1007/s10096-010-1064-2; Hindiyeh M, 2001, J CLIN MICROBIOL, V39, P377, DOI 10.1128/JCM.39.1.377-380.2001; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Krech T, 2009, J VIROL METHODS, V162, P291, DOI 10.1016/j.jviromet.2009.08.011; Morosini MI, 2006, DIAGN MICR INFEC DIS, V56, P19, DOI 10.1016/j.diagmicrobio.2006.02.011; NCCLS (The National Committee for Clinical Laboratory Standards), 2003, M40A NCCLS; Olsen CC, 1999, J CLIN MICROBIOL, V37, P3583, DOI 10.1128/JCM.37.11.3583-3585.1999; Osterblad M, 2003, J CLIN MICROBIOL, V41, P1894, DOI 10.1128/JCM.41.5.1894-1900.2003; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Perry JL, 1997, J CLIN MICROBIOL, V35, P1269, DOI 10.1128/JCM.35.5.1269-1271.1997; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Roelofsen E, 1999, J CLIN MICROBIOL, V37, P3041, DOI 10.1128/JCM.37.9.3041-3043.1999; ROTH RR, 1989, J AM ACAD DERMATOL, V20, P367, DOI 10.1016/S0190-9622(89)70048-7; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Smismans A, 2009, DIAGN MICR INFEC DIS, V65, P108, DOI 10.1016/j.diagmicrobio.2009.06.015; Stahl DL, 2012, ANAESTHESIA, V67, P479, DOI 10.1111/j.1365-2044.2011.06916.x; Tan TY, 2014, PATHOLOGY, V46, P230, DOI 10.1097/PAT.0000000000000074; Tjeenk RM, 2005, INJURY, V36, P100, DOI 10.1016/j.injury.2004.04.011; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Van Horn KG, 2008, DIAGN MICR INFEC DIS, V62, P471, DOI 10.1016/j.diagmicrobio.2008.08.004; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; Wiley DJ, 2013, J LOW GENIT TRACT DI, V17, P414, DOI 10.1097/LGT.0b013e318281d36e; York MK, 2010, CLIN MICROBIOLOGY PR, V1, P3319	47	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102215	10.1371/journal.pone.0102215	http://dx.doi.org/10.1371/journal.pone.0102215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010422	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800084
J	Ammenwerth, W; Wurps, H; Klemens, MA; Crolow, C; Schulz-Menger, J; Schonfeld, N; Bittner, RC; Bauer, TT				Ammenwerth, Wilhelm; Wurps, Henrik; Klemens, Mark A.; Crolow, Catharina; Schulz-Menger, Jeanette; Schoenfeld, Nicolas; Bittner, Roland C.; Bauer, Torsten T.			Reduced Oxygen Uptake Efficiency Slope in Patients with Cardiac Sarcoidosis	PLOS ONE			English	Article							CARDIORESPIRATORY FUNCTIONAL RESERVE; CHRONIC HEART-FAILURE; MAGNETIC-RESONANCE; ENHANCED MRI; INVOLVEMENT; EXERCISE; STANDARDIZATION; PERFORMANCE; MYOCARDITIS; MANAGEMENT	Background: The non-invasive diagnosis of cardiac sarcoidosis (CS) is difficult. Cardiovascular magnetic resonance (CMR) has become a very valuable diagnostic tool in patients with suspected CS, but usually a combination of different tests is used. Oxygen uptake efficiency slope (OUES) is a parameter of cardiopulmonary exercise testing (CPET), which is used as an indicator for cardiovascular impairment. We investigated the predictive value of OUES for the diagnosis of myocardial involvement in sarcoid patients. Methods: Retrospectively 37 consecutive patients (44.9 +/- 13.8 years) with histologically confirmed sarcoidosis and clinical suspicion of heart involvement underwent noninvasive diagnostic testing including CMR. CS was diagnosed according to the guidelines from the Japanese Society of Sarcoidosis and other Granulomatous Disorders with additional consideration of CMR findings. Furthermore, CPET with calculation of predicted OUES according to equations by Hollenberg et al. was carried out. Results: Patients with CS (11/37; 30%) had a worse cardiovascular response to exercise. OUES was significantly lower in CS-group compared to non-CS-group (59.3 +/- 19.1 vs 88.0 +/- 15.4% pred., p < 0.0001). ROC curve method identified 70% pred. as the OUES cut-off point, which maximized sensitivity and specificity for detection of CS (96% sensitivity, 82% specificity, 89% overall accuracy). OUES <70% pred. was the single best predictor of CS (Odds ratio: 100.43, 95% CI: 1.99 to 5064, p < 0.001) even in multivariate analyses. Conclusion: OUES assessed in CPET may be helpful in identifying patient with cardiac involvement of sarcoidosis. Patient selection for CMR may be assisted by CPET findings in patients with sarcoidosis.	[Ammenwerth, Wilhelm; Wurps, Henrik; Crolow, Catharina; Schoenfeld, Nicolas; Bauer, Torsten T.] HELIOS Klinikum Emil von Behring, Lungenklin Heckeshorn, Dept Pneumol, Berlin, Germany; [Klemens, Mark A.; Bittner, Roland C.] HELIOS Klinikum Emil von Behring, Inst Radiol & Nucl Med, Berlin, Germany; [Schulz-Menger, Jeanette] WG Cardiac MRI ECRC, Berlin, Germany; [Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany	Helios Kliniken; Helios Kliniken; Helios Kliniken	Bauer, TT (corresponding author), HELIOS Klinikum Emil von Behring, Lungenklin Heckeshorn, Dept Pneumol, Berlin, Germany.	torsten.bauer@helios-kliniken.de		Schulz-Menger, Jeanette/0000-0003-3100-1092	Oskar-Helene-Heim Foundation, Berlin, Germany; HELIOS Research Center, Berlin, Germany	Oskar-Helene-Heim Foundation, Berlin, Germany; HELIOS Research Center, Berlin, Germany	The study was supported by the Oskar-Helene-Heim Foundation, Berlin, Germany and HELIOS Research Center, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreacci JL, 2002, J SPORT SCI, V20, P345, DOI 10.1080/026404102753576125; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Baba R, 1999, EUR J APPL PHYSIOL O, V80, P397, DOI 10.1007/s004210050610; Baba Y, 2012, INT HEART J, V53, P287, DOI 10.1536/ihj.53.287; Codreanu A, 2007, J MAGN RESON IMAGING, V25, P957, DOI 10.1002/jmri.20897; Cooper C.B., 2001, EXERCISE TESTING INT; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Davies LC, 2006, EUR HEART J, V27, P684, DOI 10.1093/eurheartj/ehi672; Dubrey SW, 2010, PROG CARDIOVASC DIS, V52, P336, DOI 10.1016/j.pcad.2009.11.010; Fahy GJ, 1996, CHEST, V109, P62, DOI 10.1378/chest.109.1.62; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Gademan MGJ, 2008, EUR J CARDIOV PREV R, V15, P140, DOI 10.1097/HJR.0b013e3282ef19986; Handa T, 2010, SARCOIDOSIS VASC DIF, V27, P27; Hiraga HYK., 1993, GUIDELINES DIAGNOSIS, P23; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; IWAI K, 1994, SARCOIDOSIS, V11, P26; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Magri D, 2013, EUR J INTERN MED, V24, P278, DOI 10.1016/j.ejim.2012.12.010; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Schulz-Menger J, 2006, HEART, V92, P399, DOI 10.1136/hrt.2004.058016; Shimada T, 2001, AM J MED, V110, P520, DOI 10.1016/S0002-9343(01)00677-5; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Smedema JP, 2005, CHEST, V128, P1629, DOI 10.1378/chest.128.3.1629; Smedema JP, 2005, CHEST, V128, P30, DOI 10.1378/chest.128.1.30; Soejima K, 2009, J CARDIOVASC ELECTR, V20, P578, DOI 10.1111/j.1540-8167.2008.01417.x; Tadamura E, 2005, AM J ROENTGENOL, V185, P110, DOI 10.2214/ajr.185.1.01850110; TELLIER P, 1988, AM J MED, V85, P189; Van Laethem C, 2005, AM HEART J, V149, P175, DOI 10.1016/j.ahj.2004.07.004; Van Laethem C, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.032; Vignaux O, 2002, CHEST, V122, P1895, DOI 10.1378/chest.122.6.1895; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	38	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102333	10.1371/journal.pone.0102333	http://dx.doi.org/10.1371/journal.pone.0102333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029031	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000341306600066
J	Deng, G; Zhong, XY; Zhang, N; Lao, CY; Wang, B; Peng, DX; Liu, LJ				Deng Gang; Zhong Xinyue; Zhang Na; Lao Chengying; Wang Bo; Peng Dingxiang; Liu Lijun			A Proteomics Sample Preparation Method for Mature, Recalcitrant Leaves of Perennial Plants	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; PROTEIN EXTRACTION; ALEURONE LAYER; TISSUES; SEED; SOLUBILIZATION; TECHNOLOGY; EXPRESSION; STORAGE; WHEAT	Sample preparation is key to the success of proteomics studies. In the present study, two sample preparation methods were tested for their suitability on the mature, recalcitrant leaves of six representative perennial plants (grape, plum, pear, peach, orange, and ramie). An improved sample preparation method was obtained: Tris and Triton X-100 were added together instead of CHAPS to the lysis buffer, and a 20% TCA-water solution and 100% precooled acetone were added after the protein extraction for the further purification of protein. This method effectively eliminates nonprotein impurities and obtains a clear two-dimensional gel electrophoresis array. The method facilitates the separation of high-molecular-weight proteins and increases the resolution of low-abundance proteins. This method provides a widely applicable and economically feasible technology for the proteomic study of the mature, recalcitrant leaves of perennial plants.	[Deng Gang; Zhong Xinyue; Lao Chengying; Wang Bo; Peng Dingxiang; Liu Lijun] Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Hubei, Peoples R China; [Deng Gang] Yunnan Univ, Sch Agr Sci, Kunming, Yunnan, Peoples R China; [Zhang Na] Wuhan Agr & Sci Inst, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Yunnan University	Liu, LJ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Hubei, Peoples R China.	liulijun@mail.hzau.edu.cn	Deng, Gang/ABB-3072-2021	Deng, Gang/0000-0002-0136-2535	National science and technology support [2010BAD02B01]; National Natural Science Foundation of China [31000731]; China Agriculture Research System [CARS-19-E12]	National science and technology support; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This research was supported by a grant from National science and technology support (2010BAD02B01), the National Natural Science Foundation of China (31000731) and China Agriculture Research System (CARS-19-E12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1993, OIKOS, V66, P144, DOI 10.2307/3545208; Bancel E, 2010, J PROTEOME RES, V9, P3299, DOI 10.1021/pr9010525; Bodzon-Kulakowska A, 2007, J CHROMATOGR B, V849, P1, DOI 10.1016/j.jchromb.2006.10.040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Deng G, 2013, INT J AGRIC BIOL, V15, P570; Freeman WM, 2004, NEUROCHEM RES, V29, P1065, DOI 10.1023/B:NERE.0000023594.21352.17; GELFI C, 1983, J BIOCHEM BIOPH METH, V8, P157, DOI 10.1016/0165-022X(83)90041-6; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Islam N, 2004, PROTEOMICS, V4, P1903, DOI 10.1002/pmic.200300816; Kottapalli KR, 2008, PLANT SCI, V175, P321, DOI 10.1016/j.plantsci.2008.05.005; Leimgruber RM, 2002, PROTEOMICS, V2, P135, DOI 10.1002/1615-9861(200202)2:2<135::AID-PROT135>3.0.CO;2-1; Magni C, 2007, PHYTOCHEMISTRY, V68, P997, DOI 10.1016/j.phytochem.2007.01.003; Meziani S, 2012, J CEREAL SCI, V55, P323, DOI 10.1016/j.jcs.2012.01.010; Molloy MP, 1998, ELECTROPHORESIS, V19, P837, DOI 10.1002/elps.1150190539; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; Rashid A, 2013, PLANT MOL BIOL REP, V31, P464, DOI 10.1007/s11105-012-0498-3; Rose JKC, 2004, PLANT J, V39, P715, DOI 10.1111/j.1365-313X.2004.02182.x; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; SAS Institute Inc, 1989, SAS STAT US GUID VER; Taulavuori E, 2010, PROTOPLASMA, V241, P19, DOI 10.1007/s00709-009-0096-x; Valcu CM, 2006, PROTEOMICS, V6, P1599, DOI 10.1002/pmic.200500314; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; Wang W, 2008, J SEP SCI, V31, P2032, DOI 10.1002/jssc.200800087; WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185; Wong M, 2006, LANDSCAPE, V50, P15; Wu QF, 2011, ACTA PHYSIOL PLANT, V33, P2387, DOI 10.1007/s11738-011-0779-8; Zellner M, 2005, ELECTROPHORESIS, V26, P2481, DOI 10.1002/elps.200410262; Zhu Y, 2011, ACTA PHYSIOL PLANT, V33, P1467, DOI 10.1007/s11738-010-0683-7	30	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102175	10.1371/journal.pone.0102175	http://dx.doi.org/10.1371/journal.pone.0102175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028960	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600041
J	Ribeiro, MBN; Jerozolimski, A; de Robert, P; Salles, NV; Kayapo, B; Pimentel, TP; Magnusson, WE				Ribeiro, Maria Beatriz N.; Jerozolimski, Adriano; de Robert, Pascale; Salles, Nilson V.; Kayapo, Biribiri; Pimentel, Tania P.; Magnusson, William E.			Anthropogenic Landscape in Southeastern Amazonia: Contemporary Impacts of Low-Intensity Harvesting and Dispersal of Brazil Nuts by the Kayapo Indigenous People	PLOS ONE			English	Article							TREE BERTHOLLETIA-EXCELSA; POPULATION-STRUCTURE; SEED DISPERSAL; EXTRACTIVE RESERVES; DASYPROCTA-LEPORINA; PRISTINE MYTH; FOREST; LECYTHIDACEAE; CONSERVATION; PREDATION	Brazil nut, the Bertholletia excelsa seed, is one of the most important non-timber forest products in the Amazon Forest and the livelihoods of thousands of traditional Amazonian families depend on its commercialization. B. excelsa has been frequently cited as an indicator of anthropogenic forests and there is strong evidence that past human management has significantly contributed to its present distribution across the Amazon, suggesting that low levels of harvesting may play a positive role in B. excelsa recruitment. Here, we evaluate the effects of Brazil nut harvesting by the Kayapo Indigenous people of southeastern Amazonia on seedling recruitment in 20 B. excelsa groves subjected to different harvesting intensities, and investigated if management by harvesters influences patterns of B. excelsa distribution. The number of years of low-intensity Brazil nut harvesting by the Kayapo over the past two decades was positively related to B. excelsa seedling density in groves. One of the mechanisms behind the higher seedling density in harvested sites seems to be seed dispersal by harvesters along trails. The Kayapo also intentionally plant B. excelsa seeds and seedlings across their territories. Our results show not only that low-intensity Brazil nut harvesting by the Kayapo people does not reduce recruitment of seedlings, but that harvesting and/or associated activities conducted by traditional harvesters may benefit B. excelsa beyond grove borders. Our study supports the hypothesis that B. excelsa dispersal throughout the Amazon was, at least in part, influenced by indigenous groups, and strongly suggests that current human management contributes to the maintenance and formation of B. excelsa groves. We suggest that changes in Brazil nut management practices by traditional people to prevent harvesting impacts may be unnecessary and even counterproductive in many areas, and should be carefully evaluated before implementation.	[Ribeiro, Maria Beatriz N.] INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Jerozolimski, Adriano; Salles, Nilson V.; Kayapo, Biribiri] AFP, Tucuma, Para, Brazil; [de Robert, Pascale] IRD, UMR PALOC, Paris, France; [de Robert, Pascale] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Pimentel, Tania P.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Dinam Ambiental CDAM, Manaus, Amazonas, Brazil; [Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institut de Recherche pour le Developpement (IRD); Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Ribeiro, MBN (corresponding author), INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	ribeiro.mbn@gmail.com			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [141697/2007-5]; Conservacao Internacional do Brasil - CI-Brasil [CPFY 08/022]; Instituto Internacional de Educacao do Brasil - IEB/Gordon and Betty Moore Foundation [B/2007/02/BDP/04]; Institut de Recherche Pour le Developpement - IRD; International Conservation Fund of Canada - ICFC; CNPq through the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Program for Biodiversity Research (PPBio); INCT-CENBAM	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservacao Internacional do Brasil - CI-Brasil; Instituto Internacional de Educacao do Brasil - IEB/Gordon and Betty Moore Foundation; Institut de Recherche Pour le Developpement - IRD; International Conservation Fund of Canada - ICFC; CNPq through the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Program for Biodiversity Research (PPBio); INCT-CENBAM	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (http://www.cnpq.br) (grant number 141697/2007-5); Conservacao Internacional do Brasil - CI-Brasil (http://www.conservation.org.br)(grant number CPFY 08/022); Instituto Internacional de Educacao do Brasil - IEB/Gordon and Betty Moore Foundation (http://www.iieb.org.br) (grant number B/2007/02/BDP/04); Institut de Recherche Pour le Developpement - IRD (http://www.ird.org); and International Conservation Fund of Canada - ICFC (http://icfcanada.org). MBNR was supported by a CNPq scholarship through the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM) during manuscript preparation. WEM is supported by the Program for Biodiversity Research (PPBio) and the INCT-CENBAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arnaud E, 1987, INDIO EXPANSAO NACL, P427; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; BAIDER C, 2000, THESIS U SAO PAULO S; Balee W., 1989, Advances in Economic Botany, V7, P1; Brockington D, 2006, CONSERV BIOL, V20, P250, DOI 10.1111/j.1523-1739.2006.00335.x; Buckland S.T., 2001, pi; BUCKLEY DP, 1988, THEOR APPL GENET, V76, P923, DOI 10.1007/BF00273682; CLAY J.W., 1997, HARVESTING WILD SPEC, P246; Clement CR, 2010, BIOTROPICA, V42, P534, DOI 10.1111/j.1744-7429.2010.00674.x; Clement CR, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P159, DOI 10.1007/1-4020-2597-1_9; Connell J.H., 1971, DYNAMICS POPULATIONS, P298; Cotta JN, 2008, FOREST ECOL MANAG, V256, P28, DOI 10.1016/j.foreco.2008.03.026; Denevan WM, 2011, GEOGR REV, V101, P576, DOI 10.1111/j.1931-0846.2011.00118.x; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Embrapa, 1997, MAN MET AN SOL; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; Hemming J, 2003, DIE YOU MUST BRAZILI, P110; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnston K., 2001, USING ARCGIS GEOSTAT; Jorge MSP, 2005, BIOTROPICA, V37, P317, DOI 10.1111/j.1744-7429.2005.00041.x; Kainer KA, 1998, ECOL APPL, V8, P397, DOI 10.1890/1051-0761(1998)008[0397:BNSEAA]2.0.CO;2; Kainer KA, 2007, FOREST ECOL MANAG, V250, P244, DOI 10.1016/j.foreco.2007.05.024; Kanashiro M, 1997, SILVAE GENET, V46, P219; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Mori S. A., 1990, Advances in Economic Botany, V8, P130; MORSELLO C, 2002, THESIS U E ANGLIA NO; Motta Maues M., 2002, POLLINATING BEES THE, P245; Myers GP, 2000, FOREST ECOL MANAG, V127, P119, DOI 10.1016/S0378-1127(99)00124-3; ORTIZ E. G., 2002, TAPPING GREEN MARKET, P61; Paiva PM, 2011, FOREST ECOL MANAG, V261, P508, DOI 10.1016/j.foreco.2010.11.001; Pereira HS, 1994, REV UNIVERSIDADE AMA, V3, P11; Peres CA, 1997, J TROP ECOL, V13, P69, DOI 10.1017/S0266467400010269; Peres CA, 1997, J TROP ECOL, V13, P595, DOI 10.1017/S0266467400010749; Peres CA, 2001, CONSERV BIOL, V15, P793, DOI 10.1046/j.1523-1739.2001.015003793.x; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Posey D. A., 1985, Agroforestry Systems, V3, P139, DOI 10.1007/BF00122640; Posey DA, 2004, KAYAPO ETHNOECOLOGY; Quinlan M., 2005, FIELD METHOD, V17, P219, DOI [10.1177/1525822X05277460, DOI 10.1177/1525822X05277460]; Ribeiro MBN, 2014, FOREST ECOL MANAG, V319, P67, DOI 10.1016/j.foreco.2014.02.005; Robert P, 2009, ANUARIO AMERICANISTA, V6-7, P563; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; Schwartzman S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0164; Scoles R., 2011, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V6, P273; Scoles R, 2012, FOREST ECOL MANAG, V265, P71, DOI 10.1016/j.foreco.2011.10.027; Scoles R, 2011, HUM ECOL, V39, P455, DOI 10.1007/s10745-011-9412-0; Shanley P, 2002, TAPPING GREEN MARKET; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Silvius KM, 2003, BIOTROPICA, V35, P74, DOI 10.1111/j.1744-7429.2003.tb00264.x; Smith J. Jerome, 1993, CULTURAL ANTHR METHO, V5, P1, DOI DOI 10.1177/1525822X9300500301; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Haugaasen JMT, 2010, J TROP ECOL, V26, P251, DOI 10.1017/S0266467410000027; TURNER Terence, 1992, HIST INDIOS BRASIL, P311; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; VIVEIROS DE CASTRO Eduardo, 1986, ARAWETE OS DEUSES CA; Wadt LHO, 2008, BIOL CONSERV, V141, P332, DOI 10.1016/j.biocon.2007.10.007; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018	66	39	44	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102187	10.1371/journal.pone.0102187	http://dx.doi.org/10.1371/journal.pone.0102187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029191	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600043
J	Ferraz-Nogueira, JP; Diez-Guerra, FJ; Llopis, J				Ferraz-Nogueira, Jose P.; Javier Diez-Guerra, F.; Llopis, Juan			Visualization of Phosphatidic Acid Fluctuations in the Plasma Membrane of Living Cells	PLOS ONE			English	Article							PHOSPHOLIPASE-D ISOFORM; DYNAMIC-RANGE; MYOSIN-II; PROTEIN; HETEROGENEITY; LOCALIZATION; LAMELLIPODIA; EXPRESSION; FILOPODIA; BINDING	We developed genetically-encoded fluorescent sensors based on Forster Resonance Energy Transfer to monitor phosphatidic acid (PA) fluctuations in the plasma membrane using Spo20 as PA-binding motif. Basal PA levels and phospholipase D activity varied in different cell types. In addition, stimuli that activate PA phosphatases, leading to lower PA levels, increased lamellipodia and filopodia formation. Lower PA levels were observed in the leading edge than in the trailing edge of migrating HeLa cells. In MSC80 and OLN93 cells, which are stable cell lines derived from Schwann cells and oligodendrocytes, respectively, a higher ratio of diacylglycerol to PA levels was demonstrated in the membrane processes involved in myelination, compared to the cell body. We propose that the PA sensors reported here are valuable tools to unveil the role of PA in a variety of intracellular signaling pathways.	[Ferraz-Nogueira, Jose P.; Llopis, Juan] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete, Spain; [Ferraz-Nogueira, Jose P.; Llopis, Juan] Univ Castilla La Mancha, Fac Med Albacete, Albacete, Spain; [Javier Diez-Guerra, F.] Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Javier Diez-Guerra, F.] Univ Autonoma Madrid, Fac Ciencias, Dept Biol Mol, E-28049 Madrid, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Llopis, J (corresponding author), Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete, Spain.	juan.llopis@uclm.es	Llopis, Juan/I-2622-2012; Diez-Guerra, Fco. Javier/K-9063-2014	Llopis, Juan/0000-0002-9460-0642; Diez-Guerra, Fco. Javier/0000-0003-1707-4519; Ferraz Nogueira, Jose Pedro/0000-0002-9839-2043	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) [BFU2012-39548]; Junta de Comunidades de Castilla-La Mancha/ERDF [PPII10-0270-6889]; Spanish Ministry of Science and Innovation [BFU2010-18297]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (ERDF)(European Commission); Junta de Comunidades de Castilla-La Mancha/ERDF(Junta de Comunidades de Castilla-La Mancha); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (ERDF) (grant BFU2012-39548 to J.L.), Junta de Comunidades de Castilla-La Mancha/ERDF (grant PPII10-0270-6889 to J.L.), and the Spanish Ministry of Science and Innovation (grant BFU2010-18297 to F.J.D-G). Institutional support from Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; BOUTRY JM, 1992, J NEUROSCI RES, V32, P15, DOI 10.1002/jnr.490320103; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Bruce Charlotte C., 2007, P427, DOI 10.1007/978-0-387-70830-0_19; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Domingo B, 2010, CELL MOL LIFE SCI, V67, P3345, DOI 10.1007/s00018-010-0386-7; Dominguez-Gonzalez I, 2007, BIOCHEM J, V404, P31, DOI 10.1042/BJ20061483; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Fiucci G, 2000, INT J CANCER, V85, P882, DOI 10.1002/(SICI)1097-0215(20000315)85:6<882::AID-IJC24>3.0.CO;2-E; Foster DA, 2003, MOL CANCER RES, V1, P789; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gomez-Cambronero J, 2013, ADV BIOL REGUL; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kollins KM, 2009, DEV NEUROBIOL, V69, P279, DOI 10.1002/dneu.20704; Kotera I, 2010, ACS CHEM BIOL, V5, P215, DOI 10.1021/cb900263z; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Krager KJ, 2012, J LIPID RES, V53, P2214, DOI 10.1194/jlr.D026468; Kunida K, 2012, J CELL SCI, V125, P2381, DOI 10.1242/jcs.096859; LISCOVITCH M, 1989, J BIOL CHEM, V264, P1450; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Picazo F, 2011, BIOSENS BIOELECTRON, V26, P2147, DOI 10.1016/j.bios.2010.09.024; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Rainteau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041985; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Tavare JM, 2001, J ENDOCRINOL, V170, P297, DOI 10.1677/joe.0.1700297; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Wang HB, 2012, J NEUROSCI RES, V90, P1547, DOI 10.1002/jnr.23036; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13	52	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102526	10.1371/journal.pone.0102526	http://dx.doi.org/10.1371/journal.pone.0102526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025521	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400083
J	Liu, ZY; Szarecka, A; Yonkunas, M; Speranskiy, K; Kurnikova, M; Cascio, M				Liu, Zhenyu; Szarecka, Agnieszka; Yonkunas, Michael; Speranskiy, Kirill; Kurnikova, Maria; Cascio, Michael			Crosslinking Constraints and Computational Models as Complementary Tools in Modeling the Extracellular Domain of the Glycine Receptor	PLOS ONE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTORS; 3-DIMENSIONAL PROTEIN STRUCTURES; MOLECULAR-DYNAMICS SIMULATIONS; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; M2 SEGMENT; RESOLUTION	The glycine receptor (GlyR), a member of the pentameric ligand-gated ion channel superfamily, is the major inhibitory neurotransmitter-gated receptor in the spinal cord and brainstem. In these receptors, the extracellular domain binds agonists, antagonists and various other modulatory ligands that act allosterically to modulate receptor function. The structures of homologous receptors and binding proteins provide templates for modeling of the ligand-binding domain of GlyR, but limitations in sequence homology and structure resolution impact on modeling studies. The determination of distance constraints via chemical crosslinking studies coupled with mass spectrometry can provide additional structural information to aid in model refinement, however it is critical to be able to distinguish between intra-and inter-subunit constraints. In this report we model the structure of GlyBP, a structural and functional homolog of the extracellular domain of human homomeric alpha 1 GlyR. We then show that intra-and intersubunit Lys-Lys crosslinks in trypsinized samples of purified monomeric and oligomeric protein bands from SDS-polyacrylamide gels may be identified and differentiated by MALDI-TOF MS studies of limited resolution. Thus, broadly available MS platforms are capable of providing distance constraints that may be utilized in characterizing large complexes that may be less amenable to NMR and crystallographic studies. Systematic studies of state-dependent chemical crosslinking and mass spectrometric identification of crosslinked sites has the potential to complement computational modeling efforts by providing constraints that can validate and refine allosteric models.	[Liu, Zhenyu; Cascio, Michael] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Szarecka, Agnieszka; Yonkunas, Michael; Speranskiy, Kirill; Kurnikova, Maria] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Szarecka, Agnieszka] Grand Valley State Univ, Dept Cell & Mol Biol, Allendale, MI 49401 USA; [Cascio, Michael] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Grand Valley State University; Duquesne University	Cascio, M (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA.	casciom@duq.edu	Yonkunas, Michael/P-8397-2019; Kurnikova, maria G/H-4510-2017	Yonkunas, Michael/0000-0002-4570-279X; Kurnikova, maria G/0000-0002-8010-8374	NIH grant [R01 NS053788]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053788] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R01 NS053788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dihazi GH, 2003, RAPID COMMUN MASS SP, V17, P2005, DOI 10.1002/rcm.1144; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2006, J MOL NEUROSCI, V30, P101, DOI 10.1385/JMN:30:1:101; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2005, J BIOL CHEM, V280, P1573, DOI 10.1074/jbc.M410881200; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobsen RB, 2006, PROTEIN SCI, V15, P1303, DOI 10.1110/ps.052040406; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Kannan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065610; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Lasker K, 2010, MOL CELL PROTEOMICS, V9, P1689, DOI 10.1074/mcp.R110.000067; Leite JF, 2000, J BIOL CHEM, V275, P13683, DOI 10.1074/jbc.275.18.13683; Leite JF, 2002, BIOCHEMISTRY-US, V41, P6140, DOI 10.1021/bi015895m; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Liu Z, 2008, BIOCHEMISTRY-US, V47, P9803, DOI 10.1021/bi800659x; Lobo IA, 2004, J NEUROCHEM, V90, P962, DOI 10.1111/j.1471-4159.2004.02561.x; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; McCracken LM, 2010, ACS CHEM NEUROSCI, V1, P482, DOI 10.1021/cn100019g; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mouradov Dmitri, 2008, V426, P459, DOI 10.1007/978-1-60327-058-8_31; Nury H, 2010, J MOL BIOL, V395, P1114, DOI 10.1016/j.jmb.2009.11.024; Paramelle D, 2013, PROTEOMICS, V13, P438, DOI 10.1002/pmic.201200305; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pottiez G, 2012, ANAL BIOCHEM, V421, P712, DOI 10.1016/j.ab.2011.12.012; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Sine SM, 2002, J BIOL CHEM, V41, P10472; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Smit AB, 2003, ANN NY ACAD SCI, V998, P81, DOI 10.1196/annals.1254.010; Smit AB, 2006, J MOL NEUROSCI, V30, P9, DOI 10.1385/JMN:30:1:9; Speranskiy K, 2007, PROTEINS, V67, P950, DOI 10.1002/prot.21251; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trakselis MA, 2005, BIOCONJUGATE CHEM, V16, P741, DOI 10.1021/bc050043a; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WANG D, 1977, BIOCHEMISTRY-US, V16, P2937, DOI 10.1021/bi00632a021; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Zheng WJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001046	68	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102571	10.1371/journal.pone.0102571	http://dx.doi.org/10.1371/journal.pone.0102571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025226	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000339992400089
J	Saito, H; Gill, CJ				Saito, Hiroki; Gill, Christopher J.			How Frequently Do the Results from Completed US Clinical Trials Enter the Public Domain? - A Statistical Analysis of the ClinicalTrials.gov Database	PLOS ONE			English	Article							BIAS	Background: Achieving transparency in clinical trials, through either publishing results in a journal or posting results to the ClinicalTrials.gov (CTG) web site, is an essential public health good. However, it remains unknown what proportion of completed studies achieve public disclosure of results (PDOR), or what factors explain these differences. Methods: We analyzed data from 400 randomly selected studies within the CTG database that had been listed as 'completed' and had at least four years in which to disclose results. Using Kaplan-Meier curves, we calculated times from completion to PDOR (defined as publishing the primary outcomes in a journal and/or posting results to CTG), and identified explanatory variables predicting these outcomes using Cox proportional hazards models. Findings: Among the 400 clinical trials, 118 (29.5%) failed to achieve PDOR within four years of completion. The median day from study completion to PDOR among 282 studies (70.5%) that achieved PDOR was 602 days (mean 647 days, SD 454 days). Studies were less likely to achieve PDOR if at earlier stages (phase 2 vs. phase 3/4, adjusted HR 0.60, 95% CI 0.47-0.78), if they only included adult subjects (adjusted HR 0.61, 95% CI 0.45-0.83), involved randomization (adjusted HR 0.62, 95% CI 0.46-0.83), or had smaller sample sizes (<= 50 subjects vs. >50, adjusted HR 0.60, 95% CI 0.44-0.83). Industry-funded studies were significantly less likely to be published than non-industry or blended studies (adjusted HR 0.49, 95% CI 0.36-0.66). Conclusions: A significant proportion of completed studies did not achieve PDOR within the four years of follow-up, particularly smaller studies at earlier stages of development with industry funding. This constitutes reporting bias and threatens the validity of the clinical research literature in the US.	[Saito, Hiroki] Carney Hosp, Dept Med, Dorchester, MA USA; [Gill, Christopher J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Gill, Christopher J.] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA USA	Boston University; Boston University	Gill, CJ (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	cgill@bu.edu		gill, christopher/0000-0003-3353-0617				Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; [Anonymous], DAT EL DEF DRAFT; DeAngelis CD, 2005, ARCH OTOLARYNGOL, V131, P479, DOI 10.1001/archotol.131.6.479; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Gill CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001186; Gopal RK, 2012, CONTEMP CLIN TRIALS, V33, P486, DOI 10.1016/j.cct.2012.02.001; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Johnson RT, 2007, NAT CLIN PRACT NEURO, V3, P590, DOI 10.1038/ncpneuro0618; Lundh A, 1996, COCHRANE DATABASE SY; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Ross JS, 2012, BMJ, V344; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	16	48	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101826	10.1371/journal.pone.0101826	http://dx.doi.org/10.1371/journal.pone.0101826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025477	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400023
J	Sampson, VB; David, JM; Puig, I; Patil, PU; de Herreros, AG; Thomas, GV; Rajasekaran, AK				Sampson, Valerie B.; David, Justin M.; Puig, Isabel; Patil, Pratima U.; Garcia de Herreros, Antonio; Thomas, George V.; Rajasekaran, Ayyappan K.			Wilms' Tumor Protein Induces an Epithelial-Mesenchymal Hybrid Differentiation State in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; SUPPRESSOR GENE; CANCER; WT1; TRANSITIONS; VHL; METASTASIS; NETWORKS; ADHESION	The Wilms' tumor transcription factor (WT1) was originally classified as a tumor suppressor, but it is now known to also be associated with cancer progression and poor prognosis in several malignancies. WT1 plays an essential role in orchestrating a developmental process known as mesenchymal-to-epithelial transition (MET) during kidney development, but also induces the reverse process, epithelial-to-mesenchymal transition (EMT) during heart development. WT1 is not expressed in the adult kidney, but shows elevated expression in clear cell renal cell carcinoma (ccRCC). However, the role of WT1 in this disease has not been characterized. In this study, we demonstrate that WT1 is upregulated in ccRCC cells that are deficient in the expression of the von Hippel-Lindau tumor suppressor protein (VHL). We found that WT1 transcriptionally activated Snail, a master transcriptional repressor that is known to induce EMT. Although Snail represses E-cadherin and induces mesenchymal characteristics, we found partial maintenance of E-cadherin and associated epithelial characteristics in kidney cells and ccRCC cells that express WT1, since WT1 upregulates E-cadherin expression and competes with Snail repression. These findings support a novel paradigm in which WT1 induces an epithelial-mesenchymal hybrid transition (EMHT), characterized by Snail up-regulation with E-cadherin maintenance, a tumor cell differentiation state in which cancer cells keep both EMT and MET characteristics which may promote tumor cell plasticity and tumor progression.	[Sampson, Valerie B.; David, Justin M.; Patil, Pratima U.; Rajasekaran, Ayyappan K.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA; [David, Justin M.; Patil, Pratima U.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Puig, Isabel; Garcia de Herreros, Antonio] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain; [Thomas, George V.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Oregon Health & Science University	Rajasekaran, AK (corresponding author), Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA.	arakaran687@gmail.com	Sampson, Valerie/AAP-8773-2021; de Herreros, A Garcia/H-3104-2014	de Herreros, A Garcia/0000-0001-5270-0808; David, Justin/0000-0003-2151-605X; Puig Borreil, Isabel/0000-0001-5614-4298; Thomas, George V/0000-0001-7416-8840	NIH [P20GM103464, DK56216]; Nemours Foundation [SAF2010-16089]; NATIONAL CANCER INSTITUTE [R01CA169172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nemours Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants P20GM103464 (Dr. Thomas Shaffer), DK56216 and the Nemours Foundation (A.K. Rajasekaran), SAF2010-16089 (A.G. de Herreros). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Brett A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-3; Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO;2-D; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Dutton JR, 2006, CELL PROLIFERAT, V39, P519, DOI 10.1111/j.1365-2184.2006.00409.x; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; KESSLER PM, 1995, MOL MED, V1, P457, DOI 10.1007/BF03401583; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Linehan WM, 2009, INT J BIOCHEM CELL B, V41, P753, DOI 10.1016/j.biocel.2008.09.024; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Moore AW, 1999, DEVELOPMENT, V126, P1845; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Scholz H, 2005, PHYSIOLOGY, V20, P54, DOI 10.1152/physiol.00048.2004; Scholz H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00004; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thiery JP, 2009, B ACAD NAT MED PARIS, V193, P1969, DOI 10.1016/S0001-4079(19)32372-6; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje	36	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102041	10.1371/journal.pone.0102041	http://dx.doi.org/10.1371/journal.pone.0102041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025131	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400037
J	Manning, L; Wright, C; Ingram, PR; Whitmore, TJ; Heath, CH; Manson, I; Page-Sharp, M; Salman, S; Dyer, J; Davis, TME				Manning, Laurens; Wright, Cameron; Ingram, Paul R.; Whitmore, Timothy J.; Heath, Christopher H.; Manson, Ingrid; Page-Sharp, Madhu; Salman, Sam; Dyer, John; Davis, Timothy M. E.			Continuous Infusions of Meropenem in Ambulatory Care: Clinical Efficacy, Safety and Stability	PLOS ONE			English	Article							PARENTERAL ANTIBIOTIC-THERAPY; CYSTIC-FIBROSIS; NEUTROPENIA; GUIDELINES; VANCOMYCIN	Objectives: Concerns regarding the clinical impact of meropenem instability in continuous infusion (CI) devices may contribute to inconsistent uptake of this method of administration across outpatient parenteral antimicrobial therapy (OPAT) services. Methods: We retrospectively reviewed the clinical efficacy and safety of CIs of meropenem in two Australian tertiary hospitals and assessed its stability under simulated OPAT conditions including in elastomeric infusion devices containing 1% (2.4 g) or 2% (4.8 g) concentrations at either 'room temperature' or 'cooled' conditions. Infusate aliquots were assayed at different time-points over 24 hours. Results: Forty-one (82%) of 50 patients had clinical improvement or were cured. Adverse patient outcomes including hemato-, hepato-and nephrotoxicity were infrequent. Cooled infusers with 1% meropenem had a mean 24-hour recovery of 90.3%. Recoveries of 1% and 2% meropenem at room temperature and 2% under cooled conditions were 88%, 83% and 87%, respectively. Patients receiving 1% meropenem are likely to receive >95% of the maximum deliverable dose (MDD) over a 24-hour period whilst patients receiving 2% meropenem should receive 93% and 87% of the MDD under cooled and room temperature conditions, respectively. Conclusions: Meropenem infusers are likely to deliver similar to 95% MDD and maintain effective plasma concentrations throughout the dosing period. These data reflect our local favourable clinical experience with meropenem CIs.	[Manning, Laurens; Salman, Sam; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia; [Manning, Laurens; Dyer, John] Fremantle Hosp & Hlth Serv, Dept Infect Dis, Fremantle, WA, Australia; [Wright, Cameron; Manson, Ingrid] Fremantle Hosp & Hlth Serv, Dept Pharm, Fremantle, WA, Australia; [Ingram, Paul R.; Whitmore, Timothy J.; Heath, Christopher H.] Royal Perth Hosp, Dept Microbiol & Infect Dis, Perth, WA 6001, Australia; [Ingram, Paul R.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Heath, Christopher H.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Page-Sharp, Madhu] Curtin Univ, Sch Pharm, Bentley, WA, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Curtin University	Manning, L (corresponding author), Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.	laurens.manning@uwa.edu.au	Dyer, John/AAD-8524-2021; Davis, Timothy ME/M-5144-2014; Salman, Sam/V-6271-2018; Manning, Laurens A/H-5360-2014; Heath, Christopher H/D-2646-2012	Salman, Sam/0000-0002-8276-6784; Manning, Laurens A/0000-0003-4334-5351; Heath, Christopher H/0000-0001-7850-6931; Davis, Timothy/0000-0003-0749-7411; Whitmore, Tim/0000-0001-9639-0995	National Health and Medical Research Council of Australia Practitioner Fellowship; School of Medicine and Pharmacology, University of Western Australia; Department of Infectious Diseases, Fremantle Hospital and Health Service; National Health and Medical Research Council of Australia [634343, 101212]	National Health and Medical Research Council of Australia Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); School of Medicine and Pharmacology, University of Western Australia; Department of Infectious Diseases, Fremantle Hospital and Health Service; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The elastomeric infusion devices, temperature monitoring strips, meropenem for infusion, ertapenem internal standard and ice bricks were provided free of charge by Baxter Healthcare, Timestrip UK Ltd, Ranbaxy Australia Pty Ltd, Merck & Co., Inc. and Interaction Branding Pty Ltd, respectively. TD was supported by a National Health and Medical Research Council of Australia Practitioner Fellowship. Internal funding for this work was provided by the School of Medicine and Pharmacology, University of Western Australia and the Department of Infectious Diseases, Fremantle Hospital and Health Service. Additional funding for the development of the meropenem assays was provided through a National Health and Medical Research Council of Australia project grants 634343 and 101212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardin C., 2011, Annales Pharmaceutiques Francaises, V69, P221, DOI 10.1016/j.pharma.2011.07.002; Berthoin K, 2010, J ANTIMICROB CHEMOTH, V65, P1073, DOI 10.1093/jac/dkq044; Bureau of Meteorology, 2013, CLIM STAT AUSTR LOC; CLSI, 2012, M100S22 CLSI; Esposito S, 2004, INT J ANTIMICROB AG, V24, P473, DOI 10.1016/j.ijantimicag.2004.06.004; FDA, 2009, GUID IND DRUG IND LI; Franceschi L, 2014, THERAPEUTIC DRUG MON; Ingram PR, 2008, J ANTIMICROB CHEMOTH, V62, P168, DOI 10.1093/jac/dkn080; Jaruratanasirikul Sutep, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P627; Kuti JL, 2004, CLIN THER, V26, P493, DOI 10.1016/S0149-2918(04)90051-3; Li CH, 2006, J CLIN PHARMACOL, V46, P1171, DOI 10.1177/0091270006291035; Mendez A, 2008, INT J PHARMACEUT, V350, P95, DOI 10.1016/j.ijpharm.2007.08.023; Nicolau DP, 2008, CLIN INFECT DIS, V47, pS32, DOI 10.1086/590064; Norton K, 2013, INTERN MED J, V43, P954, DOI 10.1111/imj.12213; Norton K, 2013, J ANTIMICRO IN PRESS; Patel PR, 1997, AM J HEALTH-SYST PH, V54, P412, DOI 10.1093/ajhp/54.4.412; Peralta FG, 2003, CLIN INFECT DIS, V37, P1568, DOI 10.1086/379519; Prescott William A Jr, 2011, P T, V36, P723; Smith DL, 2004, AM J HEALTH-SYST PH, V61, P1682, DOI 10.1093/ajhp/61.16.1682; Tice AD, 2004, CLIN INFECT DIS, V38, P1651, DOI 10.1086/420939; Viaene E, 2002, ANTIMICROB AGENTS CH, V46, P2327, DOI 10.1128/AAC.46.8.2327-2332.2002	21	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102023	10.1371/journal.pone.0102023	http://dx.doi.org/10.1371/journal.pone.0102023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019523	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600037
J	Wang, O; Zachmann, LJ; Sesnie, SE; Olsson, AD; Dickson, BG				Wang, Ophelia; Zachmann, Luke J.; Sesnie, Steven E.; Olsson, Aaryn D.; Dickson, Brett G.			An Iterative and Targeted Sampling Design Informed by Habitat Suitability Models for Detecting Focal Plant Species over Extensive Areas	PLOS ONE			English	Article							INVASIVE PLANT; BRASSICA-TOURNEFORTII; CLIMATE-CHANGE; MOJAVE DESERT; FIRE; GRASS; DISTRIBUTIONS; DISPERSAL; ECOLOGY; ABSENCE	Prioritizing areas for management of non-native invasive plants is critical, as invasive plants can negatively impact plant community structure. Extensive and multi-jurisdictional inventories are essential to prioritize actions aimed at mitigating the impact of invasions and changes in disturbance regimes. However, previous work devoted little effort to devising sampling methods sufficient to assess the scope of multi-jurisdictional invasion over extensive areas. Here we describe a large-scale sampling design that used species occurrence data, habitat suitability models, and iterative and targeted sampling efforts to sample five species and satisfy two key management objectives: 1) detecting non-native invasive plants across previously unsampled gradients, and 2) characterizing the distribution of non-native invasive plants at landscape to regional scales. Habitat suitability models of five species were based on occurrence records and predictor variables derived from topography, precipitation, and remotely sensed data. We stratified and established field sampling locations according to predicted habitat suitability and phenological, substrate, and logistical constraints. Across previously unvisited areas, we detected at least one of our focal species on 77% of plots. In turn, we used detections from 2011 to improve habitat suitability models and sampling efforts in 2012, as well as additional spatial constraints to increase detections. These modifications resulted in a 96% detection rate at plots. The range of habitat suitability values that identified highly and less suitable habitats and their environmental conditions corresponded to field detections with mixed levels of agreement. Our study demonstrated that an iterative and targeted sampling framework can address sampling bias, reduce time costs, and increase detections. Other studies can extend the sampling framework to develop methods in other ecosystems to provide detection data. The sampling methods implemented here provide a meaningful tool when understanding the potential distribution and habitat of species over multi-jurisdictional and extensive areas is needed for achieving management objectives.	[Wang, Ophelia; Zachmann, Luke J.; Sesnie, Steven E.; Olsson, Aaryn D.; Dickson, Brett G.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Lab Landscape Ecol & Conservat Biol, Flagstaff, AZ 86011 USA; [Zachmann, Luke J.; Dickson, Brett G.] Conservat Sci Partners Inc, Truckee, CA USA; [Sesnie, Steven E.] US Fish & Wildlife Serv, Albuquerque, NM USA	Northern Arizona University; United States Department of the Interior; US Fish & Wildlife Service	Wang, O (corresponding author), No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Lab Landscape Ecol & Conservat Biol, Flagstaff, AZ 86011 USA.	Ophelia.Wang@nau.edu			U.S. Department of Defense, through the Strategic Environmental Research and Development Program (SERDP) [RC-1722]; Joint Fire Science Program (JFSP) [10-1-04-7]	U.S. Department of Defense, through the Strategic Environmental Research and Development Program (SERDP)(United States Department of Defense); Joint Fire Science Program (JFSP)	This research was supported by the U.S. Department of Defense, through the Strategic Environmental Research and Development Program (SERDP; project RC-1722), and by the Joint Fire Science Program (JFSP; project ID 10-1-04-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella SR, 2012, INVAS PLANT SCI MANA, V5, P47, DOI 10.1614/IPSM-D-11-00030.1; Abella SR, 2009, ENVIRON MONIT ASSESS, V151, P221, DOI 10.1007/s10661-008-0263-0; Andrew ME, 2009, DIVERS DISTRIB, V15, P627, DOI 10.1111/j.1472-4642.2009.00568.x; Anonymous, 2005, Transactions of the Kansas Academy of Science, V108, P83, DOI 10.1660/0022-8443(2005)108[0083:DIAHOS]2.0.CO;2; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Barnett DT, 2007, ENVIRON MONIT ASSESS, V132, P235, DOI 10.1007/s10661-006-9530-0; Barrows CW, 2009, BIOL INVASIONS, V11, P673, DOI 10.1007/s10530-008-9282-6; Bass DA, 2006, EUPHYTICA, V148, P97, DOI 10.1007/s10681-006-5944-6; Bowers Janice E., 2006, Madrono, V53, P252, DOI 10.3120/0024-9637(2006)53[252:TDOCID]2.0.CO;2; Bradley BA, 2010, ECOGRAPHY, V33, P198, DOI 10.1111/j.1600-0587.2009.05684.x; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Brown DE, 1994, BIOTIC COMMUNITIES S; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chen DM, 2002, PHOTOGRAMM ENG REM S, V68, P1155; Crall AW, 2013, ECOL APPL, V23, P60, DOI 10.1890/12-0465.1; Crossman ND, 2011, ECOL INDIC, V11, P183, DOI 10.1016/j.ecolind.2008.10.011; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Dorazio RM, 2012, BIOMETRICS, V68, P1303, DOI 10.1111/j.1541-0420.2012.01779.x; Edwards TC, 2005, ECOLOGY, V86, P1081, DOI 10.1890/04-0608; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Esque TC, 2002, AZ S DES M, P165; Forseth IN, 2004, CRIT REV PLANT SCI, V23, P401, DOI 10.1080/07352680490505150; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Gavier-Pizarro GI, 2010, LANDSCAPE ECOL, V25, P1505, DOI 10.1007/s10980-010-9516-8; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; Hefley T, 2013, METHODS ECOL EVOL, DOI [10.1111/2041-1210X.12144, DOI 10.1111/2041-1210X.12144]; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Ibanez I, 2014, ECOL APPL, V24, P25, DOI 10.1890/13-0776.1; Jackson J, 2005, AUSTRAL ECOL, V30, P505, DOI 10.1111/j.1442-9993.2005.01465.x; Joly M, 2011, ENVIRON MANAGE, V48, P514, DOI 10.1007/s00267-011-9711-7; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Kalkhan MA, 2007, DIVERS DISTRIB, V13, P379, DOI 10.1111/j.1472-4642.2007.00333.x; Kerns BK, 2009, INVAS PLANT SCI MANA, V2, P200, DOI 10.1614/IPSM-08-120.1; Le Lay G, 2010, ECOGRAPHY, V33, P1015, DOI 10.1111/j.1600-0587.2010.06338.x; Manier DJ, 2014, RANGELAND ECOL MANAG, V67, P160, DOI 10.2111/REM-D-12-00056.1; Maxwell BD, 2012, INVAS PLANT SCI MANA, V5, P178, DOI 10.1614/IPSM-D-11-00022.1; McDonald CJ, 2011, RANGELAND ECOL MANAG, V64, P384, DOI 10.2111/REM-D-10-00036.1; MCLAUGHLIN SP, 1982, ECOLOGY, V63, P246, DOI 10.2307/1937048; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morisette JT, 2006, FRONT ECOL ENVIRON, V4, P11, DOI 10.1890/1540-9295(2006)004[0012:ATHSMF]2.0.CO;2; Olsson AD, 2012, DIVERS DISTRIB, V18, P10, DOI 10.1111/j.1472-4642.2011.00825.x; Philippi T, 2005, ECOLOGY, V86, P1091, DOI 10.1890/04-0621; Phillips S, 2009, BRIEF TUTORIAL MAXEN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Rew LJ, 2007, CAN J PLANT SCI, V87, P1029, DOI 10.4141/CJPS07121; Rew LJ, 2006, BIOL INVASIONS, V8, P523, DOI 10.1007/s10530-005-6420-2; Rorabaugh JC, 2010, SW DESERT RESOURCES, P181; Sanchez-Flores E, 2007, ECOL MODEL, V204, P457, DOI 10.1016/j.ecolmodel.2007.02.002; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Steers RJ, 2010, RESTOR ECOL, V18, P334, DOI 10.1111/j.1526-100X.2009.00622.x; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens J., 2009, Ecological Restoration, V27, P417, DOI 10.3368/er.27.4.417; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; Suazo AA, 2012, BIOL INVASIONS, V14, P215, DOI 10.1007/s10530-011-9998-6; Sullivan WP, 2008, J GREAT LAKES RES, V34, P86, DOI 10.3394/0380-1330(2008)34[86:ACSEDO]2.0.CO;2; SWETNAM TW, 1990, USDA ROCKY, V191, P6; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tellman B, 2002, INVASIVE EXOTIC SPEC; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; Trader Melissa R., 2006, Madrono, V53, P313, DOI 10.3120/0024-9637(2006)53[313:SPBTNB]2.0.CO;2; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Van Devender T.R., 1997, P CAL EX PEST PLANT, P1; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Wang L, 2013, PROF GEOGR, V65, P1, DOI 10.1080/00330124.2012.679440; Williams NSG, 2008, ECOL APPL, V18, P347, DOI 10.1890/07-0868.1; Xu YG, 2009, PHOTOGRAMM ENG REM S, V75, P313, DOI 10.14358/PERS.75.3.313; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	79	8	8	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101196	10.1371/journal.pone.0101196	http://dx.doi.org/10.1371/journal.pone.0101196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019621	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600011
J	Eggert, D; Rosch, K; Reimer, R; Herker, E				Eggert, Dennis; Roesch, Kathrin; Reimer, Rudolph; Herker, Eva			Visualization and Analysis of Hepatitis C Virus Structural Proteins at Lipid Droplets by Super-Resolution Microscopy	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; CORE PROTEIN; FLUORESCENCE MICROSCOPY; DIACYLGLYCEROL ACYLTRANSFERASE-1; RESOLUTION LIMIT; CELL-CULTURE; LOCALIZATION; REPLICATION; ASSOCIATION; DETERMINANT	Cytosolic lipid droplets are central organelles in the Hepatitis C Virus (HCV) life cycle. The viral capsid protein core localizes to lipid droplets and initiates the production of viral particles at lipid droplet-associated ER membranes. Core is thought to encapsidate newly synthesized viral RNA and, through interaction with the two envelope proteins E1 and E2, bud into the ER lumen. Here, we visualized the spatial distribution of HCV structural proteins core and E2 in vicinity of small lipid droplets by three-color 3D super-resolution microscopy. We observed and analyzed small areas of colocalization between the two structural proteins in HCV-infected cells with a diameter of approximately 100 nm that might represent putative viral assembly sites.	[Eggert, Dennis; Roesch, Kathrin; Reimer, Rudolph; Herker, Eva] Univ Hamburg, Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Eggert, Dennis] Univ Hamburg, Inst Phys Chem, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University of Hamburg	Herker, E (corresponding author), Univ Hamburg, Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	eva.herker@hpi.uni-hamburg.de	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484	Free and Hanseatic City of Hamburg; Federal Ministry of Health	Free and Hanseatic City of Hamburg; Federal Ministry of Health	The Heinrich Pette Institute, Leibniz Institute for Experimental Virology is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Eggert D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04159; Flottmann B, 2013, BIOTECHNIQUES, V55, P245, DOI 10.2144/000114099; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Han JJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016011; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Pereira CF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-84; Popescu CI, 2011, VIRUSES-BASEL, V3, P2238, DOI 10.3390/v3112238; Rouille Y, 2006, J CLIN VIROL, V36, pS53, DOI 10.1016/S1386-6532(06)80164-2; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wakita T, 2009, PRODUCTION USE EPITO; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697	42	19	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102511	10.1371/journal.pone.0102511	http://dx.doi.org/10.1371/journal.pone.0102511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25019511	Green Submitted, gold, Green Published			2022-12-27	WOS:000339378400100
J	Gray, TJ; Kong, FR; Jelfs, P; Sintchenko, V; Chen, SCA				Gray, Timothy J.; Kong, Fanrong; Jelfs, Peter; Sintchenko, Vitali; Chen, Sharon C. -A.			Improved Identification of Rapidly Growing Mycobacteria by a 16S-23S Internal Transcribed Spacer Region PCR and Capillary Gel Electrophoresis	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RIBOSOMAL-RNA; CLARITHROMYCIN RESISTANCE; ABSCESSUS GROUP; MASSILIENSE; AMPLIFICATION; INFECTION; SEQUENCES; DIFFERENTIATION	The identification of rapidly growing mycobacteria (RGM) remains problematic because of evolving taxonomy, limitations of current phenotypic methods and absence of a universal gene target for reliable speciation. This study evaluated a novel method of identification of RGM by amplification of the mycobacterial 16S-23S rRNA internal transcribed spacer (ITS) followed by resolution of amplified fragments by capillary gel electrophoresis (CGE). Nineteen American Type Culture Collection (ATCC) Mycobacterium strains and 178 clinical isolates of RGM (12 species) were studied. All RGM ATCC strains generated unique electropherograms with no overlap with slowly growing mycobacteria species, including M. tuberculosis. A total of 47 electropherograms for the 178 clinical isolates were observed allowing the speciation of 175/178 (98.3%) isolates, including the differentiation of the closely related species, M. massiliense (M. abscessus subspecies bolletii) and M. abscessus (M. abscessus sensu stricto). ITS fragment size ranged from 332 to 534 bp and 33.7% of clinical isolates generated electropherograms with two distinct peaks, while the remainder where characterized with a single peak. Unique peaks (fragment lengths) were identified for 11/12 (92%) RGM species with only M. moriokaense having an indistinguishable electropherogram from a rarely encountered CGE subtype of M. fortuitum. We conclude that amplification of the 16S-23S ITS gene region followed by resolution of fragments by CGE is a simple, rapid, accurate and reproducible method for species identification and characterization of the RGM.	[Gray, Timothy J.; Kong, Fanrong; Jelfs, Peter; Sintchenko, Vitali; Chen, Sharon C. -A.] Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Sintchenko, Vitali; Chen, Sharon C. -A.] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Westmead, NSW 2145, Australia; [Sintchenko, Vitali; Chen, Sharon C. -A.] Univ Sydney, Sydney Med Sch, Marie Bashir Inst Emerging Infect & Biosecur, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Gray, TJ (corresponding author), Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia.	tim.gray@tpg.com.au		Sintchenko, Vitali/0000-0002-9261-3650	Westmead Research Network	Westmead Research Network	This work was supported by a grant provided by the Westmead Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751; Brown-Elliot BA, 2011, MANUAL CLIN MICROBIO, P525; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Choi GE, 2012, AM J RESP CRIT CARE, V186, P917, DOI 10.1164/rccm.201111-2005OC; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2940 CLSI; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; Han XY, 2007, AM J CLIN PATHOL, V128, P612, DOI 10.1309/1KB2GKYT1BUEYLB5; Harada T, 2012, J CLIN MICROBIOL, V50, P3556, DOI 10.1128/JCM.01175-12; Heydari H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062443; Hoffmann M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-90; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Iwamoto T, 2002, J CLIN MICROBIOL, V40, P4705, DOI 10.1128/JCM.40.12.4705-4712.2002; Katoch VM, 2007, INDIAN J MED RES, V125, P155; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Macheras E, 2009, J CLIN MICROBIOL, V47, P2596, DOI 10.1128/JCM.00037-09; Pignone M, 2006, J CLIN MICROBIOL, V44, P1963, DOI 10.1128/JCM.01959-05; Redelman-Sidi G, 2010, CLIN INFECT DIS, V51, P422, DOI 10.1086/655140; Roth A, 2000, J CLIN MICROBIOL, V38, P1094, DOI 10.1128/JCM.38.3.1094-1104.2000; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; Saleeb PG, 2011, J CLIN MICROBIOL, V49, P1790, DOI 10.1128/JCM.02135-10; Sassi M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-3; Shallom SJ, 2013, J CLIN MICROBIOL, V51, P2943, DOI 10.1128/JCM.01132-13; Shin SJ, 2013, CLIN INFECT DIS, V57, P32, DOI 10.1093/cid/cit172; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Stout JE, 2011, CLIN INFECT DIS, V53, P787, DOI 10.1093/cid/cir539; Teng SH, 2013, J CLIN MICROBIOL, V51, P3113, DOI 10.1128/JCM.01239-13; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Wallace RJ, 1996, ANTIMICROB AGENTS CH, V40, P1676, DOI 10.1128/AAC.40.7.1676; Wehrhahn MC, 2012, J CLIN MICROBIOL, V50, P3478, DOI 10.1128/JCM.01311-12; Xiao M, 2012, J CLIN MICROBIOL, V50, P2755, DOI 10.1128/JCM.00777-12; Xiong LK, 2006, J CLIN MICROBIOL, V44, P3544, DOI 10.1128/JCM.00633-06	35	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102290	10.1371/journal.pone.0102290	http://dx.doi.org/10.1371/journal.pone.0102290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013955	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400084
J	Ha, BG; Park, JE; Shin, EJ; Shon, YH				Ha, Byung Geun; Park, Jung-Eun; Shin, Eun Ji; Shon, Yun Hee			Modulation of Glucose Metabolism by Balanced Deep-Sea Water Ameliorates Hyperglycemia and Pancreatic Function in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; MAGNESIUM; MELLITUS; CELLS; AMPK; SUPPLEMENTATION; DYSFUNCTION; OBESITY; TISSUE	The aim of this study was to determine the effects of balanced deep-sea water (BDSW) on hyperglycemia and glucose intolerance in streptozotocin (STZ)-induced diabetic mice. BDSW was prepared by mixing DSW mineral extracts and desalinated water to yield a final hardness of 1000-4000 ppm. Male ICR mice were assigned to 6 groups; mice in each group were given tap water (normal and STZ diabetic groups) or STZ with BDSW of varying hardness (0, 1000, 2000, and 4000 ppm) for 4 weeks. The STZ with BDSW group exhibited lowered fasting plasma glucose levels than the STZ-induced diabetic group. Oral glucose tolerance tests showed that BDSW improves impaired glucose tolerance in STZ-induced diabetic mice. Histopathological evaluation of the pancreas showed that BDSW restores the morphology of the pancreatic islets of Langerhans and increases the secretion of insulin in STZ-induced diabetic mice. Quantitative real-time PCR assay revealed that the expression of hepatic genes involved in gluconeogenesis, glucose oxidation, and glycogenolysis was suppressed, while the expression of the genes involved in glucose uptake, beta-oxidation, and glucose oxidation in muscle were increased in the STZ with BDSW group. BDSW stimulated PI3-K, AMPK, and mTOR pathway-mediated glucose uptake in C2C12 myotubes. BDSW increased AMPK phosphorylation in C2C12 myotubes and improved impaired AMPK phosphorylation in the muscles of STZ-induced diabetic mice. Taken together, these results suggest that BDSW is a potential anti-diabetic agent, owing to its ability to suppress hyperglycemia and improve glucose intolerance by modulating glucose metabolism, recovering pancreatic islets of Langerhans and increasing glucose uptake.	[Ha, Byung Geun; Park, Jung-Eun; Shin, Eun Ji; Shon, Yun Hee] Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea	Kyungpook National University; Kyungpook National University Hospital	Shon, YH (corresponding author), Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea.	yhshon@hmail.knu.ac.kr			Ministry of Oceans and Fisheries of the Republic of Korea	Ministry of Oceans and Fisheries of the Republic of Korea	This research was supported by a grant (technical development for supporting the DSW industry) from the Ministry of Oceans and Fisheries of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak JP, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-108; Chen IS, 2013, J CHIN MED ASSOC, V76, P95, DOI 10.1016/j.jcma.2012.10.008; Clark TA, 2014, HEART FAIL REV, V19, P123, DOI 10.1007/s10741-013-9380-0; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Fu ZY, 2012, J MED FOOD, V15, P535, DOI 10.1089/jmf.2011.2007; Gu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081724; Gu P, 2013, REV ENDOCR METAB DIS, V14, P49, DOI 10.1007/s11154-012-9230-8; Ha BG, 2014, OBESITY, V22, P1669, DOI 10.1002/oby.20740; Ha BG, 2013, MAR DRUGS, V11, P4193, DOI 10.3390/md11114193; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hata A, 2013, DIABETIC MED, V30, P1487, DOI 10.1111/dme.12250; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; Hruby A, 2013, NUTRIENTS, V5, P4990, DOI 10.3390/nu5124990; Hwang HS, 2009, MAR BIOTECHNOL, V11, P531, DOI 10.1007/s10126-008-9171-0; Jung DW, 2011, MOL BIOSYST, V7, P346, DOI 10.1039/c0mb00089b; Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Kundu Dipankar, 2013, J Nat Sci Biol Med, V4, P113, DOI 10.4103/0976-9668.107270; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055106; Mostafavi E, 2013, CLIN HEMORHEOL MICRO, V53, P239, DOI 10.3233/CH-2012-1546; Nagai N, 2013, J OLEO SCI, V62, P403, DOI 10.5650/jos.62.403; Ozturk N, 2013, WORLD J DIABETES, V4, P92, DOI 10.4239/wjd.v4.i4.92; Potter KJ, 2014, DIABETES, V63, P12, DOI 10.2337/db12-0364; Ramalingam L, 2013, CELL MOL LIFE SCI, V70, P2815, DOI 10.1007/s00018-012-1176-1; Sales CH, 2014, CLIN NUTR, V33, P879, DOI 10.1016/j.clnu.2013.10.004; Sarmento RA, 2013, ARQ BRAS CARDIOL, V101, P240, DOI 10.5935/abc.20130146; Scherer T, 2013, ENDOCRIN METAB CLIN, V42, P109, DOI 10.1016/j.ecl.2012.11.002; Sheu MJ, 2013, MAR DRUGS, V11, P2183, DOI 10.3390/md11062183; Tahrani AA, 2010, PHARMACOL THERAPEUT, V125, P328, DOI 10.1016/j.pharmthera.2009.11.001; Via Michael, 2012, ISRN Endocrinol, V2012, P103472, DOI 10.5402/2012/103472; Volpe SL, 2013, ADV NUTR, V4, p378S, DOI 10.3945/an.112.003483; Wieser V, 2013, ARCH IMMUNOL THER EX, V61, P119, DOI 10.1007/s00005-012-0210-1; Xita N, 2012, CURR MED CHEM, V19, P5451, DOI 10.2174/092986712803833182; Xu JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056750; Yerlikaya FH, 2013, INDIAN J MED RES, V137, P339	36	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102095	10.1371/journal.pone.0102095	http://dx.doi.org/10.1371/journal.pone.0102095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013896	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400065
J	Malhotra, A; Kobes, S; Bogardus, C; Knowler, WC; Baier, LJ; Hanson, RL				Malhotra, Alka; Kobes, Sayuko; Bogardus, Clifton; Knowler, William C.; Baier, Leslie J.; Hanson, Robert L.			Assessing Accuracy of Genotype Imputation in American Indians	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMER-DISEASE; POWER	Background: Genotype imputation is commonly used in genetic association studies to test untyped variants using information on linkage disequilibrium (LD) with typed markers. Imputing genotypes requires a suitable reference population in which the LD pattern is known, most often one selected from HapMap. However, some populations, such as American Indians, are not represented in HapMap. In the present study, we assessed accuracy of imputation using HapMap reference populations in a genome-wide association study in Pima Indians. Results: Data from six randomly selected chromosomes were used. Genotypes in the study population were masked (either 1% or 20% of SNPs available for a given chromosome). The masked genotypes were then imputed using the software Markov Chain Haplotyping Algorithm. Using four HapMap reference populations, average genotype error rates ranged from 7.86% for Mexican Americans to 22.30% for Yoruba. In contrast, use of the original Pima Indian data as a reference resulted in an average error rate of 1.73%. Conclusions: Our results suggest that the use of HapMap reference populations results in substantial inaccuracy in the imputation of genotypes in American Indians. A possible solution would be to densely genotype or sequence a reference American Indian population.	[Malhotra, Alka; Kobes, Sayuko; Bogardus, Clifton; Knowler, William C.; Baier, Leslie J.; Hanson, Robert L.] NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ 85014 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Malhotra, A (corresponding author), NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ 85014 USA.	alka@niddk.nih.gov	Hanson, Robert L/O-3238-2015	Hanson, Robert L/0000-0002-4252-7068	National Institute of Diabetes and Digestive and Kidney Diseases; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069071, ZIADK075012, ZIADK069028, ZIADK069000] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and a mentor grant from the American Diabetes Association (Clifton Bogardus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Beecham GW, 2010, ANN HUM GENET, V74, P189, DOI 10.1111/j.1469-1809.2010.00573.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011018; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Malhotra A, 2011, OBESITY, V19, P2102, DOI 10.1038/oby.2011.178; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Pei YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010827; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ragoussis J, 2009, ANNU REV GENOM HUM G, V10, P117, DOI 10.1146/annurev-genom-082908-150116; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102544	10.1371/journal.pone.0102544	http://dx.doi.org/10.1371/journal.pone.0102544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014012	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400103
J	Wen, QY; Li, J; Wang, WY; Xie, GY; Xu, LN; Luo, JD; Chu, SZ; She, L; Li, D; Huang, DH; Fan, SQ				Wen, Qiuyuan; Li, Jiao; Wang, Weiyuan; Xie, Guiyuan; Xu, Lina; Luo, Jiadi; Chu, Shuzhou; She, Lei; Li, Duo; Huang, Donghai; Fan, Songqing			Increased Expression of Flotillin-2 Protein as a Novel Biomarker for Lymph Node Metastasis in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							E-CADHERIN; PROGRESSION; CANCER; IDENTIFICATION; MELANOMA; SURVIVAL; ADHESION; CELLS; NGX6	Nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor rare throughout most of the world but common in Southeast Asia, especially in Southern China. Flotillin-2 (Flot-2) is not only an important component of cellular membrane, but also involves in various cellular processes such as membrane trafficking, T cell and B cell activation, regulation of several signaling pathways associated with cell growth and malignant transformation, keeping structure and junction of epidermal cells and formation of filopodia. Although such molecular effects of Flot-2 have been reported, whether the expression of Flot-2 protein is associated with clinicopathologic implication for NPC has not been reported. The purpose of this research is to investigate the expression of Flot-2 protein in NPC and control nasopharyngeal epithelial tissues by immunohistochemistry and elucidate the association between the expression of Flot-2 protein and clinicopathological characteristics of NPC. The results showed that the positive percentage of Flot-2 expression in the NPC, nasopharyngeal epithelia with atypical hyperplasia and in the control nasopharyngeal mucosa epithelia was 88.8% (119/134), 76.9% (10/13) and 5.7% (5/88), respectively. There was significantly higher expression of Flot-2 protein in NPC and nasopharyngeal epithelia with atypical hyperplasia compared to the control nasopharyngeal mucosa epithelia (P<0.001, respectively). The positive percentage of Flot-2 protein expression in NPC patients with lymph node metastasis was significantly higher than those without lymph node metastasis. Increasing of Flot-2 expression was obviously correlated with clinical stages of NPC patients. The expression of Flot-2 was proved to be the independent predicted factor for lymph node metastasis by multivariate analysis. The sensitivity of Flot-2 for predicting lymph node metastasis of NPC patients was 93%. Taken together, our results suggest that the increased expression of Flot-2 protein is a novel higher sensitivity biomarker that can predict lymph node metastases in NPC.	[Wen, Qiuyuan; Li, Jiao; Wang, Weiyuan; Xu, Lina; Luo, Jiadi; Chu, Shuzhou; She, Lei; Li, Duo; Fan, Songqing] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xie, Guiyuan] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China; [Huang, Donghai] Cent S Univ, Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Fan, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	fansongqing2003@hotmail.com	xu, li/GNH-3667-2022		National Natural Sciences Foundations of China [81071820, 81201523, 81272566, 81372906]	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Sciences Foundations of China (NO: 81071820, 81201523, 81272566 and 81372906), http://isisn.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Berger T, 2013, ONCOGENE, V32, P4989, DOI 10.1038/onc.2012.499; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Hazarika P, 1999, J CELL BIOCHEM, V75, P147, DOI 10.1002/(SICI)1097-4644(19991001)75:1<147::AID-JCB15>3.0.CO;2-D; Hwang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084218; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lee CC, 2008, CLIN OTOLARYNGOL, V33, P442, DOI 10.1111/j.1749-4486.2008.01770.x; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Pei XJ, 2014, INT J MED SCI, V11, P106, DOI 10.7150/ijms.7264; Peng SP, 2006, ONCOLOGY-BASEL, V71, P273, DOI 10.1159/000106073; Peng SP, 2007, CANCER SCI, V98, P341, DOI 10.1111/j.1349-7006.2007.00410.x; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; Shen Zhi-Hua, 2008, Ai Zheng, V27, P165; Solis GP, 2013, INT J MOL SCI, V14, P5130, DOI 10.3390/ijms14035130; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Wang X, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-190; Xu L, 2013, HUM PATHOL, V44, P1357, DOI 10.1016/j.humpath.2012.10.025; Xuan SH, 2013, CANCER BIOMARK, V13, P323, DOI 10.3233/CBM-130361; Yang XY, 2005, CELL ONCOL, V27, P215; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089220; Zhu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062365	28	18	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101676	10.1371/journal.pone.0101676	http://dx.doi.org/10.1371/journal.pone.0101676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014228	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400030
J	Molfese, C; Beare, D; Hall-Spencer, JM				Molfese, Carlotta; Beare, Doug; Hall-Spencer, Jason M.			Overfishing and the Replacement of Demersal Finfish by Shellfish: An Example from the English Channel	PLOS ONE			English	Article							MARINE FOOD WEBS; TROPHIC LEVEL; TOP-DOWN; FISHERIES; ECOSYSTEM; SEA	The worldwide depletion of major fish stocks through intensive industrial fishing is thought to have profoundly altered the trophic structure of marine ecosystems. Here we assess changes in the trophic structure of the English Channel marine ecosystem using a 90-year time-series (1920-2010) of commercial fishery landings. Our analysis was based on estimates of the mean trophic level (mTL) of annual landings and the Fishing-in-Balance index (FiB). Food webs of the Channel ecosystem have been altered, as shown by a significant decline in the mTL of fishery landings whilst increases in the FiB index suggest increased fishing effort and fishery expansion. Large, high trophic level species (e. g. spurdog, cod, ling) have been increasingly replaced by smaller, low trophic level fish (e. g. small spotted catsharks) and invertebrates (e. g. scallops, crabs and lobster). Declining trophic levels in fisheries catches have occurred worldwide, with fish catches progressively being replaced by invertebrates. We argue that a network of fisheries closures would help rebalance the trophic status of the Channel and allow regeneration of marine ecosystems.	[Molfese, Carlotta; Hall-Spencer, Jason M.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Beare, Doug] Worldfish, Batu Maung, Penang, Malaysia	University of Plymouth; CGIAR; Worldfish	Molfese, C (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	carlotta0911@gmail.com	Hall-Spencer, Jason/AFN-7866-2022	Hall-Spencer, Jason/0000-0002-6915-2518				Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; [Anonymous], 1984, 5 STANF U LAB COMP S; [Anonymous], EC FISH COOP B; Arancibia H, 2005, SCI MAR, V69, P295, DOI 10.3989/scimar.2005.69n2295; Baeta F, 2009, FISH RES, V97, P216, DOI 10.1016/j.fishres.2009.02.006; Baisre JA, 2000, 394 FAO FISH; Beare D, 2010, NATURWISSENSCHAFTEN, V97, P797, DOI 10.1007/s00114-010-0696-5; Bhathal B, 2008, FISH RES, V91, P26, DOI 10.1016/j.fishres.2007.10.022; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Dauvin JC, 2012, MAR POLLUT BULL, V64, P463, DOI 10.1016/j.marpolbul.2011.12.010; Engelhard GH, CHARM 3 PROJECT; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Freire KMF, 2010, FISH RES, V105, P57, DOI 10.1016/j.fishres.2010.02.008; Garstang W., 1900, J MAR BIOL ASSOC UK, V6, P1, DOI [10.1017/S0025315400072374, DOI 10.1017/S0025315400072374]; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Genner MJ, 2001, ARCHIVING ANAL MBA B, P1; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hawkins SJ, 2003, SCI TOTAL ENVIRON, V310, P245, DOI 10.1016/S0048-9697(02)00645-9; Heath MR, 2012, AQUAT CONSERV, V22, P337, DOI 10.1002/aqc.2244; Howarth LM, 2014, FISH FISH, V15, P690, DOI 10.1111/faf.12041; ICES, 2010, ICES CATCH STAT 1903; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaureguizar AJ, 2008, SCI MAR, V72, P25; Jones PJS, 2012, ENVIRON CONSERV, V39, P248, DOI 10.1017/S0376892912000136; Kleisner K, 2011, FISHERIES CTR RES RE, V19, P41; Marine Management Organization, 2010, FISH STAT; McHugh M, 2011, J SEA RES, V65, P187, DOI 10.1016/j.seares.2010.09.006; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; O'Leary BC, 2011, MAR POLLUT BULL, V62, P2642, DOI 10.1016/j.marpolbul.2011.09.032; Pauly D, 2003, LAR MAR ECOSYST, V12, P337; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D., 2000, CIESM WORKSHOP SERIE, V12, P61; Pauly D., 2003, PERFECT OCEAN STATE; Pew Charitable Trust, 1999, SEA AROUND US PROJ; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Pinnegar JK, 2002, J APPL ECOL, V39, P377, DOI 10.1046/j.1365-2664.2002.00723.x; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts C., 2007, UNNATURAL HIST SEA F; Robinson LA, 2008, AMBIO, V37, P362, DOI 10.1579/07-A-300.1; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Sheehan EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083883; SOUTHWARD AJ, 1988, J MAR BIOL ASSOC UK, V68, P423, DOI 10.1017/S0025315400043320; Stanford Robert, 2004, University of British Columbia Fisheries Centre Research Reports, V12, P1; Stergiou K, 2005, STATE HELLENIC MARIN, P326; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; Thurstan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011767; Valtysson Hthorn, 2003, COMPETITIVENESS GLOB, P12; Walker PA, 1998, ICES J MAR SCI, V55, P392, DOI 10.1006/jmsc.1997.0325; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	50	35	36	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101506	10.1371/journal.pone.0101506	http://dx.doi.org/10.1371/journal.pone.0101506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010196	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800027
J	Mishra, S; Pickles, M; Blanchard, JF; Moses, S; Shubber, Z; Boily, MC				Mishra, Sharmistha; Pickles, Michael; Blanchard, James F.; Moses, Stephen; Shubber, Zara; Boily, Marie-Claude			Validation of the Modes of Transmission Model as a Tool to Prioritize HIV Prevention Targets: A Comparative Modelling Analysis	PLOS ONE			English	Article							FEMALE SEX WORKERS; SEXUALLY-TRANSMITTED INFECTIONS; POLLING BOOTH SURVEYS; RISK-FACTORS; CORE GROUP; PREVALENCE; CLIENTS; CITIES; URBAN; KENYA	Background: The static Modes of Transmission (MOT) model predicts the annual fraction of new HIV infections acquired across subgroups (MOT metric), and is used to focus HIV prevention. Using synthetic epidemics via a dynamical model, we assessed the validity of the MOT metric for identifying epidemic drivers (behaviours or subgroups that are sufficient and necessary for HIV to establish and persist), and the potential consequence of MOT-guided policies. Methods and Findings: To generate benchmark MOT metrics for comparison, we simulated three synthetic epidemics (concentrated, mixed, and generalized) with different epidemic drivers using a dynamical model of heterosexual HIV transmission. MOT metrics from generic and complex MOT models were compared against the benchmark, and to the contribution of epidemic drivers to overall HIV transmission (cumulative population attributable fraction over t years, PAF(t)). The complex MOT metric was similar to the benchmark, but the generic MOT underestimated the fraction of infections in epidemic drivers. The benchmark MOT metric identified epidemic drivers early in the epidemics. Over time, the MOT metric did not identify epidemic drivers. This was not due to simplified MOT models or biased parameters but occurred because the MOT metric (irrespective of the model used to generate it) underestimates the contribution of epidemic drivers to HIV transmission over time (PAF(5-30)). MOT-directed policies that fail to reach epidemic drivers could undermine long-term impact on HIV incidence, and achieve a similar impact as random allocation of additional resources. Conclusions: Irrespective of how it is obtained, the MOT metric is not a valid stand-alone tool to identify epidemic drivers, and has limited additional value in guiding the prioritization of HIV prevention targets. Policy-makers should use the MOT model judiciously, in combination with other approaches, to identify epidemic drivers.	[Mishra, Sharmistha; Pickles, Michael; Shubber, Zara; Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Mishra, Sharmistha] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Blanchard, James F.; Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada	Imperial College London; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Manitoba	Mishra, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	sharmistha.mishra08@imperial.ac.uk		Boily, Marie-Claude/0000-0003-3919-006X; Mishra, Sharmistha/0000-0001-8492-5470; Blanchard, James/0000-0002-4701-590X; Pickles, Michael/0000-0002-6754-3945	Canadian Institutes of Health Research Fellowship; Royal College of Physicians and Surgeons of Canada Detweiler Travelling Fellowship	Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); Royal College of Physicians and Surgeons of Canada Detweiler Travelling Fellowship	We thank Drs. Peter Vickerman (University of Bristol), Helen Ward (Imperial College), and Alex Welte (SACEMA), for helpful discussion and suggestions. S Mishra is supported by a Canadian Institutes of Health Research Fellowship and a Royal College of Physicians and Surgeons of Canada Detweiler Travelling Fellowship.	ANDERSON R M, 1991; Aral SO, 2012, SEX TRANSM INFECT, V88, P157, DOI 10.1136/sextrans-2011-050389; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Baral S, 2012, SAHARA J-J SOC ASP H, V9, P127, DOI 10.1080/17290376.2012.743787; Behanzin L, 2013, SEX TRANSM INFECT, V89, P595, DOI 10.1136/sextrans-2012-050884; Behrman J, 2011, SEXUAL TRANSMISSION; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Case KK, 2012, B WORLD HEALTH ORGAN, V90, P831, DOI 10.2471/BLT.12.102574; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Deering KN, 2008, AIDS, V22, pS165, DOI 10.1097/01.aids.0000343774.59776.95; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; India Health Action Trust, 2010, HIV AIDS SIT RESP KA; Karnataka Health Promotion Trust, 2008, FEM SEX WORK IBB CHA; Kenya National Aids Control Council, 2009, KEN HIV PREV RESP MO; Khobotlo M, 2009, LESOTHO HIV PREVENTI; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Lagarde E, 2001, AIDS, V15, pS71, DOI 10.1097/00002030-200108004-00008; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lowndes CM, 2012, AIDS BEHAV, V16, P1054, DOI 10.1007/s10461-011-0004-1; Maleta K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-243; Mishra S, 2011, INT SOC SEX TRANSM D, DOI [10.1136/sextrans-2011-050108.050584, DOI 10.1136/SEXTRANS-2011-050108.050584]; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050691; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032324; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Moses SA, 2006, AIDS S ASIA UNDERSTA; National AIDS Secretariat, 2010, KEN HIV PREV RESP MO; National Epidemiology Center Department of Health, 2010, SHORT TERM EST AD HI; Nnorom J, 2008, W AFRICA HIV AIDS EP; Pettifor A, 2011, SEX TRANSM DIS, V38, P324, DOI 10.1097/OLQ.0b013e31820a8b56; Prudden HJ, 2013, AIDS, V27, P2623, DOI 10.1097/01.aids.0000432476.22616.2f; Rabenau HF, 2010, SEX TRANSM DIS, V37, P454, DOI 10.1097/OLQ.0b013e3181cfcc2b; Rajaram S, 2008, HIV STISS BELGAUM DI; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shaw SY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S4; Shubber Z, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18928; Uganda National AIDS Commission, 2009, UG HIV MOD TRANSM PR; UNAIDS, 2010, GETT ZER 2011 2015 S; UNAIDS, 2007, MOD EXP SHORT TERM D; UNAIDS, 2013, REP GLOB AIDS EP; UNAIDS COPRESIDA & DIGECITSS, 2010, HIV MOD TRANSM MOD A; UNAIDS/GAMET, 2009, AN HIV PREV RESP MOD; Vandenhoudt HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054953; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Voeten HACM, 2002, SEX TRANSM DIS, V29, P444, DOI 10.1097/00007435-200208000-00003; Vuylsteke B, 2010, TROP MED INT HEALTH, V15, P1537, DOI 10.1111/j.1365-3156.2010.02654.x; Waterman N, 2008, J PUBLIC ADM, V43, P13; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Westercamp N, 2010, AIDS BEHAV, V14, P949, DOI 10.1007/s10461-008-9458-1; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	56	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101690	10.1371/journal.pone.0101690	http://dx.doi.org/10.1371/journal.pone.0101690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25014543	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600058
J	Jiga-Boy, GM; Toma, C; Corneille, O				Jiga-Boy, Gabriela M.; Toma, Claudia; Corneille, Olivier			Work More, Then Feel More: The Influence of Effort on Affective Predictions	PLOS ONE			English	Article							DURABILITY BIAS; SELF; INTENSITY; EMOTIONS	Two studies examined how effort invested in a task shapes the affective predictions related to potential success in that task, and the mechanism underlying this relationship. In Study 1, PhD students awaiting an editorial decision about a submitted manuscript estimated the effort they had invested in preparing that manuscript for submission and how happy they would feel if it were accepted. Subjective estimates of effort were positively related to participants' anticipated happiness, an effect mediated by the higher perceived quality of one's work. In other words, the more effort one though having invested, the happier one expected to feel if it were accepted, because one expected a higher quality manuscript. We replicated this effect and its underlying mediation in Study 2, this time using an experimental manipulation of effort in the context of creating an advertising slogan. Study 2 further showed that participants mistakenly thought their extra efforts invested in the task had improved the quality of their work, while independent judges had found no objective differences in quality between the outcomes of the high-and low-effort groups. We discuss the implications of the relationship between effort and anticipated emotions and the conditions under which such relationship might be functional.	[Jiga-Boy, Gabriela M.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Toma, Claudia] Tilburg Univ, Dept Social Psychol, NL-5000 LE Tilburg, Netherlands; [Corneille, Olivier] Catholic Univ Louvain, Dept Psychol, Louvain, Belgium	Swansea University; Tilburg University; Universite Catholique Louvain	Jiga-Boy, GM (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	G.Jiga@swansea.ac.uk		Corneille, Olivier/0000-0003-4005-4372	"Fonds de la Recherche Scientifique" (Belgium)	"Fonds de la Recherche Scientifique" (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The work reported in this paper was supported by funding from "Fonds de la Recherche Scientifique" (Belgium), awarded to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1963, J ABNORM PSYCHOL, V67, P422, DOI 10.1037/h0040968; AKERLOF GA, 1990, Q J ECON, V105, P255, DOI 10.2307/2937787; ARONSON E, 1959, J ABNORM SOC PSYCH, V59, P177, DOI 10.1037/h0047195; Baumgartner H, 2008, EUR J SOC PSYCHOL, V38, P685, DOI 10.1002/ejsp.467; Buehler R, 2001, PERS SOC PSYCHOL B, V27, P1480, DOI 10.1177/01461672012711009; COVINGTON MV, 1979, J EDUC PSYCHOL, V71, P169, DOI DOI 10.1037/0022-0663.71.2.169; Dunn E. W., 2006, HEARTS MINDS AFFECTI, P177; DUNNING D, 1990, J PERS SOC PSYCHOL, V58, P568, DOI 10.1037/0022-3514.58.4.568; Falk CF, 2010, SOC COGNITION, V28, P609, DOI 10.1521/soco.2010.28.5.609; Furnham A, 2003, PERS INDIV DIFFER, V34, P795, DOI 10.1016/S0191-8869(02)00072-7; Gilbert DT, 1998, J PERS SOC PSYCHOL, V75, P617, DOI 10.1037/0022-3514.75.3.617; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Greitemeyer T, 2009, PERS SOC PSYCHOL B, V35, P172, DOI 10.1177/0146167208326124; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hoerger M, 2012, COGNITION EMOTION, V26, P1098, DOI 10.1080/02699931.2011.631985; Huberts JCD, 2012, EUR J SOC PSYCHOL, V42, P490, DOI 10.1002/ejsp.861; Igou ER, 2008, J PERS SOC PSYCHOL, V95, P899, DOI 10.1037/a0011619; Jiga-Boy GM, 2010, PSYCHOL SCI, V21, P1811, DOI 10.1177/0956797610388043; Kruger J, 2004, J EXP SOC PSYCHOL, V40, P91, DOI 10.1016/S0022-1031(03)00065-9; Mathieu MT, 2012, PSYCHOL SCI, V23, P161, DOI 10.1177/0956797611427044; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Meyvis T, 2010, J EXP PSYCHOL GEN, V139, P579, DOI 10.1037/a0020285; Mischel W, 1996, SOCIAL PSYCHOL HDB B, P329; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Robins RW, 2001, J PERS SOC PSYCHOL, V80, P340, DOI 10.1037//0022-3514.80.2.340; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Van Boven L, 2009, J EXP PSYCHOL GEN, V138, P368, DOI 10.1037/a0016074; van Dijk WW, 1999, MOTIV EMOTION, V23, P203, DOI 10.1023/A:1021315314979; Weiner B., 1974, ACHIEVEMENT MOTIVATI; Wilson T, 2005, NETW COMPUT, V16, P14; Wilson TD, 2000, J PERS SOC PSYCHOL, V78, P821, DOI 10.1037/0022-3514.78.5.821; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Zhang Y, 2010, J EXP PSYCHOL GEN, V139, P16, DOI 10.1037/a0018143	34	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101512	10.1371/journal.pone.0101512	http://dx.doi.org/10.1371/journal.pone.0101512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25028961	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600017
J	Passos, C; Tassino, B; Reyes, F; Rosenthal, GG				Passos, Carlos; Tassino, Bettina; Reyes, Federico; Rosenthal, Gil G.			Seasonal Variation in Female Mate Choice and Operational Sex Ratio in Wild Populations of an Annual Fish, Austrolebias reicherti	PLOS ONE			English	Article							MATING PREFERENCES; COLOR POLYMORPHISM; BODY-SIZE; SELECTION; CYPRINODONTIFORMES; PLASTICITY; EVOLUTION; DENSITY; QUALITY; ROLES	The intensity of mating competition and the potential benefits for female of mating with certain males can be influenced by several extrinsic factors, such that behavioral decisions can be highly context-dependent. Short-lived species with a single reproductive season are a unique model to study context-sensitive mating decisions. Through exhaustive sampling in the field and simultaneous choice tests in the laboratory, we evaluated operational sex ratio (OSR) and female mate choice at the beginning and end of the reproductive season in the annual killifish Austrolebias reicherti. We found seasonal change in both OSR and female mate choice. At the start of the reproductive season the OSR did not deviate from parity, and females preferred larger males. Later in the reproductive season, while the proportion of males in the ponds decreased, females became unselective with respect to male size. The particular biological cycle of annual killifish, where both life expectancy and mating opportunities decline sharply over a short timescale, could account for the seasonal change in female choice. Reduction in choosiness could arise from diminished reproductive prospects due to a decline in male availability. Moreover, as the end of the season approaches, any benefits of choosiness are presumably reduced: a female's fitness will be higher if she mates with any male than if she forgoes reproduction and dies. Future work will disentangle the mechanisms underlying seasonal changes in mating preferences, notably direct responses to demographic factors, environmental cues, or intrinsic changes during development.	[Passos, Carlos; Tassino, Bettina; Reyes, Federico] Univ Republica, Fac Ciencias, Secc Etol, Montevideo, Uruguay; [Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico	Universidad de la Republica, Uruguay; Texas A&M University System; Texas A&M University College Station	Passos, C (corresponding author), Univ Republica, Fac Ciencias, Secc Etol, Montevideo, Uruguay.	cpassos@fcien.edu.uy	; Rosenthal, Gil/E-6924-2015	Reyes, Federico/0000-0002-6993-2784; Rosenthal, Gil/0000-0003-0342-9024	Programa para el Desarrollo de las Ciencias Basicas; Agencia Nacional de Investigacion e Innovacion [FCE 2201117025]; Agencia Nacional de Investigacion e Innovacion	Programa para el Desarrollo de las Ciencias Basicas; Agencia Nacional de Investigacion e Innovacion; Agencia Nacional de Investigacion e Innovacion	This work was supported by the Programa para el Desarrollo de las Ciencias Basicas, and the Agencia Nacional de Investigacion e Innovacion (FCE 2201117025). The Agencia Nacional de Investigacion e Innovacion provided a Ph.D. research fellowship to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Aronsen T, 2013, EVOLUTION, V67, P3243, DOI 10.1111/evo.12201; BalshineEarn S, 1996, BEHAV ECOL SOCIOBIOL, V39, P107, DOI 10.1007/s002650050272; Basolo AL, 2004, ANIM BEHAV, V68, P75, DOI 10.1016/j.anbehav.2003.07.019; BERGLUND A, 1994, BEHAV ECOL, V5, P254, DOI 10.1093/beheco/5.3.254; BERGLUND A, 1993, BEHAV ECOL SOCIOBIOL, V32, P331; Berois N, 2012, WIRES DEV BIOL, V1, P595, DOI 10.1002/wdev.39; Borg AA, 2006, ANIM BEHAV, V72, P763, DOI 10.1016/j.anbehav.2005.11.025; Chapman BB, 2010, P ROY SOC B-BIOL SCI, V277, P1395, DOI 10.1098/rspb.2009.2055; Costa WJEM, 2006, ZOOTAXA, P1; CROWLEY PH, 1991, AM NAT, V137, P567, DOI 10.1086/285184; Darwin C., 1871, P423; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; Garcia CM, 1998, J FISH BIOL, V53, P104, DOI 10.1111/j.1095-8649.1998.tb01021.x; Garcia D, 2008, NEOTROP ICHTHYOL, V6, P243, DOI 10.1590/S1679-62252008000200012; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; HAAS R, 1976, EVOLUTION, V30, P614, DOI 10.1111/j.1558-5646.1976.tb00938.x; Heuschele J, 2009, BEHAV ECOL, V20, P1223, DOI 10.1093/beheco/arp123; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jones AG, 2005, INTEGR COMP BIOL, V45, P874, DOI 10.1093/icb/45.5.874; Kingston JJ, 2003, ANIM BEHAV, V65, P735, DOI 10.1006/anbe.2003.2110; Kokko H, 2005, EVOLUTION, V59, P1876; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; Kvarnemo C, 1999, BEHAV ECOL SOCIOBIOL, V45, P245, DOI 10.1007/s002650050559; Lehtonen TK, 2008, ANIM BEHAV, V75, P55, DOI 10.1016/j.anbehav.2007.04.011; Lindstrom K, 2001, AM NAT, V158, P64, DOI 10.1086/320867; Loureiro M, 2008, ZOOTAXA, P1; MacLaren RD, 2006, ETHOLOGY, V112, P678, DOI 10.1111/j.1439-0310.2006.01213.x; Passos C, 2013, ETHOLOGY, V119, P891, DOI 10.1111/eth.12129; Passos C, 2013, BEHAV PROCESS, V96, P20, DOI 10.1016/j.beproc.2013.01.008; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P5, DOI 10.1016/S0169-5347(00)02030-9; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Reichard M, 2009, J FISH BIOL, V74, P198, DOI 10.1111/j.1095-8649.2008.02129.x; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Rosenthal GG, 2011, BIOL LETTERS, V7, P525, DOI 10.1098/rsbl.2011.0027; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Simpson B.R.C., 1979, Symposia of the Zoological Society of London, P243; Vaz-Ferreira R, 1964, APARTADOS ARCH SOC B, V26, P44; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; Wong BBM, 2004, ANIM BEHAV, V67, P583, DOI 10.1016/j.anbehav.2003.08.015; WOURMS JP, 1972, J EXP ZOOL, V182, P389, DOI 10.1002/jez.1401820310; Zuk Marlene, 1994, P354	49	43	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101649	10.1371/journal.pone.0101649	http://dx.doi.org/10.1371/journal.pone.0101649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029019	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600018
J	Sakthivel, P; Gereke, M; Breithaupt, A; Fuchs, D; Gigliotti, L; Gruber, AD; Dianzani, U; Bruder, D				Sakthivel, Priya; Gereke, Marcus; Breithaupt, Angele; Fuchs, Dietmar; Gigliotti, Luca; Gruber, Achim D.; Dianzani, Umberto; Bruder, Dunja			Attenuation of Immune-Mediated Influenza Pneumonia by Targeting the Inducible Co-Stimulator (ICOS) Molecule on T Cells	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; REGULATORY-CELLS; IL-10 PRODUCTION; CO-STIMULATION; CUTTING EDGE; VIRUS; RESPONSES; ACTIVATION; CD4(+); LIGAND	Inducible Co-stimulator (ICOS) plays a critical role in mediating T cell differentiation and function and is considered a key player in balancing T effector and T regulatory (T-reg) cell responses. Here we show that activation of the ICOS signalling pathway during acute influenza A virus (IAV) infection by application of an agonistic ICOS antibody reduced the frequency of CD8(+) T cells in the respiratory tract of IAV infected animals and delayed pathogen elimination. In line with this, immune-mediated influenza pneumonia was significantly ameliorated in mice that received ICOS agonist as indicated by significantly reduced alveolar infiltrations and bronchointerstitial pneumonia, while at the same time virus-related pathology remained unaffected. Importantly, ICOS agonist treatment resulted in expansion of CD4(+)Foxp3(+) T-regs in IAV infected mice, which was associated with elevated levels of the immunosuppressive cytokine IL-10 in the alveolar space. Together, our findings suggest a prominent role of ICOS signaling during acute IAV infection by increasing the T-reg/CD8(+) T cell ratio with beneficial outcome on immune-mediated pneumonia and underline the suitability of ICOS as potential therapeutic target for immune intervention in those infectious conditions characterized by strong immunopathology rather than virus-mediated cytopathic effects.	[Sakthivel, Priya; Gereke, Marcus; Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Gereke, Marcus; Bruder, Dunja] Otto Von Guericke Univ, Inst Med Microbiol Infect Control & Prevent, Infect Immunol Grp, Magdeburg, Germany; [Breithaupt, Angele; Gruber, Achim D.] Free Univ Berlin, Inst Vet Pathol, Dept Vet Med, Berlin, Germany; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, A-6020 Innsbruck, Austria; [Gigliotti, Luca; Dianzani, Umberto] A Avogadro Univ Eastern Piedmont, Dept Hlth Sci, Novara, Italy; [Gigliotti, Luca; Dianzani, Umberto] A Avogadro Univ Eastern Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy	Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; Free University of Berlin; Medical University of Innsbruck; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Bruder, D (corresponding author), Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany.	dunja.bruder@med.ovgu.de	Dianzani, Umberto/K-1952-2016; Breithaupt, Angele/GON-7227-2022; Gruber, Achim D./ABA-4514-2021; Breithaupt, Angele/B-6155-2013; Fuchs, Dietmar/AAL-8011-2021; Gigliotti, Casimiro Luca/H-8809-2016	Breithaupt, Angele/0000-0002-6373-5923; Fuchs, Dietmar/0000-0003-1627-9563; Gigliotti, Casimiro Luca/0000-0002-3127-5686; DIANZANI, Umberto/0000-0001-6723-3931	Alexander-von-Humboldt Foundation; President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF) [W2/W3-029]; Centre of Dynamic Systems (CDS), Magdeburg; Associazione Italiana Ricerca sul Cancro (Milano); Fondazione Amici di Jean (Torino)	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF); Centre of Dynamic Systems (CDS), Magdeburg; Associazione Italiana Ricerca sul Cancro (Milano)(Fondazione AIRC per la ricerca sul cancro); Fondazione Amici di Jean (Torino)	This study was funded by the Alexander-von-Humboldt Foundation providing a postdoctoral fellowship to Priya Sakthivel. Dunja Bruder received financial support from the President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF) under contract number W2/W3-029 and from the Centre of Dynamic Systems (CDS), Magdeburg. Umberto Dianzani and Luca Gigliotti received financial support from the Associazione Italiana Ricerca sul Cancro (Milano) and Fondazione Amici di Jean (Torino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Bertram EM, 2004, SEMIN IMMUNOL, V16, P185, DOI 10.1016/j.smim.2004.02.006; Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y; Betts RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027849; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fox JM, 2013, J GEN VIROL, V94, P1451, DOI 10.1099/vir.0.053124-0; Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138; FUCHS D, 1990, J ACQ IMMUN DEF SYND, V3, P873; Gao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052657; Gereke M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-47; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Greenwald RJ, 2002, J IMMUNOL, V168, P991, DOI 10.4049/jimmunol.168.3.991; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Honkanen J, 2008, DIABETES-METAB RES, V24, P635, DOI 10.1002/dmrr.904; Humphreys IR, 2006, EUR J IMMUNOL, V36, P2928, DOI 10.1002/eji.200636155; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; Klingenberg R, 2005, EUR J IMMUNOL, V35, P1712, DOI 10.1002/eji.200425727; Kohyama M, 2004, P NATL ACAD SCI USA, V101, P4192, DOI 10.1073/pnas.0400214101; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Laich A, 2002, CLIN CHEM, V48, P579; Liu XS, 2006, J IMMUNOL, V177, P2873, DOI 10.4049/jimmunol.177.5.2873; Liu XL, 2001, J EXP MED, V194, P1339, DOI 10.1084/jem.194.9.1339; Liu XS, 2003, J IMMUNOL, V171, P4765, DOI 10.4049/jimmunol.171.9.4765; Marks E, 2007, INFECT IMMUN, V75, P4638, DOI 10.1128/IAI.00465-07; Mcgee HS, 2010, AM J RESP CELL MOL, V42, P331, DOI 10.1165/rcmb.2008-0397OC; Mesturini R, 2013, CYTOKINE, V64, P322, DOI 10.1016/j.cyto.2013.05.021; Mittrucker HW, 2002, J IMMUNOL, V169, P5813, DOI 10.4049/jimmunol.169.10.5813; Nouailles G, 2011, EUR J IMMUNOL, V41, P981, DOI 10.1002/eji.201040608; Nurieva RI, 2003, J CLIN INVEST, V111, P701, DOI 10.1172/JCI200317321; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Pfaff AW, 2008, INT J PARASITOL, V38, P249, DOI 10.1016/j.ijpara.2007.07.007; Quiroga MF, 2006, J IMMUNOL, V176, P5965, DOI 10.4049/jimmunol.176.10.5965; Redoglia V, 1996, EUR J IMMUNOL, V26, P2781, DOI 10.1002/eji.1830261134; Redpath SA, 2013, EUR J IMMUNOL, V43, P705, DOI 10.1002/eji.201242794; Scott BG, 2004, J NEUROIMMUNOL, V153, P16, DOI 10.1016/j.jneuroim.2004.04.019; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Telieps T, 2013, EUR J IMMUNOL, V43, P1499, DOI 10.1002/eji.201242819; Turner DL, 2013, J VIROL, V87, P4496, DOI 10.1128/JVI.03413-12; Vidric M, 2006, INFECT IMMUN, V74, P1050, DOI 10.1128/IAI.74.2.1050-1061.2006; Wallin JJ, 2001, J IMMUNOL, V167, P132, DOI 10.4049/jimmunol.167.1.132; Wang SD, 2000, BLOOD, V96, P2808; Wilson EH, 2006, J IMMUNOL, V177, P2365, DOI 10.4049/jimmunol.177.4.2365; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Yu XZ, 2006, J IMMUNOL, V176, P7394, DOI 10.4049/jimmunol.176.12.7394	53	10	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100970	10.1371/journal.pone.0100970	http://dx.doi.org/10.1371/journal.pone.0100970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029240	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600011
J	Aguirre, C; ten Brink, T; Guichou, JF; Cala, O; Krimm, I				Aguirre, Clementine; ten Brink, Tim; Guichou, Jean-Francois; Cala, Olivier; Krimm, Isabelle			Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5	PLOS ONE			English	Article							TRANSFER DIFFERENCE NMR; CHEMICAL-SHIFT PERTURBATIONS; COMPLEXATION-INDUCED CHANGES; LIGAND-BINDING; PEROXIREDOXIN; DISCOVERY; PROTEINS; SPECTROSCOPY; CRYSTALLOGRAPHY; MOLECULES	Fragment-based drug design is one of the most promising approaches for discovering novel and potent inhibitors against therapeutic targets. The first step of the process consists of identifying fragments that bind the protein target. The determination of the fragment binding mode plays a major role in the selection of the fragment hits that will be processed into drug-like compounds. Comparing the binding modes of analogous fragments is a critical task, not only to identify specific interactions between the protein target and the fragment, but also to verify whether the binding mode is conserved or differs according to the fragment modification. While X-ray crystallography is the technique of choice, NMR methods are helpful when this fails. We show here how the ligand-observed saturation transfer difference (STD) experiment and the protein-observed N-15-HSQC experiment, two popular NMR screening experiments, can be used to compare the binding modes of analogous fragments. We discuss the application and limitations of these approaches based on STD-epitope mapping, chemical shift perturbation (CSP) calculation and comparative CSP sign analysis, using the human peroxiredoxin 5 as a protein model.	[Aguirre, Clementine; ten Brink, Tim; Cala, Olivier; Krimm, Isabelle] Univ Lyon, UMR 5280, Inst Sci Analyt, CNRS, Villeurbanne, France; [Guichou, Jean-Francois] Univ Montpellier 1 & 2, Ctr Biochim Struct, INSERM, U1054,CNRS,UMR5048, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Krimm, I (corresponding author), Univ Lyon, UMR 5280, Inst Sci Analyt, CNRS, Villeurbanne, France.	isabelle.krimm@univ-lyon1.fr	Krimm, Isabelle/O-4972-2014; Cala, Olivier/AAE-8065-2019	Krimm, Isabelle/0000-0002-5981-109X; Cala, Olivier/0000-0003-3579-0973; guichou, jean-francois/0000-0002-7699-3235	Agence National de la Recherche [ANR-11JS07-0008]	Agence National de la Recherche(French National Research Agency (ANR))	Financial support was provided by the Agence National de la Recherche, project ANR-11JS07-0008. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064400; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Barelier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009744; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Caliandro R, 2013, FUTURE MED CHEM, V5, P1121, DOI [10.4155/FMC.13.84, 10.4155/fmc.13.84]; Christensen AS, 2011, J CHEM THEORY COMPUT, V7, P2078, DOI 10.1021/ct2002607; Cioffi M, 2008, J MED CHEM, V51, P2512, DOI 10.1021/jm701194r; Cioffi M, 2009, J BIOMOL NMR, V43, P11, DOI 10.1007/s10858-008-9286-7; Constantine KL, 2006, J AM CHEM SOC, V128, P7252, DOI 10.1021/ja060356w; Cowtan K, 2011, ACTA CRYSTALLOGR D, V67, P233, DOI 10.1107/S0907444911007578; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Garcia-Bonilla L, 2012, NAT MED, V18, P858, DOI 10.1038/nm.2797; Goddard T.D., 2004, SPARKY 3; Gonzalez-Ruiz D, 2009, J CHEM INF MODEL, V49, P2260, DOI 10.1021/ci900188r; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Haigh C, 1980, PROGR NMR SPECTROSCO, V13, P303; Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z; Hunter CA, 1999, CHEM-EUR J, V5, P1891, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1891::AID-CHEM1891>3.0.CO;2-G; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuo LC, 2011, METHOD ENZYMOL, V493, P159, DOI 10.1016/B978-0-12-381274-2.00007-8; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McCoy MA, 2002, J AM CHEM SOC, V124, P11758, DOI 10.1021/ja026166c; McCoy MA, 2000, J BIOMOL NMR, V18, P189, DOI 10.1023/A:1026508025631; Medek A, 2000, J AM CHEM SOC, V122, P1241, DOI 10.1021/ja993921m; Moon S, 2007, J BIOMOL NMR, V38, P139, DOI 10.1007/s10858-007-9156-8; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Parker LL, 2006, J AM CHEM SOC, V128, P9863, DOI 10.1021/ja0617901; Riedinger C, 2008, J AM CHEM SOC, V130, P16038, DOI 10.1021/ja8062088; Shah DM, 2012, J MED CHEM, V55, P10786, DOI 10.1021/jm301396d; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Turnbull Andrew P, 2013, Methods Mol Biol, V1008, P457, DOI 10.1007/978-1-62703-398-5_17; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Yan JL, 2003, J MAGN RESON, V163, P270, DOI 10.1016/S1090-7807(03)00106-X	41	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102300	10.1371/journal.pone.0102300	http://dx.doi.org/10.1371/journal.pone.0102300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025339	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400062
J	Almlof, JC; Lundmark, P; Lundmark, A; Ge, B; Pastinen, T; Goodall, AH; Cambien, F; Deloukas, P; Ouwehand, WH; Syvanen, AC				Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Ge, Bing; Pastinen, Tomi; Goodall, Alison H.; Cambien, Francois; Deloukas, Panos; Ouwehand, Willem H.; Syvanen, Ann-Christine		Cardiogenics Consortium	Single Nucleotide Polymorphisms with Cis-Regulatory Effects on Long Non-Coding Transcripts in Human Primary Monocytes	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; X-INACTIVATION CENTER; HUMAN GENOME; HUMAN-CELLS; RNAS; GENE; ENHANCERS; LOCI; BIAS; MAP	We applied genome-wide allele-specific expression analysis of monocytes from 188 samples. Monocytes were purified from white blood cells of healthy blood donors to detect cis-acting genetic variation that regulates the expression of long non-coding RNAs. We analysed 8929 regions harboring genes for potential long non-coding RNA that were retrieved from data from the ENCODE project. Of these regions, 60% were annotated as intergenic, which implies that they do not overlap with protein-coding genes. Focusing on the intergenic regions, and using stringent analysis of the allele-specific expression data, we detected robust cis-regulatory SNPs in 258 out of 489 informative intergenic regions included in the analysis. The cis-regulatory SNPs that were significantly associated with allele-specific expression of long non-coding RNAs were enriched to enhancer regions marked for active or bivalent, poised chromatin by histone modifications. Out of the IncRNA regions regulated by cis-acting regulatory SNPs, 20% (n = 52) were co-regulated with the closest protein coding gene. We compared the identified cis-regulatory SNPs with those in the catalog of SNPs identified by genome-wide association studies of human diseases and traits. This comparison identified 32 SNPs in loci from genome-wide association studies that displayed a strong association signal with allele-specific expression of non-coding RNAs in monocytes, with p-values ranging from 6.7x10(-7) to 9.5x10(-89). The identified cis-regulatory SNPs are associated with diseases of the immune system, like multiple sclerosis and rheumatoid arthritis.	[Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden; [Ge, Bing; Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Goodall, Alison H.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Cambien, Francois] Sch Med, Paris, France; [Deloukas, Panos] Queen Mary Univ London, Ctr Heart, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Deloukas, Panos; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia; [Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge, England	Uppsala University; McGill University; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; University of London; Queen Mary University London; Wellcome Trust Sanger Institute; King Abdulaziz University; NHS Blood & Transplant (NHSBT)	Syvanen, AC (corresponding author), Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se	Cambien, Francois/AAP-9751-2020; Deloukas, Panos/B-2922-2013; Erdmann, Jeanette/P-7513-2014; Almlöf, Jonas/E-1608-2017	Deloukas, Panos/0000-0001-9251-070X; Erdmann, Jeanette/0000-0002-4486-6231; Almlöf, Jonas/0000-0002-1211-9821; Maouche, Seraya/0000-0001-8186-1635; Rendon, Augusto/0000-0001-8994-0039; Wallace, Chris/0000-0001-9755-1703; Matvienko-Sikar, Karen/0000-0003-2777-6581; Ouwehand, Willem/0000-0002-7744-1790	EU [LSHM-CT-2006-037593]; European Union [262055]; European Sequencing and Genotyping Infrastructure (ESGI); Swedish Research Council [A028001, C0524801]; Knut and Alice Wallenberg Foundation [KAW 2011.0073];  [282510 BLUEPRINT]; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10214, RP-PG-0310-1002, NF-SI-0513-10151] Funding Source: researchfish	EU(European Commission); European Union(European Commission); European Sequencing and Genotyping Infrastructure (ESGI); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was performed as part of WP5 of the Cardiogenics EU FP6 project (grant number LSHM-CT-2006-037593). The work leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements no 262055, European Sequencing and Genotyping Infrastructure (ESGI) and 282510 BLUEPRINT. A full list of the investigators in the Blueprint consortium who contributed to the generation of the data is available from www.blueprint-epigenome.eu. The study received funding from the Swedish Research Council (grants no A028001 and C0524801 to A-CS) and the Knut and Alice Wallenberg Foundation (KAW 2011.0073 to A-CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2011, NATURE, V477, P518, DOI 10.1038/477518a; Almlof JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052260; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Li Xiaoyan, 2002, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V16, P412; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Satya RV, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks425; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018	34	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102612	10.1371/journal.pone.0102612	http://dx.doi.org/10.1371/journal.pone.0102612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025429	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400093
J	Toma, MI; Erdmann, K; Diezel, M; Meinhardt, M; Zastrow, S; Fuessel, S; Wirth, MP; Baretton, GB				Toma, Marieta I.; Erdmann, Kati; Diezel, Michael; Meinhardt, Matthias; Zastrow, Stefan; Fuessel, Susanne; Wirth, Manfred P.; Baretton, Gustavo B.			Lack of Ephrin Receptor A1 Is a Favorable Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							TYROSINE KINASE; EPHA2 OVEREXPRESSION; DOWN-REGULATION; GROWTH-FACTOR; EXPRESSION; ANGIOGENESIS; METASTASIS; INVASION; LIGAND	The EPH receptor tyrosine kinases and their cell-bound ligands, the ephrins, have been shown to be associated with cancer development and progression. In this study, mRNA and protein expression of the receptors EPHA1 and EPHA2 as well as of their ligand EFNA1 and their prognostic relevance in clear cell renal cell carcinoma was evaluated. Gene expression was measured in 75 cryo-preserved primary tumors and matched non-malignant renal specimens by quantitative PCR. Protein expression was analyzed by immunohistochemistry on tissue microarrays comprising non-malignant, primary tumors and metastatic renal tissues of 241 patients. Gene and protein expression of all three factors was altered in tumor specimens with EPHA1 and EPHA2 being generally diminished in tumors compared to normal renal tissue, whereas EFNA1 was commonly elevated. A positive EPHA1 and EPHA2 protein staining as well as a low EFNA1 protein level were significantly linked to more aggressive tumor features, but only a positive EPHA1 immunoreactivity was significantly associated with poor survival. In subgroup analyses, EPHA1 and EPHA2 protein levels were significantly higher in metastatic than in primary lesions. Patients with EPHA1/EPHA2-positive tumors or with tumors with positive EPHA1 and low EFNA1 immunoreactivity had the shortest survival rates compared to the respective other combinations. In a multivariate model, EPHA1 was an independent prognostic marker for different survival endpoints. In conclusion, an impaired EPH-ephrin signaling could contribute to the pathogenesis and progression of clear cell renal cell carcinoma.	[Toma, Marieta I.; Diezel, Michael; Meinhardt, Matthias; Baretton, Gustavo B.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst Pathol, Dresden, Germany; [Erdmann, Kati; Zastrow, Stefan; Fuessel, Susanne; Wirth, Manfred P.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Urol, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Toma, MI (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst Pathol, Dresden, Germany.	marieta.toma@uniklinikum-dresden.de	Zastrow, Stefan/ABF-3692-2021; Toma, Marieta/AAI-8022-2021		MedDrive grant program of the Technical University Dresden [60.207]	MedDrive grant program of the Technical University Dresden	This study was funded by the MedDrive grant program of the Technical University Dresden. Grant Nr 60.207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar U, 2008, CAN J UROL, V15, P3954; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen G, 2010, ONCOL REP, V23, P563, DOI 10.3892/or_00000670; Cheng N, 2002, MOL CANCER RES, V1, P2; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; Dong YC, 2009, MODERN PATHOL, V22, P151, DOI 10.1038/modpathol.2008.188; Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Giaginis C, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-8; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Herrem CJ, 2005, CLIN CANCER RES, V11, P226; Holm R, 2007, J CLIN PATHOL, V60, P1086, DOI 10.1136/jcp.2006.041194; Holm Ruth, 2008, Int J Med Sci, V5, P121; Ishikawa M, 2012, LUNG CANCER, V76, P431, DOI 10.1016/j.lungcan.2011.12.004; Kamat AA, 2009, CANCER-AM CANCER SOC, V115, P2684, DOI 10.1002/cncr.24335; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Li X, 2010, TUMOR BIOL, V31, P477, DOI 10.1007/s13277-010-0060-6; Liu Y, 2012, J CANCER RES CLIN, V138, P195, DOI 10.1007/s00432-011-1087-9; Liu Y, 2011, J CANCER RES CLIN, V137, P761, DOI 10.1007/s00432-010-0936-2; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Merritt WM, 2010, CANCER BIOL THER, V10, P1306, DOI 10.4161/cbt.10.12.13582; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Patel NS, 2009, TUMOR BIOL, V30, P292, DOI 10.1159/000260241; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Shahzad MMK, 2009, CANCER BIOL THER, V8, P1027, DOI 10.4161/cbt.8.11.8523; Taddei ML, 2011, MOL CANCER RES, V9, P149, DOI 10.1158/1541-7786.MCR-10-0298; Tatsumi T, 2003, CANCER RES, V63, P4481; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang JD, 2013, APMIS, V121, P30, DOI 10.1111/j.1600-0463.2012.02941.x; Wu D, 2004, GYNECOL ONCOL, V94, P312, DOI 10.1016/j.ygyno.2004.05.019; Yuan WJ, 2009, DIGEST DIS SCI, V54, P2410, DOI 10.1007/s10620-008-0649-4	35	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102262	10.1371/journal.pone.0102262	http://dx.doi.org/10.1371/journal.pone.0102262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025847	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400056
J	Ferrandiz, MJ; Arnanz, C; Martin-Galiano, AJ; Rodriguez-Martin, C; de la Campa, AG				Ferrandiz, Maria-Jose; Arnanz, Cristina; Martin-Galiano, Antonio J.; Rodriguez-Martin, Carlos; de la Campa, Adela G.			Role of Global and Local Topology in the Regulation of Gene Expression in Streptococcus pneumoniae	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEINS; ESCHERICHIA-COLI GYRA; DNA GYRASE; H-NS; TOPOISOMERASE-I; TRANSCRIPTION; NOVOBIOCIN; FIS; PROMOTERS; RESISTANT	The most basic level of transcription regulation in Streptococcus pneumoniae is the organization of its chromosome in topological domains. In response to drugs that caused DNA-relaxation, a global transcriptional response was observed. Several chromosomal domains were identified based on the transcriptional response of their genes: up-regulated (U), down-regulated (D), non-regulated (N), and flanking (F). We show that these distinct domains have different expression and conservation characteristics. Microarray fluorescence units under non-relaxation conditions were used as a measure of gene transcriptional level. Fluorescence units were significantly lower in F genes than in the other domains with a similar AT content. The transcriptional level of the domains categorized them was D>U>F. In addition, a comparison of 12 S. pneumoniae genome sequences showed a conservation of gene composition within U and D domains, and an extensive gene interchange in F domains. We tested the organization of chromosomal domains by measuring the relaxation-mediated transcription of eight insertions of a heterologous P(tc)cat cassette, two in each type of domain, showing that transcription depended on their chromosomal location. Moreover, transcription from the four promoters directing the five genes involved in supercoiling homeostasis, located either in U (gyrB), D (topA), or N (gyrA and parEC) domains was analyzed both in their chromosomal locations and in a replicating plasmid. Although expression from the chromosomal P-gyrB and P-topA showed the expected domain regulation, their expression was down-regulated in the plasmid, which behaved as a D domain. However, both P-parE and P-gyrA carried their own regulatory signals, their topology-dependent expression being equivalent in the plasmid or in the chromosome. In P-gyrA a DNA bend acted as a DNA supercoiling sensor. These results revealed that DNA topology functions as a general transcriptional regulator, superimposed upon other more specific regulatory mechanisms.	[Ferrandiz, Maria-Jose; Arnanz, Cristina; Martin-Galiano, Antonio J.; Rodriguez-Martin, Carlos; de la Campa, Adela G.] Inst Salud Carlos III, Unidad Genet Bacteriana, Ctr Nacl Microbiol, Madrid, Spain; [Ferrandiz, Maria-Jose; Arnanz, Cristina; Martin-Galiano, Antonio J.; Rodriguez-Martin, Carlos; de la Campa, Adela G.] CIBER Enfermedades Resp, Madrid, Spain; [de la Campa, Adela G.] CSIC, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC)	de la Campa, AG (corresponding author), Inst Salud Carlos III, Unidad Genet Bacteriana, Ctr Nacl Microbiol, Madrid, Spain.	agcampa@isciii.es	de la Campa, Adela G/K-1654-2014; Ferrandiz, Maria-Jose/K-2820-2014	de la Campa, Adela G/0000-0002-3598-2548; Ferrandiz, Maria-Jose/0000-0003-1428-9506; Rodriguez-Martin, Carlos/0000-0003-3279-1292; Martin-Galiano, Antonio Javier/0000-0002-6662-329X	Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion [BIO2011-25343]	Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by grant BIO2011-25343 from Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion. CIBER Enfermedades Respiratorias is an initiative from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balas D, 1998, J BACTERIOL, V180, P2854, DOI 10.1128/JB.180.11.2854-2861.1998; BALLESTER S, 1990, GENE, V86, P71, DOI 10.1016/0378-1119(90)90115-8; BALLESTER S, 1986, GENE, V41, P153, DOI 10.1016/0378-1119(86)90094-6; Balsalobre L, 2008, ANTIMICROB AGENTS CH, V52, P822, DOI 10.1128/AAC.00731-07; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Choulet F, 2006, MOL BIOL EVOL, V23, P2361, DOI 10.1093/molbev/msl108; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dorman CJ, 2009, NUCLEIC ACIDS RES, V37, P672, DOI 10.1093/nar/gkn996; DORMAN CJ, 1991, INFECT IMMUN, V59, P745, DOI 10.1128/IAI.59.3.745-749.1991; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; FENOLL A, 1994, MOL MICROBIOL, V12, P587, DOI 10.1111/j.1365-2958.1994.tb01045.x; Ferrandiz MJ, 2010, NUCLEIC ACIDS RES, V38, P3570, DOI 10.1093/nar/gkq106; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Gmuender H, 2001, GENOME RES, V11, P28, DOI 10.1101/gr.157701; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Jeong KS, 2006, PLOS GENET, V2, P1464, DOI 10.1371/journal.pgen.0020152; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Marr C, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-18; Martin-Galiano AJ, 2004, MICROBIOL-SGM, V150, P2313, DOI 10.1099/mic.0.27097-0; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; MENZEL R, 1987, J BACTERIOL, V169, P1272, DOI 10.1128/jb.169.3.1272-1278.1987; MENZEL R, 1987, P NATL ACAD SCI USA, V84, P4185, DOI 10.1073/pnas.84.12.4185; MUNOZ R, 1995, J BACTERIOL, V177, P4166, DOI 10.1128/jb.177.14.4166-4170.1995; Ouafa ZA, 2012, NUCLEIC ACIDS RES, V40, P4306, DOI 10.1093/nar/gks014; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; PEREZMARTIN J, 1991, EMBO J, V10, P1375, DOI 10.1002/j.1460-2075.1991.tb07657.x; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; POLJAK LG, 1987, NUCLEIC ACIDS RES, V15, P5433, DOI 10.1093/nar/15.13.5433; Ruiz-Cruz S, 2010, J MICROBIOL METH, V83, P156, DOI 10.1016/j.mimet.2010.08.004; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; Slage J, 2014, CELL, V157, P95; Stellwagen E, 2005, NUCLEIC ACIDS RES, V33, P4425, DOI 10.1093/nar/gki748; THIARA AS, 1989, GENE, V81, P65, DOI 10.1016/0378-1119(89)90337-5; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TSEDINH YC, 1985, NUCLEIC ACIDS RES, V13, P4751, DOI 10.1093/nar/13.13.4751; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Weinstein-Fischer D, 2007, MOL MICROBIOL, V63, P1131, DOI 10.1111/j.1365-2958.2006.05569.x	46	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101574	10.1371/journal.pone.0101574	http://dx.doi.org/10.1371/journal.pone.0101574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019515	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600019
J	Hyde, GD; Taylor, RF; Ashton, N; Borland, SJ; Wu, HSG; Gilmore, AP; Canfield, AE				Hyde, Gareth D.; Taylor, Rebecca F.; Ashton, Nick; Borland, Samantha J.; Wu, Hon Sing Geoffrey; Gilmore, Andrew P.; Canfield, Ann E.			Axl Tyrosine Kinase Protects against Tubulo-Interstitial Apoptosis and Progression of Renal Failure in a Murine Model of Chronic Kidney Disease and Hyperphosphataemia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARREST-SPECIFIC GENE-6; PHOSPHATE-INDUCED CALCIFICATION; ARTERIAL MEDIAL CALCIFICATION; OSTEOGENIC DIFFERENTIATION; CARDIOVASCULAR MORTALITY; DIABETIC-NEPHROPATHY; AORTIC CALCIFICATION; GENDER-DIFFERENCES; ALL-CAUSE	Chronic kidney disease (CKD) is defined as the progressive loss of renal function often involving glomerular, tubulointerstitial and vascular pathology. CKD is associated with vascular calcification; the extent of which predicts morbidity and mortality. However, the molecular regulation of these events and the progression of chronic kidney disease are not fully elucidated. To investigate the function of Axl receptor tyrosine kinase in CKD we performed a sub-total nephrectomy and fed high phosphate (1%) diet to Axl+/+ and Axl-/- mice. Plasma Gas6 (Axl' ligand), renal Axl expression and downstream Akt signalling were all significantly up-regulated in Axl+/+ mice following renal mass reduction and high phosphate diet, compared to age-matched controls. Axl-/- mice had significantly enhanced uraemia, reduced bodyweight and significantly reduced survival following sub-total nephrectomy and high phosphate diet compared to Axl+/+ mice; only 45% of Axl-/- mice survived to 14 weeks post-surgery compared to 87% of Axl+/+ mice. Histological analysis of kidney remnants revealed no effect of loss of Axl on glomerular hypertrophy, calcification or renal sclerosis but identified significantly increased tubulo-interstitial apoptosis in Axl-/- mice. Vascular calcification was not induced in Axl+/+ or Axl-/- mice in the time frame we were able to examine. In conclusion, we identify the up-regulation of Gas6/Axl signalling as a protective mechanism which reduces tubulo-interstitial apoptosis and slows progression to end-stage renal failure in the murine nephrectomy and high phosphate diet model of CKD.	[Hyde, Gareth D.; Taylor, Rebecca F.; Borland, Samantha J.; Canfield, Ann E.] Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Manchester, Lancs, England; [Hyde, Gareth D.; Taylor, Rebecca F.; Gilmore, Andrew P.; Canfield, Ann E.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Ashton, Nick; Wu, Hon Sing Geoffrey; Gilmore, Andrew P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Canfield, AE (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Manchester, Lancs, England.	ann.canfield@manchester.ac.uk		Taylor, Rebecca/0000-0003-4033-3793; Borland, Samantha/0000-0001-7358-5829; Ashton, Nick/0000-0003-3366-1617; Canfield, Ann/0000-0002-8983-5674	British Heart Foundation [PG/08/075/25545]; Wellcome Trust [097820/Z/11/Z, 088785/Z/09/Z]; BBSRC; University of Manchester Strategic Fund	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund	This work was supported by the British Heart Foundation [PG/08/075/25545] and the Wellcome Trust [097820/Z/11/Z]. The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, is supported by core funding from the Wellcome Trust [088785/Z/09/Z]. The Bioimaging Facility microscopes used were purchased with grants from BBSRC, Wellcome Trust and the University of Manchester Strategic Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchu N, 2013, HYPERTENSION, V62, P302, DOI 10.1161/HYPERTENSIONAHA.113.01382; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Carrero JJ, 2010, KIDNEY BLOOD PRESS R, V33, P383, DOI 10.1159/000320389; Collett G, 2003, CIRC RES, V92, P1123, DOI 10.1161/01.RES.0000074881.56564.46; Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Fiebeler A, 2004, AM J KIDNEY DIS, V43, P286, DOI 10.1053/j.ajkd.2003.10.016; Guo JK, 2012, J AM SOC NEPHROL, V23, P429, DOI 10.1681/ASN.2011040396; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Halbesma N, 2008, KIDNEY INT, V74, P505, DOI 10.1038/ki.2008.200; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Lau WL, 2012, KIDNEY INT, V82, P1261, DOI 10.1038/ki.2012.322; Lee IJ, 2012, NEPHROL DIAL TRANSPL, V27, P4166, DOI 10.1093/ndt/gfs337; Lemos CCS, 2005, J NEPHROL, V18, P368; Li KL, 2012, CARDIOVASC J AFR, V23, pE1, DOI 10.5830/CVJA-2011-069; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066759; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Pai A, 2011, AM J PATHOL, V178, P764, DOI 10.1016/j.ajpath.2010.10.006; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shao WH, 2010, CLIN IMMUNOL, V136, P236, DOI 10.1016/j.clim.2010.04.002; Silbiger S, 2008, GENDER MED, V5, pS3, DOI 10.1016/j.genm.2008.03.002; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503; Yin JL, 2003, TRANSPL INT, V16, P681, DOI 10.1007/s00147-003-0593-3; Yin JL, 2002, TRANSPLANTATION, V73, P657, DOI 10.1097/00007890-200202270-00032	40	15	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102096	10.1371/journal.pone.0102096	http://dx.doi.org/10.1371/journal.pone.0102096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019319	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600044
J	Khatami, A; Clutterbuck, EA; Thompson, AJ; McKenna, JA; Pace, D; Birks, J; Snape, MD; Pollard, AJ				Khatami, Ameneh; Clutterbuck, Elizabeth A.; Thompson, Amber J.; McKenna, Jennifer A.; Pace, David; Birks, Jacqueline; Snape, Matthew D.; Pollard, Andrew J.			Evaluation of the Induction of Immune Memory following Infant Immunisation with Serogroup C Neisseria meningitidis Conjugate Vaccines - Exploratory Analyses within a Randomised Controlled Trial	PLOS ONE			English	Article							B-CELL; GLYCOCONJUGATE VACCINE; IMMUNOLOGICAL MEMORY; PRIMARY SCHEDULE; PLASMA-CELLS; POLYSACCHARIDE; IMMUNOGENICITY; RESPONSES; ANTIBODY; PERSISTENCE	Aim: We measured meningococcal serogroup C (MenC)-specific memory B-cell responses in infants by Enzyme-Linked Immunospot (ELISpot) following different MenC conjugate vaccine schedules to investigate the impact of priming on immune memory. Methods: Infants aged 2 months were randomised to receive 1 or 2 doses of MenC-CRM197 at 3 or 3 and 4 months, 1 dose of MenC-TT at 3 months, or no primary MenC doses. All children received a Haemophilus influenzae type b (Hib)-MenC booster at 12 months. Blood was drawn at 5, 12, 12 months +6 days and 13 months of age. Results: Results were available for 110, 103, 76 and 44 children from each group respectively. Following primary immunisations, and prior to the 12-month booster, there were no significant differences between 1- or 2-dose primed children in the number of MenC memory B-cells detected. One month following the booster, children primed with 1 dose MenC-TT had more memory B-cells than children primed with either 1-dose (p = 0.001) or 2-dose (p<0.0001) MenC-CRM197. There were no differences in MenC memory B-cells detected in children who received 1 or 2 doses of MenC-CRM197 in infancy and un-primed children. Conclusions: MenC-specific memory B-cell production may be more dependent on the type of primary vaccine used than the number of doses administered. Although the mechanistic differences between MenC-CRM197 and MenC-TT priming are unclear, it is possible that structural differences, including the carrier proteins, may underlie differential interactions with B- and T-cell populations, and thus different effects on various memory B-cell subsets. A MenC-TT/Hib-MenC-TT combination for priming/boosting may offer an advantage in inducing more persistent antibody.	[Khatami, Ameneh; Clutterbuck, Elizabeth A.; Thompson, Amber J.; McKenna, Jennifer A.; Snape, Matthew D.; Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England; [Khatami, Ameneh; Clutterbuck, Elizabeth A.; Thompson, Amber J.; McKenna, Jennifer A.; Snape, Matthew D.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Pace, David] Mater Dei Hosp, Malta Childrens Vaccine Grp, Msida, Malta; [Birks, Jacqueline] Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Khatami, A (corresponding author), Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England.	ameneh.khatami@gmail.com	Pace, David/AAO-8928-2021; Khatami, Ameneh/ABH-9982-2020	Pace, David/0000-0002-3275-1189; Snape, Matthew/0000-0003-0531-5426; Khatami, Ameneh/0000-0001-9114-6694	University of Oxford; NIHR Oxford Biomedical Research Centre; GlaxoSmithKline Biologicals, Rixensart, Belgium; European Society for Pediatric Infectious Diseases; NIHR Biomedical Research Centre Programme through the Oxford Partnership Comprehensive Biomedical Research Centre; James Martin Vaccine Design Institute	University of Oxford; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); GlaxoSmithKline Biologicals, Rixensart, Belgium(GlaxoSmithKline); European Society for Pediatric Infectious Diseases; NIHR Biomedical Research Centre Programme through the Oxford Partnership Comprehensive Biomedical Research Centre; James Martin Vaccine Design Institute	This study was sponsored by the University of Oxford. Funding was received from the NIHR Oxford Biomedical Research Centre, GlaxoSmithKline Biologicals, Rixensart, Belgium, and the European Society for Pediatric Infectious Diseases. AJP and MDS act as chief or principal investigators for clinical trials conducted by the University of Oxford, sponsored by vaccine manufacturers, but receive no personal payments from them. MDS has participated in advisory boards and industry sponsored symposium for vaccine manufacturers, but receives no personal payments for this work. AK and MDS have received financial assistance from vaccine manufacturers to attend conferences. Funding from the NIHR Biomedical Research Centre Programme through the Oxford Partnership Comprehensive Biomedical Research Centre provides support to the Oxford Vaccine Group, including salary support for AK and MDS. AJP is a Jenner Investigator and James Martin Senior Fellow. AK was a James Martin Fellow and has received funding from the James Martin Vaccine Design Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; BEREK C, 1992, IMMUNOL REV, V126, P5, DOI 10.1111/j.1600-065X.1992.tb00628.x; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2003, INFECT IMMUN, V71, P5549, DOI 10.1128/IAI.71.10.5549-5555.2003; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Clutterbuck EA, 2008, CLIN VACCINE IMMUNOL, V15, P182, DOI 10.1128/CVI.00336-07; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, P148, DOI 10.1097/INF.0b013e3181b9a831; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Granoff DM, 2007, PEDIATR INFECT DIS J, V26, P716, DOI 10.1097/INF.0b013e3180cc2c25; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hodgkin PD, 2005, TISSUE ANTIGENS, V66, P259, DOI 10.1111/j.1399-0039.2005.00475.x; HOLDER MJ, 1993, INT IMMUNOL, V5, P1059, DOI 10.1093/intimm/5.9.1059; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Kelly DF, 2009, IMMUNOLOGY, V127, P134, DOI 10.1111/j.1365-2567.2008.02934.x; Khatami A, 2013, PEDIAT INFECT DIS J; Khatami A, 2011, PEDIATR INFECT DIS J, V30, P197, DOI 10.1097/INF.0b013e3181f728fd; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; MAURER D, 1992, J IMMUNOL, V148, P3700; Nanan R, 2001, VACCINE, V20, P498, DOI 10.1016/S0264-410X(01)00328-0; Obukhanych TV, 2006, J EXP MED, V203, P305, DOI 10.1084/jem.20052036; Pace D, 2008, ARCH DIS CHILD, V93, P963, DOI 10.1136/adc.2007.136036; Pace D, 2013, IMMUNOGENICITY CONJU; Poellabauer EM, 2013, VACCINE, V31, P3611, DOI 10.1016/j.vaccine.2013.04.070; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Russell FM, 2010, VACCINE, V28, P3086, DOI 10.1016/j.vaccine.2010.02.065; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Vora KA, 1999, J IMMUNOL, V163, P4315	35	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101672	10.1371/journal.pone.0101672	http://dx.doi.org/10.1371/journal.pone.0101672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020050	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600022
J	Zhu, ZL; Wang, YY; Liang, Z; Wang, WW; Zhang, HM; Li, BH; Ying, GG				Zhu, Zhongling; Wang, Yuanyuan; Liang, Zheng; Wang, Wenwen; Zhang, Huamei; Li, Binghui; Ying, Guoguang			Regulation of Cell Transformation by Rb-controlled Redox Homeostasis	PLOS ONE			English	Article							KINASE INHIBITORS; N-ACETYLCYSTEINE; LUNG-CANCER; PROTEIN; MECHANISMS; RESISTANCE; MUTATIONS; APOPTOSIS; OXIDANTS; BCL-2	Rb is a tumor suppressor, and regulates various biological progresses, such as cell proliferation, development, metabolism and cell death. In the current study, we show that Rb knockout in 3T3 cells leads to oxidative redox state and low mitochondrial membrane potential by regulating mitochondrial activity. Our results indicate that Rb plays an important role in controlling redox homeostasis. More importantly, the functions of Rb in modulating cell proliferation, death and transformation are, at least in part, mediated by its controlling cellular redox state. In addition, our results also suggest that the cellular redox state possibly determines various biological activities, including cell survival, death and transformation, where Rb is functioning as a regulator of redox homeostasis.	[Zhu, Zhongling; Wang, Yuanyuan; Liang, Zheng; Wang, Wenwen; Zhang, Huamei; Li, Binghui; Ying, Guoguang] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Canc Cell Biol Lab, Tianjin, Peoples R China	Tianjin Medical University	Li, BH (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Canc Cell Biol Lab, Tianjin, Peoples R China.	binghuili@tmu.edu.cn; yingguoguang@tmu.edu.cn	Lv, Yuanjie/AER-0767-2022	Liang, Zheng/0000-0003-4532-4888	National Natural Science Foundation of China [81171898, 81372185]; 973 program from National Basic Research Program of China [2011CB933100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program from National Basic Research Program of China(National Basic Research Program of China)	This work is supported by Grants 81171898 and 81372185 from National Natural Science Foundation of China, and 973 program 2011CB933100 from National Basic Research Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Clem BF, 2012, CLIN CANCER RES, V18, P6096, DOI 10.1158/1078-0432.CCR-11-3164; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Ho E, 1999, FASEB J, V13, P1845, DOI 10.1096/fasebj.13.13.1845; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Huang RFS, 2002, J NUTR, V132, P2151, DOI 10.1093/jn/132.8.2151; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kontzias A, 2012, CURR OPIN PHARMACOL, V12, P464, DOI 10.1016/j.coph.2012.06.008; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macleod KF, 2008, NAT REV CANCER, V8, P769, DOI 10.1038/nrc2504; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Nicolay BN, 2013, GENE DEV, V27, P182, DOI 10.1101/gad.206227.112; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Premzl A, 2001, BIOL CHEM, V382, P853, DOI 10.1515/BC.2001.104; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; ROBINSON JP, 1994, METHOD CELL BIOL, V41, P437; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Verbon EH, 2012, GENE, V511, P1, DOI 10.1016/j.gene.2012.08.038; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102582	10.1371/journal.pone.0102582	http://dx.doi.org/10.1371/journal.pone.0102582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019272	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600094
J	Bates, ML; Farrell, ET; Drezdon, A; Jacobson, JE; Perlman, SB; Eldridge, MW				Bates, Melissa L.; Farrell, Emily T.; Drezdon, Alyssa; Jacobson, Joseph E.; Perlman, Scott B.; Eldridge, Marlowe W.			Hypoxia and Exercise Increase the Transpulmonary Passage of Tc-99m-Labeled Albumin Particles in Humans	PLOS ONE			English	Article							INTRAPULMONARY ARTERIOVENOUS SHUNT; HEALTHY HUMANS; GAS-EXCHANGE; CARDIAC-OUTPUT; PULMONARY-EDEMA; SODIUM-NITROPRUSSIDE; ARTERIAL HYPOXEMIA; HUMAN LUNG; CIRCULATION; DOGS	Intrapulmonary arteriovenous anastomoses (IPAVs) are large diameter connections that allow blood to bypass the lung capillaries and may provide a route for right-to-left embolus transmission. These anastomoses are recruited by exercise and catecholamines and hypoxia. Yet, whether IPAVs are recruited via direct, oxygen sensitive regulatory mechanisms or indirect effects secondary to redistribution pulmonary blood flow is unknown. Here, we hypothesized that the addition of exercise to hypoxic gas breathing, which increases cardiac output, would augment IPAVs recruitment in healthy humans. To test this hypothesis, we measured the transpulmonary passage of Tc-99m-macroaggregated albumin particles (Tc-99m-MAA) in seven healthy volunteers, at rest and with exercise at 85% of volitional max, with normoxic (FIO2 = 0.21) and hypoxic (FIO2 = 0.10) gas breathing. We found increased Tc-99m-MAA passage in both exercise conditions and resting hypoxia. However, contrary to our hypothesis, we found the greatest Tc-99m-MAA passage with resting hypoxia. As an additional, secondary endpoint, we also noted that the transpulmonary passage of Tc-99m-MAA was well-correlated with the alveolar-arterial oxygen difference (A-aDO(2)) during exercise. While increased cardiac output has been proposed as an important modulator of IPAVs recruitment, we provide evidence that the modulation of blood flow through these pathways is more complex and that increasing cardiac output does not necessarily increase IPAVs recruitment. As we discuss, our data suggest that the resistance downstream of IPAVs is an important determinant of their perfusion.	[Bates, Melissa L.; Farrell, Emily T.; Drezdon, Alyssa; Jacobson, Joseph E.; Eldridge, Marlowe W.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Crit Care Div, Madison, WI 53706 USA; [Bates, Melissa L.; Farrell, Emily T.; Drezdon, Alyssa; Jacobson, Joseph E.; Eldridge, Marlowe W.] Univ Wisconsin, Sch Med & Publ Hlth, John Rankin Lab Pulm Med, Madison, WI USA; [Perlman, Scott B.] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Eldridge, Marlowe W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI USA; [Eldridge, Marlowe W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Kinesiol, Madison, WI USA; [Jacobson, Joseph E.] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Michigan State University College of Human Medicine	Bates, ML (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Crit Care Div, Madison, WI 53706 USA.	mlbates@pediatrics.wisc.edu	Bates, Melissa/K-1404-2017	Bates, Melissa/0000-0002-2605-0984	National Institutes of Health [5R01HL086897, 5T32HL007654]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007654, R01HL086897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the National Institutes of Health (5R01HL086897 and 5T32HL007654) and the American Heart Association (Postdoctoral Fellowship, Bates). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; Bates M, 2012, J APPL PHYSL; Bates ML, 2012, J APPL PHYSIOL, V112, P1915, DOI 10.1152/japplphysiol.00985.2011; BISHOP MJ, 1983, ANESTHESIOLOGY, V58, P130, DOI 10.1097/00000542-198302000-00005; BREEN PH, 1985, J APPL PHYSIOL, V59, P1313, DOI 10.1152/jappl.1985.59.4.1313; BREEN PH, 1982, J APPL PHYSIOL, V53, P1273, DOI 10.1152/jappl.1982.53.5.1273; Bryan TL, 2012, J APPL PHYSIOL, V113, P541, DOI 10.1152/japplphysiol.00404.2012; Cleophas T. J., 2006, STAT APPL CLIN TRIAL; COLLEY PS, 1979, ANESTHESIOLOGY, V50, P489, DOI 10.1097/00000542-197906000-00003; COLLEY PS, 1977, ANESTHESIOLOGY, V47, P338, DOI 10.1097/00000542-197710000-00003; CONHAIM RL, 1980, J APPL PHYSIOL, V48, P848, DOI 10.1152/jappl.1980.48.5.848; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; DANTZKER DR, 1980, CHEST, V77, P636, DOI 10.1378/chest.77.5.636; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; DINGEMANS KP, 1978, AM J PATHOL, V93, P353; DOGAN AS, 1993, J NUCL MED, V34, P1607; Eldridge MW, 2004, J APPL PHYSIOL, V97, P797, DOI 10.1152/japplphysiol.00137.2004; Eldridge MW, 1996, J APPL PHYSIOL, V81, P911, DOI 10.1152/jappl.1996.81.2.911; Elliott JE, 2011, J APPL PHYSIOL, V110, P35, DOI 10.1152/japplphysiol.00145.2010; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; GLEDHILL N, 1977, MUSCULAR EXERCISE LU, P325; Hopkins SR, 2009, J APPL PHYSIOL, V107, P993, DOI 10.1152/japplphysiol.91489.2008; JIANG ZL, 1994, J APPL PHYSIOL, V76, P882, DOI 10.1152/jappl.1994.76.2.882; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; KATO M, 1966, CIRC RES, V19, P426, DOI 10.1161/01.RES.19.2.426; KELMAN GR, 1966, J APPL PHYSIOL, V21, P1375, DOI 10.1152/jappl.1966.21.4.1375; KNUDSON RJ, 1980, AM REV RESPIR DIS, V122, P990; La Gerche A, 2010, J APPL PHYSIOL, V109, P1307, DOI 10.1152/japplphysiol.00457.2010; Lalande S, 2012, J PHYSIOL-LONDON, V590, P4279, DOI 10.1113/jphysiol.2012.234310; Laurie SS, 2011, J APPL PHYSIOL, V110, P1502, DOI 10.1152/japplphysiol.zdg-9606-corr.2011; Laurie SS, 2012, J APPL PHYSL; Lovering AT, 2008, J PHYSIOL-LONDON, V586, P4559, DOI 10.1113/jphysiol.2008.159350; Lovering AT, 2008, J APPL PHYSIOL, V104, P1418, DOI 10.1152/japplphysiol.00208.2007; Lovering AT, 2007, AM J PHYSIOL-HEART C, V292, pH1777, DOI 10.1152/ajpheart.01024.2006; Lovering AT, 2010, INJURY, V41, pS16, DOI 10.1016/S0020-1383(10)70004-8; Lovering AT, 2009, J APPL PHYSIOL, V107, P994, DOI 10.1152/japplphysiol.91489.2008a; Lovering AT, 2009, J APPL PHYSIOL, V106, P1986, DOI 10.1152/japplphysiol.01357.2007; Manohar M, 2005, J APPL PHYSIOL, V99, P224, DOI 10.1152/japplphysiol.01230.2004; Marriott K, 2013, J AM SOC ECHOCARDIOG, V26, P96, DOI 10.1016/j.echo.2012.09.007; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MOTLEY HL, 1947, AM J PHYSIOL, V150, P315, DOI 10.1152/ajplegacy.1947.150.2.315; NIDEN AH, 1956, CIRC RES, V4, P67, DOI 10.1161/01.RES.4.1.67; Pharmalucence, 2010, PULM KIT PREP TECHN; PRINZMETAL M, 1948, AM J PHYSIOL, V152, P48, DOI 10.1152/ajplegacy.1947.152.1.48; Reeves JT, 2005, AM J PHYSIOL-LUNG C, V288, pL419, DOI 10.1152/ajplung.00162.2004; STAUB NC, 1985, CHEST, V88, pS240, DOI 10.1378/chest.88.4_Supplement.240S; Stickland MK, 2007, AM J RESP CRIT CARE, V176, P300, DOI 10.1164/rccm.200702-206OC; Tabuchi A, 2013, AM J RESP CRIT CARE, V188, P474, DOI 10.1164/rccm.201212-2177OC; TOBIN CE, 1966, THORAX, V21, P197, DOI 10.1136/thx.21.3.197; Vogiatzis I, 2008, J PHYSIOL-LONDON, V586, P2381, DOI 10.1113/jphysiol.2007.150128; WAGNER PD, 1991, J APPL PHYSIOL, V71, P2191, DOI 10.1152/jappl.1991.71.6.2191; West JB., 2008, WESTS RESP PHYSL ESS, V9th	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101146	10.1371/journal.pone.0101146	http://dx.doi.org/10.1371/journal.pone.0101146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013985	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400018
J	Kruger, R; Rasmussen, LM; Argraves, WS; Eugen-Olsen, J; Nielsen, OW; Blyme, A; Willenheimer, R; Wachtell, K; Olsen, MH				Kruger, Ruan; Rasmussen, Lars M.; Argraves, William S.; Eugen-Olsen, Jesper; Nielsen, Olav W.; Blyme, Adam; Willenheimer, Ronnie; Wachtell, Kristian; Olsen, Michael H.			Extracellular Matrix Biomarker, Fibulin-1, Is Closely Related to NT-proBNP and Soluble Urokinase Plasminogen Activator Receptor in Patients with Aortic Valve Stenosis (The SEAS Study)	PLOS ONE			English	Article							ECHOCARDIOGRAPHIC ASSESSMENT; CARDIOVASCULAR-DISEASE; SIMVASTATIN; EZETIMIBE; RISK	Background: Fibulin-1, a circulating extracellular matrix glycoprotein, has been associated with arterial disease and elevated N-terminal prohormone B-type natriuretic peptide (NT-proBNP) in diabetes. Soluble urokinase plasminogen activator receptor (suPAR), a marker of inflammation, has been associated with subclinical atherosclerosis. Therefore, we aimed to explore the interplay between these biomarkers and mild to moderate aortic valve stenosis (AS). Methods: In 374 patients with mild to moderate AS, we investigated the relationship of fibulin-1 with NT-proBNP, levels of suPAR and the degree of AS at baseline and after one and four years of treatment with Simvastatin 40 mg and Ezetimibe 10 mg or placebo. Results: During treatment, fibulin-1 became more closely associated with NT-proBNP (beta(year0) = 0.10, p = 0.08, beta(year1) = 0.16, p = 0.005, beta(year4) = 0.22, p < 0.001) and suPAR (beta(year0) = 0.05, p = 0.34, beta(year1) = 0.16, p = 0.006, beta(year4) = 0.13, p = 0.03) at the expense of the association to aortic valve area index (AVAI) (beta(year0) = -0.14, p = 0.005, beta(year1) = -0.08, p = 0.11, beta(year4) = -0.06, p = 0.22) independently of age, gender, creatinine, and serum aspartate aminotransferase (Adj.R-year0(2) = 0.19, Adj.R-year1(2) = 0.22, Adj.R-year4(2) = 0.27). Fibulin-1 was unrelated to aortic regurgitation, left ventricular mass, and ejection fraction. In patients with baseline AVAI < 0.58 cm(2)/m(2) (median value), fibulin-1 was more closely associated to NT-proBNP (beta(year0) = 0.25, beta(year1) = 0.21, beta(year4) = 0.22, all p < 0.01), and suPAR (beta(year0) = 0.09, p = 0.26, beta(year1) = 0.23, beta(year4) = 0.21, both p < 0.01) independently of age, gender, AST and treatment allocation. Conclusions: Increased levels of fibulin-1 were independently associated with higher levels of suPAR and NT-proBNP especially in patients with lower AVAI, suggesting that fibulin-1 may be an early marker of AS as well as cardiac fibrosis secondarily to elevated left ventricular hemodynamic load.	[Kruger, Ruan; Olsen, Michael H.] North West Univ, Hypertens Africa Res Team, Potchefstroom, South Africa; [Kruger, Ruan; Olsen, Michael H.] Odense Univ Hosp, Cardiovasc & Metab Prevent Clin, Dept Endocrinol, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense, Denmark; [Rasmussen, Lars M.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense, Denmark; [Argraves, William S.] Med Univ S Carolina, Dept Cell Biol, Charleston, SC 29425 USA; [Eugen-Olsen, Jesper] Hvidovre Univ Hosp, Clin Res Ctr 136, Copenhagen, Denmark; [Nielsen, Olav W.] Bispebjerg Hosp, Dept Cardiol, DK-2400 Copenhagen, Denmark; [Blyme, Adam] Glostrup Cty Hosp, Dept Cardiol, Copenhagen, Denmark; [Willenheimer, Ronnie] Lund Univ, Malmo, Sweden; [Willenheimer, Ronnie] Heart Hlth Grp, Malmo, Sweden; [Wachtell, Kristian] Glostrup Cty Hosp, Dept Med, Copenhagen, Denmark	North West University - South Africa; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Medical University of South Carolina; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Lund University; University of Copenhagen	Kruger, R (corresponding author), North West Univ, Hypertens Africa Res Team, Potchefstroom, South Africa.	ruan.kruger@nwu.ac.za	Olsen, Michael H/H-8176-2014; Nielsen, Olav Wendelboe/S-4390-2016; Kruger, Ruan/N-7618-2015	Nielsen, Olav Wendelboe/0000-0003-3532-9431; Kruger, Ruan/0000-0001-7680-2032; Olsen, Michael Hecht/0000-0003-2230-5780; Rasmussen, Lars Melholt/0000-0001-5795-4794; Eugen-Olsen, Jesper/0000-0002-4630-4275	Novo Nordisk Fonden [NNF13OC0003736] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Agno FS, 2005, J HYPERTENS, V23, P867, DOI 10.1097/01.hjh.0000163157.14493.c7; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; Cangemi C, 2011, CLIN CHEM, V57, P1556, DOI 10.1373/clinchem.2011.162966; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; CURRIE PJ, 1985, CIRCULATION, V71, P1162, DOI 10.1161/01.CIR.71.6.1162; Dahl JS, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003889; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drolet MC, 2006, J AM COLL CARDIOL, V47, P850, DOI 10.1016/j.jacc.2005.09.049; Drolet MC, 2003, J AM COLL CARDIOL, V41, P1211, DOI 10.1016/S0735-1097(03)00090-1; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fay WP, 2007, ARTERIOSCL THROM VAS, V27, P1231, DOI 10.1161/ATVBAHA.107.140046; Fuhrman B, 2012, ATHEROSCLEROSIS, V222, P8, DOI 10.1016/j.atherosclerosis.2011.10.044; Godyna S, 1996, BLOOD, V88, P2569, DOI 10.1182/blood.V88.7.2569.bloodjournal8872569; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Kruger R, 2012, ATHEROSCLEROSIS, V222, P216, DOI 10.1016/j.atherosclerosis.2012.01.045; Kruger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058506; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Nicholl Suzanne M., 2006, Current Vascular Pharmacology, V4, P101, DOI 10.2174/157016106776359880; NODAHEINY H, 1995, ARTERIOSCL THROM VAS, V15, P37, DOI 10.1161/01.ATV.15.1.37; PERAKIS AC, 1990, EUR HEART J, V11, P492, DOI 10.1093/oxfordjournals.eurheartj.a059741; Rajamannan NM, 2001, J HEART VALVE DIS, V10, P371; Ramaraj R, 2008, BMJ-BRIT MED J, V336, P550, DOI 10.1136/bmj.39478.498819.AD; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Rossebo AB, 2007, AM J CARDIOL, V99, P970, DOI 10.1016/j.amjcard.2006.10.064; Sackner-Bernstein J D, 2000, Curr Cardiol Rep, V2, P112, DOI 10.1007/s11886-000-0007-4; Scholze A, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-6; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; VILLARI B, 1995, CIRCULATION, V91, P2353, DOI 10.1161/01.CIR.91.9.2353; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101522	10.1371/journal.pone.0101522	http://dx.doi.org/10.1371/journal.pone.0101522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014213	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400025
J	Woolpert, T; Phillips, CJ; Sevick, C; Crum-Cianflone, NF; Blair, PJ; Faix, D				Woolpert, Tabitha; Phillips, Christopher J.; Sevick, Carter; Crum-Cianflone, Nancy F.; Blair, Patrick J.; Faix, Dennis			Health-Related Behaviors and Effectiveness of Trivalent Inactivated versus Live Attenuated Influenza Vaccine in Preventing Influenza-Like Illness among Young Adults	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; IMMUNE-RESPONSE; DISEASES; VIRUS; SURVEILLANCE; INDUCTION; HUMANS; ABUSE	Background: Vaccination is the preferred preventive strategy against influenza. Though health behaviors are known to affect immunity and vaccine delivery modes utilize different immune processes, data regarding the preferred influenza vaccine type among adults endorsing specific health-related behaviors (alcohol use, tobacco use, and exercise level) are limited. Methods: The relative effectiveness of two currently available influenza vaccines were compared for prevention of influenza-like illness during 2 well-matched influenza seasons (2006/2007, 2008/2009) among US military personnel aged 18-49 years. Relative vaccine effectiveness was compared between those self-reporting and not reporting recent smoking history and potential alcohol problem, and by exercise level using Cox proportional hazard modeling adjusted for sociodemographic and military factors, geographic area, and other health behaviors. Results: 28,929 vaccination events and 3936 influenza-like illness events over both influenza seasons were studied. Of subjects, 27.5% were smokers, 7.7% had a potential alcohol-related problem, 10.5% reported minimal exercise, and 4.4% reported high exercise levels. Overall, the risk of influenza-like illness did not significantly differ between live attenuated and trivalent inactivated influenza vaccine recipients (hazard ratio, 0.98; 95% confidence interval, 0.90-1.06). In the final adjusted model, the relative effectiveness of the 2 vaccine types did not differ by smoking status (p = 0.10), alcohol status (p = 0.21), or activity level (p = 0.11). Conclusions: Live attenuated and trivalent inactivated influenza vaccines were similarly effective in preventing influenza-like illness among young adults and did not differ by health-related behavior status. Influenza vaccine efforts should continue to focus simply on delivering vaccine.	[Woolpert, Tabitha; Phillips, Christopher J.; Sevick, Carter; Crum-Cianflone, Nancy F.; Blair, Patrick J.; Faix, Dennis] Naval Hlth Res Ctr, San Diego, CA 92106 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Phillips, CJ (corresponding author), Naval Hlth Res Ctr, San Diego, CA 92106 USA.	chris.phillips@med.navy.mil			US Military Vaccine Agency (MILVAX)	US Military Vaccine Agency (MILVAX)	This work was supported by the US Military Vaccine Agency (MILVAX). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Brown LAS, 2006, ALCOHOL CLIN EXP RES, V30, P1624, DOI 10.1111/j.1530-0277.2006.00195.x; Bruunsgaard H, 1997, MED SCI SPORT EXER, V29, P1176, DOI 10.1097/00005768-199709000-00009; Centers for Disease Control and P, 2008, 2007 2008 INFL FLU S; Centers for Disease Control and P, 2008, INFL ACT US WORLDW 2, P692; Centers for Disease Control and P, 2007, UPD INFL ACT US WORL, P789; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Centers for Disease Control Prevention, 2011, MUCH PHYS ACT DO AD; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Cruijff M, 1999, VACCINE, V17, P426, DOI 10.1016/S0264-410X(98)00213-8; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DUDDING BA, 1973, AM J EPIDEMIOL, V97, P187, DOI 10.1093/oxfordjournals.aje.a121499; Edwards D, 2009, COPD, V6, P48, DOI 10.1080/15412550902724206; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; ESKOLA J, 1978, CLIN EXP IMMUNOL, V32, P339; FINKLEA JF, 1969, AM J EPIDEMIOL, V90, P390, DOI 10.1093/oxfordjournals.aje.a121084; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; GAYDOS CA, 1995, MIL MED, V160, P300, DOI 10.1093/milmed/160.6.300; Gleeson M, 1996, CLIN EXP IMMUNOL, V105, P238, DOI 10.1046/j.1365-2249.1996.d01-752.x; Gleeson M, 1999, MED SCI SPORT EXER, V31, P67, DOI 10.1097/00005768-199901000-00012; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Lau AH, 2009, TRENDS IMMUNOL, V30, P13, DOI 10.1016/j.it.2008.09.005; Mackinnon L., 1993, AUST J SCI MED SPORT, V25, P94; Mandrekar P, 2006, ALCOHOL CLIN EXP RES, V30, P135, DOI 10.1111/j.1530-0277.2006.00012.x; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Meyerholz DK, 2008, J IMMUNOL, V181, P641, DOI 10.4049/jimmunol.181.1.641; Nieman DC, 1999, SPORTS MED, V27, P73, DOI 10.2165/00007256-199927020-00001; Pavia CS, 2004, BIOMED PHARMACOTHER, V58, P84, DOI 10.1016/j.biopha.2003.12.005; Roseman C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3923; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; STANLEY WM, 1945, J EXP MED, V81, P193, DOI 10.1084/jem.81.2.193; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Szabo G, 1999, J CLIN IMMUNOL, V19, P67, DOI 10.1023/A:1020518703050; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; United States Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; Venkatraman JT, 1997, AGING CLIN EXP RES, V9, P42, DOI 10.1007/BF03340127; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265	46	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102154	10.1371/journal.pone.0102154	http://dx.doi.org/10.1371/journal.pone.0102154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013931	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400073
J	Zhang, SC; Gremer, L; Heise, H; Janning, P; Shymanets, A; Cirstea, IC; Krause, E; Nurnberg, B; Ahmadian, MR				Zhang, Si-Cai; Gremer, Lothar; Heise, Henrike; Janning, Petra; Shymanets, Aliaksei; Cirstea, Ion C.; Krause, Eberhard; Nuernberg, Bernd; Ahmadian, Mohammad Reza			Liposome Reconstitution and Modulation of Recombinant Prenylated Human Rac1 by GEFs, GDI1 and Pak1	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; GTPASE-ACTIVATING PROTEINS; NUCLEOTIDE EXCHANGE FACTOR; RHO-FAMILY GTPASES; NADPH OXIDASE; MEMBRANE TRANSLOCATION; STRUCTURAL BASIS; IN-VIVO; COMPLEX; BINDING	Small Rho GTPases are well known to regulate a variety of cellular processes by acting as molecular switches. The regulatory function of Rho GTPases is critically dependent on their posttranslational modification at the carboxyl terminus by isoprenylation and association with proper cellular membranes. Despite numerous studies, the mechanisms of recycling and functional integration of Rho GTPases at the biological membranes are largely unclear. In this study, prenylated human Rac1, a prominent member of the Rho family, was purified in large amount from baculovirus-infected Spodoptera frugiperda insect cells using a systematic detergent screening. In contrast to non-prenylated human Rac1 purified from Escherichia coli, prenylated Rac1 from insect cells was able to associate with synthetic liposomes and to bind Rho-specific guanine nucleotide dissociation inhibitor 1 (GDI1). Subsequent liposome reconstitution experiments revealed that GDI1 efficiently extracts Rac1 from liposomes preferentially in the inactive GDP-bound state. The extraction was prevented when Rac1 was activated to its GTP-bound state by Rac-specific guanine nucleotide exchange factors (GEFs), such as Vav2, Dbl, Tiam1, P-Rex1 and TrioN, and bound by the downstream effector Pak1. We found that dissociation of Rac1-GDP from its complex with GDI1 strongly correlated with two distinct activities of especially Dbl and Tiam1, including liposome association and the GDP/GTP exchange. Taken together, our results provided first detailed insights into the advantages of the in vitro liposome-based reconstitution system to study both the integration of the signal transducing protein complexes and the mechanisms of regulation and signaling of small GTPases at biological membranes.	[Zhang, Si-Cai; Gremer, Lothar; Cirstea, Ion C.; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Gremer, Lothar; Heise, Henrike] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Gremer, Lothar; Heise, Henrike] Res Ctr Julich GmbH, ICS 6, Inst Complex Syst, Julich, Germany; [Janning, Petra] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany; [Shymanets, Aliaksei; Nuernberg, Bernd] Tubingen Med Sch, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany; [Cirstea, Ion C.] Leibniz Inst Age Res, Jena, Germany; [Krause, Eberhard] Leibniz Inst Mol Pharmacol, Lab Mass Spectrometry, Berlin, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Heise, Henrike/A-7703-2010; Cirstea, Ion Cristian/AAQ-7670-2020; Gremer, Lothar/H-9128-2013	Heise, Henrike/0000-0002-9081-3894; Cirstea, Ion Cristian/0000-0003-3204-1598; Gremer, Lothar/0000-0001-7065-5027; Nurnberg, Bernd/0000-0002-5995-6555	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 [SFB 974]; International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich-Heine-University of Dusseldorf; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974; International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich-Heine-University of Dusseldorf; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf	This research was gratefully supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration'', and the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich-Heine-University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2009, CHEMBIOCHEM, V10, P98, DOI 10.1002/cbic.200800275; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Boissier P, 2013, TRAFFIC, V14, P1255, DOI 10.1111/tra.12123; Boura E, 2012, P NATL ACAD SCI USA, V109, P1901, DOI 10.1073/pnas.1117597109; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Contreras-Gomez A, 2013, BIOTECHNOL PROG; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fansa EK, 2013, BIOCHEM BIOPH RES CO, V434, P785, DOI 10.1016/j.bbrc.2013.04.012; Faure J, 1999, EUR J BIOCHEM, V262, P879, DOI 10.1046/j.1432-1327.1999.00458.x; FUCHS A, 1994, EUR J BIOCHEM, V226, P587, DOI 10.1111/j.1432-1033.1994.tb20084.x; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Herbrand U, 2006, BIOL CHEM, V387, P311, DOI 10.1515/BC.2006.041; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaiswal M, 2013, BIOL CHEM, V394, P89, DOI 10.1515/hsz-2012-0207; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mena JA, 2003, BIOTECHNIQUES, V34, P260, DOI 10.2144/03342bm05; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Ognibene M, 2014, GENE, V537, P220, DOI 10.1016/j.gene.2013.12.064; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Philips MR, 2007, J CLIN INVEST, V117, P1223, DOI 10.1172/JCI32108; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Shymanets A, 2012, BIOCHEM J, V441, P851, DOI 10.1042/BJ20111664; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Tnimov Z, 2012, J BIOL CHEM, V287, P26549, DOI 10.1074/jbc.M112.371294; Triola G, 2012, ACS CHEM BIOL, V7, P87, DOI 10.1021/cb200460u; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; Weise K, 2012, J AM CHEM SOC, V134, P11503, DOI 10.1021/ja305518h; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	72	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102425	10.1371/journal.pone.0102425	http://dx.doi.org/10.1371/journal.pone.0102425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014207	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400096
J	Coquery, CM; Wade, NS; Loo, WM; Kinchen, JM; Cox, KM; Jiang, C; Tung, KS; Erickson, LD				Coquery, Christine M.; Wade, Nekeithia S.; Loo, William M.; Kinchen, Jason M.; Cox, Kelly M.; Jiang, Chao; Tung, Kenneth S.; Erickson, Loren D.			Neutrophils Contribute to Excess Serum BAFF Levels and Promote CD4(+) T Cell and B Cell Responses in Lupus-Prone Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS; INTERFERON-GAMMA; IFN-GAMMA; LYMPHOCYTE STIMULATOR; MURINE LUPUS; DEFICIENT MICE; PLASMA-CELLS; ERYTHEMATOSUS; AUTOIMMUNITY; ACTIVATION	Despite increased frequencies of neutrophils found in autoimmune diseases such as systemic lupus erythematosus (SLE), how they contribute to disease pathogenesis and the mechanisms that affect the accumulation of neutrophils are poorly understood. The aim of this study was to identify factors in autoantibody-mediated autoimmunity that controls the accumulation of spleen resident neutrophils and to determine whether neutrophils contribute to abnormal B cell responses. Increased levels of the cytokine BAFF have been linked to loss of B cell tolerance in autoimmunity, but the cellular source responsible for excess BAFF is unknown. B cell maturation antigen (BCMA) is a receptor for BAFF and is critical for the survival of bone marrow plasma cells. Paradoxically, BCMA deficiency exacerbates the formation of autoantibody-secreting plasma cells in spleens of lupus-prone mice and the reasons for this effect are not understood. Here we analyzed the phenotype, localization and function of neutrophils in spleens of healthy mice and congenic lupus-prone mice, and compared mice sufficient or deficient in BCMA expression. Neutrophils were found to be significantly increased in frequency and activation status in spleens of lupus-prone mice when BCMA was absent. Furthermore, neutrophils localized within T cell zones and enhanced CD4(+) T cell proliferation and IFN gamma production through the production of BAFF. Reduced BAFF and IFN gamma serum levels, decreased frequencies of IFN gamma-producing T cells, germinal center B cells, and autoantibody production after neutrophil depletion indicated the involvement of neutrophils in these autoimmune traits. Thus, we have identified a novel role for BCMA to control excess BAFF production in murine lupus through restraining the accumulation of BAFF-producing neutrophils. Our data suggests that devising therapeutic strategies to reduce neutrophils in autoimmunity may decrease BAFF levels and ameliorate disease.	[Coquery, Christine M.; Kinchen, Jason M.; Cox, Kelly M.; Erickson, Loren D.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Coquery, Christine M.; Wade, Nekeithia S.; Loo, William M.; Kinchen, Jason M.; Cox, Kelly M.; Tung, Kenneth S.; Erickson, Loren D.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA USA; [Kinchen, Jason M.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA USA; [Tung, Kenneth S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Jiang, Chao] NIH, Div Extramural Res, Bethesda, MD 20892 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; National Institutes of Health (NIH) - USA	Erickson, LD (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	lde9w@virginia.edu	Kinchen, Jason/ABC-5663-2021	Kinchen, Jason/0000-0001-8430-2265	National Institutes of Health [R01 AI 093722, F31 AR 064145, 5T32A1007496-19]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041236, R01AI093722, T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR064145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant R01 AI 093722, F31 AR 064145, and 5T32A1007496-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; Assi LK, 2007, ARTHRITIS RHEUM-US, V56, P1776, DOI 10.1002/art.22697; Atzeni F, 2002, CELL IMMUNOL, V220, P20, DOI 10.1016/S0008-8749(03)00002-9; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Bonville CA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-14; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BUCKLE AM, 1989, J IMMUNOL, V143, P2295; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coquery CM, 2012, CYTOM PART A, V81A, P806, DOI 10.1002/cyto.a.22096; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gloyn AL, 2006, DIABETES, V55, P2272, DOI 10.2337/db06-0216; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Huard B, 2004, INT IMMUNOL, V16, P467, DOI 10.1093/intimm/dxh043; Jiang C, 2011, J IMMUNOL, V186, P6136, DOI 10.4049/jimmunol.1001931; Jorgensen TN, 2010, J IMMUNOL, V184, P775, DOI 10.4049/jimmunol.0901322; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Kim J, 2011, AUTOIMMUNITY, V44, P69, DOI 10.3109/08916934.2010.509122; KIM T, 1987, CLIN EXP IMMUNOL, V70, P562; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Pollard KM, 2013, DISCOV MED, V16, P123; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ratner PA, 2006, J EPIDEMIOL COMMUN H, V60, P606, DOI 10.1136/jech.2005.037952; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scapini P, 2008, IMMUNOL LETT, V116, P1, DOI 10.1016/j.imlet.2007.11.009; Scapini P, 2010, J EXP MED, V207, P1757, DOI 10.1084/jem.20100086; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200; Ye OR, 2004, EUR J IMMUNOL, V34, P2750, DOI 10.1002/eji.200425198; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	53	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102284	10.1371/journal.pone.0102284	http://dx.doi.org/10.1371/journal.pone.0102284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010693	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800088
J	Costes, LMM; van der Vliet, J; Farro, G; Matteoli, G; van Bree, SHW; Olivier, BJ; Nolte, MA; Boeckxstaens, GE; Cailotto, C				Costes, Lea M. M.; van der Vliet, Jan; Farro, Giovanna; Matteoli, Gianluca; van Bree, Sjoerd H. W.; Olivier, Brenda J.; Nolte, Martijn A.; Boeckxstaens, Guy E.; Cailotto, Cathy			The Spleen Responds to Intestinal Manipulation but Does Not Participate in the Inflammatory Response in a Mouse Model of Postoperative Ileus	PLOS ONE			English	Article							LYMPHOID-TISSUE; T-CELLS; CHEMOKINE; STROKE; MICE; STIMULATION; TRAFFICKING; INNERVATION; CONTRIBUTES; ACTIVATION	Background: Postoperative ileus is characterized by a transient impairment of the gastrointestinal motility after abdominal surgery. The intestinal inflammation, triggered by handling of the intestine, is the main factor responsible for the prolonged dysmotility of the gastrointestinal tract. Secondary lymphoid organs of the intestine were identified as essential components in the dissemination of inflammation to the entire gastrointestinal tract also called field effect. The involvement of the spleen, however, remains unclear. Aim: In this study, we investigated whether the spleen responds to manipulation of the intestine and participates in the intestinal inflammation underlying postoperative ileus. Methods: Mice underwent Laparotomy (L) or Laparotomy followed by Intestinal Manipulation (IM). Twenty-four hours later, intestinal and colonic inflammation was assessed by QPCR and measurement of the intestinal transit was performed. Analysis of homeostatic chemokines in the spleen was performed by QPCR and splenic cell populations analysed by Flow Cytometry. Blockade of the egress of cells from the spleen was performed by administration of the Sphingosine-1-phosphate receptor 1 (S1P(1)) agonist CYM-5442 10 h after L/IM. Results: A significant decrease in splenic weight and cellularity was observed in IM mice 24 h post-surgery, a phenomenon associated with a decreased splenic expression level of the homeostatic chemokine CCL19. Splenic denervation restored the expression of CCL19 and partially prevented the reduction of splenocytes in IM mice. Treatment with CYM-5442 prevented the egress of splenocytes but did not ameliorate the intestinal inflammation underlying postoperative ileus. Conclusions: Intestinal manipulation results in two distinct phenomena: local intestinal inflammation and a decrease in splenic cellularity. The splenic response relies on an alteration of cell trafficking in the spleen and is partially regulated by the splenic nerve. The spleen however does not participate in the intestinal inflammation during POI.	[Costes, Lea M. M.; van der Vliet, Jan; van Bree, Sjoerd H. W.; Olivier, Brenda J.; Cailotto, Cathy] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Olivier, Brenda J.; Nolte, Martijn A.] Sanquin Res & Landsteiner Lab AMC UvA, Dept Hematopoiesis, Adapt Immun Lab, Amsterdam, Netherlands; [Farro, Giovanna; Matteoli, Gianluca; Boeckxstaens, Guy E.] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; KU Leuven	Costes, LMM (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.m.costes@amc.nl	Nolte, Martijn A./AAC-8092-2022; Boeckxstaens, Guy/AAP-2502-2020	Nolte, Martijn A./0000-0002-5447-0839; Matteoli, Gianluca/0000-0002-2902-4976	Netherlands Organization for Scientific Research (NWO Vici grant) [918-76 623]; Maag Lever Darm Stichting [W09-30]	Netherlands Organization for Scientific Research (NWO Vici grant)(Netherlands Organization for Scientific Research (NWO)); Maag Lever Darm Stichting	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO Vici grant 918-76 623) (http://www.nwo.nl/) and by the Maag Lever Darm Stichting (W09-30) (http://www.mdl.nl/p_home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Ajmo CT, 2009, EXP NEUROL, V218, P47, DOI 10.1016/j.expneurol.2009.03.044; Asgeirsson T, 2010, J AM COLL SURGEONS, V210, P228, DOI 10.1016/j.jamcollsurg.2009.09.028; Cailotto C, 2012, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Engel DR, 2010, NAT MED, V16, P1407, DOI 10.1038/nm.2255; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HARRIS TJ, 1995, J AM COLL CARDIOL, V26, P102, DOI 10.1016/0735-1097(95)00123-H; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; Iyer S, 2009, J MANAGE CARE PHARM, V15, P485, DOI 10.18553/jmcp.2009.15.6.485; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Koscielny A, 2013, AM J PHYSIOL-GASTR L, V304, pG401, DOI 10.1152/ajpgi.00161.2012; Koscielny A, 2011, AM J PHYSIOL-GASTR L, V300, pG665, DOI 10.1152/ajpgi.00224.2010; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Perez SD, 2009, BRAIN RES, V1302, P106, DOI 10.1016/j.brainres.2009.09.012; Potsch C, 1999, EUR J IMMUNOL, V29, P3562, DOI 10.1002/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; Seeley EJ, 2013, J IMMUNOL, V190, P4717, DOI 10.4049/jimmunol.1300027; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Stewart IB, 2002, SPORTS MED, V32, P361, DOI 10.2165/00007256-200232060-00002; Stoffels B, 2009, GUT, V58, P648, DOI 10.1136/gut.2008.153288; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van Bree SHW, 2013, NEUROGASTROENT MOTIL, V25, pE540, DOI 10.1111/nmo.12157; van Bree SHW, 2012, NAT REV GASTRO HEPAT, V9, P675, DOI 10.1038/nrgastro.2012.134; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang J, 2007, EUR J PHARMACOL, V565, P76, DOI 10.1016/j.ejphar.2007.02.030; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102211	10.1371/journal.pone.0102211	http://dx.doi.org/10.1371/journal.pone.0102211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010202	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800082
J	Rocchi, L; Barbosa, AJM; Onofrillo, C; Del Rio, A; Montanaro, L				Rocchi, Laura; Barbosa, Armenio J. M.; Onofrillo, Carmine; Del Rio, Alberto; Montanaro, Lorenzo			Inhibition of Human Dyskerin as a New Approach to Target Ribosome Biogenesis	PLOS ONE			English	Article							PHASE-II EVALUATION; GUIDED PSEUDOURIDINE SYNTHASE; MESSENGER-RNA TRANSLATION; HUMAN BREAST-CANCER; TELOMERASE ACTIVITY; PYRAZOFURIN; EXPRESSION; THERAPEUTICS; MECHANISM; CARCINOMA	The product of the DKC1 gene, dyskerin, is required for both ribosome biogenesis and telomerase complex stabilization. Targeting these cellular processes has been explored for the development of drugs to selectively or preferentially kill cancer cells. Presently, intense research is conducted involving the identification of new biological targets whose modulation may simultaneously interfere with multiple cellular functions that are known to be hyper-activated by neoplastic transformations. Here, we report, for the first time, the computational identification of small molecules able to inhibit dyskerin catalytic activity. Different in silico techniques were applied to select compounds and analyze the binding modes and the interaction patterns of ligands in the human dyskerin catalytic site. We also describe a newly developed and optimized fast real-time PCR assay that was used to detect dyskerin pseudouridylation activity in vitro. The identification of new dyskerin inhibitors constitutes the first proof of principle that the pseudouridylation activity can be modulated by means of small molecule agents. Therefore, the presented results, obtained through the usage of computational tools and experimental validation, indicate an alternative therapeutic strategy to target ribosome biogenesis pathway.	[Rocchi, Laura; Barbosa, Armenio J. M.; Onofrillo, Carmine; Del Rio, Alberto; Montanaro, Lorenzo] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Rocchi, Laura] Univ Hosp Parma, Surg Pathol Unit, Parma, Italy; [Onofrillo, Carmine] Univ Bologna, Giorgio Prodi Interdept Canc Res Ctr, Bologna, Italy; [Del Rio, Alberto] CNR, Inst Organ Chem & Photoreact, Bologna, Italy	University of Bologna; University of Parma; University Hospital of Parma; University of Bologna; Consiglio Nazionale delle Ricerche (CNR)	Del Rio, A (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	alberto.delrio@gmail.com; lorenzo.montanaro@unibo.it	Barbosa, Arménio J Moura/O-2456-2015; Montanaro, Lorenzo/I-4236-2019; Barbosa, Arménio Moura/AAO-1899-2020; Del Rio, Alberto/F-5230-2010; Onofrillo, Carmine/X-7557-2019	Barbosa, Arménio J Moura/0000-0002-9756-4958; Montanaro, Lorenzo/0000-0001-9776-9518; Barbosa, Arménio Moura/0000-0002-9756-4958; Del Rio, Alberto/0000-0002-1890-6797; Onofrillo, Carmine/0000-0002-1076-6419; Onofrillo, Carmine/0000-0003-2537-6672	Associazione Italiana per la Ricerca sul Cancro (AIRC) - Emilia Romagna Start-Up grant [6266, IG-11416]; PRIN grant from the Italian Ministry of Education, University and Research [20104AE23N_002]; "Cassa di risparmio di Bologna (Carisbo)'' foundation	Associazione Italiana per la Ricerca sul Cancro (AIRC) - Emilia Romagna Start-Up grant(Fondazione AIRC per la ricerca sul cancro); PRIN grant from the Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); "Cassa di risparmio di Bologna (Carisbo)'' foundation	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) - Emilia Romagna Start-Up grant 6266 to ADR and IG-11416 to LM and by PRIN grant from the Italian Ministry of Education, University and Research n. 20104AE23N_002 to LM. The authors thank "Cassa di risparmio di Bologna (Carisbo)'' foundation for supporting LR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2011, HEAD NECK-J SCI SPEC, V33, P1041, DOI 10.1002/hed.21579; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barbosa AJM, 2012, CURR TOP MED CHEM, V12, P866; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BUDMAN D, 1977, CANCER TREAT REP, V61, P1733; CADMAN EC, 1978, CANCER RES, V38, P682; CARROLL DS, 1979, CANCER TREAT REP, V63, P139; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cormier WJ, CANC TREAT REP, V64, P655; CUMMINGS FJ, 1979, CANCER TREAT REP, V63, P1363; Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014; Del Rio A, 2010, MOL BIOSYST, V6, P2122, DOI 10.1039/c0mb00039f; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Duan JQ, 2009, MOL CELL, V34, P427, DOI 10.1016/j.molcel.2009.05.005; Edmonson JH, CANC TREAT REP, V65, P1127; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRALLA RJ, 1978, CANCER TREAT REP, V62, P1573; GRALLA RJ, 1978, CANCER TREAT REP, V62, P451; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Hoang C, 2005, PROTEIN SCI, V14, P2201, DOI 10.1110/ps.051493605; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2011, GENE DEV, V25, P2409, DOI 10.1101/gad.175299.111; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043147; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Montanaro L, 2008, CELL ONCOL, V30, P483, DOI 10.3233/CLO-2008-0436; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Montanaro L, 2012, BBA-REV CANCER, V1825, P101, DOI 10.1016/j.bbcan.2011.10.006; Montanaro L, 2010, J PATHOL, V222, P345, DOI 10.1002/path.2777; Montanaro L, 2010, CANCER RES, V70, P4767, DOI 10.1158/0008-5472.CAN-09-4024; NICHOLS WC, 1978, CANCER TREAT REP, V62, P837; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Rocchi L, 2013, NUCLEIC ACIDS RES, P1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sieron P, 2009, BRIT J CANCER, V101, P1410, DOI 10.1038/sj.bjc.6605299; Turano M, 2008, ACTA ONCOL, V47, P1598, DOI 10.1080/02841860801898616; VOGLER WR, 1978, CANCER TREAT REP, V62, P1569; Wang C, 2002, MOL CELL BIOL, V22, P8457, DOI 10.1128/MCB.22.24.8457-8466.2002; Wright WE, 1996, DEV GENET, V18, P173; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	49	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101971	10.1371/journal.pone.0101971	http://dx.doi.org/10.1371/journal.pone.0101971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010840	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800056
J	Christianson, D; Creel, S				Christianson, David; Creel, Scott			Ecosystem Scale Declines in Elk Recruitment and Population Growth with Wolf Colonization: A Before-After-Control-Impact Approach	PLOS ONE			English	Article							NORTHERN YELLOWSTONE ELK; ROCKY-MOUNTAIN ELK; ADULT FEMALE ELK; DENSITY-DEPENDENCE; PREDATION RISK; ANTIPREDATOR RESPONSE; TEMPORAL VARIATION; CERVUS-ELAPHUS; GRIZZLY BEARS; NATIONAL-PARK	The reintroduction of wolves (Canis lupus) to Yellowstone provided the unusual opportunity for a quasi-experimental test of the effects of wolf predation on their primary prey (elk - Cervus elaphus) in a system where top-down, bottom-up, and abiotic forces on prey population dynamics were closely and consistently monitored before and after reintroduction. Here, we examined data from 33 years for 12 elk population segments spread across southwestern Montana and northwestern Wyoming in a large scale before-after-control-impact analysis of the effects of wolves on elk recruitment and population dynamics. Recruitment, as measured by the midwinter juvenile: female ratio, was a strong determinant of elk dynamics, and declined by 35% in elk herds colonized by wolves as annual population growth shifted from increasing to decreasing. Negative effects of population density and winter severity on recruitment, long recognized as important for elk dynamics, were detected in uncolonized elk herds and in wolf-colonized elk herds prior to wolf colonization, but not after wolf colonization. Growing season precipitation and harvest had no detectable effect on recruitment in either wolf treatment or colonization period, although harvest rates of juveniles: females declined by 37% in wolf-colonized herds. Even if it is assumed that mortality due to predation is completely additive, liberal estimates of wolf predation rates on juvenile elk could explain no more than 52% of the total decline in juvenile: female ratios in wolf-colonized herds, after accounting for the effects of other limiting factors. Collectively, these long-term, large-scale patterns align well with prior studies that have reported substantial decrease in elk numbers immediately after wolf recolonization, relatively weak additive effects of direct wolf predation on elk survival, and decreased reproduction and recruitment with exposure to predation risk from wolves.	[Christianson, David] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Creel, Scott] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	University of Arizona; Montana State University System; Montana State University Bozeman	Christianson, D (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	dchristianson@email.arizona.edu			National Science Foundation (DEB 610) [1067129]; Division Of Environmental Biology [1067129] Funding Source: National Science Foundation	National Science Foundation (DEB 610); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (DEB 610 #1067129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Becker MS, 2009, TERR ECOL SER, V3, P339, DOI 10.1016/S1936-7961(08)00217-0; Bonenfant C, 2005, J APPL ECOL, V42, P361, DOI 10.1111/j.1365-2664.2005.01008.x; BRAZDA AR, 1953, J WILDLIFE MANAGE, V17, P9, DOI 10.2307/3796798; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; Christianson D, 2008, BEHAV ECOL, V19, P1258, DOI 10.1093/beheco/arn079; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Citta JJ, 2014, MAR MAMMAL SCI, V30, P20, DOI 10.1111/mms.12013; Coughenour MB, 1996, ECOL APPL, V6, P573, DOI 10.2307/2269393; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Creel S, 2013, ECOL EVOL, V3, P5189, DOI 10.1002/ece3.896; Creel S, 2011, ECOL APPL, V21, P2847, DOI 10.1890/11-0768.1; Creel S, 2011, ECOLOGY, V92, P2190, DOI 10.1890/11-0327.1; Creel S, 2009, J ANIM ECOL, V78, P1291, DOI 10.1111/j.1365-2656.2009.01581.x; Cunningham JA, 2009, J WILDLIFE MANAGE, V73, P639, DOI 10.2193/2008-010; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Doak DF, 2014, CONSERV LETT, V7, P312, DOI 10.1111/conl.12048; Eberhardt LL, 2007, J WILDLIFE MANAGE, V71, P594, DOI 10.2193/2005-770; Eberhardt LL, 1998, J WILDLIFE MANAGE, V62, P1046, DOI 10.2307/3802557; Evans SB, 2006, J WILDLIFE MANAGE, V70, P1372, DOI 10.2193/0022-541X(2006)70[1372:SOAFEI]2.0.CO;2; Fortin JK, 2013, J WILDLIFE MANAGE, V77, P270, DOI 10.1002/jwmg.483; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Garrott RA, 2009, TERR ECOL SER, V3, P1; Garrott RA, 2009, TERR ECOL SER, V3, P191, DOI 10.1016/S1936-7961(08)00211-X; Garrott RA, 2009, TERR ECOL SER, V3, P489, DOI 10.1016/S1936-7961(08)00223-6; GREER KENNETH R., 1964, TRANS N AMER WILDLIFE NATUR RESOURCES CONF, V29, P237; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; GUNTHER KA, 1990, INT C BEAR, V8, P329; Hamlin KL, 2009, TERR ECOL SER, V3, P541, DOI 10.1016/S1936-7961(08)00225-X; Haroldson MA, 2000, ANN REPORT INTERAGEN, P36; Haroldson MA, 2011, YELLOWSTONE GRIZZLY, P10; Harris NC, 2008, J WILDLIFE MANAGE, V72, P1143, DOI 10.2193/2007-277; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Houston D. B., 1982, NO YELLOWSTONE ELK; Johnson BK, 2013, J WILDLIFE MANAGE, V77, P102, DOI 10.1002/jwmg.427; Kay CE, 1997, J RANGE MANAGE, V50, P139, DOI 10.2307/4002370; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lime DW, 1993, ECOLOGICAL ISSUES RE, P306; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Middleton AD, 2013, ECOL LETT, V16, P1023, DOI 10.1111/ele.12133; Middleton AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0870; Murtaugh PA, 2007, ECOLOGY, V88, P56, DOI 10.1890/0012-9658(2007)88[56:SACIED]2.0.CO;2; Peacor SD, 2008, NONCONSUMPTIVE EFFEC; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; PEEK JM, 1967, J WILDLIFE MANAGE, V31, P304, DOI 10.2307/3798321; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Raithel JD, 2007, J WILDLIFE MANAGE, V71, P795, DOI 10.2193/2005-608; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Singer FJ, 1997, J WILDLIFE MANAGE, V61, P12, DOI 10.2307/3802410; Smith BL, 2006, NEONATAL MORTALITY E; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Stephenson S, 2010, WYOMING WILDL, V11, P2; Taper ML, 2002, J WILDLIFE MANAGE, V66, P106, DOI 10.2307/3802877; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x; Vucetich JA, 2011, J ANIM ECOL, V80, P1236, DOI 10.1111/j.1365-2656.2011.01855.x; White PJ, 2011, ECOL APPL, V21, P3, DOI 10.1890/09-2123.1; White PJ, 2005, WILDLIFE SOC B, V33, P942, DOI 10.2193/0091-7648(2005)33[942:NYEAWR]2.0.CO;2; White PJ, 2005, BIOL CONSERV, V125, P141, DOI 10.1016/j.biocon.2005.01.048; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wright GJ, 2006, J WILDLIFE MANAGE, V70, P1070, DOI 10.2193/0022-541X(2006)70[1070:SONYEB]2.0.CO;2	69	31	32	3	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102330	10.1371/journal.pone.0102330	http://dx.doi.org/10.1371/journal.pone.0102330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028933	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600064
J	Dhamecha, TI; Singh, R; Vatsa, M; Kumar, A				Dhamecha, Tejas Indulal; Singh, Richa; Vatsa, Mayank; Kumar, Ajay			Recognizing Disguised Faces: Human and Machine Evaluation	PLOS ONE			English	Article							RECOGNITION ALGORITHMS; SYSTEM; REPRESENTATION; VERIFICATION; EIGENFACES; ROBUST; AGE	Face verification, though an easy task for humans, is a long-standing open research area. This is largely due to the challenging covariates, such as disguise and aging, which make it very hard to accurately verify the identity of a person. This paper investigates human and machine performance for recognizing/verifying disguised faces. Performance is also evaluated under familiarity and match/mismatch with the ethnicity of observers. The findings of this study are used to develop an automated algorithm to verify the faces presented under disguise variations. We use automatically localized feature descriptors which can identify disguised face patches and account for this information to achieve improved matching accuracy. The performance of the proposed algorithm is evaluated on the IIIT-Delhi Disguise database that contains images pertaining to 75 subjects with different kinds of disguise variations. The experiments suggest that the proposed algorithm can outperform a popular commercial system and evaluates them against humans in matching disguised face images.	[Dhamecha, Tejas Indulal; Singh, Richa; Vatsa, Mayank] IIIT Delhi, New Delhi, India; [Kumar, Ajay] Hong Kong Polytech Univ, Dept Comp, Hong Kong, Hong Kong, Peoples R China	Indraprastha Institute of Information Technology Delhi; Hong Kong Polytechnic University	Vatsa, M (corresponding author), IIIT Delhi, New Delhi, India.	mayank@iiitd.ac.in	Singh, Richa/M-9961-2017; Vatsa, Mayank/I-5050-2013; Vatsa, Mayank/AAR-7199-2020	Singh, Richa/0000-0003-4060-4573; Vatsa, Mayank/0000-0001-5952-2274; Vatsa, Mayank/0000-0001-5952-2274; Kumar, Ajay/0000-0002-3761-2436	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This research is partly supported through a research grant from Department of Science and Technology, Government of India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2004, LECT NOTES COMPUT SC, V3021, P469; Bartlett MS, 1997, P ANN JOINT S NEUR C; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bhatt HS, 2012, IEEE T INF FOREN SEC, V7, P1522, DOI 10.1109/TIFS.2012.2204252; Bicego M., 2006, P C COMP VIS PATT RE, V2006, P35, DOI [DOI 10.1109/CVPRW.2006.149, 10.1109/CVPRW.2006.149]; Bigun J, 2001, LECT NOTES COMPUT SC, V2091, P44; Biswas S, 2008, P IEEE INT C BIOM TH, DOI [10.1109/BTAS.2008.4699331, DOI 10.1109/BTAS.2008.4699331]; Bolme DS, 2003, LECT NOTES COMPUT SC, V2626, P304; Burton AM, 2011, BRIT J PSYCHOL, V102, P943, DOI 10.1111/j.2044-8295.2011.02039.x; Chen J, 2010, IEEE T PATTERN ANAL, V32, P1705, DOI 10.1109/TPAMI.2009.155; Chen X, 2005, COMPUT VIS IMAGE UND, V99, P332, DOI 10.1016/j.cviu.2005.03.001; Choi I, 2010, LECT NOTES COMPUT SC, V6455, P199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; De Marsico M, 2012, PATTERN RECOGN, V45, P2348, DOI 10.1016/j.patcog.2011.12.005; De Marsico M, 2009, LECT NOTES COMPUT SC, V5414, P1, DOI 10.1007/978-3-540-92957-4_1; Dhamecha TI, 2013, INT CONF BIOMETR; Douma A., 2012, J VISION, V12, P980, DOI [10.1167/12.9.980, DOI 10.1167/12.9.980]; Dubois S, 1999, NEUROIMAGE, V9, P278, DOI 10.1006/nimg.1998.0409; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Grother P. J., 2010, REPORT EVALUATION 2D; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Kim J, 2005, LECT NOTES ARTIF INT, V3533, P65; Kim J, 2005, IEEE T PATTERN ANAL, V27, P1977, DOI 10.1109/TPAMI.2005.242; Klare B., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1513, DOI 10.1109/ICPR.2010.374; Klare BF, 2011, IEEE T PATTERN ANAL, V33, P639, DOI 10.1109/TPAMI.2010.180; Leder H, 2005, Q J EXP PSYCHOL-A, V58, P235, DOI 10.1080/02724980343000936; Li ZF, 2011, IEEE T INF FOREN SEC, V6, P1028, DOI 10.1109/TIFS.2011.2156787; Martinez A., 1998, AR FACE DATABASE CVC; Martinez AM, 2002, IEEE T PATTERN ANAL, V24, P748, DOI 10.1109/TPAMI.2002.1008382; Moniz E, 2010, J VISUAL-JAPAN, V10, P615; O'Toole AJ, 2007, IEEE T SYST MAN CY B, V37, P1149, DOI 10.1109/TSMCB.2007.907034; O'Toole AJ, 2007, IEEE T PATTERN ANAL, V29, P1642, DOI 10.1109/TPAMI.2007.1107; O'Toole AJ, 2012, ACM T APPL PERCEPT, V9, DOI 10.1145/2355598.2355599; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; Pavlidis I, 2000, IEEE WORKSHOP ON COMPUTER VISION BEYOND THE VISIBLE SPECTRUM: METHODS AND APPLICATIONS, PROCEEDINGS, P15, DOI 10.1109/CVBVS.2000.855246; Phillips PJ, 2011, ACM T APPL PERCEPT, V8, DOI 10.1145/1870076.1870082; Ramanathan N, 2004, IEEE IMAGE PROC, P1999; Ramanathan N, 2006, IEEE T IMAGE PROCESS, V15, P3349, DOI 10.1109/TIP.2006.881993; Righi G, 2012, VIS COGN, V20, P143, DOI 10.1080/13506285.2012.654624; Rui Min, 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P442, DOI 10.1109/FG.2011.5771439; Singh R, 2008, INFORM FUSION, V9, P200, DOI 10.1016/j.inffus.2006.06.002; Singh R, 2010, IEEE T INF FOREN SEC, V5, P441, DOI 10.1109/TIFS.2010.2054083; Singh R, 2009, IMAGE VISION COMPUT, V27, P245, DOI 10.1016/j.imavis.2007.06.010; Sinha P, 2006, P IEEE, V94, P1948, DOI 10.1109/JPROC.2006.884093; 't Hart BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025373; Tajima Y, 2013, INT CONF BIOMETR; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Toseeb U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034144; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Wiskott L, 1997, IEEE T PATTERN ANAL, V19, P775, DOI 10.1109/34.598235; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang M, 2010, LECT NOTES COMPUT SC, V6316, P448, DOI 10.1007/978-3-642-15567-3_33; Yoon S.M., 2002, P IAPR C MACH VIS AP, P546; Yoon S, 2012, IEEE T PATTERN ANAL, V34, P451, DOI 10.1109/TPAMI.2011.161; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	56	68	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e99212	10.1371/journal.pone.0099212	http://dx.doi.org/10.1371/journal.pone.0099212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029188	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600003
J	Hertel, A; Kaminski, J; Tomasello, M				Hertel, Anne; Kaminski, Juliane; Tomasello, Michael			Generalize or Personalize - Do Dogs Transfer an Acquired Rule to Novel Situations and Persons?	PLOS ONE			English	Article							CANIS-FAMILIARIS; ASSOCIATION	Recent studies have raised the question of whether dogs, like human infants, comprehend an established rule as generalizable, normative knowledge or rather as episodic information, existing only in the immediate situation. In the current study we tested whether dogs disobeyed a prohibition to take a treat (i) in the presence of the communicator of the ban, (ii) after a temporary absence of the communicator, and (iii) in the presence of a novel person. Dogs disobeyed the rule significantly more often when the communicator left the room for a moment or when they were faced with a new person, than when she stayed present in the room. These results indicate that dogs "forget" a rule as soon as the immediate human context becomes disrupted.	[Hertel, Anne; Kaminski, Juliane; Tomasello, Michael] Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany; [Hertel, Anne] Univ Bremen, Inst Ecol, D-28359 Bremen, Germany; [Kaminski, Juliane] Univ Portsmouth, Portsmouth, Hants, England	Max Planck Society; University of Bremen; University of Portsmouth	Hertel, A (corresponding author), Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany.	anne.hertel@hotmail.com		Kaminski, Juliane/0000-0002-3437-3484; Hertel, Anne/0000-0001-7952-8243	Volkswagenstiftung	Volkswagenstiftung(Volkswagen)	Juliane Kaminski was funded by a grant from the Volkswagenstiftung (http://www.volkswagen-stiftung.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Ashton RL, 2011, J COMP PSYCHOL, V125, P194, DOI 10.1037/a0022584; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D. M., 2010, LME4 MIXED EFFECTS M; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Carpenter M., 1998, MONOGR SOC RES CHILD, V63; Csibra G, 2006, ATTENTION PERFORM, P249; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Dumas C, 1998, BEHAV PROCESS, V42, P101, DOI 10.1016/S0376-6357(97)00071-5; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T., 2011, EXACTRANKTESTS EXACT; MARSHALLPESCINI S, 2012, PLOS ONE, V7; Piaget J., 1954, CONSTRUCTION REALITY; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rakoczy H, 2008, DEV PSYCHOL, V44, P875, DOI 10.1037/0012-1649.44.3.875; Rakoczy H, 2013, CHILD DEV PERSPECT, V7, P17, DOI 10.1111/cdep.12010; Rakoczy H, 2009, BRIT J DEV PSYCHOL, V27, P445, DOI 10.1348/026151008X337752; Rakoczy H, 2009, COGNITIVE DEV, V24, P61, DOI 10.1016/j.cogdev.2008.07.004; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Tomasello M, 2009, SCIENCE, V325, P1213, DOI 10.1126/science.1179670; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Watson JS, 2001, J COMP PSYCHOL, V115, P219, DOI 10.1037//0735-7036.115.3.219; Zuur Alain F., 2009, P1	28	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102666	10.1371/journal.pone.0102666	http://dx.doi.org/10.1371/journal.pone.0102666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029253	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600091
J	Larsson, AI; Jarnegren, J; Stromberg, SM; Dahl, MP; Lundalv, T; Brooke, S				Larsson, Ann I.; Jarnegren, Johanna; Stromberg, Susanna M.; Dahl, Mikael P.; Lundalv, Tomas; Brooke, Sandra			Embryogenesis and Larval Biology of the Cold-Water Coral Lophelia pertusa	PLOS ONE			English	Article							BROADCAST-SPAWNING CORALS; NON-MENDELIAN INHERITANCE; FOOD-SUPPLY MECHANISMS; DEEP-SEA CORAL; SCLERACTINIAN CORAL; GENETIC-STRUCTURE; ENVIRONMENTAL CONTROLS; MICROSATELLITE LOCI; MARINE POPULATIONS; ASEXUAL PRODUCTION	Cold-water coral reefs form spectacular and highly diverse ecosystems in the deep sea but little is known about reproduction, and virtually nothing about the larval biology in these corals. This study is based on data from two locations of the North East Atlantic and documents the first observations of embryogenesis and larval development in Lophelia pertusa, the most common framework-building cold-water scleractinian. Embryos developed in a more or less organized radial cleavage pattern from similar to 160 mu m large neutral or negatively buoyant eggs, to 120-270 mu m long ciliated planulae. Embryogenesis was slow with cleavage occurring at intervals of 6-8 hours up to the 64-cell stage. Genetically characterized larvae were sexually derived, with maternal and paternal alleles present. Larvae were active swimmers (0.5 mm s(-1)) initially residing in the upper part of the water column, with bottom probing behavior starting 3-5 weeks after fertilization. Nematocysts had developed by day 30, coinciding with peak bottom-probing behavior, and possibly an indication that larvae are fully competent to settle at this time. Planulae survived for eight weeks under laboratory conditions, and preliminary results indicate that these planulae are planktotrophic. The late onset of competency and larval longevity suggests a high dispersal potential. Understanding larval biology and behavior is of paramount importance for biophysical modeling of larval dispersal, which forms the basis for predictions of connectivity among populations.	[Larsson, Ann I.; Stromberg, Susanna M.; Dahl, Mikael P.] Univ Gothenburg, Dept Biol & Environm Sci, Tjarno, Sweden; [Jarnegren, Johanna] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Lundalv, Tomas] Univ Gothenburg, Sven Loven Ctr Marine Sci, Tjarno, Sweden; [Brooke, Sandra] Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA	University of Gothenburg; Norwegian Institute Nature Research; University of Gothenburg; State University System of Florida; Florida State University	Jarnegren, J (corresponding author), Univ Tromsoe, Dept Med Biol, Tromso, Norway.	Johanna.Jarnegren@nina.no	Lundälv, Tomas/O-7121-2019; Larsson, Ann/I-1807-2013		Statoil through the CORAMM (Coral Risk Assessment, Monitoring and Modelling) project; VISTA project [6153]; Research Council of Norway [204025 DIACORA]; FORMAS [2010-1604]; Oscar and Lili Lamm foundation; EC FP 7 project HERMIONE [226354]	Statoil through the CORAMM (Coral Risk Assessment, Monitoring and Modelling) project; VISTA project; Research Council of Norway(Research Council of Norway); FORMAS(Swedish Research Council Formas); Oscar and Lili Lamm foundation; EC FP 7 project HERMIONE	This work was funded by Statoil through the CORAMM (Coral Risk Assessment, Monitoring and Modelling) project, by VISTA project No. 6153 and by the Research Council of Norway through project No. 204025 DIACORA. Additional support was provided by FORMAS (contract No. 2010-1604; http://www.formas.se), by Oscar and Lili Lamm foundation (http://www.stiftelsenlamm.a.se), and by EC FP 7 project HERMIONE, grant agreement No. 226354 (http://www.eu-hermione.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abr`amoff M.D., 2004, IMAGE PROCESSING IMA; Altieri AH, 2003, BIOL BULL-US, V204, P241, DOI 10.2307/1543595; Ayre DJ, 1997, MAR ECOL PROG SER, V159, P175, DOI 10.3354/meps159175; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Baird AH, 2004, MAR FRESHWATER RES, V55, P469, DOI 10.1071/MF03121; Ball EE, 2002, INT J DEV BIOL, V46, P671; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Bell N, 1999, NATURE, V402, P601, DOI 10.1038/45127; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Brooke S, 2005, MAR BIOL, V146, P665, DOI 10.1007/s00227-004-1481-9; Brooke S, 2003, CONT SHELF RES, V23, P847, DOI 10.1016/S0278-4343(03)00080-3; Brooke S, DEEPWATER P IN PRESS; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; Brusca RC, 2003, INVERTEBRATES; CHIA FS, 1979, J MORPHOL, V160, P275, DOI 10.1002/jmor.1051600303; CHIA FS, 1973, MAR BIOL, V23, P73, DOI 10.1007/BF00394113; Chinga-Carrasco, 2002, MICROSCOPY SCI TECH, P2182; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cordes EE, 2008, DEEP-SEA RES PT I, V55, P777, DOI 10.1016/j.dsr.2008.03.005; Corell H, 2012, MAR ECOL PROG SER, V467, P29, DOI 10.3354/meps09963; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dahl MP, 2012, CORAL REEFS, V31, P1135, DOI 10.1007/s00338-012-0937-5; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; Dobrowolski MP, 2002, FUNGAL GENET BIOL, V35, P197, DOI 10.1006/fgbi.2001.1319; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; Gleason DF, 2009, CORAL REEFS, V28, P549, DOI 10.1007/s00338-009-0480-1; Gleason DF, 2011, J EXP MAR BIOL ECOL, V408, P42, DOI 10.1016/j.jembe.2011.07.025; Harii S, 2002, MAR TECHNOL SOC J, V36, P76, DOI 10.4031/002533202787914188; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hayashibara T., 1997, P 8 INT COR REEF S, V2, P1231; Hayward DC, 2004, DEV GENES EVOL, V214, P257, DOI 10.1007/s00427-004-0398-0; Hellberg ME, 2002, MAR BIOL, V141, P629, DOI 10.1007/s00227-002-0861-2; Henry LA, 2007, DEEP-SEA RES PT I, V54, P654, DOI 10.1016/j.dsr.2007.01.005; Heyward AJ, 2012, SCIENCE, V335, P1064, DOI 10.1126/science.1216055; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; JACKSON JBC, 1986, B MAR SCI, V39, P588; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; KERR AM, 2010, P ROY SOC LOND B BIO, V278, P75; Larsson AI, 2006, ECOLOGY, V87, P1960, DOI 10.1890/0012-9658(2006)87[1960:BLASFE]2.0.CO;2; Larsson AI, 2013, MAR ECOL PROG SER, V483, P169, DOI 10.3354/meps10284; Lavaleye M, 2009, OCEANOGRAPHY, V22, P76, DOI 10.5670/oceanog.2009.08; Lavaleye MSS, 2001, CORAL RECRUITMENT EX, V20; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Levin Lisa A., 1995, P1; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Mangubhai S, 2009, MAR ECOL PROG SER, V374, P305, DOI 10.3354/meps07910; Martin Vicki J., 2002, P51; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Mercier A, 2011, MAR BIOL, V158, P371, DOI 10.1007/s00227-010-1565-7; Morrison CL, 2008, MOL ECOL RESOUR, V8, P1037, DOI 10.1111/j.1755-0998.2008.02147.x; Morrison CL, 2011, CONSERV GENET, V12, P713, DOI 10.1007/s10592-010-0178-5; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mullineaux LS, 1997, DEEP-SEA RES PT I, V44, P745, DOI 10.1016/S0967-0637(96)00130-6; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Raimondi PT, 2000, ECOLOGY, V81, P3193, DOI 10.1890/0012-9658(2000)081[3193:TCOCLB]2.0.CO;2; REED JK, 1980, B MAR SCI, V30, P667; Rentzsch F, 2008, DEVELOPMENT, V135, P1761, DOI 10.1242/dev.020784; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2002, UNDERWATER TECHNOL, V25, P83, DOI 10.3723/175605402783219163; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROSEN BR, 1969, SCIENCE, V166, P119, DOI 10.1126/science.166.3901.119; SAMMARCO PW, 1982, MAR ECOL PROG SER, V10, P57, DOI 10.3354/meps010057; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Smith KL, 2000, AM J PRIMATOL, V51, P219; Sponaugle S, 2002, B MAR SCI, V70, P341; Stake JL, 2003, J EXP MAR BIOL ECOL, V288, P181, DOI 10.1016/S0022-0981(03)00018-2; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; STODDART JA, 1988, MAR BIOL, V99, P489, DOI 10.1007/BF00392556; Strathmann M.F., 1987, P83; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; TRANTER PRG, 1982, J MAR BIOL ASSOC UK, V62, P845, DOI 10.1017/S0025315400070387; Valentine JW, 1997, P NATL ACAD SCI USA, V94, P8001, DOI 10.1073/pnas.94.15.8001; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Waller RG, 2005, CORAL REEFS, V24, P514, DOI 10.1007/s00338-005-0501-7; Waller RG, 2008, DEEP-SEA RES PT II, V55, P2527, DOI 10.1016/j.dsr2.2008.07.001; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Williams B, 2006, GEOLOGY, V34, P773, DOI 10.1130/G22685.1; Wisshak M, 2005, ERLANGEN EARTH C SER, P979, DOI 10.1007/3-540-27673-4_49; Yamashita K, 2003, BIOL BULL-US, V204, P256, DOI 10.2307/1543597; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y	97	48	48	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102222	10.1371/journal.pone.0102222	http://dx.doi.org/10.1371/journal.pone.0102222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028936	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600048
J	Neshati, Z; Liu, J; Zhou, GQ; Schalij, MJ; de Vries, AAF				Neshati, Zeinab; Liu, Jia; Zhou, Guangqian; Schalij, Martin J.; de Vries, Antoine A. F.			Development of a Lentivirus Vector-Based Assay for Non-Destructive Monitoring of Cell Fusion Activity	PLOS ONE			English	Article							GENE-EXPRESSION; LUCIFERASE REPORTER; DIFFERENTIATION; CARDIOMYOCYTES; EFFICIENCY; CULTURE; CODON	Cell-to-cell fusion can be quantified by endowing acceptor and donor cells with latent reporter genes/proteins and activators of these genes/proteins, respectively. One way to accomplish this goal is by using a bipartite lentivirus vector (LV)-based cell fusion assay system in which the cellular fusion partners are transduced with a flippase-activatable Photinus pyralis luciferase (PpLuc) expression unit (acceptor cells) or with a recombinant gene encoding FLPe(NLS+), a nuclear-targeted and molecularly evolved version of flippase (donor cells). Fusion of both cell populations will lead to the FLPe-dependent generation of a functional PpLuc gene. PpLuc activity is typically measured in cell lysates, precluding consecutive analysis of one cell culture. Therefore, in this study the PpLuc-coding sequence was replaced by that of Gaussia princeps luciferase (GpLuc), a secretory protein allowing repeated analysis of the same cell culture. In myotubes the spread of FLPe(NLS+) may be limited due to its nuclear localization signal (NLS) causing low signal outputs. To test this hypothesis, myoblasts were transduced with LVs encoding either FLPe(NLS+) or an NLS-less version of FLPe (FLPe(NLS+)) and subsequently co-cultured in different ratios with myoblasts containing the FLPe-activatable GpLuc expression cassette. At different times after induction of cell-to-cell fusion the GpLuc activity in the culture medium was determined. FLPe(NLS+) and FLPe(NLS+) both activated the latent GpLuc gene but when the percentage of FLPe-expressing myoblasts was limiting, FLPe(NLS+) generally yielded slightly higher signals than FLPe(NLS+) while at low acceptor-to-donor cell ratios FLPe(NLS+) was usually superior. The ability of FLPe(NLS+) to spread through myofibers and to induce reporter gene expression is thus not limited by its NLS. However, at high FLPe concentrations the presence of the NLS negatively affected reporter gene expression. In summary, a rapid and simple chemiluminescence assay for quantifying cell-to-cell fusion progression based on GpLuc has been developed.	[Neshati, Zeinab; Liu, Jia; Schalij, Martin J.; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Heart Ctr Leiden, Leiden, Netherlands; [Liu, Jia; Zhou, Guangqian] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Shenzhen University	de Vries, AAF (corresponding author), Leiden Univ, Med Ctr, Heart Ctr Leiden, Leiden, Netherlands.	a.a.f.de_vries@lumc.nl	Neshati, Zeinab/O-5856-2017; de Vries, Antoine/ABG-5787-2021	Neshati, Zeinab/0000-0003-2644-6679; 	Dutch Duchenne Parent Project (DPP); Iranian Ministry of Science, Research and Technology	Dutch Duchenne Parent Project (DPP); Iranian Ministry of Science, Research and Technology	This work was supported by research grants from the Dutch Duchenne Parent Project (DPP) and the Iranian Ministry of Science, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; Feng T, 2002, BIOTECHNIQUES, V32, P992, DOI 10.2144/02325bm03; Goncalves MAFV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010954; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GRZESCHIK KH, 1986, EXPERIENTIA, V42, P1128, DOI 10.1007/BF01941287; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Holkers M, 2006, BIOTECHNIQUES, V41, P711, DOI 10.2144/000112307; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Maguire CA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.25; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Ramkisoensing AA, 2012, STEM CELLS, V30, P2830, DOI 10.1002/stem.1236; Ramkisoensing AA, 2012, STEM CELLS, V30, P1236, DOI 10.1002/stem.1086; Sambrook J., 2001, MOL CLONING LAB MANU; Sanges D, 2011, ADV EXP MED BIOL, V713, P137, DOI 10.1007/978-94-007-0763-4_9; Serov OL, 2011, INT REV CEL MOL BIO, V291, P155, DOI 10.1016/B978-0-12-386035-4.00005-7; Shinn-Thomas JH, 2011, INT REV CEL MOL BIO, V289, P149, DOI 10.1016/B978-0-12-386039-2.00005-5; Shinn-Thomas Jessica H., 2008, V475, P347, DOI 10.1007/978-1-59745-250-2_20; Sinkovics JG, 2011, ADV EXP MED BIOL, V714, P5, DOI 10.1007/978-94-007-0782-5_2; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Uil TG, 2009, J GENE MED, V11, P990, DOI 10.1002/jgm.1395; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102433	10.1371/journal.pone.0102433	http://dx.doi.org/10.1371/journal.pone.0102433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028973	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600073
J	Cukras, S; Morffy, N; Ohn, T; Kee, Y				Cukras, Scott; Morffy, Nicholas; Ohn, Takbum; Kee, Younghoon			Inactivating UBE2M Impacts the DNA Damage Response and Genome Integrity Involving Multiple Cullin Ligases	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; UBIQUITIN LIGASE; BETA-TRCP; S-PHASE; MEDIATED DEGRADATION; NEDD8 CONJUGATION; CDK INHIBITOR; CELL-CYCLE; REPLICATION; NEDDYLATION	Protein neddylation is involved in a wide variety of cellular processes. Here we show that the DNA damage response is perturbed in cells inactivated with an E2 Nedd8 conjugating enzyme UBE2M, measured by RAD51 foci formation kinetics and cell based DNA repair assays. UBE2M knockdown increases DNA breakages and cellular sensitivity to DNA damaging agents, further suggesting heightened genomic instability and defective DNA repair activity. Investigating the downstream Cullin targets of UBE2M revealed that silencing of Cullin 1, 2, and 4 ligases incurred significant DNA damage. In particular, UBE2M knockdown, or defective neddylation of Cullin 2, leads to a blockade in the G1 to S progression and is associated with delayed S-phase dependent DNA damage response. Cullin 4 inactivation leads to an aberrantly high DNA damage response that is associated with increased DNA breakages and sensitivity of cells to DNA damaging agents, suggesting a DNA repair defect is associated. siRNA interrogation of key Cullin substrates show that CDT1, p21, and Claspin are involved in elevated DNA damage in the UBE2M knockdown cells. Therefore, UBE2M is required to maintain genome integrity by activating multiple Cullin ligases throughout the cell cycle.	[Cukras, Scott; Morffy, Nicholas; Kee, Younghoon] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33606 USA; [Ohn, Takbum] Chosun Univ, Coll Med, Dept Cellular & Mol Med, Kwangju, South Korea	State University System of Florida; University of South Florida; Chosun University	Kee, Y (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33606 USA.	Ykee@usf.edu	Kee, Younghoon/J-4107-2019	Morffy, Nicholas/0000-0003-3170-2032	University of South Florida Research & Innovation Internal Awards Program [0088622]; USF Proposal Enhancement Grant	University of South Florida Research & Innovation Internal Awards Program; USF Proposal Enhancement Grant	This work was supported, in part, by the University of South Florida Research & Innovation Internal Awards Program under Grant No. 0088622, and USF Proposal Enhancement Grant to Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bacquin A, 2013, NUCLEIC ACIDS RES, V41, P6501, DOI 10.1093/nar/gkt397; Bai J, 2011, HUM PATHOL, V42, P375, DOI 10.1016/j.humpath.2010.09.003; Bo Hideki, 2004, Journal of Nippon Medical School, V71, P172, DOI 10.1272/jnms.71.172; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen LC, 1998, CANCER RES, V58, P3677; Cron KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073710; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; Garcia K, 2014, MOL CANC THER; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kee Y, 2012, MOL CANCER RES, V10, P369, DOI 10.1158/1541-7786.MCR-11-0497; Kee Y, 2009, GENE DEV, V23, P555, DOI 10.1101/gad.1761309; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li JM, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00079, 10.3389/fonc.2012.00029]; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Ma T, 2013, MOL CELL, V49, P897, DOI 10.1016/j.molcel.2013.01.006; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Moss J, 2010, GENE DEV, V24, P2705, DOI 10.1101/gad.1970810; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nawrocki ST, 2013, CLIN CANCER RES, V19, P3577, DOI 10.1158/1078-0432.CCR-12-3212; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Salon C, 2007, J PATHOL, V213, P303, DOI 10.1002/path.2223; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Sorensen CS, 2004, CELL CYCLE, V3, P941; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Starostina NG, 2010, DEV CELL, V19, P753, DOI 10.1016/j.devcel.2010.10.013; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wada H, 1999, BIOCHEM BIOPH RES CO, V257, P100, DOI 10.1006/bbrc.1999.0339; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang ZW, 2012, ONCOTARGET, V3, P1026; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Zhao Y, 2014, ANTIOXID REDOX SIGNA	60	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101844	10.1371/journal.pone.0101844	http://dx.doi.org/10.1371/journal.pone.0101844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025768	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400025
J	Yeh, YC; Liu, CJ; Kuo, RN; Lai, CL; Shau, WY; Chen, PJ; Lai, MS				Yeh, Yi-Chun; Liu, Chun-Jen; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Shau, Wen-Yi; Chen, Pei-Jer; Lai, Mei-Shu			Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; INTERFERON THERAPY; LIVER RESECTION; RECURRENCE; LAMIVUDINE; ALPHA; PREVENTION; SURVIVAL; EFFICACY; HCC	Background: Limited information about tumor status and the time at which antiviral therapy was initiated may have influenced effect estimation in previous research. The aim of this study was to investigate the effect of antiviral therapies on HBV-related HCC progression and deaths in patients receiving curative treatment based on clear clinical-pathological cancer status and the association of start time of adjuvant antiviral therapy initiation and outcomes. Methodology: A nationwide inception cohort study of newly diagnosed HCC patients who suffered from viral hepatitis B and received curative HCC therapy as the first course of treatment were identified from the Taiwan Cancer Registry between January 1, 2004, and December 31, 2009. Matched Cox proportional hazards models based on propensity score matching and incorporated time-varying exposure were used to estimate adjusted hazard ratios and 95% confidence intervals (CIs). Findings: Among 3,855 HCC patients with HBV, antiviral therapy was administered to 490 (12.7%) following curative treatment. Antiviral-treated patients had a higher percentage of young age, early stage, and smaller tumor size of HCC compared with untreated patients. After propensity score matching, treated patients demonstrated a higher risk of HCC progression (hazard ratio, 1.42; 95% CI, 1.20-1.69) and death from all causes (1.45; 1.15-1.82) than untreated patients. Similar results were also obtained in sub-cohort of patients who were alive with cancer-free status at least one year after receiving curative treatment and the sub-cohort of patients with liver resection. The interval length between initiation of antiviral therapy and first-line curative treatment did not show a significant association with all-cause mortality. Conclusions: This study found that adjuvant antiviral therapy did not reduce the risk of HCC progression or mortality in HBV-related HCC patients after cancer status adjusting.	[Yeh, Yi-Chun; Lai, Mei-Shu] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Yeh, Yi-Chun; Lai, Mei-Shu] Natl Taiwan Univ Hosp, Ctr Comparat Effectiveness Res, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Liu, Chun-Jen; Shau, Wen-Yi; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Kuo, Raymond Nienchen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Lai, Chiu-Ling] Kainan Univ, Dept Hlth Ind Management, Sch Healthcare Management, Taoyuan, Taiwan; [Shau, Wen-Yi] Pfizer Ltd, Med Affairs Div, New Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Nan Kai University Technology; Pfizer	Chen, PJ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	peijerchen@ntu.edu.tw; mslai@ntu.edu.tw	Kuo, Raymond N./N-2558-2018	Kuo, Raymond N./0000-0003-4980-853X; Lai, Mei-shu/0000-0001-6130-3468; Chen, Pei-Jer/0000-0001-8316-3785; LIU, CHUN-JEN/0000-0002-6202-0993	Science and Technology Unit, Ministry of Health and Welfare in Taiwan [DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001]	Science and Technology Unit, Ministry of Health and Welfare in Taiwan	This study was supported by a grant from the Science and Technology Unit, Ministry of Health and Welfare (formerly the Department of Health) in Taiwan (DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of National Health Insurance Department of Health Executive Yuan, 2011, NAT HLTH INS TAIW 20; Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; Chen LT, 2012, ANN SURG, V255, P8, DOI 10.1097/SLA.0b013e3182363ff9; Germani G, 2010, J HEPATOL, V52, P380, DOI 10.1016/j.jhep.2009.12.004; Greene FL, 2002, AJCC CANC STAGING MA, P131; Hsu CS, 2013, JAMA-J AM MED ASSOC, V309, P765, DOI 10.1001/jama.2013.568; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kuzuya T, 2007, J GASTROEN HEPATOL, V22, P1929, DOI 10.1111/j.1440-1746.2006.04707.x; Li N, 2010, ANN SURG ONCOL, V17, P179, DOI 10.1245/s10434-009-0694-z; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lin SM, 2004, CANCER-AM CANCER SOC, V100, P376, DOI 10.1002/cncr.20004; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Piao CY, 2005, ACTA MED OKAYAMA, V59, P217; Poon RTP, 2009, ANN SURG ONCOL, V16, P792, DOI 10.1245/s10434-009-0330-y; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Someya T, 2006, J GASTROENTEROL, V41, P1206, DOI 10.1007/s00535-006-1912-0; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Taiwan Cancer Registry, 2010, TAIW CANC REG DAT 20; Wu C-Y, 2013, JAMA-J AM MED ASSOC, V309, P765; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yoshida H, 2008, HEPATOL INT, V2, P89, DOI 10.1007/s12072-007-9020-7; Yuen MF, 2007, ANTIVIR THER, V12, P1295	32	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102051	10.1371/journal.pone.0102051	http://dx.doi.org/10.1371/journal.pone.0102051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025231	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400039
J	Jin, ZY; Wu, M; Han, RQ; Zhang, XF; Wang, XS; Liu, AM; Zhou, JY; Lu, QY; Kim, CH; Mu, LN; Zhang, ZF; Zhao, JK				Jin, Zi-Yi; Wu, Ming; Han, Ren-Qiang; Zhang, Xiao-Feng; Wang, Xu-Shan; Liu, Ai-Ming; Zhou, Jin-Yi; Lu, Qing-Yi; Kim, Claire H.; Mu, Lina; Zhang, Zuo-Feng; Zhao, Jin-Kou			Household Ventilation May Reduce Effects of Indoor Air Pollutants for Prevention of Lung Cancer: A Case-Control Study in a Chinese Population	PLOS ONE			English	Article							COOKING OIL FUMES; TOBACCO-SMOKE; RISK; POLLUTION; COAL; WOMEN; EMISSIONS; FUELS	Background: Although the International Agency for Research on Cancer (IARC) has classified various indoor air pollutants as carcinogenic to humans, few studies evaluated the role of household ventilation in reducing the impact of indoor air pollutants on lung cancer risk. Objectives: To explore the association between household ventilation and lung cancer. Methods: A population-based case-control study was conducted in a Chinese population from 2003 to 2010. Epidemiologic and household ventilation data were collected using a standardized questionnaire. Unconditional logistic regression was employed to estimate adjusted odds ratios (ORadj) and their 95% confidence intervals (CI). Results: Among 1,424 lung cancer cases and 4,543 healthy controls, inverse associations were observed for good ventilation in the kitchen (ORadj = 0.86, 95% CI: 0.75, 0.98), bedroom (ORadj = 0.90, 95% CI: 0.79, 1.03), and both kitchen and bedroom (ORadj = 0.87, 95% CI: 0.75, 1.00). Stratified analyses showed lung cancer inversely associated with good ventilation among active smokers (ORadj = 0.85, 95% CI: 0.72, 1.00), secondhand smokers at home (ORadj = 0.77, 95% CI: 0.63, 0.94), and those exposed to high-temperature cooking oil fumes (ORadj = 0.82, 95% CI: 0.68, 0.99). Additive interactions were found between household ventilation and secondhand smoke at home as well as number of household pollutant sources. Conclusions: A protective association was observed between good ventilation of households and lung cancer, most likely through the reduction of exposure to indoor air pollutants, indicating ventilation may serve as one of the preventive measures for lung cancer, in addition to tobacco cessation.	[Jin, Zi-Yi; Wu, Ming; Han, Ren-Qiang; Zhou, Jin-Yi; Zhao, Jin-Kou] Jiangsu Prov Ctr Dis Control & Prevent, Dept Noncommunicable Chron Dis Control, Nanjing, Jiangsu, Peoples R China; [Jin, Zi-Yi] Jiangyin Ctr Dis Control & Prevent, Jiangyin, Jiangsu, Peoples R China; [Zhang, Xiao-Feng; Wang, Xu-Shan] Ganyu Ctr Dis Control & Prevent, Ganyu, Jiangsu, Peoples R China; [Liu, Ai-Ming] Dafeng Ctr Dis Control & Prevent, Dafeng, Jiangsu, Peoples R China; [Lu, Qing-Yi] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA; [Kim, Claire H.; Zhang, Zuo-Feng] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Mu, Lina] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	Jiangsu Provincial Center for Disease Control & Prevention; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhao, JK (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Noncommunicable Chron Dis Control, Nanjing, Jiangsu, Peoples R China.	jinkouzhao@hotmail.com		Lu, Qing-Yi/0000-0002-1704-382X; Zhang, Zuo-Feng/0000-0002-4669-3995; Zhao, Jinkou/0000-0001-9184-3385; Jin, Zi-Yi/0000-0002-8091-2266	Jiangsu Provincial Health Department [RC 2003090]; National Institutes of Health, National Institute of Environmental Health Sciences, National Cancer Institute, Department of Health and Human Services [ES06718, ES01167, CA90833, CA077954, CA09142, CA96134, DA11386]; Alper Research Center for Environmental Genomics of the University of California, Los Angeles Jonsson Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA090833, R03CA077954, T32CA009142, U01CA096134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011386] Funding Source: NIH RePORTER	Jiangsu Provincial Health Department; National Institutes of Health, National Institute of Environmental Health Sciences, National Cancer Institute, Department of Health and Human Services; Alper Research Center for Environmental Genomics of the University of California, Los Angeles Jonsson Comprehensive Cancer Center(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by Jiangsu Provincial Health Department (RC 2003090); was partially supported by the National Institutes of Health, National Institute of Environmental Health Sciences, National Cancer Institute, Department of Health and Human Services, Grants ES06718, ES01167, CA90833, CA077954, CA09142, CA96134, DA11386; and the Alper Research Center for Environmental Genomics of the University of California, Los Angeles Jonsson Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Boffetta P, 2002, SCAND J WORK ENV HEA, V28, P30; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galeone C, 2008, EUR J CANCER PREV, V17, P473, DOI 10.1097/CEJ.0b013e328305a0b9; Gao YT, 1996, LUNG CANCER-J IASLC, V14, pS39, DOI 10.1016/S0169-5002(96)90209-3; Hao J, 2011, CHINESE CANC REGISTR; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hoh E, 2012, ENVIRON SCI TECHNOL, V46, P4174, DOI 10.1021/es300267g; Hosgood HD, 2008, BRIT J CANCER, V99, P1934, DOI 10.1038/sj.bjc.6604744; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; IARC, GLOBOCAN 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V95, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin ZY, 2013, CANCER PREV RES, V6, P711, DOI 10.1158/1940-6207.CAPR-13-0015; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Ko YC, 2000, AM J EPIDEMIOL, V151, P140, DOI 10.1093/oxfordjournals.aje.a010181; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Lan Q, 2000, CANCER EPIDEM BIOMAR, V9, P605; Lee CH, 2010, INT J CANCER, V127, P932, DOI 10.1002/ijc.25108; Lee T, 2013, J IMMIGR MINOR HEALT, V15, P646, DOI 10.1007/s10903-012-9651-1; Li MC, 2008, LUNG CANCER, V62, P145, DOI 10.1016/j.lungcan.2008.03.002; Lissowska J, 2005, AM J EPIDEMIOL, V162, P326, DOI 10.1093/aje/kwi204; MOHTASHAMIPUR E, 1990, J CANCER RES CLIN, V116, P604, DOI 10.1007/BF01637081; Mu LN, 2013, CANCER CAUSE CONTROL, V24, P439, DOI 10.1007/s10552-012-0130-8; Mu LN, 2005, INT J CANCER, V116, P972, DOI 10.1002/ijc.21137; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; QING L, 1993, AM J EPIDEMIOL, V137, P145, DOI 10.1093/oxfordjournals.aje.a116654; Taylor R, 2007, INT J EPIDEMIOL, V36, P1048, DOI 10.1093/ije/dym158; Travis WD, 2004, PATHOLOGY GENETICS T; Wang XR, 2009, ANN ONCOL, V20, P746, DOI 10.1093/annonc/mdn699; Yu ITS, 2006, CANCER RES, V66, P4961, DOI 10.1158/0008-5472.CAN-05-2932; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhao JK, 2004, ZHONGGUO ZHONGLIU, V13, P757; Zhao Y, 2006, SCI TOTAL ENVIRON, V366, P500, DOI 10.1016/j.scitotenv.2005.10.010	38	13	13	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102685	10.1371/journal.pone.0102685	http://dx.doi.org/10.1371/journal.pone.0102685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019554	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600097
J	Kidera, Y; Kawakami, H; Sakiyama, T; Okamoto, K; Tanaka, K; Takeda, M; Kaneda, H; Nishina, S; Tsurutani, J; Fujiwara, K; Nomura, M; Yamazoe, Y; Chiba, Y; Nishida, S; Tamura, T; Nakagawa, K				Kidera, Yasuhiro; Kawakami, Hisato; Sakiyama, Tsutomu; Okamoto, Kunio; Tanaka, Kaoru; Takeda, Masayuki; Kaneda, Hiroyasu; Nishina, Shin-ichi; Tsurutani, Junji; Fujiwara, Kimiko; Nomura, Morihiro; Yamazoe, Yuzuru; Chiba, Yasutaka; Nishida, Shozo; Tamura, Takao; Nakagawa, Kazuhiko			Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection	PLOS ONE			English	Article							PATIENTS RECEIVING CISPLATIN; HIGH-DOSE CISPLATIN; INDUCED HYPOMAGNESEMIA; PERFORMANCE STATUS; ONCOLOGY-GROUP; LUNG-CANCER; CHEMOTHERAPY; TRIAL	Background: Nephrotoxicity remains a problem for patients who receive cisplatin chemotherapy. We retrospectively evaluated potential risk factors for cisplatin-induced nephrotoxicity as well as the potential impact of intravenous magnesium supplementation on such toxicity. Patients and Methods: We reviewed clinical data for 401 patients who underwent chemotherapy including a high dose (>= 60 mg/m(2)) of cisplatin in the first-line setting. Nephrotoxicity was defined as an increase in the serum creatinine concentration of at least grade 2 during the first course of cisplatin chemotherapy, as assessed on the basis of National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0. The severity of nephrotoxicity was evaluated on the basis of the mean change in the serum creatinine level. Magnesium was administered intravenously to 67 patients (17%). Results: Cisplatin-induced nephrotoxicity was observed in 127 patients (32%). Multivariable analysis revealed that an Eastern Cooperative Oncology Group performance status of 2 (risk ratio, 1.876; P = 0.004) and the regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) (risk ratio, 1.357; P = 0.047) were significantly associated with an increased risk for cisplatin nephrotoxicity, whereas intravenous magnesium supplementation was associated with a significantly reduced risk for such toxicity (risk ratio, 0.175; P = 0.0004). The development of hypomagnesemia during cisplatin treatment was significantly associated with a greater increase in serum creatinine level (P = 0.0025). Magnesium supplementation therapy was also associated with a significantly reduced severity of renal toxicity (P = 0.012). Conclusions: A relatively poor performance status and the regular use of NSAIDs were significantly associated with cisplatin-induced nephrotoxicity, although the latter association was marginal. Our findings also suggest that the ability of magnesium supplementation to protect against the renal toxicity of cisplatin warrants further investigation in a prospective trial.	[Kidera, Yasuhiro; Nishida, Shozo] Kinki Univ, Fac Pharm, Div Pharmacotherapy, Higashiosaka, Osaka 577, Japan; [Kidera, Yasuhiro; Fujiwara, Kimiko; Nomura, Morihiro; Yamazoe, Yuzuru] Kinki Univ, Fac Med, Dept Pharm, Osaka, Japan; [Kawakami, Hisato; Sakiyama, Tsutomu; Okamoto, Kunio; Tanaka, Kaoru; Takeda, Masayuki; Kaneda, Hiroyasu; Nishina, Shin-ichi; Tsurutani, Junji; Tamura, Takao; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Chiba, Yasutaka] Kinki Univ, Fac Med, Div Biostat, Clin Res Ctr, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University)	Kawakami, H (corresponding author), Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan.	kawakami_h@dotd.med.kindai.ac.jp	Kawakami, Hisato/L-6845-2019	Kawakami, Hisato/0000-0002-3280-4850	Grants-in-Aid for Scientific Research [24701037] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Al Bahrani B J, 2009, Gulf J Oncolog, P30; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Ariceta G, 1997, MED PEDIATR ONCOL, V28, P35, DOI 10.1002/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U; Bodnar L, 2008, EUR J CANCER, V44, P2608, DOI 10.1016/j.ejca.2008.08.005; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; DAUGAARD G, 1988, CLIN PHARMACOL THER, V44, P164, DOI 10.1038/clpt.1988.132; de Jongh FE, 2003, BRIT J CANCER, V88, P1199, DOI 10.1038/sj.bjc.6600884; EVANS TRJ, 1995, EUR J CANCER, V31A, P174, DOI 10.1016/0959-8049(94)00420-A; Gridelli C, 2006, ANN ONCOL, V17, pV72, DOI 10.1093/annonc/mdj955; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Hesketh PJ, 2006, J THORAC ONCOL, V1, P537, DOI 10.1097/01243894-200607000-00007; KOVACH JS, 1973, CANCER CHEMOTH REP 1, V57, P357; Lajer H, 2005, CANCER CHEMOTH PHARM, V56, P535, DOI 10.1007/s00280-005-1010-7; Lajer H, 1999, CANCER TREAT REV, V25, P47, DOI 10.1053/ctrv.1999.0097; MARTIN M, 1992, AM J CLIN ONCOL-CANC, V15, P348, DOI 10.1097/00000421-199208000-00016; MAVICHAK V, 1985, KIDNEY INT, V28, P914, DOI 10.1038/ki.1985.217; National Comprehensive Cancer Network, 2013, NCCN CHEM ORD TEMPL; NETTEN PM, 1990, ANN ONCOL, V1, P369, DOI 10.1093/oxfordjournals.annonc.a057776; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; RIES F, 1986, AM J KIDNEY DIS, V8, P368, DOI 10.1016/S0272-6386(86)80112-3; Ripamonti CI, 2011, ANN ONCOL S, V22, pvi69; ROZENCWEIG M, 1977, ANN INTERN MED, V86, P803, DOI 10.7326/0003-4819-86-6-803; STEWART AF, 1985, AM J OBSTET GYNECOL, V153, P660, DOI 10.1016/S0002-9378(85)80255-6; Stewart DJ, 1997, CANCER CHEMOTH PHARM, V40, P293, DOI 10.1007/s002800050661; Sweeney CJ, 2001, CANCER, V92, P2639, DOI 10.1002/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8; Tiseo M, 2007, TUMORI, V93, P138; VOKES EE, 1990, BRIT J CANCER, V62, P1015, DOI 10.1038/bjc.1990.429; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Whelton A, 2000, Am J Ther, V7, P159, DOI 10.1097/00045391-200007030-00004; WILLOX JC, 1986, BRIT J CANCER, V54, P19, DOI 10.1038/bjc.1986.147; Yokoo K, 2009, CLIN EXP NEPHROL, V13, P578, DOI 10.1007/s10157-009-0215-1	32	83	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101902	10.1371/journal.pone.0101902	http://dx.doi.org/10.1371/journal.pone.0101902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020203	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600032
J	Laine, M; Morin, S; Tison-Rosebery, J				Laine, Manon; Morin, Soizic; Tison-Rosebery, Juliette			A Multicompartment Approach - Diatoms, Macrophytes, Benthic Macroinvertebrates and Fish - To Assess the Impact of Toxic Industrial Releases on a Small French River	PLOS ONE			English	Article							INVERTEBRATE COMMUNITIES; RIOU-MORT; STREAM; INDEX; BIOFILM; CONTAMINATION; COLONIZATION; INDICATORS; RESPONSES; HEALTH	The River Luzou flows through a sandy substrate in the South West of France. According to the results of two assessment surveys, the Water Agency appraised that this river may not achieve the good ecological status by 2015 as required by the Water Framework Directive (2000/60/EC). This ecosystem is impacted by industrial effluents (organic matter, metals and aromatic compounds). In order to assess and characterize the impact, this study aimed to combine a set of taxonomic and non-taxonomic metrics for diatoms, macrophytes, macroinvertebrates and fish along the up-to downstream gradient of the river. Diversity metrics, biological indices, biological and ecological traits were determined for the four biological quality elements (BQE). Various quantitative metrics (biomass estimates) were also calculated for diatom communities. The results were compared to physicochemical analysis. Biological measurements were more informative than physicochemical analysis, in the context of the study. Biological responses indicated both the contamination of water and its intensity. Diversity metrics and biological indices strongly decreased with pollution for all BQE but diatoms. Convergent trait selection with pollution was observed among BQE: reproduction, colonization strategies, or trophic regime were clearly modified at impaired sites. Taxon size and relation to the substrate diverged among biological compartments. Multiple anthropogenic pollution calls for alternate assessment methods of rivers' health. Our study exemplifies the fact that, in the case of complex contaminations, biological indicators can be more informative for environmental risk, than a wide screening of contaminants by chemical analysis alone. The combination of diverse biological compartments provided a refined diagnostic about the nature (general mode of action) and intensity of the contamination.	[Laine, Manon; Morin, Soizic; Tison-Rosebery, Juliette] Irstea, UR EABX, Cestas, France	INRAE	Morin, S (corresponding author), Irstea, UR EABX, Cestas, France.	soizic.morin@irstea.fr	Morin, Soizic/J-1204-2019	Morin, Soizic/0000-0003-0360-9383; Tison-Rosebery, Juliette/0000-0003-1090-7020	Adour-Garonne Water Agency	Adour-Garonne Water Agency	This study was funded by the Adour-Garonne Water Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFNOR, 2009, XP T90 333 QUAL EAU; AFNOR, 2005, 872 ISO EN, P10; AFNOR, 2004, T90350 AFNOR NF; AFNOR, 2011, T90344 AFNOR NF; AFNOR, 2003, QUAL EAU CHANT POISS; AFNOR, 2010, T90388 AFNOR XP; AFNOR, 2003, T90395 AFNOR NF; AFNOR (Association Francaise de Normalisation), 2007, T90354 AFNOR NF; [Anonymous], 1982, ETUDE METHODES BIOL; Archaimbault V., 2010, SCI EAUX TERRITOIRES, P46; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Beketov MA, 2008, ENVIRON POLLUT, V156, P980, DOI 10.1016/j.envpol.2008.05.005; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; BOURNAUD M, 1984, B ECOL, V15, P199; BURKHOLDER JM, 1990, APPL ENVIRON MICROB, V56, P2882, DOI 10.1128/AEM.56.9.2882-2890.1990; Camargo JA, 2011, ECOL INDIC, V11, P911, DOI 10.1016/j.ecolind.2010.10.001; Cellamare M, 2012, ENVIRON MONIT ASSESS, V184, P4685, DOI 10.1007/s10661-011-2295-0; Cortelezzi A, 2013, ENVIRON MONIT ASSESS, V185, P5801, DOI 10.1007/s10661-012-2985-2; Coste M, 2009, ECOL INDIC, V9, P621, DOI 10.1016/j.ecolind.2008.06.003; De Mendiburu F., 2007, AGRICOLAE STAT PROCE; Ettl H., 1991, SUSSWASSERFLORA MITT, V2/3; Falasco E, 2009, HYDROBIOLOGIA, V623, P1, DOI 10.1007/s10750-008-9687-3; Gillett ND, 2011, HYDROBIOLOGIA, V665, P79, DOI 10.1007/s10750-011-0606-7; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; Hering D, 2006, FRESHWATER BIOL, V51, P1757, DOI 10.1111/j.1365-2427.2006.01610.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Johnson RK, 2006, HYDROBIOLOGIA, V566, P139, DOI 10.1007/s10750-006-0100-9; Keith P, 2001, ATLAS POISSONS EAU D; Kelly M. G, 2005, COMMON FRESHWATER DI; Khoshmanesh A, 1997, CHEM ENG J, V65, P13; Lange-Bertalot H, 1995, ANNOTATED DIATOM MON, V1-23; Lavoie I, 2012, SCI TOTAL ENVIRON, V425, P231, DOI 10.1016/j.scitotenv.2012.02.057; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Luis AT, 2014, ECOTOXICOLO IN PRESS; Marzin A, 2014, ECOL INDIC, V43, P195, DOI 10.1016/j.ecolind.2014.02.011; Marzin A, 2012, ECOL INDIC, V23, P56, DOI 10.1016/j.ecolind.2012.03.010; Mondy CP, 2012, ECOL INDIC, V18, P452, DOI 10.1016/j.ecolind.2011.12.013; Morin S, 2008, ENVIRON POLLUT, V151, P532, DOI 10.1016/j.envpol.2007.04.023; Morin S, 2010, VIE MILIEU, V60, P109; Morin S, 2012, EMERGING PRIORITY PO, P117, DOI [10.1007/978-3-642-25722-3_5, DOI 10.1007/978-3-642-25722-3_5]; Morin S, 2008, HYDROBIOLOGIA, V614, P285, DOI 10.1007/s10750-008-9513-y; Morin S, 2007, FUND APPL LIMNOL, V168, P179, DOI 10.1127/1863-9135/2007/0168-0179; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Potapova M, 2003, FRESHWATER BIOL, V48, P1311, DOI 10.1046/j.1365-2427.2003.01080.x; R Core Team, 2018, R LANG ENV STAT COMP; Rogers C., 2005, CREATION BASE DONNEE; Rosebery J, 2010, BILAN HYDROBIOLOGIQU; Schultheis AS, 1997, HYDROBIOLOGIA, V346, P85, DOI 10.1023/A:1002909914774; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Stevenson RJ, 1999, PERIPHYTON PROTOCOLS, V6, P1; Tison J, 2005, WATER RES, V39, P3177, DOI 10.1016/j.watres.2005.05.029; TOWNSEND CR, 1976, J ANIM ECOL, V45, P759, DOI 10.2307/3579; Usseglio-Polatera, 2010, INVERTEBRES EAU DOUC, V15; Usseglio-Polatera P, 2000, FRESHWATER BIOL, V43, P175, DOI 10.1046/j.1365-2427.2000.00535.x; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; Wang YK, 2005, J N AM BENTHOL SOC, V24, P990, DOI 10.1899/03-028.1; Willby NJ, 2000, FRESHWATER BIOL, V43, P43, DOI 10.1046/j.1365-2427.2000.00523.x	63	21	21	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102358	10.1371/journal.pone.0102358	http://dx.doi.org/10.1371/journal.pone.0102358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019954	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600073
J	Plongthongkum, N; van Eijk, KR; de Jong, S; Wang, T; Sul, JH; Boks, MPM; Kahn, RS; Fung, HL; Ophoff, RA; Zhang, K				Plongthongkum, Nongluk; van Eijk, Kristel R.; de Jong, Simone; Wang, Tina; Sul, Jae Hoon; Boks, Marco P. M.; Kahn, Rene S.; Fung, Ho-Lim; Ophoff, Roel A.; Zhang, Kun			Characterization of Genome-Methylome Interactions in 22 Nuclear Pedigrees	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; GENE-EXPRESSION VARIATION; DNA METHYLATION; GENOTYPE IMPUTATION; HUMAN AUTOSOMES; GNAS LOCUS; DISEASE; WIDESPREAD; RESOLUTION; SIGNATURES	Genetic polymorphisms can shape the global landscape of DNA methylation, by either changing substrates for DNA methyltransferases or altering the DNA binding affinity of cis-regulatory proteins. The interactions between CpG methylation and genetic polymorphisms have been previously investigated by methylation quantitative trait loci (mQTL) and allele-specific methylation (ASM) analysis. However, it remains unclear whether these approaches can effectively and comprehensively identify all genetic variants that contribute to the inter-individual variation of DNA methylation levels. Here we used three independent approaches to systematically investigate the influence of genetic polymorphisms on variability in DNA methylation by characterizing the methylation state of 96 whole blood samples in 52 parent-child trios from 22 nuclear pedigrees. We performed targeted bisulfite sequencing with padlock probes to quantify the absolute DNA methylation levels at a set of 411,800 CpG sites in the human genome. With mid-parent offspring analysis (MPO), we identified 10,593 CpG sites that exhibited heritable methylation patterns, among which 70.1% were SNPs directly present in methylated CpG dinucleotides. We determined the mQTL analysis identified 49.9% of heritable CpG sites for which regulation occurred in a distal cis-regulatory manner, and that ASM analysis was only able to identify 5%. Finally, we identified hundreds of clusters in the human genome for which the degree of variation of CpG methylation, as opposed to whether or not CpG sites were methylated, was associated with genetic polymorphisms, supporting a recent hypothesis on the genetic influence of phenotypic plasticity. These results show that cis-regulatory SNPs identified by mQTL do not comprise the full extent of heritable CpG methylation, and that ASM appears overall unreliable. Overall, the extent of genome-methylome interactions is well beyond what is detectible with the commonly used mQTL and ASM approaches, and is likely to include effects on plasticity.	[Plongthongkum, Nongluk; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [de Jong, Simone; Wang, Tina; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA; [van Eijk, Kristel R.; Boks, Marco P. M.; Kahn, Rene S.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Sul, Jae Hoon] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	Ophoff, RA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA.	ROphoff@mednet.ucla.edu; kzhang@bioeng.ucsd.edu	Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; de Jong, Simone/0000-0002-8002-7195; Boks, Marco/0000-0001-6163-7484; Plongthongkum, Nongluk/0000-0002-1305-285X	National Institutes of Health Grants [GM097253, HG003233, DA028526, MH090553]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028526] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by National Institutes of Health Grants GM097253 and HG003233 to K.Z., and DA028526 and MH090553 to R.A.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bastepe M, 2007, CURR GENOMICS, V8, P398, DOI 10.2174/138920207783406488; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Drong AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055923; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Greaves IK, 2012, EPIGENETICS-US, V7, P800, DOI 10.4161/epi.20820; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hellman A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-11; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Luykx J. J., 2013, MOL PSYCHIAT; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Plagge A, 2006, CYTOGENET GENOME RES, V113, P178, DOI 10.1159/000090830; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Teperino R, 2013, CELLULAR MOL LIFE SC; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e99313	10.1371/journal.pone.0099313	http://dx.doi.org/10.1371/journal.pone.0099313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019935	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600002
J	Yuan, W; Sui, CG; Liu, Q; Tang, WY; An, HY; Ma, J				Yuan, Wei; Sui, Chenguang; Liu, Qian; Tang, Wanyan; An, Huaying; Ma, Jie			Up-Regulation of MicroRNA-145 Associates with Lymph Node Metastasis in Colorectal Cancer	PLOS ONE			English	Article							SHOCK-PROTEIN 27; COLON-CANCER; PROSTATE-CANCER; EXPRESSION; CELLS; CARCINOMA; INVASION; TISSUES; IDENTIFICATION; MIR-145	Metastasis is the main cause of mortality in patients with solid tumours. Identifying the exact molecules associated with CRC metastasis may be crucial to understand the process, which might also be translated to the diagnosis and treatment of CRC. In this study, we investigate the association of microRNA expression patterns with the lymph node metastasis of colorectal cancer. Among these candidate miRNAs, the expression of miRNA-145 was significantly related to lymph node metastasis of CRC. Both in vitro and in vivo study demonstrated that up-regulation of miR-145 could improve the ability of migration and invasion of colorectal cancer cell, while no effect on proliferation was observed. The mechanism of this promotion is associated with the stabilization of Hsp-27, a protein which plays an important role in the promotion of metastasis. These results may be crucial to understanding CRC metastasis and may be translated to the diagnosis and treatment of CRC.	[Yuan, Wei; Sui, Chenguang; Tang, Wanyan; An, Huaying; Ma, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Peking Union Med Coll, Beijing 100730, Peoples R China; [Liu, Qian] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg Oncol, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Ma, J (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Peking Union Med Coll, Beijing 100730, Peoples R China.	majie1965@163.com			National Basic Research Program of China [2011CB911004]; The Beijing Training Project for The Leading Talents [Z131107000513001]; Beijing Nova Program [Z131107000413066]; Beijing Natural Science Foundation of China [7122150]	National Basic Research Program of China(National Basic Research Program of China); The Beijing Training Project for The Leading Talents; Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This study was supported by the National Basic Research Program of China (Grant no. 2011CB911004), The Beijing Training Project for The Leading Talents (Z131107000513001), Beijing Nova Program (Z131107000413066) and Beijing Natural Science Foundation of China (Grant no. 7122150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chaudhuri K, 2007, DNA CELL BIOL, V26, P321, DOI 10.1089/dna.2006.0549; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Choong LY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011030; Cornford PA, 2000, CANCER RES, V60, P7099; Dai SJ, 2008, J PROTEOME RES, V7, P4384, DOI 10.1021/pr800376w; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Pei HP, 2007, J PROTEOME RES, V6, P2495, DOI 10.1021/pr060644r; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Reinert JT, 2008, CANC RES, V68, P6416; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Song HY, 2006, J CANCER RES CLIN, V132, P92, DOI 10.1007/s00432-005-0044-x; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhu ZK, 2010, MOL PHARMACEUT, V7, P1283, DOI 10.1021/mp100073s	33	28	32	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102017	10.1371/journal.pone.0102017	http://dx.doi.org/10.1371/journal.pone.0102017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019299	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600035
J	Busch, S; Kannt, A; Kolibabka, M; Schlotterer, A; Wang, Q; Lin, JH; Feng, YX; Hoffmann, S; Gretz, N; Hammes, HP				Busch, Stephanie; Kannt, Aimo; Kolibabka, Matthias; Schlotterer, Andreas; Wang, Qian; Lin, Jihong; Feng, Yuxi; Hoffmann, Sigrid; Gretz, Norbert; Hammes, Hans-Peter			Systemic Treatment with Erythropoietin Protects the Neurovascular Unit in a Rat Model of Retinal Neurodegeneration	PLOS ONE			English	Article							EXPERIMENTAL DIABETIC-RETINOPATHY; INTRAVITREAL INJECTION; TISSUE INHIBITOR; DEGENERATION; NEUROPROTECTION; ISCHEMIA; DISEASE; ANGIOGENESIS; POLYCYSTIN-2; MICROGLIA	Rats expressing a transgenic polycystic kidney disease (PKD) gene develop photoreceptor degeneration and subsequent vasoregression, as well as activation of retinal microglia and macroglia. To target the whole neuroglialvascular unit, neuro- and vasoprotective Erythropoietin (EPO) was intraperitoneally injected into four -week old male heterozygous PKD rats three times a week at a dose of 256 IU/kg body weight. For comparison EPO-like peptide, lacking unwanted side effects of EPO treatment, was given five times a week at a dose of 10 mg/kg body weight. Matched EPO treated Sprague Dawley and water-injected PKD rats were held as controls. After four weeks of treatment the animals were sacrificed and analysis of the neurovascular morphology, glial cell activity and pAkt localization was performed. The number of endothelial cells and pericytes did not change after treatment with EPO or EPO-like peptide. There was a nonsignificant reduction of migrating pericytes by 23% and 49%, respectively. Formation of acellular capillaries was significantly reduced by 49% (p<0.001) or 40% (p<0.05). EPO-treatment protected against thinning of the central retina by 10% (p<0.05), a composite of an increase of the outer nuclear layer by 12% (p<0.01) and in the outer segments of photoreceptors by 26% (p<0.001). Quantification of cell nuclei revealed no difference. Microglial activity, shown by gene expression of CD74, decreased by 67% (p<0.01) after EPO and 36% (n.s.) after EPO-like peptide treatment. In conclusion, EPO safeguards the neuroglialvascular unit in a model of retinal neurodegeneration and secondary vasoregression. This finding strengthens EPO in its protective capability for the whole neuroglialvascular unit.	[Busch, Stephanie; Kolibabka, Matthias; Schlotterer, Andreas; Wang, Qian; Lin, Jihong; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany; [Kannt, Aimo] Sanofi Diabet Res & Translat Med, Frankfurt, Germany; [Feng, Yuxi] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Mannheim, Germany; [Hoffmann, Sigrid; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Med Fac Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; Sanofi-Aventis; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Busch, S (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany.	StephanieBusch@web.de	Hammes, Hans-Peter/S-3719-2019; Kannt, Aimo/AAZ-6898-2020; Kolibabka, Matthias/T-5812-2017	Kolibabka, Matthias/0000-0001-6741-5436; Kannt, Aimo/0000-0002-5197-2286	DDG (Deutsche Diabetes Gesellschaft); DFG (Deutsche Forschungsgemeinschaft)	DDG (Deutsche Diabetes Gesellschaft); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This research was supported by the DDG (Deutsche Diabetes Gesellschaft) and the DFG (Deutsche Forschungsgemeinschaft). Both institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabpoor Zohreh, 2012, Adv Biomed Res, V1, P50, DOI 10.4103/2277-9175.100157; Barbera L, 2010, RADIOTHER ONCOL, V95, P269, DOI 10.1016/j.radonc.2010.02.008; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Busch S, 2012, CELL PHYSIOL BIOCHEM, V30, P1436, DOI 10.1159/000343331; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Garcia-Ramirez M, 2008, DIABETES CARE, V31, P1189, DOI 10.2337/dc07-2075; Garcia-Ramirez M, 2011, CELL SIGNAL, V23, P1596, DOI 10.1016/j.cellsig.2011.05.011; Guo LJ, 2006, CALCIFIED TISSUE INT, V78, P285, DOI 10.1007/s00223-005-0092-x; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hernandez C, 2012, ENDOCRINE, V41, P220, DOI 10.1007/s12020-011-9579-6; Hu Liu-Mei, 2011, Front Biosci (Elite Ed), V3, P1541; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Kanaan NM, 2006, BRAIN RES, V1068, P221, DOI 10.1016/j.brainres.2005.10.078; Kawachi K, 2012, HEART VESSELS, V27, P79, DOI 10.1007/s00380-011-0197-2; Keogh CL, 2007, J PHARMACOL EXP THER, V322, P521, DOI 10.1124/jpet.107.121392; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P537, DOI 10.1055/s-0030-1255448; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Mitsuhashi J, 2013, EXP EYE RES, V106, P64, DOI 10.1016/j.exer.2012.11.001; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Pfister F, 2008, DIABETES, V57, P2495, DOI 10.2337/db08-0325; Rezaeian F, 2010, LAB INVEST, V90, P40, DOI 10.1038/labinvest.2009.117; Shang YC, 2012, AGING-US, V4, P187, DOI 10.18632/aging.100440; Sorg H, 2012, MED RES REV; Souvenir R, 2011, NEUROBIOL DIS, V44, P28, DOI 10.1016/j.nbd.2011.05.020; Teng RF, 2011, BASIC RES CARDIOL, V106, P343, DOI 10.1007/s00395-011-0158-z; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang Q, 2011, CELL PHYSIOL BIOCHEM, V27, P769, DOI 10.1159/000330085; Wang ZY, 2011, MED HYPOTHESES, V76, P266, DOI 10.1016/j.mehy.2010.10.017; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721	35	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102013	10.1371/journal.pone.0102013	http://dx.doi.org/10.1371/journal.pone.0102013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013951	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400054
J	Liu, C; Zhang, W; Yang, H; Sun, WD; Gong, XD; Zhao, JX; Sun, Y; Diao, GW				Liu, Chang; Zhang, Wang; Yang, Hao; Sun, Weidong; Gong, Xiangdong; Zhao, Junxian; Sun, Yun; Diao, Guowang			A Water-Soluble Inclusion Complex of Pedunculoside with the Polymer beta-Cyclodextrin: A Novel Anti-Inflammation Agent with Low Toxicity	PLOS ONE			English	Article							SAFETY EVALUATION; EAR EDEMA; IN-VITRO; TERPENOIDS; MICE; INHIBITORS; EFFICACY; CANCER; CELLS; OIL	More than 50% of new drug candidates in drug discovery are lipophilic and exhibit poor aqueous solubility, which results in poor bioavailability and a lack of dose proportionality. Here, we improved the solubility of pedunculoside (PE) by generating a water-soluble inclusion complex composed of PE and the polymer beta-cyclodextrin (CDP). We characterized this novel complex by H-1 NMR, FT-IR, UV-vis spectroscopy, powder X-ray diffractometry and thermogravimetric analysis. The ratio of beta-cyclodextrin (beta-CD) units in CDP to PE was determined to be 2:1. The K-D value of the inclusion complex was determined to be 4.29x10(-3) mol.L-1. In contrast to the low solubility of PE, the water-solubility of the PE-CDP complex was greatly enhanced. A preclinical toxicological study indicated that PE-CDP was well tolerated for a single administration. Importantly, the anti-inflammation potency of the PE-CDP complex was higher than that of PE. As a result, the formation of inclusion complexes by water-soluble CDP opens up possible aqueous applications of insoluble drug candidates in drug delivery.	[Liu, Chang; Yang, Hao; Zhao, Junxian; Sun, Yun] Yangzhou Univ, Coll Med, Yangzhou, Jiangsu, Peoples R China; [Zhang, Wang; Gong, Xiangdong; Diao, Guowang] Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou, Jiangsu, Peoples R China; [Sun, Weidong] Chinese Med Hosp Yangzhou City, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Sun, Y (corresponding author), Yangzhou Univ, Coll Med, Yangzhou, Jiangsu, Peoples R China.	ysun@yzu.edu.cn; gwdiao@yzu.edu.cn	Liu, Chang/J-6985-2019; Zhang, Wang/H-7304-2013; Zhang, Wang/AAH-2938-2019	Zhang, Wang/0000-0002-4558-3487; 	National Natural Science Foundation of China [21273195]; Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions	This work was largely supported by grants from the National Natural Science Foundation of China (Grant Nos. 21273195), the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Arima H, 2002, RRD CHE PHA, V2, P155; Boztas AO, 2013, MOL PHARMACEUT, V10, P2676, DOI 10.1021/mp400101k; Cao F, 2012, MOL PHARMACEUT, V9, P2127, DOI 10.1021/mp200447r; Chen M, 2006, CHEMOSPHERE, V63, P522, DOI 10.1016/j.chemosphere.2005.08.033; Fan DS, 2011, FITOTERAPIA, V82, P805, DOI 10.1016/j.fitote.2011.04.007; Glojnaric I, 2013, TOXICOL LETT, V221, pS93, DOI 10.1016/j.toxlet.2013.05.123; Huang XX, 2011, AAPS PHARMSCITECH, V12, P665, DOI 10.1208/s12249-011-9631-0; IRIE T, 1982, J PHARMACOBIO-DYNAM, V5, P741; Irie T, 1997, J PHARM SCI-US, V86, P147, DOI 10.1021/js960213f; Jahromi MAF, 1999, PHARM BIOL, V37, P37, DOI 10.1076/phbi.37.1.37.6314; Jean-Baptiste E, 2012, EUR J VASC ENDOVASC, V43, P188, DOI 10.1016/j.ejvs.2011.10.017; Jiang Y, 2011, INT J PHARMACEUT, V415, P252, DOI 10.1016/j.ijpharm.2011.05.056; Kulkarni AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063798; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Li G., 2013, PLOS ONE, V8; Li HQ, 2014, BIOMACROMOLECULES, V15, P43, DOI 10.1021/bm4012562; Liu C, 2013, ORG BIOMOL CHEM, V11, P4993, DOI 10.1039/c3ob40715b; Liu J, 2007, AM J CHINESE MED, V35, P317, DOI 10.1142/S0192415X07004849; May M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060628; Mondjinou YA, 2013, BIOMACROMOLECULES, V14, P4189, DOI 10.1021/bm400922a; *OECD, 2002, 11 ADD OECD GUID TES; RANDHAWA PS, 1993, AM J SURG PATHOL, V17, P60, DOI 10.1097/00000478-199301000-00007; Renard E, 1997, EUR POLYM J, V33, P49, DOI 10.1016/S0014-3057(96)00123-1; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Saraiva RA, 2011, J ETHNOPHARMACOL, V136, P504, DOI 10.1016/j.jep.2010.07.002; Sawadogo WR, 2013, MOLECULES, V18, P3641, DOI 10.3390/molecules18043641; Schneider HJ, 1998, CHEM REV, V98, P1755, DOI 10.1021/cr970019t; Silva F, 2014, FOOD CHEM, V145, P115, DOI 10.1016/j.foodchem.2013.08.034; Sugiura Y, 2013, J FUNCT FOODS, V5, P2019, DOI 10.1016/j.jff.2013.08.010; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Totterman AM, 1997, J PHARM PHARMACOL, V49, P43; Wang C, 2012, CHINESE J STRUC CHEM, V31, P1729; Watson R, 2012, BIOACTIVE FOOD DIETA; Wen XA, 2008, J MED CHEM, V51, P3540, DOI 10.1021/jm8000949; Wilmer JL, 1997, IN VITRO TOXICOL, V10, P429; Xian YF, 2011, J ETHNOPHARMACOL, V137, P1425, DOI 10.1016/j.jep.2011.08.014; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yanez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041072; Ye M, 2014, CHEMOSPHERE, V105, P119, DOI 10.1016/j.chemosphere.2013.12.058; Zhang W, 2014, J MATER CHEM B, V2, P5107, DOI 10.1039/c4tb00560k; Zhang W, 2013, CARBON, V61, P154, DOI 10.1016/j.carbon.2013.04.079; Zhang W, 2013, CARBOHYD POLYM, V95, P366, DOI 10.1016/j.carbpol.2013.03.020; Zhang W, 2012, PHYS CHEM CHEM PHYS, V14, P9729, DOI 10.1039/c2cp41092c; Zhang W, 2011, ELECTROCHIM ACTA, V56, P5129, DOI 10.1016/j.electacta.2011.03.062	45	29	31	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101761	10.1371/journal.pone.0101761	http://dx.doi.org/10.1371/journal.pone.0101761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013908	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400035
J	Schultz, RD; Bennett, EE; Ellis, EA; Gumienny, TL				Schultz, Robbie D.; Bennett, Emily E.; Ellis, E. Ann; Gumienny, Tina L.			Regulation of Extracellular Matrix Organization by BMP Signaling in Caenorhabditis elegans	PLOS ONE			English	Article							TGF-BETA; BODY-SIZE; SMAD PROTEINS; C-ELEGANS; GENES; EXPRESSION; CUTICLE; GROWTH; TRANSPORT; RECEPTOR	In mammals, Bone Morphogenetic Protein (BMP) pathway signaling is important for the growth and homeostasis of extracellular matrix, including basement membrane remodeling, scarring, and bone growth. A conserved BMP member in Caenorhabditis elegans, DBL-1, regulates body length in a dose-sensitive manner. Loss of DBL-1 pathway signaling also results in increased anesthetic sensitivity. However, the physiological basis of these pleiotropic phenotypes is largely unknown. We created a DBL-1 over-expressing strain and show that sensitivity to anesthetics is inversely related to the dose of DBL-1. Using pharmacological, genetic analyses, and a novel dye permeability assay for live, microwave-treated animals, we confirm that DBL-1 is required for the barrier function of the cuticle, a specialized extracellular matrix. We show that DBL-1 signaling is required to prevent animals from forming tail-entangled aggregates in liquid. Stripping lipids off the surface of wild-type animals recapitulates this phenotype. Finally, we find that DBL-1 signaling affects ultrastructure of the nematode cuticle in a dose-dependent manner, as surface lipid content and cuticular organization are disrupted in animals with genetically altered DBL-1 levels. We propose that the lipid layer coating the nematode cuticle normally prevents tail entanglement, and that reduction of this layer by loss of DBL-1 signaling promotes aggregation. This work provides a physiological mechanism that unites the DBL-1 signaling pathway roles of not only body size regulation and drug responsiveness, but also the novel Hoechst 33342 staining and aggregation phenotypes, through barrier function, content, and organization of the cuticle.	[Schultz, Robbie D.; Bennett, Emily E.; Gumienny, Tina L.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Schultz, Robbie D.; Gumienny, Tina L.] Texas A&M Univ, Interdisciplinary Program Genet, College Stn, TX USA; [Ellis, E. Ann] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Gumienny, TL (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	gumienny@medicine.tamhsc.edu	Gumienny, Tina/AAJ-5273-2020	Gumienny, Tina/0000-0002-3932-7815	NIH [1R01GM097591]; MCMD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097591] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MCMD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant 1R01GM097591 from the NIH (http://www.nih.gov/) and by MCMD departmental start-up funds to TLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health.	Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Baird SE, 1999, DEV BIOL, V212, P93, DOI 10.1006/dbio.1999.9322; Bandyopadhyay Amitabha, 2006, PLoS Genet, V2, pe216; BARBERCHECK ME, 1991, ENVIRON ENTOMOL, V20, P582, DOI 10.1093/ee/20.2.582; Beifuss KK, 2012, JOVE-J VIS EXP, DOI 10.3791/3442; BLAXTER ML, 1993, J BIOL CHEM, V268, P6600; BRENNER S, 1974, GENETICS, V77, P71; Carmichael FJ, 1985, PRINCIPLES MED PHARM, P265; Croll N.A., 1970, BEHAV NEMATODES THEI; de Gives PM, 1999, PARASITOLOGY, V119, P95, DOI 10.1017/S0031182099004424; DUNCAN HM, 1966, J BIOL CHEM, V241, P1694; Ellis EA, 2006, MICROSC MICROANAL, V12, P288, DOI DOI 10.1017/S1431927606062660; Fang-Yen C, 2012, METHOD CELL BIOL, V107, P177, DOI 10.1016/B978-0-12-394620-1.00006-0; Fernando T, 2011, DEV BIOL, V352, P92, DOI 10.1016/j.ydbio.2011.01.016; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Gullapalli RR, 2008, PHYS CHEM CHEM PHYS, V10, P3548, DOI 10.1039/b716979e; Gumienny Tina L, 2013, WormBook, P1, DOI 10.1895/wormbook.1.22.2; Hall DH, 2012, METHOD CELL BIOL, V107, P93, DOI 10.1016/B978-0-12-394620-1.00004-7; Haut H. van, 1956, Nematologica, V1, P165; HERWEIJER MA, 1985, BIOCHIM BIOPHYS ACTA, V809, P81, DOI 10.1016/0005-2728(85)90170-7; HIMMELHOCH S, 1983, EXP PARASITOL, V55, P299, DOI 10.1016/0014-4894(83)90026-7; HO NFH, 1992, MOL BIOCHEM PARASIT, V52, P1, DOI 10.1016/0166-6851(92)90031-E; HO NFH, 1994, J PHARM SCI, V83, P1052, DOI 10.1002/jps.2600830725; HO NFH, 1990, MOL BIOCHEM PARASIT, V41, P153, DOI 10.1016/0166-6851(90)90178-O; Hodgkin J, 2013, CURR BIOL, V23, P2157, DOI 10.1016/j.cub.2013.08.060; Hope IA, 2004, GENOME RES, V14, P2070, DOI 10.1101/gr.2463804; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; JANSSON HB, 1986, J NEMATOL, V18, P570; Jiang LI, 1999, DEV BIOL, V211, P88, DOI 10.1006/dbio.1999.9293; JONES JT, 1991, J MICROSC-OXFORD, V164, P43, DOI 10.1111/j.1365-2818.1991.tb03190.x; Kage-Nakadai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008857; Krishna S, 1999, DEVELOPMENT, V126, P251; Lee Byung H., 2002, Current Topics in Medicinal Chemistry, V2, P779, DOI 10.2174/1568026023393705; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; LINK CD, 1992, GENETICS, V131, P867; LINK CD, 1988, DEVELOPMENT, V103, P485; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Lozano E, 2006, CURR BIOL, V16, P493, DOI 10.1016/j.cub.2006.01.048; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Morita K, 2002, EMBO J, V21, P1063, DOI 10.1093/emboj/21.5.1063; Morita K, 1999, DEVELOPMENT, V126, P1337; Nagamatsu Y, 2004, GENES CELLS, V9, P39, DOI 10.1111/j.1356-9597.2004.00700.x; Natsuka S, 2005, J BIOCHEM, V138, P209, DOI 10.1093/jb/mvi117; Nystrom J, 2002, GENETICS, V161, P83; Page AP, 2007, C ELEGANS RES COMMUN, DOI DOI 10.1895/WORMBOOK.1.138.1; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Portal-Celhay C, 2013, FASEB J, V27, P760, DOI 10.1096/fj.12-218420; PYE AE, 1981, NEMATOLOGICA, V27, P117, DOI 10.1163/187529281X00133; Rand JB, 1995, METHOD CELL BIOL, V48, P187; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roberts AF, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-61; Ruiz-Lancheros E, 2011, INT J PARASITOL, V41, P455, DOI 10.1016/j.ijpara.2010.11.009; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Savage-Dunn C, 2000, DEV BIOL, V223, P70, DOI 10.1006/dbio.2000.9713; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schultz RD, 2012, JOVE-J VIS EXP, DOI 10.3791/3362; Shaham Sm, 2006, METHOD CELL BIOL, DOI [10.1895/wormbook.1.49.1, DOI 10.1895/WORMBOOK.1.49.1]; SHEPHERD AM, 1976, NEMATOLOGICA, V22, P332, DOI 10.1163/187529276X00625; So SH, 2011, MECH AGEING DEV, V132, P210, DOI 10.1016/j.mad.2011.02.005; Stock SP, 2005, NEMATOLOGY, V7, P363, DOI 10.1163/156854105774355590; SUDHAUS W, 1994, NEMATOLOGICA, V40, P508, DOI 10.1163/003525994X00391; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Taneja-Bageshwar S, 2012, DEV BIOL, V371, P66, DOI 10.1016/j.ydbio.2012.08.006; TEICHMAN RJ, 1972, BIOL REPROD, V7, P73, DOI 10.1093/biolreprod/7.1.73; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Tuck S, 2014, EXP CELL RES, V321, P71, DOI 10.1016/j.yexcr.2013.11.007; VANDERBEND RL, 1985, ARCH BIOCHEM BIOPHYS, V241, P461, DOI 10.1016/0003-9861(85)90571-5; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; Woodring JL., 1988, SO COOPERATIVE SERIE, V331; Wyeth RC, 2009, J NEUROSCI METH, V176, P121, DOI 10.1016/j.jneumeth.2008.08.028; YOELI M., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P132, DOI 10.1016/0035-9203(57)90057-3; Yoshida S, 2001, DEV BIOL, V240, P32, DOI 10.1006/dbio.2001.0443; ZUCKERMAN BM, 1979, EXP PARASITOL, V47, P419, DOI 10.1016/0014-4894(79)90095-X; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	87	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101929	10.1371/journal.pone.0101929	http://dx.doi.org/10.1371/journal.pone.0101929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013968	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400047
J	Ando, K; Takahashi, F; Kato, M; Kaneko, N; Doi, T; Ohe, Y; Koizumi, F; Nishio, K; Takahashi, K				Ando, Katsutoshi; Takahashi, Fumiyuki; Kato, Motoyasu; Kaneko, Norihiro; Doi, Tokuhide; Ohe, Yuichiro; Koizumi, Fumiaki; Nishio, Kazuto; Takahashi, Kazuhisa			Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer	PLOS ONE			English	Article							ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; WEIGHT-LOSS; PANCREATIC-CANCER; CASTLEMAN-DISEASE; BEARING MICE; TUMOR-GROWTH; T-CELLS; INTERLEUKIN-6; MECHANISMS; PROGNOSIS	Background: We previously reported the role of IL-6 in a murine model of cancer cachexia and currently documented a patient in whom tocilizumab, anti-IL-6 receptor antibody, dramatically improved cachexia induced by IL-6 over-expressing lung cancer. Despite this potential to alleviate cancer cachexia, tocilizumab has not been approved for this clinical use. Therefore, preceding our planned clinical trial of tocilizumab, we designed the two studies described here to evaluate the levels of IL-6 in patients with lung cancer and the effect of tocilizumab in a murine model of human cancer cachexia. Methods: First, we measured serum IL-6 levels in patients with lung cancer and analyzed its association with cachexia and survival. Next, we examined the effect of a rodent analog of tocilizumab (MR16-1) in the experimental cachexia model. Results: Serum IL-6 levels were higher in patients with cachexia than those without cachexia. In patients with chemotherapy-resistant lung cancer, a high IL-6 serum level correlated strongly with survival, and the cut-off level for affecting their prognosis was 21 pg/mL. Meanwhile, transplantation of IL-6-expressing Lewis Lung Carcinoma cells caused cachexia in mice, which then received either MR16-1 or 0.9% saline. Tumor growth was similar in both groups; however, the MR16-1 group lost less weight, maintained better food and water intake and had milder cachectic features in blood. MR16-1 also prolonged the survival of LLC-IL6 transplanted mice (36.6 vs. 28.5 days, p = 0.016). Conclusion: Our clinical and experimental studies revealed that serum IL-6 is a surrogate marker for evaluating cachexia and the prognosis of patients with chemotherapy resistant metastatic lung cancer and that tocilizumab has the potential of improving prognosis and ameliorating the cachexia that so devastates their quality of life. This outcome greatly encourages our clinical trials to evaluate the safety and efficacy of tocilizumab treatment for patients with increased serum IL-6.	[Ando, Katsutoshi; Takahashi, Fumiyuki; Kato, Motoyasu; Takahashi, Kazuhisa] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Ando, Katsutoshi; Takahashi, Fumiyuki; Kato, Motoyasu; Takahashi, Kazuhisa] Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Kaneko, Norihiro] Kameda Med Ctr, Dept Resp Internal Med, Kamogawa City, Chiba, Japan; [Doi, Tokuhide] Fukuoka Clin, Adachi Ku, Tokyo, Japan; [Ohe, Yuichiro] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan; [Koizumi, Fumiaki] Natl Canc Ctr, Shien Lab, Chuo Ku, Tokyo, Japan; [Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan	Juntendo University; National Cancer Center - Japan; National Cancer Center - Japan; Kindai University (Kinki University)	Ando, K (corresponding author), Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan.	kando@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21591003, 23591906]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research no. 21591003 (Kazuhisa Takahashi) and no. 23591906 (Fumiyuki Takahashi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ando K, 2013, J CLIN ONCOL, V31, P2971, DOI 10.1200/JCO.2013.50.4324; Ando K, 2013, J CLIN ONCOL, V31, pE69, DOI 10.1200/JCO.2012.44.2020; Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; BRUERA E, 1985, CANCER TREAT REP, V69, P751; Davis MP, 2004, J CLIN ONCOL, V22, P1510, DOI 10.1200/JCO.2004.03.103; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; Gioulbasanis I, 2011, LUNG CANCER, V74, P516, DOI 10.1016/j.lungcan.2011.05.009; Gordon JN, 2005, QJM-INT J MED, V98, P779, DOI 10.1093/qjmed/hci127; Hirama M, 2003, CANCER LETT, V198, P107, DOI 10.1016/S0304-3835(03)00286-6; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Lambert JW, 2013, UROLOGY, V81, P587, DOI 10.1016/j.urology.2012.10.055; Lu HJ, 2013, JPN J CLIN ONCOL, V43, P532, DOI 10.1093/jjco/hyt043; MERRIMAN RL, 1989, CANCER RES, V49, P4509; Mori K, 2009, BIOMED RES-TOKYO, V30, P47, DOI 10.2220/biomedres.30.47; MOSHAGE HJ, 1987, J CLIN INVEST, V79, P1635, DOI 10.1172/JCI113000; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Narita Y, 2013, J IMMUNOL, V190, P812, DOI 10.4049/jimmunol.1103797; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Ogata A, 2012, CLIN MED INSIGHTS-AR, V5, P27, DOI 10.4137/CMAMD.S7371; OHE Y, 1993, BRIT J CANCER, V67, P939, DOI 10.1038/bjc.1993.174; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; POPIELA T, 1989, EUR J CANCER CLIN ON, V25, P1823; RAMADORI G, 1988, EUR J IMMUNOL, V18, P1259, DOI 10.1002/eji.1830180817; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; SUGIURA K, 1955, CANCER RES, V15, P38; Takahashi F, 2002, INT J CANCER, V98, P707, DOI 10.1002/ijc.10261; Tisdale Michael J, 2003, J Support Oncol, V1, P159; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; VANDENBREKEL AJS, 1995, J CLIN ONCOL, V13, P2600, DOI 10.1200/JCO.1995.13.10.2600; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Yae S, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/976926; Zhang YF, 2008, INT IMMUNOPHARMACOL, V8, P1767, DOI 10.1016/j.intimp.2008.08.008	44	70	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102436	10.1371/journal.pone.0102436	http://dx.doi.org/10.1371/journal.pone.0102436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010770	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800101
J	Lundberg, IV; Burstrom, AL; Edin, S; Eklof, V; Oberg, A; Stenling, R; Palmqvist, R; Wikberg, ML				Lundberg, Ida V.; Burstrom, Anna Lofgren; Edin, Sofia; Eklof, Vincy; Oberg, Ake; Stenling, Roger; Palmqvist, Richard; Wikberg, Maria L.			SOX2 Expression Is Regulated by BRAF and Contributes to Poor Patient Prognosis in Colorectal Cancer	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; TRANSCRIPTION FACTOR SOX2; DNA COPY NUMBER; GENE-EXPRESSION; MICROSATELLITE INSTABILITY; V600E MUTATION; LUNG-CANCER; STEM-CELLS; CARCINOMA; GROWTH	Sporadic colorectal cancer (CRC) is a common malignancy and also one of the main causes of cancer deaths worldwide. Aberrant expression of the transcription factor SOX2 has recently been observed in several cancer types, but its role in CRC has not been fully elucidated. Here we studied the expression of SOX2 in 441 CRC patients by immunohistochemistry and related the expression to clinicopathological and molecular variables and patient prognosis. SOX2 was expressed in 11% of the tumors and was significantly associated to BRAF(V600E) mutation, but not to KRAS mutations (codon 12 and 13). SOX2 positivity was correlated to poor patient survival, especially in BRAF(V600E) mutated cases. In vitro studies showed that cells expressing the constitutively active BRAF(V600E) had increased SOX2 expression, a finding not found in cells expressing KRAS(G12V). Furthermore, blocking downstream BRAF signalling using a MEK-inhibitor resulted in a decreased expression of SOX2. Since SOX2 overexpression has been correlated to increased migration and invasion, we investigated the SOX2 expression in human CRC liver metastasis and found that a SOX2 positive primary CRC also had SOX2 expression in corresponding liver metastases. Finally we found that cells overexpressing SOX2 in vitro showed enhanced expression of FGFR1, which has been reported to correlate with liver metastasis in CRC. Our novel findings suggest that SOX2 expression is partly regulated by BRAF signalling, and an increased SOX2 expression may promote CRC metastasis and mediate a poor patient prognosis.	[Lundberg, Ida V.; Burstrom, Anna Lofgren; Edin, Sofia; Eklof, Vincy; Stenling, Roger; Palmqvist, Richard; Wikberg, Maria L.] Umea Univ, Dept Med Biosci, Umea, Sweden; [Oberg, Ake] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University	Wikberg, ML (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	maria.wikberg@medbio.umu.se			Cancer Research Foundation in Northern Sweden; OE and Edla Johanssons foundation; Petrus and Augusta Hedlunds Foundation; Magn Bergvall Foundation; Swedish Cancer Society; Swedish Research Council; Umea University	Cancer Research Foundation in Northern Sweden; OE and Edla Johanssons foundation; Petrus and Augusta Hedlunds Foundation; Magn Bergvall Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University	This study was supported by grants from The Cancer Research Foundation in Northern Sweden, OE and Edla Johanssons foundation, Petrus and Augusta Hedlunds Foundation, Magn Bergvall Foundation, The Swedish Cancer Society, The Swedish Research Council and Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Cimpean AM, 2011, CLIN EXP MED, V11, P251, DOI 10.1007/s10238-010-0127-0; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; Eklof V, 2013, BRIT J CANCER, V108, P2153, DOI 10.1038/bjc.2013.212; Fang XF, 2010, OMICS, V14, P369, DOI 10.1089/omi.2010.0053; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gallo M, 2013, CANCER RES, V73, P417, DOI 10.1158/0008-5472.CAN-12-1881; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jang JH, 2005, ONCOGENE, V24, P945, DOI 10.1038/sj.onc.1208254; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Li XL, 2004, INT J ONCOL, V24, P257; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Lou XY, 2013, OMICS, V17, P510, DOI 10.1089/omi.2013.0058; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Park ET, 2008, INT J CANCER, V122, P1253, DOI 10.1002/ijc.23225; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Pham DL, 2013, INT J GYNECOL PATHOL, V32, P358, DOI 10.1097/PGP.0b013e31826a642b; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Ruan J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0445-z; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sato T, 2009, ONCOL REP, V21, P211, DOI 10.3892/or_00000210; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang XB, 2013, AURIS NASUS LARYNX, V40, P481, DOI 10.1016/j.anl.2013.01.003; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yang F, 2013, INT J CLIN EXP PATHO, V6, P2846	40	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101957	10.1371/journal.pone.0101957	http://dx.doi.org/10.1371/journal.pone.0101957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010701	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800054
J	Aberhan, M; Kiessling, W				Aberhan, Martin; Kiessling, Wolfgang			Rebuilding Biodiversity of Patagonian Marine Molluscs after the End-Cretaceous Mass Extinction	PLOS ONE			English	Article							WEST-CENTRAL ARGENTINA; NEUQUEN BASIN; NORTHERN PATAGONIA; PALEOGENE BOUNDARY; FOSSIL RECORD; RECOVERY; DIVERSITY; BIVALVES; ABUNDANCE; DYNAMICS	We analysed field-collected quantitative data of benthic marine molluscs across the Cretaceous-Palaeogene boundary in Patagonia to identify patterns and processes of biodiversity reconstruction after the end-Cretaceous mass extinction. We contrast diversity dynamics from nearshore environments with those from offshore environments. In both settings, Early Palaeogene (Danian) assemblages are strongly dominated by surviving lineages, many of which changed their relative abundance from being rare before the extinction event to becoming the new dominant forms. Only a few of the species in the Danian assemblages were newly evolved. In offshore environments, however, two newly evolved Danian bivalve species attained ecological dominance by replacing two ecologically equivalent species that disappeared at the end of the Cretaceous. In both settings, the total number of Danian genera at a locality remained below the total number of late Cretaceous (Maastrichtian) genera at that locality. We suggest that biotic interactions, in particular incumbency effects, suppressed post-extinction diversity and prevented the compensation of diversity loss by originating and invading taxa. Contrary to the total number of genera at localities, diversity at the level of individual fossiliferous horizons before and after the boundary is indistinguishable in offshore environments. This indicates an evolutionary rapid rebound to pre-extinction values within less than ca 0.5 million years. In nearshore environments, by contrast, diversity of fossiliferous horizons was reduced in the Danian, and this lowered diversity lasted for the entire studied post-extinction interval. In this heterogeneous environment, low connectivity among populations may have retarded the recolonisation of nearshore habitats by survivors.	[Aberhan, Martin; Kiessling, Wolfgang] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Kiessling, Wolfgang] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Erlangen Nuremberg	Aberhan, M (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany.	martin.aberhan@mfn-berlin.de	Kiessling, Wolfgang/E-2259-2015	Kiessling, Wolfgang/0000-0002-1088-2014	Deutsche Forschungsgemeinschaft [Ab 109/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (grant number: Ab 109/8-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M, 2007, GEOLOGY, V35, P227, DOI 10.1130/G23197A.1; AGUIRREURRETA MB, 1989, PALAEONTOLOGY, V32, P499; Algar AC, 2013, GLOBAL ECOL BIOGEOGR, V22, P391, DOI 10.1111/geb.12003; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2010, PALEONTOLOGICAL SOC, V16, P55, DOI [10.1017/S1089332600001819, DOI 10.1017/S1089332600001819]; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; Barreda VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052455; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; BRYAN JR, 1989, PALAEOGEOGR PALAEOCL, V69, P279, DOI 10.1016/0031-0182(89)90170-3; Casadio S, 2005, CRETACEOUS RES, V26, P507, DOI 10.1016/j.cretres.2005.01.009; Casadio S, 2009, AMEGHINIANA, V46, P27; Chavan A., 1946, Bull Mus Hist nat Paris (2), V18, P345; CHIESA JO, 1995, ACAD NACL CIENCIAS E, V11, P17; Chiesa Jorge O., 2001, Revista Espanola de Paleontologia, V16, P299; Coxall HK, 2006, GEOLOGY, V34, P297, DOI 10.1130/G21702.1; Darragh Thomas A., 1997, Proceedings of the Royal Society of Victoria, V109, P57; del Rio CJ, 2004, J PALEONTOL, V78, P1097, DOI 10.1666/0022-3360(2004)078<1097:TMMAOE>2.0.CO;2; del Rio CJ, 2002, GEOLOGIA RECURSOS NA, V2, P1; del Rio CJ, 2008, NEUES JAHRB GEOL P-A, V249, P281, DOI 10.1127/0077-7749/2008/0249-0281; Del Rio CJ, 2007, ALCHERINGA, V31, P241, DOI 10.1080/03115510701484713; del Rio CJ, 2011, NEUES JAHRB GEOL P-A, V259, P129, DOI 10.1127/0077-7749/2011/0103; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Erwin Douglas H., 2007, Palaeoworld, V16, P9, DOI 10.1016/j.palwor.2007.05.013; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; GRIFFIN M, 1994, J PALEONTOL, V68, P257, DOI 10.1017/S002233600002285X; Hallam A., 1990, P249; HANSEN T, 1987, Cretaceous Research, V8, P229, DOI 10.1016/0195-6671(87)90023-1; Hansen TA, 2004, PALAEOGEOGR PALAEOCL, V214, P233, DOI 10.1016/j.palaeo.2004.06.017; HANSEN TA, 1993, PALEOBIOLOGY, V19, P251, DOI 10.1017/S0094837300015906; Harries P.J., 1996, BIOTIC RECOVERY MASS, V102, P41; Harrington HJ, 1958, NZ GEOLOGICAL SURVEY, V59, P1; Heinberg C, 1999, PALAEOGEOGR PALAEOCL, V154, P87, DOI 10.1016/S0031-0182(99)00088-7; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P389, DOI 10.1016/j.tree.2013.05.019; Hull PM, 2011, NAT GEOSCI, V4, P856, DOI 10.1038/NGEO1302; Hull PM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002082; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kafanov Alexander I., 2004, Science Reports of the Institute of Geoscience University of Tsukuba Section B Geological Sciences, V25, P9; Kauffman EG, 2004, J PALEONTOL, V78, P1187, DOI 10.1666/0022-3360(2004)078<1187:ARNGOM>2.0.CO;2; Keller G, 2007, CRETACEOUS RES, V28, P939, DOI 10.1016/j.cretres.2007.01.006; Kiessling W, 2007, PALEOBIOLOGY, V33, P414, DOI 10.1666/06069.1; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Lazo DG, 2007, GEOL J, V42, P127, DOI 10.1002/gj.1080; Lazo DG, 2011, J PALEONTOL, V85, P719, DOI 10.1666/10-098.1; Lazo DG, 2003, CRETACEOUS RES, V24, P765, DOI 10.1016/j.cretres.2003.09.001; Lockwood R, 2003, P NATL ACAD SCI USA, V100, P2478, DOI 10.1073/pnas.0535132100; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Patzkowsky ME, 2007, PALEOBIOLOGY, V33, P295, DOI 10.1666/06078.1; Roopnarine PD, 2006, PALEOBIOLOGY, V32, P1; Scasso RA, 2012, CRETACEOUS RES, V36, P37, DOI 10.1016/j.cretres.2012.02.002; Scasso RA, 2005, CRETACEOUS RES, V26, P283, DOI 10.1016/j.cretres.2004.12.003; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sessa JA, 2012, PALEOBIOLOGY, V38, P218, DOI 10.1666/10042.1; Sheehan PM, 2008, LETHAIA, V41, P147, DOI 10.1111/j.1502-3931.2008.00116.x; Simpson C, 2009, PALEOBIOLOGY, V35, P631, DOI 10.1666/0094-8373-35.4.631; Sole RV, 2010, J THEOR BIOL, V267, P193, DOI 10.1016/j.jtbi.2010.08.015; SQUIRES RL, 1994, VELIGER, V37, P253; Stilwell JD, 2003, ALCHERINGA, V27, P245, DOI 10.1080/03115510308619107; Stilwell JD, 2003, PALAEOGEOGR PALAEOCL, V195, P319, DOI 10.1016/S0031-0182(03)00364-X; Stilwell Jeffrey D., 2004, Bulletins of American Paleontology, V367, P1; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Vermeij GJ, 2013, PALEOBIOLOGY, V39, P560, DOI 10.1666/13009; WALLER TR, 1992, J PALEONTOL, V66, P215, DOI 10.1017/S0022336000033746; Woods H., 1917, NZ GEOLOGICAL SURVEY, V4, P1; ZINSMEISTER WJ, 1995, J PALEONTOL, V69, P692, DOI 10.1017/S0022336000035216	74	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102629	10.1371/journal.pone.0102629	http://dx.doi.org/10.1371/journal.pone.0102629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028930	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600088
J	Carroll, AL; Sillett, SC; Kramer, RD				Carroll, Allyson L.; Sillett, Stephen C.; Kramer, Russell D.			Millennium-Scale Crossdating and Inter-Annual Climate Sensitivities of Standing California Redwoods	PLOS ONE			English	Article							COAST REDWOOD; FIRE HISTORY; GIANT SEQUOIA; TEMPERATURE PATTERNS; DOUGLAS-FIR; DROUGHT; FORESTS; FOG; DENDROCLIMATOLOGY; RECONSTRUCTIONS	Extremely decay-resistant wood and fire-resistant bark allow California's redwoods to accumulate millennia of annual growth rings that can be useful in biological research. Whereas tree rings of Sequoiadendron giganteum (SEGI) helped formalize the study of dendrochronology and the principle of crossdating, those of Sequoia sempervirens (SESE) have proven much more difficult to decipher, greatly limiting dendroclimatic and other investigations of this species. We overcame these problems by climbing standing trees and coring trunks at multiple heights in 14 old-growth forest locations across California. Overall, we sampled 1,466 series with 483,712 annual rings from 120 trees and were able to crossdate 83% of SESE compared to 99% of SEGI rings. Standard and residual tree-ring chronologies spanning up to 1,685 years for SESE and 1,538 years for SEGI were created for each location to evaluate crossdating and to examine correlations between annual growth and climate. We used monthly values of temperature, precipitation, and drought severity as well as summer cloudiness to quantify potential drivers of inter-annual growth variation over century-long time series at each location. SESE chronologies exhibited a latitudinal gradient of climate sensitivities, contrasting cooler northern rainforests and warmer, drier southern forests. Radial growth increased with decreasing summer cloudiness in northern rainforests and a central SESE location. The strongest dendroclimatic relationship occurred in our southernmost SESE location, where radial growth correlated negatively with dry summer conditions and exhibited responses to historic fires. SEGI chronologies showed negative correlations with June temperature and positive correlations with previous October precipitation. More work is needed to understand quantitative relationships between SEGI radial growth and moisture availability, particularly snowmelt. Tree-ring chronologies developed here for both redwood species have numerous scientific applications, including determination of tree ages, accurate dating of fire-return intervals, archaeology, analyses of stable isotopes, long-term climate reconstructions, and quantifying rates of carbon sequestration.	[Carroll, Allyson L.; Sillett, Stephen C.; Kramer, Russell D.] Humboldt State Univ, Dept Forestry & Wildland Resources, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	Carroll, AL (corresponding author), Humboldt State Univ, Dept Forestry & Wildland Resources, Arcata, CA 95521 USA.	allyson.carroll@gmail.com		Kramer, Russell/0000-0001-5723-771X	Save-the-Redwoods League's Redwoods; Climate Change Initiative (RCCI); National Science Foundation [IOB-0445277]	Save-the-Redwoods League's Redwoods; Climate Change Initiative (RCCI); National Science Foundation(National Science Foundation (NSF))	This research was funded by the Save-the-Redwoods League's Redwoods and Climate Change Initiative (RCCI) and the endowment creating the Kenneth L. Fisher Chair in Redwood Forest Ecology at Humboldt State University. Earlier work in Humboldt Redwoods State Park was funded by the National Science Foundation (IOB-0445277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2013, INT J CLIMATOL, V33, P121, DOI 10.1002/joc.3413; Ambrose AR, 2009, PLANT CELL ENVIRON, V32, P743, DOI 10.1111/j.1365-3040.2009.01950.x; [Anonymous], 2014, R LANG ENV STAT COMP; Antevs E, 1925, MONTHLY WEATHER REV, V53, P449; Averill J. L, 1924, J FOREST, V22, P31; Biondi F, 1997, AM MIDL NAT, V138, P237, DOI 10.2307/2426817; Briffa KR, 1995, ANALYSIS OF CLIMATE VARIABILITY, P77; BRIFFA KR, 1992, J CLIMATE, V5, P735, DOI 10.1175/1520-0442(1992)005<0735:TRDROS>2.0.CO;2; Brown P. M., 1992, Tree-Ring Bulletin, V52, P1; Brown PM, 2003, NORTHWEST SCI, V77, P147; BROWN PM, 1994, CAN J FOREST RES, V24, P21, DOI 10.1139/x94-004; Brown PM, 1999, NORTHWEST SCI, V73, P205; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Carroll A. L., 2005, Madrono, V52, P114, DOI 10.3120/0024-9637(2005)52[114:CAOAYC]2.0.CO;2; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cook E.R, 1985, TIME SERIES ANAL APP; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; Douglass A. E., 1945, TREE RING BULL, V11, P26; Douglass AE, 1933, CARNEGIE I WASHINGTO, V32; Douglass AE, 1928, CARNEGIE I WASHINGTO, VII; Douglass AE, 1919, CARNEGIE I WASHINGTO, VI; Drake F, 1628, WORLD ENCOMPAS UNPUB; Dunning D, 1925, TIMBERMAN, V26, P200; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; FRITTS HC, 1974, ECOL MONOGR, V44, P411, DOI 10.2307/1942448; FRITZ EMANUEL, 1940, TREE RING BULL, V6, P19; Gedalof Z, 2001, CAN J FOREST RES, V31, P322, DOI 10.1139/cjfr-31-2-322; GRAUMLICH LJ, 1987, ANN ASSOC AM GEOGR, V77, P19, DOI 10.1111/j.1467-8306.1987.tb00142.x; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hughes MK, 1992, CLIM DYNAM, V6, P161, DOI 10.1007/BF00193528; Hughes MK, 1996, TREE RINGS, ENVIRONMENT AND HUMANITY, P225; Hughes MK, 1990, P 6 ANN PAC CLIM PAC, P111; Johnstone JA, 2013, J GEOPHYS RES-BIOGEO, V118, P1438, DOI 10.1002/jgrg.20111; Johnstone JA, 2010, P NATL ACAD SCI USA, V107, P4533, DOI 10.1073/pnas.0915062107; Kapnick S, 2009, CEC5002009016F PIER; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; KELLY KA, 1985, J GEOPHYS RES-OCEANS, V90, P1783, DOI 10.1029/JC090iC06p11783; Knapp PA, 2004, J CLIMATE, V17, P140, DOI 10.1175/1520-0442(2004)017&lt;0140:OOSDIT&gt;2.0.CO;2; Kramer RD, 2014, TREE PHYSIOL, V34, P314, DOI 10.1093/treephys/tpu011; Larjavaara M, 2014, NEW PHYTOL, V202, P344, DOI 10.1111/nph.12656; Mastrandrea MD, 2012, CLIMATIC CHANGE, V111, P5, DOI 10.1007/s10584-011-0240-4; MEKO D, 1993, J CLIMATE, V6, P1773, DOI [10.1175/1520-0442(1993)006<1773:SPOTGA>2.0.CO;2, 10.1175/1520-0442(1993)006&lt;1773:SPOTGA&gt;2.0.CO;2]; Meko DM, 2001, J AM WATER RESOUR AS, V37, P1029, DOI 10.1111/j.1752-1688.2001.tb05530.x; Meko DM, 2001, INT J CLIMATOL, V21, P697, DOI 10.1002/joc.646; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Osborn T. J., 1997, Dendrochronologia, V15, P89; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Regent Instruments Canada Inc, 2009, WINDENDRO TREE RING; RIENECKER MM, 1986, J GEOPHYS RES-OCEANS, V91, P6597, DOI 10.1029/JC091iC05p06597; Roden JS, 2009, HOLOCENE, V19, P189, DOI 10.1177/0959683608098959; RUNDEL PW, 1972, AM MIDL NAT, V87, P81, DOI 10.2307/2423883; Sawyer J. O., 2000, REDWOOD FOREST, P39; SCHULMAN EDMUND, 1940, TREE RING BULL, V6, P22; Sillett SC, 2007, ECOL MONOGR, V77, P335, DOI 10.1890/06-0994.1; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Speer JH, 2010, FUNDAMENTALS TREE RI; Spickler JC, 2006, HERPETOL CONSERV BIO, V1, P16; Stahle DW, 2013, EARTH INTERACT, V17, DOI 10.1175/2013EI000518.1; Stahle DW., 2000, EOS, V81, P121, DOI [10.1029/00EO00076, DOI 10.1029/00EO00076]; Stecker R.E., 1980, GIANT SEQUOIA ECOLOG; Stephens SL, 2005, FIRE ECOL, V1, P2, DOI DOI 10.4996/FIREECOLOGY.0101002; Stephenson Nathan L., 2000, Madrono, V47, P61; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Swetnam TW, 1987, FIRE HIST DENDROCLIM; Timell T. E, 1986, COMPRESSION WOOD GYM; Van Pelt R., 2001, FOREST GIANTS PACIFI; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Waring KM, 2006, CAN J FOREST RES, V36, P2216, DOI 10.1139/X06-127; WARING RH, 1979, SCIENCE, V204, P1380, DOI 10.1126/science.204.4400.1380; Watson E, 2002, CAN J FOREST RES, V32, P1858, DOI 10.1139/X02-096; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Willard D, 2000, GUIDE SEQUOIA GROVES; Williams AP, 2008, OECOLOGIA, V156, P601, DOI 10.1007/s00442-008-1025-y; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zang C, 2013, DENDROCHRONOLOGIA, V31, P68, DOI 10.1016/j.dendro.2012.08.001	83	41	42	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102545	10.1371/journal.pone.0102545	http://dx.doi.org/10.1371/journal.pone.0102545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029026	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600082
J	Song, HS; Hora, B; Bhattacharya, T; Goonetilleke, N; Liu, MKP; Wiehe, K; Li, H; Iyer, SS; McMichael, AJ; Perelson, AS; Gao, F				Song, Hongshuo; Hora, Bhavna; Bhattacharya, Tanmoy; Goonetilleke, Nilu; Liu, Michael K. P.; Wiehe, Kevin; Li, Hui; Iyer, Shilpa S.; McMichael, Andrew J.; Perelson, Alan S.; Gao, Feng			Reversion and T Cell Escape Mutations Compensate the Fitness Loss of a CD8(+) T Cell Escape Mutant in Their Cognate Transmitted/Founder Virus	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL REPLICATION CAPACITY; SUBTYPE C INFECTION; HIV-1 INFECTION; IN-VIVO; ELITE CONTROLLERS; TYPE-1 INFECTION; P24 GAG; EVOLUTION; HLA	Immune escape mutations that revert back to the consensus sequence frequently occur in newly HIV-1-infected individuals and have been thought to render the viruses more fit. However, their impact on viral fitness and their interaction with other immune escape mutations have not been evaluated in the background of their cognate transmitted/founder (T/F) viral genomes. To precisely determine the role of reversion mutations, we introduced reversion mutations alone or together with CD8(+) T cell escape mutations in their unmodified cognate T/F viral genome and determined their impact on viral fitness in primary CD4(+) T cells. Two reversion mutations, V247I and I64T, were identified in Gag and Tat, respectively, but neither had measurable effect on the fitness of their cognate T/F virus. The V247I and G248A mutations that were detected before and concurrently with the potent T cell escape mutation T242N, respectively, were selected by early T cell responses. The V247I or the G248A mutation alone partially restored the fitness loss caused by the T242N mutation. Together they could fully restore the fitness of the T242N mutant to the T/F level. These results demonstrate that the fitness loss caused by a T cell escape mutation could be compensated by preexisting or concurrent reversion and other T cell escape mutations. Our findings indicate that the overall viral fitness is modulated by the complex interplay among T cell escape, compensatory and reversion mutations to maintain the balance between immune escape and viral replication capacity.	[Song, Hongshuo; Hora, Bhavna; Wiehe, Kevin; Gao, Feng] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Bhattacharya, Tanmoy; Perelson, Alan S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Bhattacharya, Tanmoy] Santa Fe Inst, Santa Fe, NM 87501 USA; [Goonetilleke, Nilu; Liu, Michael K. P.; McMichael, Andrew J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Li, Hui; Iyer, Shilpa S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Li, Hui; Iyer, Shilpa S.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	Duke University; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of Oxford; University of Pennsylvania; University of Pennsylvania	Gao, F (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA.	fgao@duke.edu	Perelson, Alan S/Z-1959-2019; Bhattacharya, Tanmoy/J-8956-2013	Perelson, Alan S/0000-0002-2455-0002; Bhattacharya, Tanmoy/0000-0002-1060-652X	Center for HIV/AIDS Vaccine Immunology [AI067854]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [AI100645]; Duke Centers for AIDS Research from the National Institutes of Health (NIH) [AI064518]; United States Department of Energy [DE-AC52-06NA25396]; NIH [AI028433]; National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) [OD011095]; MRC [MR/K012037/1] Funding Source: UKRI; Medical Research Council [MR/K012037/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, P30AI064518, R01AI028433, UM1AI100645, U01AI067854, R37AI028433] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; Duke Centers for AIDS Research from the National Institutes of Health (NIH); United States Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Center for HIV/AIDS Vaccine Immunology (AI067854) and the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (AI100645) and the Duke Centers for AIDS Research (AI064518) from the National Institutes of Health (NIH). Portions of this work were done under the auspices of the United States Department of Energy under contract DE-AC52-06NA25396 and ASP was also supported by NIH grants AI028433 and the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) through grant OD011095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Bailey JR, 2007, J INFECT DIS, V196, P50, DOI 10.1086/518515; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Chopera DR, 2012, J VIROL, V86, P13423, DOI 10.1128/JVI.02171-12; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Duda A, 2009, J VIROL, V83, P1228, DOI 10.1128/JVI.01545-08; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Ferrari G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001273; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Gao F, 2014, CELL IN PRESS; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Huang KHG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019018; Jiang CL, 2011, J VIROL, V85, P10669, DOI 10.1128/JVI.05249-11; King AA, 2008, SUBPLEX SUBPLEX OPTI; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Nielsen HB, 2012, UCMINF GEN PURPOSE U; Novitsky V, 2010, VIROLOGY, V403, P37, DOI 10.1016/j.virol.2010.04.001; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rolland M, 2013, J VIROL, V87, P5461, DOI 10.1128/JVI.03033-12; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Song HS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-89; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	49	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102734	10.1371/journal.pone.0102734	http://dx.doi.org/10.1371/journal.pone.0102734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028937	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600096
J	Fletcher, TL; Kolias, AG; Hutchinson, PJA; Sutcliffe, MPF				Fletcher, Tim L.; Kolias, Angelos G.; Hutchinson, Peter J. A.; Sutcliffe, Michael P. F.			Development of a Finite Element Model of Decompressive Craniectomy	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; MICROSCOPY	Decompressive craniectomy (DC), an operation whereby part of the skull is removed, is used in the management of patients with brain swelling. While the aim of DC is to reduce intracranial pressure, there is the risk that brain deformation and mechanical strain associated with the operation could damage the brain tissue. The nature and extent of the resulting strain regime is poorly understood at present. Finite element (FE) models of DC can provide insight into this applied strain and hence assist in deciding on the best surgical procedures. However there is uncertainty about how well these models match experimental data, which are difficult to obtain clinically. Hence there is a need to validate any modelling approach outside the clinical setting. This paper develops an axisymmetric FE model of an idealised DC to assess the key features of such an FE model which are needed for an accurate simulation of DC. The FE models are compared with an experimental model using gelatin hydrogel, which has similar poro-viscoelastic material property characteristics to brain tissue. Strain on a central plane of the FE model and the front face of the experimental model, deformation and load relaxation curves are compared between experiment and FE. Results show good agreement between the FE and experimental models, providing confidence in applying the proposed FE modelling approach to DC. Such a model should use material properties appropriate for brain tissue and include a more realistic whole head geometry.	[Fletcher, Tim L.; Sutcliffe, Michael P. F.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Kolias, Angelos G.; Hutchinson, Peter J. A.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J. A.] Univ Cambridge, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Sutcliffe, MPF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mpfs@eng.cam.ac.uk		Hutchinson, Peter/0000-0002-2796-1835; Kolias, Angelos/0000-0003-3992-0587; Sutcliffe, Michael/0000-0001-9729-4460	Engineering and Physical Sciences Research Council (EPSRC); Royal College of Surgeons of England Research Fellowship; Freemasons; Rosetrees Trust; NIHR Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research Centre; Medical Research Council [G0601025] Funding Source: researchfish; National Institute for Health Research [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish; MRC [G0601025] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal College of Surgeons of England Research Fellowship; Freemasons; Rosetrees Trust(Rosetrees Trust); NIHR Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TLF acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC). AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), an NIHR Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Cruz-Flores S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003435.pub2; Dassault Systemes Simulia, 2011, AB US MAN 6 11 1 SEC; Detournay E, 1993, FUNDAMENTALS POROELA, P113, DOI DOI 10.1016/B978-0-08-040615-2.50011-3; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Franceschini G, 2006, THESIS U TRENTO; Galli M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2957993; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Hert S., CGAL USER REFERENCE, V5; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Kalyanam S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127250; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0; Lakes R, 2009, VISCOELASTIC MAT, DOI [10.1017/CBO9780511626722, DOI 10.1017/CB09780511626722]; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2010, INT J NUMER METH BIO, V26, P117, DOI 10.1002/cnm.1260; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Screen HRC, 2009, J STRAIN ANAL ENG, V44, P327, DOI 10.1243/03093247JSA491; Strange DGT, 2012, J MECH BEHAV BIOMED, V11, P16, DOI 10.1016/j.jmbbm.2011.10.003; Suh JK, 1999, J APPL MECH-T ASME, V66, P528, DOI 10.1115/1.2791079; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; von Holst H, 2012, ACTA NEUROCHIR, P1; Wright RM, 2011, BIOMECH MODEL MECHAN, V11, P245; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021	32	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102131	10.1371/journal.pone.0102131	http://dx.doi.org/10.1371/journal.pone.0102131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025666	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400044
J	Lutz, SZ; Franck, O; Bohm, A; Machann, J; Schick, F; Machicao, F; Fritsche, A; Haring, HU; Staiger, H				Lutz, Stefan Z.; Franck, Olga; Boehm, Anja; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			Common Genetic Variation in the Human CTF1 Locus, Encoding Cardiotrophin-1, Determines Insulin Sensitivity	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; RESISTANCE; OBESITY; HOMEOSTASIS; METABOLISM; CYTOKINE; INDEXES; CELLS; LIVER	Aims/Hypothesis: Recently, cardiotrophin-1, a member of the interleukin-6 family of cytokines was described to protect beta-cells from apoptosis, to improve glucose-stimulated insulin secretion and insulin resistance, and to prevent streptozotocin-induced diabetes in mice. Here, we studied whether common single nucleotide polymorphisms (SNPs) in the CTF1 locus, encoding cardiotrophin-1, influence insulin secretion and insulin sensitivity in humans. Methods: We genotyped 1,771 German subjects for three CTF1 tagging SNPs (rs1046276, rs1458201, and rs8046707). The subjects were metabolically characterized by an oral glucose tolerance test. Subgroups underwent magnetic resonance (MR) imaging/spectroscopy and hyperinsulinaemic-euglycaemic clamps. Results: After appropriate adjustment, the minor allele of CTF1 SNP rs8046707 was significantly associated with decreased in vivo measures of insulin sensitivity. The other tested SNPs were not associated with OGTT-derived sensitivity parameters, nor did the three tested SNPs show any association with OGTT-derived parameters of insulin release. In the MR subgroup, SNP rs8046707 was nominally associated with lower visceral adipose tissue. Furthermore, the SNP rs1458201 showed a nominal association with increased VLDL levels. Conclusions: In conclusion, this study, even though preliminary and awaiting further confirmation by independent replication, provides first evidence that common genetic variation in CTF1 could contribute to insulin sensitivity in humans. Our SNP data indicate an insulin-desensitizing effect of cardiotrophin-1 and underline that cardiotrophin-1 represents an interesting target to influence insulin sensitivity.	[Lutz, Stefan Z.; Franck, Olga; Boehm, Anja; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany; [Lutz, Stefan Z.; Boehm, Anja; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany; [Lutz, Stefan Z.; Boehm, Anja; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Tubingen, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Nutr & Prevent Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Schick, Fritz/0000-0002-4231-3406; Staiger, Harald/0000-0002-9507-5333; Moller, Anja/0000-0002-5344-8533	German Federal Ministry of Education and Research (BMBF) [01GI0925]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the University of Tubingen	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen	The study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, we acknowledge the support by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen.	Asrih M, 2013, J MOL CELL CARDIOL, V56, P106, DOI 10.1016/j.yjmcc.2012.12.015; Bustos M, 2003, GASTROENTEROLOGY, V125, P192, DOI 10.1016/S0016-5085(03)00698-X; Castano D, 2014, J HEPATOL, V60, P1017, DOI 10.1016/j.jhep.2013.12.012; Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Hung HC, 2013, INT J CARDIOL, V169, pE33, DOI 10.1016/j.ijcard.2013.08.112; Jimenez-Gonzalez M, 2013, DIABETOLOGIA, V56, P838, DOI 10.1007/s00125-012-2822-8; Machann J, 2006, MAGN RESON MED, V55, P913, DOI 10.1002/mrm.20825; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Malavazos AE, 2008, HYPERTENSION, V51, pE8, DOI 10.1161/HYPERTENSIONAHA.107.105346; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitsumoto H, 2001, MUSCLE NERVE, V24, P769, DOI 10.1002/mus.1068; Moreno-Aliaga MJ, 2012, ADIPOCYTE, V1, P112, DOI 10.4161/adip.19696; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Natal C, 2008, AM J PHYSIOL-ENDOC M, V294, pE52, DOI 10.1152/ajpendo.00506.2007; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Weigert C, 2005, AM J PHYSIOL-ENDOC M, V289, pE251, DOI 10.1152/ajpendo.00448.2004; Zvonic S, 2004, J BIOL CHEM, V279, P47572, DOI 10.1074/jbc.M403998200	25	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100391	10.1371/journal.pone.0100391	http://dx.doi.org/10.1371/journal.pone.0100391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025664	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400003
J	Pal, S; Dey, SK; Saha, C				Pal, Sandip; Dey, Subrata Kumar; Saha, Chabita			Inhibition of Catalase by Tea Catechins in Free and Cellular State: A Biophysical Approach	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; CANCER PREVENTION; OXIDATIVE DAMAGE; IN-VIVO; BINDING; GREEN; DNA; ANTIOXIDANT; APOPTOSIS	Tea flavonoids bind to variety of enzymes and inhibit their activities. In the present study, binding and inhibition of catalase activity by catechins with respect to their structure-affinity relationship has been elucidated. Fluorimetrically determined binding constants for (-)-epigallocatechin gallate (EGCG) and (-)-epicatechin gallate (ECG) with catalase were observed to be 2.27x10(6) M-1 and 1.66x10(6) M-1, respectively. Thermodynamic parameters evidence exothermic and spontaneous interaction between catechins and catalase. Major forces of interaction are suggested to be through hydrogen bonding along with electrostatic contributions and conformational changes. Distinct loss of a-helical structure of catalase by interaction with EGCG was captured in circular dichroism (CD) spectra. Gallated catechins demonstrated higher binding constants and inhibition efficacy than non-gallated catechins. EGCG exhibited maximum inhibition of pure catalase. It also inhibited cellular catalase in K562 cancer cells with significant increase in cellular ROS and suppression of cell viability (IC50 54.5 mu M). These results decipher the molecular mechanism by which tea catechins interact with catalase and highlight the potential of gallated catechin like EGCG as an anticancer drug. EGCG may have other non-specific targets in the cell, but its anticancer property is mainly defined by ROS accumulation due to catalase inhibition.	[Pal, Sandip; Dey, Subrata Kumar; Saha, Chabita] West Bengal Univ Technol, Dept Biotechnol, Kolkata, W Bengal, India	Maulana Abul Kalam Azad University of Technology	Saha, C (corresponding author), West Bengal Univ Technol, Dept Biotechnol, Kolkata, W Bengal, India.	k.chabita@gmail.com	Saha, chabita/AAW-5020-2021		Indian Council of Medical Research (ICMR); Department of Science and Technology (DST), Govt. of India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India))	Mr. Sandip Pal is financially supported by Senior Research Fellowship (SRF) Grant of Indian Council of Medical Research (ICMR). Dr. Chabita Saha is thankful to Department of Science and Technology (DST), Govt. of India for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; ALSHAKHSHIR R, 1994, VACCINE, V12, P472, DOI 10.1016/0264-410X(94)90127-9; Ashoka S, 2006, J LUMIN, V121, P179, DOI 10.1016/j.jlumin.2005.12.001; Attar F, 2009, ANN NY ACAD SCI, V1171, P292, DOI 10.1111/j.1749-6632.2009.04683.x; Bechtel W, 2009, ANTICANCER RES, V29, P4541; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Dong ZG, 1997, CANCER RES, V57, P4414; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Fang MZ, 2003, CANCER RES, V63, P7563; Ghosh D, 2012, J ENVIRON PATHOL TOX, V31, P1; Gohlke Holger, 2002, Angew Chem Int Ed Engl, V41, P2644, DOI 10.1002/1521-3773(20020802)41:15<2644::AID-ANIE2644>3.0.CO;2-O; HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Hasni I, 2011, FOOD CHEM, V126, P630, DOI 10.1016/j.foodchem.2010.11.087; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Hu YD, 2014, SPECTROCHIM ACTA A, V121, P230, DOI 10.1016/j.saa.2013.09.078; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2009, CHEM RES TOXICOL, V22, P1689, DOI 10.1021/tx900148k; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jha NS, 2009, THERMOCHIM ACTA, V482, P21, DOI 10.1016/j.tca.2008.10.012; Kanakis CD, 2011, FOOD CHEM, V127, P1046, DOI 10.1016/j.foodchem.2011.01.079; Khan MA, 2002, INT J BIOL MACROMOL, V30, P243, DOI 10.1016/S0141-8130(02)00038-7; LENEHAN PF, 1995, CANCER CHEMOTH PHARM, V35, P377, DOI 10.1007/s002800050250; Leone M, 2003, CANCER RES, V63, P8118; Liang YC, 1999, J CELL BIOCHEM, V75, P1; Liu JQ, 2004, J PHARMACEUT BIOMED, V35, P671, DOI 10.1016/j.jpba.2004.02.010; Liu WB, 2010, NEUROCHEM INT, V57, P206, DOI 10.1016/j.neuint.2010.05.011; Lyn-Cook BD, 1999, NUTR CANCER, V35, P80, DOI 10.1207/S1532791480-86; Nair CKK, 2008, MUTAT RES-GEN TOX EN, V650, P48, DOI 10.1016/j.mrgentox.2007.10.001; Nelson DL, 2004, LEHNINGER PRINCIPLES, P190; Oikawa S, 2003, FREE RADICAL RES, V37, P881, DOI 10.1080/1071576031000150751; Pal S, 2013, RADIAT ENVIRON BIOPH, V52, P269, DOI 10.1007/s00411-013-0463-z; Pal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043321; PERCY ME, 1984, CAN J BIOCHEM CELL B, V62, P1006, DOI 10.1139/o84-129; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Prochazkova D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Richi B, 2012, MUTAT RES-GEN TOX EN, V747, P62, DOI 10.1016/j.mrgentox.2012.04.002; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; Sanchez-Del-Campo L, 2009, INT J MOL SCI, V10, P5398, DOI 10.3390/ijms10125398; Sazuka M, 1996, BIOSCI BIOTECH BIOCH, V60, P1317, DOI 10.1271/bbb.60.1317; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185; Siddiqui IA, 2006, MOL NUTR FOOD RES, V50, P130, DOI 10.1002/mnfr.200500113; Stern KG, 1936, J BIOL CHEM, V112, P661; SUND H, 1967, EUR J BIOCHEM, V1, P400, DOI 10.1111/j.1432-1033.1967.tb00088.x; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trevisanato SI, 2000, NUTR REV, V58, P1, DOI 10.1111/j.1753-4887.2000.tb01818.x; Wang X, 2003, BIOCHEM PHARMACOL, V66, P2039, DOI 10.1016/S0006-2952(03)00585-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamashita N, 1998, CHEM RES TOXICOL, V11, P855, DOI 10.1021/tx970129v; Yamashita N, 2000, FREE RADICAL RES, V33, P623, DOI 10.1080/10715760000301141; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang GY, 1998, CARCINOGENESIS, V19, P611, DOI 10.1093/carcin/19.4.611; Yang L, 2011, CANCER SCI, V102, P870, DOI 10.1111/j.1349-7006.2011.01874.x	60	33	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102460	10.1371/journal.pone.0102460	http://dx.doi.org/10.1371/journal.pone.0102460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025898	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400076
J	Xu, Z; Huo, XY; Ye, H; Tang, CN; Nandakumar, V; Lou, F; Zhang, DD; Dong, HC; Sun, H; Jiang, SW; Zhang, GC; Liu, ZY; Dong, ZS; Guo, BS; He, Y; Yan, CW; Wang, L; Su, ZY; Li, YY; Gu, DY; Zhang, XJ; Wu, XM; Wei, XW; Hong, LZ; Zhang, YM; Yang, JS; Gong, YL; Tang, CJ; Jones, L; Huang, XF; Chen, SY; Chen, JF				Xu, Zhi; Huo, Xinying; Ye, Hua; Tang, Chuanning; Nandakumar, Vijayalakshmi; Lou, Feng; Zhang, Dandan; Dong, Haichao; Sun, Hong; Jiang, Shouwen; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; He, Yan; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang; Gu, Dongying; Zhang, Xiaojing; Wu, Xiaomin; Wei, Xiaowei; Hong, Lingzhi; Zhang, Yangmei; Yang, Jinsong; Gong, Yonglin; Tang, Cuiju; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi; Chen, Jinfei			Genetic Mutation Analysis of Human Gastric Adenocarcinomas Using Ion Torrent Sequencing Platform	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; IDENTIFIES FREQUENT MUTATION; MULTICENTER PHASE-II; ADVANCED ESOPHAGEAL; SOMATIC MUTATIONS; STOMACH-CANCER; CARCINOMA; EXPRESSION; REVEALS; PROTEIN	Gastric cancer is the one of the major causes of cancer-related death, especially in Asia. Gastric adenocarcinoma, the most common type of gastric cancer, is heterogeneous and its incidence and cause varies widely with geographical regions, gender, ethnicity, and diet. Since unique mutations have been observed in individual human cancer samples, identification and characterization of the molecular alterations underlying individual gastric adenocarcinomas is a critical step for developing more effective, personalized therapies. Until recently, identifying genetic mutations on an individual basis by DNA sequencing remained a daunting task. Recent advances in new next-generation DNA sequencing technologies, such as the semiconductor-based Ion Torrent sequencing platform, makes DNA sequencing cheaper, faster, and more reliable. In this study, we aim to identify genetic mutations in the genes which are targeted by drugs in clinical use or are under development in individual human gastric adenocarcinoma samples using Ion Torrent sequencing. We sequenced 737 loci from 45 cancer-related genes in 238 human gastric adenocarcinoma samples using the Ion Torrent Ampliseq Cancer Panel. The sequencing analysis revealed a high occurrence of mutations along the TP53 locus (9.7%) in our sample set. Thus, this study indicates the utility of a cost and time efficient tool such as Ion Torrent sequencing to screen cancer mutations for the development of personalized cancer therapy.	[Xu, Zhi; Huo, Xinying; Gu, Dongying; Zhang, Xiaojing; Wu, Xiaomin; Wei, Xiaowei; Hong, Lingzhi; Zhang, Yangmei; Yang, Jinsong; Gong, Yonglin; Tang, Cuiju; Chen, Jinfei] Nanjing Med Univ, Dept Oncol, Affiliated Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Ye, Hua; Tang, Chuanning; Lou, Feng; Zhang, Dandan; Dong, Haichao; Sun, Hong; Jiang, Shouwen; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; He, Yan; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang] San Valley Biotechnol Inc, Beijing, Peoples R China; [Nandakumar, Vijayalakshmi; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Nanjing Medical University; University of Southern California	Chen, JF (corresponding author), Nanjing Med Univ, Dept Oncol, Affiliated Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	siyichen@usc.edu; jinfeichen@sohu.com	Hong, Lingzhi/GNO-9746-2022		National Natural Science Foundation of China [81272469, 81000880]; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Wu Jieping Foundation; National Institutes of Health [R01 CA90427, R01 AI084811]; NATIONAL CANCER INSTITUTE [R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084811] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Wu Jieping Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grants from National Natural Science Foundation of China to Dr. Jinfei Chen (Grant No. 81272469) and Dr. Zhi Xu (Grant No. 81000880); a grant from Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project to Dr. Jinfei Chen; and the grants from the Wu Jieping Foundation and the National Institutes of Health (R01 CA90427 and R01 AI084811 to Si-Yi Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batran SE, 2012, INT J CANCER, V130, P491, DOI 10.1002/ijc.26396; [Anonymous], EX VAR SERV NHLBI GO; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Arkenau HT, 2009, J CANCER RES CLIN, V135, P855, DOI 10.1007/s00432-009-0583-7; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bang Y-J, LANCET, V376, P687; Borch K, 2000, BRIT J SURG, V87, P618, DOI 10.1046/j.1365-2168.2000.01425.x; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; Chan JA, 2011, ANN ONCOL, V22, P1367, DOI 10.1093/annonc/mdq604; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Chen J, 2011, J CANCER RES CLIN, V137, P1799, DOI 10.1007/s00432-011-1057-2; Corso G, 2011, EUR J CANCER, V47, P443, DOI 10.1016/j.ejca.2010.09.008; Davis PA, 2001, CRIT REV ONCOL HEMAT, V40, P77, DOI 10.1016/S1040-8428(00)00131-1; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Doi T, 2010, J CLIN ONCOL, V28, P1904, DOI 10.1200/JCO.2009.26.2923; Ferry DR, 2007, CLIN CANCER RES, V13, P5869, DOI 10.1158/1078-0432.CCR-06-1970; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Hartgrink HH, 2002, BRIT J SURG, V89, P1438, DOI 10.1046/j.1365-2168.2002.02220.x; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; Ilson DH, 2011, CANCER-AM CANCER SOC, V117, P1409, DOI 10.1002/cncr.25602; Jackson JR, 2000, CANCER RES, V60, P566; Janmaat ML, 2006, J CLIN ONCOL, V24, P1612, DOI 10.1200/JCO.2005.03.4900; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Shahi PK, 2007, CLIN TRANSL ONCOL, V9, P438, DOI 10.1007/s12094-007-0082-8; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Machado AMD, 2010, BBA-REV CANCER, V1806, P58, DOI 10.1016/j.bbcan.2010.01.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Okines AFC, 2010, EUR J CANCER, V46, P1949, DOI 10.1016/j.ejca.2010.05.003; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peart MJ, 2006, CANCER CELL, V10, P173, DOI 10.1016/j.ccr.2006.08.014; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Pourmand N, 2006, P NATL ACAD SCI USA, V103, P6466, DOI 10.1073/pnas.0601184103; Sigal A, 2000, CANCER RES, V60, P6788; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vidal O, 2009, BRIT J SURG, V96, P1443, DOI 10.1002/bjs.6780; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yoon DH, 2012, BRIT J CANCER, V106, P1039, DOI 10.1038/bjc.2012.47	44	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100442	10.1371/journal.pone.0100442	http://dx.doi.org/10.1371/journal.pone.0100442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025766	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400004
J	Espinola, SM; Ferreira, HB; Zaha, A				Espinola, Sergio Martin; Ferreira, Henrique Bunselmeyer; Zaha, Arnaldo			Validation of Suitable Reference Genes for Expression Normalization in Echinococcus spp. Larval Stages	PLOS ONE			English	Article							MULTILOCULARIS METACESTODES; RELATIVE EXPRESSION; GENUS ECHINOCOCCUS; PCR DATA; RT-PCR; GRANULOSUS; ANTIGEN; CYSTS; HOST; QUANTIFICATION	In recent years, a significant amount of sequence data (both genomic and transcriptomic) for Echinococcus spp. has been published, thereby facilitating the analysis of genes expressed during a specific stage or involved in parasite development. To perform a suitable gene expression quantification analysis, the use of validated reference genes is strongly recommended. Thus, the aim of this work was to identify suitable reference genes to allow reliable expression normalization for genes of interest in Echinococcus granulosus sensu stricto (s.s.) (G1) and Echinococcus ortleppi upon induction of the early pre-adult development. Untreated protoscoleces (PS) and pepsin-treated protoscoleces (PSP) from E. granulosus s.s. (G1) and E. ortleppi metacestode were used. The gene expression stability of eleven candidate reference genes (beta TUB, NDUFV2, RPL13, TBP, CYP-1, RPII, EF-1 alpha, beta ACT-1, GAPDH, ETIF4A-III and MAPK3) was assessed using geNorm, Normfinder, and RefFinder. Our qPCR data showed a good correlation with the recently published RNA-seq data. Regarding expression stability, EF-1 alpha and TBP were the most stable genes for both species. Interestingly, beta ACT-1 (the most commonly used reference gene), and GAPDH and ETIF4A-III (previously identified as housekeeping genes) did not behave stably in our assay conditions. We propose the use of EF-1 alpha as a reference gene for studies involving gene expression analysis in both PS and PSP experimental conditions for E. granulosus s.s. and E. ortleppi. To demonstrate its applicability, EF-1 alpha was used as a normalizer gene in the relative quantification of transcripts from genes coding for antigen B subunits. The same EF-1 alpha reference gene may be used in studies with other Echinococcus sensu lato species. This report validates suitable reference genes for species of class Cestoda, phylum Platyhelminthes, thus providing a foundation for further validation in other epidemiologically important cestode species, such as those from the Taenia genus.	[Espinola, Sergio Martin; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Ferreira, Henrique Bunselmeyer; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, BR-90049 Porto Alegre, RS, Brazil; [Ferreira, Henrique Bunselmeyer; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Zaha, A (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.	zaha@cbiot.ufrgs.br	Espinola, Sergio/L-1504-2015; Zaha, Arnaldo/D-3165-2013; Ferreira, Henrique B/H-4189-2012	Espinola, Sergio/0000-0001-9000-2883; Ferreira, Henrique B/0000-0003-3611-6040; Zaha, Arnaldo/0000-0001-6336-474X	CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (www.cnpq.br) and CAPES (www.capes.gov.br) grants. SME is a recipient of a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balbinotti H, 2012, VET PARASITOL, V188, P255, DOI 10.1016/j.vetpar.2012.04.007; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cabrera G, 2008, J CELL PHYSIOL, V216, P498, DOI 10.1002/jcp.21418; CAMERON TWM, 1969, CAN J ZOOLOG, V47, P1405, DOI 10.1139/z69-216; Colebrook AL, 2004, PARASITOLOGY, V129, P497, DOI 10.1017/S0031182004005773; Cui SJ, 2013, J PROTEOMICS, V84, P158, DOI 10.1016/j.jprot.2013.04.013; Graichen DAS, 2007, GENE, V392, P98, DOI 10.1016/j.gene.2006.11.015; Koziol U, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-10; Li J, 2011, CHINESE MED J-PEKING, V124, P2838, DOI 10.3760/cma.j.issn.0366-6999.2011.18.008; Liu S, 2012, MOL BIOCHEM PARASIT, V182, P75, DOI 10.1016/j.molbiopara.2011.12.007; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mamuti W, 2006, EXP PARASITOL, V113, P75, DOI 10.1016/j.exppara.2005.12.007; Matsumoto J, 2006, PARASITOLOGY, V132, P83, DOI 10.1017/S0031182005008632; McManus DP, 2013, PARASITOLOGY, V140, P1617, DOI 10.1017/S0031182013000802; Monteiro KM, 2010, PROTEOMICS, V10, P1985, DOI 10.1002/pmic.200900506; Muzulin PM, 2008, EXP PARASITOL, V118, P156, DOI 10.1016/j.exppara.2007.07.004; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Pan D, 2010, J HELMINTHOL, V84, P394, DOI 10.1017/S0022149X10000064; Pan D, 2010, J HELMINTHOL, V84, P241, DOI 10.1017/S0022149X09990605; Parkinson J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001897; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Santos GB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-327; Siles-Lucas M, 2001, PARASITOLOGY, V122, P281, DOI 10.1017/S0031182001007405; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Thompson RCA, 2008, EXP PARASITOL, V119, P439, DOI 10.1016/j.exppara.2008.04.016; Thompson R. C. A., 1995, P1; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANKEULEN H, 1985, MOL BIOCHEM PARASIT, V15, P215, DOI 10.1016/0166-6851(85)90121-5; Zhang WB, 2003, AM J TROP MED HYG, V68, P40, DOI 10.4269/ajtmh.2003.68.40; Zhang WB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000784; Zheng HJ, 2013, NAT GENET, V45, P1168, DOI 10.1038/ng.2757	36	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102228	10.1371/journal.pone.0102228	http://dx.doi.org/10.1371/journal.pone.0102228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014071	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400078
J	Lo Sasso, G; Ryu, D; Mouchiroud, L; Fernando, SC; Anderson, CL; Katsyuba, E; Piersigilli, A; Hottiger, MO; Schoonjans, K; Auwerx, J				Lo Sasso, Giuseppe; Ryu, Dongryeol; Mouchiroud, Laurent; Fernando, Samodha C.; Anderson, Christopher L.; Katsyuba, Elena; Piersigilli, Alessandra; Hottiger, Michael O.; Schoonjans, Kristina; Auwerx, Johan			Loss of Sirt1 Function Improves Intestinal Anti-Bacterial Defense and Protects from Colitis-Induced Colorectal Cancer	PLOS ONE			English	Article							PANETH CELL-DIFFERENTIATION; ETS TRANSCRIPTION FACTOR; STEM-CELLS; ULCERATIVE-COLITIS; GENE-EXPRESSION; COLON-CANCER; MICE; DEACETYLASE; METABOLISM; EPITHELIUM	Dysfunction of Paneth and goblet cells in the intestine contributes to inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC). Here, we report a role for the NAD(+)-dependent histone deacetylase SIRT1 in the control of anti-bacterial defense. Mice with an intestinal specific Sirt1 deficiency (Sirt1(int-/-)) have more Paneth and goblet cells with a consequent rearrangement of the gut microbiota. From a mechanistic point of view, the effects on mouse intestinal cell maturation are mediated by SIRT1-dependent changes in the acetylation status of SPDEF, a master regulator of Paneth and goblet cells. Our results suggest that targeting SIRT1 may be of interest in the management of IBD and CAC.	[Lo Sasso, Giuseppe; Ryu, Dongryeol; Mouchiroud, Laurent; Katsyuba, Elena; Piersigilli, Alessandra; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Fernando, Samodha C.; Anderson, Christopher L.] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA; [Anderson, Christopher L.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Piersigilli, Alessandra] Univ Bern, Inst Anim Pathol, Bern, Switzerland; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland; [Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Bern; University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Hottiger, Michael O./J-7747-2013; Ryu, Dongryeol/AAQ-3642-2020	Hottiger, Michael O./0000-0002-7323-2270; Ryu, Dongryeol/0000-0001-5905-6760; Anderson, Christopher/0000-0002-2385-1049; Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393	Outgoing Italian Association for Cancer Research (AIRC)/Marie Curie Fellowship; Ecole Polytechnique Federale de Lausanne; EU Ideas program [AdG-231138]; Swiss National Science Foundation [31003A-140780, 310030-143748]; Krebsforschung Schweiz [KFS-3082-02-2013, KFS-2809-08-2011]; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	Outgoing Italian Association for Cancer Research (AIRC)/Marie Curie Fellowship(Fondazione AIRC per la ricerca sul cancro); Ecole Polytechnique Federale de Lausanne; EU Ideas program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Krebsforschung Schweiz; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GLS is supported by an Outgoing Italian Association for Cancer Research (AIRC)/Marie Curie Fellowship. JA KS laboratory is supported by grants from the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (AdG-231138), the Swiss National Science Foundation (31003A-140780 and 310030-143748), the Krebsforschung Schweiz (KFS-3082-02-2013 and KFS-2809-08-2011), and NIH (R01AG043930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Angelakis E, 2014, ANTIMICROB AGENTS CH; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; Gregorieff A, 2010, CURR PROTOC STEM CEL; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gubelmann C, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.38; GUSTAFSSON BE, 1970, SCAND J GASTROENTERO, V5, P309; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kazgan N, 2013, GASTROENTEROLOGY; Leko V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066283; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Morotomi M, 2008, INT J SYST EVOL MICR, V58, P2716, DOI 10.1099/ijs.0.2008/000810-0; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Noah TK, 2013, GASTROENTEROLOGY, V144, P1012, DOI 10.1053/j.gastro.2013.01.043; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pal M, 2013, J BIOL CHEM, V288, P12222, DOI 10.1074/jbc.M112.434225; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wehkamp J, 2010, J CROHNS COLITIS, V4, P523, DOI 10.1016/j.crohns.2010.05.010; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035294; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	48	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102495	10.1371/journal.pone.0102495	http://dx.doi.org/10.1371/journal.pone.0102495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013930	Green Published, Green Accepted, gold			2022-12-27	WOS:000339378400099
J	Puig-Vilanova, E; Ausin, P; Martinez-Llorens, J; Gea, J; Barreiro, E				Puig-Vilanova, Ester; Ausin, Pilar; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther			Do Epigenetic Events Take Place in the Vastus Lateralis of Patients with Mild Chronic Obstructive Pulmonary Disease?	PLOS ONE			English	Article							OXIDATIVE STRESS; MUSCLE DYSFUNCTION; PREDICTION EQUATIONS; QUADRICEPS MUSCLE; GENE-EXPRESSION; COPD; ACETYLATION; ENDURANCE; ATROPHY; IDENTIFICATION	Muscle dysfunction is a major comorbidity in Chronic Obstructive Pulmonary Disease (COPD). Several biological mechanisms including epigenetic events regulate muscle mass and function in models of muscle atrophy. Investigations conducted so far have focused on the elucidation of biological mechanisms involved in muscle dysfunction in advanced COPD. We assessed whether the epigenetic profile may be altered in the vastus lateralis of patients with mild COPD, normal body composition, and mildly impaired muscle function and exercise capacity. In vastus lateralis (VL) of mild COPD patients with well-preserved body composition and in healthy age-matched controls, expression of DNA methylation, muscle-enriched microRNAs, histone acetyltransferases (HTAs) and deacetylases (HDACs), protein acetylation, small ubiquitin-related modifier (SUMO) ligases, and muscle structure were explored. All subjects were clinically evaluated. Compared to healthy controls, in the VL of mild COPD patients, muscle function and exercise capacity were moderately reduced, DNA methylation levels did not differ, miR-1 expression levels were increased and positively correlated with both forced expiratory volume in one second (FEV1) and quadriceps force, HDAC4 protein levels were increased, and muscle fiber types and sizes were not different. Moderate skeletal muscle dysfunction is a relevant feature in patients with mild COPD and preserved body composition. Several epigenetic events are differentially expressed in the limb muscles of these patients, probably as an attempt to counterbalance the underlying mechanisms that alter muscle function and mass. The study of patients at early stages of their disease is of interest as they are a target for timely therapeutic interventions that may slow down the course of the disease and prevent the deleterious effects of major comorbidities.	[Puig-Vilanova, Ester; Ausin, Pilar; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] Univ Pompeu Fabra, Dept Pulmonol, Muscle & Resp Syst Res Unit URMAR, IMIM Hosp del Mar,Hlth & Expt Sci Dept CEXS, Barcelona, Spain; [Puig-Vilanova, Ester; Ausin, Pilar; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] Inst Salud Carlos III, Ctr Invest Red Enfermedades Resp CIBERES, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Barreiro, E (corresponding author), Univ Pompeu Fabra, Dept Pulmonol, Muscle & Resp Syst Res Unit URMAR, IMIM Hosp del Mar,Hlth & Expt Sci Dept CEXS, Parc Salut Mar,Barcelona Biomed Res Pk PRBB, Barcelona, Spain.	ebarreiro@imim.es	Gea, Joaquim/E-4841-2014	Gea, Joaquim/0000-0001-8718-7346; Ausin, Pilar/0000-0003-4559-567X	Centro de Investigacion en Red de Enfermedades Respiratorias (CIBERES); Fondo de Investigaciones Sanitarias (FIS) [11/02029]; FIS [12/02534]; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); FUCAP; Marato TV3 (Spain) [MTV3-07-1010]; European Respiratory Society (ERS) COPD Research Award;  [SAF-2011-26908];  [2009-SGR-393]	Centro de Investigacion en Red de Enfermedades Respiratorias (CIBERES); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); FUCAP; Marato TV3 (Spain); European Respiratory Society (ERS) COPD Research Award; ; 	This study has been supported by Centro de Investigacion en Red de Enfermedades Respiratorias (CIBERES); Fondo de Investigaciones Sanitarias (FIS) 11/02029; FIS 12/02534; SAF-2011-26908; 2009-SGR-393; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) 2009; Fundacio Catalana de Pneumologia (FUCAP) 2011; FUCAP 2012; and Marato TV3 (MTV3-07-1010) (Spain). Dr. Esther Barreiro was a recipient of the European Respiratory Society (ERS) COPD Research Award 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Natanek SA, 2011, ARCH BRONCONEUMOL, V47, P296, DOI 10.1016/j.arbres.2011.02.015; Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Barreiro E, 2005, AM J RESP CRIT CARE, V171, P1116, DOI 10.1164/rccm.200407-887OC; Barreiro E, 2009, THORAX, V64, P13, DOI 10.1136/thx.2008.105163; Barreiro E, 2013, J APPL PHYSIOL, V114, P1263, DOI 10.1152/japplphysiol.01027.2012; Barreiro E, 2011, J APPL PHYSIOL, V111, P808, DOI 10.1152/japplphysiol.01017.2010; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC; Donaldson A, 2013, THORAX, V68, P1140, DOI 10.1136/thoraxjnl-2012-203129; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Gagnon P, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-4; Gayan-Ramirez G, 2013, J APPL PHYSIOL, V114, P1291, DOI 10.1152/japplphysiol.00847.2012; Gea J, 2013, J APPL PHYSIOL, V114, P1222, DOI 10.1152/japplphysiol.00981.2012; Hadoux J, 2014, INT J CANCER, V135, P2711, DOI 10.1002/ijc.28913; Hussain SNA, 2013, J APPL PHYSIOL, V114, P1273, DOI 10.1152/japplphysiol.00893.2012; Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maltais Francois, 2014, Am J Respir Crit Care Med, V189, pe15, DOI 10.1164/rccm.201402-0373ST; Marin-Corral J, 2009, EUR RESPIR J, V33, P1309, DOI 10.1183/09031936.00072008; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P86, DOI 10.1016/j.arbres.2011.10.007; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Ortega F, 2002, AM J RESP CRIT CARE, V166, P669, DOI 10.1164/rccm.2107081; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puente-Maestu L, 2013, J APPL PHYSIOL, V114, P1282, DOI 10.1152/japplphysiol.00815.2012; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Rieger-Reyes C, 2014, ARCH BRONCONEUMOL, V50, P129, DOI 10.1016/j.arbres.2013.09.014; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Roca J, 1998, RESP MED, V92, P454, DOI 10.1016/S0954-6111(98)90291-8; ROCA J, 1990, AM REV RESPIR DIS, V141, P1026, DOI 10.1164/ajrccm/141.4_Pt_1.1026; Rodriguez DA, 2012, FREE RADICAL BIO MED, V52, P88, DOI 10.1016/j.freeradbiomed.2011.09.022; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sancho-Munoz A, 2014, ARCH BRONCONEUMOL, V50, P221, DOI 10.1016/j.arbres.2013.10.011; Schakman O, 2009, HORM RES, V72, P36, DOI 10.1159/000229762; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Shrikrishna D, 2012, EUR RESPIR J, V40, P1115, DOI 10.1183/09031936.00170111; Slot IGM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090150; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; van den Borst B, 2013, J APPL PHYSIOL, V114, P1319, DOI 10.1152/japplphysiol.00508.2012; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35	56	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102296	10.1371/journal.pone.0102296	http://dx.doi.org/10.1371/journal.pone.0102296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013984	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400085
J	Schmitt, DR; Kuper, J; Elias, A; Kisker, C				Schmitt, Dominik R.; Kuper, Jochen; Elias, Agnes; Kisker, Caroline			The Structure of the TFIIH p34 Subunit Reveals a Von Willebrand Factor A Like Fold	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; SNAKE-VENOM; P44 SUBUNIT; DNA; DOMAIN; REPAIR; DISSOCIATION; ARCHITECTURE	RNA polymerase II dependent transcription and nucleotide excision repair are mediated by a multifaceted interplay of subunits within the general transcription factor II H (TFIIH). A better understanding of the molecular structure of TFIIH is the key to unravel the mechanism of action of this versatile protein complex within these vital cellular processes. The importance of this complex becomes further evident in the context of severe diseases like xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy, that arise from single point mutations in TFIIH subunits. Here we describe the structure of the p34 subunit of the TFIIH complex from the eukaryotic thermophilic fungus Chaetomium thermophilum. The structure revealed that p34 contains a von Willebrand Factor A (vWA) like domain, a fold which is generally known to be involved in protein-protein interactions. Within TFIIH p34 strongly interacts with p44, a positive regulator of the helicase XPD. Putative protein-protein interfaces are analyzed and possible binding sites for the p34-p44 interaction suggested.	[Schmitt, Dominik R.; Kuper, Jochen; Elias, Agnes; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany	University of Wurzburg	Kisker, C (corresponding author), Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany.	caroline.kisker@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026	Deutsche Forschungsgemeinschaft [KI-562/2, Forschungszentrum FZ-82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft (KI-562/2 and Forschungszentrum FZ-82). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguilar-Fuentes J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000253; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andressoo JO, 2005, MUTAT RES-FUND MOL M, V577, P179, DOI 10.1016/j.mrfmmm.2005.04.004; [Anonymous], PYMOL MOL GRAPH SYST; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bedez F, 2013, GENOMICS, V101, P178, DOI 10.1016/j.ygeno.2012.11.003; Busso D, 2000, J BIOL CHEM, V275, P22815, DOI 10.1074/jbc.M002578200; Castro J, 2002, DNA REPAIR, V1, P359, DOI 10.1016/S1568-7864(02)00012-5; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Chen J, 2003, CELL CYCLE, V2, P503, DOI 10.4161/cc.2.6.558; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Fribourg S, 2001, J MOL BIOL, V306, P363, DOI 10.1006/jmbi.2000.4376; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Hashimoto S, 2009, HUM MOL GENET, V18, pR224, DOI 10.1093/hmg/ddp390; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kainov DE, 2010, DNA REPAIR, V9, P33, DOI 10.1016/j.dnarep.2009.10.002; Kellenberger E, 2005, J BIOL CHEM, V280, P20785, DOI 10.1074/jbc.M412999200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraemer Kenneth H, 2007, Mech Ageing Dev, V128, P229, DOI 10.1016/j.mad.2006.11.028; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mourgues S, 2013, P NATL ACAD SCI USA, V110, P17927, DOI 10.1073/pnas.1305009110; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sahin Erinc, 2012, Methods Mol Biol, V899, P403, DOI 10.1007/978-1-61779-921-1_25; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Tremeau-Bravard A, 2001, J BIOL CHEM, V276, P27693, DOI 10.1074/jbc.M102457200; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	57	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102389	10.1371/journal.pone.0102389	http://dx.doi.org/10.1371/journal.pone.0102389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013903	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400092
J	Zhang, W; Hetzel, A; Shah, B; Atchley, D; Blume, SR; Padival, MA; Rosenkranz, JA				Zhang, Wei; Hetzel, Andrea; Shah, Bijal; Atchley, Derek; Blume, Shannon R.; Padival, Mallika A.; Rosenkranz, J. Amiel			Greater Physiological and Behavioral Effects of Interrupted Stress Pattern Compared to Daily Restraint Stress in Rats	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL AXIS; CORTICOTROPIN-RELEASING-FACTOR; BODY-WEIGHT; PLASMA-CATECHOLAMINE; SOCIAL STRESS; ADRENAL AXIS; CORTICOSTERONE RESPONSE; COLONIC TRANSIT; VARIABLE STRESS; LIFE STRESS	Repeated stress can trigger a range of psychiatric disorders, including anxiety. The propensity to develop abnormal behaviors after repeated stress is related to the severity, frequency and number of stressors. However, the pattern of stress exposure may contribute to the impact of stress. In addition, the anxiogenic nature of repeated stress exposure can be moderated by the degree of coping that occurs, and can be reflected in homotypic habituation to the repeated stress. However, expectations are not clear when a pattern of stress presentation is utilized that diminishes habituation. The purpose of these experiments is to test whether interrupted stress exposure decreases homotypic habituation and leads to greater effects on anxiety-like behavior in adult male rats. We found that repeated interrupted restraint stress resulted in less overall homotypic habituation compared to repeated daily restraint stress. This was demonstrated by greater production of fecal boli and greater corticosterone response to restraint. Furthermore, interrupted restraint stress resulted in a lower body weight and greater adrenal gland weight than daily restraint stress, and greater anxiety-like behavior in the elevated plus maze. Control experiments demonstrated that these effects of the interrupted pattern could not be explained by differences in the total number of stress exposures, differences in the total number of days that the stress periods encompased, nor could it be explained as a result of only the stress exposures after an interruption from stress. These experiments demonstrate that the pattern of stress exposure is a significant determinant of the effects of repeated stress, and that interrupted stress exposure that decreases habituation can have larger effects than a greater number of daily stress exposures. Differences in the pattern of stress exposure are therefore an important factor to consider when predicting the severity of the effects of repeated stress on psychiatric disorders.	[Zhang, Wei; Hetzel, Andrea; Shah, Bijal; Atchley, Derek; Blume, Shannon R.; Padival, Mallika A.; Rosenkranz, J. Amiel] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Rosenkranz, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA.	amiel.rosenkranz@rosalindfranklin.edu			National Institutes of Health [MH84970]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research was funded by National Institutes of Health (www.nih.gov; MH84970) to JAR. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 1996, ENDOCR RES, V22, P433, DOI 10.1080/07435809609043729; ARMARIO A, 1988, NEUROENDOCRINOLOGY, V47, P263, DOI 10.1159/000124921; ARMARIO A, 1986, NEUROSCI BIOBEHAV R, V10, P245, DOI 10.1016/0149-7634(86)90011-4; BARONE FC, 1990, AM J PHYSIOL, V258, pG329, DOI 10.1152/ajpgi.1990.258.3.G329; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bevans K, 2008, DEV PSYCHOPATHOL, V20, P257, DOI 10.1017/S0954579408000126; Bhatnagar S, 2006, J NEUROENDOCRINOL, V18, P13, DOI 10.1111/j.1365-2826.2005.01375.x; Bhatnagar S, 2002, J NEUROENDOCRINOL, V14, P403, DOI 10.1046/j.0007-1331.2002.00792.x; BILLINGS AG, 1984, J PERS SOC PSYCHOL, V46, P877, DOI 10.1037/0022-3514.46.4.877; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Blanchard RJ, 1998, PHYSIOL BEHAV, V63, P561, DOI 10.1016/S0031-9384(97)00508-8; BROWN SA, 1990, J ABNORM PSYCHOL, V99, P344, DOI 10.1037/0021-843X.99.4.344; COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; DEBOER SF, 1989, PHYSIOL BEHAV, V45, P789, DOI 10.1016/0031-9384(89)90296-5; DESOUZA EB, 1982, ENDOCRINOLOGY, V110, P23, DOI 10.1210/endo-110-1-23; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; GAMALLO A, 1986, PHYSIOL BEHAV, V36, P217, DOI 10.1016/0031-9384(86)90006-5; Gray M, 2010, J NEUROENDOCRINOL, V22, P92, DOI 10.1111/j.1365-2826.2009.01941.x; Grissom N, 2008, BEHAV BRAIN RES, V191, P219, DOI 10.1016/j.bbr.2008.03.030; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Harris RBS, 2002, PHYSIOL BEHAV, V76, P543, DOI 10.1016/S0031-9384(02)00754-0; Harris RBS, 2006, HORM BEHAV, V49, P615, DOI 10.1016/j.yhbeh.2005.12.001; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; KANT GJ, 1985, PHARMACOL BIOCHEM BE, V22, P631; Kearns RR, 2013, PHYSIOL BEHAV, V122, P193, DOI 10.1016/j.physbeh.2013.03.029; Kendler KS, 2001, PSYCHOL MED, V31, P411, DOI 10.1017/S0033291701003622; KONARSKA M, 1990, PHYSIOL BEHAV, V47, P647, DOI 10.1016/0031-9384(90)90072-C; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Li HY, 1998, J COMP NEUROL, V393, P244; Ma XM, 1998, J PHYSIOL-LONDON, V510, P605, DOI 10.1111/j.1469-7793.1998.605bk.x; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Marin TJ, 2007, HEALTH PSYCHOL, V26, P447, DOI 10.1037/0278-6133.26.4.447; Marti, 1997, Stress, V1, P179; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; MARTI O, 1993, PSYCHONEUROENDOCRINO, V18, P67, DOI 10.1016/0306-4530(93)90056-Q; Masini CV, 2008, BEHAV NEUROSCI, V122, P210, DOI 10.1037/0735-7044.122.1.210; MEERLO P, 1996, STRESS, V1, P21, DOI DOI 10.3109/10253899609001093; MONNIKES H, 1993, GASTROENTEROLOGY, V104, P716; MOTOWIDLO SJ, 1986, J APPL PSYCHOL, V71, P618, DOI 10.1037/0021-9010.71.4.618; NATELSON BH, 1988, PHYSIOL BEHAV, V43, P41, DOI 10.1016/0031-9384(88)90096-0; ORR TE, 1990, PSYCHONEUROENDOCRINO, V15, P317, DOI 10.1016/0306-4530(90)90057-G; Ostrander MM, 2006, ENDOCRINOLOGY, V147, P2008, DOI 10.1210/en.2005-1041; PITMAN DL, 1995, BEHAV NEUROSCI, V109, P767, DOI 10.1037/0735-7044.109.4.767; PITMAN DL, 1990, BEHAV NEUROSCI, V104, P28, DOI 10.1037/0735-7044.104.1.28; PITMAN DL, 1988, PHYSIOL BEHAV, V43, P47, DOI 10.1016/0031-9384(88)90097-2; Rabasa C, 2013, STRESS, V16, P698, DOI 10.3109/10253890.2013.824964; Rabasa C, 2011, PHYSIOL BEHAV, V103, P125, DOI 10.1016/j.physbeh.2011.02.022; RATNER A, 1989, PSYCHONEUROENDOCRINO, V14, P393, DOI 10.1016/0306-4530(89)90008-5; Ruis MAW, 1999, PSYCHONEUROENDOCRINO, V24, P285, DOI 10.1016/S0306-4530(98)00050-X; SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7; Smith AS, 2013, STRESS, V16, P531, DOI 10.3109/10253890.2013.794449; Stamp JA, 1999, NEUROSCIENCE, V94, P1313, DOI 10.1016/S0306-4522(99)00368-1; Tamashiro KLK, 2007, AM J PHYSIOL-REG I, V293, pR1864, DOI 10.1152/ajpregu.00371.2007; TERRAZZINO S, 1995, J NEUROCHEM, V65, P263; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; WILLIAMS CL, 1987, AM J PHYSIOL, V253, pG582, DOI 10.1152/ajpgi.1987.253.4.G582; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026	60	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102247	10.1371/journal.pone.0102247	http://dx.doi.org/10.1371/journal.pone.0102247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014526	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400081
J	Fitzgerald, AJ; Pickwell-MacPherson, E; Wallace, VP				Fitzgerald, Anthony J.; Pickwell-MacPherson, Emma; Wallace, Vincent P.			Use of Finite Difference Time Domain Simulations and Debye Theory for Modelling the Terahertz Reflection Response of Normal and Tumour Breast Tissue	PLOS ONE			English	Article							HUMAN SKIN; DIELECTRIC-RELAXATION; EX-VIVO; IN-VIVO; SPECTROSCOPY; CANCER; GEOMETRY; WATER	The aim of this work was to evaluate the capabilities of Debye theory combined with Finite Difference Time Domain (FDTD) methods to simulate the terahertz (THz) response of breast tissues. Being able to accurately model breast tissues in the THz regime would facilitate the understanding of image contrast parameters used in THz imaging of breast cancer. As a test case, the model was first validated using liquid water and simulated reflection pulses were compared to experimental measured pulses with very good agreement (p = 1.00). The responses of normal and cancerous breast tissues were simulated with Debye properties and the correlation with measured data was still high for tumour (p = 0.98) and less so for normal breast (p = 0.82). Sections of the time domain pulses showed clear differences that were also evident in the comparison of pulse parameter values. These deviations may arise from the presence of adipose and other inhomogeneities in the breast tissue that are not accounted for when using the Debye model. In conclusion, the study demonstrates the power of the model for simulating THz reflection imaging; however, for biological tissues extra Debye terms or a more detailed theory may be required to link THz image contrast to physiological composition and structural changes of breast tissue associated with differences between normal and tumour tissues.	[Fitzgerald, Anthony J.; Wallace, Vincent P.] Univ Western Australia, Sch Phys, Nedlands, WA 6009, Australia; [Pickwell-MacPherson, Emma] Chinese Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China	University of Western Australia; Chinese University of Hong Kong	Wallace, VP (corresponding author), Univ Western Australia, Sch Phys, Nedlands, WA 6009, Australia.	vincent.wallace@uwa.edu.au	Wallace, Vincent P/A-9320-2012; MacPherson, Emma/AAO-5260-2020	Wallace, Vincent P/0000-0003-3814-5400; MacPherson, Emma/0000-0001-6062-5959	Australia Research Council [DP1096514]	Australia Research Council(Australian Research Council)	We acknowledge funding from the Australia Research Council (DP1096514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth P, 2008, INTRAOPERATIVE THZ P; Ashworth PC, 2009, OPT EXPRESS, V17, P12444, DOI 10.1364/OE.17.012444; Bennett DB, 2011, IEEE SENS J, V11, P1253, DOI 10.1109/JSEN.2010.2088387; Brun MA, 2010, PHYS MED BIOL, V55, P4615, DOI 10.1088/0031-9155/55/16/001; Cerussi A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337546; Chen H, 2011, OPT EXPRESS, V19, P21552, DOI 10.1364/OE.19.021552; Chen H, 2011, OPT EXPRESS, V19, P19523, DOI 10.1364/OE.19.019523; Cole BE, 2001, PROC SPIE, V4276, P1, DOI 10.1117/12.448865; Debye P., 1913, INTERSCIENCE NEW YOR, V15, P777; Eadie LH, 2013, EXPERT SYST APPL, V40, P2043, DOI 10.1016/j.eswa.2012.10.019; Feldman Y, 2002, CHEM PHYS, V284, P139, DOI 10.1016/S0301-0104(02)00545-1; Fitzgerald AJ, 2006, RADIOLOGY, V239, P533, DOI 10.1148/radiol.2392041315; Fitzgerald AJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016005; Huang S, 2009, OPT EXPRESS, V17, P3848, DOI 10.1364/OE.17.003848; Ji YB, 2009, OPT EXPRESS, V17, P17082, DOI 10.1364/OE.17.017082; Joseph CS, 2011, LASER SURG MED, V43, P457, DOI 10.1002/lsm.21078; Jung E, 2011, J OPT SOC KOREA, V15, P155, DOI 10.3807/JOSK.2011.15.2.155; Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g; LIEBE HJ, 1991, INT J INFRARED MILLI, V12, P659, DOI 10.1007/BF01008897; Oh SJ, 2009, OPT EXPRESS, V17, P3469, DOI 10.1364/OE.17.003469; Pickwell E, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2137667; Pickwell E, 2004, PHYS MED BIOL, V49, P1595, DOI 10.1088/0031-9155/49/9/001; Pickwell E, 2004, APPL PHYS LETT, V84, P2190, DOI 10.1063/1.1688448; Pickwell-MacPherson E, 2012, P SOC PHOTO-OPT INS, V8221, p82210M; Pickwell-MacPherson E, 2007, IEEE MTT S INT MICR, P1375; Png GM, 2009, ELECTRON LETT, V45, P343, DOI 10.1049/el.2009.3413; Reid CB, 2011, PHYS MED BIOL, V56, P4333, DOI 10.1088/0031-9155/56/14/008; Reid CB, 2010, PHYS MED BIOL, V55, P4825, DOI 10.1088/0031-9155/55/16/013; Ronne C, 1997, J CHEM PHYS, V107, P5319, DOI 10.1063/1.474242; Ronne C, 2002, J MOL LIQUIDS, V101; Sy S, 2010, PHYS MED BIOL, V55, P7587, DOI 10.1088/0031-9155/55/24/013; Taday P. F., 2004, Spectroscopy Europe, V16, P20; Truong BCQ, 2012, IEEE ENG MED BIO, P5474, DOI 10.1109/EMBC.2012.6347233; Truong BCQ, 2012, 2012 FOURTH INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND ELECTRONICS (ICCE), P364, DOI 10.1109/CCE.2012.6315929; Wahaia F, 2011, J MOL STRUCT, V1006, P77, DOI 10.1016/j.molstruc.2011.05.049; Wallace VP, 2004, BRIT J DERMATOL, V151, P424, DOI 10.1111/j.1365-2133.2004.06129.x; Wallace VP, 2004, FARADAY DISCUSS, V126, P255, DOI 10.1039/b309357n; Woodward RM, 2002, P SOC PHOTO-OPT INS, V4625, P160, DOI 10.1117/12.469785; Woodward RM, 2002, PHYS MED BIOL, V47, P3853, DOI 10.1088/0031-9155/47/21/325; Yaroslavsky A, 2012, LASER SURG MED, V44, P36	40	32	34	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e99291	10.1371/journal.pone.0099291	http://dx.doi.org/10.1371/journal.pone.0099291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010734	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800001
J	Karatayev, VA; Karatayev, AY; Burlakova, LE; Rudstam, LG				Karatayev, Vadim A.; Karatayev, Alexander Y.; Burlakova, Lyubov E.; Rudstam, Lars G.			Eutrophication and Dreissena Invasion as Drivers of Biodiversity: A Century of Change in the Mollusc Community of Oneida Lake	PLOS ONE			English	Article							POLYMORPHA PALLAS INVASION; FRESH-WATER BIODIVERSITY; ZEBRA MUSSELS; BENTHIC INVERTEBRATES; INTERMEDIATE HOST; GENETIC-STRUCTURE; SHALLOW LAKES; ECOSYSTEM; IMPACTS; STATE	Changes in nutrient loading and invasive species are among the strongest human-driven disturbances in freshwater ecosystems, but our knowledge on how they affect the biodiversity of lakes is still limited. We conducted a detailed historical analysis of the mollusc community of Oneida Lake based on our comprehensive lakewide study in 2012 and previous surveys dating back to 1915. In the early 20th century, the lake had a high water clarity, with abundant macrophytes and benthic algae, and hosted the most diverse molluscan community in New York State, including 32 gastropod and 9 unionid species. By the 1960s, lake turbidity increased during a period of anthropogenic eutrophication, resulting in a 38% decline in species richness and a 95% reduction in abundance of native gastropods grazing on benthic algae. Following the invasion of Dreissena spp. in 1991 and subsequent increases in water clarity, native gastropod species richness expanded by 37% and abundance increased 20-fold by 2012. In contrast, filter-feeding unionids were unaffected by increased turbidity during the period of eutrophication but were extirpated by dreissenids. Through contrasting effects on turbidity, eutrophication and Dreissena spp. have likely driven the observed changes in native grazing gastropods by affecting the abundance of light-limited benthic algae. Given the high species richness and ecological importance of benthic grazers, monitoring and managing turbidity is important in preserving molluscan diversity.	[Karatayev, Vadim A.] Cornell Univ, Off Undergrad Biol, Ithaca, NY 14850 USA; [Karatayev, Alexander Y.; Burlakova, Lyubov E.] SUNY Buffalo, Great Lakes Ctr, Buffalo, NY 14260 USA; [Burlakova, Lyubov E.] SUNY Buffalo, Res Fdn, Buffalo, NY 14260 USA; [Rudstam, Lars G.] Cornell Univ, Dept Nat Resources, Cornell Biol Field Stn, Bridgeport, NY USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cornell University	Karatayev, VA (corresponding author), Cornell Univ, Off Undergrad Biol, Ithaca, NY 14850 USA.	vkaratayev@ucdavis.edu		Karatayev, Vadim/0000-0001-7112-8069; Burlakova, Lyubov/0000-0002-2995-919X; Rudstam, Lars/0000-0002-3732-6368	Cornell University Agricultural Experiment Station federal formula funds; National Institute of Food and Agriculture (NIFA) [NYC-14453]; United States Department of Agriculture (USDA); Research Foundation for SUNY/Buffalo State	Cornell University Agricultural Experiment Station federal formula funds; National Institute of Food and Agriculture (NIFA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Research Foundation for SUNY/Buffalo State	This research was supported in part by the Cornell University Agricultural Experiment Station federal formula funds, Project No. NYC-14453 received from the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (USDA), and the Research Foundation for SUNY/Buffalo State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed in the publication are those of the author(s) and do not necessarily reflect the view of NIFA, USDA, or SUNY RF.	Akcakaya H.R., 2006, KEY TOPICS CONSERVAT, P64; Baker F. C., 1916, NEW YORK STATE COLL, V16, P1; BAKER F. C., 1918, NEW YORK STATE COLL, V9, P1; Barbiero RP, 2011, J GREAT LAKES RES, V37, P78, DOI 10.1016/j.jglr.2010.11.013; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Botts PS, 1996, J N AM BENTHOL SOC, V15, P179, DOI 10.2307/1467947; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown KM, 2010, AQUAT ECOL SER, P277, DOI 10.1016/B978-0-12-374855-3.00010-8; Bunnell DB, 2014, BIOSCIENCE, V64, P26, DOI 10.1093/biosci/bit001; Burlakova LE, 2000, INT REV HYDROBIOL, V85, P529, DOI 10.1002/1522-2632(200011)85:5/6<529::AID-IROH529>3.3.CO;2-F; Burlakova LE, 2012, HYDROBIOLOGIA, V685, P121, DOI 10.1007/s10750-011-0791-4; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; CATTANEO A, 1987, CAN J FISH AQUAT SCI, V44, P296, DOI 10.1139/f87-038; Cecala RK, 2008, J INTEGR PLANT BIOL, V50, P1452, DOI 10.1111/j.1744-7909.2008.00755.x; Charbonnel N, 2002, J EVOLUTION BIOL, V15, P248, DOI 10.1046/j.1420-9101.2002.00381.x; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; DeVanna KM, 2011, J GREAT LAKES RES, V37, P632, DOI 10.1016/j.jglr.2011.07.005; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Fetzer WW, 2013, DISENTANGLING EFFECT; Fitzgerald DG, ONEIDA LAKE LONG TER; Gorley C.K., 2006, GETTING STARTED PRIM; Gow JL, 2004, MOL ECOL, V13, P3561, DOI 10.1111/j.1365-294X.2004.02339.x; Greeson P. E, 1971, LIMNOLOGY ONEIDA LAK; HANSSON LA, 1990, FRESHWATER BIOL, V24, P265, DOI 10.1111/j.1365-2427.1990.tb00707.x; HARMAN WN, 1970, LIMNOL OCEANOGR, V15, P454, DOI 10.4319/lo.1970.15.3.0454; Harman WN, 2000, NAUTILUS, V114, P120; Harman WN, 1998, J FRESHWATER ECOL, V13, P207, DOI 10.1080/02705060.1998.9663608; Harman WN, 1993, SUNY ONEONTA BIOL FI, P202; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Ibelings BW, 2007, ECOSYSTEMS, V10, P4, DOI 10.1007/s10021-006-9009-4; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2003, LIMNOL OCEANOGR, V48, P1913, DOI 10.4319/lo.2003.48.5.1913; Johnson PD, 2013, FISHERIES, V38, P247, DOI 10.1080/03632415.2013.785396; Jokinen EH, 1992, NY STATE MUS B, V482, P1; Karatayev AY, 2008, HYDROBIOLOGIA, V605, P99, DOI 10.1007/s10750-008-9323-2; Karatayev AY, 2007, J SHELLFISH RES, V26, P205, DOI 10.2983/0730-8000(2007)26[205:TIBDPA]2.0.CO;2; Karatayev AY, 2011, J SHELLFISH RES, V30, P923, DOI 10.2983/035.030.0334; Karatayev AY, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P433; Karatayev AY, 1997, J SHELLFISH RES, V16, P187; KENKEL NC, 1986, ECOLOGY, V67, P919, DOI 10.2307/1939814; Kummu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020578; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lucy F.E., 2014, QUAGGA ZEBRA MUSSELS, V2nd ed., P623; Manly BFJ, 1992, DESIGN ANAL RES STUD; Mayer CM, 2002, J N AM BENTHOL SOC, V21, P616, DOI 10.2307/1468434; Mayer CM, 2001, CAN J FISH AQUAT SCI, V58, P2459, DOI 10.1139/cjfas-58-12-2459; Mayer CM., 2014, QUAGGA ZEBRA MUSSELS, V2, P575; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Mills EL, ONEIDA LAKE LONG TER; Muenscher WC, 1928, 17 NY CONS DEP ANN S, P140; Noble LR, 1968, EFFECT LIMNOLOGICAL; Pieczynska E, 1998, HYDROBIOLOGIA, V391, P9, DOI 10.1023/A:1003503731720; Ricciardi A, 1998, J ANIM ECOL, V67, P613, DOI 10.1046/j.1365-2656.1998.00220.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Romme WH, 1998, ECOSYSTEMS, V1, P524, DOI 10.1007/s100219900048; Rudstam LG, 2013, LIMNOLOGICAL DATA DE; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; Stewart TW, 1998, J N AM BENTHOL SOC, V17, P81, DOI 10.2307/1468053; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Strayer DL, 2009, FRONT ECOL ENVIRON, V7, P135, DOI 10.1890/080020; Thorp JH, 2010, AQUAT ECOL SER, P1, DOI 10.1016/B978-0-12-374855-3.00001-7; Uddin MB, 2011, THESIS U BAYREUTH; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; vandenBerg MS, 1997, HYDROBIOLOGIA, V342, P143, DOI 10.1023/A:1017094013491; Vander Zanden MJ, 2011, ECOSYSTEMS, V14, P894, DOI 10.1007/s10021-011-9454-6; Viard F, 1997, EVOLUTION, V51, P1518, DOI [10.2307/2411204, 10.1111/j.1558-5646.1997.tb01475.x]; Zhu B, 2006, ECOSYSTEMS, V9, P1017, DOI 10.1007/s10021-005-0049-y	74	16	17	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101388	10.1371/journal.pone.0101388	http://dx.doi.org/10.1371/journal.pone.0101388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010705	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800023
J	Braulik, GT; Arshad, M; Noureen, U; Northridge, SP				Braulik, Gill T.; Arshad, Masood; Noureen, Uzma; Northridge, Simon P.			Habitat Fragmentation and Species Extirpation in Freshwater Ecosystems; Causes of Range Decline of the Indus River Dolphin (Platanista gangetica minor)	PLOS ONE			English	Article							EXTINCTION; BIODIVERSITY; DYNAMICS; FUTURE; FLOW	Habitat fragmentation of freshwater ecosystems is increasing rapidly, however the understanding of extinction debt and species decline in riverine habitat fragments lags behind that in other ecosystems. The mighty rivers that drain the Himalaya - the Ganges, Brahmaputra, Indus, Mekong and Yangtze - are amongst the world's most biodiverse freshwater ecosystems. Many hundreds of dams have been constructed, are under construction, or are planned on these rivers and large hydrological changes and losses of biodiversity have occurred and are expected to continue. This study examines the causes of range decline of the Indus dolphin, which inhabits one of the world's most modified rivers, to demonstrate how we may expect other vertebrate populations to respond as planned dams and water developments come into operation. The historical range of the Indus dolphin has been fragmented into 17 river sections by diversion dams; dolphin sighting and interview surveys show that river dolphins have been extirpated from ten river sections, they persist in 6, and are of unknown status in one section. Seven potential factors influencing the temporal and spatial pattern of decline were considered in three regression model sets. Low dry-season river discharge, due to water abstraction at irrigation barrages, was the principal factor that explained the dolphin's range decline, influencing 1) the spatial pattern of persistence, 2) the temporal pattern of subpopulation extirpation, and 3) the speed of extirpation after habitat fragmentation. Dolphins were more likely to persist in the core of the former range because water diversions are concentrated near the range periphery. Habitat fragmentation and degradation of the habitat were inextricably intertwined and in combination caused the catastrophic decline of the Indus dolphin.	[Braulik, Gill T.; Northridge, Simon P.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Braulik, Gill T.; Arshad, Masood; Noureen, Uzma] World Wildlife Fund Pakistan, Lahore, Pakistan; [Braulik, Gill T.] Wildlife Conservat Soc, Zanzibar, Tanzania	University of St Andrews	Braulik, GT (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	gillbraulik@downstream.vg	Braulik, Gill/X-9184-2019	Braulik, Gill/0000-0001-8919-4187; Northridge, Simon/0000-0002-7402-3462	World Wildlife Fund-Pakistan; Pakistan Wetlands Project; US Marine Mammal Commission [E4047595]; Natural Environment Research Council [smru10001] Funding Source: researchfish	World Wildlife Fund-Pakistan; Pakistan Wetlands Project; US Marine Mammal Commission; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	World Wildlife Fund-Pakistan -(http://www.wwfpak.org/) funded the interview surveys with support through the Pakistan Wetlands Project. The US Marine Mammal Commission (www.mmc.gov) provided funding to GB for reporting and analysis in grant number E4047595. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J., 1879, ANATOMICAL ZOOLOGICA, DOI 10.5962/bhl.title.50434; Baruah Debojit, 2012, Environmentalist, V32, P85, DOI 10.1007/s10669-011-9375-0; Bashir T, 2010, CURR SCI INDIA, V98, P287; Behera Sandeep K., 2008, Journal of the Bombay Natural History Society, V105, P90; Braulik GT, 2012, AQUAT CONSERV, V22, P533, DOI 10.1002/aqc.2246; Braulik GT, 2006, BIOL CONSERV, V129, P579, DOI 10.1016/j.biocon.2005.11.026; Braulik Gillian T., 2012, Endangered Species Research, V17, P201, DOI 10.3354/esr00425; Braulik GT, 2012, CONSERVATION ECOLOGY; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butchart S. H. M., 2006, Bulletin of the British Ornithologists' Club, V126, P7; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; Collen B, 2010, DIVERS DISTRIB, V16, P755, DOI 10.1111/j.1472-4642.2010.00689.x; Crawley M.J., 2007, R BOOK; Dharmadhikary S., 2008, MOUNTAINS CONCRETE D; Directorate of Land Reclamation Punjab, 2007, SURF WAT QUAL MON PL; Dudgeon D, 2000, BIOSCIENCE, V50, P793, DOI 10.1641/0006-3568(2000)050[0793:LSHCIT]2.0.CO;2; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dutta AP, 2010, EARTH           0501, P32; FAO, 2012, FAO WAT REP, V38; Fox J, 2008, APPL REGRESSION ANAL; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Gilpin M., 1990, LIVING PATCHY ENV, P177; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2011, PAK WAT GAT GAT WAT; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Kelkar N, 2010, CONSERV BIOL, V24, P1130, DOI 10.1111/j.1523-1739.2010.01467.x; Khan H., 1947, J BOMBAY NAT HIST SO, V46, P529; LOMOLINO MV, 1995, J MAMMAL, V76, P335, DOI 10.2307/1382345; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Pilleri G., 1972, P23; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Development Core Team, 2012, R LANG ENV STAT COMP; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves R. R., 1991, NATURA UTRECHT, V5, P3; REEVES RR, 1991, ENVIRON CONSERV, V18, P341, DOI 10.1017/S0376892900022591; REEVES RR, 1994, AMBIO, V23, P172; Ryan GE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00171.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Simberloff D., 1986, Life Sciences Research Report, P259; Sinha R. K., 2000, BIOL CONSERVATION FR, V23, P54; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Verma S, 2009, PHYS CHEM EARTH, V34, P261, DOI 10.1016/j.pce.2008.05.002; World Water Assessment Programme, 2012, 4 UNESCO WORLD WAT A; Xenopoulos MA, 2006, ECOLOGY, V87, P1907, DOI 10.1890/0012-9658(2006)87[1907:GWTFUS]2.0.CO;2; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	48	38	40	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101657	10.1371/journal.pone.0101657	http://dx.doi.org/10.1371/journal.pone.0101657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029270	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600020
J	Clancy, KBH; Nelson, RG; Rutherford, JN; Hinde, K				Clancy, Kathryn B. H.; Nelson, Robin G.; Rutherford, Julienne N.; Hinde, Katie			Survey of Academic Field Experiences (SAFE): Trainees Report Harassment and Assault	PLOS ONE			English	Article							WORKPLACE SEXUAL-HARASSMENT; INTERNATIONAL-RELATIONS; GENDER DISCRIMINATION; WOMEN; CONSEQUENCES; PERCEPTIONS; INCIVILITY; TARGET; METAANALYSIS; ANTECEDENTS	Little is known about the climate of the scientific fieldwork setting as it relates to gendered experiences, sexual harassment, and sexual assault. We conducted an internet-based survey of field scientists (N = 666) to characterize these experiences. Codes of conduct and sexual harassment policies were not regularly encountered by respondents, while harassment and assault were commonly experienced by respondents during trainee career stages. Women trainees were the primary targets; their perpetrators were predominantly senior to them professionally within the research team. Male trainees were more often targeted by their peers at the research site. Few respondents were aware of mechanisms to report incidents; most who did report were unsatisfied with the outcome. These findings suggest that policies emphasizing safety, inclusivity, and collegiality have the potential to improve field experiences of a diversity of researchers, especially during early career stages. These include better awareness of mechanisms for direct and oblique reporting of harassment and assault and, the implementation of productive response mechanisms when such behaviors are reported. Principal investigators are particularly well positioned to influence workplace culture at their field sites.	[Clancy, Kathryn B. H.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Nelson, Robin G.] Skidmore Coll, Dept Anthropol, Saratoga Springs, NY 12866 USA; [Rutherford, Julienne N.] Univ Illinois, Dept Women Children & Family Hlth Sci, Chicago, IL USA; [Hinde, Katie] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	University of Illinois System; University of Illinois Urbana-Champaign; Skidmore College; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University	Clancy, KBH (corresponding author), Univ Illinois, Dept Anthropol, 109 Davenport Hall, Urbana, IL 61801 USA.	kclancy@illinois.edu		Rutherford, Julienne/0000-0001-6536-6888; Hinde, Katie/0000-0002-0528-866X	University of Illinois; Urbana-Champaign Department of Anthropology; Institute for Genomic Biology; Academic Senate funds from the University of California, Riverside; Skidmore College; National Institutes of Health Building Interdisciplinary Research Careers in Women's Health Program [K12HD055892]; Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055892] Funding Source: NIH RePORTER	University of Illinois; Urbana-Champaign Department of Anthropology; Institute for Genomic Biology; Academic Senate funds from the University of California, Riverside; Skidmore College; National Institutes of Health Building Interdisciplinary Research Careers in Women's Health Program; Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided by start-up funds from the University of Illinois, Urbana-Champaign Department of Anthropology and Institute for Genomic Biology (KC), Academic Senate funds from the University of California, Riverside, and start-up funds from Skidmore College (RN), K12HD055892 (National Institutes of Health Building Interdisciplinary Research Careers in Women's Health Program (JR)), and start-up funds from Harvard University (KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antecol H, 2009, J ECON PSYCHOL, V30, P782, DOI 10.1016/j.joep.2009.06.009; Barling J, 1996, J MANAGERIAL PSYCHOL, V11, P4, DOI DOI 10.1108/02683949610124771; Basford TE, 2013, PSYCHOL WOMEN Q; Bergman ME, 2002, J APPL PSYCHOL, V87, P230, DOI 10.1037//0021-9010.87.2.230; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Bitton MS, 2013, J APPL SOC PSYCHOL, V43, P2136, DOI 10.1111/jasp.12166; Bohannon J, 2013, SURVEY FINDS SEX HAR; Bowling NA, 2006, J APPL PSYCHOL, V91, P998, DOI 10.1037/0021-9010.91.5.998; Carr PL, 2000, ANN INTERN MED, V132, P889, DOI 10.7326/0003-4819-132-11-200006060-00007; Chan DKS, 2008, PSYCHOL WOMEN QUART, V32, P362, DOI 10.1111/j.1471-6402.2008.00451.x; Chui CWS, 2014, SEX ROLES, V71, P95, DOI 10.1007/s11199-014-0367-7; Clancy Kate, 2013, CONTEXT VARIATION SC; Clancy KBH, 2013, COTEXT VARIATION SCI; Clark JN, 2012, HUM RIGHTS QUART, V34, P823, DOI 10.1353/hrq.2012.0052; CLEVELAND JN, 1993, J VOCAT BEHAV, V42, P49, DOI 10.1006/jvbe.1993.1004; Corr PJ, 2001, PERS INDIV DIFFER, V30, P525, DOI 10.1016/S0191-8869(00)00052-0; DiTomaso N, 2007, ANNU REV SOCIOL, V33, P473, DOI 10.1146/annurev.soc.33.040406.131805; GUTEK BA, 1993, J VOCAT BEHAV, V42, P28, DOI 10.1006/jvbe.1993.1003; Hebert LC, 2007, INDIANA LAW J, V82, P711; Hershcovis MS, 2010, J ORGAN BEHAV, V31, P24, DOI 10.1002/job.621; Holleran SE, 2011, SOC PSYCHOL PERS SCI, V2, P65, DOI 10.1177/1948550610379921; Isbell LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049682; KOMAROMY M, 1993, NEW ENGL J MED, V328, P322, DOI 10.1056/NEJM199302043280507; Lee D, 2002, PERS REV, V31, P205, DOI 10.1108/00483480210416874; Lim S, 2005, J APPL PSYCHOL, V90, P483, DOI 10.1037/0021-9010.90.3.483; LJ Fry, 2013, GENDER BEHAV, V11; Lock R, 1998, INT J SCI EDUC, V20, P633, DOI 10.1080/0950069980200602; Luthar HK, 2000, HUMAN RESOURCE MANAG, V10, P211; Maliniak D, 2013, INT ORGAN, V67, P889, DOI 10.1017/S0020818313000209; McDonald P, 2012, INT J MANAG REV, V14, P1, DOI 10.1111/j.1468-2370.2011.00300.x; McGuire KL, 2012, BIOSCIENCE, V62, P189, DOI 10.1525/bio.2012.62.2.12; Miner KN, 2012, SEX ROLES, V66, P492, DOI 10.1007/s11199-011-0108-0; Mitchell SM, 2013, INT STUD PERSPECT, V14, P485, DOI 10.1111/insp.12026; Monk J, 2004, J GEOGR HIGHER EDUC, V28, P83, DOI 10.1080/0309826042000198657; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Science Foundation (NSF), 2013, WOM MIN PERS DIS SCI; Neeti R, 2012, INJURY PREV, V18, pA145; Nelson CG, 2012, WORK QUALITY LIFE, P395; Neuman, 2010, ADM THEORY PRAXIS, V32, P48, DOI DOI 10.2753/ATP1084-1806320103; O'Leary-Kelly AM., 2004, HUMAN RESOURCE MANAG, V14, P85, DOI [10.1016/j.hrmr.2004.02.005, DOI 10.1016/J.HRMR.2004.02.005]; Patterson D, 2009, HEALTH SOC WORK, V34, P127, DOI 10.1093/hsw/34.2.127; Popovich PM, 2010, HUM RESOUR MANAGE R, V20, P45, DOI 10.1016/j.hrmr.2009.05.003; Raymond GWGS, 2012, J SCI EDUC TECHNOL, V21, P11; Rutherford JN, 2013, BIOL ANTHR SECTION A; Settles IH, 2006, PSYCHOL WOMEN QUART, V30, P47, DOI 10.1111/j.1471-6402.2006.00261.x; Stockdale MS, 2004, J FORENSIC PSYCHOL P, V4, P65, DOI DOI 10.1300/J158V04N01_05; Thoroughgood CN, 2012, J LEADERSH ORG STUD, V19, P230, DOI 10.1177/1548051811436327; Towns M.H., 2010, J COLL SCI TEACH, V39, P6; Tudor T, 2012, FRANKLIN BUSINESS LA, V2012, P81; USEEOC, SEX HAR; Wasson C, 2008, WEVE COME LONG WAY, P1; Wegge J, 2008, J APPL PSYCHOL, V93, P1301, DOI 10.1037/a0012680; Willness CR, 2007, PERS PSYCHOL, V60, P127, DOI 10.1111/j.1744-6570.2007.00067.x; Witte FM, 2006, ACAD MED, V81, P648, DOI 10.1097/01.ACM.0000232421.04170.d2; Wolitzky-Taylor KB, 2011, J INTERPERS VIOLENCE, V26, P807, DOI 10.1177/0886260510365869; WomensLaw, 2009, SEX ASS RAP; Zabrodska K., 2012, EMPLOYEE RESPONSIBIL, P1	57	205	214	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102172	10.1371/journal.pone.0102172	http://dx.doi.org/10.1371/journal.pone.0102172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25028932	Green Published, gold			2022-12-27	WOS:000341306600040
J	Tan, Y; Tseng, PO; Wang, DR; Zhang, H; Hunter, K; Hertzberg, J; Stenmark, KR; Tan, W				Tan, Yan; Tseng, Pi-Ou; Wang, Daren; Zhang, Hui; Hunter, Kendall; Hertzberg, Jean; Stenmark, Kurt R.; Tan, Wei			Stiffening-Induced High Pulsatility Flow Activates Endothelial Inflammation via a TLR2/NF-kappa B Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PULMONARY-HYPERTENSION; ARTERIAL STIFFNESS; INNATE IMMUNITY; SHEAR-STRESS; EXPRESSION; TOLL-LIKE-RECEPTOR-2; PRESSURE; TLR2	Stiffening of large arteries is increasingly used as an independent predictor of risk and therapeutic outcome for small artery dysfunction in many diseases including pulmonary hypertension. The molecular mechanisms mediating downstream vascular cell responses to large artery stiffening remain unclear. We hypothesize that high pulsatility flow, induced by large artery stiffening, causes inflammatory responses in downstream pulmonary artery endothelial cells (PAECs) through toll-like receptor (TLR) pathways. To recapitulate the stiffening effect of large pulmonary arteries that occurs in pulmonary hypertension, ultrathin silicone tubes of variable mechanical stiffness were formulated and were placed in a flow circulatory system. These tubes modulated the simulated cardiac output into pulsatile flows with different pulsatility indices, 0.5 (normal) or 1.5 (high). PAECs placed downstream of the tubes were evaluated for their expression of proinflammatory molecules (ICAM-1, VCAM-1, E-selectin and MCP-1), TLR receptors and intracellular NF-kappa B following flow exposure. Results showed that compared to flow with normal pulsatility, high pulsatility flow induced proinflammatory responses in PAECs, enhanced TLR2 expression but not TLR4, and caused NF-kappa B activation. Pharmacologic (OxPAPC) and siRNA inhibition of TLR2 attenuated high pulsatility flow-induced pro-inflammatory responses and NF-kappa B activation in PAECs. We also observed that PAECs isolated from small pulmonary arteries of hypertensive animals exhibiting proximal vascular stiffening demonstrated a durable ex-vivo proinflammatory phenotype (increased TLR2, TLR4 and MCP-1 expression). Intralobar PAECs isolated from vessels of IPAH patients also showed increased TLR2. In conclusion, this study demonstrates for the first time that TLR2/NF-kappa B signaling mediates endothelial inflammation under high pulsatility flow caused by upstream stiffening, but the role of TLR4 in flow pulsatility-mediated endothelial mechanotransduction remains unclear.	[Tan, Yan; Tseng, Pi-Ou; Hertzberg, Jean; Tan, Wei] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Tan, Yan; Wang, Daren; Zhang, Hui; Hunter, Kendall; Stenmark, Kurt R.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Boulder; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Tan, W (corresponding author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.	wei.tan-1@colorado.edu	stenmark, kurt/AFI-6776-2022; Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; stenmark, kurt/AAH-3124-2022	Tan, Weihong/0000-0002-8066-1524; HERTZBERG, JEAN/0000-0002-8984-6808	National Institutes of Health (NIH) [HL K25-097246, HL-14985-36]; American Heart Association [13GRNT16990019]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL097246, R01HL114887] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded in part by grants from the National Institutes of Health (NIH) (HL K25-097246 to W. T., HL-14985-36 to K. R. S.) and the American Heart Association (13GRNT16990019 to W. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adji A, 2011, AM J HYPERTENS, V24, P5, DOI 10.1038/ajh.2010.192; Bauer EM, 2014, CIRC RES, V114, P1596, DOI 10.1161/CIRCRESAHA.114.303662; Bertocchi C, 2011, CELL PHYSIOL BIOCHEM, V28, P625, DOI 10.1159/000335758; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Broen JCA, 2012, ARTHRITIS RHEUM-US, V64, P264, DOI 10.1002/art.33325; Burton AC., 1966, PHYSL BIOPHYSICS CIR; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; CHIU RCJ, 1995, J THORAC CARDIOV SUR, V109, P810, DOI 10.1016/S0022-5223(95)70368-3; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Dunzendorfer S, 2004, CIRC RES, V95, P684, DOI 10.1161/01.RES.0000143900.19798.47; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Erridge C, 2009, J INNATE IMMUN, V1, P340, DOI 10.1159/000191413; Grignola JC, 2011, INT J CARDIOL; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hashimoto J, 2011, HYPERTENSION, V58, P839, DOI 10.1161/HYPERTENSIONAHA.111.177469; Higashikuni Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000267; Hochleitner BW, 2000, ARTERIOSCL THROM VAS, V20, P617, DOI 10.1161/01.ATV.20.3.617; Hunter KS, 2010, J APPL PHYSIOL, V108, P968, DOI 10.1152/japplphysiol.01173.2009; Jang HJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE1077, DOI 10.1152/ajpendo.00578.2012; Lammers S, 2012, COMPR PHYSL, V1, P1; Lau EMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033331; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Mian MOR, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0413-9; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; PAZ R, 1993, EUR HEART J, V14, P1524, DOI 10.1093/eurheartj/14.11.1524; Peng XQ, 2003, HYPERTENSION, V41, P378, DOI 10.1161/01.HYP.0000049624.99844.3D; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; REUBEN SR, 1971, CIRC RES, V29, P40, DOI 10.1161/01.RES.29.1.40; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Singh MV, 2014, IMMUNOLOGIC RES; Spirig R, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/181394; Stenmark KR, 2005, CIRC RES, V97, P95, DOI 10.1161/01.RES.00000175934.68087.29; Tian L, 2011, AM J PHYSIOL-HEART C, V301, pH1810, DOI 10.1152/ajpheart.00025.2011; Wang Zhijie, 2011, Pulm Circ, V1, P212, DOI 10.4103/2045-8932.83453; Zachariah JP, 2012, HYPERTENSION, V59, P773, DOI 10.1161/HYPERTENSIONAHA.111.179242	39	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102195	10.1371/journal.pone.0102195	http://dx.doi.org/10.1371/journal.pone.0102195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029271	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600044
J	De Paolo, S; Salvemini, M; Gaudio, L; Aceto, S				De Paolo, Sofia; Salvemini, Marco; Gaudio, Luciano; Aceto, Serena			De Novo Transcriptome Assembly from Inflorescence of Orchis italica: Analysis of Coding and Non-Coding Transcripts	PLOS ONE			English	Article							MADS-BOX GENES; PI/GLO-LIKE LOCUS; RNA-SEQ DATA; IDENTIFICATION; EVOLUTIONARY; EXPRESSION; ROLES; ANNOTATION; PROTEINS; GENOME	The floral transcriptome of Orchis italica, a wild orchid species, was obtained using Illumina RNA-seq technology and specific de novo assembly and analysis tools. More than 100 million raw reads were processed resulting in 132,565 assembled transcripts and 86,079 unigenes with an average length of 606 bp and N50 of 956 bp. Functional annotation assigned 38,984 of the unigenes to records present in the NCBI non-redundant protein database, 32,161 of them to Gene Ontology terms, 15,775 of them to Eukaryotic Orthologous Groups (KOG) and 7,143 of them to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The in silico expression analysis based on the Fragments Per Kilobase of transcript per Million mapped reads (FPKM) was confirmed by real-time RT-PCR experiments on 10 selected unigenes, which showed high and statistically significant positive correlation with the RNA-seq based expression data. The prediction of putative long non-coding RNAs was assessed using two different software packages, CPC and Portrait, resulting in 7,779 unannotated unigenes that matched the threshold values for both of the analyses. Among the predicted long non-coding RNAs, one is the homologue of TAS3, a long non-coding RNA precursor of trans-acting small interfering RNAs (ta-siRNAs). The differential expression pattern observed for the selected putative long non-coding RNAs suggests their possible functional role in different floral tissues.	[De Paolo, Sofia; Salvemini, Marco; Gaudio, Luciano; Aceto, Serena] Univ Naples Federico II, Dept Biol, Naples, Italy	University of Naples Federico II	Aceto, S (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	serena.aceto@unina.it	Aceto, Serena/E-5350-2010; Gaudio, Luciano/AAF-4322-2020; Salvemini, Marco/AAJ-5560-2021	Gaudio, Luciano/0000-0002-0172-2190; Aceto, Serena/0000-0003-3906-4872; SALVEMINI, Marco/0000-0003-2297-9267	Regione Campania Grant [L.R. N5/2002]	Regione Campania Grant(Regione Campania)	This work was supported by 2009 Regione Campania Grant L.R. N5/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2007, GENE, V392, P299, DOI 10.1016/j.gene.2007.01.005; Aceto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097839; Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Aceto S, 2010, J HERED, V101, P124, DOI 10.1093/jhered/esp082; Acri-Nunes-Miranda R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00076; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; BIANCO P, 1991, PLANT SYST EVOL, V178, P235; Cantone C, 2009, GENE, V434, P9, DOI 10.1016/j.gene.2008.12.015; Cantone C, 2011, GENE, V481, P48, DOI 10.1016/j.gene.2011.04.004; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Chao YT, 2014, PLANT MOL BIOL, V84, P529, DOI 10.1007/s11103-013-0150-0; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chou ML, 2013, PLANTA, V237, P1425, DOI 10.1007/s00425-013-1850-z; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanno A, 2007, THESCIENTIFICWORLDJO, V7, P268, DOI 10.1100/tsw.2007.86; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085480; Lin CS, 2013, PLANT MOL BIOL, V82, P193, DOI 10.1007/s11103-013-0055-y; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Mondragon-Palomino M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-81; Montieri S, 2004, GENE, V333, P101, DOI 10.1016/j.gene.2004.02.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Quintero Andres, 2013, Genomics Proteomics & Bioinformatics, V11, P172, DOI 10.1016/j.gpb.2013.03.001; Rudall PJ, 2002, BIOL REV, V77, P403, DOI 10.1017/S1464793102005936; Salemme M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077454; Salemme M, 2013, MOL BIOL REP, V40, P3523, DOI 10.1007/s11033-012-2426-x; Salemme M, 2011, DEV GENES EVOL, V221, P241, DOI 10.1007/s00427-011-0372-6; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Skipper M, 2006, GENE, V366, P266, DOI 10.1016/j.gene.2005.08.014; Song IJ, 2006, DEV GENES EVOL, V216, P301, DOI 10.1007/s00427-005-0057-0; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Tsai WC, 2008, PLANT CELL PHYSIOL, V49, P814, DOI 10.1093/pcp/pcn059; Wang SY, 2011, PLANT CELL PHYSIOL, V52, P563, DOI 10.1093/pcp/pcr015; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yamaguchi A, 2012, J PLANT RES, V125, P693, DOI 10.1007/s10265-012-0513-7; Zhang CQ, 2013, INT J MOL SCI, V14, P14689, DOI 10.3390/ijms140714689; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang JH, 2013, PLANTA, V237, P89, DOI 10.1007/s00425-012-1753-4; ZHANG XS, 1993, PLANT CELL, V5, P403, DOI 10.1105/tpc.5.4.403; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	75	21	21	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102155	10.1371/journal.pone.0102155	http://dx.doi.org/10.1371/journal.pone.0102155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025767	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400045
J	Mucciarelli, M; Ferrazzini, D; Belletti, P				Mucciarelli, Marco; Ferrazzini, Diana; Belletti, Piero			Genetic Variability and Population Divergence in the Rare Fritillaria tubiformis subsp moggridgei Rix (Liliaceae) as Revealed by RAPD Analysis	PLOS ONE			English	Article							NARCISSUS-LONGISPATHUS; HABITAT FRAGMENTATION; DNA MARKERS; DIVERSITY; PLANT; DIFFERENTIATION; ISSR	Fritillaria tubiformis subsp. moggridgei Rix. is a rare alpine geophyte with shiny yellow flowers. This plant is sporadically distributed across the southwestern Alps where it is biogeographically close to F. tubiformis var. burnatii Planch. The latter has dark purple flowers and ranges in the majority of the Western and Central Alps. In order to develop appropriate strategies of conservation, a RAPD based analysis was conducted to study the genetic status of these taxa and the distribution of genetic variability of the subspecies by sampling seven populations distributed across the subspecies' range. Four populations of var. burnatii were chosen within this range and included in the genetic analysis. Some 264 individuals were analysed and 201 polymorphic loci were scored. Genetic diversity scored in the subspecies was in line with expectations for endemic species (H-e = 0.194). F. tubiformis var. burnatii showed lower intraspecific diversity (H-e = 0.173), notwithstanding a wider range than the subspecies. Most of the total phenotypic variation (about 83%) was allocated within populations, and significant lower proportions between taxa (6.45%) and between populations of the same taxon (10.64%). Moreover, PCoA analysis and Bayesian clustering separated populations into two genetically differentiated groups corresponding with the subspecific taxa. However, three populations ascribed to the subsp. moggridgei repeatedly showed genetic admixture with var. burnatii populations. Our findings suggest that: i) although the different flower colour, the two taxa are genetically very similar and share a consistent part of their gene pool, ii) the majority of genetic variability is allocated within populations rather than among them, iii) a representative amount of genetic diversity can be preserved by sampling from a restricted number of populations. The efficacy of RAPD markers in analysing genetic variation, and the contribution of the results to the preservation of biodiversity of the species, are discussed.	[Mucciarelli, Marco] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Ferrazzini, Diana; Belletti, Piero] Univ Turin, Dept Agr Forest & Food Sci, Turin, Italy	University of Turin; University of Turin	Mucciarelli, M (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	marco.mucciarelli@unito.it	Mucciarelli, Marco/D-6054-2011					Badfar-Chaleshtori S, 2012, BIOCHEM SYST ECOL, V42, P35, DOI 10.1016/j.bse.2011.12.027; Barrett SCH, 2004, HEREDITY, V92, P459, DOI 10.1038/sj.hdy.6800441; Bartolucci F, 2012, CANDOLLEA, V67, P23, DOI 10.15553/c2012v671a2; Bekessy SA, 2003, BIOL CONSERV, V110, P267, DOI 10.1016/S0006-3207(02)00225-2; Casazza G, 2013, BOT J LINN SOC, V173, P637, DOI 10.1111/boj.12110; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; del Hoyo A, 2012, PLANT ECOL DIVERS, V5, P501, DOI 10.1080/17550874.2012.735270; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Jump AS, 2006, P NATL ACAD SCI USA, V103, P8096, DOI 10.1073/pnas.0510127103; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li XJ, 2008, BELG J BOT, V141, P95; Liu JF, 2013, INT J MOL SCI, V14, P14860, DOI 10.3390/ijms140714860; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; MACPHERSON JM, 1993, MOL CELL PROBE, V7, P293, DOI 10.1006/mcpr.1993.1043; Medrano M, 2008, ANN BOT-LONDON, V102, P183, DOI 10.1093/aob/mcn086; Mucciarelli M, 2013, PHYTOTAXA, V91, P1, DOI 10.11646/phytotaxa.91.1.1; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Pautasso M, 2009, PERSPECT PLANT ECOL, V11, P157, DOI 10.1016/j.ppees.2009.01.003; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Rohlf, 2001, NTSYS PC NUMERAL TAX; Rustaiee AR, 2010, HORTIC ENVIRON BIOTE, V51, P335; Schneider S., 2000, ARLEQUIN VER 2 000 S; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Sozen E, 2010, EKOLOJI, V19, P1, DOI 10.5053/ekoloji.2010.771; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Wang BY, 2011, GENET MOL RES, V10, P114, DOI 10.4238/vol10-1gmr995; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WOLF PG, 1993, SYST BOT, V18, P652, DOI 10.2307/2419539; Yamagishi M, 2010, LANDSC ECOL ENG, V6, P75, DOI 10.1007/s11355-009-0084-5; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zych M, 2012, PLANT BIOLOGY, V14, P285, DOI 10.1111/j.1438-8677.2011.00510.x	46	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101967	10.1371/journal.pone.0101967	http://dx.doi.org/10.1371/journal.pone.0101967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025317	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400031
J	Stoop, JN; Liu, BS; Shi, J; Jansen, DTSL; Hegen, M; Huizinga, TWJ; Trouw, LA; Toes, REM				Stoop, Jeroen N.; Liu, Bi-Sheng; Shi, Jing; Jansen, Diahann T. S. L.; Hegen, Martin; Huizinga, Tom W. J.; Trouw, Leendert A.; Toes, Rene E. M.			Antibodies Specific for Carbamylated Proteins Precede the Onset of Clinical Symptoms in Mice with Collagen Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CITRULLINATED PROTEINS; T-CELLS; AUTOIMMUNE ARTHRITIS; ANIMAL-MODELS; II COLLAGEN; AUTOANTIBODIES; PREDICT	Objective: The immune response to post-translationally modified antigens is a key characteristic of rheumatoid arthritis. Carbamylation is such a posttranslational modification. Recently, we demonstrated that autoantibodies recognizing carbamylated proteins are present in sera of rheumatoid arthritis. The molecular mechanisms underlying the break of tolerance and hence the induction of anti-CarP antibody responses are unknown as well as their appearance in mouse models for systemic arthritis. Therefore we analyzed their appearance in the mouse collagen-induced arthritis model. Methods: collagen induced arthritis was induced by immunization with type II collagen in complete Freund's adjuvant. Arthritis severity was monitored by clinical scoring and anti-CarP antibody levels were determined by ELISA. Results: Anti-CarP antibodies were detectable in mice with collagen induced arthritis. We did not detect ACPA in mice with collagen induced arthritis. The specificity of the antibodies for carbamylated proteins was confirmed by inhibition assays and immunoblotting. Injection with complete Freund's adjuvant without type II collagen could also induce anti-CarP antibodies, however, in mice with arthritis, the anti-CarP antibody response was stronger and developed more rapidly. The onset of collagen induced arthritis was preceded by an increase of anti-CarP IgG2a levels in the serum. Conclusion: In mice with collagen induced arthritis we did not observe an immune response against citrullinated antigens, but we did observe an immune response against carbamylated antigens. This anti-CarP response already appeared before disease onset, indicating that collagen induced arthritis can be used as an in vivo model to study anti-CarP antibodies. Our data also indicate that the tolerance to carbamylated proteins, in contrast to the response to citrullinated proteins, is easily broken and that arthritis boosts the immune response against these proteins. The anti-CarP response in mice with CIA can be used as a model for immune responses to post-translationally modified proteins.	[Stoop, Jeroen N.; Liu, Bi-Sheng; Shi, Jing; Jansen, Diahann T. S. L.; Huizinga, Tom W. J.; Trouw, Leendert A.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Hegen, Martin] Pfizer Worldwide Res & Dev, Immunosci Res Unit, Cambridge, MA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pfizer	Stoop, JN (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands.	J.N.Stoop@lumc.nl	Trouw, Leendert/AGK-5202-2022	Trouw, Leendert/0000-0001-5186-2290; Jansen, Diahann/0000-0003-4535-9167; Toes, Rene/0000-0002-9618-6414	IMI JU [115142-2]; Dutch Arthritis Foundation; Netherlands Organization for Scientific Research; Pfizer; Janssen biologics BV; ReumaFonds [13-3-401] Funding Source: researchfish	IMI JU; Dutch Arthritis Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Pfizer(Pfizer); Janssen biologics BV; ReumaFonds	This work was supported by the IMI JU funded project BeTheCure, contract no 115142-2, the Dutch Arthritis Foundation, The Netherlands Organization for Scientific Research and Pfizer. Leendert Trouw receives a fellowship from Janssen biologics BV. Martin Hegen (who is an employee of Pfizer) has been involved in the design of the study and in the preparation of the manuscript in a scientific collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Backlund J, 2013, ANN RHEUM DIS, V72, P1225, DOI 10.1136/annrheumdis-2012-202055; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Burkhardt H, 2002, ARTHRITIS RHEUM, V46, P2339, DOI 10.1002/art.10472; Cantaert T, 2013, ARTHRITIS RHEUM-US, V65, P939, DOI 10.1002/art.37839; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Shi J, 2013, ANN RHEUM DIS; Shi J, 2014, AUTOIMMUN REV, V13, P225, DOI 10.1016/j.autrev.2013.10.008; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Sirpal S, 2009, CLIN SCI, V116, P681, DOI 10.1042/CS20080322; TERATO K, 1985, J EXP MED, V162, P637, DOI 10.1084/jem.162.2.637; Trouw LA, 2009, ARTHRITIS RHEUM-US, V60, P1923, DOI 10.1002/art.24622; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; van Duivenvoorde LM, 2007, J IMMUNOL, V179, P1506, DOI 10.4049/jimmunol.179.3.1506; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Weinstein JS, 2012, IMMUNOL REV, V247, P160, DOI 10.1111/j.1600-065X.2012.01122.x	24	37	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102163	10.1371/journal.pone.0102163	http://dx.doi.org/10.1371/journal.pone.0102163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025869	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400046
J	Yamanaka, S; Yokote, S; Yamada, A; Katsuoka, Y; Izuhara, L; Shimada, Y; Omura, N; Okano, HJ; Ohki, T; Yokoo, T				Yamanaka, Shuichiro; Yokote, Shinya; Yamada, Akifumi; Katsuoka, Yuichi; Izuhara, Luna; Shimada, Yohta; Omura, Nobuo; Okano, Hirotaka James; Ohki, Takao; Yokoo, Takashi			Adipose Tissue-Derived Mesenchymal Stem Cells in Long-Term Dialysis Patients Display Downregulation of PCAF Expression and Poor Angiogenesis Activation	PLOS ONE			English	Article							GENE-EXPRESSION; STROMAL CELLS; HYPOXIA; GROWTH; FIBROBLASTS; RESPONSES; RB	We previously demonstrated that mesenchymal stem cells (MSCs) differentiate into functional kidney cells capable of urine and erythropoietin production, indicating that they may be used for kidney regeneration. However, the viability of MSCs from dialysis patients may be affected under uremic conditions. In this study, we isolated MSCs from the adipose tissues of end-stage kidney disease (ESKD) patients undergoing long-term dialysis (KD-MSCs; mean: 72.3 months) and from healthy controls (HC-MSCs) to compare their viability. KD-MSCs and HC-MSCs were assessed for their proliferation potential, senescence, and differentiation capacities into adipocytes, osteoblasts, and chondrocytes. Gene expression of stem cell-specific transcription factors was analyzed by PCR array and confirmed by western blot analysis at the protein level. No significant differences of proliferation potential, senescence, or differentiation capacity were observed between KD-MSCs and HC-MSCs. However, gene and protein expression of p300/CBP-associated factor (PCAF) was significantly suppressed in KD-MSCs. Because PCAF is a histone acetyltransferase that mediates regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha), we examined the hypoxic response in MSCs. HC-MSCs but not KD-MSCs showed upregulation of PCAF protein expression under hypoxia. Similarly, HIF-1 alpha and vascular endothelial growth factor (VEGF) expression did not increase under hypoxia in KD-MSCs but did so in HC-MSCs. Additionally, a directed in vivo angiogenesis assay revealed a decrease in angiogenesis activation of KD-MSCs. In conclusion, long-term uremia leads to persistent and systematic downregulation of PCAF gene and protein expression and poor angiogenesis activation of MSCs from patients with ESKD. Furthermore, PCAF, HIF-1 alpha, and VEGF expression were not upregulated by hypoxic stimulation of KD-MSCs. These results suggest that the hypoxic response may be blunted in MSCs from ESKD patients.	[Yamanaka, Shuichiro; Katsuoka, Yuichi; Izuhara, Luna; Okano, Hirotaka James] Jikei Univ, Sch Med, Dept Internal Med, Div Regenerat Med, Tokyo, Japan; [Yamanaka, Shuichiro; Yokote, Shinya; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan; [Yamada, Akifumi] Jikei Univ, Dept Pediat, Sch Med, Tokyo, Japan; [Shimada, Yohta] Jikei Univ, Dept Gene Therapy, Inst DNA Med, Sch Med, Tokyo, Japan; [Omura, Nobuo; Ohki, Takao] Jikei Univ, Dept Surg, Sch Med, Tokyo, Japan	Jikei University; Jikei University; Jikei University; Jikei University; Jikei University	Yokoo, T (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan.	tyokoo@jikei.ac.jp		Shimada, Yohta/0000-0003-2003-1552; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Bechtel-Walz W, 2014, CELL TISSUE RES, V356, P601, DOI 10.1007/s00441-014-1884-y; Berger A, 2009, AM J MANAG CARE, V15, P509; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Chen SW, 2011, J BIOL CHEM, V286, P32775, DOI 10.1074/jbc.M111.248278; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Drewa T, 2008, TRANSPL P, V40, P1668, DOI 10.1016/j.transproceed.2008.03.141; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Gonzalez-Cruz RD, 2012, P NATL ACAD SCI USA, V109, pE1523, DOI 10.1073/pnas.1120349109; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Japanese Society of Nephrology, 2012, JPN J NEPHROL, V54, P1031; Jin YT, 2002, J BIOL CHEM, V277, P30838, DOI 10.1074/jbc.M204078200; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Noh H, 2012, NEPHROL DIAL TRANSPL, V27, P218, DOI 10.1093/ndt/gfr267; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Roemeling-van Rhijn M, 2012, KIDNEY INT, V82, P748, DOI 10.1038/ki.2012.187; SAHAGUN G, 1989, AM J PATHOL, V134, P1227; Shakib K, 2005, PROTEOMICS, V5, P2819, DOI 10.1002/pmic.200401108; Shimada Y, 2011, BIOCHEM BIOPH RES CO, V415, P274, DOI 10.1016/j.bbrc.2011.10.038; Sonoda T, 2003, TRANSPLANTATION, V75, P199, DOI 10.1097/01.TP.0000040867.67360.9F; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yamada A, 2014, HUM CELL, V27, P59, DOI 10.1007/s13577-013-0082-7; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Yokoo T, 2008, TRANSPLANTATION, V85, P1654, DOI 10.1097/TP.0b013e318173a35d; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	42	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102311	10.1371/journal.pone.0102311	http://dx.doi.org/10.1371/journal.pone.0102311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025381	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400063
J	Althaus, N; Mareschal, D				Althaus, Nadja; Mareschal, Denis			Labels Direct Infants' Attention to Commonalities during Novel Category Learning	PLOS ONE			English	Article							FACILITATE OBJECT CATEGORIZATION; AUDITORY INPUT; WORDS; LANGUAGE; SPEECH; BIRTH; FORM	Recent studies have provided evidence that labeling can influence the outcome of infants' visual categorization. However, what exactly happens during learning remains unclear. Using eye-tracking, we examined infants' attention to object parts during learning. Our analysis of looking behaviors during learning provide insights going beyond merely observing the learning outcome. Both labeling and non-labeling phrases facilitated category formation in 12-month-olds but not 8-month-olds (Experiment 1). Non-linguistic sounds did not produce this effect (Experiment 2). Detailed analyses of infants' looking patterns during learning revealed that only infants who heard labels exhibited a rapid focus on the object part successive exemplars had in common. Although other linguistic stimuli may also be beneficial for learning, it is therefore concluded that labels have a unique impact on categorization.	[Althaus, Nadja; Mareschal, Denis] Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England; [Althaus, Nadja] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; Birkbeck University London; University of Oxford	Althaus, N (corresponding author), Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England.	nadja.althaus@psy.ox.ac.uk	Mareschal, Denis/ABE-4342-2020; Mareschal, Denis/C-4671-2008	Mareschal, Denis/0000-0002-9828-9548; Mareschal, Denis/0000-0002-9828-9548; Althaus, Nadja/0000-0003-4888-1508	European Commission [MESTCT-2005-020725]; Economic and Social Research Council UK [RES-062-23-0819]; Winkler Career Development Fellowship at St Hugh's College; Royal Society Wolfson research merit award	European Commission(European CommissionEuropean Commission Joint Research Centre); Economic and Social Research Council UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Winkler Career Development Fellowship at St Hugh's College; Royal Society Wolfson research merit award(Royal Society of London)	This work was supported by European Commission grant MESTCT-2005-020725 (http://ec.europa.eu/research/mariecurieactions/), Economic and Social Research Council UK grant RES-062-23-0819 (http://www.esrc.ac.uk/) and the Winkler Career Development Fellowship at St Hugh's College (http://www.st-hughs.ox.ac.uk) to Nadja Althaus. Denis Mareschal is partially supported by a Royal Society Wolfson research merit award (http://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus N, 2013, IEEE T AUTON MENT DE, V5, P288, DOI 10.1109/TAMD.2013.2264858; Balaban MT, 1997, J EXP CHILD PSYCHOL, V64, P3, DOI 10.1006/jecp.1996.2332; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; EIMAS PD, 1994, CHILD DEV, V65, P903; Ferry AL, 2013, P NATL ACAD SCI USA, V110, P15231, DOI 10.1073/pnas.1221166110; Ferry AL, 2010, CHILD DEV, V81, P472, DOI 10.1111/j.1467-8624.2009.01408.x; Fulkerson AL, 2003, INFANCY, V4, P349, DOI 10.1207/S15327078IN0403_03; Fulkerson AL, 2007, COGNITION, V105, P218, DOI 10.1016/j.cognition.2006.09.005; Gliga T, 2010, J COGNITIVE NEUROSCI, V22, P2781, DOI 10.1162/jocn.2010.21427; Grossmann T, 2009, J COGNITIVE NEUROSCI, V21, P2276, DOI 10.1162/jocn.2009.21188; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; KATZ PA, 1969, J EXP PSYCHOL, V80, P73, DOI 10.1037/h0027157; Kovack-Lesh KA, 2007, J EXP CHILD PSYCHOL, V98, P69, DOI 10.1016/j.jecp.2007.05.001; Lupyan G, 2008, J EXP PSYCHOL GEN, V137, P348, DOI 10.1037/0096-3445.137.2.348; Lupyan G, 2007, PSYCHOL SCI, V18, P1077, DOI 10.1111/j.1467-9280.2007.02028.x; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Mani N, 2010, PSYCHOL SCI, V21, P908, DOI 10.1177/0956797610373371; Mareschal D, 2001, TRENDS COGN SCI, V5, P443, DOI 10.1016/S1364-6613(00)01752-6; Mather E, 2011, COGNITION, V119, P438, DOI 10.1016/j.cognition.2011.02.008; Oakes LM, 1997, INFANT BEHAV DEV, V20, P457, DOI 10.1016/S0163-6383(97)90036-9; Oakes LM, 2009, LEARNING INFANT MIND; Plunkett K, 2008, COGNITION, V106, P665, DOI 10.1016/j.cognition.2007.04.003; Pruden SM, 2006, CHILD DEV, V77, P266, DOI 10.1111/j.1467-8624.2006.00869.x; Quinn PC, 2006, PSYCHOL SCI, V17, P59, DOI 10.1111/j.1467-9280.2005.01665.x; Quinn PC, 1996, ADV INFAN R, V10, P1; Rakison DH, 2010, WIRES COGN SCI, V1, P894, DOI 10.1002/wcs.81; Ribar RJ, 2004, PSYCHON B REV, V11, P536, DOI 10.3758/BF03196607; Robinson CW, 2007, INFANCY, V11, P233, DOI 10.1111/j.1532-7078.2007.tb00225.x; Robinson CW, 2007, DEVELOPMENTAL SCI, V10, P734, DOI 10.1111/j.1467-7687.2007.00627.x; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; Sloutsky V, 2005, P 27 ANN C COGN SCI, P2033; Tincoff R, 1999, PSYCHOL SCI, V10, P172, DOI 10.1111/1467-9280.00127; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Waxman SR, 1995, COGNITIVE PSYCHOL, V29, P257, DOI 10.1006/cogp.1995.1016; Waxman SR, 2005, COGNITION, V95, pB59, DOI 10.1016/j.cognition.2004.09.003; Whorf B.L., 2012, LANGUAGE THOUGHT REA; Xu F, 2005, PSYCHOL SCI, V16, P372, DOI 10.1111/j.0956-7976.2005.01543.x	40	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e99670	10.1371/journal.pone.0099670	http://dx.doi.org/10.1371/journal.pone.0099670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014254	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000339378400006
J	Amini, ZN; Olson, KE; Muller, UF				Amini, Zhaleh N.; Olson, Karen E.; Mueller, Ulrich F.			Spliceozymes: Ribozymes that Remove Introns from Pre-mRNAs in Trans	PLOS ONE			English	Article							GROUP-I INTRON; SELF-SPLICING RNA; GUANOSINE-BINDING-SITE; HUMAN CANCER-CELLS; TRANSSPLICING RIBOZYMES; TETRAHYMENA RIBOZYME; SELECTIVE INDUCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MAMMALIAN-CELLS	Group I introns are pre-mRNA introns that do not require the spliceosome for their removal. Instead, they fold into complex three-dimensional structures and catalyze two transesterification reactions, thereby excising themselves and joining the flanking exons. These catalytic RNAs (ribozymes) have been modified previously to work in trans, whereby the ribozymes can recognize a splice site on a substrate RNA and replace the 5'- or 3'-portion of the substrate. Here we describe a new variant of the group I intron ribozyme from Tetrahymena that recognizes two splice sites on a substrate RNA, removes the intron sequences between the splice sites, and joins the flanking exons, analogous to the action of the spliceosome. This 'group I spliceozyme' functions in vitro and in vivo, and it is able to mediate a growth phenotype in E. coli cells. The intron sequences of the target pre-mRNAs are constrained near the splice sites but can carry a wide range of sequences in their interior. Because the splice site recognition sequences can be adjusted to different splice sites, the spliceozyme may have the potential for wide applications as tool in research and therapy.	[Amini, Zhaleh N.; Olson, Karen E.; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Muller, UF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			National Institutes of Health [T32GM008326]; Hellman Family foundation [2011/2012, 2012/2013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hellman Family foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Molecular Biophysics Training Grant (grant number T32GM008326) to ZNA and by the Hellman Family foundation (http://www.hellmanfellows.org/hellman-fellows-fund/) with two fellowships (2011/2012 and 2012/2013) to UFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Alexander RC, 2005, BIOCHEMISTRY-US, V44, P7796, DOI 10.1021/bi047284a; Ayre BG, 1999, P NATL ACAD SCI USA, V96, P3507, DOI 10.1073/pnas.96.7.3507; Baum DA, 2005, RNA, V11, P897, DOI 10.1261/rna.2050505; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; Bell MA, 2004, BIOCHEMISTRY-US, V43, P4323, DOI 10.1021/bi035874n; Bell MA, 2002, BIOCHEMISTRY-US, V41, P15327, DOI 10.1021/bi0267386; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BURKE JM, 1989, FEBS LETT, V250, P129, DOI 10.1016/0014-5793(89)80704-5; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Dayie KT, 2008, RNA, V14, P1697, DOI 10.1261/rna.1154408; Dotson PP, 2008, NUCLEIC ACIDS RES, V36, P5281, DOI 10.1093/nar/gkn507; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Guo F, 2002, RNA, V8, P647, DOI 10.1017/S1355838202029011; Hagen M, 1999, EMBO J, V18, P6491, DOI 10.1093/emboj/18.22.6491; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; Hsu SN, 2009, RNA BIOL, V6, P526, DOI 10.4161/rna.6.5.9860; INOUE T, 1985, CELL, V43, P431, DOI 10.1016/0092-8674(85)90173-4; Jones JT, 1997, NAT BIOTECHNOL, V15, P902, DOI 10.1038/nbt0997-902; Kastanos E, 2004, BIOCHEM BIOPH RES CO, V322, P930, DOI 10.1016/j.bbrc.2004.07.203; Kohler U, 1999, J MOL BIOL, V285, P1935, DOI 10.1006/jmbi.1998.2447; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; LEGAULT P, 1992, NUCLEIC ACIDS RES, V20, P6613, DOI 10.1093/nar/20.24.6613; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Meluzzi D, 2012, RNA, V18, P590, DOI 10.1261/rna.029884.111; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; Nikolcheva T, 1999, J MOL BIOL, V292, P557, DOI 10.1006/jmbi.1999.3083; Olson KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086473; Olson KE, 2012, RNA, V18, P581, DOI 10.1261/rna.028472.111; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Rogers CS, 2002, J CLIN INVEST, V110, P1783, DOI 10.1172/JCI200216481; Russell R, 1999, RNA, V5, P158, DOI 10.1017/S1355838299981839; Ryu KJ, 2003, MOL THER, V7, P386, DOI 10.1016/S1525-0016(02)00063-1; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Shaw W V, 1975, Methods Enzymol, V43, P737; SHAW WV, 1967, J BIOL CHEM, V242, P687; Shin KS, 2004, MOL THER, V10, P365, DOI 10.1016/j.ymthe.2004.05.007; Song MS, 2006, FEBS LETT, V580, P5033, DOI 10.1016/j.febslet.2006.08.021; Stahley MR, 2006, CURR OPIN STRUC BIOL, V16, P319, DOI 10.1016/j.sbi.2006.04.005; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; TRITTON TR, 1979, ARCH BIOCHEM BIOPHYS, V197, P10, DOI 10.1016/0003-9861(79)90212-1; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; WARING RB, 1986, NATURE, V321, P133, DOI 10.1038/321133a0; Watanabe T, 2000, P NATL ACAD SCI USA, V97, P8490, DOI 10.1073/pnas.150104097; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Will CL, 2011, COLD SPRING HARB PER, V3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	11	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101932	10.1371/journal.pone.0101932	http://dx.doi.org/10.1371/journal.pone.0101932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014025	Green Published, gold			2022-12-27	WOS:000339378400048
J	Giallongo, C; Parrinello, N; Tibullo, D; La Cava, P; Romano, A; Chiarenza, A; Barbagallo, I; Palumbo, GA; Stagno, F; Vigneri, P; Di Raimondo, F				Giallongo, Cesarina; Parrinello, Nunziatina; Tibullo, Daniele; La Cava, Piera; Romano, Alessandra; Chiarenza, Annalisa; Barbagallo, Ignazio; Palumbo, Giuseppe A.; Stagno, Fabio; Vigneri, Paolo; Di Raimondo, Francesco			Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients	PLOS ONE			English	Article							COMPLETE MOLECULAR REMISSION; CML PATIENTS; DENDRITIC CELLS; IMMUNE-RESPONSES; T-CELLS; IMATINIB; CANCER; DISCONTINUATION; RECRUITMENT; NEUTROPHILS	Tumor immune tolerance can derive from the recruitment of suppressor cell population, including myeloid derived suppressor cells (MDSCs), able to inhibit T cells activity. We identified a significantly expanded MDSCs population in chronic myeloid leukemia (CML) patients at diagnosis that decreased to normal levels after imatinib therapy. In addition, expression of arginase 1 (Arg1) that depletes microenvironment of arginine, an essential aminoacid for T cell function, resulted in an increase in patients at diagnosis. Purified CML CD11b+CD33+CD14-HLADR- cells markedly suppressed normal donor T cell proliferation in vitro. Comparing CML Gr-MDSCs to autologous polymorphonuclear leukocytes (PMNs) we observed a higher Arg1 expression and activity in PMNs, together with an inhibitory effect on T cells in vitro. Our data indicate that CML cells create an immuno-tolerant environment associated to MDSCs expansion with immunosuppressive capacity mediated by Arg1. In addition, we demonstrated for the first time also an immunosuppressive activity of CML PMNs, suggesting a strong potential immune escape mechanism created by CML cells, which control the anti-tumor reactive T cells. MDSCs should be monitored in imatinib discontinuation trials to understand their importance in relapsing patients.	[Giallongo, Cesarina; Parrinello, Nunziatina; Tibullo, Daniele; La Cava, Piera; Romano, Alessandra; Chiarenza, Annalisa; Palumbo, Giuseppe A.; Stagno, Fabio; Di Raimondo, Francesco] Univ Catania, Dept Clin & Mol Biomed, Ferrarotto Hosp, Sect Hematol, Catania, Italy; [Barbagallo, Ignazio] Univ Catania, Dept Drug Sci, Biochem Sect, Catania, Italy; [Vigneri, Paolo] Univ Catania, Dept Pediat & Med Sci, Catania, Italy	University of Catania; University of Catania; University of Catania	Tibullo, D (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Ferrarotto Hosp, Sect Hematol, Catania, Italy.		TIBULLO, Daniele/AAC-1276-2019; Vigneri, Paolo G/K-8504-2016; Tibullo, Daniele/J-3946-2016; Romano, Alessandra/I-9201-2012; Stagno, Fabio/AAH-2033-2020; parrinello, nunziatina laura/J-4099-2016; Palumbo, Giuseppe/W-7072-2019; Giallongo, Cesarina/J-7225-2016; Di Raimondo, Francesco/K-7965-2016; Chiarenza, Annalisa/AAC-2013-2019	TIBULLO, Daniele/0000-0002-4416-8556; Vigneri, Paolo G/0000-0002-5943-6066; Tibullo, Daniele/0000-0002-4416-8556; Romano, Alessandra/0000-0002-6333-4433; Stagno, Fabio/0000-0002-7947-158X; parrinello, nunziatina laura/0000-0002-9978-2908; Palumbo, Giuseppe/0000-0003-1859-6319; Giallongo, Cesarina/0000-0002-7667-6088; Di Raimondo, Francesco/0000-0002-7749-0293; Chiarenza, Annalisa/0000-0002-8759-4854; Barbagallo, Ignazio/0000-0002-7761-0662	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	This study has been supported in part by A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania and by FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachy E, 2011, BRIT J HAEMATOL, V153, P139, DOI 10.1111/j.1365-2141.2010.08453.x; Bertazzoli C, 2000, CLIN CANCER RES, V6, P1931; Boelte KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018534; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Chen X, 2000, BRIT J HAEMATOL, V111, P817, DOI 10.1046/j.1365-2141.2000.02415.x; Chen XL, 2008, CANCER BIOL THER, V7, P622, DOI 10.4161/cbt.7.5.5689; Chikamatsu K, 2012, CANCER SCI, V103, P976, DOI 10.1111/j.1349-7006.2012.02248.x; Christiansson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055818; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Davies J, 2011, LANCET ONCOL, V12, P826, DOI 10.1016/S1470-2045(11)70228-5; Dong R, 2003, BLOOD, V101, P3560, DOI 10.1182/blood-2002-06-1841; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Filipazzi P, 2012, CANCER IMMUNOL IMMUN, V61, P255, DOI 10.1007/s00262-011-1161-9; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hock BD, 2012, IMMUNOLOGY, V137, P249, DOI 10.1111/imm.12004; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Hus I, 2011, FOLIA HISTOCHEM CYTO, V49, P153, DOI 10.5603/FHC.2011.0022; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Muller L, 2002, LEUKEMIA LYMPHOMA, V43, P943, DOI 10.1080/10428190290021687; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Ohyashiki K, 2012, BRIT J HAEMATOL, V157, P254, DOI 10.1111/j.1365-2141.2011.08939.x; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Pawelec G, 1996, CANCER IMMUNOL IMMUN, V42, P193, DOI 10.1007/s002620050270; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Rojas JM, 2010, EXP HEMATOL, V38, P1209, DOI 10.1016/j.exphem.2010.09.004; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Rotondo R, 2011, J LEUKOCYTE BIOL, V89, P721, DOI 10.1189/jlb.1109737; Rotondo R, 2009, INT J CANCER, V125, P887, DOI 10.1002/ijc.24448; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Simonsson B, 2011, CURR DRUG TARGETS, V12, P420, DOI 10.2174/138945011794815301; Thakur A, 2012, CANCER IMMUNOL IMMUN, V61, P497, DOI 10.1007/s00262-011-1116-1; Tibullo D, 2012, CURR PHARM DES; Van Rompaey N, 2011, METHODS MOL BIOL, V677, P169, DOI 10.1007/978-1-60761-869-0_12; Zitta K, 2012, MOL MED, V18, P29, DOI 10.2119/molmed.2011.00278	50	56	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101848	10.1371/journal.pone.0101848	http://dx.doi.org/10.1371/journal.pone.0101848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014230	Green Submitted, gold, Green Published			2022-12-27	WOS:000339378400041
J	Marcombe, S; Farajollahi, A; Healy, SP; Clark, GG; Fonseca, DM				Marcombe, Sebastien; Farajollahi, Ary; Healy, Sean P.; Clark, Gary G.; Fonseca, Dina M.			Insecticide Resistance Status of United States Populations of Aedes albopictus and Mechanisms Involved	PLOS ONE			English	Article							PYRETHROID RESISTANCE; DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; GROWTH-REGULATORS; CULEX-PIPIENS; MOSQUITO; SUSCEPTIBILITY; AEGYPTI; DENGUE; VECTOR	Aedes albopictus (Skuse) is an invasive mosquito that has become an important vector of chikungunya and dengue viruses. Immature Ae. albopictus thrive in backyard household containers that require treatment with larvicides and when adult populations reach pest levels or disease transmission is ongoing, adulticiding is often required. To assess the feasibility of control of USA populations, we tested the susceptibility of Ae. albopictus to chemicals representing the main insecticide classes with different modes of action: organochlorines, organophosphates, carbamates, pyrethroids, insect growth regulators (IGR), naturalytes, and biolarvicides. We characterized a susceptible reference strain of Ae. albopictus, ATM95, and tested the susceptibility of eight USA populations to five adulticides and six larvicides. We found that USA populations are broadly susceptible to currently available larvicides and adulticides. Unexpectedly, however, we found significant resistance to dichlorodiphenyltrichloroethane (DDT) in two Florida populations and in a New Jersey population. We also found resistance to malathion, an organophosphate, in Florida and New Jersey and reduced susceptibility to the IGRs pyriproxyfen and methoprene. All populations tested were fully susceptible to pyrethroids. Biochemical assays revealed a significant up-regulation of GSTs in DDT-resistant populations in both larval and adult stages. Also, beta-esterases were up-regulated in the populations with suspected resistance to malathion. Of note, we identified a previously unknown amino acid polymorphism (Phe -> Leu) in domain III of the VGSC, in a location known to be associated with pyrethroid resistance in another container-inhabiting mosquito, Aedes aegypti L. The observed DDT resistance in populations from Florida may indicate multiple introductions of this species into the USA, possibly from tropical populations. In addition, the mechanisms underlying DDT resistance often result in pyrethroid resistance, which would undermine a remaining tool for the control of Ae. albopictus. Continued monitoring of the insecticide resistance status of this species is imperative.	[Marcombe, Sebastien; Farajollahi, Ary; Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Farajollahi, Ary] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Healy, Sean P.] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Clark, Gary G.] Agr Res Serv, Mosquito & Fly Res Unit, USDA, Gainesville, FL USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Fonseca, DM (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA.	dinafons@rci.rutgers.edu	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100	United States Department of Agriculture (USDA); Rutgers University [USDA-ARS58-6615-8-105]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Rutgers University	This work was funded by a cooperative Agreement between the United States Department of Agriculture (USDA) and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1995, J AM MOSQUITO CONTR, V11, P72; Alout H, 2009, INSECT BIOCHEM MOLEC, V39, P884, DOI 10.1016/j.ibmb.2009.10.005; ANDRIGHETTI MTM, 2008, DENGUE B, V32, P186; [Anonymous], 2006, PESTICIDES THEIR APP; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chen C D, 2005, Trop Biomed, V22, P195; Chen L, 2013, REGUL TOXICOL PHARM, V65, P287, DOI 10.1016/j.yrtph.2012.12.010; Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x; Coleman M, 2007, J PESTIC SCI, V32, P69, DOI 10.1584/jpestics.R07-01; Crans WJ, 1996, J AM MOSQUITO CONTR, V12, P307; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; Davis RS, 2007, INTEGR ENVIRON ASSES, V3, P373, DOI 10.1002/ieam.5630030308; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Finney D.J., 1971, PROBIT ANAL; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Hamdan Hidayati, 2005, Trop Biomed, V22, P45; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Kasai S, 2011, JPN J INFECT DIS, V64, P217; Kawada H, 2010, JPN J INFECT DIS, V63, P19; KHOO BK, 1988, J AM MOSQUITO CONTR, V4, P310; Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946; Lo Presti A, 2012, INFECT GENETICS EVOL; Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; McAllister JC, 2012, J VECTOR ECOL, V37, P325, DOI 10.1111/j.1948-7134.2012.00234.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Mogi M, 2012, J MED ENTOMOL, V49, P1233, DOI 10.1603/ME12104; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; MOUCHET J, 1972, B WORLD HEALTH ORGAN, V46, P675; Nayar JK, 2002, J AM MOSQUITO CONTR, V18, P196; NENG W, 1992, J AM MOSQUITO CONTR, V8, P394; Ng LFP, 2009, MICROBES INFECT, V11, P1163, DOI 10.1016/j.micinf.2009.09.001; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Peterson RKD, 2006, ENVIRON HEALTH PERSP, V114, P366, DOI 10.1289/ehp.8667; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Ranson H., 2010, INSECTICIDE RESISTAN; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; ROBERT LL, 1989, J AM MOSQUITO CONTR, V5, P251; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Romi R, 2003, J AM MOSQUITO CONTR, V19, P419; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Selvi S, 2010, TROP BIOMED, V27, P534; Sparks TC, 2012, PESTIC BIOCHEM PHYS, V102, P1, DOI 10.1016/j.pestbp.2011.11.004; Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; WESSON DM, 1990, J AM MOSQUITO CONTR, V6, P258; World Health Organization, 2005, GUIDELINES LAB FIELD	65	128	134	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101992	10.1371/journal.pone.0101992	http://dx.doi.org/10.1371/journal.pone.0101992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013910	Green Published, gold			2022-12-27	WOS:000339378400052
J	Cadavez, L; Montane, J; Alcarraz-Vizan, G; Visa, M; Vidal-Fabrega, L; Servitja, JM; Novials, A				Cadavez, Lisa; Montane, Joel; Alcarraz-Vizan, Gema; Visa, Montse; Vidal-Fabrega, Laia; Servitja, Joan-Marc; Novials, Anna			Chaperones Ameliorate Beta Cell Dysfunction Associated with Human Islet Amyloid Polypeptide Overexpression	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN DISULFIDE-ISOMERASE; FATTY-ACIDS; ER STRESS; MOLECULAR CHAPERONES; INSULIN-SECRETION; LEPTIN RESISTANCE; INDUCED APOPTOSIS; OXIDATIVE STRESS; TRANSGENIC MICE	In type 2 diabetes, beta-cell dysfunction is thought to be due to several causes, one being the formation of toxic protein aggregates called islet amyloid, formed by accumulations of misfolded human islet amyloid polypeptide (hIAPP). The process of hIAPP misfolding and aggregation is one of the factors that may activate the unfolded protein response (UPR), perturbing endoplasmic reticulum (ER) homeostasis. Molecular chaperones have been described to be important in regulating ER response to ER stress. In the present work, we evaluate the role of chaperones in a stressed cellular model of hIAPP overexpression. A rat pancreatic beta-cell line expressing hIAPP exposed to thapsigargin or treated with high glucose and palmitic acid, both of which are known ER stress inducers, showed an increase in ER stress genes when compared to INS1E cells expressing rat IAPP or INS1E control cells. Treatment with molecular chaperone glucose-regulated protein 78 kDa (GRP78, also known as BiP) or protein disulfite isomerase (PDI), and chemical chaperones taurine-conjugated ursodeoxycholic acid (TUDCA) or 4-phenylbutyrate (PBA), alleviated ER stress and increased insulin secretion in hIAPP-expressing cells. Our results suggest that the overexpression of hIAPP induces a stronger response of ER stress markers. Moreover, endogenous and chemical chaperones are able to ameliorate induced ER stress and increase insulin secretion, suggesting that improving chaperone capacity can play an important role in improving beta-cell function in type 2 diabetes.	[Cadavez, Lisa; Montane, Joel; Alcarraz-Vizan, Gema; Visa, Montse; Vidal-Fabrega, Laia; Servitja, Joan-Marc; Novials, Anna] Hosp Clin Barcelona, IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain; [Cadavez, Lisa; Montane, Joel; Alcarraz-Vizan, Gema; Visa, Montse; Servitja, Joan-Marc; Novials, Anna] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Novials, A (corresponding author), Hosp Clin Barcelona, IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain.	anovials@clinic.ub.es	Montane, Joel/ABE-6021-2021; Visa, Montse/AAQ-8529-2021	SERVITJA, JOAN-MARC/0000-0002-1241-8004; Montane, Joel/0000-0001-9531-9580; Novials, Anna/0000-0003-0465-2949; Alcarraz-Vizan, Gema/0000-0002-2429-0597	Fundacao da Ciencia e Tecnologia (FCT-PhD) - POPH-QREN [SFRH/BD/65645/2009]; IDIBAPS - European Community [229673]; Spanish Ministry of Economy and Competitiveness (MINECO) [COFUND2013-40261]; FIS [PI08/0088, PI1100679]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Fundacao da Ciencia e Tecnologia (FCT-PhD) - POPH-QREN; IDIBAPS - European Community; Spanish Ministry of Economy and Competitiveness (MINECO); FIS(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	LC was a recipient of Fundacao da Ciencia e Tecnologia (FCT-PhD) fellowship SFRH/BD/65645/2009 financed by POPH-QREN. JM is a recipient of an IDIBAPS Postdoctoral Fellowship BIOTRACK, supported by the European Community's Seventh Framework Programme (ECFP7/2007-2013) under grant agreement number 229673 and the Spanish Ministry of Economy and Competitiveness (MINECO) through the grant COFUND2013-40261. This work was supported by grants from FIS (PI08/0088 and PI1100679) and Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Chien V, 2010, BIOCHEM J, V432, P113, DOI 10.1042/BJ20100434; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hong J, 2009, DIABETES OBES METAB, V11, P397, DOI 10.1111/j.1463-1326.2008.00971.x; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marzban L, 2005, MOL ENDOCRINOL, V19, P2154, DOI 10.1210/me.2004-0407; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Montane J, 2014, METABOLIC SYNDROME O, V2014, P24; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Papp E, 2006, FASEB J, V20, P1018, DOI 10.1096/fj.05-5065fje; Penas C, 2011, CELL DEATH DIFFER, V18, P1617, DOI 10.1038/cdd.2011.24; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Potter KJ, 2014, DIABETES, V63, P12, DOI 10.2337/db12-0364; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sitia Roberto, 2004, Sci STKE, V2004, ppe27, DOI 10.1126/stke.2392004pe27; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Soty M, 2011, J BIOL CHEM, V286, P40857, DOI 10.1074/jbc.M111.232801; Srivastava S, 2007, FREE RADICAL RES, V41, P38, DOI 10.1080/10715760600943900; Sun AH, 2010, J PROTEOME RES, V9, P50, DOI 10.1021/pr900191p; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8; Teodoro-Morrison T, 2013, DIABETOLOGIA, V56, P1057, DOI 10.1007/s00125-013-2855-7; Tokuyama T, 1997, METABOLISM, V46, P1044, DOI 10.1016/S0026-0495(97)90276-6; Wu X, 2011, 71 SCI SESS AM DIAB; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	53	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101797	10.1371/journal.pone.0101797	http://dx.doi.org/10.1371/journal.pone.0101797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010593	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800042
J	Chen, WT; Tseng, CH; Tsai, CW				Chen, Wei-Te; Tseng, Chien-Hao; Tsai, Chi-Wei			Effect of Watermelon Silver Mottle Virus on the Life History and Feeding Preference of Thrips palmi	PLOS ONE			English	Article							SPOTTED WILT VIRUS; FRANKLINIELLA-OCCIDENTALIS; FLOWER THRIPS; INSECT VECTOR; DEVELOPMENT TIME; SALICYLIC-ACID; PLANT-VIRUSES; HOST PLANTS; TOSPOVIRUS; INFECTION	Thrips-borne tospoviruses cause numerous plant diseases that produce severe economic losses worldwide. In the disease system, thrips not only damage plants through feeding but also transmit causative agents of epidemics. In addition, thrips are infected with tospoviruses in the course of virus transmission. Most studies on the effect of tospoviruses on vector thrips have focused on the Tomato spotted wilt virus-Frankliniella occidentalis system. Thus, we focused on another thrips-borne tospovirus, Watermelon silver mottle virus (WSMoV), to examine the effect of virus infection on its vector, Thrips palmi. In this study, the direct and indirect effects of WSMoV on the life history traits and feeding preference of T. palmi were examined. The survival rate and developmental time of the WSMoV-infected larval thrips did not differ significantly from those of the virus-free thrips. Comparing the developmental time of larval thrips fed on the healthy plants, thrips-damaged plants, and thrips-inoculated plants (the WSMoV-infected plants caused by thrips feeding), feeding on the thrips-damaged plants reduced the developmental time, and the WSMoV infection in host plants partially canceled the effect of thrips damage on the developmental time. In addition, no significant variations between the virus-free and WSMoV-infected adult thrips regarding longevity and fecundity were observed. These results implied that WSMoV did not directly affect the life history traits of T. palmi, but the WSMoV infection indirectly affected the development of T. palmi through the virus-infected plants. Furthermore, feeding preference tests indicated that T. palmi preferred feeding on either the thrips-damaged plants or the thrips-inoculated plants to the healthy plants. The effect of tospoviruses on the life history and feeding preference of vector thrips might vary among host plants, virus species, vector species, and environmental factors.	[Chen, Wei-Te; Tseng, Chien-Hao; Tsai, Chi-Wei] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan	National Taiwan University	Tsai, CW (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan.	chiwei@ntu.edu.tw		TSAI, CHI-WEI/0000-0002-3880-7251	National Science Council of Taiwan [NSC 100-2321-B-002-035-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council of Taiwan (NSC 100-2321-B-002-035-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, PLANT CELL PHYSIOL, V53, P204, DOI 10.1093/pcp/pcr173; Abe H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-97; BAUTISTA RC, 1995, PHYTOPATHOLOGY, V85, P953, DOI 10.1094/Phyto-85-953; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Chen G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02253; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; DEANGELIS JD, 1993, ENVIRON ENTOMOL, V22, P1308, DOI 10.1093/ee/22.6.1308; Hamilton JGC, 2005, J CHEM ECOL, V31, P1369, DOI 10.1007/s10886-005-1351-z; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hosmer DWJ., 2008, APPL SURVIVAL ANAL; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones DR, 2005, EUR J PLANT PATHOL, V113, P119, DOI 10.1007/s10658-005-2334-1; Kritzman A, 2002, ARCH VIROL, V147, P2143, DOI 10.1007/s00705-002-0871-x; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Medina-Ortega KJ, 2009, ENVIRON ENTOMOL, V38, P836, DOI 10.1603/022.038.0337; Milne M, 2002, J INSECT BEHAV, V15, P351, DOI 10.1023/A:1016265109231; Nagata T, 1999, J GEN VIROL, V80, P507, DOI 10.1099/0022-1317-80-2-507; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; NUESSLY GS, 1995, FLA ENTOMOL, V78, P258, DOI 10.2307/3495898; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Persley DM, 2006, AUSTRALAS PLANT PATH, V35, P161, DOI 10.1071/AP06015; Radwan DEM, 2007, PLANT PHYSIOL BIOCH, V45, P480, DOI 10.1016/j.plaphy.2007.03.002; Reiskind MH, 2010, J VECTOR ECOL, V35, P61, DOI 10.1111/j.1948-7134.2010.00029.x; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Roca E, 1997, PLANT PATHOL, V46, P407, DOI 10.1046/j.1365-3059.1997.d01-29.x; Shalitin D, 2000, PLANT PHYSIOL, V123, P597, DOI 10.1104/pp.123.2.597; Shrestha A, 2012, ENTOMOL EXP APPL, V145, P260, DOI 10.1111/eea.12011; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Stumpf CF, 2005, ENTOMOL EXP APPL, V114, P215, DOI 10.1111/j.1570-7458.2005.00251.x; Stumpf CF, 2007, ENTOMOL EXP APPL, V123, P139, DOI 10.1111/j.1570-7458.2007.00541.x; Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2; Uga H, 2005, PHYTOPATHOLOGY, V95, P166, DOI 10.1094/PHYTO-95-0166; Ullman DE, 2002, ADV BOT RES, V36, P113, DOI 10.1016/S0065-2296(02)36061-0; ULLMAN DE, 1993, PHYTOPATHOLOGY, V83, P456, DOI 10.1094/Phyto-83-456; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Wijkamp I, 1996, ENTOMOL EXP APPL, V81, P285, DOI 10.1007/BF00187037; YEH SD, 1992, PLANT DIS, V76, P835, DOI 10.1094/PD-76-0835; Zhang PJ, 2011, PHYSIOL ENTOMOL, V36, P317, DOI 10.1111/j.1365-3032.2011.00796.x	43	14	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102021	10.1371/journal.pone.0102021	http://dx.doi.org/10.1371/journal.pone.0102021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010157	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800060
J	Kawakami, S; Kumazaki, Y; Manda, Y; Oki, K; Minagi, S				Kawakami, Shigehisa; Kumazaki, Yohei; Manda, Yosuke; Oki, Kazuhiro; Minagi, Shogo			Specific Diurnal EMG Activity Pattern Observed in Occlusal Collapse Patients: Relationship between Diurnal Bruxism and Tooth Loss Progression	PLOS ONE			English	Article							SLEEP	Aim: The role of parafunctional masticatory muscle activity in tooth loss has not been fully clarified. This study aimed to reveal the characteristic activity of masseter muscles in bite collapse patients while awake and asleep. Materials and Methods: Six progressive bite collapse patients (PBC group), six age-and gender-matched control subjects (MC group), and six young control subjects (YC group) were enrolled. Electromyograms (EMG) of the masseter muscles were continuously recorded with an ambulatory EMG recorder while patients were awake and asleep. Diurnal and nocturnal parafunctional EMG activity was classified as phasic, tonic, or mixed using an EMG threshold of 20% maximal voluntary clenching. Results: Highly extended diurnal phasic activity was observed only in the PBC group. The three groups had significantly different mean diurnal phasic episodes per hour, with 13.29 +/- 7.18 per hour in the PBC group, 0.95 +/- 0.97 per hour in the MC group, and 0.87 +/- 0.98 per hour in the YC group (p<0.01). ROC curve analysis suggested that the number of diurnal phasic episodes might be used to predict bite collapsing tooth loss. Conclusion: Extensive bite loss might be related to diurnal masticatory muscle parafunction but not to parafunction during sleep. Clinical Relevance: Scientific rationale for study: Although mandibular parafunction has been implicated in stomatognathic system breakdown, a causal relationship has not been established because scientific modalities to evaluate parafunctional activity have been lacking. Principal findings: This study used a newly developed EMG recording system that evaluates masseter muscle activity throughout the day. Our results challenge the stereotypical idea of nocturnal bruxism as a strong destructive force. We found that diurnal phasic masticatory muscle activity was most characteristic in patients with progressive bite collapse. Practical implications: The incidence of diurnal phasic contractions could be used for the prognostic evaluation of stomatognathic system stability.	[Kawakami, Shigehisa; Kumazaki, Yohei; Manda, Yosuke; Oki, Kazuhiro; Minagi, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama 7008530, Japan	Okayama University	Kawakami, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama 7008530, Japan.	s-kawa-10@t.okadai.jp	Minagi, Shogo/B-2473-2011; Kawakami, Shigehisa/F-5057-2011; Manda, Yousuke/AAD-7055-2022	Minagi, Shogo/0000-0002-7559-3627; Manda, Yousuke/0000-0001-6666-908X	MEXT KAKENHI [24390433]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by MEXT KAKENHI (grant number 24390433 to SM; http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bernhardt O, 2006, J PERIODONTOL, V77, P506, DOI 10.1902/jop.2006.050167; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fujisawa M, 2013, J ORAL REHABIL, V40, P731, DOI 10.1111/joor.12087; Hiltunen K, 2002, INT J PROSTHODONT, V15, P539; HOUSTON F, 1987, ACTA ODONTOL SCAND, V45, P239, DOI 10.3109/00016358709097536; Ikebe K, 2010, INT J PROSTHODONT, V23, P521; Kalaykova SI, 2011, J OROFAC PAIN, V25, P153; Kato T, 2013, J PROSTHODONT RES, V57, P69, DOI 10.1016/j.jpor.2013.03.001; Kumazaki Y, 2014, J ORAL REHABIL, V41, P266, DOI 10.1111/joor.12138; Lavigne GJ, 1996, J DENT RES, V75, P546, DOI 10.1177/00220345960750010601; Manfredini D, 2013, J OROFAC PAIN, V27, P99, DOI 10.11607/jop.921; VELLYMIGUEL AM, 1992, J CRANIOMANDIB DISOR, V6, P71; Watanabe A, 2011, J PROSTHODONT RES, V55, P75, DOI 10.1016/j.jpor.2010.09.003	14	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101882	10.1371/journal.pone.0101882	http://dx.doi.org/10.1371/journal.pone.0101882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010348	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800050
J	Qin, YY; Gong, W; Zhang, MD; Wang, JD; Tang, ZH; Quan, ZW				Qin, Yiyu; Gong, Wei; Zhang, Mingdi; Wang, Jiandong; Tang, Zhaohui; Quan, Zhiwei			Forkhead Box L1 Is Frequently Downregulated in Gallbladder Cancer and Inhibits Cell Growth through Apoptosis Induction by Mitochondrial Dysfunction	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; INCREASES SENSITIVITY; PANCREATIC-CANCER; CYTOCHROME-C; LUNG-CANCER; EXPRESSION; LYMPHOMA; PROTEINS; CANDIDATE; SURVIVAL	Background: Forkhead box L1 (FOXL1), considered as a novel candidate tumor suppressor, suppresses proliferation and invasion in certain cancers. However, the regulation and function of FOXL1 in gallbladder cancer (GBC) remains unclear. Methods: FOXL1 expression at mRNA and protein levels in GBC tissues and cell lines were examined by RT-PCR, immunohistochemistry and western blot assay. FOXL1 expression in GBC cell lines was up-regulated by transfection with pcDNA-FOXL1. The effects of FOXL1 overexpression on cell proliferation, apoptosis, migration and invasion were evaluated in vitro or in vivo. In addition, the status of mediators involved in migration, invasion and apoptosis was examined using western blot after transfection with pcDNA-FOXL1. Results: FOXL1 was frequently downregulated in GBC tissues and cell lines. Its higher expression is associated with better prognosis, while its lower expression is correlated with advanced TNM stage and poor differentiation. FOXL1 overexpression in NOZ cells significantly suppresses cell proliferation, migration and invasion in vitro and tumorigenicity in nude mice. FOXL1 overexpression disrupted mitochondrial transmembrane potential and triggered mitochondria-mediated apoptosis in NOZ cells. In addition, FOXL1 overexpression suppressed ZEB1 expression and induced E-cadherin expression in NOZ cells. Conclusion: Our findings suggested that dysregulated FOXL1 is involved in tumorigenesis and progression of GBC and may serve as a predictor of clinical outcome or even a therapeutic target for patients with GBC.	[Qin, Yiyu; Gong, Wei; Zhang, Mingdi; Wang, Jiandong; Tang, Zhaohui; Quan, Zhiwei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, JD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China.	wangjiandongdr@163.com; zhiwquan@163.com			National Natural Science Foundation of China [81272747, 81372642]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81272747 and No. 81372642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kiran RP, 2007, ANN SURG ONCOL, V14, P827, DOI 10.1245/s10434-006-9224-4; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; NAGORNEY DM, 1988, SEMIN ONCOL, V15, P106; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Priya TP, 2010, VIRCHOWS ARCH, V456, P507, DOI 10.1007/s00428-010-0908-6; Rosen A, 1997, J CELL BIOCHEM, V64, P50, DOI 10.1002/(SICI)1097-4644(199701)64:1<50::AID-JCB8>3.0.CO;2-Z; Sasaki CY, 2000, INT J CANCER, V86, P660, DOI 10.1002/(SICI)1097-0215(20000601)86:5<660::AID-IJC9>3.0.CO;2-X; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Streubel B, 2005, LEUKEMIA, V19, P652, DOI 10.1038/sj.leu.2403644; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Yao-qin Y, 2003, J TONGJI U MED SCI, V24, P457; Zhang G, 2013, CANCER RES, V73, P5416, DOI 10.1158/0008-5472.CAN-13-0362	28	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102084	10.1371/journal.pone.0102084	http://dx.doi.org/10.1371/journal.pone.0102084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010679	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800066
J	Szabo, A; Salameh, MA; Ludwig, M; Radisky, ES; Sahin-Toth, M				Szabo, Andras; Salameh, Moh'd A.; Ludwig, Maren; Radisky, Evette S.; Sahin-Toth, Miklos			Tyrosine Sulfation of Human Trypsin Steers S2 ' Subsite Selectivity towards Basic Amino Acids	PLOS ONE			English	Article							HUMAN CATIONIC TRYPSINOGEN; HUMAN ANIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; PROTEASE INHIBITORS; CONVERTING TRYPSIN; S1 SPECIFICITY; ACTIVE-SITE; CHYMOTRYPSIN; BPTI; ACTIVATION	Human cationic and anionic trypsins are sulfated on Tyr154, a residue which helps to shape the prime side substrate-binding subsites. Here, we used phage display technology to assess the significance of tyrosine sulfation for the specificity of human trypsins. The prime side residues P1'-P4' in the binding loop of bovine pancreatic trypsin inhibitor (BPTI) were fully randomized and tight binding inhibitor phages were selected against non-sulfated and sulfated human cationic trypsin. The selection pattern for the two targets differed mostly at the P2' position, where variants selected against non-sulfated trypsin contained primarily aliphatic residues (Leu, Ile, Met), while variants selected against sulfated trypsin were enriched also for Arg. BPTI variants carrying Arg, Lys, Ile, Leu or Ala at the P2' position of the binding loop were purified and equilibrium dissociation constants were determined against non-sulfated and sulfated cationic and anionic human trypsins. BPTI variants harboring apolar residues at P2' exhibited 3-12-fold lower affinity to sulfated trypsin relative to the non-sulfated enzyme, whereas BPTI variants containing basic residues at P2' had comparable affinity to both trypsin forms. Taken together, the observations demonstrate that the tyrosyl sulfate in human trypsins interacts with the P2' position of the substrate-like inhibitor and this modification increases P2' selectivity towards basic side chains.	[Szabo, Andras; Ludwig, Maren; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA; [Salameh, Moh'd A.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL USA; [Ludwig, Maren] Tech Univ Munich, D-80290 Munich, Germany; [Ludwig, Maren] Tech Univ Munich, EKFZ, D-80290 Munich, Germany	Boston University; Mayo Clinic; Technical University of Munich; Technical University of Munich	Szabo, A (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA.	szaboa@bu.edu	Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X; Ewers, Maren/0000-0002-9029-2240; Szabo, Andras/0000-0001-8687-470X; Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01DK058088, R01DK082412, R01DK095753, R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK058088, R01DK082412, and R01DK095753 (to MS-T) and R01CA154387 (to ESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; CHRISTENSEN U, 1979, BIOCHIM BIOPHYS ACTA, V569, P177, DOI 10.1016/0005-2744(79)90052-4; CREIGHTON TE, 1987, J MOL BIOL, V194, P11, DOI 10.1016/0022-2836(87)90711-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Grahn S, 1999, BBA-PROTEIN STRUCT M, V1431, P329, DOI 10.1016/S0167-4838(99)00059-X; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; Itkonen O, 2008, FEBS J, V275, P289, DOI 10.1111/j.1742-4658.2007.06200.x; Kiczak L, 2001, BBA-PROTEIN STRUCT M, V1550, P153, DOI 10.1016/S0167-4838(01)00282-5; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kurth T, 1998, BIOCHEMISTRY-US, V37, P11434, DOI 10.1021/bi980842z; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Marcello MR, 2011, J BIOL CHEM, V286, P13060, DOI 10.1074/jbc.M110.175463; Moore KL, 2009, P NATL ACAD SCI USA, V106, P14741, DOI 10.1073/pnas.0908376106; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Petrassi HM, 2005, BIOORG MED CHEM LETT, V15, P3162, DOI 10.1016/j.bmcl.2005.04.019; Rezaie AR, 1997, BIOCHEMISTRY-US, V36, P1026, DOI 10.1021/bi9620823; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Rosendahl J, 2010, PANCREATOLOGY, V10, P165, DOI 10.1159/000231979; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4349, DOI 10.1021/bi00067a026; SCHELLENBERGER V, 1994, BIOCHEMISTRY-US, V33, P4251, DOI 10.1021/bi00180a020; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Westmuckett AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071822; Westmuckett AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020406	40	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102063	10.1371/journal.pone.0102063	http://dx.doi.org/10.1371/journal.pone.0102063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010489	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800063
J	Wang, SQ; Li, XJ; Qiu, HB; Jiang, ZM; Simon, M; Ma, XR; Liu, L; Liu, JX; Wang, FF; Liang, YF; Wu, JM; Di, WH; Zhou, SB				Wang, Shu-Qiu; Li, Xiao-Jie; Qiu, Hong-Bin; Jiang, Zhi-Mei; Simon, Maria; Ma, Xiao-Ru; Liu, Lei; Liu, Jun-Xing; Wang, Fang-Fang; Liang, Yan-Feng; Wu, Jia-Mei; Di, Wei-Hua; Zhou, Shaobo			Anti-Epileptic Effect of Ganoderma Lucidum Polysaccharides by Inhibition of Intracellular Calcium Accumulation and Stimulation of Expression of CaMKII alpha in Epileptic Hippocampal Neurons	PLOS ONE			English	Article							PROTEIN-KINASE-II; SEIZURE ACTIVITY; CULTURE MODEL; PILOCARPINE MODEL; RURAL CHINA; MECHANISMS; CA2+; INACTIVATION; DISCHARGES; ACTIVATION	Purpose: To investigate the mechanism of the anti-epileptic effect of Ganoderma lucidum polysaccharides (GLP), the changes of intracellular calcium and CaMK II alpha expression in a model of epileptic neurons were investigated. Method: Primary hippocampal neurons were divided into: 1) Control group, neurons were cultured with Neurobasal medium, for 3 hours; 2) Model group I: neurons were incubated with Mg2+ free medium for 3 hours; 3) Model group II: neurons were incubated with Mg2+ free medium for 3 hours then cultured with the normal medium for a further 3 hours; 4) GLP group I: neurons were incubated with Mg2+ free medium containing GLP (0.375 mg/ml) for 3 hours; 5) GLP group II: neurons were incubated with Mg2+ free medium for 3 hours then cultured with a normal culture medium containing GLP for a further 3 hours. The CaMK II alpha protein expression was assessed by Western-blot. Ca2+ turnover in neurons was assessed using Fluo-3/AM which was added into the replacement medium and Ca2+ turnover was observed under a laser scanning confocal microscope. Results: The CaMK II alpha expression in the model groups was less than in the control groups, however, in the GLP groups, it was higher than that observed in the model group. Ca2+ fluorescence intensity in GLP group I was significantly lower than that in model group I after 30 seconds, while in GLP group II, it was reduced significantly compared to model group II after 5 minutes. Conclusion: GLP may inhibit calcium overload and promote CaMK II alpha expression to protect epileptic neurons.	[Wang, Shu-Qiu; Ma, Xiao-Ru; Liu, Lei; Liu, Jun-Xing; Wang, Fang-Fang; Liang, Yan-Feng; Wu, Jia-Mei; Di, Wei-Hua; Zhou, Shaobo] Jiamusi Univ, Sch Basic Med Sci, Dept Pathophysiol, Jiamusi, Peoples R China; [Li, Xiao-Jie; Jiang, Zhi-Mei] Jiamusi Univ, Sch Rehabil Med Sci, Children Neural Rehabil Lab, Jiamusi, Heilongjiang Pr, Peoples R China; [Qiu, Hong-Bin] Jiamusi Univ, Sch Publ Hlth, Jiamusi, Heilongjiang Pr, Peoples R China; [Simon, Maria; Zhou, Shaobo] Univ Bedfordshire, Inst Biomed & Environm Sci & Technol, Dept Life Sci, Luton, Beds, England	Jiamusi University; Jiamusi University; Jiamusi University; University of Bedfordshire	Wang, SQ (corresponding author), Jiamusi Univ, Sch Basic Med Sci, Dept Pathophysiol, Jiamusi, Peoples R China.	wangshuq_jms@163.com	Zhou, Shaobo/I-1536-2019	Zhou, Shaobo/0000-0001-5214-2973	National Natural Science Foundation, Beijing, P. R. China [81241112]; Heilongjiang Province, P. R. China [2012TD013]; Jiamusi University, P. R. China [04099904]	National Natural Science Foundation, Beijing, P. R. China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province, P. R. China; Jiamusi University, P. R. China	This work was supported by the National Natural Science Foundation, Beijing, P. R. China (No. 81241112); Scientific and technological innovation team on mechanism of neurological cell injury and its protection in Universities (2012TD013, Heilongjiang Province, P. R. China); Team focus on fostering technological innovation project funding (project number: 04099904, Jiamusi University, P. R. China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET, V380, P1121, DOI 10.1016/S0140-6736(12)61646-8; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Blair RE, 1999, BRAIN RES, V851, P54, DOI 10.1016/S0006-8993(99)02100-9; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; BRONSTEIN J, 1988, NEUROCHEM RES, V13, P83, DOI 10.1007/BF00971859; BRONSTEIN JM, 1992, BRAIN RES, V584, P257, DOI 10.1016/0006-8993(92)90903-M; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Churn SB, 2000, BRAIN RES, V875, P66, DOI 10.1016/S0006-8993(00)02623-8; CHURN SB, 1995, J NEUROSCI, V15, P3200; CROUCHER MJ, 1992, NEUROCHEM RES, V17, P409, DOI 10.1007/BF00969885; Croucher MJ, 1997, EUR J PHARMACOL, V319, P207, DOI 10.1016/S0014-2999(96)00868-0; Daniel S, 2012, PLOS ONE, V7; DeCoster MA, 1995, ADV NEUROIMMUNOL, V5, P233, DOI 10.1016/0960-5428(95)00015-T; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; DeLorenzo Robert J, 2006, Adv Neurol, V97, P187; Dong Y, 2004, NEUROSCI LETT, V357, P95, DOI 10.1016/j.neulet.2003.11.069; Goodkin HP, 2005, J NEUROSCI, V25, P5511, DOI 10.1523/JNEUROSCI.0900-05.2005; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Ilangaratne NB, 2012, B WORLD HEALTH ORGAN, V90, P871, DOI 10.2471/BLT.12.113183; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kwan P, 2013, EPILEPSIA, V54, P537, DOI 10.1111/epi.12022; Loughrey CM, 2003, CELL CALCIUM, V34, P1, DOI 10.1016/S0143-4160(03)00012-5; Mangan PS, 2004, J NEUROPHYSIOL, V91, P946, DOI 10.1152/jn.00547.2003; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Pal S, 2001, CELL CALCIUM, V30, P285, DOI 10.1054/ceca.2001.0236; Pal S, 2000, CELL CALCIUM, V28, P181, DOI 10.1054/ceca.2000.0146; PERLIN JB, 1992, EPILEPSY RES, V11, P111, DOI 10.1016/0920-1211(92)90045-U; Raol YH, 2012, PROG MOL BIOL TRANSL, V105, P57, DOI 10.1016/B978-0-12-394596-9.00003-2; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Wang H, 2005, ZHONGGUO LINCHUANG K, V48, P71; Wang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061687; Wang WZ, 2012, EPILEPSY RES, V102, P201, DOI 10.1016/j.eplepsyres.2012.06.004; Wang WQ, 2005, HEILONGJIANG MED PHA, P48; Xu DF, 2006, J ANHUI MED U, V41, P522; Yamagata Y, 2006, NEUROSCIENCE, V140, P981, DOI 10.1016/j.neuroscience.2006.02.054; Yi YL, 2004, J CAPITAL MED U, V25, P540; Zhang SL, 2008, NEURAL REGEN RES, V3, P1304; Zhao S, 2005, HEILONGJIANG YIYAO K, V28, P1; [赵爽 ZHAO Shuang], 2007, [中国病理生理杂志, Chinese Journal of Pathophysiology], V23, P1153	46	22	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102161	10.1371/journal.pone.0102161	http://dx.doi.org/10.1371/journal.pone.0102161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010576	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800075
J	Ziegler, YS; Moresco, JJ; Tu, PG; Yates, JR; Nardulli, AM				Ziegler, Yvonne S.; Moresco, James J.; Tu, Patricia G.; Yates, John R., III; Nardulli, Ann M.			Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and Treatment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-TUBULIN EXPRESSION; GENE-EXPRESSION; PROSTATE-CANCER; ADHESION MOLECULE; POOR-PROGNOSIS; OVARIAN-CANCER; TUMOR-CELLS; MYOSIN-II; RECEPTOR	The use of broad spectrum chemotherapeutic agents to treat breast cancer results in substantial and debilitating side effects, necessitating the development of targeted therapies to limit tumor proliferation and prevent metastasis. In recent years, the list of approved targeted therapies has expanded, and it includes both monoclonal antibodies and small molecule inhibitors that interfere with key proteins involved in the uncontrolled growth and migration of cancer cells. The targeting of plasma membrane proteins has been most successful to date, and this is reflected in the large representation of these proteins as targets of newer therapies. In view of these facts, experiments were designed to investigate the plasma membrane proteome of a variety of human breast cancer cell lines representing hormone-responsive, ErbB2 over-expressing and triple negative cell types, as well as a benign control. Plasma membranes were isolated by using an aqueous two-phase system, and the resulting proteins were subjected to mass spectrometry analysis. Overall, each of the cell lines expressed some unique proteins, and a number of proteins were expressed in multiple cell lines, but in patterns that did not always follow traditional clinical definitions of breast cancer type. From our data, it can be deduced that most cancer cells possess multiple strategies to promote uncontrolled growth, reflected in aberrant expression of tyrosine kinases, cellular adhesion molecules, and structural proteins. Our data set provides a very rich and complex picture of plasma membrane proteins present on breast cancer cells, and the sorting and categorizing of this data provides interesting insights into the biology, classification, and potential treatment of this prevalent and debilitating disease.	[Ziegler, Yvonne S.; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Moresco, James J.; Tu, Patricia G.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Nardulli, AM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	anardull@life.illinois.edu		Moresco, James/0000-0003-1178-1642	National Institutes of Health [R01 DK053884]; National Institute of General Medical Sciences [8 P41 GM103533]; National Institute on Aging [R01AG027463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YSZ and AMN were supported by the National Institutes of Health (R01 DK053884 to AMN, www.nih.gov). PGT, JJM, and JRY were supported by the National Institute of General Medical Sciences (8 P41 GM103533 to JRY, www.nigms.nih.gov). JJM and JRY were supported by the National Institute on Aging (R01AG027463 to JRY, www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2013, J NUCL MED, V54, P913, DOI 10.2967/jnumed.112.111534; Alshareeda AT, 2013, BREAST CANCER RES TR, V139, P23, DOI 10.1007/s10549-013-2518-x; Aptsiauri N, 2013, SPRINGER BRIEFS CANC, V6, P13; Arjonen A, 2014, J CLIN INVE IN PRESS; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Boichuk S, 2014, CANCER RES, V74, P1200, DOI 10.1158/0008-5472.CAN-13-1955; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Carvalho PC, 2010, ANONYMOUS CURRENT PR; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chettouh H, 2013, CANCER RES, V73, P3974, DOI 10.1158/0008-5472.CAN-12-3824; Cho SH, 2012, INT J ONCOL, V41, P211, DOI 10.3892/ijo.2012.1453; Christiansen DH, 2005, LEUKEMIA, V19, P2232, DOI 10.1038/sj.leu.2404009; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; Cooper ZA, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24320; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; de Groote ML, 2014, INT J CANCER, V134, P280, DOI 10.1002/ijc.28375; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Fujihara Tomofumi, 1999, Gastric Cancer, V2, P221, DOI 10.1007/s101200050067; Giarnieri E, 2005, ANTICANCER RES, V25, P3237; Gonzalez L, 2012, ANN DIAGN PATHOL, V16, P260, DOI 10.1016/j.anndiagpath.2011.11.004; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Haeuw JF, 2011, BIOCHEM SOC T, V39, P553, DOI 10.1042/BST0390553; Hai J, 2012, CLIN CANCER RES, V18, P1914, DOI 10.1158/1078-0432.CCR-11-2893; Heideman MR, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3564; Hsu KS, 2013, VITAM HORM, V93, P323, DOI 10.1016/B978-0-12-416673-8.00005-8; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Hwang JR, 2012, CARCINOGENESIS, V33, P77, DOI 10.1093/carcin/bgr257; Imbert AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043752; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jensen M, 2007, CANCER LETT, V258, P9, DOI 10.1016/j.canlet.2007.09.004; Kaneko K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-454; Kischel P, 2012, ANTICANCER RES, V32, P5211; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Levallet G, 2012, MOL CANCER THER, V11, P1203, DOI 10.1158/1535-7163.MCT-11-0899; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039766; Lili LN, 2014, PANCREAS, V43, P198, DOI 10.1097/MPA.0000000000000020; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039989; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; Liu Z, 2014, INT J MOL MED, V33, P589, DOI 10.3892/ijmm.2013.1598; Malaguarnera Roberta, 2011, Front Endocrinol (Lausanne), V2, P93, DOI 10.3389/fendo.2011.00093; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morre DM, 2000, J CHROMATOGR B, V743, P377, DOI 10.1016/S0378-4347(00)00058-X; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Nakopoulou L, 2002, HISTOPATHOLOGY, V40, P536, DOI 10.1046/j.1365-2559.2002.01392.x; Nallapalli RK, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-50; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Ou YQ, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.06.017; Park SJ, 2013, CELL SIGNAL, V25, P2147, DOI 10.1016/j.cellsig.2013.07.001; Pillai SKK, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-18; Rangel LBA, 2004, CANCER BIOL THER, V3, P1021, DOI 10.4161/cbt.3.10.1142; Raymond JR, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-6; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Saifo MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-310; Samuel J, 2014, NEW ENGL J MED, V370, P286, DOI 10.1056/NEJMc1310849; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Schindler J, 2006, MOL CELL PROTEOMICS, V5, P390, DOI 10.1074/mcp.T500017-MCP200; Schneider SA, 2013, MOD PATHOL IN PRESS; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Schulz WA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-505; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siu IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078895; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Suizu F, 2000, J BIOCHEM-TOKYO, V128, P435, DOI 10.1093/oxfordjournals.jbchem.a022771; Tsang Stella W Y, 2003, Methods Mol Biol, V227, P351, DOI 10.1385/1-59259-387-9:351; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Veitonmaki N, 2013, CANCER CELL, V23, P502, DOI 10.1016/j.ccr.2013.02.026; Volakis LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086110; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Ward Y, 2013, ONCOGENE, V32, P2726, DOI 10.1038/onc.2012.301; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wazir U, 2013, CANCER GENOM PROTEOM, V10, P69; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wobus M, 2006, MOL CARCINOGEN, V45, P881, DOI 10.1002/mc.20262; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065463; Yao Jian, 2012, Cancer Biology Medicine, V9, P234, DOI 10.7497/j.issn.2095-3941.2012.04.003; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Yu JW, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/210205; Yue JY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-7; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zeimet AG, 2013, JNCI-J NATL CANCER I, V105, P1142, DOI 10.1093/jnci/djt144	110	32	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102341	10.1371/journal.pone.0102341	http://dx.doi.org/10.1371/journal.pone.0102341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029196	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600067
J	Ilgen, P; Stoldt, S; Conradi, LC; Wurm, CA; Ruschoff, J; Ghadimi, BM; Liersch, T; Jakobs, S				Ilgen, Peter; Stoldt, Stefan; Conradi, Lena-Christin; Wurm, Christian Andreas; Rueschoff, Josef; Ghadimi, B. Michael; Liersch, Torsten; Jakobs, Stefan			STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; BRAIN-SLICES; RESOLUTION; NANOSCOPY; IMMUNOFLUORESCENCE; SYNAPSES; REVEALS	Formalin fixed and paraffin-embedded human tissue resected during cancer surgery is indispensable for diagnostic and therapeutic purposes and represents a vast and largely unexploited resource for research. Optical microscopy of such specimen is curtailed by the diffraction-limited resolution of conventional optical microscopy. To overcome this limitation, we used STED super-resolution microscopy enabling optical resolution well below the diffraction barrier. We visualized nanoscale protein distributions in sections of well-annotated paraffin-embedded human rectal cancer tissue stored in a clinical repository. Using antisera against several mitochondrial proteins, STED microscopy revealed distinct sub-mitochondrial protein distributions, suggesting a high level of structural preservation. Analysis of human tissues stored for up to 17 years demonstrated that these samples were still amenable for super-resolution microscopy. STED microscopy of sections of HER2 positive rectal adenocarcinoma revealed details in the surface and intracellular HER2 distribution that were blurred in the corresponding conventional images, demonstrating the potential of super-resolution microscopy to explore the thus far largely untapped nanoscale regime in tissues stored in biorepositories.	[Ilgen, Peter; Stoldt, Stefan; Wurm, Christian Andreas; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Conradi, Lena-Christin; Ghadimi, B. Michael; Liersch, Torsten] Univ Med Ctr Gottingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany; [Rueschoff, Josef] Inst Pathol Nordhessen, Kassel, Germany; [Rueschoff, Josef] Univ Med Ctr Gottingen, Dept Pathol, Gottingen, Germany; [Jakobs, Stefan] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Jakobs, Stefan] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Liersch, T (corresponding author), Univ Med Ctr Gottingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany.	tliersc@gwdg.de; sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012	Jakobs, Stefan/0000-0002-8028-3121	Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; EU project IMAGINT [Health-F5-2011-259881];  [KFO179]	Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; EU project IMAGINT; 	Part of the work was supported by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain" and the EU project IMAGINT (Health-F5-2011-259881) (both to SJ) as well as through the KFO179 "Biological Basis of Individual Tumor Response in Patients with Rectal Cancer." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NATURE, V486, P141, DOI 10.1038/486141a; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Chmyrov A, 2013, NAT METHODS, V10, P737, DOI 10.1038/nmeth.2556; Conradi LC, 2013, AM J SURG PATHOL, V37, P522, DOI 10.1097/PAS.0b013e318272ff4d; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Eiseman E., 1999, HDB HUMAN TISSUE SOU; Glynne-Jones R, 2013, J GASTROINTEST ONCOL, V4, P264, DOI 10.3978/j.issn.2078-6891.2013.037; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jakobs S, 2014, CURR OPIN CHEM BIOL, V20, P9, DOI 10.1016/j.cbpa.2014.03.019; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; Kempf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062893; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kolmakov K, 2010, CHEM-EUR J, V16, P158, DOI 10.1002/chem.200902309; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Punge A, 2008, MICROSC RES TECHNIQ, V71, P644, DOI 10.1002/jemt.20602; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Rodel C, 2012, CURR OPIN ONCOL, V24, P441, DOI 10.1097/CCO.0b013e328352ea02; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Wurm CA, 2011, P NATL ACAD SCI USA, V108, P13546, DOI 10.1073/pnas.1107553108; Yang B., 2013, ARXIV13073833PHYSICS	34	23	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101563	10.1371/journal.pone.0101563	http://dx.doi.org/10.1371/journal.pone.0101563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025184	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400018
J	Ng, OW; Keng, CT; Leung, CSW; Peiris, JSM; Poon, LLM; Tan, YJ				Ng, Oi-Wing; Keng, Choong-Tat; Leung, Cynthia Sau-Wai; Peiris, J. S. Malik; Poon, Leo Lit Man; Tan, Yee-Joo			Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; RECEPTOR-BINDING DOMAIN; FUNCTIONAL-CHARACTERIZATION; FUSION CORE; PROTEIN; COV; VIRUS; VACCINE; ENTRY	The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is the etiological agent for the infectious disease, SARS, which first emerged 10 years ago. SARS-CoV is a zoonotic virus that has crossed the species barriers to infect humans. Bats, which harbour a diverse pool of SARS-like CoVs (SL-CoVs), are believed to be the natural reservoir. The SARS-CoV surface Spike (S) protein is a major antigenic determinant in eliciting neutralizing antibody production during SARS-CoV infection. In our previous work, we showed that a panel of murine monoclonal antibodies (mAbs) that target the S2 subunit of the S protein are capable of neutralizing SARS-CoV infection in vitro (Lip KM et al, J Virol. 2006 Jan; 80(2): 941-50). In this study, we report our findings on the characterization of one of these mAbs, known as 1A9, which binds to the S protein at a novel epitope within the S2 subunit at amino acids 1111-1130. MAb 1A9 is a broadly neutralizing mAb that prevents viral entry mediated by the S proteins of human and civet SARS-CoVs as well as bat SL-CoVs. By generating mutant SARS-CoV that escapes the neutralization by mAb 1A9, the residue D1128 in S was found to be crucial for its interaction with mAb 1A9. S protein containing the substitution of D1128 with alanine (D1128A) exhibited a significant decrease in binding capability to mAb 1A9 compared to wild-type S protein. By using a pseudotyped viral entry assay, it was shown that the D1128A substitution in the escape virus allows it to overcome the viral entry blockage by mAb 1A9. In addition, the D1128A mutation was found to exert no effects on the S protein cell surface expression and incorporation into virion particles, suggesting that the escape virus retains the same viral entry property as the wild-type virus.	[Ng, Oi-Wing; Tan, Yee-Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, NUHS, Singapore 117595, Singapore; [Keng, Choong-Tat; Tan, Yee-Joo] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Leung, Cynthia Sau-Wai; Peiris, J. S. Malik; Poon, Leo Lit Man] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Hong Kong	Tan, YJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, NUHS, Singapore 117595, Singapore.	Yee_Joo_TAN@NUHS.edu.sg	Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Tan, Yee-Joo/0000-0002-2278-4497; KENG, CHOONG TAT/0000-0003-2898-5924	A*STAR BMRC Grant [10/1/21/19/652]	A*STAR BMRC Grant(Agency for Science Technology & Research (A*STAR))	This work was supported by an A*STAR BMRC Grant (10/1/21/19/652) awarded to Y.-J. Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Chakraborti S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-73; Coughlin MM, 2012, REV MED VIROL, V22, P2, DOI 10.1002/rmv.706; Coughlin MM, 2009, VIROLOGY, V394, P39, DOI 10.1016/j.virol.2009.07.028; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Duan JZ, 2005, BIOCHEM BIOPH RES CO, V333, P186, DOI 10.1016/j.bbrc.2005.05.089; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Garcia JM, 2011, EXPERT REV ANTI-INFE, V9, P443, DOI [10.1586/eri.11.25, 10.1586/ERI.11.25]; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He YX, 2006, J IMMUNOL, V176, P6085, DOI 10.4049/jimmunol.176.10.6085; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Hofmann H, 2004, J VIROL, V78, P6134, DOI 10.1128/JVI.78.12.6134-6142.2004; Keng CT, 2005, J VIROL, V79, P3289, DOI 10.1128/JVI.79.6.3289-3296.2005; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Lip KM, 2006, J VIROL, V80, P941, DOI 10.1128/JVI.80.2.941-950.2006; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; McReynolds S, 2008, BIOCHEMISTRY-US, V47, P6802, DOI 10.1021/bi800622t; Mitsuki YY, 2008, MICROBES INFECT, V10, P908, DOI 10.1016/j.micinf.2008.05.009; Miyoshi-Akiyama T, 2011, J INFECT DIS, V203, P1574, DOI 10.1093/infdis/jir084; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Rockx B, 2008, J VIROL, V82, P3220, DOI 10.1128/JVI.02377-07; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sainz B, 2005, J VIROL, V79, P7195, DOI 10.1128/JVI.79.11.7195-7206.2005; Sainz B, 2006, VIRUS RES, V120, P146, DOI 10.1016/j.virusres.2006.03.001; Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012; Spiga O, 2003, BIOCHEM BIOPH RES CO, V310, P78, DOI 10.1016/j.bbrc.2003.08.122; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Temperton NJ, 2005, EMERG INFECT DIS, V11, P411, DOI 10.3201/eid1103.040906; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; Tripp RA, 2005, J VIROL METHODS, V128, P21, DOI 10.1016/j.jviromet.2005.03.021; Tsunetsugu-Yokota Y, 2006, REV MED VIROL, V16, P117, DOI 10.1002/rmv.492; Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, BIOCHEMISTRY-US, V43, P14064, DOI 10.1021/bi049101q; Yeung KS, 2006, MED RES REV, V26, P414, DOI 10.1002/med.20055; Zhong XF, 2005, J VIROL, V79, P3401, DOI 10.1128/JVI.79.6.3401-3408.2005; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104	55	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102415	10.1371/journal.pone.0102415	http://dx.doi.org/10.1371/journal.pone.0102415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019613	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600081
J	Zeug, SC; Cavallo, BJ				Zeug, Steven C.; Cavallo, Bradley J.			Controls on the Entrainment of Juvenile Chinook Salmon (Oncorhynchus tshawytscha) into Large Water Diversions and Estimates of Population-Level Loss	PLOS ONE			English	Article							JOAQUIN RIVER DELTA; IRRIGATION CANALS; FISH ENTRAINMENT; POWER-STATION; SURVIVAL; ESTUARY; BIODIVERSITY; CONSERVATION; MIGRATION; SYSTEM	Diversion of freshwater can cause significant changes in hydrologic dynamics and this can have negative consequences for fish populations. Additionally, fishes can be directly entrained into diversion infrastructure (e.g. canals, reservoirs, pumps) where they may become lost to the population. However, the effect of diversion losses on fish population dynamics remains unclear. We used 15 years of release and recovery data from coded-wire-tagged juvenile Chinook Salmon (Oncorhynchus tshawytscha) to model the physical, hydrological and biological predictors of salvage at two large water diversions in the San Francisco Estuary. Additionally, entrainment rates were combined with estimates of mortality during migration to quantify the proportion of total mortality that could be attributed to diversions. Statistical modeling revealed a strong positive relationship between diversion rate and fish entrainment at both diversions and all release locations. Other significant relationships were specific to the rivers where the fish were released, and the specific diversion facility. Although significant relationships were identified in statistical models, entrainment loss and the mean contribution of entrainment to total migration mortality were low. The greatest entrainment mortality occurred for fish released along routes that passed closest to the diversions and certain runs of Chinook Salmon released in the Sacramento River suffered greater mortality but only at the highest diversion rates observed during the study. These results suggest losses at diversions should be put into a population context in order to best inform effective management of Chinook Salmon populations.	[Zeug, Steven C.; Cavallo, Bradley J.] Cramer Fish Sci, Auburn, CA 95602 USA		Zeug, SC (corresponding author), Cramer Fish Sci, Auburn, CA 95602 USA.	stevez@fishsciences.net		Zeug, Steven/0000-0003-4330-1236	California Department of Water Resources	California Department of Water Resources	This study was funded by the California Department of Water Resources. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Staff from the funding agency participated in data collection in coordination with other state and federal resource agencies.	Baumgartner LJ, 2009, FISHERIES MANAG ECOL, V16, P429, DOI 10.1111/j.1365-2400.2009.00693.x; Buchanan RA, 2013, N AM J FISH MANAGE, V33, P216, DOI 10.1080/02755947.2012.728178; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carlson AJ, 2007, T AM FISH SOC, V136, P1335, DOI 10.1577/T06-111.1; Carter KL, 2000, FISHERIES MANAG ECOL, V7, P447, DOI 10.1046/j.1365-2400.2000.00224.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gingras M, 1997, TECHNICAL REPORT; Grimaldo LF, 2009, N AM J FISH MANAGE, V29, P1253, DOI 10.1577/M08-062.1; Hadderingh RH, 2002, J FISH BIOL, V61, P105, DOI 10.1006/jfbi.2002.2071; KELSO J R M, 1979, Journal of Great Lakes Research, V5, P182; Kimmerer W.J., 2008, SAN FRANCISCO ESTUAR, V6, particl; Michel CJ, 2010, THESIS U CALIFORNIA; Moyle PB, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:UA]2.0.CO;2; National Marine Fisheries Service, 2009, NMFS FIN 2009 BIOL O; Newman K.B., 2008, EVALUATION 4 SACRAME; Newman KB, 2003, STAT MODEL, V3, P157, DOI 10.1191/1471082X03st055oa; Newman KB, 2002, J AM STAT ASSOC, V97, P983, DOI 10.1198/016214502388618771; Newman KB, 2010, N AM J FISH MANAGE, V30, P157, DOI 10.1577/M07-188.1; Nobriga ML, 2004, AM FISH S S, V39, P281; Perry R. W., 2010, THESIS U WASHINGTON; Perry RW, 2010, N AM J FISH MANAGE, V30, P142, DOI 10.1577/M08-200.1; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Post JR, 2006, N AM J FISH MANAGE, V26, P875, DOI 10.1577/M05-047.1; R Core Team, 2012, R LANG ENV STAT COMP; Roberts JJ, 2008, T AM FISH SOC, V137, P951, DOI 10.1577/T07-058.1; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Walters AW, 2012, T AM FISH SOC, V141, P1180, DOI 10.1080/00028487.2012.679019; Yoshiyama R.M., 2001, FISH B-NOAA, V179, P71; Zabel RW, 2008, HYDROBIOLOGIA, V609, P289, DOI 10.1007/s10750-008-9407-z; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719; Zeug SC, 2013, ECOL FRESHW FISH, V22, P157, DOI 10.1111/eff.12013	31	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101479	10.1371/journal.pone.0101479	http://dx.doi.org/10.1371/journal.pone.0101479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019205	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600016
J	Han, XQ; Yue, GL; Yue, RQ; Dong, CX; Chan, CL; Ko, CH; Cheung, WS; Luo, KW; Dai, H; Wong, CK; Leung, PC; Han, QB				Han, Xiao-Qiang; Yue, Gar-Lee; Yue, Rui-Qi; Dong, Cai-Xia; Chan, Chung-Lap; Ko, Chun-Hay; Cheung, Wing-Shing; Luo, Ke-Wang; Dai, Hui; Wong, Chun-Kwok; Leung, Ping-Chung; Han, Quan-Bin			Structure Elucidation and Immunomodulatory Activity of A Beta Glucan from the Fruiting Bodies of Ganoderma Sinense	PLOS ONE			English	Article							EDIBLE MUSHROOM; PLEUROTUS-FLORIDA; B-CELLS; POLYSACCHARIDE; MACROPHAGES; ANTITUMOR; IMMUNITY; LUCIDUM; CULTURE; EDODES	A polysaccharide named GSP-2 with a molecular size of 32 kDa was isolated from the fruiting bodies of Ganoderma sinense. Its structure was well elucidated, by a combined utilization of chemical and spectroscopic techniques, to be a beta-glucan with a backbone of (1 -> 4)- and (1 -> 6)-Glcp, bearing terminal- and (1 -> 3)-Glcp side-chains at O-3 position of (1 -> 6)-Glcp. Immunological assay exhibited that GSP-2 significantly induced the proliferation of BALB/c mice splenocytes with target on only B cells, and enhanced the production of several cytokines in human peripheral blood mononuclear cells and derived dendritic cells. Besides, the fluorescent labeled GSP-2 was phagocytosed by the RAW 264.7 cells and induced the nitric oxide secretion from the cells.	[Han, Xiao-Qiang; Yue, Gar-Lee; Chan, Chung-Lap; Ko, Chun-Hay; Cheung, Wing-Shing; Luo, Ke-Wang; Wong, Chun-Kwok; Leung, Ping-Chung; Han, Quan-Bin] Chinese Univ Hong Kong, Inst Chinese Med, State Key Lab Phytochem & Plant Resources West Ch, Shatin, Hong Kong, Peoples R China; [Han, Xiao-Qiang] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China; [Yue, Rui-Qi; Dong, Cai-Xia; Han, Quan-Bin] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Dai, Hui] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Hong Kong Baptist University; Peking University	Dai, H (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China.	daihui@bjmu.edu.cn; simonhan@hkbu.edu.hk	Wong, CK/H-3256-2016; Yue, Grace Gar-Lee/AAY-3945-2020; Ko, Chun Hay/H-9652-2013	Wong, CK/0000-0002-5637-8331; Yue, Grace Gar-Lee/0000-0002-1726-3566; Han, Quanbin/0000-0001-9051-1485; Ko, Chun Hay/0000-0001-9180-2196	Innovation and Technology Fund of the Government of the Hong Kong Special Administrative Region [ITS/311/09, InP/108/10]; National Natural Science Foundation of China [81303210, 81102253]; Hong Kong Baptist University [FRG2/11-12/048, FRG1/12-13/018, FRG2/12-13/006]	Innovation and Technology Fund of the Government of the Hong Kong Special Administrative Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Baptist University	The chemical research work of this study is funded by the Innovation and Technology Fund (ITS/311/09 and InP/108/10) of the Government of the Hong Kong Special Administrative Region, Hong Kong Baptist University (FRG2/11-12/048, FRG1/12-13/018, FRG2/12-13/006, and RC-start up grant). The immune study is funded by the National Natural Science Foundation of China (81303210, 81102253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando I, 2002, INT IMMUNOPHARMACOL, V2, P1155, DOI 10.1016/S1567-5769(02)00076-0; Bhanja SK, 2012, CARBOHYD RES, V357, P83, DOI 10.1016/j.carres.2012.04.007; Bhunia SK, 2011, CARBOHYD RES, V346, P2039, DOI 10.1016/j.carres.2011.05.029; Chan C. F. G., 2009, J HEMATOL ONCOL, V25, P1; Chen XP, 2009, CARBOHYD POLYM, V77, P389, DOI 10.1016/j.carbpol.2009.01.009; Cheng CH, 2010, NUTR CANCER, V62, P648, DOI 10.1080/01635581003605516; Da J, 2012, J CHROMATOGR A, V1222, P59, DOI 10.1016/j.chroma.2011.12.017; Delamarre L, 2011, SEMIN IMMUNOL, V23, P2, DOI 10.1016/j.smim.2011.02.001; Dey B, 2010, CARBOHYD RES, V345, P2736, DOI 10.1016/j.carres.2010.09.032; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P1301, DOI 10.1016/S1567-5769(03)00118-8; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P683, DOI 10.1016/S1567-5769(03)00056-0; Han SB, 2001, INT IMMUNOPHARMACOL, V1, P1969, DOI 10.1016/S1567-5769(01)00124-2; Han XQ, 2012, INT J BIOL MACROMOL, V51, P597, DOI 10.1016/j.ijbiomac.2012.06.029; Han XQ, 2012, J AGR FOOD CHEM, V60, P4276, DOI 10.1021/jf205056u; Ito H, 1977, SUBJECT STRAIN BIBLI; Jimenez E, 2005, CANCER IMMUNOL IMMUN, V54, P395, DOI 10.1007/s00262-004-0601-1; Kim HM, 1996, INT J IMMUNOPHARMACO, V18, P295, DOI 10.1016/0192-0561(96)00028-8; LAWRENCE JF, 1985, J CHROMATOGR, V350, P237, DOI 10.1016/S0021-9673(01)93522-8; Lin YL, 2009, J LEUKOCYTE BIOL, V86, P877, DOI 10.1189/jlb.0708441; Liu JQ, 2012, PLANTA MED, V78, P368, DOI 10.1055/s-0031-1280441; Liu JJ, 2009, EXP MOL PATHOL, V86, P208, DOI 10.1016/j.yexmp.2009.01.006; Liu MQ, 1998, IMMUNOPHARMACOLOGY, V40, P187, DOI 10.1016/S0162-3109(98)00043-5; Liu YW, 2009, J AGR FOOD CHEM, V57, P3087, DOI 10.1021/jf900011f; Lv GP, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-10; Maji PK, 2013, CARBOHYD RES, V368, P22, DOI 10.1016/j.carres.2012.12.008; Mandal EK, 2012, CARBOHYD RES, V347, P172, DOI 10.1016/j.carres.2011.10.040; Mandal S, 2010, CARBOHYD RES, V345, P2657, DOI 10.1016/j.carres.2010.10.005; NEEDS PW, 1993, CARBOHYD RES, V245, P1, DOI 10.1016/0008-6215(93)80055-J; Nie S., 2013, BIOACT CARBOHYDRATES, V1, P10, DOI [10.1016/j.bcdf.2013.01.001, DOI 10.1016/J.BCDF.2013.01.001]; Ojha AK, 2010, CARBOHYD RES, V345, P2157, DOI 10.1016/j.carres.2010.06.015; Ooi V. E. C., 1999, International Journal of Medicinal Mushrooms, V1, P195; Rice PJ, 2005, J PHARMACOL EXP THER, V314, P1079, DOI 10.1124/jpet.105.085415; Rout D, 2008, CARBOHYD RES, V343, P982, DOI 10.1016/j.carres.2007.12.022; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sato N, 2009, CHEM PHARM BULL, V57, P1076, DOI 10.1248/cpb.57.1076; Sliva D, 2006, LEUKEMIA RES, V30, P767, DOI 10.1016/j.leukres.2005.12.015; STAUB A. M., 1965, METHOD CARBOHYD CHEM, V5, P5; SWEET DP, 1975, CARBOHYD RES, V40, P217, DOI 10.1016/S0008-6215(00)82604-X; Yue GGL, 2006, J ALTERN COMPLEM MED, V12, P777, DOI 10.1089/acm.2006.12.777; Yue GGL, 2013, NUTR CANCER, V65, P765, DOI 10.1080/01635581.2013.788725	40	73	77	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100380	10.1371/journal.pone.0100380	http://dx.doi.org/10.1371/journal.pone.0100380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014571	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400008
J	Yamamoto, K; Mizumoto, A; Nishimura, K; Uda, A; Mukai, A; Yamashita, K; Kume, M; Makimoto, H; Bito, T; Nishigori, C; Nakagawa, T; Hirano, T; Hirai, M				Yamamoto, Kazuhiro; Mizumoto, Atsushi; Nishimura, Kohji; Uda, Atsushi; Mukai, Akira; Yamashita, Kazuhiko; Kume, Manabu; Makimoto, Hiroo; Bito, Toshinori; Nishigori, Chikako; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori			Association of Toxicity of Sorafenib and Sunitinib for Human Keratinocytes with Inhibition of Signal Transduction and Activator of Transcription 3 (STAT3)	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; FOOT SKIN REACTION; KINASE; APOPTOSIS; MANAGEMENT; THERAPY; PROLIFERATION; EXPRESSION; TARGETS; CANCER	Hand-foot skin reaction is a most common multi-kinase inhibitor-related adverse event. This study aimed to examine whether the toxicity of sorafenib and sunitinib for human keratinocytes was associated with inhibiting signal transduction and activator of transcription 3 (STAT3). We studied whether STAT3 activity affects sorafenib-and sunitinib-induced cell growth inhibition in HaCaT cells by WST-8 assay. Stattic enhanced the cell-growth inhibitory and apoptotic effects of sorafenib and sunitinib. HaCaT cells transfected with constitutively-active STAT3 (STAT3C) were resistant to the sorafenib-and sunitinib-induced cell growth inhibition. STAT3 activity decreased after short-term treatment with sorafenib and sunitinib in a dose-dependent manner and recovered after long-term treatment with sorafenib and sunitinib at low doses. Moreover, the expression of survivin and bcl-2 decreased after treatment with sorafenib and sunitinib was concomitant with variations in STAT3 activity. Sorafenib-induced STAT3 inhibition was mediated by regulation via MAPK pathways in HaCaT cells, while sunitinib-induced STAT3 inhibition was not. Thus, STAT3 activation mediating apoptosis suppressors may be a key factor in sorafenib and sunitinib-induced keratinocyte cytotoxicity.	[Yamamoto, Kazuhiro; Uda, Atsushi; Mukai, Akira; Yamashita, Kazuhiko; Kume, Manabu; Makimoto, Hiroo; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori] Kobe Univ Hosp, Dept Pharm, Kobe, Hyogo, Japan; [Mizumoto, Atsushi; Nishimura, Kohji; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori] Kobe Univ, Grad Sch Med, Div Pharmacokinet, Kobe, Hyogo 657, Japan; [Bito, Toshinori; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Div Dermatol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University	Yamamoto, K (corresponding author), Kobe Univ Hosp, Dept Pharm, Kobe, Hyogo, Japan.	yamakz@med.kobe-u.ac.jp	HIRAI, Midori/GYR-2866-2022		Nakatomi Foundation; JSPS KAKENHI [24790156]; Grants-in-Aid for Scientific Research [26860104] Funding Source: KAKEN	Nakatomi Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research grant from The Nakatomi Foundation and JSPS KAKENHI (Grant Number 24790156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Bai LF, 2012, INT J CANCER, V130, P2693, DOI 10.1002/ijc.26303; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Calvo E, 2013, CANCER TREAT REV, V39, P366, DOI 10.1016/j.ctrv.2012.06.010; Carlo-Stella C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061603; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Coriat R, 2012, MOL CANCER THER, V11, P2284, DOI 10.1158/1535-7163.MCT-12-0093; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Degen A, 2010, J DTSCH DERMATOL GES, V8, P652, DOI 10.1111/j.1610-0387.2010.07449.x; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fortugno P, 2002, J CELL SCI, V115, P575; Fournier Christa, 2010, Dermatol Online J, V16, P17; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Iijima M, 2011, J DERMATOL, V38, P261, DOI 10.1111/j.1346-8138.2010.01059.x; Lacouture ME, 2008, ONCOLOGIST, V13, P1001, DOI 10.1634/theoncologist.2008-0131; Larkin J, 2013, EXPERT OPIN PHARMACO, V14, P27, DOI 10.1517/14656566.2013.758713; Lee WJ, 2009, BRIT J DERMATOL, V161, P1045, DOI 10.1111/j.1365-2133.2009.09290.x; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Marconi A, 2007, STEM CELLS, V25, P149, DOI 10.1634/stemcells.2006-0165; McLellan B, 2011, DERMATOL THER, V24, P396, DOI 10.1111/j.1529-8019.2011.01435.x; Park GB, 2014, INT J ONCOL, V44, P977, DOI 10.3892/ijo.2014.2252; Poprach A, 2012, ANN ONCOL, V23, P3137, DOI 10.1093/annonc/mds145; Quadros MRD, 2004, CANCER RES, V64, P3934, DOI 10.1158/0008-5472.CAN-04-0214; Rainer PP, 2012, BJU INT, V110, P1455, DOI 10.1111/j.1464-410X.2012.11134.x; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sen N, 2012, P NATL ACAD SCI USA, V109, P600, DOI 10.1073/pnas.1114232109; Sonpavde G, 2012, EUR UROL, V61, P307, DOI 10.1016/j.eururo.2011.10.032; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Tarutani M, 2013, J DERMATOL SCI, V72, P110, DOI 10.1016/j.jdermsci.2013.06.007; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yamamoto K, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-83; Yang CH, 2010, EXPERT OPIN DRUG SAF, V9, P459, DOI 10.1517/14740331003596349; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	39	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102110	10.1371/journal.pone.0102110	http://dx.doi.org/10.1371/journal.pone.0102110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013907	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400066
J	Agam, Y; Vangel, M; Roffman, JL; Gallagher, PJ; Chaponis, J; Haddad, S; Goff, DC; Greenberg, JL; Wilhelm, S; Smoller, JW; Manoach, DS				Agam, Yigal; Vangel, Mark; Roffman, Joshua L.; Gallagher, Patience J.; Chaponis, Jonathan; Haddad, Stephen; Goff, Donald C.; Greenberg, Jennifer L.; Wilhelm, Sabine; Smoller, Jordan W.; Manoach, Dara S.			Dissociable Genetic Contributions to Error Processing: A Multimodal Neuroimaging Study	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE SCALE; DOPAMINE-D4 RECEPTOR GENE; SURFACE-BASED ANALYSIS; ANTERIOR CINGULATE; COMMON MUTATION; CEREBRAL-CORTEX; POLYMORPHISM; BRAIN; ASSOCIATION; NEURONS	Background: Neuroimaging studies reliably identify two markers of error commission: the error-related negativity (ERN), an event-related potential, and functional MRI activation of the dorsal anterior cingulate cortex (dACC). While theorized to reflect the same neural process, recent evidence suggests that the ERN arises from the posterior cingulate cortex not the dACC. Here, we tested the hypothesis that these two error markers also have different genetic mediation. Methods: We measured both error markers in a sample of 92 comprised of healthy individuals and those with diagnoses of schizophrenia, obsessive-compulsive disorder or autism spectrum disorder. Participants performed the same task during functional MRI and simultaneously acquired magnetoencephalography and electroencephalography. We examined the mediation of the error markers by two single nucleotide polymorphisms: dopamine D4 receptor (DRD4) C-521T (rs1800955), which has been associated with the ERN and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133), which has been associated with error-related dACC activation. We then compared the effects of each polymorphism on the two error markers modeled as a bivariate response. Results: We replicated our previous report of a posterior cingulate source of the ERN in healthy participants in the schizophrenia and obsessive-compulsive disorder groups. The effect of genotype on error markers did not differ significantly by diagnostic group. DRD4 C-521T allele load had a significant linear effect on ERN amplitude, but not on dACC activation, and this difference was significant. MTHFR C677T allele load had a significant linear effect on dACC activation but not ERN amplitude, but the difference in effects on the two error markers was not significant. Conclusions: DRD4 C-521T, but not MTHFR C677T, had a significant differential effect on two canonical error markers. Together with the anatomical dissociation between the ERN and error-related dACC activation, these findings suggest that these error markers have different neural and genetic mediation.	[Agam, Yigal; Roffman, Joshua L.; Goff, Donald C.; Greenberg, Jennifer L.; Wilhelm, Sabine; Smoller, Jordan W.; Manoach, Dara S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Agam, Yigal; Vangel, Mark; Manoach, Dara S.] Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Gallagher, Patience J.; Chaponis, Jonathan; Haddad, Stephen; Smoller, Jordan W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Manoach, DS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	dara@nmr.mgh.harvard.edu	Roffman, Joshua/G-8228-2012	Roffman, Joshua/0000-0003-4073-532X	NIH [F32 MH088081, K24MH094614, R01 MH67720]; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH094614, F32MH088081, R01MH067720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by NIH grants F32 MH088081 (YA); K24MH094614 (JWS); and R01 MH67720 (DSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2011, P NATL ACAD SCI USA, V108, P17556, DOI 10.1073/pnas.1103475108; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Althaus M, 2010, BIOL PSYCHOL, V85, P19, DOI 10.1016/j.biopsycho.2010.04.007; Althaus M, 2009, CLIN NEUROPHYSIOL, V120, P93, DOI 10.1016/j.clinph.2008.10.012; Anokhin AP, 2008, PSYCHOPHYSIOLOGY, V45, P524, DOI 10.1111/j.1469-8986.2008.00664.x; Belopolsky AV, 2006, BRAIN RES, V1081, P171, DOI 10.1016/j.brainres.2006.01.082; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Biehl SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028396; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Bruijn ERA, 2006, BRAIN RES, V1105, P122, DOI 10.1016/j.brainres.2006.01.006; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Endrass T, 2005, J PSYCHOPHYSIOL, V19, P275, DOI 10.1027/0269-8803.19.4.275; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Frank MJ, 2007, COGN AFFECT BEHAV NE, V7, P297, DOI 10.3758/CABN.7.4.297; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GOLDMANRAKIC PS, 1989, P NATL ACAD SCI USA, V86, P9015, DOI 10.1073/pnas.86.22.9015; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamalainen MS, 1984, TKKFA559 U TECHN DEP; Heilbronner SR, 2013, NEURON, V80, P1384, DOI 10.1016/j.neuron.2013.09.028; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito J, 2006, J GERIATR PSYCH NEUR, V19, P46, DOI 10.1177/0891988705284716; Kereszturi E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-18; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lord C., 1999, AUTISM DIAGNOSTIC OB; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Manoach DS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00350; Meyer A, 2012, GENES BRAIN BEHAV, V11, P695, DOI 10.1111/j.1601-183X.2012.00812.x; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller MW, 2009, CINGULATE NEUROBIOLO, P163; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Okuyama Y, 1999, BIOCHEM BIOPH RES CO, V258, P292, DOI 10.1006/bbrc.1999.0630; Osinsky R, 2012, BRAIN RES, V1452, P108, DOI 10.1016/j.brainres.2012.02.054; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Purcell S, 2007, AM J HUM GENET, P81; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; ROFFMAN JL, 2008, AM J MED GENET B; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Roffman JL, 2008, BIOL PSYCHIAT, V63, P42, DOI 10.1016/j.biopsych.2006.12.017; Roffman JL, 2007, SCHIZOPHR RES, V92, P181, DOI 10.1016/j.schres.2007.01.003; Roffman JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025253; Roffman JL, 2011, BRAIN IMAGING BEHAV, V5, P65, DOI 10.1007/s11682-010-9111-2; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Rutter M, 2003, SOCIAL COMMUNICATION; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Taulu S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1935742; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004898, 10.1371/journal.pone.0006453]; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wittfoth M, 2008, BRAIN RES, V1194, P118, DOI 10.1016/j.brainres.2007.11.067; Xing QH, 2003, SCHIZOPHR RES, V65, P9, DOI 10.1016/S0920-9964(03)00064-1; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	74	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101784	10.1371/journal.pone.0101784	http://dx.doi.org/10.1371/journal.pone.0101784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010186	Green Published, gold			2022-12-27	WOS:000338763800038
J	Mendez, JC; Perez, O; Prado, L; Merchant, H				Carlos Mendez, Juan; Perez, Oswaldo; Prado, Luis; Merchant, Hugo			Linking Perception, Cognition, and Action: Psychophysical Observations and Neural Network Modelling	PLOS ONE			English	Article							DECISION-MAKING; MOVEMENT PREPARATION; PREMOTOR CORTEX; WORKING-MEMORY; RESPONSE COMPETITION; REACHING MOVEMENTS; PREFRONTAL CORTEX; PARIETAL CORTEX; MEASURING TIME; ARM MOVEMENTS	It has been argued that perception, decision making, and movement planning are in reality tightly interwoven brain processes. However, how they are implemented in neural circuits is still a matter of debate. We tested human subjects in a temporal categorization task in which intervals had to be categorized as short or long. Subjects communicated their decision by moving a cursor into one of two possible targets, which appeared separated by different angles from trial to trial. Even though there was a 1 second-long delay between interval presentation and decision communication, categorization difficulty affected subjects' performance, reaction (RT) and movement time (MT). In addition, reaction and movement times were also influenced by the distance between the targets. This implies that not only perceptual, but also movement-related considerations were incorporated into the decision process. Therefore, we searched for a model that could use categorization difficulty and target separation to describe subjects' performance, RT, and MT. We developed a network consisting of two mutually inhibiting neural populations, each tuned to one of the possible categories and composed of an accumulation and a memory node. This network sequentially acquired interval information, maintained it in working memory and was then attracted to one of two possible states, corresponding to a categorical decision. It faithfully replicated subjects' RT and MT as a function of categorization difficulty and target distance; it also replicated performance as a function of categorization difficulty. Furthermore, this model was used to make new predictions about the effect of untested durations, target distances and delay durations. To our knowledge, this is the first biologically plausible model that has been proposed to account for decision making and communication by integrating both sensory and motor planning information.	[Carlos Mendez, Juan; Perez, Oswaldo; Prado, Luis; Merchant, Hugo] UNAM, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Merchant, H (corresponding author), UNAM, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico.	hugomerchant@unam.mx	Merchant, Hugo/E-8703-2019	Merchant, Hugo/0000-0002-3488-9501; Perez, Oswaldo/0000-0002-1888-7434; Mendez Nunez, Juan Carlos/0000-0002-7251-0750	Consejo Nacional de Ciencia y Tecnologia [151223]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN201214-25]; Consejo Nacional de Ciencia y Tecnologia scholarship [244466]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Consejo Nacional de Ciencia y Tecnologia scholarship	Supported by Consejo Nacional de Ciencia y Tecnologia (151223) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (IN201214-25) grants to H. M., and Consejo Nacional de Ciencia y Tecnologia scholarship 244466 to J.C.M. This work is part of the Doctoral Thesis of Juan Carlos Mendez - Programa de Doctorado en Ciencias Biomedicas - Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrouillet P, 2011, J EXP PSYCHOL LEARN, V37, P1302, DOI 10.1037/a0022933; Bartolo R, 2014, J NEUROSCI, V34, P3910, DOI 10.1523/JNEUROSCI.2679-13.2014; Bastian A, 2003, EUR J NEUROSCI, V18, P2047, DOI 10.1046/j.1460-9568.2003.02906.x; Bock O, 2000, BEHAV BRAIN RES, V108, P85, DOI 10.1016/S0166-4328(99)00134-5; BOCK O, 1992, EXP BRAIN RES, V90, P209; Bongers RM, 2010, NEUROSCI LETT, V469, P189, DOI 10.1016/j.neulet.2009.11.072; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Mendez JC, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00050; Chang SWC, 2004, J GEN PSYCHOL, V131, P328; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2007, PROG BRAIN RES, V165, P475, DOI 10.1016/S0079-6123(06)65030-9; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Grent-'t-Jong T, 2014, J NEUROPHYSIOL; Haggard P, 1996, J EXP PSYCHOL HUMAN, V22, P42, DOI 10.1037/0096-1523.22.1.42; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Keri S, 2003, BRAIN RES REV, V43, P85, DOI 10.1016/S0165-0173(03)00204-2; Keulen RF, 2002, J EXP PSYCHOL HUMAN, V28, P515, DOI 10.1037/0096-1523.28.3.515; Lebedev MA, 2008, J NEUROPHYSIOL, V99, P166, DOI 10.1152/jn.00734.2007; Lemus L, 2007, P NATL ACAD SCI USA, V104, P17174, DOI 10.1073/pnas.0707961104; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Martinez-Garcia M, 2011, P NATL ACAD SCI USA, V108, P11626, DOI 10.1073/pnas.1108137108; McDowell K, 2002, EXP BRAIN RES, V144, P303, DOI 10.1007/s00221-002-1046-4; Merchant H, 1997, J NEUROPHYSIOL, V77, P1132, DOI 10.1152/jn.1997.77.3.1132; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2014, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00274; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Merchant H, 2013, J NEUROSCI, V33, P9082, DOI 10.1523/JNEUROSCI.5513-12.2013; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; MIALL RC, 1995, EXP BRAIN RES, V103, P421; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3231, DOI 10.1152/jn.00487.2006; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pastor-Bernier A, 2011, J NEUROSCI, V31, P7083, DOI 10.1523/JNEUROSCI.5681-10.2011; Pellizzer G, 2003, EXP BRAIN RES, V150, P276, DOI 10.1007/s00221-003-1453-1; Perez O, 2013, J NEUROSCI METH, V212, P203, DOI 10.1016/j.jneumeth.2012.10.019; Ponce-Alvarez A, 2012, J NEUROSCI, V32, P11956, DOI 10.1523/JNEUROSCI.6176-11.2012; Portrat S, 2008, J EXP PSYCHOL LEARN, V34, P1561, DOI 10.1037/a0013356; Praamstra P, 2009, J NEUROPHYSIOL, V102, P2084, DOI 10.1152/jn.00413.2009; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rao SM, 1997, J NEUROSCI, V17, P5528; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; ROMO R, 1993, J NEUROPHYSIOL, V70, P2690, DOI 10.1152/jn.1993.70.6.2690; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 1996, NEUROREPORT, V7, P1273, DOI 10.1097/00001756-199605170-00011; Schneider BA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001413; Smyrnis N, 2000, EXP BRAIN RES, V134, P21, DOI 10.1007/s002210000416; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; Van Thiel E, 1998, Motor Control, V2, P331; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Welsh TN, 1999, EXP BRAIN RES, V127, P207, DOI 10.1007/s002210050790; WOLPERT DM, 1994, EXP BRAIN RES, V98, P153; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460	60	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102553	10.1371/journal.pone.0102553	http://dx.doi.org/10.1371/journal.pone.0102553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029193	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600083
J	Gohler, A; Hetzer, A; Holtfreter, B; Geisel, MH; Schmidt, CO; Steinmetz, I; Kocher, T				Goehler, Andre; Hetzer, Adrian; Holtfreter, Birte; Geisel, Marie Henrike; Schmidt, Carsten Oliver; Steinmetz, Ivo; Kocher, Thomas			Quantitative Molecular Detection of Putative Periodontal Pathogens in Clinically Healthy and Periodontally Diseased Subjects	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; RIBOSOMAL-RNA GENES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; METHANOGENIC ARCHAEA; BACTERIAL PATHOGENS; INFECTIONS; MICROBIOTA; POPULATION	Periodontitis is a multi-microbial oral infection with high prevalence among adults. Putative oral pathogens are commonly found in periodontally diseased individuals. However, these organisms can be also detected in the oral cavity of healthy subjects. This leads to the hypothesis, that alterations in the proportion of these organisms relative to the total amount of oral microorganisms, namely their abundance, rather than their simple presence might be important in the transition from health to disease. Therefore, we developed a quantitative molecular method to determine the abundance of various oral microorganisms and the portion of bacterial and archaeal nucleic acid relative to the total nucleic acid extracted from individual samples. We applied quantitative real-time PCRs targeting single-copy genes of periodontal bacteria and 16S-rRNA genes of Bacteria and Archaea. Testing tongue scrapings of 88 matched pairs of periodontally diseased and healthy subjects revealed a significantly higher abundance of P. gingivalis and a higher total bacterial abundance in diseased subjects. In fully adjusted models the risk of being periodontally diseased was significantly higher in subjects with high P. gingivalis and total bacterial abundance. Interestingly, we found that moderate abundances of A. actinomycetemcomitans were associated with reduced risk for periodontal disease compared to subjects with low abundances, whereas for high abundances, this protective effect leveled off. Moderate archaeal abundances were health associated compared to subjects with low abundances. In conclusion, our methodological approach unraveled associations of the oral flora with periodontal disease, which would have gone undetected if only qualitative data had been determined.	[Goehler, Andre; Hetzer, Adrian; Steinmetz, Ivo] Ernst Moritz Arndt Univ Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany; [Holtfreter, Birte; Geisel, Marie Henrike; Kocher, Thomas] Ernst Moritz Arndt Univ Greifswald, Univ Med, Sch Dent, Unit Periodontol, Greifswald, Germany; [Geisel, Marie Henrike] Univ Duisburg Essen, Univ Hosp Essen, IMIBE, Essen, Germany; [Schmidt, Carsten Oliver] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Sect Methods Community Med, Univ Med Greifswald, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Friedrich Loeffler Institute; Ernst Moritz Arndt Universitat Greifswald; University of Duisburg Essen; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School	Steinmetz, I (corresponding author), Ernst Moritz Arndt Univ Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany.	steinmetz.ivo@uni-greifswald.de; kocher@uni-greifswald.de	Goehler, André/AAZ-7067-2020; Schmidt, Carsten Oliver/AAH-2778-2019	Goehler, André/0000-0002-4006-3511; Schmidt, Carsten Oliver/0000-0001-5266-9396; Steinmetz, Ivo/0000-0003-0510-7336	Federal Ministry of Education and Research [ZZ9603, 01ZZ0103, 01ZZ0701, 0313801O]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; GABA International, Switzerland	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; GABA International, Switzerland	SHIP is part of the Community Medicine Research net (CMR) of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grant no. ZZ9603, 01ZZ0103, 01ZZ0701) and the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania (http://www.community-medicine.de). Microbial analysis, A. H. and A. G were supported by grant no 0313801O (Federal Ministry of Education and Research) to T. K. and I. S. B. H. was supported by an unlimited educational grant by GABA International, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammann TW, 2012, J PERIODONTAL RES; Ardila Carlos M, 2012, J Indian Soc Periodontol, V16, P65, DOI [10.4103/0972-124x.94607, 10.4103/0972-124X.94607]; Asikainen Sirkka, 2008, P1; Bandhaya P, 2012, J CLIN PERIODONTOL, V39, P519, DOI 10.1111/j.1600-051X.2012.01871.x; Beck JD, 1999, AM HEART J, V138, pS528, DOI 10.1016/S0002-8703(99)70293-0; Beikler T, 2004, J CLIN PERIODONTOL, V31, P777, DOI 10.1111/j.1600-051X.2004.00557.x; Beikler T, 2006, J PERIODONTOL, V77, P1323, DOI 10.1902/jop.2006.050204; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conrads G, 2002, INT J SYST EVOL MICR, V52, P493, DOI 10.1099/00207713-52-2-493; D'Ercole S, 2008, CRIT REV MICROBIOL, V34, P33, DOI [10.1080/10408410701693317, 10.1080/10408410701693317 ]; Do Nascimento C, 2008, Minerva Stomatol, V57, P561; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Eick S, 2013, CLIN ORAL INVEST, V17, P79, DOI 10.1007/s00784-012-0696-2; Gmur R, 1999, EUR J ORAL SCI, V107, P225, DOI 10.1046/j.0909-8836...x; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Hujoel P, 2013, EUR J ORAL SCI, V121, P2, DOI 10.1111/eos.12011; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; KEIL U, 1988, ACTA MED SCAND, P119; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kilian M, 2006, PERIODONTOL 2000, V42, P158, DOI 10.1111/j.1600-0757.2006.00159.x; Kingman A, 2008, J CLIN PERIODONTOL, V35, P659, DOI 10.1111/j.1600-051X.2008.01243.x; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Lee HJ, 2012, CURR MICROBIOL; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; LOESCHE WJ, 1992, J CLIN MICROBIOL, V30, P427, DOI 10.1128/JCM.30.2.427-433.1992; Mager DL, 2003, J CLIN PERIODONTOL, V30, P1031, DOI 10.1046/j.0303-6979.2003.00418.x; Matarazzo F, 2012, CLIN MICROBIOL INFEC, V18, P834, DOI 10.1111/j.1469-0691.2012.03958.x; Matarazzo F, 2011, J CLIN PERIODONTOL, V38, P621, DOI 10.1111/j.1600-051X.2011.01734.x; Morikawa M, 2008, J PERIODONTAL RES, V43, P268, DOI 10.1111/j.1600-0765.2007.01025.x; Morillo JM, 2004, J CLIN PERIODONTOL, V31, P1054, DOI [10.1111/j.1600-051x.2004.00608.x, 10.1111/j.1600-051X.2004.00608.x]; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; POULSEN K, 1994, MICROBIOL-UK, V140, P2049, DOI 10.1099/13500872-140-8-2049; Quirynen M, 2001, J CLIN PERIODONTOL, V28, P499, DOI 10.1034/j.1600-051x.2001.028006499.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rylev M, 2008, J CLIN PERIODONTOL, V35, P346, DOI 10.1111/j.1600-051X.2008.01280.x; Sanz M, 2004, J CLIN PERIODONTOL, V31, P1034, DOI 10.1111/j.1600-051X.2004.00609.x; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stingu CS, 2012, QUINTESSENCE INT, V43, pE23; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Suzuki N, 2004, J CLIN MICROBIOL, V42, P3827, DOI 10.1128/JCM.42.8.3827-3830.2004; Suzuki N, 2005, CLIN MED RES, V3, P176, DOI 10.3121/cmr.3.3.176; Tanner ACR, 2006, J DENT RES, V85, P318, DOI 10.1177/154405910608500407; Torrungruang K, 2009, J PERIODONTOL, V80, P122, DOI [10.1902/jop.2009.080248, 10.1902/jop.2009.080248 ]; Vianna ME, 2008, J BACTERIOL, V190, P3779, DOI 10.1128/JB.01861-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Yoshida A, 2003, J CLIN MICROBIOL, V41, P863, DOI 10.1128/JCM.41.2.863-866.2003; Yoshida Y, 2003, ORAL MICROBIOL IMMUN, V18, P135, DOI 10.1034/j.1399-302X.2003.00034.x; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e99244	10.1371/journal.pone.0099244	http://dx.doi.org/10.1371/journal.pone.0099244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029268	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600004
J	Roscher, C; Schumacher, J; Gerighausen, U; Schmid, B				Roscher, Christiane; Schumacher, Jens; Gerighausen, Uta; Schmid, Bernhard			Different Assembly Processes Drive Shifts in Species and Functional Composition in Experimental Grasslands Varying in Sown Diversity and Community History	PLOS ONE			English	Article							TRAIT CONVERGENCE; PLANT-COMMUNITIES; DIVERGENCE; BIODIVERSITY; MECHANISMS; RICHNESS; INVASION; SIMILARITY; FRAMEWORK; PATTERNS	Background: The prevalence of different biotic processes (limiting similarity, weaker competitor exclusion) and historical contingency due to priority effects are in the focus of ongoing discussions about community assembly and non-random functional trait distributions. Methodology/Principal Findings: We experimentally manipulated assembly history in a grassland biodiversity experiment (Jena Experiment) by applying two factorially crossed split-plot treatments to all communities: (i) duration of weeding (never weeded since sowing or cessation of weeding after 3 or 6 years); (ii) seed addition (control vs. seed addition 4 years after sowing). Spontaneous colonization of new species in the control treatment without seed addition increased realized species richness and functional richness (FRic), indicating continuously denser packing of niches. Seed addition resulted in forced colonization and increased realized species richness, FRic, functional evenness (FEve) and functional divergence (FDiv), i. e. higher abundances of species with extreme trait values. Furthermore, the colonization of new species led to a decline in FEve through time, suggesting that weaker competitors were reduced in abundance or excluded. Communities with higher initial species richness or with longer time since cessation of weeding were more restricted in the entry of new species and showed smaller increases in FRic after seed addition than other communities. The two assembly-history treatments caused a divergence of species compositions within communities originally established with the same species. Communities originally established with different species converged in species richness and functional trait composition over time, but remained more distinct in species composition. Conclusions/Significance: Contrasting biotic processes (limiting similarity, weaker competitor exclusion) increase functional convergence between communities initially established with different species. Historical contingency with regard to realized species compositions could not be eradicated by cessation of weeding or forced colonization and was still detectable 5 years after application of these treatments, providing evidence for the role of priority effects in community assembly.	[Roscher, Christiane] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany; [Gerighausen, Uta] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Bernhard] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; Max Planck Society; University of Zurich; University of Zurich	Roscher, C (corresponding author), UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	christiane.roscher@ufz.de	Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214	German Science Foundation [FOR 456, RO2397/3]; Max Planck Society; Friedrich Schiller University of Jena; Swiss National Science Foundation [310030E-131193]	German Science Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Friedrich Schiller University of Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the German Science Foundation (FOR 456 and RO2397/3) with additional support from the Max Planck Society and the Friedrich Schiller University of Jena. BS was additionally supported by the Swiss National Science Foundation (310030E-131193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2013, ECOLOGY, V94, P465, DOI 10.1890/11-2279.1; Bernard-Verdier M, 2012, J ECOL, V100, P1422, DOI 10.1111/1365-2745.12003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cadotte MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019363; CAILLIEZ F, 1983, PSYCHOMETRIKA, V48, P305, DOI 10.1007/BF02294026; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; de Bello F, 2009, J VEG SCI, V20, P475, DOI 10.1111/j.1654-1103.2009.01042.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Ellenberg H., 1988, VEGETATION ECOLOGY C; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gerhold P, 2013, J VEG SCI, V24, P843, DOI 10.1111/jvs.12052; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hubbell Stephen P., 2001, V32, pi; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S, 2003, SCHRREIHE VEGKD, V38, P1; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Laliberte E, 2010, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MCCUNE B., 1997, PC ORD MULTIVARIATE; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Pinheiro J., 2019, NLME LINEAR NONLINEA; Price JN, 2014, FUNCT ECOL, V28, P509, DOI 10.1111/1365-2435.12186; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2009, OIKOS, V118, P1425; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Roscher C, 2013, BASIC APPL ECOL, V14, P187, DOI 10.1016/j.baae.2013.01.003; Rothmaler R, 2005, EXKURSIONSFLORA DEUT, V4; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051	52	19	19	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101928	10.1371/journal.pone.0101928	http://dx.doi.org/10.1371/journal.pone.0101928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029105	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600026
J	Chen, CH; Huang, CC; Liao, DL				Chen, Chia-Hsiang; Huang, Chia-Chun; Liao, Ding-Lieh			Association Analysis of GABRB3 Promoter Variants with Heroin Dependence	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; RECEPTOR BETA-3 SUBUNIT; D-2 DOPAMINE-RECEPTOR; GABA(A) RECEPTORS; DRUG-ABUSE; GENES; ADDICTION; NEURONS; RELAPSE; SEEKING	GABRB3 encoding the beta 3 subunit of GABAA receptor has been implicated in multiple neuropsychiatric disorders, including substance abuse. Previous studies reported that SNPs at the 5' regulatory region of GABRB3 could regulate GABRB3 gene expression and associated with childhood absence epilepsy (CAE). The study aimed to investigate whether SNPs at the 5' regulatory region of GABRB3 were associated with heroin dependence in our population. We first re-sequenced 1.5 kb of the 5' regulatory region of GABRB3 gene to examine the SNP profile in the genomic DNA of 365 control subjects. Then, we conducted a case-control association analysis between 576 subjects with heroin dependence (549 males, 27 females) and 886 controls (472 males, 414 females) by genotyping the rs4906902 as a tag SNP. We also conducted a reporter gene assay to assess the promoter activity of two major haplotypes derived from SNPs at this region. We detected 3 common SNPs (rs4906902, rs8179184 and rs20317) at this region that had strong pair-wise linkage disequilibrium. The C allele of rs4906902 was found to be associated with increased risk of heroin dependence (odds ratio: 1.27, p = 0.002). Two major haplotypes (C-A-G and T-G-C) derived from these 3 SNPs accounted for 99% of this sample, and reporter gene activity assay showed that haplotype C-A-G that contained the C allele of the tag SNP rs4906902 had higher activity than haplotype T-G-C. Our data suggest that GABRB3 might be associated with heroin dependence, and increased expression of GABRB3 might contribute to the pathogenesis of heroin dependence.	[Chen, Chia-Hsiang] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Dept & Grad Inst Biomed Sci, Taoyuan, Taiwan; [Huang, Chia-Chun] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liao, Ding-Lieh] Bali Psychiat Ctr, Dept Hlth, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Tzu Chi University	Chen, CH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan.	cchen3801@gmail.com		Chen, Chia-Hsiang/0000-0002-8232-2403	National Health Research Institutes, Taiwan; National Science Council, Taiwan	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by an intramural grant from the National Health Research Institutes, Taiwan, and a grant from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Conner BT, 2010, J SUBST ABUSE TREAT, V38, P178, DOI 10.1016/j.jsat.2009.07.004; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Janssen MJ, 2009, J NEUROSCI, V29, P5116, DOI 10.1523/JNEUROSCI.4737-08.2009; Lachance-Touchette P, 2010, EPILEPSIA, V51, P1894, DOI 10.1111/j.1528-1167.2010.02642.x; Levran O, 2009, GENES BRAIN BEHAV, V8, P531, DOI 10.1111/j.1601-183X.2009.00501.x; Liao HM, 2012, SCHIZOPHR RES, V139, P229, DOI 10.1016/j.schres.2012.05.015; Loh EW, 2007, AM J MED GENET B, V144B, P439, DOI 10.1002/ajmg.b.30429; Maria SS, 2007, NEUROPHARMACOLOGY, V52, P1555, DOI 10.1016/j.neuropharm.2007.02.012; Mark TL, 2001, DRUG ALCOHOL DEPEN, V61, P195, DOI 10.1016/S0376-8716(00)00162-9; Noble EP, 1998, PSYCHIAT RES, V81, P133, DOI 10.1016/S0165-1781(98)00084-5; Parker JG, 2011, J NEUROSCI, V31, P17103, DOI 10.1523/JNEUROSCI.1715-11.2011; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simon EW, 2010, AM J MED GENET B, V153B, P463, DOI 10.1002/ajmg.b.31000; Smith KR, 2012, J NEUROSCI, V32, P2485, DOI 10.1523/JNEUROSCI.1622-11.2011; Song JZ, 2003, AM J MED GENET B, V117B, P39, DOI 10.1002/ajmg.b.10022; Sutcliffe JS, 2003, J AM ACAD CHILD PSY, V42, P253, DOI 10.1097/00004583-200302000-00021; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Tanaka M, 2012, EPILEPSIA, V53, P1450, DOI 10.1111/j.1528-1167.2012.03572.x; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Urak L, 2006, HUM MOL GENET, V15, P2533, DOI 10.1093/hmg/ddl174; Van den Oever MC, 2010, NEUROPSYCHOPHARMACOL, V35, P2120, DOI 10.1038/npp.2010.90; Vlachou S, 2010, ADV PHARMACOL, V58, P315, DOI 10.1016/S1054-3589(10)58013-X; Vogels A, 2002, GENET COUNSEL, V13, P385; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wu W, 2012, BIOCHEM BIOPH RES CO, V422, P91, DOI 10.1016/j.bbrc.2012.04.112; Young RMD, 2004, PSYCHIAT RES, V127, P171, DOI 10.1016/j.psychres.2003.11.004	30	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102227	10.1371/journal.pone.0102227	http://dx.doi.org/10.1371/journal.pone.0102227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025424	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400053
J	Jin, HK; Xie, XX; Wang, H; Hu, J; Liu, F; Liu, ZG; Zhou, JM; Zhang, YY; Xi, XP; Hu, BQ; Liao, YP; Tang, JT				Jin, Hekun; Xie, Xiaoxue; Wang, Hui; Hu, Jun; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Zhang, Yingying; Xi, Xuping; Hu, Bingqiang; Liao, Yuping; Tang, Jingtian			ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma	PLOS ONE			English	Article							REPAIR GENE POLYMORPHISMS; CELL LUNG-CANCER; CISPLATIN-BASED CHEMOTHERAPY; PLATINUM-BASED CHEMOTHERAPY; IONIZING-RADIATION SENSITIVITY; ACID SUBSTITUTION VARIANTS; DNA-REPAIR; CHROMOSOMAL-ABERRATIONS; PROGNOSTIC-SIGNIFICANCE; PROTEIN EXPRESSION	Background: Single nucleotide polymorphisms (SNPs) in DNA repair genes can alter gene expression and activity and affect response to cancer treatment and, correspondingly, survival. The present study was designed to evaluate the utility of the XRCC1 Arg399Gln and ERCC1 Cys8092Ala SNPs, measured in pretreatment biopsy samples, as predictors of response to radiotherapy in patients with non-metastatic nasopharyngeal carcinoma (NPC). Materials and methods: The study included 75 consecutive patients with stage II-IVA-B NPC. XRCC1 Arg399Glu and ERCC1 Cys8092Ala SNPs were identified from paraffin-embedded biopsy specimens via Sanger sequencing. Expression of p53 and pAkt protein was analyzed by immunohistochemical staining. Potential relationships between genetic polymorphisms and progression-free survival (PFS) were analyzed by using a Cox proportional hazards model, the Kaplan-Meier method, and the log-rank test. Results: Multivariate analysis showed that carriers of the ERCC1 8092 Ala/Ala genotype [hazard ratio (HR) 1.882; 95% confidence interval (CI) 1.031-3.438; P = 0.039] and heavy smokers (>= 20 pack-years) carrying the XRCC1 Arg/Arg genotype (HR 2.019; 95% CI 1.010-4.036; P = 0.047) had significantly lower PFS rates. Moreover, combined positive expression of p53 and pAkt led to significantly increased PFS in subgroups carrying the XRCC1 Gln allele (HR 7.057; 95% CI 2.073-24.021; P = 0.002) or the ERCC1 Cys allele (HR 2.568; 95% CI 1.056-6.248; P = 0.038). Conclusions: The ERCC1 Cys8092Ala polymorphism is an independent predictor of response to radiotherapy for NPC, and the XRCC1 Arg399Glu mutation combined with smoking status seems to predict PFS as well. Our results further suggest a possible correlation between these genetic polymorphisms and p53 protein status on survival.	[Jin, Hekun; Zhang, Yingying; Liao, Yuping] Cent S Univ, Xiangya Hosp, Dept Radiat Oncol, Changsha, Hunan, Peoples R China; [Xie, Xiaoxue; Wang, Hui; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Xi, Xuping; Hu, Bingqiang] Cent S Univ, Dept Radiat Oncol, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Xie, Xiaoxue; Wang, Hui; Hu, Jun; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Xi, Xuping; Hu, Bingqiang] Cent S Univ, Affiliated Tumor Hosp, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Hu, Jun] Cent S Univ, Dept Pathol, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Tang, Jingtian] Tsinghua Univ, Dept Engn Phys, Inst Med Phys & Engn, Key Lab Particle & Radiat Imaging,Minist Educ, Beijing 100084, Peoples R China	Central South University; Central South University; Central South University; Central South University; Tsinghua University	Tang, JT (corresponding author), Tsinghua Univ, Dept Engn Phys, Inst Med Phys & Engn, Key Lab Particle & Radiat Imaging,Minist Educ, Beijing 100084, Peoples R China.	tangjt@mail.tsinghua.edu.cn	tang, jing/HHR-9815-2022		National Natural Science Foundation of China [81301942]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Grant No.:81301942). (URLs: http://www.nsfc.gov.cn/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SZ, 2000, CANCER LETT, V159, P63, DOI 10.1016/S0304-3835(00)00532-2; Angelini S, 2005, MUTAT RES-FUND MOL M, V570, P105, DOI 10.1016/j.mrfmmm.2004.10.007; Chen C, 2013, CANCER CHEMOTH PHARM, V72, P315, DOI 10.1007/s00280-013-2196-8; Chen PC, 2000, CANCER EPIDEM BIOMAR, V9, P843; Erculj N, 2012, ANN ONCOL, V23, P961, DOI 10.1093/annonc/mdr324; Hara A, 2004, ACTA NEUROPATHOL, V108, P43, DOI 10.1007/s00401-004-0860-0; Hu JJ, 2001, CARCINOGENESIS, V22, P917, DOI 10.1093/carcin/22.6.917; Hu JJ, 2002, ENVIRON MOL MUTAGEN, V39, P208, DOI 10.1002/em.10058; Ito H, 2004, CARCINOGENESIS, V25, P1395, DOI 10.1093/carcin/bgh153; Kalikaki A, 2009, CLIN LUNG CANCER, V10, P118, DOI 10.3816/CLC.2009.n.015; Khrunin AV, 2010, PHARMACOGENOMICS J, V10, P54, DOI 10.1038/tpj.2009.45; Kiuru A, 2005, ENVIRON MOL MUTAGEN, V46, P198, DOI 10.1002/em.20155; Lei YC, 2002, MUTAT RES-GEN TOX EN, V519, P93, DOI 10.1016/S1383-5718(02)00127-4; LEVINE AJ, 1992, CANCER SURV, V12, P59; Lunn RM, 1999, CANCER RES, V59, P2557; Ma BBT, 2003, HEAD NECK-J SCI SPEC, V25, P864, DOI 10.1002/hed.10307; Maity A, 1997, INT J RADIAT ONCOL, V37, P639, DOI 10.1016/S0360-3016(96)00598-6; Marintchev A, 2000, NUCLEIC ACIDS RES, V28, P2049, DOI 10.1093/nar/28.10.2049; Masuda M, 1998, HEAD NECK-J SCI SPEC, V20, P640, DOI 10.1002/(SICI)1097-0347(199810)20:7<640::AID-HED11>3.0.CO;2-K; McGurk CJ, 2006, J CELL BIOCHEM, V97, P1121, DOI 10.1002/jcb.20711; McMillan TJ, 2002, BASIC CLIN RADIOBIOL, P71; Monaco R, 2007, PROTEIN J, V26, P541, DOI 10.1007/s10930-007-9095-y; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okuda K, 2011, J SURG RES, V168, P206, DOI 10.1016/j.jss.2009.09.006; Park SY, 2006, MED ONCOL, V23, P489, DOI 10.1385/MO:23:4:489; Pastorelli R, 2002, INT J CANCER, V100, P9, DOI 10.1002/ijc.10463; Quintela-Fandino M, 2006, J CLIN ONCOL, V24, P4333, DOI 10.1200/JCO.2006.05.8768; Salles B, 1999, FOOD CHEM TOXICOL, V37, P1009, DOI 10.1016/S0278-6915(99)00094-0; Shen MR, 1998, CANCER RES, V58, P604; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Takenaka T, 2010, LUNG CANCER, V67, P101, DOI 10.1016/j.lungcan.2009.03.007; Tuimala J, 2004, MUTAT RES-FUND MOL M, V554, P319, DOI 10.1016/j.mrfmmm.2004.05.009; Wang LF, 2006, ACTA OTO-LARYNGOL, V126, P769, DOI 10.1080/00016480500469545; Wang Y, 2011, ONCOL REP, V25, P1047, DOI 10.3892/or.2011.1170; Wei QY, 2000, J NATL CANCER I, V92, P1764; Wei QY, 1998, CANCER EPIDEM BIOMAR, V7, P309; Wilson MD, 2001, ENVIRON MOL MUTAGEN, V38, P209, DOI 10.1002/em.1073; Wu XF, 2008, PHARMACOGENET GENOM, V18, P955, DOI 10.1097/FPC.0b013e32830efdd4; Yang M, 2006, EUR J CANCER PREV, V15, P269, DOI 10.1097/01.cej.0000195709.79696.0c; Yang ZH, 2009, MOL CARCINOGEN, V48, P196, DOI 10.1002/mc.20468; Yin M, 2011, LUNG CANCER, V72, P370, DOI 10.1016/j.lungcan.2010.10.011; Yip WK, 2008, ONCOL REP, V19, P319; Zhou W, 2004, CLIN CANCER RES, V10, P4939, DOI 10.1158/1078-0432.CCR-04-0247; Zhou W, 2003, CANCER EPIDEM BIOMAR, V12, P359; Zipprich Jennifer, 2010, J Carcinog, V9, P4, DOI 10.4103/1477-3163.62535	46	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101256	10.1371/journal.pone.0101256	http://dx.doi.org/10.1371/journal.pone.0101256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025378	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400012
J	Liu, Z; Zhang, GW; Li, J; Liu, JB; Lv, PF				Liu, Zheng; Zhang, Guangwu; Li, Jian; Liu, Jiabang; Lv, Pengfeng			The Tumor-Suppressive MicroRNA-135b Targets c-Myc in Osteoscarcoma	PLOS ONE			English	Article							HUMAN OSTEOSARCOMA; GASTRIC-CANCER; PROSTATE-CANCER; PROTEIN EXPRESSION; BREAST-CANCER; METASTASIS; CELLS; PROGRESSION; PROGNOSIS; PATHWAY	Osteosarcoma is the most common primary tumor of the bone. It leads to many deaths because of its rapid proliferation and metastasis. Recent studies have shown that microRNAs are important gene regulators that are involved in various cancer-related processes. In this study, we found that miR-135b was down-regulated in both osteoscarcoma patient tumor tissues and osteoscarcoma cell lines in comparison to paired adjacent non-tumor bone tissue. We observed that a lower level of miR-135b was associated with metastasis. The ectopic expression of miR-135b markedly suppressed osteoscarcoma cell proliferation, migration, and invasion. Conversely, the inhibition of miR-135b expression dramatically accelerated cell proliferation, migration, and invasion. The forced expression of miR-135b in osteosarcoma cells resulted in a significant reduction in the protein level of c-Myc and repressed the activity of a luciferase reporter that contained the 39-untranslated region of the c-Myc mRNA. These effects were abolished by the mutation of the predicted miR-135b-binding site, which indicates that c-Myc may be a miR-135b target gene. Moreover, the ectopic expression of c-Myc partially reversed the inhibition of cell proliferation and invasion that was caused by miR-135b. These data therefore suggest that miR-135b may function as a tumor suppressor to regulate osteosarcoma cell proliferation and invasion through a mechanism that targets the c-Myc oncogene. These findings indicate that miR-135b may play a role in the pathogenesis of osteosarcoma.	[Liu, Zheng; Zhang, Guangwu; Li, Jian; Liu, Jiabang; Lv, Pengfeng] Peking Univ, Dept Orthoped Surg, Shougang Hosp, Beijing 100871, Peoples R China	Peking University	Liu, Z (corresponding author), Peking Univ, Dept Orthoped Surg, Shougang Hosp, Beijing 100871, Peoples R China.	lz301198@aliyun.com						Akinyeke T, 2013, CARCINOGENESIS, V34, P2823, DOI 10.1093/carcin/bgt307; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Dueck AC, 2013, CLIN CANCER RES, V19, P5798, DOI 10.1158/1078-0432.CCR-13-0558; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Halappanavar S, 2013, J IMMUNOL, V190, P3679, DOI 10.4049/jimmunol.1202456; Huang J, 2009, SCI CHINA SER C, V52, P31, DOI 10.1007/s11427-009-0014-7; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Li K, 2013, CHINESE MED J-PEKING, V126, P82, DOI 10.3760/cma.j.issn.0366-6999.20122477; Li YF, 2013, CELL TISSUE RES, V354, P533, DOI 10.1007/s00441-013-1715-6; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu ZJ, 2013, J MOL CELL BIOL, V5, P280, DOI 10.1093/jmcb/mjt020; Miao J, 2013, TUMOUR BIOL; Nair R, 2013, ONCOGENE; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Pello OM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22984; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Scionti I, 2008, ANN ONCOL, V19, P1500, DOI 10.1093/annonc/mdn148; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Thayanithy V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043720; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Wu WY, 2011, WORLD J GASTROENTERO, V17, P3645, DOI 10.3748/wjg.v17.i31.3645; Wu X, 2012, CANCER EPIDEMIOL, V36, P212, DOI 10.1016/j.canep.2011.08.002; Wu XY, 2013, INT J MED SCI, V10, P676, DOI 10.7150/ijms.5528; Xu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079752; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhang H, 2008, INT J CANCER, V123, P810, DOI 10.1002/ijc.23638; Zhao HE, 2012, INT J MOL MED, V30, P1013, DOI 10.3892/ijmm.2012.1111; Zhao LY, 2012, INT J BIOCHEM CELL B, V44, P2051, DOI 10.1016/j.biocel.2012.08.005; Zheng YY, 2011, CANCER BIOMARK, V10, P71, DOI 10.3233/CBM-2011-0231; Zhou GX, 2013, J INT MED RES, V41, P1, DOI 10.1177/0300060513475959	33	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102621	10.1371/journal.pone.0102621	http://dx.doi.org/10.1371/journal.pone.0102621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025684	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400094
J	Melendez, L; Laiolo, P; Mironov, S; Garcia, M; Magana, O; Jovani, R				Melendez, Leandro; Laiolo, Paola; Mironov, Sergey; Garcia, Monica; Magana, Oscar; Jovani, Roger			Climate-Driven Variation in the Intensity of a Host-Symbiont Animal Interaction along a Broad Elevation Gradient	PLOS ONE			English	Article							FEATHER MITE ABUNDANCE; COMMUNITY RESPONSES; HIGH-ALTITUDE; BIRDS; DIVERSITY; IMPACT; ACARI; TITS; PROCTOPHYLLODIDAE; PARASITISM	Gradients of environmental stress may affect biotic interactions in unpredictable ways responding to climate variation, depending on the abiotic stress tolerance of interacting partners. Here, we study the effect of local climate on the intensity of feather mites in six mountain passerines along a 1400 m elevational gradient characterized by shifting temperature and rainfall. Although obligatory symbionts of warm-blooded organisms are assumed to live in mild and homeothermic environments, those inhabiting external, non-blood-irrigated body portions of the host organism, such as feather mites, are expected to endure exposure to the direct influence of a fluctuating climate. As expected, feather mite intensity declined with elevation in all bird species, a pattern that was also found in cold-adapted passerines that have typical alpine habits. The elevation cline was mainly explained by a positive effect of the average temperature upon mite intensity in five of the six species studied. Precipitation explained less variance in mite intensity than average temperature, and showed a negative correlation in half of the studied species. We found no climate-driven migration of mites along the wings of birds, no replacement of mite species along elevation gradients and no association with available food resources for mites (estimated by the size of the uropygial gland). This study suggests that ectosymbionts of warm-blooded animals may be highly sensitive to climatic variation and become less abundant under stressful environmental conditions, providing empirical evidence of the decline of specialized biotic interactions among animal species at high elevations.	[Melendez, Leandro; Laiolo, Paola; Garcia, Monica; Magana, Oscar] Univ Oviedo, Res Unit Biodivers UO, CSIC, PA, Mieres, Spain; [Jovani, Roger] Estn Biol Donana CSIC, Dept Evolutionary Ecol, Seville, Spain; [Mironov, Sergey] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Jovani, R (corresponding author), Estn Biol Donana CSIC, Dept Evolutionary Ecol, Amer Vespucio S-N, Seville, Spain.	jovani@ebd.csic.es	Laiolo, Paola/Q-3747-2019; Laiolo, Paola/B-6566-2014; Jovani, Roger/C-7080-2013	Laiolo, Paola/0000-0002-2009-6797; Laiolo, Paola/0000-0002-2009-6797; Jovani, Roger/0000-0002-8693-9742	Spanish Ministries of Science and Innovation (Ramon y Cajal research contract) [RYC-2009-03967, CGL2008-02749, CGL2011-28177]; Fundacion Biodiversidad	Spanish Ministries of Science and Innovation (Ramon y Cajal research contract); Fundacion Biodiversidad(European Commission)	Funding was provided by the Spanish Ministries of Science and Innovation (Ramon y Cajal research contract RYC-2009-03967 to RJ; CGL2008-02749 and CGL2011-28177 to PL) and Fundacion Biodiversidad (to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Antoniazzi LR, 2011, J ZOOL, V283, P126, DOI 10.1111/j.1469-7998.2010.00753.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Atyeo W. T., 1966, Bulletin of the University of Nebraska State Museum, V5, P1; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Blanco G, 1997, J AVIAN BIOL, V28, P197, DOI 10.2307/3676970; Blanco G, 2001, J AVIAN BIOL, V32, P271, DOI 10.1111/j.0908-8857.2001.320310.x; Brown CR, 2006, CAN J ZOOL, V84, P1307, DOI 10.1139/Z06-110; CERNY V, 1982, Angewandte Parasitologie, V23, P158; Dabert J, 1999, EXP APPL ACAROL, V23, P437, DOI 10.1023/A:1006180705101; Dubinin V. B., 1951, Fauna USSR Moscow, V6, P1; Fabina NS, 2013, GLOBAL CHANGE BIOL, V19, P3306, DOI 10.1111/gcb.12320; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; GAEDE K, 1987, EXP APPL ACAROL, V3, P45, DOI 10.1007/BF01200412; Galvan I, 2008, J EVOLUTION BIOL, V21, P133, DOI 10.1111/j.1420-9101.2007.01459.x; Galvan I, 2006, IBIS, V148, P687, DOI 10.1111/j.1474-919X.2006.00576.x; Galvan I, 2012, J AVIAN BIOL, V43, P273, DOI 10.1111/j.1600-048X.2012.05686.x; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaud J., 1996, ANN MUSEE ROYAL LAFR, V277, P1; Giauque H, 2013, AM J BOT, V100, P1435, DOI 10.3732/ajb.1200568; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Haribal M, 2011, INT J ACAROL, V37, P75, DOI 10.1080/01647954.2010.495952; Harper DGC, 1999, ANIM BEHAV, V58, P553, DOI 10.1006/anbe.1999.1154; HERR DG, 1986, AM STAT, V40, P265, DOI 10.2307/2684597; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Inouye DW, 2003, TASK VEG SC, V39, P195; Jovani R, 2006, CAN J ZOOL, V84, P729, DOI 10.1139/Z06-042; Jovani R, 2001, ANIM BEHAV, V62, P723, DOI 10.1006/anbe.2001.1814; Jovani R, 2000, ECOSCIENCE, V7, P428, DOI 10.1080/11956860.2000.11682613; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Krantz G., 2009, MANUAL ACAROLOGY; Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x; Laiolo P, 2013, J EVOLUTION BIOL, V26, P2171, DOI 10.1111/jeb.12213; Laiolo P, 2013, OECOLOGIA, V171, P207, DOI 10.1007/s00442-012-2392-y; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Melendez L, 2014, IBIS, V156, P276, DOI 10.1111/ibi.12127; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Merrill RM, 2008, J ANIM ECOL, V77, P145, DOI 10.1111/j.1365-2656.2007.01303.x; Mironov S.V., 2002, Parazitologiya (St. Petersburg), V36, P356; Moya-Larano J, 2012, ADV ECOL RES, V47, P1, DOI 10.1016/B978-0-12-398315-2.00001-6; Moyer BR, 2002, OIKOS, V97, P223, DOI 10.1034/j.1600-0706.2002.970208.x; Newton I, 2010, MIGRATION ECOLOGY BI; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Perez-Tris J, 2002, BIOL J LINN SOC, V76, P481, DOI 10.1046/j.1095-8312.2002.00083.x; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Proctor H, 2000, TRENDS ECOL EVOL, V15, P358, DOI 10.1016/S0169-5347(00)01924-8; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; R Core Team, 2012, R LANG ENV STAT COMP; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Rozsa L, 1997, CAN J ZOOL, V75, P1535, DOI 10.1139/z97-778; Ruotsalainen AL, 2004, OECOLOGIA, V140, P226, DOI 10.1007/s00442-004-1586-3; Sandilands V, 2004, COMP BIOCHEM PHYS A, V137, P217, DOI 10.1016/j.cbpb.2003.10.004; SPIEKSMA FT, 1971, BMJ-BRIT MED J, V1, P82, DOI 10.1136/bmj.1.5740.82; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Thompson CW, 1997, AM NAT, V149, P270, DOI 10.1086/285990; Wiles PR, 2000, CAN J ZOOL, V78, P1397, DOI 10.1139/cjz-78-8-1397	59	25	26	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101942	10.1371/journal.pone.0101942	http://dx.doi.org/10.1371/journal.pone.0101942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025873	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400026
J	Shekar, S; Yeo, ZX; Wong, JCL; Chan, MKL; Ong, DCT; Tongyoo, P; Wong, SY; Lee, ASG				Shekar, Sandhya; Yeo, Zhen Xuan; Wong, Joshua C. L.; Chan, Maurice K. L.; Ong, Danny C. T.; Tongyoo, Pumipat; Wong, Sin-Yew; Lee, Ann S. G.			Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							DRUG-RESISTANCE; DNA FINGERPRINTS; SEQUENCING DATA; SOUTH-AFRICA; MUTATIONS; DIVERSITY; SELECTION; SYNTHASE; COMPLEX; TARGETS	Background: Isoniazid (INH) is a highly effective antibiotic central for the treatment of Mycobacterium tuberculosis (MTB). INH-resistant MTB clinical isolates are frequently mutated in the katG gene and the inhA promoter region, but 10 to 37% of INH-resistant clinical isolates have no detectable alterations in currently known gene targets associated with INH-resistance. We aimed to identify novel genes associated with INH-resistance in these latter isolates. Methodology/Principal Findings: INH-resistant clinical isolates of MTB were pre-screened for mutations in the katG, inhA, kasA and ndh genes and the regulatory regions of inhA and ahpC. Twelve INH-resistant isolates with no mutations, and 17 INH-susceptible MTB isolates were subjected to whole genome sequencing. Phylogenetically related variants and synonymous mutations were excluded and further analysis revealed mutations in 60 genes and 4 intergenic regions associated with INH-resistance. Sanger sequencing verification of 45 genes confirmed that mutations in 40 genes were observed only in INH-resistant isolates and not in INH-susceptible isolates. The ratios of non-synonymous to synonymous mutations (dN/dS ratio) for the INH-resistance associated mutations identified in this study were 1.234 for INH-resistant and 0.654 for INH-susceptible isolates, strongly suggesting that these mutations are indeed associated with INH-resistance. Conclusion: The discovery of novel targets associated with INH-resistance described in this study may potentially be important for the development of improved molecular detection strategies.	[Shekar, Sandhya; Yeo, Zhen Xuan; Wong, Joshua C. L.; Chan, Maurice K. L.; Ong, Danny C. T.; Tongyoo, Pumipat; Lee, Ann S. G.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Wong, Sin-Yew] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Lee, Ann S. G.] Duke NUS Grad Med Sch, Off Clin & Acad Fac Affairs, Singapore, Singapore; [Lee, Ann S. G.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National University of Singapore	Lee, ASG (corresponding author), Natl Canc Ctr, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg		Tongyoo, Pumipat/0000-0002-3274-5475	Biomedical Research Council (BMRC) of Singapore [BMRC 08/1/31/19/584]	Biomedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Biomedical Research Council (BMRC) of Singapore (BMRC 08/1/31/19/584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Chopra T, 2009, METHOD ENZYMOL, V459, P259, DOI 10.1016/S0076-6879(09)04612-6; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Gladki A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-36; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Lee ASG, 1999, ANTIMICROB AGENTS CH, V43, P2087, DOI 10.1128/AAC.43.8.2087; Lee ASG, 2002, J CLIN MICROBIOL, V40, P657, DOI 10.1128/JCM.40.2.657-659.2002; Lee ASG, 2001, ANTIMICROB AGENTS CH, V45, P2157, DOI 10.1128/AAC.45.7.2157-2159.2001; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Miesel L, 1998, J BACTERIOL, V180, P2459, DOI 10.1128/JB.180.9.2459-2467.1998; Motiwala AS, 2010, J INFECT DIS, V201, P881, DOI 10.1086/650999; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Ong DCT, 2010, J CLIN MICROBIOL, V48, P1047, DOI 10.1128/JCM.02036-09; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Rousseau C, 2003, MICROBIOL-SGM, V149, P1837, DOI 10.1099/mic.0.26278-0; Safi H, 2010, ANTIMICROB AGENTS CH, V54, P103, DOI 10.1128/AAC.01288-09; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilson TM, 1996, MOL MICROBIOL, V19, P1025, DOI 10.1046/j.1365-2958.1996.449980.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang CJ, 2013, BIOINFORMATICS, V29, P645, DOI 10.1093/bioinformatics/btt009; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang M, 2005, J CLIN MICROBIOL, V43, P5477, DOI 10.1128/JCM.43.11.5477-5482.2005; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	39	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102383	10.1371/journal.pone.0102383	http://dx.doi.org/10.1371/journal.pone.0102383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025225	Green Submitted, gold, Green Published			2022-12-27	WOS:000339992400069
J	Catalan, A; Simons, CJP; Bustamante, S; Drukker, M; Madrazo, A; de Artaza, MG; Gorostiza, I; van Os, J; Gonzalez-Torres, MA				Catalan, Ana; Simons, Claudia J. P.; Bustamante, Sonia; Drukker, Marjan; Madrazo, Aranzazu; Gonzalez de Artaza, Maider; Gorostiza, Inigo; van Os, Jim; Gonzalez-Torres, Miguel A.			Novel Evidence hat Attributing Affectively Salient Signal to Random Noise Is Associated with Psychosis	PLOS ONE			English	Article							AUDITORY HALLUCINATIONS; SCHIZOPHRENIA; RELIABILITY; INSTRUMENT; FAILURE; RISK; CAPE	We wished to replicate evidence that an experimental paradigm of speech illusions is associated with psychotic experiences. Fifty-four patients with a first episode of psychosis (FEP) and 150 healthy subjects were examined in an experimental paradigm assessing the presence of speech illusion in neutral white noise. Socio-demographic, cognitive function and family history data were collected. The Positive and Negative Syndrome Scale (PANSS) was administered in the patient group and the Structured Interview for Schizotypy-Revised (SIS-R), and the Community Assessment of Psychic Experiences (CAPE) in the control group. Patients had a much higher rate of speech illusions (33.3% versus 8.7%, ORadjusted: 5.1, 95% CI: 2.3-11.5), which was only partly explained by differences in IQ (ORadjusted: 3.4, 95% CI: 1.4-8.3). Differences were particularly marked for signals in random noise that were perceived as affectively salient (ORadjusted: 9.7, 95% CI: 1.8-53.9). Speech illusion tended to be associated with positive symptoms in patients (ORadjusted: 3.3, 95% CI: 0.9-11.6), particularly affectively salient illusions (ORadjusted: 8.3, 95% CI: 0.7-100.3). In controls, speech illusions were not associated with positive schizotypy (ORadjusted: 1.1, 95% CI: 0.3-3.4) or self-reported psychotic experiences (ORadjusted: 1.4, 95% CI: 0.4-4.6). Experimental paradigms indexing the tendency to detect affectively salient signals in noise may be used to identify liability to psychosis.	[Catalan, Ana; Bustamante, Sonia; Gonzalez de Artaza, Maider; Gonzalez-Torres, Miguel A.] Univ Basque Country, Dept Neurosci, Basque Country, Spain; [Catalan, Ana; Bustamante, Sonia; Madrazo, Aranzazu; Gonzalez-Torres, Miguel A.] Basurto Univ Hosp, Dept Psychiat, Bilbao, Spain; [Simons, Claudia J. P.; Drukker, Marjan; van Os, Jim] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, Maastricht, Netherlands; [Simons, Claudia J. P.] GGzE, Eindhoven, Netherlands; [Gorostiza, Inigo] Basurto Univ Hosp, REDISSEC, Res Unit, Bilbao, Spain; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London WC2R 2LS, England	University of Basque Country; Basurto Hospital; Maastricht University; Basurto Hospital; University of London; King's College London	Catalan, A (corresponding author), Univ Basque Country, Dept Neurosci, Basque Country, Spain.	ana.catalanalcantara@gmail.com	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Catalan, Ana/AAL-2224-2020; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019	Catalan, Ana/0000-0002-0418-7904; van Os, Jim/0000-0002-7245-1586; Bustamante, Sonia/0000-0002-7226-2910; Madrazo, Arantza/0000-0002-5142-7245; Gonzalez-Torres, Miguel Angel/0000-0002-4017-2785; Gorostiza, Inigo/0000-0001-5896-6148				Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Brebion G, 2000, PSYCHIAT RES, V95, P119, DOI 10.1016/S0165-1781(00)00174-8; Choong C, 2007, Curr Psychiatry Rep, V9, P206, DOI 10.1007/s11920-007-0020-z; Daalman K, 2011, J CLIN PSYCHIAT, V72, P320, DOI 10.4088/JCP.09m05797yel; de Leede-Smith S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00367; Franck N, 2000, SCHIZOPHR RES, V41, P357, DOI 10.1016/S0920-9964(99)00067-5; Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029; Hoffman RE, 2007, BRIT J PSYCHIAT, V191, P355, DOI 10.1192/bjp.bp.106.031195; Honig A, 1998, J NERV MENT DIS, V186, P646, DOI 10.1097/00005053-199810000-00009; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P553, DOI 10.1111/j.1467-9450.2009.00775.x; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Mossaheb N, 2012, SCHIZOPHR RES, V141, P210, DOI 10.1016/j.schres.2012.08.008; Peralta Martin V, 1994, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V22, P171; Sommer IEC, 2010, SCHIZOPHRENIA BULL, V36, P633, DOI 10.1093/schbul/sbn130; StataCorp, 2021, STATA STAT SOFTWARE; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Vercammen A, 2010, SCHIZOPHRENIA BULL, V36, P151, DOI 10.1093/schbul/sbn063; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482	20	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102520	10.1371/journal.pone.0102520	http://dx.doi.org/10.1371/journal.pone.0102520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1PC	25020079	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600091
J	Ferrer, MCC; Shuvaev, VV; Zern, BJ; Composto, RJ; Muzykantov, VR; Eckmann, DM				Ferrer, M. Carme Coll; Shuvaev, Vladimir V.; Zern, Blaine J.; Composto, Russell J.; Muzykantov, Vladimir R.; Eckmann, David M.			ICAM-1 Targeted Nanogels Loaded with Dexamethasone Alleviate Pulmonary Inflammation	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; ACUTE LUNG INJURY; DRUG-DELIVERY; INTRACELLULAR DELIVERY; POSTOPERATIVE NAUSEA; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; IN-VIVO; NANOPARTICLES; ANTIOXIDANT	Lysozyme dextran nanogels (NG) have great potential in vitro as a drug delivery platform, combining simple chemistry with rapid uptake and cargo release in target cells with "stealth'' properties and low toxicity. In this work, we study for the first time the potential of targeted NG as a drug delivery platform in vivo to alleviate acute pulmonary inflammation in animal model of LPS-induced lung injury. NG are targeted to the endothelium via conjugation with an antibody (Ab) directed to Intercellular Adhesion Molecule-1(ICAM-NG), whereas IgG conjugated NG (IgG-NG) are used for control formulations. The amount of Ab conjugated to the NG and distribution in the body after intravenous (IV) injection have been quantitatively analyzed using a tracer isotope-labeled [I-125]IgG. As a proof of concept, Ab-NG are loaded with dexamethasone, an anti-inflammatory therapeutic, and the drug uptake and release kinetics are measured by HPLC. In vivo studies in mice showed that: i) ICAM-NG accumulates in mouse lungs (similar to 120% ID/g vs similar to 15% ID/g of IgG-NG); and, ii) DEX encapsulated in ICAM-NG, but not in IgG-NG practically blocks LPS-induced overexpression of pro-inflammatory cell adhesion molecules including ICAM-1 in the pulmonary inflammation.	[Ferrer, M. Carme Coll; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Shuvaev, Vladimir V.; Zern, Blaine J.; Muzykantov, Vladimir R.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Shuvaev, Vladimir V.; Zern, Blaine J.; Muzykantov, Vladimir R.] Univ Penn, Ctr Targeted Therapeut & Translat Nanomed, Philadelphia, PA 19104 USA; [Ferrer, M. Carme Coll; Composto, Russell J.] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Eckmann, DM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	eckmanndm@uphs.upenn.edu	Eckmann, David/O-5472-2016; Shuvaev, Vladimir/O-1719-2014	Eckmann, David/0000-0002-8954-8827; 	National Institutes of Health [NIH R01 EB006818]; NSF Nano-Bio Interface Center [DMR08-32802]; NSF [DMR09-07493]; NSF/CEMRI [DMR11-20901]; Center for Translational Targeted Therapeutics and Nanomedicine (CT3) of the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Nano-Bio Interface Center; NSF(National Science Foundation (NSF)); NSF/CEMRI; Center for Translational Targeted Therapeutics and Nanomedicine (CT3) of the National Center for Advancing Translational Sciences of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The National Institutes of Health provided support via grant NIH R01 EB006818 (DME). A pilot grant from NSF Nano-Bio Interface Center DMR08-32802 (RJC) facilitated this work, as well as partial support from NSF DMR09-07493 (RJC). Facilities at the Nanoscale Characterization Center supported by NSF/CEMRI (DMR11-20901) are acknowledged. Research reported in this publication was supported in part by the Center for Translational Targeted Therapeutics and Nanomedicine (CT3) of the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Arruebo M, 2009, J NANOMATER, V2009, DOI 10.1155/2009/439389; Asgeirdottir SA, 2007, MOL PHARMACOL, V72, P121, DOI 10.1124/mol.107.034140; Buxton DB, 2009, NANOMEDICINE-UK, V4, P331, DOI [10.2217/nnm.09.8, 10.2217/NNM.09.8]; Carnemolla R, 2010, SEMIN THROMB HEMOST, V36, P332, DOI 10.1055/s-0030-1253455; Charoenphol P, 2011, ATHEROSCLEROSIS, V217, P364, DOI 10.1016/j.atherosclerosis.2011.04.016; Chen CC, 2012, WORLD J SURG, V36, P61, DOI 10.1007/s00268-011-1343-9; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Chittasupho C, 2009, EUR J PHARM SCI, V37, P141, DOI 10.1016/j.ejps.2009.02.008; Christofidou-Solomidou M, 2003, AM J PHYSIOL-LUNG C, V285, pL283, DOI 10.1152/ajplung.00021.2003; Cliffel DE, 2009, WIRES NANOMED NANOBI, V1, P47, DOI 10.1002/wnan.20; Coll Ferrer M. C., 2013, J NANOTECHNOLOGY ENG, V4; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; DANILOV SM, 1991, LAB INVEST, V64, P118; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Eberhart LHJ, 2000, ANAESTHESIST, V49, P713, DOI 10.1007/PL00002508; El Azab SR, 2002, BRIT J ANAESTH, V88, P496, DOI 10.1093/bja/88.4.496; Everts M, 2002, J IMMUNOL, V168, P883, DOI 10.4049/jimmunol.168.2.883; Ferrer M.C.C., 2013, J NANOTECHNOLOGY ENG, V4, P1; Ferrer MCC, 2012, SOFT MATTER, V8, P2423, DOI 10.1039/c2sm06969e; Ferrer MCC, 2014, ACTA BIOMAT IN PRESS; Ferrer MCC, 2013, J NANOPART RES, V15, P1; Greineder CF, 2013, BLOOD, V122, P1565, DOI 10.1182/blood-2013-03-453498; Henzi I, 2000, ANESTH ANALG, V90, P186, DOI 10.1097/00000539-200001000-00038; Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00127; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Li J, 2008, LANGMUIR, V24, P3486, DOI 10.1021/la702785b; Liu J, 2010, P NATL ACAD SCI USA, V107, P16530, DOI 10.1073/pnas.1006611107; MARUYAMA K, 1990, J PHARM SCI, V79, P978, DOI 10.1002/jps.2600791107; MITTAL V., 2012, ANAL IMAGING TECHNIQ; Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Muzykantov VR, 1996, P NATL ACAD SCI USA, V93, P5213, DOI 10.1073/pnas.93.11.5213; Pan H, 2013, FASEB J, V27, P255, DOI 10.1096/fj.12-218081; Rocksen D, 2000, CLIN EXP IMMUNOL, V122, P249, DOI 10.1046/j.1365-2249.2000.01373.x; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; TAKEI F, 1985, J IMMUNOL, V134, P1403; Vinogradov SV, 2002, ADV DRUG DELIVER REV, V54, P135, DOI 10.1016/S0169-409X(01)00245-9; Zern BJ, 2013, ACS NANO, V7, P2461, DOI 10.1021/nn305773f; Zhang N, 2008, BIOCONJUGATE CHEM, V19, P145, DOI 10.1021/bc700227z	47	54	55	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102329	10.1371/journal.pone.0102329	http://dx.doi.org/10.1371/journal.pone.0102329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019304	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600069
J	Rodriguez, A; Villegas, E; Montoya-Rosales, A; Rivas-Santiago, B				Rodriguez, Alexis; Villegas, Elba; Montoya-Rosales, Alejandra; Rivas-Santiago, Bruno			Characterization of Antibacterial and Hemolytic Activity of Synthetic Pandinin 2 Variants and Their Inhibition against Mycobacterium tuberculosis	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; HELICAL ANTIMICROBIAL PEPTIDES; CIRCULAR-DICHROISM SPECTRA; TRANSMEMBRANE HELICES; SECONDARY STRUCTURE; SKIN SECRETIONS; AMPHIBIAN SKIN; VENOM; CELLS; PROTEINS	The contention and treatment of Mycobacterium tuberculosis and other bacteria that cause infectious diseases require the use of new type of antibiotics. Pandinin 2 (Pin2) is a scorpion venom antimicrobial peptide highly hemolytic that has a central proline residue. This residue forms a structural "kink'' linked to its pore-forming activity towards human erythrocytes. In this work, the residue Pro14 of Pin2 was both substituted and flanked using glycine residues (P14G and P14GPG) based on the low hemolytic activities of antimicrobial peptides with structural motifs Gly and GlyProGly such as magainin 2 and ponericin G1, respectively. The two Pin2 variants showed antimicrobial activity against E. coli, S. aureus, and M. tuberculosis. However, Pin2 [GPG] was less hemolytic (30%) than that of Pin2 [G] variant. In addition, based on the primary structure of Pin2 [G] and Pin2 [GPG], two short peptide variants were designed and chemically synthesized keeping attention to their physicochemical properties such as hydrophobicity and propensity to adopt alpha-helical conformations. The aim to design these two short antimicrobial peptides was to avoid the drawback cost associated to the synthesis of peptides with large sequences. The short Pin2 variants named Pin2 [14] and Pin2 [17] showed antibiotic activity against E. coli and M. tuberculosis. Besides, Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 mu M, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration. Furthermore, these short antimicrobial peptides had better activity at molar concentrations against multidrug resistance M. tuberculosis than that of the conventional antibiotics ethambutol, isoniazid and rifampicin. Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.	[Rodriguez, Alexis; Rivas-Santiago, Bruno] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Rodriguez, Alexis; Villegas, Elba] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico; [Montoya-Rosales, Alejandra; Rivas-Santiago, Bruno] UIMZ IMSS, Mexican Inst Social Secur, Med Res Unit Zacatecas, Zacatecas, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Instituto Mexicano del Seguro Social	Rivas-Santiago, B (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico.	corzo@ibt.unam.mx	Rivas-Santiago, Bruno/AAJ-1885-2020; Rodríguez, Alexis/C-5086-2015; Corzo, Gerardo/B-3778-2014	Rivas-Santiago, Bruno/0000-0002-1521-1519; Rodríguez, Alexis/0000-0002-1503-5156; Corzo, Gerardo/0000-0002-9513-1622; Villegas Villarreal, Elba Cristina/0000-0003-1795-0427; Montoya-Rosales, Alejandra del Rocio/0000-0003-0565-4380	CONACyT [153606, 83962/2007, 106949/2008]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was also supported by CONACyT project Grants 153606 to GC, and 83962/2007 and 106949/2008 to Elba Villegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bywater RP, 2001, J COMPUT AID MOL DES, V15, P533, DOI 10.1023/A:1011197908960; Conlon JM, 2012, PEPTIDES, V37, P113, DOI 10.1016/j.peptides.2012.07.005; Conlon JM, 2005, DEV COMP IMMUNOL, V29, P83, DOI 10.1016/j.dci.2004.05.003; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Dathe M, 1998, BBA-BIOMEMBRANES, V1370, P175, DOI 10.1016/S0005-2736(97)00260-5; DEMPSEY CE, 1991, FEBS LETT, V281, P240, DOI 10.1016/0014-5793(91)80402-O; erovsky V, 2008, PEPTIDES, V29, P992; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Gopal R, 2012, INT J MOL SCI, V13, P3229, DOI 10.3390/ijms13033229; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Jin LL, 2009, INT J ANTIMICROB AG, V33, P538, DOI 10.1016/j.ijantimicag.2008.11.010; Kamysz Wojciech, 2005, Nucl Med Rev Cent East Eur, V8, P78; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KREIL G, 1973, FEBS LETT, V33, P241, DOI 10.1016/0014-5793(73)80202-9; KUBICA G P, 1972, International Journal of Systematic Bacteriology, V22, P99; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladokhin AS, 1999, BIOCHEMISTRY-US, V38, P12313, DOI 10.1021/bi9907936; Liu L, 2008, IFMBE PROC, V19, P167, DOI 10.1007/978-3-540-79039-6_43; Liu R, 2011, J PROTEOME RES, V10, P1806, DOI 10.1021/pr101285n; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Oh H, 2000, ANTIMICROB AGENTS CH, V44, P68, DOI 10.1128/AAC.44.1.68-72.2000; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Orivel J, 2001, J BIOL CHEM, V276, P17823, DOI 10.1074/jbc.M100216200; Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971; Patrzykat A, 2003, ANTIMICROB AGENTS CH, V47, P2464, DOI 10.1128/AAC.47.8.2464-2470.2003; Rastogi N, 1996, CURR MICROBIOL, V33, P167, DOI 10.1007/s002849900095; Riemen AJ, 2010, ORG BIOMOL CHEM, V8, P5411, DOI 10.1039/c0ob00202j; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Rivas-Santiago B, 2008, SCAND J IMMUNOL, V67, P448, DOI 10.1111/j.1365-3083.2008.02088.x; Rivas-Santiago B, 2013, INT J ANTIMICROB AG, V41, P143, DOI 10.1016/j.ijantimicag.2012.09.015; Rodriguez A, 2011, AMINO ACIDS, V40, P61, DOI 10.1007/s00726-009-0449-y; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; Shin SY, 1999, B KOR CHEM SOC, V20, P1078; Slaninova J, 2012, PEPTIDES, V33, P18, DOI 10.1016/j.peptides.2011.11.002; Thennarasu S, 1996, PROTEIN ENG, V9, P1219, DOI 10.1093/protein/9.12.1219; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang H, 2012, PEPTIDES, V33, P27, DOI 10.1016/j.peptides.2011.10.030; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yanmei L, 2012, PEPTIDES, V37, P2207; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zidovetzki R, 2003, BIOPHYS CHEM, V100, P555, DOI 10.1016/S0301-4622(02)00306-X	56	44	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101742	10.1371/journal.pone.0101742	http://dx.doi.org/10.1371/journal.pone.0101742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019413	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600027
J	Williams, CB; Hughes, MC; Edgett, BA; Scribbans, TD; Simpson, CA; Perry, CGR; Gurd, BJ				Williams, Cameron B.; Hughes, Meghan C.; Edgett, Brittany A.; Scribbans, Trisha D.; Simpson, Craig A.; Perry, Christopher G. R.; Gurd, Brendon J.			An Examination of Resveratrol's Mechanisms of Action in Human Tissue: Impact of a Single Dose In Vivo and Dose Responses in Skeletal Muscle Ex Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER CHEMOPREVENTIVE AGENT; MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; EXERCISE INCREASES; HEALTHY-VOLUNTEERS; GLUCOSE-TRANSPORT; NUCLEAR ABUNDANCE; AMPK ACTIVATION	The current study tested the hypothesis that a single, moderate dose of RSV would activate the AMPK/SIRT1 axis in human skeletal muscle and adipose tissue. Additionally, the effects of RSV on mitochondrial respiration in PmFBs were examined. Eight sedentary men (23.8 +/- 2.4 yrs; BMI: 32.7 +/- 7.1) reported to the lab on two occasions where they were provided a meal supplemented with 300 mg of RSV or a placebo. Blood samples, and a muscle biopsy were obtained in the fasted state and again, with the addition of an adipose tissue biopsy, two hours post-prandial. The effect of RSV on mitochondrial respiration was examined in PmFBs taken from muscle biopsies from an additional eight men (23.4 +/- 5.4 yrs; BMI: 24.4 +/- 2.8). No effect of RSV was observed on nuclear SIRT1 activity, acetylation of p53, or phosphorylation of AMPK, ACC or PKA in either skeletal muscle or adipose tissue. A decrease in post absorptive insulin levels was accompanied by elevated skeletal muscle phosphorylation of p38 MAPK, but no change in either skeletal muscle or adipose tissue insulin signalling. Mitochondrial respiration in PmFBs was rapidly inhibited by RSV at 100-300 uM depending on the substrate examined. These results question the efficacy of a single dose of RSV at altering skeletal muscle and adipose tissue AMPK/SIRT1 activity in humans and suggest that RSV mechanisms of action in humans may be associated with altered cellular energetics resulting from impaired mitochondrial ATP production.	[Williams, Cameron B.; Edgett, Brittany A.; Scribbans, Trisha D.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Simpson, Craig A.] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Hughes, Meghan C.; Perry, Christopher G. R.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	Queens University - Canada; Queens University - Canada; York University - Canada	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca		Edgett, Brittany/0000-0002-8232-0432	NSERC; Canaian Foundation for Innovation (CFI)	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canaian Foundation for Innovation (CFI)	Funding was provided by NSERC (CGRP and BJG) and the Canaian Foundation for Innovation (CFI) (BJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen G, 2011, MOL NUTR FOOD RES, V55, P1197, DOI 10.1002/mnfr.201100292; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chung JH, 2012, TRENDS CELL BIOL, V22, P546, DOI 10.1016/j.tcb.2012.07.004; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; Furtado LM, 2002, BIOCHEM CELL BIOL, V80, P569, DOI 10.1139/O02-156; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Guerra B, 2011, J APPL PHYSIOL, V110, P1708, DOI 10.1152/japplphysiol.00091.2011; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, pR67, DOI 10.1152/ajpregu.00417.2010; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Horowitz JF, 2003, TRENDS ENDOCRIN MET, V14, P386, DOI 10.1016/S1043-2760(03)00143-7; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kane DA, 2011, AM J PHYSIOL-ENDOC M, V300, pE528, DOI 10.1152/ajpendo.00389.2010; Kang W, 2012, METABOLISM, V61, P424, DOI 10.1016/j.metabol.2011.08.003; Kuznetsov AV, 1996, EUR J BIOCHEM, V241, P909, DOI 10.1111/j.1432-1033.1996.00909.x; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lasa A, 2012, MOL NUTR FOOD RES, V56, P1559, DOI 10.1002/mnfr.201100772; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Marchal J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034289; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Perry CGR, 2013, DIABETES, V62, P1041, DOI 10.2337/db12-1219; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Szkudelski T, 2007, AM J PHYSIOL-ENDOC M, V293, pE901, DOI 10.1152/ajpendo.00564.2006; Thong FSL, 2003, J APPL PHYSIOL, V94, P2337, DOI 10.1152/japplphysiol.00036.2003; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vissing K, 2004, FASEB J, V18, P94, DOI 10.1096/fj.04-2084fje; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; White AT, 2012, AM J PHYSIOL-ENDOC M, V303, pE308, DOI 10.1152/ajpendo.00054.2012; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	56	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102406	10.1371/journal.pone.0102406	http://dx.doi.org/10.1371/journal.pone.0102406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019209	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600077
J	Zhou, X; Wang, XP; Huang, ZB; Wang, J; Zhu, W; Shu, YQ; Liu, P				Zhou, Xin; Wang, Xiaping; Huang, Zebo; Wang, Jian; Zhu, Wei; Shu, Yongqian; Liu, Ping			Prognostic Value of miR-21 in Various Cancers: An Updating Meta-Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; II COLON-CANCER; MICRORNA EXPRESSION; BREAST-CANCER; SERUM MIR-21; ADJUVANT CHEMOTHERAPY; CIRCULATING MICRORNAS; COLORECTAL-CANCER; PANCREATIC-CANCER; GENE-EXPRESSION	Background: Recently, more and more studies investigated the value of microRNA (miRNA) as a diagnostic or prognostic biomarker in various cancers. MiR-21 was found dysregulated in almost all types of cancers. While the prognostic role of miR-21 in many cancers has been studied, the results were not consistent. Methods: We performed a meta-analysis to investigate the correlation between miR-21 and survival of general cancers by calculating pooled hazard ratios (HR) and 95% confidence intervals (CI). Results: The pooled results of 63 published studies showed that elevated miR-21 was a predictor for poor survival of general carcinomas, with pooled HR of 1.91 (95% CI: 1.66-2.19) for OS, 1.42 (95% CI: 1.16-1.74) for DFS and 2.2 (95% CI: 1.64-2.96) for RFS/CSS. MiR-21 was also a prognostic biomarker in the patients who received adjuvant therapy, with pooled HR of 2.4 (95% CI: 1.18-4.9) for OS. Conclusions: Our results showed that miR-21 could act as a significant biomarker in the prognosis of various cancers. Further studies are warranted before the application of the useful biomarker in the clinical.	[Zhou, Xin; Huang, Zebo; Wang, Jian; Zhu, Wei; Shu, Yongqian; Liu, Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Shu, Yongqian; Liu, Ping] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaping] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Clin Diabet Ctr Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	zhuwei1983213@163.com; liu-ping@csco.org.cn	Shu, Yongqian/ABD-5698-2021		National Natural Science Foundation of China [81171908]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant number: 81171908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi I, 2013, CANCER RES, V73, P3821, DOI 10.1158/0008-5472.CAN-13-0031; Amankwah EK, 2013, ASIAN J ANDROL, V15, P226, DOI 10.1038/aja.2012.160; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Avissar M, 2009, CARCINOGENESIS, V30, P2059, DOI 10.1093/carcin/bgp277; Bao LL, 2013, CANCER LETT, V337, P226, DOI 10.1016/j.canlet.2013.05.007; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Capodanno A, 2013, INT J ONCOL, V43, P765, DOI 10.3892/ijo.2013.2003; Caponi S, 2013, ANN ONCOL, V24, P734, DOI 10.1093/annonc/mds513; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chakraborty P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058291, 10.1371/journal.pone.0068543]; Chen TH, 2013, COLORECTAL DIS; Chusorn P, 2013, TUMOR BIOL, V34, P1579, DOI 10.1007/s13277-013-0688-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faltejskova P, 2012, INT J COLORECTAL DIS, V27, P1401, DOI 10.1007/s00384-012-1461-3; Faragalla H, 2012, J MOL DIAGN, V14, P385, DOI 10.1016/j.jmoldx.2012.02.003; Ferrajoli A, 2013, BLOOD, V122, P1891, DOI 10.1182/blood-2013-01-478222; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Gao W, 2012, CANCER BIOL THER, V13, P330, DOI 10.4161/cbt.19073; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Gombos K, 2013, ANTICANCER RES, V33, P1511; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hermansen SK, 2013, J NEURO-ONCOL, V111, P71, DOI 10.1007/s11060-012-0992-3; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Huang Q, 2013, ASIAN PAC J CANCER P, V14, P829, DOI 10.7314/APJCP.2013.14.2.829; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023271; Jiang L, 2012, ACTA HISTOCHEM, V114, P582, DOI 10.1016/j.acthis.2011.11.001; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Kadera BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071978; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Kjaer-Frifeldt S, 2012, BRIT J CANCER, V107, P1169, DOI 10.1038/bjc.2012.365; Komatsu S, 2013, ANTICANCER RES, V33, P271; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Le HB, 2012, MED ONCOL, V29, P3190, DOI 10.1007/s12032-012-0303-z; Lee JA, 2011, J BREAST CANCER, V14, P269, DOI 10.4048/jbc.2011.14.4.269; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2012, J UROLOGY, V187, P1466, DOI 10.1016/j.juro.2011.11.082; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Liu S, 2013, ACTA BIOCH BIOPHYS S; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Lusi EA, 2009, ANAL CHEM, V81, P2819, DOI 10.1021/ac8026788; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mar-Aguilar F, 2013, DIS MARKERS, V34, P163, DOI [10.1155/2013/259454, 10.3233/DMA-120957]; Markou A, 2013, LUNG CANCER, V81, P388, DOI 10.1016/j.lungcan.2013.05.007; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Menendez P, 2013, J SURG ONCOL; Nagao Y, 2012, MODERN PATHOL, V25, P112, DOI 10.1038/modpathol.2011.142; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Osawa S, 2011, ONCOL LETT, V2, P613, DOI 10.3892/ol.2011.313; Ota D, 2011, INT J ONCOL, V38, P955, DOI 10.3892/ijo.2011.926; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Seca H, 2013, CURR DRUG TARGETS; Shibuya H, 2010, ONCOLOGY-BASEL, V79, P313, DOI 10.1159/000323283; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soria-Valles C, 2013, ONCOGENE; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Valladares-Ayerbes M, 2011, INT J ONCOL, V39, P1253, DOI 10.3892/ijo.2011.1112; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Walter BA, 2011, J CANCER, V2, P67, DOI 10.7150/jca.2.67; Wang P, 2013, MOL ONCOL, V7, P334, DOI 10.1016/j.molonc.2012.10.011; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Xu YJ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/640168; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang Q, 2011, CLIN CHIM ACTA, V412, P2167, DOI 10.1016/j.cca.2011.07.029; Yu L, 2010, INT J CANCER, V127, P2870, DOI 10.1002/ijc.25289; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003; Zhou L, 2013, INT J ONCOL, V43, P661, DOI 10.3892/ijo.2013.1965	102	50	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102413	10.1371/journal.pone.0102413	http://dx.doi.org/10.1371/journal.pone.0102413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019505	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600080
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			The Enigmatic Marine Reptile Nanchangosaurus from the Lower Triassic of Hubei, China and the Phylogenetic Affinities of Hupehsuchia	PLOS ONE			English	Article							DIAPSIDA SAUROPTERYGIA; SOUTHWESTERN CHINA; EVOLUTION; PROVINCE; POLAND	The study of the holotype and of a new specimen of Nanchangosaurus suni (Reptilia; Diapsida; Hupehsuchia) revealed a suite of hitherto unrecognized characters. For example, Nanchangosaurus has bipartite neural spines and its vertebral count is nearly identical to that of Hupehsuchus. It differs from the latter in having poorly developed forelimbs despite the advanced ossification in the rest of the skeleton. Other differences all pertain to hupehsuchian plesiomorphies retained in Nanchangosaurus, such as low neural spines. The relationship of Hupehsuchia within Diapsida was analyzed based on a data matrix containing 41 taxa coded for 213 characters, of which 18 were identified as aquatic adaptations from functional inferences. These aquatic adaptations may be vulnerable to the argumentation of character homology because expectation for homoplasy is high. There is an apparent incongruence between phylogenetic signals from aquatic adaptations and the rest of the data, with aquatic adaptations favoring all marine reptiles but Helveticosaurus to form a super-clade. However, this super-clade does not obtain when aquatic adaptations were deleted, whereas individual marine reptile clades are all derived without them. We examined all possible combinations of the 18 aquatic adaptations (n = 262143) and found that four lineages of marine reptiles are recognized almost regardless of which of these features were included in the analysis: Hupehsuchia-Ichthyopterygia clade, Sauropterygia-Saurosphargidae clade, Thalattosauria, and Helveticosaurus. The interrelationships among these four depended on the combination of aquatic adaptations to be included, i.e., assumed to be homologous a priori by bypassing character argumentation. Hupehsuchia always appeared as the sister taxon of Ichthyopterygia.	[Chen, Xiao-hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Dept Geol, MOE, Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	China Geological Survey [1212010611603, 1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]	China Geological Survey(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Geological Survey Project 1212010611603 to Xiao-hong Chen, the China Geological Survey Projects 1212011120148 to Long Cheng, and the National Natural Science Foundation of China Projects 40920124002 and 41372016 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094396; Cheng L, 2012, J EARTH SCI-CHINA, V23, P33, DOI 10.1007/s12583-012-0231-z; de Ricgles A., 1975, Annales Paleont (Vert), V61, P49; Dong Z.-m., 1979, Rivista Italiana di Paleontologia e Stratigrafia, V85, P1231; Evans Susan E., 2009, Palaeontologia Polonica, P145; Evans Susan E., 2009, Palaeontologia Polonica, P179; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Jiang DY, 2008, J VERTEBR PALEONTOL, V28, P1055, DOI 10.1671/0272-4634-28.4.1055; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Li C, 2014, GEOL MAG, V151, P100, DOI 10.1017/S001675681300023X; Li C, 2011, J VERTEBR PALEONTOL, V31, P303, DOI 10.1080/02724634.2011.550368; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; MCGOWAN C, 1992, CAN J EARTH SCI, V29, P380, DOI 10.1139/e92-034; McGowan C., 2003, ICHTHYOPTERYGIA; Merriam JC, 1906, U CALIFORNIA PLUBLIC, V5, P71; Motani R, 1998, NATURE, V393, P255, DOI 10.1038/30473; Motani R, 1999, J PALEONTOL, V73, P924, DOI 10.1017/S0022336000040750; Motani R, J VERTEBRAT IN PRESS; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Reisz RR, 2011, P ROY SOC B-BIOL SCI, V278, P3731, DOI 10.1098/rspb.2011.0439; Rieppel O, 1999, PALAEOGEOGR PALAEOCL, V153, P1, DOI 10.1016/S0031-0182(99)00067-X; Rieppel O, 1989, PALAEONTOGR ABT A, P123; Rieppel O, 2000, HDB PALAOHERPETOLO A; Rieppel O, 2008, J VERTEBR PALEONTOL, V28, P95, DOI 10.1671/0272-4634(2008)28[95:TSAOTT]2.0.CO;2; Rieppel O, 2013, CLADISTICS, V29, P328, DOI 10.1111/j.1096-0031.2012.00428.x; Rieppel O, 2009, BIOL PHILOS, V24, P607, DOI 10.1007/s10539-008-9122-1; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Wu XC, 2011, J VERTEBR PALEONTOL, V31, P70, DOI 10.1080/02724634.2011.546724; Young CC, 1972, AQUATIC REPTILES TRI, P28	33	28	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102361	10.1371/journal.pone.0102361	http://dx.doi.org/10.1371/journal.pone.0102361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014493	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400089
J	de la Pena, P; Wadley, L				de la Pena, Paloma; Wadley, Lyn			Quartz Knapping Strategies in the Howiesons Poort at Sibudu (KwaZulu-Natal, South Africa)	PLOS ONE			English	Article							MIDDLE-STONE-AGE; DIEPKLOOF ROCK SHELTER; WESTERN-CAPE; MUMBA ROCKSHELTER; COMPLEX COGNITION; CAVE; TECHNOLOGY; TOOLS; TANZANIA; BEHAVIOR	The variability associated with Sibudu's Howiesons Poort Industry highlights the unpredictable trajectory of technology in the Middle Stone Age. We reach this conclusion through a study of the technology on quartz from one of the Howiesons Poort layers (Grey Sand) from Sibudu rock shelter. Quartz bifacial technology has previously been described at the site, but this new in-depth study of the quartz technology reveals other strategies. First is the recurring employment of bipolar knapping, formerly considered as a defining feature of the Later Stone Age. Secondly, we highlight a laminar technology with emphasis on small quartz bladelets. Bipolar cores are most common, followed by prismatic cores. The knapping strategies in Grey Sand seem to involve systematic recycling and the deliberate production of microliths.	[de la Pena, Paloma; Wadley, Lyn] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa	University of Witwatersrand	de la Pena, P (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.	paloma.delapenya@gmail.com	de la Peña, Paloma/ABB-3086-2021; Wadley, Lyn/AAC-6577-2022; de la Peña, Paloma/AAA-6605-2021	de la Peña, Paloma/0000-0001-9731-7001; 	National Research Foundation of South Africa; University of the Witwatersrand	National Research Foundation of South Africa(National Research Foundation - South Africa); University of the Witwatersrand	The National Research Foundation of South Africa and the University of the Witwatersrand gave funding for the excavation of Sibudu, and fellowship funding for the research of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; [Anonymous], 2010, UNDERSTANDING QUARTZ; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Barham L, 2002, J HUM EVOL, V43, P585, DOI 10.1006/jhev.2002.0597; Barham L, 1987, S AFRICAN ARCH B, V42, P45, DOI DOI 10.2307/3887773; Beaumont P.B., 1978, THESIS U CAPE TOWN C; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Callahan E., 1985, EVALUATION LITHIC TE; CLARK JD, 1988, J WORLD PREHIST, V2, P235, DOI 10.1007/BF00975618; Clarke B.M., 2007, GEOLOGY VERULAM AREA; Clarkson C, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P43, DOI 10.1007/978-1-4419-6861-6_3; Cochrane G.W.G., 2006, SOUTH AFR HUMANIT, V18, P69; Costa, 2009, BAR INT SERIES, P5; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; Crabtree D.E., 1972, OCCASIONAL PAPERS ID; DANA ES, 1966, TXB MINERALOGY EXTEN; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; Alonso PD, 2011, TRABAJOS PREHIST, V68, P79, DOI 10.3989/tp.2011.11060; de la Pena P, 2013, J ANTHROPOL RES, V69, P33, DOI DOI 10.3998/JAR.0521004.0069.103; de la Pena P, 2014, QUATERNARY IN PRESS; Deacon J., 1984, P221; Delagnes A., 2006, SO AFRICAN HUMANITIE, V18, P43; Diez-Martin F, 2009, J AFR ARCHAEOL, V7, P147, DOI 10.3213/1612-1651-10136; Diez-Martin F, 2009, J ANTHROPOL ARCHAEOL, V28, P274, DOI 10.1016/j.jaa.2009.03.001; Eren MI, 2013, J ARCHAEOL SCI, V40, P248, DOI 10.1016/j.jas.2012.08.012; Flenniken J. Jeffrey, 1981, WASHINGTON STATE U L, V59; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Goodwin AJH, 1929, AFRICA, V2, P174, DOI 10.2307/1155825; Harper PTN, 1997, S AFR J SCI, V93, P470; Hayden B., 1980, LITHIC TECHNOL, V9, P2, DOI DOI 10.1080/01977261.1980.11754456; Hensilwood C., 2003, INDOPACIFIC PREHISTO, V44, P627, DOI DOI 10.7152/BIPPA.V15I0.11544; Igreja M, 2013, J ARCHAEOL SCI, V40, P3475, DOI 10.1016/j.jas.2013.02.026; Jacobs Z, 2008, S AFRICAN ARCHAEOLOG, V10, P9; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jeske R.J., 1993, MIDCONT J ARCHAEOL, V18, P131; Kaplan J, 1990, SOUTH AFR HUMANIT, P94; Karlin C., 1991, OBSERVER LACTION TEC, P101; KLEIN RG, 1995, J WORLD PREHIST, V9, P167, DOI 10.1007/BF02221838; Knutsson K, 1988, PATTERNS TOOL USE SC; Kuhn SL., 2002, ARCHEOLOGICAL PAPERS, V12, P1; Langejans GHJ, 2012, J ARCHAEOL SCI, V39, P1694, DOI 10.1016/j.jas.2011.12.036; Le Brun-Ricalens F, 2006, PALEO, V18, P95, DOI 10.4000/paleo.181; Leakey LSB, 1929, S AFR J SCI, P99; LEMONNIER P, 1986, J ANTHROPOL ARCHAEOL, V5, P147, DOI 10.1016/0278-4165(86)90012-7; Lemonnier P, 1976, TECHNIQUES CULTURE, V1, P101; Livingstone D., 1992, GEOGRAPHICAL TRADITI; Lombard M, 2007, ARCHAEOLOGICAL USE T; Lombard M, 2011, J ARCHAEOL SCI, V38, P1918, DOI 10.1016/j.jas.2011.04.001; Mackay A., 2009, HIST SELECTION LATE; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Mercader J, 2001, J ANTHROPOL RES, V57, P197, DOI 10.1086/jar.57.2.3631567; Minichillo T.J, 2005, MIDDLE STONE AGE LIT; Mitchell PJ., 1995, S AFR ARCHAEOL BULL, V50, P28, DOI DOI 10.2307/3889272; Mourre V, 1996, PALEO, V8, P205, DOI DOI 10.3406/PAL.1996.1160; Orton J., 2004, THESIS U CAPE TOWN C; Pelegrin J., 1995, CAHIERS QUATERNAIRE, V20, P297; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Shott MJ., 1989, N AM ARCHAEOL, V10, P1, DOI DOI 10.2190/AAKD-X5Y1-89H6-NGJW; Singer R., 1982, MIDDLE STONE AGE KLA; Stapleton P., 1927, S AFR J SCI, V24, P574; Stapleton P., 1928, S AFR J SCI, V25, P399; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; THACKERAY AI, 1992, J WORLD PREHIST, V6, P385, DOI 10.1007/BF00975633; Van Riet Lowe C, 1956, S AFR J SCI, VXLII, P240; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Volman TP, 1980, MIDDLE STONE AGE SO; WADLEY L, 1993, J WORLD PREHIST, V7, P243, DOI 10.1007/BF00974721; WADLEY L, 2005, S AFRICAN ARCHAEOLOG, V60, P1; Wadley L., 1996, S AFR ARCHAEOL BULL, V51, P64, DOI DOI 10.2307/3888841; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L, 2008, S AFRICAN ARCHAEOLOG, V1, P122; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; Wadley L, 2011, SOUTH AFR HUMANIT, V23, P87; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wurz S, 2000, MIDDLE STONE AGE SEQ; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079	81	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101534	10.1371/journal.pone.0101534	http://dx.doi.org/10.1371/journal.pone.0101534			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014352	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400026
J	Deres, L; Bartha, E; Palfi, A; Eros, K; Riba, A; Lantos, J; Kalai, T; Hideg, K; Sumegi, B; Gallyas, F; Toth, K; Halmosi, R				Deres, Laszlo; Bartha, Eva; Palfi, Anita; Eros, Krisztian; Riba, Adam; Lantos, Janos; Kalai, Tamas; Hideg, Kalman; Sumegi, Balazs; Gallyas, Ferenc; Toth, Kalman; Halmosi, Robert			PARP-Inhibitor Treatment Prevents Hypertension Induced Cardiac Remodeling by Favorable Modulation of Heat Shock Proteins, Akt-1/GSK-3 beta and Several PKC Isoforms	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ENDOTHELIAL DYSFUNCTION; ISCHEMIA-REPERFUSION; SIGNALING PATHWAYS; OXIDATIVE STRESS; ANGIOTENSIN-II; FAILURE; RATS; ACTIVATION; APOPTOSIS	Spontaneously hypertensive rat (SHR) is a suitable model for studies of the complications of hypertension. It is known that activation of poly(ADP-ribose) polymerase enzyme (PARP) plays an important role in the development of postinfarction as well as long-term hypertension induced heart failure. In this study, we examined whether PARP-inhibitor (L-2286) treatment could prevent the development of hypertensive cardiopathy in SHRs. 6-week-old SHR animals were treated with L-2286 (SHR-L group) or placebo (SHR-C group) for 24 weeks. Wistar-Kyoto rats were used as aged-matched, normotensive controls (WKY group). Echocardiography was performed, brain-derived natriuretic peptide (BNP) activity and blood pressure were determined at the end of the study. We detected the extent of fibrotic areas. The amount of heat-shock proteins (Hsps) and the phosphorylation state of Akt-1(Ser473), glycogen synthase kinase (GSK)-3 beta(Ser9), forkhead transcription factor (FKHR)(Ser256), mitogen activated protein kinases (MAPKs), and protein kinase C (PKC) isoenzymes were monitored. The elevated blood pressure in SHRs was not influenced by PARP-inhibitor treatment. Systolic left ventricular function and BNP activity did not differ among the three groups. L-2286 treatment decreased the marked left ventricular (LV) hypertrophy which was developed in SHRs. Interstitial collagen deposition was also decreased by L-2286 treatment. The phosphorylation of extracellular signal-regulated kinase (ERK) 1/2(Thr183-Tyr185), Akt-1(Ser473), GSK-3 beta(Ser9), FKHRSer256, and PKC epsilon(Ser729) and the level of Hsp90 were increased, while the activity of PKC alpha/beta IIThr638/641, zeta/lambda(410/403) were mitigated by L-2286 administration. We could detect signs of LV hypertrophy without congestive heart failure in SHR groups. This alteration was prevented by PARP inhibition. Our results suggest that PARP-inhibitor treatment has protective effect already in the early stage of hypertensive myocardial remodeling.	[Deres, Laszlo; Bartha, Eva; Palfi, Anita; Eros, Krisztian; Riba, Adam; Toth, Kalman; Halmosi, Robert] Univ Pecs, Dept Med 1, Div Cardiol, Pecs, Hungary; [Deres, Laszlo; Eros, Krisztian; Riba, Adam; Sumegi, Balazs; Halmosi, Robert] Univ Pecs, Sch Med, Szentagothai Janos Res Ctr, Pecs, Hungary; [Lantos, Janos] Univ Pecs, Dept Surg Res & Tech, Pecs, Hungary; [Kalai, Tamas] Univ Pecs, Dept Organ & Med Chem, Pecs, Hungary; [Hideg, Kalman; Sumegi, Balazs; Gallyas, Ferenc] Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary; [Sumegi, Balazs; Gallyas, Ferenc] MTA PTE Nuclear Mitochondrial Interact Res Grp, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Halmosi, R (corresponding author), Univ Pecs, Dept Med 1, Div Cardiol, Pecs, Hungary.	dr.halmosi.robert@gmail.com	Gallyas, Ferenc/C-2272-2012; Halmosi, Róbert/AAK-1880-2020; Gallyas, Ferenc/AAY-5343-2020	Halmosi, Robert/0000-0002-6965-7743; Gallyas, Ferenc/0000-0002-1906-4333; Bartha, Eva/0000-0003-4318-9459	Hungarian National Research Foundations [OTKA F-46594, OTKA K-73738, OTKA K-81123, OTKA NN-109841]	Hungarian National Research Foundations(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The work was supported by Hungarian National Research Foundations (OTKA F-46594, OTKA K-73738, OTKA K-81123, OTKA NN-109841). This research was realized in the frames of SROP 4.2.1.B-10/2/KONV-2010-0002, 4.2.4. A/2-11-1-2012-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bartha E, 2009, CARDIOVASC RES, V83, P501, DOI 10.1093/cvr/cvp144; Bogoyevitch MA, 2000, CARDIOVASC RES, V45, P826, DOI 10.1016/S0008-6363(99)00386-7; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; COOPER RS, 1990, AM J CARDIOL, V65, P441, DOI 10.1016/0002-9149(90)90807-D; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Inagaki K, 2002, J MOL CELL CARDIOL, V34, P1377, DOI 10.1006/jmcc.2002.2089; Ito N, 2007, AM J HYPERTENS, V20, P792, DOI 10.1016/j.amjhyper.2007.02.004; Jiang BM, 2005, CELL STRESS CHAPERON, V10, P252, DOI 10.1379/CSC-124R.1; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Koide Y, 2003, HYPERTENS RES, V26, P421, DOI 10.1291/hypres.26.421; Kokubo M, 2005, HYPERTENS RES, V28, P601, DOI 10.1291/hypres.28.601; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Kovacs K, 2006, BIOCHEM PHARMACOL, V71, P441, DOI 10.1016/j.bcp.2005.05.036; KULCSAR GY, 2006, ARKIVOC, V4, P121; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Lip GYH, 2000, EUR HEART J, V21, P1653, DOI 10.1053/euhj.2000.2339; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; McCrossan ZA, 2004, CARDIOVASC RES, V63, P283, DOI 10.1016/j.cardiores.2004.04.013; Meurrens K, 2007, CARDIOVASC RES, V76, P311, DOI 10.1016/j.cardiores.2007.06.033; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Pacher P, 2002, INT J MOL MED, V9, P659; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Palfi A, 2005, J PHARMACOL EXP THER, V315, P273, DOI 10.1124/jpet.105.088336; Palfi A, 2006, J MOL CELL CARDIOL, V41, P149, DOI 10.1016/j.yjmcc.2006.03.427; PFEFFER JM, 1982, P NATL ACAD SCI-BIOL, V79, P3310, DOI 10.1073/pnas.79.10.3310; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Shinohara T, 2007, AM J PHYSIOL-HEART C, V293, pH1892, DOI 10.1152/ajpheart.00493.2007; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Szabo C, 2004, MOL MED, V10, P28, DOI 10.2119/2004-00001.Szabo; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Taniike M, 2008, CIRCULATION, V117, P545, DOI 10.1161/CIRCULATIONAHA.107.710434; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589	40	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102148	10.1371/journal.pone.0102148	http://dx.doi.org/10.1371/journal.pone.0102148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014216	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400071
J	Dorca-Arevalo, J; Pauillac, S; Diaz-Hidalgo, L; Martin-Satue, M; Popoff, MR; Blasi, J				Dorca-Arevalo, Jonatan; Pauillac, Serge; Diaz-Hidalgo, Laura; Martin-Satue, Mireia; Popoff, Michel R.; Blasi, Juan			Correlation between In Vitro Cytotoxicity and In Vivo Lethal Activity in Mice of Epsilon Toxin Mutants from Clostridium perfringens	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; MDCK CELLS; BINDING; BRAINS; SYSTEM; SHEEP; PORE; ENTEROTOXEMIA; HIPPOCAMPUS; PROTOTOXIN	Epsilon toxin (Etx) from Clostridium perfringens is a pore-forming protein with a lethal effect on livestock, producing severe enterotoxemia characterized by general edema and neurological alterations. Site-specific mutations of the toxin are valuable tools to study the cellular and molecular mechanism of the toxin activity. In particular, mutants with paired cysteine substitutions that affect the membrane insertion domain behaved as dominant-negative inhibitors of toxin activity in MDCK cells. We produced similar mutants, together with a well-known non-toxic mutant (Etx-H106P), as green fluorescent protein (GFP) fusion proteins to perform in vivo studies in an acutely intoxicated mouse model. The mutant (GFP-Etx-I51C/A114C) had a lethal effect with generalized edema, and accumulated in the brain parenchyma due to its ability to cross the blood-brain barrier (BBB). In the renal system, this mutant had a cytotoxic effect on distal tubule epithelial cells. The other mutants studied (GFP-Etx-V56C/F118C and GFP-Etx-H106P) did not have a lethal effect or cross the BBB, and failed to induce a cytotoxic effect on renal epithelial cells. These data suggest a direct correlation between the lethal effect of the toxin, with its cytotoxic effect on the kidney distal tubule cells, and the ability to cross the BBB.	[Dorca-Arevalo, Jonatan; Diaz-Hidalgo, Laura; Martin-Satue, Mireia; Blasi, Juan] Univ Barcelona, Lab Cellular & Mol Neurosci, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Dorca-Arevalo, Jonatan; Martin-Satue, Mireia; Blasi, Juan] IDIBELL Bellvitge Biomed Res Inst, Barcelona, Spain; [Pauillac, Serge; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Blasi, J (corresponding author), Univ Barcelona, Lab Cellular & Mol Neurosci, Dept Pathol & Expt Therapeut, Barcelona, Spain.	blasi@ub.edu	Popoff, Michel/O-7719-2016; Dorca, Jonatan/C-9220-2018; Dorca-Arévalo, Jonatan/F-8984-2016; Blasi, Juan/K-7943-2014	Popoff, Michel/0000-0001-9305-8989; Dorca, Jonatan/0000-0001-7606-0462; Blasi, Juan/0000-0002-0482-9444	MINECO, Spanish Government) [SAF2011-27566]; AGAUR (Generalitat de Catalunya) [2009 SGR 152]	MINECO, Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This work was supported by grant SAF2011-27566 (MINECO, Spanish Government) and grant 2009 SGR 152 from AGAUR (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUXTON D, 1976, J COMP PATHOL, V86, P67, DOI 10.1016/0021-9975(76)90029-3; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; Femandez-Miyakawa ME, 2008, VET MICROBIOL, V127, P379, DOI 10.1016/j.vetmic.2007.09.013; Miyakawa MEF, 2011, HUM EXP TOXICOL, V30, P275, DOI 10.1177/0960327110371700; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P4282, DOI 10.1128/IAI.00562-07; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P1443, DOI 10.1128/IAI.01672-06; Finnie JW, 1999, J COMP PATHOL, V120, P415, DOI 10.1053/jcpa.1998.0289; Finnie JW, 2004, ANAEROBE, V10, P145, DOI 10.1016/j.anaerobe.2003.08.003; FINNIE JW, 1984, J COMP PATHOL, V94, P445, DOI 10.1016/0021-9975(84)90031-8; FINNIE JW, 1992, AUST VET J, V69, P261, DOI 10.1111/j.1751-0813.1992.tb09878.x; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; GRINER LA, 1961, AM J VET RES, V22, P443; HUNTER SEC, 1992, INFECT IMMUN, V60, P102, DOI 10.1128/IAI.60.1.102-110.1992; Ivie SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017787; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Lonchamp E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013046; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyamoto O, 1998, INFECT IMMUN, V66, P2501, DOI 10.1128/IAI.66.6.2501-2508.1998; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; MORGAN KT, 1975, J COMP PATHOL, V85, P461, DOI 10.1016/0021-9975(75)90034-1; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Oyston PCF, 1998, MICROBIOL-SGM, V144, P333, DOI 10.1099/00221287-144-2-333; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Pelish TM, 2009, J BIOL CHEM, V284, P29446, DOI 10.1074/jbc.M109.021782; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Robertson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022053; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Shimamoto S, 2005, MICROBIOL IMMUNOL, V49, P245, DOI 10.1111/j.1348-0421.2005.tb03726.x; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Stiles BG, 2013, TOXINS, V5, P2138, DOI 10.3390/toxins5112138; Tamai E, 2003, INFECT IMMUN, V71, P5371, DOI 10.1128/IAI.71.9.5371-5375.2003; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; WORTHINGTON R W, 1975, Onderstepoort Journal of Veterinary Research, V42, P25; Zhu C, 2001, EXP NEUROL, V169, P72, DOI 10.1006/exnr.2001.7652	48	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102417	10.1371/journal.pone.0102417	http://dx.doi.org/10.1371/journal.pone.0102417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013927	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400093
J	Garrison-Schilling, KL; Kaluskar, ZM; Lambert, B; Pettis, GS				Garrison-Schilling, Katherine L.; Kaluskar, Zelam M.; Lambert, Bliss; Pettis, Gregg S.			Genetic Analysis and Prevalence Studies of the brp Exopolysaccharide Locus of Vibrio vulnificus	PLOS ONE			English	Article							PHASE VARIATION; CAPSULAR POLYSACCHARIDES; COLONY MORPHOLOGY; ESCHERICHIA-COLI; IDENTIFICATION; VIRULENCE; PATHOGENESIS; BIOFILMS; BIOSYNTHESIS; MUTAGENESIS	Phase variation in the Gram-negative human pathogen Vibrio vulnificus involves three colonial morphotypes-smooth opaque colonies due to production of capsular polysaccharide (CPS), smooth translucent colonies as the result of little or no CPS expression, and rugose colonies due to production of a separate extracellular polysaccharide (EPS), which greatly enhances biofilm formation. Previously, it was shown that the brp locus, which consists of nine genes arranged as an operon, is up-regulated in rugose strains in a c-di-GMP-dependent manner, and that plasmid insertions into the locus resulted in loss of rugosity and efficient biofilm production. Here, we have used non-polar mutagenesis to assess the involvement of individual brp genes in production of EPS and related phenotypes. Inactivation of genes predicted to be involved in various stages of EPS biosynthesis eliminated both the rugose colonial appearance and production of EPS, while knockout of a predicted flippase function involved in EPS transport resulted in a dry, lightly striated phenotype, which was associated with a reduction of brp-encoded EPS on the cell surface. All brp mutants retained the reduced motility characteristic of rugose strains. Lastly, we provide evidence that the brp locus is highly prevalent among strains of V.vulnificus.	[Garrison-Schilling, Katherine L.; Kaluskar, Zelam M.; Lambert, Bliss; Pettis, Gregg S.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Pettis, GS (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	gpettis@lsu.edu	Kaluskar, Zelam/AAE-3759-2020	Kaluskar, Zelam/0000-0002-2826-1769	Louisiana Sea Grant College Program; National Oceanic and Atmospheric Administration Office of Sea Grant, Department of Commerce [NA06OAR4170022, R/PMO-21]; Louisiana State University	Louisiana Sea Grant College Program; National Oceanic and Atmospheric Administration Office of Sea Grant, Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA); Louisiana State University	This work was supported by the Louisiana Sea Grant College Program (http://www.laseagrant.org/) with funds from the National Oceanic and Atmospheric Administration Office of Sea Grant, Department of Commerce, under grant no. NA06OAR4170022, project no. R/PMO-21 and Louisiana State University. Statements, findings, conclusions, and recommendations are those of the author(s) and do not necessarily reflect the views of either the Louisiana Sea Grant College Program or the U.S. Department of Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; BRASCH MA, 1993, J BACTERIOL, V175, P3067, DOI 10.1128/JB.175.10.3067-3074.1993; Brown RN, 2009, INFECT IMMUN, V77, P3768, DOI 10.1128/IAI.00205-09; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Garrison-Schilling KL, 2011, ENVIRON MICROBIOL, V13, P643, DOI 10.1111/j.1462-2920.2010.02369.x; Grau BL, 2005, J BACTERIOL, V187, P2519, DOI 10.1128/JB.187.7.2519-2525.2005; Grau BL, 2008, INFECT IMMUN, V76, P1485, DOI 10.1128/IAI.01289-07; Gulig PA, 2005, J MICROBIOL, V43, P118; Guo YZ, 2011, ENVIRON MICROBIOL, V13, P2888, DOI 10.1111/j.1462-2920.2011.02564.x; Guo YZ, 2010, INFECT IMMUN, V78, P1390, DOI 10.1128/IAI.01188-09; Hilton T, 2006, APPL ENVIRON MICROB, V72, P6986, DOI 10.1128/AEM.00544-06; Hong YQ, 2014, J BACTERIOL, V196, P1713, DOI 10.1128/JB.01323-13; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Islam ST, 2013, MBIO, V4, DOI 10.1128/mBio.00678-13; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kajimura J, 2005, J BACTERIOL, V187, P6917, DOI 10.1128/JB.187.20.6917-6927.2005; KELLEY JT, 1981, J BACTERIOL, V145, P1018, DOI 10.1128/JB.145.2.1018-1024.1981; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; MARTIN SJ, 1991, J CLIN MICROBIOL, V29, P1684, DOI 10.1128/JCM.29.8.1684-1688.1991; MENARD R, 1993, J BACTERIOL, V175, P5899; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanjuan E, 2004, APPL ENVIRON MICROB, V70, P7024, DOI 10.1128/AEM.70.12.7024-7032.2004; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SIMPSON LM, 1987, INFECT IMMUN, V55, P269, DOI 10.1128/IAI.55.1.269-272.1987; Smith AB, 2003, INFECT IMMUN, V71, P1091, DOI 10.1128/IAI.71.3.1091-1097.2003; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wright AC, 2001, INFECT IMMUN, V69, P6893, DOI 10.1128/IAI.69.11.6893-6901.2001; YOSHIDA SI, 1985, INFECT IMMUN, V47, P446, DOI 10.1128/IAI.47.2.446-451.1985; ZAKARIAMEEHAN Z, 1988, INFECT IMMUN, V56, P275, DOI 10.1128/IAI.56.1.275-277.1988; Zuppardo AB, 1998, INFECT IMMUN, V66, P2601, DOI 10.1128/IAI.66.6.2601-2606.1998	43	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100890	10.1371/journal.pone.0100890	http://dx.doi.org/10.1371/journal.pone.0100890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013926	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400015
J	Suweis, S; D'Odorico, P				Suweis, Samir; D'Odorico, Paolo			Early Warning Signs in Social-Ecological Networks	PLOS ONE			English	Article							REGIME SHIFTS; INDICATORS; VARIANCE	A number of social-ecological systems exhibit complex behaviour associated with nonlinearities, bifurcations, and interaction with stochastic drivers. These systems are often prone to abrupt and unexpected instabilities and state shifts that emerge as a discontinuous response to gradual changes in environmental drivers. Predicting such behaviours is crucial to the prevention of or preparation for unwanted regime shifts. Recent research in ecology has investigated early warning signs that anticipate the divergence of univariate ecosystem dynamics from a stable attractor. To date, leading indicators of instability in systems with multiple interacting components have remained poorly investigated. This is a major limitation in the understanding of the dynamics of complex social-ecological networks. Here, we develop a theoretical framework to demonstrate that rising variance-measured, for example, by the maximum element of the covariance matrix of the network-is an effective leading indicator of network instability. We show that its reliability and robustness depend more on the sign of the interactions within the network than the network structure or noise intensity. Mutualistic, scale free and small world networks are less stable than their antagonistic or random counterparts but their instability is more reliably predicted by this leading indicator. These results provide new advances in multidimensional early warning analysis and offer a framework to evaluate the resilience of social-ecological networks.	[Suweis, Samir] Univ Padua, Dept Phys, Padua, Italy; [D'Odorico, Paolo] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	University of Padua; University of Virginia	D'Odorico, P (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	paolo@virginia.edu	D'Odorico, Paolo/A-5836-2008	D'Odorico, Paolo/0000-0002-0007-5833; Suweis, Samir/0000-0002-1603-8375				Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Berkes F., 2000, LINKING SOCIAL ECOLO; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Brock WA, 2006, ECOL SOC, V11; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Colbaugh Richard, 2012, SECURITY INFORM, V1, P1, DOI DOI 10.1186/2190-8532-1-18; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2012, ECOLOGY, V93, P264, DOI 10.1890/11-0889.1; Davis KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053723; Gardiner C.W., 1986, HDB STOCHASTIC METHO; Horsthemke W., 1984, NOISE INDUCED TRANSI; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kuehn C, 2014, ARXIV14017125; Kuehn C, 2014, J COMPLEX NETW, V2, P141, DOI 10.1093/comnet/cnt022; Lade SJ, 2013, THEOR ECOL-NETH, V6, P359, DOI 10.1007/s12080-013-0187-3; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Suweis S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046837; Suweis S, 2014, OIKOS, V123, P525, DOI 10.1111/j.1600-0706.2013.00822.x; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Suweis S, 2013, P NATL ACAD SCI USA, V110, P4230, DOI 10.1073/pnas.1222452110; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Walker B., 2006, RESILIENCE THINKING	33	31	32	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101851	10.1371/journal.pone.0101851	http://dx.doi.org/10.1371/journal.pone.0101851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013901	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400043
J	Edwards, JK; Cole, SR; Westreich, D; Moore, R; Mathews, C; Geng, E; Eron, JJ; Mugavero, MJ				Edwards, Jessie K.; Cole, Stephen R.; Westreich, Daniel; Moore, Richard; Mathews, Christopher; Geng, Elvin; Eron, Joseph J.; Mugavero, Michael J.		CNICS Res Network	Loss to Clinic and Five-Year Mortality among HIV-Infected Antiretroviral Therapy Initiators	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; FOLLOW-UP; PRIMARY-CARE; RETENTION; PROGRAMS; AFRICA; NONADHERENCE; PREVENTION; SURVIVAL; OUTCOMES	Missing outcome data due to loss to follow-up occurs frequently in clinical cohort studies of HIV-infected patients. Censoring patients when they become lost can produce inaccurate results if the risk of the outcome among the censored patients differs from the risk of the outcome among patients remaining under observation. We examine whether patients who are considered lost to follow up are at increased risk of mortality compared to those who remain under observation. Patients from the US Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) who newly initiated combination antiretroviral therapy between January 1, 1998 and December 31, 2009 and survived for at least one year were included in the study. Mortality information was available for all participants regardless of continued observation in the CNICS. We compare mortality between patients retained in the cohort and those lost-to-clinic, as commonly defined by a 12-month gap in care. Patients who were considered lost-to-clinic had modestly elevated mortality compared to patients who remained under observation after 5 years (risk ratio (RR): 1.2; 95% CI: 0.9, 1.5). Results were similar after redefining loss-to-clinic as 6 months (RR: 1.0; 95% CI: 0.8, 1.3) or 18 months (RR: 1.2; 95% CI: 0.8, 1.6) without a documented clinic visit. The small increase in mortality associated with becoming lost to clinic suggests that these patients were not lost to care, rather they likely transitioned to care at a facility outside the study. The modestly higher mortality among patients who were lost-to-clinic implies that when we necessarily censor these patients in studies of time-varying exposures, we are likely to incur at most a modest selection bias.	[Edwards, Jessie K.; Cole, Stephen R.; Westreich, Daniel] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Moore, Richard] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Mathews, Christopher] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Geng, Elvin] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Eron, Joseph J.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Mugavero, Michael J.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alabama System; University of Alabama Birmingham	Edwards, JK (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	jessedwards@unc.edu		Edwards, Jessie/0000-0002-1741-335X; Westreich, Daniel/0000-0003-3069-1650	National Institutes of Health [NIH R01AI100654, NIH R24AI067039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, P30AI050410, R01AI100654, U01AI069918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health [NIH R01AI100654 and NIH R24AI067039]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2012, AM J EPIDEMIOL, V175, P1080, DOI 10.1093/aje/kwr444; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hill T, 2010, J CLIN EPIDEMIOL, V63, P1101, DOI 10.1016/j.jclinepi.2009.12.007; Horberg MA, 2013, AIDS PATIENT CARE ST, V27, P442, DOI 10.1089/apc.2013.0073; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kitahata MM, 2008, INT J EPIDEMIOL, V37, P948, DOI 10.1093/ije/dym231; Klein JP, 2005, SURVIVAL ANAL TECHNI; Lanoy E, 2009, HIV MED, V10, P236, DOI 10.1111/j.1468-1293.2008.00678.x; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sitapati AM, 2012, J HEALTH CARE POOR U, V23, P81, DOI 10.1353/hpu.2012.0139; Toh S, 2010, EPIDEMIOLOGY, V21, P528, DOI 10.1097/EDE.0b013e3181df1b69; Westreich D, 2010, AM J EPIDEMIOL, V171, P691, DOI 10.1093/aje/kwp418; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102305	10.1371/journal.pone.0102305	http://dx.doi.org/10.1371/journal.pone.0102305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010739	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800089
J	Silhavy, J; Zidek, V; Mlejnek, P; Landa, V; Simakova, M; Strnad, H; Oliyarnyk, O; Skop, V; Kazdova, L; Kurtz, T; Pravenec, M				Silhavy, Jan; Zidek, Vaclav; Mlejnek, Petr; Landa, Vladimir; Simakova, Miroslava; Strnad, Hynek; Oliyarnyk, Olena; Skop, Vojtech; Kazdova, Ludmila; Kurtz, Theodore; Pravenec, Michal			Fumaric Acid Esters Can Block Pro-Inflammatory Actions of Human CRP and Ameliorate Metabolic Disturbances in Transgenic Spontaneously Hypertensive Rats	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FALSE DISCOVERY RATE; DIMETHYL FUMARATE; OXIDATIVE STRESS; NICOTINIC-ACID; GPR109A; INNATE	Inflammation and oxidative stress have been implicated in the pathogenesis of metabolic disturbances. Esters of fumaric acid, mainly dimethyl fumarate, exhibit immunomodulatory, anti-inflammatory, and anti-oxidative effects. In the current study, we tested the hypothesis that fumaric acid ester (FAE) treatment of an animal model of inflammation and metabolic syndrome, the spontaneously hypertensive rat transgenically expressing human C-reactive protein (SHR-CRP), will ameliorate inflammation, oxidative stress, and metabolic disturbances. We studied the effects of FAE treatment by administering Fumaderm, 10 mg/kg body weight for 4 weeks, to male SHR-CRP. Untreated male SHR-CRP rats were used as controls. All rats were fed a high sucrose diet. Compared to untreated controls, rats treated with FAE showed significantly lower levels of endogenous CRP but not transgenic human CRP, and amelioration of inflammation (reduced levels of serum IL6 and TNF alpha) and oxidative stress (reduced levels of lipoperoxidation products in liver, heart, kidney, and plasma). FAE treatment was also associated with lower visceral fat weight and less ectopic fat accumulation in liver and muscle, greater levels of lipolysis, and greater incorporation of glucose into adipose tissue lipids. Analysis of gene expression profiles in the liver with Affymetrix arrays revealed that FAE treatment was associated with differential expression of genes in pathways that involve the regulation of inflammation and oxidative stress. These findings suggest potentially important antiinflammatory, anti-oxidative, and metabolic effects of FAE in a model of inflammation and metabolic disturbances induced by human CRP.	[Silhavy, Jan; Zidek, Vaclav; Mlejnek, Petr; Landa, Vladimir; Simakova, Miroslava; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Strnad, Hynek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Oliyarnyk, Olena; Skop, Vojtech; Kazdova, Ludmila] Inst Clin & Expt Med, Ctr Med Expt, Prague, Czech Republic; [Kurtz, Theodore] Univ Calif San Francisco, San Francisco, CA 94143 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM); University of California System; University of California San Francisco	Pravenec, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	pravenec@biomed.cas.cz	Strnad, Hynek/B-7361-2008; Pravenec, Michal/B-1666-2012; Simakova, Miroslava/B-7493-2012; Landa, Vladimir/B-8908-2012; Zidek, Vaclav/C-6685-2012; Oliyarnyk, Olena/Q-6380-2019; Simakova, Miroslava/R-5367-2019; Mlejnek, Petr/C-2305-2012; Silhavy, Jan/B-5292-2014	Strnad, Hynek/0000-0002-0141-8340; Pravenec, Michal/0000-0001-9197-5871; Simakova, Miroslava/0000-0003-1468-5832; Mlejnek, Petr/0000-0002-4218-8983; Silhavy, Jan/0000-0001-8042-5890; Skop, Vojtech/0000-0002-4685-4429; Oliyarnyk, Olena/0000-0002-4912-6187	Ministry of Health of the Czech Republic [NT/14325]; MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM") [IN 0002301]; Ministry Education, Youth and Sports of the Czech Republic [LH12061, LL1204]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM"); Ministry Education, Youth and Sports of the Czech Republic	This study was supported by grant NT/14325 from the Ministry of Health of the Czech Republic, grant MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM, IN 0002301") and grants LH12061 to VL and LL1204 (within the ERC CZ program) from the Ministry Education, Youth and Sports of the Czech Republic to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Benes J, 2011, CLIN SCI, V121, P29, DOI 10.1042/CS20100527; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238; Chai JT, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0325-9; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Foresti R, 2013, PHARMACOL RES, V76, P132, DOI 10.1016/j.phrs.2013.07.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanson J, 2010, J CLIN INVEST, V120, P2910, DOI 10.1172/JCI42273; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Litjens Nicolle H. R., 2004, BMC Pharmacology, V4, P22, DOI 10.1186/1471-2210-4-22; Malinska H, 2010, MOL CELL BIOCHEM, V335, P119, DOI 10.1007/s11010-009-0248-5; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meissner M, 2012, J DTSCH DERMATOL GES, V10, P793, DOI 10.1111/j.1610-0387.2012.07996.x; Paraskevas KI, 2008, CURR MED RES OPIN, V24, P75, DOI 10.1185/030079908X253654; Pravenec M, 2011, HYPERTENSION, V57, P731, DOI 10.1161/HYPERTENSIONAHA.110.164350; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Silhavy J, 2014, CARDIOVASC THER, V32, P59, DOI 10.1111/1755-5922.12061; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Zhang KM, 2011, J CELL BIOCHEM, V112, P488, DOI 10.1002/jcb.22936	32	18	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101906	10.1371/journal.pone.0101906	http://dx.doi.org/10.1371/journal.pone.0101906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010431	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800051
J	Li, C; Xu, XF; Wang, XJ; Pan, YJ				Li, Chang; Xu, Xiaofei; Wang, Xiu Jun; Pan, Yuanjiang			Imine Resveratrol Analogues: Molecular Design, Nrf2 Activation and SAR Analysis	PLOS ONE			English	Article							CANCER PREVENTION; EPITHELIAL-CELLS; HEME OXYGENASE-1; PATHWAY; INDUCTION; PHYTOCHEMICALS; DERIVATIVES; EXPRESSION; PROTECT; ENZYMES	Resveratrol is a natural phenol with protective effects against cancer and inflammation-related diseases. Its mechanism of action involves the activation of nuclear factor E2 p45-related factor 2 (Nrf2), which plays a key role in regulation of genes driven by antioxidant response element (ARE). Inspired by the effect of resveratrol, here we synthesized a series of imine resveratrol analogs (IRAs), evaluated their abilities to activate Nrf2 by using cell based ARE-reporter assay. After the first-round screening, preliminary and quantitative structure-activity relationship (SAR) was analyzed, and the structural features determining Nrf2 activation ability were proposed. Two novel IRAs were designed and subsequently synthesized, namely 2-methoxyl-3,6-dihydroxyl-IRA and 2,3,6-trihydroxyl-IRA. They were proved to be the most potent Nrf2 activators among the IRAs.	[Li, Chang; Xu, Xiaofei; Pan, Yuanjiang] Zhejiang Univ, Dept Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xiu Jun] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, XJ (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310003, Zhejiang, Peoples R China.	xjwang@zju.edu.cn; panyuanjiang@zju.edu.cn	Li, Chang/AAP-7203-2020	Li, Chang/0000-0003-4681-0191	Joint Sino-German Research Project [GZ689]; Ministry of Commerce; PRC (Research and Development of Natural Herbal Medicine Phase II, a Technology Aid Project to Republic of Indonesia); Science and Technology Department of Zhejiang Province, China [2010C33156]; National Natural Science Foundation of China [81172230]; Zhejiang Natural Science Foundation [LZ12H16001]	Joint Sino-German Research Project; Ministry of Commerce; PRC (Research and Development of Natural Herbal Medicine Phase II, a Technology Aid Project to Republic of Indonesia); Science and Technology Department of Zhejiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was financially supported from Joint Sino-German Research Project (GZ689), Ministry of Commerce, PRC (Research and Development of Natural Herbal Medicine Phase II, a Technology Aid Project to Republic of Indonesia), Science and Technology Department of Zhejiang Province, China (2010C33156), the National Natural Science Foundation of China (81172230) and the Zhejiang Natural Science Foundation (LZ12H16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 2013, CHEM RES TOXICOLOGY; Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Akiyama T, 2008, ADV SYNTH CATAL, V350, P399, DOI 10.1002/adsc.200700521; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bishayee A, 2010, CANCER PREV RES, V3, P753, DOI 10.1158/1940-6207.CAPR-09-0171; Cheung KL, 2011, CHEM RES TOXICOL, V24, P670, DOI 10.1021/tx1004369; Dinikova-Kostova AT, 2004, METHOD ENZYMOL, V382, P423; Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Hsieh Tze-chen, 2006, Med Chem, V2, P275, DOI 10.2174/157340606776930709; Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jiang LY, 2010, J AGR FOOD CHEM, V58, P9020, DOI 10.1021/jf102005z; Juan Andres R, 2008, EUROPEAN J PHARM, V591, P66; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kumar V, 2011, J MED CHEM, V54, P4147, DOI 10.1021/jm2002348; Lee CY, 2010, EUR J MED CHEM, V45, P2957, DOI 10.1016/j.ejmech.2010.03.023; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lu J, 2012, BIOORG MED CHEM LETT, V22, P5744, DOI 10.1016/j.bmcl.2012.06.026; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nair S, 2006, PHARM RES-DORDR, V23, P2621, DOI 10.1007/s11095-006-9099-x; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Tanaka K, 2000, GREEN CHEM, V2, P272, DOI 10.1039/b006424f; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Umar A, 2012, NAT REV CANCER, V12, P835, DOI 10.1038/nrc3397; Vrba J, 2013, J MED CHEM, V56, P856, DOI 10.1021/jm3013344; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Xi MY, 2013, EUR J MED CHEM, V66, P364, DOI 10.1016/j.ejmech.2013.06.007; Yamanaka M, 2007, J AM CHEM SOC, V129, P6756, DOI 10.1021/ja0684803	33	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101455	10.1371/journal.pone.0101455	http://dx.doi.org/10.1371/journal.pone.0101455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028928	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600016
J	Moran, JL; Solomon, PJ				Moran, John L.; Solomon, Patricia J.		ANZICS	Fixed Effects Modelling for Provider Mortality Outcomes: Analysis of the Australia and New Zealand Intensive Care Society (ANZICS) Adult Patient Data-Base	PLOS ONE			English	Article							RISK PREDICTION; CASE-MIX; PERFORMANCE; SURGERY; VOLUME; UNITS; STANDARDIZATION; ADMISSIONS; REGRESSION; MARGINS	Background: Risk adjusted mortality for intensive care units (ICU) is usually estimated via logistic regression. Random effects (RE) or hierarchical models have been advocated to estimate provider risk-adjusted mortality on the basis that standard estimators increase false outlier classification. The utility of fixed effects (FE) estimators (separate ICU-specific intercepts) has not been fully explored. Methods: Using a cohort from the Australian and New Zealand Intensive Care Society Adult Patient Database, 2009-2010, the model fit of different logistic estimators (FE, random-intercept and random-coefficient) was characterised: Bayesian Information Criterion (BIC; lower values better), receiver-operator characteristic curve area (AUC) and Hosmer-Lemeshow (H-L) statistic. ICU standardised hospital mortality ratios (SMR) and 95% CI were compared between models. ICU site performance (FE), relative to the grand observation-weighted mean (GO-WM) on odds ratio (OR), risk ratio (RR) and probability scales were assessed using model-based average marginal effects (AME). Results: The data set consisted of 145355 patients in 128 ICUs, years 2009 (47.5%) & 2010 (52.5%), with mean(SD) age 60.9(18.8) years, 56% male and ICU and hospital mortalities of 7.0% and 10.9% respectively. The FE model had a BIC = 64058, AUC = 0.90 and an H-L statistic P-value = 0.22. The best-fitting random-intercept model had a BIC = 64457, AUC = 0.90 and H-L statistic P-value = 0.32 and random-coefficient model, BIC = 64556, AUC = 0.90 and H-L statistic P-value = 0.28. Across ICUs and over years no outliers (SMR 95% CI excluding null-value = 1) were identified and no model difference in SMR spread or 95% CI span was demonstrated. Using AME (OR and RR scale), ICU site-specific estimates diverged from the GO-WM, and the effect spread decreased over calendar years. On the probability scale, a majority of ICUs demonstrated calendar year decrease, but in the for-profit sector, this trend was reversed. Conclusions: The FE estimator had model advantage compared with conventional RE models. Using AME, between and over-year ICU site-effects were easily characterised.	[Moran, John L.] Queen Elizabeth Hosp, Dept Intens Care Med, Woodville, SA 5011, Australia; [Solomon, Patricia J.] Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia; [ANZICS] Australian & New Zealand Intens Care Soc, Carlton, Vic, Australia	University of Adelaide	Moran, JL (corresponding author), Queen Elizabeth Hosp, Dept Intens Care Med, Woodville, SA 5011, Australia.	john.moran@adelaide.edu.au						Alexandrescu R, 2011, J AM COLL SURGEONS, V213, P392, DOI 10.1016/j.jamcollsurg.2011.06.423; Angrist JD, 2001, J BUS ECON STAT, V19, P2, DOI 10.1198/07350010152472571; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P293; ANZICS Centre for Outcome and Resource Evaluation (CORE) of the Australian and New Zealand Intensive Care Society (ANZICS), 2012, APD DAT DICT VERS 3; Ash AS, 2012, STAT ISSUES ASSESSIN; Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443; Bartus T, 2005, STATA J, V5, P309, DOI 10.1177/1536867X0500500303; Bryan ML, 2013, ISER WORKING PAPER S, V2013, P14; Cameron CC, 2010, MICROECONOMICS USING, P319; CHAN CK, 1988, J CLIN EPIDEMIOL, V41, P1125, DOI 10.1016/0895-4356(88)90082-0; CHANG IM, 1982, J CHRON DIS, V35, P669, DOI 10.1016/0021-9681(82)90019-4; Christiansen CL, 1997, ANN INTERN MED, V127, P764, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00065; Clarke PS, 2010, BIOSTATISTICS, V11, P756, DOI 10.1093/biostatistics/kxq024; Cohen ME, 2009, J AM COLL SURGEONS, V209, P687, DOI 10.1016/j.jamcollsurg.2009.08.020; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Fielding A., 2004, MULTILEVEL MODELLING, V16; GABRIEL KR, 1990, STAT MED, V9, P469, DOI 10.1002/sim.4780090502; Gelman A, 2007, DATA ANAL USING REGR, P79; Glance LG, 2006, MED CARE, V44, P311, DOI 10.1097/01.mlr.0000204106.64619.2a; Glance LG, 2003, INTENS CARE MED, V29, P2223, DOI 10.1007/s00134-003-1959-9; GOLDSTEIN H, 1995, J ROY STAT SOC A STA, V158, P175, DOI 10.2307/2983411; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Greene W., 2001, ESTIMATING ECONOMETR; Grunkemeier GL, 2007, ANN THORAC SURG, V83, P1240, DOI 10.1016/j.athoracsur.2006.12.080; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Hannan EL, 2005, MED CARE, V43, P726, DOI 10.1097/01.mlr.0000167802.27044.44; Harrell FE, 2001, REGRESSION MODELING; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Hosmer DW, 1997, STAT MED, V16, P1303; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kalbfleisch J, 2013, STAT BIOSCI, P1; Kasza J, 2013, STAT MED, V32, P3720, DOI 10.1002/sim.5779; Kipnis P, 2010, MED CARE, V48, P458, DOI 10.1097/MLR.0b013e3181d5fe8f; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; MacKenzie TA, 2012, ANN THORAC SURG, V93, P1416, DOI 10.1016/j.athoracsur.2011.12.094; Madigan D, 2013, AM J EPIDEMIOL; Mitchell NM, 2012, INTERPRET INTERPRETI, P167; Mohammed MA, 2008, ANN THORAC SURG, V86, P348, DOI 10.1016/j.athoracsur.2007.10.028; Mohammed MA, 2012, STAT METHODS MED RES; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Moore L, 2010, J TRAUMA, V69, P1132, DOI 10.1097/TA.0b013e3181cc8449; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Moran JL, 2012, CRIT CARE MED, V40, P800, DOI 10.1097/CCM.0b013e318236f2af; Moran JL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-32; Mroz TA, 2008, REV ECON STAT, V90, P406, DOI 10.1162/rest.90.3.406; Mukamel DB, 2010, AM J PUBLIC HEALTH, V100, P264, DOI 10.2105/AJPH.2008.153759; Muller CJ, 2014, INT J EPIDEMIOL; Mustillo S, 2012, SOCIOL METHOD RES, V41, P467, DOI 10.1177/0049124112452397; Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Norton E. C, 2012, NBER WORKING PAPER S; OBRIEN BJ, 1994, MED CARE, V32, P150, DOI 10.1097/00005650-199402000-00006; Paul P, 2013, STAT MED, V32, P67, DOI 10.1002/sim.5525; Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rogers WH., 1993, STATA TECHNICAL B RE, V13, P19; ROWAN KM, 1993, BRIT MED J, V307, P972, DOI 10.1136/bmj.307.6910.972; Sanagou M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-28; Shahian DM, 2008, CIRCULATION, V117, P1955, DOI 10.1161/CIRCULATIONAHA.107.747873; Shahian DM, 2005, ANN THORAC SURG, V80, P2106, DOI 10.1016/j.athoracsur.2005.06.078; Silber JH, 2010, HEALTH SERV RES, V45, P1148, DOI 10.1111/j.1475-6773.2010.01130.x; Solomon PJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-53; Spiegelhalter D, 2002, QUAL SAF HEALTH CARE, V11, P390, DOI 10.1136/qhc.11.4.390-a; Stata Corporation, 2013, EST POST COMM; Stata Corporation, 2013, MARG MARG MEANS PRED; Stata Corporation, 2013, RMCOLL REM COLL VAR; Stata Corporation, 2013, PWCOMP PAIRW COMP; Stata Corporation, 2013, NLCOM NONL COMB EST; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; van Gestel YRBM, 2012, MED CARE, V50, P662, DOI 10.1097/MLR.0b013e31824ebd9f; Verbeke G, 2013, BIOSTATISTICS, V14, P477, DOI 10.1093/biostatistics/kxs059; Vittinghoff E, 2012, REGRESSION METHODS B, P331; WAGNER D, 1989, CRIT CARE MED, V17, pS194, DOI 10.1097/00003246-198912001-00008; WILK MB, 1968, BIOMETRIKA, V55, P1; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	81	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102297	10.1371/journal.pone.0102297	http://dx.doi.org/10.1371/journal.pone.0102297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029164	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600058
J	Cho, BJ; Heo, JW; Shin, JP; Ahn, J; Kim, TW; Chung, H				Cho, Bum-Joo; Heo, Jang Won; Shin, Jae Pil; Ahn, Jeeyun; Kim, Tae Wan; Chung, Hum			Association between Reproductive Factors and Age-Related Macular Degeneration in Postmenopausal Women: The Korea National Health and Nutrition Examination Survey 2010-2012	PLOS ONE			English	Article							RISK-FACTORS; HORMONE REPLACEMENT; VISUAL IMPAIRMENT; MACULOPATHY; LACTATION; PREVALENCE; ESTROGEN; THERAPY; EYE; POPULATION	Purpose: To examine the association between female reproductive factors and age-related macular degeneration (AMD) in postmenopausal women. Design: Nationwide population-based cross-sectional study. Methods: A nationally representative dataset acquired from the 2010-2012 Korea National Health and Nutrition Examination Survey was analyzed. The dataset involved information for 4,377 postmenopausal women aged >= 50 years with a fundus photograph evaluable for AMD in either eye. All participants were interviewed using standardized questionnaires to determine reproductive factors including menstruation, pregnancy, parity, lactation, and hormonal use. The association between reproductive factors and each type of AMD was investigated. Results: The mean age of the study participants was 63.1 +/- 0.2 years. Mean ages at menarche and menopause were 16.1 +/- 0.0 and 49.2 +/- 0.1 years, respectively. The overall prevalence rates of early and late AMD were 11.2% (95% confidence interval [CI], 10.1-12.5) and 0.8% (95% CI, 0.5-1.2), respectively. When adjusted for age, neither smoking nor alcohol use was associated with the presence of any AMD or late AMD. Multivariate logistic regression analysis revealed age (OR, 1.12 per 1 year), duration of lactation (OR, 0.91 per 6 months), and duration of use of oral contraceptive pills (OCP) (OR, 1.10 per 6 months) as associated factors for late AMD. The other variables did not yield a significant correlation with the risk of any AMD or late AMD. Conclusion: After controlling for confounders, a longer duration of lactation appeared to protect against the development of late AMD. A longer duration of OCP use was associated with a higher risk of late AMD.	[Cho, Bum-Joo; Heo, Jang Won; Ahn, Jeeyun; Kim, Tae Wan; Chung, Hum] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Cho, Bum-Joo; Heo, Jang Won; Chung, Hum] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Shin, Jae Pil] Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, Taegu, South Korea; [Ahn, Jeeyun; Kim, Tae Wan] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; Seoul National University (SNU); Seoul National University Hospital	Heo, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	jangwonheo@gmail.com		Ahn, Jeeyun/0000-0001-9017-1652; Cho, Bum-Joo/0000-0002-0244-388X				Abramov Y, 2004, MENOPAUSE, V11, P62, DOI 10.1097/01.GME.0000074701.19603.11; [Anonymous], 2013, AM J OPHTHALMOL; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cheung CMG, 2013, AM J OPHTHALMOL, V155, P764, DOI 10.1016/j.ajo.2012.10.013; Cho BJ, 2014, INVEST OPHTH VIS SCI, V55, P1101, DOI 10.1167/iovs.13-13096; Christin-Maitre S, 2013, BEST PRACT RES CL EN, V27, P3, DOI 10.1016/j.beem.2012.11.004; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Connell PP, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/360764; Edwards DRV, 2010, INVEST OPHTH VIS SCI, V51, P1873, DOI 10.1167/iovs.09-4000; Erke MG, 2013, BRIT J OPHTHALMOL, V97, P1036, DOI 10.1136/bjophthalmol-2012-302461; Fagerhaug TN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1070; Feskanich D, 2008, ARCH OPHTHALMOL-CHIC, V126, P519, DOI 10.1001/archopht.126.4.519; Fraser-Bell S, 2006, AM J OPHTHALMOL, V141, P79, DOI 10.1016/j.ajo.2005.08.024; Gemmy Cheung CM, 2013, AM J OPHTHALMOL, V155, pe761; Haan MN, 2006, ARCH OPHTHALMOL-CHIC, V124, P988, DOI 10.1001/archopht.124.7.988; KJOS SL, 1993, OBSTET GYNECOL, V82, P451; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; Klein R, 2003, OPHTHALMOLOGY, V110, P636, DOI 10.1016/S0161-6420(02)01448-3; La Corte AIC, 2008, J RENIN-ANGIO-ALDO S, V9, P221, DOI 10.1177/1470320308096405; McClure CK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.030; Nirmalan PK, 2004, INVEST OPHTH VIS SCI, V45, P4273, DOI 10.1167/iovs.04-0285; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P1740, DOI 10.1167/iovs.02-0775; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Schwarz EB, 2009, OBSTET GYNECOL, V113, P974, DOI 10.1097/01.AOG.0000346884.67796.ca; Sitruk-Ware R, 2013, BEST PRACT RES CL EN, V27, P13, DOI 10.1016/j.beem.2012.09.004; Smith W, 1997, AUST NZ J OPHTHALMOL, V25, pS13; Snow KK, 2002, AM J OPHTHALMOL, V134, P842, DOI 10.1016/S0002-9394(02)01755-5; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Urrutia RP, 2013, OBSTET GYNECOL, V122, P380, DOI 10.1097/AOG.0b013e3182994c43; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; Wiegratz I, 2004, CONTRACEPTION, V70, P97, DOI 10.1016/j.contraception.2004.03.004; Williams MJA, 2006, J EPIDEMIOL COMMUN H, V60, P146, DOI 10.1136/jech.2005.039222; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102816	10.1371/journal.pone.0102816	http://dx.doi.org/10.1371/journal.pone.0102816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025761	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400105
J	Lassen, LM; Nielsen, AZ; Olsen, CE; Bialek, W; Jensen, K; Moller, BL; Jensen, PE				Lassen, Laerke Munter; Nielsen, Agnieszka Zygadlo; Olsen, Carl Erik; Bialek, Wojciech; Jensen, Kenneth; Moller, Birger Lindberg; Jensen, Poul Erik			Anchoring a Plant Cytochrome P450 via PsaM to the Thylakoids in Synechococcus sp PCC 7002: Evidence for Light-Driven Biosynthesis	PLOS ONE			English	Article							PHOTOSYSTEM-I; CYANOBACTERIA; INACTIVATION; COMPLEX; P450	Plants produce an immense variety of specialized metabolites, many of which are of high value as their bioactive properties make them useful as for instance pharmaceuticals. The compounds are often produced at low levels in the plant, and due to their complex structures, chemical synthesis may not be feasible. Here, we take advantage of the reducing equivalents generated in photosynthesis in developing an approach for producing plant bioactive natural compounds in a photosynthetic microorganism by functionally coupling a biosynthetic enzyme to photosystem I. This enables driving of the enzymatic reactions with electrons extracted from the photosynthetic electron transport chain. As a proof of concept, we have genetically fused the soluble catalytic domain of the cytochrome P450 CYP79A1, originating from the endoplasmic reticulum membranes of Sorghum bicolor, to a photosystem I subunit in the cyanobacterium Synechococcus sp. PCC 7002, thereby targeting it to the thylakoids. The engineered enzyme showed light-driven activity both in vivo and in vitro, demonstrating the possibility to achieve light-driven biosynthesis of high-value plant specialized metabolites in cyanobacteria.	[Lassen, Laerke Munter; Nielsen, Agnieszka Zygadlo; Olsen, Carl Erik; Jensen, Kenneth; Moller, Birger Lindberg; Jensen, Poul Erik] Univ Copenhagen, Ctr Synthet Biol BioSYNergy, VILLUM Res Ctr Plant Plast, Copenhagen Plant Sci Ctr,Dept Plant & Environm Sc, Copenhagen, Denmark; [Bialek, Wojciech] Univ Wroclaw, Dept Biophys, Fac Biotechnol, PL-50138 Wroclaw, Poland	University of Copenhagen; University of Wroclaw	Jensen, PE (corresponding author), Univ Copenhagen, Ctr Synthet Biol BioSYNergy, VILLUM Res Ctr Plant Plast, Copenhagen Plant Sci Ctr,Dept Plant & Environm Sc, Copenhagen, Denmark.	peje@plen.ku.dk	Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022; Bialek, Wojciech/R-6858-2019; Jensen, Poul Erik/A-4862-2014; Olsen, Carl E/H-3031-2014; Jensen, Kenneth/G-3638-2011; Bialek, Wojciech/GMX-2583-2022; Zygadlo Nielsen, Agnieszka/J-4850-2016	Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; Bialek, Wojciech/0000-0002-3390-5450; Jensen, Poul Erik/0000-0001-6524-7723; Olsen, Carl E/0000-0002-2275-0596; Jensen, Kenneth/0000-0001-6286-5577; Zygadlo Nielsen, Agnieszka/0000-0002-7948-8912	VILLUM Center of Excellence "Plant Plasticity"; Center of Synthetic Biology "bioSYNergy" - UCPH Excellence Program for Interdisciplinary Research; "Plant Power: Light-driven synthesis of complex terpenoids using cytochrome P450s" - Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies [12-131834]; ERC Advanced Research Grant [323034]; Villum Fonden [00007523] Funding Source: researchfish	VILLUM Center of Excellence "Plant Plasticity"; Center of Synthetic Biology "bioSYNergy" - UCPH Excellence Program for Interdisciplinary Research; "Plant Power: Light-driven synthesis of complex terpenoids using cytochrome P450s" - Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies; ERC Advanced Research Grant; Villum Fonden(Villum Fonden)	The authors gratefully acknowledge financial support from 1) the VILLUM Center of Excellence "Plant Plasticity", 2) Center of Synthetic Biology "bioSYNergy" funded by the UCPH Excellence Program for Interdisciplinary Research, 3) "Plant Power: Light-driven synthesis of complex terpenoids using cytochrome P450s" (12-131834) funded by the Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies and 4) ERC Advanced Research Grant No. 323034 "Light driven P450s". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2008, PLANT PHYSIOL BIOCH, V46, P228, DOI 10.1016/j.plaphy.2007.12.013; Amunts A, 2009, STRUCTURE, V17, P637, DOI 10.1016/j.str.2009.03.006; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; BALANDRIN MF, 1985, SCIENCE, V228, P1154, DOI 10.1126/science.3890182; Bentley FK, 2013, BIOENERG RES, V6, P917, DOI 10.1007/s12155-013-9325-4; Bickley J, 1995, Methods Mol Biol, V46, P141; Chemler JA, 2008, CURR OPIN BIOTECH, V19, P597, DOI 10.1016/j.copbio.2008.10.011; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Frigaard NU, 2004, METH MOL B, V274, P325; Grimme RA, 2008, J AM CHEM SOC, V130, P6308, DOI 10.1021/ja800923y; Hamdane D, 2008, PHOTOSYNTH RES, V98, P657, DOI 10.1007/s11120-008-9322-1; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Jacobsen JH, 2011, PHOTOSYNTH RES, V107, P215, DOI 10.1007/s11120-010-9613-1; Jensen K, 2012, TRENDS PLANT SCI, V17, P60, DOI 10.1016/j.tplants.2011.12.008; Jensen K, 2012, BIOTECHNOL LETT, V34, P239, DOI 10.1007/s10529-011-0768-4; Jensen K, 2011, ACS CHEM BIOL, V6, P533, DOI 10.1021/cb100393j; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; Lassen LM, 2014, ACS SYNTH BIOL, V3, P1, DOI 10.1021/sb400136f; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P10264, DOI 10.1021/bi1016167; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Moal G, 2012, BBA-BIOENERGETICS, V1817, P1635, DOI 10.1016/j.bbabio.2012.05.015; Naithani S, 2000, PHOTOSYNTH RES, V63, P225, DOI 10.1023/A:1006463932538; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nielsen AZ, 2013, ACS SYNTH BIOL, V2, P308, DOI 10.1021/sb300128r; Nielsen KA, 2008, PHYTOCHEMISTRY, V69, P88, DOI 10.1016/j.phytochem.2007.06.033; Oliver JWK, 2014, METAB ENG, V22, P76, DOI 10.1016/j.ymben.2014.01.001; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Rosgaard L, 2012, J BIOTECHNOL, V162, P134, DOI 10.1016/j.jbiotec.2012.05.006; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; STEVENS SE, 1973, J PHYCOL, V9, P427, DOI 10.1111/j.1529-8817.1973.tb04116.x; Utschig LM, 2011, J PHYS CHEM LETT, V2, P236, DOI 10.1021/jz101728v; van Beilen JB, 2003, TRENDS BIOTECHNOL, V21, P170, DOI 10.1016/S0167-7799(03)00032-5; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Xu W, 2001, BBA-BIOENERGETICS, V1507, P32, DOI 10.1016/S0005-2728(01)00208-0; Xue Yusheng, 2013, J APPL PHYCOL, P1	51	32	33	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102184	10.1371/journal.pone.0102184	http://dx.doi.org/10.1371/journal.pone.0102184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025215	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400049
J	Okajima, I; Nakajima, S; Ochi, M; Inoue, Y				Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi			Reducing Dysfunctional Beliefs about Sleep Does Not Significantly Improve Insomnia in Cognitive Behavioral Therapy	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VALIDATION; SCALE; DISTURBANCES; METAANALYSIS; DEPRESSION; ATTITUDES; CRITERIA; VERSION; ADULTS	The present study examined to examine whether improvement of insomnia is mediated by a reduction in sleep-related dysfunctional beliefs through cognitive behavioral therapy for insomnia. In total, 64 patients with chronic insomnia received cognitive behavioral therapy for insomnia consisting of 6 biweekly individual treatment sessions of 50 minutes in length. Participants were asked to complete the Athens Insomnia Scale and the Dysfunctional Beliefs and Attitudes about Sleep scale both at the baseline and at the end of treatment. The results showed that although cognitive behavioral therapy for insomnia greatly reduced individuals' scores on both scales, the decrease in dysfunctional beliefs and attitudes about sleep with treatment did not seem to mediate improvement in insomnia. The findings suggest that sleep-related dysfunctional beliefs endorsed by patients with chronic insomnia may be attenuated by cognitive behavioral therapy for insomnia, but changes in such beliefs are not likely to play a crucial role in reducing the severity of insomnia.	[Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan; [Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi] Yoyogi Sleep Disorder Ctr, Tokyo, Japan	Tokyo Medical University	Okajima, I (corresponding author), Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan.	okajima@somnology.com			(KAKENHI) - Japan Society for the Promotion of Science (JSPS) [25780439]; Grants-in-Aid for Scientific Research [25780439] Funding Source: KAKEN	(KAKENHI) - Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) (KAKENHI) awarded by the Japan Society for the Promotion of Science (JSPS, Grant Number 25780439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASSIFICATION S, Vxviii, P297; American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR, Vxii, P370; Ancoli-Israel S, 1999, SLEEP, V22, pS347; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bastien CH, 2004, J CONSULT CLIN PSYCH, V72, P653, DOI 10.1037/0022-006X.72.4.653; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Carney CE, 2010, J PSYCHOSOM RES, V68, P57, DOI 10.1016/j.jpsychores.2009.08.007; Cohen J., 1988, STAT POWER ANAL BEHA, Vxxi, P567; Edinger JD, 2008, BEHAV THER, V39, P406, DOI 10.1016/j.beth.2007.12.001; Edinger JD, 2000, J CONSULT CLIN PSYCH, V68, P586, DOI 10.1037/0022-006X.68.4.586; Edinger JD, 2001, SLEEP, V24, P591, DOI 10.1093/sleep/24.5.591; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Espie CA, 2001, J CONSULT CLIN PSYCH, V69, P58, DOI 10.1037//0022-006X.69.1.58; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Jansson-Froejmark Markus, 2008, Cognitive Behaviour Therapy, V37, P5, DOI 10.1080/16506070801907013; Kim K, 2000, SLEEP, V23, P41; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 2002, BEHAV RES THER, V40, P741, DOI 10.1016/S0005-7967(01)00055-9; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; Munezawa T., 2009, JPN J SLEEP MED, V3, P396; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Okajima I, 2013, PSYCHIAT RES, V210, P515, DOI 10.1016/j.psychres.2013.06.028; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Okajima I, 2012, J CLIN PSYCHIAT, V73, P377, DOI 10.4088/JCP.10m06286; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Schwartz DR, 2012, CLIN PSYCHOL REV, V32, P664, DOI 10.1016/j.cpr.2012.06.006; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; van Straten A, 2009, SLEEP MED REV, V13, P61, DOI 10.1016/j.smrv.2008.04.006; World Health Organization, 1992, ICD 10 CLASS MENT BE, Vxii, P362; Wu RG, 2006, PSYCHOTHER PSYCHOSOM, V75, P220, DOI 10.1159/000092892	34	20	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102565	10.1371/journal.pone.0102565	http://dx.doi.org/10.1371/journal.pone.0102565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025164	Green Submitted, gold, Green Published			2022-12-27	WOS:000339992400088
J	Estay, SA; Labra, FA; Sepulveda, RD; Bacigalupe, LD				Estay, Sergio A.; Labra, Fabio A.; Sepulveda, Roger D.; Bacigalupe, Leonardo D.			Evaluating Habitat Suitability for the Establishment of Monochamus spp. through Climate-Based Niche Modeling	PLOS ONE			English	Article							PINE WILT DISEASE; POTENTIAL DISTRIBUTION; PEST RISK; SPECIES DISTRIBUTIONS; GLOBAL INVASION; COLEOPTERA; PREDICTION; HYMENOPTERA; TEMPERATURE; ASSESSMENTS	Pine sawyer beetle species of the genus Monochamus are vectors of the nematode pest Bursaphelenchus xylophilus. The introduction of these species into new habitats is a constant threat for those regions where the forestry industry depends on conifers, and especially on species of Pinus. To obtain information about the potential risk of establishment of these insects in Chile, we performed climate-based niche modeling using data for five North American and four Eurasian Monochamus species using a Maxent approach. The most important variables that account for current distribution of these species are total annual precipitation and annual and seasonal average temperatures, with some differences between North American and Eurasian species. Projections of potential geographic distribution in Chile show that all species could occupy at least 37% of the area between 30 degrees and 53 degrees S, where industrial plantations of P. radiata are concentrated. Our results indicated that Chile seems more suitable for Eurasian than for North American species.	[Estay, Sergio A.; Sepulveda, Roger D.; Bacigalupe, Leonardo D.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Labra, Fabio A.] Univ Santo Tomas, Fac Ciencias, Ctr Invest & Innovac Cambio Climat, Santiago, Chile	Universidad Austral de Chile; Universidad Santo Tomas	Estay, SA (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	sergio.estay@uach.cl	Labra, Fabio A/B-6992-2013	Labra, Fabio A/0000-0003-2881-3313; Sepulveda, Roger D./0000-0003-0226-5662; Estay, Sergio/0000-0002-3797-8964	CONICYT [79100021]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funded by CONICYT grant No 79100021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2012, FOREST PATHOL, V42, P89, DOI 10.1111/j.1439-0329.2011.00733.x; [Anonymous], 2010, GLOBAL FOREST RESOUR; BAIN J, 1988, New Zealand Forestry, V32, P19; Baker R. H. A., 2009, Bulletin OEPP, V39, P87, DOI 10.1111/j.1365-2338.2009.02246.x; Bidinger K, 2012, J APPL ENTOMOL, V136, P109, DOI 10.1111/j.1439-0418.2010.01598.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CABI, 2013, INV SPEC COMP; Campbell FT, 2001, BIOSCIENCE, V51, P148, DOI 10.1641/0006-3568(2001)051[0148:TSORAF]2.0.CO;2; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Chen SL, 2010, ACTA ENTOMOL SINICA, V53, P183; Cherepanov AI, 1983, CERAMBYCIDAE NORTHEM, V3; Dillon L. S., 1941, READING PUBLIC MUSEU, V1; Dudik M, 2004, LECT NOTES COMPUT SC, V3120, P472, DOI 10.1007/978-3-540-27819-1_33; Dwinell LD, 1989, SE55 USDA FOREST SER; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; EPPO, 2013, PQR EPPO DAT QUAR PE; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; Ferrada R, 2007, INTERCEPCIONES INSEC; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Geospatial-Intelligence Agency, 2013, GEONET NAMES SERVER; Getty Information Institute, 2013, TGN THESAURUS GEOGRA; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gray GM, 1998, RISK ANAL, V18, P773, DOI 10.1023/B:RIAN.0000005922.65955.69; Herborg L. M., 2009, BIOECONOMICS INVASIV, P63; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; HOSMER DW, 1989, APPL LOGISTIC REGRES; INFOR, 2010, EST FOR CHIL 2008; IPPC (2012) International Standards for Phytosanitary Measures (ISPM) 27, 2012, INT STAND PHYT MEAS; Jikumaru S, 1996, APPL ENTOMOL ZOOL, V31, P145, DOI 10.1303/aez.31.145; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Koch FH, 2008, ENVIRON ENTOMOL, V37, P442, DOI 10.1603/0046-225X(2008)37[442:SAOXGC]2.0.CO;2; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Leung B, 2012, ECOL LETT, V15, P1475, DOI 10.1111/ele.12003; Liebhold A.M., 1995, FOREST SCI MONOGRAPH; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Ma RY, 2006, ENVIRON ENTOMOL, V35, P881, DOI 10.1603/0046-225X-35.4.881; Mack R. N., 2003, Invasive species: vectors and management strategies, P3; MacLeod A, 2002, CROP PROT, V21, P635, DOI 10.1016/S0261-2194(02)00016-9; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; McKenney D, 2003, ENVIRON MONIT ASSESS, V88, P445, DOI 10.1023/A:1025502030803; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Nam Chang Park, 1992, Research Report of the Forestry Research Institute (Seoul), V44, P151; Naves P, 2009, J PEST SCI, V82, P1, DOI 10.1007/s10340-008-0210-4; ODEPA, 2007, 7 CENS NAC AGR FOR; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; PERSHING JC, 1986, ENVIRON ENTOMOL, V15, P251, DOI 10.1093/ee/15.2.251; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimentel D., 2002, BIOL INVASIONS EC EN; Quantum GIS Development Team, 2012, QUANT GIS GEOGR INF; R Core Team, 2021, R LANGUAGE ENV STAT; RUTHERFORD TA, 1987, CAN J FOREST RES, V17, P1050, DOI 10.1139/x87-161; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Stohlgren Thomas J., 2009, P19; Strange JP, 2011, BIOL INVASIONS, V13, P2115, DOI 10.1007/s10530-011-0030-y; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Zhao B.G., 2008, PINE WILT DISEASE, P18; Zhao BG., 2008, PINE WILT DIS; [No title captured]	68	9	12	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102592	10.1371/journal.pone.0102592	http://dx.doi.org/10.1371/journal.pone.0102592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019408	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600096
J	Mayer, J; Thiel, A				Mayer, Jochen; Thiel, Ansgar			Health in Elite Sports from a Salutogenetic Perspective: Athletes' Sense of Coherence	PLOS ONE			English	Article							ANTONOVSKYS SENSE; TREE ANALYSIS; SCALE; CLASSIFICATION; VALIDATION; COMPLAINTS; STABILITY; STRESS; INJURY; WOMEN	Objective: Considering the high number of stressors encountered in the context of elite sports, a high sense of coherence (SOC) is crucial to allow athletes to maintain their health from both short- and long-term perspectives. The aim of this cross-sectional study was to investigate SOC in a population of elite athletes, focusing on identification of subsets of athletes with particularly high and low SOC scores, and any related predictors. The elite athletes' SOC scores were also evaluated for differences with those of the general population of Germany; whether a correlation between SOC and subjective health existed was additionally examined. Method: In total, 698 male and female elite athletes, drawn from Germany's highest-level national track and field squads, and first and second division handball teams, completed a survey that included the SOC-L9 Scale and measures of subjective health, sociodemographic information, and the number of injury lay-offs experienced during the athletes' careers to date. Results: Classification tree analysis reveals six contrast groups with varying SOC scores. Several interacting factors determine the group to which an athlete belongs. Together with overuse injuries, additional factors are age, gender, and completed/not completed apprenticeship/degree. Female athletes aged between 19 and 25, who had already been subject to lay-offs due to overuse injuries, comprise the group with the lowest SOC scores. Overall, the SOC of elite athletes is slightly lower than in the general population. In accordance with other studies, a stronger SOC is also correlated significantly with better global subjective health. Conclusion: The identification of contrast groups with varying SOC scores contributes to the development of more targeted salutogenetic health promotion programs. Such programs would ideally include learning modules pertaining to coping with overuse injuries, as well as social support systems aiming to effectively combine education and elite sport.	[Mayer, Jochen; Thiel, Ansgar] Univ Tubingen, Inst Sports Sci, Tubingen, Germany	Eberhard Karls University of Tubingen	Mayer, J (corresponding author), Univ Tubingen, Inst Sports Sci, Tubingen, Germany.	jochen.mayer@uni-tuebingen.de			Federal Institute of Sports Science (BISp) as part of the German Ministry of the Interior	Federal Institute of Sports Science (BISp) as part of the German Ministry of the Interior	The study was funded by the Federal Institute of Sports Science (BISp) as part of the German Ministry of the Interior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhasawneh MS, 2014, J APPL MATH, DOI 10.1155/2014/929768; Antonovsky A, 1996, HEALTH PROMOT INT, V11, P11, DOI 10.1093/heapro/11.1.11; Antonovsky A, 1987, UNRAVELING MYSTERIES; Bird S, 1998, SPORT INJURIES CAUSE; Buhl A., 2012, SPSS 20 EINFUHRUNG M, V13th ed; Caap-Ahlgren M, 2004, SCAND J CARING SCI, V18, P154, DOI 10.1111/j.1471-6712.2004.00248.x; Camp NJ, 2002, CANCER CAUSE CONTROL, V13, P813, DOI 10.1023/A:1020611416907; Chan F, 2006, DISABIL REHABIL, V28, P257, DOI 10.1080/09638280500158307; Chen Jou-An, 2012, Int J Adolesc Med Health, V24, P153, DOI 10.1515/ijamh.2012.023; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Endo S., 2012, International Journal of Sport and Health Science, V10, P1, DOI 10.5432/ijshs.201114; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Fallby J, 2006, INT J SPORT EXERC PS, V4, P111, DOI 10.1080/1612197X.2006.9671788; Feldt T, 2011, QUAL LIFE RES, V20, P69, DOI 10.1007/s11136-010-9720-7; Hannover W, 2004, PSYCHOTHER PSYCH MED, V54, P179, DOI 10.1055/s-2003-814787; Haugland S, 2001, EUR J PUBLIC HEALTH, V11, P4, DOI 10.1093/eurpub/11.1.4; Hinterberger T, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/735731; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kalimo R, 2003, WORK STRESS, V17, P109, DOI 10.1080/0267837031000149919; Kouvonen AM, 2010, J EPIDEMIOL COMMUN H, V64, P255, DOI 10.1136/jech.2008.083352; Krantz G, 2004, INT J BEHAV MED, V11, P18, DOI 10.1207/s15327558ijbm1101_3; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Liukkonen V, 2010, EUR J PUBLIC HEALTH, V20, P293, DOI 10.1093/eurpub/ckp171; Mayer J., 2010, VERLETZUNGSMANAGEMEN; McAllister DR, 2001, AM J SPORT MED, V29, P806, DOI 10.1177/03635465010290062201; Nilsson KW, 2010, J EPIDEMIOL COMMUN H, V64, P347, DOI 10.1136/jech.2008.081174; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Petrie G, 1993, PSYCHOL SPORT INJURY, P17; Ravens-Sieberer U, 2008, EUR J PUBLIC HEALTH, V18, P294, DOI 10.1093/eurpub/ckn001; Ravens-Sieberer U, 2009, INT J PUBLIC HEALTH, V54, P151, DOI 10.1007/s00038-009-5406-8; Sarenmalm EK, 2013, PSYCHO-ONCOLOGY, V22, P20, DOI 10.1002/pon.2053; Schumacher J, 2000, PSYCHOTHER PSYCH MED, V50, P472, DOI 10.1055/s-2000-9207; Simonsson B, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-4; Singer S, 2007, DIE SENSE COHERENCE; Skirka N, 2000, J SPORT MED PHYS FIT, V40, P63; Smith PM, 2003, SOC PSYCH PSYCH EPID, V38, P475, DOI 10.1007/s00127-003-0654-z; SPSS Inc, PASW DES TREES, P106; Volanen SM, 2007, SCAND J PSYCHOL, V48, P433, DOI 10.1111/j.1467-9450.2007.00598.x; Wolff AC, 1999, WESTERN J NURS RES, V21, P182, DOI 10.1177/01939459922043820; Zanagger P, 2000, J ARTHROPLASTY, V15, P283, DOI 10.1016/S0883-5403(00)90509-6	42	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102030	10.1371/journal.pone.0102030	http://dx.doi.org/10.1371/journal.pone.0102030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014085	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400057
J	Schlederer, M; Mueller, KM; Haybaeck, J; Heider, S; Huttary, N; Rosner, M; Hengstschlager, M; Moriggl, R; Dolznig, H; Kenner, L				Schlederer, Michaela; Mueller, Kristina M.; Haybaeck, Johannes; Heider, Susanne; Huttary, Nicole; Rosner, Margit; Hengstschlaeger, Markus; Moriggl, Richard; Dolznig, Helmut; Kenner, Lukas			Reliable Quantification of Protein Expression and Cellular Localization in Histological Sections	PLOS ONE			English	Article							MULTICOLOR TISSUE CYTOMETRY; HEPATIC GROWTH-HORMONE; BREAST-CANCER; SEMIQUANTITATIVE ASSESSMENT; IMAGE-ANALYSIS; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MICE	In targeted therapy, patient tumors are analyzed for aberrant activations of core cancer pathways, monitored based on biomarker expression, to ensure efficient treatment. Thus, diagnosis and therapeutic decisions are often based on the status of biomarkers determined by immunohistochemistry in combination with other clinical parameters. Standard evaluation of cancer specimen by immunohistochemistry is frequently impeded by its dependence on subjective interpretation, showing considerable intra-and inter-observer variability. To make treatment decisions more reliable, automated image analysis is an attractive possibility to reproducibly quantify biomarker expression in patient tissue samples. We tested whether image analysis could detect subtle differences in protein expression levels. Gene dosage effects generate well-graded expression patterns for most gene-products, which vary by a factor of two between wildtype and haploinsufficient cells lacking one allele. We used conditional mouse models with deletion of the transcription factors Stat5ab in the liver as well Junb deletion in a T-cell lymphoma model. We quantified the expression of total or activated STAT5AB or JUNB protein in normal (Stat5ab(+/+) or JunB(+/+)), hemizygous (Stat5ab(+/Delta) or JunB(+/Delta)) or knockout (Stat5ab (Delta/Delta) or JunB (Delta/Delta)) settings. Image analysis was able to accurately detect hemizygosity at the protein level. Moreover, nuclear signals were distinguished from cytoplasmic expression and translocation of the transcription factors from the cytoplasm to the nucleus was reliably detected and quantified using image analysis. We demonstrate that image analysis supported pathologists to score nuclear STAT5AB expression levels in immunohistologically stained human hepatocellular patient samples and decreased inter-observer variability.	[Schlederer, Michaela; Mueller, Kristina M.; Moriggl, Richard; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res LBI CR, Vienna, Austria; [Haybaeck, Johannes] Med Univ Graz, Inst Pathol, Graz, Austria; [Moriggl, Richard] Univ Vet Med Vienna Vetmeduni Vienna, Unit Translat Methods Canc Res, Vienna, Austria; [Heider, Susanne; Huttary, Nicole; Kenner, Lukas] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Rosner, Margit; Hengstschlaeger, Markus; Dolznig, Helmut] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Kenner, Lukas] Univ Vet Med Vienna Vetmeduni Vienna, Unit Pathol Lab Anim, Vienna, Austria	Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Vienna; Medical University of Vienna	Dolznig, H (corresponding author), Med Univ Vienna, Inst Med Genet, Vienna, Austria.	helmut.dolznig@meduniwien.ac.at; lukas.kenner@meduniwien.ac.at	Moriggl, Richard/H-8118-2019; Dolznig, Helmut/L-7005-2015	Moriggl, Richard/0000-0003-0918-9463; Dolznig, Helmut/0000-0002-6063-3585; Kenner, Lukas/0000-0003-2184-1338	Herzfelder Family Foundation; Niederosterr. Forschungs-und Bildungsges.m.b.H (nfb); Austrian Science Fund (FWF) [SFB-F2807, SFB-F4707]; FWF; Genome Research-Austria project "Inflammobiota'';  [P26011]; Austrian Science Fund (FWF) [F 2807] Funding Source: researchfish	Herzfelder Family Foundation; Niederosterr. Forschungs-und Bildungsges.m.b.H (nfb); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Genome Research-Austria project "Inflammobiota''; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Helmut Dolznig is supported by the Herzfelder Family Foundation and the Niederosterr. Forschungs-und Bildungsges. m.b.H (nfb). Kristina Mueller and Richard Moriggl were supported by grant SFB-F2807 and SFB-F4707 from the Austrian Science Fund (FWF). Lukas Kenner was supported by FWF, P26011 and the Genome Research-Austria project "Inflammobiota''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham N, 2005, ONCOGENE, V24, P5252, DOI 10.1038/sj.onc.1208726; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cross SS, 2001, J CLIN PATHOL, V54, P385, DOI 10.1136/jcp.54.5.385; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Diaz LK, 2005, ADV ANAT PATHOL, V12, P10, DOI 10.1097/00125480-200501000-00003; Ecker RC, 2006, CYTOM PART A, V69A, P119, DOI 10.1002/cyto.a.20219; Eckert RC, 2004, CYTOM PART A, V59A, P182, DOI 10.1002/cyto.a.20052; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Friedbichler K, 2012, HEPATOLOGY, V55, P941, DOI 10.1002/hep.24765; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Lehr HA, 2001, AM J CLIN PATHOL, V115, P814; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509; Paizs M, 2009, J MICROSC-OXFORD, V234, P103, DOI 10.1111/j.1365-2818.2009.03146.x; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Piechaczyk M, 2008, BIOCHEM SOC T, V36, P864, DOI 10.1042/BST0360864; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; Rexhepaj E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2187; Rhodes A, 2000, J CLIN PATHOL, V53, P292, DOI 10.1136/jcp.53.4.292; Rudiger T, 2002, AM J SURG PATHOL, V26, P873, DOI 10.1097/00000478-200207000-00005; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Sirota RL, 2005, ARCH PATHOL LAB MED, V129, P1228; Steiner GE, 2003, LAB INVEST, V83, P1131, DOI 10.1097/01.LAB.0000081388.40145.65; Steiner GE, 2000, J IMMUNOL METHODS, V237, P39, DOI 10.1016/S0022-1759(99)00240-9; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; TAYLOR CR, 1994, HUM PATHOL, V25, P2, DOI 10.1016/0046-8177(94)90164-3; Umemura S, 2004, APPL IMMUNOHISTO M M, V12, P8; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; Yu LR, 2007, PROTEOM CLIN APPL, V1, P1042, DOI 10.1002/prca.200700102; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	37	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100822	10.1371/journal.pone.0100822	http://dx.doi.org/10.1371/journal.pone.0100822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013898	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400012
J	Zwart, MC; Baker, A; McGowan, PJK; Whittingham, MJ				Zwart, Mieke C.; Baker, Andrew; McGowan, Philip J. K.; Whittingham, Mark J.			The Use of Automated Bioacoustic Recorders to Replace Human Wildlife Surveys: An Example Using Nightjars	PLOS ONE			English	Article							RECORDINGS; BIRDS	To be able to monitor and protect endangered species, we need accurate information on their numbers and where they live. Survey methods using automated bioacoustic recorders offer significant promise, especially for species whose behaviour or ecology reduces their detectability during traditional surveys, such as the European nightjar. In this study we examined the utility of automated bioacoustic recorders and the associated classification software as a way to survey for wildlife, using the nightjar as an example. We compared traditional human surveys with results obtained from bioacoustic recorders. When we compared these two methods using the recordings made at the same time as the human surveys, we found that recorders were better at detecting nightjars. However, in practice fieldworkers are likely to deploy recorders for extended periods to make best use of them. Our comparison of this practical approach with human surveys revealed that recorders were significantly better at detecting nightjars than human surveyors: recorders detected nightjars during 19 of 22 survey periods, while surveyors detected nightjars on only six of these occasions. In addition, there was no correlation between the amount of vocalisation captured by the acoustic recorders and the abundance of nightjars as recorded by human surveyors. The data obtained from the recorders revealed that nightjars were most active just before dawn and just after dusk, and least active during the middle of the night. As a result, we found that recording at both dusk and dawn or only at dawn would give reasonably high levels of detection while significantly reducing recording time, preserving battery life. Our analyses suggest that automated bioacoustic recorders could increase the detection of other species, particularly those that are known to be difficult to detect using traditional survey methods. The accuracy of detection is especially important when the data are used to inform conservation.	[Zwart, Mieke C.; McGowan, Philip J. K.; Whittingham, Mark J.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baker, Andrew] Baker Consultants Ltd, Matlock, Derby, England	Newcastle University - UK	Whittingham, MJ (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mark.whittingham@newcastle.ac.uk			Wildlife Acoustics Inc.; World Pheasant Association	Wildlife Acoustics Inc.; World Pheasant Association	Funding for this project was provided by Wildlife Acoustics Inc. (http://www.wildlifeacoustics.com/) and World Pheasant Association (http://www.pheasant.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, OFF J EUR UNION L, V20, P7; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Brandes TS, 2008, BIRD CONSERV INT, V18, pS163, DOI 10.1017/S0959270908000415; CADBURY CJ, 1981, BIRD STUDY, V28, P1, DOI 10.1080/00063658109476692; Campbell M, 2012, J FIELD ORNITHOL, V83, P391, DOI 10.1111/j.1557-9263.2012.00389.x; Celis-Murillo A, 2012, J FIELD ORNITHOL, V83, P166, DOI 10.1111/j.1557-9263.2012.00366.x; GILBERT G, 1994, J FIELD ORNITHOL, V65, P335; Gilbert G., 1998, BIRD MONITORING METH; Hobson KA, 2002, WILDLIFE SOC B, V30, P709; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Peake T. M., 2001, Animal Biodiversity and Conservation, V24, P81; R Core Team, 2021, R LANGUAGE ENV STAT; Rempel RS, 2005, J FIELD ORNITHOL, V76, P1, DOI 10.1648/0273-8570-76.1.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Southwood TRE, 2000, ECOLOGICAL METHODS; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Swiston KA, 2009, J FIELD ORNITHOL, V80, P42, DOI 10.1111/j.1557-9263.2009.00204.x; Trifa VM, 2008, J ACOUST SOC AM, V123, P2424, DOI 10.1121/1.2839017	19	72	75	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102770	10.1371/journal.pone.0102770	http://dx.doi.org/10.1371/journal.pone.0102770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029035	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600098
J	Akl, TJ; Wilson, MA; Ericson, MN; Farquhar, E; Cote, GL				Akl, Tony J.; Wilson, Mark A.; Ericson, M. Nance; Farquhar, Ethan; Cote, Gerard L.			Wireless Monitoring of Liver Hemodynamics In Vivo	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; IMPLANTABLE SENSOR; ALLOGRAFT FAILURE; OXYGENATION; PERFUSION; NIRS; SIGNALS	Liver transplants have their highest technical failure rate in the first two weeks following surgery. Currently, there are limited devices for continuous, real-time monitoring of the graft. In this work, a three wavelengths system is presented that combines near-infrared spectroscopy and photoplethysmography with a processing method that can uniquely measure and separate the venous and arterial oxygen contributions. This strategy allows for the quantification of tissue oxygen consumption used to study hepatic metabolic activity and to relate it to tissue stress. The sensor is battery operated and communicates wirelessly with a data acquisition computer which provides the possibility of implantation provided sufficient miniaturization. In two in vivo porcine studies, the sensor tracked perfusion changes in hepatic tissue during vascular occlusions with a root mean square error (RMSE) of 0.135 mL/min/g of tissue. We show the possibility of using the pulsatile wave to measure the arterial oxygen saturation similar to pulse oximetry. The signal is also used to extract the venous oxygen saturation from the direct current (DC) levels. Arterial and venous oxygen saturation changes were measured with an RMSE of 2.19% and 1.39% respectively when no vascular occlusions were induced. This error increased to 2.82% and 3.83% when vascular occlusions were induced during hypoxia. These errors are similar to the resolution of a commercial oximetry catheter used as a reference. This work is the first realization of a wireless optical sensor for continuous monitoring of hepatic hemodynamics.	[Akl, Tony J.; Cote, Gerard L.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA; [Wilson, Mark A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Wilson, Mark A.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Ericson, M. Nance; Farquhar, Ethan] Oak Ridge Natl Lab, Oak Ridge, TN USA	Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; United States Department of Energy (DOE); Oak Ridge National Laboratory	Akl, TJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	tja161@gmail.com	Ericson, Milton/H-9880-2016	Ericson, Milton/0000-0002-6628-4865	National Institutes of Health (NIH) through a Bioengineering Research Partnership (BRP) grant [5R01-GM077150]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077150] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through a Bioengineering Research Partnership (BRP) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (NIH) through a Bioengineering Research Partnership (BRP) grant (#5R01-GM077150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl TJ, 2013, J BIOMEDICAL OPTICS; Akl TJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077008; Akl TJ, 2011, BIOMED OPT EXPRESS, V2, P2096, DOI 10.1364/BOE.2.2096; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Eghtesad B, 2009, CLEVELAND CLIN CURRE, P564; El-Desoky AEH, 1999, LIVER TRANSPLANT SUR, V5, P219, DOI 10.1002/lt.500050316; Ericson M. N., 2011, Proceedings of the 2011 Future of Instrumentation International Workshop (FIIW), P63, DOI 10.1109/FIIW.2011.6476801; Ericson MN, 2004, MINIM INVASIV THER, V13, P87, DOI 10.1080/13645700410027866; Friebel M, 2009, J BIOMED OPT, V14; Gagnon RE, 2006, SPECTROSC-INT J, V20, P253, DOI 10.1155/2006/285157; Grassi B, 1999, J APPL PHYSIOL, V87, P348, DOI 10.1152/jappl.1999.87.1.348; Guyton AC, 1991, TXB MED PHYSL; Humeau A, 2007, MED BIOL ENG COMPUT, V45, P421, DOI 10.1007/s11517-007-0170-5; Khot MB, 2005, PLAST RECONSTR SURG, V115, P1103, DOI 10.1097/01.PRS.0000156546.45229.84; Klar E, 1996, Transpl Int, V9 Suppl 1, pS140, DOI 10.1111/j.1432-2277.1996.tb01591.x; Klar E, 1997, TRANSPL P, V29, P362, DOI 10.1016/S0041-1345(96)00120-0; Lane NJ, 1996, TRANSPLANTATION, V61, P689, DOI 10.1097/00007890-199603150-00003; Laustsen J, 1996, EUR J VASC ENDOVASC, V12, P91, DOI 10.1016/S1078-5884(96)80282-6; Lipcsey M, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-11; Mannheimer PD, 1997, IEEE T BIO-MED ENG, V44, P148, DOI 10.1109/10.554761; Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR), 2012, OPTN SRTR 2011 ANN D; QUIROGA J, 1991, HEPATOLOGY, V14, P1054, DOI 10.1016/0270-9139(91)90128-I; Rusch TL, 1996, COMPUT BIOL MED, V26, P143, DOI 10.1016/0010-4825(95)00049-6; Sahni R, 2012, CLIN PERINATOL, V39, P573, DOI 10.1016/j.clp.2012.06.012; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Subramanian H, 2005, IEEE T BIO-MED ENG, V52, P2016, DOI 10.1109/TBME.2005.857667; Subramanian H, 2005, IEEE T BIO-MED ENG, V52, P1355, DOI 10.1109/TBME.2005.847552; TAKAYA S, 1993, TRANSPLANT INT, V6, P73, DOI 10.1007/BF00336648; Tong YJ, 2010, NEUROIMAGE, V53, P553, DOI 10.1016/j.neuroimage.2010.06.049; Tortoriello TA, 2005, PEDIATR ANESTH, V15, P495, DOI 10.1111/j.1460-9592.2005.01488.x; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012	32	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102396	10.1371/journal.pone.0102396	http://dx.doi.org/10.1371/journal.pone.0102396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019160	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600076
J	Bashar, MK; Yamagata, K; Kobayashi, TJ				Bashar, Md Khayrul; Yamagata, Kazuo; Kobayashi, Tetsuya J.			Improved and Robust Detection of Cell Nuclei from Four Dimensional Fluorescence Images	PLOS ONE			English	Article							STEM-CELLS; LINEAGE; SEGMENTATION; TRACKING	Segmentation-free direct methods are quite efficient for automated nuclei extraction from high dimensional images. A few such methods do exist but most of them do not ensure algorithmic robustness to parameter and noise variations. In this research, we propose a method based on multiscale adaptive filtering for efficient and robust detection of nuclei centroids from four dimensional (4D) fluorescence images. A temporal feedback mechanism is employed between the enhancement and the initial detection steps of a typical direct method. We estimate the minimum and maximum nuclei diameters from the previous frame and feed back them as filter lengths for multiscale enhancement of the current frame. A radial intensity-gradient function is optimized at positions of initial centroids to estimate all nuclei diameters. This procedure continues for processing subsequent images in the sequence. Above mechanism thus ensures proper enhancement by automated estimation of major parameters. This brings robustness and safeguards the system against additive noises and effects from wrong parameters. Later, the method and its single-scale variant are simplified for further reduction of parameters. The proposed method is then extended for nuclei volume segmentation. The same optimization technique is applied to final centroid positions of the enhanced image and the estimated diameters are projected onto the binary candidate regions to segment nuclei volumes. Our method is finally integrated with a simple sequential tracking approach to establish nuclear trajectories in the 4D space. Experimental evaluations with five image-sequences (each having 271 3D sequential images) corresponding to five different mouse embryos show promising performances of our methods in terms of nuclear detection, segmentation, and tracking. A detail analysis with a sub-sequence of 101 3D images from an embryo reveals that the proposed method can improve the nuclei detection accuracy by 9 % over the previous methods, which used inappropriate large valued parameters. Results also confirm that the proposed method and its variants achieve high detection accuracies (> 98% mean F-measure) irrespective of the large variations of filter parameters and noise levels.	[Bashar, Md Khayrul] Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 112, Japan; [Yamagata, Kazuo] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Kobayashi, Tetsuya J.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Ochanomizu University; Osaka University; University of Tokyo	Bashar, MK (corresponding author), Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 112, Japan.	bashar.md.khayrul@ocha.ac.jp	Bashar, Md Khayrul/AHB-9800-2022	Bashar, Md Khayrul/0000-0002-5580-0422	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology;  [21116006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (KAKENHI), Grant No. 21116006; Japan Society for the Promotion of Science; and the Ministry of Education, Culture, Sports, Science and Technology. http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bashar M. K., 2012, 2012 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2012), P621, DOI 10.1109/IECBES.2012.6498044; Bashar M. K., 2012, 2012 7th International Conference on Electrical & Computer Engineering (ICECE), P256, DOI 10.1109/ICECE.2012.6471534; Bashar MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035550; Bashar MK, 2012, P 34 ANN INT C IEEE, P134; Byun JY, 2006, MOL VIS, V12, P949; Dzyubachyk O, 2010, IEEE T MED IMAGING, V29, P852, DOI 10.1109/TMI.2009.2038693; Godinez WJ, 2012, IEEE T MED IMAGING, V31, P1786, DOI 10.1109/TMI.2012.2203142; Han J, 2011, J MICROSC-OXFORD, V241, P315, DOI 10.1111/j.1365-2818.2010.03442.x; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Khan AM, 2012, LECT NOTES COMPUT SC, V7666, P575, DOI 10.1007/978-3-642-34478-7_70; Kurihara D, 2013, DEV GROWTH DIFFER, V55, P462, DOI 10.1111/dgd.12040; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lee GG, 2013, IEEE T BIOMED CIRC S, V7, P158, DOI 10.1109/TBCAS.2013.2253463; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parfitt DE, 2010, MOL BIOL CELL, V21, P2649, DOI 10.1091/mbc.E10-01-0053; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Press W. H., 1992, ART SCI COMPUTING; Santella A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-580; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Yamagata K, 2013, DEV GROWTH DIFFER, V55, P378, DOI 10.1111/dgd.12048; Yamagata K, 2010, METHODS, V52, P259, DOI 10.1016/j.ymeth.2010.04.008	27	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101891	10.1371/journal.pone.0101891	http://dx.doi.org/10.1371/journal.pone.0101891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020042	Green Submitted, gold, Green Published			2022-12-27	WOS:000339618600030
J	Kulshreshtha, V; Ayalew, LE; Islam, A; Tikoo, SK				Kulshreshtha, Vikas; Ayalew, Lisanework E.; Islam, Azharul; Tikoo, Suresh K.			Conserved Arginines of Bovine Adenovirus-3 33K Protein Are Important for Transportin-3 Mediated Transport and Virus Replication	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; MAMMALIAN-CELLS; SR PROTEINS; SUBNUCLEAR LOCALIZATION; VIRAL REPLICATION; GENE-EXPRESSION; SPLICING FACTOR; L4-22K PROTEIN; ALPHA; TRANSCRIPTION	The L6 region of bovine adenovirus (BAdV)-3 encodes a spliced protein designated 33K. The 33K specific sera detected five major proteins and three minor proteins in transfected or virus infected cells, which could arise by internal initiation of translation and alternative splicing. The 33K protein is predominantly localized to the nucleus of BAdV-3 infected cells. The 33K nuclear transport utilizes both classical importin-alpha/-beta and importin-beta dependent nuclear import pathways and preferentially binds to importin-alpha 5 and transportin-3 receptors, respectively. Analysis of mutant 33K proteins demonstrated that amino acids 201-240 of the conserved C-terminus of 33K containing RS repeat are required for nuclear localization and, binding to both importin-alpha 5 and transportin-3 receptors. Interestingly, the arginine residues of conserved RS repeat are required for binding to transportin-3 receptor but not to importin-alpha 5 receptor. Moreover, mutation of arginines residues of RS repeat proved lethal for production of progeny virus. Our results suggest that arginines of RS repeat are required for efficient nuclear transport of 33K mediated by transportin-3, which appears to be essential for replication and production of infectious virion.	[Kulshreshtha, Vikas; Ayalew, Lisanework E.; Islam, Azharul; Tikoo, Suresh K.] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Kulshreshtha, Vikas; Ayalew, Lisanework E.; Tikoo, Suresh K.] Univ Saskatchewan, Saskatoon, SK, Canada; [Tikoo, Suresh K.] Univ Saskatchewan, Sch Publ Hlth, Vaccinol & Immunotherapeut Program, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Tikoo, SK (corresponding author), Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada.	Suresh.tik@usask.ca		Ayalew, Lisanework E./0000-0002-4157-9552	NSERC Canada [155081-2007]	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by NSERC Canada (WWW.NSERC.CA) Grant #155081-2007. The funders have no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Ali H, 2007, J VIROL, V81, P1327, DOI 10.1128/JVI.01584-06; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Du EQ, 2010, J GENE MED, V12, P840, DOI 10.1002/jgm.1505; Ewing SG, 2007, J VIROL, V81, P12450, DOI 10.1128/JVI.01470-07; Farley DC, 2004, J VIROL, V78, P1782, DOI 10.1128/JVI.78.4.1782-1791.2004; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Finnen RL, 2001, VIROLOGY, V289, P388, DOI 10.1006/viro.2001.1130; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Guimet D, 2013, J VIROL, V87, P7688, DOI 10.1128/JVI.00859-13; Hamelberg D, 2007, P NATL ACAD SCI USA, V104, P14947, DOI 10.1073/pnas.0703151104; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Hindley CE, 2007, TRAFFIC, V8, P1313, DOI 10.1111/j.1600-0854.2007.00618.x; IMAMOTO N, 1995, J BIOL CHEM, V270, P8559, DOI 10.1074/jbc.270.15.8559; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kulshreshtha V, 2004, VIROLOGY, V323, P59, DOI 10.1016/j.virol.2004.02.024; Kulshreshtha V, 2009, THESIS U SASKATCHEWA; Kulshreshtha V, 2008, VIROLOGY, V381, P29, DOI 10.1016/j.virol.2008.08.015; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Ostapchuk P, 2006, J VIROL, V80, P6973, DOI 10.1128/JVI.00123-06; Ostberg S, 2012, VIROLOGY, V433, P273, DOI 10.1016/j.virol.2012.08.021; Pante N, 1996, CURR OPIN CELL BIOL, V8, P397, DOI 10.1016/S0955-0674(96)80016-0; Paterson CP, 2012, VIROLOGY, V432, P63, DOI 10.1016/j.virol.2012.05.021; Reddy PS, 1999, J VIROL, V73, P9137, DOI 10.1128/JVI.73.11.9137-9144.1999; Reddy PS, 1998, J VIROL, V72, P1394, DOI 10.1128/JVI.72.2.1394-1402.1998; Tachibana T, 2000, CELL STRUCT FUNCT, V25, P115, DOI 10.1247/csf.25.115; Tormanen H, 2006, J BIOL CHEM, V281, P36510, DOI 10.1074/jbc.M607601200; Welch K, 1999, MOL CELL BIOL, V19, P8400; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Wu K, 2013, J VIROL, V87, P6739, DOI 10.1128/JVI.00652-13; Wu K, 2012, J VIROL, V86, P10474, DOI 10.1128/JVI.01463-12; Wu Q, 2004, ARCH VIROL, V149, P1783, DOI 10.1007/s00705-004-0323-x; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Zakhartchouk AN, 1998, VIROLOGY, V250, P220, DOI 10.1006/viro.1998.9351	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101216	10.1371/journal.pone.0101216	http://dx.doi.org/10.1371/journal.pone.0101216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019945	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600012
J	Vargo, EL; Crissman, JR; Booth, W; Santangelo, RG; Mukha, DV; Schal, C				Vargo, Edward L.; Crissman, Jonathan R.; Booth, Warren; Santangelo, Richard G.; Mukha, Dmitry V.; Schal, Coby			Hierarchical Genetic Analysis of German Cockroach (Blattella germanica) Populations from within Buildings to across Continents	PLOS ONE			English	Article							COPTOTERMES-FORMOSANUS ISOPTERA; BIOLOGICAL INVASIONS; APARTMENT BUILDINGS; PERIPLANETA-AMERICANA; MOLECULAR MARKERS; DNA-SEQUENCES; UNITED-STATES; F-STATISTICS; DISPERSAL; DISTANCE	Understanding the population structure of species that disperse primarily by human transport is essential to predicting and controlling human-mediated spread of invasive species. The German cockroach (Blattella germanica) is a widespread urban invader that can actively disperse within buildings but is spread solely by human-mediated dispersal over longer distances; however, its population structure is poorly understood. Using microsatellite markers we investigated population structure at several spatial scales, from populations within single apartment buildings to populations from several cities across the U. S. and Eurasia. Both traditional measures of genetic differentiation and Bayesian clustering methods revealed increasing levels of genetic differentiation at greater geographic scales. Our results are consistent with active dispersal of cockroaches largely limited to movement within a building. Their low levels of genetic differentiation, yet limited active spread between buildings, suggests a greater likelihood of human-mediated dispersal at more local scales (within a city) than at larger spatial scales (within and between continents). About half the populations from across the U. S. clustered together with other U. S. populations, and isolation by distance was evident across the U. S. Levels of genetic differentiation among Eurasian cities were greater than those in the U. S. and greater than those between the U. S. and Eurasia, but no clear pattern of structure at the continent level was detected. MtDNA sequence variation was low and failed to reveal any geographical structure. The weak genetic structure detected here is likely due to a combination of historical admixture among populations and periodic population bottlenecks and founder events, but more extensive studies are needed to determine whether signatures of global movement may be present in this species.	[Vargo, Edward L.; Crissman, Jonathan R.; Booth, Warren; Santangelo, Richard G.; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Vargo, Edward L.; Crissman, Jonathan R.; Booth, Warren; Santangelo, Richard G.; Schal, Coby] N Carolina State Univ, WM Ctr Behav Biol, Raleigh, NC 27695 USA; [Mukha, Dmitry V.] Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow, Russia	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Russian Academy of Sciences; Vavilov Institute of General Genetics	Vargo, EL (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	ed_vargo@ncsu.edu	Mukha, Dmitry V/AAO-5635-2020; Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Mukha, Dmitry/0000-0002-7380-0776	National Research Initiative of the U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service [2004-35302-14880]; USDA Risk Avoidance and Mitigation Program [2005-51101-02388]; U.S. Department of Housing and Urban Development [NCHHU0001-11]; Blanton J. Whitmire endowment at North Carolina State University; North Carolina Pest Management Association	National Research Initiative of the U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA Risk Avoidance and Mitigation Program; U.S. Department of Housing and Urban Development; Blanton J. Whitmire endowment at North Carolina State University; North Carolina Pest Management Association	This work was supported by the National Research Initiative of the U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service, grant number 2004-35302-14880; the USDA Risk Avoidance and Mitigation Program, grant number 2005-51101-02388; the U.S. Department of Housing and Urban Development, grant NCHHU0001-11; the Blanton J. Whitmire endowment at North Carolina State University; and the North Carolina Pest Management Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Appel Arthur G., 1995, P1; Austin JW, 2006, FLA ENTOMOL, V89, P183, DOI 10.1653/0015-4040(2006)89[183:GEFTIO]2.0.CO;2; Avise J, 2004, MOL MARKERS NATURAL; Booth W, 2007, MOL ECOL NOTES, V7, P648, DOI 10.1111/j.1471-8286.2006.01663.x; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; Booth W, 2011, J HERED, V102, P175, DOI 10.1093/jhered/esq108; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cloarec A, 1999, ENTOMOL EXP APPL, V92, P311, DOI 10.1023/A:1003877800605; CLOAREC A, 1992, EPIDEMIOL INFECT, V109, P483, DOI 10.1017/S0950268800050470; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crissman JR, 2010, J MED ENTOMOL, V47, P553, DOI 10.1603/ME09036; Elgderi RM, 2006, ANN TROP MED PARASIT, V100, P55, DOI 10.1179/136485906X78463; FOTEDAR R, 1992, ACTA TROP, V50, P339, DOI 10.1016/0001-706X(92)90069-A; FOTEDAR R, 1991, EPIDEMIOL INFECT, V107, P181, DOI 10.1017/S0950268800048809; Garb JE, 2004, MOL PHYLOGENET EVOL, V31, P1127, DOI 10.1016/j.ympev.2003.10.012; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; Gore JC, 2004, J ECON ENTOMOL, V97, P715, DOI 10.1603/0022-0493-97.2.715; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graczyk TK, 2005, CLIN MICROBIOL REV, V18, P128, DOI 10.1128/CMR.18.1.128-132.2005; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Jobet E, 2000, MOL ECOL, V9, P481, DOI 10.1046/j.1365-294x.2000.00880.x; Jones CJ, 1997, MOL BREEDING, V3, P381, DOI 10.1023/A:1009612517139; Lack JB, 2013, BIOL INVASIONS, V15, P1067, DOI 10.1007/s10530-012-0351-5; Li HF, 2009, ANN ENTOMOL SOC AM, V102, P684, DOI 10.1603/008.102.0413; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Mukha DV, 2007, MED VET ENTOMOL, V21, P132, DOI 10.1111/j.1365-2915.2007.00670.x; Nagaraja, 2004, GENES GENET SYST, V79, P293, DOI 10.1266/ggs.79.293; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pai HH, 2003, ACTA TROP, V87, P355, DOI 10.1016/S0001-706X(03)00140-2; Pai HH, 2005, ACTA TROP, V93, P259, DOI 10.1016/j.actatropica.2004.11.006; Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; ROTH LM, 1985, ENTOMOL SCAND, P1; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; RUNSTROM ES, 1984, J ECON ENTOMOL, V77, P407, DOI 10.1093/jee/77.2.407; RUNSTROM ES, 1990, J MED ENTOMOL, V27, P515, DOI 10.1093/jmedent/27.4.515; Saenz VL, 2012, J MED ENTOMOL, V49, P865, DOI 10.1603/ME11202; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schal C., 2011, MALLIS HDB PEST CONT, P150; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; TAJIMA F, 1983, GENETICS, V105, P437; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; WRIGHT S, 1951, ANN EUGENIC, V15, P323; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050	58	22	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102321	10.1371/journal.pone.0102321	http://dx.doi.org/10.1371/journal.pone.0102321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020136	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600066
J	Cremona, F; Koiv, T; Kisand, V; Laas, A; Zingel, P; Agasild, H; Feldmann, T; Jarvalt, A; Noges, P; Noges, T				Cremona, Fabien; Koiv, Toomas; Kisand, Veljo; Laas, Alo; Zingel, Priit; Agasild, Helen; Feldmann, Tonu; Jarvalt, Ain; Noges, Peeter; Noges, Tiina			From Bacteria to Piscivorous Fish: Estimates of Whole-Lake and Component-Specific Metabolism with an Ecosystem Approach	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; LARGE SHALLOW LAKE; PHYTOPLANKTON PRODUCTION; RESPIRATION RATES; TEMPORAL DYNAMICS; GROWTH EFFICIENCY; BENTHIC PATHWAYS; EUTROPHIC LAKE; CARBON BUDGET; MASS-BALANCE	The influence of functional group specific production and respiration patterns on a lake's metabolic balance remains poorly investigated to date compared to whole-system estimates of metabolism. We employed a summed component ecosystem approach for assessing lake-wide and functional group-specific metabolism (gross primary production (GPP) and respiration (R)) in shallow and eutrophic Lake Vortsjarv in central Estonia during three years. Eleven functional groups were considered: piscivorous and benthivorous fish; phyto-, bacterio-, proto-and metazooplankton; benthic macroinvertebrates, bacteria and ciliates; macrophytes and their associated epiphytes. Metabolism of these groups was assessed by allometric equations coupled with daily records of temperature and hydrology of the lake and measurements of food web functional groups biomass. Results revealed that heterotrophy dominated most of the year, with a short autotrophic period observed in late spring. Most of the metabolism of the lake could be attributed to planktonic functional groups, with phytoplankton contributing the highest share (90% of GPP and 43% of R). A surge of protozooplankton and bacterioplankton populations forming the microbial loop caused the shift from auto-to heterotrophy in midsummer. Conversely, the benthic functional groups had overall a very small contribution to lake metabolism. We validated our ecosystem approach by comparing the GPP and R with those calculated from O-2 measurements in the lake. Our findings are also in line with earlier productivity studies made with C-14 or chlorophyll a (chl-a) based equations. Ideally, the ecosystem approach should be combined with diel O-2 approach for investigating critical periods of metabolism shifts caused by dynamics in food-web processes.	[Cremona, Fabien; Koiv, Toomas; Kisand, Veljo; Laas, Alo; Zingel, Priit; Agasild, Helen; Feldmann, Tonu; Jarvalt, Ain; Noges, Peeter; Noges, Tiina] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia; [Kisand, Veljo] Univ Tartu, Inst Technol, Fac Sci & Technol, EE-50090 Tartu, Estonia	Estonian University of Life Sciences; University of Tartu	Cremona, F (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia.	fabien.cremona@emu.ee	Nõges, Peeter/AAL-5343-2020; Noges, Tiina/AAL-5373-2020; Cremona, Fabien/D-1385-2013; Laas, Alo/G-7992-2016; Kõiv, Toomas/H-3466-2016; Kisand, Veljo/H-2466-2012; Cremona, Fabien/AAP-1362-2020; Zingel, Priit/H-8822-2016	Nõges, Peeter/0000-0003-2919-6038; Noges, Tiina/0000-0002-4558-7373; Cremona, Fabien/0000-0002-0559-6259; Laas, Alo/0000-0002-4801-0377; Kõiv, Toomas/0000-0002-0051-3952; Kisand, Veljo/0000-0002-5535-1639; Cremona, Fabien/0000-0002-0559-6259; Zingel, Priit/0000-0003-1629-2063	Estonian Ministry of Education and Research [SF0170011s08, IUT 21-2]; Estonian Science Foundation [ETF9102, ETF8486, ETF8729]; MARS project (Managing Aquatic ecosystems and water Resources under multiple Stress) under the 7th EU Framework Programme [603378]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; MARS project (Managing Aquatic ecosystems and water Resources under multiple Stress) under the 7th EU Framework Programme	The study was supported by institutional research funding (SF0170011s08 and IUT 21-2) of the Estonian Ministry of Education and Research, by the Estonian Science Foundation through grants ETF9102, ETF8486 and ETF8729, and by the MARS project (Managing Aquatic ecosystems and water Resources under multiple Stress) funded under the 7th EU Framework Programme, Theme 6 (Environment including Climate Change), Contract No. 603378 (http://www.mars-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasild H, 2007, HYDROBIOLOGIA, V584, P167, DOI 10.1007/s10750-007-0575-z; Andersson E, 2006, AQUAT SCI, V68, P52, DOI 10.1007/s00027-005-0807-0; Andersson E, 2006, AMBIO, V35, P476, DOI 10.1579/0044-7447(2006)35[476:COAMBA]2.0.CO;2; Apple JK, 2006, AQUAT MICROB ECOL, V43, P243, DOI 10.3354/ame043243; Arst H, 2008, AQUAT BIOL, V3, P19, DOI 10.3354/ab00059; Balushkina EV, 1979, HEADLINES WATER ECOS, P169; Berggren M, 2012, ISME J, V6, P984, DOI 10.1038/ismej.2011.157; Biddanda B, 2001, LIMNOL OCEANOGR, V46, P730, DOI 10.4319/lo.2001.46.3.0730; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; Coloso JJ, 2011, ECOSYSTEMS, V14, P935, DOI 10.1007/s10021-011-9455-5; Cremona F, 2014, HYDROBIOLOGIA, V731, P109, DOI 10.1007/s10750-013-1686-3; Cremona F, 2014, FRESHWATER IN PRESS, V33; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; DELGIORGIO PA, 1993, CAN J FISH AQUAT SCI, V50, P282, DOI 10.1139/f93-032; DELGIORGIO PA, 1994, LIMNOL OCEANOGR, V39, P772, DOI 10.4319/lo.1994.39.4.0772; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duhamel S, 2006, J MICROBIOL METH, V64, P316, DOI 10.1016/j.mimet.2005.05.008; FENCHEL T, 1983, MICROBIAL ECOL, V9, P99, DOI 10.1007/BF02015125; FINLAY BJ, 1982, ARCH PROTISTENKD, V125, P215, DOI 10.1016/S0003-9365(82)80018-3; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1551, DOI 10.4319/lo.2010.55.4.1551; FOY RH, 1982, BRIT PHYCOL J, V17, P183, DOI 10.1080/00071618200650181; Freiberg R, 2011, EST J EARTH SCI, V60, P91, DOI 10.3176/earth.2011.2.03; Galkowskaya GA, 1980, IZV AKAD NAUK BSSR, V6, P114; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Hallfors G, 2004, BALTIC SEA ENV P; Hanson PC, 2003, LIMNOL OCEANOGR, V48, P1112, DOI 10.4319/lo.2003.48.3.1112; Heinsalu A, 2008, HYDROBIOLOGIA, V599, P23, DOI 10.1007/s10750-007-9206-y; Ikeda T., 2000, P455, DOI 10.1016/B978-012327645-2/50011-6; Jaani A., 1973, VORTSJARV, P37; Jarvalt A., 2011, VORTSJARVE KALAVARUD; Jonasson Petur M., 2004, P341; Joung SH, 2006, J MICROBIOL, V44, P562; Kangur K., 2004, LAKE VORTSJARV, P265; KAUTSKY U, 1995, THESIS STOCKHOLM U S; Kemp WM, 1997, MAR ECOL PROG SER, V150, P229, DOI 10.3354/meps150229; Laas A, 2012, HYDROBIOLOGIA, V694, P57, DOI 10.1007/s10750-012-1131-z; Liboriussen L, 2003, FRESHWATER BIOL, V48, P418, DOI 10.1046/j.1365-2427.2003.01018.x; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Lopez-Rodas V, 2006, PHYCOLOGIA, V45, P243, DOI 10.2216/04-31.1; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lovett G, 2006, ECOSYSTEMS, V9, P152, DOI 10.1007/s10021-005-0036-3; Middelburg Jack J., 2005, P206; Noges P, 1995, REPORT SERIES GEOPHY, V32, P81; NOGES P, 2004, LAKE VORTSJARV, P217; Noges Peeter, 1998, Proceedings of the Estonian Academy of Sciences Biology Ecology, V47, P268; Noges Peeter, 2012, Estonian Journal of Ecology, V61, P227, DOI 10.3176/eco.2012.4.01; Noges P, 2010, HYDROBIOLOGIA, V646, P33, DOI 10.1007/s10750-010-0178-y; Noges T, 1999, HYDROBIOLOGIA, V408, P277; Noges T., 2004, LAKE VORTSJARV, P335; Noges T, 2011, HYDROBIOLOGIA, V667, P205, DOI 10.1007/s10750-011-0647-y; Noges T, 2010, AQUAT ECOL, V44, P83, DOI 10.1007/s10452-009-9249-4; Piirsoo K, 2012, J HYDROL, V475, P306, DOI 10.1016/j.jhydrol.2012.10.015; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Plus M, 2003, CONT SHELF RES, V23, P1877, DOI 10.1016/j.csr.2003.03.001; Reinart Anu, 1999, Proceedings of the Estonian Academy of Sciences Biology Ecology, V48, P267; Ruttner-Kolisko A., 1977, ARCH HYDROBIOL, V8, P71; Staehr PA, 2007, LIMNOL OCEANOGR, V52, P108, DOI 10.4319/lo.2007.52.1.0108; Staehr PA, 2012, AQUAT SCI, V74, P15, DOI 10.1007/s00027-011-0199-2; Studenikina E. I., 1969, Gidrobiologicheskii Zhurnal, V5, P89; Suschenya LM, 1972, RESP CRUSTACEANS; TANG EPY, 1995, J PLANKTON RES, V17, P303, DOI 10.1093/plankt/17.2.303; Toming K, 2013, LIMNOL OCEANOGR, V58, P1259, DOI 10.4319/lo.2013.58.4.1259; Tsertova N, 2013, AQUAT MICROB ECOL, V70, P77, DOI 10.3354/ame01647; Tsertova N, 2011, ENV MICROBIOL REP, V3, P270, DOI 10.1111/j.1758-2229.2010.00221.x; Utermohl H., 1931, MITTEILUNGEN INT VER, V5, P567, DOI DOI 10.1080/05384680.1958; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vis C, 2006, CAN J FISH AQUAT SCI, V63, P1014, DOI 10.1139/F06-021; Welker M, 1999, HYDROBIOLOGIA, V408, P233, DOI 10.1023/A:1017027723782; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Winberg GG, 1983, J GEN BIOL, V44, P31; WOODWELL GM, 1968, AM ZOOL, V8, P19; Zingel P, 2007, MICROB ECOL, V53, P134, DOI 10.1007/s00248-006-9155-4	74	20	20	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101845	10.1371/journal.pone.0101845	http://dx.doi.org/10.1371/journal.pone.0101845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014117	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400040
J	Wang, YY; Freemantle, N; Nazareth, I; Hunt, K				Wang, Yingying; Freemantle, Nick; Nazareth, Irwin; Hunt, Kate			Gender Differences in Survival and the Use of Primary Care Prior to Diagnosis of Three Cancers: An Analysis of Routinely Collected UK General Practice Data	PLOS ONE			English	Article							CELL LUNG-CANCER; COLORECTAL-CANCER; ILLNESS BEHAVIOR; SEX DISPARITIES; COMORBIDITY; SEEKING; MORTALITY; SYMPTOMS; PATIENT; DELAY	Objective: To explore whether there are gender differences in the number of GP recorded cases, the probability of survival and consulting pattern prior to diagnosis amongst patients with three non-sex-specific cancers. Design: Cross sectional study. Setting: UK primary care. Subjects: 12,189 patients aged 16 years or over diagnosed with colorectal cancer (CRC), 11,081 patients with lung cancer and 4,352 patients with malignant melanoma, with first record of cancer diagnosis during 1997-2006. Main outcome measures: Cancer cases recorded in primary care; probability of survival following diagnosis; and number of GP contacts within the 24 months preceding diagnosis. Results: From 1997-2006, overall rates of GP recorded CRC and lung cancer cases recorded were higher in men than in women, but rates of malignant melanoma were higher in women than in men. Gender differences in survival were small; 49% of men and 53% of women survived at least 5 years following CRC diagnosis; 9% of men and 12% of women with lung cancer, and 77% of men and 86% of women with malignant melanoma. The adjusted male to female relative hazard ratio of death in all patients was 1.20 (95% CI 1.13-1.30), 1.24 (95% CI 1.16-1.33) and 1.73 (95% CI 1.51-2.00) for CRC, lung cancer and malignant melanoma respectively. However, gender differences in the relative risk were much smaller amongst those who died during follow-up. For each cancer, there was little evidence of gender difference in the percentage who consulted and the number of GP contacts made within 24 months prior to diagnosis. Conclusions: This study found that patterns of consulting prior to cancer diagnosis differed little between two genders, providing no support for the hypothesis that gender differences in survival are explained by gender differences in consultation for more serious illness, and suggests the need for a more critical view of gender and consultation.	[Wang, Yingying; Hunt, Kate] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Freemantle, Nick; Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; University College London	Wang, YY (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	Ying-Ying.Wang@glasgow.ac.uk	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; wang, yi/GVT-8516-2022		Medical Research Council; MRC [MC_UU_12017/3, MC_U130059811] Funding Source: UKRI; Medical Research Council [MC_U130059811, MC_UU_12017/3] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; Bird CE, 1999, SOC SCI MED, V48, P745, DOI 10.1016/S0277-9536(98)00402-X; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bowen EF, 2002, LUNG CANCER-J IASLC, V37, P227, DOI 10.1016/S0169-5002(02)00143-5; Cancer Research UK, 2012, CANC STATS CANC CAS; Cancer Research UK, 2011, CANC MORT STAT CANC; Cancer Research UK, 2013, EXC CANC BURD MEN; Cancer Research UK, 2012, CANC STATS ALL CANC; Cancer Research UK, 2012, CANC INC STAT CANC I; Cegedim, 2012, CEG STRAT DAT DAT; Christensen KG, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-224; Clarke N, 2013, EXCESS BURDEN CANC M; Cockburn J, 2003, AM J HEALTH BEHAV, V27, P401, DOI 10.5993/AJHB.27.4.12; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Galdas P. M., 2009, MENS HLTH BODY IDENT; Gatta G, 2000, GUT, V47, P533, DOI 10.1136/gut.47.4.533; Grann AF, 2013, BRIT J CANCER, V109, P265, DOI 10.1038/bjc.2013.246; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Haynes K, 2009, PHARMACOEPIDEM DR S, V18, P730, DOI 10.1002/pds.1774; Hippisley-Cox J, 2009, TREND CONSULTATION R; Hunt K, 2010, PALGRAVE HDB GENDER, P207, DOI DOI 10.1057/9780230290334_13; Iyen-Omofoman B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-857; Janssen-Heijnen MLG, 2005, CRIT REV ONCOL HEMAT, V55, P231, DOI 10.1016/j.critrevonc.2005.04.008; Keeble S, 2014, INT J CANC; Koo JH, 2008, AM J GASTROENTEROL, V103, P1488, DOI 10.1111/j.1572-0241.2007.01779.x; Luchtenborg M, 2012, EUR J CANCER, V48, P3386, DOI 10.1016/j.ejca.2012.06.012; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Majek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068077; MARSHALL JR, 1986, WOMEN HEALTH, V11, P67; MARSHALL JR, 1982, J HEALTH SOC BEHAV, V23, P197, DOI 10.2307/2136629; McArdle CS, 2004, BRIT J SURG, V91, P605, DOI 10.1002/bjs.4456; McArdle CS, 2003, BRIT J SURG, V90, P711, DOI 10.1002/bjs.4098; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Micheli A, 1998, EUR J CANCER, V34, P2271, DOI 10.1016/S0959-8049(98)00324-4; Najari BB, 2013, J UROLOGY, V189, P1470, DOI 10.1016/j.juro.2012.11.153; Ogle KS, 2000, CANCER, V88, P653, DOI 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1; Ries LAG, 2003, ONCOLOGIST, V8, P541; Shack LG, 2010, POSTGRAD MED J, V86, P73, DOI 10.1136/pgmj.2009.084566; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; Tudiver F, 1999, J FAM PRACTICE, V48, P47; Waldron I, 1999, GENDER INEQUALITIES IN HEALTH, P150; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Wichmann MW, 2001, BRIT J SURG, V88, P1092, DOI 10.1046/j.0007-1323.2001.01819.x; Wilkins D, 2006, P EXP S HELD LEEDS M; Wizemann TM, 2001, EXPLOREING BIOL CONT; Yancik R, 1998, CANCER, V82, P2123, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.0.CO;2-W; Young CJ, 2000, AUST NZ J SURG, V70, P635, DOI 10.1046/j.1440-1622.2000.01916.x	53	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101562	10.1371/journal.pone.0101562	http://dx.doi.org/10.1371/journal.pone.0101562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014510	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000339378400027
J	Zhu, Y; Wu, N; Huang, HD; Dong, YC; Sun, QY; Zhang, W; Wang, Q; Li, Q				Zhu, Ying; Wu, Ning; Huang, Hai-Dong; Dong, Yu-Chao; Sun, Qin-Ying; Zhang, Wei; Wang, Qin; Li, Qiang			A Clinical Study of Tracheobronchopathia Osteochondroplastica: Findings from a Large Chinese Cohort	PLOS ONE			English	Article							TRACHEOPATHIA OSTEOPLASTICA; BRONCHOSCOPY; DIAGNOSIS; BRONCHUS	Background and Study Aims: Tracheobronchopathia osteochondroplastica (TO) is an uncommon disease of the tracheobronchial system that leads to narrowing of the airway lumen from cartilaginous and/or osseous submucosal nodules. The aim of this study is to perform a detailed review of this rare disease in a large cohort of patients with TO proven by fiberoptic bronchoscopy from China. Patients and Methods: Retrospective chart review was performed on 41,600 patients who underwent bronchoscopy in the Department of Respiratory Medicine of Changhai Hospital between January 2005 and December 2012. Cases of TO were identified based on characteristic features during bronchoscopic examination. Results: 22 cases of bronchoscopic TO were identified. Among whom one-half were male and the mean age was 47.45 +/- 10.91 years old. The most frequent symptoms at presentation were chronic cough (n = 14) and increased sputum production (n = 10). Radiographic abnormalities were observed in 3/18 patients and findings on computed tomography consistent with TO such as beaded intraluminal calcifications and/or increased luminal thickenings were observed in 18/22 patients. Patients were classified into the following categories based on the severity of bronchoscopic findings: Stage I (n = 2), Stage II (n = 6) and Stage III (n = 14). The result that bronchoscopic improvement was observed in 2 patients administered with inhaled corticosteroids suggested that resolution of this disease is possible. Conclusions: TO is a benign disease with slow progression, which could be roughly divided into 3 stages on the basis of the characteristic endoscopic features and histopathologic findings. Chronic inflammation was thought to be more important than the other existing plausible hypotheses in the course of TO. Inhaled corticosteroids might have some impact on patients at Stage I/II.	[Zhu, Ying; Wu, Ning; Huang, Hai-Dong; Dong, Yu-Chao; Sun, Qin-Ying; Zhang, Wei; Wang, Qin; Li, Qiang] Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China	Naval Medical University	Li, Q (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China.	liqres@hotmail.com	Zhang, Wei/AAE-9322-2021	Zhang, Wei/0000-0001-5292-7308; Zhu, Ying/0000-0002-0256-3216				Abu-Hijleh M, 2008, LUNG, V186, P353, DOI 10.1007/s00408-008-9113-7; Barthwal M S, 2004, Indian J Chest Dis Allied Sci, V46, P43; Bioque C., 2001, J BRONCHOL, V8, P78; Chen AY, 1997, OTOLARYNG HEAD NECK, V117, pS102, DOI 10.1016/S0194-5998(97)70071-8; Coetmeur D, 1997, RESP MED, V91, P496, DOI 10.1016/S0954-6111(97)90116-5; Dalgaard Jorgen B., 1947, ACTA PATH ET MICROBIOL SCAND, V24, P118; Doshi H, 2005, J THORAC CARDIOV SUR, V130, P901, DOI 10.1016/j.jtcvs.2005.01.020; Dutau H, 2004, J BRONCHOL INTERV PU, V11, P182; Fabrega RM, 2006, EUROPEAN J RADIOLOGY, V59, P111; Hantous-Zannad S, 2003, EUR J RADIOL, V45, P113, DOI 10.1016/S0720-048X(02)00028-1; Harma R, 1997, ACTA OTO-LARYNGOL, V84, P118; Hiebaum K, 1934, FRANKFURT Z PATHOL, V47, P249; HODGES MK, 1988, CHEST, V94, P842, DOI 10.1378/chest.94.4.842; Huang CC, 2010, CAN MED ASSOC J, V182, pE859, DOI 10.1503/cmaj.091762; Jabbardarjani HR, 2008, LUNG, V186, P293, DOI 10.1007/s00408-008-9088-4; JEPSEN O, 1960, Acta Otolaryngol, V51, P79, DOI 10.3109/00016486009124466; JONES AW, 1977, BRIT J DIS CHEST, V71, P268, DOI 10.1016/0007-0971(77)90124-3; Karlikaya C, 2000, Respirology, V5, P377, DOI 10.1046/j.1440-1843.2000.00278.x; Khan AM, 2006, J THORAC CARDIOV SUR, V132, P714, DOI 10.1016/j.jtcvs.2006.05.024; Kirbas G, 2009, YONSEI MED J, V50, P721, DOI 10.3349/ymj.2009.50.5.721; Kutlu CA, 2002, EUR J CARDIO-THORAC, V21, P140, DOI 10.1016/S1010-7940(01)01080-6; Leske V, 2001, MEDICINE, V80, P378, DOI 10.1097/00005792-200111000-00004; Li Shiyue, 2001, Zhonghua Jiehe He Huxi Zazhi, V24, P414; Li Yuan-yuan, 2009, Zhonghua Jiehe He Huxi Zazhi, V32, P489, DOI 10.3760/cma.j.issn.1001-0939.2009.07.003; LUNDGREN R, 1981, CHEST, V80, P706, DOI 10.1378/chest.80.6.706; Magro P, 2007, REV MAL RESPIR, V24, P883, DOI 10.1016/S0761-8425(07)91391-1; MARTIN CJ, 1974, ARCH OTOLARYNGOL, V100, P290; Matsuba T, 2001, Diagn Ther Endosc, V7, P63, DOI 10.1155/DTE.7.63; Meyer CN, 1997, RESP MED, V91, P499, DOI 10.1016/S0954-6111(97)90117-7; Muckleston HS, 1909, LARYNGOSCOPE, V19, P881; Nanushi M, 2011, EUROPEAN J INTERNA S, V22s, ps1; NIENHUIS DM, 1990, ANN OTO RHINOL LARYN, V99, P689, DOI 10.1177/000348949009900903; PEREZRODRIGUEZ E, 1990, CHEST, V97, P763, DOI 10.1378/chest.97.3.763a; PRAKASH UBS, 1989, MAYO CLIN PROC, V64, P1091, DOI 10.1016/S0025-6196(12)64978-7; Prakash UBS, 2002, SEMIN RESP CRIT CARE, V23, P167, DOI 10.1055/s-2002-25305; SECREST PG, 1964, AM J MED, V36, P815, DOI 10.1016/0002-9343(64)90189-5; Shigematsu Y, 2005, ANN THORAC SURG, V80, P1936, DOI 10.1016/j.athoracsur.2004.06.101; Tadjeddein A, 2006, ANN THORAC SURG, V81, P1480, DOI 10.1016/j.athoracsur.2005.04.013; Tatar D, 2012, CHINESE MED J-PEKING, V125, P2942, DOI 10.3760/cma.j.issn.0366-6999.2012.16.026; VILKMAN S, 1995, RESPIRATION, V62, P151; White B D, 2005, Australas Radiol, V49, P319, DOI 10.1111/j.1440-1673.2005.01444.x; Willms H, 2008, COUGH, V4, P4, DOI DOI 10.1186/1745-9974-4-4; Wilson R, 1996, EUR RESPIR J, V9, P1523, DOI 10.1183/09031936.96.09071523; Wong JSW, 2005, CHEST, V128, P3671, DOI 10.1378/chest.128.5.3671; Zhu Y, 2012, CHIN J RESP CRIT CAR, V11, P596; 谢宝松, 2008, [中华结核和呼吸杂志, Chinese Journal of Tuberculosis and Respiratiory Diseases], V31, P786	46	27	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102068	10.1371/journal.pone.0102068	http://dx.doi.org/10.1371/journal.pone.0102068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013916	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400061
J	Di Battista, A; Godfrey, C; Soo, C; Catroppa, C; Anderson, V				Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki			Depression and Health Related Quality of Life in Adolescent Survivors of a Traumatic Brain Injury: A Pilot Study	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; ANXIETY DISORDERS; SYMPTOMS; RELIABILITY; PREVALENCE; PREDICTORS; CHILDHOOD; SEVERITY; VALIDITY; IMPACT	Traumatic brain injury is (TBI) a leading cause of morbidity and mortality in youth. Adult survivors of a severe pediatric TBI are vulnerable to global impairments, including greater employment difficulties, poor quality of life (HRQoL) and increased risk of mental health problems. When estimating the health related quality of life in adolescents, the presence of anxiety and depression and the quality of social relationships are important considerations, because adolescents are entrenched in social development during this phase of maturation. The influence of anxiety, depression and loneliness on health related quality of life in adolescent survivors of TBI has not been documented. This pilot study aimed to identify and measure the relationship between anxiety, depression and loneliness and perceived health related quality of life in adolescent survivors of a TBI. Method: mixed method/cohort pilot study (11 adolescents, mild to severe TBI; 9 parents), using self-report and proxy-report measures of anxiety, depression, health related quality of life, loneliness and clinical psychiatric interviews (adolescent only). Results: Self-reported depression was significantly correlated with self-reported HRQoL (rs [11] = 20.88, p<0.001). Age at injury was significantly correlated with self-reported HRQoL (rs [11] = -0.68, p = 0.02). Self-reported depression predicted self-reported HRQoL (R-2 = 0.79, F [1,10] = 33.48, p<0.001), but age at injury did not (R-2 = 0.19, F [1,10] = 2.09, p = 0.18). Conclusions: Our results suggest that depression is a predictor of health related quality of life in youth post-TBI. The possibility of using targeted assessment and therapy for depression post-TBI to improve health related quality of life should be explored.	[Di Battista, Ashley; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia; [Di Battista, Ashley] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	University of Melbourne; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Di Battista, A (corresponding author), Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia.	ashley.dibattista@sickkids.ca	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Victorian Government; Victorian Neurotrauma Initiative; Australian National Health & Medical Research Council; Canadian Institutes of Health Research; Canadian Institutes of Health Research (CIHR), Canada; Victorian Government, Australia	Victorian Government; Victorian Neurotrauma Initiative; Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR), Canada(Canadian Institutes of Health Research (CIHR)); Victorian Government, Australia	Funding provided by Victorian Government Operational Infrastructure Scheme, Victorian Neurotrauma Initiative - fellowship to CS, Australian National Health & Medical Research Council - fellowships to VA and CC and Canadian Institutes of Health Research - Doctoral Research Award to AD. This research was supported in part by grants from the Canadian Institutes of Health Research (CIHR) Doctoral Research Award (DRA), Canada - awarded to ADB, and the Victorian Government Operations Infrastructure Funding, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Anderson VA, 2010, J NEUROTRAUM, V27, P1; Avenevoli S, 2001, BIOL PSYCHIAT, V49, P1071, DOI 10.1016/S0006-3223(01)01142-8; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bloom D, 1997, J INT NEUROPSYCH SOC, V5, P127; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Eapen V, 2012, CURR OPIN PSYCHIATR, V25, P7, DOI 10.1097/YCO.0b013e32834de3bd; First MB., 1997, USERS GUIDE STRUCTUR; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Graham S., 2001, PEER HARASSMENT SCH; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HODGES K, 1993, J CHILD PSYCHOL PSYC, V34, P49, DOI 10.1111/j.1469-7610.1993.tb00967.x; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Hoza B, 2000, J CLIN CHILD PSYCHOL, V29, P119, DOI 10.1207/S15374424jccp2901_12; Irons C, 2005, J ADOLESCENCE, V28, P325, DOI 10.1016/j.adolescence.2004.07.004; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kazadin AE, 1983, J AM ACAD CHILD ADOL, V22, P157; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kovacs M., 1992, CHILDRENS DEPRESSION; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCarthy ML, 2006, ARCH PHYS MED REHAB, V160, P253; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Saro J, 2013, BEST PRACTICES USING; SCHMIDT N, 1983, J PERS SOC PSYCHOL, V44, P1038, DOI 10.1037/0022-3514.44.5.1038; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Statistics ABo, 2008, STAT ABO ED UPD 17 J; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Ware JE, 1994, SF 36 PHYSL MENTAL H; Wechsler D, 1999, CORPORATION TP	42	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101842	10.1371/journal.pone.0101842	http://dx.doi.org/10.1371/journal.pone.0101842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010719	Green Published, gold			2022-12-27	WOS:000338763800045
J	Jim, B; Mehta, S; Qipo, A; Kim, K; Cohen, HW; Moore, RM; He, JC; Sharma, S				Jim, Belinda; Mehta, Swati; Qipo, Andi; Kim, Kwanghee; Cohen, Hillel W.; Moore, Robert M.; He, John C.; Sharma, Shuchita			A Comparison of Podocyturia, Albuminuria and Nephrinuria in Predicting the Development of Preeclampsia: A Prospective Study	PLOS ONE			English	Article							ANTIANGIOGENIC FACTORS; ANGIOGENIC FACTORS; URINARY-EXCRETION; PROTEINURIA; HYPERTENSION; BIOMARKERS; PREGNANCY; WOMEN	Preeclampsia, a hypertensive multisystem disease that complicates 5-8% of all pregnancy, is a major cause for maternal and fetal mortality and morbidity. The disease is associated with increased spontaneous and evoked preterm birth and remote cardio-renal disorders in the mother and offspring. Thus the ability to predict the disease should lead to earlier care and decreased morbidity. This has led to fervent attempts to identify early predictive biomarkers and research endeavors that have expanded as we learn more regarding possible causes of the disease. As preeclampsia is associated with specific renal pathology including podocyte injury, early urinary podocyte (podocyturia), or the podocyte specific proteinuria nephrin in the urine (nephrinuria), as well as the more easily measured urinary albumin (albuminuria), have all been suggested as predictive markers. We performed a prospective study recruiting 91 pregnant women (78 of whom were high risk) and studied the predictive ability of these three urinary biomarkers. The subjects were recruited between 15-38 weeks of gestation. Fourteen patients, all in the high-risk obstetric group, developed preeclampsia. The levels of podocyturia, nephrinuria, and albuminuria were variably higher in the high-risk pregnant patients who developed preeclampsia. The sensitivities and specificities for podocyturia were 70% and 43%, for albuminuria were 36% and 96%, and for nephrinuria were 57% and 58%, respectively. Also, abnormal nephrinuria (69%) and podocyturia (38%) were detected in low risk women who had uncomplicated gestations; none of these women exhibited albuminuria. In our study, none of the three urinary markers achieved the minimum predictive values required for clinical testing. The lack of excessive albuminuria, however, may indicate a preeclampsia-free gestation. Given a discrepant literature, further studies with larger sample size should be considered.	[Jim, Belinda; Qipo, Andi] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Nephrol Med, Bronx, NY 10467 USA; [Mehta, Swati; He, John C.] James J Peters VA Med Ctr, Dept Nephrol Med, Bronx, NY USA; [Kim, Kwanghee] Providence Alaska Med Ctr, Anchorage, AK USA; [Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Moore, Robert M.] Albert Einstein Coll Med, Dept Obstet & Gynecol, Jacobi Med Ctr, Bronx, NY 10467 USA; [He, John C.; Sharma, Shuchita] Mt Sinai Sch Med, Dept Nephrol Med, New York, NY USA	Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Yeshiva University; Albert Einstein College of Medicine; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Jim, B (corresponding author), Albert Einstein Coll Med, Jacobi Med Ctr, Dept Nephrol Med, Bronx, NY 10467 USA.	belindajim286@gmail.com		Cohen, Hillel/0000-0002-4524-0898	CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [1 UL1 TR001073-01, 1 TL1 TR001072-01, 1 KL2 TR001071-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001072, KL2TR001071, UL1TR001073] Funding Source: NIH RePORTER	CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported in part by the CTSA Grant 1 UL1 TR001073-01, 1 TL1 TR001072-01, 1 KL2 TR001071-01 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita K, 2009, NEPHRON CLIN PRACT, V112, pC65, DOI 10.1159/000213083; Camici M, 2008, BIOMARK MED, V2, P613, DOI 10.2217/17520363.2.6.613; Craici IM, 2013, HYPERTENSION, V61, P1289, DOI 10.1161/HYPERTENSIONAHA.113.01115; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Garovic VD, 2007, NEPHROL DIAL TRANSPL, V22, P1136, DOI 10.1093/ndt/gfl711; Garovic VD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.007; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Jim B, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/984630; Kelder TP, 2012, HYPERTENSION; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Perni U, 2012, HYPERTENSION, V59, P740, DOI 10.1161/HYPERTENSIONAHA.111.181735; Polliotti BM, 2003, OBSTET GYNECOL, V101, P1266, DOI 10.1016/S0029-7844(03)00338-7; Polsani S, 2013, ADV CHRONIC KIDNEY D, V20, P271, DOI 10.1053/j.ackd.2013.01.001; Qazi U, 2008, J RHEUMATOL, V35, P631; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Rana S, 2014, HYPERTENSION, V63, P198, DOI 10.1161/HYPERTENSIONAHA.113.02293; Rolfo A, 2013, KIDNEY INT, V83, P177, DOI 10.1038/ki.2012.348; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002	22	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101445	10.1371/journal.pone.0101445	http://dx.doi.org/10.1371/journal.pone.0101445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010746	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800024
J	Lentes, CJ; Mir, SH; Boehm, M; Ganea, C; Fendler, K; Hunte, C				Lentes, Christopher J.; Mir, Syed H.; Boehm, Marc; Ganea, Constanta; Fendler, Klaus; Hunte, Carola			Molecular Characterization of the Na+/H+-Antiporter NhaA from Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; MEMBRANE-PROTEINS; TRANSPORT PROTEINS; OLIGOMERIC STATE; ALKALINE PH; EXPRESSION; DETERGENT; GENE; MECHANISM; MIGRATION	Na+/H+ antiporters are integral membrane proteins that are present in almost every cell and in every kingdom of life. They are essential for the regulation of intracellular pH-value, Na+-concentration and cell volume. These secondary active transporters exchange sodium ions against protons via an alternating access mechanism, which is not understood in full detail. Na+/H+ antiporters show distinct species-specific transport characteristics and regulatory properties that correlate with respective physiological functions. Here we present the characterization of the Na+/H+ antiporter NhaA from Salmonella enterica serovar Thyphimurium LT2, the causing agent of food-born human gastroenteritis and typhoid like infections. The recombinant antiporter was functional in vivo and in vitro. Expression of its gene complemented the Na+ sensitive phenotype of an E. coli strain that lacks the main Na+/H+ antiporters. Purified to homogeneity, the antiporter was a dimer in solution as accurately determined by size-exclusion chromatography combined with multi-angle laser-light scattering and refractive index monitoring. The purified antiporter was fully capable of electrogenic Na+(Li+)/H+-antiport when reconstituted in proteoliposomes and assayed by solid-supported membrane-based electrophysiological measurements. Transport activity was inhibited by 2-aminoperimidine. The recorded negative currents were in agreement with a 1Na(+)(Li+)/2H(+) stoichiometry. Transport activity was low at pH 7 and up-regulation above this pH value was accompanied by a nearly 10-fold decrease of K-m(Na) (16 mM at pH 8.5) supporting a competitive substrate binding mechanism. K+ does not affect Na+ affinity or transport of substrate cations, indicating that selectivity of the antiport arises from the substrate binding step. In contrast to homologous E. coli NhaA, transport activity remains high at pH values above 8.5. The antiporter from S. Typhimurium is a promising candidate for combined structural and functional studies to contribute to the elucidation of the mechanism of pH-dependent Na+/H+ antiporters and to provide insights in the molecular basis of species-specific growth and survival strategies.	[Lentes, Christopher J.; Mir, Syed H.; Hunte, Carola] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, ZBMZ, Inst Biochem & Mol Biol, D-79106 Freiburg, Germany; [Lentes, Christopher J.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Mir, Syed H.] Univ Kashmir, Dept Clin Biochem, Srinagar 190006, Jammu & Kashmir, India; [Boehm, Marc] Max Planck Inst Biophys, Dept Mol Membrane Biol, Frankfurt, Germany; [Ganea, Constanta] Carol Davila Univ Med & Pharm, Fac Med, Dept Biophys, Bucharest, Romania; [Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany	University of Freiburg; University of Freiburg; University of Kashmir; Max Planck Society; Carol Davila University of Medicine & Pharmacy; Max Planck Society	Hunte, C (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, ZBMZ, Inst Biochem & Mol Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	carola.hunte@biochemie.uni-freiburg.de	Hunte, Carola/E-4071-2015; Ganea, Constanta/A-8561-2011	Hunte, Carola/0000-0002-0826-3986; Ganea, Constanta/0000-0003-3489-6901; Fendler, Klaus/0000-0002-5699-7060	Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; German Research Foundation [SFB 746]; European Community [HEALTH-F4-2007-201924]	Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; German Research Foundation(German Research Foundation (DFG)); European Community(European Commission)	This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294 to C.H.), SFB 746 (German Research Foundation to C.H.) and received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no HEALTH-F4-2007-201924, EDICT Consortium (to C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadeff R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025182; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Calinescu O, 2014, FEBS LETT IN PRESS; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Dibrov P, 2005, FEBS LETT, V579, P373, DOI 10.1016/j.febslet.2004.11.098; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Furrer EM, 2007, FEBS LETT, V581, P572, DOI 10.1016/j.febslet.2006.12.059; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Grewer C, 2013, ANNU REV BIOPHYS, V42, P95, DOI 10.1146/annurev-biophys-083012-130312; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Inoue H, 1999, FEBS LETT, V443, P11, DOI 10.1016/S0014-5793(98)01652-4; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mager T, 2013, J BIOL CHEM, V288, P24666, DOI 10.1074/jbc.M113.484071; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Minato Y, 2013, INFECT IMMUN, V81, P3163, DOI 10.1128/IAI.00071-13; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2013, BIOCHIM BIOPHYS ACTA, V1837, P1047, DOI DOI 10.1016/J.BBABI0.2013.12.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; PINNER E, 1992, ARCH MICROBIOL, V157, P323, DOI 10.1007/BF00248676; PINNER E, 1993, J BIOL CHEM, V268, P1729; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	48	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101575	10.1371/journal.pone.0101575	http://dx.doi.org/10.1371/journal.pone.0101575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010413	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800029
J	Tzeng, TJ; Cao, L; Fu, YX; Zeng, HW; Cheng, WH				Tzeng, Tiffany J.; Cao, Lei; Fu, YangXin; Zeng, Huawei; Cheng, Wen-Hsing			Methylseleninic Acid Sensitizes Notch3-Activated OVCA429 Ovarian Cancer Cells to Carboplatin	PLOS ONE			English	Article							NOTCH SIGNALING PATHWAY; DNA-DAMAGE RESPONSE; COPPER TRANSPORTER CTR1; PROSTATE-CANCER; OXIDATIVE STRESS; INDUCED OTOTOXICITY; N-ACETYLCYSTEINE; TARGETING NOTCH; SELENIUM; CISPLATIN	Ovarian cancer, the deadliest of gynecologic cancers, is usually not diagnosed until advanced stages. Although carboplatin has been popular for treating ovarian cancer for decades, patients eventually develop resistance to this platinum-containing drug. Expression of neurogenic locus notch homolog 3 (Notch3) is associated with chemoresistance and poor overall survival in ovarian cancer patients. Overexpression of NICD3 (the constitutively active form of Notch3) in OVCA429 ovarian cancer cells (OVCA429/NICD3) renders them resistance to carboplatin treatment compared to OVCA429/pCEG cells expressing an empty vector. We have previously shown that methylseleninic acid (MSeA) induces oxidative stress and activates ataxia-telangiectasia mutated and DNA-dependent protein kinase in cancer cells. Here we tested the hypothesis that MSeA and carboplatin exerted a synthetic lethal effect on OVCA429/NICD3 cells. Co-treatment with MSeA synergistically sensitized OVCA429/NICD3 but not OVCA429/pCEG cells to the killing by carboplatin. This synergism was associated with a cell cycle exit at the G2/M phase and the induction of NICD3 target gene HES1. Treatment of N-acetyl cysteine or inhibitors of the above two kinases did not directly impact on the synergism in OVCA429/NICD3 cells. Taken together, these results suggest that the efficacy of carboplatin in the treatment of high grade ovarian carcinoma can be enhanced by a combinational therapy with MSeA.	[Tzeng, Tiffany J.; Cheng, Wen-Hsing] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Cao, Lei; Cheng, Wen-Hsing] Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA; [Fu, YangXin] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Zeng, Huawei] ARS, USDA, Grand Forks Human Res Ctr, Grand Forks, ND USA	University System of Maryland; University of Maryland College Park; Mississippi State University; University of Alberta; United States Department of Agriculture (USDA)	Cheng, WH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	wcheng@fsnhp.msstate.edu			Maryland Agricultural Experimental Station; Mississippi Agricultural and Forestry Experimental Station; Women and Children's Health Research Institute; Royal Alexandra Hospital Foundation, Canada	Maryland Agricultural Experimental Station; Mississippi Agricultural and Forestry Experimental Station; Women and Children's Health Research Institute; Royal Alexandra Hospital Foundation, Canada	This study was partially supported by Maryland Agricultural Experimental Station and Mississippi Agricultural and Forestry Experimental Station (to W.-H. Cheng), and by Women and Children's Health Research Institute with funding donated by the Royal Alexandra Hospital Foundation, Canada (to Y. Fu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alana L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-74; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Camphausen K, 2004, MOL CANCER THER, V3, P409; Chen HH, 2010, MOL PHARMACOL, V78, P36, DOI 10.1124/mol.109.061101; Chen HP, 2013, J ONCOL, V2013, DOI 10.1155/2013/872957; Cheng CF, 2008, APOPTOSIS, V13, P883, DOI 10.1007/s10495-008-0214-9; Cheng WH, 2012, BIOCHEM BIOPH RES CO, V420, P24, DOI 10.1016/j.bbrc.2012.02.104; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Combs GF, 2004, BRIT J CANCER, V91, P195, DOI 10.1038/sj.bjc.6601974; Cruet-Hennequart S, 2009, CELL CYCLE, V8, P3039; Dailey DD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-130; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; El-Sehemy A, 2013, CELL SIGNAL, V25, P2780, DOI 10.1016/j.cellsig.2013.09.008; Fakih MG, 2008, CANCER CHEMOTH PHARM, V62, P499, DOI 10.1007/s00280-007-0631-4; Finley JW, 2000, J NUTR, V130, P2384, DOI 10.1093/jn/130.9.2384; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Guo X, 2013, MOL CARCINOGEN, V52, P879, DOI 10.1002/mc.21933; Gupta N, 2013, GYNECOL ONCOL, V130, P200, DOI 10.1016/j.ygyno.2013.03.019; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Itamochi H, 2002, OBSTET GYNECOL, V100, P281, DOI 10.1016/S0029-7844(02)02040-9; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kwintkiewicz J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096032; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Maillard I, 2003, CANCER CELL, V3, P203, DOI 10.1016/S1535-6108(03)00052-7; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Moon IJ, 2011, CLIN EXP OTORHINOLAR, V4, P11, DOI 10.3342/ceo.2011.4.1.11; OGURI S, 1988, J CLIN PHARMACOL, V28, P208, DOI 10.1002/j.1552-4604.1988.tb03134.x; Okur E, 2007, LARYNGOSCOPE, V117, P2183, DOI 10.1097/MLG.0b013e31813e6041; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Qi YF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031539, 10.1371/journal.pone.0033859]; Qi YM, 2010, J BIOL CHEM, V285, P33010, DOI 10.1074/jbc.M110.137406; Qian XZ, 2006, MOL CANCER THER, V5, P2086, DOI 10.1158/1535-7163.MCT-06-0111; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rocourt CRB, 2013, J NUTR BIOCHEM, V24, P781, DOI 10.1016/j.jnutbio.2012.04.011; Rose SL, 2009, INT J GYNECOL CANCER, V19, P564, DOI 10.1111/IGC.0b013e3181a12ed2; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Song IS, 2004, MOL CANCER THER, V3, P1543; Steinbrenner H, 2013, ANTIOXID REDOX SIGN, V19, P181, DOI 10.1089/ars.2013.5246; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Uchida T, 2014, EXP HEMATOL, V42, P369, DOI 10.1016/j.exphem.2014.01.009; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang L, 2014, NUTR CANCER, V66, P295, DOI 10.1080/01635581.2014.868911; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wu L, 2004, J BIOL CHEM, V279, P12126, DOI 10.1074/jbc.M307097200; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wu XJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-192; Yin ST, 2012, APOPTOSIS, V17, P388, DOI 10.1007/s10495-011-0687-9; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zeng HW, 2011, BIOL TRACE ELEM RES, V143, P1209, DOI 10.1007/s12011-010-8935-3; Zhang S, 2011, J NUTR BIOCHEM, V22, P1137, DOI 10.1016/j.jnutbio.2010.09.014	62	6	7	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101664	10.1371/journal.pone.0101664	http://dx.doi.org/10.1371/journal.pone.0101664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010594	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800031
J	Xu, FY; Zhou, GQ; Han, SL; Yuan, WG; Chen, S; Fu, ZK; Li, DL; Zhang, H; Li, DJ; Pang, D				Xu, Fengyan; Zhou, Guiqin; Han, Shaoli; Yuan, Weiguang; Chen, Shuang; Fu, Zhenkun; Li, Dalin; Zhang, Hua; Li, Dianjun; Pang, Da			Association of TNF-alpha, TNFRSF1A and TNFRSF1B Gene Polymorphisms with the Risk of Sporadic Breast Cancer in Northeast Chinese Han Women	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MULTIPLE-SCLEROSIS; FACTOR RECEPTOR; INFLAMMATION; EXPRESSION; PROMOTER; SUSCEPTIBILITY; BENIGN; SNPS; LTA	Background: The interaction of tumor necrosis factor-alpha (TNF-alpha) with its receptors: TNFRSF1A and TNFRSF1B is critical for the promotion of tumor growth, invasion and metastasis. To better understand the roles of single nucleotide polymorphisms (SNPs) in the TNF-alpha, TNFRSF1A and TNFRSF1B genes in the development of breast cancer, we explored the associations between SNPs in these three genes and breast cancer susceptibility in northeast Chinese Han women. Methodology/Principal Findings: This case-control study was conducted among 1016 breast cancer patients and 806 age-matched healthy controls. Seven SNPs in the TNF-alpha (rs1800629, rs361525), TNFRSF1A (rs767455, rs4149577 and rs1800693) and TNFRSF1B (rs1061622 and rs1061624) genes were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. In TNFRSF1B, the rs1061622 GT genotype and the G allele conferred a reduced susceptibility to breast cancer (P = 0.000662, OR = 0.706, 95% CI: 0.578-0.863; P = 0.002, OR = 0.769, 95% CI; 0.654-0.905, respectively). Moreover, the AG genotype, the AA genotype and the A allele in rs1061624 conferred an increased risk of breast cancer (P = 0.007, OR = 1.470, 95% CI: 1.112-1.943; P = 0.00109, OR = 1.405 95% CI: 1.145-1.724; P = 0.001, OR = 1.248 95% CI: 1.092-1.426, respectively). These two SNPs also had associations with breast cancer risk under the dominant model. In haplotype analysis, the CTA (rs767455 C-rs4149577 T-rs1800693 A) haplotype in TNFRSF1A and the TA (rs1061622 T-rs1061624 A) haplotype in TNFRSF1B had higher frequencies in breast cancer patients (P = 0.00324; P = 0.000370, respectively), but the frequency of GG (rs1061622 G-rs1061624 G) haplotype in TNFRSF1B was lower in breast cancer patients (P = 0.000251). The associations of the three haplotypes remained significant after correcting for multiple testing. In addition, significant associations were also observed between TNFRSF1A polymorphisms and lymph node metastasis, P53, estrogen receptor (ER) and progesterone receptor (PR) statuses. Conclusions: Our results suggest that rs1061622 and rs1061624 in TNFRSF1B may affect breast cancer risk, and SNPs in TNFRSF1A are associated with the clinical features of breast cancer.	[Xu, Fengyan] Harbin Med Univ, Dept Anat, Harbin, Peoples R China; [Zhou, Guiqin; Han, Shaoli; Chen, Shuang; Fu, Zhenkun; Zhang, Hua; Li, Dianjun] Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China; [Yuan, Weiguang; Li, Dianjun] Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China; [Li, Dalin; Pang, Da] Harbin Med Univ, Dept Surg, Affiliated Hosp 3, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, DJ (corresponding author), Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China.	dianjunli@163.com; pangdasir@163.com			National Natural Science Foundation of China [31070780]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (31070780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Fang F, 2010, BREAST CANCER RES TR, V122, P267, DOI 10.1007/s10549-009-0698-1; Ferguson LR, 2009, GASTROENT RES PRACT, V2009, DOI 10.1155/2009/591704; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Garcia-Tunon I, 2006, CANCER SCI, V97, P1044, DOI 10.1111/j.1349-7006.2006.00277.x; Gaudet MM, 2007, HUM GENET, V121, P483, DOI 10.1007/s00439-006-0315-x; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Guan XX, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-447; Huizinga TWJ, 1997, J NEUROIMMUNOL, V72, P149, DOI 10.1016/S0165-5728(96)00182-8; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Int Multiple Sclerosis Genetics, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018813; Kamali-Sarvestani E, 2005, CANCER LETT, V223, P113, DOI 10.1016/j.canlet.2004.09.025; Karaderi T, 2012, CLIN EXP RHEUMATOL, V30, P110; Kohaar I, 2009, BREAST CANCER RES TR, V114, P347, DOI 10.1007/s10549-008-0006-5; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Leek RD, 1998, BRIT J CANCER, V77, P2246, DOI 10.1038/bjc.1998.373; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Madeleine MM, 2011, BREAST CANCER RES TR, V129, P887, DOI 10.1007/s10549-011-1520-4; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; Mokrousov I, 2011, INFECT GENET EVOL, V11, P1312, DOI 10.1016/j.meegid.2011.04.025; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Ni B, 2014, PLOS ONE, V28; Park KS, 2002, EUR J IMMUNOGENET, V29, P7, DOI 10.1046/j.0960-7420.2001.00260.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pooja S, 2011, BREAST CANCER RES TR, V126, P739, DOI 10.1007/s10549-010-1175-6; Rakha EA, 2007, J CLIN ONCOL, V25, P4772, DOI 10.1200/JCO.2007.12.2747; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Steenholdt C, 2012, ALIMENT PHARM THER, V36, P650, DOI 10.1111/apt.12010; Stendahl M, 2006, CLIN CANCER RES, V12, P4614, DOI 10.1158/1078-0432.CCR-06-0248; Till A, 2005, J BIOL CHEM, V280, P5994, DOI 10.1074/jbc.M411541200; Tran TA, 1998, CANCER, V83, P276, DOI 10.1002/(SICI)1097-0142(19980715)83:2<276::AID-CNCR11>3.3.CO;2-5; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Xu FY, 2012, BREAST CANCER RES TR, V133, P1105, DOI 10.1007/s10549-012-1987-7; Yang Y, 2011, BREAST CANCER RES TR, V129, P513, DOI 10.1007/s10549-011-1494-2	40	26	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101138	10.1371/journal.pone.0101138	http://dx.doi.org/10.1371/journal.pone.0101138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010932	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800013
J	Treton, X; Pedruzzi, E; Guichard, C; Ladeiro, Y; Sedghi, S; Vallee, M; Fernandez, N; Bruyere, E; Woerther, PL; Ducroc, R; Montcuquet, N; Freund, JN; Van Seuningen, I; Barreau, F; Marah, A; Hugot, JP; Cazals-Hatem, D; Bouhnik, Y; Daniel, F; Ogier-Denis, E				Treton, Xavier; Pedruzzi, Eric; Guichard, Cecile; Ladeiro, Yannick; Sedghi, Shirin; Vallee, Melissa; Fernandez, Neike; Bruyere, Emilie; Woerther, Paul-Louis; Ducroc, Robert; Montcuquet, Nicolas; Freund, Jean-Noel; Van Seuningen, Isabelle; Barreau, Frederick; Marah, Assiya; Hugot, Jean-Pierre; Cazals-Hatem, Dominique; Bouhnik, Yoram; Daniel, Fanny; Ogier-Denis, Eric			Combined NADPH Oxidase 1 and Interleukin 10 Deficiency Induces Chronic Endoplasmic Reticulum Stress and Causes Ulcerative Colitis-Like Disease in Mice	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; EPITHELIAL-CELLS; CANCER; NOX1; EXPRESSION; RECEPTOR; SUSCEPTIBILITY; SENSITIVITY; IMPACT; IL-10	Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the rectum which progressively extents. Its etiology remains unknown and the number of treatments available is limited. Studies of UC patients have identified an unbalanced endoplasmic reticulum (ER) stress in the non-inflamed colonic mucosa. Animal models with impaired ER stress are sensitive to intestinal inflammation, suggesting that an unbalanced ER stress could cause inflammation. However, there are no ER stress-regulating strategies proposed in the management of UC partly because of the lack of relevant preclinical model mimicking the disease. Here we generated the IL10/Nox1(dKO) mouse model which combines immune dysfunction (IL-10 deficiency) and abnormal epithelium (NADPH oxidase 1 (Nox1) deficiency) and spontaneously develops a UC-like phenotype with similar complications (colorectal cancer) than UC. Our data identified an unanticipated combined role of IL10 and Nox1 in the fine-tuning of ER stress responses in goblet cells. As in humans, the ER stress was unbalanced in mice with decreased eIF2 alpha phosphorylation preceding inflammation. In IL10/Nox1(dKO) mice, salubrinal preserved eIF2 alpha phosphorylation through inhibition of the regulatory subunit of the protein phosphatase 1 PP1R15A/GADD34 and prevented colitis. Thus, this new experimental model highlighted the central role of epithelial ER stress abnormalities in the development of colitis and defined the defective eIF2 alpha pathway as a key pathophysiological target for UC. Therefore, specific regulators able to restore the defective eIF2 alpha pathway could lead to the molecular remission needed to treat UC.	[Treton, Xavier; Pedruzzi, Eric; Ladeiro, Yannick; Sedghi, Shirin; Vallee, Melissa; Fernandez, Neike; Ducroc, Robert; Marah, Assiya; Cazals-Hatem, Dominique; Bouhnik, Yoram; Daniel, Fanny; Ogier-Denis, Eric] Ctr Rech Inflammat, Team Physiopathol Inflammatory Bowel Dis, INSERM, UMRS1149, Paris, France; [Treton, Xavier; Pedruzzi, Eric; Guichard, Cecile; Ladeiro, Yannick; Sedghi, Shirin; Vallee, Melissa; Fernandez, Neike; Ducroc, Robert; Barreau, Frederick; Marah, Assiya; Hugot, Jean-Pierre; Cazals-Hatem, Dominique; Bouhnik, Yoram; Daniel, Fanny; Ogier-Denis, Eric] Sorbonne Paris Cite, Univ Paris Diderot, Paris, France; [Treton, Xavier; Marah, Assiya; Bouhnik, Yoram] PMAD Hopital Beaujon, Serv Gastroenterol & Assistance Nutr, Clichy La Garenne, France; [Treton, Xavier; Pedruzzi, Eric; Ladeiro, Yannick; Sedghi, Shirin; Vallee, Melissa; Fernandez, Neike; Ducroc, Robert; Barreau, Frederick; Marah, Assiya; Hugot, Jean-Pierre; Cazals-Hatem, Dominique; Bouhnik, Yoram; Daniel, Fanny; Ogier-Denis, Eric] PRES Paris Sorbonne Cite, Lab Excellence Labex INFLAMEX, Paris, France; [Guichard, Cecile] Ctr Biomed Cordeliers, INSERM, UMRS871, Paris, France; [Bruyere, Emilie; Van Seuningen, Isabelle] Jean Pierre Aubert Res Ctr, Team Mucins Epithelial Differentiat & Carcinogene, INSERM, UMR837, Lille, France; [Woerther, Paul-Louis] Hop Bichat Claude Bernard, Bacteriol Lab, F-75877 Paris 18, France; [Montcuquet, Nicolas] Univ Paris 05, INSERM, U989, Paris, France; [Montcuquet, Nicolas] Univ Paris 05, Fac Med Rene Descartes, Paris, France; [Freund, Jean-Noel] Univ Louis Pasteur, INSERM, U682, Strasbourg, France; [Barreau, Frederick; Hugot, Jean-Pierre] U843 Hop R Debre, INSERM, Paris, France; [Cazals-Hatem, Dominique] Hop Beaujon, Serv Anat Pathol, Clichy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Treton, X (corresponding author), Ctr Rech Inflammat, Team Physiopathol Inflammatory Bowel Dis, INSERM, UMRS1149, Paris, France.	xtreton@gmail.com	WOERTHER, Paul-Louis/AAC-4637-2019; Ogier-Denis, Eric/E-5030-2016; pedruzzi, eric/B-6050-2017; VAN SEUNINGEN, Isabelle/N-6176-2016; Freund, Jean-Noel/R-4383-2016; Woerther, Paul-Louis/ABD-9084-2020	VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; Freund, Jean-Noel/0000-0002-0971-3774; Woerther, Paul-Louis/0000-0002-6957-9482; Ogier-Denis, Eric/0000-0002-0057-7593; Barreau, Frederick/0000-0002-7150-9619; Hugot, Jean-Pierre/0000-0002-8446-6056; Ladeiro, Yannick/0000-0001-9986-3276; treton, xavier/0000-0001-8123-9213; Fernandez, Neike/0000-0001-9127-248X	Institut National de la Sante et de la Recherche Medicale (INSERM); INSERM-Transfert (CopoC's); Agence Nationale de la Recherche (ANR); Association Francois Aupetit (AFA); Assistance Publique-Hopitaux de Paris (AP-HP); University Denis Diderot Paris 7; labex "Inflamex''	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM-Transfert (CopoC's); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association Francois Aupetit (AFA); Assistance Publique-Hopitaux de Paris (AP-HP); University Denis Diderot Paris 7; labex "Inflamex''	This work was supported by grants from: Institut National de la Sante et de la Recherche Medicale (INSERM), INSERM-Transfert (CoPoC's grant to XT and EOD), Agence Nationale de la Recherche (ANR Emergence to EOD), Association Francois Aupetit (AFA) (to XT and EOD), Assistance Publique-Hopitaux de Paris (AP-HP) (to EOD: Interface Fellowship), University Denis Diderot Paris 7, and labex "Inflamex'' (to EOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A., 2013, MUCOSAL IMMUNOL; AUGERON C, 1984, CANCER RES, V44, P3961; Barreau F, 2010, GUT, V59, P207, DOI 10.1136/gut.2008.171546; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Cao SS, 2012, INFLAMM BOWEL DIS; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glocker EO, 2010, ANN NY ACAD SCI, V1246, P102; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Hasnain SZ, 2012, GASTROENTEROLOGY; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Itoh H, 1999, J CLIN INVEST, V104, P1539, DOI 10.1172/JCI6211; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leiper K, 2001, CLIN SCI, V101, P395, DOI 10.1042/CS20010078; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Lindsay JO, 2003, GUT, V52, P981, DOI 10.1136/gut.52.7.981; Ogier-Denis E, 2008, SEMIN IMMUNOPATHOL, V30, P291, DOI 10.1007/s00281-008-0120-9; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUIMY R, 1994, INT J SYST BACTERIOL, V44, P416, DOI 10.1099/00207713-44-3-416; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Treton X, 2011, GASTROENTEROLOGY, V141, P1024, DOI 10.1053/j.gastro.2011.05.033; Tytgat KMAJ, 1996, BIOCHEM BIOPH RES CO, V224, P397, DOI 10.1006/bbrc.1996.1039; Valente AJ, 2008, FREE RADICAL BIO MED, V44, P430, DOI 10.1016/j.freeradbiomed.2007.10.035; Werner T, 2007, J PROTEOME RES, V6, P3691, DOI 10.1021/pr070222x; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053; ZHAO F, 2009, DEV BIOL, V338, P270	39	36	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101669	10.1371/journal.pone.0101669	http://dx.doi.org/10.1371/journal.pone.0101669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25014110	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600054
J	Chen, J; Hu, WJ; Wang, C; Liu, TW; Chalifour, A; Chen, J; Shen, ZJ; Liu, X; Wang, WH; Zheng, HL				Chen, Juan; Hu, Wen-Jun; Wang, Chao; Liu, Ting-Wu; Chalifour, Annie; Chen, Juan; Shen, Zhi-Jun; Liu, Xiang; Wang, Wen-Hua; Zheng, Hai-Lei			Proteomic Analysis Reveals Differences in Tolerance to Acid Rain in Two Broad-Leaf Tree Species, Liquidambar formosana and Schima superba	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; SALT STRESS; RESPONSIVE PROTEINS; DROUGHT TOLERANCE; SEEDLING GROWTH; PHYTOCHROME B; EXPRESSION; BIOSYNTHESIS; GERMINATION	Acid rain (AR) is a serious environmental issue inducing harmful impacts on plant growth and development. It has been reported that Liquidambar formosana, considered as an AR-sensitive tree species, was largely injured by AR, compared with Schima superba, an AR-tolerant tree species. To clarify the different responses of these two species to AR, a comparative proteomic analysis was conducted in this study. More than 1000 protein spots were reproducibly detected on two-dimensional electrophoresis gels. Among them, 74 protein spots from L. formosana gels and 34 protein spots from S. superba gels showed significant changes in their abundances under AR stress. In both L. formosana and S. superba, the majority proteins with more than 2 fold changes were involved in photosynthesis and energy production, followed by material metabolism, stress and defense, transcription, post-translational and modification, and signal transduction. In contrast with L. formosana, no hormone response-related protein was found in S. superba. Moreover, the changes of proteins involved in photosynthesis, starch synthesis, and translation were distinctly different between L. formosana and S. superba. Protein expression analysis of three proteins (ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit, ascorbate peroxidase and glutathione-S-transferase) by Western blot was well correlated with the results of proteomics. In conclusion, our study provides new insights into AR stress responses in woody plants and clarifies the differences in strategies to cope with AR between L. formosana and S. superba.	[Chen, Juan; Hu, Wen-Jun; Liu, Ting-Wu; Chen, Juan; Shen, Zhi-Jun; Liu, Xiang; Wang, Wen-Hua; Zheng, Hai-Lei] Xiamen Univ, Key Lab Coastal & Wetland Ecosyst, Minist Educ, Coll Environm & Ecol, Xiamen, Fujian, Peoples R China; [Wang, Chao] Chinese Acad Sci, Inst Urban & Environm, Xiamen, Peoples R China; [Liu, Ting-Wu] Huaiyin Normal Univ, Dept Biol, Huaian, Jiangsu, Peoples R China; [Chalifour, Annie] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS; Huaiyin Normal University; City University of Hong Kong	Zheng, HL (corresponding author), Xiamen Univ, Key Lab Coastal & Wetland Ecosyst, Minist Educ, Coll Environm & Ecol, Xiamen, Fujian, Peoples R China.	zhenghl@xmu.edu.cn	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529; Chalifour, Annie/0000-0003-2266-3094	Natural Science Foundation of China (NSFC) [31300505, 30930076, 31260057, 30770192, 30670317]; China Postdoctoral Science Foundation [2012M521278]; Foundation of the Chinese Ministry of Education [20070384033, 209084]; Program for New Century Excellent Talents in Xiamen University [NCETXMU X07115]; Scholarship Award for Excellent Doctoral Student - Chinese Ministry of Education	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of the Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in Xiamen University(Program for New Century Excellent Talents in University (NCET)); Scholarship Award for Excellent Doctoral Student - Chinese Ministry of Education(Ministry of Education, China)	This study was financially supported by the Natural Science Foundation of China (NSFC) (31300505, 30930076, 31260057, 30770192, 30670317), China Postdoctoral Science Foundation (2012M521278), the Foundation of the Chinese Ministry of Education (20070384033, 209084), the Program for New Century Excellent Talents in Xiamen University (NCETXMU X07115), and the Scholarship Award for Excellent Doctoral Student granted by the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Beato VM, 2011, PLANT PHYSIOL BIOCH, V49, P1350, DOI 10.1016/j.plaphy.2011.06.001; Carvalho RF, 2011, J INTEGR PLANT BIOL, V53, P920, DOI 10.1111/j.1744-7909.2011.01081.x; Chen J, 2013, PLANT PHYSIOL BIOCH, V64, P41, DOI 10.1016/j.plaphy.2012.12.012; Chen J, 2012, ENVIRON POLLUT, V160, P192, DOI 10.1016/j.envpol.2011.09.007; Cheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054154; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Dai Z, 2012, ENVIRON SCI POLLUT R, V20, P4216; DeHayes DH, 1999, BIOSCIENCE, V49, P789, DOI 10.2307/1313570; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Fan HB, 2000, FOREST ECOL MANAG, V126, P321, DOI 10.1016/S0378-1127(99)00103-6; Feng ZW, 2002, J ENVIRON SCI-CHINA, V14, P227; Firon N, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls024; Flagella Z, 2006, FUNCT PLANT BIOL, V33, P357, DOI 10.1071/FP05244; Foo E, 2006, PLANT J, V46, P911, DOI 10.1111/j.1365-313X.2006.02754.x; Fu JM, 2010, PLANT MOL BIOL, V73, P339, DOI 10.1007/s11103-010-9622-7; Ho SL, 2013, PLANT MOL BIOL, V81, P347, DOI 10.1007/s11103-012-0006-z; Hossain Z, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00310; Hu WJ, 2014, PLANT SOIL, V380, P285, DOI 10.1007/s11104-014-2086-9; Hu WJ, 2014, INT J MOL SCI, V15, P4333, DOI 10.3390/ijms15034333; Hu WJ, 2014, NITRIC OXIDE-BIOL CH, V36, P19, DOI 10.1016/j.niox.2013.10.008; Huang SS, 2011, PHYSIOL PLANTARUM, V144, P73; Ji XL, 2009, PROTEOMICS, V9, P5328, DOI 10.1002/pmic.200900012; Jiang H, 2013, CHEMOSPHERE, V91, P1213, DOI 10.1016/j.chemosphere.2013.01.041; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Kim DW, 2005, ELECTROPHORESIS, V26, P4521, DOI 10.1002/elps.200500334; Kovacik J, 2014, PLANT PHYSIOL BIOCH, V80, P33, DOI 10.1016/j.plaphy.2014.03.015; Kovacik J, 2014, J HAZARD MATER, V273, P110, DOI 10.1016/j.jhazmat.2014.03.040; Kovacik J, 2012, J HAZARD MATER, V239, P175, DOI 10.1016/j.jhazmat.2012.08.062; Kovacik J, 2011, ECOTOXICOLOGY, V20, P348, DOI 10.1007/s10646-010-0585-x; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Kwon Y, 2007, PLANT J, V49, P184, DOI 10.1111/j.1365-313X.2006.02950.x; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Liu J, 2012, PLANT MOL BIOL, V78, P289, DOI 10.1007/s11103-011-9860-3; Liu JX, 2007, ACTA PHYSIOL PLANT, V29, P33, DOI 10.1007/s11738-006-0005-2; Liu TW, 2013, GENOME, V56, P49, DOI 10.1139/gen-2012-0090; Liu TW, 2011, TREE PHYSIOL, V31, P402, DOI 10.1093/treephys/tpr019; Liu TW, 2011, J PROTEOME RES, V10, P2579, DOI 10.1021/pr200056a; Liu TW, 2011, PROTEOMICS, V11, P2079, DOI 10.1002/pmic.201000307; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Neves NR, 2009, SCI TOTAL ENVIRON, V407, P3740, DOI 10.1016/j.scitotenv.2009.02.035; Pandey A, 2008, MOL CELL PROTEOMICS, V7, P88, DOI 10.1074/mcp.M700314-MCP200; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Sehrawat A, 2013, PROTEOMICS, V13, P1816, DOI 10.1002/pmic.201200445; Sun ZG, 2012, ECOTOX ENVIRON SAFE, V79, P62, DOI 10.1016/j.ecoenv.2011.12.004; Symons GM, 2008, PLANTA, V227, P1115, DOI 10.1007/s00425-007-0685-x; Sysoeva MI, 2013, RUSS J PLANT PHYSL+, V60, P383, DOI 10.1134/S1021443713020180; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Tapia G, 2011, PLANT BIOLOGY, V13, P69, DOI 10.1111/j.1438-8677.2009.00311.x; Villeth GR, 2009, FEMS MICROBIOL LETT, V298, P260, DOI 10.1111/j.1574-6968.2009.01728.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang LX, 2013, J PROTEOME RES, V12, P5124, DOI 10.1021/pr4006469; Wang SJ, 2006, BIOL PLANTARUM, V50, P537, DOI 10.1007/s10535-006-0085-2; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518; Yang QS, 2007, PROTEOMICS, V7, P737, DOI 10.1002/pmic.200600703; Zorb C, 2010, PROTEOMICS, V10, P4441, DOI 10.1002/pmic.201000231	63	6	7	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102532	10.1371/journal.pone.0102532	http://dx.doi.org/10.1371/journal.pone.0102532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025692	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400084
J	Fu, SH; Jha, P; Gupta, PC; Kumar, R; Dikshit, R; Sinha, D				Fu, Sze Hang; Jha, Prabhat; Gupta, Prakash C.; Kumar, Rajesh; Dikshit, Rajesh; Sinha, Dhirendra			Geospatial Analysis on the Distributions of Tobacco Smoking and Alcohol Drinking in India	PLOS ONE			English	Article							CONSUMPTION; HEALTH; PATTERNS; ASSOCIATION; POPULATION; PREVALENCE; STATE; MEN	Background: Tobacco smoking and binge alcohol drinking are two of the leading risk factors for premature mortality worldwide. In India, studies have examined the geographic distributions of tobacco smoking and alcohol drinking only at the state-level; sub-state variations and the spatial association between the two consumptions are poorly understood. Methodology: We used data from the Special Fertility and Mortality Survey conducted in 1998 to examine the geographic distributions of tobacco smoking and alcohol drinking at the district and postal code levels. We used kriging interpolation to generate smoking and drinking distributions at the postal code level. We also examined spatial autocorrelations and identified spatial clusters of high and low prevalence of smoking and drinking. Finally, we used bivariate analyses to examine the spatial correlations between smoking and drinking, and between cigarette and bidi smoking. Results: There was a high prevalence of any smoking in the central and northeastern states, and a high prevalence of any drinking in Himachal Pradesh, Arunachal Pradesh, and eastern Madhya Pradesh. Spatial clusters of early smoking (started smoking before age 20) were identified in the central states. Cigarette and bidi smoking showed distinctly different geographic patterns, with high levels of cigarette smoking in the northeastern states and high levels of bidi smoking in the central states. The geographic pattern of bidi smoking was similar to early smoking. Cigarette smoking was spatially associated with any drinking. Smoking prevalences in 1998 were correlated with prevalences in 2004 at the district level and 2010 at the state level. Conclusion: These results along with earlier evidence on the complementarities between tobacco smoking and alcohol drinking suggest that local public health action on smoking might also help to reduce alcohol consumption, and vice versa. Surveys that properly represent tobacco and alcohol consumptions at the district level are recommended.	[Fu, Sze Hang; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON, Canada; [Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, Navi Mumbai, India; [Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Dikshit, Rajesh] Tata Mem Hosp, Dept Epidemiol, Mumbai 400012, Maharashtra, India; [Sinha, Dhirendra] World Hlth Org, South East Asia Reg Off, New Delhi, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Tata Memorial Centre (TMC); Tata Memorial Hospital; World Health Organization	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON, Canada.	prabhat.jha@utoronto.ca		Fu, Sze Hang/0000-0003-4890-9339	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2005, EXPLORING SPATIAL DA; Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816; Benegal V, 2005, ADDICTION, V100, P1051, DOI 10.1111/j.1360-0443.2005.01176.x; Census of India, 2001, SER GEN POP TABL; Census of India, 2001, SER SOC CULT TABL; Census of India, 2011, PRIM CENS ABSTR DAT; CHAKRAVARTHY C, 1990, Indian Journal of Psychological Medicine, V13, P49; Das SK, 2006, NATL MED J INDIA, V19, P94; Gupta P. C., 2008, BIDI SMOKING PUBLIC; Gupta PC, 2005, NATL MED J INDIA, V18, P88; Gupta PC, 2003, ALCOHOL ALCOHOLISM, V38, P327, DOI 10.1093/alcalc/agg077; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Indian Institute of Population Sciences (IIPS), 2010, GLOB AD TOB SURV IND; International Institute of Population Sciences (IIPS), 2000, NAT FAM HLTH SURV 2; Jacob KS, 2010, NATL MED J INDIA, V23, P224; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P., 2011, Economic and Political Weekly, V46, P44; Jha P, 2012, CHALLENGE PAPER COPE; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; John A, 2009, NATL MED J INDIA, V22, P123; John RM, 2005, HEALTH POLICY, V71, P213, DOI 10.1016/j.healthpol.2004.08.008; John RM., 2010, EC TOBACCO TOBACCO T; Joshi RA, 2010, DALITS TRIBES INDIA; Kalman D, 2010, CLIN PSYCHOL REV, V30, P12, DOI 10.1016/j.cpr.2009.08.009; Kandwal R, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-18; Kaur Jagdish, 2011, Indian J Public Health, V55, P220, DOI 10.4103/0019-557X.89941; Mahal A., 2000, ECON POLIT WEEKLY, P3959, DOI DOI 10.2307/4409926; Mathers C, 2009, GLOB HLTH RISKS MORT; Mckee SA, 2013, ALCOHOL CLIN EXP RES, V37, P804, DOI 10.1111/acer.12041; Mehrotra R, 2010, Indian J Cancer, V47 Suppl 1, P75, DOI 10.4103/0019-509X.63870; Mohan D, 2002, INDIAN J MED RES, V116, P150; Narayan KMV, 1996, BRIT MED J, V312, P1576, DOI 10.1136/bmj.312.7046.1576; Neufeld KJ, 2005, DRUG ALCOHOL DEPEN, V77, P283, DOI 10.1016/j.drugalcdep.2004.08.022; O'Sullivan D., 2010, GEOGRAPHIC INFORM AN; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Prasad R, 2009, LANCET, V373, P17, DOI 10.1016/S0140-6736(08)61939-X; Rahman M, 2000, PUBLIC HEALTH, V114, P123, DOI 10.1016/S0033-3506(00)00320-6; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Registrar General of India, 2004, SAMPL REG SYST SRS B; Registrar General of India, 2005, SPEC FERT MORT SURV; Registrar General of India, 1996, SAMPL REG SYST STAT; Ricketts TC, 2003, ANNU REV PUBL HEALTH, V24, P1, DOI 10.1146/annurev.publhealth.24.100901.140924; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026856; Sinha DN, 2007, ASIAN PAC J CANCER P, V8, P417; Srivastava A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-30; Subramanian SV, 2005, B WORLD HEALTH ORGAN, V83, P829; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; Tiwari Rajnarayan, 2006, Indian J Med Sci, V60, P271	52	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102416	10.1371/journal.pone.0102416	http://dx.doi.org/10.1371/journal.pone.0102416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025379	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400072
J	Russell, JR; Hedley, PE; Cardle, L; Dancey, S; Morris, J; Booth, A; Odee, D; Mwaura, L; Omondi, W; Angaine, P; Machua, J; Muchugi, A; Milne, I; Kindt, R; Jamnadass, R; Dawson, IK				Russell, Joanne R.; Hedley, Peter E.; Cardle, Linda; Dancey, Siobhan; Morris, Jenny; Booth, Allan; Odee, David; Mwaura, Lucy; Omondi, William; Angaine, Peter; Machua, Joseph; Muchugi, Alice; Milne, Iain; Kindt, Roeland; Jamnadass, Ramni; Dawson, Ian K.			tropiTree: An NGS-Based EST-SSR Resource for 24 Tropical Tree Species	PLOS ONE			English	Article							PRUNUS-AFRICANA; GENETIC DIVERSITY; MICROSATELLITE DEVELOPMENT; AGROFORESTRY; GENOME; PHYLOGEOGRAPHY; DOMESTICATION; ANNOTATION; MANAGEMENT; HIGHLANDS	The development of genetic tools for non-model organisms has been hampered by cost, but advances in next-generation sequencing (NGS) have created new opportunities. In ecological research, this raises the prospect for developing molecular markers to simultaneously study important genetic processes such as gene flow in multiple non-model plant species within complex natural and anthropogenic landscapes. Here, we report the use of bar-coded multiplexed paired-end Illumina NGS for the de novo development of expressed sequence tag-derived simple sequence repeat (EST-SSR) markers at low cost for a range of 24 tree species. Each chosen tree species is important in complex tropical agroforestry systems where little is currently known about many genetic processes. An average of more than 5,000 EST-SSRs was identified for each of the 24 sequenced species, whereas prior to analysis 20 of the species had fewer than 100 nucleotide sequence citations. To make results available to potential users in a suitable format, we have developed an open-access, interactive online database, tropiTree (http://bioinf.hutton.ac.uk/tropiTree), which has a range of visualisation and search facilities, and which is a model for the efficient presentation and application of NGS data.	[Russell, Joanne R.; Hedley, Peter E.; Cardle, Linda; Dancey, Siobhan; Morris, Jenny; Booth, Allan; Milne, Iain; Dawson, Ian K.] James Hutton Inst, Invergowrie, Scotland; [Dancey, Siobhan] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Odee, David; Omondi, William; Angaine, Peter; Machua, Joseph] Kenya Forestry Res Inst, Headquarters, Nairobi, Kenya; [Odee, David] Ctr Ecol & Hydrol, Ctr Ecol & Hydrol Edinburgh, Penicuik, Midlothian, Scotland; [Mwaura, Lucy; Muchugi, Alice; Kindt, Roeland; Jamnadass, Ramni; Dawson, Ian K.] World Agroforestry Ctr, Headquarters, Nairobi, Kenya	James Hutton Institute; University of Dundee; UK Centre for Ecology & Hydrology (UKCEH); CGIAR; World Agroforestry (ICRAF)	Dawson, IK (corresponding author), James Hutton Inst, Invergowrie, Scotland.	iankdawson@aol.com	Hedley, Peter/F-1149-2011; Angaine, Peter Murithi/AAV-6572-2020	Hedley, Peter/0000-0003-0866-324X; Angaine, Peter M./0000-0002-6477-8802; Dawson, Ian/0000-0003-4245-6973; Milne, Iain/0000-0002-4126-0859; Dawson, Ian/0000-0003-1345-3642; Machua, Joseph/0000-0002-0442-5407; Milne, Linda/0000-0002-1798-8022	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes R.D., 2003, TROPICAL FORESTRY PA; Bayala J, 2011, CONSERVATION AGR TRE; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Garcia-Lopez MC, 2014, TREE GENET GENOMES, V10, P585, DOI 10.1007/s11295-014-0706-4; Carsan S, 2014, CURR OPIN ENV SUST, V6, P35, DOI 10.1016/j.cosust.2013.10.007; CLC bio, 2012, CLC ASS CELL 4 0; CLC bio, 2014, US MAN CLC ASS CELL; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dangasuk G.O., 2006, AFRICAN CROP SCI, V14, P263; Dawson IK, 2013, BIODIVERS CONSERV, V22, P301, DOI 10.1007/s10531-012-0429-5; Dawson IK, 2009, BIODIVERS CONSERV, V18, P969, DOI 10.1007/s10531-008-9516-z; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Fernandez-Silva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055990; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garrity DP, 2004, AGROFOREST SYST, V61-2, P5, DOI 10.1023/B:AGFO.0000028986.37502.7c; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hall JB, 2000, PRUNUS AFRICANA MONO, P3; Harris SA, 1997, PLANT SYST EVOL, V207, P119, DOI 10.1007/BF00985213; Joy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056694; Kadu CAC, 2011, MOL ECOL, V20, P165, DOI 10.1111/j.1365-294X.2010.04931.x; Kadu CAC, 2013, ANN BOT-LONDON, V111, P47, DOI 10.1093/aob/mcs235; Kadu CAC, 2012, PHYTOCHEMISTRY, V83, P70, DOI 10.1016/j.phytochem.2012.06.001; Kehlenbeck K, 2011, AGROFOREST SYST, V83, P133, DOI 10.1007/s10457-011-9413-4; Kumar V, 2014, TREE GENET GENOMES, V10, P449, DOI 10.1007/s11295-013-0690-0; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Lilleso JBL, 2011, AGROFOREST SYST, V83, P347, DOI 10.1007/s10457-011-9412-5; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083549; Mayer C, 2010, PHOBOS TANDEM REPEAT; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Muchugi A, 2006, S AFR J BOT, V72, P498, DOI 10.1016/j.sajb.2006.01.003; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Rico C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03376; Russell JR, 2009, TREE GENET GENOMES, V5, P517, DOI 10.1007/s11295-009-0205-1; Schoebel CN, 2013, J EVOLUTION BIOL, V26, P600, DOI 10.1111/jeb.12077; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Merwe M, 2014, MOL ECOL RESOUR, V14, P199, DOI 10.1111/1755-0998.12176; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang SJ, 2014, TREE GENET GENOMES, V10, P573, DOI 10.1007/s11295-014-0705-5; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394	44	9	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102502	10.1371/journal.pone.0102502	http://dx.doi.org/10.1371/journal.pone.0102502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025376	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000339992400081
J	Su, HX; Zhou, HH; Wang, MY; Cheng, J; Zhang, SC; Hui, F; Chen, XZ; Liu, SH; Liu, QJ; Zhu, ZJ; Hu, QR; Wu, Y; Ji, SR				Su, Hai-Xiang; Zhou, Hai-Hong; Wang, Ming-Yu; Cheng, Jin; Zhang, Shi-Chao; Hui, Feng; Chen, Xue-Zhong; Liu, Shan-Hui; Liu, Qin-Jiang; Zhu, Zi-Jiang; Hu, Qing-Rong; Wu, Yi; Ji, Shang-Rong			Mutations of C-Reactive Protein (CRP)-286 SNP, APC and p53 in Colorectal Cancer: Implication for a CRP-Wnt Crosstalk	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; COMPLEMENT ACTIVATION; TUMORICIDAL ACTIVITY; ENDOTHELIAL-CELLS; GENE PROMOTER; INFLAMMATION; PLATELETS; BINDS; LIPOPOLYSACCHARIDE; ATHEROSCLEROSIS	C-reactive protein (CRP) is an established marker of inflammation with pattern-recognition receptor-like activities. Despite the close association of the serum level of CRP with the risk and prognosis of several types of cancer, it remains elusive whether CRP contributes directly to tumorigenesis or just represents a bystander marker. We have recently identified recurrent mutations at the SNP position -286 (rs3091244) in the promoter of CRP gene in several tumor types, instead suggesting that locally produced CRP is a potential driver of tumorigenesis. However, it is unknown whether the -286 site is the sole SNP position of CRP gene targeted for mutation and whether there is any association between CRP SNP mutations and other frequently mutated genes in tumors. Herein, we have examined the genotypes of three common CRP non-coding SNPs (rs7553007, rs1205, rs3093077) in tumor/normal sample pairs of 5 cancer types (n = 141). No recurrent somatic mutations are found at these SNP positions, indicating that the -286 SNP mutations are preferentially selected during the development of cancer. Further analysis reveals that the -286 SNP mutations of CRP tend to co-occur with mutated APC particularly in rectal cancer (p = 0.04; n = 67). By contrast, mutations of CRP and p53 or K-ras appear to be unrelated. There results thus underscore the functional importance of the -286 mutation of CRP in tumorigenesis and imply an interaction between CRP and Wnt signaling pathway.	[Su, Hai-Xiang; Zhou, Hai-Hong; Chen, Xue-Zhong; Liu, Qin-Jiang; Zhu, Zi-Jiang; Hu, Qing-Rong] Gansu Prov Acad Inst Med Res, Lanzhou, Peoples R China; [Su, Hai-Xiang; Zhou, Hai-Hong; Chen, Xue-Zhong; Liu, Qin-Jiang; Zhu, Zi-Jiang; Hu, Qing-Rong] Gansu Prov Tumor Hosp, Lanzhou, Peoples R China; [Wang, Ming-Yu; Cheng, Jin; Zhang, Shi-Chao; Hui, Feng; Liu, Shan-Hui; Wu, Yi; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China; [Wu, Yi] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China.	wuy@lzu.edu.cn; jsr@lzu.edu.cn		Ji, Shang-Rong/0000-0001-8595-3756; Wu, Yi/0000-0003-0365-5590	Ministry of Science and Technology of China [2011CB910500]; National Natural Science Foundation of China [30930024, 31222015, 31270813, 31170696]; Ministry of Education of China [PCSIRT: IRT1137, 121108]; Gansu Province [1011FKCA089]; Lanzhou University [lzujbky-2013-bt05, lzujbky-2014-86]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Gansu Province; Lanzhou University(Lanzhou University)	This work was supported by grants from the Ministry of Science and Technology of China [grant number 2011CB910500]; the National Natural Science Foundation of China [grant numbers 30930024, 31222015, 31270813, 31170696]; the Ministry of Education of China [grant numbers PCSIRT: IRT1137, 121108]; Gansu Province [grant number: 1011FKCA089]; and Lanzhou University [grant numbers: lzujbky-2013-bt05, lzujbky-2014-86]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Allin KH, 2010, JNCI-J NATL CANCER I, V102, P202, DOI 10.1093/jnci/djp459; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; BARNA BP, 1984, CANCER RES, V44, P305; BARNA BP, 1987, CANCER RES, V47, P3959; Bisoendial RJ, 2005, CIRC RES, V96, P714, DOI 10.1161/01.RES.0000163015.67711.AB; Boncler M, 2011, PHARMACOL REP, V63, P464, DOI 10.1016/S1734-1140(11)70513-8; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Carlucci F, 2010, ARTHRITIS RHEUM-US, V62, P245, DOI 10.1002/art.27232; Choi YS, 2007, NUCLEIC ACIDS RES, V35, P5511, DOI 10.1093/nar/gkm547; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DEODHAR SD, 1982, CANCER RES, V42, P5084; Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040; Eisenhardt SU, 2009, TRENDS CARDIOVAS MED, V19, P232, DOI 10.1016/j.tcm.2010.02.002; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Filep JG, 2009, CIRC RES, V105, P109, DOI 10.1161/CIRCRESAHA.109.202010; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Hirschfield GM, 2003, J IMMUNOL, V171, P6046, DOI 10.4049/jimmunol.171.11.6046; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Kim EE, 2013, CURR MED IMAGING REV, V9, P1; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; Lane T, 2014, CIRC RES, V114, P672, DOI 10.1161/CIRCRESAHA.114.302770; Li HY, 2014, J BIOL CHEM, V289, P14283, DOI 10.1074/jbc.M114.555318; Ma X, 2013, CHINESE SCI BULL, V58, P1642, DOI 10.1007/s11434-012-5591-3; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Molins B, 2011, CARDIOVASC RES, V92, P328, DOI 10.1093/cvr/cvr226; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Rodriguez W, 2005, ARTHRITIS RHEUM-US, V52, P642, DOI 10.1002/art.20846; Schwedler SB, 2006, AM J KIDNEY DIS, V47, P212, DOI 10.1053/j.ajkd.2005.10.028; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Skoglund C, 2008, IMMUNOL CELL BIOL, V86, P466, DOI 10.1038/icb.2008.9; Slevin M, 2010, BRAIN PATHOL, V20, P151, DOI 10.1111/j.1750-3639.2008.00256.x; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Turu MM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-47; Wang MY, 2014, CELL RES, V24, P505, DOI 10.1038/cr.2014.7; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Xu PC, 2014, INNATE IMMUN-LONDON, V20, P440, DOI 10.1177/1753425913508164; Yang J, 2007, CANCER CELL, V12, P252, DOI 10.1016/j.ccr.2007.08.008; Yang XW, 2012, HUM IMMUNOL, V73, P156, DOI 10.1016/j.humimm.2011.12.007; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	63	18	19	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102418	10.1371/journal.pone.0102418	http://dx.doi.org/10.1371/journal.pone.0102418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025473	Green Submitted, gold, Green Published			2022-12-27	WOS:000339992400073
J	Zhu, GL; Ju, WM; Chen, JM; Liu, YB				Zhu, Gaolong; Ju, Weimin; Chen, J. M.; Liu, Yibo			A Novel Moisture Adjusted Vegetation Index (MAVI) to Reduce Background Reflectance and Topographical Effects on LAI Retrieval	PLOS ONE			English	Article							LEAF-AREA INDEX; FOREST; NDVI; SENSITIVITY; BANDS	A new moisture adjusted vegetation index (MAVI) is proposed using the red, near infrared, and shortwave infrared (SWIR) reflectance in band-ratio form in this paper. The effectiveness of MAVI in retrieving leaf area index (LAI) is investigated using Landsat-5 data and field LAI measurements in two forest and two grassland areas. The ability of MAVI to retrieve forest LAI under different background conditions is further evaluated using canopy reflectance of Jack Pine and Black Spruce forests simulated by the 4-Scale model. Compared with several commonly used two-band vegetation index, such as normalized difference vegetation index, soil adjusted vegetation index, modified soil adjusted vegetation index, optimized soil adjusted vegetation index, MAVI is a better predictor of LAI, on average, which can explain 70% of variations of LAI in the four study areas. Similar to other SWIR-related three-band vegetation index, such as modified normalized difference vegetation index (MNDVI) and reduced simple ratio (RSR), MAVI is able to reduce the background reflectance effects on forest canopy LAI retrieval. MAVI is more suitable for retrieving LAI than RSR and MNDVI, because it avoids the difficulty in properly determining the maximum and minimum SWIR values required in RSR and MNDVI, which improves the robustness of MAVI in retrieving LAI of different land cover types. Moreover, MAVI is expressed as ratios between different spectral bands, greatly reducing the noise caused by topographical variations, which makes it more suitable for applications in mountainous area.	[Zhu, Gaolong] Minjiang Univ, Dept Geog, Fuzhou, Peoples R China; [Zhu, Gaolong; Ju, Weimin; Chen, J. M.] Nanjing Univ, Int Inst Earth Syst Sci, Nanjing 210008, Jiangsu, Peoples R China; [Ju, Weimin] Nanjing Univ, Inst Climate & Global Change Res, Nanjing 210008, Jiangsu, Peoples R China; [Chen, J. M.] Univ Toronto, Dept Geog, Toronto, ON M5S 1A1, Canada; [Liu, Yibo] Nanjing Univ Informat Sci & Technol, Jiangsu Key Lab Agr Meteorol, Coll Appl Meteorol, Nanjing, Jiangsu, Peoples R China	Minjiang University; Nanjing University; Nanjing University; University of Toronto; Nanjing University of Information Science & Technology	Ju, WM (corresponding author), Nanjing Univ, Int Inst Earth Syst Sci, Nanjing 210008, Jiangsu, Peoples R China.	juweimin@nju.edu.cn	liu, yibo/H-8936-2012; Chen, Jing/AAD-4768-2020	liu, yibo/0000-0002-4345-0138; Chen, Jing/0000-0002-8682-1293	National Natural Science Foundation of China [41271354]; National Basic Research Program of China [2010CB950702]; Program for New Century Excellent Talents in Fujian Province University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grant No. 41271354), the National Basic Research Program of China (Grant No. 2010CB950702), and the Program for New Century Excellent Talents in Fujian Province University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; Bannari A., 1995, REMOTE SENS REV, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; BARET F, 1991, REMOTE SENS ENVIRON, V35, P161, DOI 10.1016/0034-4257(91)90009-U; BARET F, 1988, REMOTE SENS ENVIRON, V26, P213, DOI 10.1016/0034-4257(88)90078-8; Baret F., 1993, REMOTE SENS REV, V7, P65, DOI [10.1080/02757259309532166, DOI 10.1080/02757259309532166]; Brown L, 2000, REMOTE SENS ENVIRON, V71, P16, DOI 10.1016/S0034-4257(99)00035-8; Burgess DW, 1995, REMOTE SENS ENVIRON, V54, P223, DOI 10.1016/0034-4257(95)00155-7; BUTERA MK, 1986, IEEE T GEOSCI REMOTE, V24, P122, DOI 10.1109/TGRS.1986.289693; Chen J.M., 1996, CAN J REMOTE SENS, V22, P229, DOI [10.1080/07038992.1996.10855178, DOI 10.1080/07038992.1996.10855178]; Chen JM, 1997, IEEE T GEOSCI REMOTE, V35, P1316, DOI 10.1109/36.628798; Chen JM, 1996, REMOTE SENS ENVIRON, V55, P153, DOI 10.1016/0034-4257(95)00195-6; CLEVERS JGPW, 1989, REMOTE SENS ENVIRON, V29, P25, DOI 10.1016/0034-4257(89)90076-X; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Gilabert MA, 2002, REMOTE SENS ENVIRON, V82, P303, DOI 10.1016/S0034-4257(02)00048-2; Gilabert MA, 1998, PROC SPIE, V3499, P396, DOI 10.1117/12.332774; Gong P, 2003, IEEE T GEOSCI REMOTE, V41, P1355, DOI 10.1109/TGRS.2003.812910; Huang JJ, 2007, FOREST ECOL MANAG, V239, P150, DOI 10.1016/j.foreco.2006.11.019; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Kusaka T, 1997, INT GEOSCI REMOTE SE, P972, DOI 10.1109/IGARSS.1997.615314; LePrieur D, 1994, REMOTE SENSING REV, V10, P265, DOI DOI 10.1080/02757259409532250; Li Jin, 2010, Acta Prataculturae Sinica, V19, P243; LIU HQ, 1995, IEEE T GEOSCI REMOTE, V33, P457, DOI 10.1109/36.377946; Lymburner L, 2000, PHOTOGRAMM ENG REM S, V66, P183; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Matsushita B, 2007, SENSORS-BASEL, V7, P2636, DOI 10.3390/s7112636; MYNENI RB, 1994, REMOTE SENS ENVIRON, V49, P200, DOI 10.1016/0034-4257(94)90016-7; NEMANI R, 1993, INT J REMOTE SENS, V14, P2519, DOI 10.1080/01431169308904290; Ning Bo, 2009, Journal of Northeast Forestry University, V37, P56; Pan QingMin, 2004, Acta Phytoecologica Sinica, V28, P665; PANIGRAHY S, 1992, INT J REMOTE SENS, V13, P2943, DOI 10.1080/01431169208904092; Pisek J, 2010, IEEE T GEOSCI REMOTE, V48, P499, DOI 10.1109/TGRS.2009.2024756; PROY C, 1989, REMOTE SENS ENVIRON, V30, P21, DOI 10.1016/0034-4257(89)90044-8; QI J, 1994, REMOTE SENS ENVIRON, V48, P119, DOI 10.1016/0034-4257(94)90134-1; RICHARDSON AJ, 1977, PHOTOGRAMM ENG REM S, V43, P1541; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Vermote EF, 1997, IEEE T GEOSCI REMOTE, V35, P675, DOI 10.1109/36.581987; Vescovo L, 2008, ADV SPACE RES, V41, P1764, DOI 10.1016/j.asr.2007.07.043; Wu JD, 2007, FIELD CROP RES, V102, P33, DOI 10.1016/j.fcr.2007.01.003	41	11	12	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102560	10.1371/journal.pone.0102560	http://dx.doi.org/10.1371/journal.pone.0102560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025128	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400087
J	Bhavsar, RB; Tsonis, PA				Bhavsar, Rital B.; Tsonis, Panagiotis A.			Exogenous Oct-4 Inhibits Lens Transdifferentiation in the Newt Notophthalmus viridescens	PLOS ONE			English	Article							REGENERATION; CELL; EXPRESSION	From the cocktail of four factors that were able to induce pluripotent stem cells from differentiated cells, Oct-4, c-Myc, Sox-2 and Klf4, only Oct-4 was not expressed during regeneration in newts. To explore the possible action of this stemness factor we developed an assay where we introduced exogenous Oct-4 protein to an in vitro system for lens regeneration in newts. We found that exogenous Oct-4 inhibits differentiation of iris pigmented epithelial cells into lens cells and also regulates Sox-2 and Pax-6, both important players during lens development. Thus, presence of Oct-4 hinders transdifferentiation of iris cells.	[Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; Univ Dayton, Ctr Tissue Regenerat & Engn, Dayton, OH 45469 USA	University of Dayton; University of Dayton	Tsonis, PA (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	ptsonis1@udayton.edu			National Eye Institute grant [10540]	National Eye Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grant 10540 to PAT. URL: https://www.nei.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Bhavsar RB, 2011, JOVE-J VIS EXP, DOI 10.3791/2713; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Dang CV, 1999, MOL CELL BIOL, V19, P1; Hoffmann A, 2013, TISSUE ENG C; Kondoh H, 2004, INT J DEV BIOL, V48, P819, DOI 10.1387/ijdb.041868hk; Madhavan M, 2006, P NATL ACAD SCI USA, V103, P14848, DOI 10.1073/pnas.0601949103; Makarev E, 2007, FEBS LETT, V581, P1865, DOI 10.1016/j.febslet.2007.03.082; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Neff AW, 2011, DEV DYNAM, V240, P979, DOI 10.1002/dvdy.22554; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	14	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102510	10.1371/journal.pone.0102510	http://dx.doi.org/10.1371/journal.pone.0102510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019378	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600088
J	Brand, JS; Rovers, MM; Yeap, BB; Schneider, HJ; Tuomainen, TP; Haring, R; Corona, G; Onat, A; Maggio, M; Bouchard, C; Tong, PCY; Chen, RYT; Akishita, M; Gietema, JA; Gannage-Yared, MH; Unden, AL; Hautanen, A; Goncharov, NP; Kumanov, P; Chubb, SAP; Almeida, OP; Wittchen, HU; Klotsche, J; Wallaschofski, H; Volzke, H; Kauhanen, J; Salonen, JT; Ferrucci, L; van der Schouw, YT				Brand, Judith S.; Rovers, Maroeska M.; Yeap, Bu B.; Schneider, Harald J.; Tuomainen, Tomi-Pekka; Haring, Robin; Corona, Giovanni; Onat, Altan; Maggio, Marcello; Bouchard, Claude; Tong, Peter C. Y.; Chen, Richard Y. T.; Akishita, Masahiro; Gietema, Jourik A.; Gannage-Yared, Marie-Helene; Unden, Anna-Lena; Hautanen, Aarno; Goncharov, Nicolai P.; Kumanov, Philip; Chubb, S. A. Paul; Almeida, Osvaldo P.; Wittchen, Hans-Ulrich; Klotsche, Jens; Wallaschofski, Henri; Voelzke, Henry; Kauhanen, Jussi; Salonen, Jukka T.; Ferrucci, Luigi; van der Schouw, Yvonne T.			Testosterone, Sex Hormone-Binding Globulin and the Metabolic Syndrome in Men: An Individual Participant Data Meta-Analysis of Observational Studies	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; ANDROGEN DEFICIENCY; SERUM TESTOSTERONE; OBESE MEN; MASS-SPECTROMETRY; PRIMARY-CARE; OLDER MEN; ASSOCIATION; PREVALENCE	Background: Low total testosterone (TT) and sex hormone-binding globulin (SHBG) concentrations have been associated with the metabolic syndrome (MetS) in men, but the reported strength of association varies considerably. Objectives: We aimed to investigate whether associations differ across specific subgroups (according to age and body mass index (BMI)) and individual MetS components. Data sources: Two previously published meta-analyses including an updated systematic search in PubMed and EMBASE. Study Eligibility Criteria: Cross-sectional or prospective observational studies with data on TT and/or SHBG concentrations in combination with MetS in men. Methods: We conducted an individual participant data meta-analysis of 20 observational studies. Mixed effects models were used to assess cross-sectional and prospective associations of TT, SHBG and free testosterone (FT) with MetS and its individual components. Multivariable adjusted odds ratios (ORs) and hazard ratios (HRs) were calculated and effect modification by age and BMI was studied. Results: Men with low concentrations of TT, SHBG or FT were more likely to have prevalent MetS (ORs per quartile decrease were 1.69 (95% CI 1.60-1.77), 1.73 (95% CI 1.62-1.85) and 1.46 (95% CI 1.36-1.57) for TT, SHBG and FT, respectively) and incident MetS (HRs per quartile decrease were 1.25 (95% CI 1.16-1.36), 1.44 (95% 1.30-1.60) and 1.14 (95% 1.01-1.28) for TT, SHBG and FT, respectively). Overall, the magnitude of associations was largest in non-overweight men and varied across individual components: stronger associations were observed with hypertriglyceridemia, abdominal obesity and hyperglycaemia and associations were weakest for hypertension. Conclusions: Associations of testosterone and SHBG with MetS vary according to BMI and individual MetS components. These findings provide further insights into the pathophysiological mechanisms linking low testosterone and SHBG concentrations to cardiometabolic risk.	[Brand, Judith S.; Rovers, Maroeska M.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept EBH Room, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Operating Room, NL-6525 ED Nijmegen, Netherlands; [Yeap, Bu B.; Chubb, S. A. Paul] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Schneider, Harald J.] Univ Munich, Med Klin Innenstadt, D-80539 Munich, Germany; [Tuomainen, Tomi-Pekka; Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Haring, Robin; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Corona, Giovanni] Univ Florence, Dept Clin Physiopathol, Androl & Sexual Med Unit, Florence, Italy; [Onat, Altan] Istanbul Univ, Dept Cardiol, Istanbul, Turkey; [Maggio, Marcello] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy; [Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Tong, Peter C. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chen, Richard Y. T.] Changing Gen Hosp, Dept Endocrinol, Singapore, Singapore; [Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Gietema, Jourik A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Gannage-Yared, Marie-Helene] St Joseph Univ, Dept Endocrinol, Beirut, Lebanon; [Unden, Anna-Lena] Ctr Family & Community Med, Stockholm, Sweden; [Hautanen, Aarno] Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; [Goncharov, Nicolai P.] Endocrinol Res Ctr, Moscow, Russia; [Kumanov, Philip] Med Univ Sofia, Clin Ctr Endocrinol & Gerontol, Sofia, Bulgaria; [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Wittchen, Hans-Ulrich; Klotsche, Jens] Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies, Inst Clin Psychol, Dresden, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Salonen, Jukka T.] MAS Metab Analyt Serv Oy, Helsinki, Finland; [Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; University of Western Australia; University of Munich; University of Eastern Finland; Greifswald Medical School; University of Florence; Istanbul University; University of Parma; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Chinese University of Hong Kong; Changi General Hospital; University of Tokyo; University of Groningen; American University of Beirut; University of Helsinki; Russian Academy of Medical Sciences; Endocrinology Research Centre; Medical University Sofia; University of Western Australia; Technische Universitat Dresden; Greifswald Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	van der Schouw, YT (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	y.t.vanderschouw@umcutrecht.nl	Kauhanen, Jussi/ABC-4064-2021; Almeida, Osvaldo P./A-4925-2008; Bouchard, Claude/AAE-2035-2019; Wittchen, Hans-Ulrich/A-8507-2014; Rovers, Maroeska/F-2969-2014; Wittchen, Hans-Ulrich/ABA-8901-2020; Bouchard, Claude/A-7637-2009; van der Schouw, Yvonne T./F-8327-2014; Wilkening, Robin/J-5535-2018	Almeida, Osvaldo P./0000-0002-8689-6199; Rovers, Maroeska/0000-0002-3095-170X; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Bouchard, Claude/0000-0002-0048-491X; van der Schouw, Yvonne T./0000-0002-4605-435X; Wilkening, Robin/0000-0002-8332-5016; Gietema, Jourik/0000-0003-0629-7354; Brand, Judith S./0000-0002-3720-1274	NATIONAL INSTITUTE ON AGING [ZIAAG000971] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akishita M, 2010, HYPERTENS RES, V33, P587, DOI 10.1038/hr.2010.43; Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837; Bhasin S, 2011, DIABETES CARE, V34, P2464, DOI 10.2337/dc11-0888; Brand JS, 2011, INT J EPIDEMIOL, V40, P189, DOI 10.1093/ije/dyq158; Chen RYT, 2006, DIABETES OBES METAB, V8, P429, DOI 10.1111/j.1463-1326.2005.00532.x; Chen RYT, 2010, AGING MALE, V13, P233, DOI 10.3109/13685538.2010.487550; Chubb SAP, 2008, EUR J ENDOCRINOL, V158, P785, DOI 10.1530/EJE-07-0893; Corona G, 2008, J SEX MED, V5, P2454, DOI 10.1111/j.1743-6109.2008.00856.x; Corona G, 2007, J SEX MED, V4, P1038, DOI 10.1111/j.1743-6109.2007.00529.x; Corona G, 2011, J SEX MED, V8, P272, DOI 10.1111/j.1743-6109.2010.01991.x; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Gabriely I, 2002, DIABETES, V51, P1016, DOI 10.2337/diabetes.51.4.1016; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gannage-Yared MH, 2006, EUR J ENDOCRINOL, V155, P167, DOI 10.1530/eje.1.02175; Goncharov NP, 2008, AGING MALE, V11, P118, DOI 10.1080/13685530802204629; Haring R, 2013, EUR J ENDOCRINOL, V169, P463, DOI 10.1530/EJE-13-0222; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; Huhtaniemi IT, 2012, EUR J ENDOCRINOL, V166, P983, DOI 10.1530/EJE-11-1051; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Kaukua J, 2003, OBES RES, V11, P689, DOI 10.1038/oby.2003.98; Khosla S, 2008, OSTEOPOROSIS INT, V19, P1465, DOI 10.1007/s00198-008-0591-5; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Laaksonen DE, 2003, EUR J ENDOCRINOL, V149, P601, DOI 10.1530/eje.0.1490601; Lappalainen S, 2008, J CLIN ENDOCR METAB, V93, P1304, DOI 10.1210/jc.2007-2707; Li CY, 2010, DIABETES CARE, V33, P1618, DOI 10.2337/dc09-1788; Lidfeldt J, 2003, DIABETES OBES METAB, V5, P106, DOI 10.1046/j.1463-1326.2003.00250.x; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lorenzo C, 2006, DIABETES CARE, V29, P625, DOI 10.2337/diacare.29.03.06.dc05-1755; Maggio M, 2006, J AM GERIATR SOC, V54, P1832, DOI 10.1111/j.1532-5415.2006.00963.x; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Muller M, 2005, J CLIN ENDOCR METAB, V90, P2618, DOI 10.1210/jc.2004-1158; Niskanen L, 2004, DIABETES OBES METAB, V6, P208, DOI 10.1111/j.1462-8902.2004.00335.x; Nuver J, 2005, J CLIN ONCOL, V23, P3718, DOI 10.1200/JCO.2005.02.176; Onat A, 2007, METABOLISM, V56, P1356, DOI 10.1016/j.metabol.2007.05.020; Perry JRB, 2010, HUM MOL GENET, V19, P535, DOI 10.1093/hmg/ddp522; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P2636, DOI 10.1210/jc.2004-2190; Robeva R, 2006, ANDROLOGIA, V38, P216, DOI 10.1111/j.1439-0272.2006.00743.x; Rodriguez A, 2007, J CLIN ENDOCR METAB, V92, P3568, DOI 10.1210/jc.2006-2764; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; Soderberg S, 2001, INT J OBESITY, V25, P98, DOI 10.1038/sj.ijo.0801467; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Taieb J, 2003, CLIN CHEM, V49, P1381, DOI 10.1373/49.8.1381; TIERNEY L, 1989, BIOMETRIKA, V76, P425, DOI 10.1093/biomet/76.3.425; Tong PCY, 2005, J CLIN ENDOCR METAB, V90, P6418, DOI 10.1210/jc.2005-0228; Ukkola O, 2001, EUR J ENDOCRINOL, V145, P1, DOI 10.1530/eje.0.1450001; Unden AL, 2005, CLIN ENDOCRINOL, V63, P94, DOI 10.1111/j.1365-2265.2005.02306.x; Veldhuis JD, 2014, J CLIN ENDOCR METAB, V99, P184, DOI 10.1210/jc.2013-2642; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Wittchen HU, 2005, CURR MED RES OPIN, V21, P619, DOI 10.1185/030079905X38187	57	139	143	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e100409	10.1371/journal.pone.0100409	http://dx.doi.org/10.1371/journal.pone.0100409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019163	gold, Green Submitted, Green Published			2022-12-27	WOS:000339618600006
J	Cushnie, EK; Ulery, BD; Nelson, SJ; Deng, M; Sethuraman, S; Doty, SB; Lo, KWH; Khan, YM; Laurencin, CT				Cushnie, Emily K.; Ulery, Bret D.; Nelson, Stephen J.; Deng, Meng; Sethuraman, Swaminathan; Doty, Stephen B.; Lo, Kevin W. H.; Khan, Yusuf M.; Laurencin, Cato T.			Simple Signaling Molecules for Inductive Bone Regenerative Engineering	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; TISSUE; CELLS; FRACTURES; COMPOSITE; SCAFFOLDS; REPAIR; HYDROXYAPATITE; DEGRADATION; MATRICES	With greater than 500,000 orthopaedic procedures performed in the United States each year requiring a bone graft, the development of novel graft materials is necessary. We report that some porous polymer/ceramic composite scaffolds possess intrinsic osteoinductivity as shown through their capacity to induce in vivo host osteoid mineralization and in vitro stem cell osteogenesis making them attractive synthetic bone graft substitutes. It was discovered that certain low crystallinity ceramics partially dissociate into simple signaling molecules (i.e., calcium and phosphate ions) that induce stem cells to endogenously produce their own osteoinductive proteins. Review of the literature has uncovered a variety of simple signaling molecules (i.e., gases, ions, and redox reagents) capable of inducing other desirable stem cell differentiation through endogenous growth factor production. Inductive simple signaling molecules, which we have termed inducerons, represent a paradigm shift in the field of regenerative engineering where they can be utilized in place of recombinant protein growth factors.	[Ulery, Bret D.; Deng, Meng; Lo, Kevin W. H.; Khan, Yusuf M.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA; [Ulery, Bret D.; Deng, Meng; Khan, Yusuf M.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Ctr Biol Phys & Engn Sc, Farmington, CT USA; [Cushnie, Emily K.] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA; [Ulery, Bret D.; Deng, Meng; Khan, Yusuf M.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT USA; [Nelson, Stephen J.] Univ Connecticut, Ctr Hlth, Sch Med, Farmington, CT USA; [Sethuraman, Swaminathan] SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat, Thanjavur, Tamil Nadu, India; [Doty, Stephen B.] Hosp Special Surg, New York, NY 10021 USA; [Lo, Kevin W. H.] Univ Connecticut, Ctr Hlth, Dept Med, Div Endocrinol, Farmington, CT USA; [Khan, Yusuf M.] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT USA; [Laurencin, Cato T.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Virginia; University of Connecticut; University of Connecticut; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); University of Connecticut; University of Connecticut; University of Connecticut	Laurencin, CT (corresponding author), Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA.	Laurencin@uchc.edu		Khan, Yusuf/0000-0003-3792-3477	National Institutes of Health [R21AR062771, R21AR060480, R01AR052536]; National Science Foundation [EFRI0736002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052536, R21AR060480, R21AR062771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the National Institutes of Health (Grant No. R21AR062771, Grant No. R21AR060480, and Grant No. R01AR052536) (www.nih.gov) and the National Science Foundation (Grant No. EFRI0736002) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrosio AM, 2001, J BIOMEDICAL MAT RES, V58, P295; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267; Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5; Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5; Brinker MR, 2004, J BONE JOINT SURG AM, V86A, P290, DOI 10.2106/00004623-200402000-00011; Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.tea.2010.0160, 10.1089/ten.TEA.2010.0160]; Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876; Cushnie EK, 2008, J BIOMED MATER RES A, V84A, P54, DOI 10.1002/jbm.a.31380; Cushnie EK, 2010, J BIOMED MATER RES A, V94A, P568, DOI 10.1002/jbm.a.32722; Deng M, 2011, MRS P, V1417; Ensor CR, 2011, PHARMACOTHERAPY, V31, P1111, DOI 10.1592/phco.31.11.1111; Fasolis M, 2012, OR SURG OR MED OR PA, V114, P586, DOI 10.1016/j.oooo.2012.01.038; Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311; GlobalData, 2011, MARK RES REP; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Graham SM, 2010, EXPERT OPIN BIOL TH, V10, P885, DOI 10.1517/14712598.2010.481669; HOLDEN JL, 1995, J BONE MINER RES, V10, P1400; Hwang CJ, 2009, J NEUROSURG-SPINE, V10, P443, DOI 10.3171/2009.1.SPINE08473; Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023; Kanakaris NK, 2008, INJURY, V39, pS83, DOI 10.1016/S0020-1383(08)70019-6; Kappe T, 2010, CELL TISSUE BANK, V11, P253, DOI 10.1007/s10561-009-9140-5; Khan YM, 2004, J BIOMED MATER RES A, V69A, P728, DOI 10.1002/jbm.a.30051; Khan YM, 2007, J MATER SCI, V42, P4183, DOI 10.1007/s10853-006-0636-0; Lin FH, 1999, ARTIF ORGANS, V23, P186, DOI 10.1046/j.1525-1594.1999.06164.x; Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249; Nauth A, 2009, INJURY, V40, P27; Pollock R, 2008, EUR SPINE J, V17, P845, DOI 10.1007/s00586-008-0648-3; Pramanik S., 2005, TRENDS BIOMATERIALS, V19, P46; Rupani A, 2012, J BIOMED MATER RES A, V100A, P1089, DOI 10.1002/jbm.a.34037; Singhatanadgit W, 2008, INT J BIOCHEM CELL B, V40, P2854, DOI 10.1016/j.biocel.2008.06.005; US Department of Health and Human Services, ORG PROC TRANSPL NET; Ylinen P, 2002, INT J ORAL MAX SURG, V31, P405, DOI 10.1054/ijom.2002.0252; Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	29	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101627	10.1371/journal.pone.0101627	http://dx.doi.org/10.1371/journal.pone.0101627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019622	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600020
J	Yu, ER; Fan, CC; Yang, QY; Li, XD; Wan, BX; Dong, YN; Wang, XM; Zhou, YM				Yu, Erru; Fan, Chuchuan; Yang, Qingyong; Li, Xiaodong; Wan, Bingxi; Dong, Yanni; Wang, Xuemin; Zhou, Yongming			Identification of Heat Responsive Genes in Brassica napus Siliques at the Seed-Filling Stage through Transcriptional Profiling	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; ARABIDOPSIS-THALIANA; ACQUIRED THERMOTOLERANCE; REACTIVE OXYGEN; SHOCK PROTEINS; KEY REGULATOR; ABSCISIC-ACID; EXPRESSION; TOLERANCE; ETHYLENE	High temperature stress results in yield loss and alterations to seed composition during seed filling in oilseed rape (Brassica napus). However, the mechanism underlying this heat response is poorly understood. In this study, global transcription profiles of 20 d-old siliques of B. napus were analyzed after heat stress using a Brassica 95k EST microarray. The up-regulated genes included many HSF/HSP transcripts and other heat-related marker genes, such as ROF2, DREB2a, MBF1c and Hsa32, reflecting the conservation of key heat resistance factors among plants. Other up-regulated genes were preferentially expressed in heat-stressed silique walls or seeds, including some transcription factors and potential developmental regulators. In contrast, down-regulated genes differed between the silique wall and seeds and were largely tied to the biological functions of each tissue, such as glucosinolate metabolism in the silique wall and flavonoid synthesis in seeds. Additionally, a large proportion (one-third) of these differentially expressed genes had unknown functions. Based on these gene expression profiles, Arabidopsis mutants for eight heat-induced Brassica homologous genes were treated with different heat stress methods, and thermotolerance varied with each mutation, heat stress regimen and plant development stage. At least two of the eight mutants exhibited sensitivity to the heat treatments, suggesting the importance of the respective genes in responding to heat stress. In summary, this study elucidated the molecular bases of the heat responses in siliques during later reproductive stages and provides valuable information and gene resources for the genetic improvement of heat tolerance in oilseed rape breeding.	[Yu, Erru; Fan, Chuchuan; Yang, Qingyong; Li, Xiaodong; Wan, Bingxi; Dong, Yanni; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Li, Xiaodong] Guizhou Acad Agr Sci, Guizhou Inst Prataculture, Guiyang, Guizhou, Peoples R China; [Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Huazhong Agricultural University; Guizhou Academy of Agricultural Sciences; University of Missouri System; University of Missouri Saint Louis	Zhou, YM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	ymzhou@mail.hzau.edu.cn	Wang, Xuemin/M-2853-2013	Fan, Chuchuan/0000-0001-8443-7194; wang, xuemin/0000-0002-6251-6745; Yang, Qing-Yong/0000-0002-3510-8906	National Natural Science Foundation of China [30900787, 31171188]; Ministry of Agriculture of China [nycytx-00503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by National Natural Science Foundation of China (No. 30900787 and 31171188), and Ministry of Agriculture of China (nycytx-00503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksouh-Harradj NM, 2006, CAN J PLANT SCI, V86, P967, DOI 10.4141/P05-130; Angadi SV, 2000, CAN J PLANT SCI, V80, P693, DOI 10.4141/P99-152; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Cao MJ, 2013, PLANT J, V73, P607, DOI 10.1111/tpj.12059; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Charng YY, 2006, PLANT PHYSIOL, V140, P1297, DOI 10.1104/pp.105.074898; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; DEBOUILLE P, 1989, PLANT PHYSIOL, V90, P876, DOI 10.1104/pp.90.3.876; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; FOWLER DB, 1970, CAN J PLANT SCI, V50, P233, DOI 10.4141/cjps70-047; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Gan Y, 2004, CAN J PLANT SCI, V84, P697, DOI 10.4141/P03-109; Giorno Filomena, 2013, Plants-Basel, V2, P489, DOI 10.3390/plants2030489; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Guan M, 2012, PLANT CELL REP, V31, P929, DOI 10.1007/s00299-011-1213-9; Hall A.E., 1992, PLANT BREEDING REV, P129, DOI DOI 10.1002/9780470650011.CH5; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; Huang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-256; Jenkins ME, 1997, PLANT PHYSIOL, V115, P1351, DOI 10.1104/pp.115.4.1351; JOHNSONFLANAGAN AM, 1994, PLANT PHYSIOL, V106, P601, DOI 10.1104/pp.106.2.601; JONSSON R, 1977, HEREDITAS, V87, P205; KITTOCK DL, 1988, J AGRON CROP SCI, V161, P305, DOI 10.1111/j.1439-037X.1988.tb00673.x; Ko CB, 2007, PLANT PHYSIOL BIOCH, V45, P722, DOI 10.1016/j.plaphy.2007.07.010; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Kuno N, 2003, PLANT CELL, V15, P2476, DOI 10.1105/tpc.014217; Kutcher HR, 2010, AGR FOREST METEOROL, V150, P161, DOI 10.1016/j.agrformet.2009.09.011; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Liu JJ, 2013, PLANT PHYSIOL, V162, P512, DOI 10.1104/pp.112.205864; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Maruyama-Nakashita A, 2006, PLANT CELL, V18, P3235, DOI 10.1105/tpc.106.046458; Meiri D, 2010, PLANT MOL BIOL, V72, P191, DOI 10.1007/s11103-009-9561-3; Morrison MJ, 2002, CROP SCI, V42, P797, DOI 10.2135/cropsci2002.0797; MORRISON MJ, 1993, CAN J BOT, V71, P303, DOI 10.1139/b93-031; MURPHY DJ, 1989, J PLANT PHYSIOL, V135, P63, DOI 10.1016/S0176-1617(89)80225-1; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Nesi N, 2009, PLANT CELL REP, V28, P601, DOI 10.1007/s00299-008-0667-x; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nishizawa-Yokoi A, 2009, BIOSCI BIOTECH BIOCH, V73, P890, DOI 10.1271/bbb.80809; Noh YS, 1999, PLANT MOL BIOL, V41, P195, DOI 10.1023/A:1006389803990; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Oshino T, 2007, MOL GENET GENOMICS, V278, P31, DOI 10.1007/s00438-007-0229-x; Panikulangara TJ, 2004, PLANT PHYSIOL, V136, P3148, DOI 10.1104/pp.104.042606; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Park CH, 2010, PHYTOCHEMISTRY, V71, P380, DOI 10.1016/j.phytochem.2009.11.003; Park HY, 2011, BIOCHEM BIOPH RES CO, V414, P135, DOI 10.1016/j.bbrc.2011.09.039; PAULSEN GM, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P365; Peltonen-Sainio P, 2010, AGR ECOSYST ENVIRON, V139, P483, DOI 10.1016/j.agee.2010.09.006; Poschet G, 2011, PLANT PHYSIOL, V157, P1664, DOI 10.1104/pp.111.186825; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Redovnikovic IR, 2012, PLANT PHYSIOL BIOCH, V53, P77, DOI 10.1016/j.plaphy.2012.01.015; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Rose J, 2008, U.S. Patent Application, Patent No. [12/665,893, 12665893]; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Rozwadowski K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-88; SAINI HS, 1983, AUST J PLANT PHYSIOL, V10, P137, DOI 10.1071/PP9830137; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; SCHOPER JB, 1987, CROP SCI, V27, P27, DOI 10.2135/cropsci1987.0011183X002700010007x; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Tanabe N, 2007, PLANT CELL PHYSIOL, V48, P1036, DOI 10.1093/pcp/pcm069; TAYO TO, 1975, J AGR SCI-CAMBRIDGE, V85, P103, DOI 10.1017/S0021859600053466; Thomas J, 2012, PLANT J, V72, P935, DOI 10.1111/tpj.12004; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Tsutsui T, 2009, J PLANT RES, V122, P633, DOI 10.1007/s10265-009-0252-6; VANDEYNZE AE, 1993, CAN J PLANT SCI, V73, P383; Vivian-Smith A, 1999, PLANT PHYSIOL, V121, P437, DOI 10.1104/pp.121.2.437; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; WANG XM, 1988, PHYSIOL PLANTARUM, V72, P127, DOI 10.1111/j.1399-3054.1988.tb06633.x; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; WHITECROSS MI, 1972, AUST J BOT, V20, P87, DOI 10.1071/BT9720087; Wingenter K, 2010, PLANT PHYSIOL, V154, P665, DOI 10.1104/pp.110.162040; WORKMAN C, 2002, GENOME BIOL, V0003; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yang KA, 2006, PLANT SCI, V171, P175, DOI 10.1016/j.plantsci.2006.03.013; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yoshimura K, 2011, PLANT CELL PHYSIOL, V52, P1786, DOI 10.1093/pcp/pcr115; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038; Yu BY, 2010, PLANT SCI, V178, P381, DOI 10.1016/j.plantsci.2010.02.007; Yu HD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002669; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; ZANEWICH KP, 1993, J PLANT GROWTH REGUL, V12, P41, DOI 10.1007/BF00193677; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652	98	33	38	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101914	10.1371/journal.pone.0101914	http://dx.doi.org/10.1371/journal.pone.0101914			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013950	gold, Green Published			2022-12-27	WOS:000339378400046
J	Harvig, L; Frei, KM; Price, TD; Lynnerup, N				Harvig, Lise; Frei, Karin Margarita; Price, T. Douglas; Lynnerup, Niels			Strontium Isotope Signals in Cremated Petrous Portions as Indicator for Childhood Origin	PLOS ONE			English	Article							BONE; PATTERNS; TEETH	Dental enamel is currently of high informative value in studies concerning childhood origin and human mobility because the strontium isotope ratio in human dental enamel is indicative of geographical origin. However, many prehistoric burials involve cremation and although strontium retains its original biological isotopic composition, even when exposed to very high temperatures, intact dental enamel is rarely preserved in cremated or burned human remains. When preserved, fragments of dental enamel may be difficult to recognize and identify. Finding a substitute material for strontium isotope analysis of burned human remains, reflecting childhood values, is hence of high priority. This is the first study comparing strontium isotope ratios from cremated and non-cremated petrous portions with enamel as indicator for childhood origin. We show how strontium isotope ratios in the otic capsule of the petrous portion of the inner ear are highly correlated with strontium isotope ratios in dental enamel from the same individual, whether inhumed or cremated. This implies that strontium isotope ratios in the petrous bone, which practically always survives cremation, are indicative of childhood origin for human skeletal remains. Hence, the petrous bone is ideal as a substitute material for strontium isotope analysis of burned human remains.	[Harvig, Lise; Lynnerup, Niels] Univ Copenhagen, Fac Hlth Sci, Dept Forens Med, Lab Biol Anthropol, Copenhagen, Denmark; [Frei, Karin Margarita] Natl Museum Denmark, Conservat & Nat Sci Dept, Copenhagen, Denmark; [Frei, Karin Margarita] Danish Natl Res Fdn, Ctr Text Res CTR Prinsens Palae, Copenhagen, Denmark; [Price, T. Douglas] Univ Wisconsin, Lab Archaeol Chem, Madison, WI USA	University of Copenhagen; Danmarks Grundforskningsfond; University of Wisconsin System; University of Wisconsin Madison	Lynnerup, N (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Forens Med, Lab Biol Anthropol, Copenhagen, Denmark.	nly@sund.ku.dk			Elisabeth Munksgaard Foundation; Danish National Research Foundation (DNRF) [64]; European Union / ERC [269442]	Elisabeth Munksgaard Foundation; Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond); European Union / ERC(European Research Council (ERC))	We thank the Elisabeth Munksgaard Foundation for funding the actual Sr Isotope analyses. K.M.F. thanks The Danish National Research Foundation (DNRF Grant Number-64) and European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. 269442 (THE RISE) for financial support and Robert Frei for access to the laboratory facilities at the Danish Center for Isotope Geology, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Bohnert M, 1997, FORENSIC SCI INT, V87, P55, DOI 10.1016/S0379-0738(97)02136-1; Dolphin AE, 2005, AM J PHYS ANTHROPOL, V128, P878, DOI 10.1002/ajpa.20213; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; Frei KM, 2012, ARCHAEOL ANTHROP SCI, V4, P103, DOI 10.1007/s12520-011-0087-7; Frisch T, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/000348940010900106; Harbeck M, 2011, FORENSIC SCI INT, V204, P191, DOI 10.1016/j.forsciint.2010.06.004; HILLSON S, 1996, DENT ANTHR; HORWITZ EP, 1992, SOLVENT EXTR ION EXC, V10, P313, DOI 10.1080/07366299208918107; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jorkov MLS, 2009, AM J PHYS ANTHROPOL, V138, P199, DOI 10.1002/ajpa.20919; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Price T, 2013, APPL GEOCHEM, V9, P413; Price TD, 2012, J ARCHAEOL SCI, V39, P3714, DOI 10.1016/j.jas.2012.06.015; Price TD, 2011, ANTIQUITY, V85, P476, DOI 10.1017/S0003598X00067880; Price TD, 2013, DANISH J ARCHAEOLOGY, V1, P93; Schmidt CW, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P55, DOI 10.1016/B978-012372510-3.50005-8; Schweissing MM, 2003, J ARCHAEOL SCI, V30, P1373, DOI 10.1016/S0305-4403(03)00025-6; Sorensen MS., 1994, ACTA OTOLARYNGOL, V114, P5, DOI [10.3109/00016489409127318, DOI 10.3109/00016489409127318]; Sorensen MS, 1997, KUGLER PUBLICATIONS, P23; Symes SA, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P15, DOI 10.1016/B978-012372510-3.50004-6; Ubelaker DH, 1999, ANN ARCHAEOLOGY, V2; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125	23	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101603	10.1371/journal.pone.0101603	http://dx.doi.org/10.1371/journal.pone.0101603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010496	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800030
J	Husain, S; Vasishth, S; Srinivasan, N				Husain, Samar; Vasishth, Shravan; Srinivasan, Narayanan			Strong Expectations Cancel Locality Effects: Evidence from Hindi	PLOS ONE			English	Article							SENTENCE; MEMORY	Expectation-driven facilitation (Hale, 2001; Levy, 2008) and locality-driven retrieval difficulty (Gibson, 1998, 2000; Lewis & Vasishth, 2005) are widely recognized to be two critical factors in incremental sentence processing; there is accumulating evidence that both can influence processing difficulty. However, it is unclear whether and how expectations and memory interact. We first confirm a key prediction of the expectation account: a Hindi self-paced reading study shows that when an expectation for an upcoming part of speech is dashed, building a rarer structure consumes more processing time than building a less rare structure. This is a strong validation of the expectation-based account. In a second study, we show that when expectation is strong, i.e., when a particular verb is predicted, strong facilitation effects are seen when the appearance of the verb is delayed; however, when expectation is weak, i.e., when only the part of speech "verb'' is predicted but a particular verb is not predicted, the facilitation disappears and a tendency towards a locality effect is seen. The interaction seen between expectation strength and distance shows that strong expectations cancel locality effects, and that weak expectations allow locality effects to emerge.	[Husain, Samar; Vasishth, Shravan] Univ Potsdam, Potsdam, Brandenburg, Germany; [Vasishth, Shravan] Univ Sheffield, Sch Math & Stat, Sheffield, S Yorkshire, England; [Srinivasan, Narayanan] Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India	University of Potsdam; University of Sheffield; University of Allahabad	Husain, S (corresponding author), Univ Potsdam, Potsdam, Brandenburg, Germany.	samarhusain@gmail.com; vasishth@uni-potsdam.de	Srinivasan, Narayanan/E-7882-2010	Srinivasan, Narayanan/0000-0001-5342-0381; Vasishth, Shravan/0000-0003-2027-1994	University of Potsdam	University of Potsdam	The research was funded by the University of Potsdam (URL: http://www.uni-potsdam.de). There is no grant number since this was funding provided to the Chair of Psycholinguistics and Neurolinguistics as part of the Chair's annual budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DJ, 2013, J MEMORY LANGUAGE; Bartek B, 2011, J EXP PSYCHOL LEARN, V37, P1178, DOI 10.1037/a0024194; Bhatt R, 2009, P 3 LINGUISTIC ANNOT, P186; Boston MF, 2011, LANG COGNITIVE PROC, V26, P301, DOI 10.1080/01690965.2010.492228; Boston MF, 2008, J EYE MOVEMENT RES, V2; Butt M., 1995, STRUCTURE COMPLEX PR; Chung Y, 2015, J EDUC BEHAV STAT, V40, P136, DOI 10.3102/1076998615570945; Davison A, 2005, YEARB S ASIAN LANG L, P83; Demberg V, 2008, COGNITION, V109, P193, DOI 10.1016/j.cognition.2008.07.008; Frank SL, 2014, PROCEEDINGS OF THE 2; Gambhir V., 1981, THESIS U PENNSYLVANI; Gelman A., 2021, BAYESIAN DATA ANAL; Gibson E, 1999, LANG COGNITIVE PROC, V14, P225, DOI 10.1080/016909699386293; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Grodner D, 2005, COGNITIVE SCI, V29, P261, DOI 10.1207/s15516709cog0000_7; Hale J., 2001, P 2 M N AM CHAPT ASS; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kidwai Ayesha, 2000, XP ADJUNCTION UNIVER; Konieczny L, 2000, J PSYCHOLINGUIST RES, V29, P627, DOI 10.1023/A:1026528912821; Levy R, 2012, J MEMORY LANGUAGE; Levy R, 2013, J MEMORY LANGUAGE; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Levy RP, 2013, J MEM LANG, V68, P199, DOI 10.1016/j.jml.2012.02.005; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Lewis RL, 2006, TRENDS COGN SCI, V10, P447, DOI 10.1016/j.tics.2006.08.007; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Lewis RL, 1998, CUNY SENT PROC C; Mahajan A., 1990, A A BAR DISTINCTION; Mohanan Tara., 1994, ARGUMENT STRUCTURE H; Nakatani K, 2010, COGNITIVE SCI, V34, P94, DOI 10.1111/j.1551-6709.2009.01067.x; Prasad R, 2000, P DISC AN REF RES C, P66; R Development Core Team, 2006, R LANG ENV STAT COMP; Roland D, 2007, J MEM LANG, V57, P348, DOI 10.1016/j.jml.2007.03.002; Sells P., 1997, COMPLEX PREDICATES, P431; Stan Development Team, 2013, STAN A C LIB PROB S; Stan Development Team, 2022, STAN US GUID VERS 2; Staub A, 2010, COGNITION, V116, P71, DOI 10.1016/j.cognition.2010.04.002; Van Dyke JA, 2003, J MEM LANG, V49, P285, DOI 10.1016/S0749-596X(03)00081-0; Van Dyke JA, 2006, J MEM LANG, V55, P157, DOI 10.1016/j.jml.2006.03.007; Vasishth S, 2003, THESIS; Vasishth S., 2011, DIALOGUE DISCOURSE, V1, P59, DOI DOI 10.5087/DAD.2011.104; Vasishth S, 2008, COGNITIVE SCI, V32, P685, DOI 10.1080/03640210802066865; Vasishth S, 2006, LANGUAGE, V82, P767, DOI 10.1353/lan.2006.0236; Vasishth S, 2010, LANG COGNITIVE PROC, V25, P533, DOI 10.1080/01690960903310587	44	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100986	10.1371/journal.pone.0100986	http://dx.doi.org/10.1371/journal.pone.0100986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK9RG	25010700	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800011
J	Minois, N; Rockenfeller, P; Smith, TK; Carmona-Gutierrez, D				Minois, Nadege; Rockenfeller, Patrick; Smith, Terry K.; Carmona-Gutierrez, Didac			Spermidine Feeding Decreases Age-Related Locomotor Activity Loss and Induces Changes in Lipid Composition	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; DROSOPHILA-MELANOGASTER; STRESS RESISTANCE; AUTOPHAGY; POLYAMINES; LONGEVITY; RAPAMYCIN; RESVERATROL; SURVIVAL; HEALTH	Spermidine is a natural polyamine involved in many important cellular functions, whose supplementation in food or water increases life span and stress resistance in several model organisms. In this work, we expand spermidine's range of age-related beneficial effects by demonstrating that it is also able to improve locomotor performance in aged flies. Spermidine's mechanism of action on aging has been primarily related to general protein hypoacetylation that subsequently induces autophagy. Here, we suggest that the molecular targets of spermidine also include lipid metabolism: Spermidine-fed flies contain more triglycerides and show altered fatty acid and phospholipid profiles. We further determine that most of these metabolic changes are regulated through autophagy. Collectively, our data suggests an additional and novel lipid-mediated mechanism of action for spermidine-induced autophagy.	[Minois, Nadege; Smith, Terry K.] Univ St Andrews, St Andrews, Fife, Scotland; [Rockenfeller, Patrick; Carmona-Gutierrez, Didac] Graz Univ, Inst Mol Biosci, Graz, Austria	University of St Andrews; University of Graz	Minois, N (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.	nm61@st-andrews.ac.uk; carmonag@uni-graz.at		Carmona-Gutierrez, Didac/0000-0001-7548-7771	TKS Wellcome Trust [093228]; FWF [P23490, P24381, I1000]	TKS Wellcome Trust(Wellcome Trust); FWF(Austrian Science Fund (FWF))	This work was supported in part by TKS Wellcome Trust grant 093228. DCG and PR are grateful to the FWF for grants LIPOTOX, P23490, P24381, and I1000 (DACH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Banerjee KK, 2012, AGING-US, V4, P206, DOI 10.18632/aging.100435; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bennetzen MV, 2012, CELL CYCLE, V11, P1827, DOI 10.4161/cc.20233; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Carmona-Gutierrez D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.43; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Cheng L, 2012, J ZHEJIANG UNIV-SC B, V13, P283, DOI 10.1631/jzus.B1100060; Choi YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-31; Ledesma MD, 2012, PROG LIPID RES, V51, P23, DOI 10.1016/j.plipres.2011.11.004; Eckmann J, 2013, INT J BIOCHEM CELL B, V45, P76, DOI 10.1016/j.biocel.2012.06.009; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gonzalez-Covarrubias V, 2013, BIOGERONTOLOGY, V14, P663, DOI 10.1007/s10522-013-9450-7; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Harrison B, 2010, GERIATR GERONTOL INT, V10, P110, DOI 10.1111/j.1447-0594.2009.00569.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huang X, 2013, BIOCH BIOPHYS ACTA; Hyvonen MT, 2013, BIOCHEM J, DOI [10.1043/BJ20130263, DOI 10.1043/BJ20130263]; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Ishii I, 2012, AMINO ACIDS, V42, P619, DOI 10.1007/s00726-011-1037-5; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Katewa SD, 2012, CELL METAB, V16, P97, DOI 10.1016/j.cmet.2012.06.005; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Lee NKL, 2011, J CELL PHYSIOL, V226, P1453, DOI 10.1002/jcp.22569; Lee SH, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/854502; Liao CY, 2011, AGING CELL, V10, P629, DOI 10.1111/j.1474-9726.2011.00702.x; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lin Yuh-Ru, 2011, Small GTPases, V2, P158; Lin YR, 2011, AGING CELL, V10, P438, DOI 10.1111/j.1474-9726.2011.00678.x; Luchessi AD, 2009, J CELL PHYSIOL, V218, P480, DOI 10.1002/jcp.21619; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Markaki M, 2011, BIOGERONTOLOGY, V12, P377, DOI 10.1007/s10522-011-9324-9; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Minois N, 2001, EXP GERONTOL, V36, P1137, DOI 10.1016/S0531-5565(00)00263-1; Minois N, 2014, GERONTOLOGY, V60, P319, DOI 10.1159/000356748; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003; O'Rourke EJ, 2013, GENE DEV, V27, P429, DOI 10.1101/gad.205294.112; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; Poon PC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000356; Pucciarelli S, 2012, REJUV RES, V15, P590, DOI 10.1089/rej.2012.1349; Rajeeve V, 2013, BIOCHEM J, V450, P619, DOI 10.1042/BJ20121525; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slack C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000881; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Stark F, 2011, CELL SIGNAL, V23, P876, DOI 10.1016/j.cellsig.2011.01.013; Suppola S, 2001, BIOCHEM J, V358, P343, DOI 10.1042/0264-6021:3580343; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P266, DOI 10.1016/0003-2697(65)90014-X; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	68	32	37	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102435	10.1371/journal.pone.0102435	http://dx.doi.org/10.1371/journal.pone.0102435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010732	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800100
J	Shi, XQ; Qi, YH; Shi, D; Yan, C; Shi, JX; Cao, BL; Liu, D; Luo, LR; Wang, HY				Shi, Xiu-Quan; Qi, Yong-Hong; Shi, Dan; Yan, Cheng; Shi, Junxin; Cao, Bo-Ling; Liu, Dan; Luo, Li-Rong; Wang, Hai-Yan			Features and Risk Factors of Nonfatal Injury among the Rural Children: A Survey of Seven Schools in a Mountain Area in Southwest China	PLOS ONE			English	Article							UNINTENTIONAL INJURIES; EPIDEMIOLOGIC SURVEY; EMERGENCY-DEPARTMENT; LOGISTIC-REGRESSION; CHILDHOOD INJURIES; SAMPLE-SIZE; PREVENTION; URBAN	Objective: We aimed to investigate the patterns and risk factors of nonfatal injuries among rural mountain-area children in southwest China. Methods: A stratified sampling method was used to recruit rural children aged 8 to 17 years (mainly 9-14 years) from 7 schools. Self-reported injuries during the past 12 months and relevant concerns were collected from June to December 2012 by using a structured questionnaire in a class interview. Results: The mean age of the 2,854 children was 12.2 +/- 1.5 years. The probability of annual injury was 16.7% (95% confidence interval [95% CI] 15.3-18.1%), with slightly higher injury risk for boys than girls (17.7% vs. 16.0%; P>0.05). The top 3 causes of injuries were falls (37.3%), animal-related incidents (20.6%), and burns (14.9%). The main injury risk factors included being involved in a violent episode (odds ratio [OR] 1.34, 95% CI 1.08-1.66, P = 0.007), maltreatment by parents or guardians (1.42, 1.17-1.72, P<0.001), and being from a single-child family (1.30, 1.10-1.66, P = 0.039). Older age was a protective factor (0.81, 0.76-0.87, P<0.001). Conclusions: The incidence of nonfatal injury among rural children was high, and falls were the leading cause. Younger children and boys from poor-care and poor-living environments were at increased risk of injury, which requires urgent attention. Injury prevention programs targeting these issues are needed in this mountain area and similar rural regions of China.	[Shi, Xiu-Quan; Qi, Yong-Hong; Cao, Bo-Ling; Liu, Dan; Wang, Hai-Yan] Zunyi Med Coll, Sch Publ Hlth, Zunyi, Peoples R China; [Shi, Dan; Yan, Cheng] Ctr Dis Control & Prevent Zunyi City, Zunyi, Peoples R China; [Shi, Junxin] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Injury Res & Policy,Res Inst, Columbus, OH 43210 USA; [Luo, Li-Rong] Zunyi Med Coll, Affiliated Hosp, Zunyi, Peoples R China	Zunyi Medical University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Zunyi Medical University	Shi, XQ (corresponding author), Zunyi Med Coll, Sch Publ Hlth, Zunyi, Peoples R China.	xqshi@zmc.edu.cn			National Natural Science Foundation of China [81160350]; Specific Foundation for the Scientific Educational Talent of President of Guizhou Province, China [Qian [2011]55]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Foundation for the Scientific Educational Talent of President of Guizhou Province, China	This project was funded by the National Natural Science Foundation of China (grant No. 81160350) and the Specific Foundation for the Scientific Educational Talent of President of Guizhou Province, China (grant No. Qian [2011]55). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; Demidenko E, 2008, STAT MED, V27, P36, DOI 10.1002/sim.2980; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Donroe J, 2009, INJURY PREV, V15, P390, DOI 10.1136/ip.2008.019893; Fang XM, 2014, SOC SCI MED, V102, P33, DOI 10.1016/j.socscimed.2013.11.022; Fatmi Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-152; Hu M, 2012, BIOMED ENVIRON SCI, V25, P407, DOI 10.3967/0895-3988.2012.04.005; Jiang X, 2010, ACCIDENT ANAL PREV, V42, P320, DOI 10.1016/j.aap.2009.08.012; Li Shaohua, 2013, J Inj Violence Res, V5, P89, DOI 10.5249/jivr.v5i2.304; Ma JX, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-122; MacInnes K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-120; Mo Health, 2007, INJ PREV REP CHIN; Monuteaux MC, 2012, ACAD EMERG MED, V19, P535, DOI 10.1111/j.1553-2712.2012.01341.x; Morrongiello BA, 2006, J PEDIATR PSYCHOL, V31, P540, DOI 10.1093/jpepsy/jsj073; Moshiro C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-11; Otters H, 2005, BRIT J GEN PRACT, V55, P630; Schnitzer PG, 2006, AM FAM PHYSICIAN, V74, P1864; Schwebel DC, 2007, J DEV BEHAV PEDIATR, V28, P245, DOI 10.1097/01.DBP.0000268561.80204.2a; Shen M, 2009, INJURY PREV, V15, P244, DOI 10.1136/ip.2008.019869; Shi HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-531; UNICEF, 2009, STAT WORLDS CHILDR S; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; WHO UNICEF, 2008, WORLD REPORT CHILD I; Xiang Wei, 2003, Zhonghua Er Ke Za Zhi, V41, P876; Yang L, 2007, INJURY PREV, V13, P178, DOI 10.1136/ip.2006.013409; Zhu HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037766; Zhu Xiao-xia, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P911	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102099	10.1371/journal.pone.0102099	http://dx.doi.org/10.1371/journal.pone.0102099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010712	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800067
J	Tang, YY; George, A; Nouvet, F; Sweet, S; Emeagwali, N; Taylor, HE; Simmons, G; Hildreth, JEK				Tang, Yuyang; George, Alvin; Nouvet, Franklin; Sweet, Stephanie; Emeagwali, Nkiruka; Taylor, Harry E.; Simmons, Glenn; Hildreth, James E. K.			Infection of Female Primary Lower Genital Tract Epithelial Cells after Natural Pseudotyping of HIV-1: Possible Implications for Sexual Transmission of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LIPID RAFTS; INTRACELLULAR TRAFFICKING; HUMAN CYTOMEGALOVIRUS; VIRAL ENTRY; HIGH-RISK; TYPE-1; TROPISM; IDENTIFICATION; EPIDEMIOLOGY	The global AIDS pandemic continues to expand and in some regions of the world, such as southern Africa, the prevalence of HIV-1 infection exceeds 20%. The devastating spread of the virus in young women in these countries appears disproportional to overall risk of infection. Regions with high prevalence of HIV-1 are often also highly endemic for other pathogenic viruses including HSV, CMV and HTLV. We propose that acquisition by HIV-1 of the envelope glycoproteins of other viruses, in a process we call "natural pseudotyping,'' expands the cellular tropism of HIV-1, enabling it to infect female genital epithelial cells directly and thereby dramatically increasing risk of infection during sexual intercourse. In this proof-of-concept study, we demonstrate that when HIV-1 co-infects T cells along with the gammaretrovirus xenotropic murine leukemia virus-related virus (XMRV), progeny HIV-1 particles are produced capable of infecting primary vaginal, ectocervical and endocervical epithelial cells. These cell types are normally resistant to HIV-1 infection. Infection of primary genital cells was neutralized by antisera against the XMRV glycoprotein, confirming that infection was mediated by the XMRV glycoprotein acquired through pseudotyping of HIV. Inhibition by AZT showed that active replication of HIV-1 occurred in these cells and ruled out non-specific endocytic uptake of the virus. These results demonstrate that natural pseudotyping can expand the tropism of HIV-1 to include genital epithelial cells and have potential implications for sexual transmission of the virus.	[Tang, Yuyang; George, Alvin; Nouvet, Franklin; Hildreth, James E. K.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Sweet, Stephanie] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [Emeagwali, Nkiruka; Taylor, Harry E.; Simmons, Glenn] Meharry Med Coll, Dept Microbiol & Immunol, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA	University of California System; University of California Davis; University of California System; University of California Davis; Meharry Medical College	Hildreth, JEK (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA.	jekhildreth@ucdavis.edu	Tang, Yuyang/AAX-5681-2020; Simmons, Glenn/AAT-6135-2020; Simmons, Glenn/A-1777-2015	Simmons, Glenn/0000-0003-2081-5672; Simmons, Glenn/0000-0003-2081-5672	NIH [8DP1HD075625]; NATIONAL CANCER INSTITUTE [U54CA163069, U54CA163066, U54CA163072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funder (NIH; grant 8DP1HD075625 to JEKH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; An DS, 2001, J VIROL, V75, P3488, DOI 10.1128/JVI.75.7.3488-3489.2001; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Arien KK, 2011, REV MED VIROLOGY; Beilke MA, 2012, AIDS RES HUM RETROV, V28, P139, DOI [10.1089/aid.2011.0342, 10.1089/AID.2011.0342]; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Briggs JAG, 2003, J GEN VIROL, V84, P757, DOI 10.1099/vir.0.18779-0; Brites C, 2009, AIDS REV, V11, P8; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Calistri A, 1999, J ACQ IMMUN DEF SYND, V21, P90; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; CANIVET M, 1990, VIROLOGY, V178, P543, DOI 10.1016/0042-6822(90)90352-R; Cavarelli M, 2013, EMBO MOL MED, V5, P776, DOI 10.1002/emmm.201202232; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; Chentoufi Aziz Alami, 2012, Curr Trends Immunol, V13, P51; Cingoz O, 2011, J VIROLOGY; Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cooke FJ, 2005, J MED VIROL, V76, P143, DOI 10.1002/jmv.20336; Costa H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003609; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferreira OC, 1997, BLOOD REV, V11, P91, DOI 10.1016/S0268-960X(97)90015-1; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Griffiths PP, 2006, J CLIN VIROL, V35, P489, DOI 10.1016/j.jcv.2005.10.016; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hioe CE, 1998, AIDS RES HUM RETROV, V14, pS247; Holmes D, 2012, LANCET INFECT DIS, V12, P834, DOI 10.1016/S1473-3099(12)70254-2; HOUSSET C, 1993, J HEPATOL, V19, P252, DOI 10.1016/S0168-8278(05)80579-3; Huang A S, 1975, Bibl Haematol, P313; HUANG AS, 1974, NATURE, V252, P743, DOI 10.1038/252743a0; Jenness SM, 2011, AM J PUBLIC HEALTH, V101, P745, DOI 10.2105/AJPH.2009.181883; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Kaushic C, 2011, METHODS, V55, P114, DOI 10.1016/j.ymeth.2011.09.022; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; LeGoff J, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-2; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Li L, 2013, J VIROLOGY; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Linde ME, 2013, J PROTEOME RES, V12, P2045, DOI 10.1021/pr300918r; Liu R, 2013, J INFECT DIS; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Makarova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018272; Manel N, 2005, ONCOGENE, V24, P6016, DOI 10.1038/sj.onc.1208972; MCCUNE JM, 1990, SCIENCE, V250, P1152, DOI 10.1126/science.2174574; Micsenyi AM, 2013, J INFECT DIS; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; NELSON JA, 1988, VIROLOGY, V165, P286, DOI 10.1016/0042-6822(88)90685-X; Nguyen DH, 1999, MOL BIOL CELL, V10, p304A; Northfield JW, 2005, ARCH IMMUNOL THER EX, V53, P3; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Provitera P, 2001, BIOPHYS J, V80, p292A; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; RAFFANTI A, 1991, AIDS, V5, P769, DOI 10.1097/00002030-199106000-00021; Ramaswamy M, 2007, EXPERT REV ANTI-INFE, V5, P231, DOI 10.1586/14787210.5.2.231; Ranjbar R, 2011, IRAN RED CRESCENT ME, V13, P855; Ray PE, 1998, KIDNEY INT, V53, P1217, DOI 10.1046/j.1523-1755.1998.00900.x; Sandrin V, 2006, J BIOL CHEM, V281, P528, DOI 10.1074/jbc.M506070200; Sandrin V, 2004, J VIROL, V78, P7153, DOI 10.1128/JVI.78.13.7153-7164.2004; Schwarzer R, 2012, BIOPHYS J, V102, p640A, DOI 10.1016/j.bpj.2011.11.3482; Shankar Esaki Muthu, 2011, Curr Infect Dis Rep, V13, P47, DOI 10.1007/s11908-010-0142-z; Shen RZ, 2010, J LEUKOCYTE BIOL, V87, P663, DOI 10.1189/jlb.0909605; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sinzger C, 1996, INTERVIROLOGY, V39, P302, DOI 10.1159/000150502; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-70; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Sutton RE, 1996, J VIROL, V70, P7322, DOI 10.1128/JVI.70.10.7322-7326.1996; Tang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048013; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; TOTH FD, 1995, J VIROL, V69, P2223; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; VANKUYK R, 1995, VIROLOGY, V209, P643, DOI 10.1006/viro.1995.1297; Varani S, 2012, J CLIN VIROL, V53, P360, DOI 10.1016/j.jcv.2011.12.028; Vidricaire G, 2004, J VIROL, V78, P11904, DOI 10.1128/JVI.78.21.11904-11915.2004; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wilflingseder D, 2007, FRONT BIOSCI-LANDMRK, V12, P2124, DOI 10.2741/2216; Witteck A, 2009, SWISS MED WKLY, V139, P207, DOI smw-12575; Wood C, 2005, CELL RES, V15, P947, DOI 10.1038/sj.cr.7290372; WOODHOUSE DE, 1994, AIDS, V8, P1331, DOI 10.1097/00002030-199409000-00018; Zehender G, 2004, J MED VIROL, V74, P207, DOI 10.1002/jmv.20165; ZHU ZH, 1990, J ACQ IMMUN DEF SYND, V3, P215	100	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101367	10.1371/journal.pone.0101367	http://dx.doi.org/10.1371/journal.pone.0101367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010677	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800022
J	Kenney, LA; Eagles-Smith, CA; Ackerman, JT; von Hippel, FA				Kenney, Leah A.; Eagles-Smith, Collin A.; Ackerman, Joshua T.; von Hippel, Frank A.			Temporal Variation in Fish Mercury Concentrations within Lakes from the Western Aleutian Archipelago, Alaska	PLOS ONE			English	Article							ORGANOCHLORINE CONTAMINANTS; ENVIRONMENTAL CONTAMINANTS; DIETARY METHYLMERCURY; SEABIRDS; ISLANDS; SEA; CALIFORNIA; DERIVATION; EMISSIONS; PATTERNS	We assessed temporal variation in mercury (Hg) concentrations of threespine stickleback (Gasterosteus aculeatus) from Agattu Island, Aleutian Archipelago, Alaska. Total Hg concentrations in whole-bodied stickleback were measured at two-week intervals from two sites in each of two lakes from June 1 to August 10, 2011 during the time period when lakes were ice-free. Across all sites and sampling events, stickleback Hg concentrations ranged from 0.37-1.07 mu g/g dry weight (dw), with a mean (+/- SE) of 0.55 +/- 0.01 mu g/g dw. Mean fish Hg concentrations declined by 9% during the study period, from 0.57 +/- 0.01 mu g/g dw in early June to 0.52 +/- 0.01 mu g/g dw in mid-August. Mean fish Hg concentrations were 6% higher in Loon Lake (0.56 +/- 0.01 mu g/g dw) than in Lake 696 (0.53 +/- 0.01 mu g/g dw), and 4% higher in males (0.56 +/- 0.01 mu g/g dw) than in females (0.54 +/- 0.01 mu g/g dw). Loon Lake was distinguished from Lake 696 by the presence of piscivorous waterbirds during the breeding season. Mercury concentrations in stickleback from Agattu Island were higher than would be expected for an area without known point sources of Hg pollution, and high enough to be of concern to the health of piscivorous wildlife.	[Kenney, Leah A.; von Hippel, Frank A.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA; [Eagles-Smith, Collin A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Ackerman, Joshua T.] US Geol Survey, Western Ecol Res Ctr, Dixon, CA USA	University of Alaska System; University of Alaska Anchorage; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Kenney, LA (corresponding author), Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA.	leahkenney@gmail.com	Ackerman, Joshua T./AAF-9503-2019; Eagles-Smith, Collin/AAH-3811-2019; Eagles-Smith, Collin/T-8580-2019	Eagles-Smith, Collin/0000-0003-1329-5285; Ackerman, Josh/0000-0002-3074-8322	USGS Forest and Rangeland Ecosystem Science Center; USGS Western Ecological Research Center; USGS Environmental Health Mission Area Contaminant Biology Program	USGS Forest and Rangeland Ecosystem Science Center(United States Geological Survey); USGS Western Ecological Research Center; USGS Environmental Health Mission Area Contaminant Biology Program	This work was partially funded by USGS Forest and Rangeland Ecosystem Science Center, USGS Western Ecological Research Center, and the USGS Environmental Health Mission Area Contaminant Biology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAP, 2002, ARCT POLL 2002 PERS; Anthony RG, 1999, ENVIRON TOXICOL CHEM, V18, P2054, DOI 10.1002/etc.5620180925; Anthony RG, 2007, ENVIRON TOXICOL CHEM, V26, P1843, DOI 10.1897/06-334R.1; Bacon CE, 1999, ENVIRON TOXICOL CHEM, V18, P452, DOI [10.1002/etc.5620180313, 10.1897/1551-5028(1999)018&lt;0452:COOCAS&gt;2.3.CO;2]; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Blais JM, 2005, SCIENCE, V309, P445, DOI 10.1126/science.1112658; BLOOM NS, 1992, CAN J FISH AQUAT SCI, V49, P1010, DOI 10.1139/f92-113; Boszke L, 2003, POL J ENVIRON STUD, V12, P275; Burger J, 2007, SCI TOTAL ENVIRON, V387, P175, DOI 10.1016/j.scitotenv.2007.07.049; Byrd GV, 2005, FISH OCEANOGR, V14, P139; Choy ES, 2010, SCI TOTAL ENVIRON, V408, P1858, DOI 10.1016/j.scitotenv.2010.01.014; Depew DC, 2012, ENVIRON TOXICOL CHEM, V31, P2399, DOI 10.1002/etc.1971; Depew DC, 2012, ENVIRON TOXICOL CHEM, V31, P1536, DOI 10.1002/etc.1859; Driscoll CT, 2013, ENVIRON SCI TECHNOL, V47, P4967, DOI 10.1021/es305071v; Eagles-Smith CA, 2009, ENVIRON SCI TECHNOL, V43, P8658, DOI 10.1021/es901400c; EPA, 2000, 7473 EPA; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; FALANDYSZ J, 1993, B ENVIRON CONTAM TOX, V51, P710; Heinz GH, 2009, ARCH ENVIRON CON TOX, V56, P129, DOI 10.1007/s00244-008-9160-3; Kaler RSA, 2014, MAR POLLUT BULL, V82, P189, DOI 10.1016/j.marpolbul.2014.02.034; Kenney LA, 2011, THESIS U ALASKA ANCH; Kenney LA, 2012, ENVIRON TOXICOL CHEM, V31, P2647, DOI 10.1002/etc.1990; Miles AK, 2009, ENVIRON TOXICOL CHEM, V28, P1643, DOI 10.1897/08-498.1; PACYNA JM, 1995, WATER AIR SOIL POLL, V80, P621, DOI 10.1007/BF01189714; Pirrone N, 2010, ATMOS CHEM PHYS, V10, P5951, DOI 10.5194/acp-10-5951-2010; Rea LD, 2013, SCI TOTAL ENVIRON, V454, P277, DOI 10.1016/j.scitotenv.2013.02.095; Reese SL, 2012, CHEMOSPHERE, V88, P873, DOI 10.1016/j.chemosphere.2012.03.096; Ricca MA, 2008, SCI TOTAL ENVIRON, V406, P308, DOI 10.1016/j.scitotenv.2008.06.030; Rocque DA, 2004, ENVIRON TOXICOL CHEM, V23, P759, DOI 10.1897/03-182; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Shedd K, 2013, THESIS U ALASKA ANCH; SLOTTON DG, 1995, WATER AIR SOIL POLL, V80, P841, DOI 10.1007/BF01189735; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Us Epa 0 0 0 A, 2013, MERC AIR TOX STAND M; USF&WS, 2008, BIRDS CONS 2008; Ward DM, 2010, T AM FISH SOC, V139, P1, DOI 10.1577/T09-032.1; Ward Scott M., 1999, North American Journal of Fisheries Management, V19, P89, DOI 10.1577/1548-8675(1999)019<0089:SVICOM>2.0.CO;2; Watras CJ, 1998, SCI TOTAL ENVIRON, V219, P183, DOI 10.1016/S0048-9697(98)00228-9; Wiener James G., 2007, P87, DOI 10.1201/9780849388897.ch4; Willacker JJ, 2013, ENVIRON TOXICOL CHEM, V32, P1623, DOI 10.1002/etc.2213; Zhang L, 2012, ENVIRON POLLUT, V161, P178, DOI 10.1016/j.envpol.2011.10.023	41	8	9	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102244	10.1371/journal.pone.0102244	http://dx.doi.org/10.1371/journal.pone.0102244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029042	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600050
J	Abdulhadi, MA; Perno, JR; Melhem, ER; Nucifora, PGP				Abdulhadi, Mike A.; Perno, Joseph R.; Melhem, Elias R.; Nucifora, Paolo G. P.			Characteristics of Spondylotic Myelopathy on 3D Driven-Equilibrium Fast Spin Echo and 2D Fast Spin Echo Magnetic Resonance Imaging: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							CERVICAL COMPRESSION MYELOPATHY; INCREASED SIGNAL INTENSITY; PREDICT PROGNOSIS; CORD; MRI; SURGERY; SEQUENCES; IMAGES; STENOSIS; RECOVERY	In patients with spinal stenosis, magnetic resonance imaging of the cervical spine can be improved by using 3D driven-equilibrium fast spin echo sequences to provide a high-resolution assessment of osseous and ligamentous structures. However, it is not yet clear whether 3D driven-equilibrium fast spin echo sequences adequately evaluate the spinal cord itself. As a result, they are generally supplemented by additional 2D fast spin echo sequences, adding time to the examination and potential discomfort to the patient. Here we investigate the hypothesis that in patients with spinal stenosis and spondylotic myelopathy, 3D driven-equilibrium fast spin echo sequences can characterize cord lesions equally well as 2D fast spin echo sequences. We performed a retrospective analysis of 30 adult patients with spondylotic myelopathy who had been examined with both 3D driven-equilibrium fast spin echo sequences and 2D fast spin echo sequences at the same scanning session. The two sequences were inspected separately for each patient, and visible cord lesions were manually traced. We found no significant differences between 3D driven-equilibrium fast spin echo and 2D fast spin echo sequences in the mean number, mean area, or mean transverse dimensions of spondylotic cord lesions. Nevertheless, the mean contrast-to-noise ratio of cord lesions was decreased on 3D driven-equilibrium fast spin echo sequences compared to 2D fast spin echo sequences. These findings suggest that 3D driven-equilibrium fast spin echo sequences do not need supplemental 2D fast spin echo sequences for the diagnosis of spondylotic myelopathy, but they may be less well suited for quantitative signal measurements in the spinal cord.	[Abdulhadi, Mike A.] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Perno, Joseph R.; Nucifora, Paolo G. P.] Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Melhem, Elias R.] Univ Maryland, Baltimore, MD 21201 USA; [Nucifora, Paolo G. P.] Univ Penn, Philadelphia, PA 19104 USA	Children's Hospitals & Clinics of Minnesota; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania	Nucifora, PGP (corresponding author), Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA.	paolo.nucifora@uphs.upenn.edu						Ahn JS, 2010, CLIN ORTHOP SURG, V2, P98, DOI 10.4055/cios.2010.2.2.98; Arvin B, 2011, NEUROSURGERY, V69, P362, DOI 10.1227/NEU.0b013e31821a418c; Avadhani A, 2010, SPINE J, V10, P475, DOI 10.1016/j.spinee.2010.03.024; Chatley A, 2009, J NEUROSURG-SPINE, V11, P562, DOI 10.3171/2009.6.SPINE091; Chiewvit Pipat, 2011, Journal of the Medical Association of Thailand, V94, P346; Cho YE, 2011, EUR SPINE J, V20, P2267, DOI 10.1007/s00586-011-1878-3; Eck JC, 2010, SPINE, V35, pE1306, DOI 10.1097/BRS.0b013e3181e23e62; Freund PAB, 2010, J MAGN RESON IMAGING, V32, P1242, DOI 10.1002/jmri.22340; GEORGY BA, 1994, AM J ROENTGENOL, V162, P923, DOI 10.2214/ajr.162.4.8141019; Harrop JS, 2010, SPINE, V35, P620, DOI 10.1097/BRS.0b013e3181b723af; Kang Y, 2011, AM J ROENTGENOL, V197, pW134, DOI 10.2214/AJR.10.5560; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kohno K, 1997, SURG NEUROL, V48, P237, DOI 10.1016/S0090-3019(97)00166-3; Kwon JW, 2012, CLIN RADIOL, V67, P106, DOI 10.1016/j.crad.2011.06.011; Maldjian C, 1999, ACAD RADIOL, V6, P84, DOI 10.1016/S1076-6332(99)80486-3; Markl M, 2012, J MAGN RESON IMAGING, V35, P1274, DOI 10.1002/jmri.23638; MATSUDA Y, 1991, J NEUROSURG, V74, P887, DOI 10.3171/jns.1991.74.6.0887; Matsumoto M, 2000, SPINE, V25, P677, DOI 10.1097/00007632-200003150-00005; Maus TP, 2012, RADIOL CLIN N AM, V50, P651, DOI 10.1016/j.rcl.2012.04.007; MEHALIC TF, 1990, NEUROSURGERY, V26, P217, DOI 10.1227/00006123-199002000-00006; Meindl T, 2009, EUR RADIOL, V19, P713, DOI 10.1007/s00330-008-1175-7; Melhem E R, 2000, Magn Reson Imaging Clin N Am, V8, P435; Melhem ER, 2001, RADIOLOGY, V218, P283, DOI 10.1148/radiology.218.1.r01ja38283; MORIO Y, 1994, ARCH ORTHOP TRAUM SU, V113, P254, DOI 10.1007/BF00443813; Morio Y, 2001, SPINE, V26, P1238, DOI 10.1097/00007632-200106010-00012; Naraghi A, 2012, AM J ROENTGENOL, V199, pW283, DOI 10.2214/AJR.12.9099; OHSHIO I, 1993, SPINE, V18, P1140, DOI 10.1097/00007632-199307000-00005; OKADA Y, 1993, SPINE, V18, P2024, DOI 10.1097/00007632-199310001-00016; RAMANAUSKAS WL, 1989, J COMPUT ASSIST TOMO, V13, P399, DOI 10.1097/00004728-198905000-00005; Shin JJ, 2010, ACTA NEUROCHIR, V152, P1687, DOI 10.1007/s00701-010-0692-8; Suri Ashish, 2003, Spine J, V3, P33, DOI 10.1016/S1529-9430(02)00448-5; TAKAHASHI M, 1987, NEURORADIOLOGY, V29, P550, DOI 10.1007/BF00350439; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; TSURUDA JS, 1991, AM J NEURORADIOL, V12, P237; TSURUDA JS, 1990, AM J ROENTGENOL, V154, P375, DOI 10.2214/ajr.154.2.2153331; VANUIJEN CMJ, 1984, MAGNET RESON MED, V1, P502, DOI 10.1002/mrm.1910010409; Vedantam A, 2011, J NEUROSURG-SPINE, V15, P660, DOI 10.3171/2011.8.SPINE11452; WADA E, 1995, SPINE, V20, P2226, DOI 10.1097/00007632-199510001-00009; Yukawa Y, 2007, SPINE, V32, P1675, DOI 10.1097/BRS.0b013e318074d62e; Zhang YZ, 2010, SPINE, V35, pE396, DOI 10.1097/BRS.0b013e3181c6dbc4	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100964	10.1371/journal.pone.0100964	http://dx.doi.org/10.1371/journal.pone.0100964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025170	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400008
J	Deressa, T; Stoecklinger, A; Wallner, M; Himly, M; Kofler, S; Hainz, K; Brandstetter, H; Thalhamer, J; Hammerl, P				Deressa, Tekalign; Stoecklinger, Angelika; Wallner, Michael; Himly, Martin; Kofler, Stefan; Hainz, Katrina; Brandstetter, Hans; Thalhamer, Josef; Hammerl, Peter			Structural Integrity of the Antigen Is a Determinant for the Induction of T-Helper Type-1 Immunity in Mice by Gene Gun Vaccines against E.coli Beta-Galactosidase	PLOS ONE			English	Article							DERMAL DENDRITIC CELLS; EPIDERMAL LANGERHANS CELLS; CAT ALLERGEN FEL-D-1; DNA VACCINES; INFECTIOUS-DISEASES; MEDIATED-IMMUNITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INTERFERON-GAMMA; CPG MOTIFS	The type of immune response is critical for successful protection and typically determined by pathogen-associated danger molecules. In contrast, protein antigens are usually regarded as passive target structures. Here, we provide evidence that the structure of the antigen can profoundly influence the type of response that is elicited under else identical conditions. In mice, gene gun vaccines induce predominantly Th2-biased immune reactions against most antigens. One exception is E. coli beta-galactosidase (beta Gal) that induces a balanced Th1/Th2 response. Because both, the delivered material (plasmid DNA-coated gold particles) as well as the procedure (biolistic delivery to the skin surface) is the same as for other antigens we hypothesized that Th1 induction could be a function of beta Gal protein expressed in transfected cells. To test this we examined gene gun vaccines encoding structural or functional variants of the antigen. Employing a series of gene gun vaccines encoding individual structural domains of beta Gal, we found that neither of them induced IgG2a antibodies. Even disruption of the homo-tetramer association of the native protein by deletion of a few N-terminal amino acids was sufficient to abrogate IgG2a production. However, enzymatically inactive beta Gal with only one point mutation in the catalytic center retained the ability to induce Th1 reactions. Thus, structural but not functional integrity of the antigen must be retained for Th1 induction. beta Gal is not a Th1 adjuvant in the classical sense because neither were beta Gal-transgenic ROSA26 mice particularly Th1-biased nor did co-administration of a beta Gal-encoding plasmid induce IgG2a against other antigens. Despite this, gene gun vaccines elicited Th1 reactions to antigens fused to the open reading frame of beta Gal. We interpret these findings as evidence that different skin-borne antigens may be differentially handled by the immune system and that the three-dimensional structure of an antigen is an important determinant for this.	[Deressa, Tekalign; Stoecklinger, Angelika; Wallner, Michael; Himly, Martin; Kofler, Stefan; Hainz, Katrina; Brandstetter, Hans; Thalhamer, Josef; Hammerl, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University	Hammerl, P (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	peter.hammerl@sbg.ac.at	Wallner, Michael/L-5437-2015; Brandstetter, Hans/E-6754-2011; Thalhamer, Josef/E-5787-2011; Stoecklinger, Angelika/C-7616-2016; Himly, Martin/D-1568-2015	Wallner, Michael/0000-0001-6568-7892; Brandstetter, Hans/0000-0002-6089-3045; Thalhamer, Josef/0000-0003-2285-6400; Stoecklinger, Angelika/0000-0002-0351-8142; Himly, Martin/0000-0001-5416-085X	Austrian Research Fund, FWF [W1213, P25243-B22]; Christian Doppler Laboratory for Allergy Diagnosis Therapy	Austrian Research Fund, FWF(Austrian Science Fund (FWF)); Christian Doppler Laboratory for Allergy Diagnosis Therapy	This work was supported by the Austrian Research Fund, FWF, grants W1213 and P25243-B22, and the Christian Doppler Laboratory for Allergy Diagnosis & Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alvarez D, 2005, J IMMUNOL, V174, P1664, DOI 10.4049/jimmunol.174.3.1664; ANSEL J, 1990, J INVEST DERMATOL, V94, pS101, DOI 10.1111/1523-1747.ep12876053; Brtko J, 1999, MOL CELL ENDOCRINOL, V152, P85, DOI 10.1016/S0303-7207(99)00054-4; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; De Vooght V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012581; Fomsgaard A, 1998, SCAND J IMMUNOL, V47, P289, DOI 10.1046/j.1365-3083.1998.00323.x; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Fuller DH, 2007, VIROLOGY, V364, P245, DOI 10.1016/j.virol.2007.02.024; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gronlund H, 2003, J BIOL CHEM, V278, P40144, DOI 10.1074/jbc.M301416200; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kwok SC, 2003, J BIOL CHEM, V278, P35248, DOI 10.1074/jbc.M305306200; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; LANGLEY KE, 1976, BIOCHEMISTRY-US, V15, P4866, DOI 10.1021/bi00667a018; Larsen L, 2011, J DERMATOL SCI, V64, P85, DOI 10.1016/j.jdermsci.2011.07.008; Leitner WW, 1997, J IMMUNOL, V159, P6112; Locksley RM, 1999, J INFECT DIS, V179, pS305, DOI 10.1086/513843; Ludwig-Portugall I, 2004, J ALLERGY CLIN IMMUN, V114, P951, DOI 10.1016/j.jaci.2004.06.013; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Miller LS, 2007, J INVEST DERMATOL, V127, P262, DOI 10.1038/sj.jid.5700559; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Mueller GA, 1998, BIOCHEMISTRY-US, V37, P12707, DOI 10.1021/bi980578+; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; Ohkuri T, 2010, J IMMUNOL, V185, P4199, DOI 10.4049/jimmunol.0902249; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Roy MJ, 2000, VACCINE, V19, P764, DOI 10.1016/S0264-410X(00)00302-9; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Scheiblhofer S, 2007, MOL IMMUNOL, V44, P1879, DOI 10.1016/j.molimm.2006.09.023; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Stoecklinger A, 2007, J IMMUNOL, V179, P886, DOI 10.4049/jimmunol.179.2.886; Stoecklinger A, 2011, J IMMUNOL, V186, P1377, DOI 10.4049/jimmunol.1002557; TABE L, 1984, J MOL BIOL, V180, P645, DOI 10.1016/0022-2836(84)90031-7; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas JC, 2013, HUM VACC IMMUNOTHER, V9, P744, DOI 10.4161/hv.22998; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tuzun Y, 2007, DERMATOL CLIN, V25, P467, DOI 10.1016/dct.2007.06.003; Turner MS, 2014, DIABETOLOGIA, V57, P1428, DOI 10.1007/s00125-014-3233-9; Vrtala S, 1999, J IMMUNOL, V163, P5489; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Weiss R, 2002, VACCINE, V20, P3148, DOI 10.1016/S0264-410X(02)00250-5; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	64	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102280	10.1371/journal.pone.0102280	http://dx.doi.org/10.1371/journal.pone.0102280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025197	gold, Green Published, Green Submitted			2022-12-27	WOS:000339992400059
J	Parmar, C; Velazquez, ER; Leijenaar, R; Jermoumi, M; Carvalho, S; Mak, RH; Mitra, S; Shankar, BU; Kikinis, R; Haibe-Kains, B; Lambin, P; Aerts, HJWL				Parmar, Chintan; Velazquez, Emmanuel Rios; Leijenaar, Ralph; Jermoumi, Mohammed; Carvalho, Sara; Mak, Raymond H.; Mitra, Sushmita; Shankar, B. Uma; Kikinis, Ron; Haibe-Kains, Benjamin; Lambin, Philippe; Aerts, Hugo J. W. L.			Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation	PLOS ONE			English	Article							CELL LUNG-CANCER; INTEROBSERVER VARIABILITY; TEXTURAL FEATURES; PET IMAGES; TUMOR; REPRODUCIBILITY; HETEROGENEITY	Due to advances in the acquisition and analysis of medical imaging, it is currently possible to quantify the tumor phenotype. The emerging field of Radiomics addresses this issue by converting medical images into minable data by extracting a large number of quantitative imaging features. One of the main challenges of Radiomics is tumor segmentation. Where manual delineation is time consuming and prone to inter-observer variability, it has been shown that semi-automated approaches are fast and reduce inter-observer variability. In this study, a semiautomatic region growing volumetric segmentation algorithm, implemented in the free and publicly available 3D-Slicer platform, was investigated in terms of its robustness for quantitative imaging feature extraction. Fifty-six 3D-radiomic features, quantifying phenotypic differences based on tumor intensity, shape and texture, were extracted from the computed tomography images of twenty lung cancer patients. These radiomic features were derived from the 3D-tumor volumes defined by three independent observers twice using 3D-Slicer, and compared to manual slice-by-slice delineations of five independent physicians in terms of intra-class correlation coefficient (ICC) and feature range. Radiomic features extracted from 3D-Slicer segmentations had significantly higher reproducibility (ICC = 0.85+/-0.15, p = 0.0009) compared to the features extracted from the manual segmentations (ICC = 0.77+/-0.17). Furthermore, we found that features extracted from 3D-Slicer segmentations were more robust, as the range was significantly smaller across observers (p = 3.819e-07), and overlapping with the feature ranges extracted from manual contouring (boundary lower: p = 0.007, higher: p = 5.863e-06). Our results show that 3D-Slicer segmented tumor volumes provide a better alternative to the manual delineation for feature quantification, as they yield more reproducible imaging descriptors. Therefore, 3D-Slicer can be employed for quantitative image feature extraction and image data mining research in large patient cohorts.	[Parmar, Chintan; Velazquez, Emmanuel Rios; Jermoumi, Mohammed; Mak, Raymond H.; Lambin, Philippe; Aerts, Hugo J. W. L.] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol,Med Sch, Boston, MA 02115 USA; [Parmar, Chintan; Velazquez, Emmanuel Rios; Leijenaar, Ralph; Carvalho, Sara; Aerts, Hugo J. W. L.] Maastricht Univ, Dept Radiat Oncol MAASTRO, Maastricht, Netherlands; [Parmar, Chintan; Mitra, Sushmita; Shankar, B. Uma] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India; [Jermoumi, Mohammed] Univ Massachusetts, Lowell, MA USA; [Kikinis, Ron; Aerts, Hugo J. W. L.] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA; [Haibe-Kains, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Haibe-Kains, Benjamin] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Maastricht University; Indian Statistical Institute; Indian Statistical Institute Kolkata; University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Parmar, C (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol,Med Sch, Boston, MA 02115 USA.	Chintan_Parmar@dfci.harvard.edu; Hugo_Aerts@dfci.harvard.edu	parmar, chintan/J-2977-2019; Aerts, Hugo/ABF-2821-2020; Aerts, Hugo/P-6350-2015; Haibe-Kains, Benjamin/D-3702-2011	parmar, chintan/0000-0002-2140-814X; Aerts, Hugo/0000-0002-2122-2003; Aerts, Hugo/0000-0002-2122-2003; Haibe-Kains, Benjamin/0000-0002-7684-0079; Lambin, Philippe/0000-0001-7961-0191; SHANKAR, B. UMA/0000-0003-0332-2294; Mitra, Sushmita/0000-0001-9285-1117; Mak, Raymond/0000-0002-8754-0565	National Institutes of Health [NIH-USA U01 CA 143062-01]; National Institutes of Health (NIH HHS/United States) [U54-EB005149, P41-EB015902]; CTMM framework (AIRFORCE project) [030-103]; EU; euroCAT (IVA Interreg); Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Dutch Cancer Society [KWF UM 2011-5020, KWF UM 2009-4454]; QuIC-ConCePT project [115151]; NATIONAL CANCER INSTITUTE [U01CA143062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902, U54EB005149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH HHS/United States)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTMM framework (AIRFORCE project); EU(European Commission); euroCAT (IVA Interreg); Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Dutch Cancer Society(KWF Kankerbestrijding); QuIC-ConCePT project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge financial support from the National Institutes of Health (NIH-USA U01 CA 143062-01, Radiomics of NSCLC, and NIH HHS/United States U54-EB005149, P41-EB015902), the CTMM framework (AIRFORCE project, grant 030-103), EU 6th and 7th framework program (METOXIA, EURECA, ARTFORCE), euroCAT (IVA Interreg - www.eurocat.info), Kankeronderzoekfonds Limburg from the Health Foundation Limburg and the Dutch Cancer Society (KWF UM 2011-5020, KWF UM 2009-4454). The authors also acknowledge financial support from the QuIC-ConCePT project (Grant Agreement No. 115151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts H. J., 2014, NATURE COMMUNICATION; Buckler AJ, 2011, RADIOLOGY, V258, P906, DOI 10.1148/radiol.10100799; Buckler AJ, 2011, RADIOLOGY, V259, P875, DOI 10.1148/radiol.10100800; Deasy JO, 2003, MED PHYS, V30, P979, DOI 10.1118/1.1568978; Egger J, 2013, SCI REPORTS, V3; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Gamer M, 2013, R PACKAGE VERSION 0; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Gu Y, 2012, PATTERN RECOGN, V46, P692; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Heye T, 2013, RADIOLOGY, V266, P812, DOI 10.1148/radiol.12120255; Hunter LA, 2013, MED PHYS, V40, DOI 10.1118/1.4829514; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Van Baardwijk A, 2007, INT J RADIAT ONCOL, V68, P771, DOI 10.1016/j.ijrobp.2006.12.067; van Baardwijk A, 2010, J CLIN ONCOL, V28, P1380, DOI 10.1200/JCO.2009.24.7221; Velazquez ER, 2013, SCI REP-UK, V3, DOI 10.1038/srep03529; Velazquez ER, 2012, RADIOTHER ONCOL, V105, P167, DOI 10.1016/j.radonc.2012.09.023; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	31	370	388	8	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102107	10.1371/journal.pone.0102107	http://dx.doi.org/10.1371/journal.pone.0102107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025374	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400042
J	Pereira, AM; Tudor, C; Pouille, PA; Shekhar, S; Kanger, JS; Subramaniam, V; Martin-Blanco, E				Pereira, Andrea M.; Tudor, Cicerone; Pouille, Philippe-Alexandre; Shekhar, Shashank; Kanger, Johannes S.; Subramaniam, Vinod; Martin-Blanco, Enrique			Plasticity of the MAPK Signaling Network in Response to Mechanical Stress	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REGULATING JNK ACTIVITY; N-TERMINAL KINASE; GENE-EXPRESSION; DORSAL CLOSURE; CELL-SURVIVAL; GROWTH-FACTOR; CROSS-TALK; DROSOPHILA; PHOSPHORYLATION	Cells display versatile responses to mechanical inputs and recent studies have identified the mitogen-activated protein kinase (MAPK) cascades mediating the biological effects observed upon mechanical stimulation. Although, MAPK pathways can act insulated from each other, several mechanisms facilitate the crosstalk between the components of these cascades. Yet, the combinatorial complexity of potential molecular interactions between these elements have prevented the understanding of their concerted functions. To analyze the plasticity of the MAPK signaling network in response to mechanical stress we performed a non-saturating epistatic screen in resting and stretched conditions employing as readout a JNK responsive dJun-FRET biosensor. By knocking down MAPKs, and JNK pathway regulators, singly or in pairs in Drosophila S2R+ cells, we have uncovered unexpected regulatory links between JNK cascade kinases, Rho GTPases, MAPKs and the JNK phosphatase Puc. These relationships have been integrated in a system network model at equilibrium accounting for all experimentally validated interactions. This model allows predicting the global reaction of the network to its modulation in response to mechanical stress. It also highlights its context-dependent sensitivity.	[Pereira, Andrea M.; Pouille, Philippe-Alexandre; Martin-Blanco, Enrique] Inst Biol Mol Barcelona CSIC, Barcelona, Spain; [Tudor, Cicerone; Shekhar, Shashank; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Shekhar, Shashank; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Twente; University of Twente	Subramaniam, V (corresponding author), Univ Twente, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.	v.subramaniam@utwente.nl; embbmc@ibmb.csic.es	Subramaniam, Vinod/B-4197-2010; Pereira, Andrea/AAL-2973-2020; Shekhar, Shashank/B-3068-2013; Martin-Blanco, Enrique/ABH-1280-2020	Subramaniam, Vinod/0000-0001-6712-7266; Martin-Blanco, Enrique/0000-0002-6926-910X; Shekhar, Shashank/0000-0003-1494-0151	Spanish FPU; Marie Curie Research Training Network IMMUNANOMAP; Ministry of Economy and Competitivity (DGI); Ministry of Economy and Competitivity (Consolider); "Stitching voor Fundamenteel Onderzoek der Materie" (FOM); Nederlandse Organisatie voor Wetenschappelik Onderzoek (N.W.O.); European Union	Spanish FPU(Spanish Government); Marie Curie Research Training Network IMMUNANOMAP; Ministry of Economy and Competitivity (DGI); Ministry of Economy and Competitivity (Consolider); "Stitching voor Fundamenteel Onderzoek der Materie" (FOM)(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelik Onderzoek (N.W.O.)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	A.M.P held a Spanish FPU PhD studentship, and C.T. was supported by the Marie Curie Research Training Network IMMUNANOMAP. Research in the E.M.-B. laboratory is funded by grants of the Ministry of Economy and Competitivity (DGI and Consolider). Research in the V.S. laboratory is supported by "Stitching voor Fundamenteel Onderzoek der Materie" (FOM), the Nederlandse Organisatie voor Wetenschappelik Onderzoek (N.W.O.), and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Canela-Xandri O, 2008, BIOPHYS J, V95, P5111, DOI 10.1529/biophysj.108.133306; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; GIRARD PR, 1995, J CELL PHYSIOL, V163, P179, DOI 10.1002/jcp.1041630121; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Jeschke M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003357; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komuro I, 1996, FASEB J, V10, P631, DOI 10.1096/fasebj.10.5.8621062; Kreeger PK, 2009, CANCER RES, V69, P8191, DOI 10.1158/0008-5472.CAN-09-1921; Li SP, 2003, CANCER RES, V63, P3473; LIU M, 1992, AM J PHYSIOL, V263, pL376; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Blanco E, 1998, INT J DEV BIOL, V42, P363; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Pereira AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026182; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; Ren KW, 2012, CELL PHYSIOL BIOCHEM, V30, P827, DOI 10.1159/000341461; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Shvartsman SY, 2009, FLY, V3, P62, DOI 10.4161/fly.3.1.7776; Sonna LA, 2003, PHYSIOL GENOMICS, V12, P195, DOI 10.1152/physiolgenomics.00104.2002; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101963	10.1371/journal.pone.0101963	http://dx.doi.org/10.1371/journal.pone.0101963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025279	Green Published, Green Submitted, gold			2022-12-27	WOS:000339992400030
J	Zhu, JJ; Liu, SS; Ye, FQ; Shen, Y; Tie, Y; Zhu, J; Jin, YH; Zheng, XF; Wu, YG; Fu, HJ				Zhu, Juanjuan; Liu, Shanshan; Ye, Fuqiang; Shen, Yuan; Tie, Yi; Zhu, Jie; Jin, Yinghua; Zheng, Xiaofei; Wu, Yongge; Fu, Hanjiang			The Long Noncoding RNA Expression Profile of Hepatocellular Carcinoma Identified by Microarray Analysis	PLOS ONE			English	Article							GENE; ENHANCER; CANCER; EPIDEMIOLOGY; PROGNOSIS; DISEASE	Background: Thousands of long noncoding RNAs (lncRNAs) have been reported in mammalian genomes. These RNAs represent an important subset of pervasive genes involved in a broad range of biological functions. Aberrant expression of lncRNAs is associated with many types of cancers. Here, in order to explore the potential lncRNAs involved in hepatocellular carcinoma (HCC) oncogenesis, we performed lncRNA gene expression profile analysis in 3 pairs of human HCC and adjacent non-tumor (NT) tissues by microarray. Methodology: Differentially expressed lncRNAs and mRNAs were detected by human lncRNA microarray containing 33,045 lncRNAs and 30,215 coding transcripts. Bioinformatic analyses (gene ontology, pathway and network analysis) were applied for further study of these differentially expressed mRNAs. By qRT-PCR analysis in nineteen pairs of HCC and adjacent normal tissues, we found that eight lncRNAs were aberrantly expressed in HCC compared with adjacent NT tissues, which is consistent with microarray data. Conclusions: We identified 214 lncRNAs and 338 mRNAs abnormally expressed in all three HCC tissues (Fold Change >= 2.0, P < 0.05 and FDR < 0.05) with the genome-wide lncRNAs and mRNAs expression profile analysis. The lncRNA-mRNA co-expression network was constructed, which may be used for predicting target genes of lncRNAs. Furthermore, we demonstrated for the first time that BC017743, ENST00000395084, NR_026591, NR_015378 and NR_024284 were up-regulated, whereas NR_027151, AK056988 and uc003yqb. 1 were down-regulated in nineteen pairs of HCC samples compared with adjacent NT samples. Expression of seven lncRNAs was significantly correlated to their nearby coding genes. In conclusion, our results indicated that the lncRNA expression profile in HCC was significantly changed, and we identified a series of new hepatocarcinoma associated lncRNAs. These results provide important insights about the lncRNAs in HCC pathogenesis.	[Zhu, Juanjuan; Liu, Shanshan; Jin, Yinghua; Wu, Yongge] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Zhu, Juanjuan; Liu, Shanshan; Ye, Fuqiang; Shen, Yuan; Tie, Yi; Zhu, Jie; Zheng, Xiaofei; Fu, Hanjiang] Beijing Inst Radiat Med, Beijing, Peoples R China	Jilin University; Academy of Military Medical Sciences - China	Wu, YG (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China.	ygwu@jlu.edu.cn; fuhj75@126.com		Fu, Hanjiang/0000-0002-4352-1178	Chinese State Key Projects for Basic Research [2010CB912801, 2013CB910801]; Chinese National Natural Science Foundation [31070702, 81072021, 31170713]	Chinese State Key Projects for Basic Research; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported partially by Chinese State Key Projects for Basic Research (2010CB912801, 2013CB910801), Chinese National Natural Science Foundation projects (31070702, 81072021, 31170713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kowalczyk MS, 2012, NATURE, V482, P310, DOI 10.1038/482310a; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan YF, 2011, CHINESE MED J-PEKING, V124, P2378, DOI 10.3760/cma.j.issn.0366-6999.2011.15.023; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Puszyk WM, 2013, LAB INVEST, V93, P983, DOI 10.1038/labinvest.2013.94; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Smith Robert J, 2013, Hepatobiliary Surg Nutr, V2, P89, DOI 10.3978/j.issn.2304-3881.2012.11.02; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Yuan SX, 2012, HEPATOLOGY, V56, P2231, DOI 10.1002/hep.25895; Zhang LS, 2013, HEPATOLOGY, V57, P1919, DOI 10.1002/hep.26162	41	55	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101707	10.1371/journal.pone.0101707	http://dx.doi.org/10.1371/journal.pone.0101707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025236	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400020
J	Jo, G; Lim, W; Bae, SM; Bazer, FW; Song, G				Jo, Gahee; Lim, Whasun; Bae, Seung-Min; Bazer, Fuller W.; Song, Gwonhwa			Avian SERPINB12 Expression in the Avian Oviduct Is Regulated by Estrogen and Up-Regulated in Epithelial Cell-Derived Ovarian Carcinomas of Laying Hens	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CHICK OVIDUCT; DIFFERENTIAL EXPRESSION; PARADOXICAL EXPRESSION; PROTEIN-SYNTHESIS; OVALBUMIN; CANCER; GENE; EVOLUTION; TUMORS	Serine protease inhibitors (SERPINs) are involved in a variety of biological processes such as blood clotting, angiogenesis, immune system, and embryogenesis. Although, of these, SERPINB12 is identified as the latest member of clade B in humans, little is known of it in chickens. Thus, in this study, we investigated SERPINB12 expression profiles in various tissues of chickens and focused on effects of steroid hormone regulation of its expression. In the chicken oviduct, SERPINB12 mRNA and protein are abundant in the luminal (LE) and glandular (GE) epithelia of the magnum in response to endogenous or exogenous estrogen. Furthermore, SERPINB12 mRNA and protein increase significantly in GE of cancerous ovaries of laying hens with epithelia-derived ovarian cancer. Collectively, these results indicate that SERPINB12 is a novel estrogen-stimulated gene that is up-regulated by estrogen in epithelial cells of the chicken oviduct and that it is a potential biomarker for early detection of ovarian carcinomas in laying hens and women.	[Jo, Gahee; Lim, Whasun; Bae, Seung-Min; Song, Gwonhwa] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Korea University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Song, G (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea.	ghsong@korea.ac.kr	gwonhwa, song/H-3208-2015; Lim, Whasun/AAP-3156-2020; Song, Gwonhwa/H-3647-2015; Bazer, Fuller/AAF-4317-2021	Lim, Whasun/0000-0002-1328-0465; Bazer, Fuller/0000-0002-5823-5086	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2013R1A1A2A10005948]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008142]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(National Research Foundation of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was funded by the Basic Science Research Program (2013R1A1A2A10005948) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SE, 2012, GEN COMP ENDOCR, V175, P194, DOI 10.1016/j.ygcen.2011.11.013; Ahn SE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-100; Askew YS, 2001, J BIOL CHEM, V276, P49320, DOI 10.1074/jbc.M108879200; Bae SM, 2014, MOL CELL ENDOCRINOL, V382, P46, DOI 10.1016/j.mce.2013.09.010; Baekelandt MM, 2008, ANN ONCOL, V19, P19, DOI 10.1093/annonc/mdn113; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; BERRY WD, 1985, POULTRY SCI, V64, P2027, DOI 10.3382/ps.0642027; Berry WD, 2003, POULTRY SCI, V82, P971, DOI 10.1093/ps/82.6.971; Chechlinska M, 2010, TUMOR BIOL, V31, P559, DOI 10.1007/s13277-010-0069-x; CREGER CR, 1977, POULTRY SCI, V56, P1706; Crum CP, 2012, CLIN OBSTET GYNECOL, V55, P24, DOI 10.1097/GRF.0b013e31824b1725; Dougherty DC, 2005, TRENDS ENDOCRIN MET, V16, P414, DOI 10.1016/j.tem.2005.09.001; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Giles JR, 2006, EXP BIOL MED, V231, P1718, DOI 10.1177/153537020623101108; GRONROOS M, 1987, ANN CHIR GYNAECOL FE, V76, P76; Hsu KF, 2007, INT J GYNECOL CANCER, V17, P174, DOI 10.1111/j.1525-1438.2006.00663.x; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076784; Jeong W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049204; Jeong W, 2012, EXP BIOL MED, V237, P758, DOI 10.1258/ebm.2012.011433; Kaiserman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-167; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051592; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; Li HWR, 2007, ONCOL REP, V17, P393; Lim W, 2013, MOL CELL ENDOCRINOL, V366, P1, DOI 10.1016/j.mce.2012.10.031; Lim W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049869; Lim W, 2012, BIOCHEM BIOPH RES CO, V422, P494, DOI 10.1016/j.bbrc.2012.05.026; Lim W, 2012, EXP BIOL MED, V237, P150, DOI 10.1258/ebm.2011.011250; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Lim W, 2011, BIOL REPROD, V85, P1260, DOI 10.1095/biolreprod.111.093526; Lim W, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; MCKNIGHT GS, 1978, CELL, V14, P403; Nakashima T, 2006, HEAD NECK-J SCI SPEC, V28, P24, DOI 10.1002/hed.20293; PALMITER RD, 1972, J BIOL CHEM, V247, P6770; PALMITER RD, 1972, J BIOL CHEM, V247, P6450; SANDERS MM, 1988, BIOCHEMISTRY-US, V27, P6550, DOI 10.1021/bi00417a053; Shiiba M, 2010, ONCOL REP, V24, P241, DOI 10.3892/or_00000852; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Stewart MD, 2000, BIOL REPROD, V62, P1779, DOI 10.1095/biolreprod62.6.1779; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; Trevino Lindsey S., 2010, Hormones & Cancer, V1, P177, DOI 10.1007/s12672-010-0024-8	51	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e99792	10.1371/journal.pone.0099792	http://dx.doi.org/10.1371/journal.pone.0099792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020046	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600003
J	Pavese, JM; Ogden, IM; Voll, EA; Huang, XK; Xu, L; Jovanovic, B; Bergan, RC				Pavese, Janet M.; Ogden, Irene M.; Voll, Eric A.; Huang, Xiaoke; Xu, Li; Jovanovic, Borko; Bergan, Raymond C.			Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4) Promotes Human Prostate Cancer Metastasis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE TYPE-2; N-TERMINAL KINASE; CELL INVASION; SIGNALING PATHWAYS; ANDROGEN ABLATION; MMP-2A EXPRESSION; SUPPRESSOR GENE; MKK4; MIGRATION; PROGRESSION	Prostate cancer (PCa) is the second leading cause of cancer death in the US. Death from PCa primarily results from metastasis. Mitogen-activated protein kinase kinase 4 (MAP2K4) is overexpressed in invasive PCa lesions in humans, and can be inhibited by small molecule therapeutics that demonstrate favorable activity in phase II studies. However, MAP2K4's role in regulating metastatic behavior is controversial and unknown. To investigate, we engineered human PCa cell lines which overexpress either wild type or constitutive active MAP2K4. Orthotopic implantation into mice demonstrated MAP2K4 increases formation of distant metastasis. Constitutive active MAP2K4, though not wild type, increases tumor size and circulating tumor cells in the blood and bone marrow. Complementary in vitro studies establish stable MAP2K4 overexpression promotes cell invasion, but does not affect cell growth or migration. MAP2K4 overexpression increases the expression of heat shock protein 27 (HSP27) protein and protease production, with the largest effect upon matrix metalloproteinase 2 (MMP-2), both in vitro and in mouse tumor samples. Further, MAP2K4-mediated increases in cell invasion are dependent upon heat shock protein 27 (HSP27) and MMP-2, but not upon MAP2K4's immediate downstream targets, p38 MAPK or JNK. We demonstrate that MAP2K4 increases human PCa metastasis, and prolonged over expression induces long term changes in cell signaling pathways leading to independence from p38 MAPK and JNK. These findings provide a mechanistic explanation for human studies linking increases in HSP27 and MMP-2 to progression to metastatic disease. MAP2K4 is validated as an important therapeutic target for inhibiting human PCa metastasis.	[Pavese, Janet M.; Ogden, Irene M.; Voll, Eric A.; Huang, Xiaoke; Xu, Li; Bergan, Raymond C.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Jovanovic, Borko; Bergan, Raymond C.] Northwestern Univ, Dept Preventat Med, Chicago, IL 60611 USA; [Jovanovic, Borko; Bergan, Raymond C.] Northwestern Univ, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Bergan, Raymond C.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Bergan, RC (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	r-bergan@northwestern.edu			National Institutes of Health (NIH) [CA122985]; Prostate SPORE [CA90386]; NIH [T32 AG000260]; Walter S. And Lucienne Driskill Graduate Program in Life Sciences at Northwestern University; NATIONAL CANCER INSTITUTE [R01CA122985, P50CA090386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate SPORE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter S. And Lucienne Driskill Graduate Program in Life Sciences at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (NIH) to R. C. B., CA122985 and Prostate SPORE CA90386, and to J.M.P, NIH T32 AG000260 "Drug Discovery Training in Age-Related Disorders'', and by the Walter S. And Lucienne Driskill Graduate Program in Life Sciences at Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATCC, 2007, ATCC TECHN B, V8, P1; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Ben-Ami I, 2011, J BIOL CHEM, V286, P31022, DOI 10.1074/jbc.M111.247726; Bjorkblom B, 2012, MOL CELL BIOL, V32, P3513, DOI 10.1128/MCB.00713-12; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cornford PA, 2000, CANCER RES, V60, P7099; Craft CS, 2008, MOL PHARMACOL, V73, P235, DOI 10.1124/mol.107.038935; Cunningham SC, 2006, CANCER RES, V66, P5560, DOI 10.1158/0008-5472.CAN-06-0555; Ding Yongzeng, 2007, J Biomol Tech, V18, P321; El-Haibi CP, 2011, CELL PROLIFERAT, V44, P311, DOI 10.1111/j.1365-2184.2011.00757.x; Griend DJV, 2005, CANCER RES, V65, P10984, DOI 10.1158/0008-5472.CAN-05-2382; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; Hickson JA, 2006, CANCER RES, V66, P2264, DOI 10.1158/0008-5472.CAN-05-3676; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Ishikawa M, 2010, ONCOLOGY-BASEL, V79, P238, DOI 10.1159/000322644; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kim HL, 2001, CANCER RES, V61, P2833; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Lakshman M, 2011, CLIN EXP METASTAS, V28, P39, DOI 10.1007/s10585-010-9356-6; Liang H, 2012, J ANESTH, V26, P381, DOI 10.1007/s00540-011-1317-y; Liu KC, 2011, ONCOL REP, V26, P177, DOI 10.3892/or.2011.1264; Liu YQ, 2002, ONCOGENE, V21, P8272, DOI 10.1038/sj.onc.1206117; Liu YQ, 2001, PROSTATE CANCER P D, V4, P81, DOI 10.1038/sj.pcan.4500506; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan TL, 2007, J PATHOL, V212, P386, DOI 10.1002/path.2194; Miyake H, 2010, UROL ONCOL-SEMIN ORI, V28, P145, DOI 10.1016/j.urolonc.2008.08.001; Nakayama K, 2006, CANCER BIOL THER, V5, P630, DOI 10.4161/cbt.5.6.2675; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Rocchi P, 2004, CANCER RES, V64, P6595, DOI 10.1158/0008-5472.CAN-03-3998; Schilling D, 2012, NAT REV UROL; Shen KH, 2010, MOL CELL BIOCHEM, V333, P279, DOI 10.1007/s11010-009-0229-8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stearns M, 1996, ONCOL RES, V8, P69; Stearns ME, 1996, ONCOL RES, V8, P63; STEARNS ME, 1993, CANCER RES, V53, P878; Szmulewitz RZ, 2012, INT J CANCER, V130, P509, DOI 10.1002/ijc.26005; Vihinen P, 2005, CURR CANCER DRUG TAR, V5, P203, DOI 10.2174/1568009053765799; Wang L, 2004, ONCOGENE, V23, P5978, DOI 10.1038/sj.onc.1207802; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Wood M, 1997, CLIN EXP METASTAS, V15, P246, DOI 10.1023/A:1018421431388; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Yeasmin S, 2011, TUMOR BIOL, V32, P661, DOI 10.1007/s13277-011-0166-5; Zelefsky M, 2008, CANC PRINCIPLES PRAC	47	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102289	10.1371/journal.pone.0102289	http://dx.doi.org/10.1371/journal.pone.0102289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019290	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600060
J	Schmidt, JR; Weissman, DH				Schmidt, James R.; Weissman, Daniel H.			Congruency Sequence Effects without Feature Integration or Contingency Learning Confounds	PLOS ONE			English	Article							DIFFERENT PERCEPTUAL CATEGORIES; CONFLICT ADAPTATION; COGNITIVE CONTROL; PROPORTION CONGRUENT; IDENTIFYING STIMULI; MIXED BLOCKS; TASK; MODULATIONS; ADJUSTMENTS; TRIALS	The congruency effect in distracter interference (e. g., Stroop) tasks is often reduced after incongruent trials, relative to congruent trials. It has been proposed that this congruency sequence effect (CSE) results from trial-by-trial adjustments of attention, which are triggered by changes in response conflict, expectancy, or negative affect. Hence, a large literature has developed to investigate the source(s) of attention adaptation in distracter interference tasks. Recent work, however, suggests that CSEs may stem from feature integration and/or contingency learning processes that are confounded with congruency sequence in the vast majority of distracter interference tasks. By combining an established method for measuring CSEs in the absence of these learning and memory confounds with a prime-probe task, we observed robust CSEs in two experiments. These findings provide strong evidence of CSEs independent of learning and memory confounds, which might be explainable by trial-by-trial adjustments of attention. They also reveal a highly effective approach for observing CSEs independent of the typical confounds, which will facilitate future studies of how people adapt to distraction.	[Schmidt, James R.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Weissman, Daniel H.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	Ghent University; University of Michigan System; University of Michigan	Weissman, DH (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	danweiss@umich.edu	Schmidt, James/C-9704-2010	Schmidt, James/0000-0002-0412-396X	University of Michigan	University of Michigan(University of Michigan System)	This research was supported by start-up funds from the University of Michigan awarded to DHW. JRS is a postdoctoral researcher of the Research Foundation - Flanders (FWO - Vlaanderen; http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blais C, 2012, ACTA PSYCHOL, V141, P133, DOI 10.1016/j.actpsy.2012.07.009; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Dreisbach G, 2012, BRAIN COGNITION, V78, P94, DOI 10.1016/j.bandc.2011.12.003; Duthoo W, 2013, PSYCHON B REV, V20, P798, DOI 10.3758/s13423-013-0390-7; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Freitas AL, 2007, PSYCHOL SCI, V18, P1040, DOI 10.1111/j.1467-9280.2007.02022.x; Fritz J, 2013, COGN AFFECT BEHAV NE, V13, P311, DOI 10.3758/s13415-012-0147-1; Grandjean J, 2013, NEUROPSYCHOLOGIA, V51, P1040, DOI 10.1016/j.neuropsychologia.2013.02.015; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hazeltine E, 2011, J EXP PSYCHOL HUMAN, V37, P1898, DOI 10.1037/a0024662; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Funes MJ, 2010, COGNITION, V114, P338, DOI 10.1016/j.cognition.2009.10.007; Funes MJ, 2010, J EXP PSYCHOL HUMAN, V36, P147, DOI 10.1037/a0017598; Jimenez L, 2013, J EXP PSYCHOL HUMAN, V39, P271, DOI 10.1037/a0027734; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim S, 2014, ACTA PSYCHOL, V149, P60, DOI 10.1016/j.actpsy.2014.03.004; Kinoshita S, 2011, J EXP PSYCHOL GEN, V140, P622, DOI 10.1037/a0024230; Kunde W, 2006, MEM COGNITION, V34, P356, DOI 10.3758/BF03193413; Lamers MJM, 2011, Q J EXP PSYCHOL, V64, P1056, DOI 10.1080/17470218.2010.523792; Lee J, 2013, ACTA PSYCHOL, V144, P617, DOI 10.1016/j.actpsy.2013.09.013; Los SA, 1999, ACTA PSYCHOL, V103, P173, DOI 10.1016/S0001-6918(99)00031-1; Los SA, 1999, J EXP PSYCHOL HUMAN, V25, P3, DOI 10.1037/0096-1523.25.1.3; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2009, PSYCHOL RES-PSYCH FO, V73, P794, DOI 10.1007/s00426-008-0191-1; Mordkoff JT, 2012, PSYCHON B REV, V19, P750, DOI 10.3758/s13423-012-0257-3; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2007, J EXP PSYCHOL HUMAN, V33, P1256, DOI 10.1037/0096-1523.33.5.1256; Schmidt JR, 2007, CONSCIOUS COGN, V16, P421, DOI 10.1016/j.concog.2006.06.010; Schmidt JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082320; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Torres-Quesada M, 2013, ACTA PSYCHOL, V142, P203, DOI 10.1016/j.actpsy.2012.11.015; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Wendt M, 2006, J EXP PSYCHOL HUMAN, V32, P644, DOI 10.1037/0096-1523.32.3.644	44	130	131	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102337	10.1371/journal.pone.0102337	http://dx.doi.org/10.1371/journal.pone.0102337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1PC	25019526	Green Submitted, Green Published, gold			2022-12-27	WOS:000339618600071
J	Song, SE; Yang, J; Lee, KS; Kim, H; Kim, YM; Kim, S; Park, MS; Oh, SY; Lee, JB; Lee, E; Park, SH; Kim, HJ				Song, Seung-Eun; Yang, JiYeon; Lee, Kil Soo; Kim, Hyungjun; Kim, Young Mi; Kim, Seonghan; Park, Mi-Sun; Oh, Su Yeon; Lee, Jin Bum; Lee, EunPyo; Park, Sang-Hee; Kim, Hee-Jin			Comparison of the Tuberculin Skin Test and Interferon Gamma Release Assay for the Screening of Tuberculosis in Adolescents in Close Contact with Tuberculosis TB Patients	PLOS ONE			English	Article							INFECTION; PERFORMANCE; DIAGNOSIS; BCG	Background: The tuberculin skin test (TST) frequently yields false positive results among BCG-vaccinated persons thereby limiting its diagnostic value particularly in settings with high BCG vaccination rate. We determined the agreement between IGRA and TST using 2 cutoff values and identified possible relationships between the results of these tests and the development of active tuberculosis. Methodology: Adolescents aged 11-19 years in close contact with smear-positive tuberculosis cases and with normal chest radiographs were recruited from middle and high schools in South Korea. The TST was conducted by trained nurses, and blood was drawn for the QuantiFERON-TB Gold In-Tube (QFT-GIT). Participants were followed up for 2 years to check for incidence tuberculosis. Results: A total of 2,982 subjects were included in the study, the average age was 15.1 years (SD 1.3), 61% had BCG vaccination scars. The agreement of QFT-GIT and the TST was low (kappa = 0.38, 95% CI 0.32 to 0.42) using 10 mm cutoff; however, when the 15 mm cutoff was used, the agreement was intermediate (kappa = 0.56, 95% CI 0.50 to 0.61). The odds ratio (OR) for the development of active tuberculosis was 7.9 (95% CI 3.46 to 18.06) for QFT-GIT positive patients, 7.96 (95% CI 3.14-20.22) for TST/QFT-GIT+ and the OR 4.62 (95% CI 2.02 to 10.58) and 16.35 (95% CI 7.09 to 37.71) for TST 10 mm and 15 mm cutoff respectively. Conclusions: The results of this study suggest that the TST cutoff point for patients aged 11-17 years would be 15 mm in other study. The OR of QFT-GIT for the development of active tuberculosis and its intermediate agreement with TST using 15 mm cutoff demonstrates its role as an adjunct diagnostic tool to current clinical practice. Positive responders to both TST and QFT-GIT at the outset may benefit from chemoprophylaxis.	[Song, Seung-Eun; Yang, JiYeon; Lee, Kil Soo; Kim, Hyungjun; Kim, Young Mi; Kim, Seonghan; Park, Mi-Sun; Park, Sang-Hee] Korea Natl Inst Hlth, Div TB & Bacterial Resp Infect, Chungcheongbuk Do, South Korea; [Oh, Su Yeon; Lee, Jin Bum; Lee, EunPyo; Kim, Hee-Jin] Korean Inst TB, Chungcheongbuk Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease	Park, SH (corresponding author), Korea Natl Inst Hlth, Div TB & Bacterial Resp Infect, Chungcheongbuk Do, South Korea.	park3hee@korea.kr; hachingbird@gmail.com	Kim, Heejin/HII-8568-2022	Park, Sanghee/0000-0002-1515-4235	Research of Korea Centers for Disease Control and Prevention [2008-E00226-00, 2009-E46002-00, 2010-E46003-00, 2011-E46006-00, 2012-E46001-00]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund (2008-E00226-00, 2009-E46002-00, 2010-E46003-00, 2011-E46006-00, and 2012-E46001-00) by Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chun JK, 2008, DIAGN MICR INFEC DIS, V62, P389, DOI 10.1016/j.diagmicrobio.2008.08.022; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; JIN BW, 1989, TUBERCLE, V70, P241, DOI 10.1016/0041-3879(89)90018-4; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Lighter J, 2009, PEDIATRICS, V123, P30, DOI 10.1542/peds.2007-3618; Mahomed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059652; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Petrie A, 2000, MED STAT GLANCE, P138; Song S, 2012, CHEST, V141, P983, DOI 10.1378/chest.11-1158; Wang XJ, 2012, TUBERCULOSIS, V92, P513, DOI 10.1016/j.tube.2012.06.005	14	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e100267	10.1371/journal.pone.0100267	http://dx.doi.org/10.1371/journal.pone.0100267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020161	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600005
J	Vendelbo, MH; Moller, AB; Christensen, B; Nellemann, B; Clasen, BFF; Nair, KS; Jorgensen, JOL; Jessen, N; Moller, N				Vendelbo, Mikkel Holm; Moller, Andreas Buch; Christensen, Britt; Nellemann, Birgitte; Clasen, Berthil Frederik Forrest; Nair, K. Sreekumaran; Jorgensen, Jens Otto Lunde; Jessen, Niels; Moller, Niels			Fasting Increases Human Skeletal Muscle Net Phenylalanine Release and This Is Associated with Decreased mTOR Signaling	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; GROWTH-HORMONE; CELL-GROWTH; RIBOSOME BIOGENESIS; MAMMALIAN TARGET; BINDING PARTNER; DISUSE ATROPHY; WHOLE-BODY; BED REST; PROTEIN	Aim: Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth. Methods: Eight healthy male volunteers were studied twice: in the postabsorptive state and following 72 hours of fasting. Regional muscle amino acid kinetics was measured in the forearm using amino acid tracers. Signaling to protein synthesis and breakdown were assessed in skeletal muscle biopsies obtained during non-insulin and insulin stimulated conditions on both examination days. Results: Fasting significantly increased forearm net phenylalanine release and tended to decrease phenylalanine rate of disappearance. mTOR phosphorylation was decreased by similar to 50% following fasting, together with reduced downstream phosphorylation of 4EBP1, ULK1 and rpS6. In addition, the insulin stimulated increase in mTOR and rpS6 phosphorylation was significantly reduced after fasting indicating insulin resistance in this part of the signaling pathway. Autophagy initiation is in part regulated by mTOR through ULK1 and fasting increased expression of the autophagic marker LC3B-II by similar to 30%. p62 is degraded during autophagy but was increased by similar to 10% during fasting making interpretation of autophagic flux problematic. MAFbx and MURF1 ubiquitin ligases remained unaltered after fasting indicating no change in protesomal protein degradation. Conclusions: Our results show that during fasting increased net phenylalanine release in skeletal muscle is associated to reduced mTOR activation and concomitant decreased downstream signaling to cell growth.	[Vendelbo, Mikkel Holm; Christensen, Britt; Nellemann, Birgitte; Clasen, Berthil Frederik Forrest; Jorgensen, Jens Otto Lunde; Jessen, Niels; Moller, Niels] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Moller, Andreas Buch; Clasen, Berthil Frederik Forrest; Jessen, Niels] Aarhus Univ Hosp, Res Lab Biochem Pathol, DK-8000 Aarhus, Denmark; [Jessen, Niels] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Nair, K. Sreekumaran] Mayo Clin, Endocrine Res Unit, Div Endocrinol, Rochester, MN USA	Aarhus University; Aarhus University; Aarhus University; Mayo Clinic	Vendelbo, MH (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark.	mikkel.vendelbo@ki.au.dk	Moller, Niels/E-5091-2011; Jessen, Niels/E-1731-2011; Jorgensen, Jens Otto Lunde/O-8003-2019	Moller, Niels/0000-0001-5627-7322; Vendelbo, Mikkel Holm/0000-0003-0431-2522; Jorgensen, Jens Otto Lunde/0000-0001-7408-1526; Jessen, Niels/0000-0001-5613-7274	FOOD Study Group/Danish Ministry of Food, Agriculture, and Fisheries; Ministry of Family and Consumer Affairs Grant [2101-05-0044]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER	FOOD Study Group/Danish Ministry of Food, Agriculture, and Fisheries; Ministry of Family and Consumer Affairs Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the FOOD Study Group/Danish Ministry of Food, Agriculture, and Fisheries; and Ministry of Family and Consumer Affairs Grant 2101-05-0044 (to N. Moller). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SCAND J MED SCI SPOR; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Cong HL, 2011, HUM GENE THER, V22, P313, DOI 10.1089/hum.2010.057; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; COPELAND KC, 1994, J CLIN ENDOCR METAB, V78, P1040, DOI 10.1210/jc.78.5.1040; Drummond MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1113, DOI 10.1152/ajpendo.00603.2011; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; FRYBURG DA, 1990, AM J PHYSIOL, V259, pE477, DOI 10.1152/ajpendo.1990.259.4.E477; Gjedsted J, 2009, ACTA PHYSIOL, V197, P197, DOI 10.1111/j.1748-1716.2009.02009.x; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Larsen AE, 2006, ANN NUTR METAB, V50, P476, DOI 10.1159/000095354; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moller N, 2000, P NATL ACAD SCI USA, V97, P1242, DOI 10.1073/pnas.97.3.1242; NAIR KS, 1987, AM J CLIN NUTR, V46, P557, DOI 10.1093/ajcn/46.4.557; NAIR KS, 1995, J CLIN INVEST, V95, P2926, DOI 10.1172/JCI118000; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Norrelund H, 2001, DIABETES, V50, P96, DOI 10.2337/diabetes.50.1.96; Owen OE, 1998, AM J CLIN NUTR, V68, P12, DOI 10.1093/ajcn/68.1.12; POZEFSKY T, 1976, J CLIN INVEST, V57, P444, DOI 10.1172/JCI108295; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Sakuma K, 2009, ACTA PHYSIOL, V197, P151, DOI 10.1111/j.1748-1716.2009.01995.x; Salanova M, 2008, J ANAT, V212, P306, DOI 10.1111/j.1469-7580.2008.00854.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; THOMPSON GN, 1989, AM J PHYSIOL, V256, pE631, DOI 10.1152/ajpendo.1989.256.5.E631; THOMSON TJ, 1966, LANCET, V2, P992; Urso ML, 2007, J PHYSIOL-LONDON, V579, P877, DOI 10.1113/jphysiol.2006.118042; Vendelbo MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE190, DOI 10.1152/ajpendo.00207.2011; Vendelbo MH, 2010, J CLIN ENDOCR METAB, V95, pE64, DOI 10.1210/jc.2010-0689; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	51	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102031	10.1371/journal.pone.0102031	http://dx.doi.org/10.1371/journal.pone.0102031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020061	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600040
J	Xu, WR; Jiao, YT; Li, RM; Zhang, NB; Xiao, DM; Ding, XL; Wang, ZP				Xu, Weirong; Jiao, Yuntong; Li, Ruimin; Zhang, Ningbo; Xiao, Dongming; Ding, Xiaoling; Wang, Zhenping			Chinese Wild-Growing Vitis amurensis ICE1 and ICE2 Encode MYC-Type bHLH Transcription Activators that Regulate Cold Tolerance in Arabidopsis	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; FREEZING TOLERANCE; FUNCTIONAL-ANALYSIS; STRESS TOLERANCE; DNA-BINDING; DROUGHT; ACCLIMATION; PROTEINS; OVEREXPRESSION; GRAPEVINE	Winter hardiness is an important trait for grapevine breeders and producers, so identification of the regulatory mechanisms involved in cold acclimation is of great potential value. The work presented here involves the identification of two grapevine ICE gene homologs, VaICE1 and VaICE2, from an extremely cold-tolerant accession of Chinese wild-growing Vitis amurnensis, which are phylogenetically related to other plant ICE1 genes. These two structurally different ICE proteins contain previously reported ICE-specific amino acid motifs, the bHLH-ZIP domain and the S-rich motif. Expression analysis revealed that VaICE1 is constitutively expressed but affected by cold stress, unlike VaICE2 that shows not such changed expression as a consequence of cold treatment. Both genes serve as transcription factors, potentiating the transactivation activities in yeasts and the corresponding proteins localized to the nucleus following transient expression in onion epidermal cells. Overexpression of either VaICE1 or VaICE2 in Arabidopsis increase freezing tolerance in nonacclimated plants. Moreover, we show that they result in multiple biochemical changes that were associated with cold acclimation: VaICE1/2-overexpressing plants had evaluated levels of proline, reduced contents of malondialdehyde (MDA) and decreased levels of electrolyte leakage. The expression of downstream cold responsive genes of CBF1, COR15A, and COR47 were significantly induced in Arabidopsis transgenically overexpressing VaICE1 or VaICE2 upon cold stress. VaICE2, but not VaICE1 overexpression induced KIN1 expression under cold-acclimation conditions. Our results suggest that VaICE1 and VaICE2 act as key regulators at an early step in the transcriptional cascade controlling freezing tolerance, and modulate the expression levels of various low-temperature associated genes involved in the C-repeat binding factor (CBF) pathway.	[Xu, Weirong; Zhang, Ningbo; Xiao, Dongming; Ding, Xiaoling; Wang, Zhenping] Ningxia Univ, Sch Agron, Ningxia, Peoples R China; [Xu, Weirong; Zhang, Ningbo; Xiao, Dongming; Ding, Xiaoling; Wang, Zhenping] Ningxia Univ, Minist Educ, Engn Res Ctr Grape & Wine, Ningxia, Peoples R China; [Xu, Weirong; Zhang, Ningbo; Xiao, Dongming; Wang, Zhenping] Ningxia Univ, Ningxia Engn & Technol Res Ctr Grape & Wine, Ningxia, Peoples R China; [Jiao, Yuntong; Li, Ruimin] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Ningxia University; Ningxia University; Ningxia University; Northwest A&F University - China	Xu, WR (corresponding author), Ningxia Univ, Sch Agron, Ningxia, Peoples R China.	xuwr@nxu.edu.cn; wzhenping@yahoo.com	Xu, Weirong/I-2671-2016	Xu, Weirong/0000-0003-2821-0360	National Natural Science Foundation of China [31101512]; Ningxia Innovation Program for the Returned Overseas Scholars	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningxia Innovation Program for the Returned Overseas Scholars	This work was supported by the National Natural Science Foundation of China (Grant no. 31101512) and Ningxia Innovation Program for the Returned Overseas Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi M, 2008, PLANT CELL PHYSIOL, V49, P1237, DOI 10.1093/pcp/pcn100; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; C FAaL, 2013, ENV EXPT BOT; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Christen D, 2007, ENVIRON EXP BOT, V60, P504, DOI 10.1016/j.envexpbot.2007.02.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Daldoul S, 2010, PLANT SCI, V179, P489, DOI 10.1016/j.plantsci.2010.07.017; Deng YM, 2011, PLANT CELL REP, V30, P2177, DOI 10.1007/s00299-011-1123-x; Dexter ST, 1932, PLANT PHYSIOL, V7, P63, DOI 10.1104/pp.7.1.63; Dong C, 2013, PLANT PHYSIOL BIOCH, V71, P212, DOI 10.1016/j.plaphy.2013.07.012; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; GUY CL, 1992, PLANT PHYSIOL, V100, P502, DOI 10.1104/pp.100.1.502; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Houde M, 2004, PLANT BIOTECHNOL J, V2, P381, DOI 10.1111/j.1467-7652.2004.00082.x; ITURRIAGA G, 1992, PLANT MOL BIOL, V20, P555, DOI 10.1007/BF00040614; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kadioglu A, 2012, PLANT SCI, V182, P42, DOI 10.1016/j.plantsci.2011.01.013; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kaye C, 1998, PLANT PHYSIOL, V116, P1367, DOI 10.1104/pp.116.4.1367; Kobayashi M, 2010, J PLANT PHYSIOL, V167, P812, DOI 10.1016/j.jplph.2009.12.005; KOSZO F, 1974, BIOCHIM BIOPHYS ACTA, V363, P182, DOI 10.1016/0005-2736(74)90057-1; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li JT, 2014, SCI HORTIC-AMSTERDAM, V165, P266, DOI 10.1016/j.scienta.2013.11.002; Lin Y, 2013, J PLANT BIOCHEM BIOT, P1; Liu LY, 2010, SCI HORTIC-AMSTERDAM, V124, P29, DOI 10.1016/j.scienta.2009.11.018; Liu LY, 2013, CAN J PLANT SCI, V93, P565, DOI 10.4141/CJPS2012-202; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Miura K, 2012, PLANT BIOTECHNOL-NAR, V29, P253, DOI 10.5511/plantbiotechnology.12.0303a; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nakamura J, 2011, PLANT BIOTECHNOL-NAR, V28, P303, DOI 10.5511/plantbiotechnology.11.0421a; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Pramanik MHR, 2005, PLANT MOL BIOL, V58, P751, DOI 10.1007/s11103-005-7404-4; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rahman MA, 2014, ENV EXPT BOT; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; Sato Y, 2011, PLANT CELL REP, V30, P399, DOI 10.1007/s00299-010-0985-7; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Trovato M, 2008, REND LINCEI-SCI FIS, V19, P325, DOI 10.1007/s12210-008-0022-8; Wan YZ, 2008, VITIS, V47, P77; Wang Xinglong, 2005, Mol Biol (Mosk), V39, P21; Wang Y, 2012, PLANT CELL REP, V31, P27, DOI 10.1007/s00299-011-1136-5; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Weigel RR, 2001, PLANT MOL BIOL, V46, P143, DOI 10.1023/A:1010652620115; Xiang DJ, 2013, MOL BREEDING, V32, P617, DOI 10.1007/s11032-013-9894-0; Xu WR, 2014, MOL BIOL REP, V41, P5329, DOI 10.1007/s11033-014-3404-2; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang Y, 2012, AM J ENOL VITICULT, V63, P377, DOI 10.5344/ajev.2012.12006	70	40	46	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102303	10.1371/journal.pone.0102303	http://dx.doi.org/10.1371/journal.pone.0102303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019620	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600063
J	Yang, XH; Shen, XR; Li, WJ; Yang, YF				Yang, Xiaohong; Shen, Xiangrong; Li, Weijun; Yang, Yufang			How Listeners Weight Acoustic Cues to Intonational Phrase Boundaries	PLOS ONE			English	Article							SYNTACTIC BOUNDARIES; PROSODIC BOUNDARIES; GERMAN INFANTS; PERCEPTION; DISCOURSE; DURATION; MANDARIN; CHINESE; SPEECH; ALOUD	The presence of an intonational phrase boundary is often marked by three major acoustic cues: pause, final lengthening, and pitch reset. The present study investigates how these three acoustic cues are weighted in the perception of intonational phrase boundaries in two experiments. Sentences that contained two intonational phrases with a critical boundary between them were used as the experimental stimuli. The roles of the three acoustic cues at the critical boundary were manipulated in five conditions. The first condition featured none of the acoustic cues. The following three conditions featured only one cue each: pause, final lengthening, and pitch reset, respectively. The fifth condition featured both pause duration and pre-final lengthening. A baseline condition was also included in which all three acoustic cues were preserved intact. Listeners were asked to detect the presence of the critical boundaries in Experiment 1 and judge the strength of the critical boundaries in Experiment 2. The results of both experiments showed that listeners used all three acoustic cues in the perception of prosodic boundaries. More importantly, these acoustic cues were weighted differently across the two experiments: Pause was a more powerful perceptual cue than both final lengthening and pitch reset, with the latter two cues perceptually equivalent; the effect of pause and the effects of the other two acoustic cues were not additive. These results suggest that the weighting of acoustic cues contributes significantly to the perceptual differences of intonational phrase boundary.	[Yang, Xiaohong; Shen, Xiangrong; Li, Weijun; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Shen, Xiangrong] Shanghai Normal Univ, Coll Humanities & Commun, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Shanghai Normal University	Li, WJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liwj88@gmail.com; yangyf@psych.ac.cn			National Natural Science Foundation of China [31000505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31000505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman M, 1986, PHONOLOGY YB, V3, P5; Bei W, 2005, ACTA ACUSTICA, V2, P177; BERKOVITS R, 1994, LANG SPEECH, V37, P237, DOI 10.1177/002383099403700302; Byrd D, 2006, J ACOUST SOC AM, V120, P1589, DOI 10.1121/1.2217135; Carlson R, 2005, SPEECH COMMUN, V46, P326, DOI 10.1016/j.specom.2005.02.013; Chen YY, 2006, J PHONETICS, V34, P176, DOI 10.1016/j.wocn.2005.05.002; Cole J, 2010, LANG COGNITIVE PROC, V25, P1141, DOI 10.1080/01690960903525507; COOPER WE, 1977, J ACOUST SOC AM, V62, P683, DOI 10.1121/1.381556; den Ouden H, 2009, SPEECH COMMUN, V51, P116, DOI 10.1016/j.specom.2008.06.003; DEPIJPER JR, 1994, J ACOUST SOC AM, V96, P2037, DOI 10.1121/1.410145; Ellis RJ, 2009, J EXP PSYCHOL HUMAN, V35, P264, DOI 10.1037/a0013482; Fon J, 2004, LANG SPEECH, V47, P57, DOI 10.1177/00238309040470010301; Fon J, 2011, LANG SPEECH, V54, P5, DOI 10.1177/0023830910372492; Frazier L, 2006, TRENDS COGN SCI, V10, P244, DOI 10.1016/j.tics.2006.04.002; Hirst D. J., 1998, INTONATION SYSTEMS S, P1; Krivokapic J, 2012, J PHONETICS; Krivokapic J, 2007, J PHONETICS, V35, P162, DOI 10.1016/j.wocn.2006.04.001; Li W, 2009, NEUROSCIENCE, V158, P1416, DOI 10.1016/j.neuroscience.2008.10.065; Liang J, 2007, TONES TUNES, V2, P12; Lin HY, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P808; Mannel C, 2009, J COGNITIVE NEUROSCI, V21, P1988, DOI 10.1162/jocn.2009.21221; Mo Y., 2010, J ACOUST SOC AM, V127, P1956; Nakai S, 2009, J PHONETICS, V37, P29, DOI 10.1016/j.wocn.2008.08.002; Nesport M, 2007, PROSODIC PHONOLOGY N; PRICE PJ, 1991, J ACOUST SOC AM, V90, P2956, DOI 10.1121/1.401770; SCOTT DR, 1982, J ACOUST SOC AM, V71, P996, DOI 10.1121/1.387581; Seidl A, 2007, J MEM LANG, V57, P24, DOI 10.1016/j.jml.2006.10.004; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Shen X.S., 1992, J INT PHON ASSOC, V22, P35; SLUIJTER AMC, 1993, PHONETICA, V50, P180, DOI 10.1159/000261938; Smith CL, 2004, SPEECH COMMUN, V42, P247, DOI 10.1016/j.specom.2003.09.004; Steinhauer K, 2003, BRAIN LANG, V86, P142, DOI 10.1016/S0093-934X(02)00542-4; STREETER LA, 1978, J ACOUST SOC AM, V64, P1582, DOI 10.1121/1.382142; SWERTS M, 1994, J ACOUST SOC AM, V96, P2064, DOI 10.1121/1.410148; THORSEN NG, 1986, J ACOUST SOC AM, V80, P1041, DOI 10.1121/1.393845; Vaissiere J., 1983, PROSODY MODELS MEASU, P53; Vaissiere J, 2006, USAGE-B LINGUIST INF, V3, P47; Venditti JJ, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P287; Wagner M, 2010, LANG COGNITIVE PROC, V99999, P1; Wellmann C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00580; WIGHTMAN CW, 1992, J ACOUST SOC AM, V91, P1707, DOI 10.1121/1.402450; Yang XH, 2012, IEEE T AUDIO SPEECH, V20, P1196, DOI 10.1109/TASL.2011.2173676; Zhang X., 2012, THESIS U MICHIGAN	43	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102166	10.1371/journal.pone.0102166	http://dx.doi.org/10.1371/journal.pone.0102166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1PC	25019156	Green Published, Green Submitted, gold			2022-12-27	WOS:000339618600051
J	AlKhatib, Z; Lagedroste, M; Fey, I; Kleinschrodt, D; Abts, A; Smits, SHJ				AlKhatib, Zainab; Lagedroste, Marcel; Fey, Iris; Kleinschrodt, Diana; Abts, Andre; Smits, Sander H. J.			Lantibiotic Immunity: Inhibition of Nisin Mediated Pore Formation by NisI	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; PRECURSOR LIPID II; LACTOCOCCUS-LACTIS; PEPTIDE; BACTERIOCINS; PROTEIN; BIOSYNTHESIS; ORIENTATION; MECHANISM; PROVIDES	Nisin, a 3.4 kDa antimicrobial peptide produced by some Lactococcus lactis strains is the most prominent member of the lantibiotic family. Nisin can inhibit cell growth and penetrates the target Gram-positive bacterial membrane by binding to Lipid II, an essential cell wall synthesis precursor. The assembled nisin-Lipid II complex forms pores in the target membrane. To gain immunity against its own-produced nisin, Lactococcus lactis is expressing two immunity protein systems, NisI and NisFEG. Here, we show that the NisI expressing strain displays an IC50 of 736 +/- 10 nM, an 8-10-fold increase when compared to the non-expressing sensitive strain. When the nisin concentration is raised above 70 nM, the cells expressing full-length NisI stop growing rather than being killed. NisI is inhibiting nisin mediated pore formation, even at nisin concentrations up to 1 mu M. This effect is induced by the C-terminus of NisI that protects Lipid II. Its deletion showed pore formation again. The expression of NisI in combination with externally added nisin mediates an elongation of the chain length of the Lactococcus lactis cocci. While the sensitive strain cell-chains consist mainly of two cells, the NisI expressing cells display a length of up to 20 cells. Both results shed light on the immunity of lantibiotic producer strains, and their survival in high levels of their own lantibiotic in the habitat.	[AlKhatib, Zainab; Lagedroste, Marcel; Fey, Iris; Kleinschrodt, Diana; Abts, Andre; Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	sander.smits@hhu.de			CLIB Graduate Cluster Industrial Biotechnology	CLIB Graduate Cluster Industrial Biotechnology	This work was supported by CLIB Graduate Cluster Industrial Biotechnology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Abts A., 2011, INT J PEPT, V2011, DOI DOI 10.1155/2011/175145; Abts A, 2013, BIOCHEMISTRY-US, V52, P5387, DOI 10.1021/bi4008116; Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barbour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077751; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1998, BIOCHEMISTRY-US, V37, P8153, DOI 10.1021/bi972797l; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; Christ NA, 2012, J BIOL CHEM, V287, P35286, DOI 10.1074/jbc.M112.401620; Claessen D, 2014, NAT REV MICROBIOL, V12, P115, DOI 10.1038/nrmicro3178; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Demel RA, 1996, EUR J BIOCHEM, V235, P267, DOI 10.1111/j.1432-1033.1996.00267.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Draper LA, 2008, CURR PROTEIN PEPT SC, V9, P39; DRIESSEN AJM, 1995, BIOCHEMISTRY-US, V34, P1606, DOI 10.1021/bi00005a017; Galvin M, 1999, LETT APPL MICROBIOL, V28, P355, DOI 10.1046/j.1365-2672.1999.00550.x; GARCERA MJG, 1993, EUR J BIOCHEM, V212, P417, DOI 10.1111/j.1432-1033.1993.tb17677.x; Giffard CJ, 1997, BIOCHEMISTRY-US, V36, P3802, DOI 10.1021/bi962506t; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hoffmann A, 2004, APPL ENVIRON MICROB, V70, P3263, DOI 10.1128/AEM.70.6.3263-3271.2004; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; JUNG G, 1991, ANGEW CHEM INT EDIT, V30, P1051, DOI 10.1002/anie.199110513; Koponen O, 2004, FEMS MICROBIOL LETT, V231, P85, DOI 10.1016/S0378-1097(03)00934-0; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; KORDEL M, 1989, FEBS LETT, V244, P99, DOI 10.1016/0014-5793(89)81171-8; Kruszewska D, 2004, J ANTIMICROB CHEMOTH, V54, P648, DOI 10.1093/jac/dkh387; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Li HP, 2006, J BACTERIOL, V188, P8496, DOI 10.1128/JB.00946-06; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Piper C, 2011, MICROB BIOTECHNOL, V4, P375, DOI 10.1111/j.1751-7915.2010.00207.x; QIAO MQ, 1995, FEMS MICROBIOL LETT, V131, P75, DOI 10.1111/j.1574-6968.1995.tb07757.x; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Ra SR, 1996, MICROBIOL-SGM, V142, P1281, DOI 10.1099/13500872-142-5-1281; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; SAHL HG, 1987, ARCH MICROBIOL, V149, P120, DOI 10.1007/BF00425076; Sambrook J., 2001, MOL CLONING LAB MANU; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; Takala TM, 2006, MICROBIOL-SGM, V152, P3543, DOI 10.1099/mic.0.29083-0; van Heusden HE, 2002, BIOCHEMISTRY-US, V41, P12171, DOI 10.1021/bi026090x; VANDEVEN FJM, 1991, EUR J BIOCHEM, V202, P1181, DOI 10.1111/j.1432-1033.1991.tb16488.x; Visweswaran GRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072167; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	59	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102246	10.1371/journal.pone.0102246	http://dx.doi.org/10.1371/journal.pone.0102246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014359	gold, Green Submitted, Green Published			2022-12-27	WOS:000339378400080
J	Chauhan, A; Sun, YY; Pani, B; Quenumzangbe, F; Sharma, J; Singh, BB; Mishra, BB				Chauhan, Arun; Sun, Yuyang; Pani, Biswaranjan; Quenumzangbe, Fredice; Sharma, Jyotika; Singh, Brij B.; Mishra, Bibhuti B.			Helminth Induced Suppression of Macrophage Activation Is Correlated with Inhibition of Calcium Channel Activity	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TAENIA-SOLIUM CYSTICERCOSIS; JUNCTIONAL COMPLEX PROTEINS; CENTRAL-NERVOUS-SYSTEM; GLAND FLUID SECRETION; OPERATED CA2+ ENTRY; INNATE IMMUNITY; MURINE NEUROCYSTICERCOSIS; DIFFERENTIAL CHANGES; STIM1	Helminth parasites cause persistent infections in humans and yet many infected individuals are asymptomatic. Neurocysticercosis (NCC), a disease of the central nervous system (CNS) caused by the cestode Taenia solium, has a long asymptomatic phase correlated with an absence of brain inflammation. However, the mechanisms of immune suppression remain poorly understood. Here we report that murine NCC displays a lack of cell surface maturation markers in infiltrating myeloid cells. Furthermore, soluble parasite ligands (PL) failed to induce maturation of macrophages, and inhibited TLR-induced inflammatory cytokine production. Importantly, PL treatment abolished both LPS and thapsigargin-induced store operated Ca2+ entry (SOCE). Moreover, electrophysiological recordings demonstrated PL-mediated inhibition of LPS or Tg-induced currents that were TRPC1-dependent. Concomitantly STIM1-TRPC1 complex was also impaired that was essential for SOCE and sustained Ca2+ entry. Likewise loss of SOCE due to PL further inhibited NFkB activation. Overall, our results indicate that the negative regulation of agonist induced Ca2+ signaling pathway by parasite ligands may be a novel immune suppressive mechanism to block the initiation of the inflammatory response associated with helminth infections.	[Chauhan, Arun; Sun, Yuyang; Pani, Biswaranjan; Quenumzangbe, Fredice; Sharma, Jyotika; Singh, Brij B.; Mishra, Bibhuti B.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Mishra, BB (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA.	bibhuti.mishra@und.med.edu	Pani, Biswaranjan/GLT-9217-2022	Singh, Brij/0000-0003-0535-5997	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER; NIAID NIH HHS [1R03AI09753] Funding Source: Medline; NIDCR NIH HHS [R01 DE017102, R01DE017102,] Funding Source: Medline; NIGMS NIH HHS [P30GM103329, P30 GM103329] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Alvarez JI, 2002, J NEUROIMMUNOL, V127, P139, DOI 10.1016/S0165-5728(02)00101-7; Alvarez JI, 2002, J COMP PATHOL, V127, P186, DOI 10.1053/jcpa.2002.0579; Alvarez JI, 2007, BRAIN RES, V1169, P98, DOI 10.1016/j.brainres.2007.07.010; Alvarez JI, 2007, J NEUROIMMUNOL, V187, P102, DOI 10.1016/j.jneuroim.2007.05.005; Alvarez JI, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000218; Ambudkar IS, 2006, CELL CALCIUM, V40, P495, DOI 10.1016/j.ceca.2006.08.011; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Brannstrom K, 2009, INFECT IMMUN, V77, P1144, DOI 10.1128/IAI.01126-08; Cardona AE, 1999, J IMMUNOL, V162, P995; Cardona AE, 2002, J IMMUNOL, V169, P3163, DOI 10.4049/jimmunol.169.6.3163; Cardona AE, 2003, INFECT IMMUN, V71, P2634, DOI 10.1128/IAI.71.5.2634-2642.2003; Cooke A, 2012, CURR OPIN RHEUMATOL, V24, P394, DOI 10.1097/BOR.0b013e3283535937; Cooke A, 2009, IMMUNOLOGY, V126, P12, DOI 10.1111/j.1365-2567.2008.03009.x; DAVIS LE, 1991, EUR NEUROL, V31, P229, DOI 10.1159/000116683; Elliott DE, 2007, INT J PARASITOL, V37, P457, DOI 10.1016/j.ijpara.2006.12.009; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Garcia HH, 2005, LANCET NEUROL, V4, P653, DOI 10.1016/S1474-4422(05)70194-0; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gomez-Garcia L, 2005, PARASITE IMMUNOL, V27, P395, DOI 10.1111/j.1365-3024.2005.00790.x; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Medzhitov R, 2007, SEMIN IMMUNOL, V19, P1, DOI 10.1016/j.smim.2007.02.001; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Mishra BB, 2009, INFECT IMMUN; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Mishra BB, 2009, CURR TOP MICROBIOL, V336, P83, DOI 10.1007/978-3-642-00549-7_5; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; MOLINARI JL, 1990, ANN TROP MED PARASIT, V84, P205, DOI 10.1080/00034983.1990.11812458; Nash TE, 2006, NEUROLOGY, V67, P1120, DOI 10.1212/01.wnl.0000238514.51747.3a; Ong HL, 2007, J BIOL CHEM, V282, P12176, DOI 10.1074/jbc.M609435200; Pani B, 2008, J BIOL CHEM, V283, P17333, DOI 10.1074/jbc.M800107200; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Pani B, 2012, FRONT BIOSCI-LANDMRK, V17, P805, DOI 10.2741/3958; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Putney JW, 2001, J CELL SCI, V114, P2223; Restrepo BI, 2001, INFECT IMMUN, V69, P4554, DOI 10.1128/IAI.69.7.4554-4560.2001; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Robinson P, 1997, INFECT IMMUN, V65, P2925, DOI 10.1128/IAI.65.7.2925-2931.1997; Sciutto E, 2007, PARASITE IMMUNOL, V29, P621, DOI 10.1111/j.1365-3024.2007.00967.x; SCIUTTO E, 1995, INFECT IMMUN, V63, P2277, DOI 10.1128/IAI.63.6.2277-2281.1995; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Singh BB, 2001, FASEB J, V15, P1652, DOI 10.1096/fj.00-0749fje; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Terrazas LI, 2008, CURR TOP MED CHEM, V8, P383, DOI 10.2174/156802608783790848; Weinstock JV, 2006, ANN NY ACAD SCI, V1072, P356, DOI 10.1196/annals.1326.033; White AC, 1997, CHEM IMMUNOL, V66, P209; White AC, 2000, ANNU REV MED, V51, P187, DOI 10.1146/annurev.med.51.1.187; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003	69	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101023	10.1371/journal.pone.0101023	http://dx.doi.org/10.1371/journal.pone.0101023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013939	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400016
J	De Preester, H; Tsakiris, M				De Preester, Helena; Tsakiris, Manos			Sensitivity to Differences in the Motor Origin of Drawings: From Human to Robot	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; IMPLIED MOTION; PERCEPTION; BRAIN; INVOLVEMENT; MECHANISMS; IMITATION; CORTEX; ART	This study explores the idea that an observer is sensitive to differences in the static traces of drawings that are due to differences in motor origin. In particular, our aim was to test if an observer is able to discriminate between drawings made by a robot and by a human in the case where the drawings contain salient kinematic cues for discrimination and in the case where the drawings only contain more subtle kinematic cues. We hypothesized that participants would be able to correctly attribute the drawing to a human or a robot origin when salient kinematic cues are present. In addition, our study shows that observers are also able to detect the producer behind the drawings in the absence of these salient kinematic cues. The design was such that in the absence of salient kinematic cues, the drawings are visually very similar, i.e. only differing in subtle kinematic differences. Observers thus had to rely on these subtle kinematic differences in the line trajectories between drawings. However, not only motor origin (human versus robot) but also motor style (natural versus mechanic) plays a role in attributing a drawing to the correct producer, because participants scored less high when the human hand draws in a relatively mechanical way. Overall, this study suggests that observers are sensitive to subtle kinematic differences between visually similar marks in drawings that have a different motor origin. We offer some possible interpretations inspired by the idea of "motor resonance''.	[De Preester, Helena] Univ Ghent, Univ Coll Ghent, Sch Arts, B-9000 Ghent, Belgium; [De Preester, Helena] Univ Ghent, Dept Philosophy & Moral Sci, B-9000 Ghent, Belgium; [Tsakiris, Manos] Univ London, Dept Psychol, London, England	Ghent University; HOGENT University College of Applied Sciences & Arts; Ghent University; University of London	De Preester, H (corresponding author), Univ Ghent, Univ Coll Ghent, Sch Arts, B-9000 Ghent, Belgium.	helena.depreester@ugent.be	De Preester, Helena/AAQ-2629-2020; TSAKIRIS, MANOS/C-1529-2008	TSAKIRIS, MANOS/0000-0001-7753-7576	University College Ghent (Belgium); Volkswagen Foundation	University College Ghent (Belgium); Volkswagen Foundation(Volkswagen)	This study was funded by the Research Fund of University College Ghent (Belgium) to HDP and European Platform for Life Sciences, Mind Sciences and Humanities of the Volkswagen Foundation to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00079; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; Bull George, 1987, LIVES ARTISTS, VI; Calvo-Merino B, 2008, CONSCIOUS COGN, V17, P911, DOI 10.1016/j.concog.2007.11.003; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Freud Sigmund., 1919, STANDARD EDITION, P217; Gallagher S., 2005, BODY SHAPES MIND; Galle J, 2011, POETISCHE MACHINE AR; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; GALLESE V., 2011, ARTS SENSES, P455; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jentsch Ernst, 1997, ANGELAKI, P7, DOI DOI 10.1080/09697259708571910; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kim CY, 2007, SPATIAL VISION, V20, P545, DOI 10.1163/156856807782758395; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; Longcamp M, 2006, NEUROIMAGE, V33, P681, DOI 10.1016/j.neuroimage.2006.06.042; Longcamp M, 2005, NEUROPSYCHOLOGIA, V43, P1801, DOI 10.1016/j.neuropsychologia.2005.01.020; Longcamp M, 2008, J COGNITIVE NEUROSCI, V20, P802, DOI 10.1162/jocn.2008.20504; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Osaka N, 2010, NEUROREPORT, V21, P264, DOI 10.1097/WNR.0b013e328335b371; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rosand D, 2002, DRAWING ACTS STUDIES, pxii; Rosand David, 2013, MOVING IMAGINATION M, P205; Saygin AP, 2012, SOC COGN AFFECT NEUR, V7, P413, DOI 10.1093/scan/nsr025; Sheets-Johnstone Maxine, 2013, MOVING IMAGINATION E, P19; Sofia Gabriele, 2013, MOVING IMAGINATION E, P69; Umilta A, 2012, PROSPETTIVE TEATRO N, P51; Umilta A, 2012, FRONTIERS NEUROSCIEN, DOI [10.3389/fnhum.2012.00311, DOI 10.3389/FNHUM.2012.00311]; Varela F.J., 1992, EMBODIED MIND COGNIT; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102318	10.1371/journal.pone.0102318	http://dx.doi.org/10.1371/journal.pone.0102318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014198	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400087
J	Song, Y; Zhan, L; Yu, MZ; Huang, C; Meng, XM; Ma, TT; Zhang, L; Li, J				Song, Yang; Zhan, Lei; Yu, Mingzhe; Huang, Cheng; Meng, Xiaoming; Ma, Taotao; Zhang, Lei; Li, Jun			TRPV4 Channel Inhibits TGF-beta 1-Induced Proliferation of Hepatic Stellate Cells	PLOS ONE			English	Article							CARDIAC FIBROBLAST DIFFERENTIATION; LIVER FIBROSIS; MICRORNAS; DISEASE; MECHANISMS; FIBROGENESIS; MIGRATION; MICE	TRPV4, one of the TRP channels, is implicated in diverse physiological and pathological processes including cell proliferation. However, the role of TRPV4 in liver fibrosis is largely unknown. Here, we characterized the role of TRPV4 in regulating HSC-T6 cell proliferation. TRPV4 mRNA and protein were measured by RT-PCR and Western blot in patients and rat model of liver fibrosis in vivo and TGF-beta 1-activated HSC-T6 cells in vitro. Both mRNA and protein of TRPV4 were dramatically increased in liver fibrotic tissues of both patients and CCl4-treated rats. Stimulation of HSC-T6 cells with TGF-beta 1 resulted in increase of TRPV4 mRNA and protein. However, TGF-beta 1-induced HSC-T6 cell proliferation was inhibited by Ruthenium Red (Ru) or synthetic siRNA targeting TRPV4, and this was accompanied by downregulation of myofibroblast markers including alpha-SMA and Col1 alpha 1. Moreover, our study revealed that miR-203 was downregulated in liver fibrotic tissues and TGF-beta 1-treated HSC-T6 cell. Bioinformatics analyses predict that TRPV4 is the potential target of miR-203. In addition, overexpression of miR-203 in TGF-beta 1-induced HSC significantly reduced TRPV4 expression, indicating TRPV4, which was regulated by miR-203, may function as a novel regulator to modulate TGF-beta 1-induced HSC-T6 proliferation.	[Song, Yang; Zhan, Lei; Yu, Mingzhe; Huang, Cheng; Meng, Xiaoming; Ma, Taotao; Zhang, Lei; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei, Peoples R China; [Song, Yang; Zhan, Lei; Yu, Mingzhe; Huang, Cheng; Meng, Xiaoming; Ma, Taotao; Zhang, Lei; Li, Jun] Anhui Med Univ, Inst Liver Dis, Hefei, Peoples R China; [Song, Yang] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Peoples R China.	lj@ahmu.edu.cn			National Science Foundation of China [81072686, 81273526, 81202978]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Science Foundation of China (NO 81072686, 81273526, 81202978) and publication fees were covered by NSFC (NO 81273526). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Chun JN, 2013, PFLUGERS ARCH; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fang L, 2013, TOXICOL APPL PHARM, V272, P713, DOI 10.1016/j.taap.2013.08.009; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Hatano N, 2013, LIFE SCI, V92, P317, DOI 10.1016/j.lfs.2013.01.002; He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023; He Y, 2012, CELL SIGNAL, V24, P1923, DOI 10.1016/j.cellsig.2012.06.003; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hu F, 2012, ARCH ORAL BIOL; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Jordt S. E., 2007, V45, P253; Lafyatis Robert, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P395; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Liu H, 2012, LIFE SCI, V90, P612, DOI 10.1016/j.lfs.2012.02.012; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Sun X, 2013, CELL SIGNAL, V25, P1870, DOI 10.1016/j.cellsig.2013.05.013; Thodeti CK, 2013, CHANNELS, V7, P211, DOI 10.4161/chan.24328; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Troidl C, 2009, J CELL MOL MED, V13, P2613, DOI 10.1111/j.1582-4934.2008.00579.x; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Zaninetti R, 2011, J NEUROCHEM, V116, P606, DOI 10.1111/j.1471-4159.2010.07144.x	31	28	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101179	10.1371/journal.pone.0101179	http://dx.doi.org/10.1371/journal.pone.0101179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013893	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400020
J	Zanetti, M; Zenti, M; Barazzoni, R; Zardi, F; Semolic, A; Messa, MG; Mearelli, F; Russi, G; Fonda, M; Scarano, L; Bonora, E; Cattin, L				Zanetti, Michela; Zenti, Mariagrazia; Barazzoni, Rocco; Zardi, Federica; Semolic, Annamaria; Messa, Michele Giuseppe; Mearelli, Filippo; Russi, Gianpaolo; Fonda, Maurizio; Scarano, Luca; Bonora, Enzo; Cattin, Luigi			HELP LDL Apheresis Reduces Plasma Pentraxin 3 in Familial Hypercholesterolemia	PLOS ONE			English	Article							DENSITY LIPOPROTEIN-APHERESIS; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; ENDOTHELIAL-CELLS; PTX3; ATHEROSCLEROSIS; INFLAMMATION; CHOLESTEROL; EXPRESSION; CHILDREN	Background: Pentraxin 3 (PTX3), a key component of the humoral arm of innate immunity, is secreted by vascular cells in response to injury, possibly aiming at tuning arterial activation associated with vascular damage. Severe hypercholesterolemia as in familial hypercholesterolemia (FH) promotes vascular inflammation and atherosclerosis; low-density lipoprotein (LDL) apheresis is currently the treatment of choice to reduce plasma lipids in FH. HELP LDL apheresis affects pro-and antiinflammatory biomarkers, however its effects on PTX3 levels are unknown. We assessed the impact of FH and of LDL removal by HELP apheresis on PTX3. Methods: Plasma lipids, PTX3, and CRP were measured in 19 patients with FH undergoing chronic HELP LDL apheresis before and after treatment and in 20 control subjects. In the patients assessment of inflammation and oxidative stress markers included also plasma TNF alpha, fibrinogen and TBARS. Results: At baseline, FH patients had higher (p = 0.0002) plasma PTX3 than matched control subjects. In FH PTX3 correlated positively (p <= 0.05) with age, gender and CRP and negatively (p = 0.01) with HELP LDL apheresis vintage. The latter association was confirmed after correction for age, gender and CRP. HELP LDL apheresis acutely reduced (p <= 0.04) plasma PTX3, CRP, fibrinogen, TBARS and lipids, but not TNF alpha. No association was observed between mean decrease in PTX3 and in LDL cholesterol. PTX3 paralleled lipids, oxidative stress and inflammation markers in time-course study. Conclusion: FH is associated with increased plasma PTX3, which is acutely reduced by HELP LDL apheresis independently of LDL cholesterol, as reflected by the lack of association between change in PTX3 and in LDL levels. These results, together with the finding of a negative relationship between PTX3 and duration of treatment suggest that HELP LDL apheresis may influence both acutely and chronically cardiovascular outcomes in FH by modulating PTX3.	[Zanetti, Michela; Barazzoni, Rocco; Semolic, Annamaria; Mearelli, Filippo] Univ Trieste, Med Clin, Dept Med Surg & Hlth Sci, Trieste, Italy; [Zenti, Mariagrazia; Zardi, Federica; Messa, Michele Giuseppe; Bonora, Enzo] Univ Verona, I-37100 Verona, Italy; [Zenti, Mariagrazia; Zardi, Federica; Messa, Michele Giuseppe; Bonora, Enzo] Azienda Osped Univ Integrata Verona, Verona, Italy; [Fonda, Maurizio; Cattin, Luigi] Univ Trieste, Dept Med Surg & Hlth Sci, Diabet & Metab Dis Unit, Trieste, Italy; [Russi, Gianpaolo; Scarano, Luca] Osped Santa Maria Nuova, Immunohematol & Transfus Unit, Reggio Emilia, Italy	University of Trieste; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Trieste; IRCCS Arcispedale S. Maria Nuova	Zanetti, M (corresponding author), Univ Trieste, Med Clin, Dept Med Surg & Hlth Sci, Trieste, Italy.	zanetti@units.it	Bonora, Enzo/AAA-5300-2022	BONORA, Enzo/0000-0003-1074-5164; ZANETTI, MICHELA/0000-0002-2634-6363; Mearelli, Filippo/0000-0002-5862-9077	Regione FVG [LR26/2005]	Regione FVG(Regione Friuli Venezia Giulia)	Funding provided by Grant LR26/2005, Regione FVG to L. Cattin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Bambauer R, 2012, SCI WORLD J, DOI 10.1100/2012/314283; Banerjee S, 2014, J CLIN APHERESIS, V29, P97, DOI 10.1002/jca.21298; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; Bondarenko S, 2014, J INNATE IMMUN, V6, P3, DOI 10.1159/000351034; Bosutti A, 2007, CLIN EXP MED, V7, P16, DOI 10.1007/s10238-007-0118-y; Cattin L, 1997, ASAIO J, V43, P209; Charakida M, 2009, ATHEROSCLEROSIS, V204, P532, DOI 10.1016/j.atherosclerosis.2008.09.025; El Messal M, 2006, CLIN CHIM ACTA, V366, P185, DOI 10.1016/j.cca.2005.09.027; Garlanda C, 2011, CURR PHARM DESIGN, V17, P38, DOI 10.2174/138161211795049750; Hemphill LC, 2010, J CLIN LIPIDOL, V4, P346, DOI 10.1016/j.jacl.2010.08.013; Hovland A, 2012, SCAND J IMMUNOL, V76, P229, DOI 10.1111/j.1365-3083.2012.02734.x; Iwata A, 2012, CORONARY ARTERY DIS, V23, P315, DOI 10.1097/MCA.0b013e328352ffec; Jylhava J, 2011, CLIN EXP IMMUNOL, V164, P211, DOI 10.1111/j.1365-2249.2011.04354.x; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Karakas MF, 2013, J INVEST MED, V61, P278, DOI 10.2310/JIM.0b013e31827c2971; Knoflach M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031474; Koga N, 1999, J INTERN MED, V246, P35, DOI 10.1046/j.1365-2796.1999.00466.x; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Leren TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016721; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Matsuzaki M, 2002, J AM COLL CARDIOL, V40, P220, DOI 10.1016/S0735-1097(02)01955-1; McGowan MP, 2013, J CLIN LIPIDOL, V7, pS21, DOI 10.1016/j.jacl.2013.03.002; Mellwig KP, 2012, CLIN RES CARDIOL S7, V7, pS45; Moriarty PM, 2001, ATHEROSCLEROSIS, V158, P495, DOI 10.1016/S0021-9150(01)00633-5; Narverud I, 2011, ATHEROSCLEROSIS, V214, P163, DOI 10.1016/j.atherosclerosis.2010.10.002; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Ohbayashi H, 2009, J ATHEROSCLER THROMB, V16, P490, DOI 10.5551/jat.No613; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Schaumann D, 1996, EUR J CLIN INVEST, V26, P1033, DOI 10.1046/j.1365-2362.1996.2320587.x; Suzuki M, 1996, ARTIF ORGANS, V20, P296, DOI 10.1111/j.1525-1594.1996.tb04448.x; van Buuren Frank, 2012, Clin Res Cardiol Suppl, V7, P24; Wang Y, 2004, ATHEROSCLEROSIS, V175, P145, DOI 10.1016/j.atherosclerosis.2004.03.011; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110	35	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101290	10.1371/journal.pone.0101290	http://dx.doi.org/10.1371/journal.pone.0101290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014007	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400023
J	Argento, E; Muldoon, KA; Duff, P; Simo, A; Deering, KN; Shannon, K				Argento, Elena; Muldoon, Katherine A.; Duff, Putu; Simo, Annick; Deering, Kathleen N.; Shannon, Kate			High Prevalence and Partner Correlates of Physical and Sexual Violence by Intimate Partners among Street and Off-Street Sex Workers	PLOS ONE			English	Article							REPRODUCTIVE HEALTH OUTCOMES; HIV RISK; DOMESTIC VIOLENCE; WOMENS HEALTH; ABUSE; REVICTIMIZATION; CANADA; BARRIER; COHORT; INDIA	Objectives: Intimate partner violence (IPV) is associated with increased risk of HIV among women globally. There is limited evidence and understanding about IPV and potential HIV risk pathways among sex workers (SWs). This study aims to longitudinally evaluate prevalence and correlates of IPV among street and off-street SWs over two-years follow-up. Methods: Longitudinal data were drawn from an open prospective cohort, AESHA (An Evaluation of Sex Workers Health Access) in Metro Vancouver, Canada (2010-2012). Prevalence of physical and sexual IPV was measured using the WHO standardized IPV scale (version 9.9). Bivariate and multivariable logistic regression using Generalized Estimating Equations (GEE) were used to examine interpersonal and structural correlates of IPV over two years. Results: At baseline, 387 SWs had a male, intimate sexual partner and were eligible for this analysis. One-fifth (n = 83, 21.5%) experienced recent physical/sexual IPV at baseline and 26.2% over two-years follow-up. In multivariable GEE analysis, factors independently correlated with physical/sexual IPV in the last six months include: childhood (<18 years) sexual/physical abuse (adjusted odds ratio [AOR] = 2.05, 95% confidence interval [CI]: 1.14-3.69), inconsistent condom use for vaginal and/or anal sex with intimate partner (AOR = 1.84, 95% CI: 1.07-3.16),, daily prescription opioid use (AOR = 1.72, 95% CI: 1.02-2.89), providing financial support to intimate partner (AOR = 1.65, 95% CI: 1.05-2.59), and sourcing drugs from intimate partner (AOR = 1.62, 95% CI: 1.02-2.26). Discussion: Our results demonstrate that over one-fifth of SWs in Vancouver report physical/sexual IPV in the last six months. The socio-structural correlates of IPV uncovered here highlight potential HIV risk pathways through SWs' intimate, non-commercial partner relationships. The high prevalence of IPV among SWs is a critical public health concern and underscores the need for integrated violence and HIV prevention and intervention strategies tailored to this key population.	[Argento, Elena; Duff, Putu; Simo, Annick; Deering, Kathleen N.; Shannon, Kate] British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada; [Muldoon, Katherine A.; Duff, Putu; Shannon, Kate] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Deering, Kathleen N.; Shannon, Kate] Univ British Columbia, Dept Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia	Shannon, K (corresponding author), British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada.	gshi@cfenet.ubc.ca	Muldoon, Katherine/AAC-4703-2021	Muldoon, Katherine/0000-0002-0766-4294	United States National Institutes of Health [R01DA028648]; Canadian Institutes of Health Research [HHP-98835]; U.S. National Institutes of Health [R01DA028648]; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028648] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by operating grants from the United States National Institutes of Health (R01DA028648) and Canadian Institutes of Health Research (HHP-98835). KS is supported by U.S. National Institutes of Health (R01DA028648), Canadian Institutes of Health Research and Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Benoit C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-76; Black M.C., 2011, NATL INTIMATE PARTNE; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; Clark JP, 2003, CAN J PUBLIC HEALTH, V94, P52, DOI 10.1007/BF03405053; Decker MR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-876; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Deering KN, 2013, JAIDS-J ACQ IMM DEF, V63, P522, DOI 10.1097/QAI.0b013e3182968d39; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; Deering KN, 2010, GLOBAL REV GENDER BA; Deribe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036189; Duff P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-643; Duff P, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-61; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Eggertson L, 2013, CAN MED ASSOC J, V185, pE743, DOI 10.1503/cmaj.109-4609; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Field NP, 2001, J ANXIETY DISORD, V15, P459, DOI 10.1016/S0887-6185(01)00076-7; Fischer B, 2012, PAIN PHYSICIAN, V15, pES191; Garcia-Moreno C., 2005, GENDER WOMEN HLTH WH; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; IASC, 2015, GUID INT GEND BAS VI; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kimerling R, 2007, WOMEN HEALTH ISS, V17, P101, DOI 10.1016/j.whi.2006.12.002; Kouyoumdjian FG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-566; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; Lazarus L, 2011, SOC SCI MED, V73, P1600, DOI 10.1016/j.socscimed.2011.09.015; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Maher Lisa, 1997, SEXED WORK GENDER RA; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; McFarlane J, 2005, OBSTET GYNECOL, V105, P99, DOI 10.1097/01.AOG.0000146641.98665.b6; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Noll JG, 2003, J INTERPERS VIOLENCE, V18, P1452, DOI 10.1177/0886260503258035; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Ramachandran DV, 2013, J COMMUN HEALTH, V38, P856, DOI 10.1007/s10900-013-9690-0; Navarro JR, 2012, REV PANAM SALUD PUBL, V31, P388, DOI 10.1590/S1020-49892012000500006; Romans S, 2007, J INTERPERS VIOLENCE, V22, P1495, DOI 10.1177/0886260507306566; Roodman AA, 2001, CLIN PSYCHOL REV, V21, P183, DOI 10.1016/S0272-7358(99)00045-8; Sanders T, 2002, FEM PSYCHOL, V12, P561, DOI 10.1177/0959353502012004016; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Silverman ME, 2010, ARCH WOMEN MENT HLTH, V13, P411, DOI 10.1007/s00737-010-0161-7; Stockman JK, 2013, AIDS BEHAV, V17, P832, DOI 10.1007/s10461-012-0361-4; Stoltz JAM, 2007, SOC SCI MED, V65, P1214, DOI 10.1016/j.socscimed.2007.05.005; Strathdee SA, 1997, ADDICTION, V92, P1339, DOI 10.1046/j.1360-0443.1997.9210133910.x; Swain SN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-357; Ulibarri MD, 2010, PSYCHOL TRAUMA-US, V2, P318, DOI 10.1037/a0017500; United Nations General Assembly, 2006, DEPTH STUD ALL FORM; United Nations Women, 2012, GEND ISS VIOL WOM; Van Oudenhove L, 2011, NEUROGASTROENT MOTIL, V23, P524, DOI 10.1111/j.1365-2982.2010.01667.x; Warr DJ, 1999, SOCIOL HEALTH ILL, V21, P290, DOI 10.1111/1467-9566.00157; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization Joint United Nations Programme on HIV/AIDS, 2010, ADDR VIOL WOM HIV AI; Zolotor AJ, 2009, PRIMARY CARE, V36, P167, DOI 10.1016/j.pop.2008.10.010	62	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102129	10.1371/journal.pone.0102129	http://dx.doi.org/10.1371/journal.pone.0102129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010362	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800073
J	Pravetoni, M; Pentel, PR; Potter, DN; Chartoff, EH; Tally, L; LeSage, MG				Pravetoni, Marco; Pentel, Paul R.; Potter, David N.; Chartoff, Elena H.; Tally, Laura; LeSage, Mark G.			Effects of an Oxycodone Conjugate Vaccine on Oxycodone Self-Administration and Oxycodone-Induced Brain Gene Expression in Rats	PLOS ONE			English	Article							MORPHINE/HEROIN VACCINE; HEROIN; MICE; RELAPSE; HAPTEN; MAINTENANCE; ANTIBODIES; DEPENDENCE; ADDICTION; ABUSE	Prescription opioid abuse is an increasing public health concern in the USA. A vaccine comprising a hapten (OXY) conjugated to the carrier protein keyhole limpet hemocyanin (OXY-KLH) has been shown to attenuate the antinociceptive effects of oxycodone. Here, the vaccine's ability to prevent acquisition of intravenous (i.v.) oxycodone self-administration was studied in rats. Effects of vaccination on oxycodone-induced changes in the expression of several genes within the mesolimbic system, which are regulated by chronic opiate use, were also examined. Vaccination with OXY-KLH reduced the proportion of rats acquiring i.v. self-administration of oxycodone under a fixed ratio (FR) 3 schedule of reinforcement compared to control rats immunized with the unconjugated KLH carrier protein. Vaccination significantly reduced the mean number of infusions at FR3, total number of infusions, and total oxycodone intake during the entire protocol. Compared to oxycodone self-administering control rats immunized with the carrier alone, rats vaccinated with the OXY-KLH immunogen showed increased levels of adenylate cyclase 5 (Adcy5) and decreased levels of early growth response protein 2 (Egr2) and the early immediate gene c-Fos in the striatum. These data suggest that vaccination with OXY-KLH can attenuate the reinforcing effects of oxycodone at a clinically-relevant exposure level. Analysis of mRNA expression identified some addiction-relevant markers that may be of interest in understanding oxycodone effects or the protection provided by vaccination.	[Pravetoni, Marco; Pentel, Paul R.; Tally, Laura; LeSage, Mark G.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA; [Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Potter, David N.; Chartoff, Elena H.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA	Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; McLean Hospital	Pravetoni, M (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA.	prave001@umn.edu	LeSage, Mark G./AAS-8628-2020	Pravetoni, Marco/0000-0003-1036-0184	NIH [DA026300]; Minneapolis Medical Research Foundation Translational Research Program Award; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026300] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minneapolis Medical Research Foundation Translational Research Program Award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH DA026300 (Pentel) and Minneapolis Medical Research Foundation Translational Research Program Award (Pravetoni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton B, 2006, VACCINE, V24, P3232, DOI 10.1016/j.vaccine.2006.01.047; Beardsley PM, 2004, EXP CLIN PSYCHOPHARM, V12, P163, DOI 10.1037/1064-1297.12.3.163; BERKOWITZ B, 1972, SCIENCE, V178, P1290, DOI 10.1126/science.178.4067.1290; BONESE KF, 1974, NATURE, V252, P708, DOI 10.1038/252708a0; Bremer PT, 2012, J MED CHEM, V55, P10776, DOI 10.1021/jm301262z; Cherrier MM, 2009, J PAIN, V10, P1038, DOI 10.1016/j.jpain.2009.03.017; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dodrill CL, 2011, AM J PSYCHIAT, V168, P466, DOI 10.1176/appi.ajp.2010.10020260; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Hassan HE, 2010, DRUG METAB DISPOS, V38, P157, DOI 10.1124/dmd.109.029199; Kantak KN, 2000, PSYCHOPHARMACOLOGY, V148, P251, DOI 10.1007/s002130050049; Kiraly KP, 2006, BRAIN RES BULL, V70, P233, DOI 10.1016/j.brainresbull.2006.05.005; Kreek MJ, 2002, J SUBST ABUSE TREAT, V23, P93, DOI 10.1016/S0740-5472(02)00259-3; Kuntz KL, 2008, PHARMACOL BIOCHEM BE, V90, P349, DOI 10.1016/j.pbb.2008.03.019; Leri F, 2005, PHARMACOL BIOCHEM BE, V82, P252, DOI 10.1016/j.pbb.2005.08.008; LeSage MG, 2006, PSYCHOPHARMACOLOGY, V184, P409, DOI 10.1007/s00213-005-0027-2; Li QQ, 2011, J NEUROCHEM, V119, P1271, DOI 10.1111/j.1471-4159.2011.07502.x; Mayer-Blackwell B, 2013, NEUROSCIENCE; McMillan DE, 2004, J PHARMACOL EXP THER, V309, P1248, DOI 10.1124/jpet.103.061762; Olesen AE, 2010, CLIN PHARMACOKINET, V49, P817, DOI 10.2165/11536610-000000000-00000; Pravetoni M, 2012, VACCINE, V30, P4617, DOI 10.1016/j.vaccine.2012.04.101; Pravetoni M, 2012, J PHARM EXP THER; Pravetoni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096547; Pravetoni M, 2013, J MED CHEM, V56, P915, DOI 10.1021/jm3013745; Raleigh MD, 2013, J PHARMACOL EXP THER, V344, P397, DOI 10.1124/jpet.112.201194; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Shen XY, 2012, CLIN PHARMACOL THER, V91, P60, DOI 10.1038/clpt.2011.281; Skolnick P, 2012, BIOL PSYCHIAT, V72, P890, DOI 10.1016/j.biopsych.2012.08.004; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Stowe GN, 2011, J MED CHEM, V54, P5195, DOI 10.1021/jm200461m; Taylor JJ, 2014, J IMMUNOL METHODS, V405, P74, DOI 10.1016/j.jim.2014.01.010; WAINER BH, 1972, SCIENCE, V176, P1143, DOI 10.1126/science.176.4039.1143; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Zhang Y, 2013, PSYCHOPHARMACOLOGY B; Zhang Y, 2009, NEUROPSYCHOPHARMACOL, V34, P912, DOI 10.1038/npp.2008.134	35	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101807	10.1371/journal.pone.0101807	http://dx.doi.org/10.1371/journal.pone.0101807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025380	Green Published, gold, Green Submitted			2022-12-27	WOS:000339992400022
J	Schafer, K; Bain, JM; Di Pietro, A; Gow, NAR; Erwig, LP				Schaefer, Katja; Bain, Judith M.; Di Pietro, Antonio; Gow, Neil A. R.; Erwig, Lars P.			Hyphal Growth of Phagocytosed Fusarium oxysporum Causes Cell Lysis and Death of Murine Macrophages	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS CONIDIA; BETA-GLUCAN RECEPTOR; CANDIDA-ALBICANS; MAMMALIAN HOSTS; VIRULENCE; RECOGNITION; INFECTIONS; PATHOGEN; DECTIN-1; ESCAPE	Fusarium oxysporum is an important plant pathogen and an opportunistic pathogen of humans. Here we investigated phagocytosis of F. oxysporum by J774.1 murine cell line macrophages using live cell video microscopy. Macrophages avidly migrated towards F. oxysporum germlings and were rapidly engulfed after cell-cell contact was established. F. oxysporum germlings continued hyphal growth after engulfment by macrophages, leading to associated macrophage lysis and escape. Macrophage killing depended on the multiplicity of infection. After engulfment, F. oxysporum inhibited macrophages from completing mitosis, resulting in large daughter cells fused together by means of a F. oxysporum hypha. These results shed new light on the initial stages of Fusarium infection and the innate immune response of the mammalian host.	[Schaefer, Katja; Di Pietro, Antonio] Univ Cordoba, Dept Genet, Cordoba, Spain; [Bain, Judith M.; Gow, Neil A. R.; Erwig, Lars P.] Univ Aberdeen, Aberdeen Fungal Grp, Inst Med Sci, Aberdeen, Scotland	Universidad de Cordoba; University of Aberdeen	Schafer, K (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.	k_scha11@hotmail.de	Di Pietro, Antonio/K-9220-2014; GOW, Neil/AAS-5323-2021; Schäfer, Katrin/P-4728-2015	Di Pietro, Antonio/0000-0001-5930-5763; GOW, Neil/0000-0002-2776-5850; bain, judith/0000-0002-1060-0419	Marie Curie Initial Training Network ARIADNE [FP7-PEOPLE-ITN-237936]; Spanish Ministerio de Economia y Competitividad (MINECO) [BIO2010-15505]; Wellcome Trust [080088, 086827, 075470, 099215]; Wellcome Trust Strategic Award [097377]; FP7 [HEALTH-F2- 2010-260338-ALLFUN]; Chief Scientist Senior Clinical Fellowship; Chief Scientist Office [SCD/03] Funding Source: researchfish	Marie Curie Initial Training Network ARIADNE; Spanish Ministerio de Economia y Competitividad (MINECO); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Strategic Award(Wellcome Trust); FP7; Chief Scientist Senior Clinical Fellowship; Chief Scientist Office	This work was supported by the following grants: Marie Curie Initial Training Network ARIADNE (FP7-PEOPLE-ITN-237936) to N.A.R.G. and A.D.P.; BIO2010-15505 from the Spanish Ministerio de Economia y Competitividad (MINECO) to A. D. P. Wellcome Trust (080088, 086827, 075470 and 099215) including a Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377 and FP7-2007-2013 grant agreement HEALTH-F2- 2010-260338-ALLFUN to NARG and Chief Scientist Senior Clinical Fellowship to L.P.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Braedel S, 2004, BRIT J HAEMATOL, V125, P392, DOI 10.1111/j.1365-2141.2004.04922.x; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Garcia-Rodas R, 2011, INFECT IMMUN, V79, P2136, DOI 10.1128/IAI.00044-11; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Gow NAR, 2012, NAT REV MICROBIOL; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Keppler-Ross S, 2010, EUKARYOT CELL, V9, P1776, DOI 10.1128/EC.00156-10; Klaas M, 2012, J IMMUNOL, V189, P2414, DOI 10.4049/jimmunol.1200776; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lewis LE, 2012, FUNGAL GENET BIOL, V49, P679, DOI 10.1016/j.fgb.2012.05.007; Lewis LE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002578; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Luo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003219; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Martinez-Rocha AL, 2008, CELL MICROBIOL, V10, P1339, DOI 10.1111/j.1462-5822.2008.01130.x; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591; Nucci M, 2002, CLIN INFECT DIS, V35, P909, DOI 10.1086/342328; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Prados-Rosales RC, 2012, J BIOL CHEM, V287, P21970, DOI 10.1074/jbc.M112.364034; Rudkin FM, 2013, MBIO, V4, DOI 10.1128/mBio.00810-13; Schafer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089920; Sole A, 2005, CLIN MICROBIOL INFEC, V11, P359, DOI 10.1111/j.1469-0691.2005.01128.x; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480	38	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101999	10.1371/journal.pone.0101999	http://dx.doi.org/10.1371/journal.pone.0101999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025395	gold, Green Published			2022-12-27	WOS:000339992400033
J	Liu, SZ; Jiang, LG; Meng, XQ; Han, XY; Cheng, D; Zhang, TL; Miao, YL				Liu, ShuZhen; Jiang, LiGang; Meng, XiaoQian; Han, XiaoYing; Cheng, Dong; Zhang, TianLiang; Miao, YiLiang			Effects of Aroclor 1254 on In Vivo Oocyte Maturation in the Mouse	PLOS ONE			English	Article							POLYCHLORINATED BIPHENYL MIXTURES; PERSISTENT ORGANIC POLLUTANTS; GENE-EXPRESSION; ENVIRONMENTAL CONTAMINANTS; ORGANOCHLORINE COMPOUNDS; REPRODUCTIVE TOXICITY; CUMULUS CELLS; BREAST-MILK; EXPOSURE; PCBS	Polychlorinated biphenyls (PCBs) are stable, lipophilic compounds that accumulate in the environment and in the food chain. Though some studies provided evidence that PCBs had adverse effects on reproductive function, most of these results were from in vitro models. Therefore we investigated the effect of Aroclor 1254 (a commercial PCBs mixture) treatments on in vivo maturation and developmental potential of mouse oocytes. In the present study, female ICR mice were treated with different doses (12.5, 25 and 50 mg/kg) of Aroclor 1254 (a commercial PCB mixture) once every 72 hours by intraperitoneal injection for 9 days. After three treatments of Aroclor 1254, the mice were superovulated to collect oocytes one day after the last exposure. The effects of Aroclor 1254 on oocyte maturation, fertilization, and preimplantation embryonic development were investigated. Immunofluorescence-stained oocytes were observed under a confocal microscope to assess the effects of Aroclor 1254 on spindle morphology. Parthenogenic activation and the incidence of cumulus apoptosis in cumulus-oocyte complexes were observed as well. Oocytes exposed to different doses of Aroclor 1254 in vivo were associated with a significant decrease in outgrowth potential, abnormal spindle configurations, and the inhibition of parthenogenetic activation of ovulated oocytes. Furthermore, the incidence of apoptosis in cumulus cells was increased after exposed to Aroclor 1254. These results may provide reference for the treatment of reproductive diseases such as infertility or miscarriage caused by environmental contaminants.	[Liu, ShuZhen; Meng, XiaoQian; Han, XiaoYing] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China; [Jiang, LiGang] Shandong Univ, Ctr Reprod Med, Qilu Hosp, Jinan 250100, Peoples R China; [Cheng, Dong; Zhang, TianLiang] Shandong Ctr Dis Control & Prevent, Dept Toxicol, Jinan, Peoples R China; [Miao, YiLiang] Huazhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Shandong Normal University; Shandong University; Huazhong Agricultural University	Liu, SZ (corresponding author), Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China.	shuzhen26@163.com			National Nature Science Foundation of China [31101068]; Shandong Province Postdoctoral Innovation Project [201103102]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Postdoctoral Innovation Project	This study was supported by the National Nature Science Foundation of China (number 31101068) and Shandong Province Postdoctoral Innovation Project (number 201103102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini David F, 2003, Reprod Biomed Online, V6, P410; Arena SM, 2003, ARCH ENVIRON CON TOX, V44, P272, DOI 10.1007/s00244-002-2022-5; Bake MA, 2007, INT J HYG ENVIR HEAL, V210, P483, DOI 10.1016/j.ijheh.2007.01.016; BERGMAN A, 1994, ENVIRON HEALTH PERSP, V102, P464, DOI 10.2307/3432042; Brevini T, 2009, EUR J HISTOCHEM, V48, P347; Cai JL, 2011, TOXICOLOGY, V287, P21, DOI 10.1016/j.tox.2011.05.010; Campagna C, 2006, MOL REPROD DEV, V73, P83, DOI 10.1002/mrd.20365; Czaja K, 1999, ARCH ENVIRON CON TOX, V36, P498, DOI 10.1007/PL00006623; De Felip E, 2004, CHEMOSPHERE, V54, P1445, DOI 10.1016/j.chemosphere.2003.10.040; DUARTEDAVIDSON R, 1994, ENVIRON POLLUT, V84, P69, DOI 10.1016/0269-7491(94)90072-8; Foster W, 2000, J CLIN ENDOCR METAB, V85, P2954, DOI 10.1210/jc.85.8.2954; Frame GM, 1996, CHEMOSPHERE, V33, P603, DOI 10.1016/0045-6535(96)00214-7; Fromberg A, 1999, CHEMOSPHERE, V38, P3075, DOI 10.1016/S0045-6535(98)00514-1; Guillette LJ, 1999, ARCH ENVIRON CON TOX, V36, P447, DOI 10.1007/PL00006617; Kato Y, 2009, DRUG METAB DISPOS, V38, P697; Katz-Jaffe MG, 2009, THERIOGENOLOGY, V71, P939, DOI 10.1016/j.theriogenology.2008.10.024; KHOLKUTE SD, 1994, REPROD TOXICOL, V8, P487, DOI 10.1016/0890-6238(94)90031-0; Kietz S, 2003, MOL REPROD DEV, V64, P251, DOI 10.1002/mrd.10226; KIMBROUGH RD, 1995, CRIT REV TOXICOL, V25, P133, DOI 10.3109/10408449509021611; Kostyniak PJ, 1999, ENVIRON RES, V80, pS166, DOI 10.1006/enrs.1998.3939; Kruger N, 2008, CURR BIOL, V18, pR646, DOI 10.1016/j.cub.2008.06.069; Ma SF, 2005, THERIOGENOLOGY, V64, P1142, DOI 10.1016/j.theriogenology.2005.03.002; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Meo SC, 2005, THERIOGENOLOGY, V63, P2089, DOI 10.1016/j.theriogenology.2004.08.012; Miao YL, 2007, THERIOGENOLOGY, V68, P640, DOI 10.1016/j.theriogenology.2007.04.061; Miao YL, 2009, ENVIRON MOL MUTAGEN, V50, P666, DOI 10.1002/em.20506; Mori T, 2000, BIOL REPROD, V62, P913, DOI 10.1095/biolreprod62.4.913; Norstrom K, 2010, ENVIRON INT, V36, P855, DOI 10.1016/j.envint.2009.03.005; Olivero J, 2001, BIOCHEM PHARMACOL, V62, P1125, DOI 10.1016/S0006-2952(01)00768-7; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Pauwels A, 2000, ENVIRON HEALTH PERSP, V108, P553, DOI 10.1289/ehp.00108553; Pocar P, 2005, REPRODUCTION, V130, P857, DOI 10.1530/rep.1.00761; Pocar P, 2001, MOL REPROD DEV, V58, P411, DOI 10.1002/1098-2795(20010401)58:4&lt;411::AID-MRD8&gt;3.0.CO;2-R; Pocar P, 2006, REPROD TOXICOL, V22, P242, DOI 10.1016/j.reprotox.2006.04.023; Ptak G, 2012, HUM REPROD, V27, P1034, DOI 10.1093/humrep/der454; Ramos L, 1999, CHEMOSPHERE, V38, P3141, DOI 10.1016/S0045-6535(98)00521-9; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Segre M, 2002, TOXICOLOGY, V174, P163, DOI 10.1016/S0300-483X(02)00039-2; SIMMONS GJ, 1992, FUND APPL TOXICOL, V19, P446, DOI 10.1016/0272-0590(92)90184-J; Stack AS, 1999, TOXICOLOGY, V139, P137; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; TRAPP M, 1984, FERTIL STERIL, V42, P146; Van Emon JM, 2013, SCI TOTAL ENVIRON, V463, P326, DOI 10.1016/j.scitotenv.2013.05.020; van Woudenberg AB, 2012, REPROD TOXICOL, V34, P251, DOI 10.1016/j.reprotox.2012.05.098; Wang Wei-Hua, 2002, Cloning and Stem Cells, V4, P269, DOI 10.1089/15362300260339557; Xia L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023996; Younglai EV, 2002, ARCH ENVIRON CON TOX, V43, P121, DOI 10.1007/s00244-001-0048-8; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102064	10.1371/journal.pone.0102064	http://dx.doi.org/10.1371/journal.pone.0102064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013911	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400060
J	Zhao, HS; Wang, LL; Dong, LL; Sun, HY; Gao, ZM				Zhao, Hansheng; Wang, Lili; Dong, Lili; Sun, Huayu; Gao, Zhimin			Discovery and Comparative Profiling of microRNAs in Representative Monopodial Bamboo (Phyllostachys edulis) and Sympodial Bamboo (Dendrocalamus latiflorus)	PLOS ONE			English	Article							SBP-BOX GENE; TARGET GENES; CDNA LIBRARY; MOSO BAMBOO; SMALL RNAS; ARABIDOPSIS; EVOLUTION; IDENTIFICATION; PLANT; SEQUENCES	Background: According to the growth pattern of bamboo, sympodial bamboo and monopodial bamboo are considered as two mainly kinds of bamboo. They have different phenotypes and different characteristics in developmental stage. Much attention had been paid on the study of bamboo cultivation, processing, physiology, biochemistry and molecular biology, which had made great progresses in the last decade, especially for the highlighted achievement of the bamboo genomics. However, there is no information available on concerning comparative profiling of miRNAs between sympodial bamboo and monopodial bamboo, which might play important roles in the regulation of bamboo development. Methodology/Principal Findings: We identified the profiles of small RNAs using leaf tissues from one sympodial bamboo i.e. moso bamboo (Phyllostachys edulis) and another monopodial bamboo i. e. mabamboo (Dendrocalamus latiflorus). The result showed that there were 19,295,759 and 11,513,888 raw sequence reads, in which 92 and 69 conserved miRNAs, as well as 95 and 62 novel miRNAs were identified in moso bamboo and ma bamboo, respectively. The ratio of high conserved miRNA families in ma bamboo is more than that in moso bamboo. In addition, a total of 49 and 106 potential targets were predicted in moso bamboo and ma bamboo, respectively, in which several targets for novel miRNAs are transcription factors that play important roles in plant development. More importantly, annotation of differentially expressed target genes was performed based on the analysis of pathway and gene ontology terms enrichment. Conclusions/Significance: This study provides the first large-scale sight of discovery and comparative characterization of miRNAomes between two representative bamboos belonged to sympodial bamboo and monopodial bamboo, respectively. Although it will be necessary to validate the function of miRNAs through more experimental research in further, these results lay a foundation for unraveling the miRNA-mediated molecular processes in different kinds of bamboo.	[Zhao, Hansheng; Wang, Lili; Dong, Lili; Sun, Huayu; Gao, Zhimin] Int Ctr Bamboo & Rattan, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China	International Centre for Bamboo & Rattan	Gao, ZM (corresponding author), Int Ctr Bamboo & Rattan, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China.	gaozhimin@icbr.ac.cn	zhao, hansheng/GRS-2764-2022; wang, lili/HDL-7210-2022		State Forestry Administration of China [2011-4-55]; International Center for Bamboo and Rattan [1632013009]	State Forestry Administration of China; International Center for Bamboo and Rattan	This work was financially supported under the introduction project of "948'' by the State Forestry Administration of China (No. 2011-4-55) and the fundamental research fund of International Center for Bamboo and Rattan (No. 1632013009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Arteaga-Vazquez M, 2006, PLANT CELL, V18, P3355, DOI 10.1105/tpc.106.044420; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gao ZM, 2011, PLANT CELL REP, V30, P2045, DOI 10.1007/s00299-011-1112-0; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Han JG, 2009, MICROB ECOL, V58, P363, DOI 10.1007/s00248-009-9491-2; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; Hou HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059358; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobovikov M., 2007, FOOD AGR ORG; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Ruiyang Chen, 2003, CHROMSOME ATLAS VARI, VIV; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Tang GL, 2010, SEMIN CELL DEV BIOL, V21, P782, DOI 10.1016/j.semcdb.2010.07.009; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Wei Qiang, 2013, Yichuan, V35, P315, DOI 10.3724/SP.J.1005.2013.00315; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057863; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6; Zhao HS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau006; Zhao HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078755; Zhou Ben-zhi, 2005, Journal of Forestry Research (Harbin), V16, P143, DOI 10.1007/BF02857909	44	9	15	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102375	10.1371/journal.pone.0102375	http://dx.doi.org/10.1371/journal.pone.0102375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013900	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400091
J	Afonso, AS; Andrade, HA; Hazin, FHV				Afonso, Andre S.; Andrade, Humber A.; Hazin, Fabio H. V.			Structure and Dynamics of the Shark Assemblage off Recife, Northeastern Brazil	PLOS ONE			English	Article							JUVENILE SANDBAR SHARKS; GALEOCERDO-CUVIER; TIGER SHARKS; RELATIVE ABUNDANCE; ENVIRONMENTAL VARIABLES; NEGAPRION-BREVIROSTRIS; GINGLYMOSTOMA CIRRATUM; CARCHARHINUS-ACRONOTUS; TRIAKIS-SEMIFASCIATA; POPULATION-STRUCTURE	Understanding the ecological factors that regulate elasmobranch abundance in nearshore waters is essential to effectively manage coastal ecosystems and promote conservation. However, little is known about elasmobranch populations in the western South Atlantic Ocean. An 8-year, standardized longline and drumline survey conducted in nearshore waters off Recife, northeastern Brazil, allowed us to describe the shark assemblage and to monitor abundance dynamics using zero-inflated generalized additive models. This region is mostly used by several carcharhinids and one ginglymostomid, but sphyrnids are also present. Blacknose sharks, Carcharhinus acronotus, were mostly mature individuals and declined in abundance throughout the survey, contrasting with nurse sharks, Ginglymostoma cirratum, which proliferated possibly due to this species being prohibited from all harvest since 2004 in this region. Tiger sharks, Galeocerdo cuvier, were mostly juveniles smaller than 200 cm and seem to use nearshore waters off Recife between January and September. No long-term trend in tiger shark abundance was discernible. Spatial distribution was similar in true coastal species (i.e. blacknose and nurse sharks) whereas tiger sharks were most abundant at the middle continental shelf. The sea surface temperature, tidal amplitude, wind direction, water turbidity, and pluviosity were all selected to predict shark abundance off Recife. Interspecific variability in abundance dynamics across spatiotemporal and environmental gradients suggest that the ecological processes regulating shark abundance are generally independent between species, which could add complexity to multi-species fisheries management frameworks. Yet, further research is warranted to ascertain trends at population levels in the South Atlantic Ocean.	[Afonso, Andre S.; Andrade, Humber A.; Hazin, Fabio H. V.] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Afonso, Andre S.] Univ Algarve, Fac Ciencias & Tecnol, Faro, Portugal	Universidade Federal Rural de Pernambuco (UFRPE); Universidade do Algarve	Afonso, AS (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil.	afonso.andre@gmail.com		Afonso, Andre/0000-0001-9129-278X; Hazin, Fabio/0000-0003-3755-5379	State Government of Pernambuco, Brazil; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/37065/2007]	State Government of Pernambuco, Brazil; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Financial support was obtained from the State Government of Pernambuco (www.sds.pe.gov.br), Brazil, and Fundacao para a Ciencia e Tecnologia (www.fct.pt), Portugal (contract no. SFRH/BD/37065/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Afonso AS, 2012, J FISH BIOL, V81, P2080, DOI 10.1111/j.1095-8649.2012.03455.x; Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Afonso AS, 2011, FISH RES, V108, P336, DOI 10.1016/j.fishres.2011.01.007; Afonso AS, 2013, THESIS U ALGRAVE FAR; [Anonymous], 2009, SHARKS RAYS AUSTR; Barreto RR, 2011, FISH RES, V110, P170, DOI 10.1016/j.fishres.2011.04.003; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Belcher CN, 2010, ENVIRON BIOL FISH, V88, P349, DOI 10.1007/s10641-010-9648-3; Bethea DM, 2004, MAR ECOL PROG SER, V268, P245, DOI 10.3354/meps268245; Bigelow H. B., 1953, MEM SEARS FDN MAR RE, V2, P514; Bigelow HB, 1948, FISHES W N ATLANTI 1, P59; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Carlson JK, 2001, ENVIRON BIOL FISH, V61, P427, DOI 10.1023/A:1011641302048; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Castro JI, 1996, B MAR SCI, V59, P508; Castro JI, 2000, ENVIRON BIOL FISH, V58, P1, DOI 10.1023/A:1007698017645; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; Cohen J., 1988, STAT POWER ANAL BEHA, P567; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; COMPAGNO LJV, 2005, FIELD GUIDE SHARKS W; Conrath CL, 2008, ENVIRON BIOL FISH, V82, P123, DOI 10.1007/s10641-007-9263-0; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Cunningham RB, 2005, ECOLOGY, V86, P1135, DOI 10.1890/04-0589; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DUDLEY SFJ, 1993, S AFR J MARINE SCI, V13, P237, DOI 10.2989/025776193784287356; Ferreira LC, 2013, ENVIRON BIOL FISH, V96, P735, DOI 10.1007/s10641-012-0067-5; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fisher RA, 1914, BIOMETRIKA, V10, P507; Giraudoux P., 2011, PGIRMESS DATA ANAL E; Green M, 2009, REPORT NSW SHARK MES; Grubbs R. Dean, 2007, V50, P87; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hazin FHV, 2014, ANIM CONSERV, V17, P287, DOI 10.1111/acv.12096; Hazin FHV, 2013, AN ACAD BRAS CIENC, V85, P1053, DOI 10.1590/S0001-37652013005000055; Hazin Fabio Hissa Vieira, 2000, Arquivos de Ciencias do Mar, V33, P33; Hazin FHV, 2002, FISH B-NOAA, V100, P143; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2003, J FISH BIOL, V63, P1357, DOI 10.1046/j.1095-8649.2003.00250.x; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hopkins TE, 2003, ENVIRON BIOL FISH, V66, P279, DOI 10.1023/A:1023907121605; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Liu H, 2011, SCAND J STAT, V38, P650, DOI 10.1111/j.1467-9469.2011.00748.x; Liu H, 2011, J AGR BIOL ENVIR ST, V16, P185, DOI 10.1007/s13253-010-0044-4; Liu H, 2010, J STAT SOFTW, V35, P1; Mann K.H, 2000, ECOLOGY COASTAL WATE, P406; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Minami M, 2007, FISH RES, V84, P210, DOI 10.1016/j.fishres.2006.10.019; Morgan M, 2009, IUCN 2013 IUCN RED L, P2; Ortiz M, 2004, FISH RES, V70, P275, DOI 10.1016/j.fishres.2004.08.028; Parsons GR, 2005, COPEIA, P914, DOI 10.1643/0045-8511(2005)005[0914:SCITDA]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahman NA, 1968, COURSE THEORETICAL S, P542; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Robins C. R., 1986, FIELD GUIDE ATLANTIC; Santander-Neto J, 2011, J MAR BIOL ASSOC UK, V91, P1193, DOI 10.1017/S0025315410001293; SCHWARTZ F J, 1984, Northeast Gulf Science, V7, P29; Shepherd TD, 2005, ECOL LETT, V8, P1095, DOI 10.1111/j.1461-0248.2005.00807.x; Siegfried KI, 2007, 13AW03 NOAA NMFS FIS; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Skomal Gregory B., 2007, V50, P17; SMITH SE, 1990, FISH B-NOAA, V88, P371; SNELSON F F JR, 1978, Florida Scientist, V41, P1; SNELSON FF, 1984, B MAR SCI, V34, P71; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; SUCHANEK TH, 1994, AM ZOOL, V34, P100; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Ulrich Glenn F., 2007, V50, P125; Vaudo JJ, 2009, MAR BIOL, V156, P2579, DOI 10.1007/s00227-009-1282-2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920; Wiley TR, 2007, B MAR SCI, V80, P171; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	91	21	22	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102369	10.1371/journal.pone.0102369	http://dx.doi.org/10.1371/journal.pone.0102369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010514	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800096
J	Oliver, KL; Lukic, V; Thorne, NP; Berkovic, SF; Scheffer, IE; Bahlo, M				Oliver, Karen L.; Lukic, Vesna; Thorne, Natalie P.; Berkovic, Samuel F.; Scheffer, Ingrid E.; Bahlo, Melanie			Harnessing Gene Expression Networks to Prioritize Candidate Epileptic Encephalopathy Genes	PLOS ONE			English	Article							DE-NOVO MUTATIONS; GRIN2A MUTATIONS; WEB TOOLS; CLASSIFICATION; ASSOCIATIONS; EPILEPSIES; DISCOVERY; PROTEINS; SEIZURES; APHASIA	We apply a novel gene expression network analysis to a cohort of 182 recently reported candidate Epileptic Encephalopathy genes to identify those most likely to be true Epileptic Encephalopathy genes. These candidate genes were identified as having single variants of likely pathogenic significance discovered in a large-scale massively parallel sequencing study. Candidate Epileptic Encephalopathy genes were prioritized according to their co-expression with 29 known Epileptic Encephalopathy genes. We utilized developing brain and adult brain gene expression data from the Allen Human Brain Atlas (AHBA) and compared this to data from Celsius: a large, heterogeneous gene expression data warehouse. We show replicable prioritization results using these three independent gene expression resources, two of which are brain-specific, with small sample size, and the third derived from a heterogeneous collection of tissues with large sample size. Of the nineteen genes that we predicted with the highest likelihood to be true Epileptic Encephalopathy genes, two (GNAO1 and GRIN2B) have recently been independently reported and confirmed. We compare our results to those produced by an established in silico prioritization approach called Endeavour, and finally present gene expression networks for the known and candidate Epileptic Encephalopathy genes. This highlights sub-networks of gene expression, particularly in the network derived from the adult AHBA gene expression dataset. These networks give clues to the likely biological interactions between Epileptic Encephalopathy genes, potentially highlighting underlying mechanisms and avenues for therapeutic targets.	[Oliver, Karen L.; Lukic, Vesna; Thorne, Natalie P.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Oliver, Karen L.; Berkovic, Samuel F.; Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic, Australia; [Scheffer, Ingrid E.] Florey Inst, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne	Bahlo, M (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia.	bahlo@wehi.edu.au	Oliver, Karen Louise/O-6159-2018; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013	Oliver, Karen Louise/0000-0001-5188-6153; Scheffer, Ingrid E/0000-0002-2311-2174; Bahlo, Melanie/0000-0001-5132-0774; Berkovic, Samuel/0000-0003-4580-841X	Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS; Australian Research Council Future Fellowship [FT100100764]; National Health and Medical Research Council of Australia Program Grant [628952]; Practitioner Fellowship [1006110]	Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MB, NT and VL were supported by Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS funding to their institute. MB was also supported by an Australian Research Council Future Fellowship (FT100100764). SFB and IES were supported by a National Health and Medical Research Council of Australia Program Grant 628952 and IES was supported by Practitioner Fellowship 1006110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Campbell IM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003797; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Chen YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021137; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Jia PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017162; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Oti M, 2011, METHODS MOL BIOL, V760, P189, DOI 10.1007/978-1-61779-176-5_12; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Piro RM, 2012, FEBS J, V279, P678, DOI 10.1111/j.1742-4658.2012.08471.x; Piro RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023149; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tebbenkamp ATN, 2014, CURR OPIN NEUROL, V27, P149, DOI 10.1097/WCO.0000000000000069; Tranchevent LC, 2011, BRIEF BIOINFORM, V12, P22, DOI 10.1093/bib/bbq007; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Venables WN., 2002, MODERN APPL STAT S 4; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Warnes GR, 2014, GTOOLS VARIOUS R PRO; Wickham H, 2007, J STAT SOFTW, V21, P1; Zheng T, 2006, J AM STAT ASSOC, V101, P409, DOI 10.1198/016214505000001168	40	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102079	10.1371/journal.pone.0102079	http://dx.doi.org/10.1371/journal.pone.0102079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25014031	Green Published, gold			2022-12-27	WOS:000339040600091
J	Luff, JA; Yuan, H; Kennedy, D; Schlegel, R; Felsburg, P; Moore, PF				Luff, Jennifer A.; Yuan, Hang; Kennedy, Douglas; Schlegel, Richard; Felsburg, Peter; Moore, Peter F.			Keratinocyte Antiviral Response to Poly(dA:dT) Stimulation and Papillomavirus Infection in a Canine Model of X-Linked Severe Combined Immunodeficiency	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; IN-VIVO; GENE; IL-15; DIFFERENTIATION; INTERLEUKIN-15; EXPRESSION; CYTOKINES; DISEASE	X-linked severe combined immunodeficiency (XSCID) is caused by a genetic mutation within the common gamma chain (cc), an essential component of the cytokine receptors for interleukin (IL)-2, IL-4, IL-7, IL-9, IL-15, and IL-21. XSCID patients are most commonly treated with bone marrow transplants (BMT) to restore systemic immune function. However, BMT-XSCID humans and dogs remain at an increased risk for development of cutaneous papillomavirus (PV) infections and their associated neoplasms, most typically cutaneous papillomas. Since basal keratinocytes are the target cell for the initial PV infection, we wanted to determine if canine XSCID keratinocytes have a diminished antiviral cytokine response to poly(dA:dT) and canine papillomavirus-2 (CPV-2) upon initial infection. We performed quantitative RT-PCR for antiviral cytokines and downstream interferon stimulated genes (ISG) on poly(dA: dT) stimulated and CPV-2 infected monolayer keratinocyte cultures derived from XSCID and normal control dogs. We found that XSCID keratinocytes responded similarly to poly(dA: dT) as normal keratinocytes by upregulating antiviral cytokines and ISGs. CPV-2 infection of both XSCID and normal keratinocytes did not result in upregulation of antiviral cytokines or ISGs at 2, 4, or 6 days post infection. These data suggest that the antiviral response to initial PV infection of basal keratinocytes is similar between XSCID and normal patients, and is not the likely source for the remaining immunodeficiency in XSCID patients.	[Luff, Jennifer A.; Moore, Peter F.] Univ Calif Davis, Dept Vet Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Yuan, Hang; Schlegel, Richard] Georgetown Univ, Sch Med, Dept Pathol, Washington, DC USA; [Kennedy, Douglas; Felsburg, Peter] Univ Penn, Sch Vet Med, Dept Immunol, Philadelphia, PA 19104 USA	University of California System; University of California Davis; Georgetown University; University of Pennsylvania	Luff, JA (corresponding author), Univ Calif Davis, Dept Vet Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.	jaluff@ucdavis.edu			Georgetown University [1R01RR032315-01]; National Center for Research Resources (NCRR) [R01AI043745, T32 RR07038]; Office of Research Infrastructure Programs (ORIP), a component of the National Institutes of Health (NIH); Center for Companion Animal Health, University of California, Davis [2011-14-F]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007038, R01RR032315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043745] Funding Source: NIH RePORTER	Georgetown University; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Companion Animal Health, University of California, Davis(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was supported by grant number 1R01RR032315-01 (Georgetown University), R01AI043745 and T32 RR07038 from the National Center for Research Resources (NCRR) and the Office of Research Infrastructure Programs (ORIP), a component of the National Institutes of Health (NIH). This work was also made possible by the Center for Companion Animal Health, University of California, Davis through grant 2011-14-F. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Fahey LM, 2009, J IMMUNOL, V183, P6151, DOI 10.4049/jimmunol.0902145; Felsburg PJ, 1997, BLOOD, V90, P3214, DOI 10.1182/blood.V90.8.3214; Felsburg PJ, 1999, VET IMMUNOL IMMUNOP, V69, P127, DOI 10.1016/S0165-2427(99)00049-5; Felsburg PJ, 1998, IMMUNOL RES, V17, P63, DOI 10.1007/BF02786431; Frazer IH, 2009, VIROLOGY, V384, P410, DOI 10.1016/j.virol.2008.10.004; Gaspar HB, 2004, BRIT J HAEMATOL, V127, P232, DOI 10.1111/j.1365-2141.2004.05176.x; Gill N, 2005, J VIROL, V79, P4470, DOI 10.1128/JVI.79.7.4470-4478.2005; Goldschmidt MH, 2006, J VIROL, V80, P6621, DOI 10.1128/JVI.02571-05; Hartnett BJ, 1999, VET IMMUNOL IMMUNOP, V69, P137, DOI 10.1016/S0165-2427(99)00050-1; HENTHORN PS, 1994, GENOMICS, V23, P69, DOI 10.1006/geno.1994.1460; Kennedy DR, 2011, VET IMMUNOL IMMUNOP, V142, P36, DOI 10.1016/j.vetimm.2011.04.003; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Loser K, 2004, EUR J IMMUNOL, V34, P2022, DOI 10.1002/eji.200324785; Luff JA, 2013, VET IMMUNOL IMMUNOP, V153, P177, DOI 10.1016/j.vetimm.2013.02.001; McInnes IB, 2006, E SCHERING RES FDN W, V56, P29; Murata T, 1998, BLOOD, V91, P3884; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Ozbun MA, 2002, J GEN VIROL, V83, P2753, DOI 10.1099/0022-1317-83-11-2753; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Ruckert R, 2000, J IMMUNOL, V165, P2240, DOI 10.4049/jimmunol.165.4.2240; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Schluns KS, 2005, INT J BIOCHEM CELL B, V37, P1567, DOI 10.1016/j.biocel.2005.02.017; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; SUTER MM, 1991, VET PATHOL, V28, P131, DOI 10.1177/030098589102800205; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Thatte A, 2011, IMMUNOL CELL BIOL, V89, P663, DOI 10.1038/icb.2011.7; Ting-De Ravin SS, 2006, BLOOD, V107, P3091, DOI [10.1182/blood-2005-104057, 10.1182/blood-2005-10-4057]; Yuan H, 2007, VIROLOGY, V359, P28, DOI 10.1016/j.virol.2006.08.029; Zhang SQ, 2008, SCAND J IMMUNOL, V68, P397, DOI 10.1111/j.1365-3083.2008.02150.x	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102033	10.1371/journal.pone.0102033	http://dx.doi.org/10.1371/journal.pone.0102033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025687	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400035
J	Spassov, S; Pfeifer, D; Strosing, K; Ryter, S; Hummel, M; Faller, S; Hoetzel, A				Spassov, Sashko; Pfeifer, Dietmar; Strosing, Karl; Ryter, Stefan; Hummel, Matthias; Faller, Simone; Hoetzel, Alexander			Genetic Targets of Hydrogen Sulfide in Ventilator-Induced Lung Injury - A Microarray Study	PLOS ONE			English	Article							CARBON-MONOXIDE; MECHANICAL VENTILATION; TIDAL VOLUMES; EXPRESSION; PROTECTS; STRESS; MICE; METALLOPROTEINASES; PATHOGENESIS; APOPTOSIS	Recently, we have shown that inhalation of hydrogen sulfide (H2S) protects against ventilator-induced lung injury (VILI). In the present study, we aimed to determine the underlying molecular mechanisms of H2S-dependent lung protection by analyzing gene expression profiles in mice. C57BL/6 mice were subjected to spontaneous breathing or mechanical ventilation in the absence or presence of H2S (80 parts per million). Gene expression profiles were determined by microarray, sqRT-PCR and Western Blot analyses. The association of Atf3 in protection against VILI was confirmed with a Vivo-Morpholino knockout model. Mechanical ventilation caused a significant lung inflammation and damage that was prevented in the presence of H2S. Mechanical ventilation favoured the expression of genes involved in inflammation, leukocyte activation and chemotaxis. In contrast, ventilation with H2S activated genes involved in extracellular matrix remodelling, angiogenesis, inhibition of apoptosis, and inflammation. Amongst others, H2S administration induced Atf3, an anti-inflammatory and anti-apoptotic regulator. Morpholino mediated reduction of Atf3 resulted in elevated lung injury despite the presence of H2S. In conclusion, lung protection by H2S during mechanical ventilation is associated with down-regulation of genes related to oxidative stress and inflammation and up-regulation of anti-apoptotic and anti-inflammatory genes. Here we show that Atf3 is clearly involved in H2S mediated protection.	[Spassov, Sashko; Strosing, Karl; Hummel, Matthias; Faller, Simone; Hoetzel, Alexander] Univ Med Ctr Freiburg, Dept Anaesthesiol & Intens Care Med, Freiburg, Germany; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Genom Core Lab, Freiburg, Germany; [Ryter, Stefan] New York Presbyterian Hosp, Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA	University of Freiburg; University of Freiburg; Cornell University; NewYork-Presbyterian Hospital	Spassov, S (corresponding author), Univ Med Ctr Freiburg, Dept Anaesthesiol & Intens Care Med, Freiburg, Germany.	sashko.spassov@uniklinik-freiburg.de	Spassov, Sashko/C-2105-2013	Spassov, Sashko/0000-0002-3585-3682; Faller, Simone/0000-0001-5345-8523	Deutsche Forschungsgemeinschaft [HO 2464/3-1]; Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by a grant from the "Deutsche Forschungsgemeinschaft'' (HO 2464/3-1 to Alexander Hoetzel). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; Aslami H, 2010, INTENS CARE MED, V36, P1946, DOI 10.1007/s00134-010-2022-2; Asuthkar S, 2011, NEURO-ONCOLOGY, V13, P1059, DOI 10.1093/neuonc/nor109; Baumgart K, 2009, CURR OPIN ANESTHESIO, V22, P168, DOI 10.1097/ACO.0b013e328328d22f; Belperio JA, 2006, SEMIN RESP CRIT CARE, V27, P350, DOI 10.1055/s-2006-948289; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Copland IB, 2003, AM J RESP CRIT CARE, V168, P1051, DOI 10.1164/rccm.200208-964OC; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; dos Santos CC, 2008, CRIT CARE MED, V36, P855, DOI 10.1097/CCM.0B013E3181659333; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faller S, 2012, LAB INVEST, V92, P999, DOI 10.1038/labinvest.2012.55; Faller S, 2012, ANESTH ANALG, V114, P747, DOI 10.1213/ANE.0b013e31824762f0; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Hoffmann DC, 2011, J BIOL CHEM, V286, P28889, DOI 10.1074/jbc.M111.249979; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; Ma SF, 2005, AM J PHYSIOL-LUNG C, V289, pL468, DOI 10.1152/ajplung.00109.2005; Meyer NJ, 2009, FASEB J, V23, P1325, DOI 10.1096/fj.08-119073; Mitra S, 2011, AM J RESP CRIT CARE, V184, P1030, DOI 10.1164/rccm.201103-0447OC; Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001; Nishina K, 1998, ANESTHESIOLOGY, V88, P1300, DOI 10.1097/00000542-199805000-00022; Papaiahgari S, 2007, AM J RESP CRIT CARE, V176, P1222, DOI 10.1164/rccm.200701-060OC; Reddy SP, 2007, ANTIOXID REDOX SIGN, V9, P2003, DOI 10.1089/ars.2007.1770; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; Roberts ES, 2008, TOXICOL PATHOL, V36, P560, DOI 10.1177/0192623308317422; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Vacek TP, 2010, AMINO ACIDS, V39, P1161, DOI 10.1007/s00726-010-0550-2; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Yang Guang-Dong, 2007, Shengli Xuebao, V59, P133; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; 2000, N ENGL J MED, V342, P1301	41	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102401	10.1371/journal.pone.0102401	http://dx.doi.org/10.1371/journal.pone.0102401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025333	Green Submitted, gold, Green Published			2022-12-27	WOS:000339992400071
J	Tan, K; Chen, WW; Dong, SH; Liu, XW; Wang, YC; Nieh, JC				Tan, Ken; Chen, Weiwen; Dong, Shihao; Liu, Xiwen; Wang, Yuchong; Nieh, James C.			Imidacloprid Alters Foraging and Decreases Bee Avoidance of Predators	PLOS ONE			English	Article							APIS-MELLIFERA; LEARNING PERFORMANCES; HONEY-BEES; PESTICIDES; HYMENOPTERA; CERANA; DELTAMETHRIN; TOXICITY; DECLINES; EXPOSURE	Concern is growing over the effects of neonicotinoid pesticides, which can impair honey bee cognition. We provide the first demonstration that sublethal concentrations of imidacloprid can harm honey bee decision-making about danger by significantly increasing the probability of a bee visiting a dangerous food source. Apis cerana is a native bee that is an important pollinator of agricultural crops and native plants in Asia. When foraging on nectar containing 40 mu g/L (34 ppb) imidacloprid, honey bees (Apis cerana) showed no aversion to a feeder with a hornet predator, and 1.8 fold more bees chose the dangerous feeder as compared to control bees. Control bees exhibited significant predator avoidance. We also give the first evidence that foraging by A. cerana workers can be inhibited by sublethal concentrations of the pesticide, imidacloprid, which is widely used in Asia. Compared to bees collecting uncontaminated nectar, 23% fewer foragers returned to collect the nectar with 40 mu g/L imidacloprid. Bees that did return respectively collected 46% and 63% less nectar containing 20 mu g/L and 40 mu g/L imidacloprid. These results suggest that the effects of neonicotinoids on honey bee decision-making and other advanced cognitive functions should be explored. Moreover, research should extend beyond the classic model, the European honey bee (A. mellifera), to other important bee species.	[Tan, Ken] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Yunnan Province, Peoples R China; [Tan, Ken; Chen, Weiwen; Dong, Shihao; Liu, Xiwen; Wang, Yuchong] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Yunnan Province, Peoples R China; [Nieh, James C.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; University of California System; University of California San Diego	Tan, K (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Yunnan Province, Peoples R China.	kentan@xtbg.ac.cn	Nieh, James C/H-8705-2014; liu, xiwen/GSJ-3861-2022	Nieh, James C/0000-0001-6237-0726; 	Key Laboratory of Tropical Forest Ecology; CAS 135 program of Chinese Academy of Science [XTBGT01]; China National Research Fund [31260585]	Key Laboratory of Tropical Forest Ecology; CAS 135 program of Chinese Academy of Science; China National Research Fund	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, and the CAS 135 program (XTBGT01) of Chinese Academy of Science, China National Research Fund (31260585) to Ken Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; Abrol DP, 2013, ASIATIC HONEYBEE API, P575, DOI [10.1007/978-94-007-6928-1_14, DOI 10.1007/978-94-007-6928-1_]; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bray A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087459; Burgett M., 1982, Psyche (Cambridge), V89, P347, DOI 10.1155/1982/37970; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Corlett RT, 2001, J TROP ECOL, V17, P155, DOI 10.1017/S0266467401001109; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dukas R, 2005, ECOSCIENCE, V12, P244, DOI 10.2980/i1195-6860-12-2-244.1; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gross M, 2013, CURR BIOL; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higo M., 1980, Honeybee Science, V1, P177; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Khan RB, 2005, ENVIRON TOXICOL, P59; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Landgraf T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021354; Lonsdorf E, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P168; Matsuura M., 1990, BIOL VESPINE WASPS; Mishra RC, 1982, INDIAN BEE J, V44, P475; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Pahl M, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P87, DOI 10.1007/978-3-642-02624-9_4; PENG YS, 1989, APIDOLOGIE, V20, P9, DOI 10.1051/apido:19890102; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schmuck Richard, 2003, Bulletin of Insectology, V56, P27; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SCHRICKER B, 1970, Journal of Apicultural Research, V9, P141; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suh YT, 1988, KOREAN J ENV AGR, V8, P47; Sun Z., 1995, J PLANT PROTECT, V2, P44; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; Tome HVV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038406; Verma L.R., 1993, ASIAN HIVE BEE APIS; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2013, INVERTEBR NEUROSCI, V13, P63, DOI 10.1007/s10158-012-0144-7; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Yu XL, 2011, ARCH INSECT BIOCHEM, V77, P163, DOI 10.1002/arch.20432; Yuchong W, 2014, J YUNNAN AG IN PRESS; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	60	58	67	3	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102725	10.1371/journal.pone.0102725	http://dx.doi.org/10.1371/journal.pone.0102725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025334	gold, Green Published			2022-12-27	WOS:000339992400102
J	Ammann, RA; Niggli, FK; Leibundgut, K; Teuffel, O; Bodmer, N				Ammann, Roland A.; Niggli, Felix K.; Leibundgut, Kurt; Teuffel, Oliver; Bodmer, Nicole			Exploring the Association of Hemoglobin Level and Adverse Events in Children with Cancer Presenting with Fever in Neutropenia	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED NEUTROPENIA; INTENSIVE-CARE-UNIT; FEBRILE NEUTROPENIA; RISK-FACTORS; INFECTION; CRITERIA; EPISODES	Background: In children and adolescents with fever in neutropenia (FN) during chemotherapy for cancer, hemoglobin >= 90 g/L at presentation with FN had been associated with adverse events (AE). This analysis explored three hypothetical pathophysiological mechanisms potentially explaining this counterintuitive finding, and further analyzed the statistical association between hemoglobin and AE. Methods: Two of 8 centers, reporting on 311 of 421 FN episodes in 138 of 215 patients participated in this retrospective analysis based on prospectively collected data from three databases (SPOG 2003 FN, transfusion and hematology laboratories). Associations with AE were analyzed using mixed logistic regression. Results: Hemoglobin was >= 90 g/L in 141 (45%) of 311 FN episodes, specifically in 59/103 (57%) episodes with AE, and in 82/208 (39%) without (OR, 2.3; 99% CI, 1.1-4.9; P = 0.004). In FN with AE, hemoglobin was bimodally distributed with a dip around 85 g/L. There were no significant interactions for center, age and sex. In multivariate mixed logistic regression, AE was significantly and independently associated with leukopenia (leukocytes <0.3 G/L; OR, 3.3; 99%CI, 1.1-99; P = 0.004), dehydration (hemoglobinPresentation/hemoglobin(8-72) hours >= 1.10 in untransfused patients; OR, 3.5; 99%CI, 1.1-11.4; P = 0.006) and non-moderate anemia (difference from 85 g/L; 1.6 per 10 g/L; 1.0-2.6; P = 0.005), but not with recent transfusion of packed red blood cells (pRBC), very recent transfusion of pRBC or platelets, or with hemoglobin >= 90 g/L as such. Conclusions: Non-moderate anemia and dehydration were significantly and relevantly associated with the risk of AE in children with cancer and FN. These results need validation in prospective cohorts before clinical implementation.	[Ammann, Roland A.; Leibundgut, Kurt; Teuffel, Oliver] Univ Bern, Dept Pediat, Bern, Switzerland; [Niggli, Felix K.; Bodmer, Nicole] Univ Zurich, Dept Pediat, Div Oncol, Zurich, Switzerland; [Teuffel, Oliver] Med Serv Statutory Hlth Insurance Baden Wurttembe, Div Oncol, Tubingen, Germany	University of Bern; University of Zurich	Ammann, RA (corresponding author), Univ Bern, Dept Pediat, Bern, Switzerland.	roland.ammann@insel.ch	Ammann, Roland A/I-4716-2019; Niggli, Felix/L-6547-2017	Ammann, Roland A/0000-0002-1902-2352; Niggli, Felix/0000-0002-7553-3712; Leibundgut, Kurt/0000-0003-2514-6041	Oncosuisse/Swiss Cancer League [OCS-01466-02-2004]; Bayer AG (Switzerland); GSK AG (Switzerland)	Oncosuisse/Swiss Cancer League; Bayer AG (Switzerland)(Bayer AG); GSK AG (Switzerland)	This study was supported by unrestricted research grants from Oncosuisse/Swiss Cancer League (OCS-01466-02-2004), Bayer AG (Switzerland), and GSK AG (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman P, 2011, PEDIATR INFECT DIS J, V30, pE114, DOI 10.1097/INF.0b013e318215a290; Alexander SW, 2002, J PEDIAT HEMATOL ONC, V24, P38, DOI 10.1097/00043426-200201000-00011; Altman DG, 1991, PRACTICAL STATISTICS; Ammann RA, 2004, PEDIATR INFECT DIS J, V23, P61, DOI 10.1097/01.inf.0000106782.30100.4f; Ammann RA, 2003, MED PEDIATR ONCOL, V41, P436, DOI 10.1002/mpo.10320; Ammann RA, 2010, J CLIN ONCOL, V28, P2008, DOI 10.1200/JCO.2009.25.8988; Badiei Z, 2011, J PEDIAT HEMATOL ONC, V33, pE9, DOI 10.1097/MPH.0b013e3181f6921a; Berridge DM, 2011, MULT GEN LIN MIX; Brack E, 2012, PEDIATR BLOOD CANCER, V59, P423, DOI 10.1002/pbc.24076; Brown H, 2006, APPLIED MIXED MODELS; Cervia JS, 2007, CLIN INFECT DIS, V45, P1008, DOI 10.1086/521896; Feld R, 1998, SUPPORT CARE CANCER, V6, P444, DOI 10.1007/s005200050192; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Kelly M, 2011, INFECT CONT HOSP EP, V32, P1079, DOI 10.1086/662376; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Koh A, 2011, PRINCIPLES PRACTICE, P1190; Luhi F, 2012, PEDIATR BLOOD CANCER, V59, P90, DOI 10.1002/pbc.23277; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Miedema KGE, 2011, J CLIN ONCOL, V29, pE182, DOI 10.1200/JCO.2010.32.7767; Phillips B, 2010, EUR J CANCER, V46, P2950, DOI 10.1016/j.ejca.2010.05.024; Phillips RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038300; Rondinelli PIP, 2006, J PEDIAT HEMATOL ONC, V28, P665, DOI 10.1097/01.mph.0000212996.94929.0b; Previsdomini M, 2007, AM J CARDIOL, V100, P579, DOI 10.1016/j.amjcard.2007.03.065; Santolaya ME, 2008, PEDIATR INFECT DIS J, V27, P538, DOI 10.1097/INF.0b013e3181673c3c; Santolaya ME, 2001, J CLIN ONCOL, V19, P3415, DOI 10.1200/JCO.2001.19.14.3415; Steiner M, 2007, PEDIATR BLOOD CANCER, V49, P640, DOI 10.1002/pbc.21022; Zhang HP, 1999, RECURSIVE PARTITIONI	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101696	10.1371/journal.pone.0101696	http://dx.doi.org/10.1371/journal.pone.0101696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020130	gold, Green Published, Green Accepted			2022-12-27	WOS:000339618600023
J	Dehmer, M; Mowshowitz, A; Shi, YT				Dehmer, Matthias; Mowshowitz, Abbe; Shi, Yongtang			Structural Differentiation of Graphs Using Hosoya-Based Indices	PLOS ONE			English	Article							D-MAX; ENTROPY; MATRIX; POLYNOMIALS; BOUNDS	In this paper, we introduce the Hosoya-Spectral indices and the Hosoya information content of a graph. The first measure combines structural information captured by partial Hosoya polynomials and graph spectra. The latter is a graph entropy measure which is based on blocks consisting of vertices with the same partial Hosoya polynomial. We evaluate the discrimination power of these quantities by interpreting numerical results.	[Dehmer, Matthias] Univ Bundeswehr Munchen, Dept Comp Sci, Neubiberg, Germany; [Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Mowshowitz, Abbe] CUNY, Dept Comp Sci, New York, NY 10021 USA; [Shi, Yongtang] Nankai Univ, Ctr Combinator, Tianjin 300071, Peoples R China; [Shi, Yongtang] Nankai Univ, LPMC TJKLC, Tianjin 300071, Peoples R China; [Shi, Yongtang] Nankai Univ, Coll Comp & Control Engn, Tianjin 300071, Peoples R China	Bundeswehr University Munich; City University of New York (CUNY) System; Nankai University; Nankai University; Nankai University	Dehmer, M (corresponding author), Univ Bundeswehr Munchen, Dept Comp Sci, Neubiberg, Germany.	matthias.dehmer@umit.at	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	Austrian Science Funds [P26142]; German Federal Ministry of Education and Research (BMBF) (project RiKoV) [13N12304]; NSFC; PCSIRT; China Postdoctoral Science Foundation; China Scholarship Council	Austrian Science Funds(Austrian Science Fund (FWF)); German Federal Ministry of Education and Research (BMBF) (project RiKoV)(Federal Ministry of Education & Research (BMBF)); NSFC(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Scholarship Council(China Scholarship Council)	Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P26142). Matthias Dehmer gratefully acknowledges financial support from the German Federal Ministry of Education and Research (BMBF) (project RiKoV, Grant No. 13N12304). Yongtang Shi are supported by NSFC, PCSIRT, China Postdoctoral Science Foundation and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALABAN AT, 1982, CHEM PHYS LETT, V89, P399, DOI 10.1016/0009-2614(82)80009-2; Bonchev, 1979, MATCH COMMUN MATH CO, V7, P65; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D, 2000, J CHEM INF COMP SCI, V40, P934, DOI 10.1021/ci990120u; Bonchev D, 1983, INFORM THEORETIC IND; Chung F, 1997, CBMS REGIONAL C SERI, V12; Cioaba SM, 2011, STRUCTURAL ANALYSIS OF COMPLEX NETWORKS, P357, DOI 10.1007/978-0-8176-4789-6_14; Cvetkovic D., 1980, SPECTRA GRAPHS THEOR; Das KC, 2009, LINEAR ALGEBRA APPL, V431, P1351, DOI 10.1016/j.laa.2009.05.007; Dehmer M, 2014, DISCRIMINATION UNPUB; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2012, MATCH-COMMUN MATH CO, V67, P147; Dehmer M, 2011, APPL MATH COMPUT, V218, P4128, DOI 10.1016/j.amc.2011.09.043; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003079; Deutsch E, 2013, MATCH-COMMUN MATH CO, V70, P627; Devillers J., 1999, TOPOLOGICAL INDICES; Doslic T, 2008, ARS MATH CONTEMP, V1, P66, DOI 10.26493/1855-3974.15.895; Elphick C, 2014, ELECTRON J GRAPH THE, V2, P52, DOI 10.5614/ejgta.2014.2.1.5; Estrada E, 2000, CHEM PHYS LETT, V319, P713, DOI 10.1016/S0009-2614(00)00158-5; Estrada E, 2002, BIOINFORMATICS, V18, P697, DOI 10.1093/bioinformatics/18.5.697; Estrada E, 2011, STRUCTURE COMPLEX NE; Fricke R., 1924, LEHRBUCH ALGEBRA; Gutman I, 2006, LINEAR ALGEBRA APPL, V414, P29, DOI 10.1016/j.laa.2005.09.008; Gutman I., 2011, SELECTED TOPICS APPL, P155; Gutman I., 2012, DISTANCE MOL GRAPHS, P49; Gutman I, 2007, CROAT CHEM ACTA, V80, P151; HOSOYA H, 1988, DISCRETE APPL MATH, V19, P239, DOI 10.1016/0166-218X(88)90017-0; HOSOYA H, 1971, B CHEM SOC JPN, V44, P2332, DOI 10.1246/bcsj.44.2332; Janezic D, 2009, ENCY COMPLEXITY SYST, V5, P9210; Konstantinova EV, 2003, INDIAN J CHEM A, V42, P1227; Konstantinova EV, 1990, VYCHISL SISTEMY, V136, P38; Korner J., 1973, T 6 PRAG C INF THEOR, P411; Li JX, 2011, MATCH-COMMUN MATH CO, V66, P777; Li X, 2012, GRAPH ENERGY; Mehler A, 2010, ENTROPY-SWITZ, V12, P1440, DOI 10.3390/e12061440; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Petrov E, 2014, MATCH-COMMUN MATH CO, V71, P645; Randic M., 2001, QSPR QSAR STUDIES MO QSPR QSAR STUDIES MO, P93; Randic M, 2013, MATCH-COMMUN MATH CO, V70, P239; Randic M, 2013, MATCH-COMMUN MATH CO, V70, P221; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Wu J, 2010, INT CONF COMP SCI, P50, DOI 10.1109/ICCSIT.2010.5563537	46	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102459	10.1371/journal.pone.0102459	http://dx.doi.org/10.1371/journal.pone.0102459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019933	Green Published, gold			2022-12-27	WOS:000339618600082
J	Fimognari, C; Turrini, E; Sestili, P; Calcabrini, C; Carulli, G; Fontanelli, G; Rousseau, M; Cantelli-Forti, G; Hrelia, P				Fimognari, Carmela; Turrini, Eleonora; Sestili, Piero; Calcabrini, Cinzia; Carulli, Giovanni; Fontanelli, Giulia; Rousseau, Martina; Cantelli-Forti, Giorgio; Hrelia, Patrizia			Antileukemic Activity of Sulforaphane in Primary Blasts from Patients Affected by Myelo- and Lympho-Proliferative Disorders and in Hypoxic Conditions	PLOS ONE			English	Article							CELL-CYCLE ARREST; FAST-HALO ASSAY; CRUCIFEROUS VEGETABLES; STRAND BREAKAGE; ACUTE-LEUKEMIA; CANCER CELLS; APOPTOSIS; GROWTH; ISOTHIOCYANATES; CONSUMPTION	Sulforaphane is a dietary isothiocyanate found in cruciferous vegetables showing antileukemic activity. With the purpose of extending the potential clinical impact of sulforaphane in the oncological field, we investigated the antileukemic effect of sulforaphane on blasts from patients affected by different types of leukemia and, taking into account the intrinsically hypoxic nature of bone marrow, on a leukemia cell line (REH) maintained in hypoxic conditions. In particular, we tested sulforaphane on patients with chronic lymphocytic leukemia, acute myeloid leukemia, T-cell acute lymphoblastic leukemia, B-cell acute lymphoblastic leukemia, and blastic NK cell leukemia. Sulforaphane caused a dose-dependent induction of apoptosis in blasts from patients diagnosed with acute lymphoblastic or myeloid leukemia. Moreover, it was able to cause apoptosis and to inhibit proliferation in hypoxic conditions on REH cells. As to its cytotoxic mechanism, we found that sulforaphane creates an oxidative cellular environment that induces DNA damage and Bax and p53 gene activation, which in turn helps trigger apoptosis. On the whole, our results raise hopes that sulforaphane might set the stage for a novel therapeutic principle complementing our growing armature against malignancies and advocate the exploration of sulforaphane in a broader population of leukemic patients.	[Fimognari, Carmela; Turrini, Eleonora; Cantelli-Forti, Giorgio] Univ Bologna, Alma Mater Studiorum, Dept Life Qual Studies, Rimini, Italy; [Sestili, Piero; Calcabrini, Cinzia] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Carulli, Giovanni; Fontanelli, Giulia; Rousseau, Martina] Univ Pisa, Dept Clin & Expt Med, Div Hematol, Pisa, Italy; [Hrelia, Patrizia] Univ Bologna, Alma Mater Studiorum, Dept Pharm & BioTechnol, Bologna, Italy	University of Bologna; University of Urbino; University of Pisa; University of Bologna	Fimognari, C (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Life Qual Studies, Rimini, Italy.	carmela.fimognari@unibo.it	Fimognari, Carmela/J-7678-2019; Turrini, Eleonora/I-3629-2019; Hrelia, Patrizia/AAC-2071-2020; Sestili, Piero/H-6082-2019	Fimognari, Carmela/0000-0002-2461-8214; Turrini, Eleonora/0000-0003-4743-1126; Sestili, Piero/0000-0001-9412-1660; HRELIA, Patrizia/0000-0002-8415-3711	Fondazione Cassa di Risparmio di Imola (Italy); Fondazione del Monte di Bologna e Ravenna (Italy)	Fondazione Cassa di Risparmio di Imola (Italy); Fondazione del Monte di Bologna e Ravenna (Italy)(Fondazione del Monte di Bologna e Ravenna)	This work was supported by Fondazione Cassa di Risparmio di Imola (Italy) and by Fondazione del Monte di Bologna e Ravenna (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Arcangeli A, 2012, CURR MED CHEM, V19, P683, DOI 10.2174/092986712798992093; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Bosanquet Andrew G, 2002, J Exp Ther Oncol, V2, P53, DOI 10.1046/j.1359-4117.2002.01007.x; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Bromidge TJ, 1998, LEUKEMIA, V12, P1230, DOI 10.1038/sj.leu.2401095; Dietrich S, 2012, CLIN CANCER RES, V18, P417, DOI 10.1158/1078-0432.CCR-11-1049; Fathi AT, 2009, CURR ONCOL REP, V11, P346, DOI 10.1007/s11912-009-0047-x; Filippi I, 2011, CURR MED CHEM, V18, P2885, DOI 10.2174/092986711796150540; Fimognari C, 2003, ANN NY ACAD SCI, V1010, P393, DOI 10.1196/annals.1299.072; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Fimognari C, 2009, ENVIRON MOL MUTAGEN, V50, P171, DOI 10.1002/em.20447; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Ghamlouch H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060370; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hsu YC, 2013, CELL BIOCHEM BIOPHYS, V66, P765, DOI 10.1007/s12013-013-9522-y; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joseph MA, 2004, NUTR CANCER, V50, P206, DOI 10.1207/s15327914nc5002_11; Karp JE, 2003, CLIN CANCER RES, V9, P307; Liu YY, 2014, J NEUROCHEM, V129, P539, DOI 10.1111/jnc.12647; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodi A, 2011, ACS CHEM BIOL, V6, P169, DOI 10.1021/cb900300j; Mohr J, 2011, BLOOD, V117, P1622, DOI 10.1182/blood-2010-08-300160; Morabito F, 1998, BRIT J HAEMATOL, V102, P528, DOI 10.1046/j.1365-2141.1998.00813.x; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; OCONNOR R, 1991, BLOOD, V77, P1534; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Pham NA, 2004, MOL CANCER THER, V3, P1239; Probst-Hensch NM, 1998, CANCER EPIDEM BIOMAR, V7, P635; Sestili P, 2002, BIOCHEM J, V364, P121, DOI 10.1042/bj3640121; Sestili P, 2006, MUTAT RES-GEN TOX EN, V607, P205, DOI 10.1016/j.mrgentox.2006.04.018; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Sestili Piero, 2009, V521, P517, DOI [10.1007/978-1-60327-815-7_30, 10.1007/978-1-60327-817-5_30]; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; Suppipat K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051251; Tang L, 2008, CANCER EPIDEM BIOMAR, V17, P938, DOI 10.1158/1055-9965.EPI-07-2502; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Traka M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002568; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Veeranki OL, 2013, BRIT J NUTR, V109, P25, DOI 10.1017/S0007114512000657	46	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101991	10.1371/journal.pone.0101991	http://dx.doi.org/10.1371/journal.pone.0101991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019218	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600034
J	Salewski, V; Siebenrock, KH; Hochachka, WM; Woog, F; Fiedler, W				Salewski, Volker; Siebenrock, Karl-Heinz; Hochachka, Wesley M.; Woog, Friederike; Fiedler, Wolfgang			Morphological Change to Birds over 120 Years Is Not Explained by Thermal Adaptation to Climate Change	PLOS ONE			English	Article							BODY-SIZE; BERGMANNS RULE; MEASUREMENT ERROR; HOUSE SPARROW; EVOLUTION; NORTH; HERITABILITY; POPULATIONS; RESPONSES; GOSHAWKS	Changes in morphology have been postulated as one of the responses of animals to global warming, with increasing ambient temperatures leading to decreasing body size. However, the results of previous studies are inconsistent. Problems related to the analyses of trends in body size may be related to the short-term nature of data sets, to the selection of surrogates for body size, to the appropriate models for data analyses, and to the interpretation as morphology may change in response to ecological drivers other than climate and irrespective of size. Using generalized additive models, we analysed trends in three morphological traits of 4529 specimens of eleven bird species collected between 1889 and 2010 in southern Germany and adjacent areas. Changes and trends in morphology over time were not consistent when all species and traits were considered. Six of the eleven species displayed a significant association of tarsus length with time but the direction of the association varied. Wing length decreased in the majority of species but there were few significant trends in wing pointedness. Few of the traits were significantly associated with mean ambient temperatures. We argue that although there are significant changes in morphology over time there is no consistent trend for decreasing body size and therefore no support for the hypothesis of decreasing body size because of climate change. Non-consistent trends of change in surrogates for size within species indicate that fluctuations are influenced by factors other than temperature, and that not all surrogates may represent size appropriately. Future analyses should carefully select measures of body size and consider alternative hypotheses for change.	[Salewski, Volker] NABU, Michael Otto Inst, Bergenhusen, Germany; [Siebenrock, Karl-Heinz; Fiedler, Wolfgang] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Hochachka, Wesley M.] Cornell Univ, Ornithol Lab, Ithaca, NY USA; [Woog, Friederike] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany	Max Planck Society; Cornell University	Fiedler, W (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	fiedler@orn.mpg.de	Woog, Friederike/AAI-1055-2020; Fiedler, Wolfgang/AAG-4510-2021; Hochachka, Wesley M./J-9768-2012	Fiedler, Wolfgang/0000-0003-1082-4161; Hochachka, Wesley M./0000-0002-0595-7827; Siebenrock, Klaus Arno/0000-0003-3627-4313				ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; ALATALO RV, 1984, J ANIM ECOL, V53, P969, DOI 10.2307/4671; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BAKER AJ, 1980, EVOLUTION, V34, P638, DOI 10.1111/j.1558-5646.1980.tb04003.x; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Bauer H.G., 2005, KOMPENDIUM VOGEL MIT; DAYAN T, 1991, PALEOBIOLOGY, V17, P189, DOI 10.1017/S0094837300010484; Dayan T, 1998, MAMMAL REV, V28, P99, DOI 10.1046/j.1365-2907.1998.00029.x; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; Eck S., 2011, MEASURING BIRDS; Fiedler W, 2003, AVIAN MIGRATION, P21; Fiedler W, 2005, ANN NY ACAD SCI, V1046, P253, DOI 10.1196/annals.1343.022; Flinks H, 2012, J ORNITHOL, V153, P1053, DOI 10.1007/s10336-012-0834-2; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; FREEMAN S, 1990, AUK, V107, P69; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Goodman RE, 2012, GLOBAL CHANGE BIOL, V18, P63, DOI 10.1111/j.1365-2486.2011.02538.x; Gosler AG, 1998, BIRD STUDY, V45, P92, DOI 10.1080/00063659809461082; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Guillemain M, 2005, WILDLIFE BIOL, V11, P81, DOI 10.2981/0909-6396(2005)11[81:LCTABS]2.0.CO;2; Hill ME, 2008, QUATERNARY SCI REV, V27, P1752, DOI 10.1016/j.quascirev.2008.07.002; Husby A, 2011, AM NAT, V178, P202, DOI 10.1086/660834; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Jakober H, 2000, J ORNITHOL, V141, P408, DOI 10.1007/BF01651570; Jenni L., 1994, MOULT AGING EUROPEAN; JOHNSTON RF, 1973, AM NAT, V107, P373, DOI 10.1086/282841; Kipp F. A., 1958, Vogelwarte, V19, P233; Kipp F.A., 1959, VOGELWARTE, V20, P77; Koontz TL, 2001, J ARID ENVIRON, V49, P581, DOI 10.1006/jare.2001.0806; Leisler B., 1985, Current Ornithology, V3, P155; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; LOUGHEED SC, 1991, AUK, V108, P432; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Merila J, 1996, J HERED, V87, P199, DOI 10.1093/oxfordjournals.jhered.a022985; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Moreno-Rueda G, 2007, J ORNITHOL, V148, P489, DOI 10.1007/s10336-007-0184-7; MOSER TJ, 1988, J WILDLIFE MANAGE, V52, P202, DOI 10.2307/3801223; Pergams ORW, 2001, GENETICA, V112, P245, DOI 10.1023/A:1013343923155; Perktas U, 2010, ACTA ORNITHOL, V45, P161, DOI 10.3161/000164510X551309; PIERSMA T, 1991, AUK, V108, P441; R Development Core Team, 2010, R LANG ENV STAT COMP; RISING JD, 1989, AUK, V106, P666; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Salewski V, 2008, BERICHTE VOGELWARTE, V18, P63; Salewski V, 2010, OECOLOGIA, V162, P247, DOI 10.1007/s00442-009-1446-2; SCHOLANDER PF, 1955, EVOLUTION, V9, P15, DOI 10.1111/j.1558-5646.1955.tb01510.x; Senar JC, 1997, ARDEA, V85, P269; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith FA, 2006, J BIOGEOGR, V33, P2061, DOI 10.1111/j.1365-2699.2006.01631.x; SMITH TB, 1995, CONSERV BIOL, V9, P107, DOI 10.1046/j.1523-1739.1995.09010107.x; Svensson L., 1992, IDENTIFICATION GUIDE; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Tornberg R, 1999, OECOLOGIA, V121, P369, DOI 10.1007/s004420050941; Van Buskirk J, 2010, OIKOS, V119, P1047, DOI 10.1111/j.1600-0706.2009.18349.x; van Vliet J, 2009, BIRD STUDY, V56, P276, DOI 10.1080/00063650902792148; Vanhooydonck B, 2009, BIOL J LINN SOC, V98, P129, DOI 10.1111/j.1095-8312.2009.01269.x; VANNOORDWIJK AJ, 1988, GENET RES, V51, P149, DOI 10.1017/S0016672300024162; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; Winkler Hans, 2005, P79; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yom-Tov Y, 2006, OIKOS, V112, P91, DOI 10.1111/j.0030-1299.2006.14183.x; Yom-Tov Y, 2005, J ANIM ECOL, V74, P803, DOI 10.1111/j.1365-2656.2005.00976.x; Yom-Tov Y, 2001, P ROY SOC B-BIOL SCI, V268, P947, DOI 10.1098/rspb.2001.1592; Yom-Tov Y, 2006, J ORNITHOL, V147, P644, DOI 10.1007/s10336-006-0090-4; Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x; YOMTOV Y, 1986, J ZOOL, V208, P583; Zuur Alain F., 2009, P1	73	24	24	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101927	10.1371/journal.pone.0101927	http://dx.doi.org/10.1371/journal.pone.0101927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019159	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600033
J	Trakarnsanga, K; Wilson, MC; Griffiths, RE; Toye, AM; Carpenter, L; Heesom, KJ; Parsons, SF; Anstee, DJ; Frayne, J				Trakarnsanga, Kongtana; Wilson, Marieangela C.; Griffiths, Rebecca E.; Toye, Ashley M.; Carpenter, Lee; Heesom, Kate J.; Parsons, Steve F.; Anstee, David J.; Frayne, Jan			Qualitative and Quantitative Comparison of the Proteome of Erythroid Cells Differentiated from Human iPSCs and Adult Erythroid Cells by Multiplex TMT Labelling and NanoLC-MS/MS	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MEMBRANE; EXPRESSION; GENERATION; PROTEINS; CADHERIN; COMPLEX; ANEMIA	Induced pluripotent stem cells (iPSC) are an attractive progenitor source for the generation of in vitro blood products. However, before iPSC-derived erythroid cells can be considered for therapeutic use their similarity to adult erythroid cells must be confirmed. We have analysed the proteome of erythroid cells differentiated from the iPSC fibroblast derived line (C19) and showed they express hallmark RBC proteins, including all those of the ankyrin and 4.1R complex. We next compared the proteome of erythroid cells differentiated from three iPSC lines (C19, OCE1, OPM2) with that of adult and cord blood progenitors. Of the 1989 proteins quantified <3% differed in level by 2-fold or more between the different iPSC-derived erythroid cells. When compared to adult cells, 11% of proteins differed in level by 2-fold or more, falling to 1.9% if a 5-fold threshold was imposed to accommodate slight inter-cell line erythropoietic developmental variation. Notably, the level of >30 hallmark erythroid proteins was consistent between the iPSC lines and adult cells. In addition, a sub-population (10-15%) of iPSC erythroid cells in each of the iPSC lines completed enucleation. Aberrant expression of some cytoskeleton proteins may contribute to the failure of the majority of the cells to enucleate since we detected some alterations in cytoskeletal protein abundance. In conclusion, the proteome of erythroid cells differentiated from iPSC lines is very similar to that of normal adult erythroid cells, but further work to improve the induction of erythroid cells in existing iPSC lines or to generate novel erythroid cell lines is required before iPSC-derived red cells can be considered suitable for transfusion therapy.	[Trakarnsanga, Kongtana; Wilson, Marieangela C.; Toye, Ashley M.; Heesom, Kate J.; Frayne, Jan] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Trakarnsanga, Kongtana] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Griffiths, Rebecca E.; Toye, Ashley M.; Parsons, Steve F.; Anstee, David J.] NHSBT, Bristol Inst Transfus Sci, Bristol, Avon, England; [Carpenter, Lee] John Radcliffe Hosp, Natl Hlth Serv Blood & Transplant, Blood Res Lab, Oxford OX3 9DU, England	University of Bristol; Mahidol University; NHS Blood & Transplant (NHSBT); University of Oxford	Frayne, J (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	Jan.Frayne@Bristol.ac.uk	Toye, Ashley Mark/AAV-7199-2021; Anstee, David/AAE-9231-2020; Griffiths, Rebecca E/C-6127-2017; Toye, Ashley Mark/AFO-2320-2022	Toye, Ashley Mark/0000-0003-4395-9396; Griffiths, Rebecca E/0000-0001-7461-0635; Toye, Ashley Mark/0000-0003-4395-9396; Frayne, Jan/0000-0002-1113-7761; Wilson, Marieangela/0000-0001-6218-3533	Department of Health (England); NHSBT RD; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	Department of Health (England); NHSBT RD; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Department of Health (England), NHSBT R&D and funding from Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee DJ, 2011, VOX SANG, V100, P140, DOI 10.1111/j.1423-0410.2010.01388.x; Bell AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060300; Bieker JJ, 2005, MT SINAI J MED, V72, P333; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Carpenter L, 2011, BLOOD, V117, P4008, DOI 10.1182/blood-2010-08-299941; Chang CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025761; CHASIS JA, 1993, J CLIN INVEST, V91, P329, DOI 10.1172/JCI116189; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Dias J, 2011, STEM CELLS DEV, V20, P1639, DOI 10.1089/scd.2011.0078; Drews K, 2012, J MOL MED, V90, P735, DOI 10.1007/s00109-012-0913-0; Flatt JF, 2011, BLOOD, V118, P5267, DOI 10.1182/blood-2010-12-326645; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HORNE WC, 1993, BLOOD, V82, P2558; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Keerthivasan G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/139851; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; Lapillonne H, 2010, HAEMATOL-HEMATOL J, V95, P1651, DOI 10.3324/haematol.2010.023556; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Peyrard T, 2011, TRANSFUS MED REV, V25, P206, DOI 10.1016/j.tmrv.2011.01.002; Ponnusamy S, 2012, J PROTEOMICS, V75, P5762, DOI 10.1016/j.jprot.2012.07.020; Rombouts K, 2012, AM J PHYSIOL-CELL PH, V303, pC357, DOI 10.1152/ajpcell.00093.2012; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Seifinejad A, 2010, BIOCHEM BIOPH RES CO, V391, P329, DOI 10.1016/j.bbrc.2009.11.058; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Toye AM, 2008, BLOOD, V111, P5380, DOI 10.1182/blood-2007-07-099473; Ubukawa K, 2012, BLOOD, V119, P1036, DOI 10.1182/blood-2011-06-361907; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Viprakasit V., 2014, BLOOD; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557	41	40	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e100874	10.1371/journal.pone.0100874	http://dx.doi.org/10.1371/journal.pone.0100874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019302	Green Published, gold, Green Submitted			2022-12-27	WOS:000339618600008
J	Oppliger, LV; von Dassow, P; Bouchemousse, S; Robuchon, M; Valero, M; Correa, JA; Mauger, S; Destombe, C				Valeria Oppliger, Luz; von Dassow, Peter; Bouchemousse, Sarah; Robuchon, Marine; Valero, Myriam; Correa, Juan A.; Mauger, Stephane; Destombe, Christophe			Alteration of Sexual Reproduction and Genetic Diversity in the Kelp Species Laminaria digitata at the Southern Limit of Its Range	PLOS ONE			English	Article							PARTHENOGENESIS; HYBRIDIZATION; ORIGIN; POLYPLOIDIZATION; PHAEOPHYCEAE; CONSERVATION; POPULATIONS; ADAPTATION; HYPOTHESIS; MANAGEMENT	Adaptation to marginal habitats at species range-limits has often been associated with parthenogenetic reproduction in terrestrial animals and plants. Laboratory observations have shown that brown algae exhibit a high propensity for parthenogenesis by various mechanisms. The kelp Laminaria digitata is an important component of the ecosystem in Northern European rocky intertidal habitats. We studied four L. digitata populations for the effects of marginality on genetic diversity and sexual reproduction. Two populations were marginal: One (Locquirec, in Northern Brittany) was well within the geographic range, but was genetically isolated from other populations by large stretches of sandy beaches. Another population was at the range limits of the species (Quiberon, in Southern Brittany) and was exposed to much higher seasonal temperature changes. Microsatellite analyses confirmed that these populations showed decreased genetic and allelic diversity, consistent with marginality and genetic isolation. Sporophytes from both marginal populations showed greatly diminished spore-production compared to central populations, but only the southern-limit population (Quiberon) showed a high propensity for producing unreduced (2N) spores. Unreduced 2N spores formed phenotypically normal gametophytes with nuclear area consistent with >= 2N DNA contents, and microsatellite studies suggested these were produced at least in part by automixis. However, despite this being the dominant path of spore production in Quiberon sporophyte individuals, the genetic evidence indicated the population was maintained mostly by sexual reproduction. Thus, although spore production and development showed the expected tendency of geographical parthenogenesis in marginal populations, this appeared to be a consequence of maladaptation, rather than an adaptation to, life in a marginal habitat.	[Valeria Oppliger, Luz; von Dassow, Peter; Correa, Juan A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Valeria Oppliger, Luz; Bouchemousse, Sarah; Robuchon, Marine; Valero, Myriam; Mauger, Stephane; Destombe, Christophe] Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, UMR 7144, Roscoff, France; [Valeria Oppliger, Luz; Bouchemousse, Sarah; Robuchon, Marine; Valero, Myriam; Mauger, Stephane; Destombe, Christophe] CNRS, Stn Biol Roscoff, UMR 7144, Roscoff, France; [von Dassow, Peter] Pontificia Univ Catolica Chile, IMO, Santiago, Chile; [Robuchon, Marine] Museum Natl Hist Nat, Inst Systemat, UMR 7205, F-75231 Paris, France; [Valeria Oppliger, Luz; Correa, Juan A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Appl Ecol & Sustainabil, Santiago, Chile	Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile	Oppliger, LV (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Alameda 340, Santiago, Chile.	valeriaoppliger@gmail.com	von Dassow, Peter/A-5399-2012; Bouchemousse, Sarah/AAT-3655-2021; Robuchon, Marine/D-4019-2018; Valero, Myriam/C-7550-2011; Valero, Myriam/M-6052-2019	Bouchemousse, Sarah/0000-0001-5283-5112; Robuchon, Marine/0000-0001-5873-2915; Valero, Myriam/0000-0002-9000-1423; Valero, Myriam/0000-0002-9000-1423; Mauger, Stephane/0000-0002-8779-1516; von Dassow, Peter/0000-0002-1858-1953; Destombe, Christophe/0000-0001-5656-9659	CONICYT-FRENCH EMBASSY Ph.D. grant; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme [PIIF-GA-2008-221812]; French Ministry of Foreign Affairs [FONDAP 1501-0001, ANR 06 BDIV 012]; Laboratoire International Associe "Dispersal and Adaptation of Marine Species (LIA DIAMS)	CONICYT-FRENCH EMBASSY Ph.D. grant; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme(European Commission); French Ministry of Foreign Affairs; Laboratoire International Associe "Dispersal and Adaptation of Marine Species (LIA DIAMS)	V. Oppliger was supported by a CONICYT-FRENCH EMBASSY Ph.D. grant. P. von Dassow was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme (Grant PIIF-GA-2008-221812). This study is part of the research programs FONDAP 1501-0001 Program 7, ANR ECOKELP (ANR 06 BDIV 012), "ARCUS'' of the French Ministry of Foreign Affairs, and the Laboratoire International Associe "Dispersal and Adaptation of Marine Species (LIA DIAMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson S, 2010, EVOLUTION, V64, P986, DOI 10.1111/j.1558-5646.2009.00872.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Asensi A, 2001, J PHYCOL, V37, P411, DOI 10.1046/j.1529-8817.2001.037003411.x; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Bartsch I, 2013, J PHYCOL, V49, P1061, DOI 10.1111/jpy.12125; BEATON MJ, 1988, AM NAT, V132, P837, DOI 10.1086/284892; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Billot C, 1998, MOL ECOL, V7, P1778, DOI 10.1046/j.1365-294x.1998.00516.x; Billot C, 2003, MAR ECOL PROG SER, V253, P111, DOI 10.3354/meps253111; Bothwell JH, 2010, NEW PHYTOL, V188, P111, DOI 10.1111/j.1469-8137.2010.03357.x; Couceiro L, 2013, AQUAT LIVING RESOUR, V26, P197, DOI 10.1051/alr/2012027; CUELLAR O, 1974, AM NAT, V108, P625, DOI 10.1086/282940; DIECK IT, 1992, PHYCOLOGIA, V31, P147, DOI 10.2216/i0031-8884-31-2-147.1; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; FANG TC, 1984, HYDROBIOLOGIA, V116, P317, DOI 10.1007/BF00027693; Fang TC, 1983, SUMMARY GENETIC STUD, P123; Fierst JL, 2010, PHYCOLOGIA, V49, P274, DOI 10.2216/PH09-41.1; Gall EA, 1996, EUR J PHYCOL, V31, P369, DOI 10.1080/09670269600651601; Gallon R, 2014, J BIOGEOGRAPHY; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Haag CR, 2004, ANN ZOOL FENN, V41, P539; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Horandl E, 2006, NEW PHYTOL, V171, P525, DOI 10.1111/j.1469-8137.2006.01769.x; Kamiya M, 2008, J PHYCOL, V44, P977, DOI 10.1111/j.1529-8817.2008.00551.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kearney M, 2006, TRENDS ECOL EVOL, V21, P10, DOI 10.1016/j.tree.2005.10.013; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kearney MR, 2003, TRENDS ECOL EVOL, V18, P605, DOI 10.1016/j.tree.2003.09.021; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; LEE JA, 1986, J PHYCOL, V22, P276, DOI 10.1111/j.1529-8817.1986.tb00024.x; Lewis RJ, 1996, PHYCOLOGIA, V35, P19, DOI 10.2216/i0031-8884-35-1-19.1; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Lundmark M, 2006, TRENDS ECOL EVOL, V21, P9, DOI 10.1016/j.tree.2005.10.007; Luning K, 1990, SEAWEEDS THEIR ENV B; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; MARIE D, 2000, CURRENT PROTOCOLS CY, P1; Maynard Smith J., 1978, EVOLUTION SEX, DOI DOI 10.1093/bioinformatics/btg412; Meleder V, 2010, MAR BIOL, V157, P1525, DOI 10.1007/s00227-010-1426-4; Mills KE, 2006, BOT MAR, V49, P417, DOI 10.1515/BOT.2006.053; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NUNNEY L, 1989, EVOLUTION, V43, P245, DOI 10.1111/j.1558-5646.1989.tb04225.x; Oppliger LV, 2007, J PHYCOL, V43, P1295, DOI 10.1111/j.1529-8817.2007.00408.x; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peck JR, 1998, NATURE, V391, P889, DOI 10.1038/36099; Raybaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066044; Robuchon M, 2014, MOL ECOL, V23, P2669, DOI 10.1111/mec.12774; Roze D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001321; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Valero M, 2011, CAH BIOL MAR, V52, P467; van Dijk PJ, 2003, PHILOS T R SOC B, V358, P1113, DOI 10.1098/rstb.2003.1302; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; Wattier R, 1997, J PHYCOL, V33, P868, DOI 10.1111/j.0022-3646.1997.00868.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; West John A., 1999, Phycological Research, V47, P115, DOI 10.1111/j.1440-1835.1999.tb00292.x	64	32	32	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102518	10.1371/journal.pone.0102518	http://dx.doi.org/10.1371/journal.pone.0102518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019953	gold, Green Published, Green Submitted			2022-12-27	WOS:000339618600090
J	Belcaid, Z; Phallen, JA; Zeng, J; See, AP; Mathios, D; Gottschalk, C; Nicholas, S; Kellett, M; Ruzevick, J; Jackson, C; Albesiano, E; Durham, NM; Ye, XB; Tran, PT; Tyler, B; Wong, JW; Brem, H; Pardoll, DM; Drake, CG; Lim, M				Belcaid, Zineb; Phallen, Jillian A.; Zeng, Jing; See, Alfred P.; Mathios, Dimitrios; Gottschalk, Chelsea; Nicholas, Sarah; Kellett, Meghan; Ruzevick, Jacob; Jackson, Christopher; Albesiano, Emilia; Durham, Nicholas M.; Ye, Xiaobu; Tran, Phuoc T.; Tyler, Betty; Wong, John W.; Brem, Henry; Pardoll, Drew M.; Drake, Charles G.; Lim, Michael			Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; ADJUVANT TEMOZOLOMIDE; IMMUNOTHERAPY; IPILIMUMAB; RADIOTHERAPY; MELANOMA; CONCOMITANT; GUIDANCE; IMMUNITY	Background: Glioblastoma (GBM) is the most common malignant brain tumor in adults and is associated with a poor prognosis. Cytotoxic T lymphocyte antigen-4 (CTLA-4) blocking antibodies have demonstrated an ability to generate robust antitumor immune responses against a variety of solid tumors. 4-1BB (CD137) is expressed by activated T lymphocytes and served as a co-stimulatory signal, which promotes cytotoxic function. Here, we evaluate a combination immunotherapy regimen involving 4-1BB activation, CTLA-4 blockade, and focal radiation therapy in an immune-competent intracranial GBM model. Methods: GL261-luciferace cells were stereotactically implanted in the striatum of C57BL/6 mice. Mice were treated with a triple therapy regimen consisted of 4-1BB agonist antibodies, CTLA-4 blocking antibodies, and focal radiation therapy using a small animal radiation research platform and mice were followed for survival. Numbers of brain-infiltrating lymphocytes were analyzed by FACS analysis. CD4 or CD8 depleting antibodies were administered to determine the relative contribution of T helper and cytotoxic T cells in this regimen. To evaluate the ability of this immunotherapy to generate an antigen-specific memory response, long-term survivors were re-challenged with GL261 glioma en B16 melanoma flank tumors. Results: Mice treated with triple therapy had increased survival compared to mice treated with focal radiation therapy and immunotherapy with 4-1BB activation and CTLA-4 blockade. Animals treated with triple therapy exhibited at least 50% long-term tumor free survival. Treatment with triple therapy resulted in a higher density of CD4(+) and CD8(+) tumor infiltrating lymphocytes. Mechanistically, depletion of CD4(+) T cells abrogated the antitumor efficacy of triple therapy, while depletion of CD8(+) T cells had no effect on the treatment response. Conclusion: Combination therapy with 4-1BB activation and CTLA-4 blockade in the setting of focal radiation therapy improves survival in an orthotopic mouse model of glioma by a CD4(+) T cell dependent mechanism and generates antigen-specific memory.	[Belcaid, Zineb; Phallen, Jillian A.; See, Alfred P.; Mathios, Dimitrios; Gottschalk, Chelsea; Nicholas, Sarah; Kellett, Meghan; Ruzevick, Jacob; Jackson, Christopher; Ye, Xiaobu; Tyler, Betty; Brem, Henry; Lim, Michael] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Zeng, Jing; Tran, Phuoc T.; Wong, John W.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21205 USA; [Albesiano, Emilia; Durham, Nicholas M.; Pardoll, Drew M.; Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol & Med, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lim, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	mlim3@jhmi.edu	See, Alfred/AAD-6766-2022; Tran, Phuoc/W-2084-2019	See, Alfred/0000-0003-3634-4692; Tran, Phuoc/0000-0002-0147-0376; Lim, Michael/0000-0003-0523-3076	Accuray; Bristol-Meyers Squibb; Celldex; Agenus; Aduro; Medarex; NATIONAL CANCER INSTITUTE [R01CA166348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	Accuray; Bristol-Meyers Squibb(Bristol-Myers Squibb); Celldex; Agenus; Aduro; Medarex; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Michael Lim is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria. Michael Lim is also a speaker for Accuray and receives research funding from Accuray, Bristol-Meyers Squibb, Celldex and Agenus. Charles Drake is a consultant for Bristol-Meyers Squibb, Compugen, Dendreon, and Roche/Genentech and he is an advisor for Aduro and Bristol-Meyers Squibb. He receives research funding from Bristol-Meyers Squibb, Aduro and Medarex and has stock ownership of Compugen. Drew Pardoll is a consultant/advisor for Jounce Therapeutics, Bristol-Meyers Squibb, ImmuneXcite and Aduro and receives research funding from Bristol-Meyers Squibb. Jing Zeng, Michael Lim, Charles Drake and Drew Pardoll hold a patent for the work related to this study. The authors declare that they have a patent relating to material pertinent to this article; this international patent application PCT/US2012/043124 entitled "Use of Adjuvant Focused Radiation Including Stereotactic Radiosurgery for Augmenting Immune Based Therapies Against Neoplasms'' was filed 19 June 2012. This application was subsequently filed on the national stage in the United Stage, Europe, Canada, Australia, India and China. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agarwalla P, 2012, J IMMUNOTHER, V35, P385, DOI 10.1097/CJI.0b013e3182562d59; Albesiano E, 2010, NEUROSURG CLIN N AM, V21, P17, DOI 10.1016/j.nec.2009.08.008; Armour M, 2010, RADIAT RES, V173, P119, DOI 10.1667/RR1845.1; Callahan MK, 2010, SEMIN ONCOL, V37, P473, DOI 10.1053/j.seminoncol.2010.09.001; Chi DDJ, 1997, AM J PATHOL, V150, P2143; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Fecci PE, 2007, CLIN CANCER RES, V13, P2158, DOI 10.1158/1078-0432.CCR-06-2070; Ferrara TA, 2009, CURR OPIN MOL THER, V11, P37; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Grossman SA, 2011, CLIN CANCER RES, V17, P5473, DOI 10.1158/1078-0432.CCR-11-0774; Hodge JW, 2008, ONCOLOGY-NY, V22, P1064; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kuang YL, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/439235; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; POLLOK KE, 1993, J IMMUNOL, V150, P771; Prins RM, 2003, CANCER RES, V63, P8487; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Silk AW, 2013, CANCER MED-US, V2, P899, DOI 10.1002/cam4.140; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wada S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-89; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025	34	174	179	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101764	10.1371/journal.pone.0101764	http://dx.doi.org/10.1371/journal.pone.0101764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013914	Green Published, Green Submitted, gold			2022-12-27	WOS:000339378400036
J	Voon, V; Mole, TB; Banca, P; Porter, L; Morris, L; Mitchell, S; Lapa, TR; Karr, J; Harrison, NA; Potenza, MN; Irvine, M				Voon, Valerie; Mole, Thomas B.; Banca, Paula; Porter, Laura; Morris, Laurel; Mitchell, Simon; Lapa, Tatyana R.; Karr, Judy; Harrison, Neil A.; Potenza, Marc N.; Irvine, Michael			Neural Correlates of Sexual Cue Reactivity in Individuals with and without Compulsive Sexual Behaviours	PLOS ONE			English	Article							IMPULSE-CONTROL DISORDERS; CINGULATE CORTEX; PSYCHIATRIC-INPATIENTS; HYPERSEXUAL DISORDER; PARKINSONS-DISEASE; COGNITIVE CONTROL; BRAIN POTENTIALS; FRONTAL-CORTEX; COCAINE CUES; HUMAN MALES	Although compulsive sexual behaviour (CSB) has been conceptualized as a "behavioural" addiction and common or overlapping neural circuits may govern the processing of natural and drug rewards, little is known regarding the responses to sexually explicit materials in individuals with and without CSB. Here, the processing of cues of varying sexual content was assessed in individuals with and without CSB, focusing on neural regions identified in prior studies of drug-cue reactivity. 19 CSB subjects and 19 healthy volunteers were assessed using functional MRI comparing sexually explicit videos with nonsexual exciting videos. Ratings of sexual desire and liking were obtained. Relative to healthy volunteers, CSB subjects had greater desire but similar liking scores in response to the sexually explicit videos. Exposure to sexually explicit cues in CSB compared to non-CSB subjects was associated with activation of the dorsal anterior cingulate, ventral striatum and amygdala. Functional connectivity of the dorsal anterior cingulate-ventral striatum-amygdala network was associated with subjective sexual desire (but not liking) to a greater degree in CSB relative to non-CSB subjects. The dissociation between desire or wanting and liking is consistent with theories of incentive motivation underlying CSB as in drug addictions. Neural differences in the processing of sexual-cue reactivity were identified in CSB subjects in regions previously implicated in drug-cue reactivity studies. The greater engagement of corticostriatal limbic circuitry in CSB following exposure to sexual cues suggests neural mechanisms underlying CSB and potential biological targets for interventions.	[Voon, Valerie; Mole, Thomas B.; Banca, Paula; Porter, Laura; Morris, Laurel; Mitchell, Simon; Lapa, Tatyana R.; Irvine, Michael] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; [Voon, Valerie; Morris, Laurel] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 2QQ, England; [Voon, Valerie; Mole, Thomas B.; Mitchell, Simon] Cambridgeshire & Peterborough Fdn Trust, Cambridge, England; [Karr, Judy] British Assoc Counselling & Psychotherapy, London, England; [Harrison, Neil A.] Brighton & Sussex Med Sch, Dept Psychiat, Brighton, E Sussex, England; [Potenza, Marc N.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Potenza, Marc N.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Brighton; University of Sussex; Yale University; Yale University; Yale University	Voon, V (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England.	vv247@cam.ac.uk	Morris, Laurel/AAS-4655-2021; Mole, Tom/P-7588-2015; Banca, Paula/G-8330-2017; Voon, Valerie/O-7038-2017	Mole, Tom/0000-0001-8732-8188; Banca, Paula/0000-0001-7617-3635; Voon, Valerie/0000-0001-6790-1776; Harrison, Neil/0000-0002-9584-3769; Morris, Laurel S./0000-0002-5862-6650	Wellcome Trust Intermediate Fellowship grant [093705/Z/10/Z]; National Institutes of Health [DA027844, R01 DA018647]; Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; Medical Research Council [G0001354B, G1000183B, G0001354] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA027844, R01DA018647] Funding Source: NIH RePORTER	Wellcome Trust Intermediate Fellowship grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding provided by Wellcome Trust Intermediate Fellowship grant (093705/Z/10/Z). Dr. Potenza was supported in part by grants P20 DA027844 and R01 DA018647 from the National Institutes of Health; the Connecticut State Department of Mental Health and Addiction Services; the Connecticut Mental Health Center; and a Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1016/B978-0-12-809324-5.05530-9]; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bocher M, 2001, NEUROIMAGE, V14, P105, DOI 10.1006/nimg.2001.0794; Carnes P. J., 2001, SHADOWS NET BREAKING; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Childress A R, 1993, NIDA Res Monogr, V137, P73; Delmonico DL, 2003, SEXUAL RELATIONSHIP, V18; Dunning JP, 2011, EUR J NEUROSCI, V33, P1716, DOI 10.1111/j.1460-9568.2011.07663.x; Euser AS, 2012, NEUROSCI BIOBEHAV R, V36, P572, DOI 10.1016/j.neubiorev.2011.09.002; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; Fong Timothy W, 2006, Psychiatry (Edgmont), V3, P51; Franken IHA, 2004, J PSYCHOPHARMACOL, V18, P544, DOI 10.1177/0269881104047282; Franken IHA, 2003, PSYCHOPHARMACOLOGY, V170, P205, DOI 10.1007/s00213-003-1542-7; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Grant JE, 2005, AM J PSYCHIAT, V162, P2184, DOI 10.1176/appi.ajp.162.11.2184; Grant JE, 2007, J CLIN PSYCHIAT, V68, P1584, DOI 10.4088/JCP.v68n1018; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Heinze M, 2007, CLIN NEUROPHYSIOL, V118, P856, DOI 10.1016/j.clinph.2006.12.003; Kafka MP, 2010, ARCH SEX BEHAV, V39, P377, DOI 10.1007/s10508-009-9574-7; Kataoka H, 2009, MOVEMENT DISORD, V24, P471, DOI 10.1002/mds.22373; Kor A, 2013, SEX ADDICT COMPULSIV, V20; Kuhn S, 2014, JAMA PSYCHIAT; Kuhn S, 2011, J SEX MED, V8, P2269, DOI 10.1111/j.1743-6109.2011.02322.x; Kuhn S, 2011, EUR J NEUROSCI, V33, P1318, DOI 10.1111/j.1460-9568.2010.07590.x; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Lubman DI, 2008, J PSYCHOPHARMACOL, V22, P836, DOI 10.1177/0269881107083846; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Miner MH, 2009, PSYCHIAT RES-NEUROIM, V174, P146, DOI 10.1016/j.pscychresns.2009.04.008; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nelson HE., 1982, NATL ADULT READING T; Odlaug B.L., 2010, PRIM CARE COMPANION, V12; Odlaug BL, 2013, ANN CLIN PSYCHIATRY, V25, P193; Paul T, 2008, HUM BRAIN MAPP, V29, P726, DOI 10.1002/hbm.20435; Perry DC, 2014, BRAIN; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Politis M, 2013, BRAIN, V136, P400, DOI 10.1093/brain/aws326; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Reid RC, 2013, SEXUAL ADDICTION COM, V20, P14; Reid RC, 2012, J SEX MED, V9, P2868, DOI 10.1111/j.1743-6109.2012.02936.x; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sescousse G, 2013, NEUROSCI BIOBEHAV R, V37, P681, DOI 10.1016/j.neubiorev.2013.02.002; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Smith DG, 2014, BIOL PSYCHIAT, V75, P124, DOI 10.1016/j.biopsych.2013.05.019; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steele VR, 2013, SOCIOAFFECTIVE NEURO, V3, DOI 10.3402/snp.v3i0.20770; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; van de Laar MC, 2004, PSYCHOPHARMACOLOGY, V177, P121, DOI 10.1007/s00213-004-1928-1; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Warren CA, 1999, CLIN NEUROPHYSIOL, V110, P1570, DOI 10.1016/S1388-2457(99)00089-9; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	68	204	205	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102419	10.1371/journal.pone.0102419	http://dx.doi.org/10.1371/journal.pone.0102419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013940	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339378400094
J	Wang, R; Wang, YW; Lin, WK; Zhang, YM; Liu, W; Huang, K; Terrar, DA; Solaro, RJ; Wang, X; Ke, YB; Lei, M				Wang, Rui; Wang, Yanwen; Lin, Wee K.; Zhang, Yanmin; Liu, Wei; Huang, Kai; Terrar, Derek A.; Solaro, R. John; Wang, Xin; Ke, Yunbo; Lei, Ming			Inhibition of Angiotensin II-Induced Cardiac Hypertrophy and Associated Ventricular Arrhythmias by a p21 Activated Kinase 1 Bioactive Peptide	PLOS ONE			English	Article							PAK1; MYOCYTES; ACTIVATION; KINASE-1; ACTIN; HEART	Cardiac hypertrophy increases the risk of morbidity and mortality of cardiovascular disease and thus inhibiting such hypertrophy is beneficial. In the present study, we explored the effect of a bioactive peptide (PAP) on angiotensin II (Ang II)-induced hypertrophy and associated ventricular arrhythmias in in vitro and in vivo models. PAP enhances p21 activated kinase 1 (Pak1) activity by increasing the level of phosphorylated Pak1 in cultured neonatal rat ventricular myocytes (NRVMs). Such PAP-induced Pak1 activation is associated with a significant reduction of Ang II-induced hypertrophy in NRVMs and C57BL/6 mice, in vitro and in vivo, respectively. Furthermore, PAP antagonizes ventricular arrhythmias associated with Ang II-induced hypertrophy in mice. Its antiarrhythmic effect is likely to be involved in multiple mechanisms to affect both substrate and trigger of ventricular arrhythmogenesis. Thus our results suggest that Pak1 activation achieved by specific bioactive peptide represents a potential novel therapeutic strategy for cardiac hypertrophy and associated ventricular arrhythmias.	[Wang, Rui; Huang, Kai; Lei, Ming] Huazhong Univ Sci & Technol, Union Hosp, Inst Cardiovasc Dis, Wuhan 430074, Peoples R China; [Wang, Yanwen; Zhang, Yanmin; Liu, Wei] Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Manchester, Lancs, England; [Wang, Yanwen; Lin, Wee K.; Terrar, Derek A.; Lei, Ming] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Solaro, R. John; Ke, Yunbo] Univ Illinois, Coll Med, Cardiovasc Res Ctr, Dept Physiol & Biophys, Chicago, IL 60607 USA; [Wang, Xin] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Huazhong University of Science & Technology; University of Manchester; University of Oxford; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Manchester	Ke, YB (corresponding author), Univ Illinois, Coll Med, Cardiovasc Res Ctr, Dept Physiol & Biophys, Chicago, IL 60607 USA.	yke@uic.edu; ming.lei@pharm.ox.ac.uk	Lei, Ming/S-7209-2016; Wang, Yanwen/I-1654-2015	Lei, Ming/0000-0002-0928-341X; Wang, Yanwen/0000-0002-7986-4500; Liu, Wei/0000-0003-1592-6693; Terrar, Derek/0000-0001-9408-6594; Zhang, Yanmin/0000-0001-7307-9408	Chinese Nature Science Foundation [31171085]; British Heart Foundation [PG/12/21/29473]; Medical Research Council [G10002647]; Wellcome Trust [081809]; NIH/NHLBI [RO1 HL064035, PO1 HL062426, CCTS UL1RR029879]; MRC [G1002647] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, P01HL062426] Funding Source: NIH RePORTER; British Heart Foundation [PG/12/76/29852, PG/09/052/27833] Funding Source: researchfish; Medical Research Council [G1002647] Funding Source: researchfish	Chinese Nature Science Foundation; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by a Chinese Nature Science Foundation Grant (31171085: ML); British Heart Foundation (PG/12/21/29473: ML, XW); Medical Research Council (G10002647: ML, XW, RJS, YK); The Wellcome Trust (081809: ML); and NIH/NHLBI grants RO1 HL064035, PO1 HL062426 (RJS), CCTS UL1RR029879 (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2011, CARDIOVASC RES, V92, P106, DOI 10.1093/cvr/cvr163; Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Beeser A, 2005, METHODS, V37, P203, DOI 10.1016/j.ymeth.2005.05.017; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; Emdad L, 2001, J MOL CELL CARDIOL, V33, P219, DOI 10.1006/jmcc.2000.1293; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Ke YB, 2007, CIRC RES, V100, P1317, DOI 10.1161/01.RES.0000266742.51389.a4; Ke YB, 2008, PROG BIOPHYS MOL BIO, V98, P238, DOI 10.1016/j.pbiomolbio.2009.01.007; Liu W, 2011, CIRCULATION, V124, P2702, DOI 10.1161/CIRCULATIONAHA.111.048785; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Qu JX, 2009, CIRC RES, V104, P365, DOI 10.1161/CIRCRESAHA.108.184044; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; Sheridan DJ, 1999, BRIT J CLIN PHARMACO, V47, P125; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Thullberg M, 2007, ONCOGENE, V26, P1820, DOI 10.1038/sj.onc.1209983; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	18	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101974	10.1371/journal.pone.0101974	http://dx.doi.org/10.1371/journal.pone.0101974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014109	gold, Green Published, Green Submitted			2022-12-27	WOS:000339378400049
J	Yang, Y; Liu, Y; Cao, FQ; Chen, XP; Cheng, LS; Romeis, J; Li, YH; Peng, YF				Yang, Yan; Liu, Yue; Cao, Fengqin; Chen, Xiuping; Cheng, Lisheng; Romeis, Joerg; Li, Yunhe; Peng, Yufa			Consumption of Bt Rice Pollen Containing Cry1C or Cry2A Protein Poses a Low to Negligible Risk to the Silkworm Bombyx mori (Lepidoptera: Bombyxidae)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; EXPRESSION; TOXICITY; LARVAE; CROPS; CHINA; LINES	By consuming mulberry leaves covered with pollen from nearby genetically engineered, insect-resistant rice lines producing Cry proteins derived from Bacillus thuringiensis (Bt), larvae of the domestic silkworm, Bombyx mori (Linnaeus) (Lepidoptera: Bombyxidae), could be exposed to insecticidal proteins. Laboratory experiments were conducted to assess the potential effects of Cry1C- or Cry2A-producing transgenic rice (T1C-19, T2A-1) pollen on B. mori fitness. In a short-term assay, B. mori larvae were fed mulberry leaves covered with different densities of pollen from Bt rice lines or their corresponding near isoline (control) for the first 3 d and then were fed mulberry leaves without pollen. No effect was detected on any life table parameter, even at 1800 pollen grains/cm(2) leaf, which is much higher than the mean natural density of rice pollen on leaves of mulberry trees near paddy fields. In a long-term assay, the larvae were fed Bt and control pollen in the same way but for their entire larval stage (approximately 27 d). Bt pollen densities >= 150 grains/cm(2) leaf reduced 14-d larval weight, increased larval development time, and reduced adult eclosion rate. ELISA analyses showed that 72.6% of the Cry protein was still detected in the pollen grains excreted with the feces. The low exposure of silkworm larvae to Cry proteins when feeding Bt rice pollen may be the explanation for the relatively low toxicity detected in the current study. Although the results demonstrate that B. mori larvae are sensitive to Cry1C and Cry2A proteins, the exposure levels that harmed the larvae in the current study are far greater than natural exposure levels. We therefore conclude that consumption of Bt rice pollen will pose a low to negligible risk to B. mori.	[Yang, Yan; Liu, Yue; Cao, Fengqin] Hainan Univ, Coll Environm & Plant Protect, Haikou, Peoples R China; [Yang, Yan; Chen, Xiuping; Romeis, Joerg; Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Yang, Yan; Cheng, Lisheng] Qiongtai Teachers Coll, Haikou, Peoples R China; [Romeis, Joerg] Agroscope, Inst Sustainabil Sci, Zurich, Switzerland	Hainan University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope	Li, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yunhe.li@hotmail.com	peng, yu/GXW-2071-2022		National GMO New Variety Breeding Program of PRC [2014ZX08011-02B, 2014ZX08011-001]	National GMO New Variety Breeding Program of PRC	The study was supported by the National GMO New Variety Breeding Program of PRC (2014ZX08011-02B, 2014ZX08011-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; [樊龙江 Fan Longjiang], 2003, [生态学报, Acta Ecologica Sinica], V23, P826; Food and Agriculture Organization of the Unites Nations United Nations University World Health Organization, 2001, FAO FOOD NUTR TECHN; GE AZ, 1989, P NATL ACAD SCI USA, V86, P4037, DOI 10.1073/pnas.86.11.4037; IHARA H, 1993, BIOSCI BIOTECH BIOCH, V57, P200, DOI 10.1271/bbb.57.200; Julia C, 2012, EUR J AGRON, V43, P166, DOI 10.1016/j.eja.2012.06.007; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Lang A, 2006, BASIC APPL ECOL, V7, P296, DOI 10.1016/j.baae.2005.10.003; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2014, ENVIRON TOXICOL CHEM, V33, P1391, DOI 10.1002/etc.2567; Li YH, 2014, PLANT CELL REP, V33, P565, DOI 10.1007/s00299-014-1567-x; Li YH, 2014, BIOL CONTROL, V69, P45, DOI 10.1016/j.biocontrol.2013.10.017; Li YH, 2013, ECOTOXICOLOGY, V22, P1413, DOI 10.1007/s10646-013-1127-0; Li YH, 2010, J INSECT PHYSIOL, V56, P157, DOI 10.1016/j.jinsphys.2009.09.011; Liu YQ, 2010, J INSECT SCI, V10, P1, DOI 10.1673/031.010.14140; Niu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072988; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; PUSZTAI M, 1991, BIOCHEM J, V273, P43, DOI 10.1042/bj2730043; Raybould A, 2011, J AGR FOOD CHEM, V59, P5877, DOI 10.1021/jf1042079; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Wang YN, 2014, ENVIRON ENTOMOL, V43, P528, DOI 10.1603/EN13254; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wang ZhongHua, 2001, Hereditas (Beijing), V23, P463; Wang ZhongHua, 2002, Scientia Agricultura Sinica, V35, P714; Yao HW, 2008, ENVIRON ENTOMOL, V37, P825, DOI 10.1603/0046-225X(2008)37[825:TAOPFD]2.0.CO;2; Yao HW, 2006, APPL ENTOMOL ZOOL, V41, P339, DOI 10.1303/aez.2006.339; Yuan Z, 2006, B SERICULTURE, V3, P23; Zhang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085395; Zhang XiuFu, 2005, Research of Agricultural Modernization, V26, P85; Zhang YJ, 2011, ENVIRON ENTOMOL, V40, P1323, DOI 10.1603/EN11035	33	10	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102302	10.1371/journal.pone.0102302	http://dx.doi.org/10.1371/journal.pone.0102302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014054	Green Published, gold, Green Submitted			2022-12-27	WOS:000339378400086
J	Deusch, O; O'Flynn, C; Colyer, A; Morris, P; Allaway, D; Jones, PG; Swanson, KS				Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Morris, Penelope; Allaway, David; Jones, Paul G.; Swanson, Kelly S.			Deep Illumina-Based Shotgun Sequencing Reveals Dietary Effects on the Structure and Function of the Fecal Microbiome of Growing Kittens	PLOS ONE			English	Article							MEGASPHAERA-ELSDENII; GUT MICROBIOTA; BACTERIAL; GENE; MUCIN; FERMENTATION; POPULATIONS; PCR; BIFIDOBACTERIA; HYBRIDIZATION	Background: Previously, we demonstrated that dietary protein: carbohydrate ratio dramatically affects the fecal microbial taxonomic structure of kittens using targeted 16S gene sequencing. The present study, using the same fecal samples, applied deep Illumina shotgun sequencing to identify the diet-associated functional potential and analyze taxonomic changes of the feline fecal microbiome. Methodology & Principal Findings: Fecal samples from kittens fed one of two diets differing in protein and carbohydrate content (high-protein, low-carbohydrate, HPLC; and moderate-protein, moderate-carbohydrate, MPMC) were collected at 8, 12 and 16 weeks of age (n = 6 per group). A total of 345.3 gigabases of sequence were generated from 36 samples, with 99.75% of annotated sequences identified as bacterial. At the genus level, 26% and 39% of reads were annotated for HPLC- and MPMC-fed kittens, with HPLC-fed cats showing greater species richness and microbial diversity. Two phyla, ten families and fifteen genera were responsible for more than 80% of the sequences at each taxonomic level for both diet groups, consistent with the previous taxonomic study. Significantly different abundances between diet groups were observed for 324 genera (56% of all genera identified) demonstrating widespread diet-induced changes in microbial taxonomic structure. Diversity was not affected over time. Functional analysis identified 2,013 putative enzyme function groups were different (p<0.000007) between the two dietary groups and were associated to 194 pathways, which formed five discrete clusters based on average relative abundance. Of those, ten contained more (p<0.022) enzyme functions with significant diet effects than expected by chance. Six pathways were related to amino acid biosynthesis and metabolism linking changes in dietary protein with functional differences of the gut microbiome. Conclusions: These data indicate that feline feces-derived microbiomes have large structural and functional differences relating to the dietary protein: carbohydrate ratio and highlight the impact of diet early in life.	[Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Morris, Penelope; Allaway, David; Jones, Paul G.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	Mars; WALTHAM Petcare Science Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Swanson, KS (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ksswanso@illinois.edu		Swanson, Kelly/0000-0001-5518-3076; Deusch, Oliver/0000-0003-3378-6129; Allaway, David/0000-0003-4602-8933	Mars Petcare	Mars Petcare	Funding was provided by Mars Petcare. The funders had no role in study design, data collection, and decision to publish (was the role of KSS). KSS, OD, and CO were the primary individuals that analyzed the data and wrote the manuscript.	AAFCO, 2007, OFF PUBL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barry KA, 2010, J ANIM SCI, V88, P2978, DOI 10.2527/jas.2009-2464; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Bermingham EN, 2013, MICROBIOLOGYOPEN, V2, P173, DOI 10.1002/mbo3.60; Biagi G, 2013, AM J VET RES, V74, P90, DOI 10.2460/ajvr.74.1.90; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Chan CKK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-215; COUNOTTE GHM, 1981, APPL ENVIRON MICROB, V42, P649, DOI 10.1128/AEM.42.4.649-655.1981; Delzenne NM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S10; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Faith J.J., 2013, SCIENCE, V341; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Goehler LE, 2008, BRAIN BEHAV IMMUN, V22, P354, DOI 10.1016/j.bbi.2007.08.009; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hartemink R, 1999, J MICROBIOL METH, V36, P181, DOI 10.1016/S0167-7012(99)00031-7; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; HISHINUMA F, 1968, AGR BIOL CHEM TOKYO, V32, P1325, DOI 10.1080/00021369.1968.10859234; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Inness VL, 2007, J ANIM PHYSIOL AN N, V91, P48, DOI 10.1111/j.1439-0396.2006.00640.x; JENSEN BB, 1994, APPL ENVIRON MICROB, V60, P1897, DOI 10.1128/AEM.60.6.1897-1904.1994; Jiao DZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002981; Kanakupt K, 2011, J ANIM SCI, V89, P1376, DOI 10.2527/jas.2010-3201; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu JM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks828; MACFARLANE GT, 1991, FEMS MICROBIOL LETT, V77, P289, DOI 10.1111/j.1574-6968.1991.tb04363.x; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Meakins TS, 1996, CLIN SCI, V90, P215, DOI 10.1042/cs0900215; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ricke SC, 1996, CRIT REV MICROBIOL, V22, P27, DOI 10.3109/10408419609106455; Ricke SC, 1996, APPL MICROBIOL BIOT, V46, P169, DOI 10.1007/s002530050800; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; ROBERTON AM, 1982, APPL ENVIRON MICROB, V43, P325, DOI 10.1128/AEM.43.2.325-330.1982; Rodriguez-Prado M, 2004, J DAIRY SCI, V87, P1413, DOI 10.3168/jds.S0022-0302(04)73290-7; Rosin FM, 2005, TRENDS PLANT SCI, V10, P516, DOI 10.1016/j.tplants.2005.09.002; Ruas-Madiedo P, 2008, APPL ENVIRON MICROB, V74, P1936, DOI 10.1128/AEM.02509-07; RUSSELL JB, 1978, APPL ENVIRON MICROB, V36, P319, DOI 10.1128/AEM.36.2.319-329.1978; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selle K, 2013, FEMS MICROBIOL REV; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; TERADA A, 1993, J VET MED SCI, V55, P291, DOI 10.1292/jvms.55.291; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2011, GUT MICROBES, V2, P183, DOI 10.4161/gmic.2.3.16105; Vester BM, 2009, ARCH ANIM NUTR, V63, P254, DOI 10.1080/17450390902860000; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; Warren YA, 2006, J CLIN MICROBIOL, V44, P2416, DOI 10.1128/JCM.00116-06; Wright DP, 2000, J BACTERIOL, V182, P3002, DOI 10.1128/JB.182.11.3002-3007.2000; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yoshida Y, 2009, ANIM SCI J, V80, P709, DOI 10.1111/j.1740-0929.2009.00692.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	76	34	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101021	10.1371/journal.pone.0101021	http://dx.doi.org/10.1371/journal.pone.0101021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010839	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800012
J	Temma, T; Hanaoka, H; Yonezawa, A; Kondo, N; Sano, K; Sakamoto, T; Seiki, M; Ono, M; Saji, H				Temma, Takashi; Hanaoka, Hirofumi; Yonezawa, Aki; Kondo, Naoya; Sano, Kohei; Sakamoto, Takeharu; Seiki, Motoharu; Ono, Masahiro; Saji, Hideo			Investigation of a MMP-2 Activity-Dependent Anchoring Probe for Nuclear Imaging of Cancer	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; PEPTIDES; FLUORESCENCE; INHIBITION; STRATEGY; THERAPY; TARGET; CELLS	Purpose: Since matrix metalloproteinase-2 (MMP-2) is an important marker of tumor malignancy, we developed an original drug design strategy, MMP-2 activity dependent anchoring probes (MDAP), for use in MMP-2 activity imaging, and evaluated the usefulness of this probe in in vitro and in vivo experiments. Methods: We designed and synthesized MDAP(1000), MDAP(3000), and MDAP(5000), which consist of 4 independent moieties: RI unit (111 In hydrophilic chelate), MMP-2 substrate unit (short peptide), anchoring unit (alkyl chain), and anchoring inhibition unit (polyethylene glycol (PEGn; where n represents the approximate molecular weight, n = 1000, 3000, and 5000). Probe cleavage was evaluated by chromatography after MMP-2 treatment. Cellular uptake of the probes was then measured. Radioactivity accumulation in tumor xenografts was evaluated after intravenous injection of the probes, and probe cleavage was evaluated in tumor homogenates. Results: MDAP(1000), MDAP(3000), and MDAP(5000) were cleaved by MMP-2 in a concentration-dependent manner. MDAP(3000) pretreated with MMP-2 showed higher accumulation in tumor cells, and was completely blocked by additional treatment with an MMP inhibitor. MDAP(3000) exhibited rapid blood clearance and a high tumor accumulation after intravenous injection in a rodent model. Furthermore, pharmacokinetic analysis revealed that MDAP(3000) exhibited a considerably slow washout rate from tumors to blood. A certain fraction of cleaved MDAP(3000) existed in tumor xenografts in vivo. Conclusions: The results indicate the possible usefulness of our MDAP strategy for tumor imaging.	[Temma, Takashi; Yonezawa, Aki; Kondo, Naoya; Sano, Kohei; Ono, Masahiro; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto, Japan; [Hanaoka, Hirofumi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chuo Ku, Chiba, Japan; [Sano, Kohei] Kyoto Univ, Fac Med, Kyoto Univ Hosp, Radioisotopes Res Lab,Sakyo Ku, Kyoto, Japan; [Sakamoto, Takeharu; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	Kyoto University; Chiba University; Kyoto University; University of Tokyo	Saji, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto, Japan.	hsaji@pharm.kyoto-u.ac.jp	Hanaoka, Hirofumi/T-6261-2019; Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015; Temma, Takashi/AAG-6809-2019	Hanaoka, Hirofumi/0000-0003-2421-7397; Sakamoto, Takeharu/0000-0002-1225-1902; Temma, Takashi/0000-0002-7345-6004; Kondo, Naoya/0000-0002-8082-8849	JSPS KAKENHI [22791189]; New Energy and Industrial Technology Development Organization (NEDO), Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by JSPS KAKENHI Grant Number 22791189. Part of this study was supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balon HR, 2001, J NUCL MED, V42, P1134; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Chen C, 2011, EXPERT OPIN DRUG DEL, V8, P1221, DOI 10.1517/17425247.2011.602399; Chien MH, 2013, EXPERT OPIN THER TAR, V17, P203, DOI 10.1517/14728222.2013.740012; Chuang CH, 2012, CLIN CANCER RES, V18, P238, DOI 10.1158/1078-0432.CCR-11-0608; Cornelissen B, 2011, J NUCL MED, V52, P776, DOI 10.2967/jnumed.110.084392; Kato K, 2004, BIOTECHNOL PROGR, V20, P897, DOI 10.1021/bp0342093; Kondo N, 2013, CANCER SCI, V104, P495, DOI 10.1111/cas.12102; Leyton JV, 2011, J NUCL MED, V52, P1465, DOI 10.2967/jnumed.111.087668; Myochin T, 2012, J AM CHEM SOC, V134, P13730, DOI 10.1021/ja303931b; Nestor JJ, 2009, CURR MED CHEM, V16, P4399, DOI 10.2174/092986709789712907; Nishigori K, 2013, NUCL MED BIOL, V40, P97, DOI 10.1016/j.nucmedbio.2012.08.002; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Sakamoto T, 2014, MOL CELL BIOL, V34, P30, DOI 10.1128/MCB.01169-13; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; Shimizu Y, 2011, CANCER SCI, V102, P1897, DOI 10.1111/j.1349-7006.2011.02020.x; Stabin MG, 2005, J NUCL MED, V46, P1023; van Duijnhoven SMJ, 2011, J NUCL MED, V52, P279, DOI 10.2967/jnumed.110.082503; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zhao T, 2010, J CONTROL RELEASE, V144, P109, DOI 10.1016/j.jconrel.2010.01.023	21	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102180	10.1371/journal.pone.0102180	http://dx.doi.org/10.1371/journal.pone.0102180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010662	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800076
J	Chen, YY; Liu, JB; Huang, XB; Cai, SX; Su, ZM; Zhong, R; Zou, L; Miao, XP				Chen, Yan-Yan; Liu, Jian-Bing; Huang, Xi-Bao; Cai, Shun-Xiang; Su, Zheng-Ming; Zhong, Rong; Zou, Li; Miao, Xiao-Ping			New Integrated Strategy Emphasizing Infection Source Control to Curb Schistosomiasis japonica in a Marshland Area of Hubei Province, China: Findings from an Eight-Year Longitudinal Survey	PLOS ONE			English	Article							DONGTING LAKE REGION; REPUBLIC-OF-CHINA; ONCOMELANIA-HUPENSIS; CONTROL TRANSMISSION; GORGES DAM; IMPACT; PRAZIQUANTEL; METAANALYSIS; DOWNSTREAM; MORBIDITY	Background: Schistosomiasis remains a major public health problem in China. The major endemic foci are the lake and marshland regions of southern China, particularly the regions along the middle and lower reach of the Yangtze River in four provinces (Hubei, Hunan, Jiangxi, and Anhui). The purpose of our study is to assess the effect of a new integrated strategy emphasizing infection source control to curb schistosomiasis in marshland regions. Methods: In a longitudinal study, we implemented an integrated control strategy emphasizing infection source control in 16 villages from 2005 through 2012 in marshland regions of Hubei province. The interventions included removing cattle from snail-infested grasslands, providing farmers with mechanized farm equipment, improving sanitation by supplying tap water, building lavatories and latrines, praziquantel chemotherapy, controlling snails, and environmental modification. Results: Following the integrated control strategy designed to reduce the role of bovines and humans as sources of Schistosoma japonicum infection, the prevalence of human S. japonicum infection declined from 1.7% in 2005 to 0.4% in 2012 (P<0.001). Reductions were also observed in both sexes, across all age groups, and among high risk occupations. Moreover, the prevalence of bovine S. japonicum infection decreased from 11.7% in 2005 to 0.6% in 2012 (P<0.001). In addition, all the 16 villages achieved the national criteria of infection control in 2008. Conclusion: Our findings indicate that the integrated strategy was likely effective in controlling the transmission of S. japonicum in marshland regions in China.	[Chen, Yan-Yan; Zhong, Rong; Zou, Li; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth,Dept Epidemio, Wuhan 430074, Peoples R China; [Chen, Yan-Yan; Liu, Jian-Bing; Huang, Xi-Bao; Cai, Shun-Xiang; Su, Zheng-Ming] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China	Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth,Dept Epidemio, Wuhan 430074, Peoples R China.	hbcdcxf@126.com; miaoxp@gmail.com	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Calu, Donna/0000-0003-2377-9494	National Science and Technology Support Program in China [2009BAI78B07]; Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China [XF2010-5, XF2010-30, XF2012-24, XF2012-26]	National Science and Technology Support Program in China; Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China	This study was funded by the National Science and Technology Support Program in China (2009BAI78B07), and the Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China (XF2010-5, XF2010-30, XF2012-24, XF2012-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EP STAT SCHIST CHIN; [Anonymous], 1992, WORLD BANK LOAN PROG; Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Chen XY, 2005, B WORLD HEALTH ORGAN, V83, P43; Chen YanYan, 2010, Chinese Journal of Schistosomiasis Control, V22, P411; Gray DJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001588; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; HALL SC, 1970, CALIF MED, V113, P75; He Hui, 2010, Redai Yixue Zazhi, V10, P1243; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Jiang MingSen, 2010, Chinese Journal of Schistosomiasis Control, V22, P201; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Kumagai T, 2010, AM J TROP MED HYG, V83, P542, DOI 10.4269/ajtmh.2010.10-0016; Li SZ, 2009, CHINESE MED J-PEKING, V122, P1009, DOI 10.3760/cma.j.issn.0366-6999.2009.09.002; Li YS, 2007, EMERG INFECT DIS, V13, P973, DOI 10.3201/eid1307.060848; Liao SiQi, 2009, Journal of Tropical Medicine (Guangzhou), V9, P1288; Liu R, 2013, PARASITOL RES, V112, P1483, DOI 10.1007/s00436-013-3295-5; Liu R, 2012, PARASITOL RES, V110, P2081, DOI 10.1007/s00436-011-2721-9; Liu Wei, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P206; MAO SB, 1986, CHINESE MED J-PEKING, V99, P439; McManus DP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001053; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Ross Allen G.P., 2001, Biologist (London), V48, P121; Seto EYW, 2008, ECOHEALTH, V5, P149, DOI 10.1007/s10393-008-0169-x; SHOUPAI M, 1982, AM J TROP MED HYG, V31, P92, DOI 10.4269/ajtmh.1982.31.92; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stone R, 2008, SCIENCE, V321, P628, DOI 10.1126/science.321.5889.628; Sun CS, 2002, ACTA TROP, V82, P169, DOI 10.1016/S0001-706X(02)00008-6; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; WHO, 2006, WHO PREV CHEM HUM HE; X-hW Yang Hao, 2006, CHIN J SCHISTO CONTR, V18, P321; Zhao GM, 2005, ACTA TROP, V96, P288, DOI 10.1016/j.actatropica.2005.07.023; Zheng J, 2002, ACTA TROP, V82, P147, DOI 10.1016/S0001-706X(02)00046-3; Zhongdao Wu, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P163; Zhou D, 1994, World Health Forum, V15, P387; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou YB, 2007, ANN TROP MED PARASIT, V101, P695, DOI 10.1179/136485907X241488; Zhou YB, 2011, AM J TROP MED HYG, V85, P83, DOI 10.4269/ajtmh.2011.10-0574; Zhu Hong, 2011, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V6, P908; Zhu Hong, 2010, Journal of Tropical Medicine (Guangzhou), V10, P982; Zhu HM, 2008, ECOHEALTH, V5, P137, DOI 10.1007/s10393-008-0168-y; Zhu HuiGuo, 2008, Chinese Journal of Schistosomiasis Control, V20, P251; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	53	30	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89779	10.1371/journal.pone.0089779	http://dx.doi.org/10.1371/journal.pone.0089779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	25025329	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200081
J	Zhang, QZ; Dijkstra, FA; Liu, XR; Wang, YD; Huang, J; Lu, N				Zhang, Qing-zhong; Dijkstra, Feike A.; Liu, Xing-ren; Wang, Yi-ding; Huang, Jian; Lu, Ning			Effects of Biochar on Soil Microbial Biomass after Four Years of Consecutive Application in the North China Plain	PLOS ONE			English	Article							FUMIGATION-EXTRACTION; MINERALIZATION; CARBON; DECOMPOSITION; CALIBRATION; COMMUNITY; NITROGEN; RELEASE; RESIDUE; IMPACT	The long term effect of biochar application on soil microbial biomass is not well understood. We measured soil microbial biomass carbon (MBC) and nitrogen (MBN) in a field experiment during a winter wheat growing season after four consecutive years of no (CK), 4.5 (B4.5) and 9.0 t biochar ha(-1) yr(-1) (B9.0) applied. For comparison, a treatment with wheat straw residue incorporation (SR) was also included. Results showed that biochar application increased soil MBC significantly compared to the CK treatment, and that the effect size increased with biochar application rate. The B9.0 treatment showed the same effect on MBC as the SR treatment. Treatments effects on soil MBN were less strong than for MBC. The microbial biomass C:N ratio was significantly increased by biochar. Biochar might decrease the fraction of biomass N mineralized (K-N), which would make the soil MBN for biochar treatments underestimated, and microbial biomass C: N ratios overestimated. Seasonal fluctuation in MBC was less for biochar amended soils than for CK and SR treatments, suggesting that biochar induced a less extreme environment for microorganisms throughout the season. There was a significant positive correlation between MBC and soil water content (SWC), but there was no significant correlation between MBC and soil temperature. Biochar amendments may therefore reduce temporal variability in environmental conditions for microbial growth in this system thereby reducing temporal fluctuations in C and N dynamics.	[Zhang, Qing-zhong; Liu, Xing-ren; Wang, Yi-ding; Huang, Jian; Lu, Ning] Chinese Acad Agr Sci, Key Lab Agr Environm, Sinoaustralian Joint Lab Sustainable Agroecosyst, Minist Agr,Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Dijkstra, Feike A.] Univ Sydney, Ctr Carbon Water & Food, Dept Environm Sci, Camden, NSW, Australia	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; University of Sydney	Zhang, QZ (corresponding author), Chinese Acad Agr Sci, Key Lab Agr Environm, Sinoaustralian Joint Lab Sustainable Agroecosyst, Minist Agr,Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	ecologyouth@126.com	Dijkstra, Feike A/H-2182-2012	Dijkstra, Feike A/0000-0002-6191-6018; Zhang, Yunchun/0000-0001-8259-5850	S & T Innovation Program of Chinese Academy of Agricultural Sciences	S & T Innovation Program of Chinese Academy of Agricultural Sciences	This work was supported by the S & T Innovation Program of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Castaldi S, 2011, CHEMOSPHERE, V85, P1464, DOI 10.1016/j.chemosphere.2011.08.031; Chen Y, 2010, AUST J SOIL RES, V48, P526, DOI 10.1071/SR10011; Contin M, 2000, SOIL BIOL BIOCHEM, V32, P1219, DOI 10.1016/S0038-0717(00)00038-9; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dempster DN, 2012, PLANT SOIL, V354, P311, DOI 10.1007/s11104-011-1067-5; GREENFIELD LG, 1995, SOIL BIOL BIOCHEM, V27, P1235, DOI 10.1016/0038-0717(95)00023-8; [郭伟 GUO Wei], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P425; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1129, DOI 10.1016/0038-0717(90)90039-3; Kallenbach C, 2011, AGR ECOSYST ENVIRON, V144, P241, DOI 10.1016/j.agee.2011.08.020; Keith A, 2011, ENVIRON SCI TECHNOL, V45, P9611, DOI 10.1021/es202186j; Kolb SE, 2009, SOIL SCI SOC AM J, V73, P1173, DOI 10.2136/sssaj2008.0232; Kumar K, 2000, ADV AGRON, V68, P197; Kushwaha CP, 2000, SOIL TILL RES, V56, P153, DOI 10.1016/S0167-1987(00)00135-5; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Liang BQ, 2010, ORG GEOCHEM, V41, P206, DOI 10.1016/j.orggeochem.2009.09.007; Lou YS, 2004, SOIL BIOL BIOCHEM, V36, P1835, DOI 10.1016/j.soilbio.2004.05.006; Luo Y, 2013, SOIL BIOL BIOCHEM, V57, P513, DOI 10.1016/j.soilbio.2012.10.033; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; O'Neill B, 2009, MICROB ECOL, V58, P23, DOI 10.1007/s00248-009-9515-y; Piccolo A, 1996, SOIL USE MANAGE, V12, P209, DOI 10.1111/j.1475-2743.1996.tb00545.x; SPARLING G, 1993, SOIL BIOL BIOCHEM, V25, P1793, DOI 10.1016/0038-0717(93)90185-E; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Steiner C, 2008, PEDOBIOLOGIA, V51, P359, DOI 10.1016/j.pedobi.2007.08.002; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Zavalloni C, 2011, APPL SOIL ECOL, V50, P45, DOI 10.1016/j.apsoil.2011.07.012; Zhang QZ, 2013, SOIL RES, V51, P521, DOI 10.1071/SR13153; Zhang QZ, 2013, SOIL SCI SOC AM J, V77, P1478, DOI 10.2136/sssaj2012.0180; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	35	79	90	12	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102062	10.1371/journal.pone.0102062	http://dx.doi.org/10.1371/journal.pone.0102062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25184224	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400041
J	Wu, CL; Qu, XH; Liu, FX; Li, HW; Mao, YQ; Zhu, ZN				Wu, Chuanlong; Qu, Xinhua; Liu, Fengxiang; Li, Huiwu; Mao, Yuanqing; Zhu, Zhenan			Risk Factors for Periprosthetic Joint Infection after Total Hip Arthroplasty and Total Knee Arthroplasty in Chinese Patients	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; DIABETES-MELLITUS; POSTOPERATIVE MORTALITY; BACTERIAL-INFECTION; MEDICARE PATIENTS; GLYCEMIC CONTROL; IMMUNE-RESPONSE; REPLACEMENT; VACCINATION; CIRRHOSIS	Purpose: The purpose of this hospital-based case-control study was to evaluate the risk factors for periprosthetic joint infection (PJI) of total hip arthroplasty (THA) and total knee arthroplasty (TKA) in Chinese patients. Method: From January 2000 to December 2012, 45 patients undergoing THA and TKA who developed PJI were recruited for case subjects; controls were 252 without PJI, matched by year of index for surgery and type of surgery. Conditional logistic regressions were run to compute odds ratios (ORs) and 95% confidence intervals (CIs). Results: Demographic factors and comorbid conditions associated with an increased adjusted risk of PJI (in decreasing order of significance) were diabetes (OR = 5.47, 95% CI: 1.77-16.97; p = 0.003), age (65-75 vs. 45-65 years) (OR = 3.36, 95% CI: 1.30-8.69; p = 0.013), BMI (>= 28 vs. 18.5-28 kg/m(2)) (OR = 2.77, 95% CI: 1.20-6.40; p = 0.017), place of residence (rural) (OR = 2.63, 95% CI: 1.13-6.10; p = 0.025) and alcohol abuse (OR = 2.95, 95% CI: 1.06-8.23; p = 0.039). Conclusion: Patients with diabetes, older age, BMI of >= 28 kg/m(2) and alcohol abuse or living in rural areas, had increased PJI risk. Additional systematic large-scale studies are needed to verify these results.	[Wu, Chuanlong; Qu, Xinhua; Liu, Fengxiang; Li, Huiwu; Mao, Yuanqing; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Mao, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	13761360486@163.com; zhenan_zhu@126.com	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890; Huang, Nicole/0000-0002-6629-1176	National Natural Science Foundation of China [81171729, 81301590]; Major Basic Research of Science and Technology Commission of Shanghai Municipality [11DJ1400303]; Fund for Key Disciplines of Shanghai Municipal Education Commission [J50206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Fund for Key Disciplines of Shanghai Municipal Education Commission	This work was supported by grants from the National Natural Science Foundation of China (No. 81171729 and No. 81301590), Major Basic Research of Science and Technology Commission of Shanghai Municipality (Grant No. 11DJ1400303), and Fund for Key Disciplines of Shanghai Municipal Education Commission (J50206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berbari EF, 2010, CLIN INFECT DIS, V50, P8, DOI 10.1086/648676; Bozic KJ, 2012, J BONE JOINT SURG AM, V94A, P794, DOI 10.2106/JBJS.K.00072; Bozic KJ, 2012, CLIN ORTHOP RELAT R, V470, P130, DOI 10.1007/s11999-011-2043-3; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Bozic KJ, 2013, J ARTHROPLASTY; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chesney D, 2008, J ARTHROPLASTY, V23, P355, DOI 10.1016/j.arth.2007.05.052; Dale H, 2012, ACTA ORTHOP, V83, P449, DOI 10.3109/17453674.2012.733918; Dowsey MM, 2008, CLIN ORTHOP RELAT R, V466, P153, DOI 10.1007/s11999-007-0016-3; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Everhart JS, 2013, CLIN ORTHOP RELAT RE; Gamble L, 2006, MED MALADIES INFECT, V36, P72, DOI 10.1016/j.medmal.2005.08.010; GOMEZ F, 1994, NEW ENGL J MED, V331, P1122, DOI 10.1056/NEJM199410273311704; Hegde V, 2013, CLIN MICROBIOL INFEC, V19, P314, DOI 10.1111/1469-0691.12157; Jamsen Esa, 2012, J Bone Joint Surg Am, V94, pe101, DOI 10.2106/JBJS.J.01935; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Lai K, 2007, J ARTHROPLASTY, V22, P651, DOI 10.1016/j.arth.2006.09.002; Malinzak RA, 2009, J ARTHROPLASTY, V24, P84, DOI 10.1016/j.arth.2009.05.016; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; Meding JB, 2003, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000093002.90435.56; MENDENHALL CL, 1991, HEPATOLOGY, V14, P581; Namba RS, 2012, J BONE JOINT SURG BR, V94B, P1330, DOI 10.1302/0301-620X.94B10.29184; Namba RS, 2013, J BONE JOINT SURG AM, V95A, P775, DOI 10.2106/JBJS.L.00211; Pedersen AB, 2010, J BONE JOINT SURG BR, V92B, P929, DOI 10.1302/0301-620X.92B7.24461; Poultsides LA, 2013, J ARTHROPLASTY, V28, P385, DOI 10.1016/j.arth.2012.06.027; POZZILLI P, 1986, DIABETOLOGIA, V29, P850, DOI 10.1007/BF00870139; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Ridgeway S, 2005, J BONE JOINT SURG BR, V87B, P844, DOI 10.1302/0301-620X.87B6.15121; Sculco T P, 1993, Instr Course Lect, V42, P349; van Kasteren MEE, 2007, CLIN INFECT DIS, V44, P921, DOI 10.1086/512192; Yurgin N, 2007, CLIN THER, V29, P316, DOI 10.1016/j.clinthera.2007.02.012; J AM ACAD ORTHOP SUR, V21, P195	33	113	124	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95300	10.1371/journal.pone.0095300	http://dx.doi.org/10.1371/journal.pone.0095300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	25014070	Green Published, gold, Green Submitted			2022-12-27	WOS:000335226500082
J	Wu, CY; Chou, YC; Huang, N; Chou, YJ; Hu, HY; Li, CP				Wu, Chen-Yi; Chou, Yi-Chang; Huang, Nicole; Chou, Yiing-Jenq; Hu, Hsiao-Yun; Li, Chung-Pin			Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly	PLOS ONE			English	Article							OBESITY PARADOX; METABOLIC SYNDROME; PLASMA-LIPIDS; OVERWEIGHT; RISK; DEATHS; ADULTS; UNDERWEIGHT; PREVALENCE; AMERICAN	Objectives: To evaluate the associations of body mass index (BMI) with all-cause, cardiovascular disease (CVD), and expanded CVD mortality in the elderly. Design: Observational cohort study. Setting: Annual physical examination program for the elderly from 2006 to 2010. Participants: We included 77,541 Taipei residents aged >= 65 years (39,365 men and 38,176 women). Measurements: BMI was categorized as underweight (BMI<18.5), normal weight (18.5 <= BMI<25), overweight (25 <= BMI<30), grade 1 obesity (30 <= BMI<35), or grade 2-3 obesity (BMI >= 35). Mortality was ascertained by national death files. Results: Underweight (hazard ratios [HRs] of all-cause, CVD, and expanded CVD mortality: 1.92, 1.74, and 1.77, respectively), grade 2-3 obesity (HRs: 1.59, 2.36, and 2.22, respectively), older age, male sex, smoking, and high fasting blood sugar were significant predictors of mortality. Meanwhile, being married/cohabitating, higher education, alcohol consumption, more regular exercise, and high total cholesterol were inversely associated with mortality. Multivariate stratified subgroup analyses verified smokers (HRs of all-cause, CVD, and expanded CVD mortality: 3.25, 10.71, and 7.86, respectively, for grade 2-3 obesity), the high triglyceride group (HRs: 5.82, 10.99, and 14.22, respectively for underweight), and patients with 3-4 factors related to metabolic syndrome (HRs: 4.86, 12.72, and 11.42, respectively, for underweight) were associated with mortality. Conclusion: The associations of BMI with all-cause, CVD, expanded CVD mortality in the elderly are represented by U-shaped curves, suggesting unilateral promotions or interventions in weight reduction in the elderly may be inappropriate. Heterogeneous effects of grades 1 and 2-3 obesity on mortality were observed and should be treated as different levels of obesity.	[Wu, Chen-Yi; Chou, Yi-Chang; Chou, Yiing-Jenq; Hu, Hsiao-Yun] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wu, Chen-Yi] Taipei City Hosp, Heping Fuyou Branch, Dept Dermatol, Taipei, Taiwan; [Chou, Yi-Chang; Huang, Nicole; Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Li, Chung-Pin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Hu, HY (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	hyhu@ym.edu.tw; cpli@vghtpe.gov.tw	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890; Huang, Nicole/0000-0002-6629-1176	Taiwan Ministry of Education; Department of Health of the Taipei City Government [10301-62-001]; Taiwan's National Science Council [98-2314-B-010-015-MY2]	Taiwan Ministry of Education(Ministry of Education, Taiwan); Department of Health of the Taipei City Government; Taiwan's National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the Taiwan Ministry of Education through its "Aim for the Top University Plan,'' by the Department of Health of the Taipei City Government (Grant 10301-62-001), and by Taiwan's National Science Council (Grant 98-2314-B-010-015-MY2). This study is based on data from the Taipei City Public Health Database provided by the Department of Health of the Taipei City Government and managed by the Databank for Public Health Analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom JL, 2008, AGE AGEING, V37, P207, DOI 10.1093/ageing/afn017; Artham SM, 2008, POSTGRAD MED, V120, P34, DOI 10.3810/pgm.2008.07.1788; Auyeung TW, 2010, J GERONTOL A-BIOL, V65, P99, DOI 10.1093/gerona/glp099; Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Flegal KM, 2010, AM J CLIN NUTR, V91, P519, DOI 10.3945/ajcn.2009.28222; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Greenberg JA, 2013, AM J CLIN NUTR, V97, P1195, DOI 10.3945/ajcn.112.045815; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; He Y, 2007, DIABETES CARE, V30, P2128, DOI 10.2337/dc06-2402; Heymsfield SB, 2013, JAMA-J AM MED ASSOC, V309, P87, DOI 10.1001/jama.2012.185445; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lavie CJ, 2008, NAT CLIN PRACT CARD, V5, P428, DOI 10.1038/ncpcardio1257; Lin WY, 2010, J AM GERIATR SOC, V58, P2092, DOI 10.1111/j.1532-5415.2010.03148.x; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Nagai M, 2010, J EPIDEMIOL, V20, P398, DOI 10.2188/jea.JE20090204; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Schenkeveld L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000535; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Tsai SP, 2008, DIABETES RES CLIN PR, V82, P148, DOI 10.1016/j.diabres.2008.07.016; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071223; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007	32	113	124	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102589	10.1371/journal.pone.0102589	http://dx.doi.org/10.1371/journal.pone.0102589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014070	Green Submitted, Green Published, gold			2022-12-27	WOS:000339378400104
J	Ritze, Y; Bardos, G; Claus, A; Ehrmann, V; Bergheim, I; Schwiertz, A; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Schwiertz, Andreas; Bischoff, Stephan C.			Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CACO-2 CELL MONOLAYERS; GUT MICROBIOTA; INTESTINAL PERMEABILITY; HEPATIC STEATOSIS; PROBIOTICS; OBESITY; FRUCTOSE; BARRIER; FLORA	Objective: Experimental evidence revealed that obesity-associated non-alcoholic fatty liver disease (NAFLD) is linked to changes in intestinal permeability and translocation of bacterial products to the liver. Hitherto, no reliable therapy is available except for weight reduction. Within this study, we examined the possible effect of the probiotic bacterial strain Lactobacillus rhamnosus GG (LGG) as protective agent against experimental NAFLD in a mouse model. Methods: Experimental NAFLD was induced by a high-fructose diet over eight weeks in C57BL/J6 mice. Fructose was administered via the drinking water containing 30% fructose with or without LGG at a concentration resulting in approximately 5x10(7) colony forming units/g body weight. Mice were examined for changes in small intestinal microbiota, gut barrier function, lipopolysaccharide (LPS) concentrations in the portal vein, liver inflammation and fat accumulation in the liver. Results: LGG increased beneficial bacteria in the distal small intestine. Moreover, LGG reduced duodenal I kappa B protein levels and restored the duodenal tight junction protein concentration. Portal LPS (P <= 0.05) was reduced and tended to attenuate TNF-alpha, IL-8R and IL-1 beta mRNA expression in the liver feeding a high-fructose diet supplemented with LGG. Furthermore liver fat accumulation and portal alanine-aminotransferase concentrations (P <= 0.05) were attenuated in mice fed the high-fructose diet and LGG. Conclusions: We show for the first time that LGG protects mice from NAFLD induced by a high-fructose diet. The underlying mechanisms of protection likely involve an increase of beneficial bacteria, restoration of gut barrier function and subsequent attenuation of liver inflammation and steatosis.	[Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Bischoff, Stephan C.] Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany; [Bergheim, Ina] Univ Jena, Dept Nutr Sci, Jena, Germany; [Schwiertz, Andreas] MVZ Inst Microecol, Herborn, Germany	University Hohenheim; Friedrich Schiller University of Jena	Bischoff, SC (corresponding author), Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany.	bischoff.stephan@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research [FKZ: 01GI0843]; Institute Danone	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute Danone(Danone Nutricia)	This work was supported by grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843) to S. C. Bischoff and the Institute Danone research grant 2010 to Y. Ritze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Donato KA, 2010, MICROBIOL-SGM, V156, P3288, DOI 10.1099/mic.0.040139-0; Dukowicz Andrew C, 2007, Gastroenterol Hepatol (N Y), V3, P112; ELLWOOD KC, 1993, P SOC EXP BIOL MED, V202, P440, DOI 10.3181/00379727-202-43556; Gratz SW, 2010, WORLD J GASTROENTERO, V16, P403, DOI 10.3748/wjg.v16.i4.403; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Haub S, 2011, J PHARMACOL EXP THER, V339, P790, DOI 10.1124/jpet.111.181834; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Ji YS, 2012, BENEF MICROBES, V3, P13, DOI 10.3920/BM2011.0046; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Le Roy T, 2012, GUT; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee Sang Kil, 2012, Korean J Gastroenterol, V60, P86; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Park SK, 2012, HEPATOLOGY; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Solga SF, 2004, HEPATOLOGY, V39, P1197, DOI 10.1002/hep.20220; Spiller R, 2008, ALIMENT PHARM THER, V28, P385, DOI 10.1111/j.1365-2036.2008.03750.x; Spruss A, 2009, J NUTR BIOCHEM, V20, P657, DOI 10.1016/j.jnutbio.2009.05.006; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vieira LQ, 2008, J CLIN GASTROENTEROL, V42, pS168, DOI 10.1097/MCG.0b013e31818063d4; Wagnerberger S, 2012, J NUTR BIOCH; Wang YH, 2012, AM J PHYSIOL-GASTR L, V303, pG32, DOI 10.1152/ajpgi.00024.2012; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Wood Natalie J, 2012, Nat Rev Gastroenterol Hepatol, V9, P123, DOI 10.1038/nrgastro.2012.21; Xu RY, 2012, J CLIN BIOCHEM NUTR, V50, P72, DOI 10.3164/jcbn.11-38; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zhang LY, 2006, J PEDIATR GASTR NUTR, V42, P545, DOI 10.1097/01.mpg.0000221905.68781.4a	50	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e80169	10.1371/journal.pone.0080169	http://dx.doi.org/10.1371/journal.pone.0080169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475018	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300004
J	Chen, YW; Fiscella, KA; Bacharach, SZ; Calu, DJ				Chen, Yu-Wei; Fiscella, Kimberly A.; Bacharach, Samuel Z.; Calu, Donna J.			Effect of Cafeteria Diet History on Cue-, Pellet-Priming-, and Stress-Induced Reinstatement of Food Seeking in Female Rats	PLOS ONE			English	Article							SUCCESSIVE NEGATIVE CONTRAST; DOPAMINE D2 RECEPTORS; COCAINE-SEEKING; DRUG-SEEKING; HEROIN-SEEKING; WEIGHT-LOSS; DARK SIDE; RELAPSE; BEHAVIOR; REWARD	Background: Relapse to unhealthy eating habits is a major problem in human dietary treatment. The individuals most commonly seeking dietary treatment are overweight or obese women, yet the commonly used rat reinstatement model to study relapse to palatable food seeking during dieting primarily uses normal-weight male rats. To increase the clinical relevance of the relapse to palatable food seeking model, here we pre-expose female rats to a calorically-dense cafeteria diet in the home-cage to make them overweight prior to examining the effect of this diet history on cue-, pellet-priming-and footshock-induced reinstatement of food seeking. Methods: Post-natal day 32 female Long-Evans rats had seven weeks of home-cage access to either chow only or daily or intermittent cafeteria diet alongside chow. Next, they were trained to self-administer normally preferred 45 mg food pellets accompanied by a tone-light cue. After extinction, all rats were tested for reinstatement induced by discrete cue, pellet-priming, and intermittent footshock under extinction conditions. Results: Access to daily cafeteria diet and to a lesser degree access to intermittent cafeteria diet decreased food pellet self-administration compared to chow-only. Prior history of these cafeteria diets also reduced extinction responding, cue-and pellet-priming-induced reinstatement. In contrast, modest stress-induced reinstatement was only observed in rats with a history of daily cafeteria diet. Conclusion: A history of cafeteria diet does not increase the propensity for cue-and pellet-priming-induced relapse in the rat reinstatement model but does appear to make rats more susceptible to footshock stress-induced reinstatement.	[Chen, Yu-Wei; Fiscella, Kimberly A.; Bacharach, Samuel Z.; Calu, Donna J.] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Calu, DJ (corresponding author), NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	donna.calu@nih.gov	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Calu, Donna/0000-0003-2377-9494	Intramural Research Program of the National Institute on Drug Abuse	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The work was supported by the Intramural Research Program of the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Anker JJ, 2011, CURR TOP BEHAV NEURO, V8, P73, DOI 10.1007/7854_2010_93; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Buczek Y, 1999, PSYCHOPHARMACOLOGY, V144, P183, DOI 10.1007/s002130050992; Calu DJ, 2014, NEUROPHARMACOLOGY, V76, P395, DOI 10.1016/j.neuropharm.2013.04.030; Cifani C, 2012, J NEUROSCI, V32, P8480, DOI 10.1523/JNEUROSCI.5895-11.2012; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Davy SR, 2006, J AM DIET ASSOC, V106, P1673, DOI 10.1016/j.jada.2006.07.017; De Vries TJ, 2002, NEUROPSYCHOPHARMACOL, V26, P18, DOI 10.1016/S0893-133X(01)00293-7; Deroche V, 1999, EUR J NEUROSCI, V11, P2731, DOI 10.1046/j.1460-9568.1999.00696.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Donahue RJ, 2014, BIOL PSYCHIAT, V76, P550, DOI 10.1016/j.biopsych.2013.12.014; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Feltenstein MW, 2011, PSYCHOPHARMACOLOGY, V216, P53, DOI 10.1007/s00213-011-2187-6; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Fuchs RA, 2005, PSYCHOPHARMACOLOGY, V179, P662, DOI 10.1007/s00213-004-2080-7; Funk D, 2005, PSYCHOPHARMACOLOGY, V183, P341, DOI 10.1007/s00213-005-0194-1; Ghitza UE, 2007, J NEUROSCI, V27, P11522, DOI 10.1523/JNEUROSCI.5405-06.2007; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; GRILO CM, 1989, J CONSULT CLIN PSYCH, V57, P488, DOI 10.1037/0022-006X.57.4.488; Grimm JW, 2000, NEUROPSYCHOPHARMACOL, V22, P473, DOI 10.1016/S0893-133X(99)00157-8; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P138, DOI 10.1037/0022-3514.60.1.138; Iemolo A, 2012, BEHAV PHARMACOL, V23, P593, DOI 10.1097/FBP.0b013e328357697f; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KAYMAN S, 1990, AM J CLIN NUTR, V52, P800, DOI 10.1093/ajcn/52.5.800; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; KRAMER FM, 1989, INT J OBESITY, V13, P123; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Martire SI, 2014, BEHAV BRAIN RES, V265, P132, DOI 10.1016/j.bbr.2014.02.027; McGuire MT, 1999, J CONSULT CLIN PSYCH, V67, P177, DOI 10.1037/0022-006X.67.2.177; Mitchell EN, 2012, BEHAV BRAIN RES, V234, P155, DOI 10.1016/j.bbr.2012.06.016; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Nair SG, 2009, PSYCHOPHARMACOLOGY, V205, P129, DOI 10.1007/s00213-009-1523-6; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; Parylak SL, 2011, PHYSIOL BEHAV, V104, P149, DOI 10.1016/j.physbeh.2011.04.063; Peterson CB, 1999, J CLIN PSYCHOL, V55, P685, DOI 10.1002/(SICI)1097-4679(199906)55:6<685::AID-JCLP3>3.0.CO;2-Y; Pickens CL, 2012, PSYCHOPHARMACOLOGY, V221, P341, DOI 10.1007/s00213-011-2585-9; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136; Polivy J, 1999, INT J EAT DISORDER, V26, P153, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;153::AID-EAT4&gt;3.0.CO;2-R; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sastre A, 2006, BEHAV BRAIN RES, V170, P34, DOI 10.1016/j.bbr.2006.01.026; See RE, 1999, DRUG ALCOHOL DEPEN, V57, P41, DOI 10.1016/S0376-8716(99)00043-5; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Self DW, 1998, DRUG ALCOHOL DEPEN, V51, P49, DOI 10.1016/S0376-8716(98)00065-9; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shaham Y, 1996, J NEUROSCI, V16, P1957; SHAHAM Y, 1995, PSYCHOPHARMACOLOGY, V119, P334, DOI 10.1007/BF02246300; Shalev U, 2001, PSYCHOPHARMACOLOGY, V156, P98, DOI 10.1007/s002130100748; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Skender ML, 1996, J AM DIET ASSOC, V96, P342, DOI 10.1016/S0002-8223(96)00096-X; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Spealman RD, 1999, PHARMACOL BIOCHEM BE, V64, P327, DOI 10.1016/S0091-3057(99)00049-0; STEWART J, 1992, PSYCHOPHARMACOLOGY, V108, P79, DOI 10.1007/BF02245289; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Vendruscolo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009296; Weiss F, 2001, NEUROPSYCHOPHARMACOL, V25, P361, DOI 10.1016/S0893-133X(01)00238-X; WEST TEG, 1988, BRAIN RES, V462, P126, DOI 10.1016/0006-8993(88)90594-X; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004	73	30	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102213	10.1371/journal.pone.0102213	http://dx.doi.org/10.1371/journal.pone.0102213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025329	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400051
J	Ritze, Y; Bardos, G; D'Haese, JG; Ernst, B; Thurnheer, M; Schultes, B; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; D'Haese, Jan G.; Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd; Bischoff, Stephan C.			Effect of High Sugar Intake on Glucose Transporter and Weight Regulating Hormones in Mice and Humans	PLOS ONE			English	Article							FOOD-INTAKE; SWEETENED BEVERAGES; ENERGY-EXPENDITURE; FRUCTOSE; APPETITE; HEALTH; GLUT2; CHOLECYSTOKININ; ABSORPTION; SATIETY	Objective: Sugar consumption has increased dramatically over the last decades in Western societies. Especially the intake of sugar-sweetened beverages seems to be a major risk for the development of obesity. Thus, we compared liquid versus solid high-sugar diets with regard to dietary intake, intestinal uptake and metabolic parameters in mice and partly in humans. Methods: Five iso-caloric diets, enriched with liquid (in water 30% vol/vol) or solid (in diet 65% g/g) fructose or sucrose or a control diet were fed for eight weeks to C57bl/6 mice. Sugar, liquid and caloric intake, small intestinal sugar transporters (GLUT2/5) and weight regulating hormone mRNA expression, as well as hepatic fat accumulation were measured. In obese versus lean humans that underwent either bariatric surgery or small bowel resection, we analyzed small intestinal GLUT2, GLUT5, and cholecystokinin expression. Results: In mice, the liquid high-sucrose diet caused an enhancement of total caloric intake compared to the solid high-sucrose diet and the control diet. In addition, the liquid high-sucrose diet increased expression of GLUT2, GLUT5, and cholecystokinin expression in the ileum (P<0.001). Enhanced liver triglyceride accumulation was observed in mice being fed the liquid high-sucrose or -fructose, and the solid high-sucrose diet compared to controls. In obese, GLUT2 and GLUT5 mRNA expression was enhanced in comparison to lean individuals. Conclusions: We show that the form of sugar intake (liquid versus solid) is presumably more important than the type of sugar, with regard to feeding behavior, intestinal sugar uptake and liver fat accumulation in mice. Interestingly, in obese individuals, an intestinal sugar transporter modulation also occurred when compared to lean individuals.	[Ritze, Yvonne; Bardos, Gyoengyi; Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany; [D'Haese, Jan G.] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany; [Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd] Interdisciplinary Obes Ctr, Rorschach, Switzerland	University Hohenheim; Technical University of Munich	Ritze, Y (corresponding author), Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany.	yvonne.ritze@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research [FKZ: 01GI0843]	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research	This work was supported with grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Atwater WO, 1900, STATE CONNECTICUT 12, V1899, P73; Atwater WO, 1903, CONN STORRS AGR EXPT, P123; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Bellissimo N, 2003, J NUTR, V133, P2319, DOI 10.1093/jn/133.7.2319; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Bielohuby M, 2010, BRIT J NUTR, V103, P1525, DOI 10.1017/S000711450999345X; Bray GA, 2000, P NUTR SOC, V59, P373, DOI 10.1017/S0029665100000422; Chaput JP, 2014, CURR OBES REP, V3, P54, DOI 10.1007/s13679-013-0086-3; Coelho SB, 2006, NUTRITION, V22, P585, DOI 10.1016/j.nut.2006.03.012; CRAWLEY JN, 1983, NATURE, V302, P703, DOI 10.1038/302703a0; Daousi C, 2009, CLIN ENDOCRINOL, V71, P195, DOI 10.1111/j.1365-2265.2008.03451.x; Date Y, 2012, METHOD ENZYMOL, V514, P261, DOI 10.1016/B978-0-12-381272-8.00016-7; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Dumoulin V, 1998, ENDOCRINOLOGY, V139, P3780, DOI 10.1210/en.139.9.3780; Dyer J, 2007, BIOCHEM SOC T, V35, P1191, DOI 10.1042/BST0351191; Eny KM, 2008, PHYSIOL GENOMICS, V33, P355, DOI 10.1152/physiolgenomics.00148.2007; FLIPOT P, 1971, CAN J ANIM SCI, V51, P801, DOI 10.4141/cjas71-108; Ford CN, 2013, J ACAD NUTR DIET, V113, P35, DOI 10.1016/j.jand.2012.08.022; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Holmes AD, 1918, US DEP AGR B, V687, P1; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Melanson KJ, 2008, AM J CLIN NUTR, V88, p1738S, DOI 10.3945/ajcn.2008.25825E; Must A, 2009, INT J OBESITY, V33, P705, DOI 10.1038/ijo.2009.60; Pereira MA, 2006, INT J OBESITY, V30, pS28, DOI 10.1038/sj.ijo.0803489; Rizkalla SW, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-82; Rubner M, 1885, I Z BIOL, V21, P250; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Siervo M, 2013, PUBLIC HEALTH NUTR, P1; SOUTHGATE DA, 1970, BRIT J NUTR, V24, P517, DOI 10.1079/BJN19700050; Stolarczyk E, 2010, AM J PHYSIOL-ENDOC M, V298, pE1078, DOI 10.1152/ajpendo.00737.2009; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tobin V, 2008, DIABETES, V57, P555, DOI 10.2337/db07-0928; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weed DL, 2011, AM J CLIN NUTR, V94, P1340, DOI 10.3945/ajcn.111.015875; WEST DB, 1984, AM J PHYSIOL, V246, pR776, DOI 10.1152/ajpregu.1984.246.5.R776; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003	51	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101702	10.1371/journal.pone.0101702	http://dx.doi.org/10.1371/journal.pone.0101702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	24475018	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800034
J	Chen, LH; Li, CX; Sargolzaei, M; Schenkel, F				Chen, Liuhong; Li, Changxi; Sargolzaei, Mehdi; Schenkel, Flavio			Impact of Genotype Imputation on the Performance of GBLUP and Bayesian Methods for Genomic Prediction	PLOS ONE			English	Article							RELATIONSHIP MATRIX; ACCURACY; SELECTION; VALUES; RELIABILITY; NUCLEOTIDE; STRATEGIES; CATTLE; CHIPS	The aim of this study was to evaluate the impact of genotype imputation on the performance of the GBLUP and Bayesian methods for genomic prediction. A total of 10,309 Holstein bulls were genotyped on the BovineSNP50 BeadChip (50 k). Five low density single nucleotide polymorphism (SNP) panels, containing 6,177, 2,480, 1,536, 768 and 384 SNPs, were simulated from the 50 k panel. A fraction of 0%, 33% and 66% of the animals were randomly selected from the training sets to have low density genotypes which were then imputed into 50 k genotypes. A GBLUP and a Bayesian method were used to predict direct genomic values (DGV) for validation animals using imputed or their actual 50 k genotypes. Traits studied included milk yield, fat percentage, protein percentage and somatic cell score (SCS). Results showed that performance of both GBLUP and Bayesian methods was influenced by imputation errors. For traits affected by a few large QTL, the Bayesian method resulted in greater reductions of accuracy due to imputation errors than GBLUP. Including SNPs with largest effects in the low density panel substantially improved the accuracy of genomic prediction for the Bayesian method. Including genotypes imputed from the 6 k panel achieved almost the same accuracy of genomic prediction as that of using the 50 k panel even when 66% of the training population was genotyped on the 6 k panel. These results justified the application of the 6 k panel for genomic prediction. Imputations from lower density panels were more prone to errors and resulted in lower accuracy of genomic prediction. But for animals that have close relationship to the reference set, genotype imputation may still achieve a relatively high accuracy.	[Chen, Liuhong; Li, Changxi] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Li, Changxi] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB, Canada; [Sargolzaei, Mehdi] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Schenkel, Flavio] LAlliance Boviteq Inc, Quebec City, PQ, Canada	University of Alberta; Agriculture & Agri Food Canada; University of Guelph	Chen, LH (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	liuhong@ualberta.ca; schenkel@uoguelph.ca	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Natural Sciences and Engineering Research Council of Canada; L'Alliance Boviteq Inc., Quebec, Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); L'Alliance Boviteq Inc., Quebec, Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada, and L'Alliance Boviteq Inc., Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cleveland MA, 2013, J ANIM SCI, V91, P3583, DOI 10.2527/jas.2013-6270; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Dassonneville R, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-40; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Huang YJ, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-25; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Mulder HA, 2012, J DAIRY SCI, V95, P876, DOI 10.3168/jds.2011-4490; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Sargolzaei M, 2011, GEBV SOFTWARE; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Van Doormaal B, 2012, GENOTYPING LOW DENSI; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; Weigel KA, 2010, J DAIRY SCI, V93, P5423, DOI 10.3168/jds.2010-3149; Wiggans GR, 2013, J DAIRY SCI, V96, P1258, DOI 10.3168/jds.2012-6192; Wiggans GR, 2011, J DAIRY SCI, V94, P6188, DOI 10.3168/jds.2011-4481; Zhang Z, 2011, J DAIRY SCI, V94, P3642, DOI 10.3168/jds.2010-3917; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	34	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101544	10.1371/journal.pone.0101544	http://dx.doi.org/10.1371/journal.pone.0101544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	24551186	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400017
J	Chen, LX; Cai, Y; Zhou, GB; Shi, XJ; Su, JH; Chen, GW; Lin, K				Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Shi, Xiaojun; Su, Jianhui; Chen, Guanwu; Lin, Kun			Rapid Sanger Sequencing of the 16S rRNA Gene for Identification of Some Common Pathogens	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; BACTERIAL IDENTIFICATION; DNA; PCR; AMPLIFICATION; SHIGELLA; SYSTEM; MYCOBACTERIA; DATABASE; SAMPLES	Conventional Sanger sequencing remains time-consuming and laborious. In this study, we developed a rapid improved sequencing protocol of 16S rRNA for pathogens identification by using a new combination of SYBR Green I real-time PCR and Sanger sequencing with FTA (R) cards. To compare the sequencing quality of this method with conventional Sanger sequencing, 12 strains, including three kinds of strains (1 reference strain and 3 clinical strains, which were previously identified by biochemical tests), which have 4 Pseudomonas aeruginosa, 4 Staphyloccocus aureus and 4 Escherichia coli, were targeted. Additionally, to validate the sequencing results and bacteria identification, expanded specimens with 90 clinical strains, also comprised of the three kinds of strains which included 30 samples respectively, were performed as just described. The results showed that although statistical differences (P<0.05) were found in sequencing quality between the two methods, their identification results were all correct and consistent. The workload, the time consumption and the cost per batch were respectively light versus heavy, 8 h versus 11 h and $420 versus $400. In the 90 clinical strains, all of the Pseudomonas aeruginosa and Staphyloccocus aureus strains were correctly identified, but only 26.7% of the Escherichia coli strains were recognized as Escherichia coli, while 33.3% as Shigella sonnei and 40% as Shigella dysenteriae. The protocol described here is a rapid, reliable, stable and convenient method for 16S rRNA sequencing, and can be used for Pseudomonas aeruginosa and Staphyloccocus aureus identification, yet it is not completely suitable for discriminating Escherichia coli and Shigella strains.	[Chen, Linxiang; Shi, Xiaojun; Lin, Kun] Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Su, Jianhui; Chen, Guanwu] Shantou Entry Exit Inspect & Quarantine Bur, Mol Biol Lab, Shantou, Guangdong, Peoples R China		Lin, K (corresponding author), Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China.	klin@stu.edu.cn	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Shantou Bureau of Science and Technology [[2009]387-126]; Guangdong Entry-Exit Inspection and Quarantine Bureau [2012 GDK45]; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology; Guangdong Entry-Exit Inspection and Quarantine Bureau; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology (grant No. [2009]387-126), Guangdong Entry-Exit Inspection and Quarantine Bureau (grant No. 2012 GDK45) Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye KS, 2011, JPN J INFECT DIS, V64, P246; Becker K, 2004, J CLIN MICROBIOL, V42, P4988, DOI 10.1128/JCM.42.11.4988-4995.2004; Bhattacharya D, 2003, APPL ENVIRON MICROB, V69, P1435, DOI 10.1128/AEM.69.3.1435-1441.2003; Cloud JL, 2004, J CLIN MICROBIOL, V42, P578, DOI 10.1128/JCM.42.2.578-584.2004; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Fukushima H, 2003, J CLIN MICROBIOL, V41, P5134, DOI 10.1128/JCM.41.11.5134-5146.2003; Fukushima M, 2002, J CLIN MICROBIOL, V40, P2779, DOI 10.1128/JCM.40.8.2779-2785.2002; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Li YY, 2006, J CLIN MICROBIOL, V44, P4376, DOI 10.1128/JCM.01389-06; Menassa N, 2010, INVEST OPHTH VIS SCI, V51, P1905, DOI 10.1167/iovs.09-3737; Monnet C, 2006, APPL ENVIRON MICROB, V72, P6972, DOI 10.1128/AEM.01303-06; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Tewari D, 2011, J VET DIAGN INVEST, V23, P1104, DOI 10.1177/1040638711425583; Vliegen I, 2006, J MICROBIOL METH, V66, P156, DOI 10.1016/j.mimet.2005.11.005; Willi B, 2009, J CLIN MICROBIOL, V47, P4049, DOI 10.1128/JCM.01478-09; Woo PCY, 2001, DIAGN MICR INFEC DIS, V39, P85, DOI 10.1016/S0732-8893(01)00206-1; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003	27	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88886	10.1371/journal.pone.0088886	http://dx.doi.org/10.1371/journal.pone.0088886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551186	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500079
